PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Meinema, AC; Laba, JK; Hapsari, RA; Otten, R; Mulder, FAA; Kralt, A; van den Bogaart, G; Lusk, CP; Poolman, B; Veenhoff, LM				Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; Kralt, Annemarie; van den Bogaart, Geert; Lusk, C. Patrick; Poolman, Bert; Veenhoff, Liesbeth M.			Long Unfolded Linkers Facilitate Membrane Protein Import Through the Nuclear Pore Complex	SCIENCE			English	Article							INTRACELLULAR TRAFFICKING; ARCHITECTURE; TRANSPORT; DOMAIN	Active nuclear import of soluble cargo involves transport factors that shuttle cargo through the nuclear pore complex (NPC) by binding to phenylalanine-glycine (FG) domains. How nuclear membrane proteins cross through the NPC to reach the inner membrane is presently unclear. We found that at least a 120-residue-long intrinsically disordered linker was required for the import of membrane proteins carrying a nuclear localization signal for the transport factor karyopherin-a. We propose an import mechanism for membrane proteins in which an unfolded linker slices through the NPC scaffold to enable binding between the transport factor and the FG domains in the center of the NPC.	[Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; van den Bogaart, Geert; Poolman, Bert; Veenhoff, Liesbeth M.] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; van den Bogaart, Geert; Poolman, Bert; Veenhoff, Liesbeth M.] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Kralt, Annemarie; Veenhoff, Liesbeth M.] Univ Med Ctr Groningen, European Res Inst Biol Ageing, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Lusk, C. Patrick] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA	University of Groningen; University of Groningen; University of Groningen; Yale University	Veenhoff, LM (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	l.m.veenhoff@rug.nl	van den Bogaart, Geert/A-1089-2014; Poolman, Bert/D-1882-2012; Mulder, Frans AA/C-7158-2017; Institute, Zernike/W-7033-2019; van den Bogaart, Geert/GLV-3283-2022	van den Bogaart, Geert/0000-0003-2180-6735; Mulder, Frans AA/0000-0001-9427-8406; van den Bogaart, Geert/0000-0003-2180-6735; Lusk, C. Patrick/0000-0003-4703-0533; Veenhoff, Liesbeth/0000-0002-0158-4728; Otten, Renee/0000-0001-7342-6131	Netherlands Organization for Scientific Research [700.56.302]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank M. C. King, M. P. Rout, and D. J. Slotboom for discussion; V. Krasnikov for help with confocal microscopy; and M. Graham for assistance with immunoelectron microscopy. We thank S. R. Wente, U. K. Laemmli, and M. P. Rout for reagents and strains. This work was supported by funding from the Netherlands Organization for Scientific Research (VIDI fellowship to L.M.V. and F.A.A.M.; Top-subsidy grant 700.56.302 to B.P.). L.M.V. conceived the project. Experiments were performed and analyzed by A.C.M., J.K.L., R.A.H., C.P.L., and A. K. NMR was performed by R.O. and F.A.A.M. G.v.d.B. helped with image analysis. Experiments were designed and the manuscript was written by A.C.M., C.P.L., B.P., and L.M.V.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Ostlund C, 1999, J CELL SCI, V112, P1709; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Wu W, 2002, J CELL SCI, V115, P1361; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zuleger N, 2008, BIOCHEM SOC T, V36, P1373, DOI 10.1042/BST0361373	22	94	95	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					90	93		10.1126/science.1205741	http://dx.doi.org/10.1126/science.1205741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21659568	Bronze			2022-12-01	WOS:000292255400056
J	Howard, DH				Howard, David H.			Realigning Incentives for Developing and Pricing New Anticancer Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Emory University	Howard, DH (corresponding author), Emory Univ, Dept Hlth Policy & Management, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	david.howard@emory.edu						Centers for Medicare and Medicaid Services, PROP DEC MEM AUT CEL; CMS HHS, 2011, FED REGISTER, V76, P19528; Congressional Budget Office, LONG TERM AN BUDG PR; Elkin EB, 2010, JAMA-J AM MED ASSOC, V303, P1086, DOI 10.1001/jama.2010.283; House Committee of the Budget, PATH PROSP REST AM C; Howard DH, 2010, ARCH INTERN MED, V170, P537, DOI 10.1001/archinternmed.2010.36; Stein R., 2010, WASH POST, pA01; Zajac A, 2001, LOS ANGELES TIM 0326, pA14	8	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2347	2348		10.1001/jama.2011.793	http://dx.doi.org/10.1001/jama.2011.793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642689				2022-12-01	WOS:000291349100030
J	Kesselheim, AS; Myers, JA; Avorn, J				Kesselheim, Aaron S.; Myers, Jessica A.; Avorn, Jerry			Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACCELERATED APPROVAL; ONCOLOGY PRODUCTS; END-POINTS; EXPERIENCE; DISEASES	Context The Orphan Drug Act incentivizes medication development for rare diseases, offering substantial financial benefits to the manufacturer. Orphan products constitute most new drug approvals in oncology, but safety and efficacy questions have emerged about some of these agents. Objectives To define characteristics of orphan cancer drugs and their pivotal clinical trials and to compare these with nonorphan drugs. Design and Setting We identified all new orphan and nonorphan drugs approved between 2004 and 2010 to treat cancer. We then collected data on key development variables from publicly available information on the US Food and Drug Administration's Web site and in the Code of Federal Regulations. Main Outcome Measures We assessed clinical testing dates, approved indications, and regulatory characteristics (regular vs accelerated review, advisory committee review, postmarketing commitments). We then compared design features (randomization, blinding, primary end point) of pivotal trials supporting approval of orphan and nonorphan drugs and rates of adverse safety outcomes (deaths not attributed to disease progression, serious adverse events, dropouts) in pivotal trials. Results Fifteen orphan and 12 nonorphan drugs were approved between January 1, 2004, and December 31, 2010. Pivotal trials of orphan drugs had smaller participant numbers (median, 96 [interquartile range {IQR}, 66-152] vs 290 [IQR, 185-394] patients exposed to the drug; P<.001) and were less likely to be randomized (30% vs 80%; P=.007). Orphan and nonorphan pivotal trials varied in their blinding (P=.04), with orphan trials less likely to be double-blind (4% vs 33%). Primary study outcomes also varied (P=.04), with orphan trials more likely to assess disease response (68% vs 27%) rather than overall survival (8% vs 27%). More treated patients had serious adverse events in trials of orphan drugs vs trials of nonorphan drugs (48% vs 36%; odds ratio, 1.72; 95% confidence interval, 1.02-2.92; P=.04). Conclusion Compared with pivotal trials used to approve nonorphan cancer drugs, pivotal trials for recently approved orphan drugs for cancer were more likely to be smaller and to use nonrandomized, unblinded trial designs and surrogate end points to assess efficacy. JAMA. 2011;305(22):2320-2326 www.jama.com	[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Agency for Healthcare Research and Quality [K08HS18465-01]; Robert Wood Johnson Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Kesselheim is supported by career development award K08HS18465-01 from the Agency for Healthcare Research and Quality and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research.	[Anonymous], 2011, R LANG ENV STAT COMP; [Anonymous], NME DRUG NEW BIOL AP; Avorn J., 2005, POWERFUL MED BENEFIT; Avorn J, 2007, NEW ENGL J MED, V356, P1697, DOI 10.1056/NEJMp078041; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Buckley BM, 2008, LANCET, V371, P2051, DOI 10.1016/S0140-6736(08)60876-4; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cote T, 2010, NAT REV DRUG DISCOV, V9, P84, DOI 10.1038/nrd2546-c1; Dagher R, 2004, J NATL CANCER I, V96, P1500, DOI 10.1093/jnci/djh279; Haffner ME, 2006, NEW ENGL J MED, V354, P445, DOI 10.1056/NEJMp058317; Hirschler B, 2010, UK SAYS NOVARTIS BRI; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Johnson JR, 2003, J CLIN ONCOL, V21, P1404, DOI 10.1200/JCO.2003.08.072; Kesselheim A.S., 2010, ACCELERATING RARE DI; Mckee AE, 2010, ONCOLOGIST, V15, P13, DOI 10.1634/theoncologist.2010-S1-13; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Mitsumoto J, 2009, ANN NEUROL, V66, P184, DOI 10.1002/ana.21676; National Cancer Institute, A Z LIST CANC; Office of the Inspector General, 2011, ORPH DRUG ACT IMPL I; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P793, DOI 10.1001/jama.2010.1161; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Tsimberidou AM, 2009, J CLIN ONCOL, V27, P6243, DOI 10.1200/JCO.2009.23.6018; U. S. Food Drug Adm. (FDA), 2011, DEV PROD RAR DIS CON; US Food and Drug Administration, SEARCH ORPH DRUG DES; US Food and Drug Administration, 2011, POSTM REQ COMM; US Food and Drug Administration, 2010, MYL GEMT OZ MARK WIT; Wellman-Labadie O, 2010, HEALTH POLICY, V95, P216, DOI 10.1016/j.healthpol.2009.12.001; Yin W, 2009, J HEALTH ECON, V28, P950, DOI 10.1016/j.jhealeco.2009.06.011	29	155	159	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2320	2326		10.1001/jama.2011.769	http://dx.doi.org/10.1001/jama.2011.769			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642684	Bronze			2022-12-01	WOS:000291349100025
J	Souwer, IH; Lagro-Janssen, ALM				Souwer, I. H.; Lagro-Janssen, A. L. M.			10-MINUTE CONSULTATION Chronic chilblains	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lagro-Janssen, A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Unit Womens Studies Med, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Souwer, IH (corresponding author), Middelie 91, NL-1472 GT Middelie, Netherlands.	IHSouweri.souwer@wxs.nl	Lagro, A.L.M./H-8066-2014					GOETTE DK, 1990, J AM ACAD DERMATOL, V23, P257, DOI 10.1016/0190-9622(90)70209-Z; JACOB JR, 1986, ARCH INTERN MED, V146, P1589, DOI 10.1001/archinte.146.8.1589; Morioka N, 1991, Nihon Hifuka Gakkai Zasshi, V101, P615; RUSTIN MHA, 1989, BRIT J DERMATOL, V120, P267; Souwer IH, 2009, INT J CLIN PRACT, V63, P282, DOI 10.1111/j.1742-1241.2008.01912.x; Souwer Ibo H, 2007, Eur J Gen Pract, V13, P159, DOI 10.1080/13814780701471068; Viguier M, 2001, MEDICINE, V80, P180, DOI 10.1097/00005792-200105000-00004	7	8	8	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 7	2011	342								d2708	10.1136/bmj.d2708	http://dx.doi.org/10.1136/bmj.d2708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SL	21652748				2022-12-01	WOS:000291645200001
J	Copeland, SR; Sponheimer, M; de Ruiter, DJ; Lee-Thorp, JA; Codron, D; le Roux, PJ; Grimes, V; Richards, MP				Copeland, Sandi R.; Sponheimer, Matt; de Ruiter, Darryl J.; Lee-Thorp, Julia A.; Codron, Daryl; le Roux, Petrus J.; Grimes, Vaughan; Richards, Michael P.			Strontium isotope evidence for landscape use by early hominins	NATURE			English	Article							HUMAN-EVOLUTION; LIFE-HISTORY; RATIOS; BODY; AUSTRALOPITHECUS; SR-87/SR-86; PATTERNS; AFRICA; ORIGIN; HOMO	Ranging and residence patterns among early hominins have been indirectly inferred from morphology(1,2), stone-tool sourcing(3), referential models(4,5) and phylogenetic models(6-8). However, the highly uncertain nature of such reconstructions limits our understanding of early hominin ecology, biology, social structure and evolution. We investigated landscape use in Australopithecus africanus and Paranthropus robustus from the Sterkfontein and Swartkrans cave sites in South Africa using strontium isotope analysis, a method that can help to identify the geological substrate on which an animal lived during tooth mineralization. Here we show that a higher proportion of small hominins than large hominins had non-local strontium isotope compositions. Given the relatively high levels of sexual dimorphism in early hominins, the smaller teeth are likely to represent female individuals, thus indicating that females were more likely than males to disperse from their natal groups. This is similar to the dispersal pattern found in chimpanzees(9), bonobos(10) and many human groups(11), but dissimilar from that of most gorillas and other primates(12). The small proportion of demonstrably non-local large hominin individuals could indicate that male australopiths had relatively small home ranges, or that they preferred dolomitic landscapes.	[Copeland, Sandi R.; Grimes, Vaughan; Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Copeland, Sandi R.; Sponheimer, Matt] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Lee-Thorp, Julia A.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; [Lee-Thorp, Julia A.; le Roux, Petrus J.] Univ Cape Town, Dept Geol Sci, AEON EarthLAB, ZA-7701 Rondebosch, South Africa; [Codron, Daryl] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, CH-8057 Zurich, Switzerland; [Grimes, Vaughan] Mem Univ, Dept Archaeol, St John, NF A1C 5S7, Canada; [Richards, Michael P.] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada	Max Planck Society; University of Colorado System; University of Colorado Boulder; Texas A&M University System; Texas A&M University College Station; University of Oxford; University of Cape Town; University of Zurich; Memorial University Newfoundland; University of British Columbia	Copeland, SR (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	sandi.copeland@colorado.edu	le Roux, Petrus J./AAD-4755-2021; Richards, Michael/A-9374-2008; Grimes, Vaughan/AAG-5174-2021; Codron, Daryl/B-8867-2008; Sponheimer, Matt/A-6075-2013; Richards, Michael/O-3717-2016	le Roux, Petrus J./0000-0002-5930-4995; Richards, Michael/0000-0001-5274-8887; Grimes, Vaughan/0000-0002-2177-3147; Codron, Daryl/0000-0001-5223-9513; Sponheimer, Matt/0000-0002-8743-1123; Richards, Michael/0000-0001-5274-8887; de Ruiter, Darryl/0000-0003-1183-0352	National Science Foundation, USA [0609963]; Max Planck Society; University of Colorado	National Science Foundation, USA(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Colorado	Funding for this project was provided by the National Science Foundation, USA (grant 0609963), the Max Planck Society, a University of Colorado LEAP Associate Professor Growth Grant and the University of Colorado Dean's Fund for Excellence. We are grateful to the Ditsong National Museum of Natural History (formerly the Transvaal Museum), including F. Thackeray, S. Potze and T. Kearny, for allowing us access to the Sterkfontein and Swartkrans fossil material and for granting permission for laser ablation MC-ICP-MS analysis. We thank S. Potze and T. Perregil for flying to Cape Town to allow laser ablation MC-ICP-MS sampling of the hominins. We also thank L. Berger, J. Brophy, J. Codron and J. Hancox for help in the field, J. Montgomery for useful discussions and J. Sealy and J. Lanham for help with plant preparation in the Archaeology Department, University of Cape Town. We thank A. Anderson, C. Campbell, B. Covert, D. Grimstead, F. Grine, J. Leichliter, O. Paine, J. Quade, P. Sandberg and P. Ungar for commenting on the manuscript. The research of A. Sillen and G. Hall inspired this study.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; BEYNON AD, 1988, NATURE, V335, P509, DOI 10.1038/335509a0; Charlier BLA, 2006, CHEM GEOL, V232, P114, DOI 10.1016/j.chemgeo.2006.02.015; Copeland SR, 2008, RAPID COMMUN MASS SP, V22, P3187, DOI 10.1002/rcm.3717; Copeland SR, 2010, J ARCHAEOL SCI, V37, P1437, DOI 10.1016/j.jas.2010.01.003; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; Faure G., 1972, STRONTIUM ISOTOPE GE; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; FURUICHI T, 1989, INT J PRIMATOL, V10, P173, DOI 10.1007/BF02735199; GHIGLIERI MP, 1987, J HUM EVOL, V16, P319, DOI 10.1016/0047-2484(87)90065-0; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOSZ JR, 1983, BIOSCIENCE, V33, P23, DOI 10.2307/1309240; Graustein W.C., 1989, STABLE ISOTOPES ECOL, P491, DOI 10.1007/978-1-4612-3498-2_28; HURST RW, 1981, ENVIRON GEOL, V3, P363, DOI 10.1007/BF02473525; Lockwood CA, 2007, SCIENCE, V318, P1443, DOI 10.1126/science.1149211; Mahler P.E., 1973, METRIC VARIATION PON; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Moore Jim, 1996, P275, DOI 10.1017/CBO9780511752414.022; Plavcan JM, 1997, J HUM EVOL, V32, P345, DOI 10.1006/jhev.1996.0096; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Tooby J., 1987, P183; WHEELER PE, 1992, J HUM EVOL, V23, P351, DOI 10.1016/0047-2484(92)90071-G; William C, 1981, WOMAN GATHERER, P35; Wrangham R.W., 1987, P51	29	135	138	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					76	U100		10.1038/nature10149	http://dx.doi.org/10.1038/nature10149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637256				2022-12-01	WOS:000291156700040
J	Boal, AK; Grove, TL; McLaughlin, MI; Yennawar, NH; Booker, SJ; Rosenzweig, AC				Boal, Amie K.; Grove, Tyler L.; McLaughlin, Monica I.; Yennawar, Neela H.; Booker, Squire J.; Rosenzweig, Amy C.			Structural Basis for Methyl Transfer by a Radical SAM Enzyme	SCIENCE			English	Article							23S RIBOSOMAL-RNA; CONFERS ANTIBIOTIC-RESISTANCE; CATECHOL O-METHYLTRANSFERASE; PYRUVATE FORMATE-LYASE; CRYSTAL-STRUCTURE; 5'-DEOXYADENOSYL RADICALS; FES CLUSTER; ADENOSYLMETHIONINE; MECHANISM; CFR	The radical S-adenosyl-L-methionine (SAM) enzymes RlmN and Cfr methylate 23S ribosomal RNA, modifying the C2 or C8 position of adenosine 2503. The methyl groups are installed by a two-step sequence involving initial methylation of a conserved Cys residue (RlmN Cys(355)) by SAM. Methyl transfer to the substrate requires reductive cleavage of a second equivalent of SAM. Crystal structures of RlmN and RlmN with SAM show that a single molecule of SAM coordinates the [4Fe-4S] cluster. Residue Cys(355) is S-methylated and located proximal to the SAM methyl group, suggesting the SAM that is involved in the initial methyl transfer binds at the same site. Thus, RlmN accomplishes its complex reaction with structural economy, harnessing the two most important reactivities of SAM within a single site.	[Grove, Tyler L.; McLaughlin, Monica I.; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Grove, Tyler L.; McLaughlin, Monica I.; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Yennawar, Neela H.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northwestern University; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	squire@psu.edu; amyr@northwestern.edu		McLaughlin, Martin/0000-0003-4410-0786	NIH [GM58518, GM63847]; National Research Service Award; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM100011, R01GM063847, R01GM058518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by NIH grants GM58518 (A. C. R.) and GM63847 (S.J.B.) and a National Research Service Award fellowship to A. K. B. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). GM/CA CAT has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3RF9 (RlmN) and 3RFA (RlmN+SAM).	Allen BD, 2003, J AM CHEM SOC, V125, P9018, DOI 10.1021/ja034242l; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Cosper NJ, 2000, BIOCHEMISTRY-US, V39, P15668, DOI 10.1021/bi0022184; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; Frey P, 1992, ENZYMES, V20, P142; Frey P. A., 2007, ENZYMATIC REACTION M; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hardin JW, 2010, J MOL BIOL, V402, P412, DOI 10.1016/j.jmb.2010.07.040; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13510, DOI 10.1021/bi048692h; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kampmeier JA, 2010, BIOCHEMISTRY-US, V49, P10770, DOI 10.1021/bi101509u; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; LaMarre JM, 2011, ANTIMICROB AGENTS CH, V55, P2989, DOI 10.1128/AAC.00183-11; Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Markham G. D., 2010, ENCY LIFE SCIENCES; Miller DJ, 2003, PROTEIN SCI, V12, P1432, DOI 10.1110/ps.0302403; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Nicolet Y, 2009, P NATL ACAD SCI USA, V106, P14867, DOI 10.1073/pnas.0904385106; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Westler WM, 2011, J AM CHEM SOC, V133, P1310, DOI 10.1021/ja1049059; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	48	125	127	0	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1089	1092		10.1126/science.1205358	http://dx.doi.org/10.1126/science.1205358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527678	Green Accepted			2022-12-01	WOS:000290996700046
J	Hartvigsen, J; Foster, NE; Croft, PR				Hartvigsen, Jan; Foster, Nadine E.; Croft, Peter R.			PERSONAL VIEW We need to rethink front line care for back pain	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hartvigsen, Jan] Inst Sports Sci & Clin Biomech, Odense, Denmark; [Foster, Nadine E.; Croft, Peter R.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	University of Southern Denmark; Keele University	Hartvigsen, J (corresponding author), Inst Sports Sci & Clin Biomech, Odense, Denmark.	jhartvigsen@health.sdu.dk		Foster, Nadine/0000-0003-4429-9756; Hartvigsen, Jan/0000-0002-5876-7410	National Institute for Health Research [NF-SI-0509-10183] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	12	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2011	342								d3260	10.1136/bmj.d3260	http://dx.doi.org/10.1136/bmj.d3260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	771KE	21613346				2022-12-01	WOS:000291154800010
J	Arumugam, M; Raes, J; Pelletier, E; Le Paslier, D; Yamada, T; Mende, DR; Fernandes, GR; Tap, J; Bruls, T; Batto, JM; Bertalan, M; Borruel, N; Casellas, F; Fernandez, L; Gautier, L; Hansen, T; Hattori, M; Hayashi, T; Kleerebezem, M; Kurokawa, K; Leclerc, M; Levenez, F; Manichanh, C; Nielsen, HB; Nielsen, T; Pons, N; Poulain, J; Qin, JJ; Sicheritz-Ponten, T; Tims, S; Torrents, D; Ugarte, E; Zoetendal, EG; Wang, J; Guarner, F; Pedersen, O; de Vos, WM; Brunak, S; Dore, J; Weissenbach, J; Ehrlich, SD; Bork, P				Arumugam, Manimozhiyan; Raes, Jeroen; Pelletier, Eric; Le Paslier, Denis; Yamada, Takuji; Mende, Daniel R.; Fernandes, Gabriel R.; Tap, Julien; Bruls, Thomas; Batto, Jean-Michel; Bertalan, Marcelo; Borruel, Natalia; Casellas, Francesc; Fernandez, Leyden; Gautier, Laurent; Hansen, Torben; Hattori, Masahira; Hayashi, Tetsuya; Kleerebezem, Michiel; Kurokawa, Ken; Leclerc, Marion; Levenez, Florence; Manichanh, Chaysavanh; Nielsen, H. Bjorn; Nielsen, Trine; Pons, Nicolas; Poulain, Julie; Qin, Junjie; Sicheritz-Ponten, Thomas; Tims, Sebastian; Torrents, David; Ugarte, Edgardo; Zoetendal, Erwin G.; Wang, Jun; Guarner, Francisco; Pedersen, Oluf; de Vos, Willem M.; Brunak, Soren; Dore, Joel; Weissenbach, Jean; Ehrlich, S. Dusko; Bork, Peer		MetaHIT Consortium	Enterotypes of the human gut microbiome	NATURE			English	Article							BACTERIAL; DIVERSITY; PATHWAYS; CATALOG; GENES; MUCIN	Our knowledge of species and functional composition of the human gut microbiome is rapidly increasing, but it is still based on very few cohorts and little is known about variation across the world. By combining 22 newly sequenced faecal metagenomes of individuals from four countries with previously published data sets, here we identify three robust clusters (referred to as enterotypes hereafter) that are not nation or continent specific. We also confirmed the enterotypes in two published, larger cohorts, indicating that intestinal microbiota variation is generally stratified, not continuous. This indicates further the existence of a limited number of well-balanced host-microbial symbiotic states that might respond differently to diet and drug intake. The enterotypes are mostly driven by species composition, but abundant molecular functions are not necessarily provided by abundant species, highlighting the importance of a functional analysis to understand microbial communities. Although individual host properties such as body mass index, age, or gender cannot explain the observed enterotypes, data-driven marker genes or functional modules can be identified for each of these host properties. For example, twelve genes significantly correlate with age and three functional modules with the body mass index, hinting at a diagnostic potential of microbial markers.	[Arumugam, Manimozhiyan; Raes, Jeroen; Yamada, Takuji; Mende, Daniel R.; Fernandes, Gabriel R.; Tap, Julien; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Raes, Jeroen] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Poulain, Julie; Ugarte, Edgardo; Weissenbach, Jean] CEA, F-91000 Evry, France; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Weissenbach, Jean] CNRS, UMR8030, F-91000 Evry, France; [Pelletier, Eric; Le Paslier, Denis; Bruls, Thomas; Weissenbach, Jean] Univ Evry Val dEssone, F-91000 Evry, France; [Fernandes, Gabriel R.] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Tap, Julien; Batto, Jean-Michel; Leclerc, Marion; Levenez, Florence; Pons, Nicolas; Dore, Joel; Ehrlich, S. Dusko] INRA, F-78350 Jouy En Josas, France; [Bertalan, Marcelo; Gautier, Laurent; Nielsen, H. Bjorn; Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Borruel, Natalia; Casellas, Francesc; Manichanh, Chaysavanh; Guarner, Francisco] Univ Hosp Vall Hebron, Digest Syst Res Unit, Barcelona 08035, Spain; [Fernandez, Leyden; Torrents, David] Barcelona Supercomp Ctr, Barcelona 08034, Spain; [Hansen, Torben; Nielsen, Trine; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Sect Metab Genet, Marie Krogh Ctr Metab Res, DK-2100 Copenhagen, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark; [Hattori, Masahira] Univ Tokyo, Computat Biol Lab Bld, Chiba 2778561, Japan; [Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Div Bioenvironm Sci, Miyazaki 8891692, Japan; [Kleerebezem, Michiel; Tims, Sebastian; Zoetendal, Erwin G.; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6710 BA Ede, Netherlands; [Kurokawa, Ken] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Qin, Junjie; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Sicheritz-Ponten, Thomas] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Torrents, David] Pg Lluis Co 23, ICREA, Barcelona 08010, Spain; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Inst Biomed Sci, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Hagedom Res Inst, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [de Vos, Willem M.] Univ Helsinki, FI-00014 Helsinki, Finland; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal de Minas Gerais; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Denmark; Hospital Universitari Vall d'Hebron; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Copenhagen; University of Southern Denmark; University of Tokyo; University of Miyazaki; Wageningen University & Research; Tokyo Institute of Technology; Beijing Genomics Institute (BGI); Technical University of Denmark; ICREA; University of Copenhagen; University of Copenhagen; Aarhus University; University of Helsinki; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	dusko.ehrlich@jouy.inra.fr; bork@embl.de	Leclerc, Marion/AAZ-3950-2021; Ehrlich, S./Y-2423-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Gautier, Laurent/F-9849-2012; Guedon, Eric/S-5635-2016; Arumugam, Manimozhiyan/E-1211-2011; Hattori, Masahira/C-6958-2016; raes, jeroen/D-7835-2018; Tap, Julien/E-5760-2010; Guédon, Eric/AAP-4143-2021; Zeller, Georg/M-6484-2013; de Melo-Minardi, Raquel C./AAG-6540-2021; Borruel, Natalia/AFO-6891-2022; Casellas, Francesc/AAT-1018-2021; Duarte, Graziela Biude Silva/Q-7728-2016; Hattori, Masahira/AAD-3785-2019; Mende, Daniel R/I-3662-2019; Bork, Peer/F-1813-2013; Hayashi, Tetsuya/ABA-1074-2020; Sunagawa, Shinichi/Q-5950-2019; GUEDON, Eric/N-8624-2019; Pedersen, Oluf/AAG-8015-2020; Chervaux, Christian/N-1972-2014; Muller, Jean/L-7412-2018; Knol, Jan/AAL-6487-2020; da Rocha Fernandes, Gabriel/A-5383-2010; BLOTTIERE, Hervé M/C-6120-2011; Nielsen, Henrik/B-8961-2019; Kleerebezem, Michiel/AAT-2078-2021; InWeb, Inct/J-9839-2013; van Hylckama Vlieg, Johan/F-7887-2014; Guarner, Francisco/ABF-1192-2020; Wang, Jun/A-7261-2013; Förstner, Konrad U./B-1531-2010; Knol, Jan/A-2178-2010; Dore, Joel/ABA-8921-2020; Rescigno, Maria/J-9704-2012; Shingakujyutsu, Kurokawaken/G-1378-2011; Pedersen, Oluf/Z-1731-2019; Torrents, David/G-5785-2015; Brunak, Soren/O-6621-2016; Sicheritz-Ponten, Thomas/A-4325-2017; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Parkhill, Julian/G-4703-2011	Leclerc, Marion/0000-0001-8684-2847; Ehrlich, S./0000-0002-7563-4046; Arumugam, Manimozhiyan/0000-0002-0886-9101; Guedon, Eric/0000-0002-0901-4447; Arumugam, Manimozhiyan/0000-0002-0886-9101; Hattori, Masahira/0000-0001-9467-0344; raes, jeroen/0000-0002-1337-041X; Tap, Julien/0000-0001-8998-5413; Zeller, Georg/0000-0003-1429-7485; Borruel, Natalia/0000-0002-4449-2292; Casellas, Francesc/0000-0003-3196-039X; Mende, Daniel R/0000-0001-6831-4557; Bork, Peer/0000-0002-2627-833X; Sunagawa, Shinichi/0000-0003-3065-0314; GUEDON, Eric/0000-0002-0901-4447; Chervaux, Christian/0000-0001-6812-0912; Muller, Jean/0000-0002-7682-559X; Knol, Jan/0000-0002-2103-5961; da Rocha Fernandes, Gabriel/0000-0002-4897-8521; BLOTTIERE, Hervé M/0000-0002-8390-0607; Nielsen, Henrik/0000-0003-2281-5713; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Guarner, Francisco/0000-0002-4051-0836; Förstner, Konrad U./0000-0002-1481-2996; Knol, Jan/0000-0002-2103-5961; Rescigno, Maria/0000-0002-6464-509X; Pedersen, Oluf/0000-0002-3321-3972; Varela Castro, Encarna/0000-0001-6334-9320; Torrents, David/0000-0002-6086-9037; Le Paslier, Denis/0000-0003-4335-9956; Delorme, Christine/0000-0002-5208-7238; TORREJON, ANTONIO/0000-0002-3126-1532; Brunak, Soren/0000-0003-0316-5866; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Kleerebezem, Michiel/0000-0001-8552-2235; Pelletier, Eric/0000-0003-4228-1712; Hansen, Torben/0000-0001-8748-3831; C. de Melo-Minardi, Raquel/0000-0001-5190-100X; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Poulain, Julie/0000-0002-8744-3116; Nielsen, Trine/0000-0002-2066-7895; Parkhill, Julian/0000-0002-7069-5958; Huber, Wolfgang/0000-0002-0474-2218; Chaysavanh, Manichanh/0000-0002-2287-4003	European Community [HEALTH-F4-2007-201052]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP); Novo Nordisk Foundation; International Science and Technology Cooperation Project in China [0806]; Agence Nationale de la Recherche (ANR); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Fund for Scientific Research Flanders (FWO); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002800] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; ICREA Funding Source: Custom	European Community(European Commission); Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); International Science and Technology Cooperation Project in China; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Fund for Scientific Research Flanders (FWO)(FWO); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation); ICREA(ICREA)	The authors are grateful to C. Creevey, G. Falony and members of the Bork group at EMBL for discussions and assistance. We thank the EMBL IT core facility and Y. Yuan for managing the high-performance computing resources. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013): MetaHIT, grant agreement HEALTH-F4-2007-201052, EMBL, the Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCAMP), Novo Nordisk Foundation and the International Science and Technology Cooperation Project in China (0806). Obese/non-obese volunteers for the MicroObes study were recruited from the SU.VI.MAX cohort study coordinated by P. Galan and S. Hercberg, and metagenome sequencing was funded by Agence Nationale de la Recherche (ANR); volunteers for MicroAge study were recruited from the CROWNALIFE cohort study coordinated by S. Silvi and A. Cresci, and metagenome sequencing was funded by GenoScope. Ciberehd is funded by the Instituto de Salud Carlos III (Spain). J.R. is supported by the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) and the Odysseus programme of the Fund for Scientific Research Flanders (FWO). We are thankful to the Human Microbiome Project for generating the reference genomes from human gut microbes and the International Human Microbiome Consortium for discussions and exchange of data.	Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P334, DOI 10.1016/j.it.2009.04.004; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; MetaHITConsortium, 2010, METAHIT DRAFT BACT G; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Walker A, 2007, NAT REV MICROBIOL, V5, P572, DOI 10.1038/nrmicro1720; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Wright DP, 2000, FEMS MICROBIOL LETT, V190, P73, DOI 10.1111/j.1574-6968.2000.tb09265.x; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	40	4052	4359	63	1656	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					174	180		10.1038/nature09944	http://dx.doi.org/10.1038/nature09944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21508958	Green Submitted, Green Accepted			2022-12-01	WOS:000290487200030
J	Castro, H; Judd, A; Gibb, DM; Butler, K; Lodwick, RK; van Sighem, A; Ramos, JT; Warsawski, J; Thorne, C; Noguera-Julian, A; Obel, N; Costagliola, D; Tookey, PA; Colin, C; Kjaer, J; Grarup, J; Chene, G; Phillips, A				Castro, Hannah; Judd, Ali; Gibb, Diana M.; Butler, Karina; Lodwick, Rebecca K.; van Sighem, Ard; Ramos, Jose T.; Warsawski, Josiane; Thorne, Claire; Noguera-Julian, Antoni; Obel, Niels; Costagliola, Dominique; Tookey, Pat A.; Colin, Celine; Kjaer, Jesper; Grarup, Jesper; Chene, Genevieve; Phillips, Andrew		COHERE	Risk of triple-class virological failure in children with HIV: a retrospective cohort study	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED CHILDREN; ADHERENCE; MORTALITY; GUIDELINES; IRELAND; UK	Background In adults with HIV treated with antiretroviral drug regimens from within the three original drug classes (nucleoside or nucleotide reverse transcriptase inhibitors [NRTIs], non-NRTIs [NNRTIs], and protease inhibitors), virological failure occurs slowly, suggesting that long-term virological suppression can be achieved in most people, even in areas where access is restricted to drugs from these classes. It is unclear whether this is the case for children, the group who will need to maintain viral suppression for longest. We aimed to determine the rate and predictors of triple-class virological failure to the three original drugs classes in children. Methods In the Collaboration of Observational HIV Epidemiological Research Europe, the rate of triple-class virological failure was studied in children infected perinatally with HIV who were aged less than 16 years, starting antiretroviral therapy (ART) with three or more drugs, between 1998 and 2008. We used Kaplan-Meier and Cox regression methods to investigate the risk and predictors of triple-class virological failure after ART initiation. Findings Of 1007 children followed up for a median of 4.2 (IQR 2.4-6.5) years, 237 (24%) were triple-class exposed and 105 (10%) had triple-class virological failure, of whom 29 never had a viral-load measurement less than 500 copies per mL. Incidence of triple-class virological failure after ART initiation increased with time, and risk by 5 years after ART initiation was 12.0% (95% CI 9.4-14.6). In multivariate analysis, older age at ART initiation was associated with increased risk of failure (p=0.02). Of 686 children starting ART with NRTIs and either a NNRTI or ritonavir-boosted protease inhibitor, the rate of failure was higher than in adults with heterosexually transmitted HIV (hazard ratio 2.2 [95% CI 1.6-3.0, p<0.0001]). Interpretation Findings highlight the challenges of attaining long-term viral suppression in children who will be taking life-long ART Early identification of children not responding to ART, adherence support, particularly for children and adolescents aged 13 years or older starting ART, and ART simplification strategies are all needed to attain and sustain virological suppression.			Judd, A (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	a.judd@ctu.mrc.ac.uk	Judd, Ali/B-5132-2009; Lodwick, Rebecca/B-7578-2015; Mocroft, Amanda/G-8748-2011; Costagliola, Dominique/H-5849-2011; chene, genevieve/H-8665-2014; DEL AMO VALERO, JULIA/M-7020-2015; Tookey, Pat A/G-2732-2010; Phillips, Andrew N/B-4427-2008; Thorne, Claire/C-5943-2008; Matheron, Sophie/D-7420-2017	Judd, Ali/0000-0003-3176-5295; Lodwick, Rebecca/0000-0003-2558-4762; Mocroft, Amanda/0000-0001-8316-1122; Costagliola, Dominique/0000-0003-0765-0869; chene, genevieve/0000-0002-8368-6460; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Tookey, Pat A/0000-0001-6258-0387; Phillips, Andrew N/0000-0003-2384-4807; Thorne, Claire/0000-0003-0389-1956; Castro, Hannah/0000-0001-9086-8687; Paraskevis, Dimitrios/0000-0001-6167-7152; Noguera-Julian, Antoni/0000-0001-7485-0583; Lo Caputo, Sergio/0000-0002-4729-7548; Casabona-Barbara, Jordi/0000-0003-4816-5536; Matheron, Sophie/0000-0001-7879-6553; Obel, Niels/0000-0002-5031-0045; Gibb, Diana/0000-0002-9738-5490	UK Medical Research Council [G0700832]; European Union [260694]; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, Netherlands; Augustinus Foundation, Denmark; Swiss Bridge Foundation; MRC [G0700832, MC_U122886353, G0900274, G9620552] Funding Source: UKRI; Medical Research Council [G0900274, G9620552, G0700832, MC_U122886353] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France(ANRS); HIV Monitoring Foundation, Netherlands(Netherlands Government); Augustinus Foundation, Denmark; Swiss Bridge Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PLATO II project is funded by UK Medical Research Council award G0700832. The COHERE study group has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement number 260694; Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France; HIV Monitoring Foundation, Netherlands; and the Augustinus Foundation, Denmark. The group has also received project specific funding from the UK Medical Research Council and the Swiss Bridge Foundation. A list of the funding sources of participating cohorts can be found on the regional coordinating centre websites.	Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Boyd K, 2010, PREVALENCE DARUNAVIR, P851; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Butler L, 2010, 18 INT AIDS C VIENN; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; Deeks SG, 2000, CLIN INFECT DIS, V30, pS177, DOI 10.1086/313855; Giaquinto C, 2008, CLIN DRUG INVEST, V28, P375, DOI 10.2165/00044011-200828060-00005; Goetghebuer T, 2009, AIDS, V23, P597, DOI 10.1097/QAD.0b013e328326ca37; HIV-1 viral load CD4cellcountinuntreatedchildrenwithverticallyacquiredasymptomaticormilddisease, 1998, AIDS, V12, P1; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5; Kjaer J, 2004, ANTIVIR THER, V9, P631; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lee KJ, 2006, 8 INT C DRUG THER HI; Lodwick R, 2010, ARCH INTERN MED, V170, P410, DOI 10.1001/archinternmed.2009.472; Martin S, 2007, PEDIATR INFECT DIS J, V26, P61, DOI 10.1097/01.inf.0000250625.80340.48; Melvin A, 2010, 18 INT AIDS C VIENN; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Reddington C, 2000, PEDIATR INFECT DIS J, V19, P1148, DOI 10.1097/00006454-200012000-00005; Sabin CA, 2008, AIDS, V22, P1463; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; Swan J, 2007, PEDIATRICS, V119, P838, DOI 10.1542/peds.2007-0273; The PLATO II Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group, 2009, EUR AIDS CLIN SOC C; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; *WORK GROUP ANT TH, 2009, GUID US ANT AG PED H, P1; World Health Organization, 2010, ANT THER HIV INF INF	34	86	87	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1580	1587		10.1016/S0140-6736(11)60208-0	http://dx.doi.org/10.1016/S0140-6736(11)60208-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21511330	Green Published			2022-12-01	WOS:000290549700031
J	Sackett, B; Sakel, M				Sackett, Brian; Sakel, Mohamed			A PATIENT'S JOURNEY Motor neurone disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sakel, Mohamed] E Kent Hosp Univ NHS Fdn Trust, Kent & Canterbury Hosp, Canterbury CT1 3NG, Kent, England	University of Kent		brian@sackett.go-plus.net							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 3	2011	342								d1661	10.1136/bmj.d1661	http://dx.doi.org/10.1136/bmj.d1661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MA	21540256	Green Submitted, Bronze			2022-12-01	WOS:000290481600005
J	Ratcliff, WC; Denison, RF				Ratcliff, William Croft; Denison, Robert Ford			Alternative Actions for Antibiotics	SCIENCE			English	Editorial Material									[Ratcliff, William Croft; Denison, Robert Ford] Univ Minnesota, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ratcliff, WC (corresponding author), Univ Minnesota, St Paul, MN 55108 USA.	denis036@umn.edu						Berleman JE, 2006, J BACTERIOL, V188, P5888, DOI 10.1128/JB.00559-06; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Diggle SP, 2007, PHILOS T R SOC B, V362, P1241, DOI 10.1098/rstb.2007.2049; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Gilg O, 2010, SCIENCE, V327, P276, DOI 10.1126/science.1184964; Jousset A, 2008, FUNCT ECOL, V22, P714, DOI 10.1111/j.1365-2435.2008.01411.x; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Maynard-Smith J., 2003, ANIMAL SIGNALS; Nizak C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000212; Ratcliff WC, 2009, ISME J, V3, P870, DOI 10.1038/ismej.2009.38; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; Ward J., 2008, CONTROL BIOFILM INFE, P79; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	16	43	43	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					547	548		10.1126/science.1205970	http://dx.doi.org/10.1126/science.1205970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527704				2022-12-01	WOS:000289991100034
J	van den Elsen, JMH; Isenman, DE				van den Elsen, Jean M. H.; Isenman, David E.			A Crystal Structure of the Complex Between Human Complement Receptor 2 and Its Ligand C3d	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; STAPHYLOCOCCUS-AUREUS; BINDING-SITE; COMPONENT C3; CR-2; CD21; RESIDUES; ARTHRITIS; CR2/CD21; IMMUNITY	The interaction of complement receptor 2 (CR2)-which is present on B cells and follicular dendritic cells-with its antigen-bound ligand C3d results in an enhanced antibody response, thus providing an important link between the innate and adaptive immune systems. Although a cocrystal structure of a complex between C3d and the ligand-binding domains of CR2 has been published, several aspects of this structure, including the position in C3d of the binding interface, remained controversial because of disagreement with biochemical data. We now report a cocrystal structure of a CR2(SCR1-2):C3d complex at 3.2 angstrom resolution in which the interaction interfaces differ markedly from the previously published structure and are consistent with the biochemical data. It is likely that, in the previous structure, the interaction was influenced by the presence of zinc acetate additive in the crystallization buffer, leading to a nonphysiological complex. Detailed knowledge of the binding interface now at hand gives the potential to exploit the interaction in vaccine design or in therapeutics directed against autoreactive B cells.	[van den Elsen, Jean M. H.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Bath; University of Toronto	van den Elsen, JMH (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssjmhve@bath.ac.uk; d.isenman@utoronto.ca	van den Elsen, Jean/D-9274-2011	van den Elsen, Jean/0000-0002-0367-1956				Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; CAREL JC, 1990, J BIOL CHEM, V265, P12293; Clark EA, 2011, MOL IMMUNOL, V48, P452, DOI 10.1016/j.molimm.2010.09.017; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Del Nagro CJ, 2005, J IMMUNOL, V175, P5379, DOI 10.4049/jimmunol.175.8.5379; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DIEFENBACH RJ, 1995, J IMMUNOL, V154, P2303; Fang YF, 1998, J IMMUNOL, V160, P5273; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; Isenman DE, 2010, J IMMUNOL, V184, P1946, DOI 10.4049/jimmunol.0902919; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; KALLI KR, 1991, J IMMUNOL, V147, P590; Kovacs JM, 2009, J BIOL CHEM, V284, P9513, DOI 10.1074/jbc.M808404200; Kuhn KA, 2008, MOL IMMUNOL, V45, P2808, DOI 10.1016/j.molimm.2008.01.036; LAMBRIS JD, 1985, P NATL ACAD SCI USA, V82, P4235, DOI 10.1073/pnas.82.12.4235; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Shaw CD, 2010, J MOL BIOL, V404, P697, DOI 10.1016/j.jmb.2010.10.005; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118	26	56	64	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					608	611		10.1126/science.1201954	http://dx.doi.org/10.1126/science.1201954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527715				2022-12-01	WOS:000289991100054
J	Durand, S; Lykke-Andersen, J				Durand, Sebastien; Lykke-Andersen, Jens			SnapShot: Nonsense-Mediated mRNA Decay	CELL			English	Editorial Material									[Durand, Sebastien; Lykke-Andersen, Jens] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Durand, S (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.		Durand, Sebastien/Q-2138-2019	Durand, Sebastien/0000-0002-9960-9099; Lykke-Andersen, Jens/0000-0003-1821-0754				Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Kashima I, 2010, GENE DEV, V24, P2440, DOI 10.1101/gad.604610; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007	10	11	15	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					324	U2		10.1016/j.cell.2011.03.038	http://dx.doi.org/10.1016/j.cell.2011.03.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496649	Bronze			2022-12-01	WOS:000289549900020
J	Sievers, SA; Karanicolas, J; Chang, HW; Zhao, A; Jiang, L; Zirafi, O; Stevens, JT; Munch, J; Baker, D; Eisenberg, D				Sievers, Stuart A.; Karanicolas, John; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Zirafi, Onofrio; Stevens, Jason T.; Muench, Jan; Baker, David; Eisenberg, David			Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation	NATURE			English	Article							PAIRED HELICAL FILAMENTS; TAU-PROTEIN; PEPTIDE INHIBITORS; ALZHEIMERS-DISEASE; AGGREGATION; BINDING; MECHANISM; TOXICITY; MODEL	Many globular and natively disordered proteins can convert into amyloid fibrils. These fibrils are associated with numerous pathologies(1) as well as with normal cellular functions(2,3), and frequently form during protein denaturation(4,5). Inhibitors of pathological amyloid fibril formation could be useful in the development of therapeutics, provided that the inhibitors were specific enough to avoid interfering with normal processes. Here we show that computer-aided, structure-based design can yield highly specific peptide inhibitors of amyloid formation. Using known atomic structures of segments of amyloid fibrils as templates, we have designed and characterized an all-D-amino-acid inhibitor of the fibril formation of the tau protein associated with Alzheimer's disease, and a non-natural L.-amino-acid inhibitor of an amyloid fibril that enhances sexual transmission of human immunodeficiency virus. Our results indicate that peptides from structure-based designs can disrupt the fibril formation of full-length proteins, including those, such as tau protein, that lack fully ordered native structures. Because the inhibiting peptides have been designed on structures of dual-beta-sheet 'steric zippers', the successful inhibition of amyloid fibril formation strengthens the hypothesis that amyloid spines contain steric zippers.	[Sievers, Stuart A.; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Sievers, Stuart A.; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Karanicolas, John; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Karanicolas, John; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Karanicolas, John; Stevens, Jason T.] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Karanicolas, John; Stevens, Jason T.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Zirafi, Onofrio; Muench, Jan] Univ Hosp Ulm, Inst Mol Virol, D-89081 Ulm, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Kansas; University of Kansas; Ulm University	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Baker, David/K-8941-2012; Jiang, Lin/G-1575-2010; Eisenberg, David/E-2447-2011	Baker, David/0000-0001-7896-6217; Jan, Munch/0000-0001-7316-7141	Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award; Ministry of Science, Baden-Wurttemberg; UCLA-IGERT; NATIONAL INSTITUTE ON AGING [P50AG016570, R01AG029430] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Baden-Wurttemberg; UCLA-IGERT; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. I. Ivanova, J. Corn, T. Kortemme, D. Anderson, M. R. Sawaya, M. Phillips, S. Sambashivan, J. Park, M. Landau, A. Laganowsky, Q. Zhang, R. Clubb, F. Guo, T. Yeates, J. Nowick, J. Zheng and M. J. Thompson for discussions; the HHMI, NIH, NSF, Gates Foundation and Joint Center for Translational Medicine for support; R. Peterson for help with NMR experiments; E. Mandelkow for providing tau constructs; R. Rick for providing amyloid-beta; and J. Stroud for amyloid-beta preparation. Support came from the Damon Runyon Cancer Research Foundation (J.K.), the Ruth L. Kirschstein National Research Service Award (H.W.C.), the programme for junior professors by the Ministry of Science, Baden-Wurttemberg (J.M.), and a UCLA-IGERT bioinformatics traineeship (S.A.S.).	[Anonymous], 2020, R LANG ENV STAT COMP; ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barghorn Stefan, 2004, V299, P35; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chen ZJ, 2005, J MOL BIOL, V354, P760, DOI 10.1016/j.jmb.2005.09.055; DeLano W.L., 2002, PYMOL MOL VIEWER; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larbig G, 2007, CURR ALZHEIMER RES, V4, P315; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Perez M, 1996, J NEUROCHEM, V67, P1183; Petrassi HM, 2000, J AM CHEM SOC, V122, P2178, DOI 10.1021/ja993309v; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Quijano FAR, 2006, BIOCHEMISTRY-US, V45, P4638, DOI 10.1021/bi052226q; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt K, 1999, J NEUROSCI METH, V87, P195, DOI 10.1016/S0165-0270(99)00003-5; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	49	341	354	3	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					96	U117		10.1038/nature10154	http://dx.doi.org/10.1038/nature10154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21677644	Green Accepted, Green Submitted			2022-12-01	WOS:000292461300052
J	Trajkovski, M; Hausser, J; Soutschek, J; Bhat, B; Akin, A; Zavolan, M; Heim, MH; Stoffel, M				Trajkovski, Mirko; Hausser, Jean; Soutschek, Juergen; Bhat, Bal; Akin, Akinc; Zavolan, Mihaela; Heim, Markus H.; Stoffel, Markus			MicroRNAs 103 and 107 regulate insulin sensitivity	NATURE			English	Article							RESISTANCE; ADIPOSE; EXPRESSION; CAVEOLIN; RECEPTOR; MECHANISMS; STEATOSIS; HORMONE; OBESITY	Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes(1-3). MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism(4,5). However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.	[Trajkovski, Mirko; Hausser, Jean; Heim, Markus H.; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Trajkovski, Mirko; Stoffel, Markus] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum Basel, CH-4056 Basel, Switzerland; [Soutschek, Juergen; Bhat, Bal] Regulus Therapeut Inc, San Diego, CA 92121 USA; [Akin, Akinc] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Heim, Markus H.] Univ Basel Hosp, CH-4031 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Isis Pharmaceuticals Inc; University of Basel	Stoffel, M (corresponding author), ETH, Competence Ctr Syst Physiol & Metab Dis, Schafmattstr 18,HPM F 39-1, CH-8093 Zurich, Switzerland.	stoffel@imsb.biol.ethz.ch	Heim, Markus/A-7526-2008; Xie, Huangming/B-2260-2012; Zavolan, Mihaela/S-3888-2016	Heim, Markus/0000-0002-7523-4894; Stoffel, Markus/0000-0003-1304-5817; Trajkovski, Mirko/0000-0002-3152-9551; Hausser, Jean/0000-0002-3321-7199; Zavolan, Mihaela/0000-0002-8832-2041	Juvenile Diabetes Research Foundation International; Swiss National Science Foundation (SNF); European Community; Leducq Foundation	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Community(European Commission); Leducq Foundation(Leducq Foundation)	We would like to thank F. Preitner and B. Thorens for the hyperinsulinaemic euglycaemic clamp studies. M. T. was supported by a fellowship from the Juvenile Diabetes Research Foundation International. The work was supported in part by the Swiss National Science Foundation (SNF, LiverX), the European Community (SIROCCO, ERC and MetaboloMirs) and the Leducq Foundation.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Hansen LH, 1998, MOL ENDOCRINOL, V12, P1140, DOI 10.1210/me.12.8.1140; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Kahn C Ronald, 2003, Exp Diabesity Res, V4, P169, DOI 10.1155/EDR.2003.169; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Otsu K, 2010, AM J PHYSIOL-CELL PH, V298, pC450, DOI 10.1152/ajpcell.00077.2009; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956, DOI 10.1152/ajpendo.1995.268.5.E956; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	27	732	781	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					649	U127		10.1038/nature10112	http://dx.doi.org/10.1038/nature10112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21654750	Green Published			2022-12-01	WOS:000292204300041
J	Vitari, AC; Leong, KG; Newton, K; Yee, C; O'Rourke, K; Liu, JF; Phu, LL; Vij, R; Ferrando, R; Couto, SS; Mohan, S; Pandita, A; Hongo, JA; Arnott, D; Wertz, IE; Gao, WQ; French, DM; Dixit, VM				Vitari, Alberto C.; Leong, Kevin G.; Newton, Kim; Yee, Cindy; O'Rourke, Karen; Liu, Jinfeng; Phu, Lilian; Vij, Rajesh; Ferrando, Ronald; Couto, Suzana S.; Mohan, Sankar; Pandita, Ajay; Hongo, Jo-Anne; Arnott, David; Wertz, Ingrid E.; Gao, Wei-Qiang; French, Dorothy M.; Dixit, Vishva M.			COP1 is a tumour suppressor that causes degradation of ETS transcription factors	NATURE			English	Article							UBIQUITIN LIGASE; PROSTATE-CANCER; GENE FUSIONS; C-MYC; BURKITTS-LYMPHOMA; REGULATED GENE; MOUSE MODELS; PEA3 GROUP; IN-VIVO; MUTATIONS	The proto-oncogenes ETV1, ETV4 and ETV5 encode transcription factors in the E26 transformation-specific (ETS) family, which includes the most frequently rearranged and overexpressed genes in prostate cancer(1-4). Despite being critical regulators of development, little is known about their post-translational regulation. Here we identify the ubiquitin ligase COP1 (also known as RFWD2) as a tumour suppressor that negatively regulates ETV1, ETV4 and ETV5. ETV1, which is mutated in prostate cancer more often, was degraded after being ubiquitinated by COP1. Truncated ETV1 encoded by prostate cancer translocation TMPRSS2:ETV1 lacks the critical COP1 binding motifs and was 50-fold more stable than wild-type ETV1. Almost all patient translocations render ETV1 insensitive to COP1, implying that this confers a selective advantage to prostate epithelial cells. Indeed, COP1 deficiency in mouse prostate elevated ETV1 and produced increased cell proliferation, hyperplasia, and early prostate intraepithelial neoplasia. Combined loss of COP1 and PTEN enhanced the invasiveness of mouse prostate adenocarcinomas. Finally, rare human prostate cancer samples showed hemizygous loss of the COP1 gene, loss of COP1 protein, and elevated ETV1 protein while lacking a translocation event. These findings identify COP1 as a tumour suppressor whose downregulation promotes prostatic epithelial cell proliferation and tumorigenesis.	[Vitari, Alberto C.; Newton, Kim; O'Rourke, Karen; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Leong, Kevin G.] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Yee, Cindy; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Phu, Lilian; Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Vij, Rajesh; Hongo, Jo-Anne] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Ferrando, Ronald; Couto, Suzana S.; French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Mohan, Sankar; Pandita, Ajay] Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA; [Wertz, Ingrid E.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012; Gao, Wei/GXH-0380-2022	dixit, vishva m/0000-0001-6983-0326; Liu, Jinfeng/0000-0002-0343-8222				ALBERT T, 1994, ONCOGENE, V9, P759; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Baert JL, 2010, ONCOGENE, V29, P1810, DOI 10.1038/onc.2009.471; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; CLARK HM, 1994, CANCER RES, V54, P3383; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Gutierrez-Hartmann A, 2007, TRENDS ENDOCRIN MET, V18, P150, DOI 10.1016/j.tem.2007.03.002; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003	44	129	132	1	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					403	+		10.1038/nature10005	http://dx.doi.org/10.1038/nature10005			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21572435				2022-12-01	WOS:000291647100051
J	Shen, YC; Hsia, RY				Shen, Yu-Chu; Hsia, Renee Y.			Association Between Ambulance Diversion and Survival Among Patients With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOSPITAL CARDIAC-ARREST; LENGTH-OF-STAY; EMERGENCY-DEPARTMENTS; MORTALITY; IMPACT; DELAYS; TIMES; CARE	Context Ambulance diversion, a practice in which emergency departments (EDs) are temporarily closed to ambulance traffic, might be problematic for patients experiencing time-sensitive conditions, such as acute myocardial infarction (AMI). However, there is little empirical evidence to show whether diversion is associated with worse patient outcomes. Objective To analyze whether temporary ED closure on the day a patient experiences AMI, as measured by ambulance diversion hours of the nearest ED, is associated with increased mortality rates among patients with AMI. Design, Study, and Participants A case-crossover design of 13 860 Medicare patients with AMI from 508 zip codes within 4 California counties (Los Angeles, San Francisco, San Mateo, and Santa Clara) whose admission date was between 2000 and 2005. Data included 100% Medicare claims data that covered admissions between 2000 and 2005, linked with date of death until 2006, and daily ambulance diversion logs from the same 4 counties. Among the hospital universe, 149 EDs were identified as the nearest ED to these patients. Main Outcome Measures The percentage of patients with AMI who died within 7 days, 30 days, 90 days, 9 months, and 1 year from admission (when their nearest ED was not on diversion and when that same ED was exposed to <6, 6 to <12, and >= 12 hours of diversion out of 24 hours on the day of admission). Results Between 2000 and 2006, the mean (SD) daily diversion duration was 7.9 (6.1) hours. Based on analysis of 11 625 patients admitted to the ED between 2000 and 2005, and whose nearest ED had at least 3 diversion exposure levels (3541, 3357, 2667, and 2060 patients for no exposure, exposure to <6, 6 to <12, and >= 12 hours of diversion, respectively), there were no statistically significant differences in mortality rates between no diversion and exposure to less than 12 hours of diversion. Exposure to 12 or more hours of diversion was associated with higher 30-day mortality vs no diversion status (unadjusted mortality rate, 392 patients [19%] vs 545 patients [15%]; regression adjusted difference, 3.24 percentage points; 95% confidence interval [CI], 0.60-5.88); higher 90-day mortality (537 patients [26%] vs 762 patients [22%]; 2.89 percentage points; 95% CI, 0.13-5.64); higher 9-month mortality (680 patients [33%] vs 980 patients [28%]; 2.93 percentage points; 95% CI, 0.15-5.71); and higher 1-year mortality (731 patients [35%] vs 1034 patients [29%]; 3.04 percentage points; 95% CI, 0.33-5.75). Conclusion Among Medicare patients with AMI in 4 populous California counties, exposure to at least 12 hours of diversion by the nearest ED was associated with increased 30-day, 90-day, 9-month, and 1-year mortality. JAMA. 2011;305(23):2440-2447 www.jama.com	[Shen, Yu-Chu] USN, Postgrad Sch, Grad Sch Business & Publ Policy, Monterey, CA 93943 USA; [Shen, Yu-Chu] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Hsia, Renee Y.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Emergency Med, San Francisco, CA USA	United States Department of Defense; United States Navy; Naval Postgraduate School; National Bureau of Economic Research; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Shen, YC (corresponding author), USN, Postgrad Sch, Grad Sch Business & Publ Policy, 555 Dyer Rd,Code GB, Monterey, CA 93943 USA.	yshen@nps.edu			Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative [63974]; National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science [KL2 RR024130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative(Robert Wood Johnson Foundation (RWJF)); National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)University of California System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant 63974 from the Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative (Dr Shen), grant KL2 RR024130 from the National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science (Dr Hsia), and the Robert Wood Johnson Foundation Physician Faculty Scholars (Dr Hsia).	ANDRULIS DP, 1991, ANN EMERG MED, V20, P980, DOI 10.1016/S0196-0644(05)82976-2; Auerbach J, 0807494 DHCQ; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Buchmueller TC, 2006, J HEALTH ECON, V25, P740, DOI 10.1016/j.jhealeco.2005.10.006; Burke Laura, 2010, Virtual Mentor, V12, P483, DOI 10.1001/virtualmentor.2010.12.6.pfor2-1006; Burt Catharine W, 2006, Adv Data, P1; Burt Catharine W, 2004, Vital Health Stat 13, P1; Burt CW, 2006, ANN EMERG MED, V47, P317, DOI 10.1016/j.annemergmed.2005.12.001; Cameron Peter, 2002, Aust Health Rev, V25, P59; Castillo EM, 2011, J EMERG MED, V40, P300, DOI 10.1016/j.jemermed.2010.02.023; Cuong J, 2006, ACAD EMERG MED, V13, P1220, DOI 10.1197/j.aem.2006.05.024; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Greene W.H., 2002, ECONOMETRIC ANAL; Health Economics Research Center, I EST TRAV COSTS; Horwitz JR, 2009, J HEALTH ECON, V28, P924, DOI 10.1016/j.jhealeco.2009.06.008; Institute of Medicine, 2007, HOSP BAS EM CAR BREA; Lambe S, 2003, ANN EMERG MED, V41, P35, DOI 10.1067/mem.2003.2; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Magid DJ, 2004, ANN EMERG MED, V44, P586, DOI 10.1016/j.annemergmed.2004.07.449; Mailer's Software, 2006, MAIL SOFTW ZIP DAT; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McConnell KJ, 2005, ANN EMERG MED, V45, P471, DOI 10.1016/j.annemergmed.2004.10.032; Millard WB, 2011, ANN EMERG MED, V57, p15A, DOI 10.1016/j.annemergmed.2011.03.015; National Association of State EMS Officials, IMPL STAT AMB NO DIV; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Norris RM, 2005, HEART, V91, P1537, DOI 10.1136/hrt.2004.057018; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Pines JM, 2008, ANN EMERG MED, V51, P1, DOI 10.1016/j.annemergmed.2007.07.008; Pines JM, 2007, ANN EMERG MED, V50, P510, DOI 10.1016/j.annemergmed.2007.07.021; Pines JM, 2010, ACAD EMERG MED, V17, P834, DOI 10.1111/j.1553-2712.2010.00780.x; Robert Wood Johnson Foundation, EM DEP UT CAP; Schafermeyer Robert W, 2003, Emerg Med (Fremantle), V15, P22, DOI 10.1046/j.1442-2026.2003.00403.x; Schneider S, 2001, ACAD EMERG MED, V8, P1044, DOI 10.1111/j.1553-2712.2001.tb01113.x; Schull MJ, 2004, ANN EMERG MED, V44, P577, DOI 10.1016/j.annemergmed.2004.05.004; Schull MJ, 2003, ACAD EMERG MED, V10, P709, DOI 10.1111/j.1553-2712.2003.tb00064.x; Shenoi RP, 2009, ACAD EMERG MED, V16, P116, DOI 10.1111/j.1553-2712.2008.00317.x; Skinner J, 2009, NBER TECHNICAL WORKI; Stock JH, 2006, NBER TECHNICAL WOR T; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; WILSON M, 2004, BURSTING SEAMS IMPRO; Yankovic N, 2010, INQUIRY-J HEALTH CAR, V47, P81, DOI 10.5034/inquiryjrnl_47.01.81	41	63	63	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2440	2447		10.1001/jama.2011.811	http://dx.doi.org/10.1001/jama.2011.811			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777EB	21666277	Green Accepted, Bronze			2022-12-01	WOS:000291597300024
J	Schwartlander, B; Stover, J; Hallett, T; Atun, R; Avila, C; Gouws, E; Bartos, M; Ghys, PD; Opuni, M; Barr, D; Alsallaq, R; Bollinger, L; de Freitas, M; Garnett, G; Holmes, C; Legins, K; Pillay, Y; Stanciole, AE; McClure, C; Hirnschall, G; Laga, M; Padian, N				Schwartlaender, Bernhard; Stover, John; Hallett, Timothy; Atun, Rifat; Avila, Carlos; Gouws, Eleanor; Bartos, Michael; Ghys, Peter D.; Opuni, Marjorie; Barr, David; Alsallaq, Ramzi; Bollinger, Lori; de Freitas, Marcelo; Garnett, Geoffrey; Holmes, Charles; Legins, Ken; Pillay, Yogan; Stanciole, Anderson Eduardo; McClure, Craig; Hirnschall, Gottfried; Laga, Marie; Padian, Nancy		Investment Framework Study Grp	Towards an improved investment approach for an effective response to HIV/AIDS	LANCET			English	Article							SUB-SAHARAN AFRICA; COMMUNITY-HEALTH WORKERS; ANTIRETROVIRAL THERAPY; HIV PREVENTION; TUBERCULOSIS-CONTROL; MALE CIRCUMCISION; SOUTH-AFRICA; TRANSMISSION; INTERVENTIONS; CHALLENGES	Substantial changes are needed to achieve a more targeted and strategic approach to investment in the response to the HIV/AIDS epidemic that will yield long-term dividends. Until now, advocacy for resources has been done on the basis of a commodity approach that encouraged scaling up of numerous strategies in parallel, irrespective of their relative effects. We propose a strategic investment framework that is intended to support better management of national and international HIV/AIDS responses than exists with the present system. Our framework incorporates major efficiency gains through community mobilisation, synergies between programme elements, and benefits of the extension of antiretroviral therapy for prevention of HIV transmission. It proposes three categories of investment, consisting of six basic programmatic activities, interventions that create an enabling environment to achieve maximum effectiveness, and programmatic efforts in other health and development sectors related to HIV/AIDS. The yearly cost of achievement of universal access to HIV prevention, treatment, care, and support by 2015 is estimated at no less than US$22 billion. Implementation of the new investment framework would avert 12.2 million new HIV infections and 7.4 million deaths from AIDS between 2011 and 2020 compared with continuation of present approaches, and result in 29.4 million life-years gained. The framework is cost effective at $1060 per life-year gained, and the additional investment proposed would be largely offset from savings in treatment costs alone.	[Schwartlaender, Bernhard] Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, Geneva, Switzerland; [Stover, John; Bollinger, Lori] Futures Inst, Glastonbury, CT USA; [Hallett, Timothy; Garnett, Geoffrey] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England; [Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Barr, David] Int Treatment Preparedness Coalit, New York, NY USA; [Alsallaq, Ramzi] Univ Washington, Int Clin Res Ctr, Dept Global Hlth, Seattle, WA 98195 USA; [de Freitas, Marcelo] Natl AIDS Programme, Brasilia, DF, Brazil; [Holmes, Charles; Padian, Nancy] Off US Global AIDS Coordinator, US Presidents Emergency Plan AIDS Relief, Washington, DC USA; [Padian, Nancy] Bill & Melinda Gates Fdn, Seattle, WA USA; [Legins, Ken] UNICEF, New York, NY USA; [Pillay, Yogan] Strateg Hlth Programmes, Dept Hlth, Johannesburg, South Africa; [Stanciole, Anderson Eduardo] World Bank, Global HIVAIDS Unit, Washington, DC 20433 USA; [McClure, Craig; Hirnschall, Gottfried] WHO, CH-1211 Geneva, Switzerland; [Laga, Marie] Inst Trop Med, B-2000 Antwerp, Belgium	UNAIDS; Imperial College London; Imperial College London; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; UNICEF; The World Bank; World Health Organization; Institute of Tropical Medicine (ITM)	Schwartlander, B (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, 20 Ave Apia, Geneva, Switzerland.	schwartlanderb@unaids.org	Atun, Rifat/AAH-5537-2021; Garnett, Geoffrey P/A-9312-2008	Atun, Rifat/0000-0002-1531-5983; Opuni, Marjorie/0000-0002-0939-7695; Hallett, Timothy/0000-0002-9681-0424	Pangea Global AIDS Foundation; Wellcome Trust; GlaxoSmithKline; Merck; Sanofi Pasteur MSD for HPV vaccination works; Bill & Melinda Gates Foundation; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719B, G0600719] Funding Source: researchfish	Pangea Global AIDS Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Sanofi Pasteur MSD for HPV vaccination works; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DB received consultation fees payment from Pangea Global AIDS Foundation and unrelated honoraria from UNAIDS, International Civil Society Support Project and Merck Foundation. GG received grant from the Wellcome Trust and was paid consultancy fees by GlaxoSmithKline, Merck and Sanofi Pasteur MSD for HPV vaccination works. TH received grant from Wellcome Trust for Fellowship and received grants and consultation fees from the Bill & Melinda Gates Foundation. NP received consultation fees from the Bill & Melinda Gates Foundation. The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the US Department of State.	*AIDS 2031 COSTS F, COSTS CHOIC FIN LONG; [Anonymous], REP GLOB AIDS EP 200; [Anonymous], 2010, NEW HIV INF MOD TRAN; Atun RA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2165; Atun R, 2010, INT J DRUG POLICY, V21, P103, DOI 10.1016/j.drugpo.2010.01.002; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bollinger LA, 2008, AIDS, V22, pS51, DOI 10.1097/01.aids.0000327623.31856.45; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; DiClemente RJ, 2007, J PEDIATR PSYCHOL, V32, P888, DOI 10.1093/jpepsy/jsm056; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Frumence G, 2010, SAHARA J-J SOC ASP H, V7, P9, DOI 10.1080/17290376.2010.9724964; *GLOB FUND FIGHT A, 3 REPL 2011 13 FIN H; *GLOB FUND FIGHT A, 2008, 18 BOARD M NOV; *GLOB FUND FIGHT A, 2010, 22 BOARD M DEC; *GLOB FUND FIGHT A, GLOB FUND 2010 INN I; Gouws E, 2010, SEX TRANSM INFECT, V86, pI72, DOI 10.1136/sti.2010.044933; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; GROWN C, FINANCIAL REQUIREMEN; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hayes R, 2010, AIDS, V24, pS81, DOI 10.1097/01.aids.0000390710.04255.2b; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; HESTER V, ASSESSING C IN PRESS; Hirnschall G, 2011, LANCET, V378, P209, DOI 10.1016/S0140-6736(11)60247-X; JOUQUET G, 2009, 5 INT AIDS SOC C CAP; Kenya National Aids Control Council, 2009, KEN HIV PREV RESP MO; Kunihira NR, 2010, AFR HEALTH SCI, V10, P120; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; LOEVINSOHN M, 2003, 157 FCND INT FOOD PO; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Low-Beer D., 2010, GLOB HLTH GOV, V4, P1; Macneil J, 2011, DRUG ALCOHOL REV, V30, P26, DOI 10.1111/j.1465-3362.2010.00188.x; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Narayanan S, 2011, INT J DRUG POLICY, V22, P311, DOI 10.1016/j.drugpo.2011.01.002; *NAT I ALL INF DIS, QUEST ANSW HPTN 052; Nyamathi AM, 2011, HEALTH CARE WOMEN IN, V32, P300, DOI 10.1080/07399332.2010.536282; Oosterhoff P, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)32408-2; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; PADIAN NS, LANCET IN PRESS; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; *PEPFAR, 2011, PEPFAR MAK SMART INV; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Rhodes T., 2010, EMCDDA MONOGRAPHS HA; ROSEN S, 2011, PEPFAR SUPPORTED EVA; SABAPATHY K, 2011, J ACQ IMMUN DEF SYND, DOI DOI 10.1097/QA1.0B013E318218A713; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Scalway T., 2010, PRESENTING EVIDENCE; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Shin S, 2011, HEALTH SOC CARE COMM, V19, P261, DOI 10.1111/j.1365-2524.2010.00968.x; Sidibe M., 2010, GLOBAL HLTH GOVERNAN, V4, P1; STOVER J, 2010, FINANCIAL RESOURCES; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; TEMIN M, HIV SENSITIVE SOCIAL; *UN, REP SECR GEN UN UN A; *UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS, 2011, UNAIDS 2011 2015 STR; *UNAIDS, 2009, P THINK TANK EV METH; *UNAIDS, TREATM 2 0; *UNAIDS, 2011, AIDS 2011 PROGR OWN; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS, FIN RESP AIDS LOW MI; UNICEF UNAIDS WHO UNFPA UNESCO, 2010, CHILDR AIDS 5 STOCKT; United Nations June, 2001, DECL COMM HIV AIDS U; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; *WHO, 2010, COUNTR HLTH INF; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; World Health Organisation (WHO), 2009, WHO UNODC UNAIDS TEC; World Health Organization, 2003, WHO GUID COST EFF AN	87	355	358	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2011	377	9782					2031	2041		10.1016/S0140-6736(11)60702-2	http://dx.doi.org/10.1016/S0140-6736(11)60702-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21641026				2022-12-01	WOS:000292011700038
J	Lin, IH; Miller, DS; Bertics, PJ; Murphy, CJ; de Pablo, JJ; Abbott, NL				Lin, I-Hsin; Miller, Daniel S.; Bertics, Paul J.; Murphy, Christopher J.; de Pablo, Juan J.; Abbott, Nicholas L.			Endotoxin-Induced Structural Transformations in Liquid Crystalline Droplets	SCIENCE			English	Article							DEFECTS	The ordering of liquid crystals (LCs) is known to be influenced by surfaces and contaminants. Here, we report that picogram per milliliter concentrations of endotoxin in water trigger ordering transitions in micrometer-size LC droplets. The ordering transitions, which occur at surface concentrations of endotoxin that are less than 10(-5) Langmuir, are not due to adsorbate-induced changes in the interfacial energy of the LC. The sensitivity of the LC to endotoxin was measured to change by six orders of magnitude with the geometry of the LC (droplet versus slab), supporting the hypothesis that interactions of endotoxin with topological defects in the LC mediate the response of the droplets. The LC ordering transitions depend strongly on glycophospholipid structure and provide new designs for responsive soft matter.	[Lin, I-Hsin; Miller, Daniel S.; de Pablo, Juan J.; Abbott, Nicholas L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Bertics, Paul J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Murphy, Christopher J.] Univ Calif Davis, Sch Med, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA; [Murphy, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Vet Surg & Radiol Sci, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Abbott, NL (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.	abbott@engr.wisc.edu	de Pablo, Juan/AAJ-9161-2021; Miller, Daniel S./AAH-3422-2020; Miller, Daniel/G-8578-2013		NSF [DMR-0520527]; Army Research Office [W911NF-07-1-0446, W911NF-06-1-0314]; National Institutes of Health [CA108467, CA105730]; NATIONAL CANCER INSTITUTE [R01CA108467, R21CA105730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092004] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Army Research Office; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was primarily supported by NSF through DMR-0520527 (Materials Research Science and Engineering Center), the Army Research Office (W911NF-07-1-0446 and W911NF-06-1-0314), and the National Institutes of Health (CA108467 and CA105730). The technical assistance of B. Carlton is gratefully acknowledged. A patent application based on this work has been filed by the Wisconsin Alumni Research Foundation (P09241US02). N.L.A. and C.J.M. are members of the board of directors of Platypus Technologies LLC, a startup company set up to develop analytic methods based on liquid crystals.	Brake JM, 2003, SCIENCE, V302, P2094, DOI 10.1126/science.1091749; Chen XM, 2008, LANGMUIR, V24, P541, DOI 10.1021/la701844s; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Fernandez-Nieves A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157801; Gupta JK, 2009, ANGEW CHEM INT EDIT, V48, P1652, DOI 10.1002/anie.200804500; Hu DH, 2000, NATURE, V405, P1030, DOI 10.1038/35016520; Lavrentovich OD, 1998, LIQ CRYST, V24, P117, DOI 10.1080/026782998207640; Lee BW, 2001, SCIENCE, V291, P2576, DOI 10.1126/science.291.5513.2576; McCamley MK, 2007, PROC SPIE, V6441, DOI 10.1117/12.725767; McCamley MK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3148861; Meli MV, 2008, J AM CHEM SOC, V130, P4326, DOI 10.1021/ja077379a; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Prischepa OO, 2004, JETP LETT+, V79, P257, DOI 10.1134/1.1759405; Queisser HJ, 1998, SCIENCE, V281, P945, DOI 10.1126/science.281.5379.945; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ravnik M, 2010, FARADAY DISCUSS, V144, P159, DOI 10.1039/b908676e; Romalis M, 2008, NATURE, V455, P606, DOI 10.1038/455606a; Simon J, 2010, SCIENCE, V327, P60, DOI 10.1126/science.1183226; Sivakumar S, 2009, ADV FUNCT MATER, V19, P2260, DOI 10.1002/adfm.200900399; Skarabot M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031705; Volovik G. E., 1983, Soviet Physics - JETP, V58, P1159; Zapotocky M, 1999, SCIENCE, V283, P209, DOI 10.1126/science.283.5399.209	23	277	285	0	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1297	1300		10.1126/science.1195639	http://dx.doi.org/10.1126/science.1195639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21596951	Green Accepted			2022-12-01	WOS:000291441700039
J	Luo, DG; Yue, WWS; Ala-Laurila, P; Yau, KW				Luo, Dong-Gen; Yue, Wendy W. S.; Ala-Laurila, Petri; Yau, King-Wai			Activation of Visual Pigments by Light and Heat	SCIENCE			English	Article							DARK NOISE; SPECTRAL PROPERTIES; THERMAL-ACTIVATION; ROD PHOTORECEPTORS; RETINAL CONES; TOAD RETINA; PHOTOTRANSDUCTION; PHOTOACTIVATION; CHROMOPHORE; RHODOPSIN	Vision begins with photoisomerization of visual pigments. Thermal energy can complement photon energy to drive photoisomerization, but it also triggers spontaneous pigment activation as noise that interferes with light detection. For half a century, the mechanism underlying this dark noise has remained controversial. We report here a quantitative relation between a pigment's photoactivation energy and its peak-absorption wavelength, lambda(max). Using this relation and assuming that pigment activations by light and heat go through the same ground-state isomerization energy barrier, we can predict the relative noise of diverse pigments with multi-vibrational-mode thermal statistics. The agreement between predictions and our measurements strongly suggests that pigment noise arises from canonical isomerization. The predicted high noise for pigments with lambda(max) in the infrared presumably explains why they apparently do not exist in nature.	[Luo, Dong-Gen; Yue, Wendy W. S.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Luo, Dong-Gen; Yue, Wendy W. S.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Yue, Wendy W. S.] Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol Grad Program, Baltimore, MD 21205 USA; [Ala-Laurila, Petri] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ala-Laurila, Petri] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Ala-Laurila, Petri] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Helsinki	Luo, DG (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dgluo@jhmi.edu; kwyau@mail.jhmi.edu	Ala-Laurila, Petri/AAE-1203-2019; Luo, Donggen/D-5990-2011	Ala-Laurila, Petri/0000-0002-6139-6825; 	U.S. NIH [EY06837]; Antonio Champalimaud Vision Award; Academy of Finland [123231]; NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Champalimaud Vision Award; Academy of Finland(Academy of Finland); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a U.S. NIH grant (EY06837) and the Antonio Champalimaud Vision Award (Portugal) to K.-W.Y and a grant (123231) from the Academy of Finland to P. A.-L. We thank R. S. Molday and J.-X. Ma for the antibodies against rhodopsin and blue cone pigment, respectively; J. Chen for the transgenic mouse line expressing mouse S-cone opsin in the rods; X. Lin for mathematical help; M. T. H. Do for critique; T. Xue and Y. P. Wang for computational help; and V. S. Batista, R. R. Birge, P. J. Dagdigian, T. Ebrey, B. Honig, M. Karplus, J. E. Kim, B. E. Knox, C. L. Makino, R. A. Mathies, J. Nathans, T. P. Sakmar, J. L. Schnapf, K. Schulten, T. G. Wensel, T. B. Woolf, and E. C. Y. Yan for discussions. D.-G. L. and K.-W.Y. designed the experiments, did the data analysis, developed the theory, and wrote the paper; D.-G. L. performed all of the electrophysiological experiments; W. W. S. Y did the retinal immunolabeling and participated in the measurement of thermal activity of Bufo red rods as well as writing; and P. A.-L. contributed to the theory and participated in discussion.	Ala-Laurila P, 2004, VISION RES, V44, P2153, DOI 10.1016/j.visres.2004.03.031; Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Ala-Laurila P, 2003, VISUAL NEUROSCI, V20, P411, DOI 10.1017/S0952523803204065; Ala-Laurila P, 2002, VISUAL NEUROSCI, V19, P781, DOI 10.1017/S0952523802196088; Ala-Laurila P, 2007, J PHYSIOL-LONDON, V585, P57, DOI 10.1113/jphysiol.2007.142935; Atkins P., 2006, ATKINS PHYS CHEM, Veighth; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; CRESCITELLI F, 1984, VISION RES, V24, P1551, DOI 10.1016/S0042-6989(84)80004-8; DONNER K, 1990, J PHYSIOL-LONDON, V428, P673, DOI 10.1113/jphysiol.1990.sp018234; Dukkipati A, 2002, BIOCHEMISTRY-US, V41, P9842, DOI 10.1021/bi025883g; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Goodeve C. F., 1936, P ROY SOC LOND A MAT, V155, P664; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Hinshelwood C. N., 1940, KINETICS CHEM CHANGE, p[39, 79]; Holbrook K. A., 1996, UNIMOLECULAR REACTIO, P1; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Luo DG, 2005, J GEN PHYSIOL, V126, P263, DOI 10.1085/jgp.200509342; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MANSFIELD RJW, 1985, VISUAL SYSTEM, P89; Mathies R A, 1999, Novartis Found Symp, V224, P70; Mathies RA, 1999, NOVART FDN SYMP, V224, P84; MATSUMOTO H, 1975, BIOCHIM BIOPHYS ACTA, V404, P300, DOI 10.1016/0304-4165(75)90337-2; MATTHEWS G, 1984, J PHYSIOL-LONDON, V349, P607, DOI 10.1113/jphysiol.1984.sp015176; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Sakurai K, 2007, J GEN PHYSIOL, V130, P21, DOI 10.1085/jgp.200609729; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; STGEORGE RCC, 1952, J GEN PHYSIOL, V35, P495, DOI 10.1085/jgp.35.3.495; Stiles W. S., 1948, T OPTICAL CONVENTION, P97	41	91	94	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1307	1312		10.1126/science.1200172	http://dx.doi.org/10.1126/science.1200172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659602	Green Accepted			2022-12-01	WOS:000291441700042
J	Dolgin, E				Dolgin, Elie			The murine candidate	NATURE			English	Editorial Material							HEPATITIS-C; INFECTION; MODEL; MICE											Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Brenndorfer ED, 2010, HEPATOLOGY, V52, P1553, DOI 10.1002/hep.23870; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Ohara E, 2011, J HEPATOL, V54, P872, DOI 10.1016/j.jhep.2010.08.033; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001	7	5	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S14	S15		10.1038/474S14a	http://dx.doi.org/10.1038/474S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666729				2022-12-01	WOS:000291397800009
J	Tsukazaki, T; Mori, H; Echizen, Y; Ishitani, R; Fukai, S; Tanaka, T; Perederina, A; Vassylyev, DG; Kohno, T; Maturana, AD; Ito, K; Nureki, O				Tsukazaki, Tomoya; Mori, Hiroyuki; Echizen, Yuka; Ishitani, Ryuichiro; Fukai, Shuya; Tanaka, Takeshi; Perederina, Anna; Vassylyev, Dmitry G.; Kohno, Toshiyuki; Maturana, Andres D.; Ito, Koreaki; Nureki, Osamu			Structure and function of a membrane component SecDF that enhances protein export	NATURE			English	Article							ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; CYTOPLASMIC MEMBRANE; CHANNEL; COMPLEX; MACHINERY; MECHANISM; MOVEMENT; DOMAIN	Protein translocation across the bacterial membrane, mediated by the secretory translocon SecYEG and the SecA ATPase(1-4), is enhanced by proton motive force(5,6) and membrane-integrated SecDF(7-9), which associates with SecYEG. The role of SecDF has remained unclear, although it is proposed to function in later stages of translocation as well as in membrane protein biogenesis(4,10-13). Here, we determined the crystal structure of Thermus thermophilus SecDF at 3.3 angstrom resolution, revealing a pseudo-symmetrical, 12-helix transmembrane domain belonging to the RND superfamily and two major periplasmic domains, P1 and P4. Higher-resolution analysis of the periplasmic domains suggested that P1, which binds an unfolded protein, undergoes functionally important conformational changes. In vitro analyses identified an ATP-independent step of protein translocation that requires both SecDF and proton motive force. Electrophysiological analyses revealed that SecDF conducts protons in a manner dependent on pH and the presence of an unfolded protein, with conserved Asp and Arg residues at the transmembrane interface between SecD and SecF playing essential roles in the movements of protons and preproteins. Therefore, we propose that SecDF functions as a membrane-integrated chaperone, powered by proton motive force, to achieve ATP-independent protein translocation.	[Tsukazaki, Tomoya; Echizen, Yuka; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Mori, Hiroyuki] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Fukai, Shuya] Univ Tokyo, Synchrotron Radiat Res Org, Div Life Sci, Struct Biol Lab, Tokyo 1130032, Japan; [Fukai, Shuya] Univ Tokyo, Ctr Struct Biol Challenging Prot, Lab Macromol Complexes, Tokyo 1130032, Japan; [Tanaka, Takeshi; Kohno, Toshiyuki] Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Maturana, Andres D.] Nagaoka Univ Technol, Dept Bioengn, Niigata 9402188, Japan; [Ito, Koreaki] Kyoto Sangyo Univ, Kita Ku, Kyoto 6038555, Japan	University of Tokyo; Kyoto University; University of Tokyo; University of Tokyo; Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Nagaoka University of Technology; Kyoto Sangyo University	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan.	kito@cc.kyoto-su.ac.jp; nureki@ims.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; Tsukazaki, Tomoya/N-2299-2019; Fukai, Shuya/X-4838-2018	Tsukazaki, Tomoya/0000-0002-6386-723X; Fukai, Shuya/0000-0002-1241-1443; Mori, Hiroyuki/0000-0002-0429-1269	Ministry of Education, Culture, Sports, Science and Technology (MEXT); JST; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074840] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22121003, 20247020] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Akiyama, R. Suno, Y. Morimoto, T. Minamino, K. Namba, K. Inaba, M. Hattori and H. Nishimasu for suggestions; T. Sakamoto and A. Kurabayashi for assistance with sample preparation; R. Yamasaki, M. Sano, K. Mochizuki, K. Yoshikaie, K. Imayoshi and T. Adachi for technical support; M. Homma and S. Kojima for providing the Vibrio genomic DNA; the beamline staff members at BL41XU of SPring-8 (Hyogo, Japan) and at NW12 of KEK PF-AR (Tsukuba, Japan) for technical help during data collection and M. Ibba for comments on our manuscript. This work was supported by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to O.N., by a CREST grant from JST to K.I., by a BIRD grant from JST to H.M. and R.I., by a grant for the National Project on Protein Structural and Functional Analyses to O.N., by NIH grants to D.G.V. and by grants from MEXT to T. Tsukazaki, H.M., R.I., S.F. and K.I.	ARKOWITZ RA, 1994, EMBO J, V13, P954, DOI 10.1002/j.1460-2075.1994.tb06340.x; DRIESSEN AJM, 1991, P NATL ACAD SCI USA, V88, P2471, DOI 10.1073/pnas.88.6.2471; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Hand NJ, 2006, J BACTERIOL, V188, P1251, DOI 10.1128/JB.188.4.1251-1259.2006; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Matsuo E, 1998, J BIOL CHEM, V273, P18835, DOI 10.1074/jbc.273.30.18835; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nouwen N, 2005, J BACTERIOL, V187, P5857, DOI 10.1128/JB.187.16.5857-5860.2005; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; SAGARA K, 1994, J BACTERIOL, V176, P4111, DOI 10.1128/JB.176.13.4111-4116.1994; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Seeger MA, 2009, BIOCHEMISTRY-US, V48, P5801, DOI 10.1021/bi900446j; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tsukazaki T, 2006, ACTA CRYSTALLOGR F, V62, P376, DOI 10.1107/S1744309106007779; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Uchida K, 1995, J BIOL CHEM, V270, P30862, DOI 10.1074/jbc.270.52.30862; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	27	159	171	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					235	238		10.1038/nature09980	http://dx.doi.org/10.1038/nature09980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21562494	Green Accepted			2022-12-01	WOS:000291397800055
J	Jha, P; Kesler, MA; Kumar, R; Ram, F; Ram, U; Aleksandrowicz, L; Bassani, DG; Chandra, S; Banthia, JK				Jha, Prabhat; Kesler, Maya A.; Kumar, Rajesh; Ram, Faujdar; Ram, Usha; Aleksandrowicz, Lukasz; Bassani, Diego G.; Chandra, Shailaja; Banthia, Jayant K.			Trends in selective abortions of girls in India: analysis of nationally representative birth histories from 1990 to 2005 and census data from 1991 to 2011	LANCET			English	Article							SEX-RATIOS; TECHNOLOGY; POPULATION; MORTALITY	Background India's 2011 census revealed a growing imbalance between the numbers of girls and boys aged 0-6 years, which we postulate is due to increased prenatal sex determination with subsequent selective abortion of female fetuses. We aimed to establish the trends in sex ratio by birth order from 1990 to 2005 with three nationally representative surveys and to quantify the totals of selective abortions of girls with census cohort data. Methods We assessed sex ratios by birth order in 0.25 million births in three rounds of the nationally representative National Family Health Survey covering the period from 1990 to 2005. We estimated totals of selective abortion of girls by assessing the birth cohorts of children aged 0-6 years in the 1991,2001, and 2011 censuses. Our main statistic was the conditional sex ratio of second-order births after a firstborn girl and we used 3-year rolling weighted averages to test for trends, with differences between trends compared by linear regression. Findings The conditional sex ratio for second-order births when the firstborn was a girl fell from 906 per 1000 boys (99% CI 798-1013) in 1990 to 836 (733-939) in 2005; an annual decline of 0.52% (p for trend=0.002). Declines were much greater in mothers with 10 or more years of education than in mothers with no education, and in wealthier households compared with poorer households. By contrast, we did not detect any significant declines in the sex ratio for second-order births if the firstborn was a boy, or for firstborns. Between the 2001 and 2011 censuses, more than twice the number of Indian districts (local administrative areas) showed declines in the child sex ratio as districts with no change or increases. After adjusting for excess mortality rates in girls, our estimates of number of selective abortions of girls rose from 0-2.0 million in the 1980s, to 1.2-4.1 million in the 1990s, and to 3.1-6.0 million in the 2000s. Each 1% decline in child sex ratio at ages 0-6 years implied 1.2-3.6 million more selective abortions of girls. Selective abortions of girls totalled about 4.2-12.1 million from 1980-2010, with a greater rate of increase in the 1990s than in the 2000s. Interpretation Selective abortion of girls, especially for pregnancies after a firstborn girl, has increased substantially in India. Most of India's population now live in states where selective abortion of girls is common.	[Jha, Prabhat; Kesler, Maya A.; Ram, Usha; Aleksandrowicz, Lukasz; Bassani, Diego G.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada; [Jha, Prabhat; Kesler, Maya A.; Ram, Usha; Aleksandrowicz, Lukasz; Bassani, Diego G.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 2C5, Canada; [Kumar, Rajesh] Post Grad Inst Med Res & Educ, Sch Publ Hlth, Chandigarh, India; [Ram, Faujdar; Ram, Usha] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Chandra, Shailaja] Govt India, Natl Populat Stabilisat Fund, New Delhi, India; [Banthia, Jayant K.] Govt Maharasthra, Mumbai, Maharashtra, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; International Institute for Population Sciences	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada.	prabhat.jha@utoronto.ca	Bassani, Diego/G-2827-2015; Ram, Usha/AAS-4140-2020	Bassani, Diego/0000-0001-6704-3820; Ram, Usha/0000-0001-6722-7347; Aleksandrowicz, Lukasz/0000-0002-3644-1372	Fogarty International Centre of the US National Institutes of Health [R01 TW05991-01]; International Development Research Centre [102172]; Canadian Institute of Health Research (CIHR) [IEG-53506]; Li Ka Shing Knowledge Institute at St Michael's Hospital; University of Toronto; Canada Research Chair programme; FOGARTY INTERNATIONAL CENTER [R01TW007939, R01TW005991] Funding Source: NIH RePORTER	Fogarty International Centre of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Development Research Centre; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute at St Michael's Hospital; University of Toronto(University of Toronto); Canada Research Chair programme(Canada Research Chairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Registrar-General of India first established the ongoing national census in 1881, and is presently collaborating with several of the authors on the Million Death Study. External funding is from the Fogarty International Centre of the US National Institutes of Health (grant R01 TW05991-01]), International Development Research Centre (grant 102172), Canadian Institute of Health Research (CIHR; IEG-53506), and the Li Ka Shing Knowledge Institute at St Michael's Hospital and University of Toronto (CGHR support). PJ is supported by the Canada Research Chair programme. The opinions expressed in this report are those of the authors and do not necessarily represent those of the Government of India. We thank Rahim Moineddin and Wilson Suraweera for statistical help, Vicky Hsiao and Brendon Pezzack for graphics, and Daniel Rosenblum and Ansely Wong for comments.	Agarwal Shonali, 2007, J Indian Med Assoc, V105, P132; Almond D, 2008, P NATL ACAD SCI USA, V105, P5681, DOI 10.1073/pnas.0800703105; Almond Jr D., 2009, 15391 NBER; [Anonymous], 2009, WORLD POP PROSP; [Anonymous], 2019, NATL FAMILY HLTH SUR; Bardia A, 2004, NATL MED J INDIA, V17, P207; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; BHAT M, 2007, WATERING NEIGHBOURS; COALE AJ, 1991, POPUL DEV REV, V17, P517, DOI 10.2307/1971953; George SM, 2006, PRENATAL DIAG, V26, P604, DOI 10.1002/pd.1475; *GOV IND, 2005, ANN REP IMPL PREC PR; Hatti N, 2004, LUND PAPERS EC HIST, V93; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; International Institute for Population Sciences, 2005, NAT FAM HLTH SURV NF; International Institute for Population Sciences, 1992, NAT FAM HLTH SURV NF; International Institute of Population Sciences, 2010, DISTR LEV HOUS SURV; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Jha P., 2009, CHOOSING HLTH ENTITL; Kulkarni P.M, 2007, ESTIMATION MISSING G; Miller R. G., 1981, SURVIVAL ANAL; Pallikadavath S, 2006, INT FAM PLAN PERSPEC, V32, P120, DOI 10.1363/3212006; *REG GEN IND, 2007, SAMPL REG SYST BAS S; *REG GEN IND, 2011, CENS IND 2011 INSTR; *REG GEN IND, 2001, CENS IND 2001 POST S; Registrar General India, 2009, SAMPL REG SYST STAT; Rodgers JL., 2001, CHANCE MAG, V14, P8, DOI DOI 10.1080/09332480.2001.10542293; Subramanian SV, 2009, J EPIDEMIOL COMMUN H, V63, P245, DOI 10.1136/jech.2008.078477; Teitelbaum M S, 1970, J Biosoc Sci Suppl, V2, P61; World Bank, 2009, WORLD DEV IND; Zhu WX, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1211	30	150	153	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2011	377	9781					1921	1928		10.1016/S0140-6736(11)60649-1	http://dx.doi.org/10.1016/S0140-6736(11)60649-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777LW	21612820	Green Accepted			2022-12-01	WOS:000291623200028
J	Qian, L; Winfree, E				Qian, Lulu; Winfree, Erik			Scaling Up Digital Circuit Computation with DNA Strand Displacement Cascades	SCIENCE			English	Article							AMPLIFICATION; EXPRESSION; LANGUAGE; MACHINE	To construct sophisticated biochemical circuits from scratch, one needs to understand how simple the building blocks can be and how robustly such circuits can scale up. Using a simple DNA reaction mechanism based on a reversible strand displacement process, we experimentally demonstrated several digital logic circuits, culminating in a four-bit square-root circuit that comprises 130 DNA strands. These multilayer circuits include thresholding and catalysis within every logical operation to perform digital signal restoration, which enables fast and reliable function in large circuits with roughly constant switching time and linear signal propagation delays. The design naturally incorporates other crucial elements for large-scale circuitry, such as general debugging tools, parallel circuit preparation, and an abstraction hierarchy supported by an automated circuit compiler.	[Qian, Lulu; Winfree, Erik] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Winfree, E (corresponding author), CALTECH, Pasadena, CA 91125 USA.	winfree@caltech.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523	NSF [0728703, 0832824]; Human Frontier Science Program [RGY0074/2006-C]	NSF(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program)	We thank D. Y. Zhang for providing useful comments on the manuscript. Supported by NSF grants 0728703 and 0832824 (Molecular Programming Project) and Human Frontier Science Program award RGY0074/2006-C.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Bois J. S., 2007, THESIS CALTECH; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chiniforooshan E, 2011, LECT NOTES COMPUT SC, V6518, P25, DOI 10.1007/978-3-642-18305-8_3; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Dittmer WU, 2004, ANGEW CHEM INT EDIT, V43, P3550, DOI 10.1002/anie.200353537; Eckhoff G., 2010, J SYST CHEM, V1, P13, DOI DOI 10.1186/1759-2208-1-13; Elbaz J, 2010, NAT NANOTECHNOL, V5, P417, DOI [10.1038/NNANO.2010.88, 10.1038/nnano.2010.88]; Goel A, 2009, LECT NOTES COMPUT SC, V5877, P67, DOI 10.1007/978-3-642-10604-0_7; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Muller D. E., 1963, SWITCHING THEORY SPA, P289; Phillips A, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0072.focus; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Qian L, 2011, LECT NOTES COMPUT SC, V6518, P123, DOI 10.1007/978-3-642-18305-8_12; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Tian JD, 2009, MOL BIOSYST, V5, P714, DOI 10.1039/b822268c; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Venkataraman S, 2010, P NATL ACAD SCI USA, V107, P16777, DOI 10.1073/pnas.1006377107; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	32	916	973	41	571	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1196	1201		10.1126/science.1200520	http://dx.doi.org/10.1126/science.1200520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636773				2022-12-01	WOS:000291205200048
J	Schwartz, AV; Vittinghoff, E; Bauer, DC; Hillier, TA; Strotmeyer, ES; Ensrud, KE; Donaldson, MG; Cauley, JA; Harris, TB; Koster, A; Womack, CR; Palermo, L; Black, DM				Schwartz, Ann V.; Vittinghoff, Eric; Bauer, Douglas C.; Hillier, Teresa A.; Strotmeyer, Elsa S.; Ensrud, Kristine E.; Donaldson, Meghan G.; Cauley, Jane A.; Harris, Tamara B.; Koster, Annemarie; Womack, Catherine R.; Palermo, Lisa; Black, Dennis M.		SOF Res Grp; Osteoporotic Fractures Men MrOS Re; Hlth ABC Res Grp	Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; OSTEOPOROTIC FRACTURES; BODY-COMPOSITION; WOMEN; MEN; PREDICTION; HEALTH; HIP; THIAZOLIDINEDIONES; METAANALYSIS	Context Type 2 diabetes mellitus (DM) is associated with higher bone mineral density (BMD) and paradoxically with increased fracture risk. It is not known if low BMD, central to fracture prediction in older adults, identifies fracture risk in patients with DM. Objective To determine if femoral neck BMD T score and the World Health Organization Fracture Risk Algorithm (FRAX) score are associated with hip and nonspine fracture risk in older adults with type 2 DM. Design, Setting, and Participants Data from 3 prospective observational studies with adjudicated fracture outcomes (Study of Osteoporotic Fractures [December 1998-July 2008]; Osteoporotic Fractures in Men Study [March 2000-March 2009]; and Health, Aging, and Body Composition study [April 1997-June 2007]) were analyzed in older community-dwelling adults (9449 women and 7436 men) in the United States. Main Outcome Measure Self-reported incident fractures, which were verified by radiology reports. Results Of 770 women with DM, 84 experienced a hip fracture and 262 a nonspine fracture during a mean (SD) follow-up of 12.6 (5.3) years. Of 1199 men with DM, 32 experienced a hip fracture and 133 a nonspine fracture during a mean (SD) follow-up of 7.5 (2.0) years. Age-adjusted hazard ratios (HRs) for 1-unit decrease in femoral neck BMD T score in women with DM were 1.88 (95% confidence interval [CI], 1.43-2.48) for hip fracture and 1.52 (95% CI, 1.31-1.75) for nonspine fracture, and in men with DM were 5.71 (95% CI, 3.42-9.53) for hip fracture and 2.17 (95% CI, 1.75-2.69) for nonspine fracture. The FRAX score was also associated with fracture risk in participants with DM (HRs for 1-unit increase in FRAX hip fracture score, 1.05; 95% CI, 1.03-1.07, for women with DM and 1.16; 95% CI, 1.07-1.27, for men with DM; HRs for 1-unit increase in FRAX osteoporotic fracture score, 1.04; 95% CI, 1.02-1.05, for women with DM and 1.09; 95% CI, 1.04-1.14, for men with DM). However, for a given T score and age or for a given FRAX score, participants with DM had a higher fracture risk than those without DM. For a similar fracture risk, participants with DM had a higher T score than participants without DM. For hip fracture, the estimated mean difference in T score for women was 0.59 (95% CI, 0.31-0.87) and for men was 0.38 (95% CI, 0.09-0.66). Conclusions Among older adults with type 2 DM, femoral neck BMD T score and FRAX score were associated with hip and nonspine fracture risk; however, in these patients compared with participants without DM, the fracture risk was higher for a given T score and age or for a given FRAX score. JAMA. 2011;305(21):2184-2192 www.jama.com	[Schwartz, Ann V.; Vittinghoff, Eric; Bauer, Douglas C.; Palermo, Lisa; Black, Dennis M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94107 USA; [Hillier, Teresa A.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Strotmeyer, Elsa S.; Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ensrud, Kristine E.] Univ Minnesota, VA Med Ctr, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Donaldson, Meghan G.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Harris, Tamara B.; Koster, Annemarie] NIA, Intramural Res Program, Bethesda, MD 20892 USA; [Koster, Annemarie] Maastricht Univ, Dept Hlth Care Studies, Maastricht, Netherlands; [Womack, Catherine R.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; California Pacific Medical Center; California Pacific Medical Center Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; University of Tennessee System; University of Tennessee Health Science Center	Schwartz, AV (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Lobby 5,Ste 5700, San Francisco, CA 94107 USA.	aschwartz@psg.ucsf.edu	Strotmeyer, Elsa S/F-3015-2014; Koster, Annemarie/E-7438-2010; Newman, Anne B./C-6408-2013	Koster, Annemarie/0000-0003-1583-7391; Newman, Anne B./0000-0002-0106-1150; Cauley, Jane A/0000-0003-0752-4408; Strotmeyer, Elsa/0000-0002-4093-6036; Ensrud, Kristine/0000-0002-9069-3036	Amgen; Novartis; Roche; Merck; National Institutes of Health; National Institute on Aging [R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, R01 AG027576, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]; American Diabetes Association [1-04-JF-46]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health Roadmap for Medical Research [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]; National Institute of Nursing Research [R01-NR012459]; National Institutes of Health, National Institute on Aging; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045654, R01AR035583, U01AR045580, U01AR045583, R01AR035584, K24AR051895, U01AR045614, U01AR045632, R01AR035582, U01AR045647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, R01AG005407, U01AG018197, R01AG027574, U01AG027810, R01AG028050, R01AG027576, U01AG042140, N01AG062101, R01AG005394, N01AG062106] Funding Source: NIH RePORTER	Amgen(Amgen); Novartis(Novartis); Roche(Roche Holding); Merck(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Diabetes Association(American Diabetes Association); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Schwartz reported receiving honorarium from Amgen. Dr Bauer reported receiving research support from Amgen and Novartis. Dr Ensrud reported receiving travel support from Merck and Pfizer. Ms Palermo reported that she is a consultant for Nycomed. Dr Black reported receiving research support from Novartis, Roche, Merck, and Amgen. No other authors reported any disclosures.; This study was funded by an investigator-initiated grant from Amgen (Dr Schwartz). The Study of Osteoporotic Fractures is supported by National Institutes of Health funding. The National Institute on Aging provides support under the following grants: R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, and R01 AG027576. The Osteoporotic Fractures in Men study is supported by National Institutes of Health funding and by grant 1-04-JF-46 from the American Diabetes Association (Dr Strotmeyer). The National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute on Aging, the National Center for Research Resources, and the National Institutes of Health Roadmap for Medical Research provided support under the following grants: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140. The Health, Aging, and Body Composition study is supported by contracts N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106 from the National Institute on Aging; grant R01-AG028050 from the National Institute on Aging; grant R01-NR012459 from the National Institute of Nursing Research; and by the Intramural Research Program of the National Institutes of Health, National Institute on Aging.	[Anonymous], 2010, CLIN GUID PREV TREAT; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Bonds DE, 2006, J CLIN ENDOCR METAB, V91, P3404, DOI 10.1210/jc.2006-0614; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; Donaldson MG, 2010, J BONE MINER RES, V25, P1506, DOI 10.1002/jbmr.55; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Melton LJ, 2008, J BONE MINER RES, V23, P1334, DOI [10.1359/jbmr.080323, 10.1359/JBMR.080323]; Newman AB, 2003, J AM GERIATR SOC, V51, P323, DOI 10.1046/j.1532-5415.2003.51105.x; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Patel S, 2008, CALCIFIED TISSUE INT, V82, P87, DOI 10.1007/s00223-007-9082-5; Schwartz AV, 2002, DIABETES CARE, V25, P1749, DOI 10.2337/diacare.25.10.1749; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Strotmeyer ES, 2005, ARCH INTERN MED, V165, P1612, DOI 10.1001/archinte.165.14.1612; Vashishth Deepak, 2007, Curr Osteoporos Rep, V5, P62; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; World Health Organization, FRAX WHO FRACT RISK; Yamamoto M, 2007, CALCIFIED TISSUE INT, V80, P353, DOI 10.1007/s00223-007-9003-7	26	430	463	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2011	305	21					2184	2192		10.1001/jama.2011.715	http://dx.doi.org/10.1001/jama.2011.715			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770RN	21632482	Bronze, Green Accepted			2022-12-01	WOS:000291106300021
J	Nguitragool, W; Bokhari, AAB; Pillai, AD; Rayavara, K; Sharma, P; Turpin, B; Aravind, L; Desai, SA				Nguitragool, Wang; Bokhari, Abdullah A. B.; Pillai, Ajay D.; Rayavara, Kempaiah; Sharma, Paresh; Turpin, Brad; Aravind, L.; Desai, Sanjay A.			Malaria Parasite clag3 Genes Determine Channel-Mediated Nutrient Uptake by Infected Red Blood Cells	CELL			English	Article							SURFACE ANION CHANNEL; PLASMODIUM-FALCIPARUM; ERYTHROCYTE INVASION; MULTIGENE FAMILY; RHOPTRY PROTEIN; EXPRESSION; CYTOADHERENCE; PERMEABILITY; TRANSPORT; VIRULENCE	Development of malaria parasites within vertebrate erythrocytes requires nutrient uptake at the host cell membrane. The plasmodial surface anion channel (PSAC) mediates this transport and is an antimalarial target, but its molecular basis is unknown. We report a parasite gene family responsible for PSAC activity. We used high-throughput screening for nutrient uptake inhibitors to identify a compound highly specific for channels from the Dd2 line of the human pathogen P. falciparum. Inheritance of this compound's affinity in a Dd2xHB3 genetic cross maps to a single parasite locus on chromosome 3. DNA transfection and in vitro selections indicate that PSAC-inhibitor interactions are encoded by two clag3 genes previously assumed to function in cytoadherence. These genes are conserved in plasmodia, exhibit expression switching, and encode an integral protein on the host membrane, as predicted by functional studies. This protein increases host cell permeability to diverse solutes.	[Nguitragool, Wang; Bokhari, Abdullah A. B.; Pillai, Ajay D.; Rayavara, Kempaiah; Sharma, Paresh; Desai, Sanjay A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Turpin, Brad] Natl Instruments Inc, Austin, TX 78730 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	sdesai@niaid.nih.gov		Aravind, L/0000-0003-0771-253X; Desai, Sanjay/0000-0003-2150-2483; Nguitragool, Wang/0000-0002-5484-7130	Medicines for Malaria Venture (MMV); National Institutes of Health, National Institute of Allergy and Infectious Diseases, and the National Library of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882] Funding Source: NIH RePORTER	Medicines for Malaria Venture (MMV); National Institutes of Health, National Institute of Allergy and Infectious Diseases, and the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank John Adams, Alan Cowman, and Thomas Wellems for providing reagents; Mehreen Baakza, Kent Barbian, Yasmin El-Sayed, Juraj Kabat, Glenn Nardone, Son Nguyen, Norton Peet, Steve Porcella, Jose Riberio, Lattha Souvannaseng, Kurt Wollenberg, and Albert Youn for technical help; and the NIAID Scientific Director's office for providing required temporary laboratory space. We thank Edwin McCleskey and Thomas Wellems for critical reading of the manuscript. S. D. is a named inventor on a provisional patent application describing the PSAC antimalarial target identified in this article. B. T. is an employee and shareholder of National Instruments, Inc., which markets data analysis software used in this study. This research was supported by the Medicines for Malaria Venture (MMV) and the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases, and the National Library of Medicine.	Alkhalil A, 2004, BLOOD, V104, P4279, DOI 10.1182/blood-2004-05-2047; Alkhalil A, 2007, CELL MICROBIOL, V9, P851, DOI 10.1111/j.1462-5822.2006.00834.x; Anantharaman V, 2007, INT REV CYTOL, V262, P1, DOI 10.1016/S0074-7696(07)62001-4; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bokhari A, 2008, J MEMBRANE BIOL, V226, P27, DOI 10.1007/s00232-008-9136-2; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cohn JV, 2003, MOL BIOCHEM PARASIT, V132, P27, DOI 10.1016/j.molbiopara.2003.08.001; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; CRAIG A, 2000, PARASITOL TODAY REGU, V16, P405; Craig AG, 2000, PARASITOL TODAY, V16, P366, DOI 10.1016/S0169-4758(00)01744-0; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; Decherf G, 2004, BLOOD CELL MOL DIS, V32, P366, DOI 10.1016/j.bcmd.2004.01.008; Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; Duranton C, 2004, J GEN PHYSIOL, V123, P417, DOI 10.1085/jgp.200308919; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Ginsburg H, 1988, Prog Clin Biol Res, V252, P317; Goel S, 2010, P NATL ACAD SCI USA, V107, P16643, DOI 10.1073/pnas.1002568107; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Holt DC, 1999, INT J PARASITOL, V29, P939, DOI 10.1016/S0020-7519(99)00046-6; HOMEWOOD CA, 1974, NATURE, V252, P718, DOI 10.1038/252718a0; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Kaneko O, 2005, MOL BIOCHEM PARASIT, V143, P20, DOI 10.1016/j.molbiopara.2005.05.003; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Kaneko O, 2007, PARASITOL INT, V56, P255, DOI 10.1016/j.parint.2007.05.003; KILEJIAN A, 1991, MOL BIOCHEM PARASIT, V44, P175, DOI 10.1016/0166-6851(91)90003-O; KIRK K, 1994, J BIOL CHEM, V269, P3339; Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Lisk G, 2005, EUKARYOT CELL, V4, P2153, DOI 10.1128/EC.4.12.2153-2159.2005; Lisk G, 2008, ANTIMICROB AGENTS CH, V52, P2346, DOI 10.1128/AAC.00057-08; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Pillai AD, 2010, MOL PHARMACOL, V77, P724, DOI 10.1124/mol.109.062711; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Rungruang T, 2005, MOL BIOCHEM PARASIT, V140, P13, DOI 10.1016/j.molbiopara.2004.11.017; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; SCHMIDT JA, 1982, J CLIN INVEST, V70, P379, DOI 10.1172/JCI110627; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; UPSTON JM, 1995, BBA-BIOMEMBRANES, V1236, P249, DOI 10.1016/0005-2736(95)00055-8; Verloo P, 2004, J BIOL CHEM, V279, P10316, DOI 10.1074/jbc.M311540200; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002; Wagner MA, 2003, BIOPHYS J, V84, P116, DOI 10.1016/S0006-3495(03)74836-X; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; WELLEMS TE, 1988, REV BRAS GENET, V11, P813	55	173	177	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2011	145	5					665	677		10.1016/j.cell.2011.05.002	http://dx.doi.org/10.1016/j.cell.2011.05.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620134	Green Accepted, Bronze			2022-12-01	WOS:000291018600008
J	Cooley, RB; Rhoads, TW; Arp, DJ; Karplus, PA				Cooley, Richard B.; Rhoads, Timothy W.; Arp, Daniel J.; Karplus, P. Andrew			A Diiron Protein Autogenerates a Valine-Phenylalanine Cross-Link	SCIENCE			English	Article							MONOOXYGENASE; ACTIVATION; METHANE		[Arp, Daniel J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Cooley, Richard B.; Rhoads, Timothy W.; Karplus, P. Andrew] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Arp, DJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, 2082 Cordley Hall, Corvallis, OR 97331 USA.	Dan.J.Arp@oregonstate.edu; karplusp@science.oregonstate.edu	Rhoads, Tim/AAI-2483-2020	Rhoads, Tim/0000-0001-7364-1122; Karplus, Paul/0000-0001-8725-6292; Cooley, Richard/0000-0003-3928-2757	NIH [GM R01-083136]; Oregon Agricultural Experiment Station; National Institute of Environmental Health Sciences Environmental Health Sciences Center [ES00210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Agricultural Experiment Station; National Institute of Environmental Health Sciences Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant GM R01-083136 (P.A.K.), the Oregon Agricultural Experiment Station (D.J.A.), and National Institute of Environmental Health Sciences Environmental Health Sciences Center grant ES00210. We thank J. M. Bollinger and C. Krebs for discussions. Coordinates and structure factors are deposited as Protein Data Bank entry 3QHB.	Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Bergman RG, 2007, NATURE, V446, P391, DOI 10.1038/446391a; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Kopp DA, 2002, CURR OPIN CHEM BIOL, V6, P568, DOI 10.1016/S1367-5931(02)00366-6; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Xie LL, 2001, P NATL ACAD SCI USA, V98, P12863, DOI 10.1073/pnas.231485998	6	9	10	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					929	929		10.1126/science.1205687	http://dx.doi.org/10.1126/science.1205687			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596985	Green Accepted			2022-12-01	WOS:000290766600033
J	Zhang, ZH; Wippo, CJ; Wal, M; Ward, E; Korber, P; Pugh, BF				Zhang, Zhenhai; Wippo, Christian J.; Wal, Megha; Ward, Elissa; Korber, Philipp; Pugh, B. Franklin			A Packing Mechanism for Nucleosome Organization Reconstituted Across a Eukaryotic Genome	SCIENCE			English	Article							POSITIONS IN-VIVO; SACCHAROMYCES-CEREVISIAE; REMODELING FACTOR; DNA-SEQUENCE; PROMOTER; YEAST; TRANSCRIPTION; POLY(DA-DT); VITRO; ISWI	Near the 5' end of most eukaryotic genes, nucleosomes form highly regular arrays that begin at canonical distances from the transcriptional start site. Determinants of this and other aspects of genomic nucleosome organization have been ascribed to statistical positioning, intrinsically DNA-encoded positioning, or some aspect of transcription initiation. Here, we provide evidence for a different explanation. Biochemical reconstitution of proper nucleosome positioning, spacing, and occupancy levels was achieved across the 5' ends of most yeast genes by adenosine triphosphate-dependent trans-acting factors. These transcription-independent activities override DNA-intrinsic positioning and maintain uniform spacing at the 5' ends of genes even at low nucleosome densities. Thus, an active, nonstatistical nucleosome packing mechanism creates chromatin organizing centers at the 5' ends of genes where important regulatory elements reside.	[Wippo, Christian J.; Korber, Philipp] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Zhang, Zhenhai; Wal, Megha; Ward, Elissa; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	University of Munich; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Korber, P (corresponding author), Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany.	pkorber@lmu.de; bfp2@psu.edu	Zhang, Zhenhai/GRX-5887-2022; Wal, Megha/J-3607-2019; Korber, Philipp/AAN-7633-2021	Zhang, Zhenhai/0000-0002-4310-0525; Korber, Philipp/0000-0001-7526-6549	National Institutes of Health [HG004160]; German Research Community [SFB/TR5]; European Community; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Community(German Research Foundation (DFG)); European Community(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the members of the Penn State Center for Eukaryotic Gene Regulation and of the Molecular Biology Unit of the Adolf-Butenandt-Institut for valuable discussion and support. We are grateful to D. Blaschke for technical assistance and to S. Holmberg for the gift of the S. cerevisiae library. This work was supported by grant HG004160 from the National Institutes of Health to B.F.P.; and by the German Research Community (SFB/TR5) and the Epigenome Network of Excellence in the Sixth Framework Programme of the European Community (NET grant), both to P.K. Sequencing data are available at ArrayExpress under accession number: SRA030538.1.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Korber P, 2004, J BIOL CHEM, V279, P35113, DOI 10.1074/jbc.M405446200; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mobius W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000891; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schnitzler GR, 2008, CELL BIOCHEM BIOPHYS, V51, P67, DOI 10.1007/s12013-008-9015-6; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Vaillant C, 2010, GENOME RES, V20, P59, DOI 10.1101/gr.096644.109; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	27	229	230	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					977	980		10.1126/science.1200508	http://dx.doi.org/10.1126/science.1200508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596991	Green Accepted			2022-12-01	WOS:000290766600047
J	Petersen, CP; Reddien, PW				Petersen, Christian P.; Reddien, Peter W.			Polarized notum Activation at Wounds Inhibits Wnt Function to Promote Planarian Head Regeneration	SCIENCE			English	Article							WINGLESS MORPHOGEN GRADIENT; REQUIREMENT; SHAPE	Regeneration requires initiation of programs tailored to the identity of missing parts. Head-versus-tail regeneration in planarians presents a paradigm for study of this phenomenon. After injury, Wnt signaling promotes tail regeneration. We report that wounding elicits expression of the Wnt inhibitor notum preferentially at anterior-facing wounds. This expression asymmetry occurs at essentially any wound, even if the anterior pole is intact. Inhibition of notum with RNA interference (RNAi) causes regeneration of an anterior-facing tail instead of a head, and double-RNAi experiments indicate that notum inhibits Wnt signaling to promote head regeneration. notum expression is itself controlled by Wnt signaling, suggesting that regulation of feedback inhibition controls the binary head-tail regeneration outcome. We conclude that local detection of wound orientation with respect to tissue axes results in distinct signaling environments that initiate appropriate regeneration responses.	[Petersen, Christian P.; Reddien, Peter W.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reddien, Peter W.] MIT, Dept Biol, Cambridge, MA 02138 USA; [Reddien, Peter W.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Reddien, PW (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu	Petersen, Christian P./GZG-4541-2022	Petersen, Christian P./0000-0001-7552-6865; /0000-0002-5569-333X	NIH [R01GM080639]; ACS [RSG-07-180-01-DDC]; Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Reddien Lab for discussions and S. Lapan for hedgehog constructs. P. W. R. is a Howard Hughes Medical Institute early career scientist. We acknowledge support by NIH R01GM080639, ACS RSG-07-180-01-DDC, the Keck Foundation, and an American Cancer Society postdoctoral fellowship to C. P. P. C. P. P. and P. W. R. are inventors on a pending patent on the use of Notum inhibitors to enhance regeneration.	Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Parker DS, 2008, MOL CELL BIOL, V28, P1815, DOI 10.1128/MCB.01230-07; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Torisu Y, 2008, CANCER SCI, V99, P1139, DOI 10.1111/j.1349-7006.2008.00814.x; TRAISTER A, 2007, BIOCHEM J; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014	25	152	163	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					852	855		10.1126/science.1202143	http://dx.doi.org/10.1126/science.1202143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566195	Green Submitted, Green Accepted			2022-12-01	WOS:000290529900049
J	Brennand, KJ; Simone, A; Jou, J; Gelboin-Burkhart, C; Tran, N; Sangar, S; Li, Y; Mu, YL; Chen, G; Yu, D; McCarthy, S; Sebat, J; Gage, FH				Brennand, Kristen J.; Simone, Anthony; Jou, Jessica; Gelboin-Burkhart, Chelsea; Tran, Ngoc; Sangar, Sarah; Li, Yan; Mu, Yangling; Chen, Gong; Yu, Diana; McCarthy, Shane; Sebat, Jonathan; Gage, Fred H.			Modelling schizophrenia using human induced pluripotent stem cells	NATURE			English	Article							RABIES VIRUS; RECEPTORS; PATHOGENESIS; PATHWAYS; PATIENT	Schizophrenia (SCZD) is a debilitating neurological disorder with a world-wide prevalence of 1%; there is a strong genetic component, with an estimated heritability of 80-85%(1). Although post-mortem studies have revealed reduced brain volume, cell size, spine density and abnormal neural distribution in the prefrontal cortex and hippocampus of SCZD brain tissue(2) and neuropharmacological studies have implicated dopaminergic, glutamatergic and GABAergic activity in SCZD(3), the cell types affected in SCZD and the molecular mechanisms underlying the disease state remain unclear. To elucidate the cellular and molecular defects of SCZD, we directly reprogrammed fibroblasts from SCZD patients into human induced pluripotent stem cells (hiPSCs) and subsequently differentiated these disorder-specific hiPSCs into neurons (Supplementary Fig. 1). SCZD hiPSC neurons showed diminished neuronal connectivity in conjunction with decreased neurite number, PSD95-protein levels and glutamate receptor expression. Gene expression profiles of SCZD hiPSC neurons identified altered expression of many components of the cyclic AMP and WNT signalling pathways. Key cellular and molecular elements of the SCZD phenotype were ameliorated following treatment of SCZD hiPSC neurons with the antipsychotic loxapine. To date, hiPSC neuronal pathology has only been demonstrated in diseases characterized by both the loss of function of a single gene product and rapid disease progression in early childhood(4-6). We now report hiPSC neuronal phenotypes and gene expression changes associated with SCZD, a complex genetic psychiatric disorder.	[Brennand, Kristen J.; Simone, Anthony; Jou, Jessica; Gelboin-Burkhart, Chelsea; Tran, Ngoc; Sangar, Sarah; Li, Yan; Mu, Yangling; Yu, Diana; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Chen, Gong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [McCarthy, Shane] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Salk Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cold Spring Harbor Laboratory; University of California System; University of California San Diego; University of California System; University of California San Diego	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Brennand, Kristen J/J-8704-2012; Brennand, Kristen J/U-5470-2019	Brennand, Kristen J/0000-0003-0993-5956; Sebat, Jonathan/0000-0002-9087-526X; Chen JNU, Gong/0000-0002-1857-3670	California Institute for Regenerative Medicine; CIRM [RL1-00649-1]; Lookout and Mathers Foundation; Helmsley Foundation; Sanofi-Aventis; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072031, P01NS028121] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine); Lookout and Mathers Foundation; Helmsley Foundation; Sanofi-Aventis(Sanofi-Aventis); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	L. Moore, B. Miller, K. Stecker, J. Jepsen, D. Sepp, S. Larkin and L. Johnson provided technical assistance. T. Berggren directs, and M. Lutz manages, the Salk Stem Cell facility. D. Gibbs directs the Salk Viral Vector Core. J. Nguyen and L. Ouyang provided gene expression support. D. Chambers and J. Barrie provided FACS support. E. Callaway and I. Wickersham provided rabies trans-neuronal tracing viruses and invaluable advice and scientific feedback. M. Lawson provided assistance with statistical analysis. Thanks to G. Yeo, M. McConnell, S. Aigner, C. Marchetto and L. Boyer for advice and conversation. K.J.B. is supported by a training grant from the California Institute for Regenerative Medicine. The Gage Laboratory, and this project, is partially funded by CIRM Grant RL1-00649-1, The Lookout and Mathers Foundation, the Helmsley Foundation as well as Sanofi-Aventis.	American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Jaaro-Peled H, 2010, SCHIZOPHRENIA BULL, V36, P301, DOI 10.1093/schbul/sbp133; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Kapur S, 1997, AM J PSYCHIAT, V154, P1525, DOI 10.1176/ajp.154.11.1525; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Ugolini G, 2008, DEV BIOLOGICALS, V131, P493; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang XD, 2008, INT J NEUROPSYCHOPH, V11, P553, DOI 10.1017/S1461145707008371; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wong AHC, 2003, NEUROSCI BIOBEHAV R, V27, P269, DOI 10.1016/S0149-7634(03)00035-6	25	947	980	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					221	+		10.1038/nature09915	http://dx.doi.org/10.1038/nature09915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21490598	Green Accepted			2022-12-01	WOS:000290487200040
J	Scott, P				Scott, Phillip			Leishmania - A Parasitized Parasite	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Scott, P (corresponding author), Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA.							BARRAL A, 1992, AM J TROP MED HYG, V47, P587, DOI 10.4269/ajtmh.1992.47.587; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425; STUART KD, 1992, P NATL ACAD SCI USA, V89, P8596, DOI 10.1073/pnas.89.18.8596	5	15	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1773	1774		10.1056/NEJMcibr1101694	http://dx.doi.org/10.1056/NEJMcibr1101694			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542750				2022-12-01	WOS:000290219800017
J	Scott, J				Scott, Janet			Stillbirths: breaking the silence of a hidden grief	LANCET			English	Editorial Material									Sands Stillbirth & Neonatal Death Charity, London W1B 1LY, England		Scott, J (corresponding author), Sands Stillbirth & Neonatal Death Charity, London W1B 1LY, England.	janet.scott@uk-sands.org							0	32	33	2	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1386	1388		10.1016/S0140-6736(11)60107-4	http://dx.doi.org/10.1016/S0140-6736(11)60107-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21496914				2022-12-01	WOS:000289963000007
J	Ochiai, M; Miyamoto, K; Kaneaki, T; Hayashi, S; Nakanishi, W				Ochiai, Masahito; Miyamoto, Kazunori; Kaneaki, Takao; Hayashi, Satoko; Nakanishi, Waro			Highly Regioselective Amination of Unactivated Alkanes by Hypervalent Sulfonylimino-lambda(3)-Bromane	SCIENCE			English	Article							SINGLE-ELECTRON TRANSFER; INTERMOLECULAR AMINATION; AMIDATION; OXYFUNCTIONALIZATION; FUNCTIONALIZATION; AZIRIDINATION; MECHANISM; BONDS	Amination of alkanes has generally required metal catalysts and/or high temperatures. Here we report that simple exposure of a broad range of alkanes to N-triflylimino-lambda(3)-bromane 1 at ambient temperature results in C-H insertion of the nitrogen functionality to afford triflyl-substituted amines in moderate to high yields. Marked selectivity for tertiary over secondary C-H bonds was observed; primary (methyl) C-H bonds were inert. Addition of hexafluoroisopropanol to inhibit decomposition of 1 dramatically improved the C-H amination efficiencies. Second-order kinetics, activation parameters (negative activation entropy), deuterium isotope effects, and theoretical calculations suggest a concerted asynchronous bimolecular transition state for the metal-free C-H amination event.	[Ochiai, Masahito; Miyamoto, Kazunori; Kaneaki, Takao] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Hayashi, Satoko; Nakanishi, Waro] Wakayama Univ, Fac Syst Engn, Dept Chem & Mat Sci, Wakayama 6408510, Japan	Tokushima University; Wakayama University	Ochiai, M (corresponding author), Univ Tokushima, Grad Sch Pharmaceut Sci, 1-78 Shomachi, Tokushima 7708505, Japan.	mochiai@ph.tokushima-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) (Japan Society for the Promotion of Science). We thank Central Glass Co., Japan, for a generous gift of BrF<INF>3</INF>.	Au SM, 1999, J AM CHEM SOC, V121, P9120, DOI 10.1021/ja9913481; Badiei YM, 2008, ANGEW CHEM INT EDIT, V47, P9961, DOI 10.1002/anie.200804304; BRESLOW DS, 1969, J AM CHEM SOC, V91, P2273, DOI 10.1021/ja01037a016; BRESLOW R, 1982, J CHEM SOC CHEM COMM, P1400, DOI 10.1039/c39820001400; Chen KH, 2009, OPT ENG, V48, DOI 10.1117/1.3121987; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; DESMARTEAU DD, 1993, J AM CHEM SOC, V115, P4897, DOI 10.1021/ja00064a063; Farooq U, 2009, ANGEW CHEM INT EDIT, V48, P1018, DOI 10.1002/anie.200805027; Fiori KW, 2007, J AM CHEM SOC, V129, P562, DOI 10.1021/ja0650450; Fokin AA, 2000, J AM CHEM SOC, V122, P7317, DOI 10.1021/ja000193q; Fructos MR, 2006, J AM CHEM SOC, V128, P11784, DOI 10.1021/ja0627850; Glukhovtsev MN, 1998, J AM CHEM SOC, V120, P10528, DOI 10.1021/ja9813156; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Gomez-Emeterio BP, 2008, ORGANOMETALLICS, V27, P4126, DOI 10.1021/om800218d; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Li ZG, 2007, ANGEW CHEM INT EDIT, V46, P5184, DOI 10.1002/anie.200700760; Liang CG, 2008, J AM CHEM SOC, V130, P343, DOI 10.1021/ja076519d; Lide D.R., 1992, CRC HDB CHEM PHYS, V73; Lin XF, 2007, CHEM-ASIAN J, V2, P1101, DOI 10.1002/asia.200700068; MELLO R, 1989, J AM CHEM SOC, V111, P6749, DOI 10.1021/ja00199a039; Nakamura E, 2002, J AM CHEM SOC, V124, P7181, DOI 10.1021/ja017823o; Ochiai M, 2008, J AM CHEM SOC, V130, P2118, DOI 10.1021/ja074624h; Ochiai M, 2007, J AM CHEM SOC, V129, P12938, DOI 10.1021/ja075811i; Ochiai M, 2010, CHEM COMMUN, V46, P511, DOI 10.1039/b922033j; Ochiai M, 2009, SYNLETT, P159, DOI 10.1055/s-0028-1087355; OKUYAMA T, 1995, J AM CHEM SOC, V117, P3360, DOI 10.1021/ja00117a006; Reichardt C., 2003, SOLVENTS SOLVENT EFF, V3rd; Schreiner PR, 2004, CHEM REC, V3, P247, DOI 10.1002/tcr.10070; Stang P. J., 1979, VINYL CATIONS	29	129	130	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					448	451		10.1126/science.1201686	http://dx.doi.org/10.1126/science.1201686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512029				2022-12-01	WOS:000289784900038
J	Giugliano, D; Esposito, K				Giugliano, Dario; Esposito, Katherine			Clinical Inertia as a Clinical Safeguard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE CONTROL; PREVENTION		[Giugliano, Dario; Esposito, Katherine] Univ Naples 2, Dept Geriatr & Metab Dis, I-80138 Naples, Italy	Universita della Campania Vanvitelli	Giugliano, D (corresponding author), Univ Naples 2, Dept Geriatr & Metab Dis, Piazza L Miraglia 2, I-80138 Naples, Italy.	dario.giugliano@unina2.it	Maiorino, Maria Ida/AHE-9986-2022; Esposito, Katherine/AHE-2564-2022	Maiorino, Maria Ida/0000-0003-4659-7546; Esposito, Katherine/0000-0002-3652-5154; Giugliano, Dario/0000-0002-9377-873X				Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	10	61	63	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1591	1592		10.1001/jama.2011.490	http://dx.doi.org/10.1001/jama.2011.490			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505139				2022-12-01	WOS:000289683000031
J	Ezard, THG; Aze, T; Pearson, PN; Purvis, A				Ezard, Thomas H. G.; Aze, Tracy; Pearson, Paul N.; Purvis, Andy			Interplay Between Changing Climate and Species' Ecology Drives Macroevolutionary Dynamics	SCIENCE			English	Article							RED QUEEN; FOSSIL RECORD; COURT JESTER; EXTINCTION; DIVERSITY; TIME; FORAMINIFERA; ORIGINATION; EVOLUTION; MODELS	Ecological change provokes speciation and extinction, but our knowledge of the interplay among the biotic and abiotic drivers of macroevolution remains limited. Using the unparalleled fossil record of Cenozoic macroperforate planktonic foraminifera, we demonstrate that macroevolutionary dynamics depend on the interaction between species' ecology and the changing climate. This interplay drives diversification but differs between speciation probability and extinction risk: Speciation was more strongly shaped by diversity dependence than by climate change, whereas the reverse was true for extinction. Crucially, no single ecology was optimal in all environments, and species with distinct ecologies had significantly different probabilities of speciation and extinction. The ensuing macroevolutionary dynamics depend fundamentally on the ecological structure of species' assemblages.	[Ezard, Thomas H. G.; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Ezard, Thomas H. G.] Univ Surrey, Dept Math, Fac Engn & Phys Sci, Surrey GU2 7XH, England; [Aze, Tracy; Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales	Imperial College London; University of Surrey; Cardiff University	Ezard, THG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	t.ezard@surrey.ac.uk	Purvis, Andy/A-7529-2008; Pearson, Paul N/B-2276-2009	Purvis, Andy/0000-0002-8609-6204; Pearson, Paul N/0000-0003-4628-9818; Ezard, Thomas/0000-0001-8305-6605; Aze, Tracy/0000-0002-4201-7105	Natural Environment Research Council (UK) [NE/E015956/1]; NERC [NE/E015956/1, NE/E018165/1] Funding Source: UKRI; Natural Environment Research Council [NE/E015956/1, NE/E018165/1] Funding Source: researchfish	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Natural Environment Research Council (UK) for funding (grant NE/E015956/1 to A. P. and P.N.P.) and G. Mace, T. Barraclough, N. Bunnefeld, L.-M. Chevin, T. Coulson, L. McInnes, I. Owens, A. Phillimore, G. Thomas, and two anonymous reviewers for insightful comments that improved our work. The data we analyzed are deposited as online appendices to (13).	Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; BERGGREN WA, 1995, SEPM SPEC P, pR5; Burnham KP., 2002, MODEL SELECTION MULT, V2; De Roos AM, 2008, ECOL LETT, V11, P1, DOI 10.1111/j.1461-0248.2007.01121.x; Doran NA, 2006, PALAIOS, V21, P571, DOI 10.2110/palo.2006.p06-055r; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; Hemleben C., 1991, Geologisches Jahrbuch Reihe A, V128, P117; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; NORRIS RD, 1992, PALAEOGEOGR PALAEOCL, V95, P1, DOI 10.1016/0031-0182(92)90161-W; Norris RD, 1996, PALEOBIOLOGY, V22, P461, DOI 10.1017/S0094837300016468; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Sharpe FR, 1911, PHILOS MAG, V21, P435, DOI 10.1080/14786440408637050; Simpson GG, 1961, PRINCIPLES ANIMAL TA; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; VALENTINE JW, 1980, PALEOBIOLOGY, V6, P444, DOI 10.1017/S0094837300003614; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	28	219	220	5	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					349	351		10.1126/science.1203060	http://dx.doi.org/10.1126/science.1203060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493859	Green Submitted			2022-12-01	WOS:000289516600044
J	Han, DR; Pal, S; Nangreave, J; Deng, ZT; Liu, Y; Yan, H				Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao			DNA Origami with Complex Curvatures in Three-Dimensional Space	SCIENCE			English	Article							NANOSCALE SHAPES; FOLDING DNA; FLEXIBILITY; DESIGN	We present a strategy to design and construct self-assembling DNA nanostructures that define intricate curved surfaces in three-dimensional (3D) space using the DNA origami folding technique. Double-helical DNA is bent to follow the rounded contours of the target object, and potential strand crossovers are subsequently identified. Concentric rings of DNA are used to generate in-plane curvature, constrained to 2D by rationally designed geometries and crossover networks. Out-of-plane curvature is introduced by adjusting the particular position and pattern of crossovers between adjacent DNA double helices, whose conformation often deviates from the natural, B-form twist density. A series of DNA nanostructures with high curvature-such as 2D arrangements of concentric rings and 3D spherical shells, ellipsoidal shells, and a nanoflask-were assembled.	[Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Han, Dongran; Pal, Suchetan; Nangreave, Jeanette; Deng, Zhengtao; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Han, DR (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	dongran.han@asu.edu; yan_liu@asu.edu; hao.yan@asu.edu	Liu, Yan/K-1999-2014; Deng, Zhengtao/F-8581-2010; Pal, Suchetan/R-5525-2019; Pal, Suchetan/D-3653-2012	Liu, Yan/0000-0003-0906-2606; Deng, Zhengtao/0000-0002-8428-8982; Pal, Suchetan/0000-0001-8291-2844; Pal, Suchetan/0000-0002-6323-7502	Office of Naval Research; Army Research Office; National Science Foundation; Department of Energy; National Institutes of Health; Sloan Research Foundation; Arizona State University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001016]	Office of Naval Research(Office of Naval Research); Army Research Office; National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Research Foundation; Arizona State University; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank the AFM applications group at Bruker Nanosurfaces for assistance in acquiring some of the high-resolution AFM images, using Peak Force Tapping with ScanAsyst on the MultiMode 8. This research was partly supported by grants from the Office of Naval Research, Army Research Office, National Science Foundation, Department of Energy, and National Institutes of Health to H.Y. and Y.L. and from the Sloan Research Foundation to H.Y. Y.L. and H.Y. were supported by the Technology and Research Initiative Fund from Arizona State University and as part of the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001016.	Aldaye FA, 2007, J AM CHEM SOC, V129, P13376, DOI 10.1021/ja075966q; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105	20	845	897	27	777	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					342	346		10.1126/science.1202998	http://dx.doi.org/10.1126/science.1202998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493857				2022-12-01	WOS:000289516600042
J	Moxon, ER; Das, P; Greenwood, B; Heymann, DL; Horton, R; Levine, OS; Plotkin, S; Nossal, G				Moxon, E. Richard; Das, Pamela; Greenwood, Brian; Heymann, David L.; Horton, Richard; Levine, Orin S.; Plotkin, Stanley; Nossal, Gus			A call to action for the new decade of vaccines	LANCET			English	Editorial Material							PREVENTION		[Moxon, E. Richard] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Das, Pamela; Horton, Richard] The Lancet, London NW1 7BY, England; [Greenwood, Brian; Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Levine, Orin S.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Plotkin, Stanley] Univ Penn, Philadelphia, PA 19104 USA; [Nossal, Gus] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; University of Melbourne	Moxon, ER (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.	richard.moxon@paediatrics.ox.ac.uk						Barnighausen T, 2011, VACCINE, V29, P2371, DOI 10.1016/j.vaccine.2010.11.090; BLOOM DE, 2010, WORLD ECON, V6, P15; Chandran A, 2010, BIOL-TARGETS THER, V4, P213; Clemens J, 2005, NAT MED, V11, pS12, DOI 10.1038/nm1225; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; *GAVI ALL, GAVI ALL STRAT BUS P; GAVI Alliance, FACTS FIG; Hargreaves JR, 2011, LANCET, V378, P1885, DOI 10.1016/S0140-6736(11)60687-9; Kersten G, 2007, EXPERT OPIN DRUG DEL, V4, P459, DOI 10.1517/17425247.4.5.459; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; NOSSAL GJV, PHIL T R B IN PRESS; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; PLOTKIN SA, 2009, VACCINES, V16, P1709; Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6; Senouci K, 2010, VACCINE, V28, pA26, DOI 10.1016/j.vaccine.2010.02.028; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; SMITH J, 2011, LANCET	21	23	23	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					298	302		10.1016/S0140-6736(11)60766-6	http://dx.doi.org/10.1016/S0140-6736(11)60766-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21664682				2022-12-01	WOS:000293615800008
J	Huang, PY; He, ZY; Ji, SY; Sun, HW; Xiang, D; Liu, CC; Hu, YP; Wang, X; Hui, LJ				Huang, Pengyu; He, Zhiying; Ji, Shuyi; Sun, Huawang; Xiang, Dao; Liu, Changcheng; Hu, Yiping; Wang, Xin; Hui, Lijian			Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors	NATURE			English	Article							ENRICHED TRANSCRIPTION FACTORS; EMBRYONIC STEM-CELLS; TYROSINEMIA TYPE-I; PANCREAS PROGENITORS; HEPATIC-DYSFUNCTION; DIRECT CONVERSION; GENE-EXPRESSION; FACTOR NETWORK; LIVER-FUNCTION; MURINE MODEL	The generation of functional hepatocytes independent of donor liver organs is of great therapeutic interest with regard to regenerative medicine and possible cures for liver disease(1). Induced hepatic differentiation has been achieved previously using embryonic stem cells or induced pluripotent stem cells(2-8). Particularly, hepatocytes generated froma patient's own induced pluripotent stem cells could theoretically avoid immunological rejection. However, the induction of hepatocytes frominduced pluripotent stem cells is a complicated process that would probably be replaced with the arrival of improved technology. Overexpression of lineage-specific transcription factors directly converts terminally differentiated cells into some other lineages(9-12), including neurons(13), cardiomyocytes(14) and blood progenitors(15); however, it remains unclear whether these lineage-converted cells could repair damaged tissues in vivo. Here we demonstrate the direct induction of functional hepatocytelike (iHep) cells from mouse tail-tip fibroblasts by transduction of Gata4, Hnf1 alpha and Foxa3, and inactivation of p19(Arf). iHep cells show typical epithelial morphology, express hepatic genes and acquire hepatocyte functions. Notably, transplanted iHep cells repopulate the livers of fumarylacetoacetate-hydrolase-deficient (Fah(-/-)) mice and rescue almost half of recipients from death by restoring liver functions. Our study provides a novel strategy to generate functional hepatocyte-like cells for the purpose of liver engineering and regenerative medicine.	[Huang, Pengyu; He, Zhiying; Ji, Shuyi; Sun, Huawang; Liu, Changcheng; Hu, Yiping; Wang, Xin; Hui, Lijian] Chinese Acad Sci, Lab Mol Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [He, Zhiying; Xiang, Dao; Liu, Changcheng; Hu, Yiping] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Wang, Xin] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wang, Xin] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Naval Medical University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hui, LJ (corresponding author), Chinese Acad Sci, Lab Mol Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Yueyang Rd 320, Shanghai 200031, Peoples R China.	ljhui@sibs.ac.cn	Huang, Pengyu/ABF-5330-2021; Huang, Pengyu/ABH-1721-2021	Huang, Pengyu/0000-0001-8394-7280	National Science Foundation of China [91019014, 30801115]; Chinese Academy of Sciences [KSCX2-YW-R-241, XDA01010402]; Chinese National 863 Plan Project [2006AA02Z474]; National Key Basic Research and Development Program of China [2007CB947102, 2009CB941100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National 863 Plan Project(National High Technology Research and Development Program of China); National Key Basic Research and Development Program of China(National Basic Research Program of China)	We would like to thank X. Chen, J. Cen, L. Zhang and J. Yuan for technical support, and F. Tang and D. Li for comments. The laboratory of L. H. is funded by the National Science Foundation of China (91019014) and the Chinese Academy of Sciences (KSCX2-YW-R-241, XDA01010402 and the Hundred Talents Program). The laboratory of X. W. is supported by the National Science Foundation of China (30801115), Chinese National 863 Plan Project (2006AA02Z474) and National Key Basic Research and Development Program of China (2007CB947102 and 2009CB941100).	Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Soto-Gutierrez A, 2006, NAT BIOTECHNOL, V24, P1412, DOI 10.1038/nbt1257; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zern MA, 2009, GASTROENTEROLOGY, V136, P767, DOI 10.1053/j.gastro.2009.01.019; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	29	607	688	11	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					386	U142		10.1038/nature10116	http://dx.doi.org/10.1038/nature10116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21562492				2022-12-01	WOS:000292911200044
J	Laguette, N; Sobhian, B; Casartelli, N; Ringeard, M; Chable-Bessia, C; Segeral, E; Yatim, A; Emiliani, S; Schwartz, O; Benkirane, M				Laguette, Nadine; Sobhian, Bijan; Casartelli, Nicoletta; Ringeard, Mathieu; Chable-Bessia, Christine; Segeral, Emmanuel; Yatim, Ahmad; Emiliani, Stephane; Schwartz, Olivier; Benkirane, Monsef			SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx	NATURE			English	Article							GAMMA-INDUCED PROTEIN; INNATE IMMUNITY; INFECTION; INHIBITION; TARGET; DOMAIN	The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection(1-6). Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutieres syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response(7). We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.	[Laguette, Nadine; Sobhian, Bijan; Ringeard, Mathieu; Chable-Bessia, Christine; Yatim, Ahmad; Benkirane, Monsef] CNRS, Inst Genet Humaine, Lab Virol Mol, UPR1142, F-34000 Montpellier, France; [Casartelli, Nicoletta; Schwartz, Olivier] CNRS, Inst Pasteur, Virus & Immun Unit, URA 3015, Paris, France; [Segeral, Emmanuel; Emiliani, Stephane] Univ Paris 05, CNRS, Inst Cochin, UMR 8104,INSERM,U567, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benkirane, M (corresponding author), CNRS, Inst Genet Humaine, Lab Virol Mol, UPR1142, F-34000 Montpellier, France.	nadine.laguette@igh.cnrs.fr; monsef.benkirane@igh.cnrs.fr	Schwartz, Olivier/AAZ-3765-2021; Laguette, Nadine/A-2764-2019; Casartelli, Nicoletta/AAD-5583-2021; Casartelli, Nicoletta/L-4798-2015	Schwartz, Olivier/0000-0002-0729-1475; Sobhian, Bijan/0000-0001-7255-6006; Laguette, Nadine/0000-0001-8072-5607	ERC [250333]; Sidaction; ANRS; FRM 'equipe labellisee'; CNRS/region Languedoc Roussillon; European FP7 [201412]; Institut Pasteur	ERC(European Research Council (ERC)European Commission); Sidaction; ANRS(ANRSFrench National Research Agency (ANR)); FRM 'equipe labellisee'; CNRS/region Languedoc Roussillon(Centre National de la Recherche Scientifique (CNRS)Region Occitanie); European FP7; Institut Pasteur(European Commission)	We wish to thank members of the Molecular Virology laboratory for critical reading of the manuscript, N. Manel for SIV3<SUP>+</SUP> molecular clone and J. Luban for SIV delta Vpx and Vpx mutants. This work was supported by grants from the ERC (250333), Sidaction, ANRS and FRM 'equipe labellisee' to M. B. N. L was supported by ANRS and SIDACTION fellowships; B. S. by ANRS fellowship; M. R. by CNRS/region Languedoc Roussillon fellowship. O.S. and N. C. are supported by grants from ANRS, Sidaction, ANR, European FP7 contract 201412 and Institut Pasteur.	Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Cobb A, 2011, J IMMUNOL METHODS, V365, P27, DOI 10.1016/j.jim.2010.11.002; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Liao WP, 2008, PROTEOMICS, V8, P2640, DOI 10.1002/pmic.200700954; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Zhao DC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-114; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	27	1078	1107	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					654	U132		10.1038/nature10117	http://dx.doi.org/10.1038/nature10117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21613998	Green Accepted			2022-12-01	WOS:000292204300042
J	Cymes, GD; Grosman, C				Cymes, Gisela D.; Grosman, Claudio			Tunable pK(a) values and the basis of opposite charge selectivities in nicotinic-type receptors	NATURE			English	Article							CONGENITAL MYASTHENIC SYNDROME; GATED ION CHANNELS; ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL; DIELECTRIC-CONSTANTS; CHLORIDE CHANNEL; M2 DOMAIN; MUTATIONS; PORE; SUBUNIT	Among ion channels, only the nicotinic-receptor superfamily has evolved to generate both cation-and anion-selective members. Although other, structurally unrelated, neurotransmitter-gated cation channels exist, no other type of neurotransmitter-gated anion channel, and thus no other source of fast synaptic inhibitory signals, has been described so far. In addition to the seemingly straightforward electrostatic effect of the presence (in the cation-selective members) or absence (in the anion-selective ones) of a ring of pore-facing carboxylates, mutational studies have identified other features of the amino-acid sequence near the intracellular end of the pore-lining transmembrane segments (M2) that are also required to achieve the high charge selectivity shown by native channels(1-10). However, the mechanism underlying this more subtle effect has remained elusive(11) and a subject of speculation. Here we show, using single-channel electrophysiological recordings to estimate the protonation state of native ionizable side chains, that anion-selective-type sequences favour whereas cation-selective-type sequences prevent the protonation of the conserved, buried basic residues at the intracellular entrance of the pore (the M2 0' position). We conclude that the previously unrecognized tunable charge state of the 0' ring of buried basic side chains is an essential feature of these channels' versatile charge-selectivity filter.	[Cymes, Gisela D.; Grosman, Claudio] Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Cymes, Gisela D.; Grosman, Claudio] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Grosman, C (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	grosman@illinois.edu		Cymes, Gisela/0000-0002-4155-585X; Grosman, Claudio/0000-0001-8093-8362	US National Institutes of Health [R01-NS042169]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042169] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Sine for wild-type muscle AChR cDNA; M. Slaughter and D. Papke for wild-type alpha 1 GlyR cDNA; S. Elenes for critical advice on fast-perfusion experiments; E. Jakobsson and H. Robertson for discussions; and G. Papke, M. Maybaum, J. Pizarek and C. Staehlin for technical assistance. This work was supported by a grant from the US National Institutes of Health (R01-NS042169 to C.G.).	BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Beg AA, 2003, NAT NEUROSCI, V6, P1145, DOI 10.1038/nn1136; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Chimenti MS, 2011, J MOL BIOL, V405, P361, DOI 10.1016/j.jmb.2010.10.001; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; Elenes S, 2006, J GEN PHYSIOL, V128, P615, DOI 10.1085/jgp.200609570; Engel AG, 1996, HUM MOL GENET, V5, P1217, DOI 10.1093/hmg/5.9.1217; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Grosman C, 2000, J GEN PHYSIOL, V115, P637, DOI 10.1085/jgp.115.5.637; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Harms MJ, 2009, J MOL BIOL, V389, P34, DOI 10.1016/j.jmb.2009.03.039; Jensen ML, 2002, J BIOL CHEM, V277, P41438, DOI 10.1074/jbc.M205645200; Kamerlin SCL, 2009, J PHYS CHEM B, V113, P1253, DOI 10.1021/jp8071712; Karp DA, 2010, BIOCHEMISTRY-US, V49, P4138, DOI 10.1021/bi902114m; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; Krishek BJ, 1996, MOL PHARMACOL, V49, P494; Lee DJS, 2003, NEUROSCI LETT, V351, P196, DOI 10.1016/j.neulet.2003.08.005; Menard C, 2005, J BIOL CHEM, V280, P27502, DOI 10.1074/jbc.M501624200; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Papke D, 2011, J PHYSIOL-LONDON, V589, P1571, DOI 10.1113/jphysiol.2010.203315; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; van Nierop P, 2005, J NEUROSCI, V25, P10617, DOI 10.1523/JNEUROSCI.2015-05.2005; Wotring VE, 2003, J PHYSIOL-LONDON, V548, P527, DOI 10.1113/jphysiol.2002.032045	32	21	21	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					526	U160		10.1038/nature10015	http://dx.doi.org/10.1038/nature10015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21602825	Green Accepted			2022-12-01	WOS:000291939700052
J	Hope, T; McMillan, J				Hope, Tony; McMillan, John			The art of medicine Advance decisions, chronic mental illness, and everyday care	LANCET			English	Editorial Material							DEMENTIA; CAPACITY		[Hope, Tony] Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England; [McMillan, John] Flinders Med Ctr, Sch Med, Adelaide, SA 5001, Australia	University of Oxford; Flinders Medical Centre	Hope, T (corresponding author), Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England.	tonyhope@doctors.org.uk	McMillan, John/S-9660-2018	McMillan, John/0000-0002-7507-1861				Agich G, 2003, DEPENDENCE AUTONOMY; David A., 2010, BRIT MED J, V341, P587; Dresser R, 1995, HASTINGS CENT REP, V25, P32, DOI 10.2307/3527839; Dworkin R., 1993, LIFES DOMINION; Hope T, 2009, J MED ETHICS, V35, P733, DOI 10.1136/jme.2009.030783; Jaworska A, 1999, PHILOS PUBLIC AFF, V28, P105, DOI 10.1111/j.1088-4963.1999.00105.x; Nuffield Council on Bioethics, DEM ETH ISS	7	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2076	2077		10.1016/S0140-6736(11)60909-4	http://dx.doi.org/10.1016/S0140-6736(11)60909-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21692228	Bronze			2022-12-01	WOS:000292117800016
J	Settembre, C; Di Malta, C; Polito, VA; Garcia-Arencibia, M; Vetrini, F; Erdin, S; Erdin, SU; Huynh, T; Medina, D; Colella, P; Sardiello, M; Rubinsztein, DC; Ballabio, A				Settembre, Carmine; Di Malta, Chiara; Polito, Vinicia Assunta; Garcia-Arencibia, Moises; Vetrini, Francesco; Erdin, Serkan; Erdin, Serpil Uckac; Huynh, Tuong; Medina, Diego; Colella, Pasqualina; Sardiello, Marco; Rubinsztein, David C.; Ballabio, Andrea			TFEB Links Autophagy to Lysosomal Biogenesis	SCIENCE			English	Article							IN-VIVO; PHOSPHORYLATION SITES; PROTEIN-DEGRADATION; PREDICTION; PATHWAYS; ULK1	Autophagy is a cellular catabolic process that relies on the cooperation of autophagosomes and lysosomes. During starvation, the cell expands both compartments to enhance degradation processes. We found that starvation activates a transcriptional program that controls major steps of the autophagic pathway, including autophagosome formation, autophagosome-lysosome fusion, and substrate degradation. The transcription factor EB (TFEB), a master gene for lysosomal biogenesis, coordinated this program by driving expression of autophagy and lysosomal genes. Nuclear localization and activity of TFEB were regulated by serine phosphorylation mediated by the extracellular signal-regulated kinase 2, whose activity was tuned by the levels of extracellular nutrients. Thus, a mitogen-activated protein kinase-dependent mechanism regulates autophagy by controlling the biogenesis and partnership of two distinct cellular organelles.	[Settembre, Carmine; Di Malta, Chiara; Polito, Vinicia Assunta; Medina, Diego; Colella, Pasqualina; Ballabio, Andrea] TIGEM, I-80131 Naples, Italy; [Settembre, Carmine; Polito, Vinicia Assunta; Vetrini, Francesco; Erdin, Serkan; Erdin, Serpil Uckac; Huynh, Tuong; Sardiello, Marco; Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Settembre, Carmine; Polito, Vinicia Assunta; Erdin, Serkan; Erdin, Serpil Uckac; Huynh, Tuong; Sardiello, Marco; Ballabio, Andrea] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Garcia-Arencibia, Moises; Rubinsztein, David C.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Ballabio, Andrea] Univ Naples Federico 2, Dept Pediat, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Baylor College of Medicine; Baylor College of Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Naples Federico II	Ballabio, A (corresponding author), TIGEM, Via Pietro Castellino 111, I-80131 Naples, Italy.	ballabio@tigem.it	Garcia-Arencibia, Moises/B-5538-2012; Medina, Diego/AAC-9622-2020; BALLABIO, Andrea/AAL-2672-2020; Di Malta, Chiara/AAX-6395-2020; Rubinsztein, David C/C-3472-2011; Settembre, Carmine/AIA-9170-2022; Polito, Vinicia Assunta/AAA-5219-2020; Erdin, Serkan/B-4988-2008; Erdin, Serkan/AAE-4288-2019; Garcia-Arencibia, Moises/K-9920-2013; COLELLA, PASQUALINA/I-5478-2017	Medina, Diego/0000-0002-7347-2645; BALLABIO, Andrea/0000-0003-1381-4604; Erdin, Serkan/0000-0001-6587-2625; Garcia-Arencibia, Moises/0000-0002-1618-4487; COLELLA, PASQUALINA/0000-0002-4268-2391; Polito, Vinicia Assunta/0000-0002-5698-7778; SETTEMBRE, Carmine/0000-0002-5829-8589	Italian Telethon Foundation; Beyond Batten Disease Foundation; European Research Council [250154]; European Molecular Biology Organization; Wellcome Trust; U.K. Medical Research Council; Intellectual and Developmental Disabilities Research Center at the Baylor College of Medicine [5 P30 HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078072] Funding Source: NIH RePORTER; Medical Research Council [G0600194] Funding Source: researchfish; MRC [G0600194] Funding Source: UKRI	Italian Telethon Foundation(Fondazione Telethon); Beyond Batten Disease Foundation; European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intellectual and Developmental Disabilities Research Center at the Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank H. Bellen, A. De Matteis, G. Diez-Roux, M. Ferron, G. Karsenty, A. Luini, and H. Zoghbi for critical reading of the manuscript; R. Polishchuck for technical advice with the electron microscopy; K. Moreau, M. Renna, A. Ronza, and M. Palmieri for their contribution; and L. Naldini for the lentivirus production. We acknowledge the support of the Italian Telethon Foundation (C.S., C.D.M., V.P., M.S., and A.B.); the Beyond Batten Disease Foundation (C.S., C.D.M., V.P., S.U.E., T.H., M.S., and A.B.); European Research Council Advanced Investigator grant no. 250154 (A.B.); a European Molecular Biology Organization long-term fellowship (C.S.); a Wellcome Trust Senior Research Fellowship (D.C.R.); and a U.K. Medical Research Council program grant (D.C.R.). We wish to thank Cherie and James C. Flores for their generous donation. We also thank S. Tooze for GFP-LC3 cells, T. Yoshimori for the RFP-GFP, and P. Pandolfi for the HA-ERK2 and ca-MEK; M. Krentz for the CAG-lox-LacZ plasmid and for the useful suggestions during transgene generation; and the TIGEM AAV vector core for virus production. Confocal microscopy was supported by the Intellectual and Developmental Disabilities Research Center at the Baylor College of Medicine (5 P30 HD024064).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Dang TH, 2008, BIOINFORMATICS, V24, P2857, DOI 10.1093/bioinformatics/btn546; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2004, NEUROREPORT, V15, P2443, DOI 10.1097/00001756-200411150-00001; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	29	1887	1939	14	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1429	1433		10.1126/science.1204592	http://dx.doi.org/10.1126/science.1204592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21617040	Green Accepted			2022-12-01	WOS:000291689000041
J	Jirawatnotai, S; Hu, YD; Michowski, W; Elias, JE; Becks, L; Bienvenu, F; Zagozdzon, A; Goswami, T; Wang, YYE; Clark, AB; Kunkel, TA; van Harn, T; Xia, B; Correll, M; Quackenbush, J; Livingston, DM; Gygi, SP; Sicinski, P				Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Elias, Joshua E.; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; Goswami, Tapasree; Wang, Yaoyu E.; Clark, Alan B.; Kunkel, Thomas A.; van Harn, Tanja; Xia, Bing; Correll, Mick; Quackenbush, John; Livingston, David M.; Gygi, Steven P.; Sicinski, Piotr			A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers	NATURE			English	Article							HUMAN RAD51 PROTEIN; DOUBLE-STRAND BREAK; PHOSPHORYLATION; DAMAGE; OVEREXPRESSION; ABSENCE; CELLS	Cyclin D1 is a component of the core cell cycle machinery(1). Abnormally high levels of cyclin D1 are detected in many human cancer types(2). To elucidate the molecular functions of cyclin D1 in human cancers, we performed a proteomic screen for cyclin D1 protein partners in several types of human tumours. Analyses of cyclin D1 interactors revealed a network of DNA repair proteins, including RAD51, a recombinase that drives the homologous recombination process(3). We found that cyclin D1 directly binds RAD51, and that cyclin D1-RAD51 interaction is induced by radiation. Like RAD51, cyclin D1 is recruited to DNA damage sites in a BRCA2-dependent fashion. Reduction of cyclin D1 levels in human cancer cells impaired recruitment of RAD51 to damaged DNA, impeded the homologous recombination-mediated DNA repair, and increased sensitivity of cells to radiation in vitro and in vivo. This effect was seen in cancer cells lacking the retinoblastoma protein, which do not require D-cyclins for proliferation(4,5). These findings reveal an unexpected function of a core cell cycle protein in DNA repair and suggest that targeting cyclin D1 may be beneficial also in retinoblastoma-negative cancers which are currently thought to be unaffected by cyclin D1 inhibition.	[Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; van Harn, Tanja; Livingston, David M.; Sicinski, Piotr] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; van Harn, Tanja; Livingston, David M.; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Jirawatnotai, Siwanon] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Prathom, Thailand; [Elias, Joshua E.; Goswami, Tapasree; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Becks, Lisa] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmacol, Boston, MA 02115 USA; [Wang, Yaoyu E.; Correll, Mick; Quackenbush, John] Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02215 USA; [Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Mol Genet Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Struct Biol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Xia, Bing] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ 08903 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Quackenbush, John] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Mahidol University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Sicinski, P (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	peter_sicinski@dfci.harvard.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; Quackenbush, John/0000-0002-2702-5879	NIH [R01 CA083688, P01 CA080111, P01 CA109901]; Thailand Research Fund [MRG5280248]; Foundation for Polish Science; CCCB; Dana-Farber Strategic Plan Initiative; Division of Intramural Research of the NIH, NIEHS [Z01 ES065089]; NATIONAL CANCER INSTITUTE [P01CA109901, R01CA083688, P01CA080111, R01CA138804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065089, ZIAES065089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund(Thailand Research Fund (TRF)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); CCCB; Dana-Farber Strategic Plan Initiative; Division of Intramural Research of the NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the members of the Sicinski lab for help and advice, N. Li for help with initial experiments, S Panyim and Y. Geng for discussions and reading the manuscript, P. Nakatani for pOZ-FH-N construct, M. Jasin for DR-GFP system, D. Bulavin and E. Appella for anti-phospho-CDC25A antibodies, A. Smogorzewska for anti-FANCI antibody, A. Venkitaraman and M. Lee for GST-BRCA2 fragments, and DFCI Confocal and Light Microscopy Core Facility for assisting with confocal microscopy. This work was supported by R01 CA083688, P01 CA080111 and P01 CA109901 grants from NIH (to P.S.). S.J. is supported by The Thailand Research Fund MRG5280248, W.M. by Foundation for Polish Science, Y.E.W. through the CCCB and the Dana-Farber Strategic Plan Initiative, A.B.C. and T.A.K. by Project Z01 ES065089 (to T.A.K.) from the Division of Intramural Research of the NIH, NIEHS.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; BARTKOVA J, 1995, CANCER RES, V55, P949; BATES S, 1994, ONCOGENE, V9, P1633; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ek S, 2005, LEUKEMIA RES, V29, P205, DOI 10.1016/j.leukres.2004.06.009; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hosokawa Y, 1998, GENE CHROMOSOME CANC, V22, P66, DOI 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Li ZP, 2010, CANCER RES, V70, P8802, DOI 10.1158/0008-5472.CAN-10-0312; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Martin JMC, 1999, CANCER RES, V59, P1134; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9	29	245	250	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					230	234		10.1038/nature10155	http://dx.doi.org/10.1038/nature10155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654808	Green Accepted			2022-12-01	WOS:000291397800054
J	Maekawa, M; Yamaguchi, K; Nakamura, T; Shibukawa, R; Kodanaka, I; Ichisaka, T; Kawamura, Y; Mochizuki, H; Goshima, N; Yamanaka, S				Maekawa, Momoko; Yamaguchi, Kei; Nakamura, Tomonori; Shibukawa, Ran; Kodanaka, Ikumi; Ichisaka, Tomoko; Kawamura, Yoshifumi; Mochizuki, Hiromi; Goshima, Naoki; Yamanaka, Shinya			Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1	NATURE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; PROTEIN; MOUSE; FIBROBLASTS	Induced pluripotent stem cells (iPSCs) are generated from somatic cells by the transgenic expression of three transcription factors collectively called OSK: Oct3/4 (also called Pou5f1), Sox2 and Klf4(1). However, the conversion to iPSCs is inefficient. The protooncogene Myc enhances the efficiency of iPSC generation by OSK but it also increases the tumorigenicity of the resulting iPSCs(2). Here we show that the Gli-like transcription factor Glis1 (Glis family zinc finger 1) markedly enhances the generation of iPSCs from both mouse and human fibroblasts when it is expressed together with OSK. Mouse iPSCs generated using this combination of transcription factors can form germline-competent chimaeras. Glis1 is enriched in unfertilized oocytes and in embryos at the one-cell stage. DNA microarray analyses show that Glis1 promotes multiple pro-reprogramming pathways, including Myc, Nanog, Lin28, Wnt, Essrb and the mesenchymal-epithelial transition. These results therefore show that Glis1 effectively promotes the direct reprogramming of somatic cells during iPSC generation.	[Maekawa, Momoko; Nakamura, Tomonori; Shibukawa, Ran; Kodanaka, Ikumi; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Maekawa, Momoko; Shibukawa, Ran; Kodanaka, Ikumi; Yamanaka, Shinya] JST, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama 3320012, Japan; [Yamaguchi, Kei; Kawamura, Yoshifumi; Mochizuki, Hiromi] Japan Biol Informat Consortium, Tokyo 1350064, Japan; [Nakamura, Tomonori; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan; [Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	n-goshima@aist.go.jp; yamanaka@cira.kyoto-u.ac.jp	Nakamura, Tomonori/V-8828-2019	Nakamura, Tomonori/0000-0002-0173-0780	New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for the Promotion of Science (JSPS); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	We thank T. Yamamoto, Y. Yamada and the members of our laboratory for valuable scientific discussions and administrative support. We thank M. Nakagawa, H. Seki, M. Murakami, A. Okada, M. Narita, M. Inoue, H. Shiga and T. Matsumoto for technical assistance and H. Suemori (Kyoto University) for human ES cells. This work was supported in part by grants from the New Energy and Industrial Technology Development Organization (NEDO), the Leading Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japanese Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research from JSPS and MEXT, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). S.Y. is a member of scientific advisory boards of iPearian Inc. and iPS Academia Japan.	Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hashimoto J, 2009, J BIOMOL SCREEN, V14, P970, DOI 10.1177/1087057109341406; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	275	321	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					225	U268		10.1038/nature10106	http://dx.doi.org/10.1038/nature10106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654807	Green Submitted			2022-12-01	WOS:000291397800053
J	Ofstad, TA; Zuker, CS; Reiser, MB				Ofstad, Tyler A.; Zuker, Charles S.; Reiser, Michael B.			Visual place learning in Drosophila melanogaster	NATURE			English	Article							MUSHROOM BODIES; CENTRAL COMPLEX; SPATIAL MEMORY; FRUIT-FLY; BEHAVIOR; SYSTEM; EXPRESSION; PARADIGM; CELLS; HEAD	The ability of insects to learn and navigate to specific locations in the environment has fascinated naturalists for decades. The impressive navigational abilities of ants, bees, wasps and other insects demonstrate that insects are capable of visual place learning(1-4), but little is known about the underlying neural circuits that mediate these behaviours. Drosophila melanogaster (common fruit fly) is a powerful model organism for dissecting the neural circuitry underlying complex behaviours, from sensory perception to learning and memory. Drosophila can identify and remember visual features such as size, colour and contour orientation(5,6). However, the extent to which they use vision to recall specific locations remains unclear. Here we describe a visual place learning platform and demonstrate that Drosophila are capable of forming and retaining visual place memories to guide selective navigation. By targeted genetic silencing of small subsets of cells in the Drosophila brain, we show that neurons in the ellipsoid body, but not in the mushroom bodies, are necessary for visual place learning. Together, these studies reveal distinct neuroanatomical substrates for spatial versus non-spatial learning, and establish Drosophila as a powerful model for the study of spatial memories. [GRAPHICS] .	[Ofstad, Tyler A.; Zuker, Charles S.; Reiser, Michael B.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ofstad, Tyler A.; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurobiol, La Jolla, CA 92093 USA; [Zuker, Charles S.] Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zuker, Charles S.] Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Zuker, CS (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	cz2195@columbia.edu; reiserm@janelia.hhmi.org		Reiser, Michael/0000-0002-4108-4517	HHMI	HHMI(Howard Hughes Medical Institute)	We particularly thank M. Gallio for help with thermosensation and the development of temperature behavioural tests. We also thank G. Rubin for providing GAL4 lines before publication, A. Jenett for their anatomical annotation and M. Dickinson for discussions and advice. Brain images were provided by the Janelia Fly Light Project. T. Laverty and the Janelia Fly Core assisted with Drosophila maintenance. Additional support was provided by J. Osborne, C. Werner, D. Olbris and M. Bolstad. We also thank V. Jayaraman, members of the Reiser and Zuker labs, Janelia Farm colleagues and the Janelia Fly Olympiad Project. This project was supported through the HHMI Janelia Farm Research Campus visitor programmed (T.A.O. and C.S.Z., hosted by M.B.R.). C.S.Z. is a HHMI investigator and a Senior Fellow at Janelia Farm.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BERNSTEIN S, 1969, BRAIN RES, V16, P85, DOI 10.1016/0006-8993(69)90087-0; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Capaldi EA, 1999, J EXP BIOL, V202, P1655; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Fahrbach SE, 1995, LEARN MEMORY, V2, P199, DOI 10.1101/lm.2.5.199; Foucaud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015231; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; MCGUIRE SE, 2004, SCI STKE, pPL6; Mizunami M, 1998, J COMP NEUROL, V402, P520; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Putz G, 2002, LEARN MEMORY, V9, P349, DOI 10.1101/lm.50402; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Strauss R, 1997, J EXP BIOL, V200, P1281; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4; WEHNER R, 1979, EXPERIENTIA, V35, P1569, DOI 10.1007/BF01953197; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; Wolf R, 1998, LEARN MEMORY, V5, P166; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Wustmann G, 1997, LEARN MEMORY, V4, P328, DOI 10.1101/lm.4.4.328; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; Zars T, 2009, J NEUROGENET, V23, P104, DOI 10.1080/01677060802441364	40	259	264	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					204	U240		10.1038/nature10131	http://dx.doi.org/10.1038/nature10131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654803	Green Accepted, Green Published			2022-12-01	WOS:000291397800048
J	Pastor, WA; Pape, UJ; Huang, Y; Henderson, HR; Lister, R; Ko, M; McLoughlin, EM; Brudno, Y; Mahapatra, S; Kapranov, P; Tahiliani, M; Daley, GQ; Liu, XS; Ecker, JR; Milos, PM; Agarwal, S; Rao, A				Pastor, William A.; Pape, Utz J.; Huang, Yun; Henderson, Hope R.; Lister, Ryan; Ko, Myunggon; McLoughlin, Erin M.; Brudno, Yevgeny; Mahapatra, Sahasransu; Kapranov, Philipp; Tahiliani, Mamta; Daley, George Q.; Liu, X. Shirley; Ecker, Joseph R.; Milos, Patrice M.; Agarwal, Suneet; Rao, Anjana			Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells	NATURE			English	Article							DEVELOPMENTAL REGULATORS; MYELOID CANCERS; DNA METHYLATION; 5-METHYLCYTOSINE; HYDROXYLATION; TET1; QUANTIFICATION; SPECIFICATION; PLURIPOTENT; CONVERSION	5-hydroxymethylcytosine (5hmC) is a modified base present at low levels in diverse cell types in mammals(1-5). 5hmC is generated by the TET family of Fe(II) and 2-oxoglutarate-dependent enzymes through oxidation of 5-methylcytosine (5mC)(1,2,4-7). 5hmC and TET proteins have been implicated in stem cell biology and cancer(1,4,5,8,9), but information on the genome-wide distribution of 5hmC is limited. Here we describe two novel and specific approaches to profile the genomic localization of 5hmC. The first approach, termed GLIB (glucosylation, periodate oxidation, biotinylation) uses a combination of enzymatic and chemical steps to isolate DNA fragments containing as few as a single 5hmC. The second approach involves conversion of 5hmC to cytosine 5-methylenesulphonate (CMS) by treatment of genomic DNA with sodium bisulphite, followed by immunoprecipitation of CMS-containing DNA with a specific antiserum to CMS5. High-throughput sequencing of 5hmC-containing DNA from mouse embryonic stem (ES) cells showed strong enrichment within exons and near transcriptional start sites. 5hmC was especially enriched at the start sites of genes whose promoters bear dual histone 3 lysine 27 trimethylation (H3K27me3) and histone 3 lysine 4 trimethylation (H3K4me3) marks. Our results indicate that 5hmC has a probable role in transcriptional regulation, and suggest a model in which 5hmC contributes to the 'poised' chromatin signature found at developmentally-regulated genes in ES cells.	[McLoughlin, Erin M.; Daley, George Q.; Agarwal, Suneet] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Pape, Utz J.; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [McLoughlin, Erin M.; Daley, George Q.; Agarwal, Suneet] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Pastor, William A.; Pape, Utz J.; Henderson, Hope R.; Tahiliani, Mamta; Rao, Anjana] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Pastor, William A.; Pape, Utz J.; Henderson, Hope R.; Tahiliani, Mamta; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Pastor, William A.; Huang, Yun; Henderson, Hope R.; Ko, Myunggon; Mahapatra, Sahasransu; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Pape, Utz J.; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lister, Ryan; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Brudno, Yevgeny] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kapranov, Philipp; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); La Jolla Institute for Immunology; Harvard University; Harvard T.H. Chan School of Public Health; Salk Institute; Harvard University	Agarwal, S (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	Suneet.Agarwal@childrens.harvard.edu; arao@idi.harvard.edu	Ecker, Joseph R/B-9144-2008; Lister, Ryan/B-5168-2012	Ecker, Joseph R/0000-0001-5799-5895; Lister, Ryan/0000-0001-6637-7239; Ko, Myunggon/0000-0002-6007-2570; Brudno, Yevgeny/0000-0003-2963-3293; Kapranov, Philipp/0000-0003-2647-4856; Henderson, Hope/0000-0002-1373-296X; Huang, Yun/0000-0001-5950-9168	National Science Foundation; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine; National Institute of Health [RC1 DA028422, R01 AI44432, 1 R01 HD065812-01A1, NIH K08 HL089150]; Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH) [1 UL1 RR 025758-02]; Mary. K. Chapman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary. K. Chapman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Ren for assistance in next generation sequencing using the Illumina platform. We thank M. Guttman for making his RNASeq data set available to us. W. A. P. is supported by a predoctoral graduate research fellowship from the National Science Foundation, and Y.H. by a postdoctoral fellowship from the Leukemia and Lymphoma Society. R. L. is supported by a California Institute for Regenerative Medicine Training Grant. This study was supported by the National Institute of Health grants RC1 DA028422, R01 AI44432 and 1 R01 HD065812-01A1 and a grant from the California Institute of Regenerative Medicine (to A. R.), a pilot grant from Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH Grant 1 UL1 RR 025758-02) and NIH K08 HL089150 (to S. A.), and a grant from the Mary. K. Chapman Foundation (to J.R.E.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bowers J, 2009, NAT METHODS, V6, P593, DOI 10.1038/nmeth.1354; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156	28	614	659	1	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					394	397		10.1038/nature10102	http://dx.doi.org/10.1038/nature10102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21552279	Green Published, Green Accepted			2022-12-01	WOS:000290722400053
J	Slimak, L; Svendsen, JI; Mangerud, J; Plisson, H; Heggen, HP; Brugere, A; Pavlov, PY				Slimak, Ludovic; Svendsen, John Inge; Mangerud, Jan; Plisson, Hugues; Heggen, Herbjorn Presthus; Brugere, Alexis; Pavlov, Pavel Yurievich			Late Mousterian Persistence near the Arctic Circle	SCIENCE			English	Article							NORTHERN EURASIA; LATE QUATERNARY; EASTERN-EUROPE; NEANDERTHALS; SIBERIA; SITE; KOSTENKI; HISTORY; MAMMOTH; CLIMATE	Palaeolithic sites in Russian high latitudes have been considered as Upper Palaeolithic and thus representing an Arctic expansion of modern humans. Here we show that at Byzovaya, in the western foothills of the Polar Urals, the technological structure of the lithic assemblage makes it directly comparable with Mousterian Middle Palaeolithic industries that so far have been exclusively attributed to the Neandertal populations in Europe. Radiocarbon and optical-stimulated luminescence dates on bones and sand grains indicate that the site was occupied during a short period around 28,500 carbon-14 years before the present (about 31,000 to 34,000 calendar years ago), at the time when only Upper Palaeolithic cultures occupied lower latitudes of Eurasia. Byzovaya may thus represent a late northern refuge for Neandertals, about 1000 km north of earlier known Mousterian sites.	[Slimak, Ludovic] Univ Toulouse Le Mirail, CNRS, UMR 5608, TRACES, F-31058 Toulouse 9, France; [Svendsen, John Inge; Mangerud, Jan; Heggen, Herbjorn Presthus] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Svendsen, John Inge; Mangerud, Jan; Heggen, Herbjorn Presthus] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Plisson, Hugues] Univ Bordeaux 1, CNRS, UMR 5199, PACEA,IPGQ, F-33405 Talence, France; [Brugere, Alexis] CNRS, USR 3225, F-92023 Nanterre, France; [Brugere, Alexis] ArScAn, UMR 7041, F-92023 Nanterre, France; [Pavlov, Pavel Yurievich] Russian Acad Sci, Komi Sci Ctr, Inst Language Literature & Hist, Dept Archaeol, Syktyvkar 167000, Komi, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Russian Academy of Sciences; Institute of Language, Literature & History, Komi Scientific Centre of the RAS; Komi Science Centre of the Ural Branch of the Russian Academy of Sciences	Slimak, L (corresponding author), Univ Toulouse Le Mirail, CNRS, UMR 5608, TRACES, 5 Allees Antonio Machado, F-31058 Toulouse 9, France.	slimak@univ-tlse2.fr	Pavlov, Pavel Yu/S-3823-2016; Slimak, Ludovic/AAG-7890-2020	Pavlov, Pavel Yu/0000-0001-8827-5719; 	Fondation des Maisons des Sciences de l'Homme; French-Russian Center for Social and Human Sciences in Moscow; French Ministry of Foreign and European Affairs; Research Council of Norway; Russian Foundation for Humanitarian Research [08-01-94952a]	Fondation des Maisons des Sciences de l'Homme; French-Russian Center for Social and Human Sciences in Moscow; French Ministry of Foreign and European Affairs; Research Council of Norway(Research Council of Norway); Russian Foundation for Humanitarian Research	L.S., H. P., and A. B. analyzed the archaeological material; J.I.S, J.M., and H. P. H. performed the stratigraphic, paleoenvironmental, and chronological descriptions and interpretations; and P.Y.P. organized the archaeological field missions. All contributed to the writing of the paper. Supported by the Fondation des Maisons des Sciences de l'Homme, the French-Russian Center for Social and Human Sciences in Moscow, the French Ministry of Foreign and European Affairs, the Research Council of Norway, and Russian Foundation for Humanitarian Research grant 08-01-94952a. Kh. A. Arslanov and S. Gulliksen performed the radiocarbon dating and A. Murray the OSL dating. We thank the Komi Scientific Centre in Syktyvkar; the museums of Pechora and of Syktyvkar; and the Institute of History of Material Culture of St. Petersburg, especially A. A. Sinitsyn and A. E. Matjuhin for access to their collections and N. N. Skakun for her help. We also thank E. Bjorseth for preparing Figs. 1 and 2 and figs. S1 and S2 and J. E. Lewis for improving the English.	Anikovich MV, 2007, SCIENCE, V315, P223, DOI 10.1126/science.1133376; Bader O.N., 1978, SUNGIR UPPER PALAEOL; Barroso Ruiz C, 2003, ARQUEOLOGIA MONOGRAF, V15; Blockley SPE, 2008, J HUM EVOL, V55, P764, DOI 10.1016/j.jhevol.2008.08.009; Bordes F., 1961, TYPOLOGIE PALEOLITHI; BOSINSKI G, 2001, ZEPHYRUS, V53, P77; Bosinski G., 1967, MITTELPALAOLITHISCHE; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Giaccio B, 2008, J VOLCANOL GEOTH RES, V177, P208, DOI 10.1016/j.jvolgeores.2007.10.007; GUENTHER EW, 1991, ALTSTEINZEITLICHE FU, P101; GUSLITSER BI, 1965, SOVETSKAYA ARKHEOLOG, V2, P112; Heggen HP, 2010, BOREAS, V39, P116, DOI 10.1111/j.1502-3885.2009.00109.x; Higham T, 2006, P NATL ACAD SCI USA, V103, P553, DOI 10.1073/pnas.0510005103; Hoffecker JF, 2010, J ARCHAEOL SCI, V37, P1073, DOI 10.1016/j.jas.2009.12.008; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Hublin JJ, 2009, CR PALEVOL, V8, P503, DOI 10.1016/j.crpv.2009.04.001; Hublin JJ, 2007, RETHINKING HUMAN REV, P235; Joris O., 2004, BERICHTE R MISCH GER, V84, P49; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Mangerud J, 2010, BOREAS, V39, P328, DOI 10.1111/j.1502-3885.2009.00127.x; Pavlov P, 2004, J HUM EVOL, V47, P3, DOI 10.1016/j.jhevol.2004.05.002; Pavlov P, 2001, NATURE, V413, P64, DOI 10.1038/35092552; Pavlov P., 1986, EXCAVATION BYZOVAYA, P7; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Simonet P., 1991, Quaternaire, V2, P5; Sinitsyn AA, 2006, QUATERN INT, V152, P164, DOI 10.1016/j.quaint.2005.12.007; Slimak L., 2004, THESIS U PROVENCE AI; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Svendsen I.G., 2003, CHRONOLOGY AURIGNACI, V33, P109; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Svendsen JI, 2010, QUATERNARY SCI REV, V29, P3138, DOI 10.1016/j.quascirev.2010.06.043; Velichko AA, 2005, QUATERN INT, V126, P137, DOI 10.1016/j.quaint.2004.04.019; Wojtal P, 2005, J ARCHAEOL SCI, V32, P193, DOI 10.1016/j.jas.2004.08.005; ZilhAo J., 2006, FARMING, V2006, P95, DOI DOI 10.3828/BFARM.2006.3.3	38	54	57	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					841	845		10.1126/science.1203866	http://dx.doi.org/10.1126/science.1203866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763CD	21566192				2022-12-01	WOS:000290529900046
J	Borden, WB; Redberg, RF; Mushlin, AI; Dai, D; Kaltenbach, LA; Spertus, JA				Borden, William B.; Redberg, Rita F.; Mushlin, Alvin I.; Dai, David; Kaltenbach, Lisa A.; Spertus, John A.			Patterns and Intensity of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DATA-REGISTRY; ST-SEGMENT ELEVATION; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; PRACTICE GUIDELINES; QUALITY; CARE; PREVALENCE; TRENDS	Context The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) study, which provided optimal medical therapy (OMT) to all patients and demonstrated no incremental advantage of percutaneous coronary intervention (PCI) on outcomes other than angina-related quality of life in stable coronary artery disease (CAD), suggests that a trial of OMT is warranted before PCI. It is unknown to what degree OMT is applied before PCI in routine practice or whether its use increased after the COURAGE trial. Objective To examine the use of OMT in patients with stable angina undergoing PCI before and after the publication of the COURAGE trial. Design, Setting, and Participants An observational study of patients with stable CAD undergoing PCI in the National Cardiovascular Data Registry between September 1, 2005, and June 30, 2009. Analysis compared use of OMT, both before PCI and at the time of discharge, before and after the publication of the COURAGE trial. Optimal medical therapy was defined as either being prescribed or having a documented contraindication to all medicines (antiplatelet agent, beta-blocker, and statin). Main Outcome Measures Rates of OMT before PCI and at discharge (following PCI) between the 2 study periods. Results Among all 467 211 patients (173 416 before [37.1%] and 293 795 after [62.9%] the COURAGE trial) meeting study criteria, OMT was used in 206 569 patients (44.2%; 95% confidence interval [CI], 44.1%-44.4%) before PCI and in 303 864 patients (65.0%; 95% CI, 64.9%-65.2%) at discharge following PCI (P<.001). Before PCI, OMT was applied in 75 381 patients (43.5%; 95% CI, 43.2%-43.7%) before the COURAGE trial and in 131 188 patients (44.7%; 95% CI, 44.5%-44.8%) after the COURAGE trial (P<.001). The use of OMT at discharge following PCI before and after the COURAGE trial was 63.5% (95% CI, 63.3%-63.7%) and 66.0% (95% CI, 65.8%-66.1%), respectively (P<.001). Conclusion Among patients with stable CAD undergoing PCI, less than half were receiving OMT before PCI and approximately two-thirds were receiving OMT at discharge following PCI, with relatively little change in these practice patterns after publication of the COURAGE trial. JAMA. 2011;305(18):1882-1889 www.jama.com	[Borden, William B.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Borden, William B.; Mushlin, Alvin I.] Cornell Univ, Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Redberg, Rita F.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dai, David; Kaltenbach, Lisa A.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA	Cornell University; Cornell University; University of California System; University of California San Francisco; Duke University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Borden, WB (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Med, 1305 York Ave,8th Floor, New York, NY 10021 USA.	wbb2001@med.cornell.edu	Spertus, John/ABD-3075-2021		NCDR; American College of Cardiology Foundation; Weill Cornell Medical College; Agency for Healthcare Research and Quality [U18 HS016075]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016075] Funding Source: NIH RePORTER	NCDR; American College of Cardiology Foundation(General Electric); Weill Cornell Medical College; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the NCDR, an initiative of the American College of Cardiology Foundation. Dr Borden is funded through a Nanette Laitman Clinical Scholar in Public Health award at the Weill Cornell Medical College. Dr Mushlin is funded in part by cooperative agreement U18 HS016075 from the Agency for Healthcare Research and Quality.	Ahmed B, 2011, CIRC-CARDIOVASC QUAL, V4, P300, DOI 10.1161/CIRCOUTCOMES.110.957175; Anderson HV, 2007, AM J CARDIOL, V99, P189, DOI 10.1016/j.amjcard.2006.07.083; Association of Amercian Medical Colleges, 2008, IND FUND MED ED; Atwater Brett D, 2009, Clin Cardiol, V32, pE1, DOI 10.1002/clc.20524; Avorn J, 2010, HEALTH AFFAIR, V29, P1891, DOI 10.1377/hlthaff.2010.0696; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boden WE, 2009, AM J CARDIOL, V104, P1, DOI 10.1016/j.amjcard.2009.02.059; Bonham AC, 2010, HEALTH AFFAIR, V29, P1901, DOI 10.1377/hlthaff.2010.0790; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Butler J, 2002, J AM COLL CARDIOL, V40, P1589, DOI 10.1016/S0735-1097(02)02379-3; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Davis DA, 1997, CAN MED ASSOC J, V157, P408; Fraker Theodore D Jr, 2007, Circulation, V116, P2762, DOI 10.1161/CIRCULATIONAHA.107.187930; Gattis WA, 2004, AM J CARDIOL, V93, p74B, DOI 10.1016/j.amjcard.2004.01.019; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hyre AD, 2007, ANN EPIDEMIOL, V17, P548, DOI 10.1016/j.annepidem.2007.01.032; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kereiakes DJ, 2007, J AM COLL CARDIOL, V50, P1598, DOI 10.1016/j.jacc.2007.07.063; Krone RJ, 2006, CATHETER CARDIO INTE, V68, P696, DOI 10.1002/ccd.20910; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; Lin GA, 2010, MED CARE, V48, P733, DOI 10.1097/MLR.0b013e3181e35b3a; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Maddox TM, 2010, CIRC-CARDIOVASC QUAL, V3, P632, DOI 10.1161/CIRCOUTCOMES.109.906214; Maron David J, 2011, Curr Treat Options Cardiovasc Med, V13, P16, DOI 10.1007/s11936-010-0104-7; Maron DJ, 2010, J AM COLL CARDIOL, V55, P1348, DOI 10.1016/j.jacc.2009.10.062; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mehta RH, 2006, ARCH INTERN MED, V166, P2027, DOI 10.1001/archinte.166.18.2027; Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744; Roe MT, 2005, ARCH INTERN MED, V165, P1630, DOI 10.1001/archinte.165.14.1630; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Stafford RS, 2010, ARCH INTERN MED, V170, P851, DOI 10.1001/archinternmed.2010.130; Stafford RS, 2003, J AM COLL CARDIOL, V41, P56, DOI 10.1016/S0735-1097(02)02670-0; Steinberg BA, 2007, AM J CARDIOL, V99, P1212, DOI 10.1016/j.amjcard.2006.12.039; *VET AFF, VET AFF COOP STUD PR; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040; ISI WEB KNOWLEDGE IT	41	137	142	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2011	305	18					1882	1889		10.1001/jama.2011.601	http://dx.doi.org/10.1001/jama.2011.601			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761YH	21558519	Bronze			2022-12-01	WOS:000290438800025
J	Morikawa, T; Kuchiba, A; Yamauchi, M; Meyerhardt, JA; Shima, K; Nosho, K; Chan, AT; Giovannucci, E; Fuchs, CS; Ogino, S				Morikawa, Teppei; Kuchiba, Aya; Yamauchi, Mai; Meyerhardt, Jeffrey A.; Shima, Kaori; Nosho, Katsuhiko; Chan, Andrew T.; Giovannucci, Edward; Fuchs, Charles S.; Ogino, Shuji			Association of CTNNB1 (beta-Catenin) Alterations, Body Mass Index, and Physical Activity With Survival in Patients With Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISLAND METHYLATOR PHENOTYPE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; COLON-CANCER; MICROSATELLITE INSTABILITY; E-CADHERIN; PROGNOSTIC-SIGNIFICANCE; ACTIVITY QUESTIONNAIRE; NUCLEAR ACCUMULATION; PIK3CA MUTATION; RECTAL-CANCER	Context Alterations of the WNT signaling pathway and cadherin-associated protein beta 1 (CTNNB1 or beta-catenin) have been implicated in colorectal carcinogenesis and metabolic diseases. Objective To test the hypothesis that CTNNB1 activation in colorectal cancer modifies prognostic associations of body mass index (BMI) and level of postdiagnosis physical activity. Design, Setting, and Patients Two US prospective cohort studies (Nurses' Health Study and the Health Professionals Follow-up Study) were used to evaluate CTNNB1 localization by immunohistochemistry in 955 patients with stage I, II, III, or IV colon and rectal cancer from 1980 through 2004. A Cox proportional hazards model was used to compute the hazard ratio (HR) for mortality, adjusting for clinical and tumor features, including microsatellite instability, CpG island methylator phenotype, level of long interspersed nucleotide element 1 methylation, mutations in KRAS, BRAF, or PIK3CA, and tumor protein p53. Main Outcome Measures Colorectal cancer-specific mortality and overall mortality through June 30, 2009. Results In obese patients (BMI >= 30), positive status for nuclear CTNNB1 was associated with significantly better colorectal cancer-specific survival (adjusted HR, 0.24 [95% confidence interval {CI}, 0.12-0.49], P<.001 for interaction; 5-year survival: 0.85 for patients with positive nuclear CTNNB1 status vs 0.78 for those with negative status) and overall survival (adjusted HR, 0.56 [95% CI, 0.35-0.90], P=.03 for interaction; 5-year survival: 0.77 for patients with positive nuclear CTNNB1 status vs 0.74 for those with negative status), while CTNNB1 status was not associated with prognosis among nonobese patients (BMI <30). Among patients with negative status for nuclear CTNNB1 and cancer in stages I, II, or III, postdiagnosis physical activity was associated with better colorectal cancer-specific survival (adjusted HR, 0.33 [95% CI, 0.13-0.81], P=.05 for interaction; 5-year survival: 0.97 for >= 18 vs 0.89 for <18 metabolic equivalent task hours/week), while postdiagnosis physical activity was not associated with colorectal cancer-specific survival among patients with positive status for nuclear CTNNB1 (adjusted HR, 1.07 [95% CI, 0.50-2.30]). Conclusions Among obese patients only, activation of CTNNB1 was associated with better colorectal cancer-specific survival and overall survival. Postdiagnosis physical activity was associated with better colorectal cancer-specific survival only among patients with negative status for nuclear CTNNB1. These molecular pathological epidemiology findings suggest that the effects of alterations in the WNT-CTNNB1 pathway on outcome are modified by BMI and physical activity. JAMA. 2011;305(16):1685-1694 www.jama.com	[Ogino, Shuji] Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med Oncol, Dana Farber Canc Inst,Ctr Mol Oncol Pathol, Boston, MA 02215 USA; [Chan, Andrew T.; Giovannucci, Edward; Fuchs, Charles S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02215 USA; [Ogino, Shuji] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Ogino, S (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med Oncol, Dana Farber Canc Inst,Ctr Mol Oncol Pathol, 450 Brookline Ave,Room JF-215C, Boston, MA 02215 USA.	shuji_ogino@dfci.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323	US National Institute of Health [P01CA87969, P01CA55075, P50CA127003, K07CA122826, R01CA151993, R01CA137178]; Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Japan Society for Promotion of Science; NATIONAL CANCER INSTITUTE [R01CA151993, R01CA050385, P01CA055075, P50CA127003, R01CA137178, K07CA122826, P01CA087969] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institute of Health grants P01CA87969, P01CA55075, P50CA127003, K07CA122826, R01CA151993, and R01CA137178 and by grants from the Bennett Family Fund and the Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance. Dr Morikawa was supported by a fellowship grant from the Japan Society for Promotion of Science. Dr Chan is a Damon Runyon Clinical Investigator.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Cheah PY, 2002, CANCER-AM CANCER SOC, V95, P2479, DOI 10.1002/cncr.10986; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Chung GG, 2001, CLIN CANCER RES, V7, P4013; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Doria-Rose VP, 2006, CANCER CAUSE CONTROL, V17, P63, DOI 10.1007/s10552-005-0360-0; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Elzagheid A, 2008, WORLD J GASTROENTERO, V14, P3866, DOI 10.3748/wjg.14.3866; Fang QX, 2010, J SURG ONCOL, V102, P433, DOI 10.1002/jso.21537; Filiz AI, 2010, COLORECTAL DIS, V12, P1223, DOI 10.1111/j.1463-1318.2009.01994.x; Gunther K, 1998, DIS COLON RECTUM, V41, P1256, DOI 10.1007/BF02258226; Han QF, 2006, CANCER LETT, V231, P129, DOI 10.1016/j.canlet.2005.01.026; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hugh TJ, 1999, BRIT J CANCER, V80, P1046, DOI 10.1038/sj.bjc.6690461; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Kawada M, 2006, CANCER RES, V66, P2913, DOI 10.1158/0008-5472.CAN-05-3460; Kawasaki T, 2007, NEOPLASIA, V9, P569, DOI 10.1593/neo.07334; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lugli A, 2007, HISTOPATHOLOGY, V50, P453, DOI 10.1111/j.1365-2559.2007.02620.x; Martensson A, 2007, ONCOL REP, V17, P447; Maruyama K, 2000, ONCOLOGY-BASEL, V59, P302, DOI 10.1159/000012187; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Meyerhardt JA, 2009, CLIN CANCER RES, V15, P5931, DOI 10.1158/1078-0432.CCR-09-0496; Miyamoto S, 2004, ONCOL REP, V12, P245; Norwood MGA, 2010, HISTOPATHOLOGY, V57, P101, DOI 10.1111/j.1365-2559.2010.03587.x; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Ogino S, 2008, J CLIN ONCOL, V26, P5713, DOI [10.1200/JCO.2008.18.2675, 10.1200/JCO.2009.22.8858]; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roca F, 2006, J SURG ONCOL, V93, P151, DOI 10.1002/jso.20413; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Sinicrope FA, 2010, CLIN CANCER RES, V16, P1884, DOI 10.1158/1078-0432.CCR-09-2636; Waldman SA, 2009, JAMA-J AM MED ASSOC, V301, P745, DOI 10.1001/jama.2009.141; Wanitsuwan W, 2008, WORLD J GASTROENTERO, V14, P6052, DOI 10.3748/wjg.14.6052; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wong SCC, 2004, CLIN CANCER RES, V10, P1401, DOI 10.1158/1078-0432.CCR-0157-03; Wong SCC, 2003, J CLIN PATHOL-MOL PA, V56, P347, DOI 10.1136/mp.56.6.347; Zhang W, 2008, ONCOL REP, V20, P1013, DOI 10.3892/or_00000103; Zhao JX, 2010, BIOCHEM BIOPH RES CO, V395, P146, DOI 10.1016/j.bbrc.2010.03.161	58	147	149	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1685	1694		10.1001/jama.2011.513	http://dx.doi.org/10.1001/jama.2011.513			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521850	Bronze, Green Accepted			2022-12-01	WOS:000289890500022
J	[Anonymous]				[Anonymous]			PERSONAL VIEW Private alcohol detox clinics should be regulated	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 20	2011	342								d2399	10.1136/bmj.d2399	http://dx.doi.org/10.1136/bmj.d2399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755ON	21508046				2022-12-01	WOS:000289942900007
J	Howard, GCW; Nairn, M				Howard, G. C. W.; Nairn, M.			GUIDELINES Management of adult testicular germ cell tumours: summary of updated SIGN guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; TESTIS		[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Howard, G. C. W.] Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Nairn, Moray/0000-0001-6474-4410				ALBERS P, 2009, GUIDELINES TESTICULA; CHILVERS CED, 1989, BRIT J CANCER, V59, P126, DOI 10.1038/bjc.1989.25; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; GIWERCMAN A, 1993, EUR UROL, V23, P104; Harland SJ, 1998, J UROLOGY, V160, P1353, DOI 10.1016/S0022-5347(01)62535-7; Howard GCW, 2005, CLIN ONCOL-UK, V17, P435, DOI 10.1016/j.clon.2005.03.011; HOWARD GCW, 1995, BRIT J CANCER, V72, P1307, DOI 10.1038/bjc.1995.506; *INF STAT DIV SCOT, MAL GEN ORG CANC; *INF STAT DIV SCOT, CANC MAL GEN ORG; *INF STAT DIV SCOT, CHILDH AD YOUNG AD C; Mead GM, 1997, J CLIN ONCOL, V15, P594; *SCOTT INT GUID NE, 2011, SIGN PUBL, V124	12	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2011	342								d2005	10.1136/bmj.d2005	http://dx.doi.org/10.1136/bmj.d2005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UZ	21493673				2022-12-01	WOS:000289721700004
J	Garner, EC; Bernard, R; Wang, WQ; Zhuang, XW; Rudner, DZ; Mitchison, T				Garner, Ethan C.; Bernard, Remi; Wang, Wenqin; Zhuang, Xiaowei; Rudner, David Z.; Mitchison, Tim			Coupled, Circumferential Motions of the Cell Wall Synthesis Machinery and MreB Filaments in B. subtilis	SCIENCE			English	Article							ACTIN-LIKE PROTEINS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; CYTOSKELETON; MORPHOGENESIS; SHAPE; MBL; LOCALIZATION; SEGREGATION	Rod-shaped bacteria elongate by the action of cell wall synthesis complexes linked to underlying dynamic MreB filaments. To understand how the movements of these filaments relate to cell wall synthesis, we characterized the dynamics of MreB and the cell wall elongation machinery using high-precision particle tracking in Bacillus subtilis. We found that MreB and the elongation machinery moved circumferentially around the cell, perpendicular to its length, with nearby synthesis complexes and MreB filaments moving independently in both directions. Inhibition of cell wall synthesis by various methods blocked the movement of MreB. Thus, bacteria elongate by the uncoordinated, circumferential movements of synthetic complexes that insert radial hoops of new peptidoglycan during their transit, possibly driving the motion of the underlying MreB filaments.	[Garner, Ethan C.; Mitchison, Tim] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Bernard, Remi; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Wang, Wenqin; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Garner, EC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	ethan.garner@hms.harvard.edu; zhuang@chemistry.harvard.edu; rudner@hms.harvard.edu; timothy_mitchison@hms.harvard.edu	Garner, Ethan/J-4025-2014; Wang, Wenqin/E-9418-2012	Garner, Ethan/0000-0003-0141-3555; 	NIH [R01-GM073831, R01-GM096450, R01-GM39565]; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831, R01GM039565, R01GM096450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Graumman, J. Errington, R. Carballido-Lopez, D. Kearns, D. Popham, and D. Scheffers for strains; D. Kahne, S. Walker, T. Bernhardt, and T. Uehara for discussions; Q. Justman for editing; S. Layer for inspiration; T. Emonet for MicrobeTracker; and the HMS Nikon Imaging Center for the use of their facilites. Funding was provided by NIH grants R01-GM073831 (D.Z.R.), R01-GM096450 (X.Z.), and R01-GM39565 (T.M.). X.Z. is a Howard Hughes Medical Investigator. E.C.G. was supported by the Helen Hay Whitney Foundation.	Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kawai Y, 2009, MOL MICROBIOL, V73, P719, DOI 10.1111/j.1365-2958.2009.06805.x; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; Soufo HJD, 2006, MOL MICROBIOL, V62, P1340, DOI 10.1111/j.1365-2958.2006.05457.x; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x	19	373	378	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					222	225		10.1126/science.1203285	http://dx.doi.org/10.1126/science.1203285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636745	Green Accepted			2022-12-01	WOS:000292502700050
J	Sherman, RB; Woodcock, J; Norden, J; Grandinetti, C; Temple, RJ				Sherman, Rachel Behrman; Woodcock, Janet; Norden, Janet; Grandinetti, Cheryl; Temple, Robert J.			New FDA Regulation to Improve Safety Reporting in Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sherman, Rachel Behrman; Norden, Janet; Grandinetti, Cheryl] US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Sherman, RB (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD USA.							[Anonymous], 1995, E2A ICH; Crowe BJ, 2009, CLIN TRIALS, V6, P430, DOI 10.1177/1740774509344101; *CTR DRUG EV RES, GUID IND INV SAF REP; Food and Drug Administration HHS, 2010, Fed Regist, V75, P59935	4	33	34	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					3	5		10.1056/NEJMp1103464	http://dx.doi.org/10.1056/NEJMp1103464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21651388				2022-12-01	WOS:000292459400002
J	Noudoost, B; Moore, T				Noudoost, Behrad; Moore, Tirin			Control of visual cortical signals by prefrontal dopamine	NATURE			English	Article							FRONTAL EYE FIELD; ATTENTIONAL MODULATION; RECEPTOR ACTIONS; MESSENGER-RNAS; NEURONS; CORTEX; SELECTION; EXPRESSION	The prefrontal cortex is thought to modulate sensory signals in posterior cortices during top-down attention(1,2), but little is known about the underlying neural circuitry. Experimental and clinical evidence indicate that prefrontal dopamine has an important role in cognitive functions(3), acting predominantly through D1 receptors. Here we show that dopamine D1 receptors mediate prefrontal control of signals in the visual cortex of macaques (Macaca mulatta). We pharmacologically altered D1-receptor-mediated activity in the frontal eye field of the prefrontal cortex and measured the effect on the responses of neurons in area V4 of the visual cortex. This manipulation was sufficient to enhance the magnitude, the orientation selectivity and the reliability of V4 visual responses to an extent comparable with the known effects of top-down attention. The enhancement of V4 signals was restricted to neurons with response fields overlapping the part of visual space affected by the D1 receptor manipulation. Altering either D1- or D2-receptor-mediated frontal eye field activity increased saccadic target selection but the D2 receptor manipulation did not enhance V4 signals. Our results identify a role for D1 receptors in mediating the control of visual cortical signals by the prefrontal cortex and suggest how processing in sensory areas could be altered in mental disorders involving prefrontal dopamine.	[Noudoost, Behrad; Moore, Tirin] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Noudoost, Behrad; Moore, Tirin] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Noudoost, B (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Fairchild Bldg,299 Campus Dr W, Stanford, CA 94305 USA.	behrad@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY014924, R56 EY014924, R01 EY014924-04, R01 EY014924-06A2, EY014924, R01 EY014924-05] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014924, R56EY014924] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Bourne JA, 2001, CNS DRUG REV, V7, P399; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; HUNTSMAN MM, 1994, J NEUROSCI, V14, P2236; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Lidow MS, 1998, SYNAPSE, V28, P10, DOI 10.1002/(SICI)1098-2396(199801)28:1<10::AID-SYN2>3.0.CO;2-F; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Monosov IE, 2009, J NEUROPHYSIOL, V102, P3656, DOI 10.1152/jn.00750.2009; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Noudoost B, 2011, J NEUROSCI METH, V194, P218, DOI 10.1016/j.jneumeth.2010.10.009; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Pouget P, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.002.2009; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schiller PH, 2003, EUR J NEUROSCI, V18, P3127, DOI 10.1111/j.1460-9568.2003.03036.x; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	30	230	230	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					372	375		10.1038/nature09995	http://dx.doi.org/10.1038/nature09995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21572439	Green Accepted			2022-12-01	WOS:000291647100044
J	Stacey, T; Thompson, JMD; Mitchell, EA; Ekeroma, AJ; Zuccollo, JM; McCowan, LME				Stacey, Tomasina; Thompson, John M. D.; Mitchell, Ed A.; Ekeroma, Alec J.; Zuccollo, Jane M.; McCowan, Lesley M. E.			Association between maternal sleep practices and risk of late stillbirth: a case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFANT-DEATH; DAYTIME SLEEPINESS; FETAL-DEATH; PREGNANCY; OBESITY; ANTEPARTUM; POSITION; APNEA	Objectives To determine whether snoring, sleep position, and other sleep practices in pregnant women are associated with risk of late stillbirth. Design Prospective population based case-control study. Setting Auckland, New Zealand Participants Cases: 155 women with a singleton late stillbirth (>= 28 weeks' gestation) without congenital abnormality born between July 2006 and June 2009 and booked to deliver in Auckland. Controls: 310 women with single ongoing pregnancies and gestation matched to that at which the stillbirth occurred. Multivariable logistic regression adjusted for known confounding factors. Main outcome measure Maternal snoring, daytime sleepiness (measured with the Epworth sleepiness scale), and sleep position at the time of going to sleep and on waking (left side, right side, back, and other). Results The prevalence of late stillbirth in this study was 3.09/1000 births. No relation was found between snoring or daytime sleepiness and risk of late stillbirth. However, women who slept on their back or on their right side on the previous night (before stillbirth or interview) were more likely to experience a late stillbirth compared with women who slept on their left side (adjusted odds ratio for back sleeping 2.54 (95% CI 1.04 to 6.18), and for right side sleeping 1.74 (0.98 to 3.01)). The absolute risk of late stillbirth for women who went to sleep on their left was 1.96/1000 and was 3.93/1000 for women who did not go to sleep on their left. Women who got up to go to the toilet once or less on the last night were more likely to experience a late stillbirth compared with women who got up more frequently (adjusted odds ratio 2.28 (1.40 to 3.71)). Women who regularly slept during the day in the previous month were also more likely to experience a late stillbirth than those who did not (2.04 (1.26 to 3.27)). Conclusions This is the first study to report maternal sleep related practices as risk factors for stillbirth, and these findings require urgent confirmation in further studies.	[Stacey, Tomasina; Ekeroma, Alec J.; McCowan, Lesley M. E.] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1142, New Zealand; [Thompson, John M. D.; Mitchell, Ed A.] Univ Auckland, Dept Paediat, Auckland 1142, New Zealand; [Zuccollo, Jane M.] Wellington Sch Med, Dept Obstet & Gynaecol, Wellington 6021, New Zealand	University of Auckland; University of Auckland; University of Otago	Stacey, T (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Private Bag 92019, Auckland 1142, New Zealand.	t.stacey@auckland.ac.nz	Ekeroma, Alec/H-4938-2019; Ekeroma, Alec/Y-3211-2019; McCowan, Lesley/C-2215-2009	Ekeroma, Alec/0000-0002-7581-8275; Stacey, Tomasina/0000-0003-2002-6200; McCowan, Lesley/0000-0001-9915-7873	Cure Kids; Nurture Foundation; Auckland District Health Board Trust	Cure Kids; Nurture Foundation; Auckland District Health Board Trust	Funding received from: Cure Kids, the Nurture Foundation, and the Auckland District Health Board Trust fund. EAM, JMDT, and TS are supported in part by Cure Kids. The authors were independent of the funders in all aspects of study design, data analysis, and writing of the manuscript.	AUSTIN H, 1994, EPIDEMIOL REV, V16, P65, DOI 10.1093/oxfordjournals.epirev.a036146; Brain KA, 2001, BRIT J OBSTET GYNAEC, V108, P543, DOI 10.1111/j.1471-0528.2001.00106.x; Carbonne B, 1996, OBSTET GYNECOL, V88, P797, DOI 10.1016/0029-7844(96)00298-0; Centre for Maternal and Child Enquiries (CMACE), 2011, PER MORT 2009 UK; Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DREWS CD, 1990, INT J EPIDEMIOL, V19, P405, DOI 10.1093/ije/19.2.405; GIBBONS LE, 1993, AM J EPIDEMIOL, V137, P654, DOI 10.1093/oxfordjournals.aje.a116723; Gray R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3754; Haberman S, 2011, AM J OBSTET GYNECOL, V204, pS278; Izci B, 2006, EUR RESPIR J, V27, P321, DOI 10.1183/09031936.06.00148204; Izci B, 2005, SLEEP MED, V6, P163, DOI 10.1016/j.sleep.2004.12.007; Jeffreys RM, 2006, BJOG-INT J OBSTET GY, V113, P1239, DOI 10.1111/j.1471-0528.2006.01056.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KINSELLA SM, 1994, OBSTET GYNECOL, V83, P774; Kuo CD, 1997, ANAESTHESIA, V52, P1161, DOI 10.1111/j.1365-2044.1997.254-az0387.x; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; Maasilta P, 2001, CHEST, V120, P1448, DOI 10.1378/chest.120.5.1448; Mador MJ, 2005, CHEST, V128, P2130, DOI 10.1378/chest.128.4.2130; MILSOM I, 1984, AM J OBSTET GYNECOL, V148, P764, DOI 10.1016/0002-9378(84)90563-5; New Zealand Ministry of Health, 2004, ETHN DAT PROT HLTH D; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Olivarez SA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.008; *PER SOC AUSTR NZ, 2009, PSANZ CLIN PRACT GUI; PMMRC, 2009, PER MAT MORT NZ 2006; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Salihu HM, 2008, J OBSTET GYNAECOL RE, V34, P843, DOI 10.1111/j.1447-0756.2008.00855.x; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Salmond C., 2007, NZDEP2006 INDEX DEPR; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stacey T, 2011, AUST NZ J OBSTET GYN, V51, P3, DOI 10.1111/j.1479-828X.2010.01254.x; Stacey T, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-3; Venkata C, 2009, J AM BOARD FAM MED, V22, P158, DOI 10.3122/jabfm.2009.02.080057; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Youngstedt SD, 2004, SLEEP MED REV, V8, P159, DOI 10.1016/j.smrv.2003.10.002; [No title captured]	36	78	77	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3403	10.1136/bmj.d3403	http://dx.doi.org/10.1136/bmj.d3403			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781KY	21673002	Green Published			2022-12-01	WOS:000291932100007
J	Barnes, TRE; Paton, C				Barnes, Thomas R. E.; Paton, Carol			UNCERTAINTIES PAGE Do antidepressants improve negative symptoms in schizophrenia?	BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; ADD-ON THERAPY; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENT; MIRTAZAPINE ADD; METAANALYSIS; CLOZAPINE; ANTIPSYCHOTICS; AUGMENTATION		[Barnes, Thomas R. E.; Paton, Carol] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8RP, England	Imperial College London	Barnes, TRE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8RP, England.	t.r.barnes@imperial.ac.uk			Department of Health [07/83/01] Funding Source: Medline; National Institute for Health Research [07/83/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Abbasi SH, 2010, SCHIZOPHR RES, V116, P101, DOI 10.1016/j.schres.2009.11.008; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Berk M, 2009, HUM PSYCHOPHARM CLIN, V24, P233, DOI 10.1002/hup.1017; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1013, DOI 10.1093/schbul/sbl057; Buckley PF, 2007, ACTA PSYCHIAT SCAND, V115, P93, DOI 10.1111/j.1600-0447.2007.00992.x; CARPENTER WT, 1985, SCHIZOPHRENIA BULL, V11, P440, DOI 10.1093/schbul/11.3.440; Chang JS, 2008, J CLIN PSYCHIAT, V69, P720, DOI 10.4088/JCP.v69n0505; Cho SJ, 2011, PROG NEURO-PSYCHOPH, V35, P208, DOI 10.1016/j.pnpbp.2010.11.006; Erhart SM, 2006, SCHIZOPHRENIA BULL, V32, P234, DOI 10.1093/schbul/sbj055; Hofer A, 2005, EUR PSYCHIAT, V20, P386, DOI 10.1016/j.eurpsy.2005.02.005; Iancu I, 2010, PSYCHIAT RES, V179, P19, DOI 10.1016/j.psychres.2010.04.035; Lecrubier Y, 2007, EVID-BASED MENT HEAL, V10, DOI 10.1136/ebmh.10.4.113; Melle I, 2008, ARCH GEN PSYCHIAT, V65, P634, DOI 10.1001/archpsyc.65.6.634; Mulholland C, 2003, J PSYCHOPHARMACOL, V17, P107, DOI 10.1177/0269881103017001713; Paton C, 2007, J CLIN PSYCHOPHARM, V27, P198, DOI 10.1097/JCP.0b013e318036bfbb; Rosenheck R, 2006, AM J PSYCHIAT, V163, P411, DOI 10.1176/appi.ajp.163.3.411; RUMMEL C, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005581.PUB2; Sepehry AA, 2007, J CLIN PSYCHIAT, V68, P604, DOI 10.4088/JCP.v68n0417; Silver H, 2000, INT CLIN PSYCHOPHARM, V15, P257, DOI 10.1097/00004850-200015050-00002; Singh SP, 2010, BRIT J PSYCHIAT, V197, P174, DOI 10.1192/bjp.bp.109.067710; Tiihonen J, 2009, SCHIZOPHR RES, V109, P10, DOI 10.1016/j.schres.2009.01.002; Turkington D, 2008, SCHIZOPHR RES, V98, P1, DOI 10.1016/j.schres.2007.09.026; Turkington D, 2006, BRIT J PSYCHIAT, V189, P36, DOI 10.1192/bjp.bp.105.010884; Weiner E, 2010, NEUROPSYCHOPHARMACOL, V35, P2274, DOI 10.1038/npp.2010.101; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114	26	8	8	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2011	342								d3371	10.1136/bmj.d3371	http://dx.doi.org/10.1136/bmj.d3371			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SS	21665932				2022-12-01	WOS:000291645900002
J	DeWeerdt, S				DeWeerdt, Sarah			A testing journey	NATURE			English	Editorial Material																		Duarte CAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012822; Lee SR, 2011, J VIROL METHODS, V172, P27, DOI 10.1016/j.jviromet.2010.12.009; Shawky SM, 2010, CLIN BIOCHEM, V43, P1163, DOI 10.1016/j.clinbiochem.2010.07.001; Zuure F, 2010, EUROSURVEILLANCE, V15, P5; Zuure FR, 2011, AM J PREV MED, V40, P345, DOI 10.1016/j.amepre.2010.11.019	5	4	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S20	S21		10.1038/474S20a	http://dx.doi.org/10.1038/474S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666732	Bronze			2022-12-01	WOS:000291397800012
J	Maxmen, A				Maxmen, Amy			Playing the odds	NATURE			English	Editorial Material							CHRONIC HEPATITIS-C; IL28B											Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hitomi Y, 2011, GASTROENTEROLOGY, V140, P1314, DOI 10.1053/j.gastro.2010.12.038; Kelly C, 2011, GUT; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449	7	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S9	S10		10.1038/474S9a	http://dx.doi.org/10.1038/474S9a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666735				2022-12-01	WOS:000291397800006
J	Dieffenbach, CW; Fauci, AS				Dieffenbach, Carl W.; Fauci, Anthony S.			Thirty Years of HIV and AIDS: Future Challenges and Opportunities	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NEUTRALIZING ANTIBODIES; POTENT NEUTRALIZATION; DISEASE PROGRESSION; DOUBLE-BLIND; T-CELLS; INFECTION; VACCINE; PREVENTION; TRANSMISSION	As the third decade since AIDS was first recognized comes to an end, extraordinary advances have occurred in the understanding, treatment, and prevention of HIV infection and AIDS. As a result of these successes, it is now time to focus on future challenges. Paramount among these is reaching the goal of truly controlling and ultimately ending the HIV and AIDS pandemic. To that end, AIDS researchers and public health personnel worldwide are aggressively pursuing 3 key areas of scientific research. Given the availability of highly effective therapeutic regimens for HIV infection, the first challenge is efficiently identifying a maximum number of HIV-infected persons through voluntary HIV testing and initiating antiretroviral therapy (ART). Second, scientists are trying to develop a cure for HIV infection, which would alleviate the need for lifelong ART. Finally, preventing new cases of HIV infection, which currently number approximately 2.6 million per year globally, is critical to any attempt to end this pandemic. This article addresses each of these challenges and provides directions for the future.	[Dieffenbach, Carl W.] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dieffenbach, CW (corresponding author), NIAID, Div Aids, NIH, 6700 Rockledge Dr,MSC 7620, Bethesda, MD 20892 USA.	cdieffenba@niaid.nih.gov						Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; [Anonymous], 2010, ANTIRETROVIRAL THERA; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], SAF EFF TEN 1 GEL TE; [Anonymous], 2009, AIDS EP UPD 2009; [Anonymous], STRAT TIM ANT TREATM; [Anonymous], US PRESIDENTS EMERGE; Bailey R. C., 2010, 18 INT AIDS C VIENN; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P305; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Costello C, 1999, AIDS, V13, P1990, DOI 10.1097/00002030-199910010-00031; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fauci AS, 2009, HEALTH AFFAIR, V28, P1629, DOI 10.1377/hlthaff.28.6.1629; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Gallo RC, 2003, NEW ENGL J MED, V349, P2283, DOI 10.1056/NEJMp038194; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray G, 2009, AIDS VACC 2009 PAR F; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; HYMES KB, 1981, LANCET, V2, P598; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Margolis DM, 2011, AIDS RES HUM RETROV, V27, P347, DOI 10.1089/aid.2011.0017; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782; Walker Bruce D, 2007, Top HIV Med, V15, P134; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	58	113	117	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11					766	771		10.7326/0003-4819-154-11-201106070-00345	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00345			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21628350				2022-12-01	WOS:000291312300008
J	Kwon, HB; Sabatini, BL				Kwon, Hyung-Bae; Sabatini, Bernardo L.			Glutamate induces de novo growth of functional spines in developing cortex	NATURE			English	Article							HIPPOCAMPAL SLICE CULTURES; SINGLE DENDRITIC SPINES; SYNAPSE FORMATION; PYRAMIDAL NEURONS; ADULT CORTEX; IN-VIVO; PLASTICITY; SYNAPTOGENESIS; ACTIVATION; MATURATION	Mature cortical pyramidal neurons receive excitatory inputs onto small protrusions emanating from their dendrites called spines. Spines undergo activity-dependent remodelling, stabilization and pruning during development, and similar structural changes can be triggered by learning and changes in sensory experiences(1-4). However, the biochemical triggers and mechanisms of de novo spine formation in the developing brain and the functional significance of new spines to neuronal connectivity are largely unknown. Here we develop an approach to induce and monitor de novo spine formation in real time using combined two-photon laser-scanning microscopy and two-photon laser uncaging of glutamate. Our data demonstrate that, in mouse cortical layer 2/3 pyramidal neurons, glutamate is sufficient to trigger de novo spine growth from the dendrite shaft in a location-specific manner. We find that glutamate-induced spinogenesis requires opening of NMDARs (N-methyl-D-aspartate-type glutamate receptors) and activation of protein kinase A (PKA) but is independent of calcium-calmodulin-dependent kinase II (CaMKII) and tyrosine kinase receptor B (TrkB) receptors. Furthermore, newly formed spines express glutamate receptors and are rapidly functional such that they transduce presynaptic activity into postsynaptic signals. Together, our data demonstrate that early neural connectivity is shaped by activity in a spatially precise manner and that nascent dendrite spines are rapidly functionally incorporated into cortical circuits.	[Kwon, Hyung-Bae; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			Simons Foundation; National Institute of Neurological Disorders and Stroke [NS046579]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Sabatini laboratory for their comments on the manuscript and assistance with data analysis. We are grateful to S. Nazia for technical support and for acting as the blind evaluator. This work was supported by a SFARI grant from the Simons Foundation and the National Institute of Neurological Disorders and Stroke (NS046579).	Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HAMORI J, 1973, BRAIN RES, V62, P337, DOI 10.1016/0006-8993(73)90694-X; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sorra KE, 1998, J COMP NEUROL, V398, P225; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	30	249	251	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					100	104		10.1038/nature09986	http://dx.doi.org/10.1038/nature09986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21552280	Green Accepted			2022-12-01	WOS:000291156700046
J	Kamakura, M				Kamakura, Masaki			Royalactin induces queen differentiation in honeybees	NATURE			English	Article							CULTURED RAT HEPATOCYTES; APIS-MELLIFERA; ENHANCES PROLIFERATION; CASTE DIFFERENTIATION; PROTHORACIC GLAND; REGULATES GROWTH; BODY-SIZE; DROSOPHILA; PROTEINS; FAMILY	The honeybee (Apis mellifera) forms two female castes: the queen and the worker. This dimorphism depends not on genetic differences, but on ingestion of royal jelly, although the mechanism through which royal jelly regulates caste differentiation has long remained unknown. Here I show that a 57-kDa protein in royal jelly, previously designated as royalactin, induces the differentiation of honeybee larvae into queens. Royalactin increased body size and ovary development and shortened developmental time in honeybees. Surprisingly, it also showed similar effects in the fruitfly (Drosophila melanogaster). Mechanistic studies revealed that royalactin activated p70 S6 kinase, which was responsible for the increase of body size, increased the activity of mitogen-activated protein kinase, which was involved in the decreased developmental time, and increased the titre of juvenile hormone, an essential hormone for ovary development. Knockdown of epidermal growth factor receptor (Egfr) expression in the fat body of honeybees and fruitflies resulted in a defect of all phenotypes induced by royalactin, showing that Egfr mediates these actions. These findings indicate that a specific factor in royal jelly, royalactin, drives queen development through an Egfr-mediated signalling pathway.	Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan	Toyama Prefectural University	Kamakura, M (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan.	kamakura@pu-toyama.ac.jp	Kamakura, Masaki/E-7954-2011					BEETSMA J, 1979, BEE WORLD, V60, P24, DOI 10.1080/0005772X.1979.11097727; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Bloch Guy, 2002, P195; BOWNES M, 1994, BIOESSAYS, V16, P745, DOI 10.1002/bies.950161009; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; EBERT R, 1980, J COMP PHYSIOL, V137, P7, DOI 10.1007/BF00656912; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; GOEWIE EA, 1976, P K NED AKAD C BIOL, V79, P466; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Kamakura M, 2006, PROTEIN EXPRES PURIF, V45, P307, DOI 10.1016/j.pep.2005.08.004; Kamakura M, 2002, J BIOCHEM, V132, P911, DOI 10.1093/oxfordjournals.jbchem.a003304; Kamakura M, 2001, J NUTR SCI VITAMINOL, V47, P394, DOI 10.3177/jnsv.47.394; Kamakura M, 2001, BIOCHEM BIOPH RES CO, V282, P865, DOI 10.1006/bbrc.2001.4656; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LeVea CM, 2004, EXP CELL RES, V297, P272, DOI 10.1016/j.yexcr.2004.03.026; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Navolanic PM, 2003, INT J ONCOL, V22, P237; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PATEL NG, 1960, NATURE, V186, P633, DOI 10.1038/186633a0; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; SHUEL R. W., 1960, INSECTES SOCIAUX, V7, P265, DOI 10.1007/BF02224497; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; WEAVER NEVIN, 1957, ANN ENT SOC AMER, V50, P283; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; WIRTZ P, 1972, ENTOMOL EXP APPL, V15, P517, DOI 10.1007/BF00293616; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zinke I, 1999, DEVELOPMENT, V126, P5275	37	390	448	19	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					478	483		10.1038/nature10093	http://dx.doi.org/10.1038/nature10093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21516106	Green Submitted			2022-12-01	WOS:000290951300033
J	Ruediger, S; Vittori, C; Bednarek, E; Genoud, C; Strata, P; Sacchetti, B; Caroni, P				Ruediger, Sarah; Vittori, Claudia; Bednarek, Ewa; Genoud, Christel; Strata, Piergiorgio; Sacchetti, Benedetto; Caroni, Pico			Learning-related feedforward inhibitory connectivity growth required for memory precision	NATURE			English	Article							STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; CORTICAL CIRCUITS; HIPPOCAMPUS; CA3; CONSOLIDATION; CONTEXT; BRAIN; CELLS	In the adult brain, new synapses are formed and pre-existing ones are lost, but the function of this structural plasticity has remained unclear(1-5). Learning of new skills is correlated with formation of new synapses(6-8). These may directly encode new memories, but they may also have more general roles in memory encoding and retrieval processes(2). Here we investigated how mossy fibre terminal complexes at the entry of hippocampal and cerebellar circuits rearrange upon learning in mice, and what is the functional role of the rearrangements. We show that one-trial and incremental learning lead to robust, circuit-specific, long-lasting and reversible increases in the numbers of filopodial synapses onto fast-spiking interneurons that trigger feedforward inhibition. The increase in feedforward inhibition connectivity involved a majority of the presynaptic terminals, restricted the numbers of c-Fos-expressing postsynaptic neurons at memory retrieval, and correlated temporally with the quality of the memory. We then show that for contextual fear conditioning and Morris water maze learning, increased feedforward inhibition connectivity by hippocampal mossy fibres has a critical role for the precision of the memory and the learned behaviour. In the absence of mossy fibre long-term potentiation in Rab3a(-/-) mice(9), c-Fos ensemble reorganization and feedforward inhibition growth were both absent in CA3 upon learning, and the memory was imprecise. By contrast, in the absence of adducin 2 (Add2; also known as beta-adducin)(10) c-Fos reorganization was normal, but feedforward inhibition growth was abolished. In parallel, c-Fos ensembles in CA3 were greatly enlarged, and the memory was imprecise. Feedforward inhibition growth and memory precision were both rescued by re-expression of Add2 specifically in hippocampal mossy fibres. These results establish a causal relationship between learning-related increases in the numbers of defined synapses and the precision of learning and memory in the adult. The results further relate plasticity and feedforward inhibition growth at hippocampal mossy fibres to the precision of hippocampus-dependent memories.	[Ruediger, Sarah; Vittori, Claudia; Bednarek, Ewa; Genoud, Christel; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Vittori, Claudia; Strata, Piergiorgio; Sacchetti, Benedetto] Dept Neurosci, I-10125 Turin, Italy; [Vittori, Claudia; Strata, Piergiorgio; Sacchetti, Benedetto] Natl Inst Neurosci Italy, I-10125 Turin, Italy	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch	Sacchetti, Benedetto/AFK-4141-2022; Sacchetti, Benedetto/AAG-2916-2022; Ruediger Lee, Sarah/ABG-6969-2021	Sacchetti, Benedetto/0000-0002-8695-8310; Ruediger, Sarah/0000-0001-6684-4693; genoud, christel/0000-0002-0933-9911; Ruediger, Sarah/0000-0001-9140-872X; Vittori, Claudia/0000-0002-3467-5984				Acsady L, 1998, J NEUROSCI, V18, P3386; BEDNAREK E, NEURON IN PRESS; Biedenkapp JC, 2007, LEARN MEMORY, V14, P200, DOI 10.1101/lm.499407; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	30	184	185	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					514	U258		10.1038/nature09946	http://dx.doi.org/10.1038/nature09946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	768QM	21532590	Green Submitted			2022-12-01	WOS:000290951300041
J	Copertino, MD				Copertino, Margareth da Silva			Add coastal vegetation to the climate critical list	NATURE			English	Editorial Material									Fundacao Univ Fed Rio Grande, Inst Oceanog, Rio Grande, Brazil	Universidade Federal do Rio Grande	Copertino, MD (corresponding author), Fundacao Univ Fed Rio Grande, Inst Oceanog, Rio Grande, Brazil.	doccoper@furg.br	Fapesp, Biota/F-8655-2017; Copertino, Margareth S/C-9893-2013; Copertino, Margareth/T-6873-2019; da Silva Oliveira, Margareth/K-9670-2015	Fapesp, Biota/0000-0002-9887-8449; Copertino, Margareth S/0000-0001-5771-829X; Copertino, Margareth/0000-0001-5771-829X; da Silva Oliveira, Margareth/0000-0002-6490-5170					0	21	23	4	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 19	2011	473	7347					255	255		10.1038/473255a	http://dx.doi.org/10.1038/473255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765QA	21593818	Bronze			2022-12-01	WOS:000290722400004
J	Muller, J; Hipsley, CA; Head, JJ; Kardjilov, N; Hilger, A; Wuttke, M; Reisz, RR				Mueller, Johannes; Hipsley, Christy A.; Head, Jason J.; Kardjilov, Nikolay; Hilger, Andre; Wuttke, Michael; Reisz, Robert R.			Eocene lizard from Germany reveals amphisbaenian origins	NATURE			English	Article							SQUAMATE REPTILES; BODY-FORM; PHYLOGENETIC ANALYSIS; MIDDLE-EOCENE; EVOLUTION; SNAKES; SYSTEMATICS; RESOLUTION; POSITION	Amphisbaenia is a speciose clade of fossorial lizards characterized by a snake-like body and a strongly reinforced skull adapted for head-first burrowing(1,2). The evolutionary origins of amphisbaenians are controversial, with molecular data uniting them with lacertids(3,4), a clade of Old World terrestrial lizards, whereas morphology supports a grouping with snakes and other limbless squamates(5-9). Reports of fossil stem amphisbaenians(10) have been falsified(11), and no fossils have previously tested these competing phylogenetic hypotheses or shed light on ancestral amphisbaenian ecology. Here we report the discovery of a new lacertid-like lizard from the Eocene Messel locality of Germany that provides the first morphological evidence for lacertid-amphisbaenian monophyly on the basis of a reinforced, akinetic skull roof and braincase, supporting the view that body elongation and limblessness in amphisbaenians and snakes evolved independently. Morphometric analysis of body shape and ecology in squamates indicates that the postcranial anatomy of the new taxon is most consistent with opportunistically burrowing habits, which in combination with cranial reinforcement indicates that head-first burrowing evolved before body elongation and may have been a crucial first step in the evolution of amphisbaenian fossoriality.	[Mueller, Johannes; Hipsley, Christy A.] Humboldt Univ, Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, D-10115 Berlin, Germany; [Hipsley, Christy A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Head, Jason J.; Reisz, Robert R.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Kardjilov, Nikolay; Hilger, Andre] Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany; [Wuttke, Michael] Gen Direkt Kulturelles Erbe RLP, Direkt Landesarchaol, D-55116 Mainz, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of California System; University of California Santa Cruz; University of Toronto; University Toronto Mississauga; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Muller, J (corresponding author), Humboldt Univ, Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany.	johannes.mueller@mfn-berlin.de	Kardjilov, Nikolay/AAX-9855-2021; Müller, Johannes/A-6293-2017	Müller, Johannes/0000-0001-5801-856X; Kardjilov, Nikolay/0000-0002-0980-1440; Hipsley, Christy/0000-0002-5740-9363; Hilger, Andre/0000-0002-6454-7967	Natural Sciences and Engineering Research Council of Canada; Alexander von Humboldt-Stiftung	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation)	We thank S. Schaal for making the specimen available for study, J. J. Wiens for providing his morphometric data set of extant squamates, J. L. Conrad for providing his morphological data set of fossil and extant squamates, I. Manke for technical and administrative support, H. Mewis, H. Stohr and A. Paulke for technical support, C. Bell and D. Evans for discussion, and P. Holroyd, M. Kroniger, M. Cunningham, M.-O. Rodel, K. Seymour, H.-D. Sues and F. Tillack for access to specimens. J.J.H. was funded by Natural Sciences and Engineering Research Council of Canada Discovery and Research Tools and Instruments grants, R.R.R. was funded by a Natural Sciences and Engineering Research Council of Canada Discovery grant and the Alexander von Humboldt-Stiftung.	BERMAN DS, 1977, J PALEONTOL, V51, P986; BERMAN DS, 1973, COPEIA, P704; Brandley MC, 2008, EVOLUTION, V62, P2042, DOI 10.1111/j.1558-5646.2008.00430.x; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Estes R., 1988, P119; Estes R., 1983, HDB PALAOHERPETOL 10; Evans SE, 1998, ZOOL J LINN SOC-LOND, V124, P235, DOI 10.1006/zjls.1997.0139; Franzen J. L., 1982, COUR FORSCH I SENCKE, V54, P12; GANS C, 1975, AM ZOOL, V15, P455; Gans C., 2008, BIOL REPTILIA VOLUME, P621; GREER AE, 1991, J HERPETOL, V25, P166, DOI 10.2307/1564644; Hallermann J, 1998, ZOOL J LINN SOC-LOND, V122, P385, DOI 10.1006/zjls.1996.0109; Hipsley CA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-151; Kearney M, 2005, J MORPHOL, V264, P1, DOI 10.1002/jmor.10210; Kearney M, 2003, HERPETOL MONOGR, V17, P1, DOI 10.1655/0733-1347(2003)017[0001:SOTALB]2.0.CO;2; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P394, DOI 10.1671/0272-4634(2003)023[0394:TPPOSH]2.0.CO;2; Lee MSY, 2009, J EVOLUTION BIOL, V22, P1308, DOI 10.1111/j.1420-9101.2009.01751.x; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Muller J, 2001, J VERTEBR PALEONTOL, V21, P261, DOI 10.1671/0272-4634(2001)021[0261:OAROER]2.0.CO;2; Popov S.V., 2004, COUR FORSCH I SENCKE, V250, P1; RIEPPEL O, 1988, EVOL BIOL, V22, P37; Rieppel O, 2007, J PALEONTOL, V81, P760, DOI 10.1666/pleo0022-3360(2007)081[0760:NMDFEK]2.0.CO;2; The Deep Scaly Project, 2008, RHIN FLOR FLOR WORM; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Weber Sinje, 2004, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V561, P1; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2001, EVOLUTION, V55, P2303; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; WU XC, 1993, NATURE, V366, P57, DOI 10.1038/366057a0	30	71	75	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					364	367		10.1038/nature09919	http://dx.doi.org/10.1038/nature09919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593869				2022-12-01	WOS:000290722400046
J	Cohen-Bearak, A				Cohen-Bearak, Adena			Entering Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												adenacb@verizon.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					1944	1944		10.1001/jama.2011.621	http://dx.doi.org/10.1001/jama.2011.621			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21586704				2022-12-01	WOS:000290665500001
J	Liu, YY; Slotine, JJ; Barabasi, AL				Liu, Yang-Yu; Slotine, Jean-Jacques; Barabasi, Albert-Laszlo			Controllability of complex networks	NATURE			English	Article							CONTRACTION ANALYSIS; PERCOLATION	The ultimate proof of our understanding of natural or technological systems is reflected in our ability to control them. Although control theory offers mathematical tools for steering engineered and natural systems towards a desired state, a framework to control complex self-organized systems is lacking. Here we develop analytical tools to study the controllability of an arbitrary complex directed network, identifying the set of driver nodes with time-dependent control that can guide the system's entire dynamics. We apply these tools to several real networks, finding that the number of driver nodes is determined mainly by the network's degree distribution. We show that sparse inhomogeneous networks, which emerge in many real complex systems, are the most difficult to control, but that dense and homogeneous networks can be controlled using a few driver nodes. Counterintuitively, we find that in both model and real systems the driver nodes tend to avoid the high-degree nodes.	[Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Comp Sci & Biol, Boston, MA 02115 USA; [Liu, Yang-Yu; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Slotine, Jean-Jacques] MIT, Nonlinear Syst Lab, Cambridge, MA 02139 USA; [Slotine, Jean-Jacques] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Slotine, Jean-Jacques] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Northeastern University; Northeastern University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	alb@neu.edu	Liu, Yang-Yu/G-8885-2011; Barabasi, Albert-Laszlo/S-6474-2017	Liu, Yang-Yu/0000-0003-2728-4907; Barabasi, Albert/0000-0002-4028-3522	US Army Research Laboratory [W911NF-09-2-0053]; Office of Naval Research [N000141010968]; Defense Threat Reduction Agency [WMD BRBAA07-J-2-0035, BRBAA08-Per4-C-2-0033]; James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems	US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Office of Naval Research(Office of Naval Research); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems	We thank C. Song, G. Bianconi, H. Zhou, L. Vepstas, N. Gulbahce, H. Jeong, Y.-Y. Ahn, B. Barzel, N. Blumm, D. Wang, Z. Qu and Y. Li for discussions. This work was supported by the Network Science Collaborative Technology Alliance sponsored by the US Army Research Laboratory under Agreement Number W911NF-09-2-0053; the Office of Naval Research under Agreement Number N000141010968; the Defense Threat Reduction Agency awards WMD BRBAA07-J-2-0035 and BRBAA08-Per4-C-2-0033; and the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], STRUCTURE DYNAMICS N; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauer M, 2001, EUR PHYS J B, V24, P339, DOI 10.1007/s10051-001-8683-4; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Bollobas B., 2001, RANDOM GRAPHS; Caldarelli G., 2007, SCALE FREE NETWORKS; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Chiang M, 2007, P IEEE, V95, P255, DOI 10.1109/JPROC.2006.887322; Chung F., 2002, ANN COMB, V6, P125, DOI 10.1007/PL00012580; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; ERDOS P, 1960, B INT STATIST INST, V38, P343; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Kalman R. E.., 1963, J SOC IND APPL MAT A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kelly FP, 1998, J OPER RES SOC, V49, P237, DOI 10.1038/sj.jors.2600523; Kim DH, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113047; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu B, 2008, IEEE T AUTOMAT CONTR, V53, P1009, DOI 10.1109/TAC.2008.919548; Lohmiller W, 1998, AUTOMATICA, V34, P683, DOI 10.1016/S0005-1098(98)00019-3; Lombardi A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056110; LovuYsz L., 2009, MATCHING THEORY; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; Marucci L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008083; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesbahi M, 2010, GRAPH THEORETIC METHODS IN MULTIAGENT NETWORKS, P1; Mezard M, 2001, EUR PHYS J B, V20, P217, DOI 10.1007/PL00011099; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Motter AE, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.1; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Ou-Yang Zhong-can, 2003, MAXIMUM MATCHING RAN; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pastor-Satorras R., 2004, EVOLUTION STRUCTURE; Rahman A, 2009, SIAM J CONTROL OPTIM, V48, P162, DOI 10.1137/060674909; SHIELDS RW, 1976, IEEE T AUTOMAT CONTR, V21, P203, DOI 10.1109/TAC.1976.1101198; Slotine J.-J. E, 1991, APPL NONLINEAR CONTR, V199; Sorrentino F, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046103; Srikant R., 2004, MATH INTERNET CONGES; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tanner HG, 2004, IEEE DECIS CONTR P, P2467, DOI 10.1109/CDC.2004.1428782; Wang W, 2005, BIOL CYBERN, V92, P38, DOI 10.1007/s00422-004-0527-x; Wang XF, 2002, PHYSICA A, V310, P521, DOI 10.1016/S0378-4371(02)00772-0; Yu WW, 2010, IEEE T SYST MAN CY B, V40, P881, DOI 10.1109/TSMCB.2009.2031624; Yu WW, 2009, AUTOMATICA, V45, P429, DOI 10.1016/j.automatica.2008.07.016; Zdeborova L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/05/P05003	50	1977	2068	22	710	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					167	173		10.1038/nature10011	http://dx.doi.org/10.1038/nature10011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562557				2022-12-01	WOS:000290487200029
J	Sagiya, T; Kanamori, H; Yagi, Y; Yamada, M; Mori, J				Sagiya, Takeshi; Kanamori, Hiroo; Yagi, Yuji; Yamada, Masumi; Mori, Jim			Rebuilding seismology	NATURE			English	Editorial Material							JAPAN TRENCH		[Sagiya, Takeshi] Nagoya Univ, Nagoya, Aichi, Japan; [Kanamori, Hiroo] CALTECH, Pasadena, CA USA; [Yagi, Yuji] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Yamada, Masumi; Mori, Jim] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan	Nagoya University; California Institute of Technology; University of Tsukuba; Kyoto University	Sagiya, T (corresponding author), Nagoya Univ, Nagoya, Aichi, Japan.		Sagiya, Takeshi/N-8417-2018; Yagi, Yuji/D-8301-2014	Sagiya, Takeshi/0000-0001-7949-8048; Yagi, Yuji/0000-0001-5327-9277				Hashimoto C, 2009, NAT GEOSCI, V2, P141, DOI 10.1038/NGEO421; IKEDA Y, 1996, ACTIVE FAULT RES; Kawasaki I, 2001, TECTONOPHYSICS, V330, P267, DOI 10.1016/S0040-1951(00)00245-6; Nishimura T, 2004, GEOPHYS J INT, V157, P901, DOI 10.1111/j.1365-246X.2004.02159.x; NISHIMURA T, 2000, SPATIOTEMPORAL CHANG	5	31	32	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					146	148		10.1038/473146a	http://dx.doi.org/10.1038/473146a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562539				2022-12-01	WOS:000290487200046
J	Chen, Y; Graziano, JH; Parvez, F; Liu, ML; Slavkovich, V; Kalra, T; Argos, M; Islam, T; Ahmed, A; Rakibuz-Zaman, M; Hasan, R; Sarwar, G; Levy, D; van Geen, A; Ahsan, H				Chen, Yu; Graziano, Joseph H.; Parvez, Faruque; Liu, Mengling; Slavkovich, Vesna; Kalra, Tara; Argos, Maria; Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam; Levy, Diane; van Geen, Alexander; Ahsan, Habibul			Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOSE-RESPONSE RELATIONSHIP; PREMALIGNANT SKIN-LESIONS; ISCHEMIC-HEART-DISEASE; PERIPHERAL VASCULAR-DISEASE; CEREBROVASCULAR-DISEASE; HYPERENDEMIC VILLAGES; DIABETES-MELLITUS; BLADDER-CANCER; PULSE PRESSURE; LUNG-CANCER	Objective To evaluate the association between arsenic exposure and mortality from cardiovascular disease and to assess whether cigarette smoking influences the association. Design Prospective cohort study with arsenic exposure measured in drinking water from wells and urine. Setting General population in Araihazar, Bangladesh. Participants 11 746 men and women who provided urine samples in 2000 and were followed up for an average of 6. 6 years. Main outcome measure Death from cardiovascular disease. Results 198 people died from diseases of circulatory system, accounting for 43% of total mortality in the population. The mortality rate for cardiovascular disease was 214.3 per 100 000 person years in people drinking water containing <12.0 mu g/L arsenic, compared with 271.1 per 100 000 person years in people drinking water with >= 12.0 mu g/L arsenic. There was a dose-response relation between exposure to arsenic in well water assessed at baseline and mortality from ischaemic heart disease and other heart disease; the hazard ratios in increasing quarters of arsenic concentration in well water (0.1-12.0, 12.1-62.0, 62.1-148.0, and 148.1-864.0 mu g/L) were 1.00 (reference), 1.22 (0.65 to 2.32), 1.35 (0.71 to 2.57), and 1.92 (1.07 to 3.43) (P=0.0019 for trend), respectively, after adjustment for potential confounders including age, sex, smoking status, educational attainment, body mass index (BMI), and changes in urinary arsenic concentration since baseline. Similar associations were observed when baseline total urinary arsenic was used as the exposure variable and for mortality from ischaemic heart disease specifically. The data indicate a significant synergistic interaction between arsenic exposure and cigarette smoking in mortality from ischaemic heart disease and other heart disease. In particular, the hazard ratio for the joint effect of a moderate level of arsenic exposure (middle third of well arsenic concentration 25.3-114.0 mu g/L, mean 63.5 mu g/L) and cigarette smoking on mortality from heart disease was greater than the sum of the hazard ratios associated with their individual effect (relative excess risk for interaction 1.56, 0.05 to 3.14; P=0.010). Conclusions Exposure to arsenic in drinking water is adversely associated with mortality from heart disease, especially among smokers.	[Chen, Yu; Liu, Mengling] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA; [Graziano, Joseph H.; Parvez, Faruque; Slavkovich, Vesna; Levy, Diane] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Columbia Univ Res Project Off, Dhaka, Bangladesh; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	New York University; Columbia University; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Columbia University	Chen, Y (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA.	yu.chen@nyumc.org; habib@uchicago.edu		Liu, Mengling/0000-0001-9758-8522; Chen, Yu/0000-0002-1519-4894	US National Institute of Health; National Institute of Environmental Health Sciences [P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ESO11601, P30ES09089, CA016087, ES000260, CA014599]; National Cancer Institute [P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ESO11601, P30ES09089, CA016087, ES000260, CA014599]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA102484, P30CA014599, R01CA107431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349, R01ES017541, P30ES009089, P30ES000260] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by US National Institute of Health funding. The National Institute of Environmental Health Sciences and the National Cancer Institute provide support under the following grants: P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ES017541, R01ESO11601, P30ES09089, CA016087, ES000260, and CA014599. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; Ahsan H, 2006, AM J EPIDEMIOL, V163, P1138, DOI 10.1093/aje/kwj154; [Anonymous], 2007, MAN INT CLASS DIS IN; Argos M, 2007, AM J PUBLIC HEALTH, V97, P825, DOI 10.2105/AJPH.2005.078816; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; *BRIT GEOL SURV, 1999, GROUNDW STUD ARS CON; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Bunderson M, 2004, TOXICOL APPL PHARM, V201, P32, DOI 10.1016/j.taap.2004.04.008; Bunderson M, 2002, TOXICOL APPL PHARM, V184, P11, DOI 10.1006/taap.2002.9492; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Chen CJ, 1996, ARTERIOSCL THROM VAS, V16, P504, DOI 10.1161/01.ATV.16.4.504; Chen CL, 2004, JAMA-J AM MED ASSOC, V292, P2984, DOI 10.1001/jama.292.24.2984; Chen Y, 2004, BRIT J NUTR, V92, P851, DOI 10.1079/BJN20041277; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P1415, DOI 10.1289/ehp.10277; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P917, DOI 10.1289/ehp.9833; Chen Y, 2007, AM J EPIDEMIOL, V165, P541, DOI 10.1093/aje/kwk037; Chen Y, 2006, EPIDEMIOLOGY, V17, P459, DOI 10.1097/01.ede.0000220554.50837.7f; Chen Y, 2010, ENVIRON HEALTH PERSP, V118, P1299, DOI 10.1289/ehp.0901559; Cheng Z, 2005, ENVIRON SCI TECHNOL, V39, P4759, DOI 10.1021/es048065f; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Chiou HY, 1997, STROKE, V28, P1717, DOI 10.1161/01.STR.28.9.1717; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, pA442, DOI 10.1289/ehp.113-a442a; GREENLAND S, 1994, AM J EPIDEMIOL, V139, P747, DOI 10.1093/oxfordjournals.aje.a117069; HopenhaynRich C, 1996, ENVIRON HEALTH PERSP, V104, P620, DOI 10.2307/3433091; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hsueh YM, 1998, ATHEROSCLEROSIS, V141, P249, DOI 10.1016/S0021-9150(98)00178-6; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Karagas MR, 2004, CANCER CAUSE CONTROL, V15, P465, DOI 10.1023/B:CACO.0000036452.55199.a3; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Lindberg AL, 2010, ENVIRON HEALTH PERSP, V118, P533, DOI 10.1289/ehp.0900728; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Melkonian S, 2011, AM J EPIDEMIOL, V173, P183, DOI 10.1093/aje/kwq357; Mudur G, 2000, BRIT MED J, V320, P822; Navas-Acien A, 2005, AM J EPIDEMIOL, V162, P1037, DOI 10.1093/aje/kwi330; NIXON DE, 1991, CLIN CHEM, V37, P1575; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; Pierce BL, 2010, INT J EPIDEMIOL, V39, P1037, DOI 10.1093/ije/dyp364; Rahman M, 1999, HYPERTENSION, V33, P74, DOI 10.1161/01.HYP.33.1.74; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; Steinmaus C, 2003, AM J EPIDEMIOL, V158, P1193, DOI 10.1093/aje/kwg281; Steinmaus C, 2009, EPIDEMIOLOGY, V20, P807, DOI 10.1097/EDE.0b013e3181b0fd29; Straub AC, 2009, AM J PATHOL, V174, P1949, DOI 10.2353/ajpath.2009.081016; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; Tseng CH, 1996, ATHEROSCLEROSIS, V120, P125, DOI 10.1016/0021-9150(95)05693-9; Tseng CH, 2003, TOXICOL LETT, V137, P15, DOI 10.1016/S0378-4274(02)00377-6; Tseng CH, 1997, ANGIOLOGY, V48, P321, DOI 10.1177/000331979704800405; *US EPA, 2009, 815F00015 EPA; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang CH, 2007, TOXICOL APPL PHARM, V222, P315, DOI 10.1016/j.taap.2006.12.022; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; WU MM, 1989, AM J EPIDEMIOL, V130, P1123, DOI 10.1093/oxfordjournals.aje.a115439; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238	70	258	266	5	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2011	342								d2431	10.1136/bmj.d2431	http://dx.doi.org/10.1136/bmj.d2431			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MC	21546419	Green Published, hybrid			2022-12-01	WOS:000290481800003
J	West, S; Witt, J				West, Sophie; Witt, Johan			A PATIENT'S JOURNEY Bilateral developmental dysplasia of the hips	BRITISH MEDICAL JOURNAL			English	Editorial Material									[West, Sophie] London Deanery Sch Surg, London, England; [Witt, Johan] Univ Coll London Hosp, UCH Referrals Ctr, Orthopaed & Trauma Serv, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	West, S (corresponding author), London Deanery Sch Surg, London, England.	sophie.pinder@doctors.org.uk							0	3	3	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2011	342								d2152	10.1136/bmj.d2152	http://dx.doi.org/10.1136/bmj.d2152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MC	21546421	Bronze			2022-12-01	WOS:000290481800001
J	Baldwin, DR; White, B; Schmidt-Hansen, M; Champion, AR; Melder, AM				Baldwin, D. R.; White, B.; Schmidt-Hansen, M.; Champion, A. R.; Melder, A. M.			Diagnosis and treatment of lung cancer: summary of updated NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Baldwin, D. R.; White, B.] Nottingham Univ Hosp NHS Trust, Nottingham NG5 1PB, England; [Schmidt-Hansen, M.; Champion, A. R.] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Melder, A. M.] Ctr Clin Effectiveness, Clayton, Vic 3168, Australia	Nottingham University Hospital NHS Trust	Baldwin, DR (corresponding author), Univ Nottingham Hosp, David Evans Res Ctr, Resp Med Unit, City Campus,Hucknall Rd, Nottingham NG5 1PB, England.	david.baldwin@nuh.nhs.uk						[Anonymous], 2008, ERL TREATM NONSM CEL; Cancer Research UK, 2009, CANC MORT UK STAT; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Falcoz PE, 2007, J THORAC CARDIOV SUR, V133, P325, DOI 10.1016/j.jtcvs.2006.09.020; *NAT I HLTH CLIN, 2011, DIAGN TREATM LUNG CA; *NAT I HLTH CLIN E, 2009, TOP TREATM REL SMALL; *NAT I HLTH CLIN E, 2010, GEF 1 LIN TREATM LOC; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2009, PEM 1 LIN TREATM NON; *NHS INF CTR, 2009, IC23090809 NHS INF C	10	53	54	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 27	2011	342								d2110	10.1136/bmj.d2110	http://dx.doi.org/10.1136/bmj.d2110			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759BT	21525094				2022-12-01	WOS:000290215600002
J	Wang, ZN; Klipfell, E; Bennett, BJ; Koeth, R; Levison, BS; Dugar, B; Feldstein, AE; Britt, EB; Fu, XM; Chung, YM; Wu, YP; Schauer, P; Smith, JD; Allayee, H; Tang, WHW; DiDonato, JA; Lusis, AJ; Hazen, SL				Wang, Zeneng; Klipfell, Elizabeth; Bennett, Brian J.; Koeth, Robert; Levison, Bruce S.; Dugar, Brandon; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Wu, Yuping; Schauer, Phil; Smith, Jonathan D.; Allayee, Hooman; Tang, W. H. Wilson; DiDonato, Joseph A.; Lusis, Aldons J.; Hazen, Stanley L.			Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease	NATURE			English	Article							TRIMETHYLAMINE-N-OXIDE; CORONARY-HEART-DISEASE; GENE-EXPRESSION; CHLAMYDIA-PNEUMONIAE; MURINE MACROPHAGES; MASS-SPECTROMETRY; DNA METHYLATION; ATHEROSCLEROSIS; MOUSE; MICE	Metabolomics studies hold promise for the discovery of pathways linked to disease processes. Cardiovascular disease (CVD) represents the leading cause of death and morbidity worldwide. Here we used a metabolomics approach to generate unbiased small-molecule metabolic profiles in plasma that predict risk for CVD. Three metabolites of the dietary lipid phosphatidylcholine-choline, trimethylamine N-oxide (TMAO) and betaine-were identified and then shown to predict risk for CVD in an independent large clinical cohort. Dietary supplementation of mice with choline, TMAO or betaine promoted upregulation of multiple macrophage scavenger receptors linked to atherosclerosis, and supplementation with choline or TMAO promoted atherosclerosis. Studies using germ-free mice confirmed a critical role for dietary choline and gut flora in TMAO production, augmented macrophage cholesterol accumulation and foam cell formation. Suppression of intestinal microflora in atherosclerosis-prone mice inhibited dietary-choline-enhanced atherosclerosis. Genetic variations controlling expression of flavin monooxygenases, an enzymatic source of TMAO, segregated with atherosclerosis in hyperlipidaemic mice. Discovery of a relationship between gut-flora-dependent metabolism of dietary phosphatidylcholine and CVD pathogenesis provides opportunities for the development of new diagnostic tests and therapeutic approaches for atherosclerotic heart disease.	[Wang, Zeneng; Klipfell, Elizabeth; Koeth, Robert; Levison, Bruce S.; Dugar, Brandon; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Smith, Jonathan D.; Tang, W. H. Wilson; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Wang, Zeneng; Klipfell, Elizabeth; Levison, Bruce S.; Feldstein, Ariel E.; Britt, Earl B.; Fu, Xiaoming; Chung, Yoon-Mi; Tang, W. H. Wilson; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Bennett, Brian J.; Lusis, Aldons J.] Univ Calif Los Angeles, Ctr Hlth Sci BH 307, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA; [Wu, Yuping] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Schauer, Phil] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44195 USA; [Smith, Jonathan D.; Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Allayee, Hooman] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Allayee, Hooman] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Southern California; University of Southern California	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA.	hazens@ccf.org	Lorkiewicz, Pawel/A-2126-2011; Tang, Wai Hong Wilson/I-1238-2013; Hazen, Stanley L/ABD-5845-2021; Wang, Zeneng/AAK-6119-2021; Smith, Jonathan D./H-9723-2013	Lorkiewicz, Pawel/0000-0002-1755-9826; bennett, brian/0000-0002-0766-3195; Schauer, Philip/0000-0002-4029-7537; Levison, Bruce/0000-0002-1816-368X; Tang, W. H. Wilson/0000-0002-8335-735X; Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health [R01 HL103866, P01 HL098055, P01HL087018-020001, P01 HL28481, P01 HL30568, T32-DK07789]; Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA [1UL1RR024989]; Abbott Diagnostics;  [P01 HL076491-055328];  [R01 HL103931];  [R01 DK080732]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098193, R01HL103866, P01HL028481, P01HL030568, R01HL103931, P01HL098055, P01HL076491, P01HL087018, K99HL102223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080732, T32DK007789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA; Abbott Diagnostics(Abbott Laboratories); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We wish to thank E. Sehayek for discussions, L. W. Castellani for help with lipoprotein profile analysis, and F. McNally, M. Berk and M. Pepoy for technical assistance. This research was supported by National Institutes of Health grants R01 HL103866, P01 HL098055, P01HL087018-020001, P01 HL28481 and P01 HL30568. B.J.B. was supported by NIH training grant T32-DK07789. The clinical study GeneBank was supported in part by P01 HL076491-055328, R01 HL103931 and the Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University CTSA (1UL1RR024989). Some of the laboratory studies (haemaglobin A1C, fasting glucose) in GeneBank were supported by R01 DK080732 and Abbott Diagnostics provided supplies for performance of some of the fasting lipid profile, glucose, creatinine, troponin I and hsCRP measured in GeneBank.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baglione Julie, 2006, V129, P83; Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; Barham Ann Hiott, 2009, Prev Cardiol, V12, P95, DOI 10.1111/j.1751-7141.2008.00019.x; Bidulescu Aurelian, 2007, BMC Cardiovasc Disord, V7, P20, DOI 10.1186/1471-2261-7-20; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Cashman JR, 2003, CURR DRUG METAB, V4, P151, DOI 10.2174/1389200033489505; CHEN FCM, 1976, CAN J CHEM, V54, P3310, DOI 10.1139/v76-475; DACOSTA KA, 1990, ANAL BIOCHEM, V187, P234, DOI 10.1016/0003-2697(90)90449-J; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danne O, 2007, CLIN CHIM ACTA, V383, P103, DOI 10.1016/j.cca.2007.05.001; de Vries TJ, 2009, J LEUKOCYTE BIOL, V85, P919, DOI 10.1189/jlb.0708402; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Devlin GL, 2001, AM J RESP CELL MOL, V24, P727, DOI 10.1165/ajrcmb.24.6.4407; Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Epstein SE, 1996, LANCET, V348, pS13, DOI 10.1016/S0140-6736(96)98005-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; GADDIS ML, 1990, ANN EMERG MED, V19, P1462, DOI 10.1016/S0196-0644(05)82622-8; Gautam S, 1997, BIOMETRICS, V53, P1163, DOI 10.2307/2533575; GAUVREAU K, 1993, NUTRITION, V9, P386; GOODALL CM, 1986, J APPL TOXICOL, V6, P95, DOI 10.1002/jat.2550060206; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; LeLeiko RM, 2009, AM J CARDIOL, V104, P638, DOI 10.1016/j.amjcard.2009.04.047; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Miles EA, 2000, ATHEROSCLEROSIS, V152, P43, DOI 10.1016/S0021-9150(99)00446-3; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P517; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Nicholls SJ, 2010, J LIPID RES, V51, P3055, DOI 10.1194/jlr.M008961; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rasooly R, 2007, BRIT J NUTR, V97, P58, DOI 10.1017/S0007114507257745; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Rizzo M., 2008, STAT COMPUTING R; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; SALMON WD, 1962, ARCH PATHOL, V73, P190; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Song JL, 2001, J BIOL CHEM, V276, P40241, DOI 10.1074/jbc.M107242200; Stoves J, 2002, NEPHROL DIAL TRANSPL, V17, P2036, DOI 10.1093/ndt/17.11.2036; Traissac P, 1999, REV EPIDEMIOL SANTE, V47, P593; Treberg JR, 2002, J EXP BIOL, V205, P1419; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Westendorf T, 2005, MOL CELL BIOCHEM, V277, P143, DOI 10.1007/s11010-005-5873-z; Wijnand HP, 2000, COMPUT METH PROG BIO, V63, P21, DOI 10.1016/S0169-2607(00)00058-4; Wright SD, 2000, J EXP MED, V191, P1437, DOI 10.1084/jem.191.8.1437; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	68	3195	3421	51	1313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					57	U82		10.1038/nature09922	http://dx.doi.org/10.1038/nature09922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475195	Green Accepted, Green Submitted			2022-12-01	WOS:000289199400036
J	De Stefani, D; Raffaello, A; Teardo, E; Szabo, I; Rizzuto, R				De Stefani, Diego; Raffaello, Anna; Teardo, Enrico; Szabo, Ildiko; Rizzuto, Rosario			A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter	NATURE			English	Article							ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; CA2+ CHANNELS; COLOCALIZATION; PROPAGATION; ACTIVATION; DYNAMICS; CONTACTS; FEEDBACK; SIGNALS	Mitochondrial Ca(2+) homeostasis has a key role in the regulation of aerobic metabolism and cell survival(1), but the molecular identity of the Ca(2+) channel, the mitochondrial calcium uniporter(2), is still unknown. Here we have identified in silico a protein (named MCU) that shares tissue distribution with MICU1 (also known as CBARA1), a recently characterized uniporter regulator(3), is present in organisms in which mitochondrial Ca(2+) uptake was demonstrated and whose sequence includes two transmembrane domains. Short interfering RNA (siRNA) silencing of MCU in HeLa cells markedly reduced mitochondrial Ca(2+) uptake. MCU overexpression doubled the matrix Ca(2+) concentration increase evoked by inositol 1,4,5-trisphosphate-generating agonists, thus significantly buffering the cytosolic elevation. The purified MCU protein showed channel activity in planar lipid bilayers, with electrophysiological properties and inhibitor sensitivity of the uniporter. A mutant MCU, in which two negatively charged residues of the putative pore-forming region were replaced, had no channel activity and reduced agonist-dependent matrix Ca(2+) concentration transients when overexpressed in HeLa cells. Overall, these data demonstrate that the 40-kDa protein identified is the channel responsible for ruthenium-red-sensitive mitochondrial Ca(2+) uptake, thus providing a molecular basis for this process of utmost physiological and pathological relevance.	[De Stefani, Diego; Raffaello, Anna; Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [De Stefani, Diego; Raffaello, Anna; Rizzuto, Rosario] Univ Padua, Inst Neurosci, CNR, I-35121 Padua, Italy; [Teardo, Enrico; Szabo, Ildiko] Univ Padua, Dept Biol, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua	Rizzuto, R (corresponding author), Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy.	rosario.rizzuto@unipd.it	Szabo, Ildiko/AAW-5972-2021; Raffaello, Anna/K-7052-2016; De Stefani, Diego/I-7715-2015; Padova, Ildiko/K-5344-2016	Szabo, Ildiko/0000-0002-3637-3947; De Stefani, Diego/0000-0003-3796-8907; RAFFAELLO, ANNA/0000-0002-8344-6459; Rizzuto, Rosario/0000-0001-7044-5097	Italian Ministry of Education, University and Research; European Commission [223576]; National Institutes of Health [1P01AG025532-01A1]; Cariparo Foundation (Padua); Italian Association for Cancer Research (AIRC); Telethon-Italy [GPP1005]; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cariparo Foundation (Padua)(Fondazione Cariparo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Zoratti for help in the analysis of electrophysiological data, G. Merli for carrying out some of the experiments and P. Bernardi, T. Pozzan and L. Cendron for helpful discussions and for the N33-D1cpV expression plasmid (T. Pozzan). This research was supported by grants from the Italian Ministry of Education, University and Research, European Commission (FP7 "MyoAGE", no. 223576), National Institutes of Health (Grant #1P01AG025532-01A1), Cariparo Foundation (Padua), the Italian Association for Cancer Research (AIRC) and Telethon-Italy (GPP1005).	BENAIM G, 1990, MOL BIOCHEM PARASIT, V39, P61, DOI 10.1016/0166-6851(90)90008-A; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carafoli E, 2003, TRENDS BIOCHEM SCI, V28, P175, DOI 10.1016/S0968-0004(03)00053-7; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szabo I, 2011, CELL DEATH DIFFER, V18, P427, DOI 10.1038/cdd.2010.112; Teardo E, 2010, CELL PHYSIOL BIOCHEM, V26, P253, DOI 10.1159/000320525; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Xiong ZH, 1997, J BIOL CHEM, V272, P31022, DOI 10.1074/jbc.272.49.31022	32	1271	1285	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					336	U104		10.1038/nature10230	http://dx.doi.org/10.1038/nature10230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21685888	Green Accepted			2022-12-01	WOS:000294206500039
J	Jenkins, SJ; Ruckerl, D; Cook, PC; Jones, LH; Finkelman, FD; van Rooijen, N; MacDonald, AS; Allen, JE				Jenkins, Stephen J.; Ruckerl, Dominik; Cook, Peter C.; Jones, Lucy H.; Finkelman, Fred D.; van Rooijen, Nico; MacDonald, Andrew S.; Allen, Judith E.			Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of T(H)2 Inflammation	SCIENCE			English	Article							CD4(+) T-CELLS; ALTERNATIVE ACTIVATION; HELMINTH INFECTION; IL-4; MONOCYTES; MICE; MECHANISMS; INJURY; REPAIR; LIFE	A defining feature of inflammation is the accumulation of innate immune cells in the tissue that are thought to be recruited from the blood. We reveal that a distinct process exists in which tissue macrophages undergo rapid in situ proliferation in order to increase population density. This inflammatory mechanism occurred during T helper 2 (T(H)2)-related pathologies under the control of the archetypal T(H)2 cytokine interleukin-4 (IL-4) and was a fundamental component of T(H)2 inflammation because exogenous IL-4 was sufficient to drive accumulation of tissue macrophages through self-renewal. Thus, expansion of innate cells necessary for pathogen control or wound repair can occur without recruitment of potentially tissue-destructive inflammatory cells.	[Jenkins, Stephen J.; Ruckerl, Dominik; Cook, Peter C.; Jones, Lucy H.; MacDonald, Andrew S.; Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Jenkins, Stephen J.; Ruckerl, Dominik; Cook, Peter C.; Jones, Lucy H.; MacDonald, Andrew S.; Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr, Dept Med, Cincinnati, OH 45220 USA; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA; [Finkelman, Fred D.] Cincinnati Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Finkelman, Fred D.] Cincinnati Childrens Hosp, Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA; [van Rooijen, Nico] Free Univ Med Ctr, Dept Mol & Cell Biol, Amsterdam, Netherlands	University of Edinburgh; University of Edinburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Vrije Universiteit Amsterdam	Allen, JE (corresponding author), Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland.	j.allen@ed.ac.uk	Van Rooijen, Nico/Z-1578-2019; Allen, Judith E/C-9198-2011; Cook, Peter/E-6731-2015	Allen, Judith E/0000-0002-3829-066X; Cook, Peter/0000-0002-5208-4985; Jackson-Jones, Lucy/0000-0003-0608-8966; Jenkins, Stephen/0000-0002-0233-5424; Ruckerl, Dominik/0000-0002-0206-1451	Medical Research Council (MRC) UK [G0600818, G0701437]; European Union [INCO-CT-2006-03232]; U.S. Department of Veterans Affairs; National Institutes of Health [RO1 AI070300]; Wellcome Trust; MRC [G0600818, G0701437] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070300] Funding Source: NIH RePORTER; Medical Research Council [G0701437, G0600818] Funding Source: researchfish	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Zamoyska, F. Brombacher, and D. Gray for critical reading of the manuscript, and A. Fulton and S. Duncan for expert technical assistance. This study was funded by the Medical Research Council (MRC) UK (G0600818 to J.E.A.), with additional support from the European Union ("SCOOTT"; INCO-CT-2006-03232), MRC UK (G0701437 to A. S. M.), the U.S. Department of Veterans Affairs (Merit Award to F. D. F.), and the National Institutes of Health (RO1 AI070300 to F. D. F.). L.H.J. was funded by a Wellcome Trust Ph.D. studentship.	Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; DAEMS WT, 1982, IMMUNOBIOLOGY, V161, P204, DOI 10.1016/S0171-2985(82)80075-2; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fine JS, 2003, INFLAMMATION, V27, P161, DOI 10.1023/A:1025076111950; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Le Goff L, 2002, INT J PARASITOL, V32, P1277, DOI 10.1016/S0020-7519(02)00125-X; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MacDonald AS, 2003, MED MICROBIOL IMMUN, V192, P33, DOI 10.1007/s00430-002-0156-8; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Milner JD, 2010, BLOOD, V116, P2476, DOI 10.1182/blood-2009-11-255174; Munder M, 1998, J IMMUNOL, V160, P5347; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Siracusa MC, 2008, J LEUKOCYTE BIOL, V84, P1422, DOI 10.1189/jlb.0308199; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3	30	954	988	0	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1284	1288		10.1126/science.1204351	http://dx.doi.org/10.1126/science.1204351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21566158	Green Accepted			2022-12-01	WOS:000291441700035
J	Davis, M; Chew, MK; Hobbs, RJ; Lugo, AE; Ewel, JJ; Vermeij, GJ; Brown, JH; Rosenzweig, ML; Gardener, MR; Carroll, SP; Thompson, K; Pickett, STA; Stromberg, JC; Del Tredici, P; Suding, KN; Ehrenfeld, JG; Grime, JP; Mascaro, J; Briggs, JC				Davis, Mark; Chew, Matthew K.; Hobbs, Richard J.; Lugo, Ariel E.; Ewel, John J.; Vermeij, Geerat J.; Brown, James H.; Rosenzweig, Michael L.; Gardener, Mark R.; Carroll, Scott P.; Thompson, Ken; Pickett, Steward T. A.; Stromberg, Juliet C.; Del Tredici, Peter; Suding, Katharine N.; Ehrenfeld, Joan G.; Grime, J. Philip; Mascaro, Joseph; Briggs, John C.			Don't judge species on their origins	NATURE			English	Editorial Material							SCIENTISTS; MANAGEMENT		[Davis, Mark] Macalester Coll, St Paul, MN 55105 USA	Macalester College	Davis, M (corresponding author), Macalester Coll, St Paul, MN 55105 USA.	davis@macalester.edu	Hobbs, Richard J/F-5883-2010; Suding, Katharine/O-6290-2017	Hobbs, Richard J/0000-0003-4047-3147; Suding, Katharine/0000-0002-5357-0176; Carroll, Scott/0000-0003-2094-9398				Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Carroll SP, 2011, EVOL APPL, V4, P184, DOI 10.1111/j.1752-4571.2010.00180.x; Chew MK, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P35; Chew MK, 2009, J HIST BIOL, V42, P231, DOI 10.1007/s10739-009-9181-4; Davis MA, 2009, INVASION BIOL; Fleishman E, 2011, BIOSCIENCE, V61, P290, DOI 10.1525/bio.2011.61.4.9; Gardener MR, 2010, RANGELAND J, V32, P407, DOI 10.1071/RJ10029; Gleditsch JM, 2011, DIVERS DISTRIB, V17, P244, DOI 10.1111/j.1472-4642.2010.00733.x; Stromberg JC, 2009, RESTOR ECOL, V17, P177, DOI 10.1111/j.1526-100X.2008.00514.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	10	625	649	8	583	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					153	154		10.1038/474153a	http://dx.doi.org/10.1038/474153a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21654782				2022-12-01	WOS:000291397800026
J	Jones, MDM; Forn, I; Gadelha, C; Egan, MJ; Bass, D; Massana, R; Richards, TA				Jones, Meredith D. M.; Forn, Irene; Gadelha, Catarina; Egan, Martin J.; Bass, David; Massana, Ramon; Richards, Thomas A.			Discovery of novel intermediate forms redefines the fungal tree of life	NATURE			English	Article							OLIGONUCLEOTIDE PROBES; MOLECULAR PHYLOGENY; RIBOSOMAL-RNA; SEQUENCE DATA; LAND PLANTS; DIVERSITY; EVOLUTION; COMMUNITY; EUKARYOTES; ROZELLA	Fungi are the principal degraders of biomass in terrestrial ecosystems and establish important interactions with plants and animals(1-3). However, our current understanding of fungal evolutionary diversity is incomplete(4) and is based upon species amenable to growth in culture(1). These culturable fungi are typically yeast or filamentous forms, bound by a rigid cell wall rich in chitin. Evolution of this body plan was thought critical for the success of the Fungi, enabling them to adapt to heterogeneous habitats and live by osmotrophy: extracellular digestion followed by nutrient uptake(5). Here we investigate the ecology and cell biology of a previously undescribed and highly diverse form of eukaryotic life that branches with the Fungi, using environmental DNA analyses combined with fluorescent detection via DNA probes. This clade is present in numerous ecosystems including soil, freshwater and aquatic sediments. Phylogenetic analyses using multiple ribosomal RNA genes place this clade with Rozella, the putative primary branch of the fungal kingdom(1). Tyramide signal amplification coupled with group-specific fluorescence in situ hybridization reveals that the target cells are small eukaryotes of 3-5 mm in length, capable of forming a microtubule-based flagellum. Co-staining with cell wall markers demonstrates that representatives from the clade do not produce a chitin-rich cell wall during any of the life cycle stages observed and therefore do not conform to the standard fungal body plan(5). We name this highly diverse clade the cryptomycota in anticipation of formal classification.	[Jones, Meredith D. M.; Egan, Martin J.; Richards, Thomas A.] Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England; [Jones, Meredith D. M.; Bass, David; Richards, Thomas A.] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Forn, Irene; Massana, Ramon] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, E-08003 Barcelona, Catalonia, Spain; [Gadelha, Catarina] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Egan, Martin J.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Exeter; Natural History Museum London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Cambridge; Harvard University; Harvard Medical School	Richards, TA (corresponding author), Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England.	thomr@nhm.ac.uk	Gadelha, Catarina/ABD-5623-2021; Massana, Ramon/F-4205-2016	Gadelha, Catarina/0000-0001-5016-3682; Richards, Thomas/0000-0002-9692-0973; Massana, Ramon/0000-0001-9172-5418	Leverhulme Trust; Natural Environment Research Council, UK [NE/F011709/1]; Systematics Association; Linnean Society; MICINN [CGL2010-16304]; ERA; NERC [NE/F011709/1] Funding Source: UKRI; Natural Environment Research Council [NE/F011709/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Systematics Association; Linnean Society; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); ERA; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank: N. J. Talbot for advice, K. Gull for the TAT1 antibody, L. Guillou for access to curated SSU database and the Broad Institute of the Massachusetts Institute of Technology and Harvard for making their Rhizopus and Batrachochytrium genome sequence data publicly available. T.A.R. thanks the Leverhulme Trust for fellowship support. This work was primarily supported by a Natural Environment Research Council grant UK (NE/F011709/1). Additional support came from the Systematic Research Fund (awarded by the Systematics Association and the Linnean Society) to T.A.R., project FLAME (CGL2010-16304, MICINN) to R. M. and the BioMarKs project (European Funding Agencies from the ERA-net program BiodivERsA) to T.A.R. and R.M.	Bartnicki-Garcia S., 1987, EVOLUTIONARY BIOL FU, P389; Baschien C, 2001, INT REV HYDROBIOL, V86, P371, DOI 10.1002/1522-2632(200107)86:4/5<371::AID-IROH371>3.0.CO;2-P; Bass D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-162; Bass D, 2007, P ROY SOC B-BIOL SCI, V274, P3069, DOI 10.1098/rspb.2007.1067; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HELD AA, 1975, CAN J BOT, V53, P2212, DOI 10.1139/b75-245; HELD AA, 1981, BOT REV, V47, P451, DOI 10.1007/BF02860539; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kim E, 2011, P NATL ACAD SCI USA, V108, P1496, DOI 10.1073/pnas.1013337108; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Lepere C, 2008, APPL ENVIRON MICROB, V74, P2940, DOI 10.1128/AEM.01156-07; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mangot JF, 2009, APPL ENVIRON MICROB, V75, P6373, DOI 10.1128/AEM.00607-09; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; van Hannen EJ, 1999, APPL ENVIRON MICROB, V65, P2478; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Webster J., 2007, INTRO FUNGI, V3rd; WOODS A, 1989, J CELL SCI, V93, P491; Zettler LAA, 2001, J EUKARYOT MICROBIOL, V48, P293, DOI 10.1111/j.1550-7408.2001.tb00317.x	36	285	306	3	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					200	U234		10.1038/nature09984	http://dx.doi.org/10.1038/nature09984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21562490				2022-12-01	WOS:000291397800047
J	Turner, SL; Li, N; Guda, T; Githure, J; Carde, RT; Ray, A				Turner, Stephanie Lynn; Li, Nan; Guda, Tom; Githure, John; Carde, Ring T.; Ray, Anandasankar			Ultra-prolonged activation of CO2-sensing neurons disorients mosquitoes	NATURE			English	Article							CARBON-DIOXIDE; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; MAXILLARY PALP; DROSOPHILA; INSECT; DEET; RECEPTORS; RESPONSES; DIPTERA	Carbon dioxide (CO2) present in exhaled air is the most important sensory cue for female blood-feeding mosquitoes, causing activation of long-distance host-seeking flight, navigation towards the vertebrate host(1) and, in the case of Aedes aegypti, increased sensitivity to skin odours(2). The CO2 detection machinery is therefore an ideal target to disrupt host seeking. Here we use electrophysiological assays to identify a volatile odorant that causes an unusual, ultra-prolonged activation of CO2-detecting neurons in three major disease-transmitting mosquitoes: Anopheles gambiae, Culex quinquefasciatus and A. aegypti. Importantly, ultra-prolonged activation of these neurons severely compromises their ability subsequently to detect CO2 for several minutes. We also identify odours that strongly inhibit CO2-sensitive neurons as candidates for use in disruption of host-seeking behaviour, as well as an odour that evokes CO2-like activity and thus has potential use as a lure in trapping devices. Analysis of responses to panels of structurally related odours across the three mosquitoes and Drosophila, which have related CO2-receptor proteins, reveals a pattern of inhibition that is often conserved. We use video tracking in wind-tunnel experiments to demonstrate that the novel ultra-prolonged activators can completely disrupt CO2-mediated activation as well as source-finding behaviour in Aedes mosquitoes, even after the odour is no longer present. Lastly, semi-field studies demonstrate that use of ultra-prolonged activators disrupts CO2-mediated hut entry behaviour of Culex mosquitoes. The three classes of CO2-response-modifying odours offer powerful instruments for developing new generations of insect repellents and lures, which even in small quantities can interfere with the ability of mosquitoes to seek humans.	[Turner, Stephanie Lynn; Ray, Anandasankar] Univ Calif Riverside, Cellular Mol & Dev Biol Program, Riverside, CA 92521 USA; [Li, Nan; Carde, Ring T.; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Guda, Tom; Githure, John] ICIPE, Human Hlth Div, Nairobi, Kenya	University of California System; University of California Riverside; University of California System; University of California Riverside; International Centre of Insect Physiology & Ecology (ICIPE)	Ray, A (corresponding author), Univ Calif Riverside, Cellular Mol & Dev Biol Program, Riverside, CA 92521 USA.	anand.ray@ucr.edu		Ray, Anandasankar/0000-0003-4133-2581	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; NIAID (NIH) [R01AI087785]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087785] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; NIAID (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Lacey and S. McInally for help setting up behaviour experiments; the Malaria Group team members in ICIPE Mbita Point Research Station, Y. Afrane and G. Yan for logistical support; S. M. Boyle for help with Pharmacophores; K. Klingler for help with statistics; J. Perecko for building traps and excitorepellency chambers; A. Dahanukar and G. Tauxe for comments on the manuscript; W. Walton, P. Atkinson, P. Wirth and A. Khalon for mosquitoes. Part of this work was funded by a grant to A. Ray from the Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative, and part supported by a grant to A. Ray, Award Number R01AI087785, from the NIAID (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or NIH.	Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Grant AJ, 1996, CIBA F SYMP, V200, P233; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Klun JA, 2004, J MED ENTOMOL, V41, P418, DOI 10.1603/0022-2585-41.3.418; Krajick K, 2006, SCIENCE, V313, P36, DOI 10.1126/science.313.5783.36; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Noosidum A, 2008, J VECTOR ECOL, V33, P305, DOI 10.3376/1081-1710-33.2.305; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Rostelien T, 2000, CHEM SENSES, V25, P141, DOI 10.1093/chemse/25.2.141; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zollner GE, 2004, PHYSIOL ENTOMOL, V29, P381, DOI 10.1111/j.0307-6962.2004.00399.x; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	30	115	124	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					87	U114		10.1038/nature10081	http://dx.doi.org/10.1038/nature10081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637258	Green Accepted, Green Submitted			2022-12-01	WOS:000291156700043
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: digital rectal examination	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2011	342								d3421	10.1136/bmj.d3421	http://dx.doi.org/10.1136/bmj.d3421			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774MK	21632663				2022-12-01	WOS:000291390500015
J	Rosello-Diez, A; Ros, MA; Torres, M				Rosello-Diez, Alberto; Ros, Maria A.; Torres, Miguel			Diffusible Signals, Not Autonomous Mechanisms, Determine the Main Proximodistal Limb Subdivision	SCIENCE			English	Article							VERTEBRATE LIMB; RETINOIC ACID; VITAMIN-A; GENE-EXPRESSION; MOUSE LIMB; CELL FATE; BUD; AXIS; FGF; REGENERATION	Vertebrate limbs develop three main proximodistal (PD) segments (upper arm, forearm, and hand) in a proximal-to-distal sequence. Despite extensive research into limb development, whether PD specification occurs through nonautonomous or autonomous mechanisms is not resolved. Heterotopic transplantation of intact and recombinant chicken limb buds identifies signals in the embryo trunk that proximalize distal limb cells to generate a complete PD axis. In these transplants, retinoic acid induces proximalization, which is counteracted by fibroblast growth factors from the distal limb bud; these related actions suggest that the first limb-bud PD regionalization results from the balance between proximal and distal signals. The plasticity of limb progenitor cell identity in response to diffusible signals provides a unifying view of PD patterning during vertebrate limb development and regeneration.	[Rosello-Diez, Alberto; Torres, Miguel] Inst Salud Carlos III, Ctr Nacl Invest Cardiovasc, Dept Desarrollo & Reparac Cardiovasc, E-28029 Madrid, Spain; [Ros, Maria A.] Inst Biomed & Biotecnol Cantabria CSIC UC SODERAN, E-39011 Santander, Spain; [Ros, Maria A.] Univ Cantabria, E-39011 Santander, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Universidad de Cantabria	Torres, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Invest Cardiovasc, Dept Desarrollo & Reparac Cardiovasc, C Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mtorres@cnic.es	Ros, Maria A./K-8160-2014; Roselló-Díez, Alberto/K-7295-2016; Torres, Miguel/CAG-0003-2022; Torres, Miguel/A-7388-2013	Ros, Maria A./0000-0002-1224-7671; Roselló-Díez, Alberto/0000-0002-5550-9846; Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767	Spanish Ministry of Science and Innovation (MICINN) [RD06/0010/0008, BFU2009-08331/BMC, BFU2008-00397]; Madrid's Regional Government (CAM) [CPI/0051/2007]; MICINN; Pro-CNIC Foundation	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Madrid's Regional Government (CAM); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Pro-CNIC Foundation	We thank K. Storey and R. Diez del Corral for plasmids and C. Tabin for sharing unpublished results. Supported by grants RD06/0010/0008, BFU2009-08331/BMC (M. T.) and BFU2008-00397 (M. A. R.), from the Spanish Ministry of Science and Innovation (MICINN) and fellowship CPI/0051/2007 (A.R.-D.) from Madrid's Regional Government (CAM). The CNIC is supported by the MICINN and the Pro-CNIC Foundation.	Cooper KL, 2011, SCIENCE, V332, P1083, DOI 10.1126/science.1199499; Diez del Corral R, 2003, NEURON, V40, P65; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAYAMIZU TF, 1994, DEV BIOL, V166, P123, DOI 10.1006/dbio.1994.1301; KIENY M, 1977, ROUX ARCH DEV BIOL, V183, P177, DOI 10.1007/BF00867319; MADEN M, 1983, J EMBRYOL EXP MORPH, V77, P273; MADEN M, 1983, DEV BIOL, V98, P409, DOI 10.1016/0012-1606(83)90370-6; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Mercader N, 2009, INT J DEV BIOL, V53, P1483, DOI 10.1387/ijdb.072430nm; Nelson CE, 1996, DEVELOPMENT, V122, P1449; ROS MA, 1994, DEV BIOL, V166, P59, DOI 10.1006/dbio.1994.1296; SAXENA S, 1977, INDIAN J EXP BIOL, V15, P435; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; SUMMERBELL D, 1977, J EMBRYOL EXP MORPH, V41, P137; SUMMERBELL D, 1975, J EMBRYOL EXP MORPH, V33, P621; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Vargesson N, 1997, DEVELOPMENT, V124, P1909; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	25	97	97	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1086	1088		10.1126/science.1199489	http://dx.doi.org/10.1126/science.1199489			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21617076				2022-12-01	WOS:000290996700045
J	Roppolo, D; De Rybel, B; Tendon, VD; Pfister, A; Alassimone, J; Vermeer, JEM; Yamazaki, M; Stierhof, YD; Beeckman, T; Geldner, N				Roppolo, Daniele; De Rybel, Bert; Tendon, Valerie Denervaud; Pfister, Alexandre; Alassimone, Julien; Vermeer, Joop E. M.; Yamazaki, Misako; Stierhof, York-Dieter; Beeckman, Tom; Geldner, Niko			A novel protein family mediates Casparian strip formation in the endodermis	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; ARABIDOPSIS ROOT; PLANT; TRANSPORT; MOVEMENT; POLARITY	Polarized epithelia are fundamental to multicellular life. In animal epithelia, conserved junctional complexes establish membrane diffusion barriers, cellular adherence and sealing of the extracellular space(1). Plant cellular barriers are of independent evolutionary origin. The root endodermis strongly resembles a polarized epithelium and functions in nutrient uptake and stress resistance(2). Its defining features are the Casparian strips, belts of specialized cell wall material that generate an extracellular diffusion barrier(2). The mechanisms localizing Casparian strips are unknown. Here we identify and characterize a family of transmembrane proteins of previously unknown function. These 'CASPs' (Casparian strip membrane domain proteins) specifically mark a membrane domain that predicts the formation of Casparian strips. CASP1 displays numerous features required for a constituent of a plant junctional complex: it forms complexes with other CASPs; it becomes immobile upon localization; and it sediments like a large polymer. CASP double mutants display disorganized Casparian strips, demonstrating a role for CASPs in structuring and localizing this cell wall modification. To our knowledge, CASPs are the first molecular factors that are shown to establish a plasma membrane and extracellular diffusion barrier in plants, and represent a novel way of epithelial barrier formation in eukaryotes.	[Roppolo, Daniele; Tendon, Valerie Denervaud; Pfister, Alexandre; Alassimone, Julien; Vermeer, Joop E. M.; Yamazaki, Misako; Geldner, Niko] Univ Lausanne, UNIL Sorge, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [De Rybel, Bert; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [De Rybel, Bert; Beeckman, Tom] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Stierhof, York-Dieter] Univ Tubingen, ZMBP, D-72076 Tubingen, Germany	University of Lausanne; Ghent University; Flanders Institute for Biotechnology (VIB); Eberhard Karls University of Tubingen	Geldner, N (corresponding author), Univ Lausanne, UNIL Sorge, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	niko.geldner@unil.ch	Geldner, Niko/Y-2481-2019; Beeckman, Tom/ABA-1164-2020; Vermeer, Joop E.M./J-2232-2014; Beeckman, Tom/ABI-1703-2020	Vermeer, Joop E.M./0000-0001-8876-5873; Beeckman, Tom/0000-0001-8656-2060; Alassimone, Julien/0000-0002-8118-2605; De Rybel, Bert/0000-0002-9551-042X; Geldner, Niko/0000-0002-2300-9644	Swiss National Science Foundation; European Research Council (ERC); Belgian Interuniversity Attraction Poles program [IUAP VI/33]; Ghent University; Roche Research Foundation; Marie-Curie IEF grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Belgian Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Ghent University(Ghent University); Roche Research Foundation; Marie-Curie IEF grant	We thank the Central Imaging Facility (CIF) and the Protein Analysis Facility (PAF) of the University of Lausanne for technical support, G. Jurgens, W. Michalke, J. Chory for antibodies, T. W. J. Gadella for mTurquoise and J. Takano for mutant BOR1 clone. We thank J. Chory, E. M. N. Dohmann, Y. Lee and G. Jurgens for comments and critical reading of the manuscript. This work was supported by grants of the Swiss National Science Foundation and the European Research Council (ERC) to N.G., the Belgian Interuniversity Attraction Poles program (IUAP VI/33) and the Special Research Fund of Ghent University to B.D.R. and T.B., the Roche Research Foundation to D.R. and a Marie-Curie IEF grant to J.E.M.V.	Alassimone J, 2010, P NATL ACAD SCI USA, V107, P5214, DOI 10.1073/pnas.0910772107; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; BONNETT HT, 1968, J CELL BIOL, V37, P199, DOI 10.1083/jcb.37.1.199; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Caspary R., 1865, BEMERKUNGEN SCHUTZSC; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; CLARKSON DT, 1984, PLANT CELL ENVIRON, V7, P449, DOI 10.1111/j.1365-3040.1984.tb01435.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Enstone DE, 2002, J PLANT GROWTH REGUL, V21, P335, DOI 10.1007/s00344-003-0002-2; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; KARAHARA I, 1992, PLANT CELL PHYSIOL, V33, P555; Ma JF, 2007, NATURE, V448, P209, DOI 10.1038/nature05964; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; NAGAHASHI G, 1974, SCIENCE, V183, P670, DOI 10.1126/science.183.4125.670; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Reichardt L, 2007, CURR BIOL, V17, P2047, DOI 10.1016/j.cub.2007.10.040; Rufz de Lavison J. d., 1910, REV GEN BOT, V22, P225; Schreiber L, 1996, PLANTA, V199, P596, DOI 10.1007/BF00195192; Sriranganadane D, 2010, J PROTEOME RES, V9, P3511, DOI 10.1021/pr901202z; Steudle E, 2000, PLANT SOIL, V226, P45, DOI 10.1023/A:1026439226716; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; VANFLEET DS, 1961, BOT REV, V27, P165, DOI 10.1007/BF02860082; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241	27	248	265	7	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					380	U564		10.1038/nature10070	http://dx.doi.org/10.1038/nature10070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593871				2022-12-01	WOS:000290722400050
J	Windbichler, N; Menichelli, M; Papathanos, PA; Thyme, SB; Li, H; Ulge, UY; Hovde, BT; Baker, D; Monnat, RJ; Burt, A; Crisanti, A				Windbichler, Nikolai; Menichelli, Miriam; Papathanos, Philippos Aris; Thyme, Summer B.; Li, Hui; Ulge, Umut Y.; Hovde, Blake T.; Baker, David; Monnat, Raymond J., Jr.; Burt, Austin; Crisanti, Andrea			A synthetic homing endonuclease-based gene drive system in the human malaria mosquito	NATURE			English	Article							SPECIFICITY; BINDING; TRANSMISSION; DERIVATIVES; GENERATION; CONVERSION; PROTEIN	Genetic methods of manipulating or eradicating disease vector populations have long been discussed as an attractive alternative to existing control measures because of their potential advantages in terms of effectiveness and species specificity(1-3). The development of genetically engineered malaria-resistant mosquitoes has shown, as a proof of principle, the possibility of targeting the mosquito's ability to serve as a disease vector(4-7). The translation of these achievements into control measures requires an effective technology to spread a genetic modification from laboratory mosquitoes to field populations(8). We have suggested previously that homing endonuclease genes (HEGs), a class of simple selfish genetic elements, could be exploited for this purpose(9). Here we demonstrate that a synthetic genetic element, consisting of mosquito regulatory regions(10) and the homing endonuclease gene I-SceI(11-13), can substantially increase its transmission to the progeny in transgenic mosquitoes of the human malaria vector Anopheles gambiae. We show that the I-SceI element is able to invade receptive mosquito cage populations rapidly, validating mathematical models for the transmission dynamics of HEGs. Molecular analyses confirm that expression of I-SceI in the male germline induces high rates of site-specific chromosomal cleavage and gene conversion, which results in the gain of the I-SceI gene, and underlies the observed genetic drive. These findings demonstrate a new mechanism by which genetic control measures can be implemented. Our results also show in principle how sequence-specific genetic drive elements like HEGs could be used to take the step from the genetic engineering of individuals to the genetic engineering of populations.	[Windbichler, Nikolai; Menichelli, Miriam; Papathanos, Philippos Aris; Burt, Austin; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Thyme, Summer B.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Thyme, Summer B.; Baker, David] Univ Washington, Grad Program Biomol Struct & Design, Seattle, WA 98195 USA; [Li, Hui; Ulge, Umut Y.; Monnat, Raymond J., Jr.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Ulge, Umut Y.; Monnat, Raymond J., Jr.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Hovde, Blake T.; Monnat, Raymond J., Jr.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Burt, Austin] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Crisanti, Andrea] Univ Perugia, Dept Expt Med, I-06122 Perugia, Italy	Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Imperial College London; University of Perugia	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, S Kensington Campus, London SW7 2AZ, England.	a.drcrisanti@imperial.ac.uk	Papathanos, Philippos/ABE-4869-2021; Baker, David/K-8941-2012; Li, Hui/E-8866-2010	Baker, David/0000-0001-7896-6217; Crisanti, Andrea/0000-0002-2406-4426; Thyme, Summer/0000-0003-3593-4148; Papathanos, Philippos Aris/0000-0001-8508-4554; Hovde, Blake/0000-0002-7112-3310; Li, Hui/0000-0002-2980-2491; Ulge, Umut/0000-0002-3745-0668; Windbichler, Nikolai/0000-0001-9896-1165; Burt, Austin/0000-0001-5146-9640	Foundation for the National Institutes of Health through Grand Challenges in Global Health initiative; NIH [GM084433, CA133831]; NATIONAL CANCER INSTITUTE [RL1CA133831, T32CA080416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084433] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ashburner, S. Russell, D. Huen and S. Chan for comments, assistance and for plasmids. We thank M. P. Calos for providing the pET11phiC31polyA plasmid. We thank M. J. Fraser Jr for providing the pBSII-IFP2-orf plasmid. We thank J. Meredith and P. Eggleston for providing the docking strain. We thank A. Hall, T. Nolan, K. Magnusson, D. Rogers and S. Fuchs for assistance. We thank S. Arshiya Quadri and M. Szeto for experimental support and the members of the laboratories of D. Baker, R. Monnat, A. Scharenberg and B. Stoddard for their collective support of HEG engineering. A. F. M. Hackmann provided graphics support. Funded by a grant from the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative and by NIH RL1 awards GM084433 to D.B. and CA133831 to R.J.M.	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Bellaiche Y, 1999, GENETICS, V152, P1037; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Goddard MR, 2001, P ROY SOC B-BIOL SCI, V268, P2537, DOI 10.1098/rspb.2001.1830; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Li FW, 2005, J INFECT DIS, V192, P878, DOI 10.1086/432552; Li H, 2009, NUCLEIC ACIDS RES, V37, P1650, DOI 10.1093/nar/gkp004; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Ulge UY, 2011, NUCLEIC ACIDS RES, V39, P4330, DOI 10.1093/nar/gkr022; Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632	40	235	253	1	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					212	+		10.1038/nature09937	http://dx.doi.org/10.1038/nature09937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21508956	Green Accepted, Green Submitted			2022-12-01	WOS:000290487200038
J	Gahl, WA; Tifft, CJ				Gahl, William A.; Tifft, Cynthia J.			The NIH Undiagnosed Diseases Program Lessons Learned	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MUTATIONS		[Tifft, Cynthia J.] NHGRI, NIH, Undiagnosed Dis Program, Bethesda, MD 20892 USA; NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Tifft, CJ (corresponding author), NHGRI, NIH, Undiagnosed Dis Program, 10 Ctr Dr,MSC 1205,Bldg 10,Room CRC3-2551, Bethesda, MD 20892 USA.	ctifft@nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Markello TC, 2011, MOL GENET METAB, V103, P44, DOI 10.1016/j.ymgme.2011.01.018; *NAT TECHN INF SER, 1989, PUBL NAT TECHN INF S, P17; *NIH OFF RAR DIS R, UND DIS PROGR; Riksen NP, 2011, NEW ENGL J MED, V364, P1579, DOI 10.1056/NEJMc1102515	6	84	84	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2011	305	18					1904	1905		10.1001/jama.2011.613	http://dx.doi.org/10.1001/jama.2011.613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761YH	21558523				2022-12-01	WOS:000290438800030
J	Schilcher, J; Michaelsson, K; Aspenberg, P				Schilcher, Jorg; Michaelsson, Karl; Aspenberg, Per			Bisphosphonate Use and Atypical Fractures of the Femoral Shaft	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAPHYSEAL FEMUR FRACTURES; SUPPRESSED BONE TURNOVER; STRESS-FRACTURES; ALENDRONATE; COMPLICATION; WOMEN	BACKGROUND Studies show conflicting results regarding the possible excess risk of atypical fractures of the femoral shaft associated with bisphosphonate use. METHODS In Sweden, 12,777 women 55 years of age or older sustained a fracture of the femur in 2008. We reviewed radiographs of 1234 of the 1271 women who had a subtrochanteric or shaft fracture and identified 59 patients with atypical fractures. Data on medications and coexisting conditions were obtained from national registries. The relative and absolute risk of atypical fractures associated with bisphosphonate use was estimated by means of a nationwide cohort analysis. The 59 case patients were also compared with 263 control patients who had ordinary subtrochanteric or shaft fractures. RESULTS The age-adjusted relative risk of atypical fracture was 47.3 (95% confidence interval [CI], 25.6 to 87.3) in the cohort analysis. The increase in absolute risk was 5 cases per 10,000 patient-years (95% CI, 4 to 7). A total of 78% of the case patients and 10% of the controls had received bisphosphonates, corresponding to a multivariable-adjusted odds ratio of 33.3 (95% CI, 14.3 to 77.8). The risk was independent of coexisting conditions and of concurrent use of other drugs with known effects on bone. The duration of use influenced the risk (odds ratio per 100 daily doses, 1.3; 95% CI, 1.1 to 1.6). After drug withdrawal, the risk diminished by 70% per year since the last use (odds ratio, 0.28; 95% CI, 0.21 to 0.38). CONCLUSIONS These population-based nationwide analyses may be reassuring for patients who receive bisphosphonates. Although there was a high prevalence of current bisphosphonate use among patients with atypical fractures, the absolute risk was small.	[Schilcher, Jorg; Aspenberg, Per] Linkoping Univ, Fac Hlth Sci, Dept Expt & Clin Med, SE-58185 Linkoping, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthoped, Uppsala, Sweden; [Michaelsson, Karl] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Linkoping University; Uppsala University; Uppsala University	Aspenberg, P (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Expt & Clin Med, SE-58185 Linkoping, Sweden.	per.aspenberg@liu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217	Eli Lilly; Amgen; Swedish Research Council	Eli Lilly(Eli Lilly); Amgen(Amgen); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Dr. Aspenberg reports receiving consulting fees from Eli Lilly and Amgen and grant support to his institution, Linkoping University, from Eli Lilly and Amgen, as well as holding stock in AddBIO, a company trying to commercialize a method for bisphosphonate coating of implants to be inserted in bone, and holding a patent for this method. No other potential conflict of interest relevant to this article was reported.; Funded by the Swedish Research Council.	Abrahamsen B, 2010, J CLIN ENDOCR METAB, V95, P5258, DOI 10.1210/jc.2010-1571; Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Girgis CM, 2010, NEW ENGL J MED, V362, P1848, DOI 10.1056/NEJMc0910389; Ing-Lorenzini K, 2009, DRUG SAFETY, V32, P775, DOI 10.2165/00002018-200932090-00002; Kwek EBK, 2008, INJURY, V39, P224, DOI 10.1016/j.injury.2007.08.036; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493; NEER RM, 1995, BONE, V17, pS501, DOI 10.1016/8756-3282(95)00343-7; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Odvina CV, 2010, CLIN ENDOCRINOL, V72, P161, DOI 10.1111/j.1365-2265.2009.03581.x; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schilcher J, 2009, ACTA ORTHOP, V80, P413, DOI 10.3109/17453670903139914; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803	19	482	496	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1728	1737		10.1056/NEJMoa1010650	http://dx.doi.org/10.1056/NEJMoa1010650			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21542743				2022-12-01	WOS:000290219800009
J	Esvelt, KM; Carlson, JC; Liu, DR				Esvelt, Kevin M.; Carlson, Jacob C.; Liu, David R.			A system for the continuous directed evolution of biomolecules	NATURE			English	Article							T7 RNA-POLYMERASE; START SITE SELECTION; PHAGE; TRANSCRIPTION; RECOGNITION; INITIATION; VECTORS; MUTANTS; YEAST; ASSAY	Laboratory evolution has generated many biomolecules with desired properties, but a single round of mutation, gene expression, screening or selection, and replication typically requires days or longer with frequent human intervention(1). Because evolutionary success is dependent on the total number of rounds performed(2), a means of performing laboratory evolution continuously and rapidly could dramatically enhance its effectiveness(3). Although researchers have accelerated individual steps in the evolutionary cycle(4-9), the only previous example of continuous directed evolution was the landmark study of Wright and Joyce(10), who continuously evolved RNA ligase ribozymes with an in vitro replication cycle that unfortunately cannot be easily adapted to other biomolecules. Here we describe a system that enables the continuous directed evolution of gene-encoded molecules that can be linked to protein production in Escherichia coli. During phage-assisted continuous evolution (PACE), evolving genes are transferred from host cell to host cell through a modified bacteriophage life cycle in a manner that is dependent on the activity of interest. Dozens of rounds of evolution can occur in a single day of PACE without human intervention. Using PACE, we evolved T7 RNA polymerase (RNAP) variants that recognize a distinct promoter, initiate transcripts with ATP instead of GTP, and initiate transcripts with CTP. In one example, PACE executed 200 rounds of protein evolution over the course of 8 days. Starting from undetectable activity levels in two of these cases, enzymes with each of the three target activities emerged in less than 1 week of PACE. In all three cases, PACE-evolved polymerase activities exceeded or were comparable to that of the wild-type T7 RNAP on its wild-type promoter, representing improvements of up to several hundred-fold. By greatly accelerating laboratory evolution, PACE may provide solutions to otherwise intractable directed evolution problems and address novel questions about molecular evolution.	[Carlson, Jacob C.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Esvelt, Kevin M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	Esvelt, Kevin/0000-0001-8797-3945	National Institutes of Health/National Institute of General Medical Sciences [R01 GM065400]; HHMI; Hertz Foundation; National Science Foundation; Harvard Chemical Biology Graduate Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065400] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); Hertz Foundation; National Science Foundation(National Science Foundation (NSF)); Harvard Chemical Biology Graduate Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences R01 GM065400 and by HHMI. K. M. E. acknowledges graduate research fellowships from the Hertz Foundation and the National Science Foundation. J.C.C. was supported by the Harvard Chemical Biology Graduate Program. We thank B. Dorr for assistance with phage generation modelling, E. Curtis for suggestions and V. D'Souza for plasmid pT7-911Q.	Baker K, 2002, P NATL ACAD SCI USA, V99, P16537, DOI 10.1073/pnas.262420099; Brieba LG, 2002, BIOCHEMISTRY-US, V41, P5144, DOI 10.1021/bi016057v; Calendar R., 2006, BACTERIOPHAGES; Camps M, 2003, P NATL ACAD SCI USA, V100, P9727, DOI 10.1073/pnas.1333928100; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JN, 2010, J VIROL, V84, P1625, DOI 10.1128/JVI.01747-09; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Husimi Y, 1989, Adv Biophys, V25, P1, DOI 10.1016/0065-227X(89)90003-8; Ichetovkin IE, 1997, J BIOL CHEM, V272, P33009, DOI 10.1074/jbc.272.52.33009; IKEDA RA, 1993, BIOCHEMISTRY-US, V32, P9115, DOI 10.1021/bi00086a016; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Kuzmine I, 2003, J BIOL CHEM, V278, P2819, DOI 10.1074/jbc.M208405200; Makeyev EV, 2004, J VIROL, V78, P2114, DOI 10.1128/JVI.78.4.2114-2120.2004; MARTIN CT, 1987, BIOCHEMISTRY-US, V26, P2690, DOI 10.1021/bi00384a006; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; NELSON FK, 1981, VIROLOGY, V108, P338, DOI 10.1016/0042-6822(81)90442-6; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Rakonjac J, 1998, J MOL BIOL, V282, P25, DOI 10.1006/jmbi.1998.2006; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vidal-Aroca F, 2006, BIOTECHNIQUES, V40, P433, DOI 10.2144/000112145; Voigt CA, 2001, ADV PROTEIN CHEM, V55, P79; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005	32	357	430	25	428	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					499	U550		10.1038/nature09929	http://dx.doi.org/10.1038/nature09929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21478873	Green Accepted			2022-12-01	WOS:000289949600040
J	Lawn, JE; Blencowe, H; Pattinson, R; Cousens, S; Kumar, R; Ibiebele, I; Gardosi, J; Day, LT; Stanton, C				Lawn, Joy E.; Blencowe, Hannah; Pattinson, Robert; Cousens, Simon; Kumar, Rajesh; Ibiebele, Ibinabo; Gardosi, Jason; Day, Louise T.; Stanton, Cynthia		Lancet's Stillbirths Series Steeri	Stillbirths 2 Stillbirths: Where? When? Why? How to make the data count?	LANCET			English	Article							4-MILLION NEONATAL DEATHS; PERINATAL-MORTALITY; INTRAPARTUM STILLBIRTHS; MATERNAL MORTALITY; PRETERM BIRTH; SURVIVAL 1; HEALTH; CARE; CLASSIFICATION; FETAL	Despite increasing attention and investment for maternal, neonatal, and child health, stillbirths remain invisible not counted in the Millennium Development Goals, nor tracked by the UN, nor in the Global Burden of Disease metrics. At least 2.65 million stillbirths (uncertainty range 2.08 million to 3.79 million) were estimated worldwide in 2008 (>= 1000 g birthweight or >= 28 weeks of gestation). 98% of stillbirths occur in low-income and middle-income countries, and numbers vary from 2.0 per 1000 total births in Finland to more than 40 per 1000 total births in Nigeria and Pakistan. Worldwide, 67% of stillbirths occur in rural families, 55% in rural sub-Saharan Africa and south Asia, where skilled birth attendance and caesarean sections are much lower than that for urban births. In total, an estimated 1.19 million (range 0.82 million to 1.97 million) intrapartum stillbirths occur yearly. Most intrapartum stillbirths are associated with obstetric emergencies, whereas antepartum stillbirths are associated with maternal infections and fetal growth restriction. National estimates of causes of stillbirths are scarce, and multiple (>35) classification systems impede international comparison. Immediate data improvements are feasible through household surveys and facility audit, and improvements in vital registration, including specific perinatal certificates and revised International Classification of Disease codes, are needed. A simple, programme-relevant stillbirth classification that can be used with verbal autopsy would provide a basis for comparable national estimates. A new focus on all deaths around the time of birth is crucial to inform programmatic investment.	[Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England; [Blencowe, Hannah; Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Pattinson, Robert] Univ Pretoria, Dept Obstet & Gynaecol, MRC, Maternal & Infant Hlth Care Strategies Res Unit, ZA-0002 Pretoria, South Africa; [Kumar, Rajesh] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Ibiebele, Ibinabo] Mater Med Res Inst, Brisbane, Qld, Australia; [Gardosi, Jason] W Midlands Perinatal Inst, Birmingham, W Midlands, England; [Day, Louise T.] LAMB Hosp, Parbatipur, Bangladesh; [Stanton, Cynthia] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Save the Children; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Pretoria; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Mater Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lawn, JE (corresponding author), 11 South Way, ZA-7405 Cape Town, South Africa.	joylawn@yahoo.co.uk	Gardosi, Jason/GXN-1375-2022; Flenady, Vicki Jane/O-9609-2014; Lawn, Joy/ABE-6382-2020; Blencowe, Hannah/K-7415-2012	Flenady, Vicki Jane/0000-0001-8114-7677; Lawn, Joy/0000-0002-4573-1443; Blencowe, Hannah/0000-0003-1556-3159; Ibiebele, Ibinabo/0000-0001-6024-2958; Froen Froen, Jahn Frederik/0000-0001-9390-8509; Gardosi, Jason/0000-0002-3230-1292	Bill & Melinda Gates Foundation; Global Alliance to Prevent Prematurity and Stillbirths	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Alliance to Prevent Prematurity and Stillbirths	Some of the technical work for this paper during 2010 was funded through a grant from the Bill & Melinda Gates Foundation to the International Stillbirth Alliance secretariat for this series. JELLS funded by the Bill & Melinda Gates Foundation via Saving Newborn Lives/Save the Children. CS was partly funded by the Global Alliance to Prevent Prematurity and Stillbirths. The views expressed herein are solely those of the authors. We thank the team involved in the stillbirth rate estimates (Doris Chou, Saifuddin Ahmed, Laura Steinhardt, Andreea A Creanga, Ozge Tuncalp, Zohra Patel Balsara, Shivam Gupta, and Lale Say); Vicki Flenady, J Frederik Froen, and their team for the stillbirth cause and condition data from high-income countries; Felicity Mussell as the perinatal audit coordinator at LAMB Hospital, Bangladesh; Mikkel Oestergaard and Florence Rusciano at WHO for assistance with figure 2, the 20 scorers for the GHNRI research priority setting exercise (Romano Byaruhanga, Hannah Blencowe, Simon Cousens, Gary L Darmstadt, Louise T Day, Karen Edmond, Vincent Fauveau, Alfredo Fort, J Frederik Froen, Ron Gray, Rachel Haws, G Justus Hofmeyr, Jane Hirst, Mary Kamb, Anne C C Lee, Elizabeth M McClure, Nafissa Bique Osman, Robert Pattinson, Sonia Lansky, and Dave Woods);	AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; ACOLET D, 2008, 7 CONF ENQ MAT CHILD; Aggarwal AK, 2011, B WORLD HEALTH ORGAN, V89, P31, DOI 10.2471/BLT.10.076828; Aisien AO, 2000, INT J GYNECOL OBSTET, V71, P171, DOI 10.1016/S0020-7292(00)00214-9; AKPALA CO, 1993, J ROY SOC HEALTH, V113, P124, DOI 10.1177/146642409311300306; Ananth CV, 2009, INT J EPIDEMIOL, V38, P480, DOI 10.1093/ije/dyn194; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BARSON AJ, 1984, ARCH DIS CHILD, V59, P199, DOI 10.1136/adc.59.3.199; Bhutta Z, 2004, BRIT MED J, V328, P777, DOI 10.1136/bmj.328.7443.777; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell Oona, 2004, J Perinatol, V24, P284, DOI 10.1038/sj.jp.7211084; Costeloe K, 2006, BJOG-INT J OBSTET GY, V113, P10, DOI 10.1111/j.1471-0528.2006.01118.x; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; *CTR MAT CHILD ENQ, PER MORT 2008; DAVID RJ, 1983, PEDIATRICS, V71, P531; Doyal L, 2004, B WORLD HEALTH ORGAN, V82, P162; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Edouard L, 1985, World Health Stat Q, V38, P289; Fauveau V, 2007, LANCET, V370, P1310, DOI 10.1016/S0140-6736(07)61571-2; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; *GLOB ALL PREV PRE, 2010, BMC PREGNANCY CHI S1, V10, pS7; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Goldenberg RL, 2009, INT J GYNECOL OBSTET, V107, pS1, DOI 10.1016/j.ijgo.2009.07.014; Harvey SA, 2004, INT J GYNECOL OBSTET, V87, P203, DOI 10.1016/j.ijgo.2004.06.017; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Huang DY, 2000, OBSTET GYNECOL, V95, P215, DOI 10.1016/S0029-7844(99)00536-0; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; Kramer MS, 2002, AM J EPIDEMIOL, V156, P493, DOI 10.1093/aje/kwf077; LanghoffRoos J, 1996, ACTA OBSTET GYN SCAN, V75, P820, DOI 10.3109/00016349609054710; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn Joy, OPPORTUNITIES AFRICA; Lawn JE, 2008, PAEDIATR PERINAT EP, V22, P410, DOI 10.1111/j.1365-3016.2008.00960.x; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; Macfarlane A, 2003, EUR J OBSTET GYN R B, V111, pS15, DOI 10.1016/j.ejogrb.2003.09.003; *MAT CHILD HLTH RE, 1999, 7 MAT CHILD HLTH RES; *MRC MAT INF HLTH, SAV BAB 200 IN PRESS; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Oyelese KO, 1998, AUST NZ J OBSTET GYN, V38, P391, DOI 10.1111/j.1479-828X.1998.tb03094.x; PARSONS L, 1990, BRIT J OBSTET GYNAEC, V97, P237, DOI 10.1111/j.1471-0528.1990.tb01788.x; PATTINSON RC, 1995, S AFR MED J, V85, P145; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Petersson K, 2002, ACTA OBSTET GYN SCAN, V81, P284; PITT C, 2010, LANCET, V371, P1268; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; ROSENFIELD A, 1985, LANCET, V2, P83; Rudan I, 2007, CROAT MED J, V48, P595; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Shiffman Jeremy, 2004, Afr J Reprod Health, V8, P6, DOI 10.2307/3583389; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Spector JM, 2008, B WORLD HEALTH ORGAN, V86, P315, DOI 10.2471/BLT.07.049924; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; *STILLB RES CONS, 2010, GLOB RES AG RED STIL; Ticconi C, 2003, JAIDS-J ACQ IMM DEF, V34, P289, DOI 10.1097/00126334-200311010-00005; Vergani P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.098; Wang H, 2001, Zhonghua Yi Xue Za Zhi, V81, P1424; WARD HRG, 1995, S AFR MED J, V85, P147; WHO, 2006, PER NEON MORT YEAR 2 PER NEON MORT YEAR 2; WHO, 1993, INT STAT CLASS DIS R, V2; WHO, TRENDS MAT MORT 1990; WHO UNICEF, 2010, COUNTD 2015 DEC REP; Winbo IGB, 1998, INT J EPIDEMIOL, V27, P499, DOI 10.1093/ije/27.3.499; Winbo IGB, 1997, INT J EPIDEMIOL, V26, P1298, DOI 10.1093/ije/26.6.1298; Wood NS, 2003, ARCH DIS CHILD-FETAL, V88, pF492, DOI 10.1136/fn.88.6.F492; WOODS R, 2009, DEATH BIRTH 2009, P294; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; World Health Organization, 1996, WHOFRHMSM967; Wu ZC, 2003, BRIT MED J, V327, P1319, DOI 10.1136/bmj.327.7427.1319; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608	101	487	503	1	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1448	1463		10.1016/S0140-6736(10)62187-3	http://dx.doi.org/10.1016/S0140-6736(10)62187-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UF	21496911	Green Accepted, Green Submitted			2022-12-01	WOS:000289963000034
J	Lowden, MR; Flibotte, S; Moerman, DG; Ahmed, S				Lowden, Mia Rochelle; Flibotte, Stephane; Moerman, Donald G.; Ahmed, Shawn			DNA Synthesis Generates Terminal Duplications That Seal End-to-End Chromosome Fusions	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; GENE AMPLIFICATION; CANCER GENOMES; COPY-NUMBER; HUMAN-CELLS; TELOMERES; REARRANGEMENTS; REPLICATION; DELETION	End-to-end chromosome fusions that occur in the context of telomerase deficiency can trigger genomic duplications. For more than 70 years, these duplications have been attributed solely to breakage-fusion-bridge cycles. To test this hypothesis, we examined end-to-end fusions isolated from Caenorhabditis elegans telomere replication mutants. Genome-level rearrangements revealed fused chromosome ends having interrupted terminal duplications accompanied by template-switching events. These features are very similar to disease-associated duplications of interstitial segments of the human genome. A model termed Fork Stalling and Template Switching has been proposed previously to explain such duplications, where promiscuous replication of large, noncontiguous segments of the genome occurs. Thus, a DNA synthesis-based process may create duplications that seal end-to-end fusions, in the absence of breakage-fusion-bridge cycles.	[Lowden, Mia Rochelle; Ahmed, Shawn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Lowden, Mia Rochelle; Ahmed, Shawn] Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA; [Flibotte, Stephane; Moerman, Donald G.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of British Columbia	Ahmed, S (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	shawn@med.unc.edu		Flibotte, Stephane/0000-0001-9613-7666	NIH [GM066228, GM072150]; Genome Canada; Genome British Columbia; Michael Smith Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM072150, R01GM066228, R56GM066228] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); Genome British Columbia; Michael Smith Research Foundation(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Maydan for technical assistance; D. Reiner, J. Sekelsky, L. Shtessel, D. Shippen, and T. Petes for comments on the manuscript; and D. Ramsden for discussion. S. A. and M. L. were supported by NIH grants GM066228 and GM072150. D. G. M. was supported by funds from Genome Canada and Genome British Columbia and the Michael Smith Research Foundation. D. G. M. is a fellow of the Canadian Institute for Advanced Research.	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bosco G, 1998, GENETICS, V150, P1037; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Cheung I, 2006, NUCLEIC ACIDS RES, V34, P96, DOI 10.1093/nar/gkj417; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Letsolo BT, 2010, NUCLEIC ACIDS RES, V38, P1841, DOI 10.1093/nar/gkp1183; Lowden MR, 2008, GENETICS, V180, P741, DOI 10.1534/genetics.108.089920; Mantripragada KK, 2004, INT J MOL MED, V13, P273; McClintock B, 1941, GENETICS, V26, P234; McVey M, 2004, GENETICS, V168, P2067, DOI 10.1534/genetics.104.033902; Meier B, 2006, PLOS GENET, V2, P187, DOI 10.1371/journal.pgen.0020018; MOERMAN DG, 1991, NUCLEIC ACIDS RES, V19, P5669, DOI 10.1093/nar/19.20.5669; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stansel RM, 2001, EMBO J, V20, P5532; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645	26	39	39	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					468	471		10.1126/science.1199022	http://dx.doi.org/10.1126/science.1199022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512032	Green Submitted, Green Accepted			2022-12-01	WOS:000289784900044
J	Quagliarello, V				Quagliarello, Vincent			Dissemination of Neisseria meningitidis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA	Yale University	Quagliarello, V (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.							Butler D, 2010, NATURE, V468, P143, DOI 10.1038/468143a; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Murray CJL, 2001, GLOBAL BURDEN DIS 20; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357	5	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1573	1575		10.1056/NEJMcibr1101564	http://dx.doi.org/10.1056/NEJMcibr1101564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21506747				2022-12-01	WOS:000289722700019
J	Hargrove, LJ; Simon, AM; Lipschutz, RD; Finucane, SB; Kuiken, TA				Hargrove, Levi J.; Simon, Ann M.; Lipschutz, Robert D.; Finucane, Suzanne B.; Kuiken, Todd A.			Real-Time Myoelectric Control of Knee and Ankle Motions for Transfemoral Amputees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hargrove, Levi J.; Simon, Ann M.; Lipschutz, Robert D.; Finucane, Suzanne B.; Kuiken, Todd A.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab	Hargrove, LJ (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.	l-hargrove@northwestern.edu		Simon, Ann/0000-0002-6431-0329				Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Ha KH, 2011, IEEE T BIO-MED ENG, V58, P144, DOI 10.1109/TBME.2010.2070840; Hitt JK, 2010, J MED DEVICES, V4, DOI 10.1115/1.4001139; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Netter FH, 2010, ATLAS HUMAN ANATOMY, P511; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	6	47	57	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1542	1544		10.1001/jama.2011.465	http://dx.doi.org/10.1001/jama.2011.465			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21505133				2022-12-01	WOS:000289683000021
J	Surjit, M; Ganti, KP; Mukherji, A; Ye, T; Hua, G; Metzger, D; Li, M; Chambon, P				Surjit, Milan; Ganti, Krishna Priya; Mukherji, Atish; Ye, Tao; Hua, Guoqiang; Metzger, Daniel; Li, Mei; Chambon, Pierre			Widespread Negative Response Elements Mediate Direct Repression by Agonist-Liganded Glucocorticoid Receptor	CELL			English	Article							REV-ERB-ALPHA; MOUSE KERATINOCYTES; GENE PROMOTER; BINDING; MICE; MECHANISMS; GROWTH; TRANSACTIVATION; TRANSREPRESSION; TRANSCRIPTION	The glucocorticoid (GC) receptor (GR), when liganded to GC, activates transcription through direct binding to simple (+)GRE DNA binding sequences (DBS). GC-induced direct repression via GR binding to complex "negative" GREs (nGREs) has been reported. However, GR-mediated transrepression was generally ascribed to indirect "tethered" interaction with other DNA-bound factors. We report that GC-induces direct transrepression via the binding of GR to simple DBS (IR nGREs) unrelated to (+) GRE. These DBS act on agonist-liganded GR, promoting the assembly of cis-acting GR-SMRT/NCoR repressing complexes. IR nGREs are present in over 1000 mouse/human ortho-log genes, which are repressed by GC in vivo. Thus variations in the levels of a single ligand can coordinately turn genes on or off depending in their response element DBS, allowing an additional level of regulation in GR signaling. This mechanism suits GR signaling remarkably well, given that adrenal secretion of GC fluctuates in a circadian and stress-related fashion.	[Surjit, Milan; Ganti, Krishna Priya; Mukherji, Atish; Ye, Tao; Hua, Guoqiang; Metzger, Daniel; Li, Mei; Chambon, Pierre] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, Coll France,Inserm U964,UMR7104, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chambon, P (corresponding author), Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, Coll France,Inserm U964,UMR7104, F-67404 Illkirch Graffenstaden, France.	chambon@igbmc.fr	Ye, Tao/D-8026-2011; Ganti, Krishna Priya/AAV-2106-2021	Li, Mei/0000-0003-4225-6699; Metzger, Daniel/0000-0002-5555-046X	CNRS; INSERM; ANR [ANR 07-Physio 002-01]; Association pour la Recherche a l'IGBMC (ARI)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Association pour la Recherche a l'IGBMC (ARI)	This study is dedicated to the memory of Dr. Regine Losson, who died last year. She was a wonderful colleague and an outstanding scientist. We thank the staff of the animal and cell culture facilities of the IGBMC/ICS; Dr. H. Gronemeyer and Leo Pharmaceutical for kind gifts of RU24858 and MC903, respectively; Dr. S. Kato for floxed VDR mice; Dr. G. Richards for a critical reading of the manuscript; and Estelle Meyer for secretarial help. This work was supported by the CNRS, the INSERM, the ANR (No. ANR 07-Physio 002-01), and the Association pour la Recherche a l'IGBMC (ARI). M.S., A.M., G.H., and K.G. were supported by ARI fellowships.	Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Belvisi MG, 2001, J IMMUNOL, V166, P1975, DOI 10.4049/jimmunol.166.3.1975; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; Carey M, 2001, TRANSCRIPTIONAL REGU, DOI Cold Spring Harbor Laboratory Pr; CARO JF, 1982, J CLIN INVEST, V69, P866, DOI 10.1172/JCI110526; Chen A, 2004, ENDOCRINOLOGY, V145, P2445, DOI 10.1210/en.2003-1570; Chen A, 2006, J NEUROSCI, V26, P5500, DOI 10.1523/JNEUROSCI.3955-05.2006; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Chida D, 2007, P NATL ACAD SCI USA, V104, P18205, DOI 10.1073/pnas.0706953104; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Fassler R, 1996, EXP CELL RES, V222, P111, DOI 10.1006/excr.1996.0014; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Goodman PA, 1996, MOL CELL ENDOCRINOL, V120, P139, DOI 10.1016/0303-7207(96)03830-0; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li SW, 2001, DEV DYNAM, V222, P141, DOI 10.1002/dvdy.1178; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Mocetti P, 2001, TISSUE CELL, V33, P1, DOI 10.1054/tice.2000.0144; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Neufeld-Cohen A, 2010, P NATL ACAD SCI USA, V107, P19020, DOI 10.1073/pnas.1013761107; Ochala J, 2007, J PHYSIOL-LONDON, V581, P1283, DOI 10.1113/jphysiol.2007.129759; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramot Y, 2009, BIOESSAYS, V31, P389, DOI 10.1002/bies.200800121; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rogatsky I, 1999, MOL CELL BIOL, V19, P5036; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sasaki N, 2001, NEPHROL DIAL TRANSPL, V16, P479, DOI 10.1093/ndt/16.3.479; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Stewart PM, 1996, LANCET, V347, P88, DOI 10.1016/S0140-6736(96)90211-1; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Torra IP, 2000, ENDOCRINOLOGY, V141, P3799, DOI 10.1210/en.141.10.3799; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; WRANGE O, 1989, J BIOL CHEM, V264, P5253; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324	60	366	372	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					224	241		10.1016/j.cell.2011.03.027	http://dx.doi.org/10.1016/j.cell.2011.03.027			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496643	Bronze			2022-12-01	WOS:000289549900012
J	He, HL; Liyanarachchi, S; Akagi, K; Nagy, R; Li, JF; Dietrich, RC; Li, W; Sebastian, N; Wen, B; Xin, BZ; Singh, J; Yan, P; Alder, H; Haan, E; Wieczorek, D; Albrecht, B; Puffenberger, E; Wang, H; Westman, JA; Padgett, RA; Symer, DE; de la Chapelle, A				He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Nagy, Rebecca; Li, Jingfeng; Dietrich, Rosemary C.; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Xin, Baozhong; Singh, Jarnail; Yan, Pearlly; Alder, Hansjuerg; Haan, Eric; Wieczorek, Dagmar; Albrecht, Beate; Puffenberger, Erik; Wang, Heng; Westman, Judith A.; Padgett, Richard A.; Symer, David E.; de la Chapelle, Albert			Mutations in U4atac snRNA, a Component of the Minor Spliceosome, in the Developmental Disorder MOPD I	SCIENCE			English	Article							PRIMORDIAL DWARFISM; INTRONS; RNA; U4; PROTEIN; VIVO; PCNT	Small nuclear RNAs (snRNAs) are essential factors in messenger RNA splicing. By means of homozygosity mapping and deep sequencing, we show that a gene encoding U4atac snRNA, a component of the minor U12-dependent spliceosome, is mutated in individuals with microcephalic osteodysplastic primordial dwarfism type I (MOPD I), a severe developmental disorder characterized by extreme intrauterine growth retardation and multiple organ abnormalities. Functional assays showed that mutations (30G>A, 51G>A, 55G>A, and 111G>A) associated with MOPD I cause defective U12-dependent splicing. Endogenous U12-dependent but not U2-dependent introns were found to be poorly spliced in MOPD I patient fibroblast cells. The introduction of wild-type U4atac snRNA into MOPD I cells enhanced U12-dependent splicing. These results illustrate the critical role of minor intron splicing in human development.	[He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Nagy, Rebecca; Li, Jingfeng; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Yan, Pearlly; Alder, Hansjuerg; Westman, Judith A.; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; [He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Li, Jingfeng; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Yan, Pearlly; Alder, Hansjuerg; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Sch Biomed Sci, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Nagy, Rebecca; Westman, Judith A.; Symer, David E.] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA; [Dietrich, Rosemary C.; Singh, Jarnail; Padgett, Richard A.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Xin, Baozhong; Wang, Heng] DDC Clin Special Needs Children, Middlefield, OH 44062 USA; [Haan, Eric] SA Pathol Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Haan, Eric] Univ Adelaide, Dept Pediat, Adelaide, SA 5005, Australia; [Wieczorek, Dagmar; Albrecht, Beate] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Puffenberger, Erik] Clin Special Children, Strasburg, PA 17579 USA; [Symer, David E.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; SA Pathology; University of Adelaide; University of Duisburg Essen; University System of Ohio; Ohio State University	de la Chapelle, A (corresponding author), Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA.	albert.delachapelle@osumc.edu	Symer, David E./E-4173-2011; Yan, Pearlly S/E-4339-2011; Nagy, Rebecca Shrigley/E-4088-2011; Wieczorek, Dagmar/AAU-6008-2021; Westman, Judith/E-4294-2011	Yan, Pearlly S/0000-0003-1965-4920; Wieczorek, Dagmar/0000-0003-2812-6492; Puffenberger, Erik/0000-0002-6388-9148	Ohio Supercomputing Center [PAS0425-2]; Cleveland Foundation [L2009-0078]; NIH [GM093074, GM079527]; National Cancer Institute [P30 CA16058]; OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079527, R01GM093074] Funding Source: NIH RePORTER	Ohio Supercomputing Center; Cleveland Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Mehlen and M.-M. Coissieux for the French control sample set, P. Meinecke for information on patients, J. Palatini for sharing equipment and advice, J. Lockman for technical support, and the Microarray Shared Resource and Nucleic Acid Shared Resource of the OSU Comprehensive Cancer Center for genotyping and sequencing. Supported by Ohio Supercomputing Center grant PAS0425-2 for computational resources (K. A. and D. E. S.), Leonard Krieger Fund of the Cleveland Foundation grant L2009-0078 (H. W.), NIH grants GM093074 and GM079527 (R. A. P.), National Cancer Institute grant P30 CA16058 (H. H., S. L., K. A., J. L., R.N., W. L., N.S., B. W., P.Y., H. W., D. E. S., J. A. W., and A.dlC.), and the OSU Comprehensive Cancer Center.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MAJEWSKI F, 1982, AM J MED GENET, V12, P37, DOI 10.1002/ajmg.1320120105; MAJEWSKI F, 1976, MONATSSCHR KINDERH, V124, P499; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Pessa HKJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013215; Piane M, 2009, AM J MED GENET A, V149A, P2452, DOI 10.1002/ajmg.a.33035; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Shukla GC, 2002, NUCLEIC ACIDS RES, V30, P4650, DOI 10.1093/nar/gkf609; Sigaudy S, 1998, AM J MED GENET, V80, P16, DOI 10.1002/(SICI)1096-8628(19981102)80:1<16::AID-AJMG4>3.3.CO;2-X; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; TAYBI H, 1967, RADIOLOGY, V89, P275, DOI 10.1148/89.2.275; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	21	155	159	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					238	240		10.1126/science.1200587	http://dx.doi.org/10.1126/science.1200587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474760	Green Accepted			2022-12-01	WOS:000289251100052
J	Smith, J; Lipsitch, M; Almond, JW				Smith, Jon; Lipsitch, Marc; Almond, Jeffrey W.			New Decade of Vaccines 3 Vaccine production, distribution, access, and uptake	LANCET			English	Article							INFLUENZA VACCINE; PANDEMIC INFLUENZA; VIRUS; PROTECTION; EPIDEMIC; SPREAD; INTERVENTIONS; STRATEGIES; MORTALITY; PERTUSSIS	For human vaccines to be available on a global scale, complex production methods, meticulous quality control, and reliable distribution channels are needed to ensure that the products are potent and effective at the point of use. The technologies used to manufacture different types of vaccines can strongly affect vaccine cost, ease of industrial scale-up, stability, and, ultimately, worldwide availability. The complexity of manufacturing is compounded by the need for different formulations in different countries and age-groups. Reliable vaccine production in appropriate quantities and at affordable prices is the cornerstone of developing global vaccination policies. However, to ensure, optimum access and uptake, strong partnerships are needed between private manufacturers, regulatory authorities, and national and international public health services. For vaccines whose supply is insufficient to meet demand, prioritisation of target groups can increase the effect of these vaccines. In this report, we draw from our experience of vaccine development and focus on influenza vaccines as an example to consider production, distribution, access, and other factors that affect vaccine uptake and population-level effectiveness.	[Smith, Jon; Almond, Jeffrey W.] Sanofi Pasteur, F-69280 Marcy Letoile, France; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Almond, JW (corresponding author), Sanofi Pasteur, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.	jeffrey.almond@sanofipasteur.com		Lipsitch, Marc/0000-0003-1504-9213	National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ML's work on this report was supported by the National Institute of General Medical Sciences (award number U54GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Abramson JS, 2000, PEDIATRICS, V106, P362; Allgaier S, 2009, BIOLOGICALS, V37, P128, DOI 10.1016/j.biologicals.2009.02.006; Almond JW, 2007, NAT REV MICROBIOL, V5, P478, DOI 10.1038/nrmicro1702; ANDERSON R M, 1991; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; [Anonymous], 2011, US PHARM NAT FORM 20, P3132; [Anonymous], 2011, US PHARM NAT FORM 20, P4377; [Anonymous], 2009, GLOB AL RESP PAND H1; [Anonymous], 2011, US PHARM NAT FORM 20, P3384; [Anonymous], WHO GLOB INFL SURV N; [Anonymous], 2011, US PHARM NAT FORM 20, P3570; [Anonymous], 2011, US PHARM NAT FORM 20, P3949; [Anonymous], 2011, US PHARM NAT FORM 20, P1993; [Anonymous], 2011, US PHARM NAT FORM 20, P4187; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Cassone A, 2010, MBIO, V1, DOI 10.1128/mBio.00042-10; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI [10.1586/erv.09.31, 10.1586/ERV.09.31]; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; European Agency for the Evaluation of Medicinal Products (EMEA), CPMPBWP21496 EUR AG; European Council, COMM PROC AUTH SUP M; European Medicines Agency, EMEACPMPVEG47172003R; European Medicines Agency, ANN 1 SUMM PROD CHAR; Fedson DS, 2005, J PUBLIC HEALTH POL, V26, P4, DOI 10.1057/palgrave.jphp.3200008; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; G-Con, 2010, TEX BAS CONS ANN PRO; GAVI Alliance, WHAT YOU CAN APPL; GAVI Alliance, KEY IND MEAS ALL PRO; GAVI Alliance, INN FIN; GAVI Alliance, FACTS FIG; GAVI Alliance, EL COUNTR; GAVI Alliance, INV IMM GAVI ALL EV; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Goldstein E, 2010, J R SOC INTERFACE, V7, P755, DOI 10.1098/rsif.2009.0393; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907; Koudstaal W, 2009, VACCINE, V27, P2588, DOI 10.1016/j.vaccine.2009.02.033; Lessler J, 2010, EPIDEMICS-NETH, V2, P132, DOI 10.1016/j.epidem.2010.07.001; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; McNeil C, 2006, J NATL CANCER I, V98, P433, DOI 10.1093/jnci/djj144; Meghrous J, 2009, VACCINE, V28, P309, DOI 10.1016/j.vaccine.2009.10.048; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; Modlin JF, 2010, NEW ENGL J MED, V362, P2346, DOI 10.1056/NEJMp1005405; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; NIELSEN A, 1994, INT J EPIDEMIOL, V23, P1300, DOI 10.1093/ije/23.6.1300; Nishiura H, 2009, EUROSURVEILLANCE, V14; Novavax, RES DEV PROGR; Pan American Health Organization, 2006, POL ER FIELD GUID; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; UK Health Protection Agency, ROUT CHILDH IMM SCHE; UNICEF, SUPPL LOG GAVI; US Centers for Disease Control and Prevention, IMM SCHED; Waldor MK, 2010, NEW ENGL J MED, V363, P2279, DOI 10.1056/NEJMp1012300; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; WHO, GLOB AL RESP CONF HU; WHO, 2006, UN PREQ VACC WHO LIS; WHO, WHO AFR RG ROUT EPI; WHO, 2009, UPD H1N1 PAND SEAS V; WHO, CHOL FACT SHEET; WHO, SYST PREQ VACC UN SU; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096	83	54	55	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					428	438		10.1016/S0140-6736(11)60478-9	http://dx.doi.org/10.1016/S0140-6736(11)60478-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21664680	Green Accepted			2022-12-01	WOS:000293615900034
J	Bonaguidi, MA; Wheeler, MA; Shapiro, JS; Stadel, RP; Sun, GJ; Ming, GL; Song, HJ				Bonaguidi, Michael A.; Wheeler, Michael A.; Shapiro, Jason S.; Stadel, Ryan P.; Sun, Gerald J.; Ming, Guo-li; Song, Hongjun			In Vivo Clonal Analysis Reveals Self-Renewing and Multipotent Adult Neural Stem Cell Characteristics	CELL			English	Article							RADIAL GLIAL-CELLS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; NEURONS; ASTROCYTES; LINEAGE; PTEN; QUIESCENT; DIFFERENTIATION; PROGENITOR	Neurogenesis and gliogenesis continue in discrete regions of the adult mammalian brain. A fundamental question remains whether cell genesis occurs from distinct lineage-restricted progenitors or from self-renewing and multipotent neural stem cells in the adult brain. Here, we developed a genetic marking strategy for lineage tracing of individual, quiescent, and nestin-expressing radial glia-like (RGL) precursors in the adult mouse dentate gyrus. Clonal analysis identified multiple modes of RGL activation, including asymmetric and symmetric self-renewal. Long-term lineage tracing in vivo revealed a significant percentage of clones that contained RGL(s), neurons, and astrocytes, indicating capacity of individual RGLs for both self-renewal and multilineage differentiation. Furthermore, conditional Pten deletion in RGLs initially promotes their activation and symmetric self-renewal but ultimately leads to terminal astrocytic differentiation and RGL depletion in the adult hippocampus. Our study identifies RGLs as self-renewing and multipotent neural stem cells and provides novel insights into in vivo properties of adult neural stem cells.	[Bonaguidi, Michael A.; Wheeler, Michael A.; Shapiro, Jason S.; Stadel, Ryan P.; Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Bonaguidi, Michael A.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Stadel, Ryan P.; Song, Hongjun] Johns Hopkins Univ, Sch Med, Human Genet Predoctoral Training Program, Baltimore, MD 21205 USA; [Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	NIH [NS047344, AG024984, NS048271, HD069184]; NARSAD; MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R01NS048271, R01NS047344, R56NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Lee and members of Song and Ming laboratories for discussion; G. Fishell for sharing nestin-CreER<SUP>T2</SUP> mice; L. DeBiase for NG2 antibodies; J. Song, S. Danzer, C. Song, Y. Namgung, X. Duan and K. Sailor for help; and Q. Hussaini, Y. Cai, and L. Liu for technical support. This work was supported by grants from NIH (NS047344, AG024984) and NARSAD to H. S. and from NIH (NS048271, HD069184) and MSCRF to G.-l. M. M. A. B. was a MSCRF fellow.	ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; BRONNERFRASER M, 1991, DEVELOPMENT, P17; Brunne B, 2010, GLIA, V58, P1553, DOI 10.1002/glia.21029; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Palmer TD, 1999, J NEUROSCI, V19, P8487; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	48	562	583	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1142	1155		10.1016/j.cell.2011.05.024	http://dx.doi.org/10.1016/j.cell.2011.05.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21664664	Bronze, Green Accepted			2022-12-01	WOS:000292025700019
J	Lebon, G; Warne, T; Edwards, PC; Bennett, K; Langmead, CJ; Leslie, AGW; Tate, CG				Lebon, Guillaume; Warne, Tony; Edwards, Patricia C.; Bennett, Kirstie; Langmead, Christopher J.; Leslie, Andrew G. W.; Tate, Christopher G.			Agonist-bound adenosine A(2A) receptor structures reveal common features of GPCR activation	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; BINDING; THERMOSTABILIZATION; STABILITY; RHODOPSIN; MODELS	Adenosine receptors and beta-adrenoceptors are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins on binding the agonists adenosine(1) or noradrenaline(2), respectively. GPCRs have similar structures consisting of seven transmembrane helices that contain well-conserved sequence motifs, indicating that they are probably activated by a common mechanism(3,4). Recent structures of beta-adrenoceptors highlight residues in transmembrane region 5 that initially bind specifically to agonists rather than to antagonists, indicating that these residues have an important role in agonist-induced activation of receptors(5-7). Here we present two crystal structures of the thermostabilized human adenosine A(2A) receptor (A(2A)R-GL31) bound to its endogenous agonist adenosine and the synthetic agonist NECA. The structures represent an intermediate conformation between the inactive and active states, because they share all the features of GPCRs that are thought to be in a fully activated state, except that the cytoplasmic end of transmembrane helix 6 partially occludes the G-protein-binding site. The adenine substituent of the agonists binds in a similar fashion to the chemically related region of the inverse agonist ZM241385 (ref. 8). Both agonists contain a ribose group, not found in ZM241385, which extends deep into the ligand-binding pocket where it makes polar interactions with conserved residues in H7 (Ser 277(7.42) and His 278(7.43); superscripts refer to Ballesteros-Weinstein numbering(9)) and non-polar interactions with residues in H3. In contrast, the inverse agonist ZM241385 does not interact with any of these residues and comparison with the agonist-bound structures indicates that ZM241385 sterically prevents the conformational change in H5 and therefore it acts as an inverse agonist. Comparison of the agonist-bound structures of A(2A)R with the agonist-bound structures of beta-adrenoceptors indicates that the contraction of the ligand-binding pocket caused by the inward motion of helices 3, 5 and 7 may be a common feature in the activation of all GPCRs.	[Lebon, Guillaume; Warne, Tony; Edwards, Patricia C.; Leslie, Andrew G. W.; Tate, Christopher G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Bennett, Kirstie; Langmead, Christopher J.] BioPark, Heptares Therapeut, Welwyn Garden City AL7 3AX, Herts, England	MRC Laboratory Molecular Biology; Heptares Therapeutics Ltd.	Tate, CG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	cgt@mrc-lmb.cam.ac.uk	Lebon, Guillaume/AAZ-4486-2020	Warne, Tony/0000-0001-9646-6080; Langmead, Christopher/0000-0003-3483-1120; Tate, Christopher/0000-0002-2008-9183; Guillaume, Lebon/0000-0003-1162-5148	Medical Research Council; Heptares Therapeutics Ltd; Biotechnology and Biological Sciences Research Council [BB/G003653/1]; BBSRC [BB/G003653/1] Funding Source: UKRI; MRC [MC_U105197215, MC_U105184325] Funding Source: UKRI; Medical Research Council [MC_U105184325, MC_U105197215] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heptares Therapeutics Ltd; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by core funding from the Medical Research Council, and grants from Heptares Therapeutics Ltd and from the Biotechnology and Biological Sciences Research Council (BB/G003653/1). We would like to thank F. Magnani for technical help at the start of the project and F. Gorrec for developing the crystallization screen. We also thank the beamline staff at the European Synchrotron Radiation Facility, particularly at (beamline ID23-2; D. Flot and A. Popov), the Swiss Light Source (beamline X06SA) and at the Diamond Light Source (beamline I24; G. Evans, D. Axford and R. Owen). F. Marshall, M. Weir, M. Congreve and R. Henderson are thanked for their comments on the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Dal Ben D, 2010, CURR TOP MED CHEM, V10, P993, DOI 10.2174/156802610791293145; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gorrec F, 2011, ACTA CRYSTALLOGR D, V67, P463, DOI 10.1107/S0907444911008754; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim SK, 2003, J MED CHEM, V46, P4847, DOI 10.1021/jm0300431; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murphree LJ, 2002, MOL PHARMACOL, V61, P455, DOI 10.1124/mol.61.2.455; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Vauquelin G, 2005, FUND CLIN PHARMACOL, V19, P45, DOI 10.1111/j.1472-8206.2005.00319.x; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F., 2011, SCIENCE; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	44	642	655	3	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					521	U154		10.1038/nature10136	http://dx.doi.org/10.1038/nature10136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21593763	Green Accepted			2022-12-01	WOS:000291939700051
J	Shapses, SA; Manson, JE				Shapses, Sue A.; Manson, JoAnn E.			Vitamin D and Prevention of Cardiovascular Disease and Diabetes Why the Evidence Falls Short	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; 25-HYDROXYVITAMIN-D; SUPPLEMENTATION; CALCIUM		[Shapses, Sue A.] Rutgers State Univ, Dept Nutr Sci, Obes Grp, New Brunswick, NJ USA; [Manson, JoAnn E.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA USA	Rutgers State University New Brunswick; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Shapses, SA (corresponding author), Rutgers State Univ, Dept Nutr Sci, Obes Grp, 96 Lipman Dr, New Brunswick, NJ USA.	shapses@aesop.rutgers.edu		Shapses, Sue/0000-0002-3128-2325	NATIONAL INSTITUTE ON AGING [R01AG012161] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG012161] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Avenell A, 2009, AGE AGEING, V38, P606, DOI 10.1093/ageing/afp109; Chung M, 2009, 183 AG HEALTHC RES Q; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Institute of Medicine, DIET REF INT CALC VI; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Shankar A, 2011, DIABETES CARE, V34, P1114, DOI 10.2337/dc10-1203; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127	9	62	65	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2565	2566		10.1001/jama.2011.881	http://dx.doi.org/10.1001/jama.2011.881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693745	Green Accepted			2022-12-01	WOS:000291860400024
J	Oakhill, JS; Steel, R; Chen, ZP; Scott, JW; Ling, N; Tam, S; Kemp, BE				Oakhill, Jonathan S.; Steel, Rohan; Chen, Zhi-Ping; Scott, John W.; Ling, Naomi; Tam, Shanna; Kemp, Bruce E.			AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ACETYL-COA CARBOXYLASE; SKELETAL-MUSCLE; ENERGY-CHARGE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; ADP; PHOSPHORYLATION; INACTIVATION; METABOLISM; EXERCISE	The adenosine monophosphate (AMP)-activated protein kinase (AMPK) regulates whole-body and cellular energy balance in response to energy demand and supply. AMPK is an alpha beta gamma heterotrimer activated by decreasing concentrations of adenosine triphosphate (ATP) and increasing AMP concentrations. AMPK activation depends on phosphorylation of the alpha catalytic subunit on threonine-172 (Thr(172)) by kinases LKB1 or CaMKK beta, and this is promoted by AMP binding to the gamma subunit. AMP sustains activity by inhibiting dephosphorylation of alpha-Thr(172), whereas ATP promotes dephosphorylation. Adenosine diphosphate (ADP), like AMP, bound to gamma sites 1 and 3 and stimulated alpha-Thr(172) phosphorylation. However, in contrast to AMP, ADP did not directly activate phosphorylated AMPK. In this way, both ADP/ATP and AMP/ATP ratios contribute to AMPK regulation.	[Oakhill, Jonathan S.; Steel, Rohan; Chen, Zhi-Ping; Scott, John W.; Ling, Naomi; Tam, Shanna; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Dept Prot Chem & Metab, Fitzroy, Vic 3065, Australia	St. Vincent's Institute of Medical Research; University of Melbourne	Oakhill, JS (corresponding author), Univ Melbourne, St Vincents Inst Med Res, Dept Prot Chem & Metab, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	joakhill@svi.edu.au	Kemp, Bruce/G-9602-2019; Scott, John W/P-1170-2018; Oakhill, Jonathan S/F-5724-2011; Scott, John W/AAA-2676-2021; Kemp, Bruce E/L-2633-2014	Kemp, Bruce/0000-0001-6735-5082; Scott, John W/0000-0002-1896-9798; Oakhill, Jonathan S/0000-0002-9475-1440; Scott, John W/0000-0002-1896-9798; Kemp, Bruce E/0000-0001-6735-5082; Ling, Naomi/0000-0001-6240-4092; /0000-0002-0423-6120	Australian Research Council; National Health and Medical Research Council (NHMRC); Victorian Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	We thank F. Katsis for the preparation of antibodies and L. Macaulay at Commonwealth Scientific and Industrial Research Organisation Parkville, Victoria, Australia, for CaMKK beta expression constructs. We are most grateful to S. Gamblin and D. Carling and their colleagues at Medical Research Council National Institute of Medical Research and Hammersmith Hospital, respectively, for generously sharing with us the observation that ADP inhibited the dephosphorylation of AMPK by PP2c (30), which prompted us to test whether ADP also controlled the kinase kinase reaction. This work was supported by grants from the Australian Research Council, the National Health and Medical Research Council (NHMRC), and the Victorian Government Operational Infrastructure Support Scheme. B. E. K. is an NHMRC Fellow.	ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Atkinson D E, 1979, Methods Enzymol, V55, P229; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BROWN MS, 1975, J BIOL CHEM, V250, P2502; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1298, DOI 10.1152/ajpcell.00621.2004; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; HARWOOD HJ, 1984, J BIOL CHEM, V259, P2810; JANSSON E, 1987, CLIN PHYSIOL, V7, P337, DOI 10.1111/j.1475-097X.1987.tb00177.x; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; MEYER RA, 1985, AM J PHYSIOL, V248, pC279, DOI 10.1152/ajpcell.1985.248.3.C279; MEYER RA, 1979, AM J PHYSIOL, V237, pC111, DOI 10.1152/ajpcell.1979.237.3.C111; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; SAHLIN K, 1989, ACTA PHYSIOL SCAND, V136, P193, DOI 10.1111/j.1748-1716.1989.tb08652.x; SERAYDARIAN K, 1962, BIOCHIM BIOPHYS ACTA, V65, P443, DOI 10.1016/0006-3002(62)90447-X; SHERBAN DG, 1985, J BIOL CHEM, V260, P2579; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; YEH LA, 1980, J BIOL CHEM, V255, P2308	27	401	426	6	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1433	1435		10.1126/science.1200094	http://dx.doi.org/10.1126/science.1200094			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680840				2022-12-01	WOS:000291689000042
J	Laurance, J				Laurance, Jeremy			On Reflection Costing lives	LANCET			English	Editorial Material												j.laurance@independent.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					1996	1996		10.1016/S0140-6736(11)60852-0	http://dx.doi.org/10.1016/S0140-6736(11)60852-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21665025	Bronze			2022-12-01	WOS:000292011700016
J	Kobayashi, T; Tsang, WY; Li, J; Lane, W; Dynlacht, BD				Kobayashi, Tetsuo; Tsang, William Y.; Li, Ji; Lane, William; Dynlacht, Brian David			Centriolar Kinesin Kif24 Interacts with CP110 to Remodel Microtubules and Regulate Ciliogenesis	CELL			English	Article							INTRACELLULAR-TRANSPORT; PROTEIN; CHLAMYDOMONAS; FLAGELLAR; TUBULIN; CELLS; DEPOLYMERIZATION; MECHANISM; DYNAMICS; BINDING	We have identified a protein, Kif24, that shares homology with the kinesin-13 subfamily of motor proteins and specifically interacts with CP110 and Cep97, centrosomal proteins that play a role in regulating centriolar length and ciliogenesis. Kif24 preferentially localizes to mother centrioles. Loss of Kif24 from cycling cells resulted in aberrant cilia assembly but did not promote growth of abnormally long centrioles, unlike CP110 and Cep97 depletion. We found that loss of Kif24 leads to the disappearance of CP110 from mother centrioles, specifically in cycling cells able to form cilia. Kif24 is able to bind and depolymerize microtubules in vitro. Remarkably, ectopically expressed Kif24 specifically remodels centriolar microtubules without significantly altering cytoplasmic microtubules. Thus, our studies have identified a centriolar kinesin that specifically remodels a subset of microtubules, thereby regulating cilia assembly. These studies also suggest mechanistic differences between the regulation of microtubule elongation associated with centrioles and cilia.	[Kobayashi, Tetsuo; Tsang, William Y.; Li, Ji; Dynlacht, Brian David] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Kobayashi, Tetsuo; Tsang, William Y.; Li, Ji; Dynlacht, Brian David] NYU, Sch Med, Inst Canc, Smilow Res Ctr, New York, NY 10016 USA; [Tsang, William Y.] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Tsang, William Y.] McGill Univ, Div Expt Med, Montreal, PQ H3A 1A3, Canada; [Lane, William] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Ctr Syst Biol, Cambridge, MA 02138 USA	New York University; New York University; Universite de Montreal; McGill University; Harvard University	Dynlacht, BD (corresponding author), NYU, Sch Med, Dept Pathol, 522 1st Ave, New York, NY 10016 USA.	brian.dynlacht@med.nyu.edu	Li, Ji/J-6026-2014	Tsang, William/0000-0002-1584-616X	Irma T. Hirschl Career Scientist Award; March of Dimes research grant; DOD	Irma T. Hirschl Career Scientist Award; March of Dimes research grant(March of Dimes); DOD(United States Department of Defense)	We thank all members of the Dynlacht laboratory for constructive advice and encouragement. We thank M. Jelcic and I. Sanchez for assistance with baculoviral expression and thank J. Liu for experimental assistance. We thank J. Salisbury, E. Nigg, K. Lee, C. Janke, T. Katada, and K. Kontani for providing antibodies. B.D.D. was supported, in part, by an Irma T. Hirschl Career Scientist Award and March of Dimes research grant, for which he expresses his gratitude. J.L. was supported by a DOD Prostate Cancer pre-doctoral Training Award.	Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Moudjou M, 1996, J CELL SCI, V109, P875; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; Paoletti A, 1996, J CELL SCI, V109, P3089; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Tsang WY, 2006, MOL BIOL CELL, V17, P3423, DOI 10.1091/mbc.E06-04-0371; Tsang WY, 2009, DEV CELL, V16, P649, DOI 10.1016/j.devcel.2009.03.004; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9	32	138	152	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					914	925		10.1016/j.cell.2011.04.028	http://dx.doi.org/10.1016/j.cell.2011.04.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21620453	Bronze			2022-12-01	WOS:000291461600018
J	Thomson, M; Liu, SJ; Zou, LN; Smith, Z; Meissner, A; Ramanathan, S				Thomson, Matt; Liu, Siyuan John; Zou, Ling-Nan; Smith, Zack; Meissner, Alexander; Ramanathan, Sharad			Pluripotency Factors in Embryonic Stem Cells Regulate Differentiation into Germ Layers	CELL			English	Article							SELF-RENEWAL; ES CELLS; MOUSE EPIBLAST; NEURAL DIFFERENTIATION; IN-VITRO; FATE; SOX2; EXPRESSION; NETWORK; COMPLEX	Cell fate decisions are fundamental for development, but we do not know how transcriptional networks reorganize during the transition from a pluripotent to a differentiated cell state. Here, we asked how mouse embryonic stem cells (ESCs) leave the pluripotent state and choose between germ layer fates. By analyzing the dynamics of the transcriptional circuit that maintains pluripotency, we found that Oct4 and Sox2, proteins that maintain ESC identity, also orchestrate germ layer fate selection. Oct4 suppresses neural ectodermal differentiation and promotes mesendodermal differentiation; Sox2 inhibits mesendodermal differentiation and promotes neural ectodermal differentiation. Differentiation signals continuously and asymmetrically modulate Oct4 and Sox2 protein levels, altering their binding pattern in the genome, and leading to cell fate choice. The same factors that maintain pluripotency thus also integrate external signals and control lineage selection. Our study provides a framework for understanding how complex transcription factor networks control cell fate decisions in progenitor cells.	[Thomson, Matt; Liu, Siyuan John; Zou, Ling-Nan; Ramanathan, Sharad] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Thomson, Matt; Ramanathan, Sharad] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Thomson, Matt; Zou, Ling-Nan; Meissner, Alexander; Ramanathan, Sharad] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Smith, Zack; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ramanathan, Sharad] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Liu, Siyuan John; Ramanathan, Sharad] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University	Ramanathan, S (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	sharad@post.harvard.edu			Harvard Stem Cell Institute; Massachusetts Life Science Center;  [NIH-P50-NS40828];  [NIH-P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008197] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; Massachusetts Life Science Center; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Doug Melton, Sean Eddy, Areez Mody, and Alexander Schier for scientific discussions and Rene Maehr, Masa Yamagata, and Dawen Cai for discussions and technical assistance. We thank Manfred Baetscher and the Harvard Genome Modification Facility for assistance with the cell line generation. We thank Bodo Stern, Nicole Francis, and in particular Sean Eddy and three anonymous referees for extensive comments on the manuscript. We thank the Harvard Stem Cell Institute Seed Grant (S.R.) and the Massachusetts Life Science Center (A.M.) for support. Microarray hybridization and measurements were performed by the Molecular Genetics Core Facility at Children's Hospital Boston supported by NIH-P50-NS40828, and NIH-P30-HD18655. M.T. and S.R. conceived the project. M.T. established the experimental system and performed the immunofluorescence and perturbation experiments. S.J.L. and M.T. built the cell lines and performed microarray experiments. L.N.Z. performed the FACS experiments and established techniques for long term microscopy of ESCs on glass. M.T. and S.J.L. performed the time-lapse microscopy experiments. Z.S. and A.M. did the ChIP for Oct4 and Sox2. S.J.L., M.T., and S.R. performed the tiling qPCR experiments. M.T., S.R., and S.J.L. performed the data and mathematical analyses and wrote the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2010, DEV GROWTH DIFFER, V52, P275, DOI 10.1111/j.1440-169X.2009.01166.x; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	49	373	384	2	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					875	889		10.1016/j.cell.2011.05.017	http://dx.doi.org/10.1016/j.cell.2011.05.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663792	Green Accepted, hybrid			2022-12-01	WOS:000291461600015
J	Autran, D; Baroux, C; Raissig, MT; Lenormand, T; Wittig, M; Grob, S; Steimer, A; Barann, M; Klostermeier, UC; Leblanc, O; Vielle-Calzada, JP; Rosenstiel, P; Grimanelli, D; Grossniklaus, U				Autran, Daphne; Baroux, Celia; Raissig, Michael T.; Lenormand, Thomas; Wittig, Michael; Grob, Stefan; Steimer, Andrea; Barann, Matthias; Klostermeier, Ulrich C.; Leblanc, Olivier; Vielle-Calzada, Jean-Philippe; Rosenstiel, Phillip; Grimanelli, Daniel; Grossniklaus, Ueli			Maternal Epigenetic Pathways Control Parental Contributions to Arabidopsis Early Embryogenesis	CELL			English	Article							TO-ZYGOTIC TRANSITION; SEED DEVELOPMENT; SMALL-RNA; ENDOSPERM DEVELOPMENT; DNA METHYLATION; PATERNAL GENOME; HYBRID VIGOR; CHROMATIN; EMBRYO; MAINTENANCE	Defining the contributions and interactions of paternal and maternal genomes during embryo development is critical to understand the fundamental processes involved in hybrid vigor, hybrid sterility, and reproductive isolation. To determine the parental contributions and their regulation during Arabidopsis embryogenesis, we combined deep-sequencing-based RNA profiling and genetic analyses. At the 2-4 cell stage there is a strong, genome-wide dominance of maternal transcripts, although transcripts are contributed by both parental genomes. At the globular stage the relative paternal contribution is higher, largely due to a gradual activation of the paternal genome. We identified two antagonistic maternal pathways that control these parental contributions. Paternal alleles are initially downregulated by the chromatin siRNA pathway, linked to DNA and histone methylation, whereas transcriptional activation requires maternal activity of the histone chaperone complex CAF1. Our results define maternal epigenetic pathways controlling the parental contributions in plant embryos, which are distinct from those regulating genomic imprinting.	[Autran, Daphne; Leblanc, Olivier; Grimanelli, Daniel] Univ Montpellier, Inst Rech Dev, UMR 232, F-34394 Montpellier, France; [Baroux, Celia; Raissig, Michael T.; Grob, Stefan; Steimer, Andrea; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Baroux, Celia; Raissig, Michael T.; Grob, Stefan; Steimer, Andrea; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Lenormand, Thomas] Univ Montpellier, Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, F-34293 Montpellier, France; [Wittig, Michael; Barann, Matthias; Klostermeier, Ulrich C.; Rosenstiel, Phillip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Vielle-Calzada, Jean-Philippe] CINVESTAV, Natl Lab Genom Biodivers, Guanajuato 36500, Mexico	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Zurich; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Kiel; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Grimanelli, D (corresponding author), Univ Montpellier, Inst Rech Dev, UMR 232, F-34394 Montpellier, France.	daniel.grimanelli@ird.fr; grossnik@botinst.uzh.ch	Raissig, Michael T/AAO-9557-2020; Grossniklaus, Ueli/E-9995-2016; Grimanelli, Daniel/ABE-4777-2020; Rosenstiel, Philip/A-5137-2009; Lenormand, Thomas/A-5328-2012; Grossniklaus, Ueli/A-2736-2012; Baroux, Célia/J-5359-2013; Raissig, Michael T/AGF-0291-2022; Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Grob, Stefan/AAJ-3091-2020; Autran, Daphné/AAV-4792-2021; Autran, Daphné/D-4846-2009	Grossniklaus, Ueli/0000-0002-0522-8974; Rosenstiel, Philip/0000-0002-9692-8828; Lenormand, Thomas/0000-0001-8930-5393; Baroux, Célia/0000-0001-6307-2229; Grob, Stefan/0000-0001-6199-7383; Autran, Daphné/0000-0002-5227-8966; Autran, Daphné/0000-0002-5227-8966; Raissig, Michael/0000-0003-3179-9372; Grimanelli, Daniel/0000-0001-5424-114X; Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490	University of Zurich; Swiss National Science Foundation; European Union; Institut de Recherche pour le Developpement; Agence Nationale de la Recherche; CNRS; European Research Council; Clusters of Excellence; CONACyT	University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Institut de Recherche pour le Developpement; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); Clusters of Excellence; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank the Arabidopsis Stock Centers (NASC/ABRC), J. Carrington, R. Gross-Hardt, R. Martienssen, F. Meins, T. Lagrange, J. Paszowski, and E. Richards for seeds; C. Michaud, N. Duran-Figueroa, and V. Olmedo-Monfil for technical support; T. Nawy for advice on embryo microdissection; S. Schreiber, L. Bossen, and M. Schilhabel for sequencing support at Kiel; and M. Schmid for help in GEO data submission. We are grateful to M. Arteaga-Vazquez, O. Hamant, and T. Lagrange for helpful comments on earlier versions of the manuscript and to S. Kessler and S. Gillmor for critical reading. C. B., M. R., S. G., and A. S. were supported by the University of Zurich and grants of Swiss National Science Foundation and the European Union (FP5 ApoTool Project) to U. G. D. A., O. L., and D. G. were supported by the Institut de Recherche pour le Developpement and the Agence Nationale de la Recherche, and T. L. by CNRS and a starting grant of the European Research Council. P. R. is supported by the Clusters of Excellence: "The Future Ocean" and "Inflammation at Interfaces." J.-P. V.-C. is supported by CONACyT and is an International Scholar of the Howard Hughes Medical Institute.	ANDEOL Y, 1994, ROUX ARCH DEV BIOL, V204, P3, DOI [10.1007/BF00744867, 10.1007/BF00189062]; Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Baroux C, 2008, COLD SH Q B, V73, P89, DOI 10.1101/sqb.2008.73.053; Baroux C, 2001, FEBS LETT, V509, P11, DOI 10.1016/S0014-5793(01)03097-6; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bushell C, 2003, PLANT CELL, V15, P1430, DOI 10.1105/tpc.010496; Chaudhury AM, 2001, SEMIN CELL DEV BIOL, V12, P381, DOI 10.1006/scdb.2001.0267; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Grimanelli D, 2005, PLANT CELL, V17, P1061, DOI 10.1105/tpc.104.029819; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hennig L, 2005, TRENDS CELL BIOL, V15, P295, DOI 10.1016/j.tcb.2005.04.004; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jahnke S, 2010, THEOR APPL GENET, V120, P389, DOI 10.1007/s00122-009-1207-y; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Martienssen RA, 2010, NEW PHYTOL, V186, P46, DOI 10.1111/j.1469-8137.2010.03193.x; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Ngo QA, 2007, DEVELOPMENT, V134, P4107, DOI 10.1242/dev.007310; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Ono T, 2006, GENES CELLS, V11, P153, DOI 10.1111/j.1365-2443.2006.00928.x; Ooi SL, 2006, PLOS GENET, V2, P883, DOI 10.1371/journal.pgen.0020097; Pahlavani MH, 2006, J APPL GENET, V47, P331, DOI 10.1007/BF03194642; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Peiffer JA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-43; Pillot M, 2010, PLANT SIGNAL BEHAV, V5, P1167, DOI 10.4161/psb.5.10.11905; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Ronceret A, 2005, PLANT J, V44, P223, DOI 10.1111/j.1365-313X.2005.02521.x; Ronceret A, 2008, PLANT J, V53, P776, DOI 10.1111/j.1365-313X.2007.03372.x; Scholten S, 2002, PLANT J, V32, P221, DOI 10.1046/j.1365-313X.2002.01418.x; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051	53	147	154	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2011	145	5					707	719		10.1016/j.cell.2011.04.014	http://dx.doi.org/10.1016/j.cell.2011.04.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620136	Green Submitted, Bronze			2022-12-01	WOS:000291018600011
J	Elinav, E; Strowig, T; Kau, AL; Henao-Mejia, J; Thaiss, CA; Booth, CJ; Peaper, DR; Bertin, J; Eisenbarth, SC; Gordon, JI; Flavell, RA				Elinav, Eran; Strowig, Till; Kau, Andrew L.; Henao-Mejia, Jorge; Thaiss, Christoph A.; Booth, Carmen J.; Peaper, David R.; Bertin, John; Eisenbarth, Stephanie C.; Gordon, Jeffrey I.; Flavell, Richard A.			NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis	CELL			English	Article							NF-KAPPA-B; INTESTINAL MICROBIOTA; DIVISION TM7; BACTERIA; PREVALENCE; ACTIVATION; RECOGNITION; CASPASE-1; STRAINS; MUCIN	Inflammasomes are multiprotein complexes that function as sensors of endogenous or exogenous damage-associated molecular patterns. Here, we show that deficiency of NLRP6 in mouse colonic epithelial cells results in reduced IL-18 levels and altered fecal microbiota characterized by expanded representation of the bacterial phyla Bacteroidetes (Prevotellaceae) and TM7. NLRP6 inflammasome-deficient mice were characterized by spontaneous intestinal hyperplasia, inflammatory cell recruitment, and exacerbation of chemical colitis induced by exposure to dextran sodium sulfate (DSS). Cross-fostering and cohousing experiments revealed that the colitogenic activity of this microbiota is transferable to neonatal or adult wild-type mice, leading to exacerbation of DSS colitis via induction of the cytokine, CCL5. Antibiotic treatment and electron microscopy studies further supported the role of Prevotellaceae as a key representative of this microbiota-associated phenotype. Altogether, perturbations in this inflammasome pathway, including NLRP6, ASC, caspase-1, and IL-18, may constitute a predisposing or initiating event in some cases of human IBD.	[Elinav, Eran; Strowig, Till; Henao-Mejia, Jorge; Thaiss, Christoph A.; Eisenbarth, Stephanie C.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Peaper, David R.; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Kau, Andrew L.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Kau, Andrew L.] Washington Univ, Sch Med, Dept Internal Med, Div Allergy & Immunol, St Louis, MO 63108 USA; [Bertin, John] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Collegeville, PA 19426 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Washington University (WUSTL); Washington University (WUSTL); GlaxoSmithKline; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020; Kau, Andrew/AGX-9881-2022	Elinav, Eran/0000-0002-5775-2110; Kau, Andrew/0000-0002-9386-3766; Eisenbarth, Stephanie/0000-0002-1244-208X; Strowig, Till/0000-0003-0185-1459	Cancer Research Institute; Israel-US educational foundation; American Physicians for Medicine in Israel Foundation; W.M Keck Foundation; LLS; Howard Hughes Medical Institute; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER	Cancer Research Institute; Israel-US educational foundation; American Physicians for Medicine in Israel Foundation; W.M Keck Foundation(W.M. Keck Foundation); LLS; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank A Hafemann, S. Campton, E. Eynon, J. Alderman, W. Philbrick, C. Zorca, M. Musaheb, J. Stein, A. Ferrandino, F. Manzo, and the members of the Flavell lab for technical help and helpful discussions; K. Fitzgerald for providing AIM2<SUP>-/-</SUP> deficient mice; M. Graham and C. Rahner, CCMI EM Core Facility, Yale School of Medicine; J. Manchester and S. Deng for their assistance with DNA sequencing; V. Nagy for discussion and help with figure preparation; and H. Elinav for important discussions, suggestions, and critique. E. E. is supported by Cancer Research Institute (2010-2012) and the Israel-US educational foundation (2009) and is the recipient of the Claire and Emmanuel G. Rosenblatt award from the American Physicians for Medicine in Israel Foundation. A. L. K. is the recipient of a postdoctoral fellowship from the W.M Keck Foundation. J. H.-M. is supported by a LLS Postdoctoral Fellowship. This work was supported, in part, by Howard Hughes Medical Institute (R. A. F.) and the Crohn's and Colitis Foundation of America (J.I.G.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Bjorksten B, 1999, ALLERGY, V54, P17, DOI 10.1111/j.1398-9995.1999.tb04383.x; BREBAN MA, 1993, CLIN EXP RHEUMATOL, V11, P61; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kempster SL, 2011, AM J PHYSIOL-GASTR L, V300, pG253, DOI 10.1152/ajpgi.00397.2010; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sinkorova Z, 2008, HUM IMMUNOL, V69, P845, DOI 10.1016/j.humimm.2008.08.296; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; TSAI HH, 1995, GUT, V36, P570, DOI 10.1136/gut.36.4.570; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Wright DP, 2000, FEMS MICROBIOL LETT, V190, P73, DOI 10.1111/j.1574-6968.2000.tb09265.x; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	54	1359	1419	10	303	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2011	145	5					745	757		10.1016/j.cell.2011.04.022	http://dx.doi.org/10.1016/j.cell.2011.04.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21565393	Green Accepted, Bronze			2022-12-01	WOS:000291018600014
J	Wee, CC; Huskey, KW; Ngo, LH; Fowler-Brown, A; Leveille, SG; Mittlemen, MA; McCarthy, EP				Wee, Christina C.; Huskey, Karen W.; Ngo, Long H.; Fowler-Brown, Angela; Leveille, Suzanne G.; Mittlemen, Murray A.; McCarthy, Ellen P.			Obesity, Race, and Risk for Death or Functional Decline Among Medicare Beneficiaries A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-MASS INDEX; OLDER-ADULTS; WEIGHT-LOSS; US ADULTS; MORTALITY; OVERWEIGHT; DISABILITY; AMERICANS; PREVALENCE; MORBIDITY	Background: The adverse effect of obesity on health outcomes may be lower in older and African American adults than in the general U. S. population. Objective: To examine and compare the relationship between obesity and all-cause mortality and functional decline among older U. S. adults. Design: Longitudinal cohort study. Setting: Secondary analysis of data from the 1994 to 2000 Medicare Current Beneficiary Surveys, linked to Medicare enrollment files through 22 April 2008. Participants: 20 975 community-dwelling participants in the 1994 to 2000 Medicare Current Beneficiary Surveys who were aged 65 years or older. Measurements: All-cause mortality through 22 April 2008; new or worsening disability in performing activities of daily living (ADLs) and instrumental activities of daily living (IADLs) in 2 years. Results: 37% of the study sample were overweight (body mass index [BMI] of 25 to <30 kg/m(2)), 18% were obese (BMI >= 30 kg/m(2)), 48% died during the 14-year follow-up, and 27% had ADL and 43% had IADL disability at baseline. Among those without severe disability at baseline, 17% developed new or worsening ADL disability and 26% developed new or worsening IADL disabilor greater were the only group above the normal BMI range who had a higher risk for mortality (hazard ratio, 1.49 [95% CI, 1.20 to 1.85] in men and 1.21 [CI, 1.06 to 1.39] in women, compared with the reference group [BMI of 22.0 to 24.9 kg/m(2)]; P for BMI-sex interaction = 0.003). In contrast, both overweight and obesity were associated with new or progressive ADL and IADL disability in a dose-dependent manner, particularly for white men and women. Significant interactions were detected between BMI and sex but not between BMI and race for any outcome, although risk estimates for ADL disability seemed attenuated in African American relative to white respondents. Limitation: This was an observational study, baseline data were self-reported, and the study had limited power to detect differences between white and African American respondents. Conclusion: Among older U. S. adults, obesity was not associated with mortality, except for those with at least moderately severe obesity. However, lower levels of obesity were associated with new or worsening disability within 2 years. Efforts to prevent disability in older adults should target those who are overweight or obese.	[Wee, Christina C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Univ Massachusetts, Boston, MA 02125 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston	Wee, CC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02215 USA.	cwee@bidmc.harvard.edu	Leveille, Suzanne G/ACS-6588-2022	Leveille, Suzanne G/0000-0003-0427-1580; Mittleman, Murray/0000-0001-9788-7274	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK071083]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK087932, R01DK071083] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK071083).	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HL, 2008, J AM GERIATR SOC, V56, P689, DOI 10.1111/j.1532-5415.2007.01624.x; Doshi JA, 2007, HEALTH AFFAIR, V26, P1111, DOI 10.1377/hlthaff.26.4.1111; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Jensen GL, 2002, J AM GERIATR SOC, V50, P918, DOI 10.1046/j.1532-5415.2002.50220.x; Jensen GL, 2010, CURR OPIN CLIN NUTR, V13, P46, DOI 10.1097/MCO.0b013e32833309cf; Kuk JL, 2009, J AM GERIATR SOC, V57, P2077, DOI 10.1111/j.1532-5415.2009.02486.x; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Liou TH, 2005, NUTR REV, V63, P321, DOI [10.1111/j.1753-4887.2005.tb00110.x, 10.1301/nr.2005.oct.321.331]; Manini TM, 2010, OBESITY, V18, P1168, DOI 10.1038/oby.2009.317; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; McTigue KM, 2006, OBESITY, V14, P1485, DOI 10.1038/oby.2006.171; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Moore SC, 2009, AM J CLIN NUTR, V89, P1003, DOI 10.3945/ajcn.2009.27598; NHLBI Obesity Education Initiative Expert Panel on the Identi-fication E and T of O in A (US), 1998, CLIN GUID ID EV TREA; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Peeters A, 2004, OBES RES, V12, P1145, DOI 10.1038/oby.2004.143; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Shea MK, 2010, J GERONTOL A-BIOL, V65, P519, DOI 10.1093/gerona/glp217; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; Zamboni M, 2003, AGING CLIN EXP RES, V15, P321, DOI 10.1007/BF03324517; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005	28	51	53	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2011	154	10					645	+		10.7326/0003-4819-154-10-201105170-00003	http://dx.doi.org/10.7326/0003-4819-154-10-201105170-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	764HK	21576532	Green Accepted			2022-12-01	WOS:000290620300013
J	Schmitz, L; Motani, R				Schmitz, Lars; Motani, Ryosuke			Nocturnality in Dinosaurs Inferred from Scleral Ring and Orbit Morphology	SCIENCE			English	Article							ACTIVITY PATTERNS; EVOLUTION; CATHEMERALITY; EYEBALLS; FEATURES; MAMMALS; BRAIN; SIZE	Variation in daily activity patterns facilitates temporal partitioning of habitat and resources among species. Knowledge of temporal niche partitioning in paleobiological systems has been limited by the difficulty of obtaining reliable information about activity patterns from fossils. On the basis of an analysis of scleral ring and orbit morphology in 33 archosaurs, including dinosaurs and pterosaurs, we show that the eyes of Mesozoic archosaurs were adapted to all major types of dig activity (that is, nocturnal, diurnal, and cathemeral) and provide concrete evidence of temporal niche partitioning in the Mesozoic. Similar to extant amniotes, flyers were predominantly diurnal; terrestrial predators, at least partially, nocturnal; and large herbivores, cathemeral. These similarities suggest that ecology drives the evolution of diet activity patterns.	[Schmitz, Lars] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Schmitz, Lars; Motani, Ryosuke] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Schmitz, L (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	lschmitz@ucdavis.edu	Schmitz, Lars/G-2928-2010; Motani, Ryosuke/K-2607-2015	Schmitz, Lars/0000-0003-0210-4383; Motani, Ryosuke/0000-0001-5022-1053	NSF [EAR 0551024]; Department of Geology, University of California Davis; Royal Ontario Museum; German Academic Exchange Service; German Research Foundation	NSF(National Science Foundation (NSF)); Department of Geology, University of California Davis; Royal Ontario Museum; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG))	We thank D. Brinkmann, S. Carlson, I. Schwab, G. Vermeij, and P. Wainwright for comments. C. Cicero, A. Engilis, I. Engilis, D. Evans, M. Flannery, P. Holroyd, M. Koelbl-Ebert, J. McGuire., C. Mehling, M. Norell, R. Papendieck, O. Rauhut, M. Sander, K. Seymour, B. Shaffer, D. Unwin, X. Xu, and Z. Zhou granted specimen access. The project was supported by NSF grant EAR 0551024 to R.M. and Darrell Funds of the Department of Geology, University of California Davis, an M. A. Fritz Award of Royal Ontario Museum, a doctoral stipend of German Academic Exchange Service, and a postdoctoral fellowship of German Research Foundation to L.S.	Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Chure Daniel J., 2000, Gaia (Lisboa), V15, P233; CROMPTON AW, 1978, NATURE, V272, P333, DOI 10.1038/272333a0; Curtis DJ, 2006, FOLIA PRIMATOL, V77, P178, DOI 10.1159/000089703; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; Hall MI, 2009, ANAT REC, V292, P798, DOI 10.1002/ar.20889; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P769, DOI 10.1007/s00114-007-0258-7; Kurochkin EN, 2007, BIOL LETTERS, V3, P309, DOI 10.1098/rsbl.2006.0617; Lee MSY, 2004, ASSEMBLING THE TREE OF LIFE, P451; Longrich Nick, 2010, P308; Maloney SK, 2005, J COMP PHYSIOL A, V191, P1055, DOI 10.1007/s00359-005-0030-4; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; MCNEIL R, 1992, BIOL REV, V67, P381, DOI 10.1111/j.1469-185X.1992.tb01188.x; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; MOTANI R, EVOLUTION, DOI DOI 10.1111/J.1558-5646.2011.01271; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; OWENSMITH RN, 1988, MEGULLERBIVORES INFL; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schmitz L, 2010, VISION RES, V50, P936, DOI 10.1016/j.visres.2010.03.009; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; Seebacher F, 1999, J EXP BIOL, V202, P77; Sellwood BW, 2006, SEDIMENT GEOL, V190, P269, DOI 10.1016/j.sedgeo.2006.05.013; Swingland I. R., 1979, HDB BIOTELEMETRY RAD, P611; Tattersall I, 2006, FOLIA PRIMATOL, V77, P7, DOI 10.1159/000089692; Weishampel DB., 2004, DINOSAURIA; WIENS JA, 1961, COMMUNITY ECOLOGY, P145	30	100	101	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					705	708		10.1126/science.1200043	http://dx.doi.org/10.1126/science.1200043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21493820				2022-12-01	WOS:000290265800039
J	Mikolajczyk, RT; Zhang, J; Betran, AP; Souza, JP; Mori, R; Gulmezoglu, AM; Merialdi, M				Mikolajczyk, Rafael T.; Zhang, Jun; Betran, Ana Pilar; Souza, Joao Paulo; Mori, Rintaro; Guelmezoglu, A. Metin; Merialdi, Mario			A global reference for fetal-weight and birthweight percentiles	LANCET			English	Article							INTRAUTERINE GROWTH-RETARDATION; STANDARDS; DEFINITION; OUTCOMES; INFANTS; BORN	Background Definition of small for gestational age in various populations worldwide remains a challenge. References based on birthweight are deficient for preterm births, those derived from ultrasound estimates might not be applicable to all populations, and the individualised reference can be too complex to use in developing countries. Our aim was to create a generic reference for fetal weight and birthweight that overcame these deficiencies and could be readily adapted to local populations. Methods We used the fetal-weight reference developed by Hadlock and colleagues and the notion of proportionality proposed by Gardosi and colleagues and made the weight reference easily adjustable according to the mean birthweight at 40 weeks of gestation for any local population. For application and validation, we used data from 24 countries in Africa, Latin America, and Asia that participated in the 2004-08 WHO Global Survey on Maternal and Perinatal Health (237025 births). We compared our reference with that of Hadlock and colleagues (non-customised) and with that of Gardosi and colleagues (individualised). For every reference, the odds ratio (OR) of adverse perinatal outcomes (stillbirths, neonatal deaths, referral to higher-level or special care unit, or Apgar score lower than 7 at 5 min) for infants who were small for gestational age versus those who were not was estimated with multilevel logistic regression. Findings OR of adverse outcomes for infants small for gestational age versus those not small for gestational age was 1.59 (95% CI 1.53-1.66) for the non-customised fetal-weight reference compared with 2.87 (2.73-3.01) for our country-specific reference, and 2.84 (2.71-2.99) for the fully individualised reference. Interpretation Our generic reference for fetal-weight and birthweight percentiles can be easily adapted to local populations. It has a better ability to predict adverse perinatal outcomes than has the non-customised fetal-weight reference, and is simpler to use than the individualised reference without loss of predictive ability.	[Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE, Shanghai 200092, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200092, Peoples R China; [Mikolajczyk, Rafael T.] Bremen Inst Prevent Res & Social Med, Dept Clin Epidemiol, Bremen, Germany; [Mikolajczyk, Rafael T.] Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, Bielefeld, Germany; [Zhang, Jun] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, NIH, Bethesda, MD USA; [Betran, Ana Pilar; Souza, Joao Paulo; Guelmezoglu, A. Metin; Merialdi, Mario] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Mori, Rintaro] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bielefeld; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); World Health Organization; University of Tokyo	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE, Shanghai 200092, Peoples R China.	junjimzhang@gmail.com	Mikolajczyk, Rafael/ABB-5259-2021; Souza, João Paulo/G-1982-2010	Souza, João Paulo/0000-0002-2288-4244; Mori, Rintaro/0000-0001-7656-6156; Mikolajczyk, Rafael/0000-0003-1271-7204	UNDP/UNFPA/WHO/World Bank; WHO; United States Agency for International Development (USAID); Ministry of Health, Labour and Welfare of Japan; Ministry of Public Health of the People's Republic of China; Indian Council of Medical Research, India; Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health, USA; Grants-in-Aid for Scientific Research [23406035] Funding Source: KAKEN	UNDP/UNFPA/WHO/World Bank(World Health Organization); WHO(World Health Organization); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Public Health of the People's Republic of China; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The 2004-08 WHO Global Survey on Maternal and Perinatal Health (WHOGS) was a research project implemented by the WHO in a global network of health facilities between 2004 and 2008. The authors of this secondary analysis are grateful to all those who contributed to the project design and implementation, including researchers, study coordinators, data collectors, data clerks, and other partners such as the staff from the Ministries of Health and WHO offices. The WHOGS project was financially supported by the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development, and Research Training in Human Reproduction (HRP); WHO; United States Agency for International Development (USAID); Ministry of Health, Labour and Welfare of Japan; Ministry of Public Health of the People's Republic of China; and the Indian Council of Medical Research, India. JZ was supported by the Intramural Programme of Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health, USA. The named authors alone are responsible for the views expressed in this manuscript, which does not necessarily represent the decisions or the stated policy of the WHO.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; [Anonymous], 2004, MEDLINE DATA CHANGES; Chauhan SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.025; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Figueras F, 2009, FETAL DIAGN THER, V25, P297, DOI 10.1159/000235875; Gardosi J, 2007, BJOG-INT J OBSTET GY, V114, P1301, DOI 10.1111/j.1471-0528.2007.01432.x; Gardosi J, 2006, HORM RES, V65, P15, DOI 10.1159/000091501; Gardosi J, 2005, ULTRASOUND OBST GYN, V26, P112, DOI 10.1002/uog.1971; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P73, DOI 10.1046/j.1469-0705.1995.06020073.x; Gardosi J, 2009, BJOG-INT J OBSTET GY, V116, P1356, DOI 10.1111/j.1471-0528.2009.02245.x; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; Gardosi J, 2009, AM J OBSTET GYNECOL, V201; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Hutcheon JA, 2011, AM J EPIDEMIOL, V173, P459, DOI 10.1093/aje/kwq399; McCowan L, 2004, AUST NZ J OBSTET GYN, V44, P428, DOI 10.1111/j.1479-828X.2004.00272.x; Mongelli M, 2007, AUST NZ J OBSTET GYN, V47, P128, DOI 10.1111/j.1479-828X.2007.00698.x; Neta G, 2011, ULTRASOUND OBST GYN, V38, P62, DOI 10.1002/uog.8902; OTT WJ, 1995, AM J PERINAT, V12, P396, DOI 10.1055/s-2007-994506; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; SMEDLER AC, 1992, ACTA PAEDIATR, V81, P197, DOI 10.1111/j.1651-2227.1992.tb12203.x; SUNG IK, 1993, J PEDIATR-US, V123, P618, DOI 10.1016/S0022-3476(05)80965-5; Verkauskiene R, 2008, HORM RES, V70, P309, DOI 10.1159/000157878; von Ehrenstein OS, 2009, AM J EPIDEMIOL, V170, P1388, DOI 10.1093/aje/kwp296; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Zhang J, 2011, AM J EPIDEMIOL, V173, P539, DOI 10.1093/aje/kwq411; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889; Zhang X, 2007, BJOG-INT J OBSTET GY, V114, P474, DOI 10.1111/j.1471-0528.2007.01273.x	29	319	338	0	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2011	377	9780					1855	1861		10.1016/S0140-6736(11)60364-4	http://dx.doi.org/10.1016/S0140-6736(11)60364-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774UI	21621717				2022-12-01	WOS:000291411700031
J	Buyx, A; Tait, J				Buyx, Alena; Tait, Joyce			Ethical Framework for Biofuels	SCIENCE			English	Editorial Material									[Buyx, Alena] Nuffield Council Bioeth, London WC1B 3JS, England; [Tait, Joyce] Univ Edinburgh, Econ & Social Res Council, Innogen Ctr, Edinburgh EH1 1LZ, Midlothian, Scotland	Innogenetics NV; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Edinburgh	Buyx, A (corresponding author), Nuffield Council Bioeth, London WC1B 3JS, England.	abuyx@nuffieldbio-ethics.org			ESRC [ES/F028180/1] Funding Source: UKRI; Economic and Social Research Council [ES/F028180/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Amnesty International, 2008, BRAZ AMN INT REP 200; Dobson A., 1998, JUSTICE ENV; *EC, 2010, COMM COMM VOL SCHEM; *FOEI, 2008, MAL PALM OIL GREEN G; Humphreys S., 2009, AHRCRES104 UN; IEA International Energy Agency, 2010, WORLD EN OUTL 2010; Kaswan A., 2003, N CAROLINA LAW REV, V81, P1031; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Lapola DM, 2010, P NATL ACAD SCI USA, V107, P3388, DOI 10.1073/pnas.0907318107; Nuffield Council on Bioethics, 2011, BIOF ETH ISS; *OECD, 2006, GUID LIC GEN INV; Pogge Thomas, 2008, WORLD POVERTY HUMAN, V2nd; Rawls John, 1999, THEORY JUSTICE, DOI DOI 10.4159/9780674042605; Rawls John, 1993, POLITICAL LIBERALISM, pxviii; *REN FUELS AG, 2010, GALL REV IND EFF BIO; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; US Environmental Protection Agency, 2011, REN FUEL STAND RFS; World Bank, 2010, RISING GLOBAL INTERE	18	46	46	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					540	541		10.1126/science.1206064	http://dx.doi.org/10.1126/science.1206064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756DE	21487119				2022-12-01	WOS:000289991100029
J	Chafe, R; Born, KB; Slutsky, AS; Laupacis, A				Chafe, Roger; Born, Karen B.; Slutsky, Arthur S.; Laupacis, Andreas			The rise of people power	NATURE			English	Editorial Material							CEREBROSPINAL VENOUS INSUFFICIENCY; MULTIPLE-SCLEROSIS		[Chafe, Roger] Mem Univ Newfoundland, St John, NF A1B 3V6, Canada; [Born, Karen B.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Slutsky, Arthur S.; Laupacis, Andreas] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.; Laupacis, Andreas] King Saud Univ, Riyadh, Saudi Arabia	Memorial University Newfoundland; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; King Saud University	Chafe, R (corresponding author), Mem Univ Newfoundland, St John, NF A1B 3V6, Canada.	roger.chafe@med.mun.ca	Slutsky, Arthur/M-3325-2019					[Anonymous], 2009, CTV NEWS        1121; Canadian Institute of Health Research, 2010, JOINT INV M MULT SCL; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; LERNER IJ, 1984, CANCER, V53, P815, DOI 10.1002/1097-0142(19840201)53:3+<815::AID-CNCR2820531334>3.0.CO;2-U; Rudick RA, 2010, NAT REV NEUROL, V6, P472, DOI 10.1038/nrneurol.2010.117; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096	8	48	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					410	411		10.1038/472410a	http://dx.doi.org/10.1038/472410a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	755QC	21525907	Bronze			2022-12-01	WOS:000289949600010
J	Cao, P; Maximov, A; Sudhof, TC				Cao, Peng; Maximov, Anton; Suedhof, Thomas C.			Activity-Dependent IGF-1 Exocytosis Is Controlled by the Ca2+-Sensor Synaptotagmin-10	CELL			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; RAT OLFACTORY-BULB; CA2+ SENSORS; PC12 CELLS; SYNAPTIC-TRANSMISSION; MESSENGER-RNA; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; DISTINCT CA2+	Synaptotagmins Syt1, Syt2, Syt7, and Syt9 act as Ca2+-sensors for synaptic and neuroendocrine exocytosis, but the function of other synaptotagmins remains unknown. Here, we show that olfactory bulb neurons secrete IGF-1 by an activity-dependent pathway of exocytosis, and that Syt10 functions as the Ca2+-sensor that triggers IGF-1 exocytosis in these neurons. Deletion of Syt10 impaired activity-dependent IGF-1 secretion in olfactory bulb neurons, resulting in smaller neurons and an overall decrease in synapse numbers. Exogenous IGF-1 completely reversed the Syt10 knockout phenotype. Syt10 colocalized with IGF-1 in somatodendritic vesicles of olfactory bulb neurons, and Ca2+-binding to Syt10 caused these vesicles to undergo exocytosis, thereby secreting IGF-1. Thus, Syt10 controls a previously unrecognized pathway of Ca2+-dependent exocytosis that is spatially and temporally distinct from Ca2+-dependent synaptic vesicle exocytosis controlled by Syt1. Our findings thereby reveal that two different synaptotagmins can regulate functionally distinct Ca2+-dependent membrane fusion reactions in the same neuron.	[Cao, Peng; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94305 USA; [Cao, Peng; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94305 USA; [Maximov, Anton; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci & Mol Genet, Dallas, TX 75390 USA; [Maximov, Anton; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94305 USA.	tcs1@stanford.edu	Karakhanov, Edward/P-1660-2015		Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH085776] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085776] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGUADO F, 1993, J MOL ENDOCRINOL, V11, P231, DOI 10.1677/jme.0.0110231; Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BARTLETT WP, 1991, DEV BIOL, V147, P239, DOI 10.1016/S0012-1606(05)80021-1; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Flannery AR, 2010, J CELL BIOL, V191, P599, DOI 10.1083/jcb.201003021; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GIACOBINI MMJ, 1995, DEV BRAIN RES, V84, P67, DOI 10.1016/0165-3806(94)00154-R; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Li JL, 2009, SCI CHINA SER C, V52, P1156, DOI 10.1007/s11427-009-0160-y; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mittelsteadt T, 2009, J COMP NEUROL, V512, P514, DOI 10.1002/cne.21908; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Scolnick JA, 2008, NEURON, V57, P847, DOI 10.1016/j.neuron.2008.01.027; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; TROMBLEY PQ, 1990, J NEUROPHYSIOL, V64, P598, DOI 10.1152/jn.1990.64.2.598; Vicario-Abejon C, 2003, J NEUROSCI, V23, P895; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Wang P, 2005, MOL CELL BIOL, V25, P8693, DOI 10.1128/MCB.25.19.8693-8702.2005; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004	47	98	103	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					300	311		10.1016/j.cell.2011.03.034	http://dx.doi.org/10.1016/j.cell.2011.03.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496647	Green Accepted, Bronze			2022-12-01	WOS:000289549900017
J	Perencevich, EN; Lautenbach, E				Perencevich, Eli N.; Lautenbach, Ebbing			Infection Prevention and Comparative Effectiveness Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERVENTION; RESISTANCE; STATEMENT		[Perencevich, Eli N.] Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA 52246 USA; [Perencevich, Eli N.] Univ Iowa, Carver Coll Med, Div Gen Internal Med, Iowa City, IA USA; [Lautenbach, Ebbing] Univ Penn, Sch Med, Dept Med & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Pennsylvania; Pennsylvania Medicine	Perencevich, EN (corresponding author), Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res & Evaluat, 601 Hwy 6 W 3E21, Iowa City, IA 52246 USA.	eli-perencevich@uiowa.edu		Perencevich, Eli/0000-0002-3721-3355	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI080942] Funding Source: NIH RePORTER; NIAID NIH HHS [K24AI080942] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cook TD, 2008, J POLICY ANAL MANAG, V27, P724, DOI 10.1002/pam.20375; Harris AD, 2005, CLIN INFECT DIS, V41, P77, DOI 10.1086/430713; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Lautenbach E, 2010, CLIN INFECT DIS, V50, P523, DOI 10.1086/650169; McGinnis JM., 2010, REDESIGNING CLIN EFF; Platt R, 2010, MED CARE, V48, pS52, DOI 10.1097/MLR.0b013e3181dbebcf; Saginur R, 2009, CLIN INFECT DIS, V49, P1254, DOI 10.1086/605666; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Weber SG, 2007, INFECT CONT HOSP EP, V28, P249, DOI 10.1086/512261	10	16	18	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1482	1483		10.1001/jama.2011.450	http://dx.doi.org/10.1001/jama.2011.450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486981				2022-12-01	WOS:000289424100027
J	Hopson, J; Holmes, J				Hopson, Jackie; Holmes, Jeremy			Through the wasteland: chronic depression	BRITISH MEDICAL JOURNAL			English	Editorial Material												jh@byfleet.org							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 11	2011	342								d93	10.1136/bmj.d93	http://dx.doi.org/10.1136/bmj.d93			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UT	21482596	Bronze			2022-12-01	WOS:000289721100016
J	Smith, J				Smith, Jim			A long shadow over Fukushima	NATURE			English	Editorial Material									Univ Portsmouth, Portsmouth PO1 2UP, Hants, England	University of Portsmouth	Smith, J (corresponding author), Univ Portsmouth, Portsmouth PO1 2UP, Hants, England.	jim.smith@port.ac.uk	Smith, Jim T/G-7716-2011	Smith, Jim T/0000-0002-0808-2739					0	11	11	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					7	7		10.1038/472007a	http://dx.doi.org/10.1038/472007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745VV	21475152	Green Submitted			2022-12-01	WOS:000289199400006
J	Bhutta, ZA				Bhutta, Zulfiqar A.			The last mile in global poliomyelitis eradication	LANCET			English	Editorial Material							VACCINE-DERIVED POLIOVIRUS		Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu		Mouw, Jolien/0000-0002-9336-6022				Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; Bonu S, 2003, SOC SCI MED, V57, P1807, DOI 10.1016/S0277-9536(03)00056-X; El-Sayed N, 2007, VACCINE, V25, P5062, DOI 10.1016/j.vaccine.2007.04.022; Global Polio Eradication Initiative, 2010, PROGRESS; Global Polio Eradication Initiative, 2011, POL THIS WEEK WEDN 1; Grassly NC, 2010, J INFECT DIS, V201, P1535, DOI 10.1086/651952; Grassly NC, 2009, J INFECT DIS, V200, P794, DOI 10.1086/605330; Hasan Azra S, 2004, Indian Pediatr, V41, P1040; Independent Monitoring Board of the Global Polio Eradication Initiative, 2011, REP GLOB POL ER IN; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; McKenna MAJ, 2002, ATLANTA J CONST 1027; Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383; National Toxicology Program, 2011, Natl Toxicol Program Tech Rep Ser, P1; SABIN AB, 1979, PEDIATR RES, V13, P674, DOI 10.1203/00006450-197905001-00004; SALK D, 1980, REV INFECT DIS, V2, P243; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Assembly, 1993, GLOB ER POL YEAR 200	18	25	25	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2011	378	9791					549	552		10.1016/S0140-6736(11)60744-7	http://dx.doi.org/10.1016/S0140-6736(11)60744-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21664681				2022-12-01	WOS:000294319500008
J	Alley, JB				Alley, Joshua B.			Sleepless	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Alley, Joshua B.] Wilford Hall USAF Med Ctr, Dept Surg, Lackland Air Force Base, San Antonio, TX 78236 USA; [Alley, Joshua B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX USA; [Alley, Joshua B.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Def, Bethesda, MD 20814 USA	United States Department of Defense; United States Air Force; University of Texas System; University of Texas Health San Antonio; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Alley, JB (corresponding author), Wilford Hall USAF Med Ctr, Dept Surg, Lackland Air Force Base, San Antonio, TX 78236 USA.	joshalleymd@hotmail.com						[Anonymous], TIME	1	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2501	2502		10.1001/jama.2011.863	http://dx.doi.org/10.1001/jama.2011.863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693732				2022-12-01	WOS:000291860400001
J	Zeytinoglu, M				Zeytinoglu, Meltem			Talking It Out: Helping Our Patients Live Better While Dying	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PALLIATIVE CARE; LIFE; ASSOCIATIONS; CANCER; HEALTH; COSTS; DEATH	Although dying is an inevitable part of the life cycle, there has been extensive political debate over end-of-life care. Participating in end-of-life care conversations can be emotionally challenging for everyone involved. Messages about serious or terminal illnesses can be very hard for patients and their families to hear, and physicians frequently struggle with the burden of delivering these messages. Still, evidence shows that conversations about end-of-life care options between physicians and patients can improve the quality of life of dying patients and help to relieve the emotional burden on surviving loved ones. Legislation to support these discussions by consistently reimbursing physicians for their time spent performing this service has been blocked on multiple occasions. More research on how to improve end-of-life care will enable health care providers to optimize treatment of their patients. Overcoming political divides to support end-of-life care conversations is needed to promote care that is consistent with patients' values and needs and is a key step in encouraging better quality of life for dying patients.	[Zeytinoglu, Meltem] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zeytinoglu, M (corresponding author), Univ Chicago, NorthShore Programs, Dept Internal Med, 2650 Ridge Ave,Room 5319, Evanston, IL 60201 USA.	meltemz@gmail.com			American Cancer Society	American Cancer Society(American Cancer Society)	Grant Support: By the American Cancer Society Physician Training Award in Cancer Prevention and Control.	Billings ME, 2010, J PALLIAT MED, V13, P319, DOI 10.1089/jpm.2009.0293; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Field MJ, 1997, APPROACHING DEATH IM; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Meier DE, 2009, J PALLIAT MED, V12, P291, DOI 10.1089/jpm.2009.9648; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Pear R., 2010, NY TIMES        1225; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	13	3	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					830	832		10.7326/0003-4819-154-12-201106210-00011	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690597				2022-12-01	WOS:000291800500019
J	Velasquez, SM; Ricardi, MM; Dorosz, JG; Fernandez, PV; Nadra, AD; Pol-Fachin, L; Egelund, J; Gille, S; Harholt, J; Ciancia, M; Verli, H; Pauly, M; Bacic, A; Olsen, CE; Ulvskov, P; Petersen, BL; Somerville, C; Iusem, ND; Estevez, JM				Velasquez, Silvia M.; Ricardi, Martiniano M.; Dorosz, Javier Gloazzo; Fernandez, Paula V.; Nadra, Alejandro D.; Pol-Fachin, Laercio; Egelund, Jack; Gille, Sascha; Harholt, Jesper; Ciancia, Marina; Verli, Hugo; Pauly, Markus; Bacic, Antony; Olsen, Carl Erik; Ulvskov, Peter; Petersen, Bent Larsen; Somerville, Chris; Iusem, Norberto D.; Estevez, Jose M.			O-Glycosylated Cell Wall Proteins Are Essential in Root Hair Growth	SCIENCE			English	Article							MOLECULAR CHARACTERIZATION; PROLYL 4-HYDROXYLASE; ARABIDOPSIS; EXTENSIN; GENES; CODES; IDENTIFICATION; REQUIRES; MUTANTS; TOBACCO	Root hairs are single cells that develop by tip growth and are specialized in the absorption of nutrients. Their cell walls are composed of polysaccharides and hydroxyproline-rich glycoproteins (HRGPs) that include extensins (EXTs) and arabinogalactan-proteins (AGPs). Proline hydroxylation, an early posttranslational modification of HRGPs that is catalyzed by prolyl 4-hydroxylases (P4Hs), defines the subsequent O-glycosylation sites in EXTs (which are mainly arabinosylated) and AGPs (which are mainly arabinogalactosylated). We explored the biological function of P4Hs, arabinosyltransferases, and EXTs in root hair cell growth. Biochemical inhibition or genetic disruption resulted in the blockage of polarized growth in root hairs and reduced arabinosylation of EXTs. Our results demonstrate that correct O-glycosylation on EXTs is essential for cell-wall self-assembly and, hence, root hair elongation in Arabidopsis thaliana.	[Velasquez, Silvia M.; Ricardi, Martiniano M.; Dorosz, Javier Gloazzo; Iusem, Norberto D.; Estevez, Jose M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn IFIByNE CONICET, Inst Fisiol Biol Mol & Neurociencias, Buenos Aires, DF, Argentina; [Fernandez, Paula V.; Ciancia, Marina] Univ Buenos Aires, Fac Agron, Ctr Invest Hidratos Carbono CONICET, Dept Biol Aplicada & Alimentos,Catedra Quim Biomo, Buenos Aires, DF, Argentina; [Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Pol-Fachin, Laercio; Verli, Hugo] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil; [Egelund, Jack; Harholt, Jesper; Ulvskov, Peter; Petersen, Bent Larsen] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biotechnol, DK-1871 Copenhagen, Denmark; [Gille, Sascha; Pauly, Markus; Somerville, Chris] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Bacic, Antony] Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Melbourne, Vic 3010, Australia; [Olsen, Carl Erik] Univ Copenhagen, Fac Life Sci, Dept Nat Sci, DK-1871 Copenhagen, Denmark; [Iusem, Norberto D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, LFBM, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Universidade Federal do Rio Grande do Sul; University of Copenhagen; University of California System; University of California Berkeley; University of Melbourne; University of Copenhagen; University of Buenos Aires	Estevez, JM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn IFIByNE CONICET, Inst Fisiol Biol Mol & Neurociencias, C1428EGA, Buenos Aires, DF, Argentina.	jestevez@fbmc.fcen.uba.ar	Somerville, Christopher R/A-4048-2009; Verli, Hugo/AAZ-2148-2021; Petersen, Bent/H-9437-2014; Estevez, Jose Manuel/AAZ-9261-2020; Pauly, Markus/B-5895-2008; Olsen, Carl E/H-3031-2014; Harholt, Jesper/F-6865-2014; Ulvskov, Peter/I-1228-2014; Nadra, Alejandro/A-5668-2009; Estevez, Jose Manuel/C-2915-2018; Verli, Hugo/G-8703-2012; Harholt, Jesper/F-3760-2011	Somerville, Christopher R/0000-0003-4647-0094; Petersen, Bent/0000-0002-2004-9077; Estevez, Jose Manuel/0000-0001-6332-7738; Pauly, Markus/0000-0002-3116-2198; Olsen, Carl E/0000-0002-2275-0596; Harholt, Jesper/0000-0002-7984-0066; Ulvskov, Peter/0000-0003-3776-818X; Nadra, Alejandro/0000-0002-7860-3245; Estevez, Jose Manuel/0000-0001-6332-7738; Verli, Hugo/0000-0002-4796-8620; Bacic, Tony/0000-0001-7483-8605; Iusem, Norberto/0000-0002-3052-2489; Ricardi, Martiniano/0000-0002-7904-6305	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2007-732, PICT2006-983]; CONICET [PIP2812, PIP0890, PIP0071]; Danish Agency for Science Technology and Innovation [274-09-0082, 2101-07-0071]; Australian Research Council; Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); U.S. Department of Energy [DOE-FG02-03ER20133]; Energy Biosciences Institute; Villum Fonden [00007173] Funding Source: researchfish	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Danish Agency for Science Technology and Innovation; Australian Research Council(Australian Research Council); Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); U.S. Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute; Villum Fonden(Villum Fonden)	We thank R. A. Fernandez for his assistance in confocal microscopy, S. Maldonado and S. Petrucelli for providing the access to a stereoscope, and A. Nebenfuhr for providing vectors of the ER and Golgi markers. This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (PICT2007-732 and PICT2006-983) and CONICET (PIP2812, PIP0890, and PIP0071) to A.D.N., N.D.I., and J.M.E.; from the Danish Agency for Science Technology and Innovation from the Danish Agency for Science Technology and Innovation (274-09-0082, 2101-07-0071) to J.E, P.U., and B.L.P; from the Australian Research Council to A.B.; and Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to L.F. and H.V. We thank Arabidopsis Biological Resource Center (Ohio University) for providing T-DNA lines seed lines. Thanks to K. Kobayashi and M. Otegui for critical reading of the manuscript. This work was partially supported by a grant from the U.S. Department of Energy (DOE-FG02-03ER20133) and funding from the Energy Biosciences Institute to C.S. S.M.V. performed most of the experiments. M.M.R. analyzed and performed some of the experiments and analyzed the data. J.G.D. performed some of the experiments. P.V.F and M.C. quantified Hyp in mutants and transgenic lines. S.G. and M.P. provided the XEG113-GFP data and xeg113-2 mutant. A.D.N. performed molecular modeling of P4Hs. L.F. and H.V. measured the molecular dynamics of EXT peptides. J.E. and A.B. assessed the Golgi localization of RRAs proteins. C.E.O., P.U., and B.L.P. characterized rra3 and xeg113 EXTs using ESI-MS, and P.U. and B.L.P. isolated rra1-3 RNAi and rra3 mutants. C.S. analyzed the data. N.D.I. analyzed the data and wrote the paper. J.M.E. designed research, performed most of the experiments, analyzed the data, supervised the project, and wrote the paper. The authors declare no competing financial interests.	BARNETT NM, 1970, PLANT PHYSIOL, V45, P188, DOI 10.1104/pp.45.2.188; Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; Baumberger N, 2003, PLANT J, V35, P71, DOI 10.1046/j.1365-313X.2003.01784.x; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Estevez JM, 2006, PLANT PHYSIOL, V142, P458, DOI 10.1104/pp.106.084244; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Held MA, 2004, J BIOL CHEM, V279, P55474, DOI 10.1074/jbc.M408396200; Immerzeel P, 2006, PHYSIOL PLANTARUM, V128, P18, DOI 10.1111/j.1399-3054.2006.00712.x; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; Owens NW, 2010, J AM CHEM SOC, V132, P5036, DOI 10.1021/ja905724d; Petersen B. L., 2011, ANN PLANT REV, V41, P305; Price NJ, 2003, J BIOL CHEM, V278, P41389, DOI 10.1074/jbc.M304519200; Ringli C, 2010, PLANT J, V63, P662, DOI 10.1111/j.1365-313X.2010.04270.x; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; STAFSTROM JP, 1986, PLANT PHYSIOL, V81, P242, DOI 10.1104/pp.81.1.242; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Valentin R, 2010, LANGMUIR, V26, P9891, DOI 10.1021/la100265d; Won SK, 2009, PLANT PHYSIOL, V150, P1459, DOI 10.1104/pp.109.140905; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x	31	201	218	7	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1401	1403		10.1126/science.1206657	http://dx.doi.org/10.1126/science.1206657			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680836				2022-12-01	WOS:000291689000033
J	Sadri-Ardekani, H; Akhondi, MA; van der Veen, F; Repping, S; van Pelt, AMM				Sadri-Ardekani, Hooman; Akhondi, Mohammad A.; van der Veen, Fulco; Repping, Sjoerd; van Pelt, Ans M. M.			In Vitro Propagation of Human Prepubertal Spermatogonial Stem Cells	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sadri-Ardekani, Hooman; van der Veen, Fulco; Repping, Sjoerd; van Pelt, Ans M. M.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Akhondi, Mohammad A.] Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran	University of Amsterdam; Academic Medical Center Amsterdam	Sadri-Ardekani, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.repping@amc.uva.nl		Repping, Sjoerd/0000-0002-6959-149X; Akhondi, Mohammad mehdi/0000-0003-1707-3874; van Pelt, Ans/0000-0001-9155-548X				Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Mizrak SC, 2010, HUM REPROD, V25, P158, DOI 10.1093/humrep/dep354; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106	6	140	148	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2416	2418		10.1001/jama.2011.791	http://dx.doi.org/10.1001/jama.2011.791			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673293	Bronze			2022-12-01	WOS:000291597300018
J	Jia, HJ; Wang, XY; Liu, F; Guenther, UP; Srinivasan, S; Anderson, JT; Jankowsky, E				Jia, Huijue; Wang, Xuying; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Anderson, James T.; Jankowsky, Eckhard			The RNA Helicase Mtr4p Modulates Polyadenylation in the TRAMP Complex	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; NUCLEAR; SURVEILLANCE; DEGRADATION; EXOSOME; END; SUFFICIENT; TURNOVER; REVEALS	Many steps in nuclear RNA processing, surveillance, and degradation require TRAMP, a complex containing the poly(A) polymerase Trf4p, the Zn-knuckle protein Air2p, and the RNA helicase Mtr4p. TRAMP polyadenylates RNAs designated for decay or trimming by the nuclear exosome. It has been unclear how polyadenylation by TRAMP differs from polyadenylation by conventional poly(A) polymerase, which produces poly(A) tails that stabilize RNAs. Using reconstituted S. cerevisiae TRAMP, we show that TRAMP inherently suppresses poly(A) addition after only 3-4 adenosines. This poly(A) tail length restriction is controlled by Mtr4p. The helicase detects the number of 3'-terminal adenosines and, over several adenylation steps, elicits precisely tuned adjustments of ATP affinities and rate constants for adenylation and TRAMP dissociation. Our data establish Mtr4p as a critical regulator of polyadenylation by TRAMP and reveal that an RNA helicase can control the activity of another enzyme in a highly complex fashion and in response to features in RNA.	[Jia, Huijue; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Jankowsky, Eckhard] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Jia, Huijue; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Jankowsky, Eckhard] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Wang, Xuying; Anderson, James T.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53201 USA	Case Western Reserve University; Case Western Reserve University; Marquette University	Jankowsky, E (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	exj13@case.edu	Jia, Huijue/M-3991-2015; Wang, Xuying/C-8053-2011	Jia, Huijue/0000-0002-3592-126X; Jankowsky, Eckhard/0000-0001-7677-7412	NIH [GM067700, GM069949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM069949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Jankowsky and Anderson labs and Dr. Mike Harris (Case Western) for helpful discussions and Drs. Timothy Nilsen and Pat Maroney (Case Western) for advice on the determination of the poly(A) tail length of pre-tRNA<INF>i</INF><SUP>Met</SUP> in vivo. This work was supported by grants from the NIH to E.J. (GM067700) and J.T.A. (GM069949).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218, 10.1080/10409230802640218 ]; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bernstein J, 2010, BIOCHEMISTRY-US, V49, P10357, DOI 10.1021/bi101518x; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jensen TH, 2005, CELL, V121, P660, DOI 10.1016/j.cell.2005.05.018; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KELLER W, 1995, CELL, V81, P829, DOI 10.1016/0092-8674(95)90001-2; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Scorilas A, 2002, CRIT REV CL LAB SCI, V39, P193, DOI 10.1080/10408360290795510; SENGER B, 1992, P NATL ACAD SCI USA, V89, P10768, DOI 10.1073/pnas.89.22.10768; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wilusz JE, 2010, RNA, V16, P259, DOI 10.1261/rna.1907510; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946	36	74	75	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					890	901		10.1016/j.cell.2011.05.010	http://dx.doi.org/10.1016/j.cell.2011.05.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663793	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000291461600016
J	Clements, WK; Kim, AD; Ong, KG; Moore, JC; Lawson, ND; Traver, D				Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Moore, John C.; Lawson, Nathan D.; Traver, David			A somitic Wnt16/Notch pathway specifies haematopoietic stem cells	NATURE			English	Article							AORTIC ENDOTHELIUM; DEFINITIVE HEMATOPOIESIS; EMBRYONIC HEMATOPOIESIS; GENE-EXPRESSION; ZEBRAFISH; NOTCH; FATE; DIFFERENTIATION; PROLIFERATION; LEUKEMIA	Haematopoietic stem cells (HSCs) are a self-renewing population of cells that continuously replenish all blood and immune cells during the lifetime of an individual(1,2). HSCs are used clinically to treat a wide array of diseases, including acute leukaemias and congenital blood disorders, but obtaining suitable numbers of cells and finding immune-compatible donors remain serious problems. These difficulties have led to an interest in the conversion of embryonic stem cells or induced pluripotent stem cells into HSCs, which is not possible using current methodologies. To accomplish this goal, it is critical to understand the native mechanisms involved in the specification of HSCs during embryonic development. Here we demonstrate in zebrafish that Wnt16 controls a novel genetic regulatory network required for HSC specification. Non-canonical signalling by Wnt16 is required for somitic expression of the Notch ligands deltaC (dlc) and deltaD (dld), and these ligands are, in turn, required for the establishment of definitive haematopoiesis. Notch signalling downstream of Dlc and Dld is earlier than, and distinct from, known cell-autonomous requirements for Notch, strongly suggesting that novel Notch-dependent relay signal(s) induce the first HSCs in parallel to other established pathways. Our results demonstrate that somite-specific gene expression is required for the production of haemogenic endothelium.	[Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Moore, John C.; Lawson, Nathan D.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Worcester	Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dtraver@ucsd.edu	Clements, Wilson/C-9617-2015; Clements, Wilson/D-4153-2011	Clements, Wilson/0000-0003-4365-9553; Lawson, Nathan/0000-0001-7788-9619	AHA [0725086Y, 0815732D]; NIH [R01-HL093467, R01-DK074482]; CIRM; March of Dimes [6-FY09-508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to thank L. Zon, K. Poss, D. Kimelman, M. Lardelli, B. Appel, C. Burns, J. Campos-Ortega, D. Ransom, N. Trede, J. Lewis, M. Pack, S. Holley, C. Moens, B. Paw, R. Karlstrom and J. Waxman for probe constructs. L. Zon, R. Dorsky, S. Lin and S. Holley provided transgenic and mutant zebrafish lines. C. Weaver, K. Willert, K. J. P. Griffin, J. Bertrand, D. Stachura and Y. Lee provided critical evaluation of the manuscript. This research was funded by an AHA Postdoctoral Fellowship 0725086Y to W.K.C., an AHA Predoctoral Founders Affiliate Fellowship 0815732D to J.C.M., NIH R01-HL093467 to N.L. and NIH R01-DK074482, CIRM New Investigator Award, and March of Dimes 6-FY09-508 to D.T.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cirone P, 2008, ANGIOGENESIS, V11, P347, DOI 10.1007/s10456-008-9116-2; Clements WK, 2009, DEV DYNAM, V238, P1788, DOI 10.1002/dvdy.21977; Clements WK, 2005, DEV BIOL, V283, P322, DOI 10.1016/j.ydbio.2005.04.026; Corrigan PM, 2009, STEM CELLS DEV, V18, P759, DOI 10.1089/scd.2008.0270; Gering M, 2010, J CELL PHYSIOL, V222, P11, DOI 10.1002/jcp.21905; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Holley SA, 2002, DEVELOPMENT, V129, P1175; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Nusslein-Volhard C., 2002, ZEBRAFISH; Nygren MK, 2009, EXP HEMATOL, V37, P225, DOI 10.1016/j.exphem.2008.10.007; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Robert-Moreno A, 2005, DEVELOPMENT, V132, P1117, DOI 10.1242/dev.01660; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Westerfield M, 2004, ZEBRAFISH BOOK GUIDE; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349	36	166	173	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					220	U262		10.1038/nature10107	http://dx.doi.org/10.1038/nature10107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654806	Green Accepted			2022-12-01	WOS:000291397800052
J	Konstantinopoulos, PA; Papavassiliou, AG				Konstantinopoulos, Panagiotis A.; Papavassiliou, Athanasios G.			Seeing the Future of Cancer-Associated Transcription Factor Drug Targets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIOLOGY		[Konstantinopoulos, Panagiotis A.; Papavassiliou, Athanasios G.] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece; [Konstantinopoulos, Panagiotis A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA	Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Papavassiliou, AG (corresponding author), Univ Athens, Sch Med, Dept Biol Chem, 75 M Asias St, GR-11527 Athens, Greece.	papavas@med.uoa.gr	Karamouzis, Michalis/AAD-2860-2020					Friend SH, 2006, CANCER CELL, V10, P349, DOI 10.1016/j.ccr.2006.10.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Kaelin WG, 2009, GENOME MED, V1, DOI 10.1186/gm99; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; PAPAVASSILIOU AG, 1995, NEW ENGL J MED, V332, P45, DOI 10.1056/NEJM199501053320108; Papavassiliou AG, 2001, EMBO REP, V2, P80, DOI 10.1093/embo-reports/kve033; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003	10	26	27	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2349	2350		10.1001/jama.2011.727	http://dx.doi.org/10.1001/jama.2011.727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642690				2022-12-01	WOS:000291349100031
J	Cohen, IG; Adashi, EY				Cohen, I. Glenn; Adashi, Eli Y.			Human Embryonic Stem-Cell Research under Siege - Battle Won but Not the War	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Adashi, Eli Y.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Harvard University; Brown University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA.							Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	1	29	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22								10.1056/NEJMp1105088	http://dx.doi.org/10.1056/NEJMp1105088			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21591937				2022-12-01	WOS:000291200700006
J	Dyson, C; Austin, T; Lees, C				Dyson, Charlotte; Austin, Topun; Lees, Christoph			Could routine cardiotocography reduce long term cognitive impairment?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEONATAL ENCEPHALOPATHY; SCHOOL-AGE; ASPHYXIA; SURVIVORS; SEIZURES; OUTCOMES		[Dyson, Charlotte; Lees, Christoph] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Div Maternal Fetal Med, Cambridge CB2 2QQ, England; [Austin, Topun] Addenbrookes Hosp, Div Neonatol, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lees, C (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Div Maternal Fetal Med, Cambridge CB2 2QQ, England.	christoph.lees@addenbrookes.nhs.uk	Austin, Topun/ABG-1960-2021	Austin, Topun/0000-0002-8428-8624				Al-Macki N, 2009, PEDIATR NEUROL, V41, P399, DOI 10.1016/j.pediatrneurol.2009.06.001; Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Chen HY, 2011, AM J OBSTET GYNECOL, V204, pS43, DOI 10.1016/j.ajog.2010.10.091; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Graham EM, 2006, OBSTET GYNECOL, V108, P656, DOI 10.1097/01.AOG.0000230533.62760.ef; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Ingemarsson Ingemar, 2009, Neonatology, V95, P342, DOI 10.1159/000209299; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lindstrom K, 2006, PEDIATR NEUROL, V35, P268, DOI 10.1016/j.pediatrneurol.2006.05.003; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Morris JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3794; Moster D, 2002, ARCH DIS CHILD-FETAL, V86, pF16, DOI 10.1136/fn.86.1.F16; National Institute for Health and Clinical Excellence, 2007, NICE CLIN GUID INTR; Office for National Statistics, 2005, LIV BIRTHS MULT GEST; Office for National Statistics, FERT; ROBERTSON CMT, 1989, J PEDIATR-US, V114, P753, DOI 10.1016/S0022-3476(89)80132-5; Silverstein FS, 2007, ANN NEUROL, V62, P112, DOI 10.1002/ana.21167; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; TEMPLE CM, 1995, DEV MED CHILD NEUROL, V37, P109; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8	21	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2011	342								d3120	10.1136/bmj.d3120	http://dx.doi.org/10.1136/bmj.d3120			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774MG	21628365	Green Submitted			2022-12-01	WOS:000291390100003
J	Grigoryan, G; Kim, YH; Acharya, R; Axelrod, K; Jain, RM; Willis, L; Drndic, M; Kikkawa, JM; DeGrado, WF				Grigoryan, Gevorg; Kim, Yong Ho; Acharya, Rudresh; Axelrod, Kevin; Jain, Rishabh M.; Willis, Lauren; Drndic, Marija; Kikkawa, James M.; DeGrado, William F.			Computational Design of Virus-Like Protein Assemblies on Carbon Nanotube Surfaces	SCIENCE			English	Article							DE-NOVO DESIGN; PEPTIDES; DNA; BINDING; INDUCTION; DOMAIN; MODEL	There is a general need for the engineering of protein-like molecules that organize into geometrically specific superstructures on molecular surfaces, directing further functionalization to create richly textured, multilayered assemblies. Here we describe a computational approach whereby the surface properties and symmetry of a targeted surface define the sequence and superstructure of surface-organizing peptides. Computational design proceeds in a series of steps that encode both surface recognition and favorable intersubunit packing interactions. This procedure is exemplified in the design of peptides that assemble into a tubular structure surrounding single-walled carbon nanotubes (SWNTs). The geometrically defined, virus-like coating created by these peptides converts the smooth surfaces of SWNTs into highly textured assemblies with long-scale order, capable of directing the assembly of gold nanoparticles into helical arrays along the SWNT axis.	[Grigoryan, Gevorg; Acharya, Rudresh; DeGrado, William F.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Kim, Yong Ho; DeGrado, William F.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Axelrod, Kevin; Jain, Rishabh M.; Willis, Lauren; Drndic, Marija; Kikkawa, James M.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	DeGrado, WF (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	wdegrado@mail.med.upenn.edu	Jain, Rishabh/D-7797-2013; Acharya, Rudresh/AAD-1247-2021	Acharya, Rudresh/0000-0002-9012-9849	NSF Materials Research Science and Engineering Center [DMR05-20020]; NIH [GM54616, 5F32GM084631-02]; NSF National Science and Engineering Center [DMR-0425780]; NSF [DMR-0907226, DGE-0221664]; Roy and Diana Vagelos Program in the Molecular Life Sciences; Direct For Mathematical & Physical Scien [0907266] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084631, R37GM054616, R01GM054616] Funding Source: NIH RePORTER	NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF National Science and Engineering Center; NSF(National Science Foundation (NSF)); Roy and Diana Vagelos Program in the Molecular Life Sciences; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NSF Materials Research Science and Engineering Center DMR05-20020 grant (to J.M.K., M. D., and W. F. D.), NIH grant no. GM54616 (to W. F. D.), a NSF National Science and Engineering Center grant no. DMR-0425780 (to W. F. D. and M. D.), NSF grant no. DMR-0907226 (to J.M.K.), and NIH grant no. 5F32GM084631-02 (to G. G.). K. A. acknowledges support from the Roy and Diana Vagelos Program in the Molecular Life Sciences, and L. W. acknowledges funding from the NSF-Integrative Graduate Education and Research Traineeship program (grant DGE-0221664). We would like to thank K. A. McAllister for training Y.H.K. in peptide synthesis, and A. E. Keating for comments on the manuscript.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Calhoun JR, 2005, BIOPOLYMERS, V80, P264, DOI 10.1002/bip.20230; Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b; Chakraborty AK, 2001, ANNU REV PHYS CHEM, V52, P537, DOI 10.1146/annurev.physchem.52.1.537; Cordes MHJ, 1996, CURR OPIN STRUC BIOL, V6, P3, DOI 10.1016/S0959-440X(96)80088-1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DEGRADO WF, 1985, J AM CHEM SOC, V107, P7684, DOI 10.1021/ja00311a076; Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x; Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005; Ghirlanda G, 2002, J MOL BIOL, V319, P243, DOI 10.1016/S0022-2836(02)00233-4; Ghirlanda G, 1998, J MOL BIOL, V281, P379, DOI 10.1006/jmbi.1998.1912; Ghosh D, 2005, CURR OPIN CHEM BIOL, V9, P97, DOI 10.1016/j.cbpa.2005.02.005; Golberg D, 2007, ADV MATER, V19, P2413, DOI 10.1002/adma.200700179; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Haring D, 2001, BIOCONJUGATE CHEM, V12, P385, DOI 10.1021/bc000117c; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Katz E, 2004, CHEMPHYSCHEM, V5, P1085, DOI 10.1002/cphc.200400193; Kim JS, 1998, P NATL ACAD SCI USA, V95, P2812, DOI 10.1073/pnas.95.6.2812; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Masica DL, 2010, J AM CHEM SOC, V132, P12252, DOI 10.1021/ja1001086; Nygren P, 2008, NANO LETT, V8, P1844, DOI 10.1021/nl080386s; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Ortiz-Acevedo A, 2005, J AM CHEM SOC, V127, P9512, DOI 10.1021/ja050507f; Rapaport H, 2006, SUPRAMOL CHEM, V18, P445, DOI 10.1080/10610270600665905; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Segman S, 2010, ANGEW CHEM INT EDIT, V49, P716, DOI 10.1002/anie.200904566; Torrens ON, 2006, NANO LETT, V6, P2864, DOI 10.1021/nl062071n; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	34	161	171	2	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1071	1076		10.1126/science.1198841	http://dx.doi.org/10.1126/science.1198841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21617073	Green Accepted			2022-12-01	WOS:000290996700041
J	Shi, FM; Lemmon, MA				Shi, Fumin; Lemmon, Mark A.			KSR Plays CRAF-ty	SCIENCE			English	Editorial Material							SCAFFOLD; KINASE; INHIBITORS; BINDING; BRAF; RAS; ATP		[Shi, Fumin] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Shi, FM (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, 422 Curie Blvd, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Shi, Fumin/H-3472-2013	Lemmon, Mark/0000-0002-3379-5319				Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Cichowski K, 2010, NATURE, V464, P358, DOI 10.1038/464358a; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Morrison DK, 2001, J CELL SCI, V114, P1609; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001	15	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1043	1044		10.1126/science.1208063	http://dx.doi.org/10.1126/science.1208063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769FN	21617065				2022-12-01	WOS:000290996700032
J	Hansen, SG; Ford, JC; Lewis, MS; Ventura, AB; Hughes, CM; Coyne-Johnson, L; Whizin, N; Oswald, K; Shoemaker, R; Swanson, T; Legasse, AW; Chiuchiolo, MJ; Parks, CL; Axthelm, MK; Nelson, JA; Jarvis, MA; Piatak, M; Lifson, JD; Picker, LJ				Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Oswald, Kelli; Shoemaker, Rebecca; Swanson, Tonya; Legasse, Alfred W.; Chiuchiolo, Maria J.; Parks, Christopher L.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Picker, Louis J.			Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine	NATURE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY VIRUS SIVMAC239; PRIMARY HIV-1 INFECTION; IMMUNE-RESPONSES; RHESUS-MONKEYS; MACAQUE MODEL; REPLICATION; CHALLENGE; PROTECTION; AIDS	The acquired immunodeficiency syndrome (AIDS)-causing lentiviruses human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) effectively evade host immunity and, once established, infections with these viruses are only rarely controlled by immunological mechanisms(1-3). However, the initial establishment of infection in the first few days after mucosal exposure, before viral dissemination and massive replication, may be more vulnerable to immune control(4). Here we report that SIV vaccines that include rhesus cytomegalovirus (RhCMV) vectors(5) establish indefinitely persistent, high-frequency, SIV-specific effector memory T-cell (T(EM)) responses at potential sites of SIV replication in rhesus macaques and stringently control highly pathogenic SIV(MAC239) infection early after mucosal challenge. Thirteen of twenty-four rhesus macaques receiving either RhCMV vectors alone or RhCMV vectors followed by adenovirus 5 (Ad5) vectors (versus 0 of 9 DNA/Ad5-vaccinated rhesus macaques) manifested early complete control of SIV (undetectable plasma virus), and in twelve of these thirteen animals we observed long-term (>= 1 year) protection. This was characterized by: occasional blips of plasma viraemia that ultimately waned; predominantly undetectable cell-associated viral load in blood and lymph node mononuclear cells; no depletion of effector-site CD4(+) memory T cells; no induction or boosting of SIV Env-specific antibodies; and induction and then loss of T-cell responses to an SIV protein (Vif) not included in the RhCMV vectors. Protection correlated with the magnitude of the peak SIV-specific CD8(+) T-cell responses in the vaccine phase, and occurred without anamnestic T-cell responses. Remarkably, long-term RhCMV vector-associated SIV control was insensitive to either CD8(+) or CD4(+) lymphocyte depletion and, at necropsy, cell-associated SIV was only occasionally measurable at the limit of detection with ultrasensitive assays, observations that indicate the possibility of eventual viral clearance. Thus, persistent vectors such as CMV and their associated TEM responses might significantly contribute to an efficacious HIV/AIDS vaccine.	[Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Mol Microbiol & Immunol, Beaverton, OR 97006 USA; [Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Pathol, Beaverton, OR 97006 USA; [Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Oswald, Kelli; Shoemaker, Rebecca; Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [Chiuchiolo, Maria J.; Parks, Christopher L.] Int AIDS Vaccine Initiat, Vaccine Design & Dev Lab, Brooklyn, NY 11220 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; International AIDS Vaccine Initiative	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Mol Microbiol & Immunol, Beaverton, OR 97006 USA.	pickerl@ohsu.edu		Jarvis, Michael/0000-0002-0124-4061	National Institute of Allergy and Infectious Diseases [RO1 AI060392, HHSN272200900037C]; International AIDS Vaccine Initiative (IAVI); United States Agency for International Development (USAID); Bill & Melinda Gates Foundation; National Center for Research Resources [P51 RR00163, R24 RR016001]; National Cancer Institute [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001, P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060392, R01AI060392] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U24OD010850] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative (IAVI); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Allergy and Infectious Diseases (RO1 AI060392; contract #HHSN272200900037C); the International AIDS Vaccine Initiative (IAVI) and its donors, particularly the United States Agency for International Development (USAID); the Bill & Melinda Gates Foundation-supported Collaboration for AIDS Vaccine Discovery; the National Center for Research Resources (P51 RR00163; R24 RR016001); and the National Cancer Institute (contract HHSN261200800001E). We thank A. Sylwester, D. Seiss, R. Lum, H. Park and A. Okoye for specialized technical assistance; P. Barry, G. Pavlakis, G. Franchini, C. Miller, N. Wilson, and K. Reimann and Nonhuman Primate Reagent Resource for provision of crucial constructs or reagents; D. Watkins for MHC typing; D. Montefiori for neutralizing antibody assays; N. Letvin and L. Shen for TRIM5a typing; S. Mongoue-Tchokote and M. Mori for statistical assistance; A. Townsend and T. Schroyer for figure preparation; and K. Fruh, D. Watkins, B. Beresford, A. McDermott, R. King and W. Koff for discussion and advice.	Anton PA, 2003, AIDS, V17, P53, DOI 10.1097/00002030-200301030-00008; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Chang WLW, 2003, J VIROL, V77, P5073, DOI 10.1128/JVI.77.9.5073-5083.2003; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cline AN, 2005, J MED PRIMATOL, V34, P303; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Grovit-Ferbas K, 1999, PERSISTENT VIRAL INF, P3; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kulkarni V, 2011, VACCINE, V29, P6742, DOI 10.1016/j.vaccine.2010.12.056; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; MONTEFIORI DC, 2005, CURR PROTOC IMMUNOL, V12; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; Ruiz L, 1999, AIDS, V13, pF1, DOI 10.1097/00002030-199901140-00001; Schmitz JE, 2000, J IMMUNOL, V164, P6015, DOI 10.4049/jimmunol.164.11.6015; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Shen AD, 2007, J VIROL, V81, P1660, DOI 10.1128/JVI.01396-06; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	36	756	784	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					523	U270		10.1038/nature10003	http://dx.doi.org/10.1038/nature10003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21562493	Green Accepted, Green Submitted			2022-12-01	WOS:000290951300043
J	Conen, D; Chae, CU; Glynn, RJ; Tedrow, UB; Everett, BM; Buring, JE; Albert, CM				Conen, David; Chae, Claudia U.; Glynn, Robert J.; Tedrow, Usha B.; Everett, Brendan M.; Buring, Julie E.; Albert, Christine M.			Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; FOLLOW-UP; ALCOHOL-CONSUMPTION; PREDICTING STROKE; NATURAL-HISTORY; SECULAR TRENDS; BLOOD-PRESSURE; MORTALITY; COMMUNITY; PREVALENCE	Context The risks associated with new-onset atrial fibrillation (AF) among middle-aged women and populations with a low comorbidity burden are poorly defined. Objectives To examine the association between incident AF and mortality in initially healthy women and to evaluate the influence of associated cardiovascular comorbidities on risk. Design, Setting, and Participants Between 1993 and March 16, 2010, 34 722 women participating in the Women's Health Study underwent prospective follow-up. Participants were 95% white, older than 45 years (median, 53 [interquartile range {IQR}, 49-59] years), and free of AF and cardiovascular disease at baseline. Cox proportional hazards models with time-varying covariates were used to determine the risk of events among women with incident AF. Secondary analyses were performed among women with paroxysmal AF. Main Outcome Measures Primary outcomes included all-cause, cardiovascular, and noncardiovascular mortality. Secondary outcomes included stroke, congestive heart failure, and myocardial infarction. Results During a median follow-up of 15.4 (IQR, 14.7-15.8) years, 1011 women developed AF. Incidence rates per 1000 person-years among women with and without AF were 10.8 (95% confidence interval [CI], 8.1-13.5) and 3.1 (95% CI, 2.9-3.2) for all-cause mortality, 4.3 (95% CI, 2.6-6.0) and 0.57 (95% CI, 0.5-0.6) for cardiovascular mortality, and 6.5 (95% CI, 4.4-8.6) and 2.5 (95% CI, 2.4-2.6) for noncardiovascular mortality, respectively. In multivariable models, hazard ratios (HRs) of new-onset AF for all-cause, cardiovascular, and noncardiovascular mortality were 2.14 (95% CI, 1.64-2.77), 4.18 (95% CI, 2.69-6.51), and 1.66 (95% CI, 1.19-2.30), respectively. Adjustment for nonfatal cardiovascular events potentially on the causal pathway to death attenuated these risks, but incident AF remained associated with all mortality components (all-cause: HR, 1.70 [95% CI, 1.30-2.22]; cardiovascular: HR, 2.57 [95% CI, 1.63-4.07]; and noncardiovascular: HR, 1.42 [95% CI, 1.02-1.98]). Among women with paroxysmal AF (n=656), the increase in mortality risk was limited to cardiovascular causes (HR, 2.94; 95% CI, 1.55-5.59). Conclusion Among a group of healthy women, new-onset AF was independently associated with all-cause, cardiovascular, and noncardiovascular mortality, with some of the risk potentially explained by nonfatal cardiovascular events. JAMA. 2011; 305(20): 2080-2087	[Conen, David] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland; [Conen, David; Tedrow, Usha B.; Albert, Christine M.] Harvard Univ, Sch Med, Dept Med, Ctr Arrhythmia Prevent,Brigham & Womens Hosp, Boston, MA USA; [Conen, David; Chae, Claudia U.; Glynn, Robert J.; Everett, Brendan M.; Buring, Julie E.; Albert, Christine M.] Harvard Univ, Sch Med, Dept Med, Div Prevent Med,Brigham & Womens Hosp, Boston, MA USA; [Tedrow, Usha B.; Everett, Brendan M.; Albert, Christine M.] Harvard Univ, Sch Med, Dept Med, Cardiovasc Div,Brigham & Womens Hosp, Boston, MA USA	University of Basel; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Conen, D (corresponding author), Univ Basel Hosp, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland.	conend@uhbs.ch	Tedrow, Usha/AFV-2528-2022	Albert, Christine/0000-0002-2081-1121	Boehringer Ingelheim; Sanofi-Aventis; Novartis; Swiss National Science Foundation [PP00P3_133681]; University of Basel; AstraZeneca; St Jude Medical; Biosense Webster; Medtronic Inc; National Institutes of Health/National Heart, Lung, and Blood Institute (NHLBI); American Heart Association; Siemens Healthcare Diagnostics; Boston Scientific; NHLBI [HL-093613, HL-043851, HL-080467, HL-099355]; National Cancer Institute [CA-047988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, RC1HL099355, R21HL093613, R01HL080467] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; AstraZeneca(AstraZeneca); St Jude Medical(St. Jude Medical); Biosense Webster; Medtronic Inc(Medtronic); National Institutes of Health/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Siemens Healthcare Diagnostics; Boston Scientific(Boston Scientific); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Conen reports receiving research grants from Boehringer Ingelheim, Sanofi-Aventis, Novartis, the Swiss National Science Foundation (PP00P3_133681), and the University of Basel. Dr Glynn reports receiving an honorarium for an invited talk from Merck and research grants for data monitoring and analysis of clinical trials from AstraZeneca. Dr Tedrow reports receiving consultancy fees from St Jude Medical, research grants from Biosense Webster, and grants from Biosense Webster, St Jude Medical, and Medtronic Inc to support the fellows' program at Brigham and Women's Hospital that she directs. Dr Albert reports receiving grant and administrative support from the National Institutes of Health/National Heart, Lung, and Blood Institute (NHLBI), American Heart Association, Siemens Healthcare Diagnostics, and St Jude Medical, consultancy fees from Novartis, and speaker honorarium from Boston Scientific and St Jude Medical. No other conflict of interest disclosures were reported.; This study was supported by grant HL-093613 from the NHLBI to Dr Albert. The WHS was supported by grants HL-043851, HL-080467, and HL-099355 from the NHLBI and grant CA-047988 from the National Cancer Institute.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Conen D, 2008, JAMA-J AM MED ASSOC, V300, P2489, DOI 10.1001/jama.2008.755; Conen D, 2009, CIRCULATION, V119, P2146, DOI 10.1161/CIRCULATIONAHA.108.830042; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Di Pasquale G, 2005, J THROMB HAEMOST, V3, P428, DOI 10.1111/j.1538-7836.2005.01182.x; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Friberg L, 2007, EUR HEART J, V28, P2346, DOI 10.1093/eurheartj/ehm308; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Keating RJ, 2005, AM J CARDIOL, V96, P1420, DOI 10.1016/j.amjcard.2005.07.050; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Ott A, 1997, STROKE, V28, P316, DOI 10.1161/01.STR.28.2.316; Psaty BM, 1997, CIRCULATION, V96, P2455; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Turnbull F, 2003, LANCET, V362, P1527; Vidaillet H, 2002, AM J MED, V113, P365, DOI 10.1016/S0002-9343(02)01253-6; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Wolf PA, 1996, AM HEART J, V131, P790, DOI 10.1016/S0002-8703(96)90288-4; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	34	262	270	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2011	305	20					2080	2087		10.1001/jama.2011.659	http://dx.doi.org/10.1001/jama.2011.659			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768AC	21610240	Green Accepted, Bronze			2022-12-01	WOS:000290901700021
J	Round, JL; Lee, SM; Li, J; Tran, G; Jabri, B; Chatila, TA; Mazmanian, SK				Round, June L.; Lee, S. Melanie; Li, Jennifer; Tran, Gloria; Jabri, Bana; Chatila, Talal A.; Mazmanian, Sarkis K.			The Toll-Like Receptor 2 Pathway Establishes Colonization by a Commensal of the Human Microbiota	SCIENCE			English	Article							REGULATORY T-CELLS; BACTERIA; DIFFERENTIATION; MATURATION; DIVERSITY	Mucosal surfaces constantly encounter microbes. Toll-like receptors (TLRs) mediate recognition of microbial patterns to eliminate pathogens. By contrast, we demonstrate that the prominent gut commensal Bacteroides fragilis activates the TLR pathway to establish host-microbial symbiosis. TLR2 on CD4(+) T cells is required for B. fragilis colonization of a unique mucosal niche in mice during homeostasis. A symbiosis factor (PSA, polysaccharide A) of B. fragilis signals through TLR2 directly on Foxp3(+) regulatory T cells to promote immunologic tolerance. B. fragilis lacking PSA is unable to restrain T helper 17 cell responses and is defective in niche-specific mucosal colonization. Therefore, commensal bacteria exploit the TLR pathway to actively suppress immunity. We propose that the immune system can discriminate between pathogens and the microbiota through recognition of symbiotic bacterial molecules in a process that engenders commensal colonization.	[Round, June L.; Lee, S. Melanie; Li, Jennifer; Tran, Gloria; Mazmanian, Sarkis K.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jabri, Bana] Univ Chicago, Dept Med, Dept Pediat, Dept Pathol, Chicago, IL 60637 USA; [Chatila, Talal A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90095 USA	California Institute of Technology; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Round, JL (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jround@caltech.edu; sarkis@caltech.edu	Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513; Chatila, Talal/0000-0001-7439-2762	Crohn's and Colitis Foundation of America (CCFA) [2831, 2405]; NIH [AI 080002, DK 078938, DK 083633, AI 088626]; Damon Runyon Cancer Research Foundation; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080002, R01AI085090, R21AI088626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK083633, R01DK078938, R56DK078938] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America (CCFA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Jane Coffin Childs Memorial Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. W. McBride and Y. Shen (California Institute for Technology) for help with bacterial colonization and germ-free studies. We are grateful to A. Rudensky [Memorial Sloan-Kettering Cancer Center and Howard Hughes Medical Institute (HHMI)] for the gift of Foxp3-DTR mice and L. Hooper (University of Texas Southwestern and HHMI) for germ-free Rag1<SUP>-/-</SUP> mice. We thank members of the Mazmanian laboratory for their critical review of the manuscript. B.J. acknowledges support from the Crohn's and Colitis Foundation of America (CCFA) (award 2831) and T.A.C acknowledges support from the NIH (grant AI 080002). J.L.R. is a Merck Fellow of the Jane Coffin Childs Memorial Fund. S.K.M. is a Searle Scholar. This work was supported by funding from the NIH (grants DK 078938, DK 083633, AI 088626), the Damon Runyon Cancer Research Foundation, and the CCFA (award 2405) to S.K.M. J.L.R. and S.K.M. have a patent application (PCT/US2008/082928) on the use of PSA as a therapy for inflammatory bowel disease. The authors have no competing financial interests related to this publication.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439	24	1024	1123	9	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2011	332	6032					974	977		10.1126/science.1206095	http://dx.doi.org/10.1126/science.1206095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21512004	Green Accepted			2022-12-01	WOS:000290766600046
J	Jiao, YN; Wickett, NJ; Ayyampalayam, S; Chanderbali, AS; Landherr, L; Ralph, PE; Tomsho, LP; Hu, Y; Liang, HY; Soltis, PS; Soltis, DE; Clifton, SW; Schlarbaum, SE; Schuster, SC; Ma, H; Leebens-Mack, J; dePamphilis, CW				Jiao, Yuannian; Wickett, Norman J.; Ayyampalayam, Saravanaraj; Chanderbali, Andre S.; Landherr, Lena; Ralph, Paula E.; Tomsho, Lynn P.; Hu, Yi; Liang, Haiying; Soltis, Pamela S.; Soltis, Douglas E.; Clifton, Sandra W.; Schlarbaum, Scott E.; Schuster, Stephan C.; Ma, Hong; Leebens-Mack, Jim; dePamphilis, Claude W.			Ancestral polyploidy in seed plants and angiosperms	NATURE			English	Article							PHYLOGENETIC ANALYSIS; GENOME DUPLICATIONS; MAXIMUM-LIKELIHOOD; EVOLUTIONARY TREES; WHOLE-GENOME; GENE; ARABIDOPSIS; ORIGIN; LAND; PALEOPOLYPLOIDY	Whole-genome duplication (WGD), or polyploidy, followed by gene loss and diploidization has long been recognized as an important evolutionary force in animals, fungi and other organisms(1-3), especially plants. The success of angiosperms has been attributed, in part, to innovations associated with gene or whole-genome duplications(4-6), but evidence for proposed ancient genome duplications pre-dating the divergence of monocots and eudicots remains equivocal in analyses of conserved gene order. Here we use comprehensive phylogenomic analyses of sequenced plant genomes and more than 12.6 million new expressed-sequence-tag sequences from phylogenetically pivotal lineages to elucidate two groups of ancient gene duplications-one in the common ancestor of extant seed plants and the other in the common ancestor of extant angiosperms. Gene duplication events were intensely concentrated around 319 and 192 million years ago, implicating two WGDs in ancestral lineages shortly before the diversification of extant seed plants and extant angiosperms, respectively. Significantly, these ancestral WGDs resulted in the diversification of regulatory genes important to seed and flower development, suggesting that they were involved in major innovations that ultimately contributed to the rise and eventual dominance of seed plants and angiosperms.	[Jiao, Yuannian; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA; [Jiao, Yuannian; Wickett, Norman J.; Landherr, Lena; Ralph, Paula E.; Hu, Yi; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Inst Mol Evolutionary Genet, Dept Biol, University Pk, PA 16802 USA; [Jiao, Yuannian; Wickett, Norman J.; Landherr, Lena; Ralph, Paula E.; Hu, Yi; Ma, Hong; dePamphilis, Claude W.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Ayyampalayam, Saravanaraj; Leebens-Mack, Jim] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Chanderbali, Andre S.; Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Tomsho, Lynn P.; Schuster, Stephan C.] Penn State Univ, Ctr Infect Dis Dynam, Ctr Comparat Genom, University Pk, PA 16802 USA; [Liang, Haiying] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Clifton, Sandra W.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Schlarbaum, Scott E.] Univ Tennessee, Inst Agr, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA; [Ma, Hong] Fudan Univ, Ctr Evolutionary Biol, Inst Plant Biol, Sch Life Sci,State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ma, Hong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Clemson University; State University System of Florida; University of Florida; Washington University (WUSTL); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Fudan University; Fudan University	dePamphilis, CW (corresponding author), Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA.	cwd3@psu.edu	Soltis, Douglas/L-5957-2015; Soltis, Pamela S/GNH-5557-2022; Leebens-Mack, James/AAF-6770-2019; dePamphilis, Claude W/P-6652-2016; Soltis, Pamela S/L-5184-2015; Jiao, Yuannian/H-8668-2012; Ma, Hong/W-5251-2018; Wickett, Norman/AAV-8136-2021; Jiao, Yuannian/AAZ-7054-2021	Soltis, Pamela S/0000-0001-9310-8659; Leebens-Mack, James/0000-0003-4811-2231; Ma, Hong/0000-0001-8717-4422; Wickett, Norman/0000-0003-0944-1956; Jiao, Yuannian/0000-0002-8987-2782; Chanderbali, Andre/0000-0002-8728-6739	NSF [DEB 0638595]; Department of Biology; Huck Institutes of Life Sciences of the Pennsylvania State University; Fudan University; Direct For Biological Sciences [0830009] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0922742] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Department of Biology; Huck Institutes of Life Sciences of the Pennsylvania State University; Fudan University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported primarily by NSF Plant Genome Research Program (DEB 0638595, The Ancestral Angiosperm Genome Project) and in part by the Department of Biology and by the Huck Institutes of Life Sciences of the Pennsylvania State University. H. M. was also supported by funds from Fudan University. We thank J. Carlson, M. Frohlich, S. DiLoretto, L. Warg, S. Crutchfield, C. Johnson, N. Naznin, X. Zhou, J. Duarte, B. J. Bliss, J. Der and E. Wafula for help and discussion, D. Stevenson and C. Schultz for Zamia samples, J. McNeal, S. Kim and M. Axtell for photographs, and all the members of The Genome Center at Washington University production team, especially L. Fulton, K. Delehaunty and C. Fronick.	[Anonymous], 1991, POLLEN SPORES PATTER; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Buggs RJA, 2009, HEREDITY, V103, P73, DOI 10.1038/hdy.2009.24; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dechaine JM, 2009, PLANT CELL ENVIRON, V32, P1297, DOI 10.1111/j.1365-3040.2009.01998.x; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Hu W, 2008, J INTEGR PLANT BIOL, V50, P1031, DOI 10.1111/j.1744-7909.2008.00681.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lynch M., 2007, ORIGINS GENOME ARCHI; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Mathews S, 2003, MOL BIOL EVOL, V20, P1087, DOI 10.1093/molbev/msg123; McLachlan G.J., 1999, J STAT SOFTWARE, V4, P1, DOI DOI 10.18637/JSS.V004.I02; Miller CN, 1999, BOT REV, V65, P239, DOI 10.1007/BF02857631; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vandepoele K, 2002, TRENDS GENET, V18, P606, DOI 10.1016/S0168-9525(02)02796-8; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	54	1347	1399	21	626	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					97	U113		10.1038/nature09916	http://dx.doi.org/10.1038/nature09916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478875				2022-12-01	WOS:000290218300038
J	Ang, YS; Tsai, SY; Lee, DF; Monk, J; Su, J; Ratnakumar, K; Ding, JJ; Ge, YC; Darr, H; Chang, B; Wang, JL; Rendl, M; Bernstein, E; Schaniel, C; Lemischka, IR				Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Ratnakumar, Kajan; Ding, Junjun; Ge, Yongchao; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Bernstein, Emily; Schaniel, Christoph; Lemischka, Ihor R.			Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional Network	CELL			English	Article							CHROMATIN-STRUCTURE; DEVELOPMENTAL REGULATORS; HISTONE H3; POLYCOMB; GENES; PLURIPOTENT; BINDING; GENOME; RECOGNITION; METHYLATION	The embryonic stem (ES) cell transcriptional and chromatin-modifying networks are critical for self-renewal maintenance. However, it remains unclear whether these networks functionally interact and, if so, what factors mediate such interactions. Here, we show that WD repeat domain 5 (Wdr5), a core member of the mammalian Trithorax (trxG) complex, positively correlates with the undifferentiated state and is a regulator of ES cell self-renewal. We demonstrate that Wdr5, an "effector" of H3K4 methylation, interacts with the pluripotency transcription factor Oct4. Genome-wide protein localization and transcriptome analyses demonstrate overlapping gene regulatory functions between Oct4 and Wdr5. The Oct4-Sox2-Nanog circuitry and trxG cooperate in activating transcription of key self-renewal regulators, and furthermore, Wdr5 expression is required for the efficient formation of induced pluripotent stem (iPS) cells. We propose an integrated model of transcriptional and epigenetic control, mediated by select trxG members, for the maintenance of ES cell self-renewal and somatic cell reprogramming.	[Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Ratnakumar, Kajan; Ding, Junjun; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Bernstein, Emily; Schaniel, Christoph; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Ang, Yen-Sin; Lee, Dung-Fang; Monk, Jonathan; Su, Jie; Darr, Henia; Chang, Betty; Schaniel, Christoph; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Ang, Yen-Sin; Tsai, Su-Yi; Lee, Dung-Fang; Su, Jie; Ding, Junjun; Darr, Henia; Chang, Betty; Wang, Jianlong; Rendl, Michael; Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Ratnakumar, Kajan; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Tsai, Su-Yi; Ratnakumar, Kajan; Rendl, Michael; Bernstein, Emily] Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; [Ge, Yongchao] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ang, YS (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA.	yen-sin.ang@mssm.edu; ihor.lemischka@mssm.edu	Ge, Yongchao/AAG-9317-2021; Schaniel, Christoph/P-3836-2019; Wang, Jianlong/GQR-1191-2022; Ding, Junjun/F-8618-2015; Wang, Jianlong/AAG-9425-2020; Ding, Junjun/C-4098-2012; Schaniel, Chrisoph/C-9655-2012	Ge, Yongchao/0000-0001-6448-5703; Schaniel, Christoph/0000-0002-1343-4858; Wang, Jianlong/0000-0002-1317-6457; Monk, Jonathan M./0000-0002-3895-8949; Lee, Dung-Fang/0000-0003-2387-597X; Su, Jie/0000-0002-3071-7139; TSAI, SU-YI/0000-0002-7423-645X; Rendl, Michael/0000-0001-6326-620X; Ding, Junjun/0000-0002-9936-882X	NIH [R01GM078465]; NYSTEM [C024410, C024285]; Dermatology Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Dermatology Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.D. Allis, C. Hughes, J. Wysocka, A. Sevilla, X. Carvajal-Vergara, F. Pereira, A. Waghray, S. Pardo, S. Mendez-Ferrer, W.L. Tam, B. Lim, C. Ren, H.A. Wu, J. Gingold, and V. Nair for technical assistance, materials, and advice. This work was supported by NIH (R01GM078465) to I.R.L.; NYSTEM (C024410) to I.R.L and C.S.; and NYSTEM (C024285) to E.B.D.F.L. is a NYSCF Fellow. M.R. is supported by a Dermatology Foundation Career Development Award.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lairmore TC, 2009, ADV EXP MED BIOL, V668, P87; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Taylor MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000813; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	44	418	438	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					183	197		10.1016/j.cell.2011.03.003	http://dx.doi.org/10.1016/j.cell.2011.03.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21477851	Bronze, Green Accepted			2022-12-01	WOS:000289549900009
J	Shiels, MS; Pfeiffer, RM; Hall, HI; Li, JM; Goedert, JJ; Morton, LM; Hartge, P; Engels, EA				Shiels, Meredith S.; Pfeiffer, Ruth M.; Hall, H. Irene; Li, Jianmin; Goedert, James J.; Morton, Lindsay M.; Hartge, Patricia; Engels, Eric A.			Proportions of Kaposi Sarcoma, Selected Non-Hodgkin Lymphomas, and Cervical Cancer in the United States Occurring in Persons With AIDS, 1980-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCIDENCE PATTERNS; SURVEILLANCE DATA; HIV; TRENDS; RISK; RECOMMENDATIONS; ADOLESCENTS; ADULTS; ASSOCIATION; SOCIETY	Context Given the higher risk of AIDS-defining malignancies that include Kaposi sarcoma (KS), certain non-Hodgkin lymphomas (NHLs), and cervical cancer in persons with human immunodeficiency virus (HIV) infection, the HIV epidemic has likely contributed to the overall numbers of these cancers in the United States. Objective To quantify the proportions of KS, AIDS-defining NHLs, and cervical cancer in the United States that occurred among persons with AIDS from 1980 to 2007. Design, Setting, and Participants The HIV/AIDS Cancer Match Study (19802007) linked data from 16 US HIV/AIDS and cancer registries to identify cases with and without AIDS for KS, AIDS-defining NHLs (ie, diffuse large B-cell lymphoma [DLBCL], Burkitt lymphoma [BL], and central nervous system [CNS] lymphoma), and cervical cancer. Using linked data, we derived cancer rates for persons with and without AIDS. To estimate national counts, the rates were applied to national AIDS surveillance and US Census data. Main Outcome Measure Proportion of AIDS-defining malignancies in the United States occurring in persons with AIDS. Results In the United States, an estimated 81.6% (95% confidence interval [CI], 81.2%-81.9%) of 83 252 KS cases, 6.0% (95% CI, 5.8%-6.1%) of 351 618 DLBCL cases, 19.9% (95% CI, 18.1%-21.7%) of 17 307 BL cases, 27.1% (95% CI, 26.1%-28.1%) of 27 265 CNS lymphoma cases, and 0.42% (95% CI, 0.37%-0.47%) of 375 452 cervical cancer cases occurred among persons with AIDS during 1980-2007. The proportion of KS and AIDS-defining NHLs in persons with AIDS peaked in the early 1990s (1990-1995: KS, 90.5% [95% CI, 90.2%-90.8%]; DLBCL, 10.2% [95% CI, 9.9%-10.5%]; BL, 27.8% [95% CI, 25.0%-30.5%]; and CNS lymphoma, 48.3% [95% CI, 46.7%-49.8%]; all P < .001 [compared with 1980-1989]) and then declined (2001-2007: KS, 70.5% [95% CI, 68.1%-73.0%]; DLBCL, 4.7% [95% CI, 4.3%-5.2%]; BL, 21.5% [95% CI, 17.7%-25.4%]; and CNS lymphoma, 12.9% [95% CI, 10.5%-15.3%]; all P < .001 [compared with 1990-1995]). The proportion of cervical cancers in persons with AIDS increased over time (1980-1989: 0.11% [95% CI, 0.09%-0.13%]; 2001-2007: 0.71% [95% CI, 0.51%-0.91%]; P < .001). Conclusions In the United States, the estimated proportions of AIDS-defining malignancies that occurred among persons with AIDS were substantial, particularly for KS and some NHLs. Except for cervical cancer, the proportions of AIDS-defining malignancies occurring among persons with AIDS peaked in the mid-1990s and then declined. JAMA. 2011;305(14):1450-1459 www.jama.com	[Shiels, Meredith S.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; [Hall, H. Irene; Li, Jianmin] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Shiels, MS (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, 6120 Execut Blvd,EPS 7059, Rockville, MD 20892 USA.	shielsms@mail.nih.gov	Morton, Lindsay M/B-5234-2015; Morton, Lindsay/AAE-7495-2022	Morton, Lindsay M/0000-0001-9767-2310; Morton, Lindsay/0000-0001-9767-2310	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010150] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Intramural Research Program of the National Cancer Institute.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2011, GUID US ANT AG HIV 1; [Anonymous], HIV AIDS STAT SURV; [Anonymous], 2007, HIV AIDS SURV REP US, V17; [Anonymous], 2011, SEER STAT DAT POP TO; BASHIR R, 1994, J NEURO-ONCOL, V20, P47, DOI 10.1007/BF01057960; Bedimo R, 2004, CLIN INFECT DIS, V39, P1380, DOI 10.1086/424883; Bellan C, 2003, ONCOGENE, V22, P6639, DOI 10.1038/sj.onc.1206815; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Chiao EY, 2010, JAMA-J AM MED ASSOC, V304, P334, DOI 10.1001/jama.2010.752; Dunleavy K, 2010, BLOOD, V115, P3017, DOI 10.1182/blood-2009-11-253039; Eltom MA, 2002, J NATL CANCER I, V94, P1204, DOI 10.1093/jnci/94.16.1204; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gatter KC, 2001, PATHOLOGY GENETICS T, P171; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Green TA, 1998, STAT MED, V17, P143, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;143::AID-SIM757&gt;3.0.CO;2-Y; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Iscovich J, 2000, CANCER-AM CANCER SOC, V88, P500, DOI 10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.3.CO;2-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kadan-Lottick NS, 2002, CANCER, V95, P193, DOI 10.1002/cncr.10643; Larocca LM, 1998, BLOOD, V92, P1011; Levine AM, 2010, BLOOD, V115, P2986, DOI 10.1182/blood-2010-01-262717; Mbulaiteye SM, 2010, INT J CANCER, V126, P1732, DOI 10.1002/ijc.24934; National Cancer Institute, 2019, HIV AIDS CANC MATCH; National Cancer Institute. Surveillance E and End Results (SEER) Program, SEER STAT DAT INC SE; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Rouhani P, 2008, CANCER-AM CANCER SOC, V113, P616, DOI 10.1002/cncr.23571; Shiels M, 2010, 18 ANN INT AIDS C VI; Shiels MS, 2008, JAIDS-J ACQ IMM DEF, V48, P485, DOI 10.1097/QAI.0b013e31817dc42b; Sparano JA, 2010, BLOOD, V115, P3008, DOI 10.1182/blood-2009-08-231613; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004	37	104	107	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1450	1459		10.1001/jama.2011.396	http://dx.doi.org/10.1001/jama.2011.396			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486978	Green Accepted, Bronze			2022-12-01	WOS:000289424100022
J	Lee, JM; Lee, YK; Mamrosh, JL; Busby, SA; Griffin, PR; Pathak, MC; Ortlund, EA; Moore, DD				Lee, Jae Man; Lee, Yoon Kwang; Mamrosh, Jennifer L.; Busby, Scott A.; Griffin, Patrick R.; Pathak, Manish C.; Ortlund, Eric A.; Moore, David D.			A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects	NATURE			English	Article							ORPHAN RECEPTORS; LIVER; IDENTIFICATION; LRH-1; PHOSPHOLIPIDS; HOMOLOG-1; BINDING; DEFICIENCY; ACTIVATION; PROMOTER	Nuclear hormone receptors regulate diverse metabolic pathways and the orphan nuclear receptor LRH-1 (also known as NR5A2) regulates bile acid biosynthesis(1,2). Structural studies have identified phospholipids as potential LRH-1 ligands(3-5), but their functional relevance is unclear. Here we show that an unusual phosphatidylcholine species with two saturated 12 carbon fatty acid acyl side chains (dilauroyl phosphatidylcholine (DLPC)) is an LRH-1 agonist ligand in vitro. DLPC treatment induces bile acid biosynthetic enzymes in mouse liver, increases bile acid levels, and lowers hepatic triglycerides and serum glucose. DLPC treatment also decreases hepatic steatosis and improves glucose homeostasis in two mouse models of insulin resistance. Both the antidiabetic and lipotropic effects are lost in liver-specific Lrh-1 knockouts. These findings identify an LRH-1 dependent phosphatidylcholine signalling pathway that regulates bile acid metabolism and glucose homeostasis.	[Lee, Jae Man; Moore, David D.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Lee, Yoon Kwang; Mamrosh, Jennifer L.; Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lee, Yoon Kwang] Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, Coll Med, Rootstown, OH 44272 USA; [Lee, Yoon Kwang] Northeastern Ohio Univ Coll Med & Pharm, Coll Pharm, Rootstown, OH 44272 USA; [Busby, Scott A.; Griffin, Patrick R.] Scripps Res Inst, Scripps Res Mol Screening Ctr, Jupiter, FL 33458 USA; [Pathak, Manish C.; Ortlund, Eric A.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA	Baylor College of Medicine; Baylor College of Medicine; Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); Scripps Research Institute; Emory University	Moore, DD (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	moore@bcm.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	NIH [DK-079638, DK068804, R01 CA134873]; USDA [ARS 6250-52000-055]; Alkek Foundation; Robert R. P. Doherty Jr-Welch Chair in Science; NATIONAL CANCER INSTITUTE [R01CA134873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083572, P30DK079638, T32DK007696, R01DK068804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); Alkek Foundation; Robert R. P. Doherty Jr-Welch Chair in Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. A. Kliewer and D. J. Mangelsdorf (UT Southwestern Medical Center) for the gift of Lrh-1<SUP>f/f</SUP> mice, A. J. Cooney for the OCT4 promoter constructs, C. Mills and D. Kuruvilla for experimental assistance, the Baylor College of Medicine Diabetes Endocrine Research Center (supported by NIH DK-079638 and USDA ARS 6250-52000-055) and the services of the Mouse Metabolism Core for hyperinsulinaemic clamp studies, and the current and previous members of the D.D.M. laboratory for discussions and technical support. Supported by NIH R01 DK068804, the Alkek Foundation and the Robert R. P. Doherty Jr-Welch Chair in Science to D.D.M., and NIH R01 CA134873 to P.R.G.	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hunt AN, 2006, J CELL BIOCHEM, V97, P244, DOI 10.1002/jcb.20691; Kanayama T, 2007, J BIOL CHEM, V282, P10290, DOI 10.1074/jbc.M700270200; Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lee H, 2000, CIRC RES, V87, P516; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; Lee YK, 1999, J BIOL CHEM, V274, P20869, DOI 10.1074/jbc.274.30.20869; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Li DH, 2007, MOL CELL BIOL, V27, P6669, DOI 10.1128/MCB.00355-07; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Sablin EP, 2009, MOL ENDOCRINOL, V23, P25, DOI 10.1210/me.2007-0508; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; Vidovic D, 2011, CHEMMEDCHEM, V6, P94, DOI 10.1002/cmdc.201000428; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Whitby RJ, 2006, J MED CHEM, V49, P6652, DOI 10.1021/jm060990k	32	161	166	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					506	U135		10.1038/nature10111	http://dx.doi.org/10.1038/nature10111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21614002	Green Accepted			2022-12-01	WOS:000291939700048
J	Pickhardt, PJ; Lawrence, EM; Pooler, BD; Bruce, RJ				Pickhardt, Perry J.; Lawrence, Edward M.; Pooler, B. Dustin; Bruce, Richard J.			Diagnostic Performance of Multidetector Computed Tomography for Suspected Acute Appendicitis	ANNALS OF INTERNAL MEDICINE			English	Article							LOWER-QUADRANT PAIN; NEGATIVE APPENDECTOMY RATE; HELICAL CT; ORAL CONTRAST; ADULTS; IMPACT; US; ULTRASONOGRAPHY; ACCURACY; SCAN	Background: Use of preoperative computed tomography for suspected acute appendicitis has dramatically increased since the introduction of multidetector CT (MDCT) scanners. Objective: To evaluate the diagnostic performance of MDCT for suspected acute appendicitis in adults. Design: Analysis of MDCT findings and clinical outcomes of consecutive adults referred for MDCT for suspected appendicitis from January 2000 to December 2009. Setting: Single academic medical center in the United States. Patients: 2871 adults. Measurements: Interpretation of nonfocused abdominopelvic MDCT scans by radiologists who were aware of the study indication. Posttest assessment of diagnostic performance of MDCT for acute appendicitis, according to the reference standard of final combined clinical, surgical, and pathology findings. Results: 675 of 2871 patients (23.5%) had confirmed acute appendicitis. The sensitivity, specificity, and negative and positive predictive values of MDCT were 98.5% (95% CI, 97.3% to 99.2%) (665 of 675 patients), 98.0% (CI, 97.4% to 98.6%) (2153 of 2196 patients), 99.5% (CI, 99.2% to 99.8%) (2153 of 2163 patients), and 93.9% (CI, 91.9% to 95.5%) (665 of 708 patients), respectively. Positive and negative likelihood ratios were 51.3 (CI, 38.1 to 69.0) and 0.015 (CI, 0.008 to 0.028), respectively. The overall rate of negative findings at appendectomy was 7.5% (CI, 5.8% to 9.7%) (54 of 716 patients), but would have decreased to 4.1% (28 of 690 patients) had surgery been avoided in 26 cases with true-negative findings on MDCT. The overall perforation rate was 17.8% (120 of 675 patients) but progressively decreased from 28.9% in 2000 to 11.5% in 2009. Multidetector computed tomography provided or suggested an alternative diagnosis in 893 of 2122 patients (42.1%) without appendicitis or appendectomy. Limitation: Possible referral bias, because some patients whose appendicitis was difficult to diagnose on clinical grounds may not have been referred for MDCT for evaluation of suspected appendicitis. Conclusion: Multidetector computed tomography is a useful test for routine evaluation of suspected appendicitis in adults.	[Pickhardt, Perry J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Clin Sci Ctr E3 311, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Pickhardt, PJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Clin Sci Ctr E3 311, 600 Highland Ave, Madison, WI 53792 USA.	ppickhardt2@uwhealth.org						ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Anderson BA, 2005, AM J SURG, V190, P474, DOI 10.1016/j.amjsurg.2005.03.037; [Anonymous], 1996, RAD RISK PERSPECTIVE; BALTHAZAR EJ, 1986, AM J ROENTGENOL, V147, P705, DOI 10.2214/ajr.147.4.705; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Coursey CA, 2010, RADIOLOGY, V254, P460, DOI 10.1148/radiol.09082298; Doria AS, 2006, RADIOLOGY, V241, P83, DOI 10.1148/radiol.2411050913; Flum DR, 2001, JAMA-J AM MED ASSOC, V286, P1748, DOI 10.1001/jama.286.14.1748; GALE ME, 1985, J COMPUT ASSIST TOMO, V9, P34, DOI 10.1097/00004728-198501000-00007; Ganguli S, 2006, RADIOLOGY, V241, P175, DOI 10.1148/radiol.2411050191; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Hlibczuk V, 2010, ANN EMERG MED, V55, P51, DOI 10.1016/j.annemergmed.2009.06.509; Hu H, 1999, MED PHYS, V26, P5, DOI 10.1118/1.598470; Jacobs JE, 2001, RADIOLOGY, V220, P683, DOI 10.1148/radiol.2202001557; Johnson PT, 2009, AM J ROENTGENOL, V192, P893, DOI 10.2214/AJR.08.1685; KALENDER WA, 1990, RADIOLOGY, V176, P181, DOI 10.1148/radiology.176.1.2353088; Keyzer C, 2004, RADIOLOGY, V232, P164, DOI 10.1148/radiol.2321031115; Keyzer C, 2009, AM J ROENTGENOL, V193, P1272, DOI 10.2214/AJR.08.1959; Klingenbeck-Regn K, 1999, EUR J RADIOL, V31, P110, DOI 10.1016/S0720-048X(99)00086-8; Lane MJ, 1999, RADIOLOGY, V213, P341, DOI 10.1148/radiology.213.2.r99nv44341; Lee CC, 2007, ACAD EMERG MED, V14, P117, DOI 10.1197/j.aem.2006.08.007; Lubner MG, 2011, RADIOLOGY; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Mun S, 2006, EMERG RADIOL, V12, P99, DOI 10.1007/s10140-005-0456-6; Nathan RO, 2008, AM J ROENTGENOL, V191, P1102, DOI 10.2214/AJR.07.3466; Nikolaidis P, 2004, AM J ROENTGENOL, V183, P889, DOI 10.2214/ajr.183.4.1830889; Oto A, 2005, RADIOLOGY, V234, P445, DOI 10.1148/radiol.2341032002; Paulson EK, 2005, RADIOLOGY, V235, P879, DOI 10.1148/radiol.2353041231; Paulson EK, 2009, AM J ROENTGENOL, V193, P1268, DOI 10.2214/AJR.09.3313; Pedrosa I, 2006, RADIOLOGY, V238, P891, DOI 10.1148/radiol.2383050146; Raja AS, 2010, RADIOLOGY, V256, P460, DOI 10.1148/radiol.10091570; Raman SS, 2008, NEW ENGL J MED, V358, P972, DOI 10.1056/NEJMc0707000; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1997, RADIOLOGY, V202, P139, DOI 10.1148/radiology.202.1.8988203; Rao PM, 1997, J COMPUT ASSIST TOMO, V21, P686, DOI 10.1097/00004728-199709000-00002; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Rybkin AV, 2007, RADIOL CLIN N AM, V45, P411, DOI 10.1016/j.rcl.2007.04.003; Seo H, 2009, AM J ROENTGENOL, V193, P96, DOI 10.2214/AJR.08.1237; Stengel JW, 2010, RADIOLOGY, V256, P119, DOI 10.1148/radiol.10091229; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; van Randen A, 2010, EUR RADIOL, V20, P1657, DOI 10.1007/s00330-009-1706-x; van Randen A, 2008, RADIOLOGY, V249, P97, DOI 10.1148/radiol.2483071652; Wagner PL, 2008, SURGERY, V144, P276, DOI 10.1016/j.surg.2008.03.040; Weston AR, 2005, INT J TECHNOL ASSESS, V21, P368, DOI 10.1017/S0266462305050488; Wijetunga R, 2001, RADIOLOGY, V221, P747, DOI 10.1148/radiol.2213001581; WOLVERSON MK, 1979, AM J ROENTGENOL, V133, P1089, DOI 10.2214/ajr.133.6.1089	47	128	129	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					789	796		10.7326/0003-4819-154-12-201106210-00006	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690593				2022-12-01	WOS:000291800500014
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA An early warning for Alzheimer's disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3732	10.1136/bmj.d3732	http://dx.doi.org/10.1136/bmj.d3732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677015				2022-12-01	WOS:000291932700010
J	Dupont, S; Morsut, L; Aragona, M; Enzo, E; Giulitti, S; Cordenonsi, M; Zanconato, F; Le Digabel, J; Forcato, M; Bicciato, S; Elvassore, N; Piccolo, S				Dupont, Sirio; Morsut, Leonardo; Aragona, Mariaceleste; Enzo, Elena; Giulitti, Stefano; Cordenonsi, Michelangelo; Zanconato, Francesca; Le Digabel, Jimmy; Forcato, Mattia; Bicciato, Silvio; Elvassore, Nicola; Piccolo, Stefano			Role of YAP/TAZ in mechanotransduction	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL SELF-RENEWAL; CONTACT INHIBITION; ACTIN DYNAMICS; GROWTH-CONTROL; BREAST-CANCER; HIPPO PATHWAY; METASTASIS; TAZ; FORCE	Cells perceive their microenvironment not only through soluble signals but also through physical and mechanical cues, such as extracellular matrix (ECM) stiffness or confined adhesiveness. By mechanotransduction systems, cells translate these stimuli into biochemical signals controlling multiple aspects of cell behaviour, including growth, differentiation and cancer malignant progression, but how rigidity mechanosensing is ultimately linked to activity of nuclear transcription factors remains poorly understood. Here we report the identification of the Yorkie-homologues YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif, also known as WWTR1) as nuclear relays of mechanical signals exerted by ECM rigidity and cell shape. This regulation requires Rho GTPase activity and tension of the actomyosin cytoskeleton, but is independent of the Hippo/LATS cascade. Crucially, YAP/TAZ are functionally required for differentiation of mesenchymal stem cells induced by ECM stiffness and for survival of endothelial cells regulated by cell geometry; conversely, expression of activated YAP overrules physical constraints in dictating cell behaviour. These findings identify YAP/TAZ as sensors and mediators of mechanical cues instructed by the cellular microenvironment.	[Dupont, Sirio; Morsut, Leonardo; Aragona, Mariaceleste; Enzo, Elena; Cordenonsi, Michelangelo; Zanconato, Francesca; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35131 Padua, Italy; [Giulitti, Stefano; Elvassore, Nicola] Univ Padua, Dept Chem Engn DIPIC, I-35131 Padua, Italy; [Le Digabel, Jimmy] Univ Paris Diderot, Lab MSC, F-75205 Paris, France; [Le Digabel, Jimmy] CNRS, UMR 7057, F-75205 Paris, France; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy	University of Padua; University of Padua; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Universita di Modena e Reggio Emilia	Dupont, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35131 Padua, Italy.	dupont@bio.unipd.it; piccolo@bio.unipd.it	Bicciato, Silvio/C-9825-2009; Aragona, Mariaceleste/AAB-7307-2021; BICCIATO, Silvio/J-4466-2019; Dupont, Sirio/AAP-8133-2021; Forcato, Mattia/B-7733-2015; CORDENONSI, MICHELANGELO/K-7692-2016	Bicciato, Silvio/0000-0002-1944-7078; Aragona, Mariaceleste/0000-0002-2239-3541; BICCIATO, Silvio/0000-0002-1944-7078; Forcato, Mattia/0000-0002-7383-6576; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004; Enzo, Elena/0000-0001-9768-6368; CORDENONSI, MICHELANGELO/0000-0002-8253-5724	Telethon and Progetti di Eccellenza; AIRC (Italian Association for Cancer Research); University of Padua; IIT; Telethon; MIUR (Italian Minister of University)	Telethon and Progetti di Eccellenza(Fondazione Telethon); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); University of Padua; IIT(Istituto Italiano di Tecnologia - IIT); Telethon(Fondazione Telethon); MIUR (Italian Minister of University)(Ministry of Education, Universities and Research (MIUR))	We thank G. Scita for advice and gift of reagents; X. Yang for 5SA-YAP1 plasmid; I. Farrance for 4xGTIIC-lux plasmid; H. Miyoshi for pCSII-EF-MCS vector; L. Naldini for pMD2-VSVG vector; R. Treisman for Delta N1+C mDIA, R26D and V159N Actin plasmids; G. Posern for SRF-lux reporter; mouse TAZ and psPAX2 were Addgene plasmid 19025 and 12260. This work was supported by: Telethon and Progetti di Eccellenza CARIPARO grants to N.E.; AIRC (Italian Association for Cancer Research) PI and AIRC Special Program Molecular Clinical Oncology "5 per mille'', University of Padua Strategic grant, IIT Excellence grant and Telethon to S.P.; AIRC PI and MIUR (Italian Minister of University) grants to S.D.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Mackay A, 2003, ONCOGENE, V22, P2680, DOI 10.1038/sj.onc.1206349; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Tse J.R., 2010, CURR PROTOC CELL BIO, V47; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	44	3127	3202	42	922	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					179	U212		10.1038/nature10137	http://dx.doi.org/10.1038/nature10137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654799				2022-12-01	WOS:000291397800042
J	Edlin, BR				Edlin, Brian R.			Test and treat this silent killer	NATURE			English	Editorial Material							HEPATITIS-C VIRUS; INJECTION-DRUG USERS; UNITED-STATES; INFECTION		SUNY Downstate Coll Med, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Edlin, BR (corresponding author), SUNY Downstate Coll Med, New York, NY USA.	brian.edlin@downstate.edu	Edlin, Brian R/F-2966-2018	Edlin, Brian R/0000-0001-8172-8797	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029512, R01DA016159, R01DA021550] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA021550, R01 DA029512, R01 DA016159] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Edlin BR, 2006, CLIN INFECT DIS, V42, P673, DOI 10.1086/499960; Edlin BR, 2005, HEPATOLOGY, V42, p213A; *I MED, 2009, IN NAT PRIOR COMP EF, P126; Institute of Medicine. Hepatitis and Liver Cancer, 2010, HEP LIV CANC NAT STR; McQuillan GM, 1997, J ACQ IMMUN DEF SYND, V14, P355, DOI 10.1097/00042560-199704010-00008; Onofrey Shauna, 2011, Morbidity and Mortality Weekly Report, V60, P537; Pyenson B., 2009, CONSEQUENCES HEPATIT; Tseng FC, 2007, HEPATOLOGY, V46, P666, DOI 10.1002/hep.21765	9	62	63	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S18	S19		10.1038/474S18a	http://dx.doi.org/10.1038/474S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21613999	Green Accepted, Bronze			2022-12-01	WOS:000291397800011
J	Leproult, R; Van Cauter, E				Leproult, Rachel; Van Cauter, Eve			Effect of 1 Week of Sleep Restriction on Testosterone Levels in Young Healthy Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							OLDER MEN		[Leproult, Rachel; Van Cauter, Eve] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Leproult, R (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	evcauter@medicine.bsd.uchicago.edu			NCRR NIH HHS [M01 RR000055, MO1-RR-00055] Funding Source: Medline; NHLBI NIH HHS [R01 HL072694, 5R01HL72694-5] Funding Source: Medline; NIDDK NIH HHS [P60 DK020595, P60DK-020595] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen ML, 2008, SLEEP MED REV, V12, P365, DOI 10.1016/j.smrv.2007.12.003; Axelsson J, 2005, J CLIN ENDOCR METAB, V90, P4530, DOI 10.1210/jc.2005-0520; Bremner WJ, 2010, NEW ENGL J MED, V363, P189, DOI 10.1056/NEJMe1006197; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Penev PD, 2007, SLEEP, V30, P427, DOI 10.1093/sleep/30.4.427	6	149	156	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2011	305	21					2173	2174		10.1001/jama.2011.710	http://dx.doi.org/10.1001/jama.2011.710			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770RN	21632481	Green Accepted, Bronze			2022-12-01	WOS:000291106300017
J	Ruthenburg, AJ; Li, HT; Milne, TA; Dewell, S; McGinty, RK; Yuen, M; Ueberheide, B; Dou, YL; Muir, TW; Patel, DJ; Allis, CD				Ruthenburg, Alexander J.; Li, Haitao; Milne, Thomas A.; Dewell, Scott; McGinty, Robert K.; Yuen, Melanie; Ueberheide, Beatrix; Dou, Yali; Muir, Tom W.; Patel, Dinshaw J.; Allis, C. David			Recognition of a Mononucleosomal Histone Modification Pattern by BPTF via Multivalent Interactions	CELL			English	Article							CHROMATIN REMODELING COMPLEX; PHD FINGER; MASS-SPECTROMETRY; NATIVE CHROMATIN; BINDING MODULES; HUMAN-CELLS; FACTOR NURF; BROMODOMAIN; METHYLATION; LYSINE-4	Little is known about how combinations of histone marks are interpreted at the level of nucleosomes. The second PHD finger of human BPTF is known to specifically recognize histone H3 when methylated on lysine 4 (H3K4me2/3). Here, we examine how additional heterotypic modifications influence BPTF binding. Using peptide surrogates, three acetyllysine ligands are indentified for a PHD-adjacent bromodomain in BPTF via systematic screening and biophysical characterization. Although the bromodomain displays limited discrimination among the three possible acetyllysines at the peptide level, marked selectivity is observed for only one of these sites, H4K16ac, in combination with H3K4me3 at the mononucleosome level. In support, these two histone marks constitute a unique trans-histone modification pattern that unambiguously resides within a single nucleosomal unit in human cells, and this module colocalizes with these marks in the genome. Together, our data call attention to nucleosomal patterning of covalent marks in dictating critical chromatin associations.	[Ruthenburg, Alexander J.; Milne, Thomas A.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [McGinty, Robert K.; Yuen, Melanie; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA; [Ueberheide, Beatrix] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Li, Haitao; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; [Dou, Yali] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10065 USA.	alliscd@rockefeller.edu	Milne, Tom/E-1872-2016; Ruthenburg, Alexander/F-3992-2015; Muir, Tom/AHD-0860-2022; Li, Haitao/B-2668-2012	Milne, Tom/0000-0002-0413-4271; Ruthenburg, Alexander/0000-0003-2709-4564; Muir, Tom/0000-0001-9635-0344; Li, Haitao/0000-0001-6741-293X; Ueberheide, Beatrix/0000-0003-2512-0204	National Center for Research Resources at the National Institutes of Health; Irvington Institute of the Cancer Research Institute; MSTP; NIH; Rockefeller University; Leukemia and Lymphoma Society; Starr Foundation; Abby Rockefeller Mauze Trust; Dewitt Wallace and Maloris Foundations; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, T32GM007739, R01GM040922, R37GM053512] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Irvington Institute of the Cancer Research Institute; MSTP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Starr Foundation; Abby Rockefeller Mauze Trust; Dewitt Wallace and Maloris Foundations; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the staff at beamline 24ID-C of the Advanced Photon Source at the Argonne National Laboratory and the staff at beamline X29 of the National Synchrotron Light Source at Brookhaven National Laboratory, supported by the US Department of Energy, for assistance with data collection. This work is based upon research conducted at the Northeastern Collaborative Access Team (NE-CAT) beamlines of the Advanced Photon Source and the Macromolecular Crystallography Research Resource (PXRR) at the National Synchrotron Light Source, which are supported by the National Center for Research Resources at the National Institutes of Health. We would like to thank L. Liang for assistance in protein production and crystallization of BPTF H4 peptide complexes; H. A. Zebrowski for assistance in the preparation of the SPOT membrane; S. S. Yi of the Microchemistry and Proteomics Core at Memorial-Sloan Kettering Cancer Center for synthesis of peptides; Y. Wei of the Rockefeller Chemical Biology Spectroscopy center for use of their Biacore instrument; S. Yokoyama and H. Kurumizaka for an expression construct bearing codon optimized histone H4; K. Chiang for his 3_601_3_x32 repeat plasmid; M. Vila-Perello for HF cleavage of Boc-peptides; H. Dormann for HP1-chromodomain recombinantly produced protein; H. Yu of the Rockefeller Proteomics Core for MS assistance; C. Wu for the human BPTF cDNA; and L. Baker, F. Casadio, J. Denu, P. W. Lewis, K-M. Noh, R. G. Roeder, R. Sadeh, D. Shechter, T. Swigut, G. G. Wang, and J. Wysocka for valuable discussions and scientific input. A. J. R. is supported by Irvington Institute Fellowship Program of the Cancer Research Institute, and R. K. M. is supported by an MSTP grant. This work was supported by a MERIT grant from the NIH and funds from The Rockefeller University to C. D. A., as well as funds from the Leukemia and Lymphoma Society and Starr Foundation to C. D. A. and D. J. P. D. J. P. is supported by funds from the Abby Rockefeller Mauze Trust and the Dewitt Wallace and Maloris Foundations, and T. W. M. is supported by an award from the NIH. D. J. P. is a consultant in GlaxoSmithKline's epigenetic programs.	Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Bai X, 2007, GENETICS, V176, P1491, DOI 10.1534/genetics.107.071571; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Becker PB, 2006, NATURE, V442, P31, DOI 10.1038/442031a; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Krishnamurthy V. M., 2006, FRAGMENT BASED APPRO, P11, DOI DOI 10.1002/3527608761.CH2; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pesavento JJ, 2006, ANAL CHEM, V78, P4271, DOI 10.1021/ac0600050; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zheng CY, 2004, METHOD ENZYMOL, V375, P179; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	58	240	245	1	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					692	706		10.1016/j.cell.2011.03.053	http://dx.doi.org/10.1016/j.cell.2011.03.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21596426	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000291018600010
J	Seo, JY; Yaneva, R; Hinson, ER; Cresswell, P				Seo, Jun-Young; Yaneva, Rakina; Hinson, Ella R.; Cresswell, Peter			Human Cytomegalovirus Directly Induces the Antiviral Protein Viperin to Enhance Infectivity	SCIENCE			English	Article							AMPHIPATHIC ALPHA-HELIX; ENDOPLASMIC-RETICULUM; ATP DEPLETION; ACTIN CYTOSKELETON; GENE-EXPRESSION; BETA-OXIDATION; MITOCHONDRIA; VIRUS; CELLS; REPLICATION	Viperin is an interferon-inducible protein that is directly induced in cells by human cytomegalovirus (HCMV) infection. Why HCMV would induce viperin, which has antiviral activity, is unknown. We show that HCMV-induced viperin disrupts cellular metabolism to enhance the infectious process. Viperin interaction with the viral protein vMIA resulted in viperin relocalization from the endoplasmic reticulum to the mitochondria. There, viperin interacted with the mitochondrial trifunctional protein that mediates beta-oxidation of fatty acids to generate adenosine triphosphate (ATP). This interaction with viperin, but not with a mutant lacking the viperin iron-sulfur cluster-binding motif, reduced cellular ATP generation, which resulted in actin cytoskeleton disruption and enhancement of infection. This function of viperin, which was previously attributed to vMIA, suggests that HCMV has coopted viperin to facilitate the infectious process.	[Seo, Jun-Young; Yaneva, Rakina; Hinson, Ella R.; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA.	peter.cresswell@yale.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Rahner in the Yale Center for Cell and Molecular Imaging for EM and the Keck Biotechnology Resource Laboratory for protein identification. The work was supported by the Howard Hughes Medical Institute. J.-Y.S. and P. C. conceived the study and designed experiments. J.-Y.S. performed experiments. R.Y. and E. R. H. performed assays and produced reagents. J.-Y.S. and P. C. analyzed and interpreted the data, and wrote the manuscript. All authors contributed to the final version of the manuscript.	AlBarazi HO, 1996, J VIROL, V70, P7198, DOI 10.1128/JVI.70.10.7198-7208.1996; BACALLAO R, 1994, J CELL SCI, V107, P3301; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Boudinot P, 2000, J GEN VIROL, V81, P2675, DOI 10.1099/0022-1317-81-11-2675; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bresnahan WA, 2000, J VIROL, V74, P10816, DOI 10.1128/JVI.74.22.10816-10818.2000; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Colberg-Poley AM, 2000, J GEN VIROL, V81, P1779, DOI 10.1099/0022-1317-81-7-1779; Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Goldmacher VS, 2002, BIOCHIMIE, V84, P177, DOI 10.1016/S0300-9084(02)01367-6; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; GOLENHOFEN N, 1995, KIDNEY INT, V48, P1837, DOI 10.1038/ki.1995.482; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; JONES NL, 1986, EUR J CELL BIOL, V41, P304; Poncet D, 2006, J CELL BIOL, V174, P985, DOI 10.1083/jcb.200604069; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Sharon-Friling R, 2006, P NATL ACAD SCI USA, V103, P19117, DOI 10.1073/pnas.0609353103; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Shelden EA, 2002, J AM SOC NEPHROL, V13, P2667, DOI 10.1097/01.ASN.0000033353.21502.31; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985	30	146	156	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1093	1097		10.1126/science.1202007	http://dx.doi.org/10.1126/science.1202007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527675				2022-12-01	WOS:000290996700047
J	Buchanan, JA; Heard, K; Burbach, C; Wilson, ML; Dart, R				Buchanan, Jennie A.; Heard, Kennon; Burbach, Cynthia; Wilson, Michael L.; Dart, Richard			Prevalence of Levamisole in Urine Toxicology Screens Positive for Cocaine in an Inner-City Hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Buchanan, Jennie A.] Denver Hlth & Hosp Author, Dept Emergency Med, Denver, CO USA; [Buchanan, Jennie A.; Heard, Kennon; Dart, Richard] Rocky Mt Poison & Drug Ctr, Denver, CO USA; [Burbach, Cynthia] Dept Publ Hlth, Denver, CO USA; [Wilson, Michael L.] Denver Hlth & Hosp Author, Dept Pathol, Denver, CO USA	Denver Health Medical Center; Denver Health Medical Center	Buchanan, JA (corresponding author), Denver Hlth & Hosp Author, Dept Emergency Med, Denver, CO USA.	jennie.buchanan3@dhha.org			NIDA NIH HHS [K08 DA020573, K08DA020573, K08 DA020573-05] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA020573] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AMERY WKP, 1992, INT J IMMUNOPHARMACO, V14, P481, DOI 10.1016/0192-0561(92)90179-O; Chang A, 2010, CLIN PHARMACOL THER, V88, P408, DOI 10.1038/clpt.2010.156; *DRUG ENF ADM INT, 2010, DRUG INT BRIEF COC C; Rongioletti F, 1999, BRIT J DERMATOL, V140, P948, DOI 10.1046/j.1365-2133.1999.02833.x; Spector S, 1998, NEUROPSYCHOPHARMACOL, V19, P417, DOI 10.1016/S0893-133X(98)00034-7; Valentino AMM., 2005, MICROGRAM J, V3, P134	6	51	52	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1657	1658		10.1001/jama.2011.531	http://dx.doi.org/10.1001/jama.2011.531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521846				2022-12-01	WOS:000289890500018
J	Spence, D				Spence, Des			FROM THE FRONTLINE The importance of mistrust: drugs of diversion	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 20	2011	342								d2465	10.1136/bmj.d2465	http://dx.doi.org/10.1136/bmj.d2465			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755ON	21508049				2022-12-01	WOS:000289942900011
J	van Kuppeveld, FJM; van der Meer, JWM				van Kuppeveld, Frank J. M.; van der Meer, Jos W. M.			XMRV and CFS-the sad end of a story	LANCET			English	Editorial Material							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; NO ASSOCIATION; RETROVIRUS; FAILURE; ABSENCE; DETECT; BLOOD		[van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [van Kuppeveld, Frank J. M.; van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Kuppeveld, FJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands.	f.vankuppeveld@ncmls.ru.nl	van der Meer, Jos W.M./C-8521-2013	van der Meer, Jos W.M./0000-0001-5120-3690; van Kuppeveld, Frank/0000-0001-5800-749X				Alberts B, 2011, SCIENCE, DOI [10.1126/science.1208542, DOI 10.1126/SCIENCE.1208542]; [Anonymous], 2011, LANCET, V377, P1808, DOI 10.1016/S0140-6736(11)60696-X; [Anonymous], PHOENIX RISING TREAT; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lloyd A, 2010, SCIENCE, V328, DOI 10.1126/science.1183706; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Marcus AD, 2011, WALL STREET J   0531, V31; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Schutzer SE, 2011, ANN NEUROL, V69, P735, DOI 10.1002/ana.22389; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; van Kuppeveld FJ, 2010, BMJ-BRIT MED J, V340, P1018; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	21	11	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					E27	E28		10.1016/S0140-6736(11)60899-4	http://dx.doi.org/10.1016/S0140-6736(11)60899-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	21696817				2022-12-01	WOS:000300187800001
J	Larson, HJ; Cooper, LZ; Eskola, J; Katz, SL; Ratzan, S				Larson, Heidi J.; Cooper, Louis Z.; Eskola, Juhani; Katz, Samuel L.; Ratzan, Scott			New Decade of Vaccines 5 Addressing the vaccine confidence gap	LANCET			English	Article							ADVERSE EVENTS; TRUST; RISK; AUTISM; SAFETY; IMMUNIZATION; EXPERIENCE; RESISTANCE; INDIA	Vaccines-often lauded as one of the greatest public health interventions are losing public confidence. Some vaccine experts have referred to this decline in confidence as a crisis. We discuss some of the characteristics of the changing global environment that are contributing to increased public questioning of vaccines, and outline some of the specific determinants of public trust. Public decision making related to vaccine acceptance is neither driven by scientific nor economic evidence alone, but is also driven by a mix of psychological, sociocultural, and political factors, all of which need to be understood and taken into account by policy and other decision makers. Public trust in vaccines is highly variable and building trust depends on understanding perceptions of vaccines and vaccine risks, historical experiences, religious or political affiliations, and socioeconomic status. Although provision of accurate, scientifically based evidence on the risk benefit ratios of vaccines is crucial, it is not enough to redress the gap between current levels of public confidence in vaccines and levels of trust needed to ensure adequate and sustained vaccine coverage. We call for more research not just on individual determinants of public trust, but on what mix of factors are most likely to sustain public trust. The vaccine community demands rigorous evidence on vaccine efficacy and safety and technical and operational feasibility when introducing a new vaccine, but has been negligent in demanding equally rigorous research to understand the psychological, social, and political factors that affect public trust in vaccines.	[Larson, Heidi J.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Cooper, Louis Z.] Columbia Univ, Coll Phys & Surg, Dept Paediat, New York, NY USA; [Eskola, Juhani] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Katz, Samuel L.] Duke Univ, Dept Paediat, Durham, NC USA; [Ratzan, Scott] Johnson & Johnson, Govt Affairs & Policy, New Brunswick, NJ USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University; Finland National Institute for Health & Welfare; Duke University; Johnson & Johnson; Johnson & Johnson USA	Larson, HJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	heidi.larson@lshtm.ac.uk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583	Bill & Melinda Gates Foundation; Novartis	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novartis(Novartis)	HJL is funded by the Bill & Melinda Gates Foundation as principal investigator for research on public confidence in immunisation. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers. We thank David Salisbury for providing data for figure 2 and for useful discussion on the paper; Anne Louise-Kinmonth for reviewing subsquent drafts; and Pauline Brocard, Lee Barker, Caitlin Jarret, Isaac Ghinai, Jay Dowle, Larry Madoff, Melissa Cumming, and Louise Paushter for researching case studies.; JE received funding from Novartis for a pneumococcal advisory meeting and as a data and safety monitoring board member for meningococcal and typhoid vaccines. SR edits the Journal of Health Communication, with faculty appointments at Tufts School of Medicine and George Washington School of Public Health and Health Services. SR contributed independently of his principal employer, Johnson & Johnson. Some technical work, travel (LZC and SLK), and meetings relevant to this work were funded by the Bill & Melinda Gates Foundation. The funding organisation had no role in the drafting or direction of this report. HJL declares that she has no conflicts of interest.	Akehurst C, 1998, EURO SURVEILL, V2; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; Andrus JK, 2007, PUBLIC HEALTH REP, V122, P811; [Anonymous], MMWR, V581, P357; [Anonymous], J MCCARTHY JOINS DEF; [Anonymous], PROJECT SUPPORT PUBL; Autran B, 2009, EXPERT REV VACCINES, V8, P705, DOI [10.1586/erv.09.40, 10.1586/ERV.09.40]; Bean SJ, 2011, VACCINE, V29, P1874, DOI 10.1016/j.vaccine.2011.01.003; Bedford H, 2000, BMJ-BRIT MED J, V320, P240, DOI 10.1136/bmj.320.7229.240; Bingham A., 2009, OPEN VACCINE J, V2, P1, DOI DOI 10.2174/1875035400902010001; Black S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001738; Campbell P, PHIL T RO A IN PRESS; Centers for Disease Control and Prevention, IMP 1999 AAP USPHS J; Centers for Disease Control and Prevention, THIM VACC JOINT STAT; Chaturvedi S, 2009, INDIAN PEDIATR, V46, P963; Clements CJ, 2003, J MED ETHICS, V29, P22, DOI 10.1136/jme.29.1.22; Closser S, 2010, CHASING POLIO PAKIST; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802; Das J, 2003, SOC SCI MED, V57, P97, DOI 10.1016/S0277-9536(02)00302-7; Davis MM, 2010, VACCINE, V28, P1353, DOI 10.1016/j.vaccine.2009.11.007; Facebook, PRESS ROOM; FLYNN J, 1992, RISK ANAL, V12, P417, DOI 10.1111/j.1539-6924.1992.tb00694.x; Fombonne E, 2008, ARCH GEN PSYCHIAT, V65, P15, DOI 10.1001/archgenpsychiatry.2007.2; Fowler GL, 2007, VACCINE, V25, P3536, DOI 10.1016/j.vaccine.2007.01.082; Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962; GALAZKA AM, 1995, EUR J EPIDEMIOL, V11, P95, DOI 10.1007/BF01719954; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Global Polio Eradication Initiative, REP WHO SECR 60 WORL; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Institute of Medicine, 2004, IMM SAF REV VACC AUT; John J, 2010, INDIAN J MED RES, V132, P463; Kirby D, 2005, EVIDENCE HARM MERCUR; Larson HJ, 2010, LANCET, V376, P572, DOI 10.1016/S0140-6736(10)60881-1; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Lone Z, 2010, INDIAN J MED RES, V132, P1; Lopalco PL, 2009, BUNDESGESUNDHEITSBLA, V52, P1095, DOI 10.1007/s00103-009-0960-z; Martin R, 2009, 4 ANN GLOB IMM M NEW; MCALISTER A, 1982, AM J PUBLIC HEALTH, V72, P43, DOI 10.2105/AJPH.72.1.43; Milstien J, 1995, REPROD HEALTH MATTER, V3, P24; Mnookin S., 2011, PANIC VIRUS; Mudur G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3508; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Offit PA, 2011, DEADLY CHOICES ANTIV; [Anonymous], 2008, Bull World Health Organ, V86, P425; Peters RG, 1997, RISK ANAL, V17, P43, DOI 10.1111/j.1539-6924.1997.tb00842.x; Pidgeon N., 2003, SOCIAL AMPLIFICATION; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Poland GA, 2010, VACCINE, V28, P6549, DOI 10.1016/j.vaccine.2010.08.032; Puliyel J, 2010, INDIAN J MED RES, V131, P588; Puliyel J, 2010, GUARDIAN LONDON 1027; PULIYEL JM, 2010, BMJ-BRIT MED J, V341, P266; SAVAGE I, 1993, RISK ANAL, V13, P413, DOI 10.1111/j.1539-6924.1993.tb00741.x; Saxena KB, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4001; Schechter R, 2008, ARCH GEN PSYCHIAT, V65, P19, DOI 10.1001/archgenpsychiatry.2007.1; Shetty P, 2010, LANCET, V375, P970, DOI 10.1016/S0140-6736(10)60421-7; Spier RE, 2001, VACCINE, V20, pS78, DOI 10.1016/S0264-410X(01)00306-1; Stephens J, 2009, WASHINGTON POST 0731; Stern P. C., 1996, UNDERSTANDING RISK I; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; Taylor S, 2010, J HEALTH COMMUN, V15, P48, DOI 10.1080/10810731003698585; Tollefson J, 2010, NATURE, V466, P24, DOI 10.1038/466024a; UK National Health Service, INCR MMR VACC COV EN; UNICEF, COMB ANT RUM LESS LE; United Nations Educational Scientific and Cultural Organization, 2005, PREC PRINC; US Food and Drug Administration, COMPL LIST VACC LIC; Viral hepatitis prevention board, 1999, VACCINE, V17, P2473; WHO, POL VIR RESP NO BORD; World Health Organization, 2009, STAT WORLDS VACC IMM; World Health Organization, WHO VACC PREV DIS MO; World Health Organization, WHO PREQ VACC; Wright JA, 2006, EUR J PUBLIC HEALTH, V16, P137, DOI 10.1093/eurpub/cki194; Wroe AL, 2005, VACCINE, V23, P1428, DOI 10.1016/j.vaccine.2004.10.004; Yahya M., 2006, 261 I DEV STUD	77	473	477	2	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2011	378	9790					526	535		10.1016/S0140-6736(11)60678-8	http://dx.doi.org/10.1016/S0140-6736(11)60678-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21664679				2022-12-01	WOS:000294077200032
J	Carlet, J; Collignon, P; Goldmann, D; Goossens, H; Gyssens, IC; Harbarth, S; Jarlier, V; Levy, SB; N'Doye, B; Pittet, D; Richtmann, R; Seto, WH; van der Meer, JWM; Voss, A				Carlet, Jean; Collignon, Peter; Goldmann, Don; Goossens, Herman; Gyssens, Inge C.; Harbarth, Stephan; Jarlier, Vincent; Levy, Stuart B.; N'Doye, Babacar; Pittet, Didier; Richtmann, Rosana; Seto, Wing H.; van der Meer, Jos W. M.; Voss, Andreas			Society's failure to protect a precious resource: antibiotics	LANCET			English	Editorial Material							RESISTANCE; EMERGENCE		[Carlet, Jean] WHO, African Partnership Patient Safety Programme, Paris, France; [Collignon, Peter] Canberra Hosp, Infect Dis Unit, Woden, ACT, Australia; [Collignon, Peter] Canberra Hosp, Dept Microbiol, Woden, ACT, Australia; [Collignon, Peter] Australian Natl Univ, Sch Clin Med, Woden, ACT, Australia; [Goldmann, Don] Inst Healthcare Improvement, Cambridge, MA USA; [Goldmann, Don] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Goldmann, Don] Harvard Univ, Sch Med, Boston, MA USA; [Goossens, Herman] Univ Antwerp, Lab Med Microbiol, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Gyssens, Inge C.; van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med & Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gyssens, Inge C.; Voss, Andreas] Hasselt Univ, Diepenbeek, Belgium; [Harbarth, Stephan; Pittet, Didier] Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland; [Harbarth, Stephan; Pittet, Didier] Univ Hosp Geneva, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Harbarth, Stephan; Pittet, Didier] Univ Geneva, Fac Med, Geneva, Switzerland; [Jarlier, Vincent] UPMC Univ Paris, Bacteriol Hyg Pitie Salpetriere Hosp, AP HP, Paris, France; [Levy, Stuart B.] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Boston, MA 02111 USA; [Levy, Stuart B.] Tufts Univ, Sch Med, Dept Mol Biol Microbiol, Boston, MA 02111 USA; [Levy, Stuart B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [N'Doye, Babacar] Minist Sante & Prevent, Programme Natl Lutte Infect Nosocomiales PRONALIN, Dakar, Senegal; [Richtmann, Rosana] Emilio Ribas Infect Dis Inst, Dept Infect Dis, Sao Paulo, Brazil; [Seto, Wing H.] Hong Kong Hosp Author, Dept Qual & Safety, Hong Kong, Hong Kong, Peoples R China	World Health Organization; Australian National University; Canberra Hospital; Australian National University; Canberra Hospital; Australian National University; Institute for Healthcare Improvement; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Antwerp; Radboud University Nijmegen; Hasselt University; University of Geneva; University of Geneva; World Health Organization; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Tufts University; Tufts University; Tufts University	Carlet, J (corresponding author), 9 Rue Terrasse, F-94000 Creteil, France.	jeancarlet@gmail.com	Gyssens, Inge/ABB-9031-2021; Voss, A./H-8111-2014; van der Meer, Jos W.M./C-8521-2013; Gyssens, Inge C.J./L-4343-2015; Collignon, Peter/U-4846-2019	Gyssens, Inge/0000-0002-9226-0752; van der Meer, Jos W.M./0000-0001-5120-3690; Seto, Wing Hong/0000-0002-1139-9200; Collignon, Peter/0000-0001-8648-9203				Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Earnshaw S, 2010, EUROSURVEILLANCE, V14, P23; European Centre for Disease Prevention and Control, ECDC EMEA JOINT TECH; European Centre for Disease Prevention and Control, EARS NET DAT; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grave K, 2010, J ANTIMICROB CHEMOTH, V65, P2037, DOI 10.1093/jac/dkq247; Hughes JM, 2011, JAMA-J AM MED ASSOC, V305, P1027, DOI 10.1001/jama.2011.279; Hulscher MEJL, 2010, LANCET INFECT DIS, V10, P167, DOI 10.1016/S1473-3099(10)70027-X; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; *INF DIS SOC AM, BAD BUGS NO DRUGS; Jajoo M, 2011, PEDIATR INFECT DIS J, V30, P218, DOI 10.1097/INF.0b013e3182064bfe; Johnson PDR, 2010, J INFECT DIS, V202, P1278, DOI 10.1086/656319; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Koo SH, 2010, KOREAN J LAB MED, V30, P498, DOI 10.3343/kjlm.2010.30.5.498; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; KUNIN CM, 1973, ANN INTERN MED, V79, P555, DOI 10.7326/0003-4819-79-4-555; Li JY, 2010, FOODBORNE PATHOG DIS, V7, P1387, DOI 10.1089/fpd.2010.0581; Ofner-Agostini M., 2009, CAN J INFECT DIS MED, V20, P43; Seto WH, 2010, INFECT CONT HOSP EP, V31, P948, DOI 10.1086/655833; Uma B, 2010, INDIAN J GASTROENTER, V29, P201, DOI 10.1007/s12664-010-0044-x; Union. CotE, 2002, OJ L, V45, P13; United States Centers for Disease Prevention and Control, GET SMART PROGR; van Hal SJ, 2011, EUR J CLIN MICROBIOL, V30, P603, DOI 10.1007/s10096-010-1128-3	26	210	226	2	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					369	371		10.1016/S0140-6736(11)60401-7	http://dx.doi.org/10.1016/S0140-6736(11)60401-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21477855				2022-12-01	WOS:000293615800035
J	Rappuoli, R; Black, S; Lambert, PH				Rappuoli, Rino; Black, Steven; Lambert, Paul Henri			New Decade of Vaccines 2 Vaccine discovery and translation of new vaccine technology	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; HEPATITIS-B-VACCINE; INFLUENZA VACCINES; SYSTEMS BIOLOGY; SAFETY; PREVENTION; EFFICACY; DIPHTHERIA; PERTUSSIS; DISEASE	An unprecedented increase in new vaccine development has occurred over the past three decades. This activity has resulted in vaccines that protect against an increased range of vaccine-preventable diseases, vaccines that reduce the number of required injections, and vaccines with improved safety and purity. New methods of discovery, such as reverse vaccinology, structural biology, and systems biology, promise new vaccines for different diseases and efficient development pathways for these vaccines. We expect development of vaccines not only for infectious diseases in children but also for healthy adults, pregnant women, and elderly people, and for new indications such as autoimmune disease and cancer. We have witnessed a concomitant development of new technology for assessment of vaccine safety to rapidly identify potential safety issues. Success of these new approaches will depend on effective implementation of vaccination programmes, creative thinking on the part of manufacturers and regulators as to how best to ensure that safe and effective vaccines are available in a timely manner, and improvement of public awareness about the benefits and risks of new vaccines in a way that encourages confidence in vaccines.	[Rappuoli, Rino] Novartis Vaccines, I-53100 Siena, Italy; [Black, Steven] Univ Cincinnati, Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA; [Lambert, Paul Henri] Univ Geneva, Ctr Vaccinol, Geneva, Switzerland	Novartis; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Geneva	Rappuoli, R (corresponding author), Novartis Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	rino.rappuoli@novartis.com						Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; [Anonymous], 2005, CUTTER INCIDENT AM 1; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; BELL JF, 1949, P SOC EXP BIOL MED, V70, P457, DOI 10.3181/00379727-70-16960; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BLACK SB, 1988, PEDIATR INFECT DIS J, V7, P149, DOI 10.1097/00006454-198803000-00003; Bowden TA, 2010, BIOCHEM SOC T, V38, P1349, DOI 10.1042/BST0381349; Bringmann A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/623687; Burch P, 1994, PROSTATE, V60, P197; Centers for Disease Control and Prevention, 2011, 2011 CHILD AD IMM SC; Centers for Disease Control and Prevention, 2009, PREL RES SURV GUILL; Centers for Disease Control and Prevention, CDC IMM SCHED; Centers for Disease Control and Prevention, ACT BACT COR SURV; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Clark TW, 2009, NEW ENGL J MED, V361, P1; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FENNER F, 1982, REV INFECT DIS, V4, P916; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Galazka AM, 1996, VACCINE, V14, P845, DOI 10.1016/0264-410X(96)00021-7; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goodman JL, M CHALLENGE PANDEMIC; Greco M, 2009, NEW GENERATION VACCI; HALLIDAY ML, 1990, ARCH INTERN MED, V150, P1195, DOI 10.1001/archinte.150.6.1195; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Immunization Action Coalition, HIST DAT EV REL VACC; Kamath AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005771; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kirkwood BR, 1995, B WORLD HEALTH ORGAN, V73, P793; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; MacDonald NE, 1998, JAMA-J AM MED ASSOC, V280, P1685, DOI 10.1001/jama.280.19.1685; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; NEDELEC J, 1990, J NEUROIMMUNOL, V29, P49, DOI 10.1016/0165-5728(90)90146-E; PIALOUX G, 1995, AIDS RES HUM RETROV, V11, P875; Plotkin S., 2008, VACCINES, P1; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Roberts L, 2008, SCIENCE, V320, P1712, DOI 10.1126/science.320.5884.1712; Rosenthal S, 1996, ARCH PEDIAT ADOL MED, V150, P457, DOI 10.1001/archpedi.1996.02170300011001; Serruto D, 2006, FEBS LETT, V580, P2985, DOI 10.1016/j.febslet.2006.04.084; STEVENS CE, 1987, JAMA-J AM MED ASSOC, V257, P2612, DOI 10.1001/jama.257.19.2612; Su LL, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61854-7; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; Tsai T, 2010, VACCINE, V28, P1877, DOI 10.1016/j.vaccine.2009.11.077; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Wenger JD, 1998, PEDIATR INFECT DIS J, V17, pS132, DOI 10.1097/00006454-199809001-00008; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514; Zepp F, 2010, VACCINE, V28, pC14, DOI 10.1016/j.vaccine.2010.07.020; Zhang QB, 2010, J INFECT DIS, V201, P1753, DOI 10.1086/652495; Zhu W, 2010, VACCINE, V28, P2865, DOI 10.1016/j.vaccine.2010.01.060	61	66	69	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					360	368		10.1016/S0140-6736(11)60440-6	http://dx.doi.org/10.1016/S0140-6736(11)60440-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21664687				2022-12-01	WOS:000293615800034
J	McGraw, CM; Samaco, RC; Zoghbi, HY				McGraw, Christopher M.; Samaco, Rodney C.; Zoghbi, Huda Y.			Adult Neural Function Requires MeCP2	SCIENCE			English	Article							RETT-SYNDROME; MOUSE		[McGraw, Christopher M.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [McGraw, Christopher M.; Samaco, Rodney C.; Zoghbi, Huda Y.] Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [McGraw, Christopher M.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Samaco, Rodney C.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Samaco, Rodney/0000-0001-5636-5314	NIH [NS057819, HD024064, F31-NS073317, T32-NS043124]; International Rett Syndrome Foundation; Simons Foundation; Rett Syndrome Research Trust; Baylor Research Advocates for Student Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073317, T32NS043124, R01NS057819] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation; Simons Foundation; Rett Syndrome Research Trust; Baylor Research Advocates for Student Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Baker, Y. Lee, A. Flora, and L. Chen for discussions and NIH (grants NS057819, HD024064 to H.Z.; F31-NS073317 to C.M.; T32-NS043124 to R.S.), Baylor Research Advocates for Student Scientists (C.M.), International Rett Syndrome Foundation, Simons Foundation, and Rett Syndrome Research Trust (H.Z.) for support.	Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	6	184	189	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					186	186		10.1126/science.1206593	http://dx.doi.org/10.1126/science.1206593			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636743	Green Accepted			2022-12-01	WOS:000292502700039
J	Passacquale, G; Ferro, A				Passacquale, Gabriella; Ferro, Albert			THERAPEUTICS Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; COST-EFFECTIVENESS; ASPIRIN; THERAPY		[Passacquale, Gabriella; Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London SE1 9NH, England	University of London; King's College London	Ferro, A (corresponding author), Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London SE1 9NH, England.	albert.ferro@kcl.ac.uk		Ferro, Albert/0000-0002-5486-9145				[Anonymous], 2009, PRAS TREATM AC COR S; Barnett H, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1805; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Berg J, 2008, CURR MED RES OPIN, V24, P2089, DOI 10.1185/03007990802222261 ; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Farid NA, 2010, J CLIN PHARMACOL, V50, P126, DOI 10.1177/0091270009343005; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Heeg BMS, 2007, PHARMACOECONOMICS, V25, P769, DOI 10.2165/00019053-200725090-00005; Jolly SS, 2009, EUR HEART J, V30, P900, DOI 10.1093/eurheartj/ehn417; McCarthy MW, 2003, ANN PHARMACOTHER, V37, P216; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; *NAT I HLTH CLIN E, AC COR SYND IN PRESS; National Institute for Health and Clinical Excellence, 2010, CLOP MOD REL DIP PRE; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Serebruany VL, 2010, CIRCULATION, V122, pE436, DOI 10.1161/CIRCULATIONAHA.110.936757; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; WHO, 2000, WHO DRUG INFORM, V14; Williams ET, 2008, DRUG METAB DISPOS, V36, P1227, DOI 10.1124/dmd.107.020248; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	32	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2011	342								d3488	10.1136/bmj.d3488	http://dx.doi.org/10.1136/bmj.d3488			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781LH	21685436				2022-12-01	WOS:000291933200002
J	Skarnes, WC; Rosen, B; West, AP; Koutsourakis, M; Bushell, W; Iyer, V; Mujica, AO; Thomas, M; Harrow, J; Cox, T; Jackson, D; Severin, J; Biggs, P; Fu, J; Nefedov, M; de Jong, PJ; Stewart, AF; Bradley, A				Skarnes, William C.; Rosen, Barry; West, Anthony P.; Koutsourakis, Manousos; Bushell, Wendy; Iyer, Vivek; Mujica, Alejandro O.; Thomas, Mark; Harrow, Jennifer; Cox, Tony; Jackson, David; Severin, Jessica; Biggs, Patrick; Fu, Jun; Nefedov, Michael; de Jong, Pieter J.; Stewart, A. Francis; Bradley, Allan			A conditional knockout resource for the genome-wide study of mouse gene function	NATURE			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; CAENORHABDITIS-ELEGANS; NEGATIVE SELECTION; RAT BLASTOCYSTS; EXPRESSION; TRAP; MICE; REPORTER; VECTOR	Gene targeting in embryonic stem cells has become the principal technology for manipulation of the mouse genome, offering unrivalled accuracy in allele design and access to conditional mutagenesis. To bring these advantages to the wider research community, large-scale mouse knockout programmes are producing a permanent resource of targeted mutations in all protein-coding genes. Here we report the establishment of a high-throughput gene-targeting pipeline for the generation of reporter-tagged, conditional alleles. Computational allele design, 96-well modular vector construction and high-efficiency gene-targeting strategies have been combined to mutate genes on an unprecedented scale. So far, more than 12,000 vectors and 9,000 conditional targeted alleles have been produced in highly germline-competent C57BL/6N embryonic stem cells. High-throughput genome engineering highlighted by this study is broadly applicable to rat and human stem cells and provides a foundation for future genome-wide efforts aimed at deciphering the function of all genes encoded by the mammalian genome.	[Skarnes, William C.; Rosen, Barry; West, Anthony P.; Koutsourakis, Manousos; Bushell, Wendy; Iyer, Vivek; Mujica, Alejandro O.; Thomas, Mark; Harrow, Jennifer; Cox, Tony; Jackson, David; Severin, Jessica; Biggs, Patrick; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fu, Jun; Stewart, A. Francis] Tech Univ Dresden, Biotechnol Zentrum, D-01062 Dresden, Germany; [Nefedov, Michael; de Jong, Pieter J.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Wellcome Trust Sanger Institute; Technische Universitat Dresden; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Skarnes, WC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	skarnes@sanger.ac.uk	Fu, Jun/C-9133-2011; Severin, Jessica/AAQ-2723-2020; Biggs, Patrick Jon/H-3355-2014; Stewart, A. Francis/E-7789-2010	Severin, Jessica/0000-0003-1274-208X; Biggs, Patrick Jon/0000-0002-0285-4101; Mott, Richard/0000-0002-1022-9330; Thomas, Mark/0000-0001-7267-6884; Jackson, David/0000-0002-8090-9462; Harrow, Jennifer/0000-0003-0338-3070; Bradley, Allan/0000-0002-2349-8839	Wellcome Trust Sanger Institute; National Institutes of Health (KOMP) [U01-HG004080]; EU; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004080] Funding Source: NIH RePORTER	Wellcome Trust Sanger Institute(Wellcome Trust); National Institutes of Health (KOMP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the following people for technical assistance: D. Klose, D. Oakley, W. Yang and L. Stebbings for informatics/vector design; R. Bennett, A. Horton and A. van Brunt for manual gene annotation/vector design; L. Cho, R. Li, J.-F. Popoff, M. Sharma and Y. Zhang for recombineering; G. Belteki, P. Tate, Y. Bekele and S. Borchia for targeting vectors; D. Fraser, J. Greystrong, N. Gueorguieva, M. Jackson, P. Ramagiri, I. Walczak, J. Woodward, E. Stebbings, M. Martinez, A. Tsang and Y. Yoshinaga for vector/ES quality control; and D. Edwards, S. Harris, N. Krishnappa, R. Leah and A. Tait for ES cells. We are grateful for advice on the Gateway system from J. Chesnut of Invitrogen. Finally, we wish to thank W. Wurst, K. Lloyd, and our EUCOMM and KOMP colleagues who are contributing to the production and distribution of the conditional knockout resource. This work was funded by the Wellcome Trust Sanger Institute, grants from the National Institutes of Health (KOMP, U01-HG004080 to W. C. S., P.J.d.J. and A. B.) from the EU Sixth Framework Programme (EUCOMM, to W.C.S., A.F.S. and A.B.).	Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586; Hope IA, 2004, GENOME RES, V14, P2070, DOI 10.1101/gr.2463804; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; Lay JM, 1998, TRANSGENIC RES, V7, P135, DOI 10.1023/A:1008876526826; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Osoegawa K, 2000, GENOME RES, V10, P116; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Skarnes WC, 2005, P NATL ACAD SCI USA, V102, P13001, DOI 10.1073/pnas.0506279102; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843; Yang SH, 2009, TRANSGENIC RES, V18, P483, DOI 10.1007/s11248-008-9237-9; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	48	1112	1159	3	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					337	U361		10.1038/nature10163	http://dx.doi.org/10.1038/nature10163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677750	Green Accepted			2022-12-01	WOS:000291647100037
J	Raghavan, R; Nuila, R				Raghavan, Rajeev; Nuila, Ricardo			Survivors - Dialysis, Immigration, and U.S. Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raghavan, Rajeev; Nuila, Ricardo] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Raghavan, Rajeev] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [Nuila, Ricardo] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Raghavan, R (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.							Campbell GA, 2010, AM J KIDNEY DIS, V55, P181, DOI 10.1053/j.ajkd.2009.06.039; Goldberg AM, 2007, TRANSPLANTATION, V83, P17, DOI 10.1097/01.tp.0000247795.41898.55; Raghavan R, 2011, DIALYSIS TRANSPLANT, V40, P78, DOI 10.1002/dat.20535; Sheikh-Hamad David, 2007, Tex Med, V103, P54; USRDS, 2008, ANN DAT REP ATL CHRO	5	23	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2183	2185		10.1056/NEJMp1101195	http://dx.doi.org/10.1056/NEJMp1101195			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21651391				2022-12-01	WOS:000291392100004
J	Stiopkin, IV; Weeraman, C; Pieniazek, PA; Shalhout, FY; Skinner, JL; Benderskii, AV				Stiopkin, Igor V.; Weeraman, Champika; Pieniazek, Piotr A.; Shalhout, Fadel Y.; Skinner, James L.; Benderskii, Alexander V.			Hydrogen bonding at the water surface revealed by isotopic dilution spectroscopy	NATURE			English	Article							ULTRAFAST INFRARED-SPECTROSCOPY; SUM-FREQUENCY GENERATION; MOLECULAR-DYNAMICS SIMULATIONS; LIQUID WATER; VIBRATIONAL SPECTROSCOPY; LINE-SHAPES; INTERFACE; SPECTRUM; H2O; D2O	The air-water interface is perhaps the most common liquid interface. It covers more than 70 per cent of the Earth's surface and strongly affects atmospheric, aerosol and environmental chemistry. The air-water interface has also attracted much interest as a model system that allows rigorous tests of theory, with one fundamental question being just how thin it is. Theoretical studies have suggested a surprisingly short 'healing length' of about 3 angstroms (1 angstrom = 0.1 nm), with the bulk-phase properties of water recovered within the top few monolayers(1-3). However, direct experimental evidence has been elusive owing to the difficulty of depth-profiling the liquid surface on the angstrom scale. Most physical, chemical and biological properties of water, such as viscosity, solvation, wetting and the hydrophobic effect, are determined by its hydrogen-bond network. This can be probed by observing the lineshape of the OH-stretch mode, the frequency shift of which is related to the hydrogen-bond strength(4-6). Here we report a combined experimental and theoretical study of the air-water interface using surface-selective heterodyne-detected vibrational sum frequency spectroscopy to focus on the 'free OD' transition found only in the topmost water layer. By using deuterated water and isotopic dilution to reveal the vibrational coupling mechanism, we find that the free OD stretch is affected only by intramolecular coupling to the stretching of the other OD group on the same molecule. The other OD stretch frequency indicates the strength of one of the first hydrogen bonds encountered at the surface; this is the donor hydrogen bond of the water molecule straddling the interface, which we find to be only slightly weaker than bulk-phase water hydrogen bonds. We infer from this observation a remarkably fast onset of bulk-phase behaviour on crossing from the air into the water phase.	[Stiopkin, Igor V.; Weeraman, Champika; Shalhout, Fadel Y.; Benderskii, Alexander V.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Pieniazek, Piotr A.; Skinner, James L.] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	Wayne State University; University of Wisconsin System; University of Wisconsin Madison	Benderskii, AV (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	alex.benderskii@usc.edu			NSF [CHE-0449720, CHE-0750307]; DOE [DE-FG02-09ER16110]	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	The experiments presented here were supported by the NSF CAREER grant number CHE-0449720 (I.V.S., C.W., F.Y.S. and A.V.B.). J.L.S. thanks the NSF and the DOE for support from grants CHE-0750307 and DE-FG02-09ER16110, respectively.	Auer BM, 2009, J PHYS CHEM B, V113, P4125, DOI 10.1021/jp806644x; Auer BM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3012568; Barker EF, 1935, J CHEM PHYS, V3, P660, DOI 10.1063/1.1749572; Corcelli SA, 2005, J PHYS CHEM A, V109, P6154, DOI 10.1021/jp0506540; Corcelli SA, 2004, J CHEM PHYS, V120, P8107, DOI 10.1063/1.1683072; DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; DU Q, 1993, PHYS REV LETT, V70, P2313, DOI 10.1103/PhysRevLett.70.2313; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Gan W, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2179794; Ishiyama T, 2009, J PHYS CHEM C, V113, P16299, DOI 10.1021/jp9060957; Lawrence CP, 2003, CHEM PHYS LETT, V369, P472, DOI 10.1016/S0009-2614(02)02039-0; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Loparo JJ, 2007, CHEM PHYS, V341, P218, DOI 10.1016/j.chemphys.2007.06.056; Max JJ, 2002, J CHEM PHYS, V116, P4626, DOI 10.1063/1.1448286; Morita A, 2000, CHEM PHYS, V258, P371, DOI 10.1016/S0301-0104(00)00127-0; Nagata Y, 2010, J AM CHEM SOC, V132, P6434, DOI 10.1021/ja100508n; Nihonyanagi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3135147; Ostroverkhov V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.046102; Raymond EA, 2003, J PHYS CHEM B, V107, P546, DOI 10.1021/jp021366w; Rey R, 2002, J PHYS CHEM A, V106, P11993, DOI 10.1021/jp026419o; Richmond GL, 2002, CHEM REV, V102, P2693, DOI 10.1021/cr0006876; Shimanouchi T., 1972, TABLES MOL VIBRATION, V1, P1; Skinner JL, 2009, ADV CHEM PHYS, V142, P59, DOI 10.1002/9780470475935.ch2; Sovago M, 2009, CHEM PHYS LETT, V470, P7, DOI 10.1016/j.cplett.2009.01.009; Stiopkin IV, 2008, J AM CHEM SOC, V130, P2271, DOI 10.1021/ja076708w; Stiopkin IV, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3432776; Taylor RS, 1996, J PHYS CHEM-US, V100, P11720, DOI 10.1021/jp960615b; Tian CS, 2009, J AM CHEM SOC, V131, P2790, DOI 10.1021/ja809497y; TOWNSEND RM, 1985, J CHEM PHYS, V82, P4391, DOI 10.1063/1.448808; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058	30	308	309	7	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					192	195		10.1038/nature10173	http://dx.doi.org/10.1038/nature10173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654801				2022-12-01	WOS:000291397800045
J	Zhao, TB; Zhang, ZN; Rong, ZL; Xu, Y				Zhao, Tongbiao; Zhang, Zhen-Ning; Rong, Zhili; Xu, Yang			Immunogenicity of induced pluripotent stem cells	NATURE			English	Article							GENERATION; FIBROBLASTS; EXPRESSION	Induced pluripotent stem cells (iPSCs), reprogrammed from somatic cells with defined factors, hold great promise for regenerative medicine as the renewable source of autologous cells(1-5). Whereas it has been generally assumed that these autologous cells should be immune-tolerated by the recipient from whom the iPSCs are derived, their immunogenicity has not been vigorously examined. We show here that, whereas embryonic stem cells (ESCs) derived from inbred C57BL/6 (B6) mice can efficiently form teratomas in B6 mice without any evident immune rejection, the allogeneic ESCs from 129/SvJ mice fail to form teratomas in B6 mice due to rapid rejection by recipients. B6 mouse embryonic fibroblasts (MEFs) were reprogrammed into iPSCs by either retroviral approach (ViPSCs) or a novel episomal approach (EiPSCs) that causes no genomic integration. In contrast to B6 ESCs, teratomas formed by B6 ViPSCs were mostly immune-rejected by B6 recipients. In addition, the majority of teratomas formed by B6 EiPSCs were immunogenic in B6 mice with T cell infiltration, and apparent tissue damage and regression were observed in a small fraction of teratomas. Global gene expression analysis of teratomas formed by B6 ESCs and EiPSCs revealed a number of genes frequently over-expressed in teratomas derived from EiPSCs, and several such gene products were shown to contribute directly to the immunogenicity of the B6 EiPSC-derived cells in B6 mice. These findings indicate that, in contrast to derivatives of ESCs, abnormal gene expression in some cells differentiated from iPSCs can induce T-cell-dependent immune response in syngeneic recipients. Therefore, the immunogenicity of therapeutically valuable cells derived from patient-specific iPSCs should be evaluated before any clinical application of these autologous cells into the patients.	[Zhao, Tongbiao; Zhang, Zhen-Ning; Rong, Zhili; Xu, Yang] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	Zhao, Tongbiao/C-5761-2011; Rong, Zhili/H-7561-2014; liang, yan/H-3894-2011	Zhao, Tongbiao/0000-0003-1429-5818; Rong, Zhili/0000-0002-1699-7074; Zhang, Zhen-Ning/0000-0003-3798-7104; Xu, Yang/0000-0001-5574-921X	NIH; California Institute for Regenerative Medicine [ET-01277]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	We thank M. Abe, S. Ding and K. Hochedlinger for their generous supply of integration-free mouse iPSCs. We thank N. Shastri for his advice on how to identify antigen-specific T cells. We thank J. Fink and Blue Lake of Xu laboratory as well as UCSD Cancer Center pathologic core for technical support. This work was supported by a NIH grant and an Early Translational Award from California Institute for Regenerative Medicine to Y.X. (ET-01277).	Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Jincho Y, 2010, J BIOL CHEM, V285, P26384, DOI 10.1074/jbc.M110.115915; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kont V, 2008, MOL IMMUNOL, V45, P25, DOI 10.1016/j.molimm.2007.05.014; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	23	1000	1051	3	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					212	U251		10.1038/nature10135	http://dx.doi.org/10.1038/nature10135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21572395	Green Published			2022-12-01	WOS:000291397800050
J	Wittner, M; Hamperl, S; Stockl, U; Seufert, W; Tschochner, H; Milkereit, P; Griesenbeck, J				Wittner, Manuel; Hamperl, Stephan; Stoeckl, Ulrike; Seufert, Wolfgang; Tschochner, Herbert; Milkereit, Philipp; Griesenbeck, Joachim			Establishment and Maintenance of Alternative Chromatin States at a Multicopy Gene Locus	CELL			English	Article							RIBOSOMAL-RNA GENES; POLYMERASE-I TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; ACTIVE GENES; PROTEIN HMO1; BOX PROTEIN; YEAST; RDNA; UBF	In eukaryotes, each of the more than 100 copies of ribosomal RNA (rRNA) genes exists in either an RNA polymerase I transcribed open chromatin state or a nucleosomal, closed chromatin state. Open rRNA genes guarantee the cell's supply with structural components of the ribosome, whereas closed rRNA genes ensure genomic integrity. We report that the observed balance between open and closed rRNA gene chromatin states in proliferating yeast cells is due to a dynamic equilibrium of transcription-dependent removal and replication-dependent assembly of nucleosomes. Pol I transcription is required for the association of the HMG box protein Hmo1 with open rRNA genes, counteracting replication-independent nucleosome deposition and maintaining the open rRNA gene chromatin state outside of S phase. The findings indicate that the opposing effects of replication and transcription lead to a de novo establishment of chromatin states for rRNA genes during each cell cycle.	[Wittner, Manuel; Hamperl, Stephan; Stoeckl, Ulrike; Tschochner, Herbert; Milkereit, Philipp; Griesenbeck, Joachim] Univ Regensburg, Inst Biochem Genet & Mikrobiol, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany; [Seufert, Wolfgang] Univ Regensburg, Inst Biochem Genet & Mikrobiol, Lehrstuhl Genet, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Milkereit, P (corresponding author), Univ Regensburg, Inst Biochem Genet & Mikrobiol, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany.	philipp.milkereit@vkl.uni-regensburg.de; joachim.griesenbeck@vkl.uni-regensburg.de	Seufert, Wolfgang/F-7136-2019	Seufert, Wolfgang/0000-0001-8938-9064; Griesenbeck, Joachim/0000-0002-7817-6095; Hamperl, Stephan/0000-0002-1658-7948	DFG research unit [FOR 1068]; Elitenetzwerk Bayern	DFG research unit(German Research Foundation (DFG)); Elitenetzwerk Bayern	We would like to thank Drs. M. Nomura and K. Yankulov for providing yeast strains and plasmids. We are grateful to colleagues at the department of Biochemistry III at the University of Regensburg for discussions. We thank Dr. H. Richter for help with flow cytometric analyses. We acknowledge Drs. A. Conconi and A. Ehrensberger for comments on the manuscript. This work was supported by a grant in the context of the DFG research unit FOR 1068 (J.G.). M. W. received a fellowship of the Elitenetzwerk Bayern.	Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; Birch JL, 2008, BIOCHEM SOC T, V36, P619, DOI 10.1042/BST0360619; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Brown SE, 2008, CELL CYCLE, V7, P382, DOI 10.4161/cc.7.3.5283; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; DAMMANN R, 1995, MOL CELL BIOL, V15, P5294; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; DAVIS AH, 1983, J MOL BIOL, V167, P133, DOI 10.1016/S0022-2836(83)80038-2; Fahy D, 2005, EXP CELL RES, V305, P365, DOI 10.1016/j.yexcr.2005.01.016; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Gadal O, 2002, EMBO J, V21, P5498, DOI 10.1093/emboj/cdf539; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; GebraneYounes J, 1997, J CELL SCI, V110, P2429; Geil C, 2008, CURR BIOL, V18, P1001, DOI 10.1016/j.cub.2008.06.025; Goetze H, 2010, MOL CELL BIOL, V30, P2028, DOI 10.1128/MCB.01512-09; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Kamau E, 2004, J BIOL CHEM, V279, P55234, DOI 10.1074/jbc.M409459200; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Lu J, 1996, J BIOL CHEM, V271, P33678, DOI 10.1074/jbc.271.52.33678; Lucchini R, 2001, EMBO J, V20, P7294, DOI 10.1093/emboj/20.24.7294; LUCCHINI R, 1995, NATURE, V374, P276, DOI 10.1038/374276a0; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nemeth A, 2008, EPIGENETICS-US, V3, P243, DOI 10.4161/epi.3.5.6913; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Philippi A, 2010, NUCL ACIDS RES; Raska I, 2004, BIOL CELL, V96, P579, DOI 10.1016/j.biolcel.2004.04.015; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Stancheva I, 1997, NUCLEIC ACIDS RES, V25, P1727, DOI 10.1093/nar/25.9.1727; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x	41	54	54	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					543	554		10.1016/j.cell.2011.03.051	http://dx.doi.org/10.1016/j.cell.2011.03.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565613	Bronze			2022-12-01	WOS:000290560800008
J	Bendall, SC; Simonds, EF; Qiu, P; Amir, EAD; Krutzik, PO; Finck, R; Bruggner, RV; Melamed, R; Trejo, A; Ornatsky, OI; Balderas, RS; Plevritis, SK; Sachs, K; Pe'er, D; Tanner, SD; Nolan, GP				Bendall, Sean C.; Simonds, Erin F.; Qiu, Peng; Amir, El-ad D.; Krutzik, Peter O.; Finck, Rachel; Bruggner, Robert V.; Melamed, Rachel; Trejo, Angelica; Ornatsky, Olga I.; Balderas, Robert S.; Plevritis, Sylvia K.; Sachs, Karen; Pe'er, Dana; Tanner, Scott D.; Nolan, Garry P.			Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum	SCIENCE			English	Article							TYROSINE KINASE INHIBITOR; FLOW-CYTOMETRY; SIGNALING NETWORKS; QUANTITATIVE-ANALYSIS; MYELOGENOUS LEUKEMIA; STEM-CELLS; IDENTIFICATION; LYMPHOCYTE; DASATINIB; ACTIVATION	Flow cytometry is an essential tool for dissecting the functional complexity of hematopoiesis. We used single-cell "mass cytometry" to examine healthy human bone marrow, measuring 34 parameters simultaneously in single cells (binding of 31 antibodies, viability, DNA content, and relative cell size). The signaling behavior of cell subsets spanning a defined hematopoietic hierarchy was monitored with 18 simultaneous markers of functional signaling states perturbed by a set of ex vivo stimuli and inhibitors. The data set allowed for an algorithmically driven assembly of related cell types defined by surface antigen expression, providing a superimposable map of cell signaling responses in combination with drug inhibition. Visualized in this manner, the analysis revealed previously unappreciated instances of both precise signaling responses that were bounded within conventionally defined cell subsets and more continuous phosphorylation responses that crossed cell population boundaries in unexpected manners yet tracked closely with cellular phenotype. Collectively, such single-cell analyses provide system-wide views of immune signaling in healthy human hematopoiesis, against which drug action and disease can be compared for mechanistic studies and pharmacologic intervention.	[Bendall, Sean C.; Simonds, Erin F.; Krutzik, Peter O.; Finck, Rachel; Bruggner, Robert V.; Trejo, Angelica; Sachs, Karen; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Qiu, Peng; Plevritis, Sylvia K.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Amir, El-ad D.; Melamed, Rachel; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Ornatsky, Olga I.; Tanner, Scott D.] Univ Toronto, Toronto, ON M5S 3H6, Canada; [Ornatsky, Olga I.; Tanner, Scott D.] DVS Sci, Markham, ON L3R 6E7, Canada; [Balderas, Robert S.] BD Biosci, San Diego, CA 95131 USA; [Bruggner, Robert V.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Columbia University; University of Toronto; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Bendall, Sean/AGG-0126-2022; Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; Altan-Bonnet, Gregoire/0000-0002-7283-3162; Bendall, Sean/0000-0003-1341-2453; Melamed, Rachel/0000-0003-3089-9806; Pe'er, Dana/0000-0002-9259-8817; Simonds, Erin/0000-0002-3497-4861	Damon Runyon Cancer Research Foundation [DRG-2017-09]; NIH [U19 AI057229, P01 CA034233, 272200700038C, 1R01CA130826, U54 CA149145, 5U54 CA143907, RB2-01592, PN2 EY018228, NOI-HV-00242]; European Commission [HEALTH.2010.1.2-1]; California Institute for Regenerative Medicine [RB2-01592, DR-01477]; Genome Canada via the Ontario Genomics Institute for Cancer Research; Ontario Research Fund [ORF-GL2-01-003]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE [U54CA149145, P01CA034233, R01CA130826, U54CA143907] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Genome Canada via the Ontario Genomics Institute for Cancer Research; Ontario Research Fund; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank W. J. Fantl for critical reading of the. manuscript. S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). This work was supported by NIH grants, U19 AI057229, P01 CA034233, 272200700038C, 1R01CA130826, U54 CA149145, 5U54 CA143907, RB2-01592, PN2 EY018228, NOI-HV-00242, and HEALTH.2010.1.2-1 (European Commission grant to the Sweden Diatools Consortium), as well as California Institute for Regenerative Medicine (DR-01477, RB2-01592) to G.P.N. G.P.N. is supported by an endowed chair from Rachtford and Carlota A. Harris. S.D.T. was supported by Genome Canada via the Ontario Genomics Institute for Cancer Research and by the Ontario Research Fund ORF-GL2-01-003. D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering. Some antibodies were a gift from Becton Dickinson Biosciences. B.B. is a paid employee of Becton Dickinson, and G.P.N. and P.K. are paid consultants for Becton Dickinson Biosciences. G.P.N. is a member of the Board of Directors and a consultant for DVS Sciences. O.O., G.P.N., and S.T. have equity holdings in DVS Biosciences, and S.T. is an employee of DVS Sciences A patent has been applied for on the SPADE algorithm on behalf of Stanford University. Raw data and SPADE trees can be downloaded open access at www.cytobank.org/nolanlab.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Dohse M, 2010, DRUG METAB DISPOS, V38, P1371, DOI 10.1124/dmd.109.031302; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; Gibbs KD, 2011, BLOOD, V117, P4226, DOI 10.1182/blood-2010-07-298232; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HERZENBERG LA, 1973, J EXP MED, V137, P1311, DOI 10.1084/jem.137.6.1311; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KONDO M, 2003, Nat Med, V21, P2; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; KRASNOW MA, 1991, SCIENCE, V251, P81, DOI 10.1126/science.1898782; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lemischka IR, 2005, ANN NY ACAD SCI, V1044, P132, DOI 10.1196/annals.1349.017; Lindauer M, 2010, RECENT RESULTS CANC, V184, P83, DOI 10.1007/978-3-642-01222-8_7; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Nam S, 2007, MOL CANCER THER, V6, P1400, DOI 10.1158/1535-7163.MCT-06-0446; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Quintas-Cardama A, 2009, BLOOD, V114, P261, DOI 10.1182/blood-2008-09-180604; Robinson JP, 2005, CYTOM PART A, V67A, P61, DOI 10.1002/cyto.a.20183; Roederer M, 1997, Semin Immunol, V9, P389, DOI 10.1006/smim.1997.0097; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Russwurm G, 2010, BLOOD, V116, P2617, DOI 10.1182/blood-2010-04-279786; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schade AE, 2008, BLOOD, V111, P1366, DOI 10.1182/blood-2007-04-084814; Shapiro H.M., 2003, PRACTICAL FLOW CYTOM; Sillaber C, 2009, EUR J CLIN INVEST, V39, P1098, DOI 10.1111/j.1365-2362.2009.02206.x; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takano K, 2000, INT J HEMATOL, V72, P48; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tarnok A, 2010, CYTOM PART A, V77A, P6, DOI 10.1002/cyto.a.20844; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Yang C, 2008, LEUKEMIA, V22, P1755, DOI 10.1038/leu.2008.163	54	1575	1656	29	654	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					687	696		10.1126/science.1198704	http://dx.doi.org/10.1126/science.1198704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551058	Green Accepted, Green Submitted			2022-12-01	WOS:000290265800035
J	Fitzpatrick, K				Fitzpatrick, Kevin			Should the law on assisted dying be changed? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Not Dead Yet UK, Reynoldston, Wales		Fitzpatrick, K (corresponding author), Not Dead Yet UK, Reynoldston, Wales.	kevin@inclusion21.org						CAMPBELL J, 2006, HMV UK M ST THOM HOS; O'Neill O, 2010, AUTONOMY ASSISTED SU; Tiernan E, 2002, J ROY SOC MED, V95, P386, DOI 10.1258/jrsm.95.8.386; Wittgenstein L., 2000, TRACTATUS LOGICO PHI	4	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2011	342								d1883	10.1136/bmj.d1883	http://dx.doi.org/10.1136/bmj.d1883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OR	21511803				2022-12-01	WOS:000289943400001
J	Lu, W; Du, JA; Wacker, T; Gerbig-Smentek, E; Andrade, SLA; Einsle, O				Lue, Wei; Du, Juan; Wacker, Tobias; Gerbig-Smentek, Elke; Andrade, Susana L. A.; Einsle, Oliver			pH-Dependent Gating in a FocA Formate Channel	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; NUCLEOTIDE-SEQUENCE; MEMBRANE-PROTEINS; NITRATE; IDENTIFICATION; DEHYDROGENASE; TRANSPORTER; METABOLISM; MECHANISM; BACTERIA	The formate transporter FocA was described to switch its mode of operation from a passive export channel at high external pH to a secondary active formate/H+ importer at low pH. The crystal structure of Salmonella typhimurium FocA at pH 4.0 shows that this switch involves a major rearrangement of the amino termini of individual protomers in the pentameric channel. The amino-terminal helices open or block transport in a concerted, cooperative action that indicates how FocA is gated in a pH-dependent way. Electrophysiological studies show that the protein acts as a specific formate channel at pH 7.0 and that it closes upon a shift of pH to 5.1.	[Lue, Wei; Du, Juan; Wacker, Tobias; Gerbig-Smentek, Elke; Andrade, Susana L. A.; Einsle, Oliver] Univ Freiburg, Lehrstuhl Biochem, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg	Einsle, O (corresponding author), Univ Freiburg, Lehrstuhl Biochem, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	einsle@biochemie.uni-freiburg.de	Andrade, Susana L. A./D-5119-2012; Du, Juan/AAQ-5466-2020	Andrade, Susana L. A./0000-0003-2267-8499; Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [Ei-520/3, An-676/1, IRTG 1478]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the staff at beamline X06SA at the Swiss Light Source, in particular T. Tomizaki, for assistance with data collection and W. Hardt (ETH Zurich) for genomic DNA of S. typhimurium. R. Dutzler (University of Zurich) is acknowledged for helpful discussions. This work was supported by Deutsche Forschungsgemeinschaft (Ei-520/3 to O.E., An-676/1 to S. L. A. A., and IRTG 1478). The structural model and structure factors have been deposited with the Protein Data Bank (accession code 3Q7K).	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Aveyard R., 1973, INTRO PRINCIPLES SUR; BERG BL, 1991, J BIOL CHEM, V266, P22380; Clegg S, 2002, MOL MICROBIOL, V44, P143, DOI 10.1046/j.1365-2958.2002.02858.x; Cole J, 1996, FEMS MICROBIOL LETT, V136, P1; Hakobyan M, 2005, BIOPHYS CHEM, V118, P135, DOI 10.1016/j.bpc.2005.09.012; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1016/0378-1097(90)90689-N; Leonhartsberger S, 2002, J MOL MICROB BIOTECH, V4, P269; MACY J, 1976, J BACTERIOL, V125, P423, DOI 10.1128/JB.125.2.423-428.1976; ROSSMANN R, 1991, MOL MICROBIOL, V5, P2807, DOI 10.1111/j.1365-2958.1991.tb01989.x; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Sawers RG, 1994, ANTON LEEUW INT J G, V66, P57; STANKOWSKI S, 1991, BIOPHYS J, V60, P341, DOI 10.1016/S0006-3495(91)82059-8; Stroud RM, 2003, ADV PROTEIN CHEM, V63, P291; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; WHITE WB, 1992, J BACTERIOL, V174, P4997, DOI 10.1128/JB.174.15.4997-5004.1992; WIMPENNY JW, 1967, BIOCHIM BIOPHYS ACTA, V148, P233, DOI 10.1016/0304-4165(67)90298-X	21	60	60	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					352	354		10.1126/science.1199098	http://dx.doi.org/10.1126/science.1199098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493860				2022-12-01	WOS:000289516600045
J	Karakas, E; Simorowski, N; Furukawa, H				Karakas, Erkan; Simorowski, Noriko; Furukawa, Hiro			Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors	NATURE			English	Article							AMINO-TERMINAL DOMAIN; D-ASPARTATE RECEPTOR; NR2B SUBUNIT; GLUTAMATE RECEPTORS; CRYSTAL-STRUCTURE; IFENPRODIL; MECHANISMS; SOFTWARE; PROTEIN; MODELS	Since it was discovered that the anti-hypertensive agent ifenprodil has neuroprotective activity through its effects on NMDA (N-methyl-D-aspartate) receptors(1), a determined effort has been made to understand the mechanism of action and to develop improved therapeutic compounds on the basis of this knowledge(2-4). Neurotransmission mediated by NMDA receptors is essential for basic brain development and function(5). These receptors form heteromeric ion channels and become activated after concurrent binding of glycine and glutamate to the GluN1 and GluN2 subunits, respectively. A functional hallmark of NMDA receptors is that their ion-channel activity is allosterically regulated by binding of small compounds to the amino-terminal domain (ATD) in a subtype-specific manner. Ifenprodil and related phenylethanolamine compounds, which specifically inhibit GluN1 and GluN2B NMDA receptors(6,7), have been intensely studied for their potential use in the treatment of various neurological disorders and diseases, including depression, Alzheimer's disease and Parkinson's disease(2,4). Despite considerable enthusiasm, mechanisms underlying the recognition of phenylethanolamines and ATD-mediated allosteric inhibition remain limited owing to a lack of structural information. Here we report that the GluN1 and GluN2B ATDs forma heterodimer and that phenylethanolamine binds at the interface between GluN1 and GluN2B, rather than within the GluN2B cleft. The crystal structure of the heterodimer formed between the GluN1b ATD from Xenopus laevis and the GluN2B ATD from Rattus norvegicus shows a highly distinct pattern of subunit arrangement that is different from the arrangements observed in homodimeric non-NMDA receptors and reveals the molecular determinants for phenylethanolamine binding. Restriction of domain movement in the bi-lobed structure of the GluN2B ATD, by engineering of an inter-subunit disulphide bond, markedly decreases sensitivity to ifenprodil, indicating that conformational freedom in the GluN2B ATD is essential for ifenprodil-mediated allosteric inhibition of NMDA receptors. These findings pave the way for improving the design of subtype-specific compounds with therapeutic value for neurological disorders and diseases.	[Karakas, Erkan; Simorowski, Noriko; Furukawa, Hiro] WM Keck Struct Biol Lab, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Furukawa, H (corresponding author), WM Keck Struct Biol Lab, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	furukawa@cshl.edu			NIH [MH085926]; Alzheimer's Association; Fox family; NARSAD; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Fox family; NARSAD(NARSAD); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the staff at X25 and X29 at the National Synchrotron Light Source for beamline support. M. Mayer is thanked for comments on this work. We also thank D. Raleigh for the use of analytical ultracentrifugation. GluN1 clones from Xenopus laevis were gifts from M. Hollmann and H. Cline. This work was supported by NIH MH085926, the Alzheimer's Association and a donation from the Fox family (to H.F.). H.F. was also funded by a scientist development grant from the American Heart Association. E.K. is supported by a NARSAD Lieber Young Investigator Award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewald RC, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.004.2009; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Koller M, 2010, EXPERT OPIN THER PAT, V20, P1683, DOI 10.1517/13543776.2010.533656; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Lee C. H., 2011, PLOS ONE, V6, pe19181; Malherbe P, 2003, J PHARMACOL EXP THER, V307, P897, DOI 10.1124/jpet.103.056291; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Schmidt C, 2009, MOL CELL NEUROSCI, V42, P116, DOI 10.1016/j.mcn.2009.06.004; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	29	246	254	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					249	U170		10.1038/nature10180	http://dx.doi.org/10.1038/nature10180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21677647	Green Accepted			2022-12-01	WOS:000292690500055
J	Autry, AE; Adachi, M; Nosyreva, E; Na, ES; Los, MF; Cheng, PF; Kavalali, ET; Monteggia, LM				Autry, Anita E.; Adachi, Megunai; Nosyreva, Elena; Na, Elisa S.; Los, Maarten F.; Cheng, Peng-fei; Kavalali, Ege T.; Monteggia, Lisa M.			NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses	NATURE			English	Article							NEUROTROPHIC FACTOR; PROTEIN-SYNTHESIS; PRESYNAPTIC FUNCTION; DEPRESSION; KETAMINE; BDNF; NEUROTRANSMISSION; MODELS; PHARMACOKINETICS; ANTAGONIST	Clinical studies consistently demonstrate that a single sub-psychomimetic dose of ketamine, an ionotropic glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist, produces fast-acting antidepressant responses in patients suffering from major depressive disorder, although the underlying mechanism is unclear(1-3). Depressed patients report the alleviation of major depressive disorder symptoms within two hours of a single, low-dose intravenous infusion of ketamine, with effects lasting up to two weeks(1-3), unlike traditional antidepressants (serotonin re-uptake inhibitors), which take weeks to reach efficacy. This delay is a major drawback to current therapies for major depressive disorder and faster-acting antidepressants are needed, particularly for suicide-risk patients'. The ability of ketamine to produce rapidly acting, long-lasting antidepressant responses in depressed patients provides a unique opportunity to investigate underlying cellular mechanisms. Here we show that ketamine and other NMDAR antagonists produce fast-acting behavioural antidepressant-like effects in mouse models, and that these effects depend on the rapid synthesis of brain-derived neurotrophic factor. We find that the ketamine-mediated blockade of NMDAR at rest deactivates eukaryotic elongation factor 2 (eEF2) kinase (also called CaMKIII), resulting in reduced eEF2 phosphorylation and de-suppression of translation of brain-derived neurotrophic factor. Furthermore, we find that inhibitors of eEF2 kinase induce fast-acting behavioural antidepressant-like effects. Our findings indicate that the regulation of protein synthesis by spontaneous neurotransmission may serve as a viable therapeutic target for the development of fast-acting antidepressants.	[Autry, Anita E.; Adachi, Megunai; Na, Elisa S.; Los, Maarten F.; Cheng, Peng-fei; Monteggia, Lisa M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Nosyreva, Elena; Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kavalali, ET (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ege.kavalali@utsouthwestern.edu	Ferrua, Camila/F-5439-2015; Adachi, Megumi/M-7746-2017; Autry, Anita/ABF-9006-2021	Ferrua, Camila/0000-0001-8071-377X; Adachi, Megumi/0000-0003-3404-6640; Na, Elisa/0000-0001-7236-9868	UT Southwestern Medical Center;  [MH070727];  [MH066198];  [T32 MH 76690-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070727, T32MH076690, R01MH066198] Funding Source: NIH RePORTER	UT Southwestern Medical Center; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. A. Mahgoub for assistance with the animal experiments, S. Birnbaum and A Pettersen for assistance with the behavioural testing and members of the Monteggia and Kavalali laboratories for discussions and cornments on the manuscript. This work was supported by grant MH070727 (L.M.M.), grant MH066198 (E.T.K.) and the Division of Basic Sciences Training Program at UT Southwestern Medical Center, T32 MH 76690-02 (A.E.A.). E.T.K. is an Established Investigator of the American Heart Association.	Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Akbarian S, 2002, J NEUROSCI, V22, P4153, DOI 10.1523/JNEUROSCI.22-10-04153.2002; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Capasso A, 1996, GEN PHARMACOL, V27, P707, DOI 10.1016/0306-3623(95)02077-2; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Cleary C, 2008, BRAIN RES BULL, V76, P469, DOI 10.1016/j.brainresbull.2008.03.005; Detke MJ, 1997, EXP CLIN PSYCHOPHARM, V5, P107, DOI 10.1037/1064-1297.5.2.107; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Espinosa F, 2009, J NEUROPHYSIOL, V101, P2290, DOI 10.1152/jn.90754.2008; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Hoshaw BA, 2005, BRAIN RES, V1037, P204, DOI 10.1016/j.brainres.2005.01.007; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KRISTENSEN JD, 1995, BRIT J ANAESTH, V74, P193, DOI 10.1093/bja/74.2.193; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Poleszak E, 2007, PHARMACOL BIOCHEM BE, V88, P158, DOI 10.1016/j.pbb.2007.07.018; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; SCHWARTZ PH, 1991, RES COMMUN CHEM PATH, V73, P181; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.265pe19; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	33	1221	1284	8	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					91	U109		10.1038/nature10130	http://dx.doi.org/10.1038/nature10130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21677641	Green Accepted			2022-12-01	WOS:000292461300051
J	Liu, N; Hentschel, M; Weiss, T; Alivisatos, AP; Giessen, H				Liu, Na; Hentschel, Mario; Weiss, Thomas; Alivisatos, A. Paul; Giessen, Harald			Three-Dimensional Plasmon Rulers	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; GOLD NANOPARTICLES; MOLECULAR RULER; DNA; ANALOG; METAMATERIALS; DESIGN	Plasmon rulers can be used to determine nanoscale distances within chemical or biological species. They are based on the spectral shift of the scattering spectrum when two plasmonic nanoparticles approach one another. However, the one-dimensionality of current plasmon rulers hampers the comprehensive understanding of many intriguing processes in soft matter, which take place in three dimensions. We demonstrated a three-dimensional plasmon ruler that is based on coupled plasmonic oligomers in combination with high-resolution plasmon spectroscopy. This enables retrieval of the complete spatial configuration of complex macromolecular and biological processes as well as their dynamic evolution.	[Liu, Na; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Liu, Na; Alivisatos, A. Paul] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Hentschel, Mario; Weiss, Thomas; Giessen, Harald] Univ Stuttgart, Inst Phys 4, D-70569 Stuttgart, Germany; [Hentschel, Mario; Weiss, Thomas; Giessen, Harald] Univ Stuttgart, Res Ctr Scope, D-70569 Stuttgart, Germany; [Weiss, Thomas] Univ Clermont Ferrand, LASMEA, F-63177 Clermont Ferrand, France	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Stuttgart; University of Stuttgart	Liu, N (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	nliu@lbl.gov	Giessen, Harald/AAG-7586-2019; Hentschel, Mario/N-2093-2015; Liu, Na/C-8190-2014; Weiss, Thomas/AAS-9946-2021; Alivisatos, Paul/N-8863-2015	Giessen, Harald/0000-0002-4270-3850; Liu, Na/0000-0001-5831-3382; Weiss, Thomas/0000-0002-4991-6779; Alivisatos, Paul/0000-0001-6895-9048; Hentschel, Mario/0000-0002-6882-4183	NIH [NIH NOT-OD-09-056]; Deutsche Forschungsgemeinschaft (DFG) [SPP1391, FOR557, GI 269/11-1]; German Ministry of Science [13N9048, 13N10146]; Landesstiftung B; Deutsch-Franzosische Hochschule-Universite franco-allemande	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Science; Landesstiftung B; Deutsch-Franzosische Hochschule-Universite franco-allemande	We thank T. Pfau and M. Dressel for useful discussions and comments and S. Hein for his material visualizations. N.L. and A.P.A. were supported by the NIH Plasmon Rulers Project, grant NIH NOT-OD-09-056. M.H., T.W., and H.G. were financially supported by the Deutsche Forschungsgemeinschaft (DFG) (grants SPP1391 and FOR557), by The German Ministry of Science (grants 13N9048 and 13N10146), and by Landesstiftung B. W.T.W. were also supported by the DFG (grant GI 269/11-1) and by Deutsch-Franzosische Hochschule-Universite franco-allemande.	Alzar CLG, 2002, AM J PHYS, V70, P37, DOI 10.1119/1.1412644; Cigler P, 2010, NAT MATER, V9, P918, DOI [10.1038/NMAT2877, 10.1038/nmat2877]; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Granet G, 2002, J OPT A-PURE APPL OP, V4, pS145, DOI 10.1088/1464-4258/4/5/362; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Hentschel M, 2010, NANO LETT, V10, P2721, DOI 10.1021/nl101938p; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Jun YW, 2009, P NATL ACAD SCI USA, V106, P17735, DOI 10.1073/pnas.0907367106; Lassiter JB, 2010, NANO LETT, V10, P3184, DOI 10.1021/nl102108u; Liu GL, 2006, NAT NANOTECHNOL, V1, P47, DOI 10.1038/nnano.2006.51; Liu N, 2008, NAT MATER, V7, P31, DOI 10.1038/nmat2072; Liu N, 2010, NANO LETT, V10, P1103, DOI 10.1021/nl902621d; Liu N, 2009, NAT MATER, V8, P758, DOI [10.1038/NMAT2495, 10.1038/nmat2495]; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Mastroianni AJ, 2009, J AM CHEM SOC, V131, P8455, DOI 10.1021/ja808570g; ORDAL MA, 1983, APPL OPTICS, V22, P1099, DOI 10.1364/AO.22.001099; Papasimakis N, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.253903; Sharma J, 2009, SCIENCE, V323, P112, DOI 10.1126/science.1165831; Sonnichsen C, 2005, NANO LETT, V5, P301, DOI 10.1021/nl048089k; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]; Tassin P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.053901; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Xu H, 2010, OPT EXPRESS, V18, P17736, DOI 10.1364/OE.18.017736; Zhang S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047401; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	29	484	490	17	430	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1407	1410		10.1126/science.1199958	http://dx.doi.org/10.1126/science.1199958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680838				2022-12-01	WOS:000291689000035
J	Kozlov, AS; Baumgart, J; Risler, T; Versteegh, CPC; Hudspeth, AJ				Kozlov, Andrei S.; Baumgart, Johannes; Risler, Thomas; Versteegh, Corstiaen P. C.; Hudspeth, A. J.			Forces between clustered stereocilia minimize friction in the ear on a subnanometre scale	NATURE			English	Article							HAIR CELL STEREOCILIA; TRANSDUCTION CHANNELS; MECHANICAL AMPLIFICATION; COHERENT MOTION; BUNDLE; MEMBRANE	The detection of sound begins when energy derived from an acoustic stimulus deflects the hair bundles on top of hair cells(1). As hair bundles move, the viscous friction between stereocilia and the surrounding liquid poses a fundamental physical challenge to the ear's high sensitivity and sharp frequency selectivity. Part of the solution to this problem lies in the active process that uses energy for frequency-selective sound amplification(2,3). Here we demonstrate that a complementary part of the solution involves the fluid-structure interaction between the liquid within the hair bundle and the stereocilia. Using force measurement on a dynamically scaled model, finite-element analysis, analytical estimation of hydrodynamic forces, stochastic simulation and high-resolution interferometric measurement of hair bundles, we characterize the origin and magnitude of the forces between individual stereocilia during small hair-bundle deflections. We find that the close apposition of stereocilia effectively immobilizes the liquid between them, which reduces the drag and suppresses the relative squeezing but not the sliding mode of stereociliary motion. The obliquely oriented tip links couple the mechanotransduction channels to this least dissipative coherent mode, whereas the elastic horizontal top connectors that stabilize the structure further reduce the drag. As measured from the distortion products associated with channel gating at physiological stimulation amplitudes of tens of nanometres, the balance of viscous and elastic forces in a hair bundle permits a relative mode of motion between adjacent stereocilia that encompasses only a fraction of a nanometre. A combination of high-resolution experiments and detailed numerical modelling of fluid-structure interactions reveals the physical principles behind the basic structural features of hair bundles and shows quantitatively how these organelles are adapted to the needs of sensitive mechanotransduction.	[Kozlov, Andrei S.; Versteegh, Corstiaen P. C.; Hudspeth, A. J.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Kozlov, Andrei S.; Versteegh, Corstiaen P. C.; Hudspeth, A. J.] Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10065 USA; [Baumgart, Johannes] Tech Univ Dresden, Dept Math, Inst Comp Sci, D-01062 Dresden, Germany; [Risler, Thomas] Inst Curie, Ctr Rech, F-75005 Paris, France; [Risler, Thomas] Univ Paris 06, UMR 168, F-75005 Paris, France; [Risler, Thomas] CNRS, UMR 168, F-75005 Paris, France; [Versteegh, Corstiaen P. C.] Wageningen Univ, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Technische Universitat Dresden; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; Wageningen University & Research	Hudspeth, AJ (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	hudspaj@rockefeller.edu	Risler, Thomas/E-6943-2011; Baumgart, Johannes/A-8547-2011	Risler, Thomas/0000-0003-1677-4636; Baumgart, Johannes/0000-0001-7384-5715	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC000241-30, R01 DC000241, DC000241, F32 DC000241] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000241, R01DC000241] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Batchelor G. K., 2000, INTRO FLUID DYNAMICS, P353; BROERSMA S, 1981, J CHEM PHYS, V74, P6989, DOI 10.1063/1.441071; Cotton J, 2004, HEARING RES, V197, P105, DOI 10.1016/j.heares.2004.06.005; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hudspeth AJ, 2010, J NEUROPHYSIOL, V104, P1219, DOI 10.1152/jn.00437.2010; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; JARAMILLO F, 1993, NATURE, V364, P527, DOI 10.1038/364527a0; Karavitaki KD, 2010, J NEUROSCI, V30, P9051, DOI 10.1523/JNEUROSCI.4864-09.2010; Kozlov AS, 2007, NAT NEUROSCI, V10, P87, DOI 10.1038/nn1818; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; NEUGEBAUER DC, 1987, CELL TISSUE RES, V249, P199, DOI 10.1007/BF00215434; Perrin F, 1934, J PHYS-PARIS, V5, P497, DOI 10.1051/jphysrad:01934005010049700; PICKLES JO, 1993, HEARING RES, V68, P159, DOI 10.1016/0378-5955(93)90120-P; Stokes G. G., 1850, T CAMBRIDGE PHILOS S, V9, P1; Tamada K., 1957, Q J MECH APPL MATH, V10, P425, DOI DOI 10.1093/QJMAM/10.4.425; Verpy E, 2011, J COMP NEUROL, V519, P194, DOI 10.1002/cne.22509; Yeom J, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065025	19	51	51	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					376	379		10.1038/nature10073	http://dx.doi.org/10.1038/nature10073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21602823	Green Submitted, Green Accepted			2022-12-01	WOS:000291647100045
J	Dorner, M; Horwitz, JA; Robbins, JB; Barry, WT; Feng, Q; Mu, K; Jones, CT; Schoggins, JW; Catanese, MT; Burton, DR; Law, M; Rice, CM; Ploss, A				Dorner, Marcus; Horwitz, Joshua A.; Robbins, Justin B.; Barry, Walter T.; Feng, Qian; Mu, Kathy; Jones, Christopher T.; Schoggins, John W.; Catanese, Maria Teresa; Burton, Dennis R.; Law, Mansun; Rice, Charles M.; Ploss, Alexander			A genetically humanized mouse model for hepatitis C virus infection	NATURE			English	Article							B TYPE-I; HUMAN LIVER; REPLICATION; RECEPTOR; ANTIBODIES; FIBROBLASTS; REVEALS; VITRO; MICE; CD81	Hepatitis C virus (HCV) remains a major medical problem. Antiviral treatment is only partially effective and a vaccine does not exist. Development of more effective therapies has been hampered by the lack of a suitable small animal model. Although xenotransplantation of immunodeficient mice with human hepatocytes has shown promise, these models are subject to important challenges. Building on the previous observation that CD81 and occludin comprise the minimal human factors required to render mouse cells permissive to HCV entry in vitro(4), we attempted murine humanization via a genetic approach. Here we show that expression of two human genes is sufficient to allow HCV infection of fully immunocompetent inbred mice. We establish a precedent for applying mouse genetics to dissect viral entry and validate the role of scavenger receptor type B class I for HCV uptake. We demonstrate that HCV can be blocked by passive immunization, as well as showing that a recombinant vaccinia virus vector induces humoral immunity and confers partial protection against heterologous challenge. This system recapitulates a portion of the HCV life cycle in an immunocompetent rodent for the first time, opening opportunities for studying viral pathogenesis and immunity and comprising an effective platform for testing HCV entry inhibitors in vivo.	[Dorner, Marcus; Horwitz, Joshua A.; Barry, Walter T.; Feng, Qian; Mu, Kathy; Jones, Christopher T.; Schoggins, John W.; Catanese, Maria Teresa; Rice, Charles M.; Ploss, Alexander] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; [Robbins, Justin B.; Burton, Dennis R.; Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA	Rockefeller University; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Ploss, A (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.	aploss@rockefeller.edu	Feng, Qian/AAL-4323-2020; Ploss, Alexander/ABG-2330-2020	Ploss, Alexander/0000-0001-9322-7252; Dorner, Marcus/0000-0003-0321-4226; Dorner, Marcus/0000-0001-7936-1527; Law, Mansun/0000-0002-8934-9756	National Institute of Diabetes and Digestive and Kidney Diseases [RC1DK087193]; National Institute for Allergy and Infectious Disease [R01AI072613, R01AI079031, R01AI071084]; Starr Foundation; Greenberg Medical Institute; German Research Foundation (Deutsche Forschungsgesellschaft); Rockefeller University; National Institute of Health [F32DK082155, F32DK081193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071084, R01AI072613, R01AI079031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085713, F32DK082155, F32DK081193, RC1DK087193] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Starr Foundation; Greenberg Medical Institute; German Research Foundation (Deutsche Forschungsgesellschaft)(German Research Foundation (DFG)); Rockefeller University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Sable, E. Castillo, A. Forrest, M. Panis, S. Pouzol, S. Shirley, A. Webson and E. Giang for laboratory support, L. Chiriboga and H. Yee for technical assistance, J. Bukh and Apath, LLC for providing the prototype intergenotypic HCV chimaeras and C. Murray for editing the manuscript. This study was supported in part by award number RC1DK087193 (to C.M.R. and A.P.) from the National Institute of Diabetes and Digestive and Kidney Diseases, R01AI072613 (to C.M.R.), R01AI079031 (to M.L.) and R01AI071084 (to D.R.B.) from the National Institute for Allergy and Infectious Disease, The Starr Foundation and the Greenberg Medical Institute. M.D. was supported by a postdoctoral fellowship from the German Research Foundation (Deutsche Forschungsgesellschaft) and M.T.C. by funds from The Rockefeller University's Women & Science Fellowship Program. J.W.S. and C.T.J are recipients of Ruth L. Kirschstein National Research Service Awards from the National Institute of Health (F32DK082155 to J.W.S., F32DK081193 to C.T.J.).	Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; de Jong YP, 2010, J CLIN INVEST, V120, P650, DOI 10.1172/JCI42338; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Law Mansun, 2004, Methods Mol Biol, V269, P187; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McCaffrey AP, 2002, MOL THER, V5, P676, DOI 10.1006/mthe.2002.0600; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; RALSTON R, 1993, J VIROL, V67, P6753, DOI 10.1128/JVI.67.11.6753-6761.1993; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schoggins JW, 2003, J VIROL, V77, P1039, DOI 10.1128/JVI.77.2.1039-1048.2003; Selby M, 1999, J IMMUNOL, V162, P669; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Youn JW, 2008, J VIROL, V82, P10896, DOI 10.1128/JVI.01179-08; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	35	281	303	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					208	U246		10.1038/nature10168	http://dx.doi.org/10.1038/nature10168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654804	Green Submitted, Green Accepted			2022-12-01	WOS:000291397800049
J	Mukherjee, T; Kim, WS; Mandal, L; Banerjee, U				Mukherjee, Tina; Kim, William Sang; Mandal, Lolitika; Banerjee, Utpal			Interaction Between Notch and Hif-alpha in Development and Survival of Drosophila Blood Cells	SCIENCE			English	Article							HYPOXIA; HIF-1-ALPHA; SPECIFICATION; REQUIRES; PATHWAY; LINEAGE	A blood cell type termed crystal cell in Drosophila functions in clotting and wound healing and requires Notch for specification and maintenance. We report that crystal cells express elevated levels of Sima protein orthologous to mammalian hypoxia-inducible factor-alpha (Hif-alpha) even under conditions of normal oxygen availability. In these platelet-like crystal cells, Sima activates full-length Notch receptor signaling via a noncanonical, ligand-independent mechanism that promotes hemocyte survival during both normal hematopoietic development and hypoxic stress. This interaction initiates in early endosomes, is independent of Hif-beta (Tango in Drosophila), and does not activate hypoxia response targets. Studies in vertebrate myeloid cells have shown a similar up-regulation of Hif-alpha protein in well-oxygenated environments. This study provides a mechanistic paradigm for Hif-alpha/Notch interaction that may be conserved in mammals.	[Mukherjee, Tina; Kim, William Sang; Mandal, Lolitika; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu			NIH [R01HL067395]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067395] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank H. Bellen, C. Frei, S. Artavanis-Tsakonas, C. Delidakis, M. Guo, M. Regulski, B. Shilo, G. Struhl, P. Wappner, National Institute of Genetics, Vienna Drosophila RNAi Center, Flybase, and Bloomington for reagents and D. Walker, G. Weinmaster, and C. Evans for helpful discussion. Supported by NIH grant R01HL067395.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Duvic B, 2002, CURR BIOL, V12, P1923, DOI 10.1016/S0960-9822(02)01297-6; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kasivisvanathan V, 2011, CURR VASC PHARMACOL, V9, P333, DOI 10.2174/157016111795495602; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Nakamura H, 2005, J IMMUNOL, V174, P7592, DOI 10.4049/jimmunol.174.12.7592; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Rizki R. R., 1981, GENETICS, V97, ps90; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91, DOI 10.1007/BF00848799; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860	32	128	129	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1210	1213		10.1126/science.1199643	http://dx.doi.org/10.1126/science.1199643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636775	Green Accepted			2022-12-01	WOS:000291205200051
J	Black, ME				Black, Mary E.			THE BIGGER PICTURE Four burials and a funeral	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2011	342								d3241	10.1136/bmj.d3241	http://dx.doi.org/10.1136/bmj.d3241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	771KE	21613364				2022-12-01	WOS:000291154800009
J	Duy, C; Hurtz, C; Shojaee, S; Cerchietti, L; Geng, HM; Swaminathan, S; Klemm, L; Kweon, SM; Nahar, R; Braig, M; Park, E; Kim, YM; Hofmann, WK; Herzog, S; Jumaa, H; Koeffler, HP; Yu, JJ; Heisterkamp, N; Graeber, TG; Wu, H; Ye, BH; Melnick, A; Muschen, M				Duy, Cihangir; Hurtz, Christian; Shojaee, Seyedmehdi; Cerchietti, Leandro; Geng, Huimin; Swaminathan, Srividya; Klemm, Lars; Kweon, Soo-mi; Nahar, Rahul; Braig, Melanie; Park, Eugene; Kim, Yong-mi; Hofmann, Wolf-Karsten; Herzog, Sebastian; Jumaa, Hassan; Koeffler, H. Phillip; Yu, J. Jessica; Heisterkamp, Nora; Graeber, Thomas G.; Wu, Hong; Ye, B. Hilda; Melnick, Ari; Mueschen, Markus			BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; GERMINAL-CENTER FORMATION; IMATINIB RESISTANCE; INITIATING CELLS; IN-VITRO; B-CELLS; EXPRESSION; STAT5; PROLIFERATION; INFLAMMATION	Tyrosine kinase inhibitors (TKIs) are widely used to treat patients with leukaemia driven by BCR-ABL1 (ref. 1) and other oncogenic tyrosine kinases(2,3). Recent efforts have focused on developing more potent TKIs that also inhibit mutant tyrosine kinases(4,5). However, even effective TKIs typically fail to eradicate leukaemia-initiating cells (LICs)(6-8), which often cause recurrence of leukaemia after initially successful treatment. Here we report the discovery of a novel mechanism of drug resistance, which is based on protective feedback signalling of leukaemia cells in response to treatment with TKI. We identify BCL6 as a central component of this drug-resistance pathway and demonstrate that targeted inhibition of BCL6 leads to eradication of drug-resistant and leukaemia-initiating subclones.	[Duy, Cihangir; Hurtz, Christian; Shojaee, Seyedmehdi; Swaminathan, Srividya; Klemm, Lars; Nahar, Rahul; Mueschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Duy, Cihangir; Kweon, Soo-mi; Nahar, Rahul; Park, Eugene; Kim, Yong-mi; Heisterkamp, Nora; Mueschen, Markus] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Cerchietti, Leandro; Geng, Huimin; Melnick, Ari] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Cerchietti, Leandro; Geng, Huimin; Melnick, Ari] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Braig, Melanie] Univ Klinikum Hamburg Eppendorf, Dept Hematol & Oncol, Hamburg, Germany; [Hofmann, Wolf-Karsten] Heidelberg Univ, Klinikum Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Hurtz, Christian; Herzog, Sebastian; Jumaa, Hassan] Univ Freiburg, Fac Biol, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Hurtz, Christian; Herzog, Sebastian; Jumaa, Hassan] Max Planck Inst Immunobiol, Freiburg, Germany; [Koeffler, H. Phillip] Cedars Sinai Med Ctr, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Yu, J. Jessica; Ye, B. Hilda] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Graeber, Thomas G.; Wu, Hong] Univ Calif Los Angeles, Dept Mol Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; Children's Hospital Los Angeles; University of Southern California; Cornell University; Cornell University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Freiburg; Max Planck Society; Cedars Sinai Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Los Angeles	Muschen, M (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	markus.muschen@ucsf.edu	kim, y/AAR-6095-2020; Melnick, Ari/AAA-5763-2020; Duy, Cihangir/AAD-7735-2022; Heisterkamp, Nora/C-1698-2012	Duy, Cihangir/0000-0001-9150-9379; Heisterkamp, Nora/0000-0003-2769-2273; Herzog, Sebastian/0000-0001-7167-3489; Cerchietti, Leandro/0000-0003-0608-1350; Graeber, Thomas/0000-0001-8574-9181; Kim, Yong-Mi/0000-0003-3793-6438	National Institutes of Health/National Cancer Institute [R01CA104348, R01CA085573, R01CA026038, R01CA090321, R01CA137060, R01CA139032, R01CA157664, R21CA152497]; Leukemia and Lymphoma Society [SCOR 7005-11]; Alex's Lemonade Stand Foundation for Pediatric Cancer Research; California Institute for Regenerative Medicine [TR02-1816]; William Laurence and Blanche Hughes Foundation; Stand Up To Cancer-American Association for Cancer Research [IRG00909]; NATIONAL CANCER INSTITUTE [R01CA157664, R01CA026038, R01CA085573, R01CA139032, R01CA090321, R01CA157644, R01CA137060, R01CA104348, R21CA152497] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Alex's Lemonade Stand Foundation for Pediatric Cancer Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); William Laurence and Blanche Hughes Foundation; Stand Up To Cancer-American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Dalla-Favera and L. Hennighausen for sharing BCL6<SUP>-/-</SUP> and STAT5<SUP>fl/fl</SUP> mice and wild-type controls with us. We thank A. L. Shaffer and L. M. Staudt for sharing their inducible BCL6 constructs. This work was supported by grants from the National Institutes of Health/National Cancer Institute through R01CA104348 (to A. M.), R01CA085573 (to B.H.Y.), R01CA026038 (to H. P. K.), R01CA090321 (to N.H.), R01CA137060 (to M. M.), R01CA139032 (to M. M.), R01CA157664 (to M. M.) and R21CA152497 (to M. M.), grants from the Leukemia and Lymphoma Society (to M. M.) Leukemia and Lymphoma Society SCOR 7005-11 (PI B. J. Druker), a grant from the Alex's Lemonade Stand Foundation for Pediatric Cancer Research (to M. M.), the California Institute for Regenerative Medicine through TR02-1816 (to M. M.), the William Laurence and Blanche Hughes Foundation and a Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant IRG00909 (to M. M.). A. M. and M. M. are Scholars of the Leukemia and Lymphoma Society.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chakravarti Laha, 1967, HDB METHODS APPL STA, V1, P392; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Goldberg Z, 2004, CELL CYCLE, V3, P1188; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gruber TA, 2010, CANCER RES, V70, P7411, DOI 10.1158/0008-5472.CAN-10-1438; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Skorta I, 2009, CANCER RES, V69, P9337, DOI 10.1158/0008-5472.CAN-09-0548; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Wendel HG, 2006, P NATL ACAD SCI USA, V103, P7444, DOI 10.1073/pnas.0602402103; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	45	144	150	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					384	U572		10.1038/nature09883	http://dx.doi.org/10.1038/nature09883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593872	Green Accepted, Green Submitted			2022-12-01	WOS:000290722400051
J	Cleland, K; Peipert, JF; Westhoff, C; Spear, S; Trussell, J				Cleland, Kelly; Peipert, Jeffrey F.; Westhoff, Carolyn; Spear, Scott; Trussell, James			Family Planning as a Cost-Saving Preventive Health Service	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cleland, Kelly; Trussell, James] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Peipert, Jeffrey F.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Westhoff, Carolyn] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Westhoff, Carolyn] Columbia Univ, Dept Epidemiol, New York, NY USA; [Westhoff, Carolyn] Columbia Univ, Dept Populat & Family Hlth, New York, NY USA; [Spear, Scott] Planned Parenthood Texas Capital Reg, Austin, TX USA; [Spear, Scott] Planned Parenthood Cent Texas, Austin, TX USA; [Trussell, James] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England	Princeton University; Washington University (WUSTL); Columbia University; Columbia University; Columbia University; University of Hull; University of York - UK	Cleland, K (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.		Potter, Joseph E/A-3122-2008	Cleland, Kelly/0000-0001-9966-1260	NICHD NIH HHS [R24 HD047879] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Brown SS., 1995, BEST INTENTIONS UNIN; Frost JJ, 2008, PERSPECT SEX REPRO H, V40, P94, DOI 10.1363/4009408; Postlethwaite D, 2007, CONTRACEPTION, V76, P360, DOI 10.1016/j.contraception.2007.07.006; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Trussell J, 2010, CONTRACEPTION, V82, P391, DOI 10.1016/j.contraception.2010.04.008	5	66	69	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18								10.1056/NEJMp1104373	http://dx.doi.org/10.1056/NEJMp1104373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21506736				2022-12-01	WOS:000290219800005
J	Colquhoun, D				Colquhoun, David			WELLBEING The A to Z of the wellbeing industry: from angelic reiki to patient centred care	BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVIVAL		UCL, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, London WC1E 6BT, England.	d.colquhoun@ucl.ac.uk	Colquhoun, David/C-1664-2008	Colquhoun, David/0000-0002-4263-017X				Coyne JC, 2007, PSYCHOL BULL, V133, P367, DOI 10.1037/0033-2909.133.3.367; *DEP BUS INN SKILL, MENT CAP WELLB PROJ; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; MARMOT M, WORK STRESS HLTH WHI; Marmot M., 2010, MARMOT REPORT; Schofield P, 2004, CANCER-AM CANCER SOC, V100, P1276, DOI 10.1002/cncr.20076; Wilkinson R., 2009, SPIRIT LEVEL	8	1	1	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2711	10.1136/bmj.d2711	http://dx.doi.org/10.1136/bmj.d2711			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	21543407				2022-12-01	WOS:000290481700007
J	Vyazovskiy, VV; Olcese, U; Hanlon, EC; Nir, Y; Cirelli, C; Tononi, G				Vyazovskiy, Vladyslav V.; Olcese, Umberto; Hanlon, Erin C.; Nir, Yuval; Cirelli, Chiara; Tononi, Giulio			Local sleep in awake rats	NATURE			English	Article							SLOW-WAVE ACTIVITY; CORTICAL SYNCHRONIZATION; VISUAL-STIMULATION; THETA ACTIVITY; HOMEOSTASIS; EEG; NEURONS; WAKING; STATES; BRAIN	In an awake state, neurons in the cerebral cortex fire irregularly and electroencephalogram (EEG) recordings display low-amplitude, high-frequency fluctuations. During sleep, neurons oscillate between 'on' periods, when they fire as in an awake brain, and 'off' periods, when they stop firing altogether and the EEG displays high-amplitude slowwaves. However, what happens to neuronal firing after a long period of being awake is not known. Here we show that in freely behaving rats after a long period in an awake state, cortical neurons can go briefly 'offline' as in sleep, accompanied by slow waves in the local EEG. Neurons often go offline in one cortical area but not in another, and during these periods of 'local sleep', the incidence of which increases with the duration of the awake state, rats are active and display an 'awake' EEG. However, they are progressively impaired in a sugar pellet reaching task. Thus, although both the EEG and behaviour indicate wakefulness, local populations of neurons in the cortex may be falling asleep, with negative consequences for performance.	[Vyazovskiy, Vladyslav V.; Olcese, Umberto; Hanlon, Erin C.; Nir, Yuval; Cirelli, Chiara; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Olcese, Umberto] Scuola Super Sant Anna, PERCRO Lab, I-56217 Pisa, Italy	University of Wisconsin System; University of Wisconsin Madison; Scuola Superiore Sant'Anna	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	gtononi@wisc.edu		Nir, Yuval/0000-0002-5433-6349; Olcese, Umberto/0000-0001-6968-2503; Vyazovskiy, Vladyslav/0000-0002-4336-6681	NIMH [P20 MH077967]; NIH; AFOSR [FA9550-08-1-0244]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH077967] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIMH P20 MH077967 (C. C.), NIH Director's Pioneer award (G. T.) and AFOSR FA9550-08-1-0244 (G. T.). We thank A. Nelson, M. Dash and U. Faraguna for help with the experiments, L. Krugner-Higby for advice about surgical procedures and P. Frumento for advice on statistical procedures.	[Anonymous], 2005, PRINCIPLES PRACTICE; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Blaivas AJ, 2007, SLEEP MED, V8, P156, DOI 10.1016/j.sleep.2006.06.011; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Ferrillo F, 2000, CLIN NEUROPHYSIOL, V111, P916, DOI 10.1016/S1388-2457(00)00246-7; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Hanlon EC, 2009, SLEEP, V32, P719, DOI 10.1093/sleep/32.6.719; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Mahowald MW, 2005, NATURE, V437, P1279, DOI 10.1038/nature04287; Maquet P, 2000, J SLEEP RES, V9, P207; MARROCCO RT, 1987, J NEUROSCI, V7, P2756; MORUZZI G, 1966, FUNCTIONAL SIGNIFICA; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nunez A, 1996, NEUROSCIENCE, V72, P757, DOI 10.1016/0306-4522(95)00582-X; Pigarev IN, 1997, NEUROREPORT, V8, P2557, DOI 10.1097/00001756-199707280-00027; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Tirunahari VL, 2003, SLEEP MED, V4, P63, DOI 10.1016/S1389-9457(02)00250-2; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vyazovskiy VV, 2008, J NEUROPHYSIOL, V99, P969, DOI 10.1152/jn.01154.2007; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Vyazovskiy VV, 2009, J NEUROPHYSIOL, V101, P1921, DOI 10.1152/jn.91157.2008; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9	40	490	495	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					443	447		10.1038/nature10009	http://dx.doi.org/10.1038/nature10009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525926	Green Accepted			2022-12-01	WOS:000289949600028
J	Zhu, HL; Hu, FQ; Wang, RH; Zhou, X; Sze, SH; Liou, LW; Barefoot, A; Dickman, M; Zhang, XR				Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Zhou, Xin; Sze, Sing-Hoi; Liou, Lisa Wen; Barefoot, Ashley; Dickman, Martin; Zhang, Xiuren			Arabidopsis Argonaute10 Specifically Sequesters miR166/165 to Regulate Shoot Apical Meristem Development	CELL			English	Article							LEAF POLARITY; SMALL RNAS; GENE; EXPRESSION; PATHWAY; ESTABLISHMENT; MICRORNAS; COMPLEXES; ROLES; SIRNA	The shoot apical meristem (SAM) comprises a group of undifferentiated cells that divide to maintain the plant meristem and also give rise to all shoot organs. SAM fate is specified by class III HOMEODOMAIN-LEUCINE ZIPPER (HD-ZIP III) transcription factors, which are targets of miR166/165. In Arabidopsis, AGO10 is a critical regulator of SAM maintenance, and here we demonstrate that AGO10 specifically interacts with miR166/165. The association is determined by a distinct structure of the miR166/165 duplex. Deficient loading of miR166 into AGO10 results in a defective SAM. Notably, the miRNA-binding ability of AGO10, but not its catalytic activity, is required for SAM development, and AGO10 has a higher binding affinity for miR166 than does AGO1, a principal contributor to miRNA-mediated silencing. We propose that AGO10 functions as a decoy for miR166/165 to maintain the SAM, preventing their incorporation into AGO1 complexes and the subsequent repression of HD-ZIP III gene expression.	[Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Sze, Sing-Hoi; Liou, Lisa Wen; Barefoot, Ashley; Zhang, Xiuren] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Zhu, Hongliang; Hu, Fuqu; Wang, Ronghui; Zhou, Xin; Dickman, Martin; Zhang, Xiuren] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Sze, Sing-Hoi] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Zhou, Xin] Washington Univ, Dept Genet, St Louis, MO 63108 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Washington University (WUSTL)	Zhang, XR (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	xiuren.zhang@tamu.edu	Zhu, Hongliang/I-7035-2019	Zhu, Hongliang/0000-0002-1484-2212	NSF [MCB-0951120]; Texas AM University; NSF-REU [MCB-1037884]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097570] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0951120] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Texas AM University; NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to K. Barton for the ago10<SUP>pnh-2</SUP> mutant, T. Laux for the YFP-AGO10 lines, H. Vaucheret for the ago1-27 mutant, and D. Baulcombe for providing an anti-AGO1 antibody. We thank Drs. D. Shippen, G. Kapler, F. Qiao, T. Devarenne, and C. Kaplan for stimulating discussions and critical review of the manuscript. The work was supported by a grant from NSF (MCB-0951120) and a startup from Texas A&M University to X.Z. L.W.L. and A.B. were supported by NSF-REU (MCB-1037884).	Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mallory AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000646; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tucker MR, 2008, DEVELOPMENT, V135, P2839, DOI 10.1242/dev.023648; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Zhang XY, 2006, FASEB J, V20, pA122; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	35	311	349	9	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					242	256		10.1016/j.cell.2011.03.024	http://dx.doi.org/10.1016/j.cell.2011.03.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496644	Green Accepted, Bronze			2022-12-01	WOS:000289549900013
J	Faith, JJ; McNulty, NP; Rey, FE; Gordon, JI				Faith, Jeremiah J.; McNulty, Nathan P.; Rey, Federico E.; Gordon, Jeffrey I.			Predicting a Human Gut Microbiota's Response to Diet in Gnotobiotic Mice	SCIENCE			English	Article							MICROBES	The interrelationships between our diets and the structure and operations of our gut microbial communities are poorly understood. A model community of 10 sequenced human gut bacteria was introduced into gnotobiotic mice, and changes in species abundance and microbial gene expression were measured in response to randomized perturbations of four defined ingredients in the host diet. From the responses, we developed a statistical model that predicted over 60% of the variation in species abundance evoked by diet perturbations, and we were able to identify which factors in the diet best explained changes seen for each community member. The approach is generally applicable, as shown by a follow-up study involving diets containing various mixtures of pureed human baby foods.	[Faith, Jeremiah J.; McNulty, Nathan P.; Rey, Federico E.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu			NIH [DK30292, DK70977]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, R01DK070977, R37DK030292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to D. O'Donnell, M. Karlsson, and S. Wagoner for their help with various aspects of gnotobiotic mouse husbandry and to B. Mickelson, I. Mogno, A. Goodman, N. Griffin, H. Seedorf, G. Simon, J. Chase, and B. Cohen for their many helpful suggestions during the course of this work. This work was supported by grants from NIH (DK30292 and DK70977) and the Crohn's and Colitis Foundation of America. COPRO-seq and microbial RNA-seq data are available in the Gene Expression Omnibus (accession GSE26687). Processed data can be obtained at http://gordonlab.wustl.edu/modeling_microbiota/.	Chase J.M., 2003, ECOLOGICAL NICHES LI; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Faith JJ, 2010, ISME J, V4, P1094, DOI 10.1038/ismej.2010.110; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Handelsman J, 2008, DNA CELL BIOL, V27, P219, DOI 10.1089/dna.2008.1503; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	15	345	359	11	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					101	104		10.1126/science.1206025	http://dx.doi.org/10.1126/science.1206025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21596954	Green Accepted			2022-12-01	WOS:000292255400059
J	Wang, TY; Nallamothu, BK; Krumholz, HM; Li, S; Roe, MT; Jollis, JG; Jacobs, AK; Holmes, DR; Peterson, ED; Ting, HH				Wang, Tracy Y.; Nallamothu, Brahmajee K.; Krumholz, Harlan M.; Li, Shuang; Roe, Matthew T.; Jollis, James G.; Jacobs, Alice K.; Holmes, David R.; Peterson, Eric D.; Ting, Henry H.			Association of Door-In to Door-Out Time With Reperfusion Delays and Outcomes Among Patients Transferred for Primary Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELEVATION MYOCARDIAL-INFARCTION; CARDIOVASCULAR DATA REGISTRY; LONGITUDINAL DATA-ANALYSIS; TO-BALLOON TIME; ST-ELEVATION; PRIMARY ANGIOPLASTY; INTERHOSPITAL TRANSFER; THROMBOLYTIC THERAPY; AMERICAN-COLLEGE; SYMPTOM-ONSET	Context Patients with ST-elevation myocardial infarction (STEMI) requiring inter-hospital transfer for primary percutaneous coronary intervention (PCI) often have prolonged overall door-to-balloon (DTB) times from first hospital presentation to second hospital PCI. Door-in to door-out (DIDO) time, defined as the duration of time from arrival to discharge at the first or STEMI referral hospital, is a new clinical performance measure, and a DIDO time of 30 minutes or less is recommended to expedite reperfusion care. Objective To characterize time to reperfusion and patient outcomes associated with a DIDO time of 30 minutes or less. Design, Setting, and Patients Retrospective cohort of 14 821 patients with STEMI transferred to 298 STEMI receiving centers for primary PCI in the ACTION Registry-Get With the Guidelines between January 2007 and March 2010. Main Outcome Measures Factors associated with a DIDO time greater than 30 minutes, overall DTB times, and risk-adjusted in-hospital mortality. Results Median DIDO time was 68 minutes (interquartile range, 43-120 minutes), and only 1627 patients (11%) had DIDO times of 30 minutes or less. Significant factors associated with a DIDO time greater than 30 minutes included older age, female sex, off-hours presentation, and non-emergency medical services transport to the first hospital. Patients with a DIDO time of 30 minutes or less were significantly more likely to have an overall DTB time of 90 minutes or less compared with patients with DIDO times greater than 30 minutes (60% [95% confidence interval {CI}, 57%-62%] vs 13% [95% CI, 12%-13%]; P < .001). Among patients with DIDO times greater than 30 minutes, only 0.6% (95% CI, 0.5%-0.8%) had an absolute contraindication to fibrinolysis. Observed in-hospital mortality was significantly higher among patients with DIDO times greater than 30 minutes vs patients with DIDO times of 30 minutes or less (5.9% [95% CI, 5.5%-6.3%] vs 2.7% [95% CI, 1.9%-3.5%]; P < .001; adjusted odds ratio for in-hospital mortality, 1.56 [95% CI, 1.15-2.12]). Conclusion A DIDO time of 30 minutes or less was observed in only a small proportion of patients transferred for primary PCI but was associated with shorter reperfusion delays and lower in-hospital mortality. JAMA. 2011;305(24):2540-2547	[Wang, Tracy Y.; Li, Shuang; Roe, Matthew T.; Jollis, James G.; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Med, VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI 48104 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Jacobs, Alice K.] Boston Med Ctr, Dept Med, Cardiol Sect, Boston, MA USA; [Ting, Henry H.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Holmes, David R.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Duke University; University of Michigan System; University of Michigan; Yale University; Yale University; Boston Medical Center; Mayo Clinic; Mayo Clinic	Wang, TY (corresponding author), 2400 Pratt St, Durham, NC 27705 USA.	tracy.wang@duke.edu	Peterson, Eric David/ABF-5033-2021; , Harlan/AAI-2875-2020	Jacobs, Alice/0000-0002-2428-2458	Bristol-Myers Squibb/Sanofi; Schering Plough/Merck; Medicines Co; Heartscape; Canyon Pharmaceuticals; Eli Lilly/Daiichi Sankyo Alliance; Eli Lilly; Novartis; Merck-Schering Plough; Bristol-Myers Squibb; American College of Cardiology; American Heart Association; Glaxo Smith Kline; KAI Pharmaceuticals; Sanofi-Aventis; Orexigen; Astra Zeneca; St Jude Inc; Bayer; Pfizer; ACC Foundation's NCDR; Society of Chest Pain Centers; American College of Emergency Physicians; Society of Hospital Medicine	Bristol-Myers Squibb/Sanofi(Bristol-Myers Squibb); Schering Plough/Merck(Merck & CompanySchering Plough Corporation); Medicines Co; Heartscape; Canyon Pharmaceuticals; Eli Lilly/Daiichi Sankyo Alliance(Eli Lilly); Eli Lilly(Eli Lilly); Novartis(Novartis); Merck-Schering Plough(Merck & CompanySchering Plough Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); American College of Cardiology(General Electric); American Heart Association(American Heart Association); Glaxo Smith Kline(GlaxoSmithKline); KAI Pharmaceuticals; Sanofi-Aventis(Sanofi-Aventis); Orexigen; Astra Zeneca(AstraZeneca); St Jude Inc; Bayer(Bayer AG); Pfizer(Pfizer); ACC Foundation's NCDR; Society of Chest Pain Centers; American College of Emergency Physicians(General Electric); Society of Hospital Medicine	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. All conflicts of interest are listed at http://www.dcri.org. Dr Wang reports receiving research grants to the Duke Clinical Research Institute from the Bristol-Myers Squibb/Sanofi Partnership, Schering Plough/Merck, The Medicines Co, Heartscape, Canyon Pharmaceuticals, and Eli Lilly/Daiichi Sankyo Alliance, as well as consulting fees/honoraria for Medco and Astra Zeneca. Dr Krumholz reports chairing a scientific advisory board for United Healthcare. Dr Roe reports receiving research funding from Eli Lilly, Novartis, Merck-Schering Plough, Bristol-Myers Squibb, the American College of Cardiology, and the American Heart Association; and consulting fees/honoraria from Glaxo Smith Kline, KAI Pharmaceuticals, Novartis, Eli Lilly, Bristol-Myers Squibb, Sanofi-Aventis, Orexigen, and Astra Zeneca. Dr Jacobs reports chairing the Mission: Lifeline Advisory Working Group. Dr Peterson reports receiving research grants from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Schering Plough/Merck, and St Jude Inc and consultant fees from Bayer and Pfizer. No other disclosures were reported.; This research was supported by the ACC Foundation's NCDR. The ACTION Registry-GWTG is an initiative of the ACC Foundation and the AHA with partnering support from the Society of Chest Pain Centers, the American College of Emergency Physicians, and the Society of Hospital Medicine. The registry is sponsored in part by the Bristol-Myers Squibb/Sanofi Partnership.	American Hospital Association, 2005, ANN SURV HOSP DAT DO; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; [Anonymous], MEAS SUMM AC MYOC IN; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Bohmer E, 2010, J AM COLL CARDIOL, V55, P102, DOI 10.1016/j.jacc.2009.08.007; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; Chakrabarti A, 2008, J AM COLL CARDIOL, V51, P2442, DOI 10.1016/j.jacc.2008.02.071; Chin CT, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.004; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Ellrodt G, 2007, CIRCULATION, V116, pE49, DOI 10.1161/CIRCULATIONAHA.107.184048; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Jacobs AK, 2006, CIRCULATION, V113, P1159, DOI 10.1161/CIRCULATIONAHA.105.610345; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Jollis JG, 2007, JAMA-J AM MED ASSOC, V298, P2371, DOI 10.1001/jama.298.20.joc70124; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Krumholz HM, 2011, J AM COLL CARDIOL, V57, P637, DOI 10.1016/j.jacc.2010.12.010; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; Kushner, 2010, CIRCULATION, V121, pE257, DOI 10.1161/CIR.0b013e3181d7a65e; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Nallamothu BK, 2009, AM J CARDIOL, V103, P1051, DOI 10.1016/j.amjcard.2008.12.030; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Wang TY, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.001; Wang TY, 2011, AM HEART J, V161, pe1; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	33	123	125	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2540	2547		10.1001/jama.2011.862	http://dx.doi.org/10.1001/jama.2011.862			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693742	Bronze			2022-12-01	WOS:000291860400021
J	Alexander, GC; O'Connor, AB; Stafford, RS				Alexander, G. Caleb; O'Connor, Alec B.; Stafford, Randall S.			Enhancing Prescription Drug Innovation and Adoption	ANNALS OF INTERNAL MEDICINE			English	Article							SURROGATE END-POINTS; CLINICAL-TRIALS; FDA; RISK; INFORMATION	The adoption and use of a new drug would ideally be guided by its innovation and cost-effectiveness. However, information about the relative efficacy and safety of a drug is typically incomplete even well after market entry, and various other forces create a marketplace in which most new drugs are little better than their older counterparts. Five proposed mechanisms are considered for promoting innovation and reducing the use of therapies ultimately found to offer poor value or have unacceptable risks. These changes range from increasing the evidence required for U. S. Food and Drug Administration approval to modifying the structure of drug reimbursement. Despite the challenges of policy implementation, the United States has a long history of successfully improving the societal value and safe use of prescription medicines.	Univ Chicago, Univ Chicago Hosp, Chicago, IL 60637 USA; Univ Illinois, Sch Pharm, Chicago, IL USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	University of Chicago; University of Illinois System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Rochester; Stanford University	Alexander, GC (corresponding author), Univ Chicago, Med Ctr, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	galexand@uchicago.edu	; Stafford, Randall/F-3974-2017	O'Connor, Alec/0000-0001-8181-5567; Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality [K08 HS15699, RO1 HS0189960]; National Heart, Lung, and Blood Institute [K24 HL086703]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By grants K08 HS15699 and RO1 HS0189960 from the Agency for Healthcare Research and Quality (Dr. Alexander) and grant K24 HL086703 from the National Heart, Lung, and Blood Institute (Dr. Stafford).	Abraham J, 2005, SOC SCI MED, V61, P881, DOI 10.1016/j.socscimed.2005.01.004; Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; *ASTRAZENECA, 2010, 4 Q FULL YEAR RES 20; BACIU A, 2007, FUTURE DRUG SAFETY P; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berndt ER, 2005, NAT REV DRUG DISCOV, V4, P545, DOI 10.1038/nrd1774; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Fretheim Atle, 2003, BMC Fam Pract, V4, P19, DOI 10.1186/1471-2296-4-19; Green JA, 2007, PRESCRIBING NUMBERS; Hamburg MA, 2010, NEW ENGL J MED, V363, P2228, DOI 10.1056/NEJMsa1007467; Kesselheim AS, 2010, NEW ENGL J MED, V363, P1855, DOI 10.1056/NEJMhle1002961; Leidl R M, 1994, Int J Technol Assess Health Care, V10, P467; Lindstrom JA, 2009, DERMATOL THER, V22, P246, DOI 10.1111/j.1529-8019.2009.01238.x; Mintzes Barbara, 2005, Can J Clin Pharmacol, V12, pe22; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; *OFF INSP GEN, OEI039400760 US DEP; Olson MK, 2008, J HEALTH ECON, V27, P175, DOI 10.1016/j.jhealeco.2007.10.007; Pearson SD, 2010, HEALTH AFFAIR, V29, P1796, DOI 10.1377/hlthaff.2010.0623; Polinski JM, 2007, HEALTH AFFAIR, V26, P750, DOI 10.1377/hlthaff.26.3.750; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; RAO AR, 1989, J MARKETING RES, V26, P351, DOI 10.2307/3172907; Rogers E.M., 1983, DIFFUSION INNOVATION, DOI DOI 10.1007/978-3-642-79868-9_2; Schiff GD, 2009, JAMA-J AM MED ASSOC, V301, P865, DOI 10.1001/jama.2009.195; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; Thomas CP, 2003, NEW ENGL J MED, V349, P2186, DOI 10.1056/NEJMp038172; *US FDA, 2010, FAST TRACK ACC APPR; *US GOV ACC OFF, 2002, GAO02958 US GOV ACC; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; WITTES J, 1989, STAT MED, V8, P415, DOI 10.1002/sim.4780080405; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; Zhang YT, 2007, HEALTH AFFAIR, V26, P880, DOI 10.1377/hlthaff.26.3.880; 2001, PRESCRIRE INT, V10, P52	37	17	17	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					833	839		10.7326/0003-4819-154-12-201106210-00012	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	779SA	21690598	Green Accepted			2022-12-01	WOS:000291800500020
J	Mao, ZY; Hine, C; Tian, X; Van Meter, M; Au, M; Vaidya, A; Seluanov, A; Gorbunova, V				Mao, Zhiyong; Hine, Christopher; Tian, Xiao; Van Meter, Michael; Au, Matthew; Vaidya, Amita; Seluanov, Andrei; Gorbunova, Vera			SIRT6 Promotes DNA Repair Under Stress by Activating PARP1	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; PROTEIN SIR2; DEACETYLASE; STABILITY; CHROMATIN; POLY(ADP-RIBOSYL)ATION; LONGEVITY; KINASE; SITES	Sirtuin 6 (SIRT6) is a mammalian homolog of the yeast Sir2 deacetylase. Mice deficient for SIRT6 exhibit genome instability. Here, we show that in mammalian cells subjected to oxidative stress SIRT6 is recruited to the sites of DNA double-strand breaks (DSBs) and stimulates DSB repair, through both nonhomologous end joining and homologous recombination. Our results indicate that SIRT6 physically associates with poly[adenosine diphosphate (ADP)-ribose] polymerase 1 (PARP1) and mono-ADP-ribosylates PARP1 on lysine residue 521, thereby stimulating PARP1 poly-ADP-ribosylase activity and enhancing DSB repair under oxidative stress.	[Mao, Zhiyong; Hine, Christopher; Tian, Xiao; Van Meter, Michael; Au, Matthew; Vaidya, Amita; Seluanov, Andrei; Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Seluanov, A (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	andrei.seluanov@rochester.edu; vera.gorbunova@rochester.edu	Tian, Xiao/E-3998-2017	Tian, Xiao/0000-0001-5300-3596; Mao, Zhiyong/0000-0002-5298-1918; Gorbunova, Vera/0000-0001-8979-0333; Hine, Christopher/0000-0003-1926-7939; Seluanov, Andrei/0000-0003-3400-538X	NIH; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG027237, F31AG041603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (to V.G.) and the Ellison Medical Foundation (to V.G. and A.S.). Z.M. performed DNA repair assays, immunoblots, coimmunoprecipitations, in situ staining, and biochemical assays; C.H. and A.V. performed ChIP; X.T. analyzed PARP1 mutants; M.V.M. analyzed DNA damage foci; M.A. performed comet assays; and Z.M., C.H., A.S., and V.G. designed the study, analyzed data, and wrote the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Burkle A, 2000, BIOGERONTOLOGY, V1, P41, DOI 10.1023/A:1010089924898; di Fagagna FD, 1999, NAT GENET, V23, P76; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gorbunova V, 2005, MECH AGEING DEV, V126, P621, DOI 10.1016/j.mad.2005.02.008; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jeggo PA, 1998, CURR BIOL, V8, pR49, DOI 10.1016/S0960-9822(98)70032-6; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Paddock MN, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000428; Saunders LR, 2009, SCIENCE, V323, P1021, DOI 10.1126/science.1170007; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946	25	556	580	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1443	1446		10.1126/science.1202723	http://dx.doi.org/10.1126/science.1202723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680843	Green Accepted			2022-12-01	WOS:000291689000045
J	Florence, C; Shepherd, J; Brennan, I; Simon, T				Florence, Curtis; Shepherd, Jonathan; Brennan, Iain; Simon, Thomas			Effectiveness of anonymised information sharing and use in health service, police, and local government partnership for preventing violence related injury: experimental study and time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCIDENT	Objective To evaluate the effectiveness of anonymised information sharing to prevent injury related to violence. Design Experimental study and time series analysis of a prototype community partnership between the health service, police, and local government partners designed to prevent violence. Setting Cardiff, Wales, and 14 comparison cities designated "most similar" by the Home Office in England and Wales. Intervention After a 33 month development period, anonymised data relevant to violence prevention (precise violence location, time, days, and weapons) from patients attending emergency departments in Cardiff and reporting injury from violence were shared over 51 months with police and local authority partners and used to target resources for violence prevention. Main outcome measures Health service records of hospital admissions related to violence and police records of woundings and less serious assaults in Cardiff and other cities after adjustment for potential confounders. Results Information sharing and use were associated with a substantial and significant reduction in hospital admissions related to violence. In the intervention city (Cardiff) rates fell from seven to five a month per 100 000 population compared with an increase from five to eight in comparison cities (adjusted incidence rate ratio 0.58, 95% confidence interval 0.49 to 0.69). Average rate of woundings recorded by the police changed from 54 to 82 a month per 100 000 population in Cardiff compared with an increase from 54 to 114 in comparison cities (adjusted incidence rate ratio 0.68, 0.61 to 0.75). There was a significant increase in less serious assaults recorded by the police, from 15 to 20 a month per 100 000 population in Cardiff compared with a decrease from 42 to 33 in comparison cities (adjusted incidence rate ratio 1.38, 1.13 to 1.70). Conclusion An information sharing partnership between health services, police, and local government in Cardiff, Wales, altered policing and other strategies to prevent violence based on information collected from patients treated in emergency departments after injury sustained in violence. This intervention led to a significant reduction in violent injury and was associated with an increase in police recording of minor assaults in Cardiff compared with similar cities in England and Wales where this intervention was not implemented.	[Shepherd, Jonathan] Cardiff Univ, Violence & Soc Res Grp, Sch Dent, Cardiff CF14 4XY, S Glam, Wales; [Florence, Curtis; Simon, Thomas] Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA USA; [Brennan, Iain] Univ Hull, Dept Social Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Cardiff University; Centers for Disease Control & Prevention - USA; University of Hull	Shepherd, J (corresponding author), Cardiff Univ, Violence & Soc Res Grp, Sch Dent, Cardiff CF14 4XY, S Glam, Wales.	shepherdjp@cardiff.ac.uk		Brennan, Iain/0000-0003-2131-1599; Shepherd, Jonathan/0000-0001-6466-2298	Home Office; Wales Office for Research and Development in Health and Social Care (WORD) [R/98/037]	Home Office; Wales Office for Research and Development in Health and Social Care (WORD)	The development of the prototype partnership was funded in part by a grant from the Home Office targeted policing fund. The study was funded in part by the Wales Office for Research and Development in Health and Social Care (WORD), grant No R/98/037.	[Anonymous], PREV VIOL GUID IMPL; [Anonymous], 2002, WORLD REP VIOL HLTH; Braga A.A., 2007, CAMPBELL SYSTEMATIC, V3, P1, DOI DOI 10.4073/CSR.2007.1; BULLOCK S, 2007, POLICE SERVICE STREN; Christopherson O., 2004, POLICE SERVICE STREN; Clarke RV., 1994, CRIME PREVENTION STU, V2, P165; CLARKSON C, 1994, CRIM LAW REV, P4; Clegg M., 2006, POLICE SERVICE STREN; COTTON J, 2003, POLICE SERVICE STREN; *CTR STUD PREV VIO, BLUEPR VIOL PREV; Dahlberg Linda L, 2005, Int J Inj Contr Saf Promot, V12, P93, DOI 10.1080/15660970500086239; Dubourg R, 2005, EC SOCIAL COSTS CRIM; Faergemann Christian, 2007, J Forensic Leg Med, V14, P20, DOI 10.1016/j.jcfm.2006.01.001; FARRINGTON D, 2004, CROSS NATL STUDIES C; Giacopassi D, 2000, J CRIM JUST, V28, P397, DOI 10.1016/S0047-2352(00)00054-4; Goodwin V, 2000, J ACCID EMERG MED, V17, P196; Green L., 1995, JUSTICE Q, V12, P711, DOI DOI 10.1080/07418829500096261; HAHN H, 2007, MMWR RECOMM REP, V56, P1; HARPER G, 2002, FAMILY ORIGINS DEV G; Houry D, 2002, ANN EMERG MED, V39, P56, DOI 10.1067/mem.2002.117759; Kellermann AL, 2001, ANN EMERG MED, V38, P423, DOI 10.1067/mem.2001.117273; Mercy JA, 2006, INJURY PREV, V12, P1, DOI 10.1136/ip.2006.012542; Pinto R., 2005, POLICE SERVICE STREN; Povey D., 2001, POLICE SERVICE STREN; RITTERN, 2009, NATL I JUSTICE J, V264, P20; Sachs CJ, 1998, ANN EMERG MED, V31, P488, DOI 10.1016/S0196-0644(98)70259-8; Shepherd JP, 2001, LANCET, V358, P1717, DOI 10.1016/S0140-6736(01)06716-2; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; SHEPHERD JP, 1990, INJURY, V21, P139, DOI 10.1016/0020-1383(90)90081-5; Shepherd JP, 2001, ANN EMERG MED, V38, P430, DOI 10.1067/mem.2001.114317; SHEPHERD JP, 1993, J ROY SOC MED, V86, P87; Sherman L W, 1995, JUSTICE Q, V12, P625; Simmons J., 2003, NATL CRIME RECORDING; SISSON D, 2001, POLICE SERVICE STREN; Sivarajasingam V, 2004, INJURY, V35, P467, DOI 10.1016/S0020-1383(03)00241-9; Sivarajasingam V, 2003, INJURY PREV, V9, P312, DOI 10.1136/ip.9.4.312; SMITH C, 2002, POLICE SERVICE STREN; STPIERRE TL, 1992, AM J COMMUN PSYCHOL, V20, P673; Sutherland I, 2002, INJ PREV, V8, P246, DOI 10.1136/ip.8.3.246; The Crown Prosecution Service, OFF PERS INC CHARG S; Villaveces A, 2000, JAMA-J AM MED ASSOC, V283, P1205, DOI 10.1001/jama.283.9.1205; Walker A, 2009, CRIME ENGLAND WALES; Warburton AL, 2006, EMERG MED J, V23, P12, DOI 10.1136/emj.2004.023028; Warburton AL, 2004, EMERG MED J, V21, P473, DOI 10.1136/emj.2003.004978; World Health Organization, 2008, GLOB BURD DIS	45	88	88	2	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2011	342								d3313	10.1136/bmj.d3313	http://dx.doi.org/10.1136/bmj.d3313			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LF	21680632	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-01	WOS:000291933000004
J	Shi, ML; Zhu, JH; Wang, R; Chen, X; Mi, LZ; Walz, T; Springer, TA				Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Walz, Thomas; Springer, Timothy A.			Latent TGF-beta structure and activation	NATURE			English	Article							GROWTH-FACTOR-BETA; BINDING-PROTEIN; CRYSTAL-STRUCTURE; SECRETION; MATURE; TGF-BETA-1; DOMAIN; FACTOR-BETA-1; INFLAMMATION; REQUIREMENT	Transforming growth factor (TGF)-beta is stored in the extracellular matrix as a latent complex with its prodomain. Activation of TGF-beta 1 requires the binding of alpha(v) integrin to an RGD sequence in the prodomain and exertion of force on this domain, which is held in the extracellular matrix by latent TGF-beta binding proteins. Crystals of dimeric porcine proTGF-beta 1 reveal a ring-shaped complex, a novel fold for the prodomain, and show how the prodomain shields the growth factor from recognition by receptors and alters its conformation. Complex formation between alpha(v)beta(6) integrin and the prodomain is insufficient for TGF-beta 1 release. Force-dependent activation requires unfastening of a 'straitjacket' that encircles each growth-factor monomer at a position that can be locked by a disulphide bond. Sequences of all 33 TGF-beta family members indicate a similar prodomain fold. The structure provides insights into the regulation of a family of growth and differentiation factors of fundamental importance in morphogenesis and homeostasis.	[Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Springer, Timothy A.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Walz, Thomas] Howard Hughes Med Inst, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA.	springer@idi.harvard.edu	Zhu, Jianghai/B-7339-2014; shi, minlong/G-8734-2013; Mi, Li-Zhi/B-1371-2016	Mi, Li-Zhi/0000-0001-9907-5245; Walz, Thomas/0000-0003-2606-2835	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01 HL103526] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belville C, 2004, MOL ENDOCRINOL, V18, P708, DOI 10.1210/me.2003-0358; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BRUNNER AM, 1992, MOL ENDOCRINOL, V6, P1691, DOI 10.1210/me.6.10.1691; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chen Y, 2005, J MOL BIOL, V345, P175, DOI 10.1016/j.jmb.2004.10.039; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cui YZ, 2001, GENE DEV, V15, P2797; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derynck Rik, 2008, P29; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Lack J, 2003, J MOL BIOL, V334, P281, DOI 10.1016/j.jmb.2003.09.053; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Ulloa L, 2001, J BIOL CHEM, V276, P21387, DOI 10.1074/jbc.M006933200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; WILSON CA, 1993, MOL ENDOCRINOL, V7, P247, DOI 10.1210/me.7.2.247; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Zou ZC, 2004, PROTEIN EXPRES PURIF, V37, P265, DOI 10.1016/j.pep.2003.06.001	46	638	663	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					343	U370		10.1038/nature10152	http://dx.doi.org/10.1038/nature10152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677751	Green Accepted			2022-12-01	WOS:000291647100038
J	Jurkovic, D; Wilkinson, H				Jurkovic, Davor; Wilkinson, Helen			Diagnosis and management of ectopic pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOSE SYSTEMIC METHOTREXATE; EXPECTANT MANAGEMENT; LAPAROSCOPIC SURGERY; RANDOMIZED-TRIAL; ECONOMIC-EVALUATION; RISK-FACTORS; SONOGRAPHY		[Jurkovic, Davor] Univ Coll Hosp, Dept Obstet & Gynaecol, London NW1 2BU, England; [Wilkinson, Helen] Kings Coll Hosp London, Ectop Pregnancy Trust, London, England	University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Jurkovic, D (corresponding author), Univ Coll Hosp, Dept Obstet & Gynaecol, London NW1 2BU, England.	davor.jurkovic@uclh.nhs.uk						Agency for Healthcare Research and Quality, 2008, MED MAN ECT PREGN, P427; Ankum WM, 1996, FERTIL STERIL, V65, P1093, DOI 10.1016/S0015-0282(16)58320-4; Bouyer J, 2003, AM J EPIDEMIOL, V157, P185, DOI 10.1093/aje/kwf190; BROWN DL, 1994, J ULTRAS MED, V13, P259, DOI 10.7863/jum.1994.13.4.259; CACCIATORE B, 1989, OBSTET GYNECOL, V73, P770; Condous G, 2006, ULTRASOUND OBST GYN, V28, P121, DOI 10.1002/uog.2838; CORDINA M, 2011, BJOG; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Ehrenberg-Buchner S, 2009, CLIN OBSTET GYNECOL, V52, P372, DOI 10.1097/GRF.0b013e3181b0be24; Elson J, 2004, ULTRASOUND OBST GYN, V23, P552, DOI 10.1002/uog.1061; Hajenius PJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000324.pub2; Hajenius PJ, 1997, LANCET, V350, P774, DOI 10.1016/S0140-6736(97)05487-1; Helmy S, 2007, ULTRASOUND OBST GYN, V30, P988, DOI 10.1002/uog.5186; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Kirk E, 2007, HUM REPROD, V22, P1744, DOI 10.1093/humrep/dem073; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; KOBAYASHI M, 1969, AM J OBSTET GYNECOL, V103, P1131, DOI 10.1016/0002-9378(69)90518-3; Korhonen J, 1996, OBSTET GYNECOL, V88, P775, DOI 10.1016/0029-7844(96)00293-1; LI TC, 1991, HUM REPROD, V6, P1002, DOI 10.1093/oxfordjournals.humrep.a137449; Lundorff P, 1991, ACTA OBSTET GYN SCAN, V70, P343, DOI 10.3109/00016349109007885; Moeller LBK, 2009, ACTA OBSTET GYN SCAN, V88, P1331, DOI 10.3109/00016340903188912; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; Mol BWJ, 1999, FERTIL STERIL, V71, P155, DOI 10.1016/S0015-0282(98)00396-3; Mol F, 2008, HUM REPROD UPDATE, V14, P309, DOI 10.1093/humupd/dmn012; Murray H, 2005, CAN MED ASSOC J, V173, P905, DOI 10.1503/cmaj.050222; *ROYAL COLL OBST G, 2004, 21 ROYAL COLL OBST G; Royal College of Obstetricians and Gunecologists, 2009, UK MED EL CRIT CONTR; Sowter MC, 2001, BRIT J OBSTET GYNAEC, V108, P192, DOI 10.1111/j.1471-0528.2001.00038.x; Sowter MC, 2001, BRIT J OBSTET GYNAEC, V108, P204, DOI 10.1111/j.1471-0528.2001.00037.x; Stein JC, 2010, ANN EMERG MED, V56, P674, DOI 10.1016/j.annemergmed.2010.06.563; WANG R, 2011, ANN EMERG MED; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397	32	63	67	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2011	342								d3397	10.1136/bmj.d3397	http://dx.doi.org/10.1136/bmj.d3397			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SS	21665933				2022-12-01	WOS:000291645900003
J	Eisenstein, M				Eisenstein, Michael			A moving target	NATURE			English	Editorial Material																		Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Soderholm J, 2006, GUT, V55, P266, DOI 10.1136/gut.2005.072231	4	12	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S16	S17		10.1038/474S16a	http://dx.doi.org/10.1038/474S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666730	Bronze			2022-12-01	WOS:000291397800010
J	Borgonie, G; Garcia-Moyano, A; Litthauer, D; Bert, W; Bester, A; van Heerden, E; Moller, C; Erasmus, M; Onstott, TC				Borgonie, G.; Garcia-Moyano, A.; Litthauer, D.; Bert, W.; Bester, A.; van Heerden, E.; Moeller, C.; Erasmus, M.; Onstott, T. C.			Nematoda from the terrestrial deep subsurface of South Africa	NATURE			English	Article							WITWATERSRAND BASIN; EVOLUTION; WATER	Since its discovery over two decades ago, the deep subsurface biosphere has been considered to be the realm of single-cell organisms, extending over three kilometres into the Earth's crust and comprising a significant fraction of the global biosphere(1-4). The constraints of temperature, energy, dioxygen and space seemed to preclude the possibility of more-complex, multicellular organisms from surviving at these depths. Here we report species of the phylum Nematoda that have been detected in or recovered from 0.9-3.6-kilometre-deep fracture water in the deep mines of South Africa but have not been detected in the mining water. These subsurface nematodes, including a new species, Halicephalobus mephisto, tolerate high temperature, reproduce asexually and preferentially feed upon subsurface bacteria. Carbon-14 data indicate that the fracture water in which the nematodes reside is 3,000-12,000-year-old palaeometeoric water. Our data suggest that nematodes should be found in other deep hypoxic settings where temperature permits, and that they may control the microbial population density by grazing on fracture surface biofilm patches. Our results expand the known metazoan biosphere and demonstrate that deep ecosystems are more complex than previously accepted. The discovery of multicellular life in the deep subsurface of the Earth also has important implications for the search for subsurface life on other planets in our Solar System.	[Borgonie, G.; Bert, W.] Univ Ghent, Dept Biol, Nematol Sect, B-9000 Ghent, Belgium; [Garcia-Moyano, A.; Litthauer, D.; Bester, A.; van Heerden, E.; Moeller, C.; Erasmus, M.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, ZA-9300 Bloemfontein, South Africa; [Bert, W.] Wageningen Univ, Dept Plant Sci, Nematol Lab, NL-6708 Wageningen, Netherlands; [Onstott, T. C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Ghent University; University of the Free State; Wageningen University & Research; Princeton University	Borgonie, G (corresponding author), Univ Ghent, Dept Biol, Nematol Sect, Ledeganckstr 35, B-9000 Ghent, Belgium.	gborgonie@gmail.com; tullis@princeton.edu	Bert, Wim/D-4511-2013; Erasmus, Mariana/AAE-9823-2019; Garcia-Moyano, Antonio/AAI-8647-2020; Garcia-Moyano, Antonio/O-4791-2014	Bert, Wim/0000-0002-5864-412X; Erasmus, Mariana/0000-0003-2191-762X; Garcia-Moyano, Antonio/0000-0003-1997-8589; Garcia-Moyano, Antonio/0000-0003-1997-8589; Onstott, Tullis/0000-0002-2898-3374	FWO; BOF; UFS; National Science Foundation [EAR 0409605]; BioPAD/UFS; Directorate For Geosciences [0948659] Funding Source: National Science Foundation	FWO(FWO); BOF; UFS; National Science Foundation(National Science Foundation (NSF)); BioPAD/UFS; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	G.B. is grateful to the University of Ghent for allowing a year-long sabbatical, and for grants from the FWO, BOF and UFS. We express our recognition of the support provided by Tau Tona gold mine (AngloGold Ashanti Limited), Driefontein gold mine (Gold Fields Limited), Beatrix gold mine (Gold Fields Limited), Zondereinde mine (Northern Platinum Ltd) and Star Diamonds mine (Petra Diamonds), and by the many people without whom this work would have been impossible. In particular, we are grateful to F. Rheeder, H. Moller, T. Lineque, A. Thwala, K. Sokhela, C. Rose, R. Fynn, B. Visser, O. Holovachev, T. Moens, M. Couvreur and A. Vierstraete. We are grateful to E. Botes and K. Albertyn of the University of the Free State for their contributions to the data analysis. T.C.O. acknowledges support from a National Science Foundation Continental Dynamics Program grant (EAR 0409605). E.v.H. acknowledges support from a BioPAD/UFS Metagenomics Platform grant.	Amend JP, 2005, PALAEOGEOGR PALAEOCL, V219, P131, DOI 10.1016/j.palaeo.2004.10.018; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; Edwards KJ, 2005, TRENDS MICROBIOL, V13, P449, DOI 10.1016/j.tim.2005.07.005; Ekendahl S, 2003, MICROB ECOL, V46, P416, DOI 10.1007/s00248-003-2008-5; Engel AS, 2007, J CAVE KARST STUD, V69, P187; Ferris H, 1997, SOIL BIOL BIOCHEM, V29, P1183, DOI 10.1016/S0038-0717(97)00035-7; Foll RL, 1999, COMP BIOCHEM PHYS B, V124, P269, DOI 10.1016/S0305-0491(99)00130-3; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HOEPPLI R., 1932, HONG KONG NATURALIST SUPPL, V1, P15; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; JANA BB, 1973, HYDROBIOLOGIA, V41, P291, DOI 10.1007/BF00016623; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Lippmann J, 2003, GEOCHIM COSMOCHIM AC, V67, P4597, DOI 10.1016/S0016-7037(03)00414-9; Michel RL, 2005, ISOTOPES IN THE WATER CYCLE: PAST, PRESENT AND FUTURE OF A DEVELOPING SCIENCE, P53, DOI 10.1007/1-4020-3023-1_5; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Neher D. A., 2004, ENCY SOILS ENV, V3, P1; Ocana A., 1991, Nematologia Mediterranea, V19, P25; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; Onstott T. C., 1998, ENIGMATIC MICROORGAN, P487; PEDERSEN K, 1993, EARTH-SCI REV, V34, P243, DOI 10.1016/0012-8252(93)90058-F; PHELPS TJ, 1994, MICROBIAL ECOL, V28, P335, DOI 10.1007/BF00662027; SINCLAIR JL, 1989, GEOMICROBIOL J, V7, P15, DOI 10.1080/01490458909377847; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Wanger G, 2006, GEOMICROBIOL J, V23, P443, DOI 10.1080/01490450600875746; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; YEATES GW, 1993, J NEMATOL, V25, P315	29	125	135	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					79	82		10.1038/nature09974	http://dx.doi.org/10.1038/nature09974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637257	Green Published			2022-12-01	WOS:000291156700041
J	Baker, M				Baker, Monya			THE NEXT STEP FOR THE SYNTHETIC GENOME	NATURE			English	Editorial Material							CHEMICAL-SYNTHESIS; DNA; YEAST; CELL											Caruthers MH, 2011, BIOCHEM SOC T, V39, P575, DOI 10.1042/BST0390575; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187	13	24	27	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					403	408		10.1038/473403a	http://dx.doi.org/10.1038/473403a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593873	Bronze			2022-12-01	WOS:000290722400055
J	Wang, B; Moya, N; Niessen, S; Hoover, H; Mihaylova, MM; Shaw, RJ; Yates, JR; Fischer, WH; Thomas, JB; Montminy, M				Wang, Biao; Moya, Noel; Niessen, Sherry; Hoover, Heather; Mihaylova, Maria M.; Shaw, Reuben J.; Yates, John R., III; Fischer, Wolfgang H.; Thomas, John B.; Montminy, Marc			A Hormone-Dependent Module Regulating Energy Balance	CELL			English	Article							CREB COACTIVATOR TORC2; TRANSCRIPTION FACTOR; CLASS IIHDAC; DROSOPHILA; INSULIN; EXPRESSION; KINASE; PHOSPHORYLATION; METABOLISM; PROTEIN	Under fasting conditions, metazoans maintain energy balance by shifting from glucose to fat burning. In the fasted state, SIRT1 promotes catabolic gene expression by deacetylating the forkhead factor FOXO in response to stress and nutrient deprivation. The mechanisms by which hormonal signals regulate FOXO deacetylation remain unclear, however. We identified a hormone-dependent module, consisting of the Ser/Thr kinase SIK3 and the class IIa deacetylase HDAC4, which regulates FOXO activity in Drosophila. During feeding, HDAC4 is phosphorylated and sequestered in the cytoplasm by SIK3, whose activity is upregulated in response to insulin. SIK3 is inactivated during fasting, leading to the dephosphorylation and nuclear translocation of HDAC4 and to FOXO deacetylation. SIK3 mutant flies are starvation sensitive, reflecting FOXO-dependent increases in lipolysis that deplete triglyceride stores; reducing HDAC4 expression restored lipid accumulation. Our results reveal a hormone-regulated pathway that functions in parallel with the nutrient-sensing SIRT1 pathway to maintain energy balance.	[Wang, Biao; Thomas, John B.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Wang, Biao; Moya, Noel; Fischer, Wolfgang H.; Montminy, Marc] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA; [Niessen, Sherry; Hoover, Heather; Yates, John R., III] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Salk Institute; Scripps Research Institute	Thomas, JB (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jthomas@salk.edu; montminy@salk.edu	Mihaylova, Maria M./ACZ-4949-2022	Mihaylova, Maria M./0000-0002-2725-767X	NIH [R01-DK049777, R01-DK083834, R01-DK077979, R01 DK080425, P01CA120964]; American Diabetes Association [1-08-JF-47]; Keickhefer Foundation; Clayton Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425, R01DK083834, R37DK083834, R56DK077979, R01DK049777, R01DK077979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947, R01GM040613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056316, R01NS040963, P01NS031249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Keickhefer Foundation; Clayton Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH grants (R01-DK049777 and R01-DK083834 to M. M.; R01-DK077979 to J.B.T.; R01 DK080425 and P01CA120964 to R.J.S.), an American Diabetes Association Junior Faculty Award (1-08-JF-47 to R.J.S.), The Keickhefer Foundation, The Clayton Foundation for Medical Research, and The Leona M. and Harry B. Helmsley Charitable Trust. We thank Y. Imai and A. Fukamizu (Tsukuba) for the gift of antisera. We also thank E. Hafen, J. Chung, R. Kulnlein, J. Scott, J. Park, Bloomington Stock Center, VDRC, Exelixis, and TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for fly stocks used in this study.	Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fukuoka M, 2003, INT J MOL MED, V12, P503; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Reiter Lawrence T, 2002, Expert Opin Ther Targets, V6, P387; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wagner BL, 2000, J BIOL CHEM, V275, P8263, DOI 10.1074/jbc.275.12.8263; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011	37	165	176	1	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					596	606		10.1016/j.cell.2011.04.013	http://dx.doi.org/10.1016/j.cell.2011.04.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565616	Green Accepted, Bronze			2022-12-01	WOS:000290560800012
J	Park, E; Rapoport, TA				Park, Eunyong; Rapoport, Tom A.			Preserving the membrane barrier for small molecules during bacterial protein translocation	NATURE			English	Article							ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; SECY PROTEIN; CONDUCTING CHANNEL; TRANSLATION ARREST; SIGNAL SEQUENCE; RIBOSOME; PERMEABILITY; MAINTAINS; COMPLEX	Many proteins are translocated through the SecY channel in bacteria and archaea and through the related Sec61 channel in eukaryotes(1). The channel has an hourglass shape with a narrow constriction approximately halfway across the membrane, formed by a pore ring of amino acids(2). While the cytoplasmic cavity of the channel is empty, the extracellular cavity is filled with a short helix called the plug(2), which moves out of the way during protein translocation(3,4). The mechanism by which the channel transports large polypeptides and yet prevents the passage of small molecules, such as ions or metabolites, has been controversial(2,5-8). Here, we have addressed this issue in intact Escherichia coli cells by testing the permeation of small molecules through wild-type and mutant SecY channels, which are either in the resting state or contain a defined translocating polypeptide chain. We show that in the resting state, the channel is sealed by both the pore ring and the plug domain. During translocation, the pore ring forms a 'gasket-like' seal around the polypeptide chain, preventing the permeation of small molecules. The structural conservation of the channel in all organisms indicates that this may be a universal mechanism by which the membrane barrier is maintained during protein translocation.	[Park, Eunyong; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Park, Eunyong; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu			NIH [GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Walter, H. Bernstein and G. Phillips for materials, D. Boyd for advice, C. Akey for discussions and C. Akey, A. Osborne and A. Salic for critical reading of the manuscript. The work was supported by a grant from the NIH (GM052586). T.A.R. is a Howard Hughes Medical Institute investigator.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Heritage D, 2001, J BIOL CHEM, V276, P22655, DOI 10.1074/jbc.M102409200; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Roy A, 2003, J BIOL CHEM, V278, P4397, DOI 10.1074/jbc.M207295200; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; SCHIEBEL E, 1992, J BIOL CHEM, V267, P7505; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	30	73	74	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					239	+		10.1038/nature10014	http://dx.doi.org/10.1038/nature10014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562565	Green Accepted			2022-12-01	WOS:000290487200044
J	Selmi, C; Bowlus, CL; Gershwin, ME; Coppel, RL				Selmi, Carlo; Bowlus, Christopher L.; Gershwin, M. Eric; Coppel, Ross L.			Primary biliary cirrhosis	LANCET			English	Article							URSODEOXYCHOLIC-ACID THERAPY; RANDOMIZED CONTROLLED-TRIALS; LONG-TERM SURVIVAL; REGULATORY T-CELLS; ANTIMITOCHONDRIAL ANTIBODIES; CLINICAL-FEATURES; ANTINUCLEAR ANTIBODIES; BIOCHEMICAL RESPONSE; NATURAL-HISTORY; LIVER-DISEASE	Primary biliary cirrhosis is a chronic liver disease characterised by intrahepatic bile-duct destruction, cholestasis, and, in some cases, cirrhosis. Evidence supporting the autoimmune nature of this disorder includes the appearance of highly specific antimitochondrial antibodies (AMAs) and autoreactive T cells. Concordance rates in monozygotic twins, familial prevalence, and genetic associations underscore the importance of genetic factors, whereas findings of epidemiological studies and murine models suggest a possible role for exogenous chemicals and infectious agents through molecular mimicry. The incidence of primary biliary cirrhosis has increased over recent decades, possibly attributable to augmented testing of liver biochemistry rather than a rise in disease incidence. AMAs remain the hallmark of diagnosis in most cases and allow detection of asymptomatic patients. Symptomatic individuals usually present with either pruritus or fatigue and, more rarely, with either jaundice or complications of cirrhosis. The prognosis of primary biliary cirrhosis has improved because of early diagnosis and use of ursodeoxycholic acid, the only established medical treatment for this disorder. Although not a cure, treatment can slow disease progression and delay the need for liver transplantation. However, some patients do not respond adequately to ursodeoxycholic acid and might need alternative therapeutic approaches.	[Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Selmi, Carlo] Univ Milan, Dept Translat Med, IRCCS Ist Clin Humanitas, Milan, Italy; [Bowlus, Christopher L.] Univ Calif Davis, Div Gastroenterol & Hepatol, Davis, CA 95616 USA; [Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA	Monash University; Humanitas University; IRCCS Humanitas Research Hospital; University of Milan; University of California System; University of California Davis; University of California System; University of California Davis	Coppel, RL (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	ross.coppel@monash.edu	Selmi, Carlo/ABG-4899-2021; Coppel, Ross L/A-6626-2008; Bowlus, Christopher/N-9276-2016	Selmi, Carlo/0000-0002-0323-0376; Coppel, Ross L/0000-0002-4476-9124; Bowlus, Christopher/0000-0002-3906-6811	NIDDK NIH HHS [R01 DK090019, R01 DK067003] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067003] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS EH, 1950, MEDICINE, V29, P299, DOI 10.1097/00005792-195012000-00002; Al-Harthy N, 2010, HEPATOLOGY, V52, P562, DOI 10.1002/hep.23683; Ala A, 2006, HEPATOLOGY, V43, P525, DOI 10.1002/hep.21076; Allocca M, 2006, GUT, V55, P1795, DOI 10.1136/gut.2005.079814; Benetti A, 2008, J CLIN GASTROENTEROL, V42, P306, DOI 10.1097/01.mcg.0000248017.31386.39; Berg CP, 2009, LIVER INT, V29, P797, DOI 10.1111/j.1478-3231.2008.01942.x; Bergasa NV, 2008, CLIN LIVER DIS, V12, P385, DOI 10.1016/j.cld.2008.02.013; Bergasa NV, 1998, HEPATOLOGY, V27, P679, DOI 10.1002/hep.510270307; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Bogdanos DP, 2009, CLIN REV ALLERG IMMU, V36, P30, DOI 10.1007/s12016-008-8087-9; Bruggraber SFA, 2003, GASTROENTEROLOGY, V125, P1705, DOI 10.1053/j.gastro.2003.09.034; BURROUGHS AK, 1984, GUT, V25, P133, DOI 10.1136/gut.25.2.133; Cerri G, 2010, CLIN NEUROPHYSIOL, V121, P1321, DOI 10.1016/j.clinph.2009.12.040; CHA S, 1993, P NATL ACAD SCI USA, V90, P2527, DOI 10.1073/pnas.90.6.2527; Charatcharoenwitthaya P, 2007, LIVER TRANSPLANT, V13, P1236, DOI 10.1002/lt.21124; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; Chuang YH, 2006, J AUTOIMMUN, V26, P232, DOI 10.1016/j.jaut.2006.04.001; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1053/j.gastro.2004.11.009; CROSIGNANI A, 1991, HEPATOLOGY, V14, P1000, DOI 10.1002/hep.1840140609; Dahlan Y, 2003, GASTROENTEROLOGY, V125, P1476, DOI 10.1016/j.gastro.2003.08.022; DATTA DV, 1966, GASTROENTEROLOGY, V50, P323; de Rave S, 2005, TRANSPL INT, V18, P937, DOI 10.1111/j.1432-2277.2005.00161.x; DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; Fukushima N, 2002, HEPATOLOGY, V36, P1383, DOI 10.1053/jhep.2002.37140; FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P8654, DOI 10.1073/pnas.85.22.8654; Garcia RFL, 2001, HEPATOLOGY, V33, P22, DOI 10.1053/jhep.2001.20894; Garrido MC, 1996, J CLIN PATHOL, V49, P556, DOI 10.1136/jcp.49.7.556; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; GLUUD C, 2002, COCHRANE DB SYST REV, V1; Goldblatt J, 2002, GASTROENTEROLOGY, V122, P1235, DOI 10.1053/gast.2002.32993; Gong Y, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000551.PUB2; Gong Y, 2007, AM J GASTROENTEROL, V102, P1799, DOI 10.1111/j.1572-0241.2007.01235.x; Goulis J, 1999, LANCET, V354, P1053, DOI 10.1016/S0140-6736(98)11293-X; Granito A, 2007, ALIMENT PHARM THER, V26, P831, DOI 10.1111/j.1365-2036.2007.03433.x; Granito A, 2006, ALIMENT PHARM THER, V24, P1575, DOI 10.1111/j.1365-2036.2006.03172.x; Guanabens N, 2005, J HEPATOL, V42, P573, DOI 10.1016/j.jhep.2004.11.035; Hardy T, 2010, LIVER INT, V30, P1551, DOI 10.1111/j.1478-3231.2010.02288.x; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hollingsworth KG, 2008, CLIN GASTROENTEROL H, V6, P1041, DOI 10.1016/j.cgh.2008.04.013; Hollingsworth KG, 2009, J MAGN RESON IMAGING, V29, P780, DOI 10.1002/jmri.21555; Holtmeier J, 2001, DIGESTION, V64, P137, DOI 10.1159/000048854; Huet PM, 2008, GASTROENTEROLOGY, V135, P1552, DOI 10.1053/j.gastro.2008.07.019; Invernizzi P, 2005, SEMIN LIVER DIS, V25, P298, DOI 10.1055/s-2005-916321; Invernizzi P, 1997, HEPATOLOGY, V25, P1090, DOI 10.1002/hep.510250507; James OFW, 1999, HEPATOLOGY, V30, P390, DOI 10.1002/hep.510300213; Jones DEJ, 2007, ALIMENT PHARM THER, V25, P471, DOI 10.1111/j.1365-2036.2006.03223.x; Jones DE, 2010, J HEPATOL, V53, P911, DOI 10.1016/j.jhep.2010.05.026; Jones DEJ, 2007, GUT, V56, P1615, DOI 10.1136/gut.2007.122150; Jones DEJ, 2006, GUT, V55, P536, DOI 10.1136/gut.2005.080317; Kikuchi K, 2005, GASTROENTEROLOGY, V128, P304, DOI 10.1053/j.gastro.2004.11.005; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Lan RY, 2006, HEPATOLOGY, V43, P729, DOI 10.1002/hep.21123; Lee J, 2007, CLIN GASTROENTEROL H, V5, P1313, DOI 10.1016/j.cgh.2007.07.015; Leslie WD, 2003, GASTROENTEROLOGY, V125, P941, DOI 10.1016/S0016-5085(03)01062-X; Leung PSC, 2007, J IMMUNOL, V179, P2651, DOI 10.4049/jimmunol.179.4.2651; LEUSCHNER U, 1994, J HEPATOL, V21, P624, DOI 10.1016/S0168-8278(94)80111-8; Lindor KD, 1996, GASTROENTEROLOGY, V110, P1515, DOI 10.1053/gast.1996.v110.pm8613058; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Lleo A, 2008, AUTOIMMUN REV, V7, P626, DOI 10.1016/j.autrev.2008.06.009; Lleo A, 2010, HEPATOLOGY, V52, P987, DOI 10.1002/hep.23783; Lleo A, 2009, HEPATOLOGY, V49, P871, DOI 10.1002/hep.22736; Lleo A, 2008, J AUTOIMMUN, V31, P257, DOI 10.1016/j.jaut.2008.04.009; Locke GR, 1996, HEPATOLOGY, V23, P52, DOI 10.1053/jhep.1996.v23.pm0008550048; Longhi MS, 2008, HEPATOLOGY, V47, P581, DOI 10.1002/hep.22071; Longo M, 2002, GUT, V51, P265, DOI 10.1136/gut.51.2.265; LOZANO F, 1988, HEPATOLOGY, V8, P930, DOI 10.1002/hep.1840080438; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Mackay IR, 2009, J AUTOIMMUN, V33, P170, DOI 10.1016/j.jaut.2009.09.006; MacQuillan Gerry C, 2003, Clin Liver Dis, V7, P941, DOI 10.1016/S1089-3261(03)00099-0; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; Marasini B, 2001, ANN RHEUM DIS, V60, P1046, DOI 10.1136/ard.60.11.1046; Marzioni M, 2007, J HEPATOL, V46, P583, DOI 10.1016/j.jhep.2007.01.006; Mason A, 2010, J HEPATOL, V52, pS1, DOI 10.1016/S0168-8278(10)60004-9; Mattalia A, 1998, HEPATOLOGY, V27, P656, DOI 10.1002/hep.510270303; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; McNally RJQ, 2009, HEPATOLOGY, V50, P1169, DOI 10.1002/hep.23139; Metcalf JV, 1996, LANCET, V348, P1399, DOI 10.1016/S0140-6736(96)04410-8; Miyachi K, 1996, MOL BIOL REP, V23, P227, DOI 10.1007/BF00351173; Miyakawa H, 1999, AUTOIMMUNITY, V30, P11, DOI 10.3109/08916939908994755; Miyakawa H, 2001, HEPATOLOGY, V34, P243, DOI 10.1053/jhep.2001.26514; Moteki S, 1996, HEPATOLOGY, V24, P97; Muratori P, 2004, CLIN EXP IMMUNOL, V135, P154, DOI 10.1111/j.1365-2249.2004.02332.x; Muratori P, 2003, AM J GASTROENTEROL, V98, P431, DOI 10.1016/S0002-9270(02)05925-7; MUTIMER DJ, 1989, HEPATOLOGY, V10, P403, DOI 10.1002/hep.1840100402; MYSZOR M, 1990, Q J MED, V75, P377; Nakamura M, 2005, J HEPATOL, V42, P386, DOI 10.1016/j.jhep.2004.11.016; Nakamura M, 2007, HEPATOLOGY, V45, P118, DOI 10.1002/hep.21472; Newton JL, 2007, HEPATOLOGY, V45, P1496, DOI 10.1002/hep.21609; Newton JL, 2006, HEPATOLOGY, V44, P91, DOI 10.1002/hep.21230; Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI200110716; Oertelt S, 2007, HEPATOLOGY, V45, P659, DOI 10.1002/hep.21583; Padgett KA, 2005, J AUTOIMMUN, V24, P209, DOI 10.1016/j.jaut.2005.01.012; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Pla X, 2007, EUR J GASTROEN HEPAT, V19, P859, DOI 10.1097/MEG.0b013e328277594a; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; Prince M, 2002, GASTROENTEROLOGY, V123, P1044, DOI 10.1053/gast.2002.36027; PRINCE M, 2005, COCHRANE DB SYST REV, V2; Prince MI, 2010, GUT, V59, P508, DOI 10.1136/gut.2009.184218; Prince MI, 2004, GUT, V53, P865, DOI 10.1136/gut.2003.023937; Ramos-Casals M, 2005, J VIRAL HEPATITIS, V12, P648, DOI 10.1111/j.1365-2893.2005.00642.x; Ray-Chadhuri D, 2001, GUT, V48, P42; Reuben A, 2003, HEPATOLOGY, V37, P225, DOI 10.1002/hep.510370134; Rieger R, 2007, J AUTOIMMUN, V28, P76, DOI 10.1016/j.jaut.2007.02.003; Rieger R, 2006, J AUTOIMMUN, V27, P7, DOI 10.1016/j.jaut.2006.06.002; Rigamonti C, 2006, GUT, V55, P388, DOI 10.1136/gut.2005.075002; ROLL J, 1983, NEW ENGL J MED, V308, P1, DOI 10.1056/NEJM198301063080101; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Selmi C, 2005, SEMIN LIVER DIS, V25, P265, DOI 10.1055/s-2005-916319; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Selmi C, 2004, GASTROENTEROLOGY, V127, P493, DOI 10.1053/j.gastro.2004.05.033; Selmi C, 2003, HEPATOLOGY, V38, P1250, DOI 10.1053/jhep.2003.50446; SHERLOCK S, 1968, Acta Gastro-Enterologica Belgica, V31, P416; Shimoda S, 2003, GASTROENTEROLOGY, V124, P1915, DOI 10.1016/S0016-5085(03)00387-1; Shimoda S, 2008, J AUTOIMMUN, V31, P110, DOI 10.1016/j.jaut.2008.05.003; Silveira MG, 2008, HEPATOLOGY, V48, P1149, DOI 10.1002/hep.22458; Silveira MG, 2007, AM J GASTROENTEROL, V102, P1244, DOI 10.1111/j.1572-0241.2007.01136.x; Sood S, 2004, GASTROENTEROLOGY, V127, P470, DOI 10.1053/j.gastro.2004.04.064; Springer J, 1999, AM J GASTROENTEROL, V94, P47; Stojakovic T, 2007, HEPATOLOGY, V46, P776, DOI 10.1002/hep.21741; Sylvestre PB, 2003, LIVER TRANSPLANT, V9, P1086, DOI 10.1053/jlts.2003.50213; Tanaka A, 2007, ANN NY ACAD SCI, V1107, P259, DOI 10.1196/annals.1381.028; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; TRIGER DR, 1980, BRIT MED J, V281, P772, DOI 10.1136/bmj.281.6243.772; van Hoogstraten HJE, 1999, J HEPATOL, V31, P256, DOI 10.1016/S0168-8278(99)80222-0; Wakabayashi K, 2009, CLIN EXP IMMUNOL, V155, P577, DOI 10.1111/j.1365-2249.2008.03837.x; Wakabayashi K, 2008, HEPATOLOGY, V48, P531, DOI 10.1002/hep.22390; Walden HR, 2008, HEPATOLOGY, V48, P1874, DOI 10.1002/hep.22540; WALKER JG, 1965, LANCET, V1, P827; Wesierska-Gadek J, 2006, HEPATOLOGY, V43, P1135, DOI 10.1002/hep.21172; Xu LZ, 2003, P NATL ACAD SCI USA, V100, P8454, DOI 10.1073/pnas.1433063100; Yang GX, 2008, HEPATOLOGY, V47, P1974, DOI 10.1002/hep.22226; Zuchner D, 1997, HEPATOLOGY, V26, P1123	139	216	239	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1600	1609		10.1016/S0140-6736(10)61965-4	http://dx.doi.org/10.1016/S0140-6736(10)61965-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21529926				2022-12-01	WOS:000290549700034
J	Dunn, M; Greenhill, SJ; Levinson, SC; Gray, RD				Dunn, Michael; Greenhill, Simon J.; Levinson, Stephen C.; Gray, Russell D.			Evolved structure of language shows lineage-specific trends in word-order universals	NATURE			English	Article								Languages vary widely but not without limit. The central goal of linguistics is to describe the diversity of human languages and explain the constraints on that diversity. Generative linguists following Chomsky have claimed that linguistic diversity must be constrained by innate parameters that are set as a child learns a language(1,2). In contrast, other linguists following Greenberg have claimed that there are statistical tendencies for co-occurrence of traits reflecting universal systems biases(3-5), rather than absolute constraints or parametric variation. Here we use computational phylogenetic methods to address the nature of constraints on linguistic diversity in an evolutionary framework(6). First, contrary to the generative account of parameter setting, we show that the evolution of only a few word-order features of languages are strongly correlated. Second, contrary to the Greenbergian generalizations, we show that most observed functional dependencies between traits are lineage-specific rather than universal tendencies. These findings support the view that-at least with respect to word order-cultural evolution is the primary factor that determines linguistic structure, with the current state of a linguistic system shaping and constraining future states.	[Dunn, Michael; Levinson, Stephen C.] Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; [Dunn, Michael; Levinson, Stephen C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Greenhill, Simon J.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Greenhill, Simon J.] Univ Auckland, Computat Evolut Grp, Auckland 1142, New Zealand	Max Planck Society; Radboud University Nijmegen; University of Auckland; University of Auckland	Dunn, M (corresponding author), Max Planck Inst Psycholinguist, POB 310, NL-6500 AH Nijmegen, Netherlands.	michael.dunn@mpi.nl	Galantucci, Bruno/E-5770-2010; Dunn, Michael/F-1077-2012; Greenhill, Simon J/B-3114-2011; Greenhill, Simon/I-3554-2019; Gray, Russell/H-2078-2015	Dunn, Michael/0000-0001-5349-5252; Greenhill, Simon J/0000-0001-7832-6156; Greenhill, Simon/0000-0001-7832-6156; Gray, Russell/0000-0002-9858-0191				Baker M., 2001, ATOMS LANGUAGE; BAKKER P, 2010, OXFORD HDB LINGUISTI; CAMPBELL L, 1997, AM INDIAN LANGUAGES, P133; Cela-Conde C. J., 1998, SYNTAX, V1, P19, DOI DOI 10.1111/1467-9612.00002; Chomsky, 1986, KNOWLEDGE LANGUAGE I; Chomsky N., 1981, LECT GOVT BINDING; Croft W, 2008, ANNU REV ANTHROPOL, V37, P219, DOI 10.1146/annurev.anthro.37.081407.085156; Cysouw M, 2005, HANDB SPRACH KOMMUN, V27, P554; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Dryer M.S., 2007, LANGUAGE TYPOLOGY AN, P61, DOI DOI 10  1017/CBO9780511619427.002; DRYER MS, 1992, LANGUAGE, V68, P81, DOI 10.2307/416370; DYEN I, 1992, T AM PHILOS SOC, V82, P1; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Gordon R.G., 2005, ETHNOLOGUE LANGUAGES; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; GREENBERG J. H., 1963, UNIVERSALS LANG, P58; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Guthrie M., 1971, COMP BANTU, V2; Haspelmath M., 2008, WORLD ATLAS LANGUAGE; Hawkins J. A., 2009, LANGUAGE UNIVERSALS, P54, DOI DOI 10.1093/ACPROF:OSO/9780195305432.003.0004; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; LIGHTFOOT DW, 1989, BEHAV BRAIN SCI, V12, P321, DOI 10.1017/S0140525X00048883; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241	29	251	254	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					79	82		10.1038/nature09923	http://dx.doi.org/10.1038/nature09923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	759CQ	21490599	Green Published			2022-12-01	WOS:000290218300034
J	Plikus, MV; Baker, RE; Chen, CC; Fare, C; de la Cruz, D; Andl, T; Maini, PK; Millar, SE; Widelitz, R; Chuong, CM				Plikus, Maksim V.; Baker, Ruth E.; Chen, Chih-Chiang; Fare, Clyde; de la Cruz, Damon; Andl, Thomas; Maini, Philip K.; Millar, Sarah E.; Widelitz, Randall; Chuong, Cheng-Ming			Self-Organizing and Stochastic Behaviors During the Regeneration of Hair Stem Cells	SCIENCE			English	Article							SKIN; MORPHOGENESIS; FOLLICLES; PATTERNS; WNT	Stem cells cycle through active and quiescent states. Large populations of stem cells in an organ may cycle randomly or in a coordinated manner. Although stem cell cycling within single hair follicles has been studied, less is known about regenerative behavior in a hair follicle population. By combining predictive mathematical modeling with in vivo studies in mice and rabbits, we show that a follicle progresses through cycling stages by continuous integration of inputs from intrinsic follicular and extrinsic environmental signals based on universal patterning principles. Signaling from the WNT/bone morphogenetic protein activator/inhibitor pair is coopted to mediate interactions among follicles in the population. This regenerative strategy is robust and versatile because relative activator/inhibitor strengths can be modulated easily, adapting the organism to different physiological and evolutionary needs.	[Plikus, Maksim V.; Chen, Chih-Chiang; de la Cruz, Damon; Widelitz, Randall; Chuong, Cheng-Ming] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Baker, Ruth E.; Maini, Philip K.] Math Inst, Ctr Math Biol, Oxford OX1 3LB, England; [Chen, Chih-Chiang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chih-Chiang] Natl Yang Ming Univ, Dept Dermatol, Taipei 112, Taiwan; [Chen, Chih-Chiang] Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Fare, Clyde] Life Sci Interface Doctoral Training Ctr, Oxford OX1 3QD, England; [Andl, Thomas] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Maini, Philip K.] Oxford Ctr Integrat Syst Biol, Dept Biochem, Oxford OX1 3QU, England; [Millar, Sarah E.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Chuong, Cheng-Ming] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	University of Southern California; University of Oxford; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; University of Oxford; Vanderbilt University; University of Oxford; University of Pennsylvania; National Taiwan University	Chuong, CM (corresponding author), Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu		Plikus, Maksim/0000-0002-8845-2559; Andl, Thomas/0000-0002-5555-468X; Millar, Sarah/0000-0001-8792-6890; Baker, Ruth/0000-0002-6304-9333	National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1-AR42177, AR60306, AR47364]; UK Engineering and Physical Sciences Research Council; Royal Society; California Institute for Regenerative Medicine;  [RO1-AR47709]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060306, R01AR047364, R01AR042177, R01AR047709] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	C.-M.C. is supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases RO1-AR42177, AR60306, and AR47364; S.E.M. by RO1-AR47709; R.E.B. by a UK Engineering and Physical Sciences Research Council First grant; P.K.M. by a Royal Society Wolfson Research Merit Award; and M.V.P. by a California Institute for Regenerative Medicine postdoctoral grant. There is a USC patent application partially based on the work in this study on the compositions and methods to modulate hair growth.	Antaya RJ, 2005, J AM ACAD DERMATOL, V53, pS130, DOI 10.1016/j.jaad.2004.12.029; Chuong CM, 2009, INT J DEV BIOL, V53, P653, DOI 10.1387/ijdb.082594cc; Cutrone M, 2005, EUR J PEDIATR, V164, P630, DOI 10.1007/s00431-005-1707-y; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Halloy J, 2000, P NATL ACAD SCI USA, V97, P8328, DOI 10.1073/pnas.97.15.8328; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Plikus MV, 2008, J INVEST DERMATOL, V128, P1071, DOI 10.1038/sj.jid.5701180; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P9680, DOI 10.1073/pnas.1731184100; WHITELEY HJ, 1958, NATURE, V181, P850, DOI 10.1038/181850a0; Wolfram S., 2002, NEW KIND SCI	17	144	151	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					586	589		10.1126/science.1201647	http://dx.doi.org/10.1126/science.1201647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527712	Green Accepted			2022-12-01	WOS:000289991100048
J	Truman, RW; Singh, P; Sharma, R; Busso, P; Rougemont, J; Paniz-Mondolfi, A; Kapopoulou, A; Brisse, S; Scollard, DM; Gillis, TP; Cole, ST				Truman, Richard W.; Singh, Pushpendra; Sharma, Rahul; Busso, Philippe; Rougemont, Jacques; Paniz-Mondolfi, Alberto; Kapopoulou, Adamandia; Brisse, Sylvain; Scollard, David M.; Gillis, Thomas P.; Cole, Stewart T.			Probable Zoonotic Leprosy in the Southern United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOBACTERIUM-LEPRAE; ARMADILLO EXPOSURE; DASYPUS-NOVEMCINCTUS; 9-BANDED ARMADILLO; HANSENS-DISEASE; WILD ARMADILLOS; CONTACT; ASSOCIATION; ORIGIN	BACKGROUND In the southern region of the United States, such as in Louisiana and Texas, there are autochthonous cases of leprosy among native-born Americans with no history of foreign exposure. In the same region, as well as in Mexico, wild armadillos are infected with Mycobacterium leprae. METHODS Whole-genome resequencing of M. leprae from one wild armadillo and three U. S. patients with leprosy revealed that the infective strains were essentially identical. Comparative genomic analysis of these strains and M. leprae strains from Asia and Brazil identified 51 single-nucleotide polymorphisms and an 11-bp insertion-deletion. We genotyped these polymorphic sites, in combination with 10 variable-number tandem repeats, in M. leprae strains obtained from 33 wild armadillos from five southern states, 50 U. S. outpatients seen at a clinic in Louisiana, and 64 Venezuelan patients, as well as in four foreign reference strains. RESULTS The M. leprae genotype of patients with foreign exposure generally reflected their country of origin or travel history. However, a unique M. leprae genotype (3I-2-v1) was found in 28 of the 33 wild armadillos and 25 of the 39 U. S. patients who resided in areas where exposure to armadillo-borne M. leprae was possible. This genotype has not been reported elsewhere in the world. CONCLUSIONS Wild armadillos and many patients with leprosy in the southern United States are infected with the same strain of M. leprae. Armadillos are a large natural reservoir for M. leprae, and leprosy may be a zoonosis in the region.	[Truman, Richard W.; Sharma, Rahul; Scollard, David M.; Gillis, Thomas P.] Louisiana State Univ, Sch Vet Med, Bur Primary Hlth Care,Natl Hansens Dis Program, Hlth Resources & Serv Adm,Dept Hlth & Human Serv, Baton Rouge, LA 70803 USA; [Singh, Pushpendra; Busso, Philippe; Rougemont, Jacques; Kapopoulou, Adamandia; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Rougemont, Jacques; Kapopoulou, Adamandia] Swiss Inst Bioinformat, Lausanne, Switzerland; [Paniz-Mondolfi, Alberto] Inst Biomed, Caracas, Venezuela; [Brisse, Sylvain] Inst Pasteur, Paris, France	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; United States Health Resources & Service Administration (HRSA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Truman, RW (corresponding author), Louisiana State Univ, Sch Vet Med, Bur Primary Hlth Care,Natl Hansens Dis Program, Hlth Resources & Serv Adm,Dept Hlth & Human Serv, Skip Bertman Dr, Baton Rouge, LA 70803 USA.	rtruman@hrsa.gov	Brisse, Sylvain/M-8723-2013; SHARMA, RAHUL/F-2691-2013; Truman, Richard/E-3025-2013; Singh, Pushpendra/J-6484-2015	Brisse, Sylvain/0000-0002-2516-2108; Singh, Pushpendra/0000-0001-9453-8669	Fondation Raoul Follereau; American Leprosy Missions; Society of Saint Lazarus; IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium; Health Resources and Services Administration; National Institutes of Health, National Institute of Allergy and Infectious Diseases [RO1-AI47197-01A1, NIAID IAA-2646]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047197] Funding Source: NIH RePORTER	Fondation Raoul Follereau; American Leprosy Missions; Society of Saint Lazarus; IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Fondation Raoul Follereau, the American Leprosy Missions, the Society of Saint Lazarus, the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) Consortium, the Health Resources and Services Administration, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grants RO1-AI47197-01A1 and NIAID IAA-2646).; Funded by the National Institute of Allergy and Infectious Diseases and others	Abide JM, 2008, SOUTH MED J, V101, P635, DOI 10.1097/SMJ.0b013e31816f8610; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMEZCUA ME, 1984, INT J LEPROSY, V52, P254; Badger LF, 1955, PUBLIC HEALTH REP, V70, P525, DOI 10.2307/4589124; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Bruce S, 2000, J AM ACAD DERMATOL, V43, P223, DOI 10.1067/mjd.2000.106368; Clark BM, 2008, AM J TROP MED HYG, V78, P962, DOI 10.4269/ajtmh.2008.78.962; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; *DEP HLTH HUM SERV, 2009, SUMM HANS DIS US 200; Deps PD, 2008, INDIAN J DERMATOL VE, V74, P338, DOI 10.4103/0378-6323.42897; FILICE GA, 1977, AM J TROP MED HYG, V26, P137, DOI 10.4269/ajtmh.1977.26.137; Gillis T, 2009, LEPROSY REV, V80, P250; Hall BG, 2010, J CLIN MICROBIOL, V48, P1997, DOI 10.1128/JCM.00149-10; Hamilton HK, 2008, INT J DERMATOL, V47, P545, DOI 10.1111/j.1365-4632.2008.03722.x; KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693; Lane JE, 2006, J AM ACAD DERMATOL, V55, P714, DOI 10.1016/j.jaad.2006.02.070; Li HT, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/2/025006; Loughry WJ, 2009, J WILDLIFE DIS, V45, P144, DOI 10.7589/0090-3558-45.1.144; LUMPKIN LR, 1983, J AM ACAD DERMATOL, V9, P899, DOI 10.1016/S0190-9622(83)70206-9; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Taulman JF, 1996, J BIOGEOGR, V23, P635, DOI 10.1111/j.1365-2699.1996.tb00024.x; THOMAS DA, 1987, J INFECT DIS, V156, P990, DOI 10.1093/infdis/156.6.990; Truman R, 2005, LEPROSY REV, V76, P198; TRUMAN RW, 1986, AM J TROP MED HYG, V35, P588, DOI 10.4269/ajtmh.1986.35.588; TRUMAN RW, 1991, EPIDEMIOL INFECT, V106, P549, DOI 10.1017/S0950268800067613; WALSH GP, 1986, J LEUKOCYTE BIOL, V40, P645, DOI 10.1002/jlb.40.5.645; Weir B.S., 1996, GENETIC DATA ANAL; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P333; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	34	208	218	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1626	1633		10.1056/NEJMoa1010536	http://dx.doi.org/10.1056/NEJMoa1010536			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21524213	Green Accepted			2022-12-01	WOS:000289940400009
J	Jernberg, T; Johanson, P; Held, C; Svennblad, B; Lindback, J; Wallentin, L				Jernberg, Tomas; Johanson, Per; Held, Claes; Svennblad, Bodil; Lindback, Johan; Wallentin, Lars		SWEDEHEART RIKS-HIA	Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPY; METAANALYSIS; REPERFUSION; OUTCOMES; DISEASE; TRENDS; STATIN	Context Only limited information is available on the speed of implementation of new evidence-based and guideline-recommended treatments and its association with survival in real life health care of patients with ST-elevation myocardial infarction (STEMI). Objective To describe the adoption of new treatments and the related chances of short-and long-term survival in consecutive patients with STEMI in a single country over a 12-year period. Design, Setting, and Participants The Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA) records baseline characteristics, treatments, and outcome of consecutive patients with acute coronary syndrome admitted to almost all hospitals in Sweden. This study includes 61 238 patients with a first-time diagnosis of STEMI between 1996 and 2007. Main Outcome Measures Estimated and crude proportions of patients treated with different medications and invasive procedures and mortality over time. Results Of evidence based-treatments, reperfusion increased from 66% (95%, confidence interval [CI], 52%-79%) to 79% (95% CI, 69%-89%; P<.001), primary percutaneous coronary intervention from 12% (95% CI, 11%-14%) to 61% (95% CI, 45%-77%; P<.001), and revascularization from 10% (96% CI, 6%-14%) to 84% (95% CI, 73%-95%; P<.001). The use of aspirin, clopidogrel, beta-blockers, statins, and angiotensin-converting enzyme (ACE) inhibitors all increased: clopidogrel from 0% to 82% (95% CI, 69%-95%; P<.001), statins from 23% (95% CI, 12%-33%) to 83% (95% CI, 75%-91%; P<.001), and ACE inhibitor or angiotensin II receptor blockers from 39% (95% CI, 26%-52%) to 69% (95% CI, 58%-70%; P<.001). The estimated in-hospital, 30-day and 1-year mortality decreased from 12.5% (95% CI, 4.3%-20.6%) to 7.2% (95% CI, 1.7%-12.6%; P<.001); from 15.0% (95% CI, 6.2%-23.7%) to 8.6% (95% CI, 2.7%-14.5%; P<.001); and from 21.0% (95% CI, 11.0%-30.9%) to 13.3% (95% CI, 6.0%-20.4%; P<.001), respectively. After adjustment, there was still a consistent trend with lower standardized mortality over the years. The 12-year survival analyses showed that the decrease of mortality was sustained over time. Conclusion In a Swedish registry of patients with STEMI, between 1996 and 2007, there was an increase in the prevalence of evidence-based treatments. During this same time, there was a decrease in 30-day and 1-year mortality that was sustained during long-term follow-up. JAMA. 2011;305(16):1677-1684 www.jama.com	[Jernberg, Tomas] Dept Med, Cardiol Sect, Huddinge, Sweden; [Jernberg, Tomas] Karolinska Inst, Karolinska Univ Hosp, S-14186 Huddinge, Sweden; [Johanson, Per] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Held, Claes; Svennblad, Bodil; Lindback, Johan; Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Uppsala University	Jernberg, T (corresponding author), Karolinska Univ Hosp, Dept Cardiol, Huddinge, Sweden.	tomas.jernberg@karolinska.se	Lindbäck, Johan/R-2900-2017; Held, Claes/AAA-3973-2021	Lindbäck, Johan/0000-0002-6473-8798; Held, Claes/0000-0001-9402-7404; Jernberg, Tomas/0000-0003-1695-379X; Johanson, Per/0000-0001-9802-4147	Swedish Heart Lung Foundation; Swedish Association of Local Authorities and Regions	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Association of Local Authorities and Regions	This study was supported by the Swedish Heart Lung Foundation. Financial support for the registry is provided by the Swedish Association of Local Authorities and Regions.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759; Fang J, 2010, AM J MED, V123, P259, DOI 10.1016/j.amjmed.2009.08.018; Floyd KC, 2009, CIRC-CARDIOVASC QUAL, V2, P88, DOI 10.1161/CIRCOUTCOMES.108.811828; Flynn MR, 2005, EUR HEART J, V26, P308, DOI 10.1093/eurheartj/ehi079; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Go AS, 2006, ANN INTERN MED, V144, P229, DOI 10.7326/0003-4819-144-4-200602210-00004; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kushner, 2010, CIRCULATION, V121, pE257, DOI 10.1161/CIR.0b013e3181d7a65e; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; R Development Core Team, 2020, R VERS 4 0 3 LANG EN; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Stenestrand U, 2005, AM HEART J, V149, P82, DOI 10.1016/j.ahj.2004.07.018; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; Thygesen K, 2007, EUR HEART J, V28, P2525; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Wood S., 2006, GEN ADDITIVE MODELS; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2000, EUR HEART J, V21, P1502, DOI 10.1053/eurj.2000.2305	30	280	292	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1677	1684		10.1001/jama.2011.522	http://dx.doi.org/10.1001/jama.2011.522			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521849	Bronze			2022-12-01	WOS:000289890500021
J	Heallen, T; Zhang, M; Wang, J; Bonilla-Claudio, M; Klysik, E; Johnson, RL; Martin, JF				Heallen, Todd; Zhang, Min; Wang, Jun; Bonilla-Claudio, Margarita; Klysik, Ela; Johnson, Randy L.; Martin, James F.			Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size	SCIENCE			English	Article							GROWTH; EXPRESSION; REGULATOR; LIVER	Genetic regulation of mammalian heart size is poorly understood. Hippo signaling represents an organ-size control pathway in Drosophila, where it also inhibits cell proliferation and promotes apoptosis in imaginal discs. To determine whether Hippo signaling controls mammalian heart size, we inactivated Hippo pathway components in the developing mouse heart. Hippo-deficient embryos had overgrown hearts with elevated cardiomyocyte proliferation. Gene expression profiling and chromatin immunoprecipitation revealed that Hippo signaling negatively regulates a subset of Wnt target genes. Genetic interaction studies indicated that beta-catenin heterozygosity suppressed the Hippo cardiomyocyte overgrowth phenotype. Furthermore, the Hippo effector Yap interacts with b-catenin on Sox2 and Snai2 genes. These data uncover a nuclear interaction between Hippo and Wnt signaling that restricts cardiomyocyte proliferation and controls heart size.	[Heallen, Todd; Zhang, Min; Wang, Jun; Bonilla-Claudio, Margarita; Klysik, Ela; Martin, James F.] Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center	Martin, JF (corresponding author), Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	jmartin@ibt.tamhsc.edu		Heallen, Todd/0000-0002-6003-8743; Zhang, Min/0000-0001-7055-6790	NIH [T32 DE15355-04, R01HD052785, R01HD060579, AHA09PRE2150024, AHA10POST4140029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052785, R01HD060579] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE015355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Epstein, S. Sasakura, T. Gridley, M. Sudol, F. Long, and B. Amendt for reagents. Supported by NIH grants (J. F. M. and R. L. J.), T32 DE15355-04 (M. B. C.), R01HD052785 and R01HD060579 (R. L. J.), AHA09PRE2150024 (J. W.), and AHA10POST4140029 (T. H.). Microarray data (accession number GSE27259) can be accessed at the Gene Expression Omnibus (GEO) repository (www.ncbi.nlm.nih.gov/geo/).	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Koyanagi M, 2010, CIRC RES, V106, P1290, DOI 10.1161/CIRCRESAHA.109.206045; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007	15	711	745	4	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					458	461		10.1126/science.1199010	http://dx.doi.org/10.1126/science.1199010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512031	Green Accepted			2022-12-01	WOS:000289784900041
J	Herr, HW				Herr, Harry W.			Intravesical Bacille Calmette-Guerin in Patients With Asymptomatic Bacteriuria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Herr, HW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Urol, 1275 York Ave, New York, NY 10021 USA.	herrh@mskcc.org						Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Gross PA, 2007, CLIN INFECT DIS, V45, P1335, DOI 10.1086/522183; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Schaeffer EM, 2006, NAT CLIN PRACT UROL, V3, P24, DOI 10.1038/ncpuro0357	4	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1413	1414		10.1001/jama.2011.428	http://dx.doi.org/10.1001/jama.2011.428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486973	Bronze			2022-12-01	WOS:000289424100016
J	Knox, K; Carrigan, D; Simmons, G; Teque, F; Zhou, YC; Hackett, J; Qiu, XX; Luk, KC; Schochetman, G; Knox, A; Kogelnik, AM; Levy, JA				Knox, Konstance; Carrigan, Donald; Simmons, Graham; Teque, Fernando; Zhou, Yanchen; Hackett, John, Jr.; Qiu, Xiaoxing; Luk, Ka-Cheung; Schochetman, Gerald; Knox, Allyn; Kogelnik, Andreas M.; Levy, Jay A.			No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected	SCIENCE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; AIDS-ASSOCIATED RETROVIRUS; VIRAL GENOME; HUMAN-SERUM; MOUSE DNA; CONTAMINATION; INACTIVATION; SEQUENCES; BLOOD	Members of the gammaretroviruses-such as murine leukemia viruses (MLVs), most notably XMRV [xenotropic murine leukemia virus (X-MLV)-related virus-have been reported to be present in the blood of patients with chronic fatigue syndrome (CFS). We evaluated blood samples from 61 patients with CFS from a single clinical practice, 43 of whom had previously been identified as XMRV-positive. Our analysis included polymerase chain reaction and reverse transcription polymerase chain reaction procedures for detection of viral nucleic acids and assays for detection of infectious virus and virus-specific antibodies. We found no evidence of XMRV or other MLVs in these blood samples. In addition, we found that these gammaretroviruses were strongly (X-MLV) or partially (XMRV) susceptible to inactivation by sera from CFS patients and healthy controls, which suggested that establishment of a successful MLV infection in humans would be unlikely. Consistent with previous reports, we detected MLV sequences in commercial laboratory reagents. Our results indicate that previous evidence linking XMRV and MLVs to CFS is likely attributable to laboratory contamination.	[Teque, Fernando; Levy, Jay A.] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA; [Knox, Konstance; Carrigan, Donald; Knox, Allyn] Wisconsin Viral Res Grp, Milwaukee, WI 53226 USA; [Knox, Konstance; Carrigan, Donald; Kogelnik, Andreas M.] Open Med Inst, Mountain View, CA 94040 USA; [Simmons, Graham; Zhou, Yanchen] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Simmons, Graham; Zhou, Yanchen] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Hackett, John, Jr.; Qiu, Xiaoxing; Luk, Ka-Cheung; Schochetman, Gerald] Abbott Labs, Abbott Pk, IL 60064 USA	University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Abbott Laboratories	Levy, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	jay.levy@ucsf.edu	Simmons, Graham/G-3523-2012	Simmons, Graham/0000-0002-9615-7023				Baliji S, 2010, J VIROL, V84, P12841, DOI 10.1128/JVI.01863-10; BANAPOUR B, 1986, VIROLOGY, V152, P268, DOI 10.1016/0042-6822(86)90392-2; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; HOFFMAN AD, 1985, VIROLOGY, V147, P326, DOI 10.1016/0042-6822(85)90135-7; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; LANDAY AL, 1991, LANCET, V338, P707, DOI 10.1016/0140-6736(91)91440-6; Levy J A, 1978, Curr Top Microbiol Immunol, V79, P111; LEVY JA, 1973, SCIENCE, V182, P1151, DOI 10.1126/science.182.4117.1151; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; ROTHER RP, 1995, J EXP MED, V182, P1345, DOI 10.1084/jem.182.5.1345; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Takefman DM, 2002, J VIROL, V76, P1999, DOI 10.1128/JVI.76.4.1999-2002.2002; TAKEUCHI Y, 1994, J VIROL, V68, P8001, DOI 10.1128/JVI.68.12.8001-8007.1994; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; VARNIER OE, 1984, VIROLOGY, V132, P79, DOI 10.1016/0042-6822(84)90093-X; VARNIER OE, 1983, J GEN VIROL, V64, P425, DOI 10.1099/0022-1317-64-2-425; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	30	86	88	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					94	97		10.1126/science.1204963	http://dx.doi.org/10.1126/science.1204963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21628393				2022-12-01	WOS:000292255400057
J	Peter, IS; Davidson, EH				Peter, Isabelle S.; Davidson, Eric H.			A gene regulatory network controlling the embryonic specification of endoderm	NATURE			English	Article							SEA-URCHIN EMBRYO; NUCLEAR BETA-CATENIN; STRONGYLOCENTROTUS-PURPURATUS; CELL FATES; EXPRESSION; IDENTIFICATION; BLASTOMERES; LINEAGES; FAMILY	Specification of endoderm is the prerequisite for gut formation in the embryogenesis of bilaterian organisms. Modern lineage labelling studies(1-3) have shown that in the sea urchin embryo model system, descendants of the veg1 and veg2 cell lineages produce the endoderm, and that the veg2 lineage also gives rise to mesodermal cell types. It is known that Wnt/beta-catenin signalling is required for endoderm specification(4-6) and Delta/Notch signalling is required for mesoderm specification(7-9). Some directcis-regulatory targets of these signals have been found(10,11) and various phenomenological patterns of gene expression have been observed in the pre-gastrular endomesoderm. However, no comprehensive, causal explanation of endoderm specification has been conceived for sea urchins, nor for any other deuterostome. Here we propose a model, on the basis of the underlying genomic control system, that provides such an explanation, built at several levels of biological organization. The hardwired core of the control system consists of the cis-regulatory apparatus of endodermal regulatory genes, which determine the relationship between the inputs to which these genes are exposed and their outputs. The architecture of the network circuitry controlling the dynamic process of endoderm specification then explains, at the system level, a sequence of developmental logic operations, which generate the biological process. The control system initiates non-interacting endodermal and mesodermal gene regulatory networks in veg2-derived cells and extinguishes the endodermal gene regulatory network in mesodermal precursors. It also generates a cross-regulatory network that specifies future anterior endoderm in veg2 descendants and institutes a distinct network specifying posterior endoderm in veg1-derived cells. The network model provides an explanatory framework that relates endoderm specification to the genomic regulatory code.	[Peter, Isabelle S.; Davidson, Eric H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Davidson, EH (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	ipeter@caltech.edu; davidson@caltech.edu		Peter, Isabelle/0000-0003-3685-3147	Swiss National Science Foundation; National Institutes of Health [HD37105]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We acknowledge technical assistance from J. Yun, who executed much of the perturbation analysis matrix, and from A. Puszynska and E. Erkenbrack, who contributed to whole-mount in situ hybridization results. We are grateful to E. Rothenberg for a detailed critique of the manuscript. I. S. P. was the recipient of a fellowship from the Swiss National Science Foundation in the initial stages of this work. The research was supported by National Institutes of Health grant HD37105 to E.H.D.	Byrum CA, 2009, DEV DYNAM, V238, P1649, DOI 10.1002/dvdy.21978; CAMERON RA, 1991, DEVELOPMENT, V113, P1085; Croce JC, 2010, DEVELOPMENT, V137, P83, DOI 10.1242/dev.044149; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; De-Leon SBT, 2010, P NATL ACAD SCI USA, V107, P10103, DOI 10.1073/pnas.1004824107; Howard-Ashby M, 2006, DEV BIOL, V300, P90, DOI 10.1016/j.ydbio.2006.08.033; Howard-Ashby M, 2006, DEV BIOL, V300, P74, DOI 10.1016/j.ydbio.2006.08.039; Livi CB, 2007, GENE EXPR PATTERNS, V7, P1, DOI 10.1016/j.modgep.2006.04.009; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 1997, DEVELOPMENT, V124, P2213; Longabaugh WJR, 2009, BBA-GENE REGUL MECH, V1789, P363, DOI 10.1016/j.bbagrm.2008.07.014; Materna SC, 2006, DEV BIOL, V300, P108, DOI 10.1016/j.ydbio.2006.08.032; Materna SC, 2008, NAT PROTOC, V3, P1876, DOI 10.1038/nprot.2008.187; Minokawa T, 2005, DEV BIOL, V288, P545, DOI 10.1016/j.ydbio.2005.09.047; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Peter IS, 2010, DEV BIOL, V340, P188, DOI 10.1016/j.ydbio.2009.10.037; Peter IS, 2009, FEBS LETT, V583, P3948, DOI 10.1016/j.febslet.2009.11.060; Ransick A, 2004, METHOD CELL BIOL, V74, P601; Ransick A, 1998, DEV BIOL, V195, P38, DOI 10.1006/dbio.1997.8814; Ransick A, 2006, DEV BIOL, V297, P587, DOI 10.1016/j.ydbio.2006.05.037; Rast JP, 2000, DEV BIOL, V228, P270, DOI 10.1006/dbio.2000.9941; Revilla-I-Domingo R, 2007, P NATL ACAD SCI USA, V104, P12383, DOI 10.1073/pnas.0705324104; Rizzo F, 2006, DEV BIOL, V300, P35, DOI 10.1016/j.ydbio.2006.08.012; Sherwood DR, 1999, DEVELOPMENT, V126, P1703; Smith J, 2008, DEV BIOL, V313, P863, DOI 10.1016/j.ydbio.2007.10.042; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Sweet HC, 2002, DEVELOPMENT, V129, P1945; Sweet HC, 1999, DEVELOPMENT, V126, P5255; Tu Q, 2006, DEV BIOL, V300, P49, DOI 10.1016/j.ydbio.2006.09.031; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045	30	156	158	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					635	U110		10.1038/nature10100	http://dx.doi.org/10.1038/nature10100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21623371	Green Accepted			2022-12-01	WOS:000292204300038
J	Girgis, A; Stacey, F; Lee, T; Black, D; Kilbreath, S				Girgis, Afaf; Stacey, Fiona; Lee, Teresa; Black, Deborah; Kilbreath, Sharon			Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; PSYCHOLOGICAL DISTRESS; EARLY-DIAGNOSIS; ARM LYMPHEDEMA; SURGERY; NEEDS; MORBIDITY; SURVIVORS; PERCEPTIONS; CARE	Objective To explore the perceived unmet needs among women treated for breast cancer and in whom symptoms and signs indicate the presence of lymphoedema. Design Population based cross sectional survey with a purpose designed questionnaire (60 items). Setting Cancer registries of New South Wales, Victoria, and South Australia. Participants 237 women with symptoms and signs indicative of lymphoedema from an initial 1930 eligible women. Main outcome measure Unmet needs in the previous month across psychological, health system and information, physical and daily living, patient care and support, sexuality needs, body image, and financial domains. Results The 10 items most commonly identified as a "moderate to high current need" included having their doctor and allied health workers being fully informed about lymphoedema, acknowledge the seriousness of the condition, and be willing to treat it. Women also wanted access to up to date treatments, both mainstream and alternative, and financial assistance for their garments. The three factors that explained most of the variance were: information and support (11 items), which accounted for 49% of the variance; body image and self esteem (seven items; 7% variance); and health system (seven items; 5% variance). Examination of these three factors showed that while the levels of need were generally low, they were common. Conclusion To address the needs of women with lymphoedema and perhaps to prevent progression of lymphoedema, it is important that practitioners do not dismiss mild symptoms and that women are referred to an appropriate specialist.	[Black, Deborah; Kilbreath, Sharon] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [Stacey, Fiona] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Lee, Teresa] Royal N Shore Hosp, Canc Serv, St Leonards, NSW 2065, Australia	University of Sydney; University of Newcastle; Royal North Shore Hospital	Kilbreath, S (corresponding author), Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia.	sharon.kilbreath@sydney.edu.au	black, deborah/C-2829-2017; Girgis, Afaf/G-8660-2011; Stacey, Fiona/G-7715-2013	black, deborah/0000-0001-9174-1565; Girgis, Afaf/0000-0003-4101-4006; Kilbreath, Sharon/0000-0002-8024-8641	National Breast Cancer Foundation	National Breast Cancer Foundation	This study was funded by a grant in aid from the National Breast Cancer Foundation; SK is funded by the National Breast Cancer Foundation.	Armer Jane M, 2009, J Lymphoedema, V4, P14; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Brorson Hakan, 2009, Lymphatic Research and Biology, V7, P3, DOI 10.1089/lrb.2008.1022; Carter B J, 1997, Oncol Nurs Forum, V24, P875; Collins LG, 2004, SUPPORT CARE CANCER, V12, P106, DOI 10.1007/s00520-003-0554-5; Cormier JN, 2009, LYMPHOLOGY, V42, P161; Cornish BH, 1996, BREAST CANCER RES TR, V38, P169, DOI 10.1007/BF01806671; Cornish BH, 2000, ANN NY ACAD SCI, V904, P571; DUNN SM, 1993, J CLIN ONCOL, V11, P2279, DOI 10.1200/JCO.1993.11.11.2279; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Girgis A, 2000, AUST NZ J PUBL HEAL, V24, P166, DOI 10.1111/j.1467-842X.2000.tb00137.x; Goldberg JI, 2010, ANN SURG ONCOL, V17, P3278, DOI 10.1245/s10434-010-1155-4; Greenslade M Victoria, 2006, Can Oncol Nurs J, V16, P165; Hayes S, 2008, LYMPHOLOGY, V41, P18; Hayes SC, 2008, J CLIN ONCOL, V26, P3536, DOI 10.1200/JCO.2007.14.4899; Johansson K, 2003, SCAND J CARING SCI, V17, P35, DOI 10.1046/j.1471-6712.2003.00119.x; Kilbreath SL, 2010, BREAST CANCER RES TR, V120, P649, DOI 10.1007/s10549-010-0793-3; Lacomba MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5396; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Lee TS, 2010, ONCOL NURS FORUM, V37, P85, DOI 10.1188/10.ONF.85-91; Lee TS, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-75; Lee TS, 2009, ONCOL NURS FORUM, V36, P454, DOI 10.1188/09.ONF.454-462; MAUNSELL E, 1993, CAN J SURG, V36, P315; McNeely ML, 2011, CANCER-AM CANCER SOC, V117, P1136, DOI 10.1002/cncr.25513; Meeske KA, 2009, BREAST CANCER RES TR, V113, P383, DOI 10.1007/s10549-008-9940-5; Newman ML, 1996, J PAIN SYMPTOM MANAG, V12, P376, DOI 10.1016/S0885-3924(96)00187-X; Norman SA, 2009, J CLIN ONCOL, V27, P390, DOI 10.1200/JCO.2008.17.9291; Oliveri Jill M, 2008, J Cancer Surviv, V2, P233, DOI 10.1007/s11764-008-0065-y; Passik SD, 1998, CANCER, V83, P2817, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2817::AID-CNCR32>3.0.CO;2-2; Sanson-Fisher R, 2000, CANCER, V88, P226, DOI 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P; Schmitz KH, 2009, NEW ENGL J MED, V361, P664, DOI 10.1056/NEJMoa0810118; Shih YCT, 2009, J CLIN ONCOL, V27, P2007, DOI 10.1200/JCO.2008.18.3517; Stanton A W B, 2003, Lymphat Res Biol, V1, P121, DOI 10.1089/153968503321642615; TOBIN MB, 1993, CANCER-AM CANCER SOC, V72, P3248, DOI 10.1002/1097-0142(19931201)72:11<3248::AID-CNCR2820721119>3.0.CO;2-Z; Towers A, 2008, J PALLIAT CARE, V24, P134, DOI 10.1177/082585970802400302; Woods M, 1995, CANCER NURS, V18, P467	36	26	26	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2011	342								d3442	10.1136/bmj.d3442	http://dx.doi.org/10.1136/bmj.d3442			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AO	21693532	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000292200000002
J	Seibert, D; Hong, CH; Takeuchi, F; Olsen, C; Hathaway, O; Moss, J; Darling, TN				Seibert, Diane; Hong, Chien-Hui; Takeuchi, Fumiko; Olsen, Cara; Hathaway, Olonda; Moss, Joel; Darling, Thomas N.			Recognition of Tuberous Sclerosis in Adult Women: Delayed Presentation With Life-Threatening Consequences	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY LYMPHANGIOLEIOMYOMATOSIS; CLINICAL CHARACTERISTICS; RENAL ANGIOMYOLIPOMA; CONSENSUS CONFERENCE; FORME-FRUSTE; COMPLEX; PREVALENCE; DIAGNOSIS; MUTATION; ASSOCIATION	Background: Tuberous sclerosis complex (TSC) is associated with tumor development in the brain, retina, kidney, skin, heart, and lung. Seizures, intellectual disability, and characteristic skin lesions commonly manifest in early childhood, but some findings, notably renal angiomyolipomas and pulmonary lymphangioleiomyomatosis (LAM), emerge later, placing adults with undiagnosed TSC at increased risk for morbidity and mortality. Objective: To describe the clinical presentation and severity of TSC in adult women. Design: Retrospective cohort study. Setting: National Institutes of Health Clinical Center, Bethesda, Maryland, 1995 to 2010. Patients: 79 women aged 18 years or older who were enrolled in an observational cohort study of TSC to evaluate disease manifestations. Measurements: History, physical examination, pulmonary function testing, chest radiography, abdominal computed tomography, high-resolution chest computed tomography, and brain magnetic resonance imaging were used to evaluate patients. Results: Among the 45 patients who received a diagnosis of TSC in adulthood, 21 presented with symptoms due to LAM, 19 with renal angiomyolipomas, and 10 with seizures. Of the 45 patients, 30 met clinical criteria for TSC in childhood that remained undiagnosed for a median of 21.5 years and 15 were older than 18 years before meeting the clinical criteria for TSC. Patients diagnosed in adulthood and those diagnosed in childhood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy, and death. Limitation: No men were included in the study, and selection was biased toward patients having pulmonary LAM. Conclusion: Women who received a TSC diagnosis in adulthood had minimal morbidity during childhood but were still at risk for life-threatening pulmonary and renal manifestations.	[Darling, Thomas N.] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA; NHLBI, Bethesda, MD 20892 USA; Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kaohsiung Veterans General Hospital	Darling, TN (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Dermatol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mossj@nhlbi.nih.gov; tdarling@usuhs.mil	Seibert, Diane/S-9611-2019	Darling, Thomas/0000-0002-5161-1974	National Institutes of Health, National Heart, Lung, and Blood Institute; National Cancer Institute [R01 CA100907]; Congressionally Directed Medical Research Programs [TS080064]; NATIONAL CANCER INSTITUTE [R01CA100907] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: From the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute, and grants from the National Cancer Institute (R01 CA100907; Dr. Darling) and the Congressionally Directed Medical Research Programs (TS080064; Dr. Darling).	Aldrich SL, 2010, J AM ACAD DERMATOL, V63, P244, DOI 10.1016/j.jaad.2009.08.042; An KS, 2004, J CHILD NEUROL, V19, P699, DOI 10.1177/08830738040190091101; Avila NA, 2010, RADIOLOGY, V254, P851, DOI 10.1148/radiol.09090227; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Camposano SE, 2009, ANN HUM GENET, V73, P141, DOI 10.1111/j.1469-1809.2008.00496.x; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dabora SL, 2002, AM J HUM GENET, V71, P750, DOI 10.1086/342718; Devlin LA, 2006, DEV MED CHILD NEUROL, V48, P495, DOI 10.1017/S0012162206001058; Ewalt DH, 2005, J UROLOGY, V174, P1764, DOI 10.1097/01.ju.0000177497.31986.64; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Gomez MR, 1988, TUBEROUS SCLEROSIS; Hancock E, 2002, RESP MED, V96, P7, DOI 10.1053/rmed.2001.1206; HUNT A, 1984, J MED GENET, V21, P272, DOI 10.1136/jmg.21.4.272; Jansen AC, 2006, ANN NEUROL, V60, P528, DOI 10.1002/ana.21037; Johnson SR, 2010, RESP MED, V104, pS33, DOI 10.1016/j.rmed.2010.03.015; KERR LA, 1993, UROLOGY, V41, P440, DOI 10.1016/0090-4295(93)90504-4; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lendvay TS, 2003, J UROLOGY, V169, P1635, DOI 10.1097/01.ju.0000058253.40352.60; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; Moss J, 2001, JAMA-J AM MED ASSOC, V286, P1879, DOI 10.1001/jama.286.15.1879; Muzykewicz DA, 2009, J MED GENET, V46, P465, DOI 10.1136/jmg.2008.065342; Neumann H P, 1998, Semin Pediatr Neurol, V5, P269, DOI 10.1016/S1071-9091(98)80005-3; O'Callaghan FJ, 2004, BJU INT, V94, P853, DOI 10.1111/j.1464-410X.2004.05046.x; O'Callaghan FJ, 2000, ARCH DIS CHILD, V83, P140, DOI 10.1136/adc.83.2.140; O'Callaghan FJK, 1998, LANCET, V351, P1490, DOI 10.1016/S0140-6736(05)78872-3; Pulsifer MB, 2007, EPILEPSY BEHAV, V10, P402, DOI 10.1016/j.yebeh.2007.02.004; Qin W, 2010, HUM GENET, V127, P573, DOI 10.1007/s00439-010-0801-z; Quist SR, 2010, J AM ACAD DERMATOL, V62, P159, DOI 10.1016/j.jaad.2009.01.021; Roach ES, 1999, J CHILD NEUROL, V14, P401, DOI 10.1177/088307389901400610; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Seyam RM, 2008, UROLOGY, V72, P1077, DOI 10.1016/j.urology.2008.07.049; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; SHEPHERD CW, 1991, ARCH NEUROL-CHICAGO, V48, P400, DOI 10.1001/archneur.1991.00530160068015; SIEGEL JM, 1974, ARCH DERMATOL, V110, P476; Sparling MJD, 2007, J AM ACAD DERMATOL, V56, P786, DOI 10.1016/j.jaad.2006.11.019; Staley BA, 2011, PEDIATRICS, V127, pE117, DOI 10.1542/peds.2010-0192; Taveira-DaSilva AM, 2011, ANN INTERN MED, V154, P797, DOI 10.7326/0003-4819-154-12-201106210-00007; Vail EA, 2009, CLIN GENET, V75, P282, DOI 10.1111/j.1399-0004.2008.01129.x; Webb DW, 1996, DEV MED CHILD NEUROL, V38, P146	43	43	45	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					806	813		10.7326/0003-4819-154-12-201106210-00008	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690595	Green Accepted			2022-12-01	WOS:000291800500016
J	Karijolich, J; Yu, YT				Karijolich, John; Yu, Yi-Tao			Converting nonsense codons into sense codons by targeted pseudouridylation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; U2 SNRNA; RNA; SITE; GENE; RECOGNITION; TERMINATION; TURNOVER	All three translation termination codons, or nonsense codons, contain a uridine residue at the first position of the codon(1-3). Here, we demonstrate that pseudouridylation (conversion of uridine into pseudouridine (Psi), ref. 4) of nonsense codons suppresses translation termination both in vitro and in vivo. In vivo targeting of nonsense codons is accomplished by the expression of an H/ACA RNA capable of directing the isomerization of uridine to Psi within the nonsense codon. Thus, targeted pseudouridylation represents a novel approach for promoting nonsense suppression in vivo. Remarkably, we also show that pseudouridylated nonsense codons code for amino acids with similar properties. Specifically, Psi AA and Psi AG code for serine and threonine, whereas Psi GA codes for tyrosine and phenylalanine, thus suggesting a new mode of decoding. Our results also suggest that RNA modification, as a naturally occurring mechanism, may offer a new way to expand the genetic code.	[Karijolich, John; Yu, Yi-Tao] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Yu, YT (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	yitao_yu@urmc.rochester.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078223, R01GM062937] Funding Source: NIH RePORTER; NIGMS NIH HHS [R21 GM078223-02, R01 GM062937-09, R01 GM062937, R21 GM078223] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; ATKINS JF, 1979, CELL, V18, P1119, DOI 10.1016/0092-8674(79)90225-3; Auffinger P, 1997, J MOL BIOL, V269, P326, DOI 10.1006/jmbi.1997.1022; BRENNER S, 1967, NATURE, V213, P449, DOI 10.1038/213449a0; BRENNER S, 1965, NATURE, V206, P994, DOI 10.1038/206994a0; Charette M, 2000, IUBMB LIFE, V49, P341; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; COHN WE, 1959, BIOCHIM BIOPHYS ACTA, V32, P569, DOI 10.1016/0006-3002(59)90644-4; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; HAMER DH, 1985, SCIENCE, V228, P685, DOI 10.1126/science.3887570; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; LESSER CF, 1993, GENETICS, V133, P851; Ma XJ, 2005, EMBO J, V24, P2403, DOI 10.1038/sj.emboj.7600718; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; WEIGERT MG, 1965, NATURE, V206, P992, DOI 10.1038/206992a0; Wilusz CJ, 2001, GENE DEV, V15, P2781; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Yu YT, 2000, METHOD ENZYMOL, V318, P71; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zhao XL, 2004, RNA, V10, P996, DOI 10.1261/rna.7110804; Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504	27	208	223	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					395	+		10.1038/nature10165	http://dx.doi.org/10.1038/nature10165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677757	Green Accepted			2022-12-01	WOS:000291647100049
J	Voineagu, I; Wang, XC; Johnston, P; Lowe, JK; Tian, Y; Horvath, S; Mill, J; Cantor, RM; Blencowe, BJ; Geschwind, DH				Voineagu, Irina; Wang, Xinchen; Johnston, Patrick; Lowe, Jennifer K.; Tian, Yuan; Horvath, Steve; Mill, Jonathan; Cantor, Rita M.; Blencowe, Benjamin J.; Geschwind, Daniel H.			Transcriptomic analysis of autistic brain reveals convergent molecular pathology	NATURE			English	Article							COMMON GENETIC-VARIANTS; SPECTRUM DISORDERS; NETWORK ANALYSIS; CANDIDATE GENE; COPY NUMBER; ASSOCIATION; EXPRESSION; PATHWAYS; PACKAGE; DISEASE	Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity(1-3). Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain(4). Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.	[Voineagu, Irina; Lowe, Jennifer K.; Tian, Yuan; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet & Neurobehav Genet, Los Angeles, CA 90095 USA; [Voineagu, Irina; Lowe, Jennifer K.; Tian, Yuan; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Wang, Xinchen; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Johnston, Patrick; Mill, Jonathan] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Horvath, Steve; Cantor, Rita M.; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University of London; King's College London; University of California System; University of California Los Angeles	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet & Neurobehav Genet, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu	Mill, Jonathan/B-5678-2014; Mill, Jonathan S/B-3276-2010	Mill, Jonathan/0000-0003-1115-3224; Mill, Jonathan S/0000-0003-1115-3224; Wang, Xinchen/0000-0002-5198-6581; Voineagu, Irina/0000-0003-4162-3872	CIHR Funding Source: Medline; NIMH NIH HHS [R37 MH060233-12, R01 MH081754-03, R37 MH060233, R01 MH081754-05, R37 MH060233-11, 5R01MH081754-03, R01 MH081754, R37MH060233, R01 MH081754-04, R01 MH094714, R01 MH081754-01, R01 MH081754-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, R37MH060233, R01MH094714] Funding Source: NIH RePORTER; Medical Research Council [G9817803B] Funding Source: researchfish	CIHR(Canadian Institutes of Health Research (CIHR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Albright AV, 2004, J NEUROIMMUNOL, V157, P27, DOI 10.1016/j.jneuroim.2004.09.007; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Babatz TD, 2009, AUTISM RES, V2, P359, DOI 10.1002/aur.107; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Moy SS, 2009, BEHAV BRAIN RES, V205, P123, DOI 10.1016/j.bbr.2009.06.021; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wintle RF, 2011, AUTISM RES, V4, P89, DOI 10.1002/aur.173; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324; Zhao XZ, 2006, BIOL PSYCHIAT, V59, P747, DOI 10.1016/j.biopsych.2005.10.023; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	37	1176	1200	8	254	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					380	+		10.1038/nature10110	http://dx.doi.org/10.1038/nature10110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21614001	Green Accepted, Green Submitted			2022-12-01	WOS:000291647100046
J	Mineur, YS; Abizaid, A; Rao, Y; Salas, R; DiLeone, RJ; Gundisch, D; Diano, S; De Biasi, M; Horvath, TL; Gao, XB; Picciotto, MR				Mineur, Yann S.; Abizaid, Alfonso; Rao, Yan; Salas, Ramiro; DiLeone, Ralph J.; Guendisch, Daniela; Diano, Sabrina; De Biasi, Mariella; Horvath, Tamas L.; Gao, Xiao-Bing; Picciotto, Marina R.			Nicotine Decreases Food Intake Through Activation of POMC Neurons	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BODY-WEIGHT; SMOKING; RECEPTOR; BRAIN; OBESITY; MICE	Smoking decreases appetite, and smokers often report that they smoke to control their weight. Understanding the neurobiological mechanisms underlying the anorexic effects of smoking would facilitate the development of novel treatments to help with smoking cessation and to prevent or treat obesity. By using a combination of pharmacological, molecular genetic, electrophysiological, and feeding studies, we found that activation of hypothalamic alpha 3 beta 4 nicotinic acetylcholine receptors leads to activation of pro-opiomelanocortin (POMC) neurons. POMC neurons and subsequent activation of melanocortin 4 receptors were critical for nicotinic-induced decreases in food intake in mice. This study demonstrates that nicotine decreases food intake and body weight by influencing the hypothalamic melanocortin system and identifies critical molecular and synaptic mechanisms involved in nicotine-induced decreases in appetite.	[Mineur, Yann S.; DiLeone, Ralph J.; Picciotto, Marina R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Abizaid, Alfonso; Rao, Yan; Diano, Sabrina; Horvath, Tamas L.; Gao, Xiao-Bing] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06508 USA; [Salas, Ramiro; De Biasi, Mariella] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Guendisch, Daniela] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA	Yale University; Yale University; Baylor College of Medicine; University of Hawaii System; University Hawaii Hilo	Picciotto, MR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Pk St,3rd Floor Res, New Haven, CT 06508 USA.	marina.picciotto@yale.edu	Salas, Ramiro/A-9602-2015; De Biasi, Mariella/M-7646-2017; Mineur, Yann/E-2487-2018; Gao, Xiao-Bing/C-3121-2011; Picciotto, Marina R./F-8747-2012	De Biasi, Mariella/0000-0002-0687-8872; Mineur, Yann/0000-0002-8030-6776; Gao, Xiao-Bing/0000-0002-2035-4936; Picciotto, Marina R./0000-0002-4404-1280; Abizaid, Alfonso/0000-0001-9303-3511; DiLeone, Ralph/0000-0002-4770-2590	NIH [DA14241, DA00436, AA15632]; Transdisciplinary Tobacco Use Research Center; Natural Science and Engineering Research Council of Canada; American Diabetes Association [1-08-RA-36, DK070039];  [DK070723];  [RR016467];  [DA017173];  [OD006850];  [DK080000]; NATIONAL CANCER INSTITUTE [U19CA148127] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080000, R01DK070723, R01DK070039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA015632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014241, R01DA017173, K02DA000436] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transdisciplinary Tobacco Use Research Center; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Diabetes Association(American Diabetes Association); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by grants DA14241, DA00436, and AA15632 from the NIH. X.-B.G. was supported by DK070723. Y.M. was supported by a Transdisciplinary Tobacco Use Research Center young investigator pilot grant. Alfonso Abizaid was supported by a postdoctoral fellowship from the Natural Science and Engineering Research Council of Canada. D. G. was supported by RR016467. Y.R., X.-B.G., and S. D. were supported by American Diabetes Association grants 1-08-RA-36 and DK070039. M. D. was supported by DA017173. T. L. H. was supported by OD006850 and DK080000. The authors gratefully acknowledge U. Hochgeschwender (Oklahoma Medical Research Foundation) for providing heterozygous POMC breeding pairs.	ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Backberg M, 2004, SYNAPSE, V52, P245, DOI 10.1002/syn.20024; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Freeman M E, 2008, NEUROSCIENCE MED, P301; Fulkerson JA, 2003, J ADOLESCENT HEALTH, V32, P306, DOI 10.1016/S1054-139X(02)00566-9; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; GRUNBERG NE, 1987, PSYCHOPHARMACOLOGY, V91, P221; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Majkutewicz I, 2010, ACTA NEUROBIOL EXP, V70, P28; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Phillis J. W., 2005, Critical Reviews in Neurobiology, V17, P161; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Pistelli F, 2009, Monaldi Arch Chest Dis, V71, P81; Schafer MKH, 1998, NEUROSCIENCE, V84, P331, DOI 10.1016/S0306-4522(97)00516-2; Smart JL, 2003, ANN NY ACAD SCI, V994, P202, DOI 10.1111/j.1749-6632.2003.tb03181.x; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Voorhees CC, 2002, PREV MED, V34, P616, DOI 10.1006/pmed.2002.1026; WACK JT, 1982, AM J CLIN NUTR, V35, P366, DOI 10.1093/ajcn/35.2.366; Williams DL, 2005, AM J PHYSIOL-REG I, V289, pR2, DOI 10.1152/ajpregu.00226.2005; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M	21	273	281	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1330	1332		10.1126/science.1201889	http://dx.doi.org/10.1126/science.1201889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659607	Green Accepted			2022-12-01	WOS:000291441700047
J	Zaslaver, A; Baugh, LR; Sternberg, PW				Zaslaver, Alon; Baugh, L. Ryan; Sternberg, Paul W.			Metazoan Operons Accelerate Recovery from Growth-Arrested States	CELL			English	Article							ELEGANS DAUER LARVA; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; GLOBAL ANALYSIS; GENOME; ORGANIZATION; PROMOTERS; DYNAMICS; SEQUENCE; CHORDATE	Existing theories explain why operons are advantageous in prokaryotes, but their occurrence in metazoans is an enigma. Nematode operon genes, typically consisting of growth genes, are significantly upregulated during recovery from growth-arrested states. This expression pattern is anticorrelated to nonoperon genes, consistent with a competition for transcriptional resources. We find that transcriptional resources are initially limiting during recovery and that recovering animals are highly sensitive to any additional decrease in transcriptional resources. We provide evidence that operons become advantageous because, by clustering growth genes into operons, fewer promoters compete for the limited transcriptional machinery, effectively increasing the concentration of transcriptional resources and accelerating recovery. Mathematical modeling reveals how a moderate increase in transcriptional resources can substantially enhance transcription rate and recovery. This design principle occurs in different nematodes and the chordate C. intestinalis. As transition from arrest to rapid growth is shared by many metazoans, operons could have evolved to facilitate these processes.	[Zaslaver, Alon; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Zaslaver, Alon; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Baugh, L. Ryan] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Baugh, L. Ryan] Duke Univ, IGSP Ctr Syst Biol, Durham, NC 27708 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Duke University; Duke University	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	pws@caltech.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Sternberg, Paul/0000-0002-7699-0173	Genome Canada; European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP); Caltech Center for Biological Circuit Design; HHMI	Genome Canada(Genome Canada); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Caltech Center for Biological Circuit Design; HHMI(Howard Hughes Medical Institute)	We are grateful to Tom Blumenthal, Erich Schwarz, Hillel Schwartz, Shalev Itzkovitz, Ronen Zaidel-Bar, and Ron Milo for critical review and helpful comments. We thank Elodie Ghedin for sharing the list of operon genes in B. malayi, the Mitani laboratory and the Caenorhabditis Genetics Center for deletion strains, WormBase, and the Genome BC C. elegans Gene Expression Consortium http://elegans.bcgsc.bc.ca/ for SAGE data (produced at the Michael Smith Genome Sciences Centre with funding from Genome Canada). A.Z. was supported by the European Molecular Biology Organization (EMBO), the Human Frontier Science Program (HFSP), and the Caltech Center for Biological Circuit Design. L.R.B. was an ACS postdoctoral fellow. P.W.S. is an Investigator with the HHMI, which supported this work. A.Z. conceived the idea of this study, designed and performed all of the experiments and the mathematical modeling, and carried out all of the data and bioinformatics analyses. L.R.B. contributed experimental tools, shared unpublished data, and helped to analyze and interpret the data. A.Z. and P.W.S. wrote the paper.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Alon U, 2006, INTRO SYSTEMS BIOL D; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; BLACKWELL TK, 2006, TRANSCRIPTION MECH, P1; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Blumenthal Thomas, 2003, Nature Reviews Genetics, V4, P112; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chen NS, 2006, GENOME RES, V16, P606, DOI 10.1101/gr.4515306; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DALLEY BK, 1992, DEV BIOL, V151, P80, DOI 10.1016/0012-1606(92)90215-3; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Guiliano DB, 2006, PLOS GENET, V2, P1871, DOI 10.1371/journal.pgen.0020198; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Huang PM, 2007, GENOME RES, V17, P1478, DOI 10.1101/gr.6824707; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Mayer MG, 2011, P ROY SOC B-BIOL SCI, V278, P2784, DOI 10.1098/rspb.2010.2760; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Qian WF, 2008, GENOME RES, V18, P412, DOI 10.1101/gr.7112608; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Reinke V, 2009, GENETICS, V181, P1219, DOI 10.1534/genetics.108.099283; SANFORD T, 1983, J BIOL CHEM, V258, P2804; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	44	35	38	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					981	992		10.1016/j.cell.2011.05.013	http://dx.doi.org/10.1016/j.cell.2011.05.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663799	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000291461600023
J	Woods, LM; Coleman, MP; Lawrence, G; Rashbass, J; Berrino, F; Rachet, B				Woods, Laura M.; Coleman, Michel P.; Lawrence, Gill; Rashbass, Jem; Berrino, Franco; Rachet, Bernard			Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; RADIOTHERAPY; COUNTRIES; AUSTRALIA; EUROCARE; ENGLAND; EUROPE	Objectives To simulate each of two hypothesised errors in the National Cancer Registry (recording of the date of recurrence of cancer, instead of the date of diagnosis, for registrations initiated from a death certificate; long term survivors who are never notified to the registry), to estimate their possible effect on relative survival, and to establish whether lower survival in the UK might be due to one or both of these errors. Design Simulation study. Setting National Cancer Registry of England and Wales. Population Patients diagnosed as having breast (women), lung, or colorectal cancer during 1995-2007 in England and Wales, with follow-up to 31 December 2007. Main outcome measure Mean absolute percentage change in one year and five year relative survival associated with each simulated error. Results To explain the differences in one year survival after breast cancer between England and Sweden, under the first hypothesis, date of diagnosis would have to have been incorrectly recorded by an average of more than a year for more than 70% of women known to be dead. Alternatively, under the second hypothesis, failure to register even 40% of long term survivors would explain less than half the difference in one year survival. Results were similar for lung and colorectal cancers. Conclusions Even implausibly extreme levels of the hypothesised errors in the cancer registry data could not explain the international differences in survival observed between the UK and other European countries.	[Woods, Laura M.; Coleman, Michel P.; Rachet, Bernard] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England; [Lawrence, Gill] Univ Birmingham, W Midlands Canc Intelligence Unit, Birmingham BT5 2TT, W Midlands, England; [Rashbass, Jem] Eastern Canc Registry & Informat Ctr, Cambridge CB22 3AD, England; [Berrino, Franco] Ist Nazl Tumori, Fdn IRCCS, Dept Predict & Prevent Med, I-20133 Milan, Italy	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine; University of Birmingham; Fondazione IRCCS Istituto Nazionale Tumori Milan	Woods, LM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, Keppel St, London WC1E 7HT, England.	laura.woods@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020; Woods, Laura M/Q-1714-2017; Berrino, Franco/AAC-2364-2020	Coleman, Michel/0000-0001-8940-3807; Woods, Laura M/0000-0002-2178-1577; Berrino, Franco/0000-0002-4858-1866; Rachet, Bernard/0000-0001-5837-7773	Cancer Research UK [11700, 11415] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Anderson GF, 2007, HEALTH AFFAIR, V26, P1481, DOI 10.1377/hlthaff.26.5.1481; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Bentzen SM, 2005, RADIOTHER ONCOL, V75, P355, DOI 10.1016/j.radonc.2004.12.007; Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Berrino F, 2003, ANN ONCOL, V14, pV9, DOI 10.1093/annonc/mdg750; Berrino F, 1999, SURVIVAL CANC PATIEN; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Brenner H, 1997, J CLIN EPIDEMIOL, V50, P211, DOI 10.1016/S0895-4356(97)00280-1; Brenner H, 2009, INT J CANCER, V125, P432, DOI 10.1002/ijc.24344; *CANC RES UK CANC, 2006, STREL COMP PROGR VER, V5; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Department of Health, 2000, NHS CANC PLAN; Department of Health, 2007, CANC REF STRAT; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; Kaye JA, 2000, BRIT J CANCER, V83, P1556, DOI 10.1054/bjoc.2000.1493; Laurenti R, 2000, DEATH CERTIFICATION; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; *OFF NAT STAT, 2008, SER MB1 OFF NAT STAT, V37; Organisation for Economic Co Operation and Development, 2009, HLTH GLANC 2009; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Rooney C, 1999, HLTH STAT Q, P21; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sant M., 1995, SURVIVAL CANC PATIEN; Stotter A, 2000, BRIT MED J, V321, P214, DOI 10.1136/bmj.321.7255.214; UK Association of Cancer Registries, 2010, UKACR QUAL PERF IND; Wilkinson E, 2009, LANCET, V374, P964, DOI 10.1016/S0140-6736(09)61648-2; Williams MV, 2007, CLIN ONCOL-UK, V19, P273, DOI 10.1016/j.clon.2007.03.011; Williams MV, 2009, CLIN ONCOL-UK, V21, P575, DOI 10.1016/j.clon.2009.07.003; Woods LM, 2009, INT J CANCER, V124, P2391, DOI 10.1002/ijc.24233; 2011, EUROCARE 4 DATABASE	35	38	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2011	342								d3399	10.1136/bmj.d3399	http://dx.doi.org/10.1136/bmj.d3399			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SR	21659366	Green Accepted, Green Published, hybrid			2022-12-01	WOS:000291645800003
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING AIDS at 30: a chance to treat is now a chance to prevent	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				BROWN D, 2011, WASHINGTON POST 0530; *CDC, 1981, MMWR-MORBID MORTAL W, V30, P1; FAUCI AS, 2011, WASHINGTON POST 0528	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2011	342								d3512	10.1136/bmj.d3512	http://dx.doi.org/10.1136/bmj.d3512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SL	21652746				2022-12-01	WOS:000291645200007
J	Remorino, A; Korendovych, IV; Wu, YB; DeGrado, WF; Hochstrasser, RM				Remorino, Amanda; Korendovych, Ivan V.; Wu, Yibing; DeGrado, William F.; Hochstrasser, Robin M.			Residue-Specific Vibrational Echoes Yield 3D Structures of a Transmembrane Helix Dimer	SCIENCE			English	Article							2-DIMENSIONAL INFRARED-SPECTROSCOPY; MOLECULAR-STRUCTURE DETERMINATION; 2D IR; XPLOR-NIH; PROTEINS; DYNAMICS; WATER; CONFORMATION; SIMULATIONS; PEPTIDES	Two-dimensional (2D) vibrational echo spectroscopy has previously been applied to structural determination of small peptides. Here we extend the technique to a more complex, biologically important system: the homodimeric transmembrane dimer from the alpha chain of the integrin alpha(IIb)beta(3). We prepared micelle suspensions of the pair of 30-residue chains that span the membrane in the native structure, with varying levels of heavy ((13)C=(18)O) isotopes substituted in the backbone of the central 10th through 20th positions. The constraints derived from vibrational coupling of the precisely spaced heavy residues led to determination of an optimized structure from a range of model candidates: Glycine residues at the 12th, 15th, and 16th positions form a tertiary contact in parallel right-handed helix dimers with crossing angles of -58 degrees +/- 9 degrees and interhelical distances of 7.7 +/- 0.5 angstroms. The frequency correlation established the dynamical model used in the analysis, and it indicated the absence of mobile water associated with labeled residues. Delocalization of vibrational excitations between the helices was also quantitatively established.	[Remorino, Amanda; Hochstrasser, Robin M.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Korendovych, Ivan V.; Wu, Yibing; DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hochstrasser, RM (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	hochstra@sas.upenn.edu			NSFCHE [NIH-GM12592, NIH-RR01348]; NSF-MRSEC [NIH-GM54616, NIH-GM60610, NIH-GM56423]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056423, R01GM054616, R37GM054616, R01GM060610, R37GM012592, R01GM012592] Funding Source: NIH RePORTER	NSFCHE(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by grants NIH-GM12592, NIH-RR01348, and NSFCHE (to R.M.H.) and NIH-GM54616, NIH-GM60610, NSF-MRSEC, and NIH-GM56423 (to W.F.D.). We thank C. Schwieters and M. Clore for providing us with the Xplor-NIH source code.	Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Ernst R.R., 1987, PRINCIPLES NUCL MAGN; Fang C, 2003, CHEM PHYS LETT, V382, P586, DOI 10.1016/j.cplett.2003.10.111; Fang C, 2006, P NATL ACAD SCI USA, V103, P16740, DOI 10.1073/pnas.0608243103; Ghosh A, 2011, P NATL ACAD SCI USA, V108, P6115, DOI 10.1073/pnas.1103027108; Hamm P, 1998, J PHYS CHEM B, V102, P6123, DOI 10.1021/jp9813286; Hamm P, 1999, P NATL ACAD SCI USA, V96, P2036, DOI 10.1073/pnas.96.5.2036; Kim YS, 2005, J PHYS CHEM B, V109, P7511, DOI 10.1021/jp044989d; Kim YS, 2009, P NATL ACAD SCI USA, V106, P17751, DOI 10.1073/pnas.0909888106; Kolano C, 2006, NATURE, V444, P469, DOI 10.1038/nature05352; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kwac K, 2003, J CHEM PHYS, V119, P2256, DOI 10.1063/1.1580808; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marecek J, 2007, ORG LETT, V9, P4935, DOI 10.1021/ol701913p; Mukamel S., 1995, PRINCIPLES NONLINEAR; Mukherjee P, 2006, P NATL ACAD SCI USA, V103, P3528, DOI 10.1073/pnas.0508833103; Rubtsov IV, 2002, J PHYS CHEM B, V106, P9165, DOI 10.1021/jp020837b; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sul S, 2006, J PHYS CHEM B, V110, P19891, DOI 10.1021/jp062039h; TORII H, 1992, J CHEM PHYS, V96, P3379, DOI 10.1063/1.461939; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang JP, 2004, CHEM PHYS, V297, P195, DOI 10.1016/j.chemphys.2003.10.013; WERTHEIMER R, 1980, CHEM PHYS LETT, V75, P243, DOI 10.1016/0009-2614(80)80505-7; Woutersen S, 2000, J PHYS CHEM B, V104, P11316, DOI 10.1021/jp001546a; Woys AM, 2010, J AM CHEM SOC, V132, P2832, DOI 10.1021/ja9101776; Zhuang W, 2009, ANGEW CHEM INT EDIT, V48, P3750, DOI 10.1002/anie.200802644	28	87	87	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1206	1209		10.1126/science.1202997	http://dx.doi.org/10.1126/science.1202997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636774	Green Accepted			2022-12-01	WOS:000291205200050
J	Carter, PJ; Taylor, BJ; Williams, SM; Taylor, RW				Carter, Philippa J.; Taylor, Barry J.; Williams, Sheila M.; Taylor, Rachael W.			Longitudinal analysis of sleep in relation to BMI and body fat in children: the FLAME study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MASS INDEX; RISK-FACTORS; CHILDHOOD OVERWEIGHT; CIRCADIAN-RHYTHMS; DURATION; OBESITY; ADOLESCENTS; AGE; ACCELEROMETERS; ASSOCIATION	Objectives To determine whether reduced sleep is associated with differences in body composition and the risk of becoming overweight in young children. Design Longitudinal study with repeated annual measurements. Setting Dunedin, New Zealand. Participants 244 children recruited from a birth cohort and followed from age 3 to 7. Main outcome measures Body mass index (BMI), fat mass (kg), and fat free mass (kg) measured with bioelectrical impedance; dual energy x ray absorptiometry; physical activity and sleep duration measured with accelerometry; dietary intake (fruit and vegetables, non-core foods), television viewing, and family factors (maternal BMI and education, birth weight, smoking during pregnancy) measured with questionnaire. Results After adjustment for multiple confounders, each additional hour of sleep at ages 3-5 was associated with a reduction in BMI of 0.48 (95% confidence interval 0.01 to 0.96) and a reduced risk of being overweight (BMI >= 85th centile) of 0.39 (0.24 to 0.63) at age 7. Further adjustment for BMI at age 3 strengthened these relations. These differences in BMI were explained by differences in fat mass index (-0.43, -0.82 to -0.03) more than by differences in fat free mass index (-0.21, -0.41 to -0.00). Conclusions Young children who do not get enough sleep are at increased risk of becoming overweight, even after adjustment for initial weight status and multiple confounding factors. This weight gain is a result of increased fat deposition in both sexes rather than additional accumulation of fat free mass.	[Carter, Philippa J.; Taylor, Barry J.] Univ Otago, Dept Womens & Childrens Hlth, Dunedin, New Zealand; [Williams, Sheila M.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Taylor, Rachael W.] Univ Otago, Dept Med & Surg Sci, Edgar Natl Ctr Diabet & Obes Res, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Taylor, RW (corresponding author), Dept Human Nutr, POB 56, Dunedin 9054, New Zealand.	rachael.taylor@otago.ac.nz	Williams, Sheila/L-4028-2019; Taylor, Barry j/G-1410-2010	Taylor, Barry/0000-0002-6450-8677	University of Otago; Child Health Research Foundation; New Zealand Heart Foundation; Bequest-AAW Jones Trust	University of Otago; Child Health Research Foundation; New Zealand Heart Foundation; Bequest-AAW Jones Trust	This study was funded by the University of Otago, the Child Health Research Foundation, the New Zealand Heart Foundation, and the Dean's Bequest-AAW Jones Trust. The funders had no role in study design; or in the collection, analysis, and interpretation of data; or in the writing of the report or the decision to submit the article for publication.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Bayer O, 2009, SLEEP, V32, P1183, DOI 10.1093/sleep/32.9.1183; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Crabtree VM, 2009, CHILD ADOL PSYCH CL, V18, P799, DOI 10.1016/j.chc.2009.04.013; Dollman I, 2007, ACTA PAEDIATR, V96, P1011, DOI 10.1111/j.1651-2227.2007.00278.x; Fitzmaurice GM, 2004, APPL LONGITUDINAL AN; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Hart CN, 2008, BEHAV SLEEP MED, V6, P251, DOI 10.1080/15402000802371379; Hitze B, 2009, EUR J CLIN NUTR, V63, P739, DOI 10.1038/ejcn.2008.41; Horlick M, 2002, AM J CLIN NUTR, V76, P991, DOI 10.1093/ajcn/76.5.991; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kuczmarski RJ., 2000, CDC GROWTH CHARTS US; Landhuis CE, 2008, PEDIATRICS, V122, P955, DOI 10.1542/peds.2007-3521; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Lumeng JC, 2007, PEDIATRICS, V120, P1020, DOI 10.1542/peds.2006-3295; Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Must A, 2009, INT J OBESITY, V33, pS82, DOI 10.1038/ijo.2009.23; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Padez C, 2009, AM J HUM BIOL, V21, P371, DOI 10.1002/ajhb.20884; Patel SR, 2009, OBES REV, V10, P61, DOI 10.1111/j.1467-789X.2009.00664.x; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pfeiffer KA, 2006, MED SCI SPORT EXER, V38, P152, DOI 10.1249/01.mss.0000183219.44127.e7; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Roche A., 1996, HUMAN BODY COMPOSITI, P167; Rose G., 1992, STRATEGY PREVENTIVE; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Sadeh A, 2008, J PEDIATR PSYCHOL, V33, P406, DOI 10.1093/jpepsy/jsn018; Sadeh A, 2009, SLEEP, V32, P1602, DOI 10.1093/sleep/32.12.1602; Sazonov E, 2004, PHYSIOL MEAS, V25, P1291, DOI 10.1088/0967-3334/25/5/018; Snell EK, 2007, CHILD DEV, V78, P309, DOI 10.1111/j.1467-8624.2007.00999.x; Sugimori H, 2004, PEDIATR INT, V46, P302, DOI 10.1111/j.1442-200x.2004.01895.x; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Taveras EM, 2008, ARCH PEDIAT ADOL MED, V162, P305, DOI 10.1001/archpedi.162.4.305; Taylor RW, 2007, AM J CLIN NUTR, V86, P735, DOI 10.1093/ajcn/86.3.735; Taylor RW, 2009, MED SCI SPORT EXER, V41, P96, DOI 10.1249/MSS.0b013e3181849d81; Taylor RW, 2002, AM J CLIN NUTR, V76, P1416, DOI 10.1093/ajcn/76.6.1416; Touchette E, 2008, SLEEP, V31, P1507, DOI 10.1093/sleep/31.11.1507; von Kries R, 2002, INT J OBESITY, V26, P710, DOI 10.1038/sj.ijo.0801980; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; Yu YX, 2007, SLEEP, V30, P1688, DOI 10.1093/sleep/30.12.1688	48	124	131	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2011	342								d2712	10.1136/bmj.d2712	http://dx.doi.org/10.1136/bmj.d2712			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KG	21622518	hybrid, Green Published			2022-12-01	WOS:000291155000002
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA What GPs know about asthma	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2011	342								d2972	10.1136/bmj.d2972	http://dx.doi.org/10.1136/bmj.d2972			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QQ	21593089				2022-12-01	WOS:000290951900005
J	Burns, DM; D'Ambrogio, A; Nottrott, S; Richter, JD				Burns, David M.; D'Ambrogio, Andrea; Nottrott, Stephanie; Richter, Joel D.			CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation	NATURE			English	Article							MEDIATED CYTOPLASMIC POLYADENYLATION; RIBOSOMAL-PROTEIN L26; CELLULAR SENESCENCE; SYNAPTIC PLASTICITY; MICRORNAS; GLD-2; STABILIZATION; MOUSE; CELLS; MICE	Cytoplasmic polyadenylation-induced translation controls germ cell development(1,2), neuronal synaptic plasticity(3-5) and cellular senescence(6,7), a tumour-suppressor mechanism that limits the replicative lifespan of cells(8,9). The cytoplasmic polyadenylation element binding protein (CPEB) promotes polyadenylation by nucleating a group of factors including defective in germline development 2 (Gld2), a non-canonical poly(A) polymerase(10-12), on specific messenger RNA (mRNA) 3' untranslated regions (UTRs). Because CPEB regulation of p53 mRNA polyadenylation/translation is necessary for cellular senescence in primary human diploid fibroblasts(6), we surmised that Gld2 would be the enzyme responsible for poly(A) addition. Here we show that depletion of Gld2 surprisingly promotes rather than inhibits p53 mRNA polyadenylation/translation, induces premature senescence and enhances the stability of CPEB mRNA. The CPEB 3' UTR contains two miR-122 binding sites, which when deleted, elevate mRNA translation, as does an antagomir of miR-122. Although miR-122 is thought to be liver specific, it is present in primary fibroblasts and destabilized by Gld2 depletion. Gld4, a second non-canonical poly(A) polymerase, was found to regulate p53 mRNA polyadenylation/translation in a CPEB-dependent manner. Thus, translational regulation of p53 mRNA and cellular senescence is coordinated by Gld2/miR-122/CPEB/Gld4.	[Burns, David M.; D'Ambrogio, Andrea; Nottrott, Stephanie; Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	joel.richter@umassmed.edu	D'Ambrogio, Andrea/D-3729-2013		Max Planck Society; European Molecular Biology Organization [ALTF 995-2004]; National Institutes of Health [AG30323]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD037267] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030323] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank V. Ambros, J. Steitz, T. Kowalik and R. Davis for comments. S.N. was supported by a fellowship of the Max Planck Society and by European Molecular Biology Organization fellowship ALTF 995-2004. This work was supported by National Institutes of Health grant AG30323. Additional core support from the Diabetes Endocrinology Research Center (DK32520) is acknowledged.	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Holst LM, 2010, EXP DERMATOL, V19, pE201, DOI 10.1111/j.1600-0625.2009.01049.x; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; Schmid M, 2009, GENE DEV, V23, P824, DOI 10.1101/gad.494009; Schulte JH, 2009, CANCER LETT, V274, P10, DOI 10.1016/j.canlet.2008.06.010; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	27	144	152	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					105	U125		10.1038/nature09908	http://dx.doi.org/10.1038/nature09908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478871	Green Accepted			2022-12-01	WOS:000290218300040
J	Umena, Y; Kawakami, K; Shen, JR; Kamiya, N				Umena, Yasufumi; Kawakami, Keisuke; Shen, Jian-Ren; Kamiya, Nobuo			Crystal structure of oxygen-evolving photosystem II at a resolution of 1.9 angstrom	NATURE			English	Article							DIFFRACTION DATA; WATER; BINDING; PROTEIN; MECHANISM; OXIDATION; MANGANESE; CHANNELS; CLUSTER; CRYSTALLOGRAPHY	Photosystem II is the site of photosynthetic water oxidation and contains 20 subunits with a total molecular mass of 350 kDa. The structure of photosystem II has been reported at resolutions from 3.8 to 2.9 angstrom. These resolutions have provided much information on the arrangement of protein subunits and cofactors but are insufficient to reveal the detailed structure of the catalytic centre of water splitting. Here we report the crystal structure of photosystem II at a resolution of 1.9 angstrom. From our electron density map, we located all of the metal atoms of the Mn4CaO5 cluster, together with all of their ligands. We found that five oxygen atoms served as oxo bridges linking the five metal atoms, and that four water molecules were bound to the Mn4CaO5 cluster; some of them may therefore serve as substrates for dioxygen formation. We identified more than 1,300 water molecules in each photosystem II monomer. Some of them formed extensive hydrogen-bonding networks that may serve as channels for protons, water or oxygen molecules. The determination of the high-resolution structure of photosystem II will allow us to analyse and understand its functions in great detail.	[Kawakami, Keisuke; Shen, Jian-Ren] Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Div Biosci, Okayama 7008530, Japan; [Umena, Yasufumi; Kamiya, Nobuo] Osaka City Univ, Grad Sch Sci, Dept Chem, Osaka 5588585, Japan	Okayama University; Osaka Metropolitan University	Shen, JR (corresponding author), Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Div Biosci, Okayama 7008530, Japan.	shen@cc.okayama-u.ac.jp; nkamiya@sci.osaka-cu.ac.jp	Shen, Jian-Ren/B-2558-2011; Umena, Yasufumi/AAD-5472-2019	Kamiya, Nobuo/0000-0002-9056-7558	Ministry of Education, Culture, Sports, Science and Technology of Japan; Yamada Science foundation; Grants-in-Aid for Scientific Research [10J02491] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The X-ray diffraction data was taken at beamlines BL44XU, BL41XU and BL38B1 at SPring-8. We thank E. Yamashita, N. Shimizu, S. Baba and N. Mizuno for their help in using the beamlines. J.-R.S. thanks Y. Inoue for his support in the initiation of this work. This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (Structures of Biological Macromolecular Assemblies), a Grant-in-Aid for Creative Scientific Research, a GCOE programme on Pico-biology at the University of Hyogo, a Grant-in-Aid for Scientific Research (C), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a research grant from the Yamada Science foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Broser M, 2010, J BIOL CHEM, V285, P26255, DOI 10.1074/jbc.M110.127589; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURRELL JWK, 1959, P CHEM SOC LONDON, P263; Carrell TG, 2002, J BIOL INORG CHEM, V7, P2, DOI 10.1007/s00775-001-0305-3; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5839, DOI 10.1021/bi00017a016; CRABBE P, 1959, P CHEM SOC LONDON, P264; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DAOPIN S, 1994, ACTA CRYSTALLOGR D, V50, P85, DOI 10.1107/S090744499300808X; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DEPAULA JC, 1986, J AM CHEM SOC, V108, P4002, DOI 10.1021/ja00274a025; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hays AMA, 1999, BIOCHEMISTRY-US, V38, P11851, DOI 10.1021/bi990716a; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Joliot P, 2003, PHOTOSYNTH RES, V76, P65, DOI 10.1023/A:1024946610564; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kawakami K, 2007, FEBS LETT, V581, P4983, DOI 10.1016/j.febslet.2007.09.036; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; NIXON PJ, 1994, BIOCHEM SOC T, V22, P338, DOI 10.1042/bst0220338; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Robblee JH, 2001, BBA-BIOENERGETICS, V1503, P7, DOI 10.1016/S0005-2728(00)00217-6; Service RJ, 2010, BIOCHEMISTRY-US, V49, P6655, DOI 10.1021/bi100730d; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Vasil'ev S, 2001, P NATL ACAD SCI USA, V98, P8602, DOI 10.1073/pnas.141239598; VINCENT JB, 1987, INORG CHIM A-BIOINOR, V136, pL41, DOI 10.1016/S0020-1693(00)81142-1; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zein S, 2008, PHILOS T R SOC B, V363, P1167, DOI 10.1098/rstb.2007.2212; Zhang CX, 2007, BBA-BIOENERGETICS, V1767, P493, DOI 10.1016/j.bbabio.2006.12.008; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	40	2861	2940	30	1239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					55	U65		10.1038/nature09913	http://dx.doi.org/10.1038/nature09913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21499260	Green Submitted			2022-12-01	WOS:000290218300029
J	Ferreira, A; Marguti, I; Bechmann, I; Jeney, V; Chora, A; Palha, NR; Rebelo, S; Henri, A; Beuzard, Y; Soares, MP				Ferreira, Ana; Marguti, Ivo; Bechmann, Ingo; Jeney, Viktoria; Chora, Angelo; Palha, Nuno R.; Rebelo, Sofia; Henri, Annie; Beuzard, Yves; Soares, Miguel P.			Sickle Hemoglobin Confers Tolerance to Plasmodium Infection	CELL			English	Article							HEME OXYGENASE-1; CELL-DISEASE; FALCIPARUM-MALARIA; MOUSE MODEL; PROTECTION; TRAIT; INDUCTION; PATHOGENESIS; RESISTANCE; MECHANISM	Sickle human hemoglobin (Hb) confers a survival advantage to individuals living in endemic areas of malaria, the disease caused by Plasmodium infection. As demonstrated hereby, mice expressing sickle Hb do not succumb to experimental cerebral malaria (ECM). This protective effect is exerted irrespectively of parasite load, revealing that sickle Hb confers host tolerance to Plasmodium infection. Sickle Hb induces the expression of heme oxygenase-1 (HO-1) in hematopoietic cells, via a mechanism involving the transcription factor NF-E2-related factor 2 (Nrf2). Carbon monoxide (CO), a byproduct of heme catabolism by HO-1, prevents further accumulation of circulating free heme after Plasmodium infection, suppressing the pathogenesis of ECM. Moreover, sickle Hb inhibits activation and/or expansion of pathogenic CD8(+) T cells recognizing antigens expressed by Plasmodium, an immunoregulatory effect that does not involve Nrf2 and/or HO-1. Our findings provide insight into molecular mechanisms via which sickle Hb confers host tolerance to severe forms of malaria.	[Ferreira, Ana; Marguti, Ivo; Jeney, Viktoria; Chora, Angelo; Palha, Nuno R.; Rebelo, Sofia; Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04103 Leipzig, Germany; [Bechmann, Ingo] Goethe Univ Frankfurt, Inst Clin Neuroanat, D-60596 Frankfurt, Germany; [Henri, Annie; Beuzard, Yves] Univ Paris 07, Inst Univ Hematol, F-75221 Paris 05, France; [Henri, Annie; Beuzard, Yves] CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France; [Henri, Annie; Beuzard, Yves] INSERM, F-75654 Paris 13, France; [Henri, Annie; Beuzard, Yves] Univ Paris 11, Paris, France	Instituto Gulbenkian de Ciencia; Leipzig University; Goethe University Frankfurt; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt	Jeney, Viktoria/A-6779-2011; Soares, Miguel P/G-4188-2011; Ferreira Chora, Angelo/AAZ-6503-2021; Jeney, Viktória/AAF-5355-2019	Ferreira Chora, Angelo/0000-0002-7941-7196; Jeney, Viktoria/0000-0003-4942-7091; Ferreira, Ana/0000-0002-9171-6068; Rebelo, Sofia/0000-0001-8399-0262; Soares, Miguel/0000-0002-9314-4833	"Fundacao para a Ciencia e a Tecnologia'', Portugal [PTDC/SAU-MII/71140/2006, SFRH/BPD/21707/2005, SFHR/BD/33218/2007, PTDC/BIA-BCM/101311/2008, PTDC/SAU-FCF/100762/2008]; GEMI Fund Linde Healthcare; European Community; DFG; BMBF; Dr. Senckenberg-Stiftung; Kassel-Stiftung; Messer-Stiftung, Germany; Paris VII University; Commissariat a l'Energie Atomique; Agence Nationale de la Recherche Scientifique, France;  [LSH-2005-1.2.5-1];  [FP7-PEOPLE-2007-2-1-IEF]	"Fundacao para a Ciencia e a Tecnologia'', Portugal(Portuguese Foundation for Science and Technology); GEMI Fund Linde Healthcare; European Community(European Commission); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Dr. Senckenberg-Stiftung; Kassel-Stiftung; Messer-Stiftung, Germany; Paris VII University; Commissariat a l'Energie Atomique(French Atomic Energy Commission); Agence Nationale de la Recherche Scientifique, France(French National Research Agency (ANR)); ; 	We thank Ruslan Medzhitov for intellectual support and encouragement by means of many insightful discussions, Thiago Carvalho (Instituto Gulbenkian de Cie ncia) and Rui Costa Fundacao Champalimaud as well as Marcelo Bozza (Universidade Federal do Rio De Janeiro), Robert P. Hebbel and Gregory Vercellotti (University of Minnesota, USA) for critical review of the manuscript, Nuno Sepulveda for support in statistical analysis, Tim M. Townes and Tom M. Ryan (University of Alabama at Birmingham) for providing the HbA/A mice. Silvia Cardoso and Matteo Villa for mouse breeding and genotyping. This work was supported by "Fundacao para a Ciencia e a Tecnologia'', Portugal grants PTDC/SAU-MII/71140/2006 and SFRH/BPD/21707/2005 (AF), SFHR/BD/33218/2007 (IM), PTDC/SAU-MII/71140/2006, PTDC/BIA-BCM/101311/2008, PTDC/SAU-FCF/100762/2008, GEMI Fund Linde Healthcare, European Community and LSH-2005-1.2.5-1 (MPS), FP7-PEOPLE-2007-2-1-IEF (VJ). I. B. is supported by the DFG, BMBF, Dr. Senckenberg-Stiftung, Kassel-Stiftung and Messer-Stiftung, Germany. Annie Henri is supported by INSERM and Yves Beuzard by Paris VII University, Commissariat a l'Energie Atomique and Agence Nationale de la Recherche Scientifique, France.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Bains SK, 2010, ARTERIOSCL THROM VAS, V30, P305, DOI 10.1161/ATVBAHA.109.196360; BALLA G, 1992, J BIOL CHEM, V267, P18148; BEET E A, 1947, East Afr Med J, V24, P212; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; EISENSTEIN RS, 1991, P NATL ACAD SCI USA, V88, P688, DOI 10.1073/pnas.88.3.688; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; Hood AT, 1996, BLOOD, V87, P1600, DOI 10.1182/blood.V87.4.1600.bloodjournal8741600; Hutagalung R, 1999, J INFECT DIS, V179, P283, DOI 10.1086/314561; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JALLOW M, 2009, GENOME WIDE FINE RES; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; LIVINGSTONE FB, 1971, ANNU REV GENET, V5, P33, DOI 10.1146/annurev.ge.05.120171.000341; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Sears DA, 2001, AM J MED SCI, V322, P345, DOI 10.1097/00000441-200112000-00007; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; SHEAR HL, 1993, BLOOD, V81, P222; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TRUDEL M, 1994, BLOOD, V84, P3189; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163	55	212	216	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					398	409		10.1016/j.cell.2011.03.049	http://dx.doi.org/10.1016/j.cell.2011.03.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529713	Bronze			2022-12-01	WOS:000290022900009
J	Shrank, WH				Shrank, William H.			Our Bulging Medicine Cabinets - The Other Side of Medication Nonadherence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shrank, William H.] Brigham & Womens Hosp, Dept Med, Div Pharmacoeidemiol & Pharmacoecon, Boston, MA 02115 USA; [Shrank, William H.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shrank, WH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoeidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.							Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Catalano RF, 2011, ADDICT BEHAV, V36, P79, DOI 10.1016/j.addbeh.2010.08.028; *FOOD DRUG ADM, DISP FLUSH CERT UN M; McCabe SE, 2009, ARCH PEDIAT ADOL MED, V163, P739, DOI 10.1001/archpediatrics.2009.120; Richman PB, 2001, AM J EMERG MED, V19, P57, DOI 10.1053/ajem.2001.20035	5	26	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1591	1593		10.1056/NEJMp1011624	http://dx.doi.org/10.1056/NEJMp1011624			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755NW	21524212				2022-12-01	WOS:000289940400004
J	Marshall, BDL; Milloy, MJ; Wood, E; Montaner, JSG; Kerr, T				Marshall, Brandon D. L.; Milloy, M-J; Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas			Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study	LANCET			English	Article							NEW-YORK-CITY; DRUG-USERS; COHORT; VANCOUVER; RISK; ATTENDANCE; PATTERNS; TRENDS; IMPACT; DEATH	Background Overdose from illicit drugs is a leading cause of premature mortality in North America. Internationally, more than 65 supervised injecting facilities (SIFs), where drug users can inject pre-obtained illicit drugs, have been opened as part of various strategies to reduce the harms associated with drug use. We sought to determine whether the opening of an SIF in Vancouver, BC, Canada, was associated with a reduction in overdose mortality. Methods We examined population-based overdose mortality rates for the period before (Jan 1, 2001, to Sept 20, 2003) and after (Sept 21, 2003, to Dec 31, 2005) the opening of the Vancouver SIF. The location of death was determined from provincial coroner records. We compared overdose fatality rates within an a priori specified 500 m radius of the SIF and for the rest of the city. Findings Of 290 decedents, 229 (79.0%) were male, and the median age at death was 40 years (IQR 32-48 years). A third (89, 30.7%) of deaths occurred in city blocks within 500 m of the SIF. The fatal overdose rate in this area decreased by 35.0% after the opening of the SIF, from 253.8 to 165.1 deaths per 100000 person-years (p=0.048). By contrast, during the same period, the fatal overdose rate in the rest of the city decreased by only 9.3%, from 7.6 to 6.9 deaths per 100 000 person-years (p=0.490). There was a significant interaction of rate differences across strata (p=0.049). Interpretation SIFs should be considered where injection drug use is prevalent, particularly in areas with high densities of overdose.	[Marshall, Brandon D. L.; Milloy, M-J; Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada; [Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Milloy, M-J] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Marshall, Brandon D. L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; University of British Columbia; Columbia University	Kerr, T (corresponding author), St Pauls Hosp, BC Ctr Excellence HIV AIDS, Urban Hlth Res Initiat, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	uhri-tk@cfenet.ubc.ca	Montaner, Julio/K-7621-2012; Marshall, Brandon/B-4895-2010; Milloy, M-J/AAY-3618-2020	Marshall, Brandon/0000-0002-0134-7052; 	Abbott Laboratories; Agouron Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Borean Pharma AS; Bristol-Myers Squibb; DuPont Pharma; Gilead Sciences; GlaxoSmithKline; Hoffmann-La Roche; Immune Response Corporation; Incyte; Janssen-Ortho Inc; Kucera Pharmaceutical Company; Merck Frosst Laboratories; Pfizer Canada; Sanofi Pasteur; Shire Biochem; Tibotec Pharmaceuticals; Trimeris; Health Canada; Canadian Institutes of Health Research (CIHR); Vancouver Coastal Health; Michael Smith Foundation for Health Research (MSFHR)	Abbott Laboratories(Abbott Laboratories); Agouron Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Borean Pharma AS; Bristol-Myers Squibb(Bristol-Myers Squibb); DuPont Pharma; Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Hoffmann-La Roche(Hoffmann-La Roche); Immune Response Corporation; Incyte; Janssen-Ortho Inc; Kucera Pharmaceutical Company; Merck Frosst Laboratories; Pfizer Canada(Pfizer); Sanofi Pasteur; Shire Biochem; Tibotec Pharmaceuticals; Trimeris; Health Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vancouver Coastal Health; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	JSGM has received educational grants from, serves as an ad hoc adviser to, or speaks at various events sponsored by Abbott Laboratories, Agouron Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Borean Pharma AS, Bristol-Myers Squibb, DuPont Pharma, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Immune Response Corporation, Incyte, Janssen-Ortho Inc, Kucera Pharmaceutical Company, Merck Frosst Laboratories, Pfizer Canada, Sanofi Pasteur, Shire Biochem, Tibotec Pharmaceuticals, and Trimeris. No other authors declared any conflicts of interest.; We gratefully acknowledge the invaluable assistance of the Chief Coroner and other officials of the British Columbia Coroners Service, in particular Sara Weinstein and Tej Sidhu. We thank Daniel Kane, Deborah Graham, and Tricia Collingham of the British Columbia Centre for Excellence in HIV/AIDS for their research and administrative assistance. The SIF assessment was originally funded by a contribution from Health Canada, although the views expressed in this analysis do not represent the official policies of Health Canada. The study is now supported by the Canadian Institutes of Health Research (CIHR) and Vancouver Coastal Health. TK is supported by a CIHR New Investigator Award and a Michael Smith Foundation for Health Research (MSFHR) Scholar Award. BDLM and MJM are supported by Canada Graduate Scholarships from CIHR; BDLM is supported by a Senior Graduate Trainee Award from Michael Smith Foundation for Health Research.	*ANG REID, CAN AR SUPP INS OPP; Apparicio P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-7; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bohnert ASB, 2010, ADDICTION, V105, P1049, DOI 10.1111/j.1360-0443.2009.02887.x; Bohnert ASB, 2009, ANN EMERG MED, V54, P618, DOI 10.1016/j.annemergmed.2009.05.004; Bow C Jennifer D, 2004, Int J Health Geogr, V3, P5, DOI 10.1186/1476-072X-3-5; Brugal MT, 2005, ADDICTION, V100, P981, DOI 10.1111/j.1360-0443.2005.01089.x; BUXTON JA, VANCOUVER DRUG USE E; Cameron AC, 1997, J ECONOMETRICS, V77, P329; *CDCP, UN DRUG POIS US; Crandall CG, 2002, ANN INTERN MED, V136, P785, DOI 10.7326/0003-4819-136-11-200206040-00006; Darke S, 2003, J URBAN HEALTH, V80, P189, DOI 10.1093/jurban/jtg022; DeBeck K, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-11; Fairbairn N, 2008, SOC SCI MED, V67, P817, DOI 10.1016/j.socscimed.2008.05.012; Fielden Sarah J, 2007, Harm Reduct J, V4, P10, DOI 10.1186/1477-7517-4-10; Fischer B, 2006, CAN J PUBLIC HEALTH, V97, P384, DOI 10.1007/BF03405347; Galai N, 2003, AM J EPIDEMIOL, V158, P695, DOI 10.1093/aje/kwg209; Galea S, 2003, J URBAN HEALTH, V80, P201, DOI 10.1093/jurban/jtg023; Hall W, 2005, LANCET, V366, P271, DOI 10.1016/S0140-6736(05)66476-8; HEDRICH D, EUROPEAN REPORT DRUG; Hulse GK, 1999, ADDICTION, V94, P221, DOI 10.1046/j.1360-0443.1999.9422216.x; Kaye S, 2004, ADDICTION, V99, P1315, DOI 10.1111/j.1360-0443.2004.00875.x; Kerr T, 2006, BRIT MED J, V332, P220, DOI 10.1136/bmj.332.7535.220; Kerr T, 2005, LANCET, V366, P316, DOI 10.1016/S0140-6736(05)66475-6; Kerr T, 2008, LANCET, V372, P354, DOI 10.1016/S0140-6736(08)61138-1; Kerr T, 2007, AM J PUBLIC HEALTH, V97, P1228, DOI 10.2105/AJPH.2006.086256; Kerr T, 2006, INT J DRUG POLICY, V17, P436, DOI 10.1016/j.drugpo.2006.05.008; Kimber J, 2003, DRUG ALCOHOL REV, V22, P227, DOI 10.1080/095952301000116951; Lloyd-Smith E, 2009, DRUG ALCOHOL DEPEN, V99, P176, DOI 10.1016/j.drugalcdep.2008.07.003; Milloy MJ, 2010, ADDICTION, V105, P1962, DOI 10.1111/j.1360-0443.2010.03077.x; *MSIC EV COMM, FIN REP EV SYDN MED; Petrar S, 2007, ADDICT BEHAV, V32, P1088, DOI 10.1016/j.addbeh.2006.07.013; Rachlis BS, 2008, HEALTH PLACE, V14, P536, DOI 10.1016/j.healthplace.2007.10.006; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Small W, 2008, DRUG ALCOHOL DEPEN, V98, P159, DOI 10.1016/j.drugalcdep.2008.05.014; Small W, 2007, INT J DRUG POLICY, V18, P27, DOI 10.1016/j.drugpo.2006.11.019; Spittal PM, 2006, AIDS CARE, V18, P101, DOI 10.1080/09540120500159292; *STAT CAN, 2003, POP FAM EST METH STA; Statistics Canada, 2007, POST COD CONV FIL PC; Stoove MA, 2008, DRUG ALCOHOL DEPEN, V96, P281, DOI 10.1016/j.drugalcdep.2008.03.006; Strathdee SA, 1997, AIDS, V11, pF59, DOI 10.1097/00002030-199708000-00001; Tyndall MW, 2006, DRUG ALCOHOL DEPEN, V83, P193, DOI 10.1016/j.drugalcdep.2005.11.011; *VANC COAST HLTH, INJ DRUG US DTES; Werb D, 2010, DRUG ALCOHOL REV, V29, P271, DOI 10.1111/j.1465-3362.2009.00145.x; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; Wood E, 2006, NEW ENGL J MED, V354, P2512, DOI 10.1056/NEJMc052939; Wood E, 2006, AM J PUBLIC HEALTH, V96, P770, DOI 10.2105/AJPH.2004.057828; Wood E, 2006, ADDICTION, V101, P689, DOI 10.1111/j.1360-0443.2006.01385.x; Wood E, 2005, AM J PREV MED, V29, P126, DOI 10.1016/j.amepre.2005.04.011; Wood E, 2004, LANCET INFECT DIS, V4, P301, DOI 10.1016/S1473-3099(04)01006-0; Wood E, 2008, INT J DRUG POLICY, V19, P220, DOI 10.1016/j.drugpo.2007.11.001; Wood E, 2008, AM J PUBLIC HEALTH, V98, P515, DOI 10.2105/AJPH.2007.114595; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; Wood Evan, 2004, Harm Reduct J, V1, P9, DOI 10.1186/1477-7517-1-9; DOWNTOWN EASTSIDE CO	55	275	275	3	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1429	1437		10.1016/S0140-6736(10)62353-7	http://dx.doi.org/10.1016/S0140-6736(10)62353-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21497898				2022-12-01	WOS:000289963000032
J	Logan, AC; Yank, V; Stafford, RS				Logan, Aaron C.; Yank, Veronica; Stafford, Randall S.			Off-Label Use of Recombinant Factor VIIa in US Hospitals: Analysis of Hospital Records	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVATED FACTOR-VII; THROMBOEMBOLIC ADVERSE EVENTS; INTRACEREBRAL HEMORRHAGE; CONTROLLED-TRIALS; CARDIAC-SURGERY; CLINICAL-TRIALS; SAFETY; EFFICACY; HEMOPHILIA; TRANSFUSION	Background: Recombinant factor VIIa (rFVIIa) is approved for treatment of bleeding in patients who have hemophilia with inhibitors but has been applied to a wide range of off-label indications. Objective: To estimate patterns of off-label rFVIIa use in U. S. hospitals. Design: Retrospective database analysis. Setting: Data were extracted from the Premier Perspectives database (Premier, Charlotte, North Carolina), which contains discharge records from a sample of academic and nonacademic U. S. hospitals. Patients: 12 644 hospitalizations for patients who received rFVIIa during a hospital stay. Measurements: Hospital diagnoses and patient dispositions from 1 January 2000 to 31 December 2008. Statistical weights for each hospital were used to provide national estimates of rFVIIa use. Results: From 2000 to 2008, off-label use of rFVIIa in hospitals increased more than 140-fold, such that in 2008, 97% (95% CI, 96% to 98%) of 18 311 in-hospital uses were off-label. In contrast, in-hospital use for hemophilia increased less than 4-fold and accounted for 2.7% (CI, 1.9% to 3.5%) of use in 2008. Adult and pediatric cardiovascular surgery (29% [CI, 21% to 33%]), body and brain trauma (29% [CI, 19% to 38%]), and intracranial hemorrhage (11% [CI, 7.7% to 14%]) were the most common indications for rFVIIa use. Across all indications, in-hospital mortality was 27% (CI, 19% to 34%) and 43% (CI, 26% to 59%) of patients were discharged to home. Limitation: Accuracy and completeness of the discharge diagnoses and patient medication records in the database sample cannot be verified. Conclusion: Off-label use of rFVIIa in the hospital setting far exceeds use for approved indications. These patterns raise concern about the application of rFVIIa to conditions for which strong supporting evidence is lacking.	[Stafford, Randall S.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA	Stanford University	Stafford, RS (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Off Bldg X312,251 Campus Dr, Palo Alto, CA 94304 USA.	rstafford@stanford.edu	Logan, Aaron C/ADJ-7526-2022; Stafford, Randall/F-3974-2017	Logan, Aaron C/0000-0002-1179-5879; Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290-02-0017]; National Heart, Lung, and Blood Institute [K24HL086703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, under contract 290-02-0017. Dr. Stafford also was supported by a National Heart, Lung, and Blood Institute mentoring award (RSS, K24HL086703).	Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Aledort LM, 2010, NEW ENGL J MED, V363, P1853, DOI 10.1056/NEJMe1008857; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Carcao MD, 2008, SEMIN HEMATOL, V45, pS68, DOI 10.1053/j.seminhematol.2008.03.003; Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244; Diringer MN, 2008, STROKE, V39, P850, DOI 10.1161/STROKEAHA.107.493601; Diringer MN, 2010, STROKE, V41, P48, DOI 10.1161/STROKEAHA.109.561712; Ganguly S, 2006, CLIN LAB HAEMATOL, V28, P309, DOI 10.1111/j.1365-2257.2006.00815.x; Gill R, 2009, CIRCULATION, V120, P21, DOI 10.1161/CIRCULATIONAHA.108.834275; Goodnough LT, 2004, TRANSFUSION, V44, P1325, DOI 10.1111/j.1537-2995.2004.04052.x; Goodnough LT, 2002, INTENS CARE MED, V28, pS221, DOI 10.1007/s00134-002-1468-2; Hardy JF, 2008, ANN THORAC SURG, V86, P1038, DOI 10.1016/j.athoracsur.2008.05.013; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hedner U, 2008, THROMB HAEMOSTASIS, V100, P557, DOI 10.1160/TH08-07-0434; Heller M, 2008, PEDIATR BLOOD CANCER, V50, P1013, DOI 10.1002/pbc.21375; Howes Jeremy L, 2009, Am J Surg, V198, P895, DOI 10.1016/j.amjsurg.2009.05.026; Hsia CC, 2009, TRANSFUSION MED, V19, P43, DOI 10.1111/j.1365-3148.2009.00913.x; Hsia CC, 2008, ANN SURG, V248, P61, DOI 10.1097/SLA.0b013e318176c4ec; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; MacLaren R, 2005, TRANSFUSION, V45, P1434, DOI 10.1111/j.1537-2995.2005.00548.x; MAGNETTI S, 2007, P & T, V32, P218; Mayer SA, 2003, STROKE, V34, P224, DOI 10.1161/01.STR.0000046458.67968.E4; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; Roberts HR, 2004, BLOOD, V104, P3858, DOI 10.1182/blood-2004-06-2223; Roberts HR, 2004, SEMIN HEMATOL, V41, P101, DOI 10.1053/j.seminhematol.2003.11.019; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Webert KE, 2007, HAEMOPHILIA, V13, P518, DOI 10.1111/j.1365-2516.2007.01490.x; YANK V, 2010, COMP EFFECTIVENESS R; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004	31	99	104	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					516	522		10.7326/0003-4819-154-8-201104190-00002	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502649	Green Accepted			2022-12-01	WOS:000289622000014
J	Beaglehole, R; Bonita, R; Alleyne, G; Horton, R; Li, LM; Lincoln, P; Mbanya, JC; Mckee, M; Moodie, R; Nishtar, S; Piot, P; Reddy, KS; Stuckler, D				Beaglehole, Robert; Bonita, Ruth; Alleyne, George; Horton, Richard; Li, Liming; Lincoln, Paul; Mbanya, Jean Claude; McKee, Martin; Moodie, Rob; Nishtar, Sania; Piot, Peter; Reddy, K. Srinath; Stuckler, David		Lancet NCD Action Grp	UN High-Level Meeting on Non-Communicable Diseases: addressing four questions	LANCET			English	Article							CARDIOVASCULAR-DISEASE; LOW-INCOME; HEALTH; RISK; BURDEN	Non-communicable diseases (NCDs), principally heart disease, stroke, cancer, diabetes, and chronic respiratory diseases, are a global crisis and require a global response. Despite the threat to human development, and the availability of affordable, cost-effective, and feasible interventions, most countries, development agencies, and foundations neglect the crisis. The UN High-Level Meeting (UN HLM) on NCDs in September, 2011, is an opportunity to stimulate a coordinated global response to NCDs that is commensurate with their health and economic burdens. To achieve the promise of the UN HLM, several questions must be addressed. In this report, we present the realities of the situation by answering four questions: is there really a global crisis of NCDs; how is NCD a development issue; are affordable and cost-effective interventions available; and do we really need high-level leadership and accountability? Action against NCDs will support other global health and development priorities. A successful outcome of the UN HLM depends on the heads of states and governments attending the meeting, and endorsing and implementing the commitments to action. Long-term success requires inspired and committed national and international leadership.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Horton, Richard] The Lancet, London NW1 7BY, England; Peking Union Med Coll, Beijing 100021, Peoples R China; [Lincoln, Paul] Natl Heart Forum, London, England; [Mbanya, Jean Claude] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [McKee, Martin; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Moodie, Rob] Univ Melbourne, Melbourne, Vic, Australia; [Nishtar, Sania] HeartFile, Islamabad, Pakistan; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Stuckler, David] Harvard Univ, Boston, MA 02115 USA	University of Auckland; Pan American Health Organization; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Yaounde I; University of London; London School of Hygiene & Tropical Medicine; University of Melbourne; Public Health Foundation of India; Harvard University	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz	McKee, Marc D/E-2187-2011; Stuckler, David/H-2261-2012; McKee, Martin/E-6673-2018; Mbanya, Jean Claude N/T-5147-2018	McKee, Marc D/0000-0001-8349-965X; McKee, Martin/0000-0002-0121-9683; Moodie, Alan/0000-0002-8425-7975; Reddy, K Srinath/0000-0003-3416-3548; Mbanya, Jean Claude N/0000-0001-9651-8653; Stuckler, David/0000-0002-1288-8401				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2011, 1 GLOB MIN C HLTH LI; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bissell K, 2010, SMOKING CESSATION SM; Blanco F, 2010, AIDS REV, V12, P231; Burki TK, 2011, LANCET, V377, P1559, DOI 10.1016/S0140-6736(11)60626-0; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Donnelly J, 2011, LANCET, V377, P1393, DOI 10.1016/S0140-6736(11)60559-X; Egeland GM, 2010, DIABETIC MED, V27, P257, DOI 10.1111/j.1464-5491.2010.02944.x; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; GLUCKMAN P, 2006, WHY OUR WORLD NO LON; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Lee PT, 2010, LANCET, V376, P516, DOI 10.1016/S0140-6736(10)61254-8; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mahal A., 2010, HLTH NUTR POPUL SER; Manderbacka K, 2011, PHARMACOEPIDEM DR S, V20, P338, DOI 10.1002/pds.2072; MWATSAMA M, 2010, RAISING POLITICAL PR; *NCD ALL, 2010, NONC DIS PRIOR WOM H; *NCD ALL, PROP OUTC STAT UN HI; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Piot Peter, 2010, BMJ, V341, pc4865, DOI 10.1136/bmj.c4865; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Shi WX, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-16; Stahl T., 2006, HLTH ALL POLICIES PR; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; STUCKLER D, SICK SOC RE IN PRESS; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Suhrcke M, 2006, CHRONIC DIS EC PERSP; Suhrcke M, 2007, EC CONSEQUENCES NONC; *UN, 2010, PREV CONTR NONC DIS; *UN, 2001, UN GEN ASS SPEC SESS; WHO, 2011, GLOB STAT REP NONC D; WHO, 2010, MORT BURD DIS EST WH; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Economic Forum, 2011, GLOB RISKS 2011	43	254	269	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					449	455		10.1016/S0140-6736(11)60879-9	http://dx.doi.org/10.1016/S0140-6736(11)60879-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21665266				2022-12-01	WOS:000293615900036
J	Kenfield, SA; Stampfer, MJ; Chan, JM; Giovannucci, E				Kenfield, Stacey A.; Stampfer, Meir J.; Chan, June M.; Giovannucci, Edward			Smoking and Prostate Cancer Survival and Recurrence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CIGARETTE-SMOKING; RADICAL PROSTATECTOMY; UNITED-STATES; HEALTH-PROFESSIONALS; EPITHELIAL-CELLS; MEN; RISK; CADMIUM; RADIOTHERAPY	Context Studies of smoking in relation to prostate cancer mortality or recurrence in prostate cancer patients are limited, with few prostate cancer-specific outcomes. Objective To assess the relation of cigarette smoking and smoking cessation with overall, prostate cancer-specific, and cardiovascular disease (CVD) mortality and biochemical recurrence among men with prostate cancer. Design, Setting, and Participants Prospective observational study of 5366 men diagnosed with prostate cancer between 1986 and 2006 in the Health Professionals Follow-Up Study. Main Outcome Measures Hazard ratios (HRs) for overall, prostate cancer-specific, and CVD mortality, and biochemical recurrence, defined by an increase in prostate-specific antigen (PSA) levels. Results There were 1630 deaths, 524 (32%) due to prostate cancer and 416 (26%) to CVD, and 878 biochemical recurrences. Absolute crude rates for prostate cancer-specific death for never vs current smokers were 9.6 vs 15.3 per 1000 person-years; for all-cause mortality, the corresponding rates were 27.3 and 53.0 per 1000 person-years. In multi-variable analysis, current vs never smokers had an increased risk of prostate cancer mortality (HR, 1.61; 95% confidence interval [CI], 1.11-2.32), as did current smokers with clinical stage T1 through T3 (HR, 1.80; 95% CI, 1.04-3.12). Current smokers also had increased risk of biochemical recurrence (HR, 1.61; 95% CI, 1.16-2.22), total mortality (HR, 2.28; 95% CI, 1.87-2.80), and CVD mortality (HR, 2.13; 95% CI, 1.39-3.26). After adjusting for clinical stage and grade (likely intermediates of the relation of smoking with prostate cancer recurrence and survival), current smokers had increased risk of prostate cancer mortality (HR, 1.38; 95% CI, 0.94-2.03), as did current smokers with clinical stage T1 through T3 (HR, 1.41; 95% CI, 0.80-2.49); they also had an increased risk of biochemical recurrence (HR, 1.47; 95% CI, 1.06-2.04). Greater number of pack-years was associated with significantly increased risk of prostate cancer mortality but not biochemical recurrence. Current smokers of 40 or more pack-years vs never smokers had increased prostate cancer mortality (HR, 1.82; 95% CI, 1.03-3.20) and biochemical recurrence (HR, 1.48; 95% CI, 0.88-2.48). Compared with current smokers, those who had quit smoking for 10 or more years (HR, 0.60; 95% CI, 0.42-0.87) or who have quit for less than 10 years but smoked less than 20 pack-years (HR, 0.64; 95% CI, 0.28-1.45) had prostate cancer mortality risks similar to never smokers (HR, 0.61; 95% CI, 0.42-0.88). Conclusions Smoking at the time of prostate cancer diagnosis is associated with increased overall and CVD mortality and prostate cancer-specific mortality and recurrence. Men who have quit for at least 10 years have prostate cancer-specific mortality risks similar to those who have never smoked. JAMA. 2011;305(24):2548-2555	[Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Channing Labs, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA; [Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kenfield, Stacey A.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chan, June M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chan, June M.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kenfield, SA (corresponding author), Channing Labs, Dept Med, Brigham & Womens Hosp, 181 Longwood Ave,Room 452, Boston, MA 02115 USA.	skenfiel@hsph.harvard.edu		Chan, June/0000-0002-7620-569X	National Institutes of Health [CA055075, CA141298]; NATIONAL CANCER INSTITUTE [R25CA098566, R01CA141298, P01CA055075, R01CA090598, T32CA009001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA055075 and CA141298 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achanzar WE, 2001, CANCER RES, V61, P455; Allen NE, 2002, CANCER CAUSE CONTROL, V13, P353, DOI 10.1023/A:1015238102830; [Anonymous], 2004, HLTH CONS SMOK REP S; Benbrahim-Tallaa L, 2007, PROSTATE, V67, P135, DOI 10.1002/pros.20479; Byrne MM, 2010, CANCER EPIDEMIOL, V34, P611, DOI 10.1016/j.canep.2010.06.017; Chan JM, 1999, CANCER EPIDEM BIOMAR, V8, P893; Chan JM, 2006, CANCER CAUSE CONTROL, V17, P199, DOI 10.1007/s10552-005-0413-4; DANIELL HW, 1995, J UROLOGY, V154, P153, DOI 10.1016/S0022-5347(01)67253-7; Enokida A, 2006, CANCER, V106, P79; Freedland SJ, 2003, UROLOGY, V61, P365, DOI 10.1016/S0090-4295(02)02268-9; Giovannucci E, 1999, CANCER EPIDEM BIOMAR, V8, P277; Giovannucci E, 2007, INT J CANCER, V121, P1571, DOI 10.1002/ijc.22788; Gong ZH, 2008, CANCER CAUSE CONTROL, V19, P25, DOI 10.1007/s10552-007-9066-9; Handa K, 1997, ATHEROSCLEROSIS, V130, P37, DOI 10.1016/S0021-9150(96)06041-8; Hecht SS, 2006, LANGENBECK ARCH SURG, V391, P603, DOI 10.1007/s00423-006-0111-z; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Jager T, 2007, UROLOGE, V46, P397, DOI 10.1007/s00120-006-1252-y; Jain RK, 2001, NAT MED, V7, P775, DOI 10.1038/89889; Joshu CE, 2011, JNCI-J NATL CANCER I, V103, P835, DOI 10.1093/jnci/djr124; Kuban DA, 2006, INT J RADIAT ONCOL, V65, P1487, DOI 10.1016/j.ijrobp.2006.03.027; Kupelian PA, 2002, J CLIN ONCOL, V20, P3376, DOI 10.1200/JCO.2002.01.150; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Merrick GS, 2004, INT J RADIAT ONCOL, V58, P1056, DOI 10.1016/j.ijrobp.2003.08.021; Moreira DM, 2010, UROLOGY, V76, P1218, DOI 10.1016/j.urology.2010.01.066; Nock NL, 2006, CANCER EPIDEM BIOMAR, V15, P756, DOI 10.1158/1055-9965.EPI-05-0826; Oefelein MG, 2004, J UROLOGY, V171, P2281, DOI 10.1097/01.ju.0000125123.46733.93; Pantarotto J, 2007, BJU INT, V99, P564, DOI 10.1111/j.1464-410X.2006.06656.x; Pickles T, 2004, J UROLOGY, V171, P1543, DOI 10.1097/01.ju.0000118292.25214.a4; POUR PM, 1983, CARCINOGENESIS, V4, P49, DOI 10.1093/carcin/4.1.49; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Svartberg J, 2007, INT J ANDROL, V30, P137, DOI 10.1111/j.1365-2605.2006.00720.x; Tamimi R, 2001, EUR J CANCER PREV, V10, P275, DOI 10.1097/00008469-200106000-00012; Villablanca AC, 1998, J APPL PHYSIOL, V84, P2089, DOI 10.1152/jappl.1998.84.6.2089; Vinceti M, 2007, SCI TOTAL ENVIRON, V373, P77, DOI 10.1016/j.scitotenv.2006.11.005; WAALKES MP, 1994, J TOXICOL ENV HEALTH, V43, P251, DOI 10.1080/15287399409531920; Wilson KM, 2011, JNCI-J NATL CANCER I, V103, P876, DOI 10.1093/jnci/djr151; Yu GP, 1997, CANCER DETECT PREV, V21, P497; Zeng XB, 2004, BIOMETALS, V17, P559, DOI 10.1023/B:BIOM.0000045739.89653.67; Zu K, 2009, CANCER CAUSE CONTROL, V20, P1799, DOI 10.1007/s10552-009-9387-y	42	176	178	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2548	2555		10.1001/jama.2011.879	http://dx.doi.org/10.1001/jama.2011.879			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693743	Green Accepted, Bronze			2022-12-01	WOS:000291860400022
J	Rice, C				Rice, Charles			Miles to go before we sleep	NATURE			English	Editorial Material									Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA	Rockefeller University	Rice, C (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	ricec@mail.rockefeller.edu							0	17	17	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S8	S8		10.1038/474S8a	http://dx.doi.org/10.1038/474S8a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666734	Bronze			2022-12-01	WOS:000291397800005
J	Yahia, M				Yahia, Mohammed			A uniquely Egyptian epidemic	NATURE			English	Editorial Material																		El-Zanaty F, 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; KAMEL MA, 1992, LANCET, V340, P427, DOI 10.1016/0140-6736(92)91508-6; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107	4	23	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S12	S13		10.1038/474S12a	http://dx.doi.org/10.1038/474S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666728				2022-12-01	WOS:000291397800008
J	Larson, HJ; Ghinai, I				Larson, Heidi J.; Ghinai, Isaac			Lessons from polio eradication	NATURE			English	Editorial Material									[Larson, Heidi J.; Ghinai, Isaac] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Larson, HJ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1 7HT, England.	heidi.larson@lshtm.ac.uk	Ghinai, Isaac/AAI-7985-2021; Larson, Heidi J./N-1018-2017	Ghinai, Isaac/0000-0003-1322-1331; Larson, Heidi J./0000-0002-8477-7583				Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; Closser S, 2010, CHASING POLIO PAKIST; Donaldson L., 2011, REPORT INDEPENDENT M; Kaufmann JR, 2009, HEALTH AFFAIR, V28, P1091, DOI 10.1377/hlthaff.28.4.1091; Obregon R, 2009, B WORLD HEALTH ORGAN, V87, P624, DOI 10.2471/BLT.08.060863; Taylor S, 2010, J HEALTH COMMUN, V15, P48, DOI 10.1080/10810731003698585; Tebbens RJD, 2010, VACCINE, V29, P334, DOI 10.1016/j.vaccine.2010.10.026; Tool M., 2009, EVALUATION GLOBAL PO; UNICEF Regional Office for South Asia, 2004, EV CHILD COUNTS ENG; Yahya M., 2006, 261 IDS	10	45	47	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					446	447		10.1038/473446a	http://dx.doi.org/10.1038/473446a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	768QM	21614056	Bronze			2022-12-01	WOS:000290951300015
J	Smith, J; Humes, DJ; Spiller, RC				Smith, Janette; Humes, David J.; Spiller, Robin C.			Should we treat uncomplicated symptomatic diverticular disease with fibre?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COLON; PATTERNS		[Spiller, Robin C.] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England; [Smith, Janette; Humes, David J.] Univ Nottingham, Dept Surg, Nottingham NG7 2UH, England; [Spiller, Robin C.] Univ Nottingham, NIHR Biomed Res Ctr, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham	Spiller, RC (corresponding author), Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England.	robin.spiller@nottingham.ac.uk	spiller, robin/ABE-6690-2021	spiller, robin/0000-0001-6371-4500; Humes, David/0000-0002-7071-4098	National Institute for Health Research [CL-2006-12-002, NF-SI-0509-10005] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bijkerk CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3154; BRODRIBB AJM, 1977, LANCET, V1, P664; Clemens CHM, 2004, GUT, V53, P717, DOI 10.1136/gut.2003.018093; CORTESINI C, 1991, DIS COLON RECTUM, V34, P339, DOI 10.1007/BF02050595; Etzioni DA, 2009, ANN SURG, V249, P210, DOI 10.1097/SLA.0b013e3181952888; Humes D, 2011, CLIN EVID, V3, P405; Kang JY, 2011, ALIMENT PHARM THER, V33, P487, DOI 10.1111/j.1365-2036.2010.04540.x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; ORNSTEIN MH, 1981, BRIT MED J, V282, P1353, DOI 10.1136/bmj.282.6273.1353; PAINTER NS, 1982, S AFR MED J, V61, P1016; Rafferty J, 2006, DIS COLON RECTUM, V49, P939, DOI 10.1007/s10350-006-0578-2; Simpson J, 2003, EUR J GASTROEN HEPAT, V15, P1005, DOI 10.1097/00042737-200309000-00011; Simpson J, 2009, NEUROGASTROENT MOTIL, V21, P847, DOI 10.1111/j.1365-2982.2009.01308.x; SNOOK J, 1994, ALIMENT PHARM THERAP, V8, P511; Stollman NH, 1999, AM J GASTROENTEROL, V94, P3110, DOI 10.1111/j.1572-0241.1999.01501.x; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Tursi A, 2010, DIGEST LIVER DIS, V42, P458, DOI 10.1016/j.dld.2009.09.003	17	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2011	342								d2951	10.1136/bmj.d2951	http://dx.doi.org/10.1136/bmj.d2951			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KE	21613363				2022-12-01	WOS:000291154800004
J	Rex, DK				Rex, Douglas K.			Effect of the Centers for Medicare & Medicaid Services Policy About Deep Sedation on Use of Propofol	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OUTPATIENT COLONOSCOPY; ENDOSCOPY; NURSES; GASTROENTEROLOGY	On 11 December 2009, the Centers for Medicare & Medicaid Services issued a policy stating that deep sedation can only be administered by an anesthesiologist, a certified registered nurse anesthetist, or a trained medical doctor or a doctor of osteopathy not involved in the performance of a medical procedure. Propofol is a popular sedation agent that is usually administered by anesthesia specialists in a service termed monitored anesthesia care (MAC). Monitored anesthesia care adds substantial new fees to procedural sedation. However, available evidence shows that propofol can be used safely by nonanesthesiologists for procedural sedation. The American Society of Anesthesiologists considers that propofol implies deep sedation and should only be administered by anesthesia specialists. The Centers for Medicare & Medicaid Services policy on deep sedation can be viewed as supporting an ongoing conversion to MAC to deliver propofol for procedural sedation. However, the absence of an evidence base supporting a need for MAC to deliver propofol, combined with its high cost, suggests that alternatives to MAC to deliver propofol deserve fair and balanced evaluation.	[Rex, Douglas K.] Indiana Univ Hosp, Indianapolis, IN 46202 USA	Indiana University System	Rex, DK (corresponding author), Indiana Univ Hosp, 4100,550 N Univ Blvd, Indianapolis, IN 46202 USA.	drex@iupui.edu						*AM ASS NURS AN FE, 2009, CMS REPL AN INT GUID; *AM MED ASS, 2010, CPT STAND ED 2010, P416; *AM SOC AN, STAT GRANT PRIV NON; *AM SOC AN, POL PROC GOV AN PRIV; American Society of Anesthesiologists, STAT SAF US PROP; Bhananker SM, 2006, ANESTHESIOLOGY, V104, P228, DOI 10.1097/00000542-200602000-00005; Brill Joel V, 2008, Gastrointest Endosc Clin N Am, V18, P665, DOI 10.1016/j.giec.2008.06.012; Byrne MF, 2008, CAN J GASTROENTEROL, V22, P457, DOI 10.1155/2008/268320; Chutkan R, 2004, GASTROINTEST ENDOSC, V60, P167, DOI 10.1016/S0016-5107(04)01699-2; *CMS, CMS PUBL; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9; Cote GA, 2010, CLIN GASTROENTEROL H, V8, P137, DOI 10.1016/j.cgh.2009.07.008; Dumonceau JM, 2010, ENDOSCOPY, V42, P960, DOI 10.1055/s-0030-1255728; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Inadomi JM, 2010, GASTROINTEST ENDOSC, V72, P580, DOI 10.1016/j.gie.2010.04.040; Jain R, 2010, GASTROINTEST ENDOSC, V72, P469, DOI 10.1016/j.gie.2010.02.017; KAYE JM, 2005, SURGISTRATEGIES; Knape JTA, 2007, EUR J ANAESTH, V24, P563, DOI 10.1017/S0265021506002092; Pambianco DJ, 2011, GASTROINTEST ENDOSC, V73, P765, DOI 10.1016/j.gie.2010.10.031; Patel S, 2005, AM J GASTROENTEROL, V100, P2689, DOI 10.1111/j.1572-0241.2005.00320.x; Rex DK, 2009, GASTROENTEROLOGY, V137, P1229, DOI 10.1053/j.gastro.2009.06.042; Riphaus A, 2009, ENDOSCOPY, V41, P787, DOI 10.1055/s-0029-1215035; Sharma VK, 2007, GASTROINTEST ENDOSC, V66, P27, DOI 10.1016/j.gie.2006.12.040; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; Symington L, 2006, EMERG MED J, V23, P89, DOI 10.1136/emj.2005.023713; Ulmer BJ, 2003, CLIN GASTROENTEROL H, V1, P425, DOI 10.1016/S1542-3565(03)00226-X; VanNatta ME, 2006, AM J GASTROENTEROL, V101, P2209, DOI 10.1111/j.1572-0241.2006.00760.x; Vargo JJ, 2009, GASTROENTEROLOGY, V137, P2161, DOI 10.1053/j.gastro.2009.09.050	29	36	36	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					622	626		10.7326/0003-4819-154-9-201105030-00007	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536938				2022-12-01	WOS:000290112300005
J	Kinross, JM; Holmes, E; Darzi, AW; Nicholson, JK				Kinross, James M.; Holmes, Elaine; Darzi, Ara W.; Nicholson, Jeremy K.			Metabolic phenotyping for monitoring surgical patients	LANCET			English	Editorial Material							IDENTIFICATION		[Holmes, Elaine; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Sect Biomol Med, London SW7 2AZ, England; [Kinross, James M.; Darzi, Ara W.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Sect Biosurg & Surg Technol, London SW7 2AZ, England	Imperial College London; Imperial College London	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Sect Biomol Med, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk	Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020; Nicholson, Jeremy K/B-3395-2012	Holmes, Elaine/0000-0002-0556-8389; Nicholson, Jeremy K/0000-0002-8123-8349; Kinross, James/0000-0002-0427-7643				[Anonymous], 2010, LANCET, V376, P1025, DOI 10.1016/S0140-6736(10)61466-3; Balog J, 2010, ANAL CHEM, V82, P7343, DOI 10.1021/ac101283x; Can MF, 2008, WORLD J SURG, V32, P589, DOI 10.1007/s00268-007-9321-y; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Garcia-Miguel FJ, 2003, LANCET, V362, P1749, DOI 10.1016/S0140-6736(03)14857-X; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Kinross JM, 2011, J PROTEOME RES, V10, P277, DOI 10.1021/pr1003278; Lindon JC, 2008, TRAC-TREND ANAL CHEM, V27, P194, DOI 10.1016/j.trac.2007.08.009; Miura D, 2010, ANAL CHEM, V82, P9789, DOI 10.1021/ac101998z; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a	13	64	68	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2011	377	9780					1817	1819		10.1016/S0140-6736(11)60171-2	http://dx.doi.org/10.1016/S0140-6736(11)60171-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774UI	21596428				2022-12-01	WOS:000291411700009
J	Peralta, CA; Shlipak, MG; Judd, S; Cushman, M; McClellan, W; Zakai, NA; Safford, MM; Zhang, XA; Muntner, P; Warnock, D				Peralta, Carmen A.; Shlipak, Michael G.; Judd, Suzanne; Cushman, Mary; McClellan, William; Zakai, Neil A.; Safford, Monika M.; Zhang, Xiao; Muntner, Paul; Warnock, David			Detection of Chronic Kidney Disease With Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association With Progression to End-Stage Renal Disease and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; RACIAL-DIFFERENCES; CARDIOVASCULAR EVENTS; US ADULTS; ALL-CAUSE; REASONS; STROKE; RISK; GFR; POPULATION	Context A triple-marker approach for chronic kidney disease (CKD) evaluation has not been well studied. Objective To evaluate whether combining creatinine, cystatin C, and urine albumin-to-creatinine ratio (ACR) would improve identification of risks associated with CKD compared with creatinine alone. Design, Setting, and Participants Prospective cohort study involving 26 643 US adults enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study from January 2003 to June 2010. Participants were categorized into 8 groups defined by estimated glomerular filtration rate (GFR) determined by creatinine and by cystatin C of either <60 or >= 60 mL/min/1.73 m(2) and ACR of either <30 or >= 30 mg/g. Main Outcome Measures All-cause mortality and incident end-stage renal disease with median follow-up of 4.6 years. Results Participants had a mean age of 65 years, 40% were black, and 54% were women. Of 26 643 participants, 1940 died and 177 developed end-stage renal disease. Among participants without CKD defined by creatinine, 24% did not have CKD by either ACR or cystatin C. Compared with those with CKD defined by creatinine alone, the hazard ratio for death in multivariable-adjusted models was 3.3 (95% confidence interval [CI], 2.0-5.6) for participants with CKD defined by creatinine and ACR; 3.2 (95% CI, 2.2-4.7) for those with CKD defined by creatinine and cystatin C, and 5.6 (95% CI, 3.9-8.2) for those with CKD defined by all biomarkers. Among participants without CKD defined by creatinine, 3863 (16%) had CKD detected by ACR or cystatin C. Compared with participants who did not have CKD by any measure, the HRs for mortality were 1.7 (95% CI, 1.4-1.9) for participants with CKD defined by ACR alone, 2.2 (95% CI, 1.9-2.7) for participants with CKD defined by cystatin C alone, and 3.0 (95% CI, 2.4-3.7) for participants with CKD defined by both measures. Risk of incident end-stage renal disease was higher among those with CKD defined by all markers (34.1 per 1000 person-years; 95% CI, 28.7-40.5 vs 0.33 per 1000 person-years; 95% CI, 0.05-2.3) for those with CKD defined by creatinine alone. The second highest end-stage renal disease rate was among persons missed by the creatinine measure but detected by both ACR and cystatin C (rate per 1000 person-years, 6.4; 95% CI, 3.6-11.3). Net reclassification improvement for death was 13.3% (P<.001) and for end-stage renal disease was 6.4% (P<.001) after adding estimated GFR cystatin C in fully adjusted models with estimated GFR creatinine and ACR. Conclusion Adding cystatin C to the combination of creatinine and ACR measures improved the predictive accuracy for all-cause mortality and end-stage renal disease.	[Peralta, Carmen A.; Shlipak, Michael G.] San Francisco VA Med Ctr, Dept Med, San Francisco, CA USA; [Peralta, Carmen A.; Shlipak, Michael G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Judd, Suzanne; Zhang, Xiao] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL USA; [Muntner, Paul] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA; [Safford, Monika M.; Warnock, David] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Cushman, Mary; Zakai, Neil A.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [McClellan, William] Emory Univ, Dept Med, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Vermont; University of Vermont; Emory University	Peralta, CA (corresponding author), 4150 Clement St,111A1, San Francisco, CA 94121 USA.	carmenalicia.peralta@ucsf.edu		Cushman, Mary/0000-0002-7871-6143	Amgen; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; Amgen Corp.; National Institutes of Diabetes and Digestive and Kidney Diseases [1K23SK082793-01]; Robert Wood Johnson Harold Amos award; American Heart Association [0640012N];  [R01AG034853];  [R01DK066488];  [R01HL085757];  [R01DK078124];  [R21HL091217]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080477, R01HL085757, R21HL091217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066488, R01DK078124, K23DK082793, R03DK095877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034853] Funding Source: NIH RePORTER	Amgen(Amgen); National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amgen Corp.; National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Robert Wood Johnson Harold Amos award; American Heart Association(American Heart Association); ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Warnock reported that he is a consultant for Amgen Corp and has received research support from Amgen. Dr Cushman reported receiving research support from Amgen. Dr McClellen reported receiving research support from Amgen. Otherwise, no other conflicts of interest were reported.; This research project is supported by cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services. Additional funding was provided by an investigator-initiated grant-in-aid from Amgen Corp. Dr Peralta is funded by the National Institutes of Diabetes and Digestive and Kidney Diseases grant 1K23SK082793-01 and a Robert Wood Johnson Harold Amos award. Dr Shlipak is funded by grants R01AG034853 (PI), R01DK066488 (PI), R01HL085757 (Co-Investigator), R01DK078124 (Co-Investigator), and R21HL091217 (Co-Investigator) and by an American Heart Association Established Investigator Award (0640012N; PI)	Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Bauer C, 2008, J AM SOC NEPHROL, V19, P844, DOI 10.1681/ASN.2008010110; Couser WG, 2007, J AM SOC NEPHROL, V18, P2803, DOI 10.1681/ASN.2007080964; de Jong PE, 2008, NEPHROL DIAL TRANSPL, V23, P1092, DOI 10.1093/ndt/gfn028; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P965, DOI 10.2215/CJN.05281008; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Jaar BG, 2008, CLIN J AM SOC NEPHRO, V3, P601, DOI 10.2215/CJN.02540607; Kwong YT, 2010, AM J KIDNEY DIS, V56, P39, DOI 10.1053/j.ajkd.2010.02.347; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, AM J KIDNEY DIS, V53, pS4, DOI 10.1053/j.ajkd.2008.07.048; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; Menon V, 2008, KIDNEY INT, V73, P1310, DOI 10.1038/ki.2008.67; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2006, ANN INTERN MED, V145, P237, DOI 10.7326/0003-4819-145-4-200608150-00003; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; Warnock DG, 2010, AM J KIDNEY DIS, V56, P861, DOI 10.1053/j.ajkd.2010.05.017; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	32	318	328	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1545	1552		10.1001/jama.2011.468	http://dx.doi.org/10.1001/jama.2011.468			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21482744	Green Accepted, Bronze			2022-12-01	WOS:000289683000023
J	Himler, AG; Adachi-Hagimori, T; Bergen, JE; Kozuch, A; Kelly, SE; Tabashnik, BE; Chiel, E; Duckworth, VE; Dennehy, TJ; Zchori-Fein, E; Hunter, MS				Himler, Anna G.; Adachi-Hagimori, Tetsuya; Bergen, Jacqueline E.; Kozuch, Amaranta; Kelly, Suzanne E.; Tabashnik, Bruce E.; Chiel, Elad; Duckworth, Victoria E.; Dennehy, Timothy J.; Zchori-Fein, Einat; Hunter, Martha S.			Rapid Spread of a Bacterial Symbiont in an Invasive Whitefly Is Driven by Fitness Benefits and Female Bias	SCIENCE			English	Article							BEMISIA-TABACI; HEMIPTERA ALEYRODIDAE; AEDES-AEGYPTI; INFECTION; WOLBACHIA; RICKETTSIA; POPULATIONS; DROSOPHILA; DIVERSITY; INCOMPATIBILITY	Maternally inherited bacterial symbionts of arthropods are common, yet symbiont invasions of host populations have rarely been observed. Here, we show that Rickettsia sp. nr. bellii swept into a population of an invasive agricultural pest, the sweet potato whitefly, Bemisia tabaci, in just 6 years. Compared with uninfected whiteflies, Rickettsia-infected whiteflies produced more offspring, had higher survival to adulthood, developed faster, and produced a higher proportion of daughters. The symbiont thus functions as both mutualist and reproductive manipulator. The observed increased performance and sex-ratio bias of infected whiteflies are sufficient to explain the spread of Rickettsia across the southwestern United States. Symbiont invasions such as this represent a sudden evolutionary shift for the host, with potentially large impacts on its ecology and invasiveness.	[Himler, Anna G.; Adachi-Hagimori, Tetsuya; Bergen, Jacqueline E.; Kozuch, Amaranta; Kelly, Suzanne E.; Tabashnik, Bruce E.; Chiel, Elad; Duckworth, Victoria E.; Dennehy, Timothy J.; Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Himler, Anna G.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Chiel, Elad; Zchori-Fein, Einat] Agr Res Org, Newe Yaar Res Ctr, Entomol Lab, IL-30095 Ramat Yishay, Israel; [Adachi-Hagimori, Tetsuya] Osaka Prefectural Govt, Res Inst Environm Agr & Fisheries, Osaka 5830862, Japan; [Dennehy, Timothy J.] Bayer Crop Sci Ltd Partnership, Global Insecticide Resistance Management, Res Triangle Pk, NC 27709 USA	University of Arizona; University of Arizona; Bayer AG; Bayer CropScience	Hunter, MS (corresponding author), Univ Arizona, Dept Entomol, Forbes 410, Tucson, AZ 85721 USA.	mhunter@ag.arizona.edu	Hunter, Martha/B-7307-2012; Hunter, Martha/AAF-5288-2020	Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; Chiel, Elad/0000-0002-7146-3219	NIH [1K 12 GM00708]; United States-Israel Binational Agricultural Research and Development fellowship [GS-1-2007]; Binational (US-Israel) Science Foundation [2004416]; U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service [2006-35302-17165]; NSF [DEB-1020460]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development fellowship; Binational (US-Israel) Science Foundation(US-Israel Binational Science Foundation); U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kim, N. Doidge, N. Dowdy, and J. Garcia for technical help and V. Corby-Harris and M. Torabi for advice on analyses. We are grateful to K. Oliver for helpful comments on an earlier version of the manuscript. A. G. H. was funded by NIH training grant 1K 12 GM00708, and E. C. was funded in part by the United States-Israel Binational Agricultural Research and Development fellowship (GS-1-2007). This research was supported by Binational (US-Israel) Science Foundation grant 2004416 and U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service grant 2006-35302-17165 to M. S. H. and E.Z.-F. and NSF grant DEB-1020460 to M. S. H. and A. G. H. Sequences have been deposited in GenBank under accession numbers HQ439024 to HQ439027, HQ997365, and JF288560.	Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; Behar A, 2010, APPL ENVIRON MICROB, V76, P2280, DOI 10.1128/AEM.00026-10; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, ANN ENTOMOL SOC AM, V102, P413, DOI 10.1603/008.102.0309; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dobson SL, 2002, GENETICS, V160, P1087; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; Goodacre SL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-32; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1994, GENETICS, V136, P993; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Palumbo JC, 2001, CROP PROT, V20, P739, DOI 10.1016/S0261-2194(01)00117-X; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Schulenburg JHGV, 2002, GENETICS, V160, P1075; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	30	331	366	6	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					254	256		10.1126/science.1199410	http://dx.doi.org/10.1126/science.1199410			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474763				2022-12-01	WOS:000289251100057
J	Staton, TL; Lazarevic, V; Jones, DC; Lanser, AJ; Takagi, T; Ishii, S; Glimcher, LH				Staton, Tracy L.; Lazarevic, Vanja; Jones, Dallas C.; Lanser, Amanda J.; Takagi, Tsuyoshi; Ishii, Shunsuke; Glimcher, Laurie H.			Dampening of death pathways by schnurri-2 is essential for T-cell development	NATURE			English	Article							NEGATIVE SELECTION; POSITIVE SELECTION; THYMOCYTE DEVELOPMENT; BH3-ONLY PROTEINS; MURINE SCHNURRI-2; TRANSGENIC MICE; BCL-2 FAMILY; APOPTOSIS; ANTIGEN; BIM	Generation of a diverse and self-tolerant T-cell repertoire requires appropriate interpretation of T-cell antigen receptor (TCR) signals by CD4(+)CD8(+) double-positive thymocytes. Thymocyte cell fate is dictated by the nature of TCR-major-histocompatibility-complex (MHC)-peptide interactions, with signals of higher strength leading to death (negative selection) and signals of intermediate strength leading to differentiation (positive selection)(1). Molecules that regulate T-cell development by modulating TCR signal strength have been described but components that specifically define the boundaries between positive and negative selection remain unknown. Here we show in mice that repression of TCR-induced death pathways is critical for proper interpretation of positive selecting signals in vivo, and identify schnurri-2 (Shn2; also known as Hivep2) as a crucial death dampener. Our results indicate that Shn2(-/-) double-positive thymocytes inappropriately undergo negative selection in response to positive selecting signals, thus leading to disrupted T-cell development. Shn2(-/-) double-positive thymocytes are more sensitive to TCR-induced death in vitro and die in response to positive selection interactions in vivo. However, Shn2-deficient thymocytes can be positively selected when TCR-induced death is genetically ablated. Shn2 levels increase after TCR stimulation, indicating that integration of multiple TCR-MHC-peptide interactions may fine-tune the death threshold. Mechanistically, Shn2 functions downstream of TCR proximal signalling compenents to dampen Bax activation and the mitochondrial death pathway. Our findings uncover a critical regulator of T-cell development that controls the balance between death and differentiation.	[Staton, Tracy L.; Lazarevic, Vanja; Jones, Dallas C.; Lanser, Amanda J.; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Takagi, Tsuyoshi; Ishii, Shunsuke] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Glimcher, Laurie H.] Ragon Inst MGH MIT & Harvard, Charlestown, MA 02129 USA	Harvard University; Harvard T.H. Chan School of Public Health; RIKEN; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu	Lazarevic, Vanja/B-1160-2009; Ishii, Shunsuke/A-5271-2016	Ishii, Shunsuke/0000-0002-6530-2478; Lazarevic, Vanja/0000-0002-5783-7130	National Institutes of Health [AI29673, K99AR055668]; NATIONAL CANCER INSTITUTE [ZIABC011431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029673, T32AI007290, R01AI029673, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR055668] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23370079, 23659244] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank R. Davis for providing Bim phospho-Thr-112 specific antibody; R. Germain for providing DAP3 and P139 cell lines; M. Winslow and E. Gallo for critical reading of the manuscript and valuable comments. T.L.S. is a Fellow of the Leukemia and Lymphoma Society and V.L. was a Fellow of the Irvington Institute. Supported by the National Institutes of Health grant AI29673 (L.H.G.) and K99AR055668 (D.C.J.).	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Cainan B. J., 1995, IMMUNITY, V3, P273, DOI DOI 10.1016/1074-7613(95)90113-2; Cante-Barrett K, 2006, J IMMUNOL, V176, P2299, DOI 10.4049/jimmunol.176.4.2299; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; GLIMCHER LH, 1982, NATURE, V298, P283, DOI 10.1038/298283a0; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kimura MY, 2007, J IMMUNOL, V178, P4926, DOI 10.4049/jimmunol.178.8.4926; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001	30	31	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					105	U138		10.1038/nature09848	http://dx.doi.org/10.1038/nature09848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475200	Green Accepted			2022-12-01	WOS:000289199400046
J	Horton, R; Dos, P				Horton, Richard; Dos, Pamela			The vaccine paradox	LANCET			English	Editorial Material							IMMUNIZATION; INITIATIVES; PROGRESS		[Horton, Richard; Dos, Pamela] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Clemens J, 2010, NAT IMMUNOL, V11, P1069, DOI 10.1038/ni1210-1069; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3	4	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					296	298		10.1016/S0140-6736(11)60765-4	http://dx.doi.org/10.1016/S0140-6736(11)60765-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21664684				2022-12-01	WOS:000293615800007
J	Neunuebel, MR; Chen, Y; Gaspar, AH; Backlund, PS; Yergey, A; Machner, MP				Neunuebel, M. Ramona; Chen, Yang; Gaspar, Andrew H.; Backlund, Peter S., Jr.; Yergey, Alfred; Machner, Matthias P.			De-AMPylation of the Small GTPase Rab1 by the Pathogen Legionella pneumophila	SCIENCE			English	Article							EFFECTOR PROTEIN DRRA; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; BINDING; SYSTEM; MUTANTS	The bacterial pathogen Legionella pneumophila exploits host cell vesicle transport by transiently manipulating the activity of the small guanosine triphosphatase (GTPase) Rab1. The effector protein SidM recruits Rab1 to the Legionella-containing vacuole (LCV), where it activates Rab1 and then AMPylates it by covalently adding adenosine monophosphate (AMP). L. pneumophila GTPase-activating protein LepB inactivates Rab1 before its removal from LCVs. Because LepB cannot bind AMPylated Rab1, the molecular events leading to Rab1 inactivation are unknown. We found that the effector protein SidD from L. pneumophila catalyzed AMP release from Rab1, generating de-AMPylated Rab1 accessible for inactivation by LepB. L. pneumophila mutants lacking SidD were defective for Rab1 removal from LCVs, identifying SidD as the missing link connecting the processes of early Rab1 accumulation and subsequent Rab1 removal during infection.	[Neunuebel, M. Ramona; Chen, Yang; Gaspar, Andrew H.; Machner, Matthias P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Backlund, Peter S., Jr.; Yergey, Alfred] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biomed Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA; [Chen, Yang] Peking Univ, Ctr Hlth Sci, Beijing 100191, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Peking University	Machner, MP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	machnerm@mail.nih.gov	Machner, Matthias/G-2758-2015	Machner, Matthias/0000-0002-6971-7451	NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD001421, ZIAHD008893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank G. Storz, S. Gottesman, J. Bonifacino, J. Neunuebel, and M. Barzik for critical reading and insightful discussion and R. Isberg and V. Losick for kindly providing reagents. This work was supported by the Intramural Research Program of the NIH.	ANDERSON WB, 1970, BIOCHEM BIOPH RES CO, V41, P704, DOI 10.1016/0006-291X(70)90070-7; BACON RA, 1989, J CELL BIOL, V109, P1015, DOI 10.1083/jcb.109.3.1015; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; MANTEL M, 1970, P NATL ACAD SCI USA, V65, P660, DOI 10.1073/pnas.65.3.660; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	20	161	167	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					453	456		10.1126/science.1207193	http://dx.doi.org/10.1126/science.1207193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21680813	Green Accepted			2022-12-01	WOS:000292959600046
J	Ceccarelli, DF; Tang, XJ; Pelletier, B; Orlicky, S; Xie, WL; Plantevin, V; Neculai, D; Chou, YC; Ogunjimi, A; Al-Hakim, A; Varelas, X; Koszela, J; Wasney, GA; Vedadi, M; Dhe-Paganon, S; Cox, S; Xu, SC; Lopez-Girona, A; Mercurio, F; Wrana, J; Durocher, D; Meloche, S; Webb, DR; Tyers, M; Sicheri, F				Ceccarelli, Derek F.; Tang, Xiaojing; Pelletier, Benoit; Orlicky, Stephen; Xie, Weilin; Plantevin, Veronique; Neculai, Dante; Chou, Yang-Chieh; Ogunjimi, Abiodun; Al-Hakim, Abdallah; Varelas, Xaralabos; Koszela, Joanna; Wasney, Gregory A.; Vedadi, Masoud; Dhe-Paganon, Sirano; Cox, Sarah; Xu, Shuichan; Lopez-Girona, Antonia; Mercurio, Frank; Wrana, Jeff; Durocher, Daniel; Meloche, Sylvain; Webb, David R.; Tyers, Mike; Sicheri, Frank			An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme	CELL			English	Article							F-BOX PROTEINS; CELL-DIVISION; LIGASE; ACTIVATION; SUBSTRATE; E2; PROTEOLYSIS; P27(KIP1); COMPLEX; E3	In the ubiquitin-proteasome system (UPS), E2 enzymes mediate the conjugation of ubiquitin to substrates and thereby control protein stability and interactions. The E2 enzyme hCdc34 catalyzes the ubiquitination of hundreds of proteins in conjunction with the cullin-RING (CRL) superfamily of E3 enzymes. We identified a small molecule termed CC0651 that selectively inhibits hCdc34. Structure determination revealed that CC0651 inserts into a cryptic binding pocket on hCdc34 distant from the catalytic site, causing subtle but wholesale displacement of E2 secondary structural elements. CC0651 analogs inhibited proliferation of human cancer cell lines and caused accumulation of the SCFSkp2 substrate p27(Kip1). CC0651 does not affect hCdc34 interactions with E1 or E3 enzymes or the formation of the ubiquitin thioester but instead interferes with the discharge of ubiquitin to acceptor lysine residues. E2 enzymes are thus susceptible to noncatalytic site inhibition and may represent a viable class of drug target in the UPS.	[Xie, Weilin; Plantevin, Veronique; Cox, Sarah; Xu, Shuichan; Lopez-Girona, Antonia; Mercurio, Frank; Webb, David R.] Celgene Signal Res Div, San Diego, CA 92121 USA; [Ceccarelli, Derek F.; Tang, Xiaojing; Orlicky, Stephen; Neculai, Dante; Chou, Yang-Chieh; Ogunjimi, Abiodun; Al-Hakim, Abdallah; Varelas, Xaralabos; Wrana, Jeff; Durocher, Daniel; Tyers, Mike; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Meloche, Sylvain] Univ Montreal, Program Mol Biol, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Neculai, Dante; Wasney, Gregory A.; Vedadi, Masoud; Dhe-Paganon, Sirano] Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Koszela, Joanna; Tyers, Mike] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Tyers, Mike; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pelletier, Benoit; Meloche, Sylvain] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Universite de Montreal; Universite de Montreal; University of Toronto; Structural Genomics Consortium; University of Edinburgh; University of Toronto; Universite de Montreal	Webb, DR (corresponding author), Celgene Signal Res Div, 4550 Towne Ctr Court, San Diego, CA 92121 USA.	dwebb@celgene.com; m.tyers@ed.ac.uk; sicheri@lunenfeld.ca	Sicheri, Frank/F-8856-2013; Wrana, Jeffrey/F-8857-2013; Durocher, Daniel/A-7733-2010; Neculai, Dante/A-9923-2011; Varelas, Xaralabos/ABB-9141-2020; Tyers, Michael/ABE-3194-2021; Neculai, Dante/M-2884-2013	Durocher, Daniel/0000-0003-3863-8635; Neculai, Dante/0000-0001-8887-9168; Orlicky, Stephen/0000-0002-8172-2042; Varelas, Xaralabos/0000-0002-2882-4541; Ceccarelli, Derek/0000-0002-2674-9234	National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. Department of Energy [DE-AC02-06CH11357]; Canadian Institutes of Health Research [MOP-57795, MOP-14339, MOP-14168]; National Cancer Institute of Canada; Canada Research Chair in Cellular Signaling; Research Chair of the Scottish Universities Life Sciences Alliance; Royal Society; Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chair in Cellular Signaling; Research Chair of the Scottish Universities Life Sciences Alliance; Royal Society(Royal Society of London); Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Jean O'Donoghue and Ted Hupp for cell culture advice, Michele Pagano for SCF reagents, and Thimo Kurz for MLN4924. We also thank I. Kourinov and staff at Argonne National Laboratory for assistance with micro-diffraction experiments at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, as supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health and contract DE-AC02-06CH11357 from the U.S. Department of Energy. This work was supported by grants to F. S., M. T., J.W., and S. M. from the Canadian Institutes of Health Research (MOP-57795, MOP-14339, and MOP-14168). B. P. is recipient of a fellowship from the National Cancer Institute of Canada. S. M. is supported by a Canada Research Chair in Cellular Signaling, M. T. by a Research Chair of the Scottish Universities Life Sciences Alliance and a Royal Society Wolfson Research Merit Award, and F. S. by a Canada Research Chair in Structural Biology.	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Butz N, 2005, EXP CELL RES, V303, P482, DOI 10.1016/j.yexcr.2004.10.008; Chauhan D, 2004, ONCOGENE, V23, P3597, DOI 10.1038/sj.onc.1207458; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eliseeva E, 2001, CELL GROWTH DIFFER, V12, P427; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	52	163	170	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1075	1087		10.1016/j.cell.2011.05.039	http://dx.doi.org/10.1016/j.cell.2011.05.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21683433	Bronze			2022-12-01	WOS:000292025700014
J	Gheorghiade, M; Peterson, ED				Gheorghiade, Mihai; Peterson, Eric D.			Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT		[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Northwestern University; Feinberg School of Medicine; Duke University	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Peterson, Eric David/ABF-5033-2021					Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Dunlay SM, 2010, EUR J HEART FAIL, V12, P367, DOI 10.1093/eurjhf/hfq019; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Fonarow GC, 2011, CIRCULATION, V123, P1601, DOI 10.1161/CIRCULATIONAHA.110.989632; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Gheorghiade M, 2009, JAMA-J AM MED ASSOC, V302, P2146, DOI 10.1001/jama.2009.1657; Metra M, 2010, CIRCULATION, V122, P1782, DOI 10.1161/CIRCULATIONAHA.110.982207; Pang PS, 2010, EUR HEART J, V31, P784, DOI 10.1093/eurheartj/ehq040; Shah SJ, 2008, JAMA-J AM MED ASSOC, V300, P431, DOI 10.1001/jama.300.4.431	10	34	35	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2456	2457		10.1001/jama.2011.836	http://dx.doi.org/10.1001/jama.2011.836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673297				2022-12-01	WOS:000291597300026
J	Rabbani, P; Takeo, M; Chou, WC; Myung, P; Bosenberg, M; Chin, L; Taketo, MM; Ito, M				Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Myung, Peggy; Bosenberg, Marcus; Chin, Lynda; Taketo, M. Mark; Ito, Mayumi			Coordinated Activation of Wnt in Epithelial and Melanocyte Stem Cells Initiates Pigmented Hair Regeneration	CELL			English	Article							BETA-CATENIN; NEURAL CREST; FOLLICLE MORPHOGENESIS; TRANSCRIPTION FACTOR; SKIN; GROWTH; DIFFERENTIATION; EXPRESSION; NICHE; CYCLE	Melanocyte stem cells (McSCs) intimately interact with epithelial stem cells (EpSCs) in the hair follicle bulge and secondary hair germ (sHG). Together, they undergo activation and differentiation to regenerate pigmented hair. However, the mechanisms behind this coordinated stem cell behavior have not been elucidated. Here, we identified Wnt signaling as a key pathway that couples the behavior of the two stem cells. EpSCs and McSCs coordinately activate Wnt signaling at the onset of hair follicle regeneration within the sHG. Using genetic mouse models that specifically target either EpSCs or McSCs, we show that Wnt activation in McSCs drives their differentiation into pigment-producing melanocytes, while EpSC Wnt signaling not only dictates hair follicle formation but also regulates McSC proliferation during hair regeneration. Our data define a role for Wnt signaling in the regulation of McSCs and also illustrate a mechanism for regeneration of complex organs through collaboration between heterotypic stem cell populations.	[Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Ito, Mayumi] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA; [Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Ito, Mayumi] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Myung, Peggy] Univ Hosp Case Western Reserve, Dept Dermatol, Cleveland, OH USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Taketo, M. Mark] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Kyoto 6068501, Japan	New York University; New York University; Case Western Reserve University; Yale University; Harvard University; Dana-Farber Cancer Institute; Kyoto University	Ito, M (corresponding author), NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA.	mayumi.ito@nyumc.org		Takeo, Makoto/0000-0002-5597-5994; Rabbani, Piul/0000-0001-8302-8225	Department of Dermatology; Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU); Dermatology Foundation; Ellison Medical Foundation; Yan Deng; Microscopy Core of NYU [NCRR S10 RR023704-01A1, NCRR S10 RR024708]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023704, S10RR024708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059768] Funding Source: NIH RePORTER	Department of Dermatology; Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU); Dermatology Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Yan Deng; Microscopy Core of NYU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank funds from the Department of Dermatology and the Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU), the Dermatology Foundation Career Development Award, and the New Scholar Award in aging from the Ellison Medical Foundation to M.I. We thank Tung-Tien Sun for critical reading of the manuscript. We thank Seth Orlow and Prashiela Manga for providing Melan-a cells and helpful advice. We thank our mentors George Cotsarelis and Sarah Millar for their helpful advice and constant encouragement. We thank Radhika Atit for her input and collaboration for this work. We thank Yan Deng and the Microscopy Core of NYU for use of confocal microscopes (grants NCRR S10 RR023704-01A1 and NCRR S10 RR024708).	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Brault V, 2001, DEVELOPMENT, V128, P1253; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; DORAN TI, 1980, CELL, V22, P17, DOI 10.1016/0092-8674(80)90150-6; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kim TH, 2005, ONCOGENE, V24, P597, DOI 10.1038/sj.onc.1208237; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Sharov A, 2005, J INVEST DERMATOL, V125, P1259, DOI 10.1111/j.0022-202X.2005.23959.x; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459	58	204	226	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					941	955		10.1016/j.cell.2011.05.004	http://dx.doi.org/10.1016/j.cell.2011.05.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663796	Green Accepted, Bronze			2022-12-01	WOS:000291461600020
J	Siegel, M				Siegel, Michael			A Lost Opportunity for Public Health - The FDA Advisory Committee Report on Menthol	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA	Boston University	Siegel, M (corresponding author), Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA.			Siegel, Michael/0000-0002-2573-9616				MULLINS B, 2004, ROLL CALL       1005; SIEGEL M, 2007, REST STORY TOBACCO N; Tobacco Products Scientific Advisory Committee, 2011, MENTH CIG PUBL HLTH; Young A., 2008, ATLANTA J CONST 0529	4	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2177	2179		10.1056/NEJMp1103403	http://dx.doi.org/10.1056/NEJMp1103403			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21542736				2022-12-01	WOS:000291392100001
J	Reulen, RC; Frobisher, C; Winter, DL; Kelly, J; Lancashire, ER; Stiller, CA; Pritchard-Jones, K; Jenkinson, HC; Hawkins, MM				Reulen, Raoul C.; Frobisher, Clare; Winter, David L.; Kelly, Julie; Lancashire, Emma R.; Stiller, Charles A.; Pritchard-Jones, Kathryn; Jenkinson, Helen C.; Hawkins, Michael M.		British Childhood Canc Survivor St	Long-term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND MALIGNANT NEOPLASMS; COLORECTAL-CANCER; REGRESSION-MODELS; RELATIVE SURVIVAL; 5-YEAR SURVIVORS; FAMILY-HISTORY; SURVEILLANCE; METAANALYSIS; GUIDELINES; MORTALITY	Context Survivors of childhood cancer are at excess risk of developing subsequent primary neoplasms but the long-term risks are uncertain. Objectives To investigate long-term risks of subsequent primary neoplasms in survivors of childhood cancer, to identify the types that contribute most to long-term excess risk, and to identify subgroups of survivors at substantially increased risk of particular subsequent primary neoplasms that may require specific interventions. Design, Setting, and Participants British Childhood Cancer Survivor Study-a population-based cohort of 17 981 5-year survivors of childhood cancer diagnosed with cancer at younger than 15 years between 1940 and 1991 in Great Britain, followed up through December 2006. Main Outcome Measures Standardized incidence ratios (SIRs), absolute excess risks (AERs), and cumulative incidence of subsequent primary neoplasms. Results After a median follow-up time of 24.3 years (mean=25.6 years), 1354 subsequent primary neoplasms were ascertained; the most frequently observed being central nervous system (n=344), nonmelanoma skin cancer (n=278), digestive (n=105), genitourinary (n=100), breast (n=97), and bone (n=94). The overall SIR was 4 times more than expected (SIR, 3.9; 95% confidence interval [CI], 3.6-4.2; AER, 16.8 per 10 000 person-years). The AER at older than 40 years was highest for digestive and genitourinary subsequent primary neoplasms (AER, 5.9 [95% CI, 2.5-9.3]; and AER, 6.0 [95% CI, 2.3-9.6] per 10 000 person-years, respectively); 36% of the total AER was attributable to these 2 subsequent primary neoplasm sites. The cumulative incidence of colorectal cancer for survivors treated with direct abdominopelvic irradiation was 1.4% (95% CI, 0.7%-2.6%) by age 50 years, comparable with the 1.2% risk in individuals with at least 2 first-degree relatives affected by colorectal cancer. Conclusion Among a cohort of British childhood cancer survivors, the greatest excess risk associated with subsequent primary neoplasms at older than 40 years was for digestive and genitourinary neoplasms. JAMA. 2011;305(22):2311-2319 www.jama.com	[Reulen, Raoul C.; Frobisher, Clare; Winter, David L.; Kelly, Julie; Lancashire, Emma R.; Hawkins, Michael M.] Univ Birmingham, Sch Hlth & Populat Sci, Ctr Childhood Canc Survivor Studies, Birmingham B15 2TT, W Midlands, England; [Stiller, Charles A.] Univ Oxford, Childhood Canc Res Grp, Oxford, England; [Pritchard-Jones, Kathryn] Inst Canc Res, Dept Paediat Oncol, Surrey, England; [Jenkinson, Helen C.] Birmingham Childrens Hosp NHS Fdn Trust, Dept Paediat Oncol, Birmingham, W Midlands, England	University of Birmingham; University of Oxford; University of London; Institute of Cancer Research - UK; University of Birmingham	Reulen, RC (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Ctr Childhood Canc Survivor Studies, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	r.c.reulen@bham.ac.uk	Reulen, Raoul/AAO-1033-2020; Pritchard-Jones, Kathy/F-4286-2014; Frobisher, Clare/AAC-5728-2020	Reulen, Raoul/0000-0002-7328-0467; Pritchard-Jones, Kathy/0000-0002-2384-9475; Frobisher, Clare/0000-0003-1099-163X; Kelly, Julie S/0000-0003-1155-735X; Stiller, Charles/0000-0002-3006-7869	Cancer Research UK; Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	This work was supported by Cancer Research UK and Kay Kendall Leukaemia Fund. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers.	Baglietto L, 2006, J CLIN EPIDEMIOL, V59, P114, DOI 10.1016/j.jclinepi.2005.07.018; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Butterworth AS, 2006, EUR J CANCER, V42, P216, DOI 10.1016/j.ejca.2005.09.023; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Cancer Research UK, 2008, CANCERSTATS INC UK; Cardous-Ubbink MC, 2007, EUR J CANCER, V43, P351, DOI 10.1016/j.ejca.2006.10.004; Children's Oncology Group, 2008, LONG TERM FOLL UP GU; Cooper N, 2005, CANC ATLAS UK IRELAN, P39; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Fritz A, 2000, INT CLASSIFICATION D, V3rd; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; Kroll ME, 2011, BRIT J CANCER, V104, P1227, DOI 10.1038/bjc.2011.70; Lambert PC, 2005, STAT MED, V24, P3871, DOI 10.1002/sim.2399; Magnani C, 1996, INT J CANCER, V67, P6; Nathan PC, 2010, ANN INTERN MED, V153, P442, DOI 10.7326/0003-4819-153-7-201010050-00007; National Health Service, CANC SCREEN PROGR; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Office of National Statistics, 2006, CANC STAT REG MB1; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Shah A, 2008, BRIT J CANCER, V99, pS86, DOI 10.1038/sj.bjc.6604599; Thernau TM, 2000, MODELING SURVIVAL DA; Vincent TJ, 2007, CHILDHOOD CANC BRITA; Wilson CL, 2010, MED J AUSTRALIA, V193, P258, DOI 10.5694/j.1326-5377.2010.tb03902.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	30	217	220	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2311	2319		10.1001/jama.2011.747	http://dx.doi.org/10.1001/jama.2011.747			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642683	Bronze			2022-12-01	WOS:000291349100024
J	Hibbs, RE; Gouaux, E				Hibbs, Ryan E.; Gouaux, Eric			Principles of activation and permeation in an anion-selective Cys-loop receptor	NATURE			English	Article							X-RAY-STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED CHLORIDE CHANNEL; NEUROMUSCULAR-JUNCTION; CRYSTAL-STRUCTURE; BINDING PROTEIN; LIGAND-BINDING; ION CHANNELS; SUBUNIT; IVERMECTIN	Fast inhibitory neurotransmission is essential for nervous system function and is mediated by binding of inhibitory neurotransmitters to receptors of the Cys-loop family embedded in the membranes of neurons. Neurotransmitter binding triggers a conformational change in the receptor, opening an intrinsic chloride channel and thereby dampening neuronal excitability. Here we present the first three-dimensional structure, to our knowledge, of an inhibitory anion-selective Cys-loop receptor, the homopentameric Caenorhabditis elegans glutamate-gated chloride channel alpha (GluCl), at 3.3 angstrom resolution. The X-ray structure of the GluCl-Fab complex was determined with the allosteric agonist ivermectin and in additional structures with the endogenous neurotransmitter L-glutamate and the open-channel blocker picrotoxin. Ivermectin, used to treat river blindness, binds in the transmembrane domain of the receptor and stabilizes an open-pore conformation. Glutamate binds in the classical agonist site at subunit interfaces, and picrotoxin directly occludes the pore near its cytosolic base. GluCl provides a framework for understanding mechanisms of fast inhibitory neurotransmission and allosteric modulation of Cys-loop receptors.	[Hibbs, Ryan E.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	NIH [F32NS061404]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061404, P30NS061800] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to H. Lester for providing the initial GluCl construct, to D. Cawley for monoclonal antibody production, to J. Michel for Fab fragment cloning and sequencing, to C. Alexander and D. C. Dawson for providing Xenopus oocytes, to M. Mayer for advice and equipment related to oocyte experiments, and to L. Vaskalis for help with illustrations. We thank the staff at the Advanced Photon Source beamline 24-ID-C for assistance with X-ray data collection. We are particularly appreciative of discussions with E.G. laboratory members and E. McCleskey. This work was supported by an individual NIH National Research Service Award (F32NS061404) to R.E.H. E.G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; ARENA JP, 1991, MOL PHARMACOL, V40, P368; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AZIZ MA, 1982, LANCET, V2, P171; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P326, DOI 10.1113/jphysiol.1955.sp005412; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etter A, 1999, J NEUROCHEM, V72, P318, DOI 10.1111/jnc.1999.72.1.318; Etter A, 1996, J BIOL CHEM, V271, P16035, DOI 10.1074/jbc.271.27.16035; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harlow E LD, 1988, ANTIBODIES LAB MANUA, V1st; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hille B., 2001, ION CHANNELS EXCITAB, V3; KAO PN, 1984, J BIOL CHEM, V259, P1662; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; KUSAMA T, 1994, NEUROREPORT, V5, P1209, DOI 10.1097/00001756-199406020-00012; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Lee DJS, 2003, NEUROSCI LETT, V351, P196, DOI 10.1016/j.neulet.2003.08.005; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leslie A. G., 1992, JOINT CCP4 ESF EAMCB; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; Mancinelli R, 2007, J PHYS CHEM B, V111, P13570, DOI 10.1021/jp075913v; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Sherrington CS., 1906, INTEGRATIVE ACTION N; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; SPRINGER JP, 1981, J AM CHEM SOC, V103, P4221, DOI 10.1021/ja00404a041; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; TAKEUCHI A, 1969, J PHYSIOL-LONDON, V205, P377, DOI 10.1113/jphysiol.1969.sp008972; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueno S, 1999, BRIT J PHARMACOL, V127, P377, DOI 10.1038/sj.bjp.0702563; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wada A, 1976, Adv Biophys, P1; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang Z, 2006, J APPL CRYSTALLOGR, V39, P112, DOI 10.1107/S0021889805040677	78	767	779	6	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					54	U80		10.1038/nature10139	http://dx.doi.org/10.1038/nature10139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21572436	Green Accepted			2022-12-01	WOS:000291156700035
J	Karim, SSA				Karim, Salim S. Abdool			Stigma impedes AIDS prevention	NATURE			English	Editorial Material							HIV		[Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4001 Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	University of Kwazulu Natal; Columbia University	Karim, SSA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4001 Durban, South Africa.	karims1@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133				*BLOOMB, BLOOMB REP; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2007, NATURE, V449, P24, DOI 10.1038/449024c; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; SHIVANA O, 2009, S AFRICAN NATL HIV P; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	10	17	17	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					29	31		10.1038/474029a	http://dx.doi.org/10.1038/474029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637237	Green Published, Bronze			2022-12-01	WOS:000291156700019
J	McCannon, J; Berwick, DM				McCannon, Joseph; Berwick, Donald M.			A New Frontier in Patient Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berwick, Donald M.] US Dept HHS, Ctr Medicare Serv, Washington, DC 20201 USA; US Dept HHS, Ctr Medicaid Serv, Washington, DC 20201 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Berwick, DM (corresponding author), US Dept HHS, Ctr Medicare Serv, 200 Independence Ave SW,Ste 314, Washington, DC 20201 USA.	donald.berwick@cms.hhs.gov						[Anonymous], 2010, OEI06Y0900090; Berenholtz SM, 2011, INFECT CONT HOSP EP, V32, P305, DOI 10.1086/658938; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Interagency Working Group on Health Care Quality for the National Quality Strategy, NAT QUAL STRAT; Kohn L, 2000, ERR IS HUMAN BUILDIN; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Pronovost PJ, 2011, HEALTH AFFAIR, V30, P628, DOI 10.1377/hlthaff.2011.0047; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243	8	32	32	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2011	305	21					2221	2222		10.1001/jama.2011.742	http://dx.doi.org/10.1001/jama.2011.742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770RN	21632485				2022-12-01	WOS:000291106300025
J	Cooper, KL; Hu, JKH; ten Berge, D; Fernandez-Teran, M; Ros, MA; Tabin, CJ				Cooper, Kimberly L.; Hu, Jimmy Kuang-Hsien; ten Berge, Derk; Fernandez-Teran, Marian; Ros, Maria A.; Tabin, Clifford J.			Initiation of Proximal-Distal Patterning in the Vertebrate Limb by Signals and Growth	SCIENCE			English	Article							TISSUE INTERACTIONS; GENE-EXPRESSION; CELL FATE; WING-BUD; CHICK; SPECIFICATION; OUTGROWTH; AXIS; WNT	Two broad classes of models have been proposed to explain the patterning of the proximal-distal axis of the vertebrate limb (from the shoulder to the digit tips). Differentiating between them, we demonstrate that early limb mesenchyme in the chick is initially maintained in a state capable of generating all limb segments through exposure to a combination of proximal and distal signals. As the limb bud grows, the proximal limb is established through continued exposure to flank-derived signal(s), whereas the developmental program determining the medial and distal segments is initiated in domains that grow beyond proximal influence. In addition, the system we have developed, combining in vitro and in vivo culture, opens the door to a new level of analysis of patterning mechanisms in the limb.	[Cooper, Kimberly L.; Hu, Jimmy Kuang-Hsien; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [ten Berge, Derk] Erasmus MC, Erasmus MC Stem Cell Inst, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Fernandez-Teran, Marian; Ros, Maria A.] Univ Cantabria, Inst Biomed & Biotecnol CSIC UC IDICAN, E-39011 Santander, Spain	Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu	Ros, Maria A./K-8160-2014; Berge, Derk ten/C-1967-2012; Berge, Derk ten/ABF-2591-2020; Berge, David/P-2179-2017	Ros, Maria A./0000-0002-1224-7671; Berge, Derk ten/0000-0002-5863-0860; Berge, David/0000-0002-2918-1824; Hu, Jimmy/0000-0003-1035-0779; Fernandez-Teran, M. Angeles/0000-0002-9019-1837	NIH [R37HD032443]; Spanish Ministry of Science and Innovation [BFU2008-00397]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Nusse for generously providing Wnt3a protein, G. Martin for helpful discussions, M. Torres for sharing data before publication, and J. Gros for assistance with confocal live imaging. This work was supported by an NIH grant, R37HD032443, to C. T. and by BFU2008-00397, from the Spanish Ministry of Science and Innovation to M.R.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Fernandez-Teran M, 1999, CELL TISSUE RES, V296, P121, DOI 10.1007/s004410051273; Galloway JL, 2009, NATURE, V460, P400, DOI 10.1038/nature08117; Hamburger H, 1951, J MORPHOL, V88, P49; Herrmann H, 1967, Natl Cancer Inst Monogr, V26, P303; KRABBENHOFT KM, 1989, DEV BIOL, V131, P373, DOI 10.1016/S0012-1606(89)80011-9; LEWIS JH, 1975, J EMBRYOL EXP MORPH, V33, P419; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Pascoal S, 2007, J MOL BIOL, V368, P303, DOI 10.1016/j.jmb.2007.01.089; RAWLES ME, 1963, J EMBRYOL EXP MORPH, V11, P765; Ros MA, 2000, METH MOL B, V137, P245; Rosello-Diez A, 2011, SCIENCE, V332, P1086, DOI 10.1126/science.1199489; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; SEARLS RL, 1971, DEV BIOL, V24, P198, DOI 10.1016/0012-1606(71)90095-9; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059; ZWILLING E, 1964, DEV BIOL, V9, P20, DOI 10.1016/0012-1606(64)90012-0	25	111	113	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1083	1086		10.1126/science.1199499	http://dx.doi.org/10.1126/science.1199499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21617075	Green Accepted, Green Submitted			2022-12-01	WOS:000290996700044
J	Leask, J				Leask, Julie			Target the fence-sitters	NATURE			English	Editorial Material							VACCINATION		Univ Sydney, Sch Publ Hlth, Discipline Paediat & Child Hlth, Natl Ctr Immunisat Res & Surveillance, Sydney, NSW 2006, Australia	University of Sydney	Leask, J (corresponding author), Univ Sydney, Sch Publ Hlth, Discipline Paediat & Child Hlth, Natl Ctr Immunisat Res & Surveillance, Sydney, NSW 2006, Australia.	JulieL3@chw.edu.au	Leask, Julie/ABE-2077-2020	Leask, Julie/0000-0001-5095-1443				[Anonymous], 2010, HLTH PROTECTION REPO, V4; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Hull BP, 2010, COMMUN DIS INTELL, V34, P241; Leach M, 2007, VACCINE ANXIETIES GL; National Committee for Quality Assurance, 2010, STAT HLTH CAR QUAL; Nicoll A, 1998, BMJ-BRIT MED J, V316, P715, DOI 10.1136/bmj.316.7133.715; Petrovic M, 2001, BRIT MED J, V322, P82, DOI 10.1136/bmj.322.7278.82; *ROYAL COLL GEN PR, 1981, BMJ-BRIT MED J, V282, P23; Stefanoff P, 2010, VACCINE, V28, P5731, DOI 10.1016/j.vaccine.2010.06.009; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171	10	120	122	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					443	445		10.1038/473443a	http://dx.doi.org/10.1038/473443a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	768QM	21614055	Bronze			2022-12-01	WOS:000290951300014
J	Vijaykrishna, D; Smith, GJD; Pybus, OG; Zhu, HC; Bhatt, S; Poon, LLM; Riley, S; Bahl, J; Ma, SK; Cheung, CL; Perera, RAPM; Chen, HL; Shortridge, KF; Webby, RJ; Webster, RG; Guan, Y; Peiris, JSM				Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Pybus, Oliver G.; Zhu, Huachen; Bhatt, Samir; Poon, Leo L. M.; Riley, Steven; Bahl, Justin; Ma, Siu K.; Cheung, Chung L.; Perera, Ranawaka A. P. M.; Chen, Honglin; Shortridge, Kennedy F.; Webby, Richard J.; Webster, Robert G.; Guan, Yi; Peiris, J. S. Malik			Long-term evolution and transmission dynamics of swine influenza A virus	NATURE			English	Article							PIGS; REASSORTMENT; EMERGENCE; ORIGINS; CHINA; H9N2	Swine influenza A viruses (SwIV) cause significant economic losses in animal husbandry as well as instances of human disease(1) and occasionally give rise to human pandemics(2), including that caused by the H1N1/2009 virus(3,4). The lack of systematic and longitudinal influenza surveillance in pigs has hampered attempts to reconstruct the origins of this pandemic(4). Most existing swine data were derived from opportunistic samples collected from diseased pigs in disparate geographical regions, not from prospective studies in defined locations, hence the evolutionary and transmission dynamics of SwIV are poorly understood. Here we quantify the epidemiological, genetic and antigenic dynamics of SwIV in Hong Kong using a data set of more than 650 SwIV isolates and more than 800 swine sera from 12 years of systematic surveillance in this region, supplemented with data stretching back 34 years. Intercontinental virus movement has led to reassortment and lineage replacement, creating an antigenically and genetically diverse virus population whose dynamics are quantitatively different from those previously observed for human influenza viruses. Our findings indicate that increased antigenic drift is associated with reassortment events and offer insights into the emergence of influenza viruses with epidemic potential in swine and humans.	[Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Zhu, Huachen; Poon, Leo L. M.; Bahl, Justin; Ma, Siu K.; Cheung, Chung L.; Perera, Ranawaka A. P. M.; Chen, Honglin; Shortridge, Kennedy F.; Webster, Robert G.; Guan, Yi; Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China; [Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Zhu, Huachen; Poon, Leo L. M.; Bahl, Justin; Ma, Siu K.; Cheung, Chung L.; Perera, Ranawaka A. P. M.; Chen, Honglin; Shortridge, Kennedy F.; Webster, Robert G.; Guan, Yi; Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Zhu, Huachen; Bahl, Justin; Chen, Honglin; Shortridge, Kennedy F.; Guan, Yi] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Guangdong, Peoples R China; [Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Bahl, Justin] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Lab Virus Evolut, Singapore 169857, Singapore; [Pybus, Oliver G.; Bhatt, Samir] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Riley, Steven] Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; [Riley, Steven] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Webby, Richard J.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38015 USA; [Peiris, J. S. Malik] Univ Hong Kong, HKU Pasteur Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Shantou University; National University of Singapore; University of Oxford; University of Hong Kong; University of Hong Kong; St Jude Children's Research Hospital; University of Hong Kong	Guan, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	yguan@hkucc.hku.hk; malik@hkucc.hku.hk	Bhatt, Samir/ABE-7938-2020; Zhu, Huachen/A-8252-2017; Chen, Honglin/C-4224-2009; Pybus, Oliver G/B-2640-2012; Webby, Richard J/N-5657-2018; Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Cheung, Yiu Man/T-2708-2019; Dhanasekaran, Vijaykrishna/D-1011-2010; Vijaykrishna, Dhanasekaran/AAG-2077-2020; -, Ranawaka A.P.M Perera/N-8263-2015; Bahl, Justin/A-4728-2011	Zhu, Huachen/0000-0003-2711-0501; Chen, Honglin/0000-0001-5108-8338; Pybus, Oliver G/0000-0002-8797-2667; Poon, Leo Lit Man/0000-0002-9101-7953; Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; -, Ranawaka A.P.M Perera/0000-0003-3936-1535; Bahl, Justin/0000-0001-7572-4300; Riley, Steven/0000-0001-7904-4804; Smith, Gavin JD/0000-0001-5031-468X; Guan, Yi/0000-0001-6057-9243; Bhatt, Samir/0000-0002-0891-4611	National Institute of Allergy and Infectious Diseases (NIAID) [HHSN26600700005C]; University Grants Commission of the Hong Kong SAR Government [AoE/M-12/06]; Royal Society of London; UK COSI; Agency for Science, Technology and Research; Ministry of Health, Singapore; BBSRC [BB/H014306/1] Funding Source: UKRI; MRC [MC_G0902096] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H014306/1] Funding Source: researchfish; Medical Research Council [G0600719B, MC_G0902096] Funding Source: researchfish	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University Grants Commission of the Hong Kong SAR Government; Royal Society of London(Royal Society of London); UK COSI; Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) contract HHSN26600700005C and the Area of Excellence Scheme of the University Grants Commission (grant AoE/M-12/06) of the Hong Kong SAR Government. We acknowledge the Food and Environmental Hygiene Department of Hong Kong for facilitating the study. We acknowledge support from The Royal Society of London (O.G.P.), UK COSI (S.B.), NIAID (G.J.D.S.), the Agency for Science, Technology and Research and the Ministry of Health, Singapore (D.V., G.J.D.S and J.B.). We thank C. Y. H. Leung for producing some of the ferret antisera used in this study.	Clements ACA, 2002, PREV VET MED, V56, P19, DOI 10.1016/S0167-5877(02)00121-6; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guan Y, 1996, J VIROL, V70, P8041, DOI 10.1128/JVI.70.11.8041-8046.1996; [李海燕 Li Haiyan], 2004, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V26, P1; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; Lorusso A, 2011, J GEN VIROL, V92, P919, DOI 10.1099/vir.0.027557-0; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; REED L. J., 1938, AMER JOUR HYG, V27, P493; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Scholtissek C., 1998, TXB INFLUENZA, P137; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Wang RuoJun, 2006, Banff Pork Seminar Proceedings 2006. The Pork Wars - Internal & External Threats, 17-20 January, 2006, Banff, Alberta, Canada, P33; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Yu H, 2008, J CLIN MICROBIOL, V46, P1067, DOI 10.1128/JCM.01257-07; Zhang J., 2008, PEOPLES REPUBLIC CHI	32	170	191	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					519	U263		10.1038/nature10004	http://dx.doi.org/10.1038/nature10004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21614079	Bronze			2022-12-01	WOS:000290951300042
J	Chew, EY				Chew, Emily Y.			Fatty Acids and Retinopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NEI, Clin Trials Branch, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chew, EY (corresponding author), NEI, Clin Trials Branch, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA.							Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Stahl A, 2010, CIRC RES, V107, P495, DOI 10.1161/CIRCRESAHA.110.221317	4	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2011	364	20					1970	1971		10.1056/NEJMcibr1101606	http://dx.doi.org/10.1056/NEJMcibr1101606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765PJ	21591950				2022-12-01	WOS:000290720700016
J	Boly, M; Garrido, MI; Gosseries, O; Bruno, MA; Boveroux, P; Schnakers, C; Massimini, M; Litvak, V; Laureys, S; Friston, KJ				Boly, Melanie; Garrido, Marta Isabel; Gosseries, Olivia; Bruno, Marie-Aurelie; Boveroux, Pierre; Schnakers, Caroline; Massimini, Marcello; Litvak, Vladimir; Laureys, Steven; Friston, Karl J.			Preserved Feedforward But Impaired Top-Down Processes in the Vegetative State	SCIENCE			English	Article							MINIMALLY CONSCIOUS STATE; MISMATCH NEGATIVITY; RESPONSES; MMN; POTENTIALS; EEG	Frontoparietal cortex is involved in the explicit processing (awareness) of stimuli. Frontoparietal activation has also been found in studies of subliminal stimulus processing. We hypothesized that an impairment of top-down processes, involved in recurrent neuronal message-passing and the generation of long-latency electrophysiological responses, might provide a more reliable correlate of consciousness in severely brain-damaged patients, than frontoparietal responses. We measured effective connectivity during a mismatch negativity paradigm and found that the only significant difference between patients in a vegetative state and controls was an impairment of backward connectivity from frontal to temporal cortices. This result emphasizes the importance of top-down projections in recurrent processing that involve high-order associative cortices for conscious perception.	[Boly, Melanie; Gosseries, Olivia; Bruno, Marie-Aurelie; Schnakers, Caroline; Laureys, Steven] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium; [Boly, Melanie; Gosseries, Olivia; Bruno, Marie-Aurelie; Schnakers, Caroline; Laureys, Steven] Univ Liege, Dept Neurol, B-4000 Liege, Belgium; [Boly, Melanie; Gosseries, Olivia; Bruno, Marie-Aurelie; Boveroux, Pierre; Schnakers, Caroline; Laureys, Steven] CHU Sart Tilman Hosp, B-4000 Liege, Belgium; [Boly, Melanie; Garrido, Marta Isabel; Litvak, Vladimir; Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London WC1N 1PJ, England; [Boveroux, Pierre] Univ Liege, Dept Anesthesiol, B-4000 Liege, Belgium; [Massimini, Marcello] Univ Milan, Dept Clin Sci, I-20157 Milan, Italy	University of Liege; University of Liege; University of Liege; University of London; University College London; University of Liege; University of Milan	Boly, M (corresponding author), Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium.	mboly@ulg.ac.be	Laureys, Steven/AAN-2097-2021; Gosseries, Olivia/AAB-6469-2020; Garrido, Marta I/B-7372-2013; Friston, Karl/D-9230-2011; Laureys, Steven/A-3349-2011; Litvak, Vladimir/C-1533-2008; Massimini, Marcello/T-8115-2017	Laureys, Steven/0000-0002-3096-3807; Gosseries, Olivia/0000-0001-9011-7496; Friston, Karl/0000-0001-7984-8909; Litvak, Vladimir/0000-0001-8535-7452; Bekinschtein, Tristan/0000-0001-5501-8628; Garrido, Marta/0000-0003-0679-4959; Massimini, Marcello/0000-0003-2271-957X; Boly, Melanie/0000-0001-9584-0907	Belgian Fonds National de la Recherche Scientifique (FNRS); European Commission; Mind Science Foundation; McDonnell Foundation; French-Speaking Community Concerted Research Action [ARC 06/11-340]; Fondation Leon Fredericq; National Institutes of Health; Wellcome Trust	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Mind Science Foundation; McDonnell Foundation; French-Speaking Community Concerted Research Action; Fondation Leon Fredericq; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Belgian Fonds National de la Recherche Scientifique (FNRS), European Commission, Mind Science Foundation, McDonnell Foundation, French-Speaking Community Concerted Research Action (ARC 06/11-340), Fondation Leon Fredericq, and National Institutes of Health. M.-A. B. and O.G. are Research Fellows, M. B. and C. S. Postdoctoral Fellows, and S. L. Senior Research Associate at the FNRS. M. I. G., V. L., and K. F. are supported by the Wellcome Trust.	Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Diaz MT, 2007, J COGNITIVE NEUROSCI, V19, P1768, DOI 10.1162/jocn.2007.19.11.1768; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2007, P NATL ACAD SCI USA, V104, P20961, DOI 10.1073/pnas.0706274105; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Heinke W, 2004, ANESTHESIOLOGY, V100, P617, DOI 10.1097/00000542-200403000-00023; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Luo Q, 2009, CEREB CORTEX, V19, P1896, DOI 10.1093/cercor/bhn216; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; ROTH M, 1956, ELECTROEN CLIN NEURO, V8, P385, DOI 10.1016/0013-4694(56)90004-9; Ruby P, 2008, J COGNITIVE NEUROSCI, V20, P296, DOI 10.1162/jocn.2008.20023; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020	29	321	334	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2011	332	6031					858	862		10.1126/science.1202043	http://dx.doi.org/10.1126/science.1202043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566197	Green Submitted			2022-12-01	WOS:000290529900051
J	Schlacher, K; Christ, N; Siaud, N; Egashira, A; Wu, H; Jasin, M				Schlacher, Katharina; Christ, Nicole; Siaud, Nicolas; Egashira, Akinori; Wu, Hong; Jasin, Maria			Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11	CELL			English	Article							WERNER-SYNDROME PROTEIN; DNA-REPLICATION; HOMOLOGOUS RECOMBINATION; CANCER SUSCEPTIBILITY; GENOMIC STABILITY; ATP HYDROLYSIS; HUMAN RAD51; CELLS; COMPLEX; HYPERSENSITIVITY	Breast cancer suppressor BRCA2 is critical for maintenance of genomic integrity and resistance to agents that damage DNA or collapse replication forks, presumably through homology-directed repair of double-strand breaks (HDR). Using single-molecule DNA fiber analysis, we show here that nascent replication tracts created before fork stalling with hydroxyurea are degraded in the absence of BRCA2 but are stable in wild-type cells. BRCA2 mutational analysis reveals that a conserved C-terminal site involved in stabilizing RAD51 filaments, but not in loading RAD51 onto DNA, is essential for this fork protection but dispensable for HDR. RAD51 filament disruption in wild-type cells phenocopies BRCA2 deficiency. BRCA2 prevents chromosomal aberrations on replication stalling, which are alleviated by inhibition of MRE11, the nuclease responsible for this form of fork instability. Thus, BRCA2 prevents rather than repairs nucleolytic lesions at stalled replication forks to maintain genomic integrity and hence likely suppresses tumorigenesis through this replication-specific function.	[Schlacher, Katharina; Christ, Nicole; Siaud, Nicolas; Egashira, Akinori; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Schlacher, Katharina; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Hong] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA 90095 USA	Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Schlacher, K (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA.	schlachk@mskcc.org; m-jasin@ski.mskcc.org		SCHLACHER, KATHARINA/0000-0001-7226-6391	Susan G. Komen grant [BCTR122106]; NIH [R01CA121110, R01GM54668, P01CA94060]; NATIONAL CANCER INSTITUTE [P01CA094060, R01CA121110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER	Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francesca Cole, Jeannine LaRocque, Koji Nakanishi, Yu Zhang, and other members of the Jasin lab and for reagents and discussions, Marie-Emilie Terret (MSKCC) and Margaret Leversha (MSKCC) for technical assistance, Julia Sidorova (Seattle) for critical discussions along with Duncan Wright (MSKCC) and Reginald Hill (UCLA), and Toshiyasu Taniguchi (Seattle), Ouathek Ouerfelli (MSKCC), and Berry Sleckman (St. Louis) for reagents. K. S. is the Berger Foundation Fellow of the Damon Runyon Cancer Research Foundation (DRG 1957-07). This work was supported by Susan G. Komen grant BCTR122106 (M.J.) and NIH grants R01CA121110 (H. W.) and R01GM54668 and P01CA94060 (M.J.).	Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Franchitto A, 2004, CELL CYCLE, V3, P1331, DOI 10.4161/cc.3.10.1185; Goggins M, 1996, CANCER RES, V56, P5360; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hay T, 2005, BIOCHEM SOC T, V33, P715, DOI 10.1042/BST0330715; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Mazloum N, 2009, MOL CELL, V36, P620, DOI 10.1016/j.molcel.2009.09.033; McAllister KA, 2002, CANCER RES, V62, P990; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Morimatsu M, 1998, CANCER RES, V58, P3441; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 2002, ONCOGENE, V21, P8994, DOI 10.1038/sj.onc.1206177; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Su X, 2008, NAT STRUCT MOL BIOL, V15, P1049, DOI 10.1038/nsmb.1490; van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581; Wang Y, 2000, GENE DEV, V14, P927; Wiegant WW, 2006, MUTAT RES-FUND MOL M, V600, P79, DOI 10.1016/j.mrfmmm.2006.03.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017	53	786	796	2	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					529	542		10.1016/j.cell.2011.03.041	http://dx.doi.org/10.1016/j.cell.2011.03.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565612	Green Accepted, Bronze			2022-12-01	WOS:000290560800007
J	Allison, KR; Brynildsen, MP; Collins, JJ				Allison, Kyle R.; Brynildsen, Mark P.; Collins, James J.			Metabolite-enabled eradication of bacterial persisters by aminoglycosides	NATURE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC TOLERANCE; CELLS; RESISTANCE; MECHANISM; BIOFILMS; ROLES; DEATH; ANTIMICROBIALS	Bacterial persistence is a state in which a sub-population of dormant cells, or 'persisters', tolerates antibiotic treatment(1-4). Bacterial persisters have been implicated in biofilms and in chronic and recurrent infections(5-7). Despite this clinical relevance, there are currently no viable means for eradicating persisters. Here we show that specific metabolic stimuli enable the killing of both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) persisters with aminoglycosides. This potentiation is aminoglycoside-specific, it does not rely on growth resumption and it is effective in both aerobic and anaerobic conditions. It proceeds by the generation of a proton-motive force which facilitates aminoglycoside uptake. Our results demonstrate that persisters, although dormant, are primed for metabolite uptake, central metabolism and respiration. We show that aminoglycosides can be used in combination with specific metabolites to treat E. coli and S. aureus biofilms. Furthermore, we demonstrate that this approach can improve the treatment of chronic infections in a mouse urinary tract infection model. This work establishes a strategy for eradicating bacterial persisters that is based on metabolism, and highlights the importance of the metabolic environment to antibiotic treatment.	[Allison, Kyle R.; Brynildsen, Mark P.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr Biodynam, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02118 USA	Boston University; Howard Hughes Medical Institute; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr Biodynam, Boston, MA 02215 USA.	jcollins@bu.edu			NIH; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Slee and T. Murphy from ViviSource Laboratories for assistance with the in vivo mouse studies and T. K. Lu for guidance with the biofilm experiments. This work was supported by the NIH Director's Pioneer Award Program and the Howard Hughes Medical Institute.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; FRAIMOW HS, 1991, J BACTERIOL, V173, P2800, DOI 10.1128/JB.173.9.2800-2808.1991; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Govantes F, 2000, MOL MICROBIOL, V37, P1456, DOI 10.1046/j.1365-2958.2000.02100.x; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; HILL S, 1990, J BACTERIOL, V172, P2071, DOI 10.1128/jb.172.4.2071-2078.1990; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; MATES SM, 1982, P NATL ACAD SCI-BIOL, V79, P6693, DOI 10.1073/pnas.79.21.6693; Sandoval R, 1998, J AM SOC NEPHROL, V9, P167; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; WEISBLUM B, 1968, BACTERIOL REV, V32, P493, DOI 10.1128/MMBR.32.4_Pt_2.493-528.1968	30	589	619	17	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					216	+		10.1038/nature10069	http://dx.doi.org/10.1038/nature10069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562562	Green Accepted			2022-12-01	WOS:000290487200039
J	Beasley, BN; Unger, EF; Temple, R				Beasley, B. Nhi; Unger, Ellis F.; Temple, Robert			Anticoagulant Options - Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION; WARFARIN		[Beasley, B. Nhi] US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Unger, Ellis F.; Temple, Robert] US FDA, Off Drug Evaluat 1, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Beasley, BN (corresponding author), US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], 2010, GUIDANCE IND NONINFE; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; fda, FDA APPR DRUG PROD; *FOOD DRUG ADM CTR, DAB PROP IND PREV ST	6	190	200	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2011	364	19					1788	1790		10.1056/NEJMp1103050	http://dx.doi.org/10.1056/NEJMp1103050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MM	21488759				2022-12-01	WOS:000290483000003
J	Lucanic, M; Held, JM; Vantipalli, MC; Klang, IM; Graham, JB; Gibson, BW; Lithgow, GJ; Gill, MS				Lucanic, Mark; Held, Jason M.; Vantipalli, Maithili C.; Klang, Ida M.; Graham, Jill B.; Gibson, Bradford W.; Lithgow, Gordon J.; Gill, Matthew S.			N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans	NATURE			English	Article							RESTRICTION-INDUCED LONGEVITY; C-ELEGANS; ENDOCANNABINOID SYSTEM; EVOLUTIONARY ORIGINS; DAUER FORMATION; FOOD-INTAKE; EXTENSION; ACID; MECHANISMS; EXPRESSION	Dietary restriction is a robust means of extending adult lifespan and postponing age-related disease in many species, including yeast, nematode worms, flies and rodents(1,2). Studies of the genetic requirements for lifespan extension by dietary restriction in the nematode Caenorhabditis elegans have implicated a number of key molecules in this process(3-5), including the nutrient-sensing target of rapamycin (TOR) pathway(6) and the Foxa transcription factor PHA-4 (ref. 7). However, little is known about the metabolic signals that coordinate the organismal response to dietary restriction and maintain homeostasis when nutrients are limited. The endocannabinoid system is an excellent candidate for such a role given its involvement in regulating nutrient intake and energy balance(8). Despite this, a direct role for endocannabinoid signalling in dietary restriction or lifespan determination has yet to be demonstrated, in part due to the apparent absence of endocannabinoid signalling pathways in model organisms that are amenable to lifespan analysis(9). N-acylethanolamines (NAEs) are lipid-derived signalling molecules, which include the mammalian endocannabinoid arachidonoyl ethanolamide. Here we identify NAEs in C. elegans, show that NAE abundance is reduced under dietary restriction and that NAE deficiency is sufficient to extend lifespan through a dietary restriction mechanism requiring PHA-4. Conversely, dietary supplementation with the nematode NAE eicosapentaenoyl ethanolamide not only inhibits dietary-restriction-induced lifespan extension in wild-type worms, but also suppresses lifespan extension in a TOR pathway mutant. This demonstrates a role for NAE signalling in ageing and indicates that NAEs represent a signal that coordinates nutrient status with metabolic changes that ultimately determine lifespan.	[Lucanic, Mark; Held, Jason M.; Vantipalli, Maithili C.; Klang, Ida M.; Graham, Jill B.; Gibson, Bradford W.; Lithgow, Gordon J.; Gill, Matthew S.] Buck Inst Res Aging, Novato, CA 94945 USA; [Klang, Ida M.] Karolinska Inst, Ctr Biosci, Novum, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Buck Institute for Research on Aging; Karolinska Institutet	Gill, MS (corresponding author), Scripps Res Inst Scripps Florida, 130 Scripps Way,3B3, Jupiter, FL 33458 USA.	mgill@scripps.edu		Gill, Matthew/0000-0003-0818-8792; lucanic, mark/0000-0003-1511-1013; Held, Jason/0000-0001-8024-2736	NIH National Center for Research Resources (NCRR); NIH [T32 AG000266, R01 AG029631, PL1-AG032118, UL1 DE019608, R21 AG030192, R01 AG036992]; Larry L. Hillblom Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [PL1AG032118, T32AG000266, R01AG036992, R21AG030192, R01AG029631] Funding Source: NIH RePORTER	NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We would like to thank N. J. Harrison, A. Olsen and P. Kapahi. M.L. was supported by NIH training grant T32 AG000266 and NIH grant R01 AG029631. GC-MS analysis was made possible through the Mass Spectrometry and Imaging Technologies Core supported by NIH grant PL1-AG032118. This work was supported by a Larry L. Hillblom Foundation grant and NIH grants to G.J.L. (UL1 DE019608, supporting the Interdisciplinary Research Consortium on Geroscience and R01 AG029631) and by NIH grants R21 AG030192 and R01 AG036992 to M.S.G.	Banni S, 2010, MOL NUTR FOOD RES, V54, P82, DOI 10.1002/mnfr.200900516; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Breunig E, 2010, J NEUROSCI, V30, P8965, DOI 10.1523/JNEUROSCI.4030-09.2010; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; De Petrocellis L, 1999, NEUROSCIENCE, V92, P377, DOI 10.1016/S0306-4522(98)00749-0; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Elphick MR, 2007, GENE, V399, P65, DOI 10.1016/j.gene.2007.04.025; Elphick MR, 2005, HANDB EXP PHARMACOL, V168, P283; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Hardison S, 2006, PROSTAG OTH LIPID M, V81, P106, DOI 10.1016/j.prostaglandins.2006.08.002; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Lehtonen M, 2008, CHEM BIODIVERS, V5, P2431, DOI 10.1002/cbdv.200890208; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; McPartland JM, 2006, GENE, V370, P64, DOI 10.1016/j.gene.2005.11.004; McPartland JM, 2003, GENE, V312, P297, DOI 10.1016/S0378-1119(03)00638-3; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Soderstrom K, 2004, J NEUROSCI, V24, P10013, DOI 10.1523/JNEUROSCI.3298-04.2004; Sulston J.E., 1988, NEMATODE CAENORHABDI, P587; Sultana T, 2006, J CHROMATOGR A, V1101, P278, DOI 10.1016/j.chroma.2005.10.027; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Valenti M, 2005, J NEUROCHEM, V95, P662, DOI 10.1111/j.1471-4159.2005.03406.x; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799	39	104	111	6	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					226	+		10.1038/nature10007	http://dx.doi.org/10.1038/nature10007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562563	Green Accepted			2022-12-01	WOS:000290487200041
J	Darmstadt, GL				Darmstadt, Gary L.			Stillbirths: missing from the family and from family health	LANCET			English	Editorial Material							SURVIVAL; NEWBORN; INTERVENTIONS; STRATEGIES; MORTALITY; IMPACT		Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA 98102 USA	Bill & Melinda Gates Foundation	Darmstadt, GL (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA 98102 USA.	gary.darmstadt@gatesfoundation.org	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824				BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2008, PEDIATRICS, V121, pE1381, DOI 10.1542/peds.2007-1966; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Rubens CE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S7; Yakoob MY, 2010, SEMIN PERINATOL, V34, P387, DOI 10.1053/j.semperi.2010.09.010	14	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1550	1551		10.1016/S0140-6736(11)60099-8	http://dx.doi.org/10.1016/S0140-6736(11)60099-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21496909				2022-12-01	WOS:000290549700007
J	Kim, HJ; Ruszczycky, MW; Choi, SH; Liu, YN; Liu, HW				Kim, Hak Joong; Ruszczycky, Mark W.; Choi, Sei-hyun; Liu, Yung-nan; Liu, Hung-wen			Enzyme-catalysed [4+2] cycloaddition is a key step in the biosynthesis of spinosyn A	NATURE			English	Article							DIELS-ALDER REACTION; MACROPHOMATE SYNTHASE; SACCHAROPOLYSPORA-SPINOSA; SUGAR BIOSYNTHESIS; MECHANISM	The Diels-Alder reaction is a [4+2] cycloaddition reaction in which a cyclohexene ring is formed between a 1,3-diene and an electron-deficient alkene via a single pericyclic transition state(1). This reaction has been proposed as a key transformation in the biosynthesis of many cyclohexene-containing secondary metabolites(2-5). However, only four purified enzymes have thus far been implicated in biotransformations that are consistent with a Diels-Alder reaction, namely solanapyrone synthase(6), LovB(7,8), macrophomate synthase(9,10), and riboflavin synthase(11,12). Although the stereochemical outcomes of these reactions indicate that the product formation could be enzyme-guided in each case, these enzymes typically demonstrate more than one catalytic activity, leaving their specific influence on the cycloaddition step uncertain. In our studies of the biosynthesis of spinosyn A, a tetracyclic polyketide-derived insecticide from Saccharopolyspora spinosa(13,14), we identified a cyclase, SpnF, that catalyses a transannular [4+2] cycloaddition to form the cyclohexene ring in spinosyn A. Kinetic analysis demonstrates that SpnF specifically accelerates the ring formation reaction with an estimated 500-fold rate enhancement. A second enzyme, SpnL, was also identified as responsible for the final cross-bridging step that completes the tetracyclic core of spinosyn A in a manner consistent with a Rauhut-Currier reaction(15). This work is significant because SpnF represents the first example characterized in vitro of a standalone enzyme solely committed to the catalysis of a [4+2] cycloaddition reaction. In addition, the mode of formation of the complex perhydro-as-indacene moiety in spinosyn A is now fully established.	[Kim, Hak Joong; Choi, Sei-hyun; Liu, Hung-wen] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Ruszczycky, Mark W.; Liu, Yung-nan; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Liu, HW (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu	Kim, Hak Joong/D-1117-2013		National Institutes of Health [GM035906, F32AI082906]; Texas Higher Education Coordination Board [ARP-003658-0093-2007]; Welch Foundation [F-1511]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040541, R01GM035906, R37GM035906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Higher Education Coordination Board; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Whitman for review of the manuscript, L. Hong for carrying out the early cloning work, B. Shoulders and S. Sorey for assistance with the interpretation of the NMR spectra, and S. Mansoorabadi and E. Isiorho for discussions on the reaction mechanisms and structural modelling of SpnF. This work is supported in part by grants from the National Institutes of Health (GM035906, F32AI082906), the Texas Higher Education Coordination Board (ARP-003658-0093-2007), and the Welch Foundation (F-1511).	Aroyan CE, 2009, TETRAHEDRON, V65, P4069, DOI 10.1016/j.tet.2009.02.066; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Chen YL, 2009, J BIOL CHEM, V284, P7352, DOI 10.1074/jbc.M808441200; Draper N.R., 1998, APPL REGRESSION ANAL, V326; Eberhardt S, 2001, EUR J BIOCHEM, V268, P4315, DOI 10.1046/j.1432-1327.2001.02351.x; FRIEDEN C, 1994, METHOD ENZYMOL, V240, P311; Guimaraes CRW, 2005, J AM CHEM SOC, V127, P3577, DOI 10.1021/ja043905b; HUISGEN R, 1968, ANGEW CHEM INT EDIT, V7, P321, DOI 10.1002/anie.196803211; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kim HJ, 2007, J AM CHEM SOC, V129, P14582, DOI 10.1021/ja076580i; Kim HJ, 2010, J AM CHEM SOC, V132, P2901, DOI 10.1021/ja910223x; Kim RR, 2010, J AM CHEM SOC, V132, P2983, DOI 10.1021/ja908395r; KIRST HA, 1991, TETRAHEDRON LETT, V32, P4839, DOI 10.1016/S0040-4039(00)93474-9; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Martin CJ, 2003, ORG BIOMOL CHEM, V1, P4144, DOI 10.1039/b310740j; Mergott DJ, 2004, P NATL ACAD SCI USA, V101, P11955, DOI 10.1073/pnas.0401247101; Oikawa H, 2005, B CHEM SOC JPN, V78, P537, DOI 10.1246/bcsj.78.537; Oikawa H, 2003, J ORG CHEM, V68, P3552, DOI 10.1021/jo0267596; OIKAWA H, 1995, J CHEM SOC CHEM COMM, P1321, DOI 10.1039/c39950001321; Oikawa H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P277; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Tenenbaum M., 1985, ORDINARY DIFFERENTIA; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200	29	223	223	8	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					109	112		10.1038/nature09981	http://dx.doi.org/10.1038/nature09981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544146	Green Accepted			2022-12-01	WOS:000290218300041
J	Prud'homme, B; Minervino, C; Hocine, M; Cande, JD; Aouane, A; Dufour, HD; Kassner, VA; Gompel, N				Prud'homme, Benjamin; Minervino, Caroline; Hocine, Melanie; Cande, Jessica D.; Aouane, Aicha; Dufour, Heloise D.; Kassner, Victoria A.; Gompel, Nicolas			Body plan innovation in treehoppers through the evolution of an extra wing-like appendage	NATURE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; INSECT WINGS; GENE; CONSTRAINTS; ORIGIN	Body plans, which characterize the anatomical organization of animal groups of high taxonomic rank(1), often evolve by the reduction or loss of appendages (limbs in vertebrates and legs and wings in insects, for example). In contrast, the addition of new features is extremely rare and is thought to be heavily constrained, although the nature of the constraints remains elusive(2-4). Here we show that the treehopper (Membracidae) 'helmet' is actually an appendage, a wing serial homologue on the first thoracic segment. This innovation in the insect body plan is an unprecedented situation in 250 Myr of insect evolution. We provide evidence suggesting that the helmet arose by escaping the ancestral repression of wing formation imparted by a member of the Hox gene family, which sculpts the number and pattern of appendages along the body axis(5-8). Moreover, we propose that the exceptional morphological diversification of the helmet was possible because, in contrast to the wings, it escaped the stringent functional requirements imposed by flight. This example illustrates how complex morphological structures can arise by the expression of ancestral developmental potentials and fuel the morphological diversification of an evolutionary lineage.	[Prud'homme, Benjamin; Minervino, Caroline; Hocine, Melanie; Cande, Jessica D.; Aouane, Aicha; Gompel, Nicolas] CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, F-13288 Marseille 9, France; [Dufour, Heloise D.; Kassner, Victoria A.] Univ Wisconsin, Madison, WI 53706 USA; [Dufour, Heloise D.; Kassner, Victoria A.] Howard Hughes Med Inst, Bock Labs, Madison, WI 53706 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute	Prud'homme, B (corresponding author), CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, Case 907,Parc Sci Luminy, F-13288 Marseille 9, France.	benjamin.prudhomme@univmed.fr; nicolas.gompel@univmed.fr		Gompel, Nicolas/0000-0003-3358-7963; Dufour, Heloise/0000-0001-7934-7549; Hocine, Melanie/0000-0003-2830-9918	EURYI award; Human Frontier Science Program; CNRS	EURYI award(European Science Foundation (ESF)); Human Frontier Science Program(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS))	We are grateful to G. Moragues for inspiring the project and the loan of specimens. We thank S. B. Carroll for discussions and support during the early stage of the project; M. Morgan and S. Morgan for access to their field property; J. P. Chauvin for assistance with SEM; S. McKamey and C. Dietrich for help with bibliography; D. Milo for discussions; and D. Andrews, M. Averof, S. B. Carroll, A. Kopp, A. Salzberg and Y. Tomoyasu for sharing reagents. We used FlyBase for information support. We also thank F. Leulier, T. Lecuit, M. Averof, C. Desplan and S. B. Carroll for comments on the manuscript. This work was supported by a EURYI award, a Human Frontier Science Program Career Development Award and the CNRS. J.D.C. was supported by a Human Frontier Science Program Long-term fellowship.	Angelini DR, 2005, ANNU REV GENET, V39, P95, DOI 10.1146/annurev.genet.39.073003.112310; Averof M, 1997, NATURE, V385, P627, DOI 10.1038/385627a0; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Boulard M., 1973, Bulletin Mus Natn Hist nat Paris, V83, P145; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Chesebro J, 2009, DEV BIOL, V329, P142, DOI 10.1016/j.ydbio.2009.01.032; Cifuentes FJ, 1997, P NATL ACAD SCI USA, V94, P11405, DOI 10.1073/pnas.94.21.11405; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Comstock J.H., 1918, WINGS INSECTS; Darwin C., 1859, ORIGIN SPECIES MEANS; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; Dietrich Christopher H., 2002, Denisia, V4, P155; Fowler W. W, 1894, BIOL CENTRALI AM, P1; Grimaldi David, 2005, pi; KUKALOVAPECK J, 1978, J MORPHOL, V156, P53, DOI 10.1002/jmor.1051560104; Moczek AP, 2006, DEV GENES EVOL, V216, P655, DOI 10.1007/s00427-006-0087-2; Pavlopoulos A, 2009, P NATL ACAD SCI USA, V106, P13897, DOI 10.1073/pnas.0902804106; Poinar R., 1999, AMBER FOREST RECONST; POULTON EB, 1903, MONOGRAPH MEMBRACIDA, P273; Raff R.A., 1996, SHAPE LIFE GENES DEV; Richter L., 1953, Lozania, Vno. 7, P1; RIEDL R, 1977, Q REV BIOL, V52, P351, DOI 10.1086/410123; Rogers BT, 1997, DEVELOPMENT, V124, P149; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Snodgrass Robert Evans, 1909, Proceedings of the United States National Museum Smithsonian Institution Washington, V36; Stegmann UE, 1998, J MORPHOL, V238, P157, DOI 10.1002/(SICI)1097-4687(199811)238:2<157::AID-JMOR3>3.0.CO;2-H; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272	29	64	67	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					83	86		10.1038/nature09977	http://dx.doi.org/10.1038/nature09977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544145				2022-12-01	WOS:000290218300035
J	Chiu, JC; Ko, HW; Edery, I				Chiu, Joanna C.; Ko, Hyuk Wan; Edery, Isaac			NEMO/NLK Phosphorylates PERIOD to Initiate a Time-Delay Phosphorylation Circuit that Sets Circadian Clock Speed	CELL			English	Article							SLEEP PHASE SYNDROME; DROSOPHILA CLOCK; PROTEIN; GENE; MELANOGASTER; MUTATION; KINASE; NEUROSPORA; DOUBLETIME; MUTANTS	The speed of circadian clocks in animals is tightly linked to complex phosphorylation programs that drive daily cycles in the levels of PERIOD (PER) proteins. Using Drosophila, we identify a time-delay circuit based on hierarchical phosphorylation that controls the daily downswing in PER abundance. Phosphorylation by the NEMO/NLK kinase at the "per-short" domain on PER stimulates phosphorylation by DOUBLETIME (DBT/CK1 delta/epsilon) at several nearby sites. This multisite phosphorylation operates in a spatially oriented and graded manner to delay progressive phosphorylation by DBT at other more distal sites on PER, including those required for recognition by the F box protein SLIMB/beta-TrCP and proteasomal degradation. Highly phosphorylated PER has a more open structure, suggesting that progressive increases in global phosphorylation contribute to the timing mechanism by slowly increasing PER susceptibility to degradation. Our findings identify NEMO as a clock kinase and demonstrate that long-range interactions between functionally distinct phospho-clusters collaborate to set clock speed.	[Chiu, Joanna C.; Ko, Hyuk Wan; Edery, Isaac] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Chiu, Joanna C.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Rutgers State University New Brunswick; University of California System; University of California Davis	Edery, I (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	edery@cabm.rutgers.edu		Chiu, Joanna/0000-0001-7613-8127; KO, HYUK WAN/0000-0003-1753-1900	NIH [R01NS03498, K99/R00NS061952]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034958, R00NS061952, K99NS061952] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Paul Hardin (Texas A&M, USA) for communicating unpublished results (Yu et al., 2011), Thomas Kusch (Rutgers University, USA) for Sfx cells, and the VDRC (Vienna, Austria) for RNAi lines. We thank Axel Diernfellner and Michael Brunner (Heidelberg University, Germany) for conditions for limited proteolysis. This work was supported by NIH grant (R01NS03498) to I. E. and NIH grant (K99/R00NS061952) to J.C.C.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BAYLIES MK, 1992, NEURON, V9, P575, DOI 10.1016/0896-6273(92)90194-I; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hamblen MJ, 1998, GENETICS, V149, P165; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Ko HW, 2005, METHOD ENZYMOL, V393, P394, DOI 10.1016/S0076-6879(05)93018-8; Ko HW, 2007, J BIOL RHYTHM, V22, P488, DOI 10.1177/0748730407306929; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1994, J BIOL RHYTHM, V9, P189, DOI 10.1177/074873049400900303; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Nawathean P, 2007, MOL CELL BIOL, V27, P5002, DOI 10.1128/MCB.02338-06; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; Schibler U, 2006, PROG BRAIN RES, V153, P271, DOI 10.1016/S0079-6123(06)53016-X; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; Yu WJ, 2011, CURR BIOL, V21, P756, DOI 10.1016/j.cub.2011.02.037; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177	52	125	128	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					357	370		10.1016/j.cell.2011.04.002	http://dx.doi.org/10.1016/j.cell.2011.04.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21514639	Bronze, Green Accepted			2022-12-01	WOS:000290022900006
J	Maillard, RA; Chistol, G; Sen, M; Righini, M; Tan, JY; Kaiser, CM; Hodges, C; Martin, A; Bustamante, C				Maillard, Rodrigo A.; Chistol, Gheorghe; Sen, Maya; Righini, Maurizio; Tan, Jiongyi; Kaiser, Christian M.; Hodges, Courtney; Martin, Andreas; Bustamante, Carlos			ClpX(P) Generates Mechanical Force to Unfold and Translocate Its Protein Substrates	CELL			English	Article							GREEN FLUORESCENT PROTEIN; OPERATING PRINCIPLES; RNA-POLYMERASE; MOLECULE; DEGRADATION; MACHINE; THERMODYNAMICS; PROTEOLYSIS; RESOLUTION; PROTEASES	AAA(+) unfoldases denature and translocate polypeptides into associated peptidases. We report direct observations of mechanical, force-induced protein unfolding by the ClpX unfoldase from E. coli, alone, and in complex with the ClpP peptidase. ClpX hydrolyzes ATP to generate mechanical force and translocate polypeptides through its central pore. Threading is interrupted by pauses that are found to be off the main translocation pathway. ClpX's translocation velocity is force dependent, reaching a maximum of 80 aa/s near-zero force and vanishing at around 20 pN. ClpX takes 1, 2, or 3 nm steps, suggesting a fundamental step-size of 1 nm and a certain degree of intersubunit coordination. When ClpX encounters a folded protein, it either overcomes this mechanical barrier or slips on the polypeptide before making another unfolding attempt. Binding of ClpP decreases the slip probability and enhances the unfolding efficiency of ClpX. Under the action of ClpXP, GFP unravels cooperatively via a transient intermediate.	[Maillard, Rodrigo A.; Righini, Maurizio; Kaiser, Christian M.; Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Maillard, Rodrigo A.; Chistol, Gheorghe; Sen, Maya; Righini, Maurizio; Tan, Jiongyi; Kaiser, Christian M.; Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Maillard, Rodrigo A.; Chistol, Gheorghe; Kaiser, Christian M.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Sen, Maya; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Martin, A (corresponding author), Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA.	a.martin@berkeley.edu; carlos@alice.berkeley.edu		Chistol, Gheorghe/0000-0003-4868-3667; Martin, Andreas/0000-0003-0923-3284; Bustamante, Carlos/0000-0002-2970-0073; Righini, Maurizio/0000-0002-8454-8887; Hodges, H. Courtney/0000-0003-4441-497X	NSF; QB3 Institute; NIH [5K99GM086516, R01-GM0325543]; Searle Scholars Program; Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543, K99GM086516, R01GM094497] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); QB3 Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lacramioara Bintu, Craig Hetherington, and Phillip Elms for helpful discussions. M.S. acknowledges support from the NSF Graduate Research Fellowship. C.M.K. acknowledges support from the QB3 Institute (Distinguished Postdoctoral Fellowship) and the NIH K99 Award (5K99GM086516). This research was supported in part by the Searle Scholars Program (A.M.), the NIH grant R01-GM0325543, the Lawrence Berkeley National Laboratory, and the Howard Hughes Medical Institute (C.B.).	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Bertz M, 2008, ANGEW CHEM INT EDIT, V47, P8192, DOI 10.1002/anie.200802987; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Horwich AL, 1999, P NATL ACAD SCI USA, V96, P11033, DOI 10.1073/pnas.96.20.11033; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Mickler M, 2007, P NATL ACAD SCI USA, V104, P20268, DOI 10.1073/pnas.0705458104; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Wang JM, 1997, CELL, V91, P447, DOI 10.1016/S0092-8674(00)80431-6; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yildiz A, 2005, TRENDS CELL BIOL, V15, P112, DOI 10.1016/j.tcb.2004.12.007; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102	35	195	200	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					459	469		10.1016/j.cell.2011.04.010	http://dx.doi.org/10.1016/j.cell.2011.04.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529717	Bronze, Green Accepted			2022-12-01	WOS:000290022900014
J	Turner, MR; Camacho, X; Fischer, HD; Austin, PC; Anderson, GM; Rochon, PA; Lipscombe, LL				Turner, Marci R.; Camacho, Ximena; Fischer, Hadas D.; Austin, Peter C.; Anderson, Geoff M.; Rochon, Paula A.; Lipscombe, Lorraine L.			Levothyroxine dose and risk of fractures in older adults: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THYROID-STIMULATING HORMONE; BONE-MINERAL DENSITY; SEROTONIN-REUPTAKE INHIBITORS; SUBCLINICAL HYPERTHYROIDISM; HIP-FRACTURES; ADMINISTRATIVE DATA; HYPOTHYROID PATIENTS; SUBSEQUENT FRACTURE; ATRIAL-FIBRILLATION; LONG-TERM	Objective To quantify the effect of levothyroxine dose on risk of fractures in older adults. Design Nested case-control study. Setting Population based health databases, Ontario, Canada. Participants Adults aged 70 or more prescribed levothyroxine between 1 April 2002 and 31 March 2007 and followed for fractures until 31 March 2008. Cases were cohort members admitted to hospital for any fracture, matched with up to five controls from within the cohort who had not yet had a fracture. Main outcome measure Primary outcome was fracture (wrist or forearm, shoulder or upper arm, thoracic spine, lumbar spine and pelvis, hip or femur, or lower leg or ankle) in relation to levothyroxine use (current, recent past, remote). Risk among current users was compared between those prescribed high, medium, and low cumulative levothyroxine doses in the year before fracture. Results Of 213 511 prevalent levothyroxine users identified, 22 236 (10.4%) experienced a fracture over a mean 3.8 years of follow-up, 18 108 (88%) of whom were women. Compared with remote levothyroxine use, current use was associated with a significantly higher risk of fracture (adjusted odds ratio 1.88, 95% confidence interval 1.71 to 2.05), despite adjustment for numerous risk factors. Among current users, high and medium cumulative doses (>0.093 mg/day and 0.044-0.093 mg/day) were associated with a significantly increased risk of fracture compared with low cumulative doses (<0.044 mg/day): 3.45 (3.27 to 3.65) and 2.62 (2.50 to 2.76), respectively. Conclusion Among adults aged 70 or more, current levothyroxine treatment was associated with a significantly increased risk of fracture, with a strong dose-response relation. Ongoing monitoring of levothyroxine dose is important to avoid overtreatment in this population.	[Rochon, Paula A.; Lipscombe, Lorraine L.] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Turner, Marci R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Camacho, Ximena; Fischer, Hadas D.; Austin, Peter C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Anderson, Geoff M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto	Lipscombe, LL (corresponding author), Womens Coll Res Inst, 790 Bay St, Toronto, ON M5G 1N8, Canada.	lorraine.lipscombe@wchospital.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151	Canadian Institutes of Health Research (CIHR) [OTG-88591, HOA-80075]; Canadian Diabetes Association/CIHR; Heart and Stroke Foundation of Ontario; University of Toronto	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association/CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Toronto(University of Toronto)	This work was supported by a team grant (OTG-88591) from the Canadian Institutes of Health Research (CIHR) and by a CIHR interdisciplinary capacity enhancement grant (HOA-80075). LLL is supported by a Canadian Diabetes Association/CIHR clinician scientist award. PCA is supported by a career investigator award from the Heart and Stroke Foundation of Ontario. GMA is supported by the University of Toronto chair in health management strategies.	Acotto CG, 1998, OSTEOPOROSIS INT, V8, P455, DOI 10.1007/s001980050091; Alibhai SMH, 2010, J UROLOGY, V184, P918, DOI 10.1016/j.juro.2010.04.068; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; Brennan MD, 2006, THYROID, V16, P375, DOI 10.1089/thy.2006.16.375; Canadian Institute of Health Information, 2010, DRUG US SEN PUBL DRU; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Dennis MS, 2002, STROKE, V33, P728, DOI 10.1161/hs0302.103621; DEWHALLEY P, 1995, BRIT J GEN PRACT, V45, P93; DUNCAN WE, 1994, THYROID, V4, P183, DOI 10.1089/thy.1994.4.183; ERIKSEN EF, 1985, BONE, V6, P421, DOI 10.1016/8756-3282(85)90218-2; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; GRANT DJ, 1993, CLIN ENDOCRINOL, V39, P529, DOI 10.1111/j.1365-2265.1993.tb02404.x; Guidelines and Protocols Advisory Committee, 2010, THYR FUNCT TESTS DIA; Hadji P, 2000, EUR J ENDOCRINOL, V142, P445, DOI 10.1530/eje.0.1420445; HALL R, 1979, CLIN ENDOCRINOL META, V8, P29, DOI 10.1016/S0300-595X(79)80007-9; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Hawker GA, 1997, J CLIN EPIDEMIOL, V50, P265, DOI 10.1016/S0895-4356(96)00368-X; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hoogendoorn EH, 2004, POSTGRAD MED J, V80, P394, DOI 10.1136/pgmj.2003.017095; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; KOPEC JA, 1990, J EPIDEMIOL COMMUN H, V44, P179, DOI 10.1136/jech.44.3.179; Lee JS, 2010, ARCH INTERN MED, V170, P1876, DOI 10.1001/archinternmed.2010.424; Leslie WD, 2007, BONE, V40, P991, DOI 10.1016/j.bone.2006.11.008; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liu B, 1998, LANCET, V351, P1303, DOI 10.1016/S0140-6736(97)09528-7; Mamdani M, 2007, OSTEOPOROSIS INT, V18, P1595, DOI 10.1007/s00198-007-0446-5; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; Mazziotti G, 2010, BONE, V46, P747, DOI 10.1016/j.bone.2009.10.031; Meier C, 2004, OSTEOPOROSIS INT, V15, P209, DOI 10.1007/s00198-003-1527-8; MOORADIAN AD, 1995, CLIN GERIATR MED, V11, P159, DOI 10.1016/S0749-0690(18)30288-X; OKOSIEME OE, 2010, QJM; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Rejnmark L, 2007, OSTEOPOROSIS INT, V18, P409, DOI 10.1007/s00198-006-0250-7; RICHARDS J, 2001, P STAT CAN S STAT CA; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; RIGGS BL, 1982, J CLIN INVEST, V70, P716, DOI 10.1172/JCI110667; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; ROBBINS J, 1981, ENVIRON HEALTH PERSP, V38, P65, DOI 10.2307/3429363; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; ROSS DS, 1989, J CLIN ENDOCR METAB, V69, P684, DOI 10.1210/jcem-69-3-684; SAWIN CT, 1989, JAMA-J AM MED ASSOC, V261, P2653, DOI 10.1001/jama.261.18.2653; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; SAWIN CT, 1983, AM J MED, V75, P206, DOI 10.1016/0002-9343(83)91192-0; SCHNEIDER DL, 1994, JAMA-J AM MED ASSOC, V271, P1245, DOI 10.1001/jama.271.16.1245; Sheppard MC, 2002, ARCH INTERN MED, V162, P338, DOI 10.1001/archinte.162.3.338; Somwaru LL, 2009, J CLIN ENDOCR METAB, V94, P1342, DOI 10.1210/jc.2008-1696; STALL GM, 1990, ANN INTERN MED, V113, P265, DOI 10.7326/0003-4819-113-4-265; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Surks MI, 2010, J CLIN ENDOCR METAB, V95, P496, DOI 10.1210/jc.2009-1845; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Trimpou P, 2010, OSTEOPOROSIS INT, V21, P409, DOI 10.1007/s00198-009-0961-7; *US THYR FUNCT TES, 2006, UK GUID US THYR FUNC; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P139, DOI 10.1007/s00223-005-0068-x; Vestergaard P, 2000, THYROID, V10, P335, DOI 10.1089/thy.2000.10.335; WEJDA B, 1995, J INTERN MED, V237, P241, DOI 10.1111/j.1365-2796.1995.tb01172.x; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005	70	77	79	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2011	342								d2238	10.1136/bmj.d2238	http://dx.doi.org/10.1136/bmj.d2238			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BV	21527461	Green Published, hybrid			2022-12-01	WOS:000290215900002
J	Hochberg, T				Hochberg, Todd			Moments held-photographing perinatal loss	LANCET			English	Editorial Material												todd@toddhochberg.com							0	4	5	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1310	1311		10.1016/S0140-6736(11)60528-X	http://dx.doi.org/10.1016/S0140-6736(11)60528-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21504088				2022-12-01	WOS:000289962900017
J	Tsutakawa, SE; Classen, S; Chapados, BR; Arvai, AS; Finger, LD; Guenther, G; Tomlinson, CG; Thompson, P; Sarker, AH; Shen, BH; Cooper, PK; Grasby, JA; Tainer, JA				Tsutakawa, Susan E.; Classen, Scott; Chapados, Brian R.; Arvai, Andrew S.; Finger, L. David; Guenther, Grant; Tomlinson, Christopher G.; Thompson, Peter; Sarker, Altaf H.; Shen, Binghui; Cooper, Priscilla K.; Grasby, Jane A.; Tainer, John A.			Human Flap Endonuclease Structures, DNA Double-Base Flipping, and a Unified Understanding of the FEN1 Superfamily	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; POLYMERASE-BETA; 3'-FLAP POCKET; BINDING; REPLICATION; EXONUCLEASE; CATALYSIS; PCNA	Flap endonuclease (FEN1), essential for DNA replication and repair, removes RNA and DNA 5' flaps. FEN1 5' nuclease superfamily members acting in nucleotide excision repair (XPG), mismatch repair (EXO1), and homologous recombination (GEN1) paradoxically incise structurally distinct bubbles, ends, or Holliday junctions, respectively. Here, structural and functional analyses of human FEN1: DNA complexes show structure-specific, sequence-independent recognition for nicked dsDNA bent 100 degrees with unpaired 3' and 5' flaps. Above the active site, a helical cap over a gateway formed by two helices enforces ssDNA threading and specificity for free 5' ends. Crystallographic analyses of product and substrate complexes reveal that dsDNA binding and bending, the ssDNA gateway, and double-base unpairing flanking the scissile phosphate control precise flap incision by the two-metal-ion active site. Superfamily conserved motifs bind and open dsDNA; direct the target region into the helical gateway, permitting only nonbase-paired oligonucleotides active site access; and support a unified understanding of superfamily substrate specificity.	[Tomlinson, Christopher G.; Thompson, Peter; Grasby, Jane A.] Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England; [Tsutakawa, Susan E.; Finger, L. David; Sarker, Altaf H.; Cooper, Priscilla K.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Classen, Scott] Scripps Res Inst, Phys Biosci Div, La Jolla, CA 92037 USA; [Chapados, Brian R.; Arvai, Andrew S.; Guenther, Grant; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Chapados, Brian R.; Arvai, Andrew S.; Guenther, Grant; Tainer, John A.] Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Finger, L. David; Shen, Binghui] City Hope Natl Med Ctr, Div Radiat Biol, Duarte, CA 91010 USA; [Finger, L. David; Shen, Binghui] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Shen, Binghui] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University of Sheffield; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Zhejiang University	Grasby, JA (corresponding author), Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk; jat@scripps.edu	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Tsutakawa, Susan/0000-0002-4918-4571; Shen, Binghui/0000-0002-4408-407X; Thompson, Peter/0000-0002-4688-3414; Finger, L. David/0000-0002-2342-9569	NIH/NCI [RO1CA081967, R01CA073764, P01 CA092584]; BBSRC [BBF0147321]; ALS [DE-AC02-05CH11231]; DOE; DOE, OBER; NIH; NCRR; Biomedical Technology Program; NIGMS; BBSRC [BB/F014732/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA073764, R01CA081967, P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [B19316, BB/F014732/1] Funding Source: researchfish	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ALS; DOE(United States Department of Energy (DOE)); DOE, OBER(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work on FEN1 is supported by the NIH/NCI through RO1CA081967, R01CA073764, and P01 CA092584 (SBDR) and by BBSRC (BBF0147321). Crystal data was collected at the SIBYLS beamline 12.3.1 (ALS, Contract DE-AC02-05CH11231) and beamline 11-1 (SSRL, supported by DOE, OBER, NIH, NCRR, Biomedical Technology Program, and the NIGMS). Morphing movies were produced with CHIMERA (NIH P41 RR-01081). We thank Hong Xu and Chiharu Hitomi for technical assistance and Gareth Williams, James Holton, Mike Pique, Elizabeth Getzoff, David Moiani, Cliff Ng, and Peter Burgers for contributing to the analyses.	Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; FINGER LD, 2010, FEN1 FLAP STRUCTURE; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Hohl M, 2003, J BIOL CHEM, V278, P19500, DOI 10.1074/jbc.M213155200; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ivanov I, 2007, P NATL ACAD SCI USA, V104, P1465, DOI 10.1073/pnas.0603468104; Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008; Kim CY, 2001, BIOCHEMISTRY-US, V40, P3208, DOI 10.1021/bi002100n; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Kuppuraj G, 2009, J PHYS CHEM B, V113, P2952, DOI 10.1021/jp807972e; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Navarro MS, 2007, GENETICS, V176, P1391, DOI 10.1534/genetics.107.073056; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Qiu JZ, 2002, J BIOL CHEM, V277, P24659, DOI 10.1074/jbc.M111941200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; ROBERTS VA, 1991, J BIOL CHEM, V266, P13431; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Schroeder GK, 2006, P NATL ACAD SCI USA, V103, P4052, DOI 10.1073/pnas.0510879103; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tumey LN, 2005, BIOORG MED CHEM LETT, V15, P277, DOI 10.1016/j.bmcl.2004.10.086; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu Y, 2001, J BIOL CHEM, V276, P30167, DOI 10.1074/jbc.M100985200; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	50	192	198	8	143	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					198	211		10.1016/j.cell.2011.03.004	http://dx.doi.org/10.1016/j.cell.2011.03.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496641	Green Accepted, Bronze			2022-12-01	WOS:000289549900010
J	Cooper, MA; Shlaes, D				Cooper, Matthew A.; Shlaes, David			Fix the antibiotics pipeline	NATURE			English	Editorial Material									[Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Cooper, MA (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	m.cooper@imb.uq.edu.au; shlaes.david@earthlink.net	Cooper, Matthew A./C-7988-2009	Cooper, Matthew A./0000-0003-3147-3460				[Anonymous], REPORT EUROPEAN COMM; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Mossialos E, 2009, POLICIES INCENTIVES	3	345	353	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					32	32		10.1038/472032a	http://dx.doi.org/10.1038/472032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745VV	21475175	Bronze			2022-12-01	WOS:000289199400018
J	OCarroll, DC; Bidwell, NJ; Laughlin, SB; Warrant, EJ				OCarroll, DC; Bidwell, NJ; Laughlin, SB; Warrant, EJ			Insect motion detectors matched to visual ecology	NATURE			English	Article							SENSITIVE NEURON; DETECTION SYSTEM; ADAPTATION; SELECTIVITY	To detect motion, primates, birds and insects all use local detectors to correlate signals sampled at one location in the image with those sampled after a delay at adjacent locations(1-10) These detectors can adapt to high image velocities by shortening the delay(11-13). To investigate whether they use long delays for detecting low velocities, we compared motion-sensitive neurons in ten species of fast-flying insects, some of which encounter low velocities while hovering. Neurons of bee-flies and hawkmoths, which hover, are tuned to lower temporal frequencies than those of butterflies and bumblebees, which do not. Tuning to low frequencies indicates longer delays and extends sensitivity to lower velocities, Hoverflies retain fast temporal tuning but use their high spatial acuity for sensing low-velocity motion. Thus an unexpectedly wide range of spatio-temporal tuning matches motion detection to visual ecology.	UNIV SUSSEX,CTR NEUROSCI,BRIGHTON BN1 9QG,E SUSSEX,ENGLAND; LUND UNIV,DEPT ZOOL,S-22362 LUND,SWEDEN	University of Sussex; Lund University	OCarroll, DC (corresponding author), UNIV CAMBRIDGE,DEPT ZOOL,DOWNING ST,CAMBRIDGE CB2 3EJ,ENGLAND.		O'Carroll, David C/C-4320-2008	O'Carroll, David C/0000-0002-2352-4320; Warrant, Eric/0000-0001-7480-7016				ANDERSON SJ, 1985, VISION RES, V25, P1147, DOI 10.1016/0042-6989(85)90104-X; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BIDWELL NJ, 1993, APIDOLOGIE, V24, P333, DOI 10.1051/apido:19930311; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Buchner E., 1984, PHOTORECEPTION VISIO, P561, DOI DOI 10.1007/978-1-4613-2743-1_16; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; FARINA WM, 1994, J COMP PHYSIOL A, V174, P239; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hausen K., 1989, P391; IBBOTSON MR, 1990, J EXP BIOL, V148, P255; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; MADDESS T, 1991, J EXP BIOL, V161, P171; MORGAN MJ, 1995, NATURE, V378, P380, DOI 10.1038/378380a0; REICHARDT W, 1957, Z NATURFORSCH PT B, V12, P448, DOI 10.1515/znb-1957-0707; Reichardt W., 1961, S PRINC SENS COMM, P303; SANTEN JPH, 1985, J OPT SOC AM A, V2, P300; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; WILSON HR, 1985, BIOL CYBERN, V51, P213, DOI 10.1007/BF00337147; WOLFOBERHOLLENZER F, 1994, J NEUROPHYSIOL, V71, P1559, DOI 10.1152/jn.1994.71.4.1559	22	113	115	2	45	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					63	66		10.1038/382063a0	http://dx.doi.org/10.1038/382063a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	21638927				2022-12-01	WOS:A1996UV47300053
J	Medenbach, J; Seiler, M; Hentze, MW				Medenbach, Jan; Seiler, Markus; Hentze, Matthias W.			Translational Control via Protein-Regulated Upstream Open Reading Frames	CELL			English	Article							MSL-2 MESSENGER-RNA; SEX-LETHAL; DOSAGE COMPENSATION; BINDING PROTEIN; DROSOPHILA; INITIATION; MECHANISM; GENE; RECOGNITION; REPRESSION	Analysis of the regulation of msl-2 mRNA by Sex lethal (SXL), which is critical for dosage compensation in Drosophila, has uncovered a mode of translational control based on common 50 untranslated region elements, upstream open reading frames (uORFs), and interaction sites for RNA-binding proteins. We show that SXL binding downstream of a short uORF imposes a strong negative effect on major reading frame translation. The underlying mechanism involves increasing initiation of scanning ribosomes at the uORF and augmenting its impediment to downstreamtranslation. Our analyses reveal that SXL exerts its effect controlling initiation, not elongation or termination, at the uORF. Probing the generality of the underlying mechanism, we show that the regulatorymodule that we define experimentally functions in a heterologous context, and we identify natural Drosophila mRNAs that are regulated via this module. We propose that protein-regulated uORFs constitute a systematic principle for the regulation of protein synthesis.	[Medenbach, Jan; Seiler, Markus; Hentze, Matthias W.] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Hentze, Matthias W/V-3980-2017; Medenbach, Jan/B-6877-2018	Hentze, Matthias W/0000-0002-4023-7876; Medenbach, Jan/0000-0003-0749-7788	Deutsche Forschungsgemeinschaft [FOR855 He 1442/13-1, FOR855 He 1442/13-2]; EMBO; NGFN DiGtoP	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); NGFN DiGtoP	We thank Anne Ephrussi for kindly providing a Drosophila PTB plasmid, Toby Gibson for generous support, the EMBL Protein Expression and Purification Core Facility for recombinant proteases, and members of the Hentze lab for useful discussions. We also thank an anonymous reviewer for insightful comments that enlightened our mechanistic model. This work was supported by Deutsche Forschungsgemeinschaft Grants FOR855 He 1442/13-1 and /13-2 to M.W.H. J.M. acknowledges a long-term postdoctoral fellowship from EMBO. M.S. was funded by the NGFN DiGtoP grant.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bopp D, 1996, DEVELOPMENT, V122, P971; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Grskovic M, 2003, EMBO J, V22, P5571, DOI 10.1093/emboj/cdg539; Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova T. V., 2007, TRANSLATIONAL CONTRO, P87; Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Seiler M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-144; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788	35	98	105	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					902	913		10.1016/j.cell.2011.05.005	http://dx.doi.org/10.1016/j.cell.2011.05.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663794	Bronze			2022-12-01	WOS:000291461600017
J	Schlutter, J				Schluetter, Jana			New drugs hit the target	NATURE			English	Editorial Material																			0	50	57	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S5	S7		10.1038/474S5a	http://dx.doi.org/10.1038/474S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666733	Bronze			2022-12-01	WOS:000291397800004
J	Mummery, C				Mummery, Christine			Induced Pluripotent Stem Cells - A Cautionary Note	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mummery, C (corresponding author), Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands.			Mummery, Christine/0000-0002-4549-6535				Dambrot C, 2011, BIOCHEM J, V434, P25, DOI 10.1042/BJ20101707; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a	5	42	45	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2160	2162		10.1056/NEJMcibr1103052	http://dx.doi.org/10.1056/NEJMcibr1103052			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21631331				2022-12-01	WOS:000291200700018
J	Magklara, A; Yen, A; Colquitt, BM; Clowney, EJ; Allen, W; Markenscoff-Papadimitriou, E; Evans, ZA; Kheradpour, P; Mountoufaris, G; Carey, C; Barnea, G; Kellis, M; Lomvardas, S				Magklara, Angeliki; Yen, Angela; Colquitt, Bradley M.; Clowney, E. Josephine; Allen, William; Markenscoff-Papadimitriou, Eirene; Evans, Zoe A.; Kheradpour, Pouya; Mountoufaris, George; Carey, Catriona; Barnea, Gilad; Kellis, Manolis; Lomvardas, Stavros			An Epigenetic Signature for Monoallelic Olfactory Receptor Expression	CELL			English	Article							ODORANT RECEPTORS; GENE-EXPRESSION; BASAL-CELLS; STEM-CELLS; CHROMATIN; FAMILY; ONTOGENY; DOMAINS; NEURONS; PROTEIN	Constitutive heterochromatin is traditionally viewed as the static form of heterochromatin that silences pericentromeric and telomeric repeats in a cell cycle-and differentiation-independent manner. Here, we show that, in the mouse olfactory epithelium, olfactory receptor (OR) genes are marked in a highly dynamic fashion with the molecular hallmarks of constitutive heterochromatin, H3K9me3 and H4K20me3. The cell type and developmentally dependent deposition of these marks along the OR clusters are, most likely, reversed during the process of OR choice to allow for monogenic and monoallelic OR expression. In contrast to the current view of OR choice, our data suggest that OR silencing takes place before OR expression, indicating that it is not the product of an OR-elicited feedback signal. Our findings suggest that chromatin-mediated silencing lays a molecular foundation upon which singular and stochastic selection for gene expression can be applied.	[Magklara, Angeliki; Evans, Zoe A.; Mountoufaris, George; Carey, Catriona; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Colquitt, Bradley M.; Markenscoff-Papadimitriou, Eirene; Lomvardas, Stavros] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Clowney, E. Josephine; Lomvardas, Stavros] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Yen, Angela; Kheradpour, Pouya; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yen, Angela; Kheradpour, Pouya; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Allen, William; Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Brown University	Lomvardas, S (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu	Colquitt, Bradley/AAR-7838-2021; Kellis, Manolis/ABE-7385-2020; Magklara, Angeliki/AAK-8347-2020	Colquitt, Bradley/0000-0001-5819-7924; Kellis, Manolis/0000-0001-7113-9630; Magklara, Angeliki/0000-0003-3408-6722; Lomvardas, Stavros/0000-0002-7668-3026; Clowney, Eleanor/0000-0002-9150-9464	National Science Foundation; Royce Fellowship; McKnight Endowment Fund for Neuroscience; Rett Syndrome Research Trust; Hellman Family Foundation; NIDCD [R03 DC010273]; Director's New Innovator Award Program [1DP2 OD006667]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006667] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Royce Fellowship; McKnight Endowment Fund for Neuroscience; Rett Syndrome Research Trust; Hellman Family Foundation; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Director's New Innovator Award Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Dr. Frank Margolis for the OMP-LacZ mouse strain, Dr. John Rubenstein for the Emx2 knockout mouse, Dr. James E. Schwob for the SUS4 antibody, Drs. Andrew Feinberg and Bo Wen for the primer sequences for the positive controls for the H3K9me2 ChIPs, and Dr. Richard Axel for the P2-IRES-GFP and OMP-IRES-GFP mice as well as for the helpful discussions and support. We would also like to thank Drs. Hiten Madhani, Barbara Panning, Nirao Shah, Dimitris Thanos, Tim Mcclintock, Kevin Monahan, and Keith Yamamoto for critical reading of the manuscript. B. M. C., E.J.C., and E. M.-P. are supported by fellowships from the National Science Foundation. W. A. is supported by a Royce Fellowship, G. B. is a Pew Scholar in the Biomedical Sciences, and S. L. is funded by the McKnight Endowment Fund for Neuroscience, Rett Syndrome Research Trust, Hellman Family Foundation, NIDCD (R03 DC010273), and Director's New Innovator Award Program (1DP2 OD006667).	Axel R, 2005, ANGEW CHEM INT EDIT, V44, P6110, DOI 10.1002/anie.200501726; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cau E, 2002, DEVELOPMENT, V129, P1871; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dickson J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000804; Duggan CD, 2007, NAT NEUROSCI, V10, P673, DOI 10.1038/nn0607-673; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Jang WC, 2007, J COMP NEUROL, V502, P367, DOI 10.1002/cne.21328; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Larson JL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-557; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; ROTHMAN A, 2008, CURR BIOL, V18, pR255; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Walters E, 1996, INT J DEV NEUROSCI, V14, P813, DOI 10.1016/S0736-5748(96)00063-9; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297	48	198	199	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2011	145	4					555	570		10.1016/j.cell.2011.03.040	http://dx.doi.org/10.1016/j.cell.2011.03.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21529909	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-01	WOS:000290560800009
J	Reisch, CR; Stoudemayer, MJ; Varaljay, VA; Amster, IJ; Moran, MA; Whitman, WB				Reisch, Chris R.; Stoudemayer, Melissa J.; Varaljay, Vanessa A.; Amster, I. Jonathan; Moran, Mary Ann; Whitman, William B.			Novel pathway for assimilation of dimethylsulphoniopropionate widespread in marine bacteria	NATURE			English	Article							ACYL-COENZYME-A; DIMETHYL SULFIDE; DIMETHYLSULFONIOPROPIONATE; SULFUR; DMSP; METHANETHIOL; DEGRADATION; METHIONINE; ABUNDANT; ENZYME	Dimethylsulphoniopropionate (DMSP) accounts for up to 10% of carbon fixed by marine phytoplankton in ocean surface waters(1,2), producing an estimated 11.7-103 T mol S per year(3), most of which is processed by marine bacteria through the demethylation/demethiolation pathway(4). This pathway releases methanethiol (MeSH) instead of the climatically active gas dimethylsulphide (DMS) and enables marine microorganisms to assimilate the reduced sulphur(5-7). Despite recognition of this critical microbial transformation for over two decades, the biochemical pathway and enzymes responsible have remained unidentified. Here we show that three new enzymes related to fatty acid beta-oxidation constitute the pathway that assimilates methylmercaptopropionate (MMPA), the first product of DMSP demethylation/demethiolation, and that two previously unknown coenzyme A (CoA) derivatives, 3-methylmercaptopropionyl-CoA (MMPA-CoA) and methylthioacryloyl-CoA (MTA-CoA), are formed as novel intermediates. A member of the marine roseobacters, Ruegeria pomeroyi DSS-3, requires the MMPA-CoA pathway for MMPA assimilation and MeSH production. This pathway and the ability to produce MeSH from MMPA are present in diverse bacteria, and the ubiquitous SAR11 clade bacterium Pelagibacter ubique possesses enzymes for at least the first two steps. Analysis of marine metagenomic data indicates that the pathway is widespread among bacterioplankton in the ocean surface waters, making it one of the most important known routes for acquisition of reduced carbon and sulphur by surface ocean heterotrophs.	[Reisch, Chris R.; Varaljay, Vanessa A.; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Moran, Mary Ann] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Stoudemayer, Melissa J.; Amster, I. Jonathan] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Whitman, WB (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	whitman@uga.edu	Whitman, William/AAC-5896-2020; Moran, Mary Ann/B-6939-2012; Amster, Jon/D-6957-2011	Amster, Jon/0000-0001-7523-5144; Whitman, William/0000-0003-1229-0423; Stoudemayer, Melissa/0000-0002-2967-9948; Moran, Mary Ann/0000-0002-0702-8167	National Science Foundation [MCB-0702125, OCE-0724017]; Gordon and Betty Moore Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank G. Wylie for assistance with NMR spectroscopy, S. Sharma, S. Sun and H. Luo for bioinformatics assistance, S. Gifford for technical advice, C. Smith and W. Crabb for technical assistance, and C. English for assistance with graphics. Funding for this research was provided by the National Science Foundation (MCB-0702125 and OCE-0724017) and the Gordon and Betty Moore Foundation.	ANDREAE MO, 1990, MAR CHEM, V30, P1, DOI 10.1016/0304-4203(90)90059-L; Archer SD, 2001, AQUAT MICROB ECOL, V24, P225, DOI 10.3354/ame024225; BELL RP, 1949, PROC R SOC LON SER-A, V197, P141, DOI 10.1098/rspa.1949.0055; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; CHAMBERS ST, 1987, J BACTERIOL, V169, P4845, DOI 10.1128/jb.169.10.4845-4847.1987; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P1099, DOI 10.1111/j.1462-2920.2008.01592.x; DEUTSCH J, 1994, ANAL BIOCHEM, V220, P321, DOI 10.1006/abio.1994.1344; Gonzalez JM, 2003, INT J SYST EVOL MICR, V53, P1261, DOI 10.1099/ijs.0.02491-0; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; GUPTA N K, 1970, Archives of Biochemistry and Biophysics, V141, P632, DOI 10.1016/0003-9861(70)90183-9; HENRIKSEN JR, 2008, THESIS U GEORGIA; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; KIENE RP, 1988, APPL ENVIRON MICROB, V54, P2208, DOI 10.1128/AEM.54.9.2208-2212.1988; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Kiene RP, 1996, MAR CHEM, V54, P69, DOI 10.1016/0304-4203(96)00006-0; Koch Arthur L., 1994, P248; Ledyard KM, 1996, LIMNOL OCEANOGR, V41, P33, DOI 10.4319/lo.1996.41.1.0033; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; MYERS RW, 1993, J BIOL CHEM, V268, P24785; Neidhardt F.C., 1990, PHYSL BACTERIAL CELL; Reisch CR, 2008, J BACTERIOL, V190, P8018, DOI 10.1128/JB.00770-08; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Taylor BF, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P265; TAYLOR BF, 1991, APPL ENVIRON MICROB, V57, P3581, DOI 10.1128/AEM.57.12.3581-3584.1991; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; van Duyl FC, 1998, J SEA RES, V40, P221, DOI 10.1016/S1385-1101(98)00024-0; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000	38	94	104	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					208	+		10.1038/nature10078	http://dx.doi.org/10.1038/nature10078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562561				2022-12-01	WOS:000290487200037
J	Pattinson, R; Kerber, K; Buchmann, E; Friberg, IK; Belizan, M; Lansky, S; Weissman, E; Mathai, M; Rudan, I; Walker, N; Lawn, JE				Pattinson, Robert; Kerber, Kate; Buchmann, Eckhart; Friberg, Ingrid K.; Belizan, Maria; Lansky, Sonia; Weissman, Eva; Mathai, Matthews; Rudan, Igor; Walker, Neff; Lawn, Joy E.		Lancet's Stillbirths Series Steeri	Stillbirths 4 Stillbirths: how can health systems deliver for mothers and babies?	LANCET			English	Article							MATERNAL MORTALITY; CHILD HEALTH; OBSTETRIC CARE; GLOBAL HEALTH; PRETERM BIRTH; NEWBORN; INTERVENTIONS; CHALLENGES; FACILITIES; CONTINUUM	The causes of stillbirths are inseparable from the causes of maternal and neonatal deaths. This report focuses on prevention of stillbirths by scale-up of care for mothers and babies at the health-system level, with consideration for effects and cost. In countries with high mortality rates, emergency obstetric care has the greatest effect on maternal and neonatal deaths, and on stillbirths. Syphilis detection and treatment is of moderate effect but of lower cost and is highly feasible. Advanced antenatal care, including induction for post-term pregnancies, and detection and management of hypertensive disease, fetal growth restriction, and gestational diabetes, will further reduce mortality, but at higher cost. These interventions are best packaged and provided through linked service delivery methods tailored to suit existing health-care systems. If 99% coverage is reached in 68 priority countries by 2015, up to 1.1 million (45%) third-trimester stillbirths, 201000 (54%) maternal deaths, and 1.4 million (43%) neonatal deaths could be saved per year at an additional total cost of US$10.9 billion or $2.32 per person, which is in the range of $0.96-2.32 for other ingredients-based intervention packages with only recurrent costs.	[Pattinson, Robert; Belizan, Maria] Univ Pretoria, Dept Obstet & Gynaecol, Med Res Council Maternal & Infant Hlth Care Strat, ZA-0001 Pretoria, South Africa; [Kerber, Kate; Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Buchmann, Eckhart] Chris Hani Baragwanath Hosp, Dept Obstet & Gynaecol, Johannesburg, South Africa; [Buchmann, Eckhart] Univ Witwatersrand, Johannesburg, South Africa; [Friberg, Ingrid K.; Walker, Neff] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Belizan, Maria] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Lansky, Sonia] Univ Fed Minas Gerais, Belo Horizonte Hlth Dept, Belo Horizonte, MG, Brazil; [Weissman, Eva] Futures Inst, New York, NY USA; [Mathai, Matthews] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England	University of Pretoria; Save the Children; University of Witwatersrand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Minas Gerais; World Health Organization; University of Split; University of Edinburgh; University of London; University College London	Pattinson, R (corresponding author), Univ Pretoria, Dept Obstet & Gynaecol, Med Res Council Maternal & Infant Hlth Care Strat, POB 667, ZA-0001 Pretoria, South Africa.	robert.pattinson@up.ac.za	Lawn, Joy/ABE-6382-2020; Rudan, Igor/I-1467-2012; Flenady, Vicki Jane/O-9609-2014	Lawn, Joy/0000-0002-4573-1443; Rudan, Igor/0000-0001-6993-6884; Flenady, Vicki Jane/0000-0001-8114-7677; Belizan, Maria/0000-0002-8739-5249; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Bill & Melinda Gates Foundation; Global Alliance to Prevent Prematurity and Stillbirth; Partnership for Maternal, Newborn and Child Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Global Alliance to Prevent Prematurity and Stillbirth; Partnership for Maternal, Newborn and Child Health	Some technical work and travel for this report during 2010 were funded through a grant for The Lancet's Series from the Bill & Melinda Gates Foundation to the International Stillbirth Alliance secretariat. JEL and KK are funded by the Bill & Melinda Gates Foundation through Saving Newborn Lives/Save the Children. Some meetings and travel were partially funded by the Global Alliance to Prevent Prematurity and Stillbirth and the Partnership for Maternal, Newborn and Child Health. The funding organisations had no role in the drafting or direction of this report. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers. We thank Robert Goldenberg for helpful insights and thoughtful review of this paper; and scorers for the Child Health and Nutrition Research Initiative research priority setting exercise (in alphabetical order): Hassan Baaqeel, Zulfiqar A Bhutta, Betty Chacko, Evita Fernandez, Rajshree Jha, Ruby Jose, James Machoki M'Imunya, Suneeta Mittal, Nafissa Bique Osman, Zahida Qureshi, Gary L Darmstadt, Louise Day, Nighat Shah, Nilofer Babar, Shabnam Khowaja, and Sidrah Nausheen for low-income countries; and Hany Abdel-Aleem, Jose M Belizan, Jackie Ho, Ravindran Jegasothy, Tippawan Liabsuetrakul, Deepika Attygalle, Eckhart Buchmann, Jose Guilherme Cecatti, Yolanda Contreras Garcia, Glen Mola, Neil Moran, Metin Gulmezoglu, Matthews Mathai, Jose Ortiz-Segarra, Robert Pattinson, Alejandro Vargas, Paulino Vigil-De Gracia, and Juan Carlos Vazquez for middle-income countries.	Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; [Anonymous], 2010, TRENDS MAT MORT 1990; Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; BLENCOWE H, INT J EPIDEMIOL S1, V39, P110; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Chivu CM, 2008, AM J HEALTH PROMOT, V22, P237, DOI 10.4278/06051566R2.1; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; *GUTTM I, FACTS INV FAM PLANN; Hodnett ED, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub2; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Hounton S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1947; *INT HLTH PARTN, 2009, TASKF INN INT FIN HL; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; LAWN J, 2005, TRACKING PROGR CHILD; LAWN J, 2005, DIS CONTROL PRIORITI; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Management Sciences for Health, INT DRUG PRIC IND GU, V2014; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; MEADS CA, 2008, HEALTH TECHNOL ASSES, V12, pR3, DOI DOI 10.3310/hta12060; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; OPIYO N, 2010, COCHRANE DB SYST REV, V4; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Shiffman J, 2009, B WORLD HEALTH ORGAN, V87, P608, DOI 10.2471/BLT.08.060749; Singh S., 2009, ADDING IT COSTS BENE; *SKILL CAR IN, 2007, TEST APPR INCR SKILL; SOWDEN A, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001291; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; UNICEF, SUPPL CAT; Victora CG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S4; Vidanapathirana J, 2005, COCHRANE DB SYST REV, V3; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; *WHO, 2009, REC INT IMPR MAT NEW; *WHO, 2010, CHOOSING INT AR COST; *WHO COMM MACR HLT, 2002, IMPR HLTH OUTC POOR; World Health Organization (WHO), 2005, WORLD HLTH REP 2005	62	122	122	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1610	1623		10.1016/S0140-6736(10)62306-9	http://dx.doi.org/10.1016/S0140-6736(10)62306-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	763IJ	21496910	Green Submitted			2022-12-01	WOS:000290549700035
J	Papadopoulou, M; Cassenaer, S; Nowotny, T; Laurent, G				Papadopoulou, Maria; Cassenaer, Stijn; Nowotny, Thomas; Laurent, Gilles			Normalization for Sparse Encoding of Odors by a Wide-Field Interneuron	SCIENCE			English	Article							MUSHROOM BODY; OLFACTORY SYSTEM; ANTENNAL LOBE; LOCUST; CORTEX; REPRESENTATIONS; NEURONS; OSCILLATIONS; SEQUENCES; SYNAPSES	Sparse coding presents practical advantages for sensory representations and memory storage. In the insect olfactory system, the representation of general odors is dense in the antennal lobes but sparse in the mushroom bodies, only one synapse downstream. In locusts, this transformation relies on the oscillatory structure of antennal lobe output, feed-forward inhibitory circuits, intrinsic properties of mushroom body neurons, and connectivity between antennal lobe and mushroom bodies. Here we show the existence of a normalizing negative-feedback loop within the mushroom body to maintain sparse output over a wide range of input conditions. This loop consists of an identifiable "giant" nonspiking inhibitory interneuron with ubiquitous connectivity and graded release properties.	[Papadopoulou, Maria; Cassenaer, Stijn; Laurent, Gilles] CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Cassenaer, Stijn] CALTECH, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Nowotny, Thomas] Univ Sussex, Sch Informat, CCNR, Brighton BN1 9QJ, E Sussex, England; [Laurent, Gilles] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	California Institute of Technology; California Institute of Technology; University of Sussex; Max Planck Society	Laurent, G (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	gilles.laurent@brain.mpg.de	Laurent, Gilles/A-4583-2012; Nowotny, Thomas/C-3883-2012	Laurent, Gilles/0000-0002-2296-114X; Nowotny, Thomas/0000-0002-4451-915X	National Institute for Deafness and Communications Disorders; Lawrence Hanson Fund; Max Planck Society; Office of Naval Research [N00014-07-1-0741, N00014-10-1-0735]; Evolved Machines, Inc.; Research Council of UK; Biotechnology and Biological Sciences Research Council (UK) [BB/F005113/1]; BBSRC [BB/F005113/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005113/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500315/1] Funding Source: researchfish	National Institute for Deafness and Communications Disorders; Lawrence Hanson Fund; Max Planck Society(Max Planck SocietyFoundation CELLEX); Office of Naval Research(Office of Naval Research); Evolved Machines, Inc.; Research Council of UK; Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank G. Turner fur help with early locust experiments; V. Jayaraman, G. Turner, and G. Jefferis for help with the Drosophila recordings (fig. S9); and the Caltech Imaging Center for use of a confocal microscope. This work was funded by the National Institute for Deafness and Communications Disorders (G.L.), the Lawrence Hanson Fund (G.L.), the Max Planck Society the Office of Naval Research (grants N00014-07-1-0741 and N00014-10-1-0735 to G.L. and S.C.), a grant from Evolved Machines, Inc. (G.L. and M.P.), a Research Council of UK Academic Fellowship, and a grant from the Biotechnology and Biological Sciences Research Council (UK grant number BB/F005113/1) (T.N.).	Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; BURROWS M, 1978, J PHYSIOL-LONDON, V285, P231, DOI 10.1113/jphysiol.1978.sp012569; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kanerva P, 1988, SPARSE DISTRIBUTED M; LAURENT G, 1994, J NEUROSCI, V14, P2993; Leitch B, 1996, J COMP NEUROL, V372, P487; Li YS, 1997, J COMP NEUROL, V387, P631; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WATSON AHD, 1985, J COMP NEUROL, V240, P219, DOI 10.1002/cne.902400302; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	21	130	130	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					721	725		10.1126/science.1201835	http://dx.doi.org/10.1126/science.1201835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551062	Green Accepted			2022-12-01	WOS:000290265800044
J	Bader, M; Benjamin, S; Wapinski, OL; Smith, DM; Goldberg, AL; Steller, H				Bader, Maya; Benjamin, Sigi; Wapinski, Orly L.; Smith, David M.; Goldberg, Alfred L.; Steller, Hermann			A Conserved F Box Regulatory Complex Controls Proteasome Activity in Drosophila	CELL			English	Article							MEIOTIC CELL-CYCLE; CASPASE ACTIVITY; 20S PROTEASOMES; SPERMATID DIFFERENTIATION; PROTEIN-DEGRADATION; 26S PROTEASOMES; ACTIVATOR PA28; BETA-TUBULIN; CYTOCHROME-C; MELANOGASTER	The ubiquitin-proteasome system catalyzes the degradation of intracellular proteins. Although ubiquitination of proteins determines their stabilities, there is growing evidence that proteasome function is also regulated. We report the functional characterization of a conserved proteasomal regulatory complex. We identified DmPI31 as a binding partner of the F box protein Nutcracker, a component of an SCF ubiquitin ligase (E3) required for caspase activation during sperm differentiation in Drosophila. DmPI31 binds Nutcracker via a conserved mechanism that is also used by mammalian FBXO7 and PI31. Nutcracker promotes DmPI31 stability, which is necessary for caspase activation, proteasome function, and sperm differentiation. DmPI31 can activate 26S proteasomes in vitro, and increasing DmPI31 levels suppresses defects caused by diminished proteasome activity in vivo. Furthermore, loss of DmPI31 function causes lethality, cell-cycle abnormalities, and defects in protein degradation, demonstrating that DmPI31 is physiologically required for normal proteasome activity.	[Bader, Maya; Benjamin, Sigi; Wapinski, Orly L.; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Smith, David M.; Goldberg, Alfred L.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Steller, H (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	steller@rockefeller.edu	Smith, David/AAL-7662-2020	Smith, David/0000-0002-1502-676X	Rockefeller University; NIH [RO1GM60124]; NIGMS; Multiple Myeloma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	Rockefeller University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Multiple Myeloma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. Zucker, R. Lehmann, HD, Ryoo, L. Vosshall, and J. Belote for fly strains. R. Lehmann generously shared the Vasa antibody. B. Chait and M. Sekedat were a tremendous help in setting up the proteomic screen. E. Arama devised the original male-sterile screen. Members of the Vosshall lab consulted on generating homologous recombination mutants and provided materials. K. Sobczyk participated in the proteasome-activity experiments. We thank M. Garcia-Fernandez and M. Pratt for critically reading this manuscript. O. Wapinski was supported by The Rockefeller University SURF Program. H. Steller is an investigator of the Howard Hughes Medical Institute. This work was supported by NIH grant RO1GM60124 to H.S. and by grants from the NIGMS and the Multiple Myeloma Foundation to A.L.G.	Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227; Fuller MT., 1993, DEV DROSOPHILA MELAN, VI; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; GAUHAR Z, 2008, DROSOPHILA MELANOGAS; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Haas KF, 2007, BIOL CELL, V99, P615, DOI 10.1042/BC20070019; Hime GR, 1996, J CELL SCI, V109, P2779; HOYLE HD, 1995, DEV GENET, V16, P148, DOI 10.1002/dvg.1020160208; Jin ZG, 2005, DEVELOPMENT, V132, P4075, DOI 10.1242/dev.01965; KEMPHUES KJ, 1980, CELL, V21, P445, DOI 10.1016/0092-8674(80)90481-X; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lin TY, 1996, DEVELOPMENT, V122, P1331; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MA CP, 1992, J BIOL CHEM, V267, P10515; Masson P, 2001, J BIOL CHEM, V276, P1383, DOI 10.1074/jbc.M007379200; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; ORRWEAVER TL, 1994, TRENDS GENET, V10, P321, DOI 10.1016/0168-9525(94)90035-3; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanahashi N, 1997, GENES CELLS, V2, P195, DOI 10.1046/j.1365-2443.1997.d01-308.x; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Zaiss DMW, 1999, FEBS LETT, V457, P333, DOI 10.1016/S0014-5793(99)01072-8; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299; Zhong L, 2007, DEVELOPMENT, V134, P3517, DOI 10.1242/dev.004770	52	65	71	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					371	382		10.1016/j.cell.2011.03.021	http://dx.doi.org/10.1016/j.cell.2011.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529711	Green Accepted, Bronze			2022-12-01	WOS:000290022900007
J	Geller, RJ				Geller, Robert J.			Shake-up time for Japanese seismology	NATURE			English	Editorial Material							EARTHQUAKE		Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	University of Tokyo	Geller, RJ (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	bob@eps.s.u-tokyo.ac.jp	Geller, Robert J/A-1753-2009	Geller, Robert J/0000-0001-6628-9431				ANDO M, 1975, TECTONOPHYSICS, V25, P69, DOI 10.1016/0040-1951(75)90011-6; ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; Geller RJ, 1997, GEOPHYS J INT, V131, P425, DOI 10.1111/j.1365-246X.1997.tb06588.x; Headquarters for Earthquake Research Promotion, 2005, NAT SEISM HAZ MAPS J; Kagan YY, 1996, B SEISMOL SOC AM, V86, P274; KAGAN YY, 1991, J GEOPHYS RES-SOL EA, V96, P21419, DOI 10.1029/91JB02210; Kanamori H., 1995, SEISMOL RES LETT, V66, P7; McCaffrey R, 2008, GEOLOGY, V36, P263, DOI 10.1130/G24402A.1; Newman A., 2001, SEISMOLOGICAL RES LE, V72, P647; 1973, NATURE, V245, P174	10	132	135	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					407	409		10.1038/nature10105	http://dx.doi.org/10.1038/nature10105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	755QC	21490595	Bronze			2022-12-01	WOS:000289949600009
J	Bonnin, A; Goeden, N; Chen, K; Wilson, ML; King, J; Shih, JC; Blakely, RD; Deneris, ES; Levitt, P				Bonnin, Alexandre; Goeden, Nick; Chen, Kevin; Wilson, Melissa L.; King, Jennifer; Shih, Jean C.; Blakely, Randy D.; Deneris, Evan S.; Levitt, Pat			A transient placental source of serotonin for the fetal forebrain	NATURE			English	Article							NORMAL ANXIETY-LIKE; TRYPTOPHAN 2,3-DIOXYGENASE; AGGRESSIVE-BEHAVIOR; MONOAMINE-OXIDASE; BRAIN-SEROTONIN; EXPRESSION; MICE; TRANSPORTER; NEURONS; PREGNANCY	Serotonin (5-hydroxytryptamine or 5-HT) is thought to regulate neurodevelopmental processes through maternal-fetal interactions that have long-term mental health implications. It is thought that beyond fetal 5-HT neurons there are significant maternal contributions to fetal 5-HT during pregnancy(1,2) but this has not been tested empirically. To examine putative central and peripheral sources of embryonic brain 5-HT, we used Pet1(-/-) (also called Fev) mice in which most dorsal raphe neurons lack 5-HT3. We detected previously unknown differences in accumulation of 5-HT between the forebrain and hindbrain during early and late fetal stages, through an exogenous source of 5-HT which is not of maternal origin. Using additional genetic strategies, a new technology for studying placental biology ex vivo and direct manipulation of placental neosynthesis, we investigated the nature of this exogenous source. We uncovered a placental 5-HT synthetic pathway from a maternal tryptophan precursor in both mice and humans. This study reveals a new, direct role for placental metabolic pathways in modulating fetal brain development and indicates that maternal-placental-fetal interactions could underlie the pronounced impact of 5-HT on long-lasting mental health outcomes.	[Bonnin, Alexandre; Goeden, Nick; Levitt, Pat] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Bonnin, Alexandre; Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Chen, Kevin; Shih, Jean C.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Wilson, Melissa L.; King, Jennifer] Univ So Calif, Keck Sch Med, Dept OB GYN, Los Angeles, CA 90089 USA; [Wilson, Melissa L.; King, Jennifer] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Blakely, Randy D.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37221 USA; [Blakely, Randy D.] Vanderbilt Univ, Ctr Mol Neurosci, Med Ctr, Nashville, TN 37221 USA; [Deneris, Evan S.] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Vanderbilt University; Vanderbilt University; Case Western Reserve University	Bonnin, A (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	bonnin@usc.edu; plevitt@usc.edu	Wilson, Melissa/P-3100-2017; Chen, Kevin/GYU-8963-2022	Wilson, Melissa/0000-0001-7785-4221; 	NICHD [5R21HD065287]; NARSAD; NIMH [R01MH39085, 1P50MH078280A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039085, P50MH078028] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NARSAD(NARSAD); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. H. Wu and K. Eagleson for discussions and comments on the manuscript. We thank R. Johnson (Vanderbilt HPLC core facility), L. Zhang for technical help and E. Meng for discussions. This work was supported by the NICHD (grant 5R21HD065287 to A. B.), NARSAD (A. B.) and the NIMH (grant R01MH39085 to J.C.S. and 1P50MH078280A1 to R. D. B. and P.L.).	AITKEN AR, 1988, J COMP NEUROL, V274, P32, DOI 10.1002/cne.902740105; Anderson GM, 2002, MOL PSYCHIATR, V7, P831, DOI 10.1038/sj.mp.4001099; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; BRANCHEK TA, 1989, J COMP NEUROL, V285, P262, DOI 10.1002/cne.902850208; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Chen K, 2007, J BIOL CHEM, V282, P115, DOI 10.1074/jbc.M609830200; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; HOWD RA, 1975, LIFE SCI, V17, P803, DOI 10.1016/0024-3205(75)90538-X; Jawerbaum A, 2010, ENDOCR REV, V31, P680, DOI 10.1210/er.2009-0038; JOHANSEN PA, 1995, J NEUROCHEM, V65, P882; Kanai M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-8; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; KUHN DM, 1980, J BIOL CHEM, V255, P4137; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lebrand C, 1998, J COMP NEUROL, V401, P506; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Lynn-Bullock CP, 2004, J CHEM NEUROANAT, V27, P129, DOI 10.1016/j.jchemneu.2004.02.003; Miller CL, 2009, SCHIZOPHR RES, V113, P259, DOI 10.1016/j.schres.2009.05.014; Nabi R, 2004, AM J MED GENET B, V125B, P63, DOI 10.1002/ajmg.b.20147; Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; ROBSON JM, 1964, BRIT J PHARM CHEMOTH, V22, P380, DOI 10.1111/j.1476-5381.1964.tb02043.x; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; Suzuki S, 2001, BIOCHEM J, V355, P425, DOI 10.1042/0264-6021:3550425; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; YAVARONE MS, 1993, PLACENTA, V14, P149, DOI 10.1016/S0143-4004(05)80257-7	35	361	369	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					347	U246		10.1038/nature09972	http://dx.doi.org/10.1038/nature09972			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512572	Green Published, Green Accepted			2022-12-01	WOS:000289724600039
J	Morris, K				Morris, Kelly			Shershah Syed: improving maternal care in Pakistan	LANCET			English	Editorial Material												kellyvitalwriter@gmail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1309	1309		10.1016/S0140-6736(11)60527-8	http://dx.doi.org/10.1016/S0140-6736(11)60527-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21497689	Bronze			2022-12-01	WOS:000289962900016
J	Mullan, Z; Horton, R				Mullan, Zoe; Horton, Richard			Bringing stillbirths out of the shadows	LANCET			English	Editorial Material									[Mullan, Zoe; Horton, Richard] The Lancet, London NW1 7BY, England		Mullan, Z (corresponding author), The Lancet, London NW1 7BY, England.	zoe.mullan@lancet.com						BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; *STILLB NEON DEATH, WHAT IS WHY 17; World Health Organization, GLOB BURD DIS GBD	10	43	46	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1291	1292		10.1016/S0140-6736(11)60098-6	http://dx.doi.org/10.1016/S0140-6736(11)60098-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21496920				2022-12-01	WOS:000289962900004
J	Aubin-Tam, ME; Olivares, AO; Sauer, RT; Baker, TA; Lang, MJ				Aubin-Tam, Marie-Eve; Olivares, Adrian O.; Sauer, Robert T.; Baker, Tania A.; Lang, Matthew J.			Single-Molecule Protein Unfolding and Translocation by an ATP-Fueled Proteolytic Machine	CELL			English	Article							PLUS CLPXP PROTEASE; OPERATING PRINCIPLES; DEPENDENT PROTEASES; DEGRADATION MACHINE; FORCE SPECTROSCOPY; RNA-POLYMERASE; PORE LOOPS; DENATURATION; RECOGNITION; BINDING	All cells employ ATP-powered proteases for protein-quality control and regulation. In the ClpXP protease, ClpX is a AAA+ machine that recognizes specific protein substrates, unfolds these molecules, and then translocates the denatured polypeptide through a central pore and into ClpP for degradation. Here, we use optical-trapping nanometry to probe the mechanics of enzymatic unfolding and translocation of single molecules of a multidomain substrate. Our experiments demonstrate the capacity of ClpXP and ClpX to perform mechanical work under load, reveal very fast and highly cooperative unfolding of individual substrate domains, suggest a translocation step size of 5-8 amino acids, and support a power-stroke model of denaturation in which successful enzyme-mediated unfolding of stable domains requires coincidence between mechanical pulling by the enzyme and a transient stochastic reduction in protein stability. We anticipate that single-molecule studies of the mechanical properties of other AAA+ proteolytic machines will reveal many shared features with ClpXP.	[Aubin-Tam, Marie-Eve; Olivares, Adrian O.; Sauer, Robert T.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Aubin-Tam, Marie-Eve; Lang, Matthew J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Lang, Matthew J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tabaker@mit.edu; matt.lang@vanderbilt.edu	Aubin-Tam, Marie-Eve/F-5253-2012; Aubin-Tam, Marie-Eve/J-3337-2013; Olivares, Adrian/D-7717-2012	Aubin-Tam, Marie-Eve/0000-0001-9995-2623; Olivares, Adrian/0000-0002-0895-7988; Sauer, Robert/0000-0002-1719-5399	National Science Foundation [0643745]; Howard Hughes Medical Institute; National Institutes of Health [AI-15706, AI-82929]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015706, F32AI082929, R37AI015706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988] Funding Source: NIH RePORTER; Direct For Biological Sciences [1118490] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank F. Nakamura for filamin-A plasmids and S. Glynn, J. Kardon, A. Nager, B. Stinson, Y. Shin, and other members of our labs for advice and discussions. This study was supported by National Science Foundation Career Award 0643745 (M.J.L.), the Howard Hughes Medical Institute, and National Institutes of Health grants AI-15706 and AI-82929 (A.O.O.). T.A.B. is an employee of the Howard Hughes Medical Institute.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Aubin-Tam ME, 2011, J PHYS CHEM A, V115, P3657, DOI 10.1021/jp1031493; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Burton BM, 2001, MOL CELL, V8, P449, DOI 10.1016/S1097-2765(01)00307-0; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Fucini P, 1997, NAT STRUCT BIOL, V4, P223, DOI 10.1038/nsb0397-223; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hersch GL, 2005, CELL, V121, P1017, DOI 10.1016/j.cell.2005.05.024; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Hwang W, 2009, CELL BIOCHEM BIOPHYS, V54, P11, DOI 10.1007/s12013-009-9049-4; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Los GV, 2007, METH MOL B, V356, P195; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Martin A, 2007, MOL CELL, V27, P41, DOI 10.1016/j.molcel.2007.05.024; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlierf M, 2007, BIOPHYS J, V93, P3989, DOI 10.1529/biophysj.107.114397; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Taniguchi Y, 2010, LANGMUIR, V26, P10433, DOI 10.1021/la101658a; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200	49	188	190	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					257	267		10.1016/j.cell.2011.03.036	http://dx.doi.org/10.1016/j.cell.2011.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496645	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000289549900014
J	Egan, A; Colman, E				Egan, Amy; Colman, Eric			Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Egan, Amy; Colman, Eric] US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Metab & Endocrinol Prod, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Egan, A (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Metab & Endocrinol Prod, Silver Spring, MD USA.		Hug, Balthasar L./G-1568-2010					Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Smith MEB., 2009, DRUG CLASS REV HMG C	5	78	83	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					285	287		10.1056/NEJMp1106689	http://dx.doi.org/10.1056/NEJMp1106689			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21675881	Bronze			2022-12-01	WOS:000293172200001
J	Qian, BZ; Li, JF; Zhang, H; Kitamura, T; Zhang, JH; Campion, LR; Kaiser, EA; Snyder, LA; Pollard, JW				Qian, Bin-Zhi; Li, Jiufeng; Zhang, Hui; Kitamura, Takanori; Zhang, Jinghang; Campion, Liam R.; Kaiser, Elizabeth A.; Snyder, Linda A.; Pollard, Jeffrey W.			CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis	NATURE			English	Article							CHEMOATTRACTANT PROTEIN-1; BLOOD MONOCYTES; EXPRESSION; MODEL; PROGRESSION; SURVIVAL; SUBSETS; CELLS	Macrophages, which are abundant in the tumour microenvironment, enhance malignancy(1). At metastatic sites, a distinct population of metastasis-associated macrophages promotes the extravasation, seeding and persistent growth of tumour cells(2). Here we define the origin of these macrophages by showing that Gr1-positive inflammatory monocytes are preferentially recruited to pulmonary metastases but not to primary mammary tumours in mice. This process also occurs for human inflammatory monocytes in pulmonary metastases of human breast cancer cells. The recruitment of these inflammatory monocytes, which express CCR2 (the receptor for chemokine CCL2), as well as the subsequent recruitment of metastasis-associated macrophages and their interaction with metastasizing tumour cells, is dependent on CCL2 synthesized by both the tumour and the stroma. Inhibition of CCL2-CCR2 signalling blocks the recruitment of inflammatory monocytes, inhibits metastasis in vivo and prolongs the survival of tumour-bearing mice. Depletion of tumour-cell-derived CCL2 also inhibits metastatic seeding. Inflammatory monocytes promote the extravasation of tumour cells in a process that requires monocyte-derived vascular endothelial growth factor. CCL2 expression and macrophage infiltration are correlated with poor prognosis and metastatic disease in human breast cancer(3-6). Our data provide the mechanistic link between these two clinical associations and indicate new therapeutic targets for treating metastatic breast cancer.	[Qian, Bin-Zhi; Li, Jiufeng; Zhang, Hui; Kitamura, Takanori; Pollard, Jeffrey W.] Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Zhang, Jinghang] Albert Einstein Coll Med, Flow Cytometry Core Facil, Bronx, NY 10461 USA; [Campion, Liam R.; Kaiser, Elizabeth A.; Snyder, Linda A.] Ortho Biotech Oncol R&D, Radnor, PA 19087 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Johnson & Johnson; Johnson & Johnson USA	Pollard, JW (corresponding author), Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	pollard@aecom.yu.edu		Kitamura, Takanori/0000-0003-2032-3918	NIH [NIH PO1 CA100324, RO1 CA131270]; Albert Einstein Cancer Center Core [P30 CA 13330]; MRC [G1002033] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA131270, P30CA013330, P01CA100324] Funding Source: NIH RePORTER; Medical Research Council [G1002033] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center Core; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the NIH to J.W.P.(NIH PO1 CA100324 and RO1 CA131270) and to the Albert Einstein Cancer Center Core (P30 CA 13330). We thank J. Massague for 4173 cells and N. Ferrara for the Vegfa<SUP>flox/flox</SUP> mice. We also thank P. Marsters for statistical analyses and M. Thompson, F. Shi, C. Ferrante, F. McCabe, H. Millar-Quinn and D. Wiley for discussions and technical assistance.	Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Brandt B, 2005, SEMIN CANCER BIOL, V15, P387, DOI 10.1016/j.semcancer.2005.06.006; Carton JM, 2007, PROTEIN EXPRES PURIF, V55, P279, DOI 10.1016/j.pep.2007.05.017; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Ma Chaoyu, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5034; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsui Ping, 2007, Human Antibodies, V16, P117; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Valkovic T, 1998, PATHOL RES PRACT, V194, P335, DOI 10.1016/S0344-0338(98)80057-5	26	1775	1841	11	333	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					222	U129		10.1038/nature10138	http://dx.doi.org/10.1038/nature10138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21654748	Green Accepted			2022-12-01	WOS:000292690500049
J	Puente, XS; Pinyol, M; Quesada, V; Conde, L; Ordonez, GR; Villamor, N; Escaramis, G; Jares, P; Bea, S; Gonzalez-Diaz, M; Bassaganyas, L; Baumann, T; Juan, M; Lopez-Guerra, M; Colomer, D; Tubio, JMC; Lopez, C; Navarro, A; Tornador, C; Aymerich, M; Rozman, M; Hernandez, JM; Puente, DA; Freije, JMP; Velasco, G; Gutierrez-Fernandez, A; Costa, D; Carrio, A; Guijarro, S; Enjuanes, A; Hernandez, L; Yague, J; Nicolas, P; Romeo-Casabona, CM; Himmelbauer, H; Castillo, E; Dohm, JC; de Sanjose, S; Piris, MA; de Alava, E; Miguel, JS; Royo, R; Gelpi, JL; Torrents, D; Orozco, M; Pisano, DG; Valencia, A; Guigo, R; Bayes, M; Heath, S; Gut, M; Klatt, P; Marshall, J; Raine, K; Stebbings, LA; Futreal, PA; Stratton, MR; Campbell, PJ; Gut, I; Lopez-Guillermo, A; Estivill, X; Montserrat, E; Lopez-Otin, C; Campo, E				Puente, Xose S.; Pinyol, Magda; Quesada, Victor; Conde, Laura; Ordonez, Gonzalo R.; Villamor, Neus; Escaramis, Georgia; Jares, Pedro; Bea, Silvia; Gonzalez-Diaz, Marcos; Bassaganyas, Laia; Baumann, Tycho; Juan, Manel; Lopez-Guerra, Monica; Colomer, Dolors; Tubio, Jose M. C.; Lopez, Cristina; Navarro, Alba; Tornador, Cristian; Aymerich, Marta; Rozman, Maria; Hernandez, Jesus M.; Puente, Diana A.; Freije, Jose M. P.; Velasco, Gloria; Gutierrez-Fernandez, Ana; Costa, Dolors; Carrio, Anna; Guijarro, Sara; Enjuanes, Anna; Hernandez, Lluis; Yaguee, Jordi; Nicolas, Pilar; Romeo-Casabona, Carlos M.; Himmelbauer, Heinz; Castillo, Ester; Dohm, Juliane C.; de Sanjose, Silvia; Piris, Miguel A.; de Alava, Enrique; Miguel, Jesus San; Royo, Romina; Gelpi, Josep L.; Torrents, David; Orozco, Modesto; Pisano, David G.; Valencia, Alfonso; Guigo, Roderic; Bayes, Monica; Heath, Simon; Gut, Marta; Klatt, Peter; Marshall, John; Raine, Keiran; Stebbings, Lucy A.; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.; Gut, Ivo; Lopez-Guillermo, Armando; Estivill, Xavier; Montserrat, Emili; Lopez-Otin, Carlos; Campo, Elias			Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia	NATURE			English	Article							CANCER GENOME; B-CLL; EXPRESSION; NOTCH1; CELLS; HYPERMUTATION; NETWORK	Chronic lymphocytic leukaemia (CLL), the most frequent leukaemia in adults in Western countries, is a heterogeneous disease with variable clinical presentation and evolution(1,2). Two major molecular subtypes can be distinguished, characterized respectively by a high or low number of somatic hypermutations in the variable region of immunoglobulin genes(3,4). The molecular changes leading to the pathogenesis of the disease are still poorly understood. Here we performed whole-genome sequencing of four cases of CLL and identified 46 somatic mutations that potentially affect gene function. Further analysis of these mutations in 363 patients with CLL identified four genes that are recurrently mutated: notch 1 (NOTCH1), exportin 1 (XPO1), myeloid differentiation primary response gene 88 (MYD88) and kelch-like 6 (KLHL6). Mutations in MYD88 and KLHL6 are predominant in cases of CLL with mutated immunoglobulin genes, whereas NOTCH1 and XPO1 mutations are mainly detected in patients with unmutated immunoglobulins. The patterns of somatic mutation, supported by functional and clinical analyses, strongly indicate that the recurrent NOTCH1, MYD88 and XPO1 mutations are oncogenic changes that contribute to the clinical evolution of the disease. To our knowledge, this is the first comprehensive analysis of CLL combining whole-genome sequencing with clinical characteristics and clinical outcomes. It highlights the usefulness of this approach for the identification of clinically relevant mutations in cancer.	[Conde, Laura; Villamor, Neus; Jares, Pedro; Bea, Silvia; Lopez-Guerra, Monica; Colomer, Dolors; Lopez, Cristina; Navarro, Alba; Aymerich, Marta; Rozman, Maria; Costa, Dolors; Carrio, Anna; Guijarro, Sara; Enjuanes, Anna; Hernandez, Lluis; Campo, Elias] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Anat Patol,Unidad Hematopatol, E-08036 Barcelona, Spain; [Puente, Xose S.; Quesada, Victor; Ordonez, Gonzalo R.; Puente, Diana A.; Freije, Jose M. P.; Velasco, Gloria; Gutierrez-Fernandez, Ana; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Pinyol, Magda] IDIBAPS, Unidad Genom, Barcelona 08036, Spain; [Escaramis, Georgia; Bassaganyas, Laia; Tubio, Jose M. C.; Tornador, Cristian; Estivill, Xavier] Pompeu Fabra Univ, Ctr Genom Regulat, Genes & Dis Programme, Barcelona 08003, Spain; [Gonzalez-Diaz, Marcos; Hernandez, Jesus M.; de Alava, Enrique; Miguel, Jesus San] Univ Salamanca, Ctr Invest Canc IBMCC USAL CSIC, Univ Hosp, Serv Hematol, Salamanca 37007, Spain; [Baumann, Tycho; Lopez-Guillermo, Armando; Montserrat, Emili] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Hematol, E-08036 Barcelona, Spain; [Juan, Manel; Yaguee, Jordi] IDIBAPS, Hosp Clin, Serv Inmunol, Barcelona 08036, Spain; [Tubio, Jose M. C.] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela 15706, Spain; [Nicolas, Pilar; Romeo-Casabona, Carlos M.] Univ Basque Country, Univ Deusto, Catedra Interuniv Derechoy Genoma Humano, Bilbao 48007, Spain; [Himmelbauer, Heinz; Castillo, Ester; Dohm, Juliane C.] Pompeii Fabra Univ, Ctr Genom Regulat, Ultrasequencing Unit, Barcelona 08003, Spain; [de Sanjose, Silvia] IDIBELL, Inst Catala Oncol, Unidad Infecc & Canc, Lhospitalet De Llobregat 08907, Spain; [Piris, Miguel A.] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid 28029, Spain; [Royo, Romina; Gelpi, Josep L.; Torrents, David; Orozco, Modesto] Univ Barcelona, Spanish Natl Bioinformat Inst, IRB, Programa Conjunto Biol Computac,BSC, E-08028 Barcelona, Spain; [Pisano, David G.; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Guigo, Roderic] Pompeu Fabra Univ, Ctr Genom Regulat, Spanish Natl Bioinformat Inst, Genom Bioinformat Programme, Barcelona 08003, Spain; [Bayes, Monica; Heath, Simon; Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona 08028, Spain; [Klatt, Peter] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Marshall, John; Raine, Keiran; Stebbings, Lucy A.; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Complexo Hospitalario Universitario de Santiago de Compostela; University of Basque Country; University of Deusto; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Wellcome Trust Sanger Institute	Campo, E (corresponding author), Univ Barcelona, IDIBAPS, Hosp Clin, Serv Anat Patol,Unidad Hematopatol, E-08036 Barcelona, Spain.	clo@uniovi.es; ecampo@clinic.ub.es	de Sanjosé Llongueras, Silvia/H-6339-2014; Navarro, Alba/H-2611-2015; Juan, Manel/Q-2931-2019; López, Cristina/ABB-3519-2020; Puente, Xosé S./ADB-0672-2022; Gelpí, Josep Ll./M-6401-2013; Hernández, Jesus M/B-5459-2017; IBIS, SARCOMAS/O-1893-2015; Piris, Miguel A/AAP-1445-2020; Escaramis, Georgia/AAR-5586-2020; Guigo, Roderic/D-1303-2010; Estivill, Xavier/E-2957-2012; Velasco, Gloria/AAS-5842-2021; Gutierrez-Fernandez, Ana/ABG-6678-2020; Tornador, Cristian/S-2197-2018; Valencia, Alfonso/I-3127-2015; Estivill, Xavier/A-3125-2013; Freije, José M.P./A-6535-2008; Hernandez, Luis/D-4684-2018; Heath, Simon C/J-4138-2012; COLOMER, DOLORS/ABG-6894-2020; Tubio, Jose/AAG-7345-2019; bea, silvia/K-7699-2014; Gut, Ivo/ABF-3188-2020; Lopez-Guillermo, Armando/Z-5684-2019; Tubio, Jose M.C./H-5076-2015; López-Otín, Carlos/AAB-2106-2020; Campo, Elias/AAC-5593-2019; Quesada, Víctor/B-6557-2014; Escaramis, Georgia/B-2997-2015; de Alava, Enrique/GOH-0368-2022; Piris, Miguel A/B-7067-2008; López, Cristina/W-4621-2017; San-Miguel, Jesús F./V-8977-2018; Gutierrez-Fernandez, Ana/AAS-9954-2021; Pisano, David/N-5817-2014; ENJUANES, Anna/H-3245-2015; Jares, Pedro/T-3778-2019; Torrents, David/G-5785-2015	Navarro, Alba/0000-0002-4041-0974; López, Cristina/0000-0001-6644-1659; Puente, Xosé S./0000-0001-9525-1483; Gelpí, Josep Ll./0000-0002-0566-7723; Hernández, Jesus M/0000-0002-9661-9371; Piris, Miguel A/0000-0001-5839-3634; Guigo, Roderic/0000-0002-5738-4477; Velasco, Gloria/0000-0001-8032-5056; Tornador, Cristian/0000-0002-6437-9270; Valencia, Alfonso/0000-0002-8937-6789; Estivill, Xavier/0000-0002-0723-2256; Freije, José M.P./0000-0002-4688-8266; Hernandez, Luis/0000-0002-4854-3069; Heath, Simon C/0000-0002-9550-0897; Tubio, Jose/0000-0003-3540-2459; bea, silvia/0000-0001-7192-2385; Tubio, Jose M.C./0000-0003-3540-2459; López-Otín, Carlos/0000-0001-6964-1904; Campo, Elias/0000-0001-9850-9793; Quesada, Víctor/0000-0002-8398-3457; Escaramis, Georgia/0000-0002-5416-3177; de Alava, Enrique/0000-0001-8400-046X; Piris, Miguel A/0000-0001-5839-3634; López, Cristina/0000-0001-6644-1659; San-Miguel, Jesús F./0000-0002-9183-4857; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; Pisano, David/0000-0002-4895-4124; ENJUANES, Anna/0000-0002-4679-6687; JARES, PEDRO/0000-0002-8401-579X; COLOMER, DOLORS/0000-0001-7486-8484; Royo, Romina/0000-0003-3493-0874; Juan, Manel/0000-0002-3064-1648; BASSAGANYAS, LAIA/0000-0002-4575-0214; NICOLAS JIMENEZ, MARIA PILAR/0000-0003-4166-5941; Himmelbauer, Heinz/0000-0001-8897-2928; Orozco Lopez, Modesto/0000-0002-8608-3278; Baumann, Tycho Stephan/0000-0003-4421-0088; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Carrio, Ana/0000-0002-8394-2321; Raine, Keiran/0000-0002-5634-1539; Rozman, Maria/0000-0002-2641-1110; Torrents, David/0000-0002-6086-9037	Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	This work was funded by the Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII. C.L.-O. is an Investigator of the Botin Foundation and D.T., of the ICREA program. We thank E Santos for his support of this project, A. Carracedo and J. Benitez for genotyping studies, C. Fortuny for the supply of samples and N. Villahoz and M. C. Muro for their work in the coordination of the CLL-ICGC Consortium. We are also grateful to all patients with CLL who participated in this study.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Muzio M, 2009, BRIT J HAEMATOL, V144, P507, DOI 10.1111/j.1365-2141.2008.07475.x; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Spencer J, 2005, J IMMUNOL, V175, P5170, DOI 10.4049/jimmunol.175.8.5170; Sportoletti P, 2010, BRIT J HAEMATOL, V151, P404, DOI 10.1111/j.1365-2141.2010.08368.x; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	26	1126	1165	2	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					101	105		10.1038/nature10113	http://dx.doi.org/10.1038/nature10113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21642962	Green Accepted, Green Published, hybrid			2022-12-01	WOS:000292461300053
J	Lu, DP; Lin, WW; Gao, XQ; Wu, SJ; Cheng, C; Avila, J; Heese, A; Devarenne, TP; He, P; Shan, LB				Lu, Dongping; Lin, Wenwei; Gao, Xiquan; Wu, Shujing; Cheng, Cheng; Avila, Julian; Heese, Antje; Devarenne, Timothy P.; He, Ping; Shan, Libo			Direct Ubiquitination of Pattern Recognition Receptor FLS2 Attenuates Plant Innate Immunity	SCIENCE			English	Article							LIGASE ACTIVITY; CELL-DEATH; KINASE; ARABIDOPSIS; DEFENSE; FLAGELLIN; BAK1; PHOSPHORYLATION; PERCEPTION; RESISTANCE	Innate immune responses are triggered by the activation of pattern-recognition receptors (PRRs). The Arabidopsis PRR FLAGELLIN-SENSING 2 (FLS2) senses bacterial flagellin and initiates immune signaling through association with BAK1. The molecular mechanisms underlying the attenuation of FLS2 activation are largely unknown. We report that flagellin induces recruitment of two closely related U-box E3 ubiquitin ligases, PUB12 and PUB13, to FLS2 receptor complex in Arabidopsis. BAK1 phosphorylates PUB12 and PUB13 and is required for FLS2-PUB12/13 association. PUB12 and PUB13 polyubiquitinate FLS2 and promote flagellin-induced FLS2 degradation, and the pub12 and pub13 mutants displayed elevated immune responses to flagellin treatment. Our study has revealed a unique regulatory circuit of direct ubiquitination and turnover of FLS2 by BAK1-mediated phosphorylation and recruitment of specific E3 ligases for attenuation of immune signaling.	[Lu, Dongping; Gao, Xiquan; Cheng, Cheng; Avila, Julian; Devarenne, Timothy P.; He, Ping] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Lin, Wenwei; Wu, Shujing; Shan, Libo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Lu, Dongping; Lin, Wenwei; Gao, Xiquan; Wu, Shujing; Cheng, Cheng; He, Ping; Shan, Libo] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Lin, Wenwei] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China; [Heese, Antje] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Fujian Agriculture & Forestry University; University of Missouri System; University of Missouri Columbia	He, P (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pinghe@tamu.edu; lshan@tamu.edu	Lu, Dongping/GGB-4016-2022	Devarenne, Timothy/0000-0001-6032-8049; wu, shujing/0000-0002-1912-7699; Avila, Julian/0000-0001-9388-3946; Lu, Dongping/0000-0002-4888-0532; He, Ping/0000-0002-5926-8349	NSF [IOS-1030250]; NIH [R01GM092893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097247, R01GM092893] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Ausubel, J. Alfano, M. Dickman, and H. Scholthof for critical reading of the manuscript and F. Rolland for the yeast two-hybrid vectors. We also thank the Salk Institute and Arabidopsis Biological Resource Center for the Arabidopsis T-DNA insertion lines. This work was supported by NSF (IOS-1030250) to L.S. and NIH (R01GM092893) to P.H.	Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trujillo M, 2008, CURR BIOL, V18, P1396, DOI 10.1016/j.cub.2008.07.085; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007	26	397	424	18	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1439	1442		10.1126/science.1204903	http://dx.doi.org/10.1126/science.1204903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680842	Green Accepted			2022-12-01	WOS:000291689000044
J	McKhann, GM				McKhann, Guy M.			Changing Concepts of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA	Johns Hopkins University	McKhann, GM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 338 Krieger Hall,3400 N Charles St, Baltimore, MD 21218 USA.	guy.mckhann@jhu.edu						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jagust William, 2006, Alzheimers Dement, V2, P36, DOI 10.1016/j.jalz.2005.11.002; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003	9	66	66	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2458	2459		10.1001/jama.2011.810	http://dx.doi.org/10.1001/jama.2011.810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673298				2022-12-01	WOS:000291597300027
J	Luo, WB; Hu, HX; Chang, R; Zhong, J; Knabel, M; O'Meally, R; Cole, RN; Pandey, A; Semenza, GL				Luo, Weibo; Hu, Hongxia; Chang, Ryan; Zhong, Jun; Knabel, Matthew; O'Meally, Robert; Cole, Robert N.; Pandey, Akhilesh; Semenza, Gregg L.			Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1	CELL			English	Article							TUMOR-GROWTH; CANCER-THERAPY; OXYGEN SENSOR; HIF; HYDROXYLATION; GENE; TRANSACTIVATION; HIF-1-ALPHA; METABOLISM; TENSION	The pyruvate kinase isoforms PKM1 and PKM2 are alternatively spliced products of the PKM2 gene. PKM2, but not PKM1, alters glucose metabolism in cancer cells and contributes to tumorigenesis by mechanisms that are not explained by its known biochemical activity. We show that PKM2 gene transcription is activated by hypoxia-inducible factor 1 (HIF-1). PKM2 interacts directly with the HIF-1 alpha subunit and promotes transactivation of HIF-1 target genes by enhancing HIF-1 binding and p300 recruitment to hypoxia response elements, whereas PKM1 fails to regulate HIF-1 activity. Interaction of PKM2 with prolyl hydroxylase 3 (PHD3) enhances PKM2 binding to HIF-1 alpha and PKM2 coactivator function. Mass spectrometry and anti-hydroxyproline antibody assays demonstrate PKM2 hydroxylation on proline-403/408. PHD3 knockdown inhibits PKM2 coactivator function, reduces glucose uptake and lactate production, and increases O(2) consumption in cancer cells. Thus, PKM2 participates in a positive feedback loop that promotes HIF-1 transactivation and reprograms glucose metabolism in cancer cells.	[Luo, Weibo; Hu, Hongxia; Chang, Ryan; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Luo, Weibo; Hu, Hongxia; Knabel, Matthew; Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Zhong, Jun; O'Meally, Robert; Cole, Robert N.; Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Hu, Hongxia/Q-7765-2016; Zhong, Jun/D-1662-2010; Pandey, Akhilesh/B-4127-2009	Zhong, Jun/0000-0003-3148-4143; Pandey, Akhilesh/0000-0001-9943-6127; Luo, Weibo/0000-0002-1992-0320	NHLBI [N01-HV28180, HHS-N268201000032C]; Japan Science and Technology Agency; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Karen Padgett (Novus Biologicals) for providing antibodies against HIF-1 beta, HIF-2 alpha, PKM2, PHD2, PHD3, GLUT1, PDK1, LDHA, histone H3, p300, and rabbit IgG; Vickram Srinivas (Thomas Jefferson University) for FLAG-PHD1 vector; Frank S. Lee (University of Pennsylvania) for FLAG-PHD2 vector; Ted Dawson (The Johns Hopkins University) for shNT vector; and Kevin Bittman (Seahorse Bioscience, Inc) for assistance with OCR assays. G. L. S. is the C. Michael Armstrong Professor at The Johns Hopkins University School of Medicine. This work was supported, in part, by contracts N01-HV28180 and HHS-N268201000032C from NHLBI and an International Cooperative Research Project award from the Japan Science and Technology Agency.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	28	930	976	11	176	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					732	744		10.1016/j.cell.2011.03.054	http://dx.doi.org/10.1016/j.cell.2011.03.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620138	Green Accepted, Bronze			2022-12-01	WOS:000291018600013
J	Summerfield, D				Summerfield, Derek			FIRST PERSON Metropolitan Police blues: protracted sickness absence, ill health retirement, and the occupational psychiatrist	BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTTRAUMATIC-STRESS; DEPRESSION; STILL		Kings Coll London, Inst Psychiat, London SE5 8BB, England	University of London; King's College London	Summerfield, D (corresponding author), Kings Coll London, Inst Psychiat, London SE5 8BB, England.	derek.summerfield@slam.nhs.uk						BIGOS S, 1991, SPINE, V1, P1; Black C.M., 2008, WORKING HLTH TOMORRO; Brugha TS, 2004, BRIT J PSYCHIAT, V185, P378, DOI 10.1192/bjp.185.5.378; CANNING EC, 2003, THESIS U HULL; Cole J, 2008, BRIT J PSYCHIAT, V192, P83, DOI 10.1192/bjp.bp.107.039826; Dobson R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5688; Harvey SB, 2009, BRIT J PSYCHIAT, V194, P201, DOI 10.1192/bjp.bp.108.055111; Healthcare Commission, 2007, NO VOIC NO CHOIC JOI; Horton R, 2006, LANCET, V368, P1750, DOI 10.1016/S0140-6736(06)69641-4; Hussey S, 2004, BRIT MED J, V328, P88, DOI 10.1136/bmj.37949.656389.EE; Neal LA, 2004, BRIT J PSYCHIAT, V184, P247, DOI 10.1192/bjp.184.3.247; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Rosen GM, 2008, BRIT J PSYCHIAT, V192, P3, DOI 10.1192/bjp.bp.107.043083; Summerfield D, 2006, J ROY SOC MED, V99, P161, DOI 10.1258/jrsm.99.3.161; Summerfield D., 2004, POSTTRAUMATIC STRESS, P233, DOI [DOI 10.1002/9780470713570, 10.1002/9780470713570.ch12]; Waddell G., 2006, IS WORK GOOD YOUR HL; Waddell G, 2004, CONCEPTS REHABILITAT; Wainwright D., 2002, WORK STRESS MAKING M	18	20	20	1	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2011	342								d2127	10.1136/bmj.d2127	http://dx.doi.org/10.1136/bmj.d2127			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OI	21505221				2022-12-01	WOS:000289942200003
J	Oliver, A				Oliver, Adam			Is nudge an effective public health strategy to tackle obesity? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England	University of London; London School Economics & Political Science	Oliver, A (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth, Houghton St, London WC2A 2AE, England.	a.j.oliver@lse.ac.uk	Oliver, Adam/CAG-2031-2022					Cabinet Office, 2010, APPL BEH INS HLTH; Cassidy J, 2011, BMJ-BRIT MED J, V342, pd1648; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; PIANO STAIRS THEFUNT	5	21	21	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2011	342								d2168	10.1136/bmj.d2168	http://dx.doi.org/10.1136/bmj.d2168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752UZ	21493667				2022-12-01	WOS:000289721700005
J	Sutton, MA; Oenema, O; Erisman, JW; Leip, A; van Grinsven, H; Winiwarter, W				Sutton, Mark A.; Oenema, Oene; Erisman, Jan Willem; Leip, Adrian; van Grinsven, Hans; Winiwarter, Wilfried			Too much of a good thing	NATURE			English	Editorial Material									[Sutton, Mark A.] Ctr Ecol & Hydrol, Edinburgh EH26 0QB, Midlothian, Scotland; [Oenema, Oene] Alterra, NL-6700 AA Wageningen, Netherlands; [Sutton, Mark A.; Oenema, Oene; Erisman, Jan Willem] Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Leip, Adrian] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, Italy; [van Grinsven, Hans] PBL Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands; [Winiwarter, Wilfried] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	UK Centre for Ecology & Hydrology (UKCEH); Wageningen University & Research; Vrije Universiteit Amsterdam; European Commission Joint Research Centre; EC JRC ISPRA Site; International Institute for Applied Systems Analysis (IIASA)	Sutton, MA (corresponding author), Ctr Ecol & Hydrol, Edinburgh EH26 0QB, Midlothian, Scotland.	ms@ceh.ac.uk	Winiwarter, Wilfried/F-5073-2017	Winiwarter, Wilfried/0000-0001-7131-1496; Erisman, Jan Willem/0000-0001-5058-7012; Leip, Adrian/0000-0001-7616-5029	Natural Environment Research Council [ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amann M., 2011, 12011 CIAM IIASA; [Anonymous], 2010, DELHI DECLARATION; [Anonymous], 2009, BARSAC DECLARATION E; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Magid J, 2006, ECOL ENG, V28, P44, DOI 10.1016/j.ecoleng.2006.03.009; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Sutton MA, 2011, EUROPEAN NITROGEN AS	7	587	613	15	414	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					159	161		10.1038/472159a	http://dx.doi.org/10.1038/472159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21478874	Green Accepted			2022-12-01	WOS:000289469100016
J	Foster, CB; Sabella, C				Foster, Charles B.; Sabella, Camille			Health Care-Associated Infections in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; INFANTS		[Foster, Charles B.; Sabella, Camille] Cleveland Clin Childrens Hosp, Ctr Pediat Infect Dis, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sabella, C (corresponding author), Cleveland Clin Childrens Hosp, Ctr Pediat Infect Dis, 9500 Euclid Ave,Desk S-25, Cleveland, OH 44195 USA.	sabellc@ccf.org						Aly H, 2005, PEDIATRICS, V115, P1513, DOI 10.1542/peds.2004-1785; Bernstein HH, 2010, PEDIATRICS, V126, P809, DOI 10.1542/peds.2010-2376; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Grohskopf LA, 2002, J PEDIATR-US, V140, P432, DOI 10.1067/mpd.2002.122499; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ingraham AM, 2010, J AM COLL SURGEONS, V211, P705, DOI 10.1016/j.jamcollsurg.2010.09.006; MACDONALD NE, 1982, NEW ENGL J MED, V307, P397, DOI 10.1056/NEJM198208123070702; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841	10	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1480	1481		10.1001/jama.2011.449	http://dx.doi.org/10.1001/jama.2011.449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486980				2022-12-01	WOS:000289424100026
J	Moxon, ER; Siegrist, CA				Moxon, E. Richard; Siegrist, Claire-Anne			New Decade of Vaccines 1 The next decade of vaccines: societal and scientific challenges	LANCET			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; INFLUENZA VACCINE; HIV VACCINE; BELLS-PALSY; ANTIBODIES; EFFICACY; ADULTS; IMMUNOLOGY; IMMUNITY; DESIGN	Vaccines against microbial diseases have improved the health of millions of people. In the next decade and beyond, many conceptual and technological scientific advances offer extraordinary opportunities to expand the portfolio of immunisations against viral and bacterial diseases and to pioneer the first vaccines against human parasitic and fungal diseases. Scientists in the public and private sectors are motivated as never before to bring about these innovations in immunisation. Many societal factors threaten to compromise realisation of the public health gains that immunisation can achieve in the next decade and beyond understanding these factors is imperative. Vaccines are typically given to healthy individuals and safety issues loom high on the list of public concerns. The public needs to regain confidence in immunisation and trust the organisations responsible for the research, development, and implementation of vaccines. In the past, by use of a judicious amalgam of knowledge and empiricism, successful vaccines were largely developed by microbiologists who identified antigens that induced immune responses to conserved pathogen components. In the future, vaccines need to be developed against deadly diseases for which this strategy is often not feasible because of the extensive antigenic variability of relevant pathogens. High microbial diversity means that immunity after natural infection is often ineffective for prevention of disease on subsequent exposure, for example in HIV infection and malaria. Additionally, vaccines need to be generated to protect the people who are most vulnerable because of age or underlying diseases. Thus, in the future, a much deeper understanding of the immunological challenges including the diversifying role of host genetics and environmental factors, leading perhaps to more personalised approaches will be the touchstone for rational design and development of adjuvants that result in novel safe and effective vaccines.	[Moxon, E. Richard] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Siegrist, Claire-Anne] Univ Hosp Geneva, Ctr Vaccinol, Geneva, Switzerland; [Siegrist, Claire-Anne] Univ Geneva, Fac Med, Geneva, Switzerland	University of Oxford; University of Geneva; University of Geneva	Moxon, ER (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.	richard.moxon@paediatrics.ox.ac.uk			GlaxoSmithKline; Sanofi Pasteur; Nasvax; DBV Technologies	GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur; Nasvax; DBV Technologies	ERM has received honoraria for work as a board member for Novartis and GlycoVaxyn, and as a consultant for Novartis. C-AS's institution has received grants from GlaxoSmithKline, Sanofi Pasteur, Nasvax, and DBV Technologies; and travel and accommodation expenses from GlaxoSmithKline and Sanofi Pasteur. C-AS and C-AS's institution have received royalties for the patent for Viavac; and C-AS has patents, which have not generated royalties, with Sanofi Pasteur and DBV Technologies.	Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Baumgartner CK, 2010, IMMUNOLOGY, V130, P16, DOI 10.1111/j.1365-2567.2010.03265.x; Bayer R, 2007, EMBO REP, V8, P1099, DOI 10.1038/sj.embor.7401134; Bekker A, 2009, CURR OPIN PEDIATR, V21, P122, DOI 10.1097/MOP.0b013e32832185af; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Bonanni P, 2007, HUM VACCINES, V3, P217, DOI 10.4161/hv.3.5.4351; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Castellino F, 2009, EUR J IMMUNOL, V39, P2100, DOI 10.1002/eji.200939550; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/S0065-2776(10)07001-X, 10.1016/B978-0-12-381300-8.00008-3]; Cohen SA, 2011, J AM GERIATR SOC, V59, P327, DOI 10.1111/j.1532-5415.2010.03271.x; CRAIG A, 2003, ANTIGENIC VARIATION, P432; De Flora S, 2011, CARCINOGENESIS, V32, P787, DOI 10.1093/carcin/bgr054; Deans GD, 2010, J INTERN MED, V267, P220, DOI 10.1111/j.1365-2796.2009.02201.x; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; FINNE J, 1983, LANCET, V2, P355; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Gilca V, 2006, PEDIATR INFECT DIS J, V25, P372, DOI 10.1097/01.inf.0000207468.04665.ad; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Gupta S, 1999, PARASITOL TODAY, V15, P497, DOI 10.1016/S0169-4758(99)01559-8; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hanage WP, 2008, FUTURE MICROBIOL, V3, P23, DOI 10.2217/17460913.3.1.23; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Heath PT, 1998, PEDIATR INFECT DIS J, V17, pS117, DOI 10.1097/00006454-199809001-00005; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; JEFFERSON T, 2010, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004876.PUB3; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Ladhani S, 2008, LANCET INFECT DIS, V8, P275, DOI 10.1016/S1473-3099(08)70078-1; Lang PO, 2011, AGEING RES REV, V10, P389, DOI 10.1016/j.arr.2010.09.005; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Malik B, 2010, CURR MOL MED, V10, P47, DOI 10.2174/156652410791065417; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Manzoli L, 2009, LANCET INFECT DIS, V9, P482, DOI 10.1016/S1473-3099(09)70153-7; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Olszewska W, 2000, VIROLOGY, V272, P98, DOI 10.1006/viro.2000.0285; Pace D, 2009, VACCINE, V27, pB30, DOI 10.1016/j.vaccine.2009.05.003; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Pichichero ME, 2009, PEDIATRICS, V124, P1633, DOI 10.1542/peds.2008-3645; PITTMAN MARGARET, 1931, JOUR EXP MED, V53, P471, DOI 10.1084/jem.53.4.471; Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI [10.2217/pgs.09.25, 10.2217/PGS.09.25]; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; SABIN AB, 1954, J EXP MED, V99, P551, DOI 10.1084/jem.99.6.551; Sambhara S, 2009, CURR TOP MICROBIOL, V333, P413, DOI 10.1007/978-3-540-92165-3_20; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Siegrist CA., 2008, VACCINES-BASEL, V5, P17, DOI [10.1016/b978-1-4557-0090-5.00004-5, DOI 10.1016/B978-1-4557-0090-5.00004-5]; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Smith J, 2011, LANCET, V378, P428, DOI 10.1016/S0140-6736(11)60478-9; Stratton K, 2001, IMMUNIZATION SAFETY; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; TURK DC, 1967, HAEMOPHILUS INFLUENZ, P1; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; *US CDCP, 2009, MMWR-MORBID MORTAL W, V58, P1091; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO SAF INJ GLOB, 2010, SAF INJ GLOB NETW 20; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	88	43	46	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					348	359		10.1016/S0140-6736(11)60407-8	http://dx.doi.org/10.1016/S0140-6736(11)60407-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21664685				2022-12-01	WOS:000293615800033
J	Anthony, RM; Kobayashi, T; Wermeling, F; Ravetch, JV				Anthony, Robert M.; Kobayashi, Toshihiko; Wermeling, Fredrik; Ravetch, Jeffrey V.			Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway	NATURE			English	Article							DC-SIGN; ANTIINFLAMMATORY ACTIVITY; DENDRITIC CELL; IN-VIVO; BONE-MARROW; IMMUNE-RESPONSES; IL-4; INTERLEUKIN-4; ANTIBODIES; RECEPTORS	High-dose intravenous immunoglobulin is a widely used therapeutic preparation of highly purified immunoglobulin G (IgG) antibodies. It is administered at high doses (1-2 grams per kilogram) for the suppression of autoantibody-triggered inflammation in a variety of clinical settings'. This anti-inflammatory activity of intravenous immunoglobulin is triggered by a minor population of IgG crystallizable fragments (Fcs), with glycans terminating in alpha 2,6 sialic acids (sFc) that target myeloid regulatory cells expressing the lectin dendritic-cell-specific ICAM-3 grabbing non-integrin (DC-SIGN; also known as CD209)(2-4). Here, to characterize this response in detail, we generated humanized DC-SIGN mice (hDC-SIGN), and demonstrate that the anti-inflammatory activity of intravenous immunoglobulin can be recapitulated by the transfer of bone-marrow-derived sFc-treated hDC-SIGN(+) macrophages or dendritic cells into naive recipients. Furthermore, sFc administration results in the production of IL-33, which, in turn, induces expansion of IL-4-producing basophils that promote increased expression of the inhibitory Fc receptor Fc gamma RIIB on effector macrophages. Systemic administration of the T(H)2 cytokines IL-33 or IL-4 upregulates Fc gamma RIIB on macrophages, and suppresses serum-induced arthritis. Consistent with these results, transfer of IL-33-treated basophils suppressed induced arthritic inflammation. This novel DC-SIGN-T(H)2 pathway initiated by an endogenous ligand, sFc, provides an intrinsic mechanism for maintaining immune homeostasis that could be manipulated to provide therapeutic benefit in autoimmune diseases.	[Anthony, Robert M.; Kobayashi, Toshihiko; Wermeling, Fredrik; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA.	ravetch@rockefeller.edu	Wermeling, Fredrik/AAA-6391-2019; Ravetch, Jeffrey/Z-1596-2019	Wermeling, Fredrik/0000-0001-9633-677X; Ravetch, Jeffrey/0000-0003-2024-9041	Wenner-Gren Foundations, Sweden; Virdante Pharmaceuticals; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035875, K22AI091684] Funding Source: NIH RePORTER	Wenner-Gren Foundations, Sweden; Virdante Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank P. Smith, M. Kibe, J. Brown and K. Velinzon for technical support K. L. Jeffrey, C. Cheong, R. Steinman and J. J. Lee for discussions, M. Pack for providing human spleen sections, A. McKenzie for providing SIGN-R1<SUP>-/-</SUP> mice, T. Sparwasser for providing CD11c-hDC-SIGN mice, C. G. Park for providing hDC-SIGN and hDC-SIGN-R expressing cell lines, and H. Watarai for providing anti-IL-25R antibodies. R.M.A. is an Irvington Institute fellow of the Cancer Research Institute. F.W. is supported by the Wenner-Gren Foundations, Sweden. This work was performed with support from Virdante Pharmaceuticals and NIH grants to J.V.R.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Finkelman F., 2003, CURR PROTOC IMMUNOL, P6281; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohmura K, 2005, ARTHRITIS RHEUM-US, V52, P1866, DOI 10.1002/art.21104; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Schaefer M, 2008, J IMMUNOL, V180, P6836, DOI 10.4049/jimmunol.180.10.6836; Scherer HU, 2010, ARTHRITIS RHEUM-US, V62, P1620, DOI 10.1002/art.27414; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; SEDER RA, 1991, INT ARCH ALLER A IMM, V94, P137, DOI 10.1159/000235345; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; Wang M, 1999, CLIN IMMUNOL, V90, P47, DOI 10.1006/clim.1998.4628; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685	41	432	450	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					110	U133		10.1038/nature10134	http://dx.doi.org/10.1038/nature10134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21685887	Green Accepted			2022-12-01	WOS:000292461300055
J	Paprotka, T; Delviks-Frankenberry, KA; Cingoz, O; Martinez, A; Kung, HJ; Tepper, CG; Hu, WS; Fivash, MJ; Coffin, JM; Pathak, VK				Paprotka, Tobias; Delviks-Frankenberry, Krista A.; Cingoez, Oya; Martinez, Anthony; Kung, Hsing-Jien; Tepper, Clifford G.; Hu, Wei-Shau; Fivash, Matthew J., Jr.; Coffin, John M.; Pathak, Vinay K.			Recombinant Origin of the Retrovirus XMRV	SCIENCE			English	Article							MURINE LEUKEMIA-VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; MOUSE DNA; IN-VIVO; CONTAMINATION; INFECTION; SEQUENCES; ANDROGEN; BLOOD	The retrovirus XMRV (xenotropic murine leukemia virus-related virus) has been detected in human prostate tumors and in blood samples from patients with chronic fatigue syndrome, but these findings have not been replicated. We hypothesized that an understanding of when and how XMRV first arose might help explain the discrepant results. We studied human prostate cancer cell lines CWR22Rv1 and CWR-R1, which produce XMRV virtually identical to the viruses recently found in patient samples, as well as their progenitor human prostate tumor xenograft (CWR22) that had been passaged in mice. We detected XMRV infection in the two cell lines and in the later passage xenografts, but not in the early passages. In particular, we found that the host mice contained two proviruses, PreXMRV-1 and PreXMRV-2, which share 99.92% identity with XMRV over >3.2-kilobase stretches of their genomes. We conclude that XMRV was not present in the original CWR22 tumor but was generated by recombination of two proviruses during tumor passaging in mice. The probability that an identical recombinant was generated independently is negligible (similar to 10(-12)); our results suggest that the association of XMRV with human disease is due to contamination of human samples with virus originating from this recombination event.	[Paprotka, Tobias; Delviks-Frankenberry, Krista A.; Pathak, Vinay K.] NCI, HIV Drug Resistance Program, Viral Mutat Sect, Frederick, MD 21702 USA; [Hu, Wei-Shau] NCI, HIV Drug Resistance Program, Viral Recombinat Sect, Frederick, MD 21702 USA; [Cingoez, Oya; Coffin, John M.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Cingoez, Oya; Coffin, John M.] Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA; [Martinez, Anthony; Kung, Hsing-Jien; Tepper, Clifford G.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Kung, Hsing-Jien] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Fivash, Matthew J., Jr.] NCI, Data Management Serv Inc, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University; Tufts University; University of California System; University of California Davis; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pathak, VK (corresponding author), NCI, HIV Drug Resistance Program, Viral Mutat Sect, Frederick, MD 21702 USA.	vinay.pathak@nih.gov	Tepper, Clifford G/H-6527-2011; Kung, Hsing-Jien/C-7651-2013; Delviks-Frankenberry, Krista A/M-4822-2013; Cingöz, Oya/AAN-1739-2021	Delviks-Frankenberry, Krista A/0000-0003-3370-8542; Cingöz, Oya/0000-0002-0096-4948; Pathak, Vinay/0000-0003-2441-8412	Center for Cancer Research, National Cancer Institute, NIH; Bench-to-Bedside Award [R37 CA 089441, R01CA150197]; F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE [R01CA150197, ZIABC010504, ZIABC011339, ZIABC011436, R37CA089441, P30CA093373] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bench-to-Bedside Award; F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Shao for analysis of MLV diversity, and E. Freed and S. Hughes for helpful discussions. This research was supported in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. This work was also supported in part by a Bench-to-Bedside Award to V.K.P., research grant R37 CA 089441 to J.M.C., and R01CA150197 to H.J.K. J.M.C. was a Research Professor of the American Cancer Society with support from the F.M. Kirby Foundation.	Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Bogerd HP, 2011, VIROLOGY, V410, P234, DOI 10.1016/j.virol.2010.11.011; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; Courgnaud V, 2010, P NATL ACAD SCI USA, V107, P15666, DOI 10.1073/pnas.1007944107; Gregory CW, 2001, CANCER RES, V61, P2892; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Nagabhushan M, 1996, CANCER RES, V56, P3042; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van der Kuyl AC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00147; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124; Zhuang JL, 2006, J VIROL, V80, P6706, DOI 10.1128/JVI.00273-06	25	185	192	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					97	101		10.1126/science.1205292	http://dx.doi.org/10.1126/science.1205292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21628392	Green Accepted			2022-12-01	WOS:000292255400058
J	Isakova, T; Xie, HL; Yang, W; Xie, DW; Anderson, AH; Scialla, J; Wahl, P; Gutierrez, OM; Steigerwalt, S; He, J; Schwartz, S; Lo, J; Ojo, A; Sondheimer, J; Hsu, CY; Lash, J; Leonard, M; Kusek, JW; Feldman, HI; Wolf, M				Isakova, Tamara; Xie, Huiliang; Yang, Wei; Xie, Dawei; Anderson, Amanda Hyre; Scialla, Julia; Wahl, Patricia; Gutierrez, Orlando M.; Steigerwalt, Susan; He, Jiang; Schwartz, Stanley; Lo, Joan; Ojo, Akinlolu; Sondheimer, James; Hsu, Chi-yuan; Lash, James; Leonard, Mary; Kusek, John W.; Feldman, Harold I.; Wolf, Myles		CRIC Study Grp	Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VASCULAR DYSFUNCTION; PARATHYROID-HORMONE; FGF RECEPTOR; HEMODIALYSIS; CALCITRIOL; DEATH; FIBROBLAST-GROWTH-FACTOR-23; PROGRESSION; PHOSPHORUS; PREDICTION	Context A high level of the phosphate-regulating hormone fibroblast growth factor 23 (FGF-23) is associated with mortality in patients with end-stage renal disease, but little is known about its relationship with adverse outcomes in the much larger population of patients with earlier stages of chronic kidney disease. Objective To evaluate FGF-23 as a risk factor for adverse outcomes in patients with chronic kidney disease. Design, Setting, and Participants A prospective study of 3879 participants with chronic kidney disease stages 2 through 4 who enrolled in the Chronic Renal Insufficiency Cohort between June 2003 and September 2008. Main Outcome Measures All-cause mortality and end-stage renal disease. Results At study enrollment, the mean (SD) estimated glomerular filtration rate (GFR) was 42.8 (13.5) mL/min/1.73 m(2), and the median FGF-23 level was 145.5 RU/mL (interquartile range [IQR], 96-239 reference unit [RU]/mL). During a median follow-up of 3.5 years (IQR, 2.5-4.4 years), 266 participants died (20.3/1000 person-years) and 410 reached end-stage renal disease (33.0/1000 person-years). In adjusted analyses, higher levels of FGF-23 were independently associated with a greater risk of death (hazard ratio [HR], per SD of natural log-transformed FGF-23, 1.5; 95% confidence interval [CI], 1.3-1.7). Mortality risk increased by quartile of FGF-23: the HR was 1.3 (95% CI, 0.8-2.2) for the second quartile, 2.0 (95% CI, 1.2-3.3) for the third quartile, and 3.0 (95% CI, 1.8-5.1) for the fourth quartile. Elevated fibroblast growth factor 23 was independently associated with significantly higher risk of endstage renal disease among participants with an estimated GFR between 30 and 44 mL/min/1.73 m(2) (HR, 1.3 per SD of FGF-23 natural log-transformed FGF-23; 95% CI, 1.04-1.6) and 45 mL/min/1.73 m(2) or higher (HR, 1.7; 95% CI, 1.1-2.4), but not less than 30 mL/min/1.73 m(2). Conclusion Elevated FGF-23 is an independent risk factor for end-stage renal disease in patients with relatively preserved kidney function and for mortality across the spectrum of chronic kidney disease. JAMA. 2011;305(23):2432-2439 www.jama.com	[Isakova, Tamara; Wahl, Patricia; Wolf, Myles] Univ Miami, Miller Sch Med, Dept Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Xie, Huiliang] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Xie, Huiliang; Yang, Wei; Anderson, Amanda Hyre; Feldman, Harold I.] Childrens Hosp Philadelphia, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Leonard, Mary] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Schwartz, Stanley; Feldman, Harold I.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Scialla, Julia] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL USA; [Steigerwalt, Susan] St Johns Hlth Syst, Detroit, MI USA; [He, Jiang] Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70118 USA; [Lo, Joan] Kaiser Permanente, Oakland, CA USA; [Ojo, Akinlolu] Univ Michigan Hlth Syst, Dept Med, Div Nephrol, Ann Arbor, MI USA; [Sondheimer, James] Wayne State Univ, Sch Med, Dept Med, Div Nephrol, Detroit, MI 48201 USA; [Hsu, Chi-yuan] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Lash, James] Univ Illinois, Dept Med, Div Nephrol, Chicago, IL USA; [Kusek, John W.] NIDDK, Div Kidney Urol & Hematol Dis, Bethesda, MD USA	University of Miami; University of Miami; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Tulane University; Kaiser Permanente; University of Michigan System; University of Michigan; Wayne State University; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wolf, M (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Nephrol & Hypertens, 1120 NW 14th St,CRB 819, Miami, FL 33136 USA.	mwolf2@med.miami.edu	Yang, Wei/A-9223-2009; He, Jiang/AAF-5303-2020; Schwartz, S/I-9628-2019	Yang, Wei/0000-0001-8984-4389; He, Jiang/0000-0002-8286-9652; Scialla, Julia/0000-0003-1707-691X; Hsu, Chi-yuan/0000-0001-8182-1238	National Institutes of Health [R01DK081374, K23DK087858, R01DK077128, UL1RR024134, UL1RR025005, M01RR16500, UL1RR024989, M01RR000042, UL1RR024986, UL1RR029879, RR05096, UL1RR024131]; National Institute of Diabetes and Digestive and Kidney Diseases [5U01DK060990, 5U01DK060984, 5U01DK06102, 5U01DK061021, 5U01DK061028, 5U01DK60980, 5U01DK060963, 5U01DK060902]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989, M01RR016500, M01RR000042, M01RR013987, UL1RR024986, UL1RR024134, UL1RR024131, UL1RR029879, UL1RR025005, M01RR005096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072231, U01DK060902, K24DK062234, U01DK061028, U01DK060980, U01DK061021, U01DK060990, R01DK076116, U01DK060984, R01DK081374, K23DK087858, U01DK060963, R01DK077128, R56DK072231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This CRIC ancillary study was supported by National Institutes of Health grants R01DK081374 (Dr Wolf), K23DK087858 (Dr Isakova), and R01DK077128 (Dr Leonard). The CRIC Study is supported by cooperative agreement project grants 5U01DK060990, 5U01DK060984, 5U01DK06102, 5U01DK061021, 5U01DK061028, 5U01DK60980, 5U01DK060963, and 5U01DK060902 from the National Institute of Diabetes and Digestive and Kidney Diseases, and by grants UL1RR024134, UL1RR025005, M01RR16500, UL1RR024989, M01RR000042, UL1RR024986, UL1RR029879, RR05096, and UL1RR024131 from the National Institutes of Health.	Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Juppner H, 2010, J BONE MINER RES, V25, P2091, DOI 10.1002/jbmr.170; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Landray MJ, 2010, AM J KIDNEY DIS, V56, P1082, DOI 10.1053/j.ajkd.2010.07.016; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Norris KC, 2006, J AM SOC NEPHROL, V17, P2928, DOI 10.1681/ASN.2005101101; Oliveira RB, 2010, CLIN J AM SOC NEPHRO, V5, P286, DOI 10.2215/CJN.05420709; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	32	766	809	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2432	2439		10.1001/jama.2011.826	http://dx.doi.org/10.1001/jama.2011.826			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673295	Green Accepted, Bronze			2022-12-01	WOS:000291597300023
J	Zwilling, D; Huang, SY; Sathyasaikumar, KV; Notarangelo, FM; Guidetti, P; Wu, HQ; Lee, J; Truong, J; Andrews-Zwilling, Y; Hsieh, EW; Louie, JY; Wu, T; Scearce-Levie, K; Patrick, C; Adame, A; Giorgini, F; Moussaoui, S; Laue, G; Rassoulpour, A; Flik, G; Huang, YD; Muchowski, JM; Masliah, E; Schwarcz, R; Muchowski, PJ				Zwilling, Daniel; Huang, Shao-Yi; Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Guidetti, Paolo; Wu, Hui-Qiu; Lee, Jason; Truong, Jennifer; Andrews-Zwilling, Yaisa; Hsieh, Eric W.; Louie, Jamie Y.; Wu, Tiffany; Scearce-Levie, Kimberly; Patrick, Christina; Adame, Anthony; Giorgini, Flaviano; Moussaoui, Saliha; Laue, Grit; Rassoulpour, Arash; Flik, Gunnar; Huang, Yadong; Muchowski, Joseph M.; Masliah, Eliezer; Schwarcz, Robert; Muchowski, Paul J.			Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration	CELL			English	Article							QUINOLINIC ACID; MOUSE MODEL; TRYPTOPHAN-METABOLISM; ALZHEIMERS-DISEASE; GLUTAMATE UPTAKE; PATHWAY; EXPRESSION; AMINOTRANSFERASE; NEUROTOXICITY; INFLAMMATION	Metabolites in the kynurenine pathway, generated by tryptophan degradation, are thought to play an important role in neurodegenerative disorders, including Alzheimer's and Huntington's diseases. In these disorders, glutamate receptor-mediated excitotoxicity and free radical formation have been correlated with decreased levels of the neuroprotective metabolite kynurenic acid. Here, we describe the synthesis and characterization of JM6, a smallmolecule prodrug inhibitor of kynurenine 3-monooxygenase (KMO). Chronic oral administration of JM6 inhibits KMO in the blood, increasing kynurenic acid levels and reducing extracellular glutamate in the brain. In a transgenic mouse model of Alzheimer's disease, JM6 prevents spatial memory deficits, anxiety-related behavior, and synaptic loss. JM6 also extends life span, prevents synaptic loss, and decreases microglial activation in a mouse model of Huntington's disease. These findings support a critical link between tryptophan metabolism in the blood and neurodegeneration, and they provide a foundation for treatment of neurodegenerative diseases.	[Zwilling, Daniel; Huang, Shao-Yi; Lee, Jason; Truong, Jennifer; Andrews-Zwilling, Yaisa; Hsieh, Eric W.; Louie, Jamie Y.; Wu, Tiffany; Scearce-Levie, Kimberly; Huang, Yadong; Muchowski, Joseph M.; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA 94158 USA; [Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Guidetti, Paolo; Wu, Hui-Qiu; Schwarcz, Robert] Univ Maryland, Maryland Psychiat Res Ctr, Sch Med, Baltimore, MD 21228 USA; [Patrick, Christina; Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Moussaoui, Saliha; Laue, Grit] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Rassoulpour, Arash; Flik, Gunnar] Brains On Line BV, NL-9713 AV Groningen, Netherlands	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego; University of Leicester; Novartis	Muchowski, PJ (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Schwarcz, Robert/P-3134-2018	Giorgini, Flaviano/0000-0001-7881-9508; Wu, Tiffany/0000-0002-9273-0574	J. David Gladstone Institutes; National Institutes of Health [AG022074, NS057715]; Taube-Koret Center for Huntington's Disease Research; Hellman Family Foundation; American Health Assistance Foundation; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057715, P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taube-Koret Center for Huntington's Disease Research; Hellman Family Foundation; American Health Assistance Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the J. David Gladstone Institutes (P.J.M.), National Institutes of Health grants AG022074 (P.J.M., Y.H., and E.M.) and NS057715 (P.J.M. and R.S.), the Taube-Koret Center for Huntington's Disease Research and the Hellman Family Foundation Program in Alzheimer's Disease Research (P.J.M.), and a postdoctoral fellowship from the American Health Assistance Foundation (D.Z.). The J. David Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01. The authors thank S. Ordway and G. Howard for editorial assistance and S. Finkbeiner for helpful discussions. This study is dedicated in loving memory to Dr. Paolo Guidetti (June 5, 1966-December 28, 2007), who tragically passed away during the course of this study after a battle with cancer.	ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; BEAL MF, 1992, J NEUROL SCI, V108, P80; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; BOEGMAN RJ, 1985, NEUROBIOL AGING, V6, P331, DOI 10.1016/0197-4580(85)90012-0; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carpenedo R, 2001, EUR J NEUROSCI, V13, P2141, DOI 10.1046/j.0953-816x.2001.01592.x; Carrillo-Mora P, 2010, BEHAV BRAIN RES, V210, P240, DOI 10.1016/j.bbr.2010.02.041; Cepeda C, 2003, J NEUROSCI, V23, P961; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Eckstein JA, 2008, J MASS SPECTROM, V43, P782, DOI 10.1002/jms.1376; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Gregoire L, 2008, BEHAV BRAIN RES, V186, P161, DOI 10.1016/j.bbr.2007.08.007; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Guidetti P, 2006, NEUROBIOL DIS, V23, P190, DOI 10.1016/j.nbd.2006.02.011; Gulaj E, 2010, ADV MED SCI-POLAND, V55, P204, DOI 10.2478/v10039-010-0023-6; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Misztal M, 1996, NEUROPHARMACOLOGY, V35, P449, DOI 10.1016/0028-3908(96)00005-6; Moroni F, 1999, ADV EXP MED BIOL, V467, P199; Moroni F, 2005, NEUROPHARMACOLOGY, V48, P788, DOI 10.1016/j.neuropharm.2004.10.019; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Pellicciari R, 2006, CHEMMEDCHEM, V1, P528, DOI 10.1002/cmdc.200500095; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; Rodgers J, 2009, BRAIN, V132, P1259, DOI 10.1093/brain/awp074; Romani L, 2008, J IMMUNOL, V180, P5157, DOI 10.4049/jimmunol.180.8.5157; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Silva-Adaya D, 2011, NEUROTOXICOL TERATOL, V33, P303, DOI 10.1016/j.ntt.2010.10.002; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378	54	351	361	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					863	874		10.1016/j.cell.2011.05.020	http://dx.doi.org/10.1016/j.cell.2011.05.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21640374	Green Accepted, Bronze			2022-12-01	WOS:000291461600014
J	Oldham, ML; Chen, J				Oldham, Michael L.; Chen, Jue			Crystal Structure of the Maltose Transporter in a Pretranslocation Intermediate State	SCIENCE			English	Article							MALTODEXTRIN-BINDING-PROTEIN; BOVINE HEART-MITOCHONDRIA; ABC-TRANSPORTER; ATP-BINDING; ESCHERICHIA-COLI; CASSETTE TRANSPORTER; ALTERNATING ACCESS; ACTIVE-TRANSPORT; MECHANISM; CONFORMATION	Adenosine triphosphate (ATP)-binding cassette (ABC) transporters convert chemical energy from ATP hydrolysis to mechanical work for substrate translocation. They function by alternating between two states, exposing the substrate-binding site to either side of the membrane. A key question that remains to be addressed is how substrates initiate the transport cycle. Using x-ray crystallography, we have captured the maltose transporter in an intermediate step between the inward- and outward-facing states. We show that interactions with substrate-loaded maltose-binding protein in the periplasm induce a partial closure of the MalK dimer in the cytoplasm. ATP binding to this conformation then promotes progression to the outward-facing state. These results, interpreted in light of biochemical and functional studies, provide a structural basis to understand allosteric communication in ABC transporters.	[Oldham, Michael L.; Chen, Jue] Purdue Univ, Howard Hughes Med Inst, Dept Biol Sci, W Lafayette, IN 47907 USA	Howard Hughes Medical Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chen, J (corresponding author), Purdue Univ, Howard Hughes Med Inst, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu			NIH [GM070515]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070515, R56GM070515] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Davidson for providing the MBP(G69C/S337C) construct and comments on this manuscript and staff at the Advanced Photon Source beamline 23-ID for assistance with data collection. We are also especially grateful for thoughtful and constructive comments from the anonymous reviewers. This work was supported by an NIH grant (GM070515 to J.C.) and a postdoctoral fellowship from the American Heart Association (to M.L.O). J.C. is an investigator of the Howard Hughes Medical Institute. Coordinates and structure factors have been deposited in the Protein Data Bank under accession nos. 3PV0, 3PUY, and 3PUZ.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Haffke M, 2010, ACTA CRYSTALLOGR D, V66, P979, DOI 10.1107/S0907444910028593; Hall JA, 1997, J BIOL CHEM, V272, P17610, DOI 10.1074/jbc.272.28.17610; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunke S, 2000, J BACTERIOL, V182, P1432, DOI 10.1128/JB.182.5.1432-1436.2000; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shilton BH, 2008, BBA-BIOMEMBRANES, V1778, P1772, DOI 10.1016/j.bbamem.2007.09.005; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang YH, 1996, J BIOL CHEM, V271, P17881, DOI 10.1074/jbc.271.30.17881	43	170	172	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1202	1205		10.1126/science.1200767	http://dx.doi.org/10.1126/science.1200767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21566157				2022-12-01	WOS:000291205200049
J	Bristow, TF; Bonifacie, M; Derkowski, A; Eiler, JM; Grotzinger, JP				Bristow, Thomas F.; Bonifacie, Magali; Derkowski, Arkadiusz; Eiler, John M.; Grotzinger, John P.			A hydrothermal origin for isotopically anomalous cap dolostone cements from south China	NATURE			English	Article							GAS HYDRATE; NEOPROTEROZOIC SEAWATER; DOUSHANTUO FORMATION; METHANE SEEPS; CARBONATE; EVOLUTION; OXYGEN; FRACTIONATION; TEMPERATURE; EARTH	The release of methane into the atmosphere through destabilization of clathrates is a positive feedback mechanism capable of amplifying global warming trends that may have operated several times in the geological past(1-3). Such methane release is a hypothesized cause or amplifier for one of the most drastic global warming events in Earth history, the end of the Marinoan 'snowball Earth' ice age, similar to 635 Myr ago(4-7). A key piece of evidence supporting this hypothesis is the occurrence of exceptionally depleted carbon isotope signatures (delta(13)C(PDB) down to -48 parts per thousand; ref. 8) in post-glacial cap dolostones (that is, dolostone overlying glacial deposits) from south China; these signatures have been interpreted as products of methane oxidation at the time of deposition(5,6,8). Here we show, on the basis of carbonate clumped isotope thermometry, (87)Sr/(86)Sr isotope ratios, trace element content and clay mineral evidence, that carbonates bearing the (13)C-depleted signatures crystallized more than 1.6 Myr after deposition of the cap dolostone. Our results indicate that highly (13)C-depleted carbonate cements grew from hydrothermal fluids and suggest that their carbon isotope signatures are a consequence of thermogenic methane oxidation at depth. This finding not only negates carbon isotope evidence for methane release during Marinoan deglaciation in south China, but also eliminates the only known occurrence of a Precambrian sedimentary carbonate with highly (13)C-depleted signatures related to methane oxidation in a seep environment. We propose that the capacity to form highly (13)C-depleted seep carbonates, through biogenic anaeorobic oxidation of methane using sulphate, was limited in the Precambrian period by low sulphate concentrations in sea water(9). As a consequence, although clathrate destabilization may or may not have had a role in the exit from the 'snowball' state, it would not have left extreme carbon isotope signals in cap dolostones.	[Bristow, Thomas F.; Bonifacie, Magali; Eiler, John M.; Grotzinger, John P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Bonifacie, Magali] Univ Paris Diderot, Equipe Geochim Isotopes Stables, Inst Phys Globe Paris, CNRS,UMR 7154, F-75005 Paris, France; [Derkowski, Arkadiusz] Polish Acad Sci, Inst Geol Sci, PL-31002 Krakow, Poland	California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Polish Academy of Sciences; Institute of Geological Sciences of the Polish Academy of Sciences	Bristow, TF (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	thomas.f.bristow@nasa.gov	Bonifacie, Magali/A-5656-2011; Bonifacie, Magali/P-7737-2019	Bonifacie, Magali/0000-0002-4797-043X; Bonifacie, Magali/0000-0002-4797-043X	O.K. Earl Postdoctoral fellowship; NSF; INSU	O.K. Earl Postdoctoral fellowship; NSF(National Science Foundation (NSF)); INSU(Centre National de la Recherche Scientifique (CNRS))	We thank G. Jiang for guidance in the field and for providing samples, V. Orphan and W. Fischer for discussion and advice, M. Kennedy for supporting fieldwork and use of analytical equipment, and E. Peterman and K. Morrison for laboratory work. C. Ma and M. Anderson are thanked for analytical assistance and advice. This work was supported by an O.K. Earl Postdoctoral fellowship (to T.F.B.), by the NSF EAR and GEG programmes (to J.M.E.), and by INSU (to M.B.). Part of the work of M.B. is IPGP contribution 3138.	Bechtel A, 1999, CHEM GEOL, V156, P191, DOI 10.1016/S0009-2541(98)00185-5; Boles JR, 2004, AAPG BULL, V88, P947, DOI 10.1306/02090403040; Bristow TF, 2009, P NATL ACAD SCI USA, V106, P13190, DOI 10.1073/pnas.0901080106; Campbell KA, 2006, PALAEOGEOGR PALAEOCL, V232, P362, DOI 10.1016/j.palaeo.2005.06.018; Chen DZ, 2009, CHEM GEOL, V258, P168, DOI 10.1016/j.chemgeo.2008.10.016; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Eigenbrode JL, 2006, P NATL ACAD SCI USA, V103, P15759, DOI 10.1073/pnas.0607540103; FARVER JR, 1994, EARTH PLANET SC LETT, V121, P575, DOI 10.1016/0012-821X(94)90092-2; FRIEDMAN I, 1977, 444KK US GEOL SURV; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Grotzinger JP, 1995, PALAIOS, V10, P578, DOI 10.2307/3515096; Halverson GP, 2007, PALAEOGEOGR PALAEOCL, V256, P103, DOI 10.1016/j.palaeo.2007.02.028; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Horita J, 2008, GEOCHIM COSMOCHIM AC, V72, pA391; Huntington KW, 2009, J MASS SPECTROM, V44, P1318, DOI 10.1002/jms.1614; Jacobsen SB, 1999, CHEM GEOL, V161, P37, DOI 10.1016/S0009-2541(99)00080-7; Jiang GQ, 2006, J SEDIMENT RES, V76, P978, DOI 10.2110/jsr.2006.086; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; Kasting JF, 2005, PRECAMBRIAN RES, V137, P119, DOI 10.1016/j.precamres.2005.03.002; Kennedy M, 2008, NATURE, V453, P642, DOI 10.1038/nature06961; Kennedy MJ, 2001, GEOLOGY, V29, P443, DOI 10.1130/0091-7613(2001)029<0443:APCCAI>2.0.CO;2; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; MACDONALD GJ, 1990, CLIMATIC CHANGE, V16, P247, DOI 10.1007/BF00144504; Machel HG, 1996, GEOL SOC AM BULL, V108, P1108, DOI 10.1130/0016-7606(1996)108<1108:IEFCCA>2.3.CO;2; Maekawa T, 2004, GEOCHEM J, V38, P129, DOI 10.2343/geochemj.38.129; Meunier A., 2005, CLAYS; Orsini L., 1976, J B AFES, V4, P269; Passey BH, 2010, P NATL ACAD SCI USA, V107, P11245, DOI 10.1073/pnas.1001824107; ROSENBAUM J, 1986, GEOCHIM COSMOCHIM AC, V50, P1147, DOI 10.1016/0016-7037(86)90396-0; Sawaki Y, 2010, PRECAMBRIAN RES, V176, P46, DOI 10.1016/j.precamres.2009.10.006; SWART PK, 1991, CHEM GEOL, V86, P89, DOI 10.1016/0168-9622(91)90055-2; Wang JS, 2008, GEOLOGY, V36, P347, DOI 10.1130/G24513A.1; Wegener G, 2009, BIOGEOSCIENCES, V6, P867, DOI 10.5194/bg-6-867-2009; WELHAN JA, 1988, CHEM GEOL, V71, P183, DOI 10.1016/0009-2541(88)90114-3	37	108	111	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					68	U92		10.1038/nature10096	http://dx.doi.org/10.1038/nature10096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21613997				2022-12-01	WOS:000291156700038
J	Yeretssian, G; Correa, RG; Doiron, K; Fitzgerald, P; Dillon, CP; Green, DR; Reed, JC; Saleh, M				Yeretssian, Garabet; Correa, Ricardo G.; Doiron, Karine; Fitzgerald, Patrick; Dillon, Christopher P.; Green, Douglas R.; Reed, John C.; Saleh, Maya			Non-apoptotic role of BID in inflammation and innate immunity	NATURE			English	Article							FAMILY-MEMBER; CELL-DEATH; KAPPA-B; PROTEIN; ACTIVATION; NOD1; BCL-2; RECOGNITION; MECHANISM; BINDING	Innate immunity is a fundamental defence response that depends on evolutionarily conserved pattern recognition receptors for sensing infections or danger signals(1,2). Nucleotide-binding and oligomerization domain (NOD) proteins are cytosolic pattern-recognition receptors of paramount importance in the intestine, and their dysregulation is associated with inflammatory bowel disease(3,4). They sense peptidoglycans from commensal microorganisms and pathogens and coordinate signalling events that culminate in the induction of inflammation and anti-microbial responses(2). However, the signalling mechanisms involved in this process are not fully understood. Here, using genome-wide RNA interference, we identify candidate genes that modulate the NOD1 inflammatory response in intestinal epithelial cells. Our results reveal a significant crosstalk between innate immunity and apoptosis and identify BID, a BCL2 family protein, as a critical component of the inflammatory response. Colonocytes depleted of BID or macrophages from Bid(-/-) mice are markedly defective in cytokine production in response to NOD activation. Furthermore, Bid(-/-) mice are unresponsive to local or systemic exposure to NOD agonists or their protective effect in experimental colitis. Mechanistically, BID interacts with NOD1, NOD2 and the I kappa B kinase (IKK) complex, impacting NF-kappa B and extracellular signal-regulated kinase (ERK) signalling. Our results define a novel role of BID in inflammation and immunity independent of its apoptotic function, furthering the mounting evidence of evolutionary conservation between the mechanisms of apoptosis and immunity.	[Yeretssian, Garabet; Doiron, Karine; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada; [Correa, Ricardo G.; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Fitzgerald, Patrick; Dillon, Christopher P.; Green, Douglas R.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	McGill University; Sanford Burnham Prebys Medical Discovery Institute; St Jude Children's Research Hospital	Saleh, M (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada.	maya.saleh@mcgill.ca	Green, Douglas R/N-8083-2018; Dillon, Christopher/P-4457-2014; Correa, Ricardo G/G-7613-2012	Green, Douglas R/0000-0002-7332-1417; Dillon, Christopher/0000-0002-9458-0266; Correa, Ricardo G/0000-0001-6940-7034; Saleh, Maya/0000-0003-1538-9146	Canadian Institutes for Health Research [CIHR-MOP 82801]; Burroughs Wellcome Fund; McGill University Health Center; SASS Foundation for Medical Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); McGill University Health Center; SASS Foundation for Medical Research	We thank A. Strasser for providing Bid<SUP>-/-</SUP> mice, G. Shore for BID antibodies and the McGill University high throughput/high content screening facility. We also thank D. Zhai for BID purification. This work was supported by grants from the Canadian Institutes for Health Research (CIHR-MOP 82801) and the Burroughs Wellcome Fund to M.S. M.S. is a Canadian Institutes for Health Research New Investigator. G.Y. is supported by a PDF-Fellowship from the McGill University Health Center. C.P.D. is supported by a fellowship grant from the SASS Foundation for Medical Research.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Luo W, 2010, CURR CANCER DRUG TAR, V10, P96, DOI 10.2174/156800910790980160; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	83	84	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					96	U126		10.1038/nature09982	http://dx.doi.org/10.1038/nature09982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21552281				2022-12-01	WOS:000291156700045
J	Thigpen, MC; Whitney, CG; Messonnier, NE; Zell, ER; Lynfield, R; Hadler, JL; Harrison, LH; Farley, MM; Reingold, A; Bennett, NM; Craig, AS; Schaffner, W; Thomas, A; Lewis, MM; Scallan, E; Schuchat, A				Thigpen, Michael C.; Whitney, Cynthia G.; Messonnier, Nancy E.; Zell, Elizabeth R.; Lynfield, Ruth; Hadler, James L.; Harrison, Lee H.; Farley, Monica M.; Reingold, Arthur; Bennett, Nancy M.; Craig, Allen S.; Schaffner, William; Thomas, Ann; Lewis, Melissa M.; Scallan, Elaine; Schuchat, Anne		Emerging Infections Programs Netw	Bacterial Meningitis in the United States, 1998-2007	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; DISEASE; EPIDEMIOLOGY; SURVEILLANCE; LISTERIOSIS; ILLNESS; ADULTS	BACKGROUND The rate of bacterial meningitis declined by 55% in the United States in the early 1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine for infants was introduced. More recent prevention measures such as the pneumococcal conjugate vaccine and universal screening of pregnant women for group B streptococcus (GBS) have further changed the epidemiology of bacterial meningitis. METHODS We analyzed data on cases of bacterial meningitis reported among residents in eight surveillance areas of the Emerging Infections Programs Network, consisting of approximately 17.4 million persons, during 1998-2007. We defined bacterial meningitis as the presence of H. influenzae, Streptococcus pneumoniae, GBS, Listeria monocytogenes, or Neisseria meningitidis in cerebrospinal fluid or other normally sterile site in association with a clinical diagnosis of meningitis. RESULTS We identified 3188 patients with bacterial meningitis; of 3155 patients for whom outcome data were available, 466 (14.8%) died. The incidence of meningitis changed by -31% (95% confidence interval [CI], -33 to -29) during the surveillance period, from 2.00 cases per 100,000 population (95% CI, 1.85 to 2.15) in 1998-1999 to 1.38 cases per 100,000 population (95% CI 1.27 to 1.50) in 2006-2007. The median age of patients increased from 30.3 years in 1998-1999 to 41.9 years in 2006-2007 (P<0.001 by the Wilcoxon rank-sum test). The case fatality rate did not change significantly: it was 15.7% in 1998-1999 and 14.3% in 2006-2007 (P=0.50). Of the 1670 cases reported during 2003-2007, S. pneumoniae was the predominant infective species (58.0%), followed by GBS (18.1%), N. meningitidis (13.9%), H. influenzae (6.7%), and L. monocytogenes (3.4%). An estimated 4100 cases and 500 deaths from bacterial meningitis occurred annually in the United States during 2003-2007. CONCLUSIONS The rates of bacterial meningitis have decreased since 1998, but the disease still often results in death. With the success of pneumococcal and Hib conjugate vaccines in reducing the risk of meningitis among young children, the burden of bacterial meningitis is now borne more by older adults. (Funded by the Emerging Infections Programs, Centers for Disease Control and Prevention.)	[Thigpen, Michael C.; Whitney, Cynthia G.; Messonnier, Nancy E.; Zell, Elizabeth R.; Lewis, Melissa M.; Scallan, Elaine; Schuchat, Anne] Ctr Dis Control & Prevent, Atlanta, GA USA; [Farley, Monica M.] Georgia Dept Human Resources, Atlanta, GA USA; [Lynfield, Ruth] Minnesota Dept Hlth, Minneapolis, MN USA; [Hadler, James L.] Connecticut Dept Publ Hlth & Addict Serv, Hartford, CT 06106 USA; [Harrison, Lee H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Reingold, Arthur] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Bennett, Nancy M.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Craig, Allen S.; Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Thomas, Ann] Oregon Publ Hlth Div, Portland, OR USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley; University of Rochester; Vanderbilt University	Thigpen, MC (corresponding author), 3150 Rampart Rd, Ft Collins, CO 80521 USA.	mthigpen@cdc.gov	Walter, Elaine Scallan/AAG-4278-2020		Centers for Disease Control and Prevention, Atlanta	Centers for Disease Control and Prevention, Atlanta(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Emerging Infections Programs, Centers for Disease Control and Prevention, Atlanta.	Advisory Committee on Immunization Practices, 2009, ADV COMM IMM PRACT S, P59; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Centers for Disease Control and Prevention, ACT BACT COR SURV AB; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P392; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Centers for Disease Control and Prevention (CDC), 2010, ACT BACT COR SURV AB; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Food Safety and Inspection Service, 2000, REV ACT PLAN CONTR L; Food Safety and Inspection Service, 2008, FSIS REG TEST LM RTE; FRASER DW, 1975, AM J EPIDEMIOL, V102, P394, DOI 10.1093/oxfordjournals.aje.a112178; FRASER DW, 1974, AM J EPIDEMIOL, V100, P29, DOI 10.1093/oxfordjournals.aje.a112005; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hardnett FP, 2004, CLIN INFECT DIS, V38, pS121, DOI 10.1086/381602; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Jackson KA, 2010, EPIDEMIOL INFECT, V138, P1503, DOI 10.1017/S0950268810000294; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; SCHLECH WF, 1985, JAMA-J AM MED ASSOC, V253, P1749, DOI 10.1001/jama.253.12.1749; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Tsai CJ, 2008, CLIN INFECT DIS, V46, P1664, DOI 10.1086/587897; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Voetsch AC, 2007, CLIN INFECT DIS, V44, P513, DOI 10.1086/511006; WENGER JD, 1990, J INFECT DIS, V162, P1316, DOI 10.1093/infdis/162.6.1316; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	32	525	567	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2011	364	21					2016	2025		10.1056/NEJMoa1005384	http://dx.doi.org/10.1056/NEJMoa1005384			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768QR	21612470				2022-12-01	WOS:000290952000006
J	Banks, JA; Nishiyama, T; Hasebe, M; Bowman, JL; Gribskov, M; dePamphilis, C; Albert, VA; Aono, N; Aoyama, T; Ambrose, BA; Ashton, NW; Axtell, MJ; Barker, E; Barker, MS; Bennetzen, JL; Bonawitz, ND; Chapple, C; Cheng, CY; Correa, LGG; Dacre, M; DeBarry, J; Dreyer, I; Elias, M; Engstrom, EM; Estelle, M; Feng, L; Finet, C; Floyd, SK; Frommer, WB; Fujita, T; Gramzow, L; Gutensohn, M; Harholt, J; Hattori, M; Heyl, A; Hirai, T; Hiwatashi, Y; Ishikawa, M; Iwata, M; Karol, KG; Koehler, B; Kolukisaoglu, U; Kubo, M; Kurata, T; Lalonde, S; Li, KJ; Li, Y; Litt, A; Lyons, E; Manning, G; Maruyama, T; Michael, TP; Mikami, K; Miyazaki, S; Morinaga, S; Murata, T; Mueller-Roeber, B; Nelson, DR; Obara, M; Oguri, Y; Olmstead, RG; Onodera, N; Petersen, BL; Pils, B; Prigge, M; Rensing, SA; Riano-Pachon, DM; Roberts, AW; Sato, Y; Scheller, HV; Schulz, B; Schulz, C; Shakirov, EV; Shibagaki, N; Shinohara, N; Shippen, DE; Sorensen, I; Sotooka, R; Sugimoto, N; Sugita, M; Sumikawa, N; Tanurdzic, M; Theissen, G; Ulvskov, P; Wakazuki, S; Weng, JK; Willats, WWGT; Wipf, D; Wolf, PG; Yang, LX; Zimmer, AD; Zhu, QH; Mitros, T; Hellsten, U; Loque, D; Otillar, R; Salamov, A; Schmutz, J; Shapiro, H; Lindquist, E; Lucas, S; Rokhsar, D; Grigoriev, IV				Banks, Jo Ann; Nishiyama, Tomoaki; Hasebe, Mitsuyasu; Bowman, John L.; Gribskov, Michael; dePamphilis, Claude; Albert, Victor A.; Aono, Naoki; Aoyama, Tsuyoshi; Ambrose, Barbara A.; Ashton, Neil W.; Axtell, Michael J.; Barker, Elizabeth; Barker, Michael S.; Bennetzen, Jeffrey L.; Bonawitz, Nicholas D.; Chapple, Clint; Cheng, Chaoyang; Correa, Luiz Gustavo Guedes; Dacre, Michael; DeBarry, Jeremy; Dreyer, Ingo; Elias, Marek; Engstrom, Eric M.; Estelle, Mark; Feng, Liang; Finet, Cedric; Floyd, Sandra K.; Frommer, Wolf B.; Fujita, Tomomichi; Gramzow, Lydia; Gutensohn, Michael; Harholt, Jesper; Hattori, Mitsuru; Heyl, Alexander; Hirai, Tadayoshi; Hiwatashi, Yuji; Ishikawa, Masaki; Iwata, Mineko; Karol, Kenneth G.; Koehler, Barbara; Kolukisaoglu, Uener; Kubo, Minoru; Kurata, Tetsuya; Lalonde, Sylvie; Li, Kejie; Li, Ying; Litt, Amy; Lyons, Eric; Manning, Gerard; Maruyama, Takeshi; Michael, Todd P.; Mikami, Koji; Miyazaki, Saori; Morinaga, Shin-ichi; Murata, Takashi; Mueller-Roeber, Bernd; Nelson, David R.; Obara, Mari; Oguri, Yasuko; Olmstead, Richard G.; Onodera, Naoko; Petersen, Bent Larsen; Pils, Birgit; Prigge, Michael; Rensing, Stefan A.; Mauricio Riano-Pachon, Diego; Roberts, Alison W.; Sato, Yoshikatsu; Scheller, Henrik Vibe; Schulz, Burkhard; Schulz, Christian; Shakirov, Eugene V.; Shibagaki, Nakako; Shinohara, Naoki; Shippen, Dorothy E.; Sorensen, Iben; Sotooka, Ryo; Sugimoto, Nagisa; Sugita, Mamoru; Sumikawa, Naomi; Tanurdzic, Milos; Theissen, Guenter; Ulvskov, Peter; Wakazuki, Sachiko; Weng, Jing-Ke; Willats, William W. G. T.; Wipf, Daniel; Wolf, Paul G.; Yang, Lixing; Zimmer, Andreas D.; Zhu, Qihui; Mitros, Therese; Hellsten, Uffe; Loque, Dominique; Otillar, Robert; Salamov, Asaf; Schmutz, Jeremy; Shapiro, Harris; Lindquist, Erika; Lucas, Susan; Rokhsar, Daniel; Grigoriev, Igor V.			The Selaginella Genome Identifies Genetic Changes Associated with the Evolution of Vascular Plants	SCIENCE			English	Article							SMALL RNAS; MESSENGER-RNAS; ARABIDOPSIS; MOELLENDORFFII; MECHANISM; LAND; PERSPECTIVE; SIRNAS	Vascular plants appeared similar to 410 million years ago, then diverged into several lineages of which only two survive: the euphyllophytes (ferns and seed plants) and the lycophytes. We report here the genome sequence of the lycophyte Selaginella moellendorffii (Selaginella), the first nonseed vascular plant genome reported. By comparing gene content in evolutionarily diverse taxa, we found that the transition from a gametophyte- to a sporophyte-dominated life cycle required far fewer new genes than the transition from a nonseed vascular to a flowering plant, whereas secondary metabolic genes expanded extensively and in parallel in the lycophyte and angiosperm lineages. Selaginella differs in posttranscriptional gene regulation, including small RNA regulation of repetitive elements, an absence of the trans-acting small interfering RNA pathway, and extensive RNA editing of organellar genes.	[Banks, Jo Ann] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Nishiyama, Tomoaki] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa 9200934, Japan; [Nishiyama, Tomoaki; Hasebe, Mitsuyasu; Cheng, Chaoyang; Hirai, Tadayoshi; Ishikawa, Masaki; Iwata, Mineko; Kubo, Minoru; Kurata, Tetsuya; Obara, Mari; Oguri, Yasuko; Onodera, Naoko; Sato, Yoshikatsu; Shinohara, Naoki; Sugimoto, Nagisa; Wakazuki, Sachiko] Japan Sci & Technol Agcy, ERATO, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu; Aono, Naoki; Aoyama, Tsuyoshi; Hiwatashi, Yuji; Miyazaki, Saori; Morinaga, Shin-ichi; Murata, Takashi; Sumikawa, Naomi] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu; Aoyama, Tsuyoshi; Hiwatashi, Yuji; Murata, Takashi] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Sci, Okazaki, Aichi 4448585, Japan; [Bowman, John L.; Floyd, Sandra K.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Bowman, John L.] Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; [Gribskov, Michael; Li, Kejie; Li, Ying] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [dePamphilis, Claude; Axtell, Michael J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [dePamphilis, Claude; Axtell, Michael J.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [dePamphilis, Claude] Penn State Univ, Grad Program Plant Biol, University Pk, PA 16802 USA; [dePamphilis, Claude] Penn State Univ, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; [Albert, Victor A.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Ambrose, Barbara A.; Karol, Kenneth G.; Litt, Amy] New York Bot Garden, Bronx, NY 10458 USA; [Ashton, Neil W.; Barker, Elizabeth] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Barker, Michael S.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Bennetzen, Jeffrey L.; DeBarry, Jeremy; Yang, Lixing; Zhu, Qihui] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Bonawitz, Nicholas D.; Chapple, Clint; Weng, Jing-Ke] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Correa, Luiz Gustavo Guedes; Koehler, Barbara] Univ Potsdam, Dept Mol Biol, D-14476 Potsdam, Germany; [Dacre, Michael; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; [Dreyer, Ingo] Univ Potsdam, Heisenberg Grp Biophys & Mol Plant Biol, D-14476 Potsdam, Germany; [Elias, Marek] Charles Univ Prague, Dept Bot, Fac Sci, Prague 12801 2, Czech Republic; [Elias, Marek] Univ Prague, Fac Sci, Ostrava 71000, Czech Republic; [Engstrom, Eric M.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; [Estelle, Mark; Prigge, Michael] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Feng, Liang] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Finet, Cedric] Ecole Normale Super Lyon, Lab Reprod & Dev Plantes, F-69364 Lyon, France; [Frommer, Wolf B.; Lalonde, Sylvie] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Fujita, Tomomichi] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Gramzow, Lydia; Theissen, Guenter] Univ Jena, Dept Genet, D-07743 Jena, Germany; [Gutensohn, Michael; Schulz, Burkhard] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Gutensohn, Michael] Univ Halle Wittenberg, Inst Biol, D-06120 Halle, Germany; [Harholt, Jesper; Petersen, Bent Larsen; Sorensen, Iben; Ulvskov, Peter; Willats, William W. G. T.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Hattori, Mitsuru; Sugita, Mamoru] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Hattori, Mitsuru] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Heyl, Alexander] Free Univ Berlin, Dahlem Ctr Plant Sci, Inst Biol Appl Genet, D-14195 Berlin, Germany; [Hirai, Tadayoshi] Univ Tsukuba, Ctr Gene Res, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kolukisaoglu, Uener] Univ Rostock, Ctr Life Sci Automat, D-18119 Rostock, Germany; [Kolukisaoglu, Uener] Univ Tubingen, Studiengangskoordinat Nanosci, D-72076 Tubingen, Germany; [Kurata, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Nara 6300192, Japan; [Li, Ying] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Lyons, Eric; Scheller, Henrik Vibe] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Maruyama, Takeshi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Monsanto Co, Genome Anal Ctr, St Louis, MO 63167 USA; [Mikami, Koji] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Miyazaki, Saori] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Morinaga, Shin-ichi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Mueller-Roeber, Bernd] Bernd Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Nelson, David R.] Univ Tennessee, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Obara, Mari] Japan Sci & Technol Agcy, Sapporo, Hokkaido 0600819, Japan; [Olmstead, Richard G.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Onodera, Naoko] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Pils, Birgit] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Pils, Birgit] Sias AG, CH-8634 Hombrechtikon, Switzerland; [Rensing, Stefan A.; Zimmer, Andreas D.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, Freiburg Initiat Syst Biol FRISYS, D-79104 Freiburg, Germany; [Mauricio Riano-Pachon, Diego] Max Planck Inst Mol Plant Physiol, Bioinformat Grp, GabiPD Team, D-14476 Potsdam, Germany; [Mauricio Riano-Pachon, Diego] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Roberts, Alison W.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Scheller, Henrik Vibe; Loque, Dominique] Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA 94608 USA; [Schulz, Christian] Ruhr Univ Bochum, Dept Evolut & Biodivers Plants, D-44780 Bochum, Germany; [Shakirov, Eugene V.; Shippen, Dorothy E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Shibagaki, Nakako] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Shinohara, Naoki; Sotooka, Ryo] Hokkaido Univ, Sch Sci, Sapporo, Hokkaido 0600810, Japan; [Sorensen, Iben] Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA; [Tanurdzic, Milos] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Weng, Jing-Ke] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Wipf, Daniel] Univ Bourgogne, INRA, UMR 1088, CNRS 5184, F-21065 Dijon, France; [Wolf, Paul G.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Mitros, Therese; Rokhsar, Daniel] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hellsten, Uffe; Otillar, Robert; Salamov, Asaf; Schmutz, Jeremy; Shapiro, Harris; Lindquist, Erika; Lucas, Susan; Rokhsar, Daniel; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kanazawa University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Monash University; University of California System; University of California Davis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; New York Botanical Garden; University of Regina; University of Arizona; University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Potsdam; Salk Institute; University of Potsdam; Charles University Prague; William & Mary; University of California System; University of California San Diego; University System of Georgia; University of Georgia; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Carnegie Institution for Science; Hokkaido University; Friedrich Schiller University of Jena; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Martin Luther University Halle Wittenberg; University of Copenhagen; Nagoya University; University of Tokyo; Free University of Berlin; University of Tsukuba; University of Rostock; Eberhard Karls University of Tubingen; Nara Institute of Science & Technology; Mayo Clinic; University of California System; University of California Berkeley; Hokkaido University; Rutgers State University New Brunswick; Monsanto; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Max Planck Society; University of Tennessee System; University of Tennessee Health Science Center; Japan Science & Technology Agency (JST); University of Washington; University of Washington Seattle; Dalhousie University; University of Oxford; Wellcome Centre for Human Genetics; University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; Universidad de los Andes (Colombia); University of Rhode Island; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Ruhr University Bochum; Texas A&M University System; Texas A&M University College Station; Osaka University; Hokkaido University; Cornell University; Cold Spring Harbor Laboratory; Salk Institute; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Bourgogne; Utah System of Higher Education; Utah State University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Banks, JA (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	banksj@purdue.edu	Chapple, Clint CS/Q-5456-2017; Barker, Mike/AAE-7891-2019; Harholt, Jesper/F-3760-2011; Frommer, Wolf B/K-5042-2017; Mikami, Koji/A-9825-2012; Frommer, Wolf B/A-8256-2008; Heyl, Alexander/ABD-2145-2020; Ulvskov, Peter/I-1228-2014; Petersen, Bent/H-9437-2014; Wolf, Paul/F-7664-2010; Feng, Liang/I-5010-2014; Estelle, Mark/ABD-6742-2021; Riaño-Pachón, Diego Mauricio/B-4891-2014; Elias, Marek/D-6851-2014; Harholt, Jesper/F-6865-2014; Manning, Gerard/C-8308-2009; Ishikawa, Masaki/AAC-8162-2022; Gribskov, Michael/AAH-5905-2021; Riaño-Pachón, Diego M/A-1755-2010; Schmutz, Jeremy/N-3173-2013; Tanurdzic, Milos/A-5712-2012; Ye, Mingli/G-4909-2012; Dreyer, Ingo/N-4747-2014; Yang, Lixing/A-7073-2013; Zhu, Qihui/N-2625-2013; Li, Kejie/D-3595-2013; Loque, Dominique/A-8153-2008; Weng, Jing-Ke/A-6900-2015; dePamphilis, Claude W/P-6652-2016; Kubo, Minoru/AAH-1689-2019; Weng, Jing-Ke/V-5934-2019; Mueller-Roeber, Bernd/Z-4052-2019; Weng, Jing-Ke/E-7343-2013; Sato, Yoshikatsu/I-6129-2014; Shakirov, Eugene V/A-1363-2012; Dacre, Michael/C-1131-2008; Kolukisaoglu, Üner/J-8831-2014; Ishikawa, Masaki/Q-7598-2018; Scheller, Henrik/AAH-4770-2020	Chapple, Clint CS/0000-0002-5195-562X; Barker, Mike/0000-0001-7173-1319; Frommer, Wolf B/0000-0001-6465-0115; Mikami, Koji/0000-0003-3811-0072; Frommer, Wolf B/0000-0001-6465-0115; Ulvskov, Peter/0000-0003-3776-818X; Petersen, Bent/0000-0002-2004-9077; Wolf, Paul/0000-0002-4317-6976; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Elias, Marek/0000-0003-0066-6542; Harholt, Jesper/0000-0002-7984-0066; Ishikawa, Masaki/0000-0002-6491-5539; Riaño-Pachón, Diego M/0000-0001-9803-3465; Schmutz, Jeremy/0000-0001-8062-9172; Tanurdzic, Milos/0000-0002-7564-0868; Dreyer, Ingo/0000-0002-2781-0359; Weng, Jing-Ke/0000-0003-3059-0075; Kubo, Minoru/0000-0001-8691-6252; Weng, Jing-Ke/0000-0003-3059-0075; Weng, Jing-Ke/0000-0003-1079-3668; Shakirov, Eugene V/0000-0003-2689-7410; Dacre, Michael/0000-0002-5561-1656; Kolukisaoglu, Üner/0000-0002-8656-5963; Ishikawa, Masaki/0000-0002-6491-5539; Scheller, Henrik/0000-0002-6702-3560; DeBarry, Jeremy/0000-0001-5718-2675; Gramzow, Lydia/0000-0003-1919-6077; Bowman, John/0000-0001-7347-3691; Prigge, Michael/0000-0003-0671-2538; Rokhsar, Daniel/0000-0002-8704-2224; Gribskov, Michael/0000-0002-1718-0242; HIWATASHI, YUJI/0000-0002-3996-0549; Nishiyama, Tomoaki/0000-0003-1279-7806; Lyons, Eric/0000-0002-3348-8845; Wipf, Daniel/0000-0001-7197-5612; Schulz, Christian/0000-0002-2708-0632; Michael, Todd/0000-0001-6272-2875; Grigoriev, Igor/0000-0002-3136-8903; Zimmer, Andreas/0000-0002-5595-9388; Nelson, David/0000-0003-0583-5421; Hasebe, Mitsuyasu/0000-0001-7425-8758; Shinohara, Naoki/0000-0002-4029-239X; Sorensen, Iben/0000-0002-9768-620X; Manning, Gerard/0000-0002-5087-9151; Aoyama, Tsuyoshi/0000-0002-4184-167X; Willats, William/0000-0003-2064-4025	Office of Science of the U.S. DOE [DE-AC02-05CH11231]; NSF [0844413, 0515435, 0519970, 0638595, 0922742, 1020443, 0607123, 0744800, 1020660, 1036466, 0735191, 0228660, 0421604]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Australian Research Council [FF0561326]; Lewis B and Dorothy Cullman Program; Natural Sciences and Engineering Research Council of Canada (NSERC) [2982]; NIH [GM84051, T32 GM007757, T32-HG00035, GM065383]; Life Sciences Research Foundation; National Human Genome Research Institute (NHGRI) [HG004164]; German Science Foundation (Deutsche Forschungsgemeinschaft, DFG) [DR 430/4-2]; Czech Ministry of Education [21620828]; Jeffress Memorial Trust [J-938]; DOE [DE-FG02-04ER15542]; Danish Council for Independent Research, Technology and Production Sciences [009-066624/274-09-0314]; Villum Kann Rasmussen Foundation; U.S. Department of Agriculture (USDA) [DE-FG02-08ER64630]; Danish Council for Strategic Research [09-063090]; Marie Curie FP6 RTN ZOONET; DFG [RE 837/10-2, BMBF FRISYS 0313921]; Bundesministerium fuer Bildung und Forschung, Germany [0315046]; USDA NRI [2007-35318-18389]; Burgundy Regional Council [20100112095254682-1]; Villum Fonden [00007173] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007757, R01GM043644, R01GM065383, R01GM084051] Funding Source: NIH RePORTER; Direct For Biological Sciences [1020443] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0844413, 0922742] Funding Source: National Science Foundation	Office of Science of the U.S. DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Australian Research Council(Australian Research Council); Lewis B and Dorothy Cullman Program; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); German Science Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Jeffress Memorial Trust; DOE(United States Department of Energy (DOE)); Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Villum Kann Rasmussen Foundation(Villum Fonden); U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Marie Curie FP6 RTN ZOONET(European Commission); DFG(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung, Germany; USDA NRI(United States Department of Agriculture (USDA)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); Villum Fonden(Villum Fonden); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Selaginella sequences were deposited at GenBank with the accession numbers GL377566 to GL378322.1 and HM173080. Genome sequencing and analysis were performed by the U.S. Department of Energy (DOE), Joint Genome Institute, supported by the Office of Science of the U.S. DOE, Contract DE-AC02-05CH11231 (I.V.G., U.H., D.L., E.L., S.L., T.M., R.O., D.R., A.S., J.S., H.V.S.). Support was provided by NSF 0844413 (J.A.B.); Japan Society for the Promotion of Science (M.H., T.N., T.F., K.M., T.M., M.S.); Ministry of Education, Culture, Sports, Science, and Technology, Japan (M.H., T.N., T.F.); NSF 0515435 and Australian Research Council FF0561326 (J.L.B.); NSF 0519970 (M.G.); NSF 0638595 (C.D.); NSF 0922742 (V.A.A.); The Lewis B and Dorothy Cullman Program (B.A.A., A.L.); NSF 1020443 (B.A.A.); Natural Sciences and Engineering Research Council of Canada (NSERC) 2982 (N.W.A.); NIH GM84051 (M.J.A.); NSERC (E.I.B.); NIH T32 GM007757 and NSERC PGS-D (M.S.B.); NSF 0607123 (J.L.B.); Life Sciences Research Foundation (NDB); National Human Genome Research Institute (NHGRI) HG004164 (M.D.); German Science Foundation (Deutsche Forschungsgemeinschaft, DFG) DR 430/4-2 (I.D.); Czech Ministry of Education 21620828 (M.E.); Jeffress Memorial Trust J-938 (E.M.E.); NSF 0744800 (M.E. and M.P.); DOE DE-FG02-04ER15542 (W.B.F. and S.L.); The Danish Council for Independent Research, Technology and Production Sciences 009-066624/274-09-0314 (J.H.); The Villum Kann Rasmussen Foundation (J.H., I.S., B.P., P.U., W.W.); NIH T32-HG00035, NSF 1020660, and NSF 1036466 (K.G.K.); NSF 0735191 (E.L.); NHGRI HG004164 (G.M); U.S. Department of Agriculture (USDA) DE-FG02-08ER64630 (T.P.M.); NSF 0228660 (R.G.O.); The Danish Council for Strategic Research 09-063090 (B.L.P. and P.U.); Marie Curie FP6 RTN ZOONET (B.P.); DFG RE 837/10-2, BMBF FRISYS 0313921 (S.A.R.); Bundesministerium fuer Bildung und Forschung, Germany, GABI-FUTURE grant 0315046 (D.M.R.); USDA NRI 2007-35318-18389 (A.W.R.); NSF 0421604 (C.S.); NIH GM065383 (D.E.S.); Burgundy Regional Council 20100112095254682-1 (D.W.); and DFG RE 837/10-2 (A.D.Z.). K. Wall, D. Hurley, and S. Hentel provided computational assistance.	Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Cao Y, 2010, FITOTERAPIA, V81, P253, DOI 10.1016/j.fitote.2009.09.007; Chen DJ, 2010, BIOINFORMATICS, V26, P1391, DOI 10.1093/bioinformatics/btq150; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Floyd SK, 2006, CURR BIOL, V16, P1911, DOI 10.1016/j.cub.2006.07.067; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Harrison CJ, 2005, NATURE, V434, P509, DOI 10.1038/nature03410; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tsuji S, 2007, J PLANT RES, V120, P281, DOI 10.1007/s10265-006-0055-y; Wang WM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-10; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yasumura Y, 2007, CURR BIOL, V17, P1225, DOI 10.1016/j.cub.2007.06.037	25	581	651	4	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					960	963		10.1126/science.1203810	http://dx.doi.org/10.1126/science.1203810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21551031	Green Accepted			2022-12-01	WOS:000290766600042
J	Dunkle, JA; Wang, LY; Feldman, MB; Pulk, A; Chen, VB; Kapral, GJ; Noeske, J; Richardson, JS; Blanchard, SC; Cate, JHD				Dunkle, Jack A.; Wang, Leyi; Feldman, Michael B.; Pulk, Arto; Chen, Vincent B.; Kapral, Gary J.; Noeske, Jonas; Richardson, Jane S.; Blanchard, Scott C.; Cate, Jamie H. Doudna			Structures of the Bacterial Ribosome in Classical and Hybrid States of tRNA Binding	SCIENCE			English	Article							AMINOACYL-TRANSFER-RNA; CRYSTAL-STRUCTURE; RECYCLING FACTOR; INTERMEDIATE STATES; MESSENGER-RNA; 70S RIBOSOME; TRANSLOCATION; DYNAMICS; SITE; TRANSLATION	During protein synthesis, the ribosome controls the movement of tRNA and mRNA by means of large-scale structural rearrangements. We describe structures of the intact bacterial ribosome from Escherichia coli that reveal how the ribosome binds tRNA in two functionally distinct states, determined to a resolution of similar to 3.2 angstroms by means of x-ray crystallography. One state positions tRNA in the peptidyl-tRNA binding site. The second, a fully rotated state, is stabilized by ribosome recycling factor and binds tRNA in a highly bent conformation in a hybrid peptidyl/exit site. The structures help to explain how the ratchet-like motion of the two ribosomal subunits contributes to the mechanisms of translocation, termination, and ribosome recycling.	[Dunkle, Jack A.; Pulk, Arto; Noeske, Jonas; Cate, Jamie H. Doudna] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dunkle, Jack A.; Pulk, Arto; Noeske, Jonas; Cate, Jamie H. Doudna] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wang, Leyi; Feldman, Michael B.; Blanchard, Scott C.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Feldman, Michael B.] Weill Cornell Rockefeller Univ Sloan Kettering Tr, New York, NY 10065 USA; [Chen, Vincent B.; Kapral, Gary J.; Richardson, Jane S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Cate, Jamie H. Doudna] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cornell University; Duke University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Richardson, Jane/Q-6478-2019; Dunkle, Jack/ABB-9713-2020; Classen, Scott/AAY-8176-2020; Blanchard, Scott C./A-5804-2009	Richardson, Jane/0000-0002-3311-2944; Dunkle, Jack/0000-0001-6252-0587; Blanchard, Scott C./0000-0003-2717-9365; Chen, Vincent/0000-0003-2492-979X; Feldman, Michael/0000-0001-7364-5211; Noeske, Jonas/0000-0002-8750-2008; Pulk, Arto/0000-0001-8793-3038	National Institutes of Health [GM65050, GM079238, GM074127-04S1, GM088674, P01-GM63210, GM07739]; National Cancer Institute [CA92584]; National Center for Research Resources [RR-15301]; U.S. Department of Energy [DE-AC03 76SF00098, DE-AC02-06CH11357]; Human Frontiers in Science Program; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088674, T32GM007739, R01GM079238, P01GM063210, R01GM065050, R01GM074127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy(United States Department of Energy (DOE)); Human Frontiers in Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hamadani for purified RRF; K. Nierhaus for tRNAPhe overexpression plasmids; K. Frankel, S. Classen, and G. Meigs for help with data measurement at the SIBYLS and 8.3.1 beamlines at the Advanced Light Source (ALS); R. Kanagalaghatta, D. Neau, F. Murphy, and I. Kourinov for help with data measurement at ID-24 at the Advanced Photon Source (APS); J. Headd for help with Phenix refinement; and J. Holton for useful crystallographic discussions. We also thank J. Doudna and H. Noller for helpful comments on the manuscript. Atomic coordinates and structure factors are deposited in the Protein Data Bank (accession codes 3R8N and 3R8S for the fully rotated state R<INF>F</INF>, 3R8O and 3R8T for the unrotated state R<INF>0</INF>). This work was funded by the National Institutes of Health (GM65050 to J.H.D.C., GM079238 to S.C.B, and GM074127-04S1, GM088674, and P01-GM63210 project IV to J. S. R.), National Cancer Institute grant CA92584 for the SIBYLS and 8.3.1 beam lines at the ALS, and National Center for Research Resources grant RR-15301 for the Northeastern Collaborative Access Team beam lines at 24-ID at APS, and by the U.S. Department of Energy (DE-AC03 76SF00098 for the SIBYLS and 8.3.1 beamlines at the ALS, and DE-AC02-06CH11357 for the APS). M.B.F. is a trainee in the Weill Cornell/Rockefeller University/SloanKettering Tri-Institutional MD-PhD Program supported by NIH Medical Scientist Training Program grant GM07739. J.N. is supported by a Human Frontiers in Science Program Postdoctoral Fellowship.	Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bokov K, 2009, NATURE, V457, P977, DOI 10.1038/nature07749; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cukras AR, 2005, J MOL BIOL, V349, P47, DOI 10.1016/j.jmb.2005.03.075; Dunkle JA, 2010, ANNU REV BIOPHYS, V39, P227, DOI 10.1146/annurev.biophys.37.032807.125954; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Feldman MB, 2010, NAT CHEM BIOL, V6, P54, DOI [10.1038/NCHEMBIO.274, 10.1038/nchembio.274]; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gao N, 2005, MOL CELL, V18, P663, DOI 10.1016/j.molcel.2005.05.005; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Janosi L, 2000, J MOL BIOL, V295, P815, DOI 10.1006/jmbi.1999.3401; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Komoda T, 2006, J BIOL CHEM, V281, P32303, DOI 10.1074/jbc.M607058200; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Li W, 2007, P NATL ACAD SCI USA, V104, P16540, DOI 10.1073/pnas.0708094104; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spirin AS, 2009, J BIOL CHEM, V284, P21103, DOI 10.1074/jbc.X109.001552; Stanley RE, 2010, NAT STRUCT MOL BIOL, V17, P289, DOI 10.1038/nsmb.1755; Sternberg SH, 2009, NAT STRUCT MOL BIOL, V16, P861, DOI 10.1038/nsmb.1622; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	46	260	266	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2011	332	6032					981	984		10.1126/science.1202692	http://dx.doi.org/10.1126/science.1202692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596992	Green Accepted			2022-12-01	WOS:000290766600048
J	Pankhania, M; Judd, O; Ward, A				Pankhania, Miran; Judd, Owen; Ward, Andy			10-MINUTE CONSULTATION Otorrhoea	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pankhania, Miran] Milton Keynes Dist Gen Hosp, Dept ENT, Milton Keynes MK6 5LD, Bucks, England; [Judd, Owen] Leicester Royal Infirm, Dept ENT, Leicester LE1 5WW, Leics, England; [Ward, Andy] S Wigston Hlth Ctr, Leicester LE18 4SE, Leics, England	University of Leicester	Pankhania, M (corresponding author), Milton Keynes Dist Gen Hosp, Dept ENT, Milton Keynes MK6 5LD, Bucks, England.	pank@doctors.org.uk	Ward, Andy/AAH-8950-2021	Ward, Andy/0000-0002-4955-1984; Judd, Owen/0000-0003-3112-931X				Beers SL, 2004, PEDIATR EMERG CARE, V20, P250, DOI 10.1097/01.pec.0000121246.99242.f5; Grevers G, 2010, INT J PEDIATR OTORHI, V74, P572, DOI 10.1016/j.ijporl.2010.03.049; McHugh TP, 2007, J EMERG MED, V32, P375, DOI 10.1016/j.jemermed.2006.08.015; Phillips JS, 2007, CLIN OTOLARYNGOL, V32, P330, DOI 10.1111/j.1749-4486.2007.01532.x	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 20	2011	342								d2299	10.1136/bmj.d2299	http://dx.doi.org/10.1136/bmj.d2299			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QT	21602234				2022-12-01	WOS:000290952200001
J	He, FL; Hubbell, SP				He, Fangliang; Hubbell, Stephen P.			Species-area relationships always overestimate extinction rates from habitat loss	NATURE			English	Article							DEFORESTATION; PATTERNS	Extinction from habitat loss is the signature conservation problem of the twenty-first century(1). Despite its importance, estimating extinction rates is still highly uncertain because no proven direct methods or reliable data exist for verifying extinctions. The most widely used indirect method is to estimate extinction rates by reversing the species-area accumulation curve, extrapolating backwards to smaller areas to calculate expected species loss. Estimates of extinction rates based on this method are almost always much higher than those actually observed(2-5). This discrepancy gave rise to the concept of an 'extinction debt', referring to species 'committed to extinction' owing to habitat loss and reduced population size but not yet extinct during a non-equilibrium period(6,7). Here we show that the extinction debt as currently defined is largely a sampling artefact due to an unrecognized difference between the underlying sampling problems when constructing a species-area relationship (SAR) and when extrapolating species extinction from habitat loss. The key mathematical result is that the area required to remove the last individual of a species (extinction) is larger, almost always much larger, than the sample area needed to encounter the first individual of a species, irrespective of species distribution and spatial scale. We illustrate these results with data from a global network of large, mapped forest plots and ranges of passerine bird species in the continental USA; and we show that overestimation can be greater than 160%. Although we conclude that extinctions caused by habitat loss require greater loss of habitat than previously thought, our results must not lead to complacency about extinction due to habitat loss, which is a real and growing threat.	[He, Fangliang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Hubbell, Stephen P.] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Unit 0948, APO, AA 34002 USA	Sun Yat Sen University; Sun Yat Sen University; University of Alberta; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian Tropical Research Institute	He, FL (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	fhe@mail.sysu.edu.cn; shubbell@eeb.ucla.edu			Sun Yat-sen University; Natural Sciences and Engineering Research Council (Canada); NASA (National Aeronautics and Space Administration); US National Science Foundation	Sun Yat-sen University; Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NASA (National Aeronautics and Space Administration)(National Aeronautics & Space Administration (NASA)); US National Science Foundation(National Science Foundation (NSF))	We acknowledge the work of the principal investigators and their field assistants for collecting the field data on the large plots of the Center for Tropical Forest Science network. We are grateful to P. Gowaty, K. Gaston and M. Rosenzweig for their comments on the paper. We thank R. Condit, R. Perez and S. Agular for Barro Colorado Island, R. Valencia for Yasuni, N. Supardi Noor and R. Kassim for Pasoh, D. Thomas, D. Kenfack and G. Chuyong for Korup, W.-H. Ye for Dinghushan, I.-F. Sun and C.-F. Hseih for Fushan, X.-H. Wang for Tiantong, Z.-Q. Hao for Changbaishan and X.-L. Wang for processing the passerine data. This work was supported by Sun Yat-sen University, the Natural Sciences and Engineering Research Council (Canada), NASA (National Aeronautics and Space Administration) and the US National Science Foundation.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; [Anonymous], 2005, EC HUM WELL BEING BI; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; COLEMAN BD, 1981, MATH BIOSCI, V54, P191, DOI 10.1016/0025-5564(81)90086-9; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; DIAL R, 1994, NATURE, V370, P104, DOI 10.1038/370104b0; Ehrlich PR., 1981, EXTINCTION; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Harte J, 2004, NATURE, V430, DOI 10.1038/nature02718; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; HEYWOOD VH, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P91; HEYWOOD VH, 1994, NATURE, V368, P105, DOI 10.1038/368105a0; Kinzig AP, 2000, ECOLOGY, V81, P3305, DOI 10.2307/177495; Lovejoy T.E, 1980, GLOBAL 2000 REPORT P, V2, P328; Lugo A.E., 1988, P58; May Robert M., 1995, P1; Myers, 1979, SINKING ARK NEW LOOK; Myers N., 1983, TROPICAL RAIN FOREST, P325; National Research Council, 1980, RES PRIOR TROP BIOL; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SIMBERLOFF D, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P75; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; WCMC-World Conservation Monitoring Centre, 1992, GLOB BIOD STAT EARTH	30	265	282	12	433	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					368	371		10.1038/nature09985	http://dx.doi.org/10.1038/nature09985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593870				2022-12-01	WOS:000290722400047
J	Kim, BH; Shenoy, AR; Kumar, P; Das, R; Tiwari, S; MacMicking, JD				Kim, Bae-Hoon; Shenoy, Avinash R.; Kumar, Pradeep; Das, Rituparna; Tiwari, Sangeeta; MacMicking, John D.			A Family of IFN-gamma-Inducible 65-kD GTPases Protects Against Bacterial Infection	SCIENCE			English	Article							BINDING; IMMUNITY; AUTOPHAGY	Immune interferon gamma (IFN-gamma) is essential for mammalian host defense against intracellular pathogens. IFN-gamma induces nearly 2000 host genes, yet few have any assigned function. Here, we examined a complete mouse 65-kilodalton (kD) guanylate-binding protein (Gbp) gene family as part of a 43-member IFN-gamma-inducible guanosine triphosphatase (GTPase) superfamily in mouse and human genomes. Family-wide loss-of-function analysis found that at least four Gbps-Gbp1, Gbp6, Gbp7, and Gbp10-conferred cell-autonomous immunity to listerial or mycobacterial infection within macrophages and gene-deficient animals. These Gbps solicited host defense proteins, including the phagocyte oxidase, antimicrobial peptides, and autophagy effectors, to kill intracellular bacteria. Thus, specific 65-kD Gbps coordinate a potent oxidative and vesicular trafficking program to protect the host from infection.	[Kim, Bae-Hoon; Shenoy, Avinash R.; Kumar, Pradeep; Das, Rituparna; Tiwari, Sangeeta; MacMicking, John D.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA; [Das, Rituparna] Yale Univ, Sch Med, Dept Internal Med, Div Infect Dis, New Haven, CT 06510 USA	Yale University; Yale University	MacMicking, JD (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06510 USA.	john.macmicking@yale.edu	tiwari, sangeeta/T-5810-2019; hongbo, yi/G-9615-2011; Tiwari, Sangeeta/GWV-0350-2022; Kim, Bae-Hoon/F-3289-2012; Kim, Bae-Hoon/A-8847-2014	Shenoy, Avinash/0000-0001-6228-9303	NIH National Institute of Allergy and Infectious Diseases [R01 AI068041-01A1]; Burroughs Wellcome Fund; Searle Scholars Program; Cancer Research Institute; W.W. Winchester Foundation; Browne-Cox Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041] Funding Source: NIH RePORTER	NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Searle Scholars Program; Cancer Research Institute; W.W. Winchester Foundation; Browne-Cox Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Matsuura (NS34A DN cells); S. Ivanov (Ub-K63-GFP cells); R. Medzhitov (MyD88<SUP>-/-</SUP> Trif<SUP>-/-</SUP> mice); M. Pypaert (electron microscopy); and P. Cresswell, W. Mothes, C. Roy, G. Superti-Furga, T. Yoshimori, and H. Zhu (plasmids and antibodies). Supported by NIH National Institute of Allergy and Infectious Diseases (R01 AI068041-01A1), Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award, Searle Scholars Program, Cancer Research Institute Investigator Award, W.W. Winchester Foundation (to J.D.M.) and Browne-Cox Fellowship (to A.R.S.).	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	24	318	331	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					717	721		10.1126/science.1201711	http://dx.doi.org/10.1126/science.1201711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551061				2022-12-01	WOS:000290265800043
J	Giuseppone, N; Lutz, JF				Giuseppone, Nicolas; Lutz, Jean-Francois			MATERIALS CHEMISTRY Catalytic accordions	NATURE			English	Editorial Material							ENCAPSULATION; SYSTEMS		[Giuseppone, Nicolas] Univ Strasbourg, Fac Chem, F-67034 Strasbourg, France; [Giuseppone, Nicolas] CNRS, Inst Charles Sadron, UPR22, F-67034 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Giuseppone, N (corresponding author), Univ Strasbourg, Fac Chem, F-67034 Strasbourg, France.	giuseppone@unistra.fr; jflutz@unistra.fr	Giuseppone, Nicolas/J-1300-2016; Lutz, Jean-François/C-3264-2009	Giuseppone, Nicolas/0000-0003-4093-3000; Lutz, Jean-François/0000-0002-3893-2458				Badi N, 2009, CHEM SOC REV, V38, P3383, DOI 10.1039/b806413j; BRESLOW R, 1982, SCIENCE, V218, P532, DOI 10.1126/science.7123255; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Dwars T, 2005, ANGEW CHEM INT EDIT, V44, P7174, DOI 10.1002/anie.200501365; Hecht S, 2001, ANGEW CHEM INT EDIT, V40, P74, DOI 10.1002/1521-3773(20010105)40:1<74::AID-ANIE74>3.0.CO;2-C; Kang JM, 1997, NATURE, V385, P50, DOI 10.1038/385050a0; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Ouchi M, 2009, CHEM REV, V109, P4963, DOI 10.1021/cr900234b; Terashima T, 2011, J AM CHEM SOC, V133, P4742, DOI 10.1021/ja2004494	9	37	37	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					40	41		10.1038/473040a	http://dx.doi.org/10.1038/473040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544141				2022-12-01	WOS:000290218300026
J	Larson, DR; Zenklusen, D; Wu, B; Chao, JA; Singer, RH				Larson, Daniel R.; Zenklusen, Daniel; Wu, Bin; Chao, Jeffrey A.; Singer, Robert H.			Real-Time Observation of Transcription Initiation and Elongation on an Endogenous Yeast Gene	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SINGLE CELLS; LIVING YEAST; LIVE CELLS; DYNAMICS; ASSOCIATION; RECRUITMENT; ACTIVATION; EXPRESSION; BINDING	Cellular messenger RNA levels are achieved by the combinatorial complexity of factors controlling transcription, yet the small number of molecules involved in these pathways fluctuates stochastically. It has not yet been experimentally possible to observe the activity of single polymerases on an endogenous gene to elucidate how these events occur in vivo. Here, we describe a method of fluctuation analysis of fluorescently labeled RNA to measure dynamics of nascent RNA-including initiation, elongation, and termination-at an active yeast locus. We find no transcriptional memory between initiation events, and elongation speed can vary by threefold throughout the cell cycle. By measuring the abundance and intranuclear mobility of an upstream transcription factor, we observe that the gene firing rate is directly determined by trans-activating factor search times.	[Larson, Daniel R.; Zenklusen, Daniel; Wu, Bin; Chao, Jeffrey A.; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Larson, Daniel R.; Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Larson, Daniel R.; Singer, Robert H.] Howard Hughes Med Inst, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Zenklusen, Daniel] Univ Montreal, Dept Biochim, Montreal, PQ H3T 1J4, Canada	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Universite de Montreal	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu	Larson, Daniel R/B-9829-2008; Zenklusen, Daniel/C-4503-2008	Larson, Daniel R/0000-0001-9253-3055; Zenklusen, Daniel/0000-0002-0067-0093; Chao, Jeffrey/0000-0002-5895-9156	NIH National Institute of General Medical Sciences [57071, 86217]; NATIONAL CANCER INSTITUTE [ZIABC011383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057071, R01GM086217] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the following for critical reading of the manuscript: D. Grunwald, T. Lionnet, T. Trcek, J. Yao, X. Darzacq, R. Tjian, and M. Larson. D. R. L. thanks W. Zipfel, S. Hess, J. Atilgan, and M. Nicholas for discussions about fluctuation analysis. S. Silverman provided the fkh1fkh2 deletion strain. B. Slaughter provided the NLS-GFP strain and J. Vogel the Mbp-GFP strain. We thank E. Gruss Lipper for her gift founding the Gruss Lipper Biophotonics Center that provided the equipment used in this study. Supported by NIH National Institute of General Medical Sciences grants 57071 and 86217 to R. H. S. There is a patent (no. 6,586,240) associated with the methods for visualization of RNA in living cells as presented in this manuscript.	BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Chao JA, 2008, NAT STRUCT MOL BIOL, V15, P103, DOI 10.1038/nsmb1327; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; PIZZAGALLI A, 1992, CURR GENET, V21, P183, DOI 10.1007/BF00336839; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	27	411	418	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					475	478		10.1126/science.1202142	http://dx.doi.org/10.1126/science.1202142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512033	Green Accepted			2022-12-01	WOS:000289784900046
J	Pertel, T; Hausmann, S; Morger, D; Zuger, S; Guerra, J; Lascano, J; Reinhard, C; Santoni, FA; Uchil, PD; Chatel, L; Bisiaux, A; Albert, ML; Strambio-De-Castillia, C; Mothes, W; Pizzato, M; Grutter, MG; Luban, J				Pertel, Thomas; Hausmann, Stephane; Morger, Damien; Zueger, Sara; Guerra, Jessica; Lascano, Josefina; Reinhard, Christian; Santoni, Federico A.; Uchil, Pradeep D.; Chatel, Laurence; Bisiaux, Aurelie; Albert, Matthew L.; Strambio-De-Castillia, Caterina; Mothes, Walther; Pizzato, Massimo; Gruetter, Markus G.; Luban, Jeremy			TRIM5 is an innate immune sensor for the retrovirus capsid lattice	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; UNANCHORED POLYUBIQUITIN CHAINS; CYCLOPHILIN-A; TRIM5-ALPHA PROTEIN; HUMAN-CELLS; HIV-1; RESISTANCE; INFECTION; RESTRICTION; RECOGNITION	TRIM5 is a RING domain-E3 ubiquitin ligase that restricts infection by human immunodeficiency virus (HIV)-1 and other retroviruses immediately following virus invasion of the target cell cytoplasm(1,2). Antiviral potency correlates with TRIM5 avidity for the retrovirion capsid lattice(3,4) and several reports indicate that TRIM5 has a role in signal transduction(5-7), but the precise mechanism of restriction is unknown(8). Here we demonstrate that TRIM5 promotes innate immune signalling and that this activity is amplified by retroviral infection and interaction with the capsid lattice. Acting with the heterodimeric, ubiquitin-conjugating enzyme UBC13-UEV1A (also known as UBE2N-UBE2V1), TRIM5 catalyses the synthesis of unattached K63-linked ubiquitin chains that activate the TAK1 (also known as MAP3K7) kinase complex and stimulate AP-1 and NF kappa B signalling. Interaction with the HIV-1 capsid lattice greatly enhances the UBC13-UEV1A-dependent E3 activity of TRIM5 and challenge with retroviruses induces the transcription of AP-1 and NF-kappa B-dependent factors with a magnitude that tracks with TRIM5 avidity for the invading capsid. Finally, TAK1 and UBC13-UEV1A contribute to capsid-specific restriction by TRIM5. Thus, the retroviral restriction factor TRIM5 has two additional activities that are linked to restriction: it constitutively promotes innate immune signalling and it acts as a pattern recognition receptor specific for the retrovirus capsid lattice.	[Pertel, Thomas; Hausmann, Stephane; Guerra, Jessica; Lascano, Josefina; Reinhard, Christian; Santoni, Federico A.; Strambio-De-Castillia, Caterina; Pizzato, Massimo; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Morger, Damien; Zueger, Sara; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sect Microbial Pathogenesis, Sch Med, New Haven, CT 06536 USA; [Chatel, Laurence] Novimmune SA, CH-1228 Geneva, Switzerland; [Bisiaux, Aurelie; Albert, Matthew L.] Inst Pasteur, INSERM, U818, F-75724 Paris, France	University of Geneva; University of Zurich; Yale University; NovImmune SA; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Luban, J (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	jeremy.luban@unige.ch	Albert, Matthew L/C-9782-2009	Luban, Jeremy/0000-0001-5650-4054; Strambio De Castillia, Caterina/0000-0002-1069-1816; Pertel, Thomas/0000-0002-2286-6011; Uchil, Pradeep/0000-0002-7236-858X; Santoni, Federico/0000-0002-3258-4747; Pizzato, Massimo/0000-0002-9491-1483; Bisiaux, Aurelie/0000-0002-2447-3393	NIH [RO1AI59159, R21AI087467]; Swiss National Science Foundation [3100A0-128655, 3100A0-122342]; UZH Forschungskredit [54041402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087467, R01AI059159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UZH Forschungskredit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Baltimore, M. J. Birrer, J. Brojatsch, A. Cimarelli, A. Delaco, S. Elledge, M. Emerman, W. Ferlin, D. Garcin, S. Ghosh, O. Haller, T. Hatziioannou, J. Hiscott, A. Iwasaki, D. Kolakofsky, M. Kosco-Vilbois, H. Malik, R. Medzhitov, M. R. Neagu, G. Napolitani, P. Palese, D. Pinschewer, O. Pornillos, L. Roux, O. Schwartz, M. Strubin, V. Studer, W. Sundquist, G. Towers, D. Trono, J. Tschopp, M. Yeager, M. Zufferey, and the Functional Genomics Center (Zurich), for ideas, technical assistance, and reagents. This work was supported by NIH grant RO1AI59159 to J. L., NIH grant R21AI087467 to W. M., Swiss National Science Foundation grant 3100A0-128655 to J. L. and 3100A0-122342 to M. G. and UZH Forschungskredit 54041402 to S.Z.	Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Berthoux L, 2003, J VIROL, V77, P3167, DOI 10.1128/JVI.77.5.3167-3180.2003; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; KORNBLUTH RS, 1989, J EXP MED, V169, P1137, DOI 10.1084/jem.169.3.1137; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tareen SU, 2011, VIROLOGY, V409, P113, DOI 10.1016/j.virol.2010.09.018; Ulm JW, 2007, VIROLOGY, V363, P245, DOI 10.1016/j.virol.2006.09.048; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	27	469	489	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					361	365		10.1038/nature09976	http://dx.doi.org/10.1038/nature09976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21512573	Green Accepted			2022-12-01	WOS:000289724600042
J	Claridge, LC; Armstrong, MJ; Booth, C; Gill, PS				Claridge, Lee C.; Armstrong, Matthew J.; Booth, Caroline; Gill, Paramjit S.			10-MINUTE CONSULTATION Gilbert's syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Claridge, Lee C.; Armstrong, Matthew J.] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England; [Booth, Caroline] York Hosp NHS Trust, York YO31 8HE, N Yorkshire, England; [Gill, Paramjit S.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Claridge, LC (corresponding author), Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England.	l.c.claridge@bham.ac.uk		Armstrong, Matthew/0000-0002-3425-1161				BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Esteban A, 1999, EUR J DRUG METAB PH, V24, P9, DOI 10.1007/BF03190005; FOULK WT, 1959, MEDICINE, V38, P25, DOI 10.1097/00005792-195902000-00002; OWENS D, 1975, J MED GENET, V12, P152, DOI 10.1136/jmg.12.2.152; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P1280, DOI 10.1124/dmd.30.11.1280; Rotger M, 2005, J INFECT DIS, V192, P1381, DOI 10.1086/466531; SIEG A, 1987, DEUT MED WOCHENSCHR, V112, P1206, DOI 10.1055/s-2008-1068222; SIEG A, 1986, CLIN CHIM ACTA, V154, P41, DOI 10.1016/0009-8981(86)90086-0; THOMSEN HF, 1981, SCAND J GASTROENTERO, V16, P699, DOI 10.3109/00365528109182033	9	17	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2011	342								d2293	10.1136/bmj.d2293	http://dx.doi.org/10.1136/bmj.d2293			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755ON	21508045				2022-12-01	WOS:000289942900005
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Of swords, ploughshares, and climate change	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3806	10.1136/bmj.d3806	http://dx.doi.org/10.1136/bmj.d3806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697215				2022-12-01	WOS:000292200500007
J	Conen, D; Everett, BM; Kurth, T; Creager, MA; Buring, JE; Ridker, PM; Pradhan, AD				Conen, David; Everett, Brendan M.; Kurth, Tobias; Creager, Mark A.; Buring, Julie E.; Ridker, Paul M.; Pradhan, Aruna D.			Smoking, Smoking Status, and Risk for Symptomatic Peripheral Artery Disease in Women A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTERMITTENT CLAUDICATION; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; MORTALITY; CHOLESTEROL; POPULATION; PREVALENCE	Background: Smoking has a well-documented detrimental effect on risk for myocardial infarction and stroke, but less information is available regarding peripheral artery disease (PAD), particularly among women. Objective: To prospectively assess the association of current smoking status, cumulative smoking exposure, and smoking cessation with incident symptomatic PAD in women. Design: Prospective cohort study. Setting: U. S. female health care professionals in the Women's Health Study. Participants: 39 825 women with no cardiovascular disease who were prospectively followed for a median of 12.7 years. Measurements: Incidence of symptomatic PAD. Cox proportional hazards models were used to compare PAD risk across smoking categories. Results: 178 confirmed PAD events occurred. Across the 4 smoking categories (never, former, < 15 cigarettes/d, and >= 15 cigarettes/d), age-adjusted incidence rates were 0.12, 0.34, 0.95, and 1.63 per 1000 person-years of follow-up, respectively. Multivariate adjustment had little effect on this relationship (adjusted hazard ratios [HRs], 3.14 [95% CI, 2.01 to 4.90], 8.93 [CI, 5.02 to 15.89], and 16.95 [CI, 10.77 to 26.67], respectively, vs. women who never smoked). Additional adjustment for high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 levels among women with available blood samples (28 314 participants, 117 events) attenuated risk estimates (HR, 5.58 [CI, 2.61 to 11.93] for smoking < 15 cigarettes/d and 9.52 [CI, 5.17 to 17.53] for smoking >= 15 cigarettes/d). Lifetime exposure showed a strong dose-response relationship; fully adjusted HRs for smoking abstinence of fewer than 10, 10 to 29, and 30 or more pack-years were 2.52 (CI, 1.49 to 4.25), 6.75 (CI, 4.33 to 10.52), and 11.09 (CI, 6.94 to 17.72), respectively. Compared with current smokers, the adjusted HRs for fewer than 10 years, 10 to 20 years, more than 20 years, or lifelong abstinence were 0.39 (CI, 0.24 to 0.66), 0.28 (CI, 0.17 to 0.46), 0.16 (CI, 0.10 to 0.26), and 0.08 (CI, 0.05 to 0.12), respectively. Limitation: The use of symptomatic PAD as the a priori primary end point excludes asymptomatic disease. Conclusion: Among initially healthy women, smoking is a potent risk factor for symptomatic PAD and was associated with subclinical inflammation. Smoking cessation substantially reduces risk for PAD, but an increased occurrence of PAD persists even among former smokers who maintain abstinence.	[Pradhan, Aruna D.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Med Sch,Sch Publ Hlth, Boston, MA 02215 USA; Univ Basel Hosp, CH-4031 Basel, Switzerland; Vet Affairs Boston Med Ctr, Boston, MA USA; INSERM, Neuroepidemiol U708, Paris, France; Univ Paris 06, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; University of Basel; Boston Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pradhan, AD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Med Sch,Sch Publ Hlth, 900 Commonwealth Ave E, Boston, MA 02215 USA.	apradhan@partners.org	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620	The National Heart, Lung, and Blood Institute [HL-043851, HL-080467, HL-082740, HL-075771]; National Cancer Institute [CA-047988]; Donald W. Reynolds Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075771, RC1HL099355, R01HL043851, R01HL080467, K08HL082740] Funding Source: NIH RePORTER	The National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The National Heart, Lung, and Blood Institute and National Cancer Institute.r By the National Heart, Lung, and Blood Institute (grants HL-043851, HL-080467, HL-082740, and HL-075771), National Cancer Institute (grant CA-047988), and Donald W. Reynolds Foundation.	Aboyans V, 2007, J VASC SURG, V45, P319, DOI 10.1016/j.jvs.2006.10.032; CANTIN B, 1995, AM J CARDIOL, V75, P1224, DOI 10.1016/S0002-9149(99)80767-X; Conen D, 2009, CIRCULATION, V120, P1041, DOI 10.1161/CIRCULATIONAHA.109.863092; COX DR, 1972, J R STAT SOC B, V34, P187; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; He Y, 2008, CIRCULATION, V118, P1535, DOI 10.1161/CIRCULATIONAHA.108.784801; Heyman KM, 2009, EARLY RELEASE SELECT; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hooi JD, 2001, AM J EPIDEMIOL, V153, P666, DOI 10.1093/aje/153.7.666; INGOLFSSON IO, 1994, J CLIN EPIDEMIOL, V47, P1237, DOI 10.1016/0895-4356(94)90128-7; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Kollerits B, 2008, ATHEROSCLEROSIS, V198, P214, DOI 10.1016/j.atherosclerosis.2007.09.012; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; McDermott MM, 1999, ARCH INTERN MED, V159, P387; MCKINLAY SM, 1985, ANN INTERN MED, V103, P350, DOI 10.7326/0003-4819-103-3-350; Murabito JM, 1997, CIRCULATION, V96, P44; Organization WH Control RfIT, 2008, WHO REP GLOB TOB EP; Pradhan AD, 2008, CIRCULATION, V117, P823, DOI 10.1161/CIRCULATIONAHA.107.719369; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Tapp RJ, 2007, ATHEROSCLEROSIS, V190, P84, DOI 10.1016/j.atherosclerosis.2006.02.017; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Vavra AK, 2009, WOMENS HEALTH, V5, P669, DOI [10.2217/whe.09.60, 10.2217/WHE.09.60]; World Health Organization Regional Office for Europe, 2010, TOB CONTR DAT	30	59	64	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00003	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00003			104	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646555	Green Accepted			2022-12-01	WOS:000291312300002
J	Khan, AI; Dinh, DM; Schneider, D; Lenski, RE; Cooper, TF				Khan, Aisha I.; Dinh, Duy M.; Schneider, Dominique; Lenski, Richard E.; Cooper, Tim F.			Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial Population	SCIENCE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; FITNESS LANDSCAPES; RNA VIRUS; ADAPTATION; YEAST; SEX; EVOLVABILITY; GENERATIONS; SELECTION	Epistatic interactions between mutations play a prominent role in evolutionary theories. Many studies have found that epistasis is widespread, but they have rarely considered beneficial mutations. We analyzed the effects of epistasis on fitness for the first five mutations to fix in an experimental population of Escherichia coli. Epistasis depended on the effects of the combined mutations-the larger the expected benefit, the more negative the epistatic effect. Epistasis thus tended to produce diminishing returns with genotype fitness, although interactions involving one particular mutation had the opposite effect. These data support models in which negative epistasis contributes to declining rates of adaptation over time. Sign epistasis was rare in this genome-wide study, in contrast to its prevalence in an earlier study of mutations in a single gene.	[Khan, Aisha I.; Dinh, Duy M.; Cooper, Tim F.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Schneider, Dominique] Univ Grenoble 1, Inst Jean Roget, Lab Adaptat & Pathogenie Microorganismes, F-38041 Grenoble, France; [Schneider, Dominique] CNRS, UMR5163, F-38041 Grenoble, France; [Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	University of Houston System; University of Houston; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Michigan State University	Cooper, TF (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	tfcooper@uh.edu	Schneider, Dominique/M-6019-2014	Cooper, Timothy/0000-0001-5038-9366; Lenski, Richard/0000-0002-1064-8375	NSF [DEB-1019989, DEB-0844355]; James S. McDonnell Foundation [220020174]; Agence Nationale de la Recherche [ANR-08-GENM-023-001]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by grants from the NSF (DEB-1019989 to R.E.L. and DEB-0844355 to T.F.C.), the James S. McDonnell Foundation (220020174 to T.F.C.), the Agence Nationale de la Recherche (Program Genomique, Grant ANR-08-GENM-023-001 to D.S.) and the Defense Advanced Research Projects Agency "Fun Bio" Program (HR0011-09-1-0055 to R.E.L. and T.F.C.). We thank R. Azevedo, T. Paixao, and D. Stoebel for valuable discussions and helpful comments on the manuscript. R. E. L. will make the ancestral and evolved strains used in this study available to qualified recipients, subject to completion of a material transfer agreement that can be found at http://technologies.msu.edu/forms.html. T.F.C. will make the strains constructed in this study available to qualified recipients. Competition experiment counts, summary input data, and analysis scripts that pertain to the experiments and analyses reported in this paper have been deposited at http://dx.doi.org/10.5061/dryad.5rv40.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; de Visser JAGM, 2009, AM NAT, V174, pS15, DOI 10.1086/599081; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Jasnos L, 2008, GENETICS, V178, P2105, DOI 10.1534/genetics.107.084533; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; KONDRASHOV AS, 1994, NATURE, V369, P99, DOI 10.1038/369099a0; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; Moore FBG, 2000, P ROY SOC B-BIOL SCI, V267, P515, DOI 10.1098/rspb.2000.1030; Orr HA, 2003, GENETICS, V163, P1519; Orr HA, 2001, EVOLUTION, V55, P1085; Pepin KM, 2007, EVOLUTION, V61, P1710, DOI 10.1111/j.1558-5646.2007.00143.x; Sanjuan R, 2005, GENETICS, V170, P1001, DOI 10.1534/genetics.105.040741; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; TRAVISANO M, 1995, EVOLUTION, V49, P189, DOI 10.2307/2410304; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	36	338	338	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1193	1196		10.1126/science.1203801	http://dx.doi.org/10.1126/science.1203801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636772				2022-12-01	WOS:000291205200047
J	Annas, GJ				Annas, George J.			Sudden Death for a Challenge to Federal Funding of Stem-Cell Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2010, NEW ENGL J MED, V363, P1687, DOI 10.1056/NEJMp1010466; [Anonymous], 2009, FED REGISTER, V74, P32170	2	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22								10.1056/NEJMp1105498	http://dx.doi.org/10.1056/NEJMp1105498			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21591936				2022-12-01	WOS:000291200700005
J	Young, DA; Wright, AP; Roberts, JL; Warner, RC; Young, NW; Greenbaum, JS; Schroeder, DM; Holt, JW; Sugden, DE; Blankenship, DD; van Ommen, TD; Siegert, MJ				Young, Duncan A.; Wright, Andrew P.; Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; Greenbaum, Jamin S.; Schroeder, Dustin M.; Holt, John W.; Sugden, David E.; Blankenship, Donald D.; van Ommen, Tas D.; Siegert, Martin J.			A dynamic early East Antarctic Ice Sheet suggested by ice-covered fjord landscapes	NATURE			English	Article							SOUTHERN VICTORIA LAND; EXOBIOLOGICAL IMPLICATIONS; ALTERNATIVE ORIGIN; NUMERICAL-MODEL; LAKE VOSTOK; MIOCENE; MOUNTAINS; EVOLUTION; ROUGHNESS; EROSION	The first Cenozoic ice sheets initiated in Antarctica from the Gamburtsev Subglacial Mountains(1) and other highlands as a result of rapid global cooling similar to 34 million years ago(2). In the subsequent 20 million years, at a time of declining atmospheric carbon dioxide concentrations(2) and an evolving Antarctic circumpolar current(2), sedimentary sequence interpretation(3) and numerical modelling(4) suggest that cyclical periods of ice-sheet expansion to the continental margin, followed by retreat to the subglacial highlands, occurred up to thirty times. These fluctuations were paced by orbital changes and were a major influence on global sea levels(5). Ice-sheet models show that the nature of such oscillations is critically dependent on the pattern and extent of Antarctic topographic lowlands. Here we show that the basal topography of the Aurora Subglacial Basin of East Antarctica, at present overlain by 2-4.5 km of ice, is characterized by a series of well-defined topographic channels within a mountain block landscape. The identification of this fjord landscape, based on new data from ice-penetrating radar, provides an improved understanding of the topography of the Aurora Subglacial Basin and its surroundings, and reveals a complex surface sculpted by a succession of ice-sheet configurations substantially different from today's. At different stages during its fluctuations, the edge of the East Antarctic Ice Sheet lay pinned along the margins of the Aurora Subglacial Basin, the upland boundaries of which are currently above sea level and the deepest parts of which are more than 1 km below sea level. Although the timing of the channel incision remains uncertain, our results suggest that the fjord landscape was carved by at least two ice-flow regimes of different scales and directions, each of which would have over-deepened existing topographic depressions, reversing valley floor slopes.	[Young, Duncan A.; Greenbaum, Jamin S.; Schroeder, Dustin M.; Holt, John W.; Blankenship, Donald D.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Wright, Andrew P.; Sugden, David E.; Siegert, Martin J.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; van Ommen, Tas D.] Australian Antarctic Div, Kingston, Tas 7050, Australia; [Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; van Ommen, Tas D.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia	University of Texas System; University of Texas Austin; University of Edinburgh; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC)	Young, DA (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	duncan@utig.ig.utexas.edu; m.j.siegert@ed.ac.uk	Siegert, Martin/M-9939-2019; Wright, Andrew/HDM-9615-2022; Roberts, Jason L/B-2235-2012; Siegert, Martin J/A-3826-2008; Holt, John/C-4896-2009; van Ommen, Tas D/B-5020-2012; Young, Duncan A./G-6256-2010	Siegert, Martin/0000-0002-0090-4806; Roberts, Jason L/0000-0002-3477-4069; Siegert, Martin J/0000-0002-0090-4806; van Ommen, Tas D/0000-0002-2463-1718; Young, Duncan A./0000-0002-6866-8176; Warner, Roland/0000-0002-9778-3544; Schroeder, Dustin/0000-0003-1916-3929	NSF [ANT-0733025]; NASA [NNX09AR52G]; NERC [NE/D003733/1]; Australian Antarctic Division [3103]; Jackson School of Geoscience; Jet Propulsion Laboratory; G. Unger Vetlesen Foundation; Antarctic Climate and Ecosystems Cooperative Research Centre; Natural Environment Research Council [NE/F016646/1, NE/E018254/1] Funding Source: researchfish; NERC [NE/F016646/1, NE/E018254/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Antarctic Division; Jackson School of Geoscience; Jet Propulsion Laboratory; G. Unger Vetlesen Foundation; Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NSF grant ANT-0733025 and NASA grant NNX09AR52G to the University of Texas at Austin, NERC grant NE/D003733/1 to the University of Edinburgh, Australian Antarctic Division project 3103, the Jackson School of Geoscience, and the Jet Propulsion Laboratory, and the G. Unger Vetlesen Foundation. This research was also supported by the Antarctic Climate and Ecosystems Cooperative Research Centre. This is UTIG contribution 2344.	Alley RB, 2003, NATURE, V424, P758, DOI 10.1038/nature01839; Bo S, 2009, NATURE, V459, P690, DOI 10.1038/nature08024; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DREWRY DJ, 1976, TECTONOPHYSICS, V36, P301, DOI 10.1016/0040-1951(76)90023-8; Duxbury NS, 2001, J GEOPHYS RES-PLANET, V106, P1453, DOI 10.1029/2000JE001254; Harwood DM, 2000, ANTARCT SCI, V12, P443; Holtedahl H., 1967, GEOGRAFISKA ANN A, V49, P188, DOI DOI 10.2307/520887; HUYBRECHTS P, 1993, GEOGRAF ANN A, V75, P221, DOI DOI 10.2307/521202; Jamieson S. S. R., 2007, ANTARCTICA KEYSTONE, P39; Jamieson SSR, 2008, GEOMORPHOLOGY, V97, P91, DOI 10.1016/j.geomorph.2007.02.047; Kessler MA, 2008, NAT GEOSCI, V1, P365, DOI 10.1038/ngeo201; Kleman J, 2008, GEOMORPHOLOGY, V97, P73, DOI 10.1016/j.geomorph.2007.02.049; Le Brocq A. M., 2010, EARTH SYST SCI DATA, V2, P247, DOI [10.5194/essd-2-247-2010, DOI 10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010]; Lewis AR, 2007, GEOL SOC AM BULL, V119, P1449, DOI 10.1130/B26134; LOKEN OH, 1971, CAN J EARTH SCI, V8, P185, DOI 10.1139/e71-020; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Pekar SF, 2006, PALAEOGEOGR PALAEOCL, V231, P101, DOI 10.1016/j.palaeo.2005.07.027; Peters ME, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003222; Roberts J. L., 2011, CRYOSPHERE DISCUSSIO, V5, P655; Shepard MK, 2001, J GEOPHYS RES-PLANET, V106, P32777, DOI 10.1029/2000JE001429; Sieger MJ, 2005, GLOBAL PLANET CHANGE, V45, P249, DOI 10.1016/j.gloplacha.2004.09.008; Siegert M. J., 2001, ICE SHEETS LATE QUAT, P131; Siegert MJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002176; Sugden D.E., 1974, I BRIT GEOGRAPHERS S, V7, P177; Summerfield MA, 1999, GEOL SOC SPEC PUBL, V162, P255, DOI 10.1144/GSL.SP.1999.162.01.20; Watson D., 1992, CONTOURING GUIDE ANA, P67; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	131	131	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					72	75		10.1038/nature10114	http://dx.doi.org/10.1038/nature10114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637255				2022-12-01	WOS:000291156700039
J	Rowe, TB; Macrini, TE; Luo, ZX				Rowe, Timothy B.; Macrini, Thomas E.; Luo, Zhe-Xi			Fossil Evidence on Origin of the Mammalian Brain	SCIENCE			English	Article							EVOLUTION; DIVERSIFICATION; CYNODONTIA; THERAPSIDA; EAR	Many hypotheses have been postulated regarding the early evolution of the mammalian brain. Here, x-ray tomography of the Early Jurassic mammaliaforms Morganucodon and Hadrocodium sheds light on this history. We found that relative brain size expanded to mammalian levels, with enlarged olfactory bulbs, neocortex, olfactory (pyriform) cortex, and cerebellum, in two evolutionary pulses. The initial pulse was probably driven by increased resolution in olfaction and improvements in tactile sensitivity (from body hair) and neuromuscular coordination. A second pulse of olfactory enhancement then enlarged the brain to mammalian levels. The origin of crown Mammalia saw a third pulse of olfactory enhancement, with ossified ethmoid turbinals supporting an expansive olfactory epithelium in the nasal cavity, allowing full expression of a huge odorant receptor genome.	[Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Macrini, Thomas E.] St Marys Univ, Dept Biol Sci, San Antonio, TX 78228 USA; [Luo, Zhe-Xi] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA	University of Texas System; University of Texas Austin	Rowe, TB (corresponding author), Univ Texas Austin, Jackson Sch Geosci, C1100, Austin, TX 78712 USA.	rowe@mail.utexas.edu	Luo, Zhe-XI/AAU-2263-2021; Macrini, Thomas E./H-4577-2019	Macrini, Thomas E./0000-0001-9488-1512	NSF [DEB 0309369, EAR-0948842, AToL 0531767, DEB 0316558, EF0129959]; University of Texas Jackson School of Geosciences; NSF of China; Humboldt Foundation (Germany); National Geographic Society	NSF(National Science Foundation (NSF)); University of Texas Jackson School of Geosciences; NSF of China(National Natural Science Foundation of China (NSFC)); Humboldt Foundation (Germany)(Alexander von Humboldt Foundation); National Geographic Society(National Geographic Society)	This research was funded by NSF DEB 0309369 (T.E.M. and T.R.), NSF EAR-0948842 (T.R.), AToL 0531767 (T.R.), the University of Texas Jackson School of Geosciences (T.R. and T.E.M.), and funded by NSF DEB 0316558 and EF0129959, NSF of China, Humboldt Foundation (Germany), and National Geographic Society to Z.-X.L. Endocasts and computed tomography imagery are online at www.DigiMorph.org.	Aboitiz F, 2007, ADV ANAT EMBRYOL CEL, V193, P1; Allman J., 1990, Seminars in the Neurosciences, V2, P257; Bottorff W., 1995, THRINAXODON DIGITAL; CATANIA KC, 2009, EVOLUTIONARY NEUROSC, P697; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Hopson J.A., 1979, P39; Hulbert A.J., 1988, P148; Jerison H.J., 2009, EVOLUTIONARY NEUROSC, P497; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Kemp TS, 2009, J VERTEBR PALEONTOL, V29, P1188, DOI 10.1671/039.029.0430; Kielan-Jaworowska Z., 2004, MAMMALS AGE DINOSAUR; Krubitzer L, 2009, EVOLUTIONARY NEUROSC, P545; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2011, P ROY SOC B-BIOL SCI, V278, P28, DOI 10.1098/rspb.2010.1148; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Macrini TE, 2006, THESIS U TEXAS AUSTI; Macrini TE, 2007, J MORPHOL, V268, P844, DOI 10.1002/jmor.10556; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; QUIROGA JC, 1984, J HIRNFORSCH, V25, P285; QUIROGA JC, 1980, J HIRNFORSCH, V21, P299; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; ROWE T, 1996, CALIFORNIA ACAD SCI, V20, P71; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Rowe Timothy B., 2005, Journal of Mammalian Evolution, V12, P303, DOI 10.1007/s10914-005-5731-5; Zelena J, 1994, NERVES MECHANORECEPT; [No title captured]	30	214	216	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2011	332	6032					955	957		10.1126/science.1203117	http://dx.doi.org/10.1126/science.1203117			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596988				2022-12-01	WOS:000290766600040
J	Molgaard-Nielsen, D; Hviid, A				Molgaard-Nielsen, Ditte; Hviid, Anders			Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREGNANCY-REGISTER; UK-EPILEPSY; PRELIMINARY EXPERIENCE; LAMOTRIGINE; WOMEN; MALFORMATIONS; REGISTRATION; METAANALYSIS; FREQUENCY; EXPOSURE	Context Epilepsy during pregnancy is a therapeutic challenge. Since the 1990s, the number of licensed antiepileptic drugs has substantially increased, but safety data on first-trimester use of newer-generation antiepileptic drugs and birth defects are limited. Objective To study the association between fetal exposure to newer-generation antiepileptic drugs during the first trimester of pregnancy and the risk of major birth defects. Design, Setting, and Participants Population-based cohort study of 837 795 live-born infants in Denmark from January 1, 1996, through September 30, 2008. Individual-level information on dispensed antiepileptic drugs to mothers, birth defect diagnoses, and potential confounders were ascertained from nationwide health registries. Main Outcome Measures Prevalence odds ratios (PORs) of any major birth defect diagnosed within the first year of life by fetal exposure to antiepileptic drugs. Results Of the 1532 infants exposed to lamotrigine, oxcarbazepine, topiramate, gabapentin, or levetiracetam during the first trimester, 49 were diagnosed with a major birth defect compared with 19 911 of the 836 263 who were not exposed to an antiepileptic drug (3.2% vs 2.4%, respectively; adjusted POR [APOR], 0.99; 95% confidence interval [CI], 0.72-1.36). A major birth defect was diagnosed in 38 of 1019 infants (3.7%) exposed to lamotrigine during the first trimester (APOR, 1.18; 95% CI, 0.83-1.68), in 11 of 393 infants (2.8%) exposed to oxcarbazepine (APOR, 0.86; 95% CI, 0.46-1.59), and in 5 of 108 infants (4.6%) exposed to topiramate (APOR, 1.44; 95% CI, 0.58-3.58). Gabapentin (n=59) and levetiracetam (n=58) exposure during the first trimester was uncommon, with only 1 (1.7%) and 0 infants diagnosed with birth defects, respectively. Conclusion Among live-born infants in Denmark, first-trimester exposure to lamotrigine, oxcarbazepine, topiramate, gabapentin, or levetiracetam compared with no exposure was not associated with an increased risk of major birth defects. JAMA. 2011; 305(19): 1996-2002	[Molgaard-Nielsen, Ditte; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Molgaard-Nielsen, D (corresponding author), Artillerivej 5, DK-2300 Copenhagen S, Denmark.	dnl@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was supported by the Danish Medical Research Council and the Lundbeck Foundation.	Agergaard Peter, 2011, Clin Epidemiol, V3, P61, DOI 10.2147/CLEP.S15627; Andersen TF, 1999, DAN MED BULL, V46, P263; Artama M, 2005, NEUROLOGY, V64, P1874, DOI 10.1212/01.WNL.0000163771.96962.1F; Clayton D, 2001, STAT MODELS EPIDEMIO, P227; Cunnington M, 2007, EPILEPSIA, V48, P1207, DOI 10.1111/j.1528-1167.2007.01021.x; CZEIZEL AE, 1992, EUR J EPIDEMIOL, V8, P122; *DAN MED AG, REG MED PROD STAT; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; EUROCAT, MIN AN EXCL; EUROCAT, COD EUROCAT SUBGR CO; Fried S, 2004, DRUG SAFETY, V27, P197, DOI 10.2165/00002018-200427030-00004; Holmes LB, 2008, NEUROLOGY, V70, P2152, DOI 10.1212/01.wnl.0000304343.45104.d6; Honein MA, 1999, TERATOLOGY, V60, P356, DOI 10.1002/(SICI)1096-9926(199912)60:6<356::AID-TERA8>3.3.CO;2-2; Hunt S, 2008, NEUROLOGY, V71, P272, DOI 10.1212/01.wnl.0000318293.28278.33; Hunt S, 2006, NEUROLOGY, V67, P1876, DOI 10.1212/01.wnl.0000244491.48937.55; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Malm H, 2003, EUR J CLIN PHARMACOL, V59, P127, DOI 10.1007/s00228-003-0584-4; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Meador Kimford J, 2004, Cleve Clin J Med, V71 Suppl 2, pS38; Meador Kimford J, 2009, Epilepsy Behav, V15, P339, DOI 10.1016/j.yebeh.2009.04.026; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Sabers A, 2004, ACTA NEUROL SCAND, V109, P9, DOI 10.1034/j.1600-0404.2003.00200.x; Tomson T, 2007, CLIN PHARMACOKINET, V46, P209, DOI 10.2165/00003088-200746030-00002; Tomson T, 2009, NEUROL CLIN, V27, P993, DOI 10.1016/j.ncl.2009.06.006; Tsiropoulos I, 2006, ACTA NEUROL SCAND, V113, P405, DOI 10.1111/j.1600-0404.2006.00639.x; Vajda FJE, 2010, SEIZURE-EUR J EPILEP, V19, P558, DOI 10.1016/j.seizure.2010.07.019; WHO Collaborating Centre for Drug Statistics Methodology, ATC DDD IND 2011; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118	32	161	167	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					1996	2002		10.1001/jama.2011.624	http://dx.doi.org/10.1001/jama.2011.624			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21586715				2022-12-01	WOS:000290665500023
J	Fleishman, SJ; Whitehead, TA; Ekiert, DC; Dreyfus, C; Corn, JE; Strauch, EM; Wilson, IA; Baker, D				Fleishman, Sarel J.; Whitehead, Timothy A.; Ekiert, Damian C.; Dreyfus, Cyrille; Corn, Jacob E.; Strauch, Eva-Maria; Wilson, Ian A.; Baker, David			Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin	SCIENCE			English	Article							RECOGNITION; ANTIBODIES; INTERFACE; DOCKING; SURFACE; PAIR	We describe a general computational method for designing proteins that bind a surface patch of interest on a target macromolecule. Favorable interactions between disembodied amino acid residues and the target surface are identified and used to anchor de novo designed interfaces. The method was used to design proteins that bind a conserved surface patch on the stem of the influenza hemagglutinin (HA) from the 1918 H1N1 pandemic virus. After affinity maturation, two of the designed proteins, HB36 and HB80, bind H1 and H5 HAs with low nanomolar affinity. Further, HB80 inhibits the HA fusogenic conformational changes induced at low pH. The crystal structure of HB36 in complex with 1918/H1 HA revealed that the actual binding interface is nearly identical to that in the computational design model. Such designed binding proteins may be useful for both diagnostics and therapeutics.	[Fleishman, Sarel J.; Whitehead, Timothy A.; Corn, Jacob E.; Strauch, Eva-Maria; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ekiert, Damian C.; Dreyfus, Cyrille; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Ekiert, Damian C.; Dreyfus, Cyrille; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@uw.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Ekiert, Damian/0000-0002-2570-0404; Fleishman, Sarel/0000-0003-3177-7560	Human Frontier Science Program; Jane Coffin Childs Memorial Fund; National Institute of Allergy and Infectious Diseases, NIH [AI057141]; Defense Advanced Research Projects Agency; NIH yeast resource center; Defense Threat Reduction Agency; Howard Hughes Medical Institute; NIH [AI058113, GM080209]; Achievement Rewards for College Scientists Foundation; Skaggs Institute for Chemical Biology; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science, NIH [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Jane Coffin Childs Memorial Fund; National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH yeast resource center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); Skaggs Institute for Chemical Biology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Computational designs were generated on resources generously provided by participants of Rosetta @ Home and the Argonne National Leadership Computing Facility. We thank J. L. Gallaher for protein preparation. S. J. F. was supported by a long-term fellowship from the Human Frontier Science Program, J. E. C. was supported by the Jane Coffin Childs Memorial Fund, and E. M. S. by a career development award from the National Institute of Allergy and Infectious Diseases, NIH, AI057141. Research in the Baker laboratory was supported by grants from the Defense Advanced Research Projects Agency, the NIH yeast resource center, the Defense Threat Reduction Agency, and the Howard Hughes Medical Institute and in the Wilson laboratory by NIH AI058113, predoctoral fellowships from the Achievement Rewards for College Scientists Foundation and the NIH Molecular Evolution Training Program GM080209 (D. C. E.), and the Skaggs Institute for Chemical Biology. X-ray diffraction data sets were collected at the Stanford Synchrotron Radiation Lightsource beamline 9-2 and at the Advanced Photon Source (APS) beamline 23ID-B (GM/CA-CAT). The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science, NIH (Y1-GM-1104). Use of the APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. Coordinates and structure factors were deposited in the Protein Data Bank as entry 3R2X.	[Anonymous], 2010, NEW ENGL J MED, V362, P1708; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Ledford H, 2008, NATURE, V455, P437, DOI 10.1038/455437a; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; Lo Conte L, 1999, J MOL BIOL, V285, P2177; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Liu S, 2007, P NATL ACAD SCI USA, V104, P5330, DOI 10.1073/pnas.0606198104; Stevenson CEM, 2006, PROTEINS, V65, P1041, DOI 10.1002/prot.21136; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566	20	414	442	3	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					816	821		10.1126/science.1202617	http://dx.doi.org/10.1126/science.1202617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566186	Green Accepted			2022-12-01	WOS:000290529900039
J	Yoon, HS; Price, DC; Stepanauskas, R; Rajah, VD; Sieracki, ME; Wilson, WH; Yang, EC; Duffy, S; Bhattacharya, D				Yoon, Hwan Su; Price, Dana C.; Stepanauskas, Ramunas; Rajah, Veeran D.; Sieracki, Michael E.; Wilson, William H.; Yang, Eun Chan; Duffy, Siobain; Bhattacharya, Debashish			Single-Cell Genomics Reveals Organismal Interactions in Uncultivated Marine Protists	SCIENCE			English	Article							EUKARYOTES; PHYLOGENY; OCEAN; TIME	Whole-genome shotgun sequence data from three individual cells isolated from seawater, followed by analysis of ribosomal DNA, indicated that the cells represented three divergent clades of picobiliphytes. In contrast with the recent description of this phylum, we found no evidence of plastid DNA nor of nuclear-encoded plastid-targeted proteins, which suggests that these picobiliphytes are heterotrophs. Genome data from one cell were dominated by sequences from a widespread single-stranded DNA virus. This virus was absent from the other two cells, both of which contained non-eukaryote DNA derived from marine Bacteroidetes and large DNA viruses. By using shotgun sequencing of uncultured marine picobiliphytes, we revealed the distinct interactions of individual cells.	[Price, Dana C.; Rajah, Veeran D.; Duffy, Siobain; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Yoon, Hwan Su; Stepanauskas, Ramunas; Sieracki, Michael E.; Wilson, William H.; Yang, Eun Chan] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; [Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Rutgers State University New Brunswick; Bigelow Laboratory for Ocean Sciences; Sungkyunkwan University (SKKU)	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	bhattacharya@aesop.rutgers.edu	Yoon, Hwan Su/A-2974-2013; t, lf/AAJ-4924-2020; Duffy, Siobain/A-9104-2009	Yang, Eun Chan/0000-0001-8211-8130; Stepanauskas, Ramunas/0000-0003-4458-3108; Yoon, Hwan Su/0000-0001-9507-0105; Duffy, Siobain/0000-0003-0753-223X	NSF [EF-0827023, DEB-0936884, OCE-0821374, OCE-0623288]; Rural Development Administration, South Korea	NSF(National Science Foundation (NSF)); Rural Development Administration, South Korea(Rural Development Administration (RDA), Republic of Korea)	This project was supported by NSF grants EF-0827023, DEB-0936884, OCE-0821374, and OCE-0623288, and by Nest Generation BioGreen 21 (SSAC, 2011), Rural Development Administration, South Korea. The authors thank J. Heywood and N. Poulton for technical support. The genome sequence of the MS584-5 virus is available in GenBank under the accession number HQ322117, whereas the 454 sequence data from SAG MS584-5 and 454 + Illumina reads from MS584-11 and MS584-22 are available at the NCBI Sequence Read Archive under the accession numbers SRR068243.1, SRR068244.2, and SRR068245.2, respectively. The assembled contigs for each SAG, the phylogenomic results (alignments and trees), singleton hit lists, annotations for the 8334 proteins in the MS584-11 joint assembly, protein alignments used for the trees presented in the paper, and the Paulinella caromatophora plastid sequence and Illumina genome data used to determine the frequency of plastid genes recovered from these reads are freely available at http://dbdata.rutgers.edu/data/pico.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Kim E, 2011, P NATL ACAD SCI USA, V108, P1496, DOI 10.1073/pnas.1013337108; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moon DA, 1997, CURR GENET, V32, P132, DOI 10.1007/s002940050257; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; Okamoto N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007080; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Shirai Y, 2008, APPL ENVIRON MICROB, V74, P4022, DOI 10.1128/AEM.00509-08; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	23	212	218	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					714	717		10.1126/science.1203163	http://dx.doi.org/10.1126/science.1203163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551060				2022-12-01	WOS:000290265800042
J	Peterson, PN; Shetterly, SM; Clarke, CL; Bekelman, DB; Chan, PS; Allen, LA; Matlock, DD; Magid, DJ; Masoudi, FA				Peterson, Pamela N.; Shetterly, Susan M.; Clarke, Christina L.; Bekelman, David B.; Chan, Paul S.; Allen, Larry A.; Matlock, Daniel D.; Magid, David J.; Masoudi, Frederick A.			Health Literacy and Outcomes Among Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIMITED LITERACY; CONTROLLED-TRIAL; HOSPITAL ADMISSION; IDENTIFY PATIENTS; SKILLS; RISK; POPULATION; QUESTIONS; ENROLLEES; MORTALITY	Context Little is known about the effects of low health literacy among patients with heart failure, a condition that requires self-management and frequent interactions with the health care system. Objective To evaluate the association between low health literacy and all-cause mortality and hospitalization among outpatients with heart failure. Design, Setting, and Patients Retrospective cohort study conducted at Kaiser Permanente Colorado, an integrated managed care organization. Outpatients with heart failure were identified between January 2001 and May 2008, were surveyed by mail, and underwent follow-up for a median of 1.2 years. Health literacy was assessed using 3 established screening questions and categorized as adequate or low. Responders were excluded if they did not complete at least 1 health literacy question or if they did not have at least 1 year of enrollment prior to the survey date. Main Outcome Measures All-cause mortality and all-cause hospitalization. Results Of the 2156 patients surveyed, 1547 responded (72% response rate). Of 1494 included responders, 262 (17.5%) had low health literacy. Patients with low health literacy were older, of lower socioeconomic status, less likely to have at least a high school education, and had higher rates of coexisting illnesses. In multivariable Cox regression, low health literacy was independently associated with higher mortality (unadjusted rate, 17.6% vs 6.3%; adjusted hazard ratio, 1.97 [95% confidence interval, 1.3-2.97]; P=.001) but not hospitalization (unadjusted rate, 30.5% vs 23.2%; adjusted hazard ratio, 1.05 [95% confidence interval, 0.8-1.37]; P=.73). Conclusion Among patients with heart failure in an integrated managed care organization, low health literacy was significantly associated with higher all-cause mortality. JAMA. 2011;305(16):1695-1701 www.jama.com	[Peterson, Pamela N.] Denver Hlth Med Ctr, Div Cardiol, Denver, CO 80204 USA; [Peterson, Pamela N.; Shetterly, Susan M.; Clarke, Christina L.; Magid, David J.; Masoudi, Frederick A.] Kaiser Permanente Colorado Inst Hlth Res, Denver, CO USA; [Peterson, Pamela N.; Bekelman, David B.; Allen, Larry A.; Matlock, Daniel D.; Magid, David J.; Masoudi, Frederick A.] Univ Colorado Denver, Aurora, CO USA; [Bekelman, David B.] Denver VA Med Ctr, Denver, CO USA; [Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Chan, Paul S.] Univ Missouri, Kansas City, MO 64110 USA	Denver Health Medical Center; Kaiser Permanente; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Peterson, PN (corresponding author), Denver Hlth Med Ctr, Div Cardiol, Mail Code 0960,777 Bannock St, Denver, CO 80204 USA.	pamela.peterson@ucdenver.edu	Allen, Larry/AAI-1323-2020; Masoudi, Frederick/Q-7467-2019	Matlock, Dan/0000-0001-9597-9642	American Heart Association [067001N]; National Heart, Lung, and Blood Institute [K23HL102224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Peterson is supported by American Heart Association Pharmaceutical Roundtable grant 067001N. Dr Chan is supported by a Career Development Grant Award (K23HL102224) from the National Heart, Lung, and Blood Institute. Dr Allen is supported by an American Heart Association Scientist Development Award.	Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Baker DW, 1998, J GEN INTERN MED, V13, P791, DOI 10.1046/j.1525-1497.1998.00242.x; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Cavanaugh K, 2009, DIABETES CARE, V32, P2149, DOI 10.2337/dc09-0563; Chew LD, 2004, FAM MED, V36, P588; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; COX DR, 1972, J R STAT SOC B, V34, P187; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DeWalt DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-30; Eichler K, 2009, INT J PUBLIC HEALTH, V54, P313, DOI 10.1007/s00038-009-0058-2; Evangelista LS, 2010, J CARD FAIL, V16, P9, DOI 10.1016/j.cardfail.2009.10.026; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Institute of Medicine, 2004, PRESCR END CONF; Kripalani S, 2006, J GEN INTERN MED, V21, P852, DOI 10.1111/j.1525-1497.2006.00536.x; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Murray MD, 2009, CLIN PHARMACOL THER, V85, P651, DOI 10.1038/clpt.2009.7; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P884, DOI 10.1111/j.1525-1497.2006.00544.x; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Powers BJ, 2010, JAMA-J AM MED ASSOC, V304, P76, DOI 10.1001/jama.2010.896; Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628; Seligman HK, 2005, J GEN INTERN MED, V20, P1001, DOI 10.1111/j.1525-1497.2005.00189.x; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; Wallace LS, 2007, J SURG RES, V140, P208, DOI 10.1016/j.jss.2007.01.029; Wallace LS, 2006, J GEN INTERN MED, V21, P874, DOI 10.1111/j.1525-1497.2006.00532.x; Weiss BD, 2006, J GEN INTERN MED, V21, P823, DOI 10.1111/j.1525-1497.2006.00531.x; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166	32	269	276	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1695	1701		10.1001/jama.2011.512	http://dx.doi.org/10.1001/jama.2011.512			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521851	Green Accepted, Bronze			2022-12-01	WOS:000289890500023
J	Sergeev, AG; Hartwig, JF				Sergeev, Alexey G.; Hartwig, John F.			Selective, Nickel-Catalyzed Hydrogenolysis of Aryl Ethers	SCIENCE			English	Article							N-HETEROCYCLIC CARBENES; CARBON-CARBON BONDS; MODEL COMPOUNDS; HYDROGENATION; OXYGEN; ACTIVATION; CHEMISTRY; CHEMICALS; CLEAVAGE; BIARYLS	Selective hydrogenolysis of the aromatic carbon-oxygen (C-O) bonds in aryl ethers is an unsolved synthetic problem important for the generation of fuels and chemical feedstocks from biomass and for the liquefaction of coal. Currently, the hydrogenolysis of aromatic C-O bonds requires heterogeneous catalysts that operate at high temperature and pressure and lead to a mixture of products from competing hydrogenolysis of aliphatic C-O bonds and hydrogenation of the arene. Here, we report hydrogenolyses of aromatic C-O bonds in alkyl aryl and diaryl ethers that form exclusively arenes and alcohols. This process is catalyzed by a soluble nickel carbene complex under just 1 bar of hydrogen at temperatures of 80 to 120 C; the relative reactivity of ether substrates scale as Ar-OAr>>Ar-OMe>ArCH(2)-OMe (Ar, Aryl; Me, Methyl). Hydrogenolysis of lignin model compounds highlights the potential of this approach for the conversion of refractory aryl ether biopolymers to hydrocarbons.	[Sergeev, Alexey G.; Hartwig, John F.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hartwig, JF (corresponding author), Univ Illinois, Dept Chem, 600 S Matthews Ave, Urbana, IL 61801 USA.	jhartwig@illinois.edu	Sergeev, Alexey/H-4105-2013	Sergeev, Alexey/0000-0003-1587-2517	BP	BP	We thank the BP for financial support of this project through the Energy Biosciences Program and T. Rauchfuss for helpful discussions. A provisional patent has been filed on the methods presented herein.	Alvarez-Bercedo P, 2010, J AM CHEM SOC, V132, P17352, DOI 10.1021/ja106943q; Dabo P, 1999, CAN J CHEM, V77, P1225, DOI 10.1139/cjc-77-7-1225; Dankwardt JW, 2004, ANGEW CHEM INT EDIT, V43, P2428, DOI 10.1002/anie.200453765; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Dyson PJ, 2003, DALTON T, P2964, DOI 10.1039/b303250g; Ellsworth BA, 2008, BIOORG MED CHEM LETT, V18, P4770, DOI 10.1016/j.bmcl.2008.07.109; Furimsky E, 2000, APPL CATAL A-GEN, V199, P147, DOI 10.1016/S0926-860X(99)00555-4; Glorius F, 2007, TOP ORGANOMETAL CHEM, V21, P1, DOI 10.1007/3418_2006_059; Guan BT, 2008, CHEM COMMUN, P1437, DOI 10.1039/b718998b; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; HUUSKA MK, 1986, POLYHEDRON, V5, P233, DOI 10.1016/S0277-5387(00)84915-3; LEVINE DG, 1982, P NATL ACAD SCI USA, V79, P3365, DOI 10.1073/pnas.79.10.3365; MAERCKER A, 1987, ANGEW CHEM INT EDIT, V26, P972, DOI 10.1002/anie.198709721; Marshall AL, 2010, CHEM-EUR J, V16, P4970, DOI 10.1002/chem.200903028; POPPIUS K, 1984, ACTA CHEM SCAND B, V38, P611, DOI 10.3891/acta.chem.scand.38b-0611; Pu YQ, 2008, BIOFUEL BIOPROD BIOR, V2, P58, DOI 10.1002/bbb.48; Rylander P.N, 1985, HYDROGENATION METHOD, P157; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; STORK G, 1947, J AM CHEM SOC, V69, P576, DOI 10.1021/ja01195a034; Tobisu M, 2008, ANGEW CHEM INT EDIT, V47, P4866, DOI 10.1002/anie.200801447; Tobisu M, 2011, CHEM COMMUN, V47, P2946, DOI 10.1039/c0cc05169a; UTOH S, 1986, FUEL PROCESS TECHNOL, V14, P221, DOI 10.1016/0378-3820(86)90024-X; van der Boom ME, 1998, J AM CHEM SOC, V120, P6531, DOI 10.1021/ja9738889; Van Duzee EM, 1935, J AM CHEM SOC, V57, P147, DOI 10.1021/ja01304a040; WENKERT E, 1979, J AM CHEM SOC, V101, P2246, DOI 10.1021/ja00502a074; WENKERT E, 1984, J ORG CHEM, V49, P4894, DOI 10.1021/jo00199a030; Widegren JA, 2003, J MOL CATAL A-CHEM, V198, P317, DOI 10.1016/S1381-1169(02)00728-8; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	28	627	643	8	702	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					439	443		10.1126/science.1200437	http://dx.doi.org/10.1126/science.1200437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512027				2022-12-01	WOS:000289784900036
J	Redman, C; Duffy, S; Bromham, N; Francis, K				Redman, C.; Duffy, S.; Bromham, N.; Francis, K.			GUIDELINES Recognition and initial management of ovarian cancer: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Redman, C.] Univ Hosp N Staffordshire, Stoke On Trent ST4 6QG, Staffs, England; [Duffy, S.] Yorkshire Canc Network, Harrogate HG2 7RY, England; [Bromham, N.; Francis, K.] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales	Keele University	Redman, C (corresponding author), Univ Hosp N Staffordshire, Stoke On Trent ST4 6QG, Staffs, England.			Bromham, Nathan/0000-0003-2165-4188				JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kirwan JMJ, 2002, BRIT MED J, V324, P148, DOI 10.1136/bmj.324.7330.148; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V61; *NAT I HLTH CLIN E, 2005, CLIN GUID NAT I HLTH, V27; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V122; National Institute for Health and Clinical Excellence, 2009, GUID MAN; Neilson JP, 2009, OBSTET GYNECOL, V113, P1157, DOI [10.1002/14651858.CD004706.pub2, 10.1097/AOG.0b013e3181a4b7e8]; Office for National Statistics, 2007, SURV RAT ENGL PAT DI; WALSH P, 2005, CANC ATLAS UK IRELAN, P193	9	17	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2011	342								d2073	10.1136/bmj.d2073	http://dx.doi.org/10.1136/bmj.d2073			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OR	21511784				2022-12-01	WOS:000289943400004
J	Macheboeuf, P; Buffalo, C; Fu, CY; Zinkernagel, AS; Cole, JN; Johnson, JE; Nizet, V; Ghosh, P				Macheboeuf, Pauline; Buffalo, Cosmo; Fu, Chi-yu; Zinkernagel, Annelies S.; Cole, Jason N.; Johnson, John E.; Nizet, Victor; Ghosh, Partho			Streptococcal M1 protein constructs a pathological host fibrinogen network	NATURE			English	Article							HEPARIN-BINDING PROTEIN; GROUP-A STREPTOCOCCI; OLIGOMERIZATION STATE; CRYSTAL-STRUCTURE; SURFACE-PROTEINS; COILED COILS; FRAGMENT-D; CRYSTALLOGRAPHY; PHAGOCYTOSIS; STABILITY	M1 protein, a major virulence factor of the leading invasive strain of group A Streptococcus, is sufficient to induce toxic-shock-like vascular leakage and tissue injury. These events are triggered by the formation of a complex between M1 and fibrinogen that, unlike M1 or fibrinogen alone, leads to neutrophil activation. Here we provide a structural explanation for the pathological properties of the complex formed between streptococcal M1 and human fibrinogen. A conformationally dynamic coiled-coil dimer of M1 was found to organize four fibrinogen molecules into a specific cross-like pattern. This pattern supported the construction of a supramolecular network that was required for neutrophil activation but was distinct from a fibrin clot. Disruption of this network into other supramolecular assemblies was not tolerated. These results have bearing on the pathophysiology of streptococcal toxic shock.	[Macheboeuf, Pauline; Buffalo, Cosmo; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Fu, Chi-yu; Johnson, John E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Zinkernagel, Annelies S.; Cole, Jason N.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Cole, Jason N.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Nizet, Victor] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; University of Queensland; University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pghosh@ucsd.edu	Nizet, Victor/AAF-3190-2019; Zinkernagel, Annelies S/F-1780-2017; Johnson, Johnson/HDL-9124-2022	Zinkernagel, Annelies S/0000-0003-4700-1118; Macheboeuf, Pauline/0000-0003-4523-9923; Nizet, Victor/0000-0003-3847-0422; Buffalo, Cosmo/0000-0002-8187-4660	NIH [R21 AI071167, T32 GM007240, R01 AI077780, R01 GM54076]; National Health and Medical Research Council of Australia [514639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R01AI052453, R01AI077780, R21AI071167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240, R01GM054076] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Argonne Photon Source Laboratory GM/CA CAT staff for help with data collection, R. Doolittle and A. Royant for advice, and S. Mel and G. Ghosh for comments on the manuscript. This work was supported by NIH R21 AI071167 (P.G.), T32 GM007240 (C.B.), R01 AI077780 (V.N.), R01 GM54076 (J.E.J.), and a fellowship (J.N.C.) from the National Health and Medical Research Council of Australia (514639).	AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowley SR, 2009, BLOOD, V113, P4425, DOI 10.1182/blood-2008-09-178178; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVERSE SJ, 1995, PROTEIN SCI, V4, P1013; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Kahn F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000149; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; Medved L, 1997, BIOCHEMISTRY-US, V36, P4685, DOI 10.1021/bi962795l; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Shannon O, 2007, MOL MICROBIOL, V65, P1147, DOI 10.1111/j.1365-2958.2007.05841.x; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wagschal K, 1999, PROTEIN SCI, V8, P2312; WHITNACK E, 1985, J EXP MED, V162, P1983, DOI 10.1084/jem.162.6.1983; Yang Z, 2001, BIOCHEMISTRY-US, V40, P12515, DOI 10.1021/bi011394p	41	72	73	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					64	68		10.1038/nature09967	http://dx.doi.org/10.1038/nature09967			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475196	Green Accepted			2022-12-01	WOS:000289199400037
J	DESMET, J; DEMAEYER, M; HAZES, B; LASTERS, I				DESMET, J; DEMAEYER, M; HAZES, B; LASTERS, I			THE DEAD-END ELIMINATION THEOREM AND ITS USE IN PROTEIN SIDE-CHAIN POSITIONING	NATURE			English	Article							CONFORMATION	THE prediction of a protein's tertiary structure is still a considerable problem because the huge amount of possible conformational space' makes it computationally difficult. With regard to side-chain modelling, a solution has been attempted by the grouping of side-chain conformations into representative sets of rotamers 2-5. Nonetheless, an exhaustive combinatorial search is still limited to carefully identified packing units 5,6 containing a limited number of residues. For larger systems other strategies had to be developed, such as the Monte Carlo Procedure 6,7 and the genetic algorithm and clustering approach 8. Here we present a theorem, referred to as the 'dead-end elimination' theorem, which imposes a suitable condition to identify rotamers that cannot be members of the global minimum energy conformation. Application of this theorem effectively controls the computational explosion of the rotamer combinatorial problem, thereby allowing the determination of the global minimum energy conformation of a large collection of side chains.	CORVAS INT NV,B-9000 GHENT,BELGIUM; UNIV GRONINGEN,BIOSON RES INST,DEPT CHEM,9747 AG GRONINGEN,NETHERLANDS	University of Groningen	DESMET, J (corresponding author), KATHOLIEKE UNIV LEUVEN,INTERDISCIPLINARY RES CTR,CAMPUS KORTRIJK,B-8500 KORTRIJK,BELGIUM.							BERENSTEIN FC, 1977, J MOL BIOL, V112, P535; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DELHAISE P, 1984, J MOL GRAPHICS, V2, P103, DOI 10.1016/0263-7855(84)80002-8; HOLM L, 1991, J MOL BIOL, V218, P183, DOI 10.1016/0022-2836(91)90883-8; JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; LEE C, 1991, NATURE, V352, P448, DOI 10.1038/352448a0; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; TUFFERY P, 1991, J BIOMOL STRUCT DYN, V8, P1267, DOI 10.1080/07391102.1991.10507882	12	557	587	2	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 9	1992	356	6369					539	542		10.1038/356539a0	http://dx.doi.org/10.1038/356539a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN231	21488406				2022-12-01	WOS:A1992HN23100065
J	Baughman, JM; Perocchi, F; Girgis, HS; Plovanich, M; Belcher-Timme, CA; Sancak, Y; Bao, XR; Strittmatter, L; Goldberger, O; Bogorad, RL; Koteliansky, V; Mootha, VK				Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Bogorad, Roman L.; Koteliansky, Victor; Mootha, Vamsi K.			Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter	NATURE			English	Article							RAT KIDNEY MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; RNAI THERAPEUTICS; PROTEIN TOPOLOGY; TRANSPORT; DELIVERY; RESPIRATION; INHIBITION; LIBRARY; COMPLEX	Mitochondria from diverse organisms are capable of transporting large amounts of Ca(2+) via a ruthenium-red-sensitive, membrane-potential-dependent mechanism called the uniporter(1-4). Although the uniporter's biophysical properties have been studied extensively, its molecular composition remains elusive. We recently used comparative proteomics to identify MICU1 (also known as CBARA1), an EF-hand-containing protein that serves as a putative regulator of the uniporter(5). Here, we use whole-genome phylogenetic profiling, genome-wide RNA co-expression analysis and organelle-wide protein coexpression analysis to predict proteins functionally related to MICU1. All three methods converge on a novel predicted transmembrane protein, CCDC109A, that we now call 'mitochondrial calcium uniporter' (MCU). MCU forms oligomers in the mitochondrial inner membrane, physically interacts with MICU1, and resides within a large molecular weight complex. Silencing MCU in cultured cells or in vivo in mouse liver severely abrogates mitochondrial Ca(2+) uptake, whereas mitochondrial respiration and membrane potential remain fully intact. MCU has two predicted transmembrane helices, which are separated by a highly conserved linker facing the intermembrane space. Acidic residues in this linker are required for its full activity. However, an S259A point mutation retains function but confers resistance to Ru360, the most potent inhibitor of the uniporter. Our genomic, physiological, biochemical and pharmacological data firmly establish MCU as an essential component of the mitochondrial Ca(2+) uniporter.	[Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Bogorad, Roman L.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Koteliansky, Victor] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Mootha, VK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	vamsi@hms.harvard.edu	Bogorad, Roman/G-2609-2011	Bao, Xiaoyan/0000-0001-7931-2944; perocchi, fabiana/0000-0002-1102-6500	National Science Foundation; National Institutes of Health [GM0077465, DK080261]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Nilsson, J. Engreitz and S. Calvo for bioinformatics assistance; D. Root and S. Silver for assistance in lentiviral RNAi; B. R. Bettencourt, K. Charisse, S. Kuchimanchi and L. Speciner for siRNA design, synthesis and formulation; M. Blower, J. Avruch and R. Ward for advice; and members of the Mootha laboratory for valuable feedback. J. M. B. and L. S. were supported by graduate student fellowships from the National Science Foundation. This work was supported by grants from the National Institutes of Health (GM0077465, DK080261) awarded to V.K.M.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; CHANCE B, 1955, J BIOL CHEM, V217, P383; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rebres RA, 2011, J BIOL CHEM, V286, P942, DOI 10.1074/jbc.M110.198200; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	28	1263	1287	1	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					341	U111		10.1038/nature10234	http://dx.doi.org/10.1038/nature10234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21685886	Green Accepted			2022-12-01	WOS:000294206500040
J	Stefater, JA; Lewkowich, I; Rao, S; Mariggi, G; Carpenter, AC; Burr, AR; Fan, JQ; Ajima, R; Molkentin, JD; Williams, BO; Wills-Karp, M; Pollard, JW; Yamaguchi, T; Ferrara, N; Gerhardt, H; Lang, RA				Stefater, James A., III; Lewkowich, Ian; Rao, Sujata; Mariggi, Giovanni; Carpenter, April C.; Burr, Adam R.; Fan, Jieqing; Ajima, Rieko; Molkentin, Jeffery D.; Williams, Bart O.; Wills-Karp, Marsha; Pollard, Jeffrey W.; Yamaguchi, Terry; Ferrara, Napoleone; Gerhardt, Holger; Lang, Richard A.			Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL NEOVASCULARIZATION; MOUSE; MECHANISM; VASCULATURE; MACROPHAGES; TUMORIGENESIS; HETEROGENEITY; INHIBITION; RECEPTOR-1	Myeloid cells are a feature of most tissues. Here we show that during development, retinal myeloid cells (RMCs) produce Wnt ligands to regulate blood vessel branching. In the mouse retina, where angiogenesis occurs postnatally(1), somatic deletion in RMCs of the Wnt ligand transporter Wntless(2,3) results in increased angiogenesis in the deeper layers. We also show that mutation of Wnt5a and Wnt11 results in increased angiogenesis and that these ligands elicit RMC responses via a non-canonical Wnt pathway. Using cultured myeloid-like cells and RMC somatic deletion of Flt1, we show that an effector of Wnt-dependent suppression of angiogenesis by RMCs is Flt1, a naturally occurring inhibitor of vascular endothelial growth factor (VEGF)(4-6). These findings indicate that resident myeloid cells can use a non-canonical, Wnt-Flt1 pathway to suppress angiogenic branching.	[Stefater, James A., III; Rao, Sujata; Carpenter, April C.; Fan, Jieqing; Lang, Richard A.] Cincinnati Childrens Hosp, Visual Syst Grp, Div Pediat Ophthalmol, Med Ctr, Cincinnati, OH 45229 USA; [Stefater, James A., III; Rao, Sujata; Carpenter, April C.; Fan, Jieqing; Lang, Richard A.] Cincinnati Childrens Hosp, Div Dev Biol, Med Ctr, Cincinnati, OH 45229 USA; [Stefater, James A., III; Rao, Sujata] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Lewkowich, Ian; Wills-Karp, Marsha] Cincinnati Childrens Hosp, Div Immunobiol, Med Ctr, Cincinnati, OH 45229 USA; [Mariggi, Giovanni; Gerhardt, Holger] Canc Res UK, Vasc Biol Lab, London Res Inst, London WC2 3PX, England; [Burr, Adam R.; Molkentin, Jeffery D.] Univ Cincinnati, Div Mol Cardiovasc Biol, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Ajima, Rieko; Yamaguchi, Terry] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Molkentin, Jeffery D.] Univ Cincinnati, Med Ctr, Howard Hughes Med Inst, Cincinnati Childrens Hosp, Cincinnati, OH 45229 USA; [Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis Res, Grand Rapids, MI 49503 USA; [Pollard, Jeffrey W.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Gerhardt, Holger] VIB, Vasc Patterning Lab, Vesalius Res Ctr, B-3000 Louvain, Belgium	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cancer Research UK; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; Van Andel Institute; Yeshiva University; Albert Einstein College of Medicine; Roche Holding; Genentech; Flanders Institute for Biotechnology (VIB)	Lang, RA (corresponding author), Cincinnati Childrens Hosp, Visual Syst Grp, Div Pediat Ophthalmol, Med Ctr, Cincinnati, OH 45229 USA.	richard.lang@cchmc.org	Williams, Bart/A-3539-2013; Gerhardt, Holger/G-4610-2011; Burr, Adam/AAU-2980-2020; Lang, Richard/E-5578-2011; Gerhardt, Holger/G-4610-2011	Williams, Bart/0000-0002-5261-5301; Gerhardt, Holger/0000-0002-3030-0384; Molkentin, Jeffery/0000-0002-3558-6529; Lang, Richard/0000-0002-5212-254X; Gerhardt, Holger/0000-0001-9228-7472	NIH; HHMI; Cancer Research UK; MRC [G1002033] Funding Source: UKRI; Medical Research Council [G1002033] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY015766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053293] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Speeg for technical assistance and A. P. McMahon for the Wnt11 mice. This work was supported by the NIH (J.A.S., M.W-K., J.W.P., J.D.M., T.Y., B.O.W., R.A.L.) by the HHMI (J.D.M.) and Cancer Research UK (H.G.).	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Behringer R, 2003, MANIPULATING MOUSE E, P371; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Chan CK, 2005, LAB INVEST, V85, P721, DOI 10.1038/labinvest.3700277; Chan CK, 2004, INVEST OPHTH VIS SCI, V45, P441, DOI 10.1167/iovs.03-0869; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Gao GQ, 2002, DIABETES, V51, P1218, DOI 10.2337/diabetes.51.4.1218; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Mendes-Jorge L, 2009, INVEST OPHTH VIS SCI, V50, P5997, DOI 10.1167/iovs.09-3515; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Rohan RM, 2000, FASEB J, V14, P871, DOI 10.1096/fasebj.14.7.871; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	35	195	198	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					511	515		10.1038/nature10085	http://dx.doi.org/10.1038/nature10085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21623369	Green Accepted			2022-12-01	WOS:000291939700049
J	de Boer, IH; Rue, TC; Hall, YN; Heagerty, PJ; Weiss, NS; Himmelfarb, J				de Boer, Ian H.; Rue, Tessa C.; Hall, Yoshio N.; Heagerty, Patrick J.; Weiss, Noel S.; Himmelfarb, Jonathan			Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-INSUFFICIENCY; SERUM CREATININE; RISK; MICROALBUMINURIA; ALBUMINURIA; MORTALITY; NEPHROPATHY; PROTEINURIA; POPULATION; EPIDEMIOLOGY	Context Diabetes is the leading cause of kidney disease in the developed world. Over time, the prevalence of diabetic kidney disease (DKD) may increase due to the expanding size of the diabetes population or decrease due to the implementation of diabetes therapies. Objective To define temporal changes in DKD prevalence in the United States. Design, Setting, and Participants Cross-sectional analyses of the Third National Health and Nutrition Examination Survey (NHANES III) from 1988-1994 (N = 15 073), NHANES 1999-2004 (N = 13 045), and NHANES 2005-2008 (N = 9588). Participants with diabetes were defined by levels of hemoglobin A(1c) of 6.5% or greater, use of glucose-lowering medications, or both (n = 1431 in NHANES III; n = 1443 in NHANES 1999-2004; n = 1280 in NHANES 2005-2008). Main Outcome Measures Diabetic kidney disease was defined as diabetes with albuminuria (ratio of urine albumin to creatinine >= 30 mg/g), impaired glomerular filtration rate (<60 mL/min/1.73 m(2) estimated using the Chronic Kidney Disease Epidemiology Collaboration formula), or both. Prevalence of albuminuria was adjusted to estimate persistent albuminuria. Results The prevalence of DKD in the US population was 2.2% (95% confidence interval [CI], 1.8%-2.6%) in NHANES III, 2.8% (95% CI, 2.4%-3.1%) in NHANES 1999-2004, and 3.3% (95% CI, 2.8%-3.7%) in NHANES 2005-2008 (P < .001 for trend). The prevalence of DKD increased in direct proportion to the prevalence of diabetes, without a change in the prevalence of DKD among those with diabetes. Among persons with diabetes, use of glucose-lowering medications increased from 56.2% (95% CI, 52.1%-60.4%) in NHANES III to 74.2% (95% CI, 70.4%-78.0%) in NHANES 2005-2008 (P < .001); use of renin-angiotensin-aldosterone system inhibitors increased from 11.2% (95% CI, 9.0%-13.4%) to 40.6% (95% CI, 37.2%-43.9%), respectively (P < .001); the prevalence of impaired glomerular filtration rate increased from 14.9% (95% CI, 12.1%-17.8%) to 17.7% (95% CI, 15.2%-20.2%), respectively (P =. 03); and the prevalence of albuminuria decreased from 27.3% (95% CI, 22.0%-32.7%) to 23.7% (95% CI, 19.3%-28.0%), respectively, but this was not statistically significant (P =. 07). Conclusions Prevalence of DKD in the United States increased from 1988 to 2008 in proportion to the prevalence of diabetes. Among persons with diabetes, prevalence of DKD was stable despite increased use of glucose-lowering medications and renin-angiotensin-aldosterone system inhibitors. JAMA. 2011;305(24):2532-2539	[de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Kidney Res Inst, Seattle, WA 98104 USA; [de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Div Nephrol, Seattle, WA 98104 USA; [de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Rue, Tessa C.; Heagerty, Patrick J.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [de Boer, Ian H.; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	de Boer, IH (corresponding author), Univ Washington, Kidney Res Inst, Box 359606,325 9th Ave, Seattle, WA 98104 USA.	deboer@u.washington.edu	Hall, Yoshio/AAP-5723-2021; de Boer, Ian/GYJ-3282-2022		Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients; Nephrion/Cytopheryx Medical Advisory Board; National Center for Research Resources [5KL2RR025015]; National Institutes of Health [UL1RR025014]; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK087726, 1R01DK088762]; Satellite Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014, KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088762, R01DK087726, K23DK087900] Funding Source: NIH RePORTER	Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients; Nephrion/Cytopheryx Medical Advisory Board; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Satellite Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Himmelfarb reported that all honoraria and consulting fees from serving on the Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients and the Nephrion/Cytopheryx Medical Advisory Board are donated to the Kidney Research Institute at the University of Washington; money is paid to his institution (University of Washington) for his consulting work for Genzyme, Lilly, and Thrasos. No other authors reported disclosures.; This publication was made possible by grant 5KL2RR025015 from the National Center for Research Resources, grant UL1RR025014 from the National Institutes of Health, grants 1R01DK087726 and 1R01DK088762 from the National Institute of Diabetes and Digestive and Kidney Diseases, and funding from the Satellite Healthcare's Norman S. Coplon Extramural Grant Program.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; BORCHJOHNSEN K, 1987, BMJ-BRIT MED J, V294, P1651, DOI 10.1136/bmj.294.6588.1651; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Caramori ML, 2003, DIABETES, V52, P1036, DOI 10.2337/diabetes.52.4.1036; Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH NUTR EX SUR; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Costacou T, 2007, AM J KIDNEY DIS, V50, P721, DOI 10.1053/j.ajkd.2007.08.005; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; de Boer IH, 2009, DIABETES CARE, V32, P1833, DOI 10.2337/dc09-0191; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gerstein HC, 2000, LANCET, V355, P253; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Perkins BA, 2005, J AM SOC NEPHROL, V16, P1404, DOI 10.1681/ASN.2004100854; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Renal Data System, 2010, USRDS 2010 ANN DAT R; VIBERTI GC, 1982, LANCET, V1, P1430	41	628	638	3	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2532	2539		10.1001/jama.2011.861	http://dx.doi.org/10.1001/jama.2011.861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693741	Green Accepted			2022-12-01	WOS:000291860400020
J	Cotta-Ramusino, C; McDonald, ER; Hurov, K; Sowa, ME; Harper, JW; Elledge, SJ				Cotta-Ramusino, Cecilia; McDonald, E. Robert, III; Hurov, Kristen; Sowa, Mathew E.; Harper, J. Wade; Elledge, Stephen J.			A DNA Damage Response Screen Identifies RHINO, a 9-1-1 and TopBP1 Interacting Protein Required for ATR Signaling	SCIENCE			English	Article							REPAIR; PARTICIPATE; CHECKPOINT; COMPLEXES	The DNA damage response (DDR) is brought about by a protein kinase cascade that orchestrates DNA repair through transcriptional and posttranslational mechanisms. Cell cycle arrest is a hallmark of the DDR. We screened for cells that lacked damage-induced cell cycle arrest and uncovered a critical role for Fanconi anemia and homologous recombination proteins in ATR (ataxia telangiectasia and Rad3-related) signaling. Three DDR candidates, the RNA processing protein INTS7, the circadian transcription factor CLOCK, and a previously uncharacterized protein RHINO, were recruited to sites of DNA damage. RHINO independently bound the Rad9-Rad1-Hus1 complex (9-1-1) and the ATR activator TopBP1. RHINO was recruited to sites of DNA damage by the 9-1-1 complex to promote Chk1 activation. We suggest that RHINO functions together with the 9-1-1 complex and TopBP1 to fully activate ATR.	[Cotta-Ramusino, Cecilia; McDonald, E. Robert, III; Hurov, Kristen; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Div Genet,Dept Genet, Boston, MA 02115 USA; [Sowa, Mathew E.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Div Genet,Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	NIH; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137, R37GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Institute of Chemistry and Cell Biology-Longwood for screening assistance. We also thank K. Hofmann, A. Ciccia, A. Bredemeyer, B. Adamson, A. Burrows, A. Smogorzewska, and A. Brass for helpful discussions. This work was supported by NIH grants to S.J.E. and J.W.H. C. C. R. is the recipient of a long-term European Molecular Biology Organization fellowship. S.J.E. is a Howard Hughes Medical Institute investigator. W. H. is a paid consultant for Millennium Pharmaceuticals and its program in oncology.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Collis SJ, 2007, CHROMOSOMA, V116, P331, DOI 10.1007/s00412-007-0108-6; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Iyer LM, 2002, GENOME BIOL, V3; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837	21	145	161	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1313	1317		10.1126/science.1203430	http://dx.doi.org/10.1126/science.1203430			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659603	Green Accepted			2022-12-01	WOS:000291441700043
J	Miller, FG; Joffe, S				Miller, Franklin G.; Joffe, Steven			Balancing Access and Evaluation in the Approval of New Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCELERATED APPROVAL; CLINICAL-TRIALS		[Miller, Franklin G.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Joffe, Steven] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Joffe, Steven] Childrens Hosp, Dept Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Miller, FG (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	fmiller@nih.gov	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Allison M, 2011, NAT BIOTECHNOL, V29, P13, DOI 10.1038/nbt.1746; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Chabner BA, 2011, NEW ENGL J MED, V364, P1087, DOI 10.1056/NEJMp1100548; Ellenberg SS, 2011, J NATL CANCER I, V103, P616, DOI 10.1093/jnci/djr104; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Rawls J, 1999, THEORY JUSTICE; Rettig R. A., 2007, FALSE HOPE BONE MARR	10	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2345	2346		10.1001/jama.2011.784	http://dx.doi.org/10.1001/jama.2011.784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642688				2022-12-01	WOS:000291349100029
J	Hayden, EJ; Ferrada, E; Wagner, A				Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas			Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme	NATURE			English	Article							GROUP-I RIBOZYME; PROTEIN; EVOLVABILITY; STABILITY; EPISTASIS; MECHANISM; AZOARCUS; INTRON; VITRO; CORE	Cryptic variation is caused by the robustness of phenotypes to mutations(1). Cryptic variation has no effect on phenotypes in a given genetic or environmental background, but it can have effects after mutations or environmental change(2-5). Because evolutionary adaptation by natural selection requires phenotypic variation, phenotypically revealed cryptic genetic variation may facilitate evolutionary adaptation(6-8). This is possible if the cryptic variation happens to be pre-adapted, or "exapted"(9), to a new environment, and is thus advantageous once revealed. However, this facilitating role for cryptic variation has not been proven, partly because most pertinent work focuses on complex phenotypes of whole organisms whose genetic basis is incompletely understood. Here we show that populations of RNA enzymes with accumulated cryptic variation adapt more rapidly to a new substrate than a population without cryptic variation. A detailed analysis of our evolving RNA populations in genotype space shows that cryptic variation allows a population to explore new genotypes that become adaptive only in a new environment. Our observations show that cryptic variation contains new genotypes pre-adapted to a changed environment. Our results highlight the positive role that robustness and epistasis can have in adaptive evolution(10,11).	[Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Wagner, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland.	andreas.wagner@ieu.uzh.ch		Ferrada, Evandro/0000-0003-3242-1726	Swiss National Science Foundation [315200-116814, 315200-119697, 315230-129708]; SystemsX.ch; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; University of Zurich	We thank R. Dhar and N. de la Chaux for bioinformatic support. We thank the Functional Genomics Center, Zurich, for collecting sequence data. We acknowledge support from Swiss National Science Foundation grants 315200-116814, 315200-119697 and 315230-129708, from the YeastX program of SystemsX.ch, and from the Research Priority Program in Systems Biology at the University of Zurich.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake RD, 1996, NUCLEIC ACIDS RES, V24, P2095, DOI 10.1093/nar/24.11.2095; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; BREAKER RR, 1994, TRENDS BIOTECHNOL, V12, P268, DOI 10.1016/0167-7799(94)90138-4; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Eckert K A, 1991, PCR Methods Appl, V1, P17; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanczyc MM, 1998, RNA, V4, P268; Hartl D.L., 1997, PRINCIPLES POPULATIO; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; LEHMAN N, 1993, NATURE, V361, P182, DOI 10.1038/361182a0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Ouellet J, 2009, RNA, V15, P1822, DOI 10.1261/rna.1759009; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; Tanner MA, 1996, RNA, V2, P74; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilke CO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-3; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124	37	158	163	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					92	U120		10.1038/nature10083	http://dx.doi.org/10.1038/nature10083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637259	Green Accepted			2022-12-01	WOS:000291156700044
J	Mac Donald, CL; Johnson, AM; Cooper, D; Nelson, EC; Werner, NJ; Shimony, JS; Snyder, AZ; Raichle, ME; Witherow, JR; Fang, R; Flaherty, SF; Brody, DL				Mac Donald, Christine L.; Johnson, Ann M.; Cooper, Dana; Nelson, Elliot C.; Werner, Nicole J.; Shimony, Joshua S.; Snyder, Abraham Z.; Raichle, Marcus E.; Witherow, John R.; Fang, Raymond; Flaherty, Stephen F.; Brody, David L.			Detection of Blast-Related Traumatic Brain Injury in U.S. Military Personnel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIFFUSE AXONAL INJURY; AMYLOID PRECURSOR PROTEIN; WHITE-MATTER INJURY; CLOSED-HEAD INJURY; MILD; VETERANS; MEMORY; MODEL; TIME; IRAQ	Background Blast-related traumatic brain injuries have been common in the Iraq and Afghanistan wars, but fundamental questions about the nature of these injuries remain unanswered. Methods We tested the hypothesis that blast-related traumatic brain injury causes traumatic axonal injury, using diffusion tensor imaging (DTI), an advanced form of magnetic resonance imaging that is sensitive to axonal injury. The subjects were 63 U. S. military personnel who had a clinical diagnosis of mild, uncomplicated traumatic brain injury. They were evacuated from the field to the Landstuhl Regional Medical Center in Landstuhl, Germany, where they underwent DTI scanning within 90 days after the injury. All the subjects had primary blast exposure plus another, blast-related mechanism of injury (e. g., being struck by a blunt object or injured in a fall or motor vehicle crash). Controls consisted of 21 military personnel who had blast exposure and other injuries but no clinical diagnosis of traumatic brain injury. Results Abnormalities revealed on DTI were consistent with traumatic axonal injury in many of the subjects with traumatic brain injury. None had detectible intracranial injury on computed tomography. As compared with DTI scans in controls, the scans in the subjects with traumatic brain injury showed marked abnormalities in the middle cerebellar peduncles (P<0.001), in cingulum bundles (P=0.002), and in the right orbitofrontal white matter (P=0.007). In 18 of the 63 subjects with traumatic brain injury, a significantly greater number of abnormalities were found on DTI than would be expected by chance (P<0.001). Follow-up DTI scans in 47 subjects with traumatic brain injury 6 to 12 months after enrollment showed persistent abnormalities that were consistent with evolving injuries. Conclusions DTI findings in U. S. military personnel support the hypothesis that blast-related mild traumatic brain injury can involve axonal injury. However, the contribution of primary blast exposure as compared with that of other types of injury could not be determined directly, since none of the subjects with traumatic brain injury had isolated primary blast injury. Furthermore, many of these subjects did not have abnormalities on DTI. Thus, traumatic brain injury remains a clinical diagnosis. (Funded by the Congressionally Directed Medical Research Program and the National Institutes of Health; ClinicalTrials.gov number, NCT00785304.)	[Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Witherow, John R.; Fang, Raymond; Flaherty, Stephen F.] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Flaherty, Stephen F.] Walter Reed Army Med Ctr, Washington, DC 20307 USA	Washington University (WUSTL); Landstuhl Regional Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, Biotech Bldg,Rm 201,660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			Congressionally Directed Medical Research Program [W81XWH-08-2-0061]; National Institutes of Health [F32NS062529, 5K23HD053212, P30NS048056, P50NS06833, 5K08NS49237]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD053212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS049237, P30NS048056, F32NS062529, P50NS006833] Funding Source: NIH RePORTER	Congressionally Directed Medical Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the Congressionally Directed Medical Research Program (W81XWH-08-2-0061, to Dr. Brody) and the National Institutes of Health (F32NS062529, to Dr. Mac Donald; 5K23HD053212, to Dr. Shimony; P30NS048056, to Dr. Snyder; P50NS06833, to Drs. Raichle and Snyder; and 5K08NS49237, to Dr. Brody.)	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI 10.1089/neu.2009-0885; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mott FW, 1917, J ROY ARMY MED CORPS, V29, P662; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	43	446	449	2	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2091	2100		10.1056/NEJMoa1008069	http://dx.doi.org/10.1056/NEJMoa1008069			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772AB	21631321	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000291200700007
J	Fu, SN; Yang, L; Li, P; Hofmann, O; Dicker, L; Hide, W; Lin, XH; Watkins, SM; Ivanov, AR; Hotamisligil, GS				Fu, Suneng; Yang, Ling; Li, Ping; Hofmann, Oliver; Dicker, Lee; Hide, Winston; Lin, Xihong; Watkins, Steven M.; Ivanov, Alexander R.; Hotamisligil, Goekhan S.			Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity	NATURE			English	Article							GLUCOSE-HOMEOSTASIS; MASS-SPECTROMETRY; ADIPOSE-TISSUE; ER STRESS; MICE; CA2+-ATPASE; INSULIN; PHOSPHATIDYLETHANOLAMINE; CHOLESTEROL; ACTIVATION	The endoplasmic reticulum (ER) is the main site of protein and lipid synthesis, membrane biogenesis, xenobiotic detoxification and cellular calcium storage, and perturbation of ER homeostasis leads to stress and the activation of the unfolded protein response(1). Chronic activation of ER stress has been shown to have an important role in the development of insulin resistance and diabetes in obesity(2). However, the mechanisms that lead to chronic ER stress in a metabolic context in general, and in obesity in particular, are not understood. Here we comparatively examined the proteomic and lipidomic landscape of hepatic ER purified from lean and obese mice to explore the mechanisms of chronic ER stress in obesity. We found suppression of protein but stimulation of lipid synthesis in the obese ER without significant alterations in chaperone content. Alterations in ER fatty acid and lipid composition result in the inhibition of sarco/endoplasmic reticulum calcium ATPase (SERCA) activity and ER stress. Correcting the obesity-induced alteration of ER phospholipid composition or hepatic Serca overexpression in vivo both reduced chronic ER stress and improved glucose homeostasis. Hence, we established that abnormal lipid and calcium metabolism are important contributors to hepatic ER stress in obesity.	[Fu, Suneng; Yang, Ling; Li, Ping; Ivanov, Alexander R.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Fu, Suneng; Yang, Ling; Li, Ping; Ivanov, Alexander R.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hofmann, Oliver; Dicker, Lee; Hide, Winston; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Watkins, Steven M.] Lip Technol Inc, W Sacramento, CA 95691 USA; [Hotamisligil, Goekhan S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Hide, Winston/R-3815-2019; Yang, Ling/C-8000-2011; Hide, Winston A/V-2727-2017; Hofmann, Oliver M/F-1800-2013; Hide, Winston Hide/C-7217-2009	Hide, Winston/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Hofmann, Oliver M/0000-0002-7738-1513; Hide, Winston Hide/0000-0002-8621-3271; Yang, Ling/0000-0002-3105-3063	National Institutes of Health [DK52539, 1RC4-DK090942]; Syndexa Pharmaceuticals; NIH/NIEHS [T32ES007155]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090942, R01DK052539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Syndexa Pharmaceuticals; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Porter, E. Freeman and R. Davis for technical assistance. The anti-HERP antibody is a gift of Y. Hirabayashi. We thank the members of the G.S.H. laboratory for scientific discussions and critical reading of the manuscript. This work was supported in part by the National Institutes of Health (DK52539 and 1RC4-DK090942) and a research grant from Syndexa Pharmaceuticals to G.S.H. S.F. was supported in part by the NIH/NIEHS postdoctoral training grant (T32ES007155).	Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; CHENG KH, 1986, J BIOL CHEM, V261, P5081; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kim SJ, 2010, NEUROSCI LETT, V479, P292, DOI 10.1016/j.neulet.2010.05.083; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li SY, 2006, DIABETOLOGIA, V49, P1434, DOI 10.1007/s00125-006-0229-0; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; LODISH HF, 1990, J BIOL CHEM, V265, P10893; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; MOORE L, 1975, J BIOL CHEM, V250, P4562; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schiller J, 2001, J LIPID RES, V42, P1501	24	680	703	11	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					528	531		10.1038/nature09968	http://dx.doi.org/10.1038/nature09968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21532591	Green Accepted			2022-12-01	WOS:000290951300044
J	Smith, TJ; Hillner, BE				Smith, Thomas J.; Hillner, Bruce E.			Bending the Cost Curve in Cancer Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELL LUNG-CANCER; 2006 UPDATE; FEBRILE NEUTROPENIA; PALLIATIVE CARE; ONCOLOGY; LIFE; CHEMOTHERAPY; END; GUIDELINES; HEALTH		[Smith, Thomas J.] Virginia Commonwealth Univ, Div Hematol Oncol & Palliat Care, Richmond, VA 23284 USA; [Hillner, Bruce E.] Virginia Commonwealth Univ, Div Gen Internal Med, Richmond, VA 23284 USA; [Smith, Thomas J.; Hillner, Bruce E.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Smith, TJ (corresponding author), Virginia Commonwealth Univ, Div Hematol Oncol & Palliat Care, Richmond, VA 23284 USA.			Smith, Thomas/0000-0003-3040-6434	NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aaron HJ, 2009, HEALTH AFFAIR, V28, P1260, DOI 10.1377/hlthaff.28.5.1260; [Anonymous], 1996, J CLIN ONCOL, V14, P671; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Blayney DW, 2009, J CLIN ONCOL, V27, P3802, DOI 10.1200/JCO.2008.21.6770; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Bohlius J., 2008, COCHRANE DB SYST REV, V4; Brickates Kennedy V, 2010, MARKETWATCH     1025; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Cardoso F, 2009, JNCI-J NATL CANCER I, V101, P1174, DOI 10.1093/jnci/djp235; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Carrick S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003372.pub3; Chiew KS, 2008, HEALTH EXPECT, V11, P35, DOI 10.1111/j.1369-7625.2007.00470.x; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; Donovan RJ, 2006, LANCET ONCOL, V7, P668, DOI 10.1016/S1470-2045(06)70794-X; Dow LA, 2010, J CLIN ONCOL, V28, P299, DOI 10.1200/JCO.2009.24.6397; Eastem Cooperative Oncology Group, ECOG PERF STAT; Elkin EB, 2010, JAMA-J AM MED ASSOC, V303, P1086, DOI 10.1001/jama.2010.283; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Finn JW, 2002, P AN M AM SOC CLIN, V21, P1452; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Gade G, 2008, J PALLIAT MED, V11, P180, DOI 10.1089/jpm.2007.0055; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Hillner BE, 2009, J CLIN ONCOL, V27, P2111, DOI 10.1200/JCO.2008.21.0534; Hortobagyi GN, 2007, J CLIN ONCOL, V25, P1468, DOI 10.1200/JCO.2007.10.9397; Huskamp HA, 2009, ARCH INTERN MED, V169, P954, DOI 10.1001/archinternmed.2009.127; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Jacobson JO, 2008, J CLIN ONCOL, V26, P1893, DOI 10.1200/JCO.2007.14.2992; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; Jacobson M, 2010, HEALTH AFFAIR, V29, P1391, DOI 10.1377/hlthaff.2009.0563; Johnson A, 2010, WALL STREET J   1019; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Kelly K, 2011, 1 LINE CHEMOTHERAPY; Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; Levy AR, 2010, PHARMACOECONOMICS, V28, P813, DOI 10.2165/11536150-000000000-00000; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Loprinzi Charles L, 2003, J Clin Oncol, V21, p108s, DOI 10.1200/JCO.2003.01.190; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; National Cancer Institute, CANC TRENDS PROGR RE; Neubauer MA, 2010, J ONCOL PRACT, V6, P12, DOI 10.1200/JOP.091058; Pearson SD, 2010, HEALTH AFFAIR, V29, P1796, DOI 10.1377/hlthaff.2010.0623; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; Pyenson B, 2004, J PAIN SYMPTOM MANAG, V28, P200, DOI 10.1016/j.jpainsymman.2004.05.003; Rustin GJS, 2010, LANCET, V376, P1155, DOI 10.1016/S0140-6736(10)61268-8; SCHAPIRA DV, 1991, JAMA-J AM MED ASSOC, V265, P380, DOI 10.1001/jama.265.3.380; Sepucha KR, 2009, MED DECIS MAKING, V29, P475, DOI 10.1177/0272989X09333124; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Smith Thomas J, 2011, J Support Oncol, V9, P79; Smith TJ, 2010, ONCOLOGY-NY, V24, P521; Smith TJ, 2010, ONCOLOGIST, V15, P65, DOI 10.1634/theoncologist.2010-S1-65; Smith TJ, 2010, J CLIN ONCOL, V28, pE128, DOI 10.1200/JCO.2009.26.8243; SMITH TJ, 1995, J CLIN ONCOL, V13, P2464, DOI 10.1200/JCO.1995.13.9.2464; Smith TJ, 2005, J CLIN ONCOL, V23, P6807, DOI 10.1200/JCO.2005.01.5545; Spettell CM, 2009, J PALLIAT MED, V12, P827, DOI 10.1089/jpm.2009.0089; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Timmer-Bonte JNH, 2008, J CLIN ONCOL, V26, P290, DOI 10.1200/JCO.2007.13.0898; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	63	306	308	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2011	364	21					2060	2065		10.1056/NEJMsb1013826	http://dx.doi.org/10.1056/NEJMsb1013826			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QR	21612477	Green Accepted			2022-12-01	WOS:000290952000015
J	Alehagen, U; Dahlstrom, U; Rehfeld, JF; Goetze, JP				Alehagen, Urban; Dahlstroem, Ulf; Rehfeld, Jens F.; Goetze, Jens P.			Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARGININE-VASOPRESSIN INCREASES; LEFT-VENTRICULAR DYSFUNCTION; NATRIURETIC PEPTIDE; PROVASOPRESSIN COPEPTIN; PROGNOSTIC MARKER; DIAGNOSIS; PLASMA; BNP	Context Measurement of plasma concentrations of the biomarker copeptin may help identify patients with heart failure at high and low risk of mortality, although the value of copeptin measurement in elderly patients is not fully known. Objective To evaluate the association between plasma concentrations of copeptin, a surrogate marker of vasopressin, combined with concentrations of the N-terminal fragment of the precursor to B-type natriuretic peptide (NT-proBNP), and mortality in a cohort of elderly patients with symptoms of heart failure. Design, Setting, and Participants Primary health care population in Sweden enrolling 470 elderly patients with heart failure symptoms between January and December 1996. Clinical examination, echocardiography, and measurement of peptide concentrations were performed, with follow-up through December 2009. Main Outcome Measures All-cause mortality and cardiovascular mortality. Results After a median follow-up of 13 years, there were 226 deaths from all causes, including 146 deaths from cardiovascular causes. Increased concentration of copeptin was associated with increased risk of all-cause mortality (fourth quartile vs first quartile: 69.5% vs 38.5%, respectively; hazard ratio [HR], 2.04 [95% confidence interval {CI}, 1.38-3.02]) and cardiovascular mortality (fourth quartile vs first quartile: 46.6% vs 26.5%; HR, 1.94 [95% CI, 1.20-3.13]). The combination of elevated NT-proBNP concentrations and elevated copeptin concentrations also was associated with increased risk of all-cause mortality (copeptin fourth quartile: HR, 1.63 [95% CI, 1.08-2.47]; P=.01; NT-proBNP fourth quartile: HR, 3.17 [95% CI, 2.02-4.98]; P<.001). Using the 2 biomarkers simultaneously in the evaluation of cardiovascular mortality, there was a significant association for copeptin in the presence of NT-proBNP (log likelihood trend test, P=.048) and a significant association for NT-proBNP (fourth quartile: HR, 4.68 [95% CI 2.63-8.34]; P<.001). Conclusion Among elderly patients with symptoms of heart failure, elevated concentrations of copeptin and the combination of elevated concentrations of copeptin and NT-proBNP were associated with increased risk of all-cause mortality. JAMA. 2011; 305(20): 2088-2095	[Alehagen, Urban; Dahlstroem, Ulf] Linkoping Univ, Div Cardiovasc Med, Dept Med & Hlth Sci,Cty Council Ostergotland, Fac Hlth Sci,Dept Cardiol UHL, SE-58185 Linkoping, Sweden; [Rehfeld, Jens F.; Goetze, Jens P.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	City Council Ostergotland; Linkoping University; Rigshospitalet; University of Copenhagen	Alehagen, U (corresponding author), Linkoping Univ, Dept Cardiol, Ctr Heart, SE-58185 Linkoping, Sweden.	urban.alehagen@liu.se		Goetze, Jens Peter/0000-0001-6356-3829	County Council of Ostergotland; Swedish Heart and Lung Foundation; University of Linkoping	County Council of Ostergotland; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); University of Linkoping	This study was supported by grants from the County Council of Ostergotland, the Swedish Heart and Lung Foundation, and the University of Linkoping.	Alehagen U., 2002, HeartDrug, V2, P211, DOI 10.1159/000067723; Alehagen U, 2003, CLIN CHEM, V49, P1337, DOI 10.1373/49.8.1337; Apple FS, 2003, CLIN CHIM ACTA, V328, P191, DOI 10.1016/S0009-8981(02)00374-1; Chatterjee K, 2005, AM J CARDIOL, V95, p8B, DOI 10.1016/j.amjcard.2005.03.003; CHOY AMJ, 1994, BRIT HEART J, V72, P16; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dieplinger B, 2009, HEART, V95, P1508, DOI 10.1136/hrt.2009.170696; EBERT TJ, 1986, J CLIN INVEST, V77, P1136, DOI 10.1172/JCI112413; Fan YH, 2007, LIFE SCI, V81, P327, DOI 10.1016/j.lfs.2007.05.018; Fukuzawa J, 1999, MOL CELL BIOCHEM, V195, P93, DOI 10.1023/A:1006980517557; Gegenhuber A, 2004, CLIN CHEM, V50, P454, DOI 10.1373/clinchem.2003.028712; Jensen-Urstad K, 1998, AM J CARDIOL, V81, P538, DOI 10.1016/S0002-9149(97)00964-8; Jochberger S, 2009, CRIT CARE MED, V37, P476, DOI 10.1097/CCM.0b013e3181957532; Keller T, 2010, J AM COLL CARDIOL, V55, P2096, DOI 10.1016/j.jacc.2010.01.029; Khan SQ, 2007, CIRCULATION, V115, P2103, DOI 10.1161/CIRCULATIONAHA.106.685503; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; MOYE LA, 1991, AM J CARDIOL, V68, pD70; Nakamura T, 2006, INT J CARDIOL, V106, P191, DOI 10.1016/j.ijcard.2005.01.043; Neuhold S, 2008, J AM COLL CARDIOL, V52, P266, DOI 10.1016/j.jacc.2008.03.050; Swedberg K, 1999, J Card Fail, V5, P276, DOI 10.1016/S1071-9164(99)90013-1; URETSKY BF, 1985, AM J PHYSIOL, V248, pH396, DOI 10.1152/ajpheart.1985.248.3.H396; vanRoyen N, 1996, AM J CARDIOL, V77, P843, DOI 10.1016/S0002-9149(97)89179-5; Voors AA, 2009, EUR HEART J, V30, P1187, DOI 10.1093/eurheartj/ehp098	27	109	129	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2011	305	20					2088	2095		10.1001/jama.2011.666	http://dx.doi.org/10.1001/jama.2011.666			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768AC	21610241				2022-12-01	WOS:000290901700022
J	Dyrbye, LN; Shanafelt, TD				Dyrbye, Liselotte N.; Shanafelt, Tait D.			Physician Burnout A Potential Threat to Successful Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICAN SURGEONS		[Dyrbye, Liselotte N.; Shanafelt, Tait D.] Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA	Mayo Clinic	Dyrbye, LN (corresponding author), Mayo Clin, Coll Med, Dept Med, 200 1st St SW, Rochester, MN 55905 USA.	dyrbye.liselotte@mayo.edu						[Anonymous], REP PRES REAL FULL P; Association of American Medical Colleges, 2018, COMPL PHYS SUPPL DEM; Campbell DA, 2001, SURGERY, V130, P696, DOI 10.1067/msy.2001.116676; Dyrbye LN, 2011, ARCH SURG-CHICAGO, V146, P211, DOI 10.1001/archsurg.2010.310; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; SteelFisher GK, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0909851; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Wilson JF, 2008, ANN INTERN MED, V148, P489, DOI 10.7326/0003-4819-148-6-200803180-00029	10	229	232	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					2009	2010		10.1001/jama.2011.652	http://dx.doi.org/10.1001/jama.2011.652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21586718				2022-12-01	WOS:000290665500027
J	Kirby, T				Kirby, Tony			Profile Rebecca Ivers: driving down the toll of injury	LANCET			English	Biographical-Item												tony.kirby@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1563	1563		10.1016/S0140-6736(11)60629-6	http://dx.doi.org/10.1016/S0140-6736(11)60629-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21550470				2022-12-01	WOS:000290549700013
J	Neff, S; Goldschmidt, R				Neff, Sarah; Goldschmidt, Ronald			Centers for Disease Control and Prevention 2006 Human Immunodeficiency Virus Testing Recommendations and State Testing Laws	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Neff, Sarah; Goldschmidt, Ronald] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Neff, S (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.	neffs@nccc.ucsf.edu						[Anonymous], 2011 COMP STAT HIV T; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1	2	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1767	1768		10.1001/jama.2011.564	http://dx.doi.org/10.1001/jama.2011.564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540419	Bronze			2022-12-01	WOS:000290156200016
J	Kulkarni, S; Savan, R; Qi, Y; Gao, XJ; Yuki, Y; Bass, SE; Martin, MP; Hunt, P; Deeks, SG; Telenti, A; Pereyra, F; Goldstein, D; Wolinsky, S; Walker, B; Young, HA; Carrington, M				Kulkarni, Smita; Savan, Ram; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Bass, Sara E.; Martin, Maureen P.; Hunt, Peter; Deeks, Steven G.; Telenti, Amalio; Pereyra, Florencia; Goldstein, David; Wolinsky, Steven; Walker, Bruce; Young, Howard A.; Carrington, Mary			Differential microRNA regulation of HLA-C expression and its association with HIV control	NATURE			English	Article							SURFACE EXPRESSION; DEADENYLATION; ANTIGENS; GENOME; GENES	The HLA-C locus is distinct relative to the other classical HLA class I loci in that it has relatively limited polymorphism(1), lower expression on the cell surface(2,3), and more extensive ligand-receptor interactions with killer-cell immunoglobulin-like receptors(4). A single nucleotide polymorphism (SNP) 35 kb upstream of HLA-C (rs9264942; termed -35) associates with control of HIV5-7, and with levels of HLA-C messenger RNA transcripts(8) and cell-surface expression(7), but the mechanism underlying its varied expression is unknown. We proposed that the -35 SNP is not the causal variant for differential HLA-C expression, but rather is marking another polymorphism that directly affects levels of HLA-C-7. Here we show that variation within the 3' untranslated region (UTR) of HLA-C regulates binding of the microRNA hsa-miR-148 to its target site, resulting in relatively low surface expression of alleles that bind this microRNA and high expression of HLA-C alleles that escape post-transcriptional regulation. The 3' UTR variant associates strongly with control of HIV, potentially adding to the effects of genetic variation encoding the peptide-binding region of the HLA class I loci. Variation in HLA-C expression adds another layer of diversity to this highly polymorphic locus that must be considered when deciphering the function of these molecules in health and disease.	[Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Bass, Sara E.; Martin, Maureen P.; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Martin, Maureen P.; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] Harvard Univ, Boston, MA 02114 USA; [Kulkarni, Smita; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Martin, Maureen P.; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] MIT, Ragon Inst, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hunt, Peter; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Aids, San Francisco, CA 94110 USA; [Telenti, Amalio] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Goldstein, David] Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27708 USA; [Wolinsky, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Lausanne; Duke University; Northwestern University; Feinberg School of Medicine	Carrington, M (corresponding author), NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA.	carringm@mail.nih.gov	Goldstein, David/AAY-8125-2020; Telenti, Amalio/AAY-1674-2021; Young, Howard/R-5140-2019; Hunt, Peter W./P-2976-2017; Wolinsky, Steven/B-2893-2012; Young, Howard/A-6350-2008	Hunt, Peter W./0000-0002-4571-4870; Savan, Ram/0000-0002-3087-1355; Wolinsky, Steven/0000-0002-9625-6697; Young, Howard/0000-0002-3118-5111	National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E, N02-CP-55504, R01-DA04334, R01-DA12568]; NIH, National Cancer Institute, Center for Cancer Research; Cancer Inflammation Program Project Award; Bill & Melinda Gates Foundation; Mark and Lisa Schwartz Foundation; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung and Blood Institute [UO1-AI-35042, 5-MO1-RR-00722, UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041]; Swiss HIV Cohort Study; Swiss National Science Foundation [33CSC0-108787];  [UL1 RR024131];  [P30 AI27763]; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Inflammation Program Project Award; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Mark and Lisa Schwartz Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contracts HHSN261200800001E, N02-CP-55504, R01-DA04334 and R01-DA12568. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and the Cancer Inflammation Program Project Award for the year 2009, a grant from the Bill & Melinda Gates Foundation as part of the Collaboration for AIDS Vaccine Discovery, and the Mark and Lisa Schwartz Foundation. We would also like to thank the patients and investigators involved in the Multicenter AIDS Cohort Study (the MACS is funded by the National Institute of Allergy and Infectious Diseases, with supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute (grants UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613 and UO1-AI-35041), the Swiss HIV Cohort Study (see Supplementary Note 4 for the list of members), supported by the Swiss National Science Foundation grant number 33CSC0-108787, and the SCOPE study, which was funded by the UL1 RR024131 (Clinical and Translational Sciences Award) and P30 AI27763 (Center for AIDS Research) grants. We thank S. Anderson, G. O'Connor and R. Thomas for advice, A. Kronfli and K. Ramakrishnan for assistance in plasmid and genomic DNA preparations, A. McFarland for western blots, V. Braud for the DT9 antibody, R. Johnson and G. Nelson for statistical advice and T. Covell for administrative assistance.	Apps R, 2008, TRENDS IMMUNOL, V29, P313, DOI 10.1016/j.it.2008.02.012; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Kralovicova J, 2006, J IMMUNOL, V176, P2381, DOI 10.4049/jimmunol.176.4.2381; KRANGEL MS, 1986, J EXP MED, V163, P1173, DOI 10.1084/jem.163.5.1173; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HC, 2010, METHODS MOL BIOL, V612, P377, DOI 10.1007/978-1-60761-362-6_26; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; Schaefer MR, 2008, J IMMUNOL, V180, P7804, DOI 10.4049/jimmunol.180.12.7804; Setini A, 1996, HUM IMMUNOL, V46, P69, DOI 10.1016/0198-8859(96)00011-0; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; TILANUS MGJ, 2002, IMMUNOBIOLOGY HUMAN, V1, P304; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; ZEMMOUR J, 1992, J EXP MED, V176, P937, DOI 10.1084/jem.176.4.937	27	267	280	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					495	U548		10.1038/nature09914	http://dx.doi.org/10.1038/nature09914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21499264	Green Published, Green Accepted, Green Submitted			2022-12-01	WOS:000289949600039
J	Solt, LA; Kumar, N; Nuhant, P; Wang, YJ; Lauer, JL; Liu, J; Istrate, MA; Kamenecka, TM; Roush, WR; Vidovic, D; Schurer, SC; Xu, JH; Wagoner, G; Drew, PD; Griffin, PR; Burris, TP				Solt, Laura A.; Kumar, Naresh; Nuhant, Philippe; Wang, Yongjun; Lauer, Janelle L.; Liu, Jin; Istrate, Monica A.; Kamenecka, Theodore M.; Roush, William R.; Vidovic, Dusica; Schuerer, Stephan C.; Xu, Jihong; Wagoner, Gail; Drew, Paul D.; Griffin, Patrick R.; Burris, Thomas P.			Suppression of T(H)17 differentiation and autoimmunity by a synthetic ROR ligand	NATURE			English	Article							TH17 CELL-DIFFERENTIATION; ORPHAN RECEPTOR-ALPHA; REV-ERB-ALPHA; GAMMA-T; NUCLEAR RECEPTORS; MASS-SPECTROMETRY; TARGET GENE; IDENTIFICATION; EXCHANGE; AGONIST	T-helper cells that produce interleukin-17 (T(H)17 cells) are a recently identified CD4(+) T-cell subset with characterized pathological roles in autoimmune diseases(1-3). The nuclear receptors retinoic-acid-receptor-related orphan receptors alpha and gamma t (ROR alpha and ROR gamma t, respectively) have indispensible roles in the development of this cell type(4-7). Here we present SR1001, a high-affinity synthetic ligand-the first in a new class of compound-that is specific to both ROR alpha and ROR gamma t and which inhibits T(H)17 cell differentiation and function. SR1001 binds specifically to the ligand-binding domains of ROR alpha and ROR gamma t, inducing a conformational change within the ligand-binding domain that encompasses the repositioning of helix 12 and leads to diminished affinity for co-activators and increased affinity for co-repressors, resulting in suppression of the receptors' transcriptional activity. SR1001 inhibited the development of murine T(H)17 cells, as demonstrated by inhibition of interleukin-17A gene expression and protein production. Furthermore, SR1001 inhibited the expression of cytokines when added to differentiated murine or human T(H)17 cells. Finally, SR1001 effectively suppressed the clinical severity of autoimmune disease in mice. Our data demonstrate the feasibility of targeting the orphan receptors ROR alpha and ROR gamma t to inhibit specifically T(H)17 cell differentiation and function, and indicate that this novel class of compound has potential utility in the treatment of autoimmune diseases.	[Solt, Laura A.; Kumar, Naresh; Wang, Yongjun; Lauer, Janelle L.; Liu, Jin; Istrate, Monica A.; Griffin, Patrick R.; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Kumar, Naresh; Istrate, Monica A.; Vidovic, Dusica; Schuerer, Stephan C.; Griffin, Patrick R.] Scripps Res Inst, Scripps Res Inst Mol Screening Ctr, Jupiter, FL 33458 USA; [Nuhant, Philippe; Roush, William R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Vidovic, Dusica; Schuerer, Stephan C.] Univ Miami, Ctr Computat Sci, Miami, FL 33136 USA; [Xu, Jihong; Wagoner, Gail; Drew, Paul D.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Miami; University of Arkansas System; University of Arkansas Medical Sciences	Burris, TP (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	NIH [DK080201, DK089984, MH084512, DK088499, GM084041]; National Multiple Sclerosis Society [RG389A2/1]; NIH Molecular Library Screening Center Network (MLSCN) [U54MH074404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088499, R01DK080201, R24DK089984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769, U54MH084512, U54MH074404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH Molecular Library Screening Center Network (MLSCN); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants to T. P. B. (DK080201, DK089984 and MH084512), to L. A. S. (DK088499) and P. R. G. (GM084041) and a grant from the National Multiple Sclerosis Society to P. D. D. (RG389A2/1). Additionally, the efforts of P. R. G. and W. R. R. were supported by the NIH Molecular Library Screening Center Network (MLSCN) grant U54MH074404 (Hugh Rosen, Principal Investigator).	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Tamauchi H, 2004, INT IMMUNOL, V16, P179, DOI 10.1093/intimm/dxh026; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	25	368	415	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					491	U547		10.1038/nature10075	http://dx.doi.org/10.1038/nature10075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21499262	Green Accepted			2022-12-01	WOS:000289949600038
J	Jarvinen, TLN; Sievanen, H; Kannus, P; Jokihaara, J; Khan, KM				Jarvinen, Teppo L. N.; Sievanen, Harri; Kannus, Pekka; Jokihaara, Jarkko; Khan, Karim M.			The true cost of pharmacological disease prevention	BRITISH MEDICAL JOURNAL			English	Editorial Material							OSTEOPOROTIC FRACTURES; CONTROLLED-TRIAL; FALLS; RISK		[Jarvinen, Teppo L. N.] Univ Tampere, Dept Orthopaed Surg, Tampere 33014, Finland; [Sievanen, Harri] Cent Finland Cent Hosp, Dept Surg, Jyvaskyla 40620, Finland; [Sievanen, Harri] UKK Inst, Bone Res Grp, Tampere 33500, Finland; [Kannus, Pekka] Tampere Univ Hosp, Div Orthopaed & Traumatol, Tampere 33520, Finland; [Jokihaara, Jarkko; Khan, Karim M.] Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC V5Z 1M9, Canada	Tampere University; Central Finland Central Hospital; UKK Institute; Tampere University; Tampere University Hospital; University of British Columbia	Jarvinen, TLN (corresponding author), Univ Tampere, Dept Orthopaed Surg, Tampere 33014, Finland.	teppo.jarvinen@uta.fi	Järvinen, Teppo/B-8189-2013; Jokihaara, Jarkko/C-5817-2017	Järvinen, Teppo/0000-0003-3713-956X; Jokihaara, Jarkko/0000-0001-6153-2180				Borgstrom F, 2010, OSTEOPOROSIS INT, V21, P495, DOI 10.1007/s00198-009-0989-8; Compston JE, 2006, LANCET, V368, P973, DOI 10.1016/S0140-6736(06)69394-X; Cooper A, 2008, CLIN GUIDELINES EVID; Dawson J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c186; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Inderjeeth CA, 2009, BONE, V44, P744, DOI 10.1016/j.bone.2008.12.003; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI [10.1359/jbmr.060815, 10.1359/JBMR.060815]; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V299, P1651, DOI 10.1001/jama.299.14.1651; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; *NAT I HLTH CLIN E, 2006, NICE CLIN GUID, V34; *NICE, 2010, NICE TECHN APPR GUID, V160; Parikh S, 2009, J AM GERIATR SOC, V57, P327, DOI 10.1111/j.1532-5415.2008.02119.x; Relton C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1066; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; Sawka AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009515; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; van Staa TP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000194; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728	21	39	39	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2011	342								d2175	10.1136/bmj.d2175	http://dx.doi.org/10.1136/bmj.d2175			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755OI	21505222				2022-12-01	WOS:000289942200004
J	Roy, S; Hsiung, F; Kornberg, TB				Roy, Sougata; Hsiung, Frank; Kornberg, Thomas B.			Specificity of Drosophila Cytonemes for Distinct Signaling Pathways	SCIENCE			English	Article							EGF RECEPTOR; EYE; PATTERN; INHIBITION; TRIGGERS; SPITZ; DISC	Cytonemes are types of filopodia in the Drosophila wing imaginal disc that are proposed to serve as conduits in which morphogen signaling proteins move between producing and target cells. We investigated the specificity of cytonemes that are made by target cells. Cells in wing discs made cytonemes that responded specifically to Decapentaplegic (Dpp) and cells in eye discs made cytonemes that responded specifically to Spitz (the Drosophila epidermal growth factor protein). Tracheal cells had at least two types: one made in response to Branchless (a Drosophila fibroblast growth factor protein, Bnl), to which they segregate the Bnl receptor, and another to which they segregate the Dpp receptor. We conclude that cells can make several types of cytonemes, each of which responds specifically to a signaling pathway by means of the selective presence of a particular signaling protein receptor that has been localized to that cytoneme.	[Kornberg, Thomas B.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kornberg, TB (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	tkornberg@ucsf.edu	Roy, Sougaya/I-5341-2019	Roy, Sougaya/0000-0002-2236-9277	Herbert Boyer Postdoctoral Fellowship; National Institute of General Medical Studies; National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030637] Funding Source: NIH RePORTER	Herbert Boyer Postdoctoral Fellowship; National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Li and K. Kechris for help with data analysis; S. Liu for technical help; the Bloomington Drosophila Stock Center, I. Guerrero, E. Bier, M. Krasnow, J. Duffy, M. Sato, and K. Wharton for fly stocks; and T. Wunderlich for hCre*PR*. This work was supported in part by a Herbert Boyer Postdoctoral Fellowship (to S. R.) and by grants from the National Institute of General Medical Studies and the National Heart, Lung, and Blood Institute to T.B.K.	Alvarado D, 2004, GENETICS, V167, P187, DOI 10.1534/genetics.167.1.187; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Guha A, 2009, DEV BIOL, V335, P317, DOI 10.1016/j.ydbio.2009.09.005; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Jones C, 2004, SEMIN CELL DEV BIOL, V15, P75, DOI 10.1016/j.semcdb.2003.09.002; Kornberg TB, 2007, CURR OPIN GENET DEV, V17, P264, DOI 10.1016/j.gde.2007.05.010; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reifegerste R, 1999, BIOESSAYS, V21, P275, DOI 10.1002/(SICI)1521-1878(199904)21:4<275::AID-BIES3>3.0.CO;2-5; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592	16	174	176	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					354	358		10.1126/science.1198949	http://dx.doi.org/10.1126/science.1198949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493861	Green Accepted			2022-12-01	WOS:000289516600046
J	Pang, ZPP; Yang, N; Vierbuchen, T; Ostermeier, A; Fuentes, DR; Yang, TQ; Citri, A; Sebastiano, V; Marro, S; Sudhof, TC; Wernig, M				Pang, Zhiping P.; Yang, Nan; Vierbuchen, Thomas; Ostermeier, Austin; Fuentes, Daniel R.; Yang, Troy Q.; Citri, Ami; Sebastiano, Vittorio; Marro, Samuele; Suedhof, Thomas C.; Wernig, Marius			Induction of human neuronal cells by defined transcription factors	NATURE			English	Article							PLURIPOTENT STEM-CELLS; NEURAL DEVELOPMENT; DIFFERENTIATION; FIBROBLASTS; BLASTOCYST; PAX6	Somatic cell nuclear transfer, cell fusion, or expression of lineage-specific factors have been shown to induce cell-fate changes in diverse somatic cell types(1-12). We recently observed that forced expression of a combination of three transcription factors, Brn2 (also known as Pou3f2), Ascl1 and Myt1l, can efficiently convert mouse fibroblasts into functional induced neuronal (iN) cells(13). Here we show that the same three factors can generate functional neurons from human pluripotent stem cells as early as 6 days after transgene activation. When combined with the basic helix-loop-helix transcription factor NeuroD1, these factors could also convert fetal and postnatal human fibroblasts into iN cells showing typical neuronal morphologies and expressing multiple neuronal markers, even after downregulation of the exogenous transcription factors. Importantly, the vast majority of human iN cells were able to generate action potentials and many matured to receive synaptic contacts when co-cultured with primary mouse cortical neurons. Our data demonstrate that non-neural human somatic cells, as well as pluripotent stem cells, can be converted directly into neurons by lineage-determining transcription factors. These methods may facilitate robust generation of patient-specific human neurons for in vitro disease modelling or future applications in regenerative medicine.	[Yang, Nan; Vierbuchen, Thomas; Ostermeier, Austin; Fuentes, Daniel R.; Yang, Troy Q.; Sebastiano, Vittorio; Marro, Samuele; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Vierbuchen, Thomas; Ostermeier, Austin; Wernig, Marius] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Citri, Ami] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, 265 Campus Dr, Stanford, CA 94305 USA.	wernig@stanford.edu	Pang, Zhiping/AAF-5757-2020; Citri, Ami/R-8973-2019; Yang, Nan/H-3174-2012; Marro, Samuele G./I-4493-2014	Citri, Ami/0000-0002-9914-0278; Marro, Samuele G./0000-0002-9326-6945; Yang, Nan/0000-0003-3663-1288; Fuentes, Daniel/0000-0002-0412-6933; Pang, Zhiping/0000-0002-6183-1233; Vierbuchen, Thomas/0000-0002-5690-5680	Institute for Stem Cell Biology and Regenerative Medicine at Stanford; Ellison Medical Foundation; Stinehard-Reed Foundation; Donald E. and Delia B. Baxter Foundation; NIH [1R01MH092931, RC4NS073015]; New York Stem Cell Foundation; NARSAD Young Investigator Awards; Ruth and Robert Halperin Stanford Graduate Fellowship; AXA research fund; BioX Undergraduate Fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	Institute for Stem Cell Biology and Regenerative Medicine at Stanford; Ellison Medical Foundation(Lawrence Ellison Foundation); Stinehard-Reed Foundation; Donald E. and Delia B. Baxter Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NARSAD Young Investigator Awards(NARSAD); Ruth and Robert Halperin Stanford Graduate Fellowship; AXA research fund; BioX Undergraduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Y. Kokubu for technical assistance in molecular cloning and Y. Zhang for assistance in iPS cell induced neuron culture. We also thank Y. Sun for providing the microRNAs expression lentiviral vectors and S. Majumder for the REST-VP16 construct. This work was enabled by start-up funds from the Institute for Stem Cell Biology and Regenerative Medicine at Stanford (M. W.), the Ellison Medical Foundation (M. W.), the Stinehard-Reed Foundation (M. W.), the Donald E. and Delia B. Baxter Foundation (M. W.), the NIH grants 1R01MH092931 (M. W. and T. C. S.) and RC4NS073015 (M. W.), and a Robertson Investigator Award from the New York Stem Cell Foundation. Z.P.P. is supported by 2008 and 2010 NARSAD Young Investigator Awards. T. V. is supported by the Ruth and Robert Halperin Stanford Graduate Fellowship. A. C. is supported by the AXA research fund and D. R. F. is supported by BioX Undergraduate Fellowship.	BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	27	862	920	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					220	U122		10.1038/nature10202	http://dx.doi.org/10.1038/nature10202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21617644	Green Accepted			2022-12-01	WOS:000293731900039
J	Lobell, DB; Schlenker, W; Costa-Roberts, J				Lobell, David B.; Schlenker, Wolfram; Costa-Roberts, Justin			Climate Trends and Global Crop Production Since 1980	SCIENCE			English	Article							YIELD; TEMPERATURE; FOOD	Efforts to anticipate how climate change will affect future food availability can benefit from understanding the impacts of changes to date. We found that in the cropping regions and growing seasons of most countries, with the important exception of the United States, temperature trends from 1980 to 2008 exceeded one standard deviation of historic year-to-year variability. Models that link yields of the four largest commodity crops to weather indicate that global maize and wheat production declined by 3.8 and 5.5%, respectively, relative to a counterfactual without climate trends. For soybeans and rice, winners and losers largely balanced out. Climate trends were large enough in some countries to offset a significant portion of the increases in average yields that arose from technology, carbon dioxide fertilization, and other factors.	[Lobell, David B.; Costa-Roberts, Justin] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Lobell, David B.; Costa-Roberts, Justin] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA; [Schlenker, Wolfram] Columbia Univ, Dept Econ, New York, NY 10027 USA; [Schlenker, Wolfram] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Schlenker, Wolfram] Natl Bur Econ Res, New York, NY 10016 USA	Stanford University; Stanford University; Columbia University; Columbia University; National Bureau of Economic Research	Lobell, DB (corresponding author), Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA.	dlobell@stanford.edu		Lobell, David/0000-0002-5969-3476	Rockefeller Foundation; NASA [NNX08AV25G]; NSF [SES-0962625]	Rockefeller Foundation; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank five anonymous reviewers for helpful comments. Supported by a grant from the Rockefeller Foundation, NASA new investigator grant NNX08AV25G (D.B.L.), and NSF grant SES-0962625.	Ainsworth EA, 2008, NEW PHYTOL, V179, P5, DOI 10.1111/j.1469-8137.2008.02500.x; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Estrella N, 2007, GLOBAL CHANGE BIOL, V13, P1737, DOI 10.1111/j.1365-2486.2007.01374.x; Goswami BN, 2006, SCIENCE, V314, P1442, DOI 10.1126/science.1132027; Hertel TW, 2010, GLOBAL ENVIRON CHANG, V20, P577, DOI 10.1016/j.gloenvcha.2010.07.001; Kalra N, 2008, CURR SCI INDIA, V94, P82; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Reilly J, 2000, CLIMATIC CHANGE, V45, P253, DOI 10.1023/A:1005669807945; Reilly J, 1996, CLIMATE CHANGE 1995, P429; Roberts M J, 2010, 15921 NBER; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Solomon S., 2007, ADV CLIM CHANG RES; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107	22	2183	2342	77	1397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					616	620		10.1126/science.1204531	http://dx.doi.org/10.1126/science.1204531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21551030				2022-12-01	WOS:000293222400058
J	Sanderson, MJ; McMahon, MM; Steel, M				Sanderson, Michael J.; McMahon, Michelle M.; Steel, Mike			Terraces in Phylogenetic Tree Space	SCIENCE			English	Article							MIXED MODELS; ALGORITHMS; INFERENCE	A key step in assembling the tree of life is the construction of species-rich phylogenies from multilocus-but often incomplete-sequence data sets. We describe previously unknown structure in the landscape of solutions to the tree reconstruction problem, comprising sometimes vast "terraces" of trees with identical quality, arranged on islands of phylogenetically similar trees. Phylogenetic ambiguity within a terrace can be characterized efficiently and then ameliorated by new algorithms for obtaining a terrace's maximum-agreement subtree or by identifying the smallest set of new targets for additional sequencing. Algorithms to find optimal trees or estimate Bayesian posterior tree distributions may need to navigate strategically in the neighborhood of large terraces in tree space.	[Sanderson, Michael J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [McMahon, Michelle M.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Steel, Mike] Univ Canterbury, Allan Wilson Ctr Mol Ecol & Evolut, Christchurch 1, New Zealand	University of Arizona; University of Arizona; University of Canterbury	Sanderson, MJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	sanderm@email.arizona.edu		Steel, Mike/0000-0001-7015-4644	NSF [0829674]	NSF(National Science Foundation (NSF))	Thanks to C. Ane, M. Bordewich, D. Bryant, D. Fernandez-Baca, M. Nachman, B. O'Meara, and C. Semple for helpful comments. This work was supported by NSF award 0829674 (to M.J.S. and M. M. M.). All data used in this paper were obtained from GenBank or TreeBASE and are detailed in the Supporting Online Material.	AHO AV, 1981, SIAM J COMPUT, V10, P405, DOI 10.1137/0210030; Amir A, 1997, SIAM J COMPUT, V26, P1656, DOI 10.1137/S0097539794269461; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bordewich M, 2003, THESIS U OXFORD; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bryant D., 2003, BIOCONSENSUS, P163; CONSTANTINESCU M, 1995, J CLASSIF, V12, P101, DOI 10.1007/BF01202270; DAY WHE, 1985, J CLASSIF, V2, P7, DOI 10.1007/BF01908061; Felsenstein J., 2004, INFERRING PHYLOGENIE; MADDISON DR, 1991, SYST ZOOL, V40, P315, DOI 10.2307/2992325; McDade LA, 2008, AM J BOT, V95, P1136, DOI 10.3732/ajb.0800096; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mossel E, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P384; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salter LA, 2001, SYST BIOL, V50, P970, DOI 10.1080/106351501753462902; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Semple C, 2003, DISCRETE APPL MATH, V127, P489, DOI 10.1016/S0166-218X(02)00250-0; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; Whelan S, 2010, MOL BIOL EVOL, V27, P2674, DOI 10.1093/molbev/msq163	23	73	73	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					448	450		10.1126/science.1206357	http://dx.doi.org/10.1126/science.1206357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21680810				2022-12-01	WOS:000292959600044
J	Zhou, Y; Cashman, TJ; Nevis, KR; Obregon, P; Carney, SA; Liu, Y; Gu, AH; Mosimann, C; Sondalle, S; Peterson, RE; Heideman, W; Burns, CE; Burns, CG				Zhou, Yong; Cashman, Timothy J.; Nevis, Kathleen R.; Obregon, Pablo; Carney, Sara A.; Liu, Yan; Gu, Aihua; Mosimann, Christian; Sondalle, Samuel; Peterson, Richard E.; Heideman, Warren; Burns, Caroline E.; Burns, C. Geoffrey			Latent TGF-beta binding protein 3 identifies a second heart field in zebrafish	NATURE			English	Article							ARTERIAL POLE; OUTFLOW TRACT; GROWTH; CELLS; DIFFERENTIATION; ORIGIN	The four-chambered mammalian heart develops from two fields of cardiac progenitor cells distinguished by their spatiotemporal patterns of differentiation and contributions to the definitive heart(1-3). The first heart field differentiates earlier in lateral plate mesoderm, generates the linear heart tube and ultimately gives rise to the left ventricle. The second heart field (SHF) differentiates later in pharyngeal mesoderm, elongates the heart tube, and gives rise to the outflow tract and much of the right ventricle. Because hearts in lower vertebrates contain a rudimentary outflow tract but not a right ventricle(4), the existence and function of SHF-like cells in these species has remained a topic of speculation(4-10). Here we provide direct evidence from Cre/Lox-mediated lineage tracing and loss-of-function studies in zebrafish, a lower vertebrate with a single ventricle, that latent TGF-beta binding protein 3 (ltbp3) transcripts mark a field of cardiac progenitor cells with defining characteristics of the anterior SHF in mammals. Specifically, ltbp3(+) cells differentiate in pharyngeal mesoderm after formation of the heart tube, elongate the heart tube at the outflow pole, and give rise to three cardiovascular lineages in the outflow tract and myocardium in the distal ventricle. In addition to expressing Ltbp3, a protein that regulates the bioavailability of TGF-beta ligands(11), zebrafish SHF cells co-express nkx2.5, an evolutionarily conserved marker of cardiac progenitor cells in both fields(4). Embryos devoid of ltbp3 lack the same cardiac structures derived from ltbp3(+) cells due to compromised progenitor proliferation. Furthermore, small-molecule inhibition of TGF-beta signalling phenocopies the ltbp3-morphant phenotype whereas expression of a constitutively active TGF-beta type I receptor rescues it. Taken together, our findings uncover a requirement for ltbp3-TGF-beta signalling during zebrafish SHF development, a process that serves to enlarge the single ventricular chamber in this species.	[Zhou, Yong; Cashman, Timothy J.; Nevis, Kathleen R.; Obregon, Pablo; Gu, Aihua; Sondalle, Samuel; Burns, Caroline E.; Burns, C. Geoffrey] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Zhou, Yong; Cashman, Timothy J.; Nevis, Kathleen R.; Obregon, Pablo; Liu, Yan; Gu, Aihua; Mosimann, Christian; Sondalle, Samuel; Burns, Caroline E.; Burns, C. Geoffrey] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Carney, Sara A.; Peterson, Richard E.; Heideman, Warren] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Liu, Yan] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA 02129 USA; [Gu, Aihua] Nanjing Med Univ, Sch Publ Hlth, Nanjing 210029, Peoples R China; [Mosimann, Christian] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Mosimann, Christian] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Sondalle, Samuel; Burns, Caroline E.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts General Hospital; Nanjing Medical University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University	Burns, CE (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.	cburns6@partners.org; gburns@cvrc.mgh.harvard.edu	Sondalle, Samuel/C-1283-2014; Cashman, Tim/M-7738-2019	Sondalle, Samuel/0000-0002-4144-9897; Mosimann, Christian/0000-0002-0749-2576; Cashman, Timothy/0000-0001-6238-129X	NIH, National Institute of Environmental Health Sciences [R01 ES012716]; EMBO long-term fellowship; HFSP long-term fellowship; Cardiovascular Research Center at Massachusetts General Hospital; Claflin Distinguished Scholar Award; Harvard Stem Cell Institute; National Heart Lung and Blood Institute [5R01HL096816]; American Heart Association [10GRNT4270021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); HFSP long-term fellowship; Cardiovascular Research Center at Massachusetts General Hospital; Claflin Distinguished Scholar Award; Harvard Stem Cell Institute; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Whitman for advice on pSmad2 staining, D. Hami and M. Kirby for providing Eln2 antisera and their immunohistochemistry protocol, R. Cornell for providing tfAP2a and tfAP2c morpholinos, M. Whitman, A. Srinivasan, D. Langenau, E. Provost, S. Leach, R. Anderson, D. Stainier, I. Woods, and A. Schier for providing plasmids. J. W. Xiong for providing clo<SUP>m39</SUP> fish, B. Barut and L. Zon for providing bacterial artificial chromosomes (BACs), and the MGH Nephrology Division for access to their confocal microscopy facilities. S. C., R. E. P. and W. H. were supported by NIH grant R01 ES012716 from the National Institute of Environmental Health Sciences. C. M. received support through an EMBO long-term fellowship and an HFSP long-term fellowship. This work was funded by the Cardiovascular Research Center at Massachusetts General Hospital, a Claflin Distinguished Scholar Award and Harvard Stem Cell Institute Seed Grant to C. E. B., and by awards from the National Heart Lung and Blood Institute (5R01HL096816), American Heart Association (Grant in Aid no. 10GRNT4270021), and Harvard Stem Cell Institute (Seed Grant) to C. G. B.	Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen JN, 1997, DEVELOPMENT, V124, P4373; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; Grimes AC, 2010, EVOL DEV, V12, P552, DOI 10.1111/j.1525-142X.2010.00441.x; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Kang J, 2009, DEV BIOL, V334, P513, DOI 10.1016/j.ydbio.2009.06.041; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Li HY, 2006, J MED CHEM, V49, P2138, DOI 10.1021/jm058209g; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Miao M, 2007, MATRIX BIOL, V26, P115, DOI 10.1016/j.matbio.2006.09.011; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE	24	173	173	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					645	648		10.1038/nature10094	http://dx.doi.org/10.1038/nature10094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21623370	Green Accepted			2022-12-01	WOS:000292204300040
J	Brotherton, JML; Fridman, M; May, CL; Chappell, G; Saville, AM; Gertig, DM				Brotherton, Julia M. L.; Fridman, Masha; May, Cathryn L.; Chappell, Genevieve; Saville, A. Marion; Gertig, Dorota M.			Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study	LANCET			English	Article							PREDICTED IMPACT; PAPILLOMAVIRUS; LESIONS	Background Australia introduced a human papillomavirus (HPV) vaccination programme with the quadrivalent HPV vaccine for all women aged 12-26 years between 2007 and 2009. We analysed trends in cervical abnormalities in women in Victoria, Australia, before and after introduction of the vaccination programme. Methods With data from the Victorian Cervical Cytology Registry between 2003 and 2009, we compared the incidence of histopathologically defined high-grade cervical abnormalities (HGAs, lesions coded as cervical intraepithelial neoplasia of grade 2 or worse or adenocarcinoma in situ; primary outcome) and low-grade cytological abnormalities (LGAs) in five age groups before (Jan 1, 2003, to March 31, 2007) and after (April 1, 2007, to Dec 31, 2009) the vaccination programme began. Binary comparisons between the two periods were done with Fisher's exact test. Poisson piecewise regression analysis was used to compare incident rate trends. Findings After the introduction of the vaccination programme, we recorded a decrease in the incidence of HGAs by 0.38% (95% CI 0.61-0.16) in girls younger than 18 years. This decrease was progressive and significantly different to the linear trend in incidence before introduction of the vaccination (incident rate ratio 1.14, 1.00-1.30, p=0.05). No similar temporal decline was recorded for LGAs or in older age groups. Interpretation This is the first report of a decrease in incidence of HGAs within 3 years after the implementation of a population-wide HPV vaccination programme. Linkage between vaccination and screening registers is needed to confirm that this ecological observation is attributable to vaccination and to monitor participation in screening among vaccinated women.	[Brotherton, Julia M. L.; May, Cathryn L.; Chappell, Genevieve; Saville, A. Marion; Gertig, Dorota M.] Victorian Cytol Serv, Victorian Cytol Serv Registries, Melbourne, Vic 8002, Australia; [Fridman, Masha] Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia		Brotherton, JML (corresponding author), Victorian Cytol Serv, Victorian Cytol Serv Registries, POB 310, Melbourne, Vic 8002, Australia.	jbrother@vcs.org.au	Gertig, Dorota/Z-1087-2019		Australian Research Council; CSL Biotherapies; GlaxoSmithKline; Victorian Government	Australian Research Council(Australian Research Council); CSL Biotherapies; GlaxoSmithKline(GlaxoSmithKline); Victorian Government	JMLB, DMG, and MS are investigators on an Australian Research Council Linkage Grant, for which CSL Biotherapies is a partner organisation. JMLB was an investigator on a national HPV prevalence study that received partial, equal, and unrestricted funding from CSL Biotherapies and GlaxoSmithKline. GC, MF, and CLM declare that they have no conflicts of interest.; We thank Grace Zampogna (VCCR) for her assistance with variable definitions and appreciate the methodological advice received from Ian Gordon (Statistical Consulting Centre, University of Melbourne, Victoria, Australia), Karen Canfell (NSW Cancer Council, NSW, Australia), and Carolyn Nickson (University of Melbourne, Victoria, Australia). The VCCR is fully funded by the Victorian Government and operated by the Victorian Cytology Service.	Asghari S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-62; [Australian Institute of Health and Welfare Australasian Association of Cancer Registries], 2008, CANC SER AIHW; Australian Institute of Health and Welfare, 2010, CANC SER AIHW; Australian Institute of Health and Welfare, 2008, NAT CERV SCREEN PROG; Brameld KJ, 2003, INT J EPIDEMIOL, V32, P617, DOI 10.1093/ije/dyg191; Brotherton JML, WILL YOUNG WOMEN HAV; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Constantine R, 2008, PSYCHIAT SERV, V59, P1162, DOI 10.1176/appi.ps.59.10.1162; Cuzick J, 2010, BRIT J CANCER, V102, P933, DOI 10.1038/sj.bjc.6605528; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Frazer, 2020, GUIDELINES MANAGEMEN; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Heley S, 2009, AUST FAM PHYSICIAN, V38, P977; Immunise Australia Program, HUM PAP HPV; Kreimer AR, PROOF OF PRINCIPLE E; Kurman R.J., 1994, BETHESDA SYSTEM REPO; Levy-Bruhl D, 2009, EUR J CANCER, V45, P2709, DOI 10.1016/j.ejca.2009.07.023; Mao C, 2006, OBSTET GYNECOL, V107, P1425; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Sellors J, HPV VACCINATION DEV; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith MA, 2008, INT J CANCER, V123, P1854, DOI 10.1002/ijc.23633; Tota J, 2010, SEX HEALTH, V7, P376, DOI 10.1071/SH10022; [UCLA Academic Technology Services SCG], STAT FAQ CAN I RUN P; Victorian Cervical Cytology Registry, 2009, VICT CERV CYT REG ST; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; World Health Organization, 2009, M HPV VACC COV IMP M	29	356	364	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2085	2092		10.1016/S0140-6736(11)60551-5	http://dx.doi.org/10.1016/S0140-6736(11)60551-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	783XI	21684381				2022-12-01	WOS:000292117800030
J	Bell, G; Gonzalez, A				Bell, Graham; Gonzalez, Andrew			Adaptation and Evolutionary Rescue in Metapopulations Experiencing Environmental Deterioration	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXTINCTION; POPULATIONS; GENETICS; RANGES	It is not known whether evolution will usually be rapid enough to allow a species to adapt and persist in a deteriorating environment. We tracked the eco-evolutionary dynamics of metapopulations with a laboratory model system of yeast exposed to salt stress. Metapopulations experienced environmental deterioration at three different rates and their component populations were either unconnected or connected by local dispersal or by global dispersal. We found that adaptation was favored by gradual deterioration and local dispersal. After further abrupt deterioration, the frequency of evolutionary rescue depended on both the prior rate of deterioration and the rate of dispersal. Adaptation was surprisingly frequent and rapid in small peripheral populations. Thus, evolutionary dynamics affect both the persistence and the range of a species after environmental deterioration.	[Bell, Graham; Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Gonzalez, A (corresponding author), McGill Univ, Dept Biol, 1205 Ave Docteur Penfield, Montreal, PQ H3A 1B1, Canada.	andrew.gonzalez@mcgill.ca	Gonzalez, Andrew/F-2247-2010	Gonzalez, Andrew/0000-0001-6075-8081	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canada Research Chair Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chair Program(Canada Research Chairs)	The robot was programmed and operated by Z. M. Wang, assisted by A.-M. LeHeureux. G. B. and A. G. are supported by funding from the Natural Sciences and Engineering Research Council of Canada and by the Canadian Foundation for Innovation. A. G. is supported by the Canada Research Chair Program. We thank two anonymous reviewers for comments that improved the manuscript.	Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI [10.1111/j.1558-5646.1984.tb00380.x, 10.2307/2408444]; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Samani P, 2010, J EVOLUTION BIOL, V23, P791, DOI 10.1111/j.1420-9101.2010.01945.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100	23	240	241	4	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1327	1330		10.1126/science.1203105	http://dx.doi.org/10.1126/science.1203105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659606				2022-12-01	WOS:000291441700046
J	Fujisaki, J; Wu, J; Carlson, AL; Silberstein, L; Putheti, P; Larocca, R; Gao, WD; Saito, TI; Lo Celso, C; Tsuyuzaki, H; Sato, T; Cote, D; Sykes, M; Strom, TB; Scadden, DT; Lin, CP				Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Silberstein, Lev; Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Saito, Toshiki I.; Lo Celso, Cristina; Tsuyuzaki, Hitoshi; Sato, Tatsuyuki; Cote, Daniel; Sykes, Megan; Strom, Terry B.; Scadden, David T.; Lin, Charles P.			In vivo imaging of T-reg cells providing immune privilege to the haematopoietic stem-cell niche	NATURE			English	Article							BONE-MARROW NICHE; ENGRAFTMENT	Stem cells reside in a specialized regulatory microenvironment or niche(1,2), where they receive appropriate support for maintaining self-renewal and multi-lineage differentiation capacity(1-3). The niche may also protect stem cells from environmental insults(3) including cytotoxic chemotherapy and perhaps pathogenic immunity(4). The testis, hair follicle and placenta are all sites of residence for stem cells and are immune-suppressive environments, called immune-privileged sites, where multiple mechanisms cooperate to prevent immune attack, even enabling prolonged survival of foreign allografts without immunosuppression(4). We sought to determine if somatic stem-cell niches more broadly are immune-privileged sites by examining the haematopoietic stem/progenitor cell (HSPC) niche(1,2,5-7) in the bone marrow, a site where immune reactivity exists(8,9). We observed persistence of HSPCs from allogeneic donor mice (allo-HSPCs) in non-irradiated recipient mice for 30 days without immunosuppression with the same survival frequency compared to syngeneic HSPCs. These HSPCs were lost after the depletion of FoxP3 regulatory T (T-reg) cells. High-resolutionin vivo imaging over time demonstrated marked co-localization of HSPCs with T-reg cells that accumulated on the endosteal surface in the calvarial and trabecular bone marrow. T-reg cells seem to participate in creating a localized zone where HSPCs reside and where T-reg cells are necessary for allo-HSPC persistence. In addition to processes supporting stem-cell function, the niche will provide a relative sanctuary from immune attack.	[Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Adv Microscopy Program, Boston, MA 02114 USA; [Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Fujisaki, Joji; Wu, Juwell; Silberstein, Lev; Lo Celso, Cristina; Scadden, David T.; Lin, Charles P.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Wu, Juwell] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Silberstein, Lev; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Strom, Terry B.] Beth Israel Deaconess Med Ctr, Inst Transplantat, Boston, MA 02215 USA; [Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Strom, Terry B.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Saito, Toshiki I.; Sykes, Megan] Massachusetts Gen Hosp E, Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Bone Marrow Transplantat Sect, Boston, MA 02129 USA; [Tsuyuzaki, Hitoshi; Sato, Tatsuyuki] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Cote, Daniel] Dept Phys Genie Phys & Opt, Quebec City, PQ G1J 2G3, Canada; [Cote, Daniel] Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ G1J 2G3, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; University of Tokyo; Laval University	Fujisaki, J (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Adv Microscopy Program, CPZN 8238,185 Cambridge St, Boston, MA 02114 USA.	jfujisaki@partners.org; lin@helix.mgh.harvard.edu	Assumpcao Larocca, Rafael/H-1655-2015; Sato, Tatsuyuki/V-8183-2019; Côté, Daniel/D-5185-2011; Larocca, Rafael/J-9557-2012	Assumpcao Larocca, Rafael/0000-0002-9995-1804; Sato, Tatsuyuki/0000-0002-9229-9016; Lo Celso, Cristina/0000-0002-1163-4207	Bullock fellowship; Harvard Stem Cell Institute; DoD [W81XWH-10-1-0217]; NIH [HL097748, HL97794, CA111519, AI041521]; EMBO; HFSP; philanthropic sources; Medical Research Council [G0600698B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA111519] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097794, R01HL097748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748, P01AI041521] Funding Source: NIH RePORTER	Bullock fellowship; Harvard Stem Cell Institute; DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); philanthropic sources; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Bullock fellowship (to J.F.), the Harvard Stem Cell Institute and DoD W81XWH-10-1-0217 (to J.F. and C.P.L.), NIH HL097748 (to C.P.L.), HL97794 (to D.T.S.), CA111519 (to M.S.), AI041521 (to T.B.S), EMBO (to C.L.C.), HFSP (to C.L.C.), philanthropic sources (to D.T.S. and C.L.C.), and the National Institutes of Health. We acknowledge J. Zhao and D. Cao for cell sorting.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Huang YM, 2004, BLOOD, V104, P873, DOI 10.1182/blood-2003-11-3910; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	19	384	398	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					216	U256		10.1038/nature10160	http://dx.doi.org/10.1038/nature10160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654805	Green Accepted			2022-12-01	WOS:000291397800051
J	Reichenheim, ME; de Souza, ER; Moraes, CL; Jorge, MHPD; da Silva, CMFP; Minayo, MCD				Reichenheim, Michael Eduardo; de Souza, Edinilsa Ramos; Moraes, Claudia Leite; Prado de Mello Jorge, Maria Helena; Furtado Passos da Silva, Cosme Marcelo; de Souza Minayo, Maria Cecilia			Health in Brazil 5 Violence and injuries in Brazil: the effect, progress made, and challenges ahead	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; SEVERE PHYSICAL PUNISHMENT; DOMESTIC VIOLENCE; MENTAL-HEALTH; ELDER ABUSE; RISK-FACTORS; SAO-PAULO; CHILDREN; POPULATION; PREVALENCE	Although there are signs of decline, homicides and traffic-related injuries and deaths in Brazil account for almost two-thirds of all deaths from external causes. In 2007, the homicide rate was 26.8 per 100 000 people and traffic-related mortality was 23.5 per 100 000. Domestic violence might not lead to as many deaths, but its share of violence-related morbidity is large. These are important public health problems that lead to enormous individual and collective costs. Young, black, and poor men are the main victims and perpetrators of community violence, whereas poor black women and children are the main victims of domestic violence. Regional differentials are also substantial. Besides the sociocultural determinants, much of the violence in Brazil has been associated with the misuse of alcohol and illicit drugs, and the wide availability of firearms. The high traffic-related morbidity and mortality in Brazil have been linked to the chosen model for the transport system that has given priority to roads and private-car use without offering adequate infrastructure. The system is often poorly equipped to deal with violations of traffic rules. In response to the major problems of violence and injuries, Brazil has greatly advanced in terms of legislation and action plans. The main challenge is to assess these advances to identify, extend, integrate, and continue the successful ones.	[Reichenheim, Michael Eduardo; Moraes, Claudia Leite] Univ Estado Rio de Janeiro, Inst Social Med, Dept Epidemiol, BR-20559900 Rio De Janeiro, Brazil; [de Souza, Edinilsa Ramos; de Souza Minayo, Maria Cecilia] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Latin Amer Ctr Studies Violence & Hlth CLAVES, Rio De Janeiro, Brazil; [Moraes, Claudia Leite] Estacio de Sa Univ, Rio De Janeiro, Brazil; [Prado de Mello Jorge, Maria Helena] Univ Sao Paulo, Publ Hlth Fac, Dept Epidemiol, Sao Paulo, Brazil; [Furtado Passos da Silva, Cosme Marcelo] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Reichenheim, ME (corresponding author), Univ Estado Rio de Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524,7 Andar, BR-20559900 Rio De Janeiro, Brazil.	michael@ims.uerj.br	Moraes, claudia/AAK-9418-2020; Seguranca Publica, Inct/I-2423-2013	Moraes, claudia/0000-0002-3223-1634; 	Brazilian National Research Council (CNPq) [PQ-301221/2009-0, PQ-300515/2009-0, PQ-302851/2008-9, PQ-310503/2009-4]; Rio de Janeiro State Research Foundation (FAPERJ) [E-26/101.461/2010]; Health Surveillance Secretariat (Secretaria de Vigilancia em Saude) of the Brazilian Ministry of Health; INCa	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Health Surveillance Secretariat (Secretaria de Vigilancia em Saude) of the Brazilian Ministry of Health; INCa(Institut National du Cancer (INCA) France)	MER, ERS, CLM and MHPMJ were supported by the Brazilian National Research Council (CNPq), grants PQ-301221/2009-0, PQ-300515/2009-0, PQ-302851/2008-9 and PQ-310503/2009-4, respectively. CLM was also supported by grant E-26/101.461/2010 from the Rio de Janeiro State Research Foundation (FAPERJ). We are grateful to the National Cancer Institute (CONPREV/INCa) for providing data of the Household Survey on Risk Behaviors and Reported Morbidity from Non-Communicable Diseases used in some analyses (intimate-partner violence). This survey was financed by the Health Surveillance Secretariat (Secretaria de Vigilancia em Saude) of the Brazilian Ministry of Health, with counterpart funds from INCa. We thank Tatiana Ribeiro for her collaboration in organising the references and Christopher Peterson for his meticulous Portuguese-to-English translation.	Adorno S., 1993, BIB, V35, P3; ALFONSO R, 2003, PSIKHE, V8, P31; Anacleto AJ, 2009, CAD SAUDE PUBLICA, V25, P800, DOI 10.1590/S0102-311X2009000400011; [Anonymous], 1999, ENDING VIOLENCE WOME; ASSIS SG, 2003, VIOLENCIA SOB OLHAR, P163; Barata Rita Barradas, 2008, Rev. bras. epidemiol., V11, P3, DOI 10.1590/S1415-790X2008000100001; Beato CCFilho, 2007, HOMICIDIOS BRASIL, P177; Bordin IA, 2009, B WORLD HEALTH ORGAN, V87, P336, DOI 10.2471/BLT.07.043125; CAMARA P, 1999, REV ABRAMET, V30, P31; CAMPOS A, 2009, EVOLUCAO OCUPACAO SI; CANO I, 2007, BATITUCCI ECO, P51; CARDIA N, 1999, ATITUDES NORMAS CULT; Cecchetto F. R., 2004, VIOLENCIA ESTILOS MA; CERQUEIRA DRC, 2007, ANALISE CUSTOS CONSE; Comijs HC, 1998, J AM GERIATR SOC, V46, P885, DOI 10.1111/j.1532-5415.1998.tb02724.x; *CONS NAC DES CIEN, DIR GRUP PESQ COL DA; de Assis SG, 2009, CIENC SAUDE COLETIVA, V14, P349, DOI 10.1590/S1413-81232009000200002; De Micheli D, 2004, ADDICTION, V99, P570, DOI 10.1111/j.1360-0443.2003.00671.x; de Moraes CL, 2008, CAD SAUDE PUBLICA, V24, P2289, DOI 10.1590/S0102-311X2008001000010; de Souza ER, 2010, PSYCHOL RES PROG, P1; DUARTE PCA, 2000, ALCOOL VIOLENCIA EST, P61; FARIA L, 2006, CURINGA, V22, P183; Audi CAF, 2008, J PEDIAT-BRAZIL, V84, P60, DOI 10.2223/JPED.1744; FERRAZ SM, 2004, IMPULSO REV CIENCIAS, V15, P79; Galduróz José Carlos F, 2004, Rev. Bras. Psiquiatr., V26, P3, DOI 10.1590/S1516-44462004000500002; Gawryszewski VP, 2008, REV PANAM SALUD PUBL, V24, P400, DOI 10.1590/S1020-49892008001200004; Goncalves HS, 1999, REV SAUDE PUBL, V33, P547, DOI 10.1590/S0034-89101999000600005; *GOV RIO JAN, 2010, UN PAC; Hasselmann MH, 2006, PAEDIATR PERINAT EP, V20, P299, DOI 10.1111/j.1365-3016.2006.00735.x; Hasselmann Maria Helena, 2003, Cad. Saúde Pública, V19, P1083, DOI 10.1590/S0102-311X2003000400030; *I AVON, 2009, PESQ I AVON IBOPE PE; *I BRAS GEOGR EST, PESQ NAC AM DOM; *I NAC CANC COORD, 2003, INQ DOM COMP RISC MO; *I PESQ EC APL, 2006, IMP SOC EC AC TRANS; Silva MAI, 2007, REV LAT-AM ENFERM, V15, P275, DOI 10.1590/S0104-11692007000200013; JARDIM V, 2009, REV ABRAMET, V27, P48; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; JORGE MM, 2007, ACIDENTES TRANSITO B; KOIZUMI M, 2007, REV ABRAMET, V25, P12; Laurenti R, 1972, Rev Saude Publica, V6, P329, DOI 10.1590/S0034-89101972000400003; LIMA D, 2001, REV ABRAMET, V37, P44; Ludermir AB, 2008, SOC SCI MED, V66, P1008, DOI 10.1016/j.socscimed.2007.10.021; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; MALTA D, 2009, ATENDIMENTOS SAMU 19; Malta DC, 2010, EPIDEMIOL SERV SAUDE, V19, P77; MATIELO F, 2002, REV ABRAMET, V20, P14; Mello Jorge MHP, 2009, REV ABRAMET, V27, P16; Mello Jorge MHP, 1979, THESIS U SAO PAULO S; Melo Victor Lopes de, 2006, Rev. Bras. Saude Mater. Infant., V6, ps43, DOI 10.1590/S1519-38292006000500006; *MIN SAUD, SERV AT MOV URG SAMU; *MIN SAUD, 2010, PROGR SAUD FAM; *MIN SAUD, SIST VIG VIOL AC; *MIN SAUD, 2001, PORT GM MS 737 DE 16; *MIN SAUD, SIST INF HOSP; Minayo M C, 1993, Cad Saude Publica, V9, P65; Minayo Maria Cecília de Souza, 2003, Cad. Saúde Pública, V19, P783, DOI 10.1590/S0102-311X2003000300010; Ministerio da Saude, SIST INF MORT; Moraes CL, 2006, INT J GYNECOL OBSTET, V95, P254, DOI 10.1016/j.ijgo.2006.08.015; Moraes CL, 2002, INT J GYNECOL OBSTET, V79, P269, DOI 10.1016/S0020-7292(02)00250-3; Moraes CL, 2009, ACTA OBSTET GYN SCAN, V88, P1041, DOI 10.1080/00016340903128439; MORENO C, 2001, REV ABRAMET, V36, P17; Nadanovsky P, 2009, CAD SAUDE PUBLICA, V25, P1859, DOI 10.1590/S0102-311X2009000800022; Neri MC, 2008, NOVA CLASSE MEDIA MO; NETO GHF, 2004, J TROP MED, V50, P292; Nielsen A., 2009, CRIMINALIDADE AVANCA; O'Reilly R, 2007, CONTEMP NURSE, V25, P13, DOI 10.5172/conu.2007.25.1-2.13; OGG J, 1992, BRIT MED J, V305, P998, DOI 10.1136/bmj.305.6860.998; Organization WH, 2007, INT CLASS DIS; *PAHO, 2009, INF AN SAL SIT SAL A; Paixão Luiz Andrés Ribeiro, 2009, Econ. Apl., V13, P125, DOI 10.1590/S1413-80502009000100006; Paula CS, 2008, REV SAUDE PUBL, V42, P524, DOI 10.1590/S0034-89102008000300019; Peden M., 2004, WORLD REPORT ROAD TR; PERES M, 2006, AVALIACAO RAC REDESC; Peres MFT, 2005, REV SAUDE PUBL, V39, P58, DOI 10.1590/S0034-89102005000100008; PILLEMER K, 1988, GERONTOLOGIST, V28, P51, DOI 10.1093/geront/28.1.51; d'Oliveira AFPL, 2009, REV SAUDE PUBL, V43, P299, DOI 10.1590/S0034-89102009005000013; *PRES REP, 2006, LEI MAR PENH; RAMOS S, 2007, RESPOSTAS BRASILEIRA; Ramos Silvia, 2006, Physis, V16, P185, DOI 10.1590/S0103-73312006000200004; Rede Interagencial de Informacao para a Saude, 2008, IND BAS SAUD BRAS CO, V2a; Reichenheim ME, 2008, PUBLIC HEALTH, V122, P716, DOI 10.1016/j.puhe.2007.09.016; Reichenheim Michael Eduardo, 2006, Cad. Saúde Pública, V22, P425, DOI 10.1590/S0102-311X2006000200020; Reichenheim ME, 2006, REV SAUDE PUBL, V40, P595, DOI 10.1590/S0034-89102006000500007; Rickert VI, 2002, AM J OBSTET GYNECOL, V187, P1002, DOI 10.1067/mob.2002.126649; ROCHA PCX, CIEN SAUDE IN PRESS; Rondon V., 2003, ECONOMIA, V4, P223; Bordin IAS, 2006, REV BRAS PSIQUIATR, V28, P290, DOI 10.1590/S1516-44462006000700008; SANTOS VIM, 1978, REV ASSOC MED BRAS, V24, P255; *SECR ESP DIR HUM, 2010, OBS NAC ID; *SECR ESP POL MULH, 2007, ENFR VIOL MULH BAL A; *SECR ESP POL MULH, 2010, OBS BRAS IG GEN; Silva Iracema Viterbo, 2003, Cad. Saúde Pública, V19, pS263, DOI 10.1590/S0102-311X2003000800008; de Moura ATMS, 2008, CAD SAUDE PUBLICA, V24, P2926, DOI 10.1590/S0102-311X2008001200022; Souza Edinilsa Ramos de, 2005, Ciênc. saúde coletiva, V10, P59, DOI 10.1590/S1413-81232005000100012; SOUZA ER, 2001, CAD SAUDE PUBLICA, V17, P1291; SOUZA ER, 2005, IMPACTO VIOLENCIA SA, P279; SOUZA ER, 2006, AVALIACAO PROJETO LU; SOUZA ER, 2007, EPIDEMIOL SERV SAUDE, V16, P19, DOI DOI 10.5123/S1679-49742007000100003; Stefanello S, 2008, REV BRAS PSIQUIATR, V30, P139, DOI 10.1590/S1516-44462006005000063; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Szwarcwald C L, 1998, Rev Panam Salud Publica, V4, P161; Taft AJ, 2004, AUST NZ J PUBL HEAL, V28, P324, DOI 10.1111/j.1467-842X.2004.tb00438.x; TEIXEIRA PAS, 2010, DOSSIE MULHER 2010; TOLEDO F, 2004, VERIFICACAO USO COCA; Peres MFT, 2008, REV PANAM SALUD PUBL, V23, P268; *UN, 2010, 11 UN SURV CRIM TREN; Vasconcelos MM, 2005, ARQ NEURO-PSIQUIAT, V63, P68, DOI 10.1590/S0004-282X2005000100013; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Vitolo YLC, 2005, REV SAUDE PUBL, V39, P716, DOI 10.1590/S0034-89102005000500004; WAISELFISZ JJ, 2010, MAPA VIOLENCIA BRASI; WAISELFISZ JJ, 2004, MAPA VIOLENCIA, V4; Waiselfisz JJ, 2008, MAPA VIOLENCIA MUNIC; *WHO, 2008, AG STAND MORT RAT CA; WONG L, 2009, REDS INTERAGENCIAL I, P36; World Health Organization, WHO MULT STUD WOM HL; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2009, GLOBAL STATUS REPORT; Ximenes LF, 2009, CIENC SAUDE COLETIVA, V14, P417, DOI 10.1590/S1413-81232009000200011; Zaleski M, 2010, J INTERPERS VIOLENCE, V25, P648, DOI 10.1177/0886260509334396; Zaluar Alba, 2007, Estud. av., V21, P31, DOI 10.1590/S0103-40142007000300003; Zaluar Alba, 2004, INTEGRACAO PERVERSA; 2008, LEI SECA 11705 08; 2010, GLOBO           0804; 1997, CODIGO TRANSITO BRAS	124	179	183	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2011	377	9781					1962	1975		10.1016/S0140-6736(11)60053-6	http://dx.doi.org/10.1016/S0140-6736(11)60053-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777LW	21561649				2022-12-01	WOS:000291623200033
J	Bell, AM; Robinson, GE				Bell, Alison M.; Robinson, Gene E.			Behavior and the Dynamic Genome	SCIENCE			English	Editorial Material							EVOLUTION; ACCOMMODATION; GENES; FOXP2; LINK		[Bell, Alison M.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Bell, Alison M.; Robinson, Gene E.] Univ Illinois, Inst Genom Biol, Program Ecol Evolutionary Biol & Conservat, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bell, AM (corresponding author), Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA.	generobi@life.uiuc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082937] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM082937-01, R01 GM082937] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Aubret F, 2009, CURR BIOL, V19, P1932, DOI 10.1016/j.cub.2009.09.061; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1125, DOI 10.1098/rstb.2008.0285; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Baldwin J.M., 1902, DEV EVOLUTION; Bell AM, 2010, PHILOS T R SOC B, V365, P4001, DOI 10.1098/rstb.2010.0185; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Konopka G, 2010, NEURON, V68, P231, DOI 10.1016/j.neuron.2010.10.012; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; McGuigan K, 2009, TRENDS ECOL EVOL, V24, P305, DOI 10.1016/j.tree.2009.02.001; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Snell-Rood EC, 2011, EVOLUTION, V65, P231, DOI 10.1111/j.1558-5646.2010.01106.x; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; West-Eberhard Mary Jane, 2003, pi; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966	19	41	41	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1161	1162		10.1126/science.1203295	http://dx.doi.org/10.1126/science.1203295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636765	Green Accepted			2022-12-01	WOS:000291205200037
J	Warensjo, E; Byberg, L; Melhus, H; Gedeborg, R; Mallmin, H; Wolk, A; Michaelsson, K				Warensjo, Eva; Byberg, Liisa; Melhus, Hakan; Gedeborg, Rolf; Mallmin, Hans; Wolk, Alicja; Michaelsson, Karl			Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							25-HYDROXYVITAMIN D LEVELS; TOTAL-ENERGY INTAKE; BREAST-CANCER RISK; VITAMIN-D; SUPPLEMENT USE; WOMEN; QUESTIONNAIRE; OLDER; METAANALYSIS; PREVENTION	Objective To investigate associations between long term dietary intake of calcium and risk of fracture of any type, hip fractures, and osteoporosis. Design A longitudinal and prospective cohort study, based on the Swedish Mammography Cohort, including a subcohort, the Swedish Mammography Cohort Clinical. Setting A population based cohort in Sweden established in 1987. Participants 61 433 women (born between 1914 and 1948) were followed up for 19 years. 5022 of these women participated in the subcohort. Main outcome measures Primary outcome measures were incident fractures of any type and hip fractures, which were identified from registry data. Secondary outcome was osteoporosis diagnosed by dual energy x ray absorptiometry in the subcohort. Diet was assessed by repeated food frequency questionnaires. Results During follow-up, 14 738 women (24%) experienced a first fracture of any type and among them 3871 (6%) a first hip fracture. Of the 5022 women in the subcohort, 1012 (20%) were measured as osteoporotic. The risk patterns with dietary calcium were non-linear. The crude rate of a first fracture of any type was 17.2/1000 person years at risk in the lowest quintile of calcium intake, and 14.0/1000 person years at risk in the third quintile, corresponding to a multivariable adjusted hazard ratio of 1.18 (95% confidence interval 1.12 to 1.25). The hazard ratio for a first hip fracture was 1.29 (1.17 to 1.43) and the odds ratio for osteoporosis was 1.47 (1.09 to 2.00). With a low vitamin D intake, the rate of fracture in the first calcium quintile was more pronounced. The highest quintile of calcium intake did not further reduce the risk of fractures of any type, or of osteoporosis, but was associated with a higher rate of hip fracture, hazard ratio 1.19 (1.06 to 1.32). Conclusion Gradual increases in dietary calcium intake above the first quintile in our female population were not associated with further reductions in fracture risk or osteoporosis.	[Warensjo, Eva; Byberg, Liisa; Mallmin, Hans; Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden; [Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Warensjo, Eva; Byberg, Liisa; Melhus, Hakan; Gedeborg, Rolf; Michaelsson, Karl] Uppsala Univ, UCR, Uppsala Clin Res Ctr, Uppsala, Sweden; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-10401 Stockholm, Sweden	Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet	Warensjo, E (corresponding author), Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden.	eva.warensjo@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021; Gedeborg, Rolf/AAV-6702-2020	Gedeborg, Rolf/0000-0002-8850-7863; Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council [2008-2202, 2009-6281]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Supported by the Swedish Research Council, grant numbers 2008-2202 and 2009-6281. The funding source was not involved in the design, conduct or interpretation of the study, or in the writing of the submitted work.	[Anonymous], 2014, NUTR REF VAL AUSTR N; [Anonymous], 2005, NORDIC NUTR RECOMMEN; Bergstrom L., 1991, Var Foda, V43, P439; Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780; Bischoff-Ferrari HA, 2009, J BONE MINER RES, V24, P935, DOI [10.1359/JBMR.081242, 10.1359/jbmr.081242]; Bolland MJ, BMJ, V341, pc3691; Burgaz A, 2009, J INTERN MED, V266, P476, DOI 10.1111/j.1365-2796.2009.02125.x; Burgaz A, 2007, AM J CLIN NUTR, V86, P1399, DOI 10.1093/ajcn/86.5.1399; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; Cashman KD, 2007, J NUTR, V137, p2507S, DOI 10.1093/jn/137.11.2507S; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves M., 2009, ANAL MULTIPLE FAILUR; Cumming RG, 1997, J BONE MINER RES, V12, P1321, DOI 10.1359/jbmr.1997.12.9.1321; Cumming RG, 1997, AM J EPIDEMIOL, V145, P926, DOI 10.1093/oxfordjournals.aje.a009052; Feskanich D, 2003, AM J CLIN NUTR, V77, P504, DOI 10.1093/ajcn/77.2.504; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gedeborg R, 2008, EPIDEMIOLOGY, V19, P860, DOI 10.1097/EDE.0b013e318181319e; Griffith JF, 2010, ANN NY ACAD SCI, V1192, P45, DOI 10.1111/j.1749-6632.2009.05378.x; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Kaaks R, 2002, PUBLIC HEALTH NUTR, V5, P969, DOI 10.1079/PHN2002380; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; KANIS JA, 1989, BRIT MED J, V298, P205, DOI 10.1136/bmj.298.6668.205; Key TJ, 2007, PUBLIC HEALTH NUTR, V10, P1314, DOI 10.1017/S1368980007696402; Larsson SC, 2009, EUR J CANCER, V45, P3042, DOI 10.1016/j.ejca.2009.04.035; Larsson SC, 2009, AM J CLIN NUTR, V90, P556, DOI 10.3945/ajcn.2009.27480; Larsson SC, 2009, AM J CLIN NUTR, V89, P277, DOI 10.3945/ajcn.2008.26704; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; Messerer M, 2004, J NUTR, V134, P1800, DOI 10.1093/jn/134.7.1800; Michaelsson K, 2003, BONE, V32, P694, DOI 10.1016/S8756-3282(03)00048-6; NHS Choices, VIT MIN CALC; Orsini N, 2008, EUR J EPIDEMIOL, V23, P661, DOI 10.1007/s10654-008-9273-z; Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reid IR, 2008, OSTEOPOROSIS INT, V19, P1119, DOI 10.1007/s00198-008-0563-9; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Serra-Majem L, 2009, BRIT J NUTR, V102, pS38, DOI 10.1017/S0007114509993138; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; [STATA Corporation Stata Corporation], 2009, STAT REF MAN REL 11; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xu LZ, 2004, BRIT J NUTR, V91, P625, DOI 10.1079/BJN20031085; Yates AA, 1998, J AM DIET ASSOC, V98, P699, DOI 10.1016/S0002-8223(98)00160-6	44	123	125	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2011	342								d1473	10.1136/bmj.d1473	http://dx.doi.org/10.1136/bmj.d1473			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KC	21610048	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000291154600007
J	Lord, C; Bhandari, D; Menon, S; Ghassemian, M; Nycz, D; Hay, J; Ghosh, P; Ferro-Novick, S				Lord, Christopher; Bhandari, Deepali; Menon, Shekar; Ghassemian, Majid; Nycz, Deborah; Hay, Jesse; Ghosh, Pradipta; Ferro-Novick, Susan			Sequential interactions with Sec23 control the direction of vesicle traffic	NATURE			English	Article							CASEIN KINASE-I; ENDOPLASMIC-RETICULUM; COPII VESICLE; INTERMEDIATE COMPARTMENT; NEGATIVE REGULATION; PROTEIN-TRANSPORT; GOLGI TRANSPORT; COAT; COMPLEX; BINDING	How the directionality of vesicle traffic is achieved remains an important unanswered question in cell biology. The Sec23p/Sec24p coat complex sorts the fusion machinery (SNAREs) into vesicles as they bud from the endoplasmic reticulum (ER). Vesicle tethering to the Golgi begins when the tethering factor TRAPPI binds to Sec23p. Where the coat is released and how this event relates to membrane fusion is unknown. Here we use a yeast transport assay to demonstrate that an ER-derived vesicle retains its coat until it reaches the Golgi. A Golgi-associated kinase, Hrr25p (CK1 delta orthologue), then phosphorylates the Sec23p/Sec24p complex. Coat phosphorylation and dephosphorylation are needed for vesicle fusion and budding, respectively. Additionally, we show that Sec23p interacts in a sequential manner with different binding partners, including TRAPPI and Hrr25p, to ensure the directionality of ER-Golgi traffic and prevent the back-fusion of a COPII vesicle with the ER. These events are conserved in mammalian cells.	[Lord, Christopher; Bhandari, Deepali; Menon, Shekar; Ferro-Novick, Susan] Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, Biomol & Prote Mass Spectrometry Facil, La Jolla, CA 92093 USA; [Nycz, Deborah; Hay, Jesse] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Montana System; University of Montana; University of California System; University of California San Diego	Ferro-Novick, S (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sfnovick@ucsd.edu	Lord, Christopher/AAX-7130-2021; Lord, Christopher/B-3295-2012	Lord, Christopher/0000-0002-3226-0515; Lord, Christopher/0000-0003-0820-8298	Howard Hughes Medical Institute; Burroughs Wellcome Fund; SRP Super Fund Research Program; National Institutes of Health [GM-059378, RR-015583]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); SRP Super Fund Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Schekman, M. Cyert, L. Miller, B. Glick, M. Lowe and E. Mizuno-Yamasaki for strains, constructs, purified protein and antibody; K. Reinisch for discussions; S. Chen, H. Cai and M. Garcia-Marcos for advice; W. Zhou and A. Lougheed for technical assistance. This work was supported by the Howard Hughes Medical Institute. Salary support for S.F.-N., D.B. and S.M. was provided by the Howard Hughes Medical Institute, P.G. was funded by the Burroughs Wellcome Fund and M.G. by the SRP Super Fund Research Program. Work at the University of Montana was supported by National Institutes of Health grant GM-059378 (to J.C.H.) and the National Institutes of Health COBRE Center grant RR-015583.	BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Chin HF, 2009, J MOL BIOL, V389, P275, DOI 10.1016/j.jmb.2009.03.068; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7; Flanagan JJ, 2006, J BIOL CHEM, V281, P2281, DOI 10.1074/jbc.M511695200; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gimeno RE, 1996, MOL BIOL CELL, V7, P1815, DOI 10.1091/mbc.7.11.1815; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Murakami A, 1999, J BIOL CHEM, V274, P3804, DOI 10.1074/jbc.274.6.3804; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; SARASTE J, 1991, J CELL SCI, V100, P415; SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185; Whyte JRC, 2002, J CELL SCI, V115, P2627; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189	29	129	131	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					181	+		10.1038/nature09969	http://dx.doi.org/10.1038/nature09969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21532587	Bronze, Green Accepted			2022-12-01	WOS:000290487200031
J	O'Neill, D				O'Neill, Desmond			The art of medicine The art of the demographic dividend	LANCET			English	Editorial Material									Adelaide & Meath Hosp, Trinity Ctr Hlth Sci, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Adelaide & Meath Hosp, Trinity Ctr Hlth Sci, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Clarfield A.M., 2007, BMJ, V334, P1225, DOI [10.1136/bmj.39237.488356.94, DOI 10.1136/BMJ.39237.488356.94]; Crutch SJ, 2001, LANCET, V357, P2129, DOI 10.1016/S0140-6736(00)05187-4; DORMANDY T, 2001, OLD MASTERS GREAT AR; HAKAMIESBLOMQVI.L, 2002, BEHAVIOUR, V5, P271; Murphy KM, 2006, J POLIT ECON, V114, P871, DOI 10.1086/508033; ONEILL D, 2010, BRIT MED J, V341, pE5975; Said Edward., 2006, LATE STYLE MUSIC LIT; SHAINBERG L, 1987, PARIS REV, P100; Sontag S., 1987, ILLNESS METAPHOR	9	18	18	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2011	377	9780					1828	1829		10.1016/S0140-6736(11)60612-0	http://dx.doi.org/10.1016/S0140-6736(11)60612-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	774UI	21630498				2022-12-01	WOS:000291411700015
J	Bester, AC; Roniger, M; Oren, YS; Im, MM; Sarni, D; Chaoat, M; Bensimon, A; Zamir, G; Shewach, DS; Kerem, B				Bester, Assaf C.; Roniger, Maayan; Oren, Yifat S.; Im, Michael M.; Sarni, Dan; Chaoat, Malka; Bensimon, Aaron; Zamir, Gideon; Shewach, Donna S.; Kerem, Batsheva			Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; PAPILLOMAVIRUS TYPE-16 E6; CELL-CYCLE CHECKPOINT; DNA-DAMAGE; CERVICAL-CANCER; REPLICATION STRESS; MAMMALIAN-CELLS; ORIGIN CHOICE; FRAGILE SITE; CARCINOGENESIS	Chromosomal instability in early cancer stages is caused by stress on DNA replication. The molecular basis for replication perturbation in this context is currently unknown. We studied the replication dynamics in cells in which a regulator of S phase entry and cell proliferation, the Rb-E2F pathway, is aberrantly activated. Aberrant activation of this pathway by HPV-16 E6/E7 or cyclin E oncogenes significantly decreased the cellular nucleotide levels in the newly transformed cells. Exogenously supplied nucleosides rescued the replication stress and DNA damage and dramatically decreased oncogene-induced transformation. Increased transcription of nucleotide biosynthesis genes, mediated by expressing the transcription factor c-myc, increased the nucleotide pool and also rescued the replication-induced DNA damage. Our results suggest a model for early oncogenesis in which uncoordinated activation of factors regulating cell proliferation leads to insufficient nucleotides that fail to support normal replication and genome stability.	[Bester, Assaf C.; Roniger, Maayan; Oren, Yifat S.; Sarni, Dan; Kerem, Batsheva] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91905 Jerusalem, Israel; [Chaoat, Malka; Zamir, Gideon] Hebrew Univ Jerusalem, Dept Surg, Hadassah Med Sch, IL-91905 Jerusalem, Israel; [Im, Michael M.; Shewach, Donna S.] Univ Michigan, Dept Pharmacol, Med Ctr, Ann Arbor, MI 48109 USA; [Bensimon, Aaron] Genom Vis, F-75014 Paris, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Michigan System; University of Michigan	Kerem, B (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Edmond J Safra Campus, IL-91905 Jerusalem, Israel.	kerem@cc.huji.ac.il	Bester, Assaf/ABG-1707-2021		Nachmias Foundation of the Hebrew University; Israeli Ministry of Science; Israel Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA076581, R01CA083081] Funding Source: NIH RePORTER	Nachmias Foundation of the Hebrew University; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Israel Ministry of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Prof. Levana Sherman for the LXSN vectors and for helpful advice, Dr. Tzipora Shlomai for the F1 cells, and Prof. Jiri Bartek for the pbabe-puro-cyclin E vector. This work was partially supported by a grant from the Nachmias Foundation of the Hebrew University, France-Israel program of the Israeli Ministry of Science, and the Israel Ministry of Health.	Akli S, 2003, CANCER BIOL THER, V2, pS38; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Coquelle A, 1998, MOL CELL, V2, P259, DOI 10.1016/S1097-2765(00)80137-9; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Duensing S, 2003, CRIT REV EUKAR GENE, V13, P9, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.20; Duensing S, 2002, CANCER RES, V62, P7075; Flanagan SA, 2007, MOL CANCER THER, V6, P1858, DOI 10.1158/1535-7163.MCT-07-0068; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; Garcia-Closas R, 2005, INT J CANCER, V117, P629, DOI 10.1002/ijc.21193; Garner-Hamrick PA, 2004, J VIROL, V78, P9041, DOI 10.1128/JVI.78.17.9041-9050.2004; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(99)00210-2; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Klausner RD, 2002, CANCER CELL, V1, P3, DOI 10.1016/S1535-6108(02)00020-X; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Narisawa-Saito M, 2008, CANCER RES, V68, P5699, DOI 10.1158/0008-5472.CAN-07-6862; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Plug-DeMaggio AW, 2004, ONCOGENE, V23, P3561, DOI 10.1038/sj.onc.1207388; Rampersaud GC, 2002, J AM DIET ASSOC, V102, P1273, DOI 10.1016/S0002-8223(02)90281-6; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; SHEWACH DS, 1992, ANAL BIOCHEM, V206, P178, DOI 10.1016/S0003-2697(05)80030-2; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Thompson DA, 1997, ONCOGENE, V15, P3025, DOI 10.1038/sj.onc.1201495; Tsantoulis PK, 2008, ONCOGENE, V27, P3256, DOI 10.1038/sj.onc.1210989; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; YAN ZA, 1987, J MED GENET, V24, P593, DOI 10.1136/jmg.24.10.593	44	574	585	4	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					435	446		10.1016/j.cell.2011.03.044	http://dx.doi.org/10.1016/j.cell.2011.03.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529715	Green Accepted, Bronze			2022-12-01	WOS:000290022900012
J	Gascoigne, KE; Takeuchi, K; Suzuki, A; Hori, T; Fukagawa, T; Cheeseman, IM				Gascoigne, Karen E.; Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo; Cheeseman, Iain M.			Induced Ectopic Kinetochore Assembly Bypasses the Requirement for CENP-A Nucleosomes	CELL			English	Article							OUTER KINETOCHORE; MICROTUBULE INTERFACE; DNA-BINDING; CENTROMERE; COMPLEX; PROTEIN; CHROMATIN; IDENTIFICATION; RECOGNITION; CHROMOSOME	Accurate chromosome segregation requires assembly of the multiprotein kinetochore complex at centromeres. Although prior work identified the centromeric histone H3-variant CENP-A as the important upstream factor necessary for centromere specification, in human cells CENP-A is not sufficient for kinetochore assembly. Here, we demonstrate that two constitutive DNA-binding kinetochore components, CENP-C and CENP-T, function to direct kinetochore formation. Replacing the DNA-binding regions of CENP-C and CENP-T with alternate chromosome-targeting domains recruits these proteins to ectopic loci, resulting in CENP-A-independent kinetochore assembly. These ectopic kinetochore-like foci are functional based on the stoichiometric assembly of multiple kinetochore components, including the microtubule-binding KMN network, the presence of microtubule attachments, the microtubule-sensitive recruitment of the spindle checkpoint protein Mad2, and the segregation behavior of foci-containing chromosomes. We additionally find that CENP-T phosphorylation regulates the mitotic assembly of both endogenous and ectopic kinetochores. Thus, CENP-C and CENP-T form a critical regulated platform for vertebrate kinetochore assembly.	[Gascoigne, Karen E.; Cheeseman, Iain M.] MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Gascoigne, Karen E.; Cheeseman, Iain M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo] Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Cheeseman, IM (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.	icheese@wi.mit.edu	Suzuki, Aussie/ABF-4170-2021; Fukagawa, Tatsuo/AAK-3922-2021	Suzuki, Aussie/0000-0001-7390-5116; Cheeseman, Iain/0000-0002-3829-5612; Takeuchi, Kozo/0000-0003-2531-9264	Massachusetts Life Sciences Center; Searle Scholars Program; NIH/National Institute of General Medical Sciences [GM088313]; EMBO long-term fellowship; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088313] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22570008] Funding Source: KAKEN	Massachusetts Life Sciences Center; Searle Scholars Program; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Mike Lampson, Rick Young, Terry Orr-Weaver, David Page, Stephen Taylor, and members of the Cheeseman and Hochwagen labs for helpful discussions and critical reading of the manuscript and the anonymous reviewers for constructive suggestions. This work was supported by awards to I.M.C. from the Massachusetts Life Sciences Center and the Searle Scholars Program and a grant from the NIH/National Institute of General Medical Sciences to I.M.C. (GM088313). I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology. K.E.G. is supported by an EMBO long-term fellowship. Work in the Fukagawa Lab was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to T.F.	Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gascoigne KE, 2011, CURR OPIN CELL BIOL, V23, P102, DOI 10.1016/j.ceb.2010.07.007; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Masumoto H, 1998, CHROMOSOMA, V107, P406, DOI 10.1007/s004120050324; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; SUGIMOTO K, 1994, J BIOCHEM-TOKYO, V116, P877, DOI 10.1093/oxfordjournals.jbchem.a124610; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang CH, 1996, MOL CELL BIOL, V16, P3576	35	245	250	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					410	422		10.1016/j.cell.2011.03.031	http://dx.doi.org/10.1016/j.cell.2011.03.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529714	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000290022900010
J	Ji, AL; Wang, F; Luo, WJ; Yang, RH; Chen, JY; Cai, TJ				Ji, Ailing; Wang, Feng; Luo, Wenjing; Yang, Ruihua; Chen, Jingyuan; Cai, Tongjian			Lead poisoning in China: a nightmare from industrialisation	LANCET			English	Editorial Material							EXPOSURE		[Luo, Wenjing; Chen, Jingyuan; Cai, Tongjian] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China; [Ji, Ailing; Wang, Feng; Yang, Ruihua] Fourth Mil Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Cai, TJ (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China.	ctjcsl@netease.com	Cai, Tong-Jian/AAX-6338-2021	Cai, Tong-Jian/0000-0003-3188-6265				Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; CHEN G, 2009, CHINA NEWS AGEN 0815; Cheng HF, 2010, ENVIRON POLLUT, V158, P1134, DOI 10.1016/j.envpol.2009.12.028; CUI M, 2009, BEIJING NEWS    0823; GUO H, 2009, LEGAL DAILY     1021; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; JIA H, 2009, CHEM WORLD      0825; LE Y, 2009, MORE PARENTS PROTEST; Meyer PA, 2008, MUTAT RES-REV MUTAT, V659, P166, DOI 10.1016/j.mrrev.2008.03.003; *NAT DEV REF COMM, 2007, ACC COND LEAD ZINC I; *PEOPL REP CHIN NA, 2007, NEC ID RESP GOV DIFF; QIAN W, 2010, CHINA DAILY     0317; RAN J, 2010, SO WEEKLY       0324; Watts J, 2009, LANCET, V374, P868, DOI 10.1016/S0140-6736(09)61612-3; Zhang SM, 2009, BIOMED ENVIRON SCI, V22, P288, DOI 10.1016/S0895-3988(09)60058-1; 2010, SHENZHEN DAILY  0318	16	50	59	4	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1474	1476		10.1016/S0140-6736(10)60623-X	http://dx.doi.org/10.1016/S0140-6736(10)60623-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21492927				2022-12-01	WOS:000290419400009
J	Frank, C; Werber, D; Cramer, JP; Askar, M; Faber, M; an der Heiden, M; Bernard, H; Fruth, A; Prager, R; Spode, A; Wadl, M; Zoufaly, A; Jordan, S; Kemper, MJ; Follin, P; Muller, L; King, LA; Rosner, B; Buchholz, U; Stark, K; Krause, G				Frank, Christina; Werber, Dirk; Cramer, Jakob P.; Askar, Mona; Faber, Mirko; an der Heiden, Matthias; Bernard, Helen; Fruth, Angelika; Prager, Rita; Spode, Anke; Wadl, Maria; Zoufaly, Alexander; Jordan, Sabine; Kemper, Markus J.; Follin, Per; Muller, Luise; King, Lisa A.; Rosner, Bettina; Buchholz, Udo; Stark, Klaus; Krause, Gerard		HUS Invest Team	Epidemic Profile of Shiga-Toxin-Producing Escherichia coli O104:H4 Outbreak in Germany	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; MULTISTATE OUTBREAK; BLOODY DIARRHEA; STRAINS; O157-H7; IDENTIFICATION; INFECTION; HUMANS; GENES	BACKGROUND We describe an outbreak of gastroenteritis and the hemolytic-uremic syndrome caused by Shiga-toxin-producing Escherichia coli in Germany in May, June, and July, 2011. The consumption of sprouts was identified as the most likely vehicle of infection. METHODS We analyzed data from reports in Germany of Shiga-toxin-producing E. coli gastroenteritis and the hemolytic-uremic syndrome and clinical information on patients presenting to Hamburg University Medical Center (HUMC). An outbreak case was defined as a reported case of the hemolytic-uremic syndrome or of gastroenteritis in a patient infected by Shiga-toxin-producing E. coli, serogroup O104 or serogroup unknown, with an onset of disease during the period from May 1 through July 4, 2011, in Germany. RESULTS A total of 3816 cases (including 54 deaths) were reported in Germany, 845 of which (22%) involved the hemolytic-uremic syndrome. The outbreak was centered in northern Germany and peaked around May 21 to 22. Most of the patients in whom the hemolytic-uremic syndrome developed were adults (88%; median age, 42 years), and women were overrepresented (68%). The estimated median incubation period was 8 days, with a median of 5 days from the onset of diarrhea to the development of the hemolytic-uremic syndrome. Among 59 patients prospectively followed at HUMC, the hemolytic-uremic syndrome developed in 12 (20%), with no significant differences according to sex or reported initial symptoms and signs. The outbreak strain was typed as an enteroaggregative Shiga-toxin-producing E. coli O104:H4, producing extended-spectrum beta-lactamase. CONCLUSIONS In this outbreak, caused by an unusual E. coli strain, cases of the hemolytic-uremic syndrome occurred predominantly in adults, with a preponderance of cases occurring in women. The hemolytic-uremic syndrome developed in more than 20% of the identified cases.	[Frank, Christina; Werber, Dirk; Faber, Mirko; an der Heiden, Matthias; Bernard, Helen; Wadl, Maria; Rosner, Bettina; Buchholz, Udo; Stark, Klaus; Krause, Gerard] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany; [Fruth, Angelika; Prager, Rita] Robert Koch Inst, Dept Infect Dis, D-1000 Berlin, Germany; [Askar, Mona] Robert Koch Inst, Postgrad Training Appl Epidemiol Program, D-1000 Berlin, Germany; [Cramer, Jakob P.; Zoufaly, Alexander; Jordan, Sabine; Kemper, Markus J.] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany; [Spode, Anke] Hamburg No Dist, Dept Hlth, Hamburg, Germany; [Follin, Per] Vastra Gotaland Reg, Dept Communicable Dis Control & Prevent, Gothenburg, Sweden; [Muller, Luise] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [King, Lisa A.] Inst Veille Sanit, St Maurice, France	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Statens Serum Institut; Institute of Public Health Surveillance	Werber, D (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	werberd@rki.de	Richter, Martin Heinrich/AAB-1929-2022; Werber, Dirk/L-2264-2019; Adlhoch, Cornelia/AAH-5888-2021; Schink, Susanne Barbara/A-2669-2017; zhang, weidong/N-1070-2014; alzahrani, saud hamed/C-2014-2012; Faber, MIrko/O-1191-2018; Schink, Susanne Barbara/F-7758-2015	Richter, Martin Heinrich/0000-0002-8649-5248; Adlhoch, Cornelia/0000-0002-8842-0469; Schink, Susanne Barbara/0000-0001-7542-9416; zhang, weidong/0000-0002-8079-1185; Faber, MIrko/0000-0002-9196-570X; Krause, Gerard/0000-0003-3328-8808; Nielsen, Stine/0000-0002-5931-5379; nachtnebel, matthias/0000-0001-7077-5694; Rieck, Thorsten/0000-0002-8799-8744; Altmann, Mathias/0000-0002-8977-9270; Dudareva, Sandra/0000-0003-1803-704X; Frank, Christina/0000-0001-6776-8450; Werber, Dirk/0000-0002-8076-788X; an der Heiden, Matthias/0000-0001-5863-4549				[Anonymous], 2011, LAB INF REG STEC OUT; [Anonymous], GERM NAT INF DIS NOT; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P1048; European Food Safety Authority, 2011, TECHN REP SHIG TOX V; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fukushima H, 1999, PEDIATR INT, V41, P213, DOI 10.1046/j.1442-200X.1999.4121041.x; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; Gerber A, 2002, J INFECT DIS, V186, P493, DOI 10.1086/341940; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Guh A, 2010, CLIN INFECT DIS, V51, P1411, DOI 10.1086/657304; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Matsell DG, 2009, KIDNEY INT, V75, pS35, DOI 10.1038/ki.2008.628; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Prager R, 2007, EHEC WORKSH 2007 WIL; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Scavia G, 2011, EMERG INFECT DIS, V17, P1957, DOI 10.3201/eid1710.111072; Scheutz F, 2011, EURO SURVEILL, V16; Soderstrom A, 2008, FOODBORNE PATHOG DIS, V5, P339, DOI 10.1089/fpd.2007.0065; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Uber AP, 2006, FEMS MICROBIOL LETT, V256, P251, DOI 10.1111/j.1574-6968.2006.00124.x; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; World Health Organization, 2011, OUTBR E COL O104 H4	31	778	811	3	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1771	1780		10.1056/NEJMoa1106483	http://dx.doi.org/10.1056/NEJMoa1106483			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844QQ	21696328				2022-12-01	WOS:000296762800006
J	Wild, P; Farhan, H; McEwan, DG; Wagner, S; Rogov, VV; Brady, NR; Richter, B; Korac, J; Waidmann, O; Choudhary, C; Dotsch, V; Bumann, D; Dikic, I				Wild, Philipp; Farhan, Hesso; McEwan, David G.; Wagner, Sebastian; Rogov, Vladimir V.; Brady, Nathan R.; Richter, Benjamin; Korac, Jelena; Waidmann, Oliver; Choudhary, Chunaram; Doetsch, Volker; Bumann, Dirk; Dikic, Ivan			Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth	SCIENCE			English	Article							UBIQUITIN; TBK1; BINDING; DEGRADATION; P62/SQSTM1; INTEGRITY; BACTERIA; ADAPTER; NDP52	Selective autophagy can be mediated via receptor molecules that link specific cargoes to the autophagosomal membranes decorated by ubiquitin-like microtubule-associated protein light chain 3 (LC3) modifiers. Although several autophagy receptors have been identified, little is known about mechanisms controlling their functions in vivo. In this work, we found that phosphorylation of an autophagy receptor, optineurin, promoted selective autophagy of ubiquitin-coated cytosolic Salmonella enterica. The protein kinase TANK binding kinase 1 (TBK1) phosphorylated optineurin on serine-177, enhancing LC3 binding affinity and autophagic clearance of cytosolic Salmonella. Conversely, ubiquitin-or LC3-binding optineurin mutants and silencing of optineurin or TBK1 impaired Salmonella autophagy, resulting in increased intracellular bacterial proliferation. We propose that phosphorylation of autophagy receptors might be a general mechanism for regulation of cargo-selective autophagy.	[Wild, Philipp; McEwan, David G.; Richter, Benjamin; Waidmann, Oliver; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Main, Germany; [Wild, Philipp; McEwan, David G.; Richter, Benjamin; Waidmann, Oliver; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Main, Germany; [Farhan, Hesso; Bumann, Dirk] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Wagner, Sebastian; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth Sci, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60439 Frankfurt, Main, Germany; [Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60439 Frankfurt, Main, Germany; [Rogov, Vladimir V.] Inst Prot Res, Pushchino 142290, Russia; [Brady, Nathan R.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Korac, Jelena; Dikic, Ivan] Univ Split, Sch Med, Dept Immunol & Med Genet, Split 21000, Croatia	Goethe University Frankfurt; Goethe University Frankfurt; University of Basel; Novo Nordisk Foundation; University of Copenhagen; Goethe University Frankfurt; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); University of Split	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Main, Germany.	ivan.dikic@biochem2.de	Farhan, Hesso/C-7997-2012; Choudhary, Chunaram/E-9819-2011; choudhary, chunaram/ABE-6634-2020; Prlic, Jelena Korac/AAJ-1029-2021; Prlic, Jelena Korac/I-7988-2012; Wagner, Sebastian/B-9056-2012; Dikic, Ivan/O-4650-2015; Wild, Philipp S./M-2106-2019; Brady, Nathan/H-2452-2013; McEwan, David/AAY-6264-2020; McEwan, David/A-3754-2015	Farhan, Hesso/0000-0002-0889-8463; Choudhary, Chunaram/0000-0002-9863-433X; choudhary, chunaram/0000-0002-9863-433X; Prlic, Jelena Korac/0000-0002-7840-9979; Prlic, Jelena Korac/0000-0002-7840-9979; Dikic, Ivan/0000-0001-8156-9511; McEwan, David/0000-0003-0353-6532; Brady, Nathan/0000-0002-1901-5996; Dotsch, Volker/0000-0001-5720-212X	Deutsche Forschungsgemeinschaft; Goethe University Frankfurt [EXC115]; Landes-Offensive zur Entwicklung Wissentschaftlich-okonomischer Exzellenz; European Research Council (ERC) under the European Union [250241-LineUb]; Swiss National Fonds [3100A0-121834/1]; Novo Nordisk Foundation; Split, Croatia, government; Danish Council for Independent Research [FSS: 10-085134]; Helmholtz Association; Swiss National Science Foundation [31003A-121834]; Novo Nordisk Foundation Center for Protein Research [PI Chunaram Choudhary] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Goethe University Frankfurt; Landes-Offensive zur Entwicklung Wissentschaftlich-okonomischer Exzellenz; European Research Council (ERC) under the European Union(European Research Council (ERC)); Swiss National Fonds(Swiss National Science Foundation (SNSF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Split, Croatia, government; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Helmholtz Association(Helmholtz Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novo Nordisk Foundation Center for Protein Research	We thank P. Cohen, S. Mueller, K. Rajalingam, C. Behrends, and the members of Dikic laboratory for constructive comments and critical reading of the manuscript; P. Cohen for OPTN and TBK1 reagents; and V. Kirkin for the initial yeast two-hybrid screens. This work was supported by grants from Deutsche Forschungsgemeinschaft, the Cluster of Excellence "Macromolecular Complexes" of the Goethe University Frankfurt (EXC115), the Landes-Offensive zur Entwicklung Wissentschaftlich-okonomischer Exzellenz-funded Onkogene Signaltransduktion Frankfurt network, and the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. (250241-LineUb) to I. D. and partly by Swiss National Fonds (3100A0-121834/1) to D. B. The Center for Protein Research is funded by a generous grant from the Novo Nordisk Foundation. J.K. is supported by a scholarship from the Split, Croatia, government, S. W. by a postdoctoral fellowship from the Danish Council for Independent Research (FSS: 10-085134), N.R.B. by the Initiative and Networking Fund of the Helmholtz Association, and H. F. by Swiss National Science Foundation (31003A-121834).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; McEwan DG, 2011, TRENDS CELL BIOL, V21, P195, DOI 10.1016/j.tcb.2010.12.006; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	25	911	939	6	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					228	233		10.1126/science.1205405	http://dx.doi.org/10.1126/science.1205405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21617041	Green Accepted			2022-12-01	WOS:000292502700052
J	Tinetti, ME; Studenski, SA				Tinetti, Mary E.; Studenski, Stephanie A.			Comparative Effectiveness Research and Patients with Multiple Chronic Conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OLDER PERSONS		[Tinetti, Mary E.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Tinetti, Mary E.] Yale Univ, Sch Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Studenski, Stephanie A.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Studenski, Stephanie A.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.							Alecxih L., 2010, INDIVIDUALS LIVING C; Fried TR, 2008, J AM GERIATR SOC, V56, P1839, DOI 10.1111/j.1532-5415.2008.01923.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233	5	107	108	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2478	2481		10.1056/NEJMp1100535	http://dx.doi.org/10.1056/NEJMp1100535			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AM	21696327				2022-12-01	WOS:000292199800003
J	Ladeveze, S; de Muizon, C; Beck, RMD; Germain, D; Cespedes-Paz, R				Ladeveze, Sandrine; de Muizon, Christian; Beck, Robin M. D.; Germain, Damien; Cespedes-Paz, Ricardo			Earliest evidence of mammalian social behaviour in the basal Tertiary of Bolivia	NATURE			English	Article							SEXUAL-DIMORPHISM; SOUTH-AMERICA; MARSUPIALS; ORGANIZATION; DIDELPHIDAE; DASYURIDAE; PALEOCENE; HISTORY; ORIGIN	The vast majority of Mesozoic and early Cenozoic metatherian mammals (extinct relatives of modern marsupials) are known only from partial jaws or isolated teeth, which give insight into their probable diets and phylogenetic relationships but little else. The few skulls known are generally crushed, incomplete or both(1-4), and associated postcranial material is extremely rare. Here we report the discovery of an exceptionally large number of almost undistorted, nearly complete skulls and skeletons of a stem-metatherian, Pucadelphys andinus, in the early Palaeocene epoch(5) of Tiupampa in Bolivia(6-8). These give an unprecedented glimpse into early metatherian morphology, evolutionary relationships and, especially, ecology. The remains of 35 individuals have been collected, with 22 of these represented by nearly complete skulls and associated postcrania. These individuals were probably buried in a single catastrophic event, and so almost certainly belong to the same population(9). The preservation of multiple adult, sub-adult and juvenile individuals in close proximity (<1 m(2)) is indicative of gregarious social behaviour or at least a high degree of social tolerance and frequent interaction. Such behaviour is unknown in living didelphids, which are highly solitary and have been regarded, perhaps wrongly, as the most generalized living marsupials. The Tiupampan P. andinus population also exhibits strong sexual dimorphism, which, in combination with gregariousness, suggests strong male-male competition and polygyny. Our study shows that social interactions occurred in metatherians as early as the basal Palaeocene and that solitary behaviour may not be plesiomorphic for Metatheria as a whole.	[Ladeveze, Sandrine] Royal Belgian Inst Nat Sci, Dept Palaeontol, B-1000 Brussels, Belgium; [de Muizon, Christian; Germain, Damien] UPMC, MNHN, Dept Hist tERRE, CNRS,UMR7207,CR2P, F-75005 Paris, France; [Beck, Robin M. D.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Cespedes-Paz, Ricardo] Museo Hist Nat Alcide Orbigny, Cochabamba, Bolivia	Royal Belgian Institute of Natural Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; American Museum of Natural History (AMNH)	Ladeveze, S (corresponding author), Royal Belgian Inst Nat Sci, Dept Palaeontol, 29 Rue Vautier, B-1000 Brussels, Belgium.	sandrine.ladeveze@naturalsciences.be; muizon@mnhn.fr	De Muizon, Christian/P-4335-2017; germain, damien/I-5906-2012; De Muizon, Christian/Q-7986-2019	De Muizon, Christian/0000-0002-1247-8867; De Muizon, Christian/0000-0002-1247-8867; Beck, Robin/0000-0002-7050-7072; Germain, Damien/0000-0002-7608-2212	National Geographic Society [2908-84]; Institut Francais d'Etudes Andines; Belgian Federal Science Policy Office [MO/36/020]; NSF [DEB-0743039]	National Geographic Society(National Geographic Society); Institut Francais d'Etudes Andines; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); NSF(National Science Foundation (NSF))	Field expeditions were supported by the National Geographic Society (grants 2908-84) in 1985 and by the 'Institut Francais d'Etudes Andines' in 1997. The specimens collected are the property of the 'Museo de Historia Natural Alcide d'Orbigny' in Cochabamba, Bolivia. Additional financial support was provided by Research Project MO/36/020 of the Belgian Federal Science Policy Office (S. L.), and NSF grant DEB-0743039 (R. M.D.B., in collaboration with R. Voss at the American Museum of Natural History). Photographs are by C. Lemzaouda and P. Loubry, scanning electron microscope photographs are by J. Cillis and the reconstruction in Fig. 1 is by S. Fernandez. We thank E. Westwig for access to the AMNH collections, and O. Lambert, A. Pradel, and T. Soderquist for discussions.	Astua D, 2010, J MAMMAL, V91, P1011, DOI 10.1644/09-MAMM-A-018.1; ATRAMENTOWICZ M, 1986, BIOTROPICA, V18, P136, DOI 10.2307/2388756; Caceres NC, 2007, J NAT HIST, V41, P1979, DOI 10.1080/00222930701520835; Cifelli RL, 1998, CR ACAD SCI II A, V326, P215, DOI 10.1016/S1251-8050(00)89038-2; DE MUIZON C., 2003, PREDATORS POUCHES BI, P42; de Muizon C, ORIGINS EVO IN PRESS; de Muizon Christian, 1998, Geodiversitas, V20, P19; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Fisher DO, 2006, BEHAV ECOL, V17, P164, DOI 10.1093/beheco/arj012; Gelfo JN, 2009, PALAEONTOLOGY, V52, P251, DOI 10.1111/j.1475-4983.2008.00835.x; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; Hershkovitz P, 1997, FIELDIANA ZOOLOGY, V86, P1; Horovitz I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008278; Kraaijeveld K, 2003, P ROY SOC B-BIOL SCI, V270, pS251, DOI 10.1098/rsbl.2003.0082; LAZENBYCOHEN KA, 1988, BEHAV ECOL SOCIOBIOL, V22, P195, DOI 10.1007/BF00300569; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Marshall Larry G., 1995, Memoires du Museum National d'Histoire Naturelle, V165, P21; Marshall LG, 1997, J S AM EARTH SCI, V10, P49, DOI 10.1016/S0895-9811(97)00005-9; MARSHALL LG, 1995, PUCADELPHYS ANDINUS; MORTON SR, 1978, J MAMMAL, V59, P569, DOI 10.2307/1380234; Muizon C., 1992, REV TECNICA YACIMIEN, V12, P575; Oakwood M, 2002, J ZOOL, V257, P237, DOI 10.1017/S0952836902000833; Plavcan JM, 2000, J HUM EVOL, V39, P327, DOI 10.1006/jhev.2000.0423; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; RUSSELL EM, 1984, MAMMAL REV, V14, P101, DOI 10.1111/j.1365-2907.1984.tb00343.x; SODERQUIST TR, 1995, J ZOOL, V237, P385, DOI 10.1111/j.1469-7998.1995.tb02769.x; Szalay FS, 1996, J VERTEBR PALEONTOL, V16, P474, DOI 10.1080/02724634.1996.10011335; TYNDALEBISCOE CH, 1976, J MAMMAL, V57, P249, DOI 10.2307/1379686	28	26	26	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					83	86		10.1038/nature09987	http://dx.doi.org/10.1038/nature09987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21552278				2022-12-01	WOS:000291156700042
J	Carpenter, SR; Cole, JJ; Pace, ML; Batt, R; Brock, WA; Cline, T; Coloso, J; Hodgson, JR; Kitchell, JF; Seekell, DA; Smith, L; Weidel, B				Carpenter, S. R.; Cole, J. J.; Pace, M. L.; Batt, R.; Brock, W. A.; Cline, T.; Coloso, J.; Hodgson, J. R.; Kitchell, J. F.; Seekell, D. A.; Smith, L.; Weidel, B.			Early Warnings of Regime Shifts: A Whole-Ecosystem Experiment	SCIENCE			English	Article							TROPHIC CASCADES; ECOLOGICAL-SYSTEMS; PLANKTON; PHYTOPLANKTON; INDICATORS; PATTERNS; SIGNALS; CHAOS; FISH	Catastrophic ecological regime shifts may be announced in advance by statistical early warning signals such as slowing return rates from perturbation and rising variance. The theoretical background for these indicators is rich, but real-world tests are rare, especially for whole ecosystems. We tested the hypothesis that these statistics would be early warning signals for an experimentally induced regime shift in an aquatic food web. We gradually added top predators to a lake over 3 years to destabilize its food web. An adjacent lake was monitored simultaneously as a reference ecosystem. Warning signals of a regime shift were evident in the manipulated lake during reorganization of the food web more than a year before the food web transition was complete, corroborating theory for leading indicators of ecological regime shifts.	[Carpenter, S. R.; Batt, R.; Cline, T.; Kitchell, J. F.; Smith, L.; Weidel, B.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Cole, J. J.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Pace, M. L.; Coloso, J.; Seekell, D. A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Brock, W. A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Hodgson, J. R.] St Norbert Coll, Dept Biol, De Pere, WI 54115 USA	University of Wisconsin System; University of Wisconsin Madison; Cary Institute of Ecosystem Studies; University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Carpenter, SR (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	srcarpen@wisc.edu	Carpenter, Stephen/AAQ-6404-2020; Cole, Jonathan Jay/G-4566-2011; Batt, Ryan/D-7690-2013	Cole, Jonathan Jay/0000-0003-4633-7402; Carpenter, Stephen/0000-0001-8097-8700; Pace, Michael/0000-0001-5945-6131; Batt, Ryan/0000-0002-7267-5395	NSF	NSF(National Science Foundation (NSF))	This research was supported by the NSF. C. Brousseau, M. Dougherty, A. Farrell, R. Johnson, S. Klobucar, J. Kurtzweil, K. Lee, T. Matthys, K. McDonnell, H. Pack, T. Walsworth, and L. Zinn provided technical help. We thank the staff of the University of Notre Dame Environmental Research Center for assistance.	[Anonymous], 2005, EC HUM WELL BEING OU; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brock W., 1996, ECONOMET REV, V15, P197, DOI [10.1080/07474939608800353, DOI 10.1080/07474939608800353]; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Carpenter S. R., 1993, TROPHIC CASCADES LAK; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2001, ECOL MONOGR, V71, P163, DOI 10.1890/0012-9615(2001)071[0163:TCNALP]2.0.CO;2; Contamin R, 2009, ECOL APPL, V19, P799, DOI 10.1890/08-0109.1; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; DOVERI F, 1993, THEOR POPUL BIOL, V43, P159, DOI 10.1006/tpbi.1993.1008; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Estes J.A., 2010, TROPHIC CASCADES; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kleinen Thomas, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Kuwahara VS, 2008, J OCEANOGR, V64, P691, DOI 10.1007/s10872-008-0058-5; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; Scheffer M, 2000, CAN J FISH AQUAT SCI, V57, P1208, DOI 10.1139/cjfas-57-6-1208; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Weston K, 2008, J SEA RES, V60, P262, DOI 10.1016/j.seares.2008.09.003	30	582	603	14	597	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1079	1082		10.1126/science.1203672	http://dx.doi.org/10.1126/science.1203672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21527677				2022-12-01	WOS:000290996700043
J	Kelly, RP; Foley, MM; Fisher, WS; Feely, RA; Halpern, BS; Waldbusser, GG; Caldwell, MR				Kelly, R. P.; Foley, M. M.; Fisher, W. S.; Feely, R. A.; Halpern, B. S.; Waldbusser, G. G.; Caldwell, M. R.			Mitigating Local Causes of Ocean Acidification with Existing Laws	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; IMPACTS; EUTROPHICATION; SATURATION; COASTAL; WATER		[Kelly, R. P.; Foley, M. M.; Caldwell, M. R.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Fisher, W. S.] US EPA, Gulf Ecol Div, Gulf Breeze, FL 32561 USA; [Feely, R. A.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Halpern, B. S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Waldbusser, G. G.] Oregon State Univ, Coll Atmospher & Ocean Sci, Corvallis, OR 97331 USA	Stanford University; United States Environmental Protection Agency; National Oceanic Atmospheric Admin (NOAA) - USA; National Center for Ecological Analysis & Synthesis; Oregon State University	Kelly, RP (corresponding author), Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA.	rpk@stanford.edu	Feely, Richard A./ABI-5740-2020	Kelly, Ryan/0000-0001-5037-2441; Waldbusser, George/0000-0002-8334-580X				[Anonymous], 2009, FED REGISTER, V74, P15; Baron J.S., 2008, PRELIMINARY REV ADAP; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; Bradley P.A., 2010, EPA600R10054; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Costanza R, 1998, SCIENCE, V281, P198, DOI 10.1126/science.281.5374.198; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dove MC, 2007, J SHELLFISH RES, V26, P519, DOI 10.2983/0730-8000(2007)26[519:IOEAOS]2.0.CO;2; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fore LS, 2008, SCIENCE, V322, P1788, DOI 10.1126/science.322.5909.1788a; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0	22	93	97	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1036	1037		10.1126/science.1203815	http://dx.doi.org/10.1126/science.1203815			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769FN	21617060				2022-12-01	WOS:000290996700027
J	Teglas, E; Vul, E; Girotto, V; Gonzalez, M; Tenenbaum, JB; Bonatti, LL				Teglas, Erno; Vul, Edward; Girotto, Vittorio; Gonzalez, Michel; Tenenbaum, Joshua B.; Bonatti, Luca L.			Pure Reasoning in 12-Month-Old Infants as Probabilistic Inference	SCIENCE			English	Article							SPEECH STREAM; OBJECT; PERCEPTION; COMPUTATIONS; SEGMENTATION; STATISTICS; SEQUENCES; BELIEFS	Many organisms can predict future events from the statistics of past experience, but humans also excel at making predictions by pure reasoning: integrating multiple sources of information, guided by abstract knowledge, to form rational expectations about novel situations, never directly experienced. Here, we show that this reasoning is surprisingly rich, powerful, and coherent even in preverbal infants. When 12-month-old infants view complex displays of multiple moving objects, they form time-varying expectations about future events that are a systematic and rational function of several stimulus variables. Infants' looking times are consistent with a Bayesian ideal observer embodying abstract principles of object motion. The model explains infants' statistical expectations and classic qualitative findings about object cognition in younger babies, not originally viewed as probabilistic inferences.	[Tenenbaum, Joshua B.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Teglas, Erno] Cent European Univ, Cognit Dev Ctr, H-1015 Budapest, Hungary; [Teglas, Erno] Hungarian Acad Sci, H-1015 Budapest, Hungary; [Vul, Edward] Univ Calif San Diego, La Jolla, CA 92093 USA; [Girotto, Vittorio] Univ IUAV Venice, I-30135 Venice, Italy; [Girotto, Vittorio; Gonzalez, Michel] CNRS, F-13331 Marseille, France; [Girotto, Vittorio; Gonzalez, Michel] Aix Marseille Univ, F-13331 Marseille, France; [Bonatti, Luca L.] ICREA, Barcelona 08018, Spain; [Bonatti, Luca L.] Univ Pompeu Fabra, Barcelona 08018, Spain	Massachusetts Institute of Technology (MIT); Central European University; Hungarian Academy of Sciences; University of California System; University of California San Diego; IUAV University Venice; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; ICREA; Pompeu Fabra University	Tenenbaum, JB (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	lucabonatti@mac.com; jbt@mit.edu	Bonatti, Luca Lorenzo/AAA-2410-2019	Bonatti, Luca Lorenzo/0000-0001-8624-9007; Teglas, Erno/0000-0003-4502-3639	Ministerio de Ciencia E Innovacion [PSI2009-08232PSIC]; James S. McDonnell Foundation; Office of Naval Research [N00014-09-0124, N00014-07-1-0937]; Army Research Office MURI [W911NF-08-1-0242]; Swiss and Global-Fondazione Ca' Foscari; Marie Curie 035975 Disorders and Coherence of the Embodied Self; ICREA Funding Source: Custom	Ministerio de Ciencia E Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); James S. McDonnell Foundation; Office of Naval Research(Office of Naval Research); Army Research Office MURI(MURI); Swiss and Global-Fondazione Ca' Foscari; Marie Curie 035975 Disorders and Coherence of the Embodied Self; ICREA(ICREA)	The research was supported by grants Friuli-Venezia-Giulia "PsyScope XL," Ministerio de Ciencia E Innovacion PSI2009-08232PSIC, the James S. McDonnell Foundation Causal Learning Research Collaborative grant, Office of Naval Research grants N00014-09-0124 and N00014-07-1-0937, Army Research Office MURI W911NF-08-1-0242, the Swiss and Global-Fondazione Ca' Foscari, and Marie Curie 035975 Disorders and Coherence of the Embodied Self. E. T. and L. L. B. designed the experiments and analyzed the data. E. T. ran the experiments. J.B.T. and E. V. conceived the model and the simulations. E. T., E. V., J.B.T., and L. L. B. wrote the paper. All authors discussed the research and revised the text and the analyses. We thank D. Amati, L. Filippin, F. Gandolfo, N. Goodman, A. Isaja, and N. Sebastian for support and suggestions. J. Mehler and the Language, Cognition, and Development Laboratory in Trieste, Italy made the experimental work possible. We are deeply grateful to them.	Aguiar A, 1999, COGNITIVE PSYCHOL, V39, P116, DOI 10.1006/cogp.1999.0717; [Anonymous], 2013, ARTIF INTELL; BAILLARGEON R, 1985, COGNITION, V20, P191, DOI 10.1016/0010-0277(85)90008-3; Baillargeon R., 2009, LEARNING INFANT MIND, P66; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Brown SD, 2009, COGNITIVE PSYCHOL, V58, P49, DOI 10.1016/j.cogpsych.2008.09.002; Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8; Cover T. M., 2006, ELEMENTS INFORM THEO, p[xxiii, 74]; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Fodor J., 1975, LANGUAGE THOUGHT; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Girotto V, 2006, NORMS IN HUMAN DEVELOPMENT, P220, DOI 10.1017/CBO9780511489778.010; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Johnson SP, 2003, CHILD DEV, V74, P94, DOI 10.1111/1467-8624.00523; Johnson-Laird PN, 1999, PSYCHOL REV, V106, P62, DOI 10.1037/0033-295X.106.1.62; KELLMAN PJ, 1983, COGNITIVE PSYCHOL, V15, P483, DOI 10.1016/0010-0285(83)90017-8; KEMP C, 2009, ADV NEURAL INFORM PR, V22, P925; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; LEVY R, 2008, ADV NEURAL INFORM PR, V21, P937; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; SINHA P, 2009, OBJECT CATEGORIZATIO, P301; Spelke Elizabeth, 1986, PSYCHOL FR, V31, P67; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; Teglas E, 2007, P NATL ACAD SCI USA, V104, P19156, DOI 10.1073/pnas.0700271104; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Toro JM, 2005, PERCEPT PSYCHOPHYS, V67, P867, DOI 10.3758/BF03193539; VUL E, 2009, ADV NEURAL INFORM PR, V22, P1955; Wilcox T, 2003, INFANT BEHAV DEV, V26, P253, DOI 10.1016/S0163-6383(03)00021-3; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 1996, COGNITIVE PSYCHOL, V30, P111, DOI 10.1006/cogp.1996.0005; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105	39	169	169	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1054	1059		10.1126/science.1196404	http://dx.doi.org/10.1126/science.1196404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769FN	21617069				2022-12-01	WOS:000290996700036
J	DiMaio, F; Terwilliger, TC; Read, RJ; Wlodawer, A; Oberdorfer, G; Wagner, U; Valkov, E; Alon, A; Fass, D; Axelrod, HL; Das, D; Vorobiev, SM; Iwai, H; Pokkuluri, PR; Baker, D				DiMaio, Frank; Terwilliger, Thomas C.; Read, Randy J.; Wlodawer, Alexander; Oberdorfer, Gustav; Wagner, Ulrike; Valkov, Eugene; Alon, Assaf; Fass, Deborah; Axelrod, Herbert L.; Das, Debanu; Vorobiev, Sergey M.; Iwai, Hideo; Pokkuluri, P. Raj; Baker, David			Improved molecular replacement by density- and energy-guided protein structure optimization	NATURE			English	Article							CRYSTALLOGRAPHIC REFINEMENT; PREDICTION; ACCURACY; SOFTWARE	Molecular replacement(1-4) procedures, which search for placements of a starting model within the crystallographic unit cell that best account for the measured diffraction amplitudes, followed by automatic chain tracing methods(5-8), have allowed the rapid solution of large numbers of protein crystal structures. Despite extensive work(9-14), molecular replacement or the subsequent rebuilding usually fail with more divergent starting models based on remote homologues with less than 30% sequence identity. Here we show that this limitation can be substantially reduced by combining algorithms for protein structure modelling with those developed for crystallographic structure determination. An approach integrating Rosetta structure modelling with Autobuild chain tracing yielded high-resolution structures for 8 of 13 X-ray diffraction data sets that could not be solved in the laboratories of expert crystallographers and that remained unsolved after application of an extensive array of alternative approaches. We estimate that the new method should allow rapid structure determination without experimental phase information for over half the cases where current methods fail, given diffraction data sets of better than 3.2 angstrom resolution, four or fewer copies in the asymmetric unit, and the availability of structures of homologous proteins with >20% sequence identity.	[Terwilliger, Thomas C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [DiMaio, Frank; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Read, Randy J.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA; [Oberdorfer, Gustav; Wagner, Ulrike] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Valkov, Eugene] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Alon, Assaf; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Axelrod, Herbert L.; Das, Debanu] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Axelrod, Herbert L.; Das, Debanu] SLAC Natl Accelerator Lab, SSRL, Menlo Pk, CA 94025 USA; [Vorobiev, Sergey M.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Iwai, Hideo] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Pokkuluri, P. Raj] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Graz; University of Cambridge; Weizmann Institute of Science; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Columbia University; University of Helsinki; United States Department of Energy (DOE); Argonne National Laboratory	Terwilliger, TC (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	terwilliger@lanl.gov; dabaker@u.washington.edu	Read, Randy J/L-1418-2013; Terwilliger, Thomas/AEF-4827-2022; Iwaï, Hideo/A-6416-2009; Terwilliger, Thomas/AAM-4079-2020; Valkov, Eugene/C-1554-2010; Valkov, Eugene/AAA-1735-2020; Baker, David/K-8941-2012; Terwilliger, Thomas C/K-4109-2012	Read, Randy J/0000-0001-8273-0047; Iwaï, Hideo/0000-0001-7376-5264; Terwilliger, Thomas/0000-0001-6384-0320; Valkov, Eugene/0000-0002-3721-1739; Baker, David/0000-0001-7896-6217; Terwilliger, Thomas C/0000-0001-6384-0320; Oberdorfer, Gustav/0000-0002-6144-9114; Alon, Assaf/0000-0001-8102-5290	NIH [5R01GM092802, P41RR002250]; Wellcome Trust; HHMI; Israel Science Foundation; DK Molecular Enzymology [W901]; Austrian Science Fund [P19858]; NIH, National Cancer Institute, Center for Cancer Research; academy of Finland [1131413]; Protein Structure Initiative of National Institute of General Medical Sciences [U54 GM074958]; US Department of Energy's Office of Science, Biological and Environmental Research [DE-AC02-06CH11357]; NIH, National Institutes of General Medical Sciences, Protein Structure Initiative [U54 GM094586, GM074898]; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802, U54GM074898, P01GM063210, U54GM094586, U54GM094597, U54GM074958] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); HHMI(Howard Hughes Medical Institute); Israel Science Foundation(Israel Science Foundation); DK Molecular Enzymology(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); academy of Finland(Academy of Finland); Protein Structure Initiative of National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy's Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Institutes of General Medical Sciences, Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	R.J.R., T.C.T. and D.B. thank the NIH (5R01GM092802), the Wellcome Trust (R.J.R.), and HHMI (D.B.) for funding this research. F.D. acknowledges the NIH (P41RR002250) and HHMI. D.F. and A.A. acknowledge support from the Israel Science Foundation. G.O. thanks DK Molecular Enzymology (FWF-project W901) and the Austrian Science Fund (FWF-project P19858). The work of A.W. was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. H.I. acknowledges support from the academy of Finland (1131413). S.M.V. was supported by a grant from the Protein Structure Initiative of National Institute of General Medical Sciences (U54 GM074958). The work of P.R.P. at Argonne National Laboratory was supported by the US Department of Energy's Office of Science, Biological and Environmental Research GTL programme under contract DE-AC02-06CH11357. We thank all members of the JCSG for their general contributions to the protein production and structural work. The JCSG is supported by the NIH, National Institutes of General Medical Sciences, Protein Structure Initiative (U54 GM094586 and GM074898).	ABE H, 1984, COMPUT CHEM, V8, P239, DOI 10.1016/0097-8485(84)85015-9; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DePristo MA, 2005, STRUCTURE, V13, P1311, DOI 10.1016/j.str.2005.06.008; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; Rossmann M. G., 1972, MOL REPLACEMENT METH; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Suhre K, 2004, ACTA CRYSTALLOGR D, V60, P796, DOI 10.1107/S0907444904001982; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640; Webb B., 2006, CURR PROTOC BIOINFOR, V15, DOI DOI 10.1002/0471250953.BI0506S15; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D	29	188	189	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					540	U149		10.1038/nature09964	http://dx.doi.org/10.1038/nature09964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21532589	Green Accepted			2022-12-01	WOS:000290951300047
J	Jain, A; Liu, RJ; Ramani, B; Arauz, E; Ishitsuka, Y; Ragunathan, K; Park, J; Chen, J; Xiang, YK; Ha, T				Jain, Ankur; Liu, Ruijie; Ramani, Biswarathan; Arauz, Edwin; Ishitsuka, Yuji; Ragunathan, Kaushik; Park, Jeehae; Chen, Jie; Xiang, Yang K.; Ha, Taekjip			Probing cellular protein complexes using single-molecule pull-down	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; LIVING CELLS; ESCHERICHIA-COLI; GENE-EXPRESSION; LIVE CELLS; STOICHIOMETRY; MTOR; FRET; DNA; MICROSCOPY	Proteins perform most cellular functions in macromolecular complexes. The same protein often participates in different complexes to exhibit diverse functionality. Current ensemble approaches of identifying cellular protein interactions cannot reveal physiological permutations of these interactions. Here we describe a single-molecule pull-down (SiMPull) assay that combines the principles of a conventional pull-down assay with single-molecule fluorescence microscopy and enables direct visualization of individual cellular protein complexes. SiMPull can reveal how many proteins and of which kinds are present in the in vivo complex, as we show using protein kinase A. We then demonstrate a wide applicability to various signalling proteins found in the cytosol, membrane and cellular organelles, and to endogenous protein complexes from animal tissue extracts. The pulled-down proteins are functional and are used, without further processing, for single-molecule biochemical studies. SiMPull should provide a rapid, sensitive and robust platform for analysing protein assemblies in biological pathways.	[Jain, Ankur; Ragunathan, Kaushik; Park, Jeehae; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Jain, Ankur; Ragunathan, Kaushik; Park, Jeehae; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Liu, Ruijie; Ramani, Biswarathan; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Arauz, Edwin; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Ishitsuka, Yuji; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Ishitsuka, Yuji; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Ishitsuka, Yuji; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	kevinyx@illinois.edu; tjha@illinois.edu	Ishitsuka, Yuji/J-1921-2014; Ha, Taekjip/B-9506-2009; Diaz, Edwin Arauz/AAI-5457-2021	Ishitsuka, Yuji/0000-0002-6780-7154; Ha, Taekjip/0000-0003-2195-6258; liu, ruijie/0000-0002-2468-0579; Chen, Jie/0000-0002-7887-3747	NIH [AI083025, GM065367, HL082846, AR048914]; NSF [0646550, 0822613]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Myong, P. Jena, S. Arslan and R. Vafabakhsh for discussions. The expression vector encoding the YFP-MAVS gene was a gift from D. Lamarre. This work was funded by NIH grants (AI083025, GM065367 to T.H.; HL082846 to Y.K.X.; AR048914 to J.C.). Additional support was provided by NSF grants (0646550, 0822613 to T.H.). T.H. is an investigator with the Howard Hughes Medical Institute.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.97.7.3684; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; COLLINS S, 1991, ANNU REV PHYSIOL, V53, P497, DOI 10.1146/annurev.physiol.53.1.497; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schulte R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002061; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Ulbrich MH, 2008, P NATL ACAD SCI USA, V105, P14163, DOI 10.1073/pnas.0802075105; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zamir E, 2010, NAT METHODS, V7, P295, DOI [10.1038/NMETH.1441, 10.1038/nmeth.1441]	42	283	286	2	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					484	U322		10.1038/nature10016	http://dx.doi.org/10.1038/nature10016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21614075	Green Accepted, Green Submitted			2022-12-01	WOS:000290951300034
J	Lowy, FD				Lowy, Franklin D.			How Staphylococcus aureus Adapts to Its Host	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA	Columbia University	Lowy, FD (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA.							Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002	5	36	36	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2011	364	21					1987	1990		10.1056/NEJMp1100251	http://dx.doi.org/10.1056/NEJMp1100251			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QR	21612466				2022-12-01	WOS:000290952000002
J	Chang, CH; Stukel, TA; Flood, AB; Goodman, DC				Chang, Chiang-Hua; Stukel, Therese A.; Flood, Ann Barry; Goodman, David C.			Primary Care Physician Workforce and Medicare Beneficiaries' Health Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							US PRIMARY-CARE; REGIONAL-VARIATIONS; MORTALITY; STATES; CHALLENGE; QUALITY; REFORM; RATES; LIFE	Context Despite a widespread interest in increasing the numbers of primary care physicians to improve care and to moderate costs, the relationship of the primary care physician workforce to patient-level outcomes remains poorly understood. Objective To measure the association between the adult primary care physician workforce and individual patient outcomes. Design, Setting, and Participants A cross-sectional analysis of the outcomes of a 2007 20% sample of fee-for-service Medicare beneficiaries aged 65 years or older (N=5 132 936), which used 2 measures of adult primary care physicians (general internists and family physicians) across Primary Care Service Areas (N=6542): (1) American Medical Association (AMA) Masterfile nonfederal, office-based physicians per total population and (2) office-based primary care clinical full-time equivalents (FTEs) per Medicare beneficiary derived from Medicare claims. Main Outcome Measures Annual individual-level outcomes (mortality, ambulatory care sensitive condition [ACSC] hospitalizations, and Medicare program spending), adjusted for individual patient characteristics and geographic area variables. Results Marked variation was observed in the primary care physician workforce across areas, but low correlation was observed between the 2 primary care workforce measures (Spearman r=0.056; P<.001). Compared with areas with the lowest quintile of primary care physician measure using AMA Masterfile counts, beneficiaries in the highest quintile had fewer ACSC hospitalizations (74.90 vs 79.61 per 1000 beneficiaries; relative rate [RR], 0.94; 95% confidence interval [CI], 0.93-0.95), lower mortality (5.38 vs 5.47 per 100 beneficiaries; RR, 0.98; 95% CI, 0.97-0.997), and no significant difference in total Medicare spending ($8722 vs $8765 per beneficiary; RR, 1.00; 95% CI, 0.99-1.00). Beneficiaries residing in areas with the highest quintile of primary care clinician FTEs compared with those in the lowest quintile had lower mortality (5.19 vs 5.49 per 100 beneficiaries; RR, 0.95; 95% CI, 0.93-0.96), fewer ACSC hospitalizations (72.53 vs 79.48 per 1000 beneficiaries; RR, 0.91; 95% CI, 0.90-0.92), and higher overall Medicare spending ($8857 vs $8769 per beneficiary; RR, 1.01; 95% CI, 1.004-1.02). Conclusion A higher level of primary care physician workforce, particularly with an FTE measure that may more accurately reflect ambulatory primary care, was generally associated with favorable patient outcomes. JAMA. 2011; 305(20): 2096-2105	[Chang, Chiang-Hua] Ctr Hlth Policy Res, Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Goodman, David C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pediat, Hanover, NH 03756 USA; [Flood, Ann Barry] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA; [Stukel, Therese A.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Stukel, Therese A.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	Dartmouth College; Dartmouth College; Dartmouth College; University of Toronto; University of Toronto	Chang, CH (corresponding author), Ctr Hlth Policy Res, Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy, Lebanon, NH 03766 USA.	chiang-hua.chang@dartmouth.edu	Goodman, David/AAG-7497-2020	Stukel, Therese/0000-0002-2951-1360	Texas Medical Association; Health Action Council, Cincinnati; Richard Stockton College of New Jersey; Iowa Health Business Alliance; Alliance for Academic Internal Medicine; American Medical Association; Connecticut Children's Hospital; Mt Sinai Hospital, New York; World Congress; Rutgers University; Baystate Medical Center; Brigham and Women's Hospital; ESRI Inc; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St. Peters University Hospital, New Brunswick, New Jersey; Massachusetts Hospital Association; Cooper Health System, Camden, New Jersey; Organizzato dal Laboratorio Management e Sanita Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; Marwood Group; American Society of Clinical Oncologists; OR Manager; Delta Health Alliance; SUNY Upstate University; Intermountain Healthcare; Vermont Department of Banking, Insurance, Securities and Health Care Administration; HealthDialog; Colorado Foundation for Medical Care; Seyferth Blumenthal and Harris; American Medical Forensic Specialists; Robert Wood Johnson Foundation; National Institute on Aging [P01 AG19783]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	Texas Medical Association; Health Action Council, Cincinnati; Richard Stockton College of New Jersey; Iowa Health Business Alliance; Alliance for Academic Internal Medicine; American Medical Association; Connecticut Children's Hospital; Mt Sinai Hospital, New York; World Congress; Rutgers University; Baystate Medical Center; Brigham and Women's Hospital; ESRI Inc; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St. Peters University Hospital, New Brunswick, New Jersey; Massachusetts Hospital Association; Cooper Health System, Camden, New Jersey; Organizzato dal Laboratorio Management e Sanita Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; Marwood Group; American Society of Clinical Oncologists; OR Manager; Delta Health Alliance; SUNY Upstate University; Intermountain Healthcare; Vermont Department of Banking, Insurance, Securities and Health Care Administration; HealthDialog; Colorado Foundation for Medical Care; Seyferth Blumenthal and Harris; American Medical Forensic Specialists; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Goodman reported speaking fees from Texas Medical Association; Health Action Council, Cincinnati; Richard Stockton College of New Jersey; Iowa Health Business Alliance; Alliance for Academic Internal Medicine; American Medical Association; Connecticut Children's Hospital; Mt Sinai Hospital, New York; World Congress; Rutgers University; Baystate Medical Center; Brigham and Women's Hospital; ESRI Inc; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St. Peters University Hospital, New Brunswick, New Jersey; Massachusetts Hospital Association; Cooper Health System, Camden, New Jersey; Organizzato dal Laboratorio Management e Sanita Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; The Marwood Group; American Society of Clinical Oncologists; OR Manager; Delta Health Alliance; SUNY Upstate University; and Intermountain Healthcare; and consulting fees from Vermont Department of Banking, Insurance, Securities and Health Care Administration; HealthDialog; Colorado Foundation for Medical Care; Seyferth Blumenthal and Harris; and American Medical Forensic Specialists. Drs Chang, Stukel, and Flood reported no disclosures.; This research was supported in part by the Robert Wood Johnson Foundation and grant P01 AG19783 from the National Institute on Aging.	Billings J, 2003, USING ADM DATA MONIT; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Center for the Evaluative Clinical Sciences at Dartmouth, 1996, QUAL MED CAR US REP; Chernew ME, 2009, HEALTH AFFAIR, V28, P1327, DOI 10.1377/hlthaff.28.5.1327; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Council on Graduate Medical Education, 2010, 20 REP ADV PRIM CAR; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Franks P, 1999, HEALTH SERV RES, V34, P323; Goodman DC, 2006, HEALTH AFFAIR, V25, P521, DOI 10.1377/hlthaff.25.2.521; Goodman DC, 1996, JAMA-J AM MED ASSOC, V276, P1811, DOI 10.1001/jama.276.22.1811; Goodman DC, 2003, HEALTH SERV RES, V38, P287, DOI 10.1111/1475-6773.00116; Goodman DC., 2010, REGIONAL RACIAL VARI; Gottlieb DJ, 2010, HEALTH AFFAIR, V29, P537, DOI 10.1377/hlthaff.2009.0609; GRUMBACH K, 1995, AM J PUBLIC HEALTH, V85, P1402, DOI 10.2105/AJPH.85.10.1402; Guttmann A, 2010, PEDIATRICS, V125, P1119, DOI 10.1542/peds.2009-2821; Krakauer H, 1996, HEALTH SERV RES, V31, P191; Laditka JN, 2005, HEALTH SERV RES, V40, P1148, DOI 10.1111/j.1475-6773.2005.00403.x; Phillips RL, 2004, AM FAM PHYSICIAN, V70, P440; Ricketts TC, 2007, HEALTH SERV RES, V42, P2233, DOI 10.1111/j.1475-6773.2007.00728.x; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Rosser WW, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911519; Salsberg E, 2008, JAMA-J AM MED ASSOC, V300, P1174, DOI 10.1001/jama.300.10.1174; Sandy LG, 2009, HEALTH AFFAIR, V28, P1136, DOI 10.1377/hlthaff.28.4.1136; Shi LY, 2005, SOC SCI MED, V61, P65, DOI 10.1016/j.socscimed.2004.11.056; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B, 2005, HLTH AFF MILLWOOD S; Steinbrook R, 2009, NEW ENGL J MED, V360, P2696, DOI 10.1056/NEJMp0903460; Wennberg J. E., 2008, TRACKING CARE PATIEN; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607	33	119	120	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2011	305	20					2096	2105		10.1001/jama.2011.665	http://dx.doi.org/10.1001/jama.2011.665			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768AC	21610242	Green Accepted, Bronze			2022-12-01	WOS:000290901700023
J	Mattison, MLP; Zeidel, M				Mattison, Melissa L. P.; Zeidel, Mark			Navigating the Challenges of In-flight Emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mattison, Melissa L. P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Mattison, MLP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	mmattiso@bidmc.harvard.edu						Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; Sand M, 2009, CRIT CARE, V13, DOI 10.1186/cc7690; Shaner DM, 2010, NEW ENGL J MED, V363, P1988, DOI 10.1056/NEJMp1006331; Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9; *US FED AV ADM, 12133B US FED AV ADM; *US FED AV ADM, 12134B US FED AV ADM; *US FED AV ADM, COMM AIR CARR FAT RA; NO US AIRLINE FATALI; THERES DOCTOR BOARD	9	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					2003	2004		10.1001/jama.2011.618	http://dx.doi.org/10.1001/jama.2011.618			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21540410				2022-12-01	WOS:000290665500024
J	Lakhani, M				Lakhani, Mayur			PERSONAL VIEW Let's talk about dying	BRITISH MEDICAL JOURNAL			English	Editorial Material												MK.Lakhani@GP-C82644.nhs.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2011	342								d3018	10.1136/bmj.d3018	http://dx.doi.org/10.1136/bmj.d3018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QO	21586451				2022-12-01	WOS:000290951700007
J	Guarani, V; Deflorian, G; Franco, CA; Kruger, M; Phng, LK; Bentley, K; Toussaint, L; Dequiedt, F; Mostoslavsky, R; Schmidt, MHH; Zimmermann, B; Brandes, RP; Mione, M; Westphal, CH; Braun, T; Zeiher, AM; Gerhardt, H; Dimmeler, S; Potente, M				Guarani, Virginia; Deflorian, Gianluca; Franco, Claudio A.; Krueger, Marcus; Phng, Li-Kun; Bentley, Katie; Toussaint, Louise; Dequiedt, Franck; Mostoslavsky, Raul; Schmidt, Mirko H. H.; Zimmermann, Barbara; Brandes, Ralf P.; Mione, Marina; Westphal, Christoph H.; Braun, Thomas; Zeiher, Andreas M.; Gerhardt, Holger; Dimmeler, Stefanie; Potente, Michael			Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase	NATURE			English	Article							NEGATIVE REGULATOR; ANGIOGENESIS; CELLS; DLL4; DIFFERENTIATION; ZEBRAFISH; GROWTH; ACTS	Notch signalling is a key intercellular communication mechanism that is essential for cell specification and tissue patterning, and which coordinates critical steps of blood vessel growth(1-3). Although subtle alterations in Notch activity suffice to elicit profound differences in endothelial behaviour and blood vessel formation(2,3), little is known about the regulation and adaptation of endothelial Notch responses. Here we report that the NAD1-dependent deacetylase SIRT1 acts as an intrinsic negative modulator of Notch signalling in endothelial cells. We show that acetylation of the Notch1 intracellular domain (NICD) on conserved lysines controls the amplitude and duration of Notch responses by altering NICD protein turnover. SIRT1 associates with NICD and functions as a NICD deacetylase, which opposes the acetylation-induced NICD stabilization. Consequently, endothelial cells lacking SIRT1 activity are sensitized to Notch signalling, resulting in impaired growth, sprout elongation and enhanced Notch target gene expression in response to DLL4 stimulation, thereby promoting a non-sprouting, stalk-cell-like phenotype. In vivo, inactivation of Sirt1 in zebrafish and mice causes reduced vascular branching and density as a consequence of enhanced Notch signalling. Our findings identify reversible acetylation of the NICD as a molecular mechanism to adapt the dynamics of Notch signalling, and indicate that SIRT1 acts as rheostat to fine-tune endothelial Notch responses.	[Guarani, Virginia; Zimmermann, Barbara; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Deflorian, Gianluca; Mione, Marina] FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy; [Franco, Claudio A.; Phng, Li-Kun; Bentley, Katie; Gerhardt, Holger] London Res Inst Canc Res UK, Vasc Biol Lab, London WC2A 3LY, England; [Krueger, Marcus; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Toussaint, Louise; Dequiedt, Franck] GxABT, Lab Prot Signaling & Interact, B-5030 Gembloux, Belgium; [Toussaint, Louise; Dequiedt, Franck] Univ Liege, Interdisciplinary Cluster Appl Genoprote GIGA R, B-4000 Sart Tilman Par Liege, Belgium; [Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Schmidt, Mirko H. H.] Goethe Univ Frankfurt, Edinger Inst, Inst Neurol, D-60590 Frankfurt, Germany; [Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, Vasc Res Ctr, D-60590 Frankfurt, Germany; [Westphal, Christoph H.] Sirtris, Cambridge, MA 02139 USA; [Zeiher, Andreas M.; Potente, Michael] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany; [Gerhardt, Holger] VIB, Vesalius Res Ctr, Vasc Patterning Lab, Consultant Grp, B-3000 Louvain, Belgium	Goethe University Frankfurt; IFOM - FIRC Institute of Molecular Oncology; University of London; Institute of Cancer Research - UK; Max Planck Society; University of Liege; Harvard University; Harvard Medical School; Massachusetts General Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Flanders Institute for Biotechnology (VIB)	Potente, M (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.	potente@em.uni-frankfurt.de	Phng, Li-Kun/L-7346-2013; Schmidt, Mirko H. H./ABI-6650-2020; Gerhardt, Holger/G-4610-2011; Brandes, Ralf P/L-3058-2017; Franco, Claudio A/B-1060-2013; Franco, Claudio A/D-8117-2015; Mione, Maria Caterina/ABG-9926-2021; Braun, Thomas/B-2310-2008; Mione, Maria Caterina/I-3073-2013; Gerhardt, Holger/G-4610-2011	Schmidt, Mirko H. H./0000-0001-7411-8835; Gerhardt, Holger/0000-0002-3030-0384; Brandes, Ralf P/0000-0002-8035-0048; Franco, Claudio A/0000-0002-2861-3883; Franco, Claudio A/0000-0002-2861-3883; Bentley, Katie/0000-0002-9391-659X; Braun, Thomas/0000-0002-6165-4804; Mione, Maria Caterina/0000-0002-9040-3705; Dequiedt, Franck/0000-0003-1234-7477; Dimmeler, Stefanie/0000-0002-1045-2436; Potente, Michael/0000-0002-5689-0036; Gerhardt, Holger/0000-0001-9228-7472	DFG [PO1306/1-1, SFB 834/A6, Exc 147/1]; Interuniversity Attraction Poles Program-Belgian Science Policy [IUAP-BELSPO PVI/28]; Sidney Kimmel Cancer Research Foundation; Massachusetts Life Sciences Center; NIH [R01DK088190-01A1, R01GM093072-01]; Cancer Research UK; European Molecular Biology Organisation; Lister Institute of Preventive Medicine; Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Marie Curie FP7 People initiative; AIRC (Associazione Italiana per la Ricerca sul Cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office); Sidney Kimmel Cancer Research Foundation; Massachusetts Life Sciences Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); European Molecular Biology Organisation; Lister Institute of Preventive Medicine; Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Marie Curie FP7 People initiative; AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to F. W. Alt, R. Kopan, Z. Lou, E. Seto, S. L. Berger, S. Diane Hayward, S. McMahon, G. Thurston and N. D. Lawson for reagents and to I. Dikic for comments. This work was supported by grants from the DFG (PO1306/1-1, SFB 834/A6 and Exc 147/1). F.D. was supported by the Interuniversity Attraction Poles Program-Belgian Science Policy (IUAP-BELSPO PVI/28). R.M. is supported by the Sidney Kimmel Cancer Research Foundation, a New Investigator Grant from the Massachusetts Life Sciences Center, an AFAR Research Grant and NIH grants (R01DK088190-01A1 and R01GM093072-01). H.G. is supported by Cancer Research UK, the European Molecular Biology Organisation Young Investigator Programme, and The Lister Institute of Preventive Medicine. H.G. and K.B. are supported by the Fondation Leducq Transatlantic Network of Excellence ARTEMIS. C.A.F. is supported by the Marie Curie FP7 People initiative. G.D. and M.M. thank F. Pezzimenti for fish care and technical help, and AIRC (Associazione Italiana per la Ricerca sul Cancro) for financial support.	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095	36	272	284	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					234	+		10.1038/nature09917	http://dx.doi.org/10.1038/nature09917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21499261	Green Accepted			2022-12-01	WOS:000290487200043
J	Bers, DM; Harris, SP				Bers, Donald M.; Harris, Samantha P.			TRANSLATIONAL MEDICINE To the rescue of the failing heart	NATURE			English	Editorial Material							FAILURE		[Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Harris, Samantha P.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080367] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080367] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Kawase Y, 2011, J AM COLL CARDIOL, V57, P1169, DOI 10.1016/j.jacc.2010.11.023; Kushnir A, 2010, ADV PHARMACOL, V59, P1, DOI 10.1016/S1054-3589(10)59001-X; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Tang WHW, 2010, J AM COLL CARDIOL, V55, P688, DOI 10.1016/j.jacc.2009.10.028	6	10	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					36	39		10.1038/473036a	http://dx.doi.org/10.1038/473036a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544138				2022-12-01	WOS:000290218300024
J	Moynihan, R				Moynihan, Ray			MEDICALISATION A new deal on disease definition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ASSOCIATION; PANEL		Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Brotto L, 2009, ARCH SEXUAL BEHAV; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clayton A, 2009, J SEXUAL MED; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Cosgrove L, 2009, NEW ENGL J MED, V360, P2035, DOI 10.1056/NEJMc0810237; Frances A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1168; Godlee F, 2010, BMJ-BRIT MED J, V341, pc4766; Institute of Medicine, 2009, CONFL INT MED RES ED; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moynihan R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4442; *NIH, CONS DEV PROGR; NIH State of the Science Conference, 2009, NIH STAT SCI C DIAGN; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Ryan EA, 2011, DIABETOLOGIA, V54, P480, DOI 10.1007/s00125-010-2005-4; US Department of Health and Human Services Food and Drug Administration, 2008, FDA GUID; Welch G, 2011, DIAGNOSED MAKING PEO; WHO, REP WHO COMM SOC DET; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z	19	25	26	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2011	342								d2548	10.1136/bmj.d2548	http://dx.doi.org/10.1136/bmj.d2548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MA	21540259				2022-12-01	WOS:000290481600008
J	Brandon, MP; Bogaard, AR; Libby, CP; Connerney, MA; Gupta, K; Hasselmo, ME				Brandon, Mark P.; Bogaard, Andrew R.; Libby, Christopher P.; Connerney, Michael A.; Gupta, Kishan; Hasselmo, Michael E.			Reduction of Theta Rhythm Dissociates Grid Cell Spatial Periodicity from Directional Tuning	SCIENCE			English	Article							FREELY MOVING RATS; ENTORHINAL CORTEX; PHASE PRECESSION; REPRESENTATION; MEMORY; HIPPOCAMPUS; MODULATION; WORKING	Grid cells recorded in the medial entorhinal cortex of freely moving rats exhibit firing at regular spatial locations and temporal modulation with theta rhythm oscillations (4 to 11 hertz). We analyzed grid cell spatial coding during reduction of network theta rhythm oscillations caused by medial septum (MS) inactivation with muscimol. During MS inactivation, grid cells lost their spatial periodicity, whereas head-direction cells maintained their selectivity. Conjunctive grid-by-head-direction cells lost grid cell spatial periodicity but retained head-direction specificity. All cells showed reduced rhythmicity in autocorrelations and cross-correlations. This supports the hypothesis that spatial coding by grid cells requires theta oscillations, and dissociates the mechanisms underlying the generation of entorhinal grid cell periodicity and head-direction selectivity.	[Brandon, Mark P.; Bogaard, Andrew R.; Libby, Christopher P.; Connerney, Michael A.; Gupta, Kishan; Hasselmo, Michael E.] Boston Univ, Dept Psychol, Ctr Memory & Brain, Grad Program Neurosci, Boston, MA 02215 USA	Boston University	Brandon, MP (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, Grad Program Neurosci, 2 Cummington St, Boston, MA 02215 USA.	markpb68@bu.edu; hasselmo@bu.edu		Hasselmo, Michael/0000-0002-9925-6377	National Institute of Mental Health [R01 MH60013, MH61492]; Office of Naval Research Multidisciplinary University Research Initiative [N00014-10-1-0936]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060013, R01MH061492] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Thanks to C. Stern, S. Leutgeb, H. Eichenbaum, N. Schultheiss, E. Newman, C. Monaghan, J. Climer, and E. Zilli for advice and comments and to T. Ware for technical assistance. The research was supported by National Institute of Mental Health grants R01 MH60013 and MH61492 and Office of Naval Research Multidisciplinary University Research Initiative grant N00014-10-1-0936.	Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CHROBAK JJ, 1989, BEHAV NEURAL BIOL, V52, P357, DOI 10.1016/S0163-1047(89)90472-X; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; GIVENS B, 1994, J NEUROSCI, V14, P3578; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Martin MM, 2007, PHYSIOL BEHAV, V90, P412, DOI 10.1016/j.physbeh.2006.10.007; MITCHELL SJ, 1982, J NEUROSCI, V2, P292; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; Navratilova Z., 2011, HIPPOCAMPUS, DOI 10.1002/hipo.20939; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pang KCH, 1999, BEHAV NEUROSCI, V113, P265, DOI 10.1037/0735-7044.113.2.265; RAWLINS JNP, 1979, EXP BRAIN RES, V37, P49, DOI 10.1007/BF01474253; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646	28	285	285	5	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					595	599		10.1126/science.1201652	http://dx.doi.org/10.1126/science.1201652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527714	Green Accepted			2022-12-01	WOS:000289991100051
J	Guo, JU; Su, YJ; Zhong, C; Ming, GL; Song, HJ				Guo, Junjie U.; Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun			Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain	CELL			English	Article							SINGLE-STRANDED-DNA; METHYLATION; GLYCOSYLASE; GENOME; 5-HYDROXYMETHYLCYTOSINE; INHIBITOR; DEAMINASE; QUANTIFICATION; MECHANISMS; CONVERSION	Cytosine methylation is the major covalent modification of mammalian genomic DNA and plays important roles in transcriptional regulation. The molecular mechanism underlying the enzymatic removal of this epigenetic mark, however, remains elusive. Here, we show that 5-methylcytosine (5mC) hydroxylase TET1, by converting 5mCs to 5-hydroxymethylcytosines (5hmCs), promotes DNA demethylation in mammalian cells through a process that requires the base excision repair pathway. Though expression of the 12 known human DNA glycosylases individually did not enhance removal of 5hmCs in mammalian cells, demethylation of both exogenously introduced and endogenous 5hmCs is promoted by the AID (activation-induced deaminase)/APOBEC (apolipoprotein B mRNA-editing enzyme complex) family of cytidine deaminases. Furthermore, Tet1 and Apobec1 are involved in neuronal activity-induced, region-specific, active DNA demethylation and subsequent gene expression in the dentate gyrus of the adult mouse brain in vivo. Our study suggests a TET1-induced oxidation-deamination mechanism for active DNA demethylation in mammals.	[Guo, Junjie U.; Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013; Erlitzki, Noa/AHC-5346-2022; liyue, shi/G-4890-2011	Ming, Guo-li/0000-0002-2517-6075	AMRF; NIH [HD069184, NS048271, NS047344, AG024984, MH087874]; FARMS; MSCRF; NARSAD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087874, R21MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R01NS048271, R56NS047344, R37NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	AMRF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FARMS; MSCRF; NARSAD(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D.K.Ma and K. Christian for comments; members of Song and Ming laboratories for discussion; Y. Gao for RNA-seq; H.C. Kang, J.S. Jeong, N.Y. Jung and J. Shin for help with molecular cloning; and Q. Hussaini, Y. Cai, and L. Liu for technical support. This work was supported by AMRF and NIH (HD069184 and NS048271) to G.-I.M., by NIH (NS047344, AG024984, and MH087874) and NARSAD to H.J.S., and by fellowships from FARMS to J.U.G, AMRF to Y.S., and MSCRF to C.Z.	Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang QM, 2005, DNA REPAIR, V4, P71, DOI 10.1016/j.dnarep.2004.08.002; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	55	995	1062	0	159	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					423	434		10.1016/j.cell.2011.03.022	http://dx.doi.org/10.1016/j.cell.2011.03.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21496894	Green Accepted, Bronze			2022-12-01	WOS:000290022900011
J	Goodridge, HS; Reyes, CN; Becker, CA; Katsumoto, TR; Ma, J; Wolf, AJ; Bose, N; Chan, ASH; Magee, AS; Danielson, ME; Weiss, A; Vasilakos, JP; Underhill, DM				Goodridge, Helen S.; Reyes, Christopher N.; Becker, Courtney A.; Katsumoto, Tamiko R.; Ma, Jun; Wolf, Andrea J.; Bose, Nandita; Chan, Anissa S. H.; Magee, Andrew S.; Danielson, Michael E.; Weiss, Arthur; Vasilakos, John P.; Underhill, David M.			Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'	NATURE			English	Article							BETA-GLUCAN RECOGNITION; CANDIDA-ALBICANS; LECTIN RECEPTORS; DENDRITIC CELLS; MACROPHAGES; KINASE; CD148; CLEC-2; CD45	Innate immune cells must be able to distinguish between direct binding to microbes and detection of components shed from the surface of microbes located at a distance. Dectin-1 (also known as CLEC7A) is a pattern-recognition receptor expressed by myeloid phagocytes (macrophages, dendritic cells and neutrophils) that detects beta-glucans in fungal cell walls and triggers direct cellular antimicrobial activity, including phagocytosis and production of reactive oxygen species (ROS)(1,2). In contrast to inflammatory responses stimulated upon detection of soluble ligands by other pattern-recognition receptors, such as Toll-like receptors (TLRs), these responses are only useful when a cell comes into direct contact with a microbe and must not be spuriously activated by soluble stimuli. In this study we show that, despite its ability to bind both soluble and particulate beta-glucan polymers, Dectin-1 signalling is only activated by particulate beta-glucans, which cluster the receptor in synapse-like structures from which regulatory tyrosine phosphatases CD45 and CD148 (also known as PTPRC and PTPRJ, respectively) are excluded (Supplementary Fig. 1). The 'phagocytic synapse' now provides a model mechanism by which innate immune receptors can distinguish direct microbial contact from detection of microbes at a distance, thereby initiating direct cellular antimicrobial responses only when they are required.	[Goodridge, Helen S.; Reyes, Christopher N.; Becker, Courtney A.; Ma, Jun; Wolf, Andrea J.; Underhill, David M.] Cedars Sinai Med Ctr, IBD & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Goodridge, Helen S.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Goodridge, Helen S.; Underhill, David M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Katsumoto, Tamiko R.; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Bose, Nandita; Chan, Anissa S. H.; Magee, Andrew S.; Danielson, Michael E.; Vasilakos, John P.] Biothera, Eagan, MN 55121 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, IBD & Immunobiol Res Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	UNDERHILL, DAVID/ABE-2185-2021; Katsumoto, Tamiko/V-4086-2019	Katsumoto, Tamiko/0000-0002-7978-0315; Underhill, David/0000-0002-2989-658X	NIH [AI071116, AI066120]; American Heart Association; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066120, R01AI071116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Wawrowsky for help with confocal microscopy, and G. D. Brown for Dectin-1-deficient mice. This study was funded by grants from the NIH (AI071116 and AI066120 to D. M. U. and A. W., respectively) and the American Heart Association (D. M. U.). H. S. G. held a Research Fellowship Award from the Crohn's and Colitis Foundation of America. D. M. U. holds the Janis and William Wetsman Family Chair in Inflammatory Bowel Disease at Cedars-Sinai Medical Center.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; CZOP JK, 1985, J IMMUNOL, V134, P2588; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Feng D, 2007, J NEUROSCI, V27, P12757, DOI 10.1523/JNEUROSCI.2846-07.2007; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	24	531	552	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					471	U541		10.1038/nature10071	http://dx.doi.org/10.1038/nature10071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525931	Green Accepted, Green Submitted			2022-12-01	WOS:000289949600034
J	Habashi, JP; Doyle, JJ; Holm, TM; Aziz, H; Schoenhoff, F; Bedja, D; Chen, YC; Modiri, AN; Judge, DP; Dietz, HC				Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Bedja, Djahida; Chen, YiChun; Modiri, Alexandra N.; Judge, Daniel P.; Dietz, Harry C.			Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism	SCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; MARFAN-SYNDROME; MOUSE MODEL; BLOCKADE; GROWTH; PATHOGENESIS; CONTRIBUTES; MECHANISM; ACTIVATION; EXPRESSION	Angiotensin II (AngII) mediates progression of aortic aneurysm, but the relative contribution of its type 1 (AT1) and type 2 (AT2) receptors remains unknown. We show that loss of AT2 expression accelerates the aberrant growth and rupture of the aorta in a mouse model of Marfan syndrome (MFS). The selective AT1 receptor blocker (ARB) losartan abrogated aneurysm progression in the mice; full protection required intact AT2 signaling. The angiotensin-converting enzyme inhibitor (ACEi) enalapril, which limits signaling through both receptors, was less effective. Both drugs attenuated canonical transforming growth factor-beta (TGF beta) signaling in the aorta, but losartan uniquely inhibited TGF beta-mediated activation of extracellular signal-regulated kinase (ERK), by allowing continued signaling through AT2. These data highlight the protective nature of AT2 signaling and potentially inform the choice of therapies in MFS and related disorders.	[Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Chen, YiChun; Modiri, Alexandra N.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Doyle, Jefferson J.; Holm, Tammy M.; Aziz, Hamza; Schoenhoff, Florian; Chen, YiChun; Modiri, Alexandra N.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Div Pediat Cardiol, Dept Pediat, Baltimore, MD 21205 USA; [Bedja, Djahida] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Judge, Daniel P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Doyle, Jefferson/C-3156-2013; Chen, Yichun/AAI-3892-2020; Chen, Yi-Chun/H-4468-2013	Chen, Yichun/0000-0002-9092-7189; Judge, Daniel/0000-0002-3407-0248; Schoenhoff, Florian/0000-0002-3311-4595	NIH; Howard Hughes Medical Institute; National Marfan Foundation; Johns Hopkins School of Medicine; Smilow Center for Marfan Syndrome Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR041135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Marfan Foundation; Johns Hopkins School of Medicine(Johns Hopkins University); Smilow Center for Marfan Syndrome Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the NIH (H. C. D., D.P.J.); Howard Hughes Medical Institute (H. C. D.); the National Marfan Foundation (H. C. D., J.P.H., J.J.D.); the Cellular and Molecular Medicine Training Program, Johns Hopkins School of Medicine (J.J.D.); and the Smilow Center for Marfan Syndrome Research (H. C. D.). We thank T. Inagami for the AT2KO mice. Johns Hopkins University and the authors (H. C. D., J.P.H., D.P.J.) have filed a patent relating to the use of TGF beta antagonists, including AT1 receptor blockers, for the treatment of Marfan syndrome.	Ahimastos AA, 2007, JAMA-J AM MED ASSOC, V298, P1539, DOI 10.1001/jama.298.13.1539; Akishita M, 1999, J CLIN INVEST, V103, P63, DOI 10.1172/JCI5182; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Jones ES, 2004, J MOL CELL CARDIOL, V37, P1023, DOI 10.1016/j.yjmcc.2004.08.004; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Nagashima H, 2002, J VASC SURG, V36, P818, DOI 10.1067/mva.2002.126091; Nagashima H, 2001, CIRCULATION, V104, pI282; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Patten RD, 2003, CLIN SCI, V104, P109, DOI 10.1042/CS20020219; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Sakurabayashi-Kitade S, 2009, ATHEROSCLEROSIS, V206, P54, DOI 10.1016/j.atherosclerosis.2009.01.039; Siragy HM, 1999, P NATL ACAD SCI USA, V96, P6506, DOI 10.1073/pnas.96.11.6506; Ulmasov B, 2009, AM J PHYSIOL-GASTR L, V296, pG284, DOI 10.1152/ajpgi.90409.2008; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028; Yetman AT, 2005, AM J CARDIOL, V95, P1125, DOI 10.1016/j.amjcard.2005.01.032	23	318	324	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					361	365		10.1126/science.1192152	http://dx.doi.org/10.1126/science.1192152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493863	Green Accepted			2022-12-01	WOS:000289516600048
J	Bonner, L				Bonner, Laura			The Walk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bonnerlauram@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1393	1393		10.1001/jama.2011.368	http://dx.doi.org/10.1001/jama.2011.368			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486965				2022-12-01	WOS:000289424100030
J	Theoret, MR; Ning, YM; Zhang, JJ; Justice, R; Keegan, P; Pazdur, R				Theoret, Marc R.; Ning, Yang-Min; Zhang, Jenny J.; Justice, Robert; Keegan, Patricia; Pazdur, Richard			The Risks and Benefits of 5 alpha-Reductase Inhibitors for Prostate-Cancer Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHEMOPREVENTION		[Theoret, Marc R.; Ning, Yang-Min; Justice, Robert; Keegan, Patricia; Pazdur, Richard] US FDA, Off Oncol Drug Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Zhang, Jenny J.] US FDA, Off Biostat, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Theoret, MR (corresponding author), US FDA, Off Oncol Drug Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.		Zhang, Jenny/GXV-4980-2022					Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; *FDA, 2010, DEC 1 M ONC DRUGS AD; Kramer BS, 2009, J CLIN ONCOL, V27, P1502, DOI 10.1200/JCO.2008.16.9599; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Walsh PC, 2010, NEW ENGL J MED, V362, P1237, DOI 10.1056/NEJMe1001045	5	114	117	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					97	99		10.1056/NEJMp1106783	http://dx.doi.org/10.1056/NEJMp1106783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21675880				2022-12-01	WOS:000292685500001
J	Izawa, Y; Pun, D; Stahl, SS				Izawa, Yusuke; Pun, Doris; Stahl, Shannon S.			Palladium-Catalyzed Aerobic Dehydrogenation of Substituted Cyclohexanones to Phenols	SCIENCE			English	Article							MOLECULAR-OXYGEN; OXIDATIVE AROMATIZATION; HYDRIDE; TRIFLUOROACETATE; COMPLEXES; TURNOVER; STRATEGY; AMINES; LIGAND; BOND	Aromatic molecules are key constituents of many pharmaceuticals, electronic materials, and commodity plastics. The utility of these molecules directly reflects the identity and pattern of substituents on the aromatic ring. Here, we report a palladium(II) catalyst system, incorporating an unconventional ortho-dimethylaminopyridine ligand, for the conversion of substituted cyclohexanones to the corresponding phenols. The reaction proceeds via successive dehydrogenation of two saturated carbon-carbon bonds of the six-membered ring and uses molecular oxygen as the hydrogen acceptor. This reactivity demonstrates a versatile and efficient strategy for the synthesis of substituted aromatic molecules with fundamentally different selectivity constraints from the numerous known synthetic methods that rely on substitution of a preexisting aromatic ring.	[Izawa, Yusuke; Pun, Doris; Stahl, Shannon S.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu			NIH [RC1-GM091161]; Mitsubishi Chemical Corporation; NSF [CHE-1041934]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091161] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitsubishi Chemical Corporation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the NIH (RC1-GM091161), Mitsubishi Chemical Corporation, and NSF (CHE-1041934 to D.P.) for financial support of this work.	Ahuja R, 2011, NAT CHEM, V3, P167, DOI [10.1038/nchem.946, 10.1038/NCHEM.946]; BAMFIELD P, 1984, CHEM SOC REV, V13, P441, DOI 10.1039/cs9841300441; Bercaw JE, 2008, J ORG CHEM, V73, P8654, DOI 10.1021/jo8016296; Bercaw JE, 2008, ANGEW CHEM INT EDIT, V47, P9941, DOI 10.1002/anie.200804455; Buckle D. R., 2010, ENCY REAGENTS ORGANI; Campbell AN, 2010, J AM CHEM SOC, V132, P15116, DOI 10.1021/ja105829t; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Choi J, 2011, CHEM REV, V111, P1761, DOI 10.1021/cr1003503; Denney MC, 2006, J AM CHEM SOC, V128, P2508, DOI 10.1021/ja0562292; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; FU PP, 1978, CHEM REV, V78, P317, DOI 10.1021/cr60314a001; Gligorich KM, 2009, CHEM COMMUN, P3854, DOI 10.1039/b902868d; Heitman LH, 2009, J MED CHEM, V52, P2036, DOI 10.1021/jm801561h; HORNING EC, 1947, J AM CHEM SOC, V69, P1359, DOI 10.1021/ja01198a035; Izawa Y, 2010, ADV SYNTH CATAL, V352, P3223, DOI 10.1002/adsc.201000771; Konnick MM, 2008, J AM CHEM SOC, V130, P5753, DOI 10.1021/ja7112504; LAROCK RC, 1993, J ORG CHEM, V58, P5298, DOI 10.1021/jo00072a004; Maleczka RE, 2003, J AM CHEM SOC, V125, P7792, DOI 10.1021/ja0349857; Moriuchi T, 2009, TETRAHEDRON LETT, V50, P7385, DOI 10.1016/j.tetlet.2009.10.070; MUZART J, 1982, J MOL CATAL, V15, P373, DOI 10.1016/0304-5102(82)80029-1; Muzart J, 2010, EUR J ORG CHEM, V2010, P3779, DOI 10.1002/ejoc.201000278; SCHUDA PF, 1987, J ORG CHEM, V52, P1972, DOI 10.1021/jo00386a014; SHELDON RA, 1991, J MOL CATAL, V68, P1, DOI 10.1016/0304-5102(91)80056-9; Stahl SS, 2004, ANGEW CHEM INT EDIT, V43, P3400, DOI 10.1002/anie.200300630; Tyman J.H.P., 1996, SYNTHETIC NATURAL PH; VANBENTHEM RATM, 1994, J CHEM SOC CHEM COMM, P357, DOI 10.1039/c39940000357; WENZEL TT, 1989, J CHEM SOC CHEM COMM, P932, DOI 10.1039/c39890000932; Ye XA, 2010, GREEN CHEM, V12, P1180, DOI 10.1039/c0gc00106f; Yi CS, 2009, ORGANOMETALLICS, V28, P947, DOI 10.1021/om8010883; Zhang XW, 2011, INORG CHIM ACTA, V369, P253, DOI 10.1016/j.ica.2010.11.016	30	350	354	4	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					209	213		10.1126/science.1204183	http://dx.doi.org/10.1126/science.1204183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21659567	Green Accepted			2022-12-01	WOS:000292502700046
J	Hothorn, M; Belkhadir, Y; Dreux, M; Dabi, T; Noel, JP; Wilson, IA; Chory, J				Hothorn, Michael; Belkhadir, Youssef; Dreux, Marlene; Dabi, Tsegaye; Noel, Joseph. P.; Wilson, Ian A.; Chory, Joanne			Structural basis of steroid hormone perception by the receptor kinase BRI1	NATURE			English	Article							RICH REPEAT PROTEIN; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; BRASSINOSTEROIDS; COMPLEX; BAK1; RECOGNITION; ACTIVATION; BRI1/BAK1; MUTANT	Polyhydroxylated steroids are regulators of body shape and size in higher organisms. In metazoans, intracellular receptors recognize these molecules. Plants, however, perceive steroids at membranes, using the membrane-integral receptor kinase BRASSINOSTEROID INSENSITIVE 1 (BRI1). Here we report the structure of the Arabidopsis thaliana BRI1 ligand-binding domain, determined by X-ray diffraction at 2.5 angstrom resolution. We find a superhelix of 25 twisted leucine-rich repeats (LRRs), an architecture that is strikingly different from the assembly of LRRs in animal Toll-like receptors. A 70-amino-acid island domain between LRRs 21 and 22 folds back into the interior of the superhelix to create a surface pocket for binding the plant hormone brassinolide. Known loss- and gain-of-function mutations map closely to the hormone-binding site. We propose that steroid binding to BRI1 generates a docking platform for a co-receptor that is required for receptor activation. Our findings provide insight into the activation mechanism of this highly expanded family of plant receptors that have essential roles in hormone, developmental and innate immunity signalling.	[Hothorn, Michael; Belkhadir, Youssef; Dabi, Tsegaye; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Belkhadir, Youssef; Dabi, Tsegaye; Noel, Joseph. P.; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Dreux, Marlene] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Noel, Joseph. P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Scripps Research Institute; Salk Institute; Scripps Research Institute; Scripps Research Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Belkhadir, Youssef/GXM-6743-2022; Dreux, Marlene/M-7295-2014; Noel, Joseph P/A-9459-2009; Hothorn, Michael/C-6807-2011	Dreux, Marlene/0000-0002-6607-4796; Belkhadir, Youssef/0000-0001-7149-7139; Hothorn, Michael/0000-0002-3597-5698	Howard Hughes Medical Institute; National Science Foundation [IOS-0649389]; European Molecular Biology Organisation; International Human Frontier Science Program Organisation; Philippe Foundation; NIH [AI042266]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI042266] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organisation; International Human Frontier Science Program Organisation; Philippe Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Vanhnasy and W. Yu for maintaining insect cell stocks, M. Jinek and B. W. Han for advice, W. Kwiatowski for maintenance of the Salk X-ray equipment, Y. Jaillais for discussion, and F.V. Chisari for encouragement and support. This work was supported by the Howard Hughes Medical Institute and a grant from the National Science Foundation (IOS-0649389) to J.C. M.H. was supported by long-term fellowships from the European Molecular Biology Organisation and the International Human Frontier Science Program Organisation. Y.B. was a Howard Hughes Medical Institute fellow of the Life Sciences Research Foundation and also received support from the Philippe Foundation. I.A.W. was supported by NIH grant AI042266 and by the Skaggs Institute for Chemical Biology.	Back TG, 2003, J PLANT GROWTH REGUL, V22, P350, DOI 10.1007/s00344-003-0057-0; Belkhadir Y, 2006, SCIENCE, V314, P1410, DOI 10.1126/science.1134040; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Dievarta A, 2006, FUNCT PLANT BIOL, V33, P723, DOI 10.1071/FP06080; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gruszka D, 2011, J APPL GENET, V52, P257, DOI 10.1007/s13353-011-0031-7; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Whippo CW, 2005, PLANT PHYSIOL, V139, P448, DOI 10.1104/pp.105.064444	50	268	294	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					467	U90		10.1038/nature10153	http://dx.doi.org/10.1038/nature10153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21666665	Green Accepted, Green Submitted			2022-12-01	WOS:000291939700039
J	Anderson, E; Siegel, EH; Bliss-Moreau, E; Barrett, LF				Anderson, Eric; Siegel, Erika H.; Bliss-Moreau, Eliza; Barrett, Lisa Feldman			The Visual Impact of Gossip	SCIENCE			English	Article							BINOCULAR-RIVALRY; DOMINANCE DURATIONS; FACIAL EXPRESSIONS; PERCEPTION; ATTENTION; CONTRAST; EMOTION; FACES; RECOGNITION; PREDOMINATE	Gossip is a form of affective information about who is friend and who is foe. We show that gossip does not influence only how a face is evaluated-it affects whether a face is seen in the first place. In two experiments, neutral faces were paired with negative, positive, or neutral gossip and were then presented alone in a binocular rivalry paradigm (faces were presented to one eye, houses to the other). In both studies, faces previously paired with negative (but not positive or neutral) gossip dominated longer in visual consciousness. These findings demonstrate that gossip, as a potent form of social affective learning, can influence vision in a completely top-down manner, independent of the basic structural features of a face.	[Anderson, Eric; Siegel, Erika H.; Barrett, Lisa Feldman] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Bliss-Moreau, Eliza] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Barrett, Lisa Feldman] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; [Barrett, Lisa Feldman] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Northeastern University; University of California System; University of California Davis; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Barrett, LF (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	l.barrett@neu.edu	Barrett, Lisa Feldman/ABC-8157-2020	Anderson, Eric/0000-0002-4215-6308	NIH [DP1OD003312]; U.S. Army Research Institute for the Behavioral and Social Sciences [W91WAW-08-C-0018]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Research Institute for the Behavioral and Social Sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Preparation of this manuscript was supported by the NIH Director's Pioneer Award (DP1OD003312) and by the U.S. Army Research Institute for the Behavioral and Social Sciences (contract W91WAW-08-C-0018) to L.F.B. The views, opinions, and/or findings contained in this article are solely those of the author(s) and should not be construed as an official Department of the Army or Department of Defense position, policy, or decision. We thank J. Shang and M. Norton for their help with data collection.	Abelson RP, 1997, PSYCHOL METHODS, V2, P315, DOI 10.1037/1082-989X.2.4.315; Alpers GW, 2007, EMOTION, V7, P495, DOI 10.1037/1528-3542.7.3.495; Alpers GW, 2006, COGNITION EMOTION, V20, P596, DOI 10.1080/02699930500282249; Alpers GW, 2005, INT J PSYCHOPHYSIOL, V57, P25, DOI 10.1016/j.ijpsycho.2005.01.008; Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; Bannerman RL, 2008, OPHTHAL PHYSL OPT, V28, P317, DOI 10.1111/j.1475-1313.2008.00568.x; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111; Blake R., 2001, BRAIN MIND, V2, P5, DOI [10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, https://doi.org/10.1023/A:1017925416289]; Bliss-Moreau E, 2008, EMOTION, V8, P479, DOI 10.1037/1528-3542.8.4.479; Carmel D, 2010, CURR BIOL, V20, pR799, DOI 10.1016/j.cub.2010.07.036; Carter OL, 2005, CURR BIOL, V15, pR412, DOI 10.1016/j.cub.2005.05.043; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Delplanque S, 2007, J NEUROSCI METH, V165, P144, DOI 10.1016/j.jneumeth.2007.05.030; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; Duncan S, 2007, COGNITION EMOTION, V21, P1184, DOI 10.1080/02699930701437931; HOLLINS M, 1980, PERCEPT PSYCHOPHYS, V27, P550, DOI 10.3758/BF03198684; Kakizaki S., 1960, JPN PSYCHOL RES, V2, P94, DOI [10.4992/psycholres1954.2.94, DOI 10.4992/PSYCHOLRES1954.2.94]; Knebel JF, 2008, BRAIN TOPOGR, V20, P284, DOI 10.1007/s10548-008-0046-5; Levelt W., 1965, BINOCULAR RIVALRY; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Nagamine M, 2007, PHYSIOL BEHAV, V91, P161, DOI 10.1016/j.physbeh.2007.02.016; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; WHITTLE P, 1965, Q J EXP PSYCHOL, V17, P217, DOI 10.1080/17470216508416435; Yoon KL, 2009, EMOTION, V9, P172, DOI 10.1037/a0014714; YU K, 1992, J EXP PSYCHOL HUMAN, V18, P1158, DOI 10.1037/0096-1523.18.4.1158	34	98	103	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1446	1448		10.1126/science.1201574	http://dx.doi.org/10.1126/science.1201574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778FT	21596956	Green Accepted			2022-12-01	WOS:000291689000046
J	Phan, G; Remaut, H; Wang, T; Allen, WJ; Pirker, KF; Lebedev, A; Henderson, NS; Geibel, S; Volkan, E; Yan, J; Kunze, MBA; Pinkner, JS; Ford, B; Kay, CWM; Li, HL; Hultgren, SJ; Thanassi, DG; Waksman, G				Phan, Gilles; Remaut, Han; Wang, Tao; Allen, William J.; Pirker, Katharina F.; Lebedev, Andrey; Henderson, Nadine S.; Geibel, Sebastian; Volkan, Ender; Yan, Jun; Kunze, Micha B. A.; Pinkner, Jerome S.; Ford, Bradley; Kay, Christopher W. M.; Li, Huilin; Hultgren, Scott J.; Thanassi, David G.; Waksman, Gabriel			Crystal structure of the FimD usher bound to its cognate FimC-FimH substrate	NATURE			English	Article							CHAPERONE-SUBUNIT COMPLEXES; BACTERIAL OUTER-MEMBRANE; PILUS BIOGENESIS; MOLECULAR REPLACEMENT; ADHESIN; RECOGNITION; DOMAIN; SITE	Type 1 pili are the archetypal representative of a widespread class of adhesive multisubunit fibres in Gram-negative bacteria. During pilus assembly, subunits dock as chaperone-bound complexes to an usher, which catalyses their polymerization and mediates pilus translocation across the outer membrane. Here we report the crystal structure of the full-length FimD usher bound to the FimC-FimH chaperone-adhesin complex and that of the unbound form of the FimD translocation domain. The FimD-FimC-FimH structure shows FimH inserted inside the FimD 24-stranded beta-barrel translocation channel. FimC-FimH is held in place through interactions with the two carboxy-terminal periplasmic domains of FimD, a binding mode confirmed in solution by electron paramagnetic resonance spectroscopy. To accommodate FimH, the usher plug domain is displaced from the barrel lumen to the periplasm, concomitant with a marked conformational change in the beta-barrel. The amino-terminal domain of FimD is observed in an ideal position to catalyse incorporation of a newly recruited chaperone-subunit complex. The FimD-FimC-FimH structure provides unique insights into the pilus subunit incorporation cycle, and captures the first view of a protein transporter in the act of secreting its cognate substrate.	[Phan, Gilles; Remaut, Han; Allen, William J.; Pirker, Katharina F.; Geibel, Sebastian; Yan, Jun; Kunze, Micha B. A.; Kay, Christopher W. M.; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Phan, Gilles; Remaut, Han; Allen, William J.; Pirker, Katharina F.; Geibel, Sebastian; Yan, Jun; Kunze, Micha B. A.; Kay, Christopher W. M.; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Remaut, Han] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Wang, Tao; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Lebedev, Andrey] Univ York, Dept Chem, York YO10 5YW, N Yorkshire, England; [Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Volkan, Ender; Pinkner, Jerome S.; Ford, Bradley; Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Volkan, Ender; Pinkner, Jerome S.; Ford, Bradley; Hultgren, Scott J.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Ford, Bradley] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kay, Christopher W. M.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Kay, Christopher W. M.; Waksman, Gabriel] UCL, Res Dept Struct & Mol Biol, London WC1E 6BT, England; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; United States Department of Energy (DOE); Brookhaven National Laboratory; University of York - UK; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; University of London; University College London; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	david.thanassi@stonybrook.edu; g.waksman@ucl.ac.uk	VOLKAN, ENDER/AAJ-4583-2021; VOLKAN, ENDER/GRF-1572-2022; Kay, Christopher William Michael/C-2467-2008; VOLKAN, ENDER/ABI-7302-2020; Geibel, Sebastian/B-5607-2015	VOLKAN, ENDER/0000-0002-0071-5028; Kay, Christopher William Michael/0000-0002-5200-6004; Geibel, Sebastian/0000-0003-0068-680X; Remaut, Han/0000-0002-9775-4102; Kunze, Micha/0000-0001-8922-5510; Frederiksen, Jun/0000-0003-0764-1831; Pinkner, Jerome/0000-0002-7389-7440; Ford, Bradley/0000-0002-7871-7955; Li, Huilin/0000-0001-8085-8928	Medical Research Council [85602]; NIH [GM62987, 49950, 29549, 48689, GM74985]; BNL [10-16]; VIB; FWO-Vlaanderen; Austrian Science Fund [J 2959-N17]; Biotechnology and Biological Sciences Research Council [BB/F001134/1] Funding Source: researchfish; Medical Research Council [G0100442, G0800002] Funding Source: researchfish; BBSRC [BB/F001134/1] Funding Source: UKRI; MRC [G0100442, G0800002] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985, R01GM062987] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BNL; VIB; FWO-Vlaanderen(FWO); Austrian Science Fund(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Medical Research Council grant 85602 to G.W., NIH grant GM62987 to D.G.T., NIH grants 49950, 29549 and 48689 to S.J.H., and NIH grant GM74985 and BNL LDRD grant 10-16 to H.L.; H.R. is supported by a VIB Young PI project grant and the Odysseus program of the FWO-Vlaanderen. K.F.P. is supported by a Schrodinger Fellowship from the Austrian Science Fund, project J 2959-N17. We thank the staff of beamlines X25 and X29 at NSLS, the staff of beamline ID23-1 at ESRF, N. Cronin for technical assistance during data collection, and H. Saibil and E. Orlova for comments on the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ford B, 2010, J BACTERIOL, V192, P1824, DOI 10.1128/JB.01677-09; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li QQ, 2010, MOL MICROBIOL, V76, P159, DOI 10.1111/j.1365-2958.2010.07089.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Munera D, 2007, MOL MICROBIOL, V64, P333, DOI 10.1111/j.1365-2958.2007.05657.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ng TW, 2004, J BACTERIOL, V186, P5321, DOI 10.1128/JB.186.16.5321-5331.2004; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Rose RJ, 2008, P NATL ACAD SCI USA, V105, P12873, DOI 10.1073/pnas.0802177105; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; So SSK, 2006, MOL MICROBIOL, V60, P364, DOI 10.1111/j.1365-2958.2006.052111.x; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verger D, 2008, STRUCTURE, V16, P1724, DOI 10.1016/j.str.2008.08.012; Verger D, 2006, EMBO REP, V7, P1228, DOI 10.1038/sj.embor.7400833; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	44	137	138	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					49	U71		10.1038/nature10109	http://dx.doi.org/10.1038/nature10109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637253	Green Accepted			2022-12-01	WOS:000291156700034
J	Lee, H; Chah, OK; Sheen, J				Lee, Horim; Chah, Ok-Kyong; Sheen, Jen			Stem-cell-triggered immunity through CLV3p-FLS2 signalling	NATURE			English	Article							RECEPTOR-LIKE KINASE; BACTERIAL ELICITOR FLAGELLIN; RICH REPEAT DOMAIN; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; PERCEPTION; FLS2; CLAVATA1; MERISTEM; RESISTANCE	Stem cells in the shoot apical meristem (SAM) of plants are the self-renewable reservoir for leaf, stem and flower organogenesis(1,2). In nature, disease-free plants can be regenerated from SAM despite infections elsewhere, which underlies a horticultural practice for decades(3). However, the molecular basis of the SAM immunity remains unclear. Here we show that the CLAVATA3 peptide (CLV3p), expressed and secreted from stem cells and functioning as a key regulator of stem-cell homeostasis in the SAM of Arabidopsis(1,2,4), can trigger immune signalling and pathogen resistance via the flagellin receptor kinase FLS2 (refs 5, 6). CLV3p-FLS2 signalling acts independently from the stem-cell signalling pathway mediated through CLV1 and CLV2 receptors(1,2,4), and is uncoupled from FLS2-mediated growth suppression(5,6). Endogenous CLV3p perception in the SAM by a pattern recognition receptor for bacterial flagellin, FLS2, breaks the previously defined self and non-self discrimination in innate immunity(6,7). The dual perception of CLV3p illustrates co-evolution of plant peptide and receptor kinase signalling for both development and immunity. The enhanced immunity in SAM or germ lines may represent a common strategy towards immortal fate in plants and animals(1,2,8).	[Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Lee, Horim; Chah, Ok-Kyong; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, H (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	hrlee@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu	Lee, Horim/I-6180-2019		NSF; NIH; MGH CCIB fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493, R01GM070567] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH CCIB fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Laux for the pWUS::GUS line, Y. Matsubayashi for the purified Ara-CLV3 peptide and advice, A. Collmer for the GFP-labelled P. syringae pv. tomato DC3000, L. Shan and P. He for constructs, G. Tena, F. Ausubel, J. Bush, J. Plotnikova and ABRC for mutant seeds and bacterial strains, and Y. Xiong, M. McCormack, Y. Niu, M. Ramon and J. Li for critically reading of the manuscript. Funding was provided by the NSF, NIH and the MGH CCIB fund to J.S.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Baurle I, 2003, BIOESSAYS, V25, P961, DOI 10.1002/bies.10341; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Butenko MA, 2009, TRENDS PLANT SCI, V14, P255, DOI 10.1016/j.tplants.2009.02.002; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fiers M, 2006, PLANT PHYSIOL, V141, P1284, DOI 10.1104/pp.106.080671; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Goldsby RA, 2006, KUBY IMMUNOLOGY; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HOLLINGS M, 1965, ANNU REV PHYTOPATHOL, V3, P367, DOI 10.1146/annurev.py.03.090165.002055; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jun JH, 2008, CELL MOL LIFE SCI, V65, P743, DOI 10.1007/s00018-007-7411-5; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Miwa H, 2008, PLANT CELL PHYSIOL, V49, P1752, DOI 10.1093/pcp/pcn148; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Scheres B, 2005, CELL, V122, P499, DOI 10.1016/j.cell.2005.08.006; Schreiber K, 2008, PLANT J, V54, P522, DOI 10.1111/j.1365-313X.2008.03425.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yamamizo C, 2006, PLANT PHYSIOL, V140, P681, DOI 10.1104/pp.105.074906; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	40	57	61	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					376	U559		10.1038/nature09958	http://dx.doi.org/10.1038/nature09958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21499263	Green Accepted			2022-12-01	WOS:000290722400049
J	Mihaylova, MM; Vasquez, DS; Ravnskjaer, K; Denechaud, PD; Yu, RT; Alvarez, JG; Downes, M; Evans, RM; Montminy, M; Shaw, RJ				Mihaylova, Maria M.; Vasquez, Debbie S.; Ravnskjaer, Kim; Denechaud, Pierre-Damien; Yu, Ruth T.; Alvarez, Jacqueline G.; Downes, Michael; Evans, Ronald M.; Montminy, Marc; Shaw, Reuben J.			Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis	CELL			English	Article							CREB COACTIVATOR TORC2; STEM-CELL HOMEOSTASIS; PROTEIN-KINASE; TRANSCRIPTION FACTOR; METABOLIC SYNDROME; GENE-EXPRESSION; CLASS IIHDAC; PHOSPHORYLATION; ACETYLATION; DISEASE	Class IIa histone deacetylases (HDACs) are signal-dependent modulators of transcription with established roles in muscle differentiation and neuronal survival. We show here that in liver, class IIa HDACs (HDAC4, 5, and 7) are phosphorylated and excluded from the nucleus by AMPK family kinases. In response to the fasting hormone glucagon, class IIa HDACs are rapidly dephosphorylated and translocated to the nucleus where they associate with the promoters of gluconeogenic enzymes such as G6Pase. In turn, HDAC4/5 recruit HDAC3, which results in the acute transcriptional induction of these genes via deacetylation and activation of FOXO family transcription factors. Loss of class IIa HDACs in murine liver results in inhibition of FOXO target genes and lowers blood glucose, resulting in increased glycogen storage. Finally, suppression of class IIa HDACs in mouse models of type 2 diabetes ameliorates hyperglycemia, suggesting that inhibitors of class I/II HDACs may be potential therapeutics for metabolic syndrome.	[Mihaylova, Maria M.; Vasquez, Debbie S.; Denechaud, Pierre-Damien; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Ravnskjaer, Kim; Montminy, Marc] Salk Inst Biol Studies, Clayton Labs Peptide Biol, La Jolla, CA 92037 USA; [Yu, Ruth T.; Alvarez, Jacqueline G.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Evans, Ronald M.; Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Vasquez, Debbie S.; Ravnskjaer, Kim; Denechaud, Pierre-Damien; Yu, Ruth T.; Alvarez, Jacqueline G.; Downes, Michael; Evans, Ronald M.; Montminy, Marc; Shaw, Reuben J.] Salk Inst Biol Studies, Leona & Harry Helmsley Ctr Nutr Genom, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu	Ravnskjaer, Kim/GRJ-3065-2022; Evans, Ronald/AAF-4001-2019; Pierre-Damien, Denechaud/M-5650-2016; Mihaylova, Maria M./ACZ-4949-2022	Ravnskjaer, Kim/0000-0002-5322-3887; Evans, Ronald/0000-0002-9986-5965; Pierre-Damien, Denechaud/0000-0003-3502-4814; Mihaylova, Maria M./0000-0002-2725-767X; Yu, Ruth/0000-0002-9527-9627	NIH [HD027183, DK062434, R01 DK049777, R01DK083834, R01 DK080425, P01CA120964]; American Diabetes Association [1-08-JF-47];  [T32 CMG]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195, P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090962, R01DK049777, R01DK080425, R37DK083834, R01DK083834, U19DK062434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.M.M. performed all cell and biochemistry experiments, designed shRNAs, generated and large-scale purified all adenoviruses utilized, characterized all antisera utilized, and with assistance from D. S. V. performed all mouse experiments. M. M. M. and R.J.S. designed the study, analyzed the data, and wrote the paper. In addition, K. R. in the lab of M. M. performed ChIP in Figure 3, Figure 5, and Figure S3; P.-D.D. in the lab of R.J.S. assisted with hepatocyte generation for Figure S2. R.T.Y. in the lab of R. M. E. performed microarray analysis in Figure 3A. J.G.A. and M. D. in the lab of R. M. E. performed qPCR in Figure 3B and Figure 6D. We thank A. Fukamizu (U. of Tsukuba) and A. Brunet (Stanford) for Foxo1 antibodies; M. Karin (UCSD) and P. Chambon (IGBMC) for the Albumin-creERT2 mice; B. Wang and S. Hedrick for sharing reagents and assistance; H. Juguilon for technical assistance; D. Shackelford for assistance with the in vivo mouse imaging studies; R. Dentin for initial help with hepatocytes; L. Gerken for genotyping; R. Kohnz for initial characterization of Alb-creERT2 LKB1 mice; J. Fitzpatrick for confocal imaging assistance; and K. Lamia for comments on the manuscript. We apologize to many investigators whose primary studies in the HDAC and FOXO fields could not be cited due to space limitations. M. M. M. was supported through the T32 CMG training grant to UCSD/Salk. R. M. E. is funded by the NIH HD027183 and DK062434. M. M. is funded by the NIH R01 DK049777 and R01DK083834. R. J. S. is funded by the NIH R01 DK080425 and P01CA120964 and the American Diabetes Association Junior Faculty Award 1-08-JF-47. We thank the Leona M. and Harry B. Helmsley Charitable Trust for their generous support.	Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Dansen TB, 2004, J LIPID RES, V45, P81, DOI 10.1194/jlr.M300111-JLR200; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dequiedt F, 2006, MOL CELL BIOL, V26, P7086, DOI 10.1128/MCB.00231-06; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Imai T, 2000, GENESIS, V26, P147, DOI 10.1002/(SICI)1526-968X(200002)26:2<147::AID-GENE15>3.0.CO;2-3; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; Montminy M, 2004, ANN ENDOCRINOL-PARIS, V65, P73, DOI 10.1016/S0003-4266(04)95634-X; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Peng WT, 2009, GENESIS, V47, P590, DOI 10.1002/dvg.20538; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Salganik SV, 2009, LAB INVEST, V89, P1032, DOI 10.1038/labinvest.2009.64; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	54	403	420	2	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					607	621		10.1016/j.cell.2011.03.043	http://dx.doi.org/10.1016/j.cell.2011.03.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565617	Bronze, Green Accepted			2022-12-01	WOS:000290560800013
J	Gheorghiade, M; Braunwald, E				Gheorghiade, Mihai; Braunwald, Eugene			A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OUTCOMES; ASSOCIATION; CARDIOLOGY; SOCIETY; LUNG		[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, Chicago, IL 60611 USA; [Braunwald, Eugene] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc Med, Sch Med,Dept Med,TIMI Study Grp, Boston, MA 02115 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Flaherty JD, 2009, J AM COLL CARDIOL, V53, P254, DOI 10.1016/j.jacc.2008.08.072; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Peacock WF, 2010, J AM COLL CARDIOL, V56, P343, DOI 10.1016/j.jacc.2010.03.051	10	42	44	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1702	1703		10.1001/jama.2011.515	http://dx.doi.org/10.1001/jama.2011.515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521852				2022-12-01	WOS:000289890500024
J	Quraishi, NA; Esler, C				Quraishi, Nasir A.; Esler, Claire			EASILY MISSED? Metastatic spinal cord compression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL-MANAGEMENT; CANCER; DISEASE; RADIOTHERAPY; DIAGNOSIS; RESECTION		[Quraishi, Nasir A.] Queens Med Ctr, Ctr Spine Studies & Surg, Nottingham NG7 2UH, England; [Esler, Claire] Leicester Royal Infirm, Dept Oncol, Leicester, Leics, England	University of Nottingham; University of Leicester	Quraishi, NA (corresponding author), Queens Med Ctr, Ctr Spine Studies & Surg, Nottingham NG7 2UH, England.	nasquraishi@hotmail.com						AARON AD, 1994, JAMA-J AM MED ASSOC, V272, P1206, DOI 10.1001/jama.272.15.1206; Baur A, 2002, RADIOLOGY, V225, P730, DOI 10.1148/radiol.2253011413; Chen YJ, 2007, SPINE, V32, pE413, DOI 10.1097/BRS.0b013e318074d6c7; Fung HS, 2003, RADIOGRAPHICS, V23, P179, DOI 10.1148/rg.231025043; Graham PH, 2006, CLIN ONCOL-UK, V18, P70, DOI 10.1016/j.clon.2005.08.015; HELWEGLARSEN S, 1994, EUR J CANCER, V30A, P396, DOI 10.1016/0959-8049(94)90263-1; Klimo PJ, 2003, NEUROSURG FOCUS, V15, P1; Kwok Y, 2006, HEMATOL ONCOL CLIN N, V20, P1297, DOI 10.1016/j.hoc.2006.09.008; Levack P, 2002, CLIN ONCOL-UK, V14, P472, DOI 10.1053/clon.2002.0098; Levack P, 2001, 9708 CRAG; Loblaw DA, 2003, CLIN ONCOL, V14, P472; Mannion RJ, 2007, BRIT J NEUROSURG, V21, P593, DOI 10.1080/02688690701593579; National Institute for Health and Clinical Excellence, 2008, CLIN GUID NAT I HLTH; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Prewett S, 2010, CLIN ONCOL-UK, V22, P222, DOI 10.1016/j.clon.2010.01.006; Quraishi NA, 2010, J BONE JOINT SURG BR, V92B, P1054, DOI 10.1302/0301-620X.92B8.22296; SCHABERG J, 1985, SPINE, V10, P19, DOI 10.1097/00007632-198501000-00003; Schiff D, 2003, NEUROL CLIN, V21, P67, DOI 10.1016/S0733-8619(02)00033-6; Sciubba DM, 2006, SURG ONCOL, V15, P141, DOI 10.1016/j.suronc.2006.11.002; Senel A, 2007, NEUROSURG REV, V30, P131, DOI 10.1007/s10143-007-0067-7; Shehadi JA, 2007, EUR SPINE J, V16, P1179, DOI 10.1007/s00586-007-0357-3; SORENSEN PS, 1994, EUR J CANCER, V30A, P22, DOI 10.1016/S0959-8049(05)80011-5; White BD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2538; Witham TF, 2006, NAT CLIN PRACT NEURO, V2, P87, DOI 10.1038/ncpneuro0116	24	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2011	342								d2402	10.1136/bmj.d2402	http://dx.doi.org/10.1136/bmj.d2402			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759BT	21525095				2022-12-01	WOS:000290215600004
J	Kagaya, K; Takahata, M				Kagaya, Katsushi; Takahata, Masakazu			Sequential Synaptic Excitation and Inhibition Shape Readiness Discharge for Voluntary Behavior	SCIENCE			English	Article							CENTRAL NERVOUS SYSTEM; PROCAMBARUS-CLARKII; NEURAL ACTIVITY; CENTRAL COMPLEX; FRONTAL-CORTEX; MOTOR CORTEX; CRAYFISH; INITIATION; MOVEMENTS; WALKING	How do animals initiate voluntary behavior? A key phenomenon in neuroscience is the readiness or preparatory neural activity in specific regions of the animal brain. The neurons and synaptic mechanisms mediating this activity are unknown. We found that the readiness discharge is shaped by sequential synaptic excitation and inhibition in the brain of crayfish (Procambarus clarkii). The readiness discharge neurons extended axon collaterals that appeared to activate recurring local interneurons. Therefore, we propose that the readiness discharge is formed by sequential synaptic events within the brain without feedback signals from downstream ganglia. The circuit involved is suited for signal processing for self-generated voluntary initiation of behavior.	[Kagaya, Katsushi; Takahata, Masakazu] Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University	Kagaya, K (corresponding author), Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	kagaya@sci.hokudai.ac.jp		Kagaya, Katsushi/0000-0003-3001-7690	Ministry of Education, Culture, Sports, Science and Technology, Japan [18657025, 20370028]; Grants-in-Aid for Scientific Research [23370031] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (18657025 and 20370028).	ATWOOD HL, 1967, J EXP BIOL, V46, P249; Bender JA, 2010, CURR BIOL, V20, P921, DOI 10.1016/j.cub.2010.03.054; BOWERMAN RF, 1974, J EXP BIOL, V60, P119; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chikamoto K, 2008, ZOOL SCI, V25, P783, DOI 10.2108/zsj.25.783; CHRACHRI A, 1990, J NEUROSCI, V10, P707; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kagaya K, 2010, J NEUROSCI, V30, P1348, DOI 10.1523/JNEUROSCI.4885-09.2010; Maimon G, 2006, J NEUROSCI, V26, P2487, DOI 10.1523/JNEUROSCI.3590-05.2006; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; OKANO K, 1987, EXP BRAIN RES, V66, P155; Roskies AL, 2010, ANNU REV NEUROSCI, V33, P109, DOI 10.1146/annurev-neuro-060909-153151; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; WIERSMA CAG, 1958, J COMP NEUROL, V110, P421, DOI 10.1002/cne.901100306	16	12	12	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					365	368		10.1126/science.1202244	http://dx.doi.org/10.1126/science.1202244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493864				2022-12-01	WOS:000289516600049
J	Hauri, EH; Weinreich, T; Saal, AE; Rutherford, MC; Van Orman, JA				Hauri, Erik H.; Weinreich, Thomas; Saal, Alberto E.; Rutherford, Malcolm C.; Van Orman, James A.			High Pre-Eruptive Water Contents Preserved in Lunar Melt Inclusions	SCIENCE			English	Article							OCEAN-RIDGE BASALT; VOLATILE CONTENT; SNC METEORITES; GLASSES; MANTLE; MOON; DEHYDRATION; CONSTRAINTS; ABUNDANCES; ISOTOPES	The Moon has long been thought to be highly depleted in volatiles such as water, and indeed published direct measurements of water in lunar volcanic glasses have never exceeded 50 parts per million (ppm). Here, we report in situ measurements of water in lunar melt inclusions; these samples of primitive lunar magma, by virtue of being trapped within olivine crystals before volcanic eruption, did not experience posteruptive degassing. The lunar melt inclusions contain 615 to 1410 ppm water and high correlated amounts of fluorine (50 to 78 ppm), sulfur (612 to 877 ppm), and chlorine (1.5 to 3.0 ppm). These volatile contents are very similar to primitive terrestrial mid-ocean ridge basalts and indicate that some parts of the lunar interior contain as much water as Earth's upper mantle.	[Hauri, Erik H.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Weinreich, Thomas; Saal, Alberto E.; Rutherford, Malcolm C.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Van Orman, James A.] Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA	Carnegie Institution for Science; Brown University; Case Western Reserve University	Hauri, EH (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	ehauri@ciw.edu		Van Orman, James/0000-0001-8741-0288	Carnegie Institution of Washington; NASA; NASA Lunar Science Institute; NASA Astrobiology Institute	Carnegie Institution of Washington; NASA(National Aeronautics & Space Administration (NASA)); NASA Lunar Science Institute; NASA Astrobiology Institute	This work was supported by the Carnegie Institution of Washington, the NASA LASER and Cosmochemistry programs, the NASA Lunar Science Institute, and the NASA Astrobiology Institute. We thank J. Wang for NanoSIMS assistance, and L. Nittler and Z. Peeters for help with image processing software.	Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Bombardieri DJ, 2005, METEORIT PLANET SCI, V40, P679, DOI 10.1111/j.1945-5100.2005.tb00973.x; Boyce JW, 2010, NATURE, V466, P466, DOI 10.1038/nature09274; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Crotts APS, 2008, ASTROPHYS J, V687, P692, DOI 10.1086/591634; DELANO JW, 1986, J GEOPHYS RES-SOLID, V91, pD201, DOI 10.1029/JB091iB04p0D201; Dixon JE, 2002, NATURE, V420, P385, DOI 10.1038/nature01215; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Greenwood JP, 2011, NAT GEOSCI, V4, P79, DOI 10.1038/NGEO1050; Hauri E, 2002, CHEM GEOL, V183, P115, DOI 10.1016/S0009-2541(01)00374-6; JAMBON A, 1990, EARTH PLANET SC LETT, V101, P323, DOI 10.1016/0012-821X(90)90163-R; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; KLEIN N, 1998, LUNAR PLANET SCI, V29, P1448; Lassiter JC, 2002, EARTH PLANET SC LETT, V202, P525, DOI 10.1016/S0012-821X(02)00826-9; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; MCSWEEN HY, 1993, SCIENCE, V259, P1890, DOI 10.1126/science.259.5103.1890; MICHAEL P, 1995, EARTH PLANET SC LETT, V131, P301, DOI 10.1016/0012-821X(95)00023-6; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; ROEDDER E, 1972, EARTH PLANET SC LETT, V13, P272, DOI 10.1016/0012-821X(72)90103-3; Roedder E., 1970, P APOLLO 11 LUNAR SC, P801; Roedder E., 1971, P LUNAR PLANET SCI C, V2, P507; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Sharp ZD, 2010, SCIENCE, V329, P1050, DOI 10.1126/science.1192606; Shaw AM, 2008, EARTH PLANET SC LETT, V275, P138, DOI 10.1016/j.epsl.2008.08.015; Shaw AM, 2010, EARTH PLANET SC LETT, V289, P311, DOI 10.1016/j.epsl.2009.11.018; Shimizu N, 1998, PHYS EARTH PLANET IN, V107, P183, DOI 10.1016/S0031-9201(97)00133-7; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; Weitz CM, 1999, METEORIT PLANET SCI, V34, P527, DOI 10.1111/j.1945-5100.1999.tb01361.x; [No title captured]	30	246	256	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					213	215		10.1126/science.1204626	http://dx.doi.org/10.1126/science.1204626			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21617039				2022-12-01	WOS:000292502700047
J	Borgia, MB; Borgia, A; Best, RB; Steward, A; Nettels, D; Wunderlich, B; Schuler, B; Clarke, J				Borgia, Madeleine B.; Borgia, Alessandro; Best, Robert B.; Steward, Annette; Nettels, Daniel; Wunderlich, Bengt; Schuler, Benjamin; Clarke, Jane			Single-molecule fluorescence reveals sequence-specific misfolding in multidomain proteins	NATURE			English	Article							FOLDING MECHANISM; DOMAIN; AGGREGATION; ENERGY; TITIN; INTERMEDIATE; SPECTROSCOPY; COLLAPSE	A large range of debilitating medical conditions(1) is linked to protein misfolding, which may compete with productive folding particularly in proteins containing multiple domains(2). Seventy-five per cent of the eukaryotic proteome consists of multidomain proteins, yet it is not understood how interdomain misfolding is avoided. It has been proposed that maintaining low sequence identity between covalently linked domains is a mechanism to avoid misfolding(3). Here we use single-molecule Forster resonance energy transfer(4,5) to detect and quantify rare misfolding events in tandem immunoglobulin domains from the I band of titin under native conditions. About 5.5 per cent of molecules with identical domains misfold during refolding in vitro and form an unexpectedly stable state with an unfolding half-time of several days. Tandem arrays of immunoglobulin-like domains in humans show significantly lower sequence identity between neighbouring domains than between non-adjacent domains(3). In particular, the sequence identity of neighbouring domains has been found to be preferentially below 40 per cent(3). We observe no misfolding for a tandem of naturally neighbouring domains with low sequence identity (24 per cent), whereas misfolding occurs between domains that are 42 per cent identical. Coarse-grained molecular simulations predict the formation of domain-swapped structures that are in excellent agreement with the observed transfer efficiency of the misfolded species. We infer that the interactions underlying misfolding are very specific and result in a sequence-specific domain-swapping mechanism. Diversifying the sequence between neighbouring domains seems to be a successful evolutionary strategy to avoid misfolding in multidomain proteins.	[Borgia, Madeleine B.; Best, Robert B.; Steward, Annette; Clarke, Jane] Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England; [Borgia, Madeleine B.; Borgia, Alessandro; Nettels, Daniel; Wunderlich, Bengt; Schuler, Benjamin] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Cambridge; University of Zurich	Clarke, J (corresponding author), Univ Cambridge, Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	schuler@bioc.uzh.ch; jc162@cam.ac.uk	Schuler, Benjamin/E-7342-2011; Borgia, Alessandro/AAF-9203-2019; Best, Robert/H-7588-2016	Schuler, Benjamin/0000-0002-5970-4251; Borgia, Alessandro/0000-0002-4701-8967; Best, Robert/0000-0002-7893-3543	Wellcome Trust [064417]; Swiss National Science Foundation; Swiss National Center of Competence in Research in Structural Biology; UK Medical Research Council; Marie Curie Intra-European Fellowship; Royal Society; MRC [MC_U105485808] Funding Source: UKRI; Medical Research Council [MC_U105485808] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center of Competence in Research in Structural Biology(Swiss National Science Foundation (SNSF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Intra-European Fellowship(European Commission); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (grant number, 064417), the Swiss National Science Foundation (to B. S.) and the Swiss National Center of Competence in Research in Structural Biology (to B. S.). M. B. B. was supported by a UK Medical Research Council studentship. A. B. is supported by a Marie Curie Intra-European Fellowship. R. B. B. is supported by a Royal Society University Research Fellowship. J.C. is a Wellcome Trust Senior Research Fellow. We thank H. Hofmann, A. Soranno and A. Hoffmann for discussions and contributions to data analysis.	Arora P, 2006, BIOCHEMISTRY-US, V45, P12312, DOI 10.1021/bi060923s; Balamurali MM, 2008, PROTEIN SCI, V17, P1815, DOI 10.1110/ps.036376.108; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Borgia A, 2008, ANGEW CHEM INT EDIT, V47, P6900, DOI 10.1002/anie.200801761; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2; Gambin Y, 2009, P NATL ACAD SCI USA, V106, P10153, DOI 10.1073/pnas.0904461106; Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Hillger F, 2007, J FLUORESC, V17, P759, DOI 10.1007/s10895-007-0187-z; Hoffmann A, 2007, P NATL ACAD SCI USA, V104, P105, DOI 10.1073/pnas.0604353104; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Ivarsson Y, 2008, J BIOL CHEM, V283, P8954, DOI 10.1074/jbc.M707424200; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Karanicolas J, 2003, J MOL BIOL, V334, P309, DOI 10.1016/j.jmb.2003.09.047; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9; Nettels D, 2009, P NATL ACAD SCI USA, V106, P20740, DOI 10.1073/pnas.0900622106; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Schuler Benjamin, 2007, V350, P115; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Straub JE, 2010, CURR OPIN STRUC BIOL, V20, P187, DOI 10.1016/j.sbi.2009.12.017; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101	37	140	140	2	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					662	U142		10.1038/nature10099	http://dx.doi.org/10.1038/nature10099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21623368	Green Accepted			2022-12-01	WOS:000292204300044
J	She, J; Han, ZF; Kim, TW; Wang, JJ; Cheng, W; Chang, JB; Shi, SA; Wang, JW; Yang, MJ; Wang, ZY; Chai, JJ				She, Ji; Han, Zhifu; Kim, Tae-Wuk; Wang, Jinjing; Cheng, Wei; Chang, Junbiao; Shi, Shuai; Wang, Jiawei; Yang, Maojun; Wang, Zhi-Yong; Chai, Jijie			Structural insight into brassinosteroid perception by BRI1	NATURE			English	Article							RECEPTOR KINASE BRI1; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; EXTRACELLULAR DOMAIN; PLANT-GROWTH; COMPLEX; PHOSPHORYLATION; ACTIVATION; BRI1/BAK1	Brassinosteroids are essential phytohormones that have crucial roles in plant growth and development. Perception of brassinosteroids requires an active complex of BRASSINOSTEROID-INSENSITIVE 1 (BRI1) and BRI1-ASSOCIATED KINASE 1 (BAK1). Recognized by the extracellular leucine-rich repeat (LRR) domain of BRI1, brassinosteroids induce a phosphorylation-mediated cascade to regulate gene expression. Here we present the crystal structures of BRI1(LRR) in free and brassinolide-bound forms. BRI1(LRR) exists as a monomer in crystals and solution independent of brassinolide. It comprises a helical solenoid structure that accommodates a separate insertion domain at its concave surface. Sandwiched between them, brassinolide binds to a hydrophobicity-dominating surface groove on BRI1(LRR). Brassinolide recognition by BRI1(LRR) is through an induced-fit mechanism involving stabilization of two interdomain loops that creates a pronounced non-polar surface groove for the hormone binding. Together, our results define the molecular mechanisms by which BRI1 recognizes brassinosteroids and provide insight into brassinosteroid-induced BRI1 activation.	[She, Ji; Han, Zhifu; Wang, Jiawei; Yang, Maojun; Chai, Jijie] Tsinghua Univ, Key Lab Prot Sci, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [She, Ji] Peking Univ, Coll Biol Sci, Beijing 100084, Peoples R China; [She, Ji; Wang, Jinjing; Cheng, Wei; Chai, Jijie] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kim, Tae-Wuk; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Chang, Junbiao; Shi, Shuai] Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China	Tsinghua University; Peking University; National Institute of Biological Sciences, Beijing; Carnegie Institution for Science; Zhengzhou University	Chai, JJ (corresponding author), Tsinghua Univ, Key Lab Prot Sci, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China.	chaijj@mail.tsinghua.edu.cn	Wang, Zhi-Yong/E-3810-2012; She, Ji/AAW-6150-2021; chang, junbiao/P-1095-2014; Wang, Jiawei/D-1144-2010	Wang, Zhi-Yong/0000-0003-4602-3390; chang, junbiao/0000-0001-6236-1256; Wang, Jiawei/0000-0001-9893-8539; Chai, Jijie/0000-0001-7591-3873; Yang, Maojun/0000-0002-6798-3094	National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China [20101331722]; NIH [R01GM066258]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Huang and J. He at Shanghai Synchrotron Radiation Facility (SSRF) for assistance with data collection; J. Chory from the Salk Institute for providing the tritium-labelled brassinolide. This research was funded by the National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China grant no. 20101331722 to J. Chai and NIH R01GM066258 to Z.-Y.W.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; DeLano WL, 2002, PYMOL MOL; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2005, CURR OPIN PLANT BIOL, V8, P526, DOI 10.1016/j.pbi.2005.07.009; Li JM, 2002, SCIENCE, V295, P1299; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Sheard LB, 2009, NATURE, V462, P575, DOI 10.1038/462575a; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Whippo CW, 2005, PLANT PHYSIOL, V139, P448, DOI 10.1104/pp.105.064444; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zullo Marco António Teixeira, 2002, Braz. J. Plant Physiol., V14, P143, DOI 10.1590/S1677-04202002000300001	36	267	296	6	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					472	U96		10.1038/nature10178	http://dx.doi.org/10.1038/nature10178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21666666	Green Accepted			2022-12-01	WOS:000291939700040
J	Aylward, B; Yamada, T				Aylward, Bruce; Yamada, Tadataka			The Polio Endgame	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE; ERADICATION; TRIAL		[Aylward, Bruce] WHO, Geneva, Switzerland; [Yamada, Tadataka] Bill & Melinda Gates Fdn, Seattle, WA USA	World Health Organization; Bill & Melinda Gates Foundation	Aylward, B (corresponding author), WHO, Geneva, Switzerland.							Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kreeftenberg H, 2006, BIOLOGICALS, V34, P155, DOI 10.1016/j.biologicals.2006.02.011; Resik S, 2010, J INFECT DIS, V201, P1344, DOI 10.1086/651611; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7	5	35	36	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2273	2275		10.1056/NEJMp1104329	http://dx.doi.org/10.1056/NEJMp1104329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777RZ	21675884	Bronze			2022-12-01	WOS:000291643800001
J	Hsu, PP; Kang, SA; Rameseder, J; Zhang, Y; Ottina, KA; Lim, D; Peterson, TR; Choi, YM; Gray, NS; Yaffe, MB; Marto, JA; Sabatini, DM				Hsu, Peggy P.; Kang, Seong A.; Rameseder, Jonathan; Zhang, Yi; Ottina, Kathleen A.; Lim, Daniel; Peterson, Timothy R.; Choi, Yongmun; Gray, Nathanael S.; Yaffe, Michael B.; Marto, Jarrod A.; Sabatini, David M.			The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling	SCIENCE			English	Article							MESSENGER-RNA TRANSLATION; P-BODIES; PROTEIN; KINASE; GRB10; DISRUPTION; AUTOPHAGY; SPECIFICITY; ACTIVATION; REPRESSION	The mammalian target of rapamycin (mTOR) protein kinase is a master growth promoter that nucleates two complexes, mTORC1 and mTORC2. Despite the diverse processes controlled by mTOR, few substrates are known. We defined the mTOR-regulated phosphoproteome by quantitative mass spectrometry and characterized the primary sequence motif specificity of mTOR using positional scanning peptide libraries. We found that the phosphorylation response to insulin is largely mTOR dependent and that mTOR exhibits a unique preference for proline, hydrophobic, and aromatic residues at the +1 position. The adaptor protein Grb10 was identified as an mTORC1 substrate that mediates the inhibition of phosphoinositide 3-kinase typical of cells lacking tuberous sclerosis complex 2 (TSC2), a tumor suppressor and negative regulator of mTORC1. Our work clarifies how mTORC1 inhibits growth factor signaling and opens new areas of investigation in mTOR biology.	[Hsu, Peggy P.; Kang, Seong A.; Ottina, Kathleen A.; Peterson, Timothy R.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Peterson, Timothy R.; Yaffe, Michael B.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rameseder, Jonathan] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Rameseder, Jonathan; Lim, Daniel; Yaffe, Michael B.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Zhang, Yi; Choi, Yongmun; Gray, Nathanael S.; Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhang, Yi; Marto, Jarrod A.] DFCI, Blais Prote Ctr, Boston, MA 02115 USA; [Ottina, Kathleen A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Choi, Yongmun; Gray, Nathanael S.; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	National Institutes of Health [CA103866, AI47389, ES015339, GM68762, CA112967]; Department of Defense [W81XWH-07-0448]; W.M. Keck Foundation; LAM Foundation; Dana-Farber Cancer Institute; International Fulbright Science and Technology Award; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA103866, U54CA112967, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W.M. Keck Foundation(W.M. Keck Foundation); LAM Foundation; Dana-Farber Cancer Institute; International Fulbright Science and Technology Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini Lab for helpful discussion, especially B. Joughin, G. Bell, H. Keys, K. Birsoy, N. Kory, C. Thoreen, J. Claessen, and D. Wagner for assistance with technical or conceptual aspects of this project. This work was supported by the National Institutes of Health (grants CA103866 and AI47389 to D. M. S.; ES015339, GM68762, and CA112967 to M.B.Y.), Department of Defense (W81XWH-07-0448 to D. M. S.), the W.M. Keck Foundation (D. M. S.), LAM Foundation (D. M. S.), Dana-Farber Cancer Institute (N. S. G, J. M), the International Fulbright Science and Technology Award (J. R.), and American Cancer Society (S. A. K.). D. M. S. is an investigator of the Howard Hughes Medical Institute. Torin1, the drug used in this paper, is part of a Whitehead-DFCI patent application on which N. S. G. and D. M. S. are inventors. Shared reagents are subject to a Materials Transfer Agreement.	Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	31	768	795	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1317	1322		10.1126/science.1199498	http://dx.doi.org/10.1126/science.1199498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659604	Green Submitted, Green Accepted			2022-12-01	WOS:000291441700044
J	Scheel, C; Eaton, EN; Li, SHJ; Chaffer, CL; Reinhardt, F; Kah, KJ; Bell, G; Guo, W; Rubin, J; Richardson, AL; Weinberg, RA				Scheel, Christina; Eaton, Elinor Ng; Li, Sophia Hsin-Jung; Chaffer, Christine L.; Reinhardt, Ferenc; Kah, Kong-Jie; Bell, George; Guo, Wenjun; Rubin, Jeffrey; Richardson, Andrea L.; Weinberg, Robert A.			Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast	CELL			English	Article							STEM/PROGENITOR CELLS; CANCER-CELLS; IN-VITRO; TRANSITION; METASTASIS; PROPAGATION; EXPRESSION; PATHWAYS; DISEASE; LINES	The epithelial-mesenchymal transition (EMT) has been associated with the acquisition of motility, invasiveness, and self-renewal traits. During both normal development and tumor pathogenesis, this change in cell phenotype is induced by contextual signals that epithelial cells receive from their microenvironment. The signals that are responsible for inducing an EMT and maintaining the resulting cellular state have been unclear. We describe three signaling pathways, involving transforming growth factor (TGF)-beta and canonical and noncanonical Wnt signaling, that collaborate to induce activation of the EMT program and thereafter function in an autocrine fashion to maintain the resulting mesenchymal state. Downregulation of endogenously synthesized inhibitors of autocrine signals in epithelial cells enables the induction of the EMT program. Conversely, disruption of autocrine signaling by added inhibitors of these pathways inhibits migration and self-renewal in primary mammary epithelial cells and reduces tumorigenicity and metastasis by their transformed derivatives.	[Scheel, Christina; Eaton, Elinor Ng; Li, Sophia Hsin-Jung; Chaffer, Christine L.; Reinhardt, Ferenc; Kah, Kong-Jie; Bell, George; Guo, Wenjun; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Li, Sophia Hsin-Jung; Kah, Kong-Jie; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Weinberg, Robert A.] MIT Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Rubin, Jeffrey] NCI, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scheel, C (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	scheel@wi.mit.edu; weinberg@wi.mit.edu		Li, Sophia Hsin-Jung/0000-0001-8972-6921	National Institutes of Health/National Cancer Institute [CA12515, DE020817]; Massachusetts Institute of Technology Ludwig Center for Molecular Oncology; Ludwig Fellowship for Metastasis Research; Breast Cancer Research Foundation; Harvard Breast Cancer SPORE; Department of Defense; Samuel Waxman Foundation; NATIONAL CANCER INSTITUTE [ZIABC010251, U54CA126515, F32CA144404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020817] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Massachusetts Institute of Technology Ludwig Center for Molecular Oncology; Ludwig Fellowship for Metastasis Research; Breast Cancer Research Foundation; Harvard Breast Cancer SPORE; Department of Defense(United States Department of Defense); Samuel Waxman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Brian Bierie, Thijn Brummelkamp, Sunny Gupta, Katharina Leuchte, Julia Rastelli, Andreas Scheel, Scott Valastyan, and Irene Wuethrich for critical reading of the manuscript, members of the Weinberg lab for discussion, John Stingl for protocols, the Whitehead Microarray and Flow Cytometry Cores, and the W.M. Keck Microscopy Facility for technical support. This research was supported by the National Institutes of Health/National Cancer Institute (R.A.W.; CA12515 and DE020817), Massachusetts Institute of Technology Ludwig Center for Molecular Oncology (R.A.W.), Ludwig Fellowship for Metastasis Research (C.S.), Breast Cancer Research Foundation (A.L.R. and R.A.W.), Harvard Breast Cancer SPORE (A.L.R. and R.A.W.), Department of Defense Breast Cancer Research Program Idea Award (R.A.W.), and Samuel Waxman Foundation (R.A.W.). C.S. and R.A.W. are inventors on a patent application in part based on findings detailed in this manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; CHAFFER CL, 2011, P NATL ACAD IN PRESS; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toda H, 2003, J BIOL CHEM, V278, P35491, DOI 10.1074/jbc.M305342200; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	29	659	689	5	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					926	940		10.1016/j.cell.2011.04.029	http://dx.doi.org/10.1016/j.cell.2011.04.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663795	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000291461600019
J	Aliyu, F; Esegbona, G				Aliyu, Fatima; Esegbona, G.			A PATIENT'S JOURNEY Living with obstetric fistula	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Esegbona, G.] Specialist Hosp, Laure Fistula Ctr, Kano, Nigeria		Esegbona, G (corresponding author), Specialist Hosp, Laure Fistula Ctr, Kano, Nigeria.	gesegbona@aim.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2011	342								d2881	10.1136/bmj.d2881	http://dx.doi.org/10.1136/bmj.d2881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SR	21659374	Bronze			2022-12-01	WOS:000291645800001
J	Malovannaya, A; Lanz, RB; Jung, SY; Bulynko, Y; Le, NT; Chan, DW; Ding, C; Shi, Y; Yucer, N; Krenciute, G; Kim, BJ; Li, CS; Chen, R; Li, W; Wang, Y; O'Malley, BW; Qin, J				Malovannaya, Anna; Lanz, Rainer B.; Jung, Sung Yun; Bulynko, Yaroslava; Le, Nguyen T.; Chan, Doug W.; Ding, Chen; Shi, Yi; Yucer, Nur; Krenciute, Giedre; Kim, Beom-Jun; Li, Chunshu; Chen, Rui; Li, Wei; Wang, Yi; O'Malley, Bert W.; Qin, Jun			Analysis of the Human Endogenous Coregulator Complexome	CELL			English	Article							NUCLEAR RECEPTOR COREGULATORS; CUL3-BASED E3 LIGASE; COFACTOR COMPLEX; PROTEIN; COACTIVATOR; BRCA1; SRC-3/AIB1; DEGRADATION; ADAPTER; BREAST	Elucidation of endogenous cellular protein-protein interactions and their networks is most desirable for biological studies. Here we report our study of endogenous human coregulator protein complex networks obtained from integrative mass spectrometry-based analysis of 3290 affinity purifications. By preserving weak protein interactions during complex isolation and utilizing high levels of reciprocity in the large dataset, we identified many unreported protein associations, such as a transcriptional network formed by ZMYND8, ZNF687, and ZNF592. Furthermore, our work revealed a tiered interplay within networks that share common proteins, providing a conceptual organization of a cellular proteome composed of minimal endogenous modules (MEMOs), complex isoforms (uniCOREs), and regulatory complex-complex interaction networks (CCIs). This resource will effectively fill a void in linking correlative genomic studies with an understanding of transcriptional regulatory protein functions within the proteome for formulation and testing of future hypotheses.	[Malovannaya, Anna; Lanz, Rainer B.; Jung, Sung Yun; Bulynko, Yaroslava; Chan, Doug W.; Li, Wei; Wang, Yi; O'Malley, Bert W.; Qin, Jun] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Malovannaya, Anna; Jung, Sung Yun; Le, Nguyen T.; Chan, Doug W.; Ding, Chen; Shi, Yi; Yucer, Nur; Krenciute, Giedre; Kim, Beom-Jun; Li, Chunshu; Wang, Yi; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu; jqin@bcm.edu	Krenciute, Giedre/N-8094-2018; Shi, Yi/P-7972-2018	Krenciute, Giedre/0000-0003-4335-0644; Shi, Yi/0000-0002-2761-8324; Jung, Sung Yun/0000-0003-1521-7977; Li, Wei/0000-0001-9931-5990	NURSA [U19-DK62434]; Proteomics Strand; Collaborative Bridging Project; Center for Molecular Discovery; McLean Foundation at Baylor College of Medicine.; NIH [HD08188, DK059820, CA84199, GM080703]; CPRIT [RP101499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857, R01HD008188] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008188] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, P01DK059820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080703] Funding Source: NIH RePORTER	NURSA; Proteomics Strand; Collaborative Bridging Project; Center for Molecular Discovery; McLean Foundation at Baylor College of Medicine.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported partially by the NURSA grant U19-DK62434 including the Proteomics Strand funding to B.W.O. and J.Q. and the Collaborative Bridging Project funding to R. B. L. We acknowledge the significant financial support of the Center for Molecular Discovery and the McLean Foundation at Baylor College of Medicine. NIH grants HD08188 and DK059820 to B.W.O., CA84199 to J.Q., GM080703 to Y.W., and CPRIT RP101499 fellowship to N.Y. are also acknowledged.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brown LA, 2010, BREAST CANCER RES TR, V121, P347, DOI 10.1007/s10549-009-0479-x; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Guenther MG, 2000, GENE DEV, V14, P1048; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Ishikawa H, 2006, FEBS LETT, V580, P4784, DOI 10.1016/j.febslet.2006.07.066; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kim HT, 2008, MOL CELLS, V25, P457; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lanz RB, 2006, NUCLEIC ACIDS RES, V34, pD221, DOI 10.1093/nar/gkj029; Lanz RB, 2010, MOL ENDOCRINOL, V24, P859, DOI 10.1210/me.2009-0499; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; O'Malley BW, 2008, CURR OPIN CELL BIOL, V20, P310, DOI 10.1016/j.ceb.2008.04.005; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Raouf A, 2005, JNCI-J NATL CANCER I, V97, P1302, DOI 10.1093/jnci/dji254; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang Y, 2000, GENE DEV, V14, P927; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; York B, 2010, P NATL ACAD SCI USA, V107, P11122, DOI 10.1073/pnas.1005262107; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123	63	303	312	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2011	145	5					787	799		10.1016/j.cell.2011.05.006	http://dx.doi.org/10.1016/j.cell.2011.05.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620140	Bronze, Green Accepted			2022-12-01	WOS:000291018600017
J	Russell, HC; McDougall, V; Dutton, GN				Russell, Heather C.; McDougall, Valerie; Dutton, Gordon N.			EASILY MISSED? Congenital cataract	BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL-TREATMENT; PERIOD		[Russell, Heather C.] Princess Alexandra Eye Pavil, Edinburgh EH3 9HA, Midlothian, Scotland; [McDougall, Valerie] MacLean Med Practice, Glasgow G44 3QG, Lanark, Scotland; [Dutton, Gordon N.] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow	Russell, HC (corresponding author), Princess Alexandra Eye Pavil, Edinburgh EH3 9HA, Midlothian, Scotland.	heatherrussell74@gmail.com		Dutton, Gordon N/0000-0003-2516-5795				Birch EE, 1996, INVEST OPHTH VIS SCI, V37, P1532; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; HALL DMB, 1996, HLTH ALL CHILDREN RE; Lambert SR, 2006, J AAPOS, V10, P30, DOI 10.1016/j.jaapos.2005.10.002; McLaughlin C, 2006, PEDIATR EMERG CARE, V22, P137, DOI 10.1097/01.pec.0000199567.87134.81; Morgan S, 1999, BRIT MED J, V319, P122, DOI 10.1136/bmj.319.7202.122; Rahi JS, 1999, BRIT MED J, V318, P362, DOI 10.1136/bmj.318.7180.362; Rahi JS, 2001, INVEST OPHTH VIS SCI, V42, P1444; *ROYAL COLL OPHTH, 1994, OPHTH SERV CHILDR RE; RUSSELL HC, 2010, J PEDIATR OPHTHALMOL, V46, pE1; Sotomi O, 2007, Ir Med J, V100, P398	11	3	3	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 27	2011	342								d3075	10.1136/bmj.d3075	http://dx.doi.org/10.1136/bmj.d3075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KI	21622506				2022-12-01	WOS:000291155200003
J	Attwood, BK; Bourgognon, JM; Patel, S; Mucha, M; Schiavon, E; Skrzypiec, AE; Young, KW; Shiosaka, S; Korostynski, M; Piechota, M; Przewlocki, R; Pawlak, R				Attwood, Benjamin K.; Bourgognon, Julie-Myrtille; Patel, Satyam; Mucha, Mariusz; Schiavon, Emanuele; Skrzypiec, Anna E.; Young, Kenneth W.; Shiosaka, Sadao; Korostynski, Michal; Piechota, Marcin; Przewlocki, Ryszard; Pawlak, Robert			Neuropsin cleaves EphB2 in the amygdala to control anxiety	NATURE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; NMDA RECEPTORS; STRESS; BRAIN; GENE; POLYMORPHISMS; HIPPOCAMPAL; MODULATION; EXPRESSION; BEHAVIOR	A minority of individuals experiencing traumatic events develop anxiety disorders. The reason for the lack of correspondence between the prevalence of exposure to psychological trauma and the development of anxiety is unknown. Extracellular proteolysis contributes to fear-associated responses by facilitating neuronal plasticity at the neuron-matrix interface(1-4). Here we show in mice that the serine protease neuropsin is critical for stress-related plasticity in the amygdala by regulating the dynamics of the EphB2-NMDA-receptor interaction, the expression of Fkbp5 and anxiety-like behaviour. Stress results in neuropsin-dependent cleavage of EphB2 in the amygdala causing dissociation of EphB2 from the NR1 subunit of the NMDA receptor and promoting membrane turnover of EphB2 receptors. Dynamic EphB2-NR1 interaction enhances NMDA receptor current, induces Fkbp5 gene expression and enhances behavioural signatures of anxiety. On stress, neuropsin-deficient mice do not show EphB2 cleavage and its dissociation from NR1 resulting in a static EphB2-NR1 interaction, attenuated induction of the Fkbp5 gene and low anxiety. The behavioural response to stress can be restored by intra-amygdala injection of neuropsin into neuropsin-deficient mice and disrupted by the injection of either anti-EphB2 antibodies or silencing the Fkbp5 gene in the amygdala of wild-type mice. Our findings establish a novel neuronal pathway linking stress-induced proteolysis of EphB2 in the amygdala to anxiety.	[Attwood, Benjamin K.; Bourgognon, Julie-Myrtille; Patel, Satyam; Mucha, Mariusz; Schiavon, Emanuele; Skrzypiec, Anna E.; Pawlak, Robert] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Young, Kenneth W.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Shiosaka, Sadao] Nara Inst Sci & Technol, Div Struct Cell Biol, Nara 6300192, Japan; [Korostynski, Michal; Piechota, Marcin; Przewlocki, Ryszard] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, PL-31343 Krakow, Poland	University of Leicester; University of Leicester; Nara Institute of Science & Technology; Polish Academy of Sciences	Pawlak, R (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Univ Rd, Leicester LE1 9HN, Leics, England.	rp135@le.ac.uk	Piechota, Marcin/G-9464-2011; Shiosaka, Sadao/B-1142-2008; Korostynski, Michal/AAS-2626-2021	Korostynski, Michal/0000-0002-4273-7401; Schiavon, Emanuele/0000-0002-4592-6961; Piechota, Marcin/0000-0003-2468-151X	Medical Research Council [G0500231/73852]; European Commission [MEXT-CT-2006-042265, LSHM-CT-2004-005166]; Medisearch Fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan [20300128]; Japan Science and Technology Agency; Ministry of Science and Higher Education of Poland [NN405 274137]; Medical Research Council [G0500231] Funding Source: researchfish; MRC [G0500231] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medisearch Fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Project Grant (G0500231/73852), and a Marie Curie Excellence Grant (MEXT-CT-2006-042265 from the European Commission) to R. Pawlak, a Medisearch Fellowship to B.K.A., the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid, # 20300128) and Japan Science and Technology Agency (CREST program) to S.S., GENADDICT (LSHM-CT-2004-005166 from the European Commission) to R. Przewlocki, and NN405 274137 from the Ministry of Science and Higher Education of Poland to M.K. We are obliged to A. Kania, H. Castro and R. Fern for reagents. We are grateful to B. McEwen and A. Tobin for their comments on the manuscript and T. Gerdjikov, G. Mallucci and her laboratory members for advice.	Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI [10.1016/j.psyneuen.2008.08.018, 10.1016/j.psyneuen.2009.05.021]; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Calo L, 2005, J NEUROSCI, V25, P2245, DOI 10.1523/JNEUROSCI.4956-04.2005; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Hirata A, 2001, MOL CELL NEUROSCI, V17, P600, DOI 10.1006/mcne.2000.0945; Horii Y, 2008, BEHAV NEUROSCI, V122, P498, DOI 10.1037/0735-7044.122.3.498; Huang YY, 2007, J NEUROSCI, V27, P3111, DOI 10.1523/JNEUROSCI.3908-06.2007; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Matys T, 2004, P NATL ACAD SCI USA, V101, P16345, DOI 10.1073/pnas.0407355101; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; Shimizu C, 1998, J BIOL CHEM, V273, P11189, DOI 10.1074/jbc.273.18.11189; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Vyas A, 2002, J NEUROSCI, V22, P6810; WASHBURN MS, 1992, J NEUROSCI, V12, P4066	30	141	147	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					372	U553		10.1038/nature09938	http://dx.doi.org/10.1038/nature09938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21508957	Green Accepted			2022-12-01	WOS:000290722400048
J	Luz, PM; Vanni, T; Medlock, J; Paltiel, AD; Galvani, AP				Luz, Paula Mendes; Vanni, Tazio; Medlock, Jan; Paltiel, A. David; Galvani, Alison P.			Dengue vector control strategies in an urban setting: an economic modelling assessment	LANCET			English	Article							ADJUSTED LIFE YEARS; AEDES-AEGYPTI; COST-EFFECTIVENESS; INSECTICIDE; IMPACT; DISEASE; VIRUS; FEVER; POPULATIONS; CULICIDAE	Background An estimated 2.5 billion people are at risk of dengue. Incidence of dengue is especially high in resource-constrained countries, where control relies mainly on insecticides targeted at larval or adult mosquitoes. We did epidemiological and economic assessments of different vector control strategies. Methods We developed a dynamic model of dengue transmission that assesses the evolution of insecticide resistance and immunity in the human population, thus allowing for long-term evolutionary and immunological effects of decreased dengue transmission. We measured the dengue health burden in terms of disability-adjusted life-years (DALYs) lost. We did a cost-effectiveness analysis of 43 insecticide-based vector control strategies, including strategies targeted at adult and larval stages, at varying efficacies (high-efficacy [90% mortality], medium-efficacy [60% mortality], and low-efficacy [30% mortality]) and yearly application frequencies (one to six applications). To assess the effect of parameter uncertainty on the results, we did a probabilistic sensitivity analysis and a threshold analysis. Findings All interventions caused the emergence of insecticide resistance, which, with the loss of herd immunity, will increase the magnitude of future dengue epidemics. In our model, one or more applications of high-efficacy larval control reduced dengue burden for up to 2 years, whereas three or more applications of adult vector control reduced dengue burden for up to 4 years. The incremental cost-effectiveness ratios of the strategies for two high-efficacy adult vector control applications per year was US$615 per DALY saved and for six high-efficacy adult vector control applications per year was $1267 per DALY saved. Sensitivity analysis showed that if the cost of adult control was more than 8.2 times the cost of larval control then all strategies based on adult control became dominated. Interpretation Six high-efficacy adult vector control applications per year has a cost-effectiveness ratio that will probably meet WHO's standard for a cost-effective or very cost-effective intervention. Year-round larval control can be counterproductive, exacerbating epidemics in later years because of evolution of insecticide resistance and loss of herd immunity. We suggest the reassessment of vector control policies that are based on larval control only.	[Luz, Paula Mendes] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, BR-21040360 Rio De Janeiro, Brazil; [Luz, Paula Mendes; Medlock, Jan; Paltiel, A. David; Galvani, Alison P.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Vanni, Tazio] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Medlock, Jan] Clemson Univ, Dept Math Sci, Clemson, SC USA	Fundacao Oswaldo Cruz; Yale University; University of London; London School of Hygiene & Tropical Medicine; Clemson University	Luz, PM (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.	paula.luz@ipec.fiocruz.br	Vanni, Tazio P./B-7925-2018	Paltiel, A. David/0000-0002-4861-3290; Luz, Paula/0000-0001-9746-719X	Fulbright Programme; CAPES (Brazilian federal agency for post-graduate education); Miriam Burnett trust; Notsew Orm Sands Foundation; National Science Foundation [SBE-0624117]; NIH MIDAS [UO1 GM087719-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	Fulbright Programme; CAPES (Brazilian federal agency for post-graduate education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Miriam Burnett trust; Notsew Orm Sands Foundation; National Science Foundation(National Science Foundation (NSF)); NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PML was funded by The Fulbright Programme, CAPES (Brazilian federal agency for post-graduate education), and the Miriam Burnett trust. APG was funded by Notsew Orm Sands Foundation and the Miriam Burnett trust. JM was supported by the National Science Foundation (grant SBE-0624117) and the Notsew Orm Sands Foundation. We gratefully acknowledge support from NIH MIDAS (grant UO1 GM087719-01).	[Anonymous], 2005, METHODS EC EVALUATIO; Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Bangs Michael J., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1103; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Caldwell D, 2007, INT J EPIDEMIOL, V36, P476; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017; De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003; Donalísio Maria Rita, 2002, Rev. bras. epidemiol., V5, P259, DOI 10.1590/S1415-790X2002000300005; FENWICK E, 2009, ENCY MED DECISION MA, P1; Fernandez EA, 1998, ACTA TROP, V70, P171, DOI 10.1016/S0001-706X(98)00033-3; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015; Gold MR., 1996, COST EFFECTIVENESS H; GRATZ NG, 1991, J AM MOSQUITO CONTR, V7, P353; GRATZ NG, 1994, AM J TROP MED HYG, V50, P11, DOI 10.4269/ajtmh.1994.50.6_Suppl.TM05006S0011; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hunink M, 2001, DECISION MAKING HLTH; *INT MON FUND, DAT STAT; Jakubczyk M, 2010, HEALTH ECON, V19, P955, DOI 10.1002/hec.1534; Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Lima José Bento Pereira, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P7, DOI 10.1590/S0036-46652005000100002; Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799; Luz PM, 2009, TROP MED INT HEALTH, V14, P237, DOI 10.1111/j.1365-3156.2008.02203.x; McConnell K. John, 2003, Rev Panam Salud Publica, V14, P9, DOI 10.1590/S1020-49892003000600003; McGuire A, 2001, EC EVALUATION HLTH C, P172; Medlock J, 2009, AM NAT, V174, P565, DOI 10.1086/605403; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709; Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541; Pontes RJS, 2005, REV SOC BRAS MED TRO, V38, P316, DOI 10.1590/S0037-86822005000400007; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; Teixeira M. da G., 2002, Dengue Bulletin, V26, P70; World Health Organization, 2001, MACROECONOMICS HLTH	45	97	100	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1673	1680		10.1016/S0140-6736(11)60246-8	http://dx.doi.org/10.1016/S0140-6736(11)60246-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766JF	21546076	Green Published, Green Accepted			2022-12-01	WOS:000290777700032
J	Hah, N; Danko, CG; Core, L; Waterfall, JJ; Siepel, A; Lis, JT; Kraus, WL				Hah, Nasun; Danko, Charles G.; Core, Leighton; Waterfall, Joshua J.; Siepel, Adam; Lis, John T.; Kraus, W. Lee			A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer Cells	CELL			English	Article							DIVERGENT TRANSCRIPTION; ACTIVE PROMOTERS; GENE-EXPRESSION; RECEPTOR; RNA; ELEMENTS; ACTIVATION; DISEASE; ALPHA	We report the immediate effects of estrogen signaling on the transcriptome of breast cancer cells using global run-on and sequencing (GRO-seq). The data were analyzed using a new bioinformatic approach that allowed us to identify transcripts directly from the GRO-seq data. We found that estrogen signaling directly regulates a strikingly large fraction of the transcriptome in a rapid, robust, and unexpectedly transient manner. In addition to protein-coding genes, estrogen regulates the distribution and activity of all three RNA polymerases and virtually every class of noncoding RNA that has been described to date. We also identified a large number of previously undetected estrogen-regulated intergenic transcripts, many of which are found proximal to estrogen receptor binding sites. Collectively, our results provide the most comprehensive measurement of the primary and immediate estrogen effects to date and a resource for understanding rapid signal-dependent transcription in other systems.	[Hah, Nasun; Danko, Charles G.; Core, Leighton; Waterfall, Joshua J.; Lis, John T.; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Hah, Nasun; Lis, John T.; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA	Cornell University; Cornell University; Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	lee.kraus@utsouthwestern.edu		Danko, Charles/0000-0002-1999-7125; Waterfall, Joshua/0000-0002-3762-5050; Hah, Nasun/0000-0003-1509-2799; Siepel, Adam/0000-0002-3557-7219	NIH [T32HD052471, GM25232, HG04845]; PhRMA Foundation; NIH/NIDDK [DK058110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Andre Martins for helpful insights and suggestions and Xin Luo and Shrikanth Gadad for critical comments on this manuscript. This work was supported by an NIH training award (T32HD052471) and a postdoctoral fellowship from the PhRMA Foundation to C. G. D., grants from the NIH (GM25232 and HG04845) to J.T.L., and a grant from the NIH/NIDDK (DK058110) to W.L.K.	Acevedo ML, 2004, ESSAYS BIOCHEM, V40, P73, DOI 10.1042/bse0400073; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Danko CG, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-31; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Durbin R., 1998, BIOLOGICAL SEQUENCE; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kininis Miltiadis, 2008, Nucl Recept Signal, V6, pe005, DOI 10.1621/nrs.06005; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruhl DD, 2009, PROG MOL BIOL TRANSL, V87, P137, DOI 10.1016/S1877-1173(09)87005-1; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Theodorou V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2470; Warner M, 1999, CURR OPIN OBSTET GYN, V11, P249, DOI 10.1097/00001703-199906000-00003; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; WIDELITZ RB, 1987, EXP CELL RES, V168, P539, DOI 10.1016/0014-4827(87)90026-7	36	351	355	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					622	634		10.1016/j.cell.2011.03.042	http://dx.doi.org/10.1016/j.cell.2011.03.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21549415	Green Accepted, Bronze			2022-12-01	WOS:000290560800014
J	Phillips, RJ; Davis, BJ; Tanaka, KL; Byrne, S; Mellon, MT; Putzig, NE; Haberle, RM; Kahre, MA; Campbell, BA; Carter, LM; Smith, IB; Holt, JW; Smrekar, SE; Nunes, DC; Plaut, JJ; Egan, AF; Titus, TN; Seu, R				Phillips, Roger J.; Davis, Brian J.; Tanaka, Kenneth L.; Byrne, Shane; Mellon, Michael T.; Putzig, Nathaniel E.; Haberle, Robert M.; Kahre, Melinda A.; Campbell, Bruce A.; Carter, Lynn M.; Smith, Isaac B.; Holt, John W.; Smrekar, Suzanne E.; Nunes, Daniel C.; Plaut, Jeffrey J.; Egan, Anthony F.; Titus, Timothy N.; Seu, Roberto			Massive CO2 Ice Deposits Sequestered in the South Polar Layered Deposits of Mars	SCIENCE			English	Article							SOLID CO2; CIRCULATION; MODEL	Shallow Radar soundings from the Mars Reconnaissance Orbiter reveal a buried deposit of carbon dioxide (CO2) ice within the south polar layered deposits of Mars with a volume of 9500 to 12,500 cubic kilometers, about 30 times that previously estimated for the south pole residual cap. The deposit occurs within a stratigraphic unit that is uniquely marked by collapse features and other evidence of interior CO2 volatile release. If released into the atmosphere at times of high obliquity, the CO2 reservoir would increase the atmospheric mass by up to 80%, leading to more frequent and intense dust storms and to more regions where liquid water could persist without boiling.	[Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Phillips, Roger J.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Davis, Brian J.; Putzig, Nathaniel E.] SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; [Tanaka, Kenneth L.; Titus, Timothy N.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Byrne, Shane] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Mellon, Michael T.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Haberle, Robert M.] NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA; [Kahre, Melinda A.] NASA, Ames Res Ctr, Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Campbell, Bruce A.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20013 USA; [Carter, Lynn M.] NASA, Goddard Space Flight Ctr, Sci & Explorat Directorate, Greenbelt, MD 20771 USA; [Smith, Isaac B.; Holt, John W.] Univ Texas Austin, Jackson Sch Geosci, Inst Geophys, Austin, TX 78758 USA; [Smrekar, Suzanne E.; Nunes, Daniel C.; Plaut, Jeffrey J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Egan, Anthony F.] SW Res Inst, Dept Space Operat, Boulder, CO 80302 USA; [Seu, Roberto] Univ Roma La Sapienza, Dept Informat Engn Elect & Telecommun, I-00184 Rome, Italy	Washington University (WUSTL); United States Department of the Interior; United States Geological Survey; University of Arizona; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome	Phillips, RJ (corresponding author), SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA.	roger@boulder.swri.edu	Byrne, Shane/B-8104-2012; Nunes, Daniel C/G-1279-2018; Holt, John/C-4896-2009; Carter, Lynn/D-2937-2012; Smrekar, Suzanne/AAH-8074-2020; Mellon, Michael/C-3456-2016	Carter, Lynn/0000-0002-6245-4142; Smrekar, Suzanne/0000-0001-8775-075X; Putzig, Nathaniel/0000-0003-4485-6321; Nunes, Daniel/0000-0002-0937-7176; Smith, Isaac/0000-0002-4331-913X	NASA	NASA(National Aeronautics & Space Administration (NASA))	K. Herkenhoff and C. Fortezzo provided useful comments on an earlier version of the paper. Remarks by three anonymous referees were exceedingly helpful. Funding for this work was provided by the NASA MRO project. The radar and imaging data are available through NASA's Planetary Data System.	Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Haberle RM, 2001, J GEOPHYS RES-PLANET, V106, P23317, DOI 10.1029/2000JE001360; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; Kolb E. J., 2006, 37 LUN PLAN SCI C LE; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Newman CE, 2005, ICARUS, V174, P135, DOI 10.1016/j.icarus.2004.10.023; Nunes DC, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002609; Pettinelli E, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001869; Phillips RJ, 2008, SCIENCE, V320, P1182, DOI 10.1126/science.1157546; Putzig NE, 2009, ICARUS, V204, P443, DOI 10.1016/j.icarus.2009.07.034; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; SIMPSON RA, 1980, J GEOPHYS RES, V85, P5481, DOI 10.1029/JB085iB10p05481; Tanaka K. L., 2007, 7 INT C MARS PAS CA; Thomas PC, 2009, ICARUS, V203, P352, DOI 10.1016/j.icarus.2009.05.014; Weast, 1975, CRC HDB CHEM PHYS	19	133	135	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2011	332	6031					838	841		10.1126/science.1203091	http://dx.doi.org/10.1126/science.1203091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21512003	Green Published			2022-12-01	WOS:000290529900045
J	Charleston, B; Bankowski, BM; Gubbins, S; Chase-Topping, ME; Schley, D; Howey, R; Barnett, PV; Gibson, D; Juleff, ND; Woolhouse, MEJ				Charleston, Bryan; Bankowski, Bartlomies M.; Gubbins, Simon; Chase-Topping, Margo E.; Schley, David; Howey, Richard; Barnett, Paul V.; Gibson, Debi; Juleff, Nicholas D.; Woolhouse, Mark E. J.			Relationship Between Clinical Signs and Transmission of an Infectious Disease and the Implications for Control	SCIENCE			English	Article							MOUTH-DISEASE; VIRUS TRANSMISSION; INFLUENZA; DYNAMICS; OUTBREAK	Control of many infectious diseases relies on the detection of clinical cases and the isolation, removal, or treatment of cases and their contacts. The success of such "reactive" strategies is influenced by the fraction of transmission occurring before signs appear. We performed experimental studies of foot-and-mouth disease transmission in cattle and estimated this fraction at less than half the value expected from detecting virus in body fluids, the standard proxy measure of infectiousness. This is because the infectious period is shorter (mean 1.7 days) than currently realized, and animals are not infectious until, on average, 0.5 days after clinical signs appear. These results imply that controversial preemptive control measures may be unnecessary; instead, efforts should be directed at early detection of infection and rapid intervention.	[Charleston, Bryan; Bankowski, Bartlomies M.; Gubbins, Simon; Schley, David; Barnett, Paul V.; Gibson, Debi; Juleff, Nicholas D.] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England; [Chase-Topping, Margo E.; Howey, Richard; Woolhouse, Mark E. J.] Univ Edinburgh, Ashworth Labs, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; University of Edinburgh	Charleston, B (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Ash Rd, Woking GU24 0NF, Surrey, England.	bryan.charleston@bbsrc.ac.uk		Gubbins, Simon/0000-0003-0538-4173; Charleston, Bryan/0000-0002-6952-9338	Biotechnology and Biological Sciences Research Council, UK [BBSB00549]; Biotechnology and Biological Sciences Research Council [BBSEI00001444]; Wellcome Trust; BBSRC [BBS/E/I/00001444] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/00549, BBS/B/01480, BBS/E/I/00001444] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L. Fitzpatrick, C. Randal, and M. Jenkins for their assistance with the handling and management of experimental animals; P. Hamblin and P. Keel for help and advice with serology assays; L. Reid, M. Windsor, and S. Cox for assistance with laboratory assays; S. Alexandersen, D. Paton, and N. Savill for valuable advice on study design; and B. Grenfell, M. Keeling, M. de Jong, A. Graham, C. Dye, and four anonymous referees fur insightful comments. The work was funded by the Biotechnology and Biological Sciences Research Council (grant BBSB00549), UK. B.C. and P.V.B. are Jenner Investigators. S.G. and D.S. acknowledge funding from the Biotechnology and Biological Sciences Research Council (grant BBSEI00001444). M.E.C.T. is partly supported by the Wellcome Trust.	Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chinsangaram J, 1999, J VIROL, V73, P9891, DOI 10.1128/JVI.73.12.9891-9898.1999; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Howey R, 2009, J R SOC INTERFACE, V6, P835, DOI 10.1098/rsif.2008.0434; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Mardones F, 2010, VET RES, V41, DOI 10.1051/vetres/2010017; Orsel K, 2009, PREV VET MED, V88, P158, DOI 10.1016/j.prevetmed.2008.09.001; Orsel K, 2007, VACCINE, V25, P327, DOI 10.1016/j.vaccine.2006.07.030; Paton DJ, 2010, VET REC, V166, P569, DOI 10.1136/vr.c2300; Paton DJ, 2009, PHILOS T R SOC B, V364, P2657, DOI 10.1098/rstb.2009.0100; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; SCOTT GR, 1981, VIRUS DISEASES FOOD, V2, P401; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Tracy CS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-470; *WHO, WHO FACTSH; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Yamagishi T, 2010, JPN J INFECT DIS, V63, P327; Zinsstag J, 2001, SCIENCE, V294, P477, DOI 10.1126/science.294.5542.477	20	107	112	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					726	729		10.1126/science.1199884	http://dx.doi.org/10.1126/science.1199884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551063	Green Accepted			2022-12-01	WOS:000290265800045
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: bipolar II disorder	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	8	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2767	10.1136/bmj.d2767	http://dx.doi.org/10.1136/bmj.d2767			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	21543400				2022-12-01	WOS:000290481700009
J	Van Allen, EM				Van Allen, Eliezer M.			Paracentesis by Moonlight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												evanallen@partners.org		Van Allen, Eliezer/0000-0002-0201-4444					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1635	1636		10.1001/jama.2011.472	http://dx.doi.org/10.1001/jama.2011.472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21521838				2022-12-01	WOS:000289890500001
J	Oleksiuk, O; Jakovljevic, V; Vladimirov, N; Carvalho, R; Paster, E; Ryu, WS; Meir, Y; Wingreen, NS; Kollmann, M; Sourjik, V				Oleksiuk, Olga; Jakovljevic, Vladimir; Vladimirov, Nikita; Carvalho, Ricardo; Paster, Eli; Ryu, William S.; Meir, Yigal; Wingreen, Ned S.; Kollmann, Markus; Sourjik, Victor			Thermal Robustness of Signaling in Bacterial Chemotaxis	CELL			English	Article							ESCHERICHIA-COLI; COVALENT MODIFICATION; RECEPTOR COMPLEXES; TEMPERATURE; MECHANISM; BINDING; PRECISION; MOTOR; MODEL; TAR	Temperature is a global factor that affects the performance of all intracellular networks. Robustness against temperature variations is thus expected to be an essential network property, particularly in organisms without inherent temperature control. Here, we combine experimental analyses with computational modeling to investigate thermal robustness of signaling in chemotaxis of Escherichia coli, a relatively simple and well-established model for systems biology. We show that steady-state and kinetic pathway parameters that are essential for chemotactic performance are indeed temperature-compensated in the entire physiological range. Thermal robustness of steady-state pathway output is ensured at several levels by mutual compensation of temperature effects on activities of individual pathway components. Moreover, the effect of temperature on adaptation kinetics is counterbalanced by preprogrammed temperature dependence of enzyme synthesis and stability to achieve nearly optimal performance at the growth temperature. Similar compensatory mechanisms are expected to ensure thermal robustness in other systems.	[Oleksiuk, Olga; Jakovljevic, Vladimir; Vladimirov, Nikita; Carvalho, Ricardo; Sourjik, Victor] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Paster, Eli; Ryu, William S.; Wingreen, Ned S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Meir, Yigal] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; [Kollmann, Markus] Univ Dusseldorf, Dept Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Princeton University; Princeton University; Ben Gurion University; Heinrich Heine University Dusseldorf	Sourjik, V (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	v.sourjik@zmbh.uni-heidelberg.de	MEIR, YIGAL/F-1888-2012	Carvalho, Ricardo/0000-0002-5994-0094; Oleksiuk, Olga/0000-0002-6100-107X; Jakovljevic, Vladimir/0000-0002-6082-4867; Meir, Yigal/0000-0003-1606-8969	National Institutes of Health [GM082938]; Deutsche Forschungsgemeinschaft [SO 421/3-3, KO3442/3-1]; C.H.S.-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); C.H.S.-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Schwarz und A. Muller for help with cloning, L. Turner for sharing data, and R. Endres and M. Mayer for valuable discussions. This work was supported by grant GM082938 from the National Institutes of Health and in parts by grants SO 421/3-3 and KO3442/3-1 from the Deutsche Forschungsgemeinschaft and by the C.H.S.-Foundation.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Andrews BW, 2006, PLOS COMPUT BIOL, V2, P1407, DOI 10.1371/journal.pcbi.0020154; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; Jiang LL, 2009, BIOPHYS J, V97, P74, DOI 10.1016/j.bpj.2009.04.029; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; LOWE G, 1987, NATURE, V325, P637, DOI 10.1038/325637a0; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MAEDA K, 1976, J BACTERIOL, V127, P1039, DOI 10.1128/JB.127.3.1039-1046.1976; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Meir Y, 2010, BIOPHYS J, V99, P2766, DOI 10.1016/j.bpj.2010.08.051; Mello BA, 2005, P NATL ACAD SCI USA, V102, P17354, DOI 10.1073/pnas.0506961102; MIZUNO T, 1984, J BACTERIOL, V159, P360, DOI 10.1128/JB.159.1.360-367.1984; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; Nishiyama SI, 1997, J BACTERIOL, V179, P6573, DOI 10.1128/jb.179.21.6573-6580.1997; Paster E, 2008, P NATL ACAD SCI USA, V105, P5373, DOI 10.1073/pnas.0709903105; Rajan K, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022902; Salman H, 2007, NAT CELL BIOL, V9, P1098, DOI 10.1038/ncb1632; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Turner L, 1999, BIOPHYS J, V77, P597, DOI 10.1016/S0006-3495(99)76916-X; Virshup DM, 2009, CELL, V137, P602, DOI 10.1016/j.cell.2009.04.051; Vladimirov N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000717; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242	46	57	62	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					312	321		10.1016/j.cell.2011.03.013	http://dx.doi.org/10.1016/j.cell.2011.03.013			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496648	Bronze, Green Accepted			2022-12-01	WOS:000289549900018
J	Short, J; Murray, S				Short, Jeffrey; Murray, Susan			A frozen hell	NATURE			English	Editorial Material									[Short, Jeffrey] JWS Consulting Out Juneau, Juneau, AK USA; [Murray, Susan] Advocacy Grp Oceana, Juneau, AK 99801 USA		Short, J (corresponding author), JWS Consulting Out Juneau, Juneau, AK USA.	jwsosc@gmail.com; smurray@oceana.org	Short, Jeffrey/AAZ-9241-2021						0	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					162	163		10.1038/472162a	http://dx.doi.org/10.1038/472162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21490650				2022-12-01	WOS:000289469100017
J	Bartelds, GM; Krieckaert, CLM; Nurmohamed, MT; van Schouwenburg, PA; Lems, WF; Twisk, JWR; Dijkmans, AC; Aarden, L; Wolbink, GJ				Bartelds, Geertje M.; Krieckaert, Charlotte L. M.; Nurmohamed, Michael T.; van Schouwenburg, Pauline A.; Lems, Willem F.; Twisk, Jos W. R.; Dijkmans, A. C.; Aarden, Lucien; Wolbink, Gerrit Jan			Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; CLINICAL-RESPONSE; CROHNS-DISEASE; IMMUNOGENICITY; INFLIXIMAB; THERAPY; COHORT	Context Short-term data on the immunogenicity of monoclonal antibodies showed associations between the development of antidrug antibodies and diminished serum drug levels, and a diminished treatment response. Little is known about the clinical relevance of antidrug antibodies against these drugs during long-term follow-up. Objective To examine the course of antidrug antibody formation against fully human monoclonal antibody adalimumab and its clinical relevance during long-term (3-year) follow-up of patients with rheumatoid arthritis (RA). Design, Setting, and Patients Prospective cohort study February 2004-September 2008; end of follow-up was September 2010. All 272 patients were diagnosed with RA and started treatment with adalimumab in an outpatient clinic. Main Outcome Measures Disease activity was monitored and trough serum samples were obtained at baseline and 8 time points to 156 weeks. Serum adalimumab concentrations and antiadalimumab antibody titers were determined after follow-up. Treatment discontinuation, minimal disease activity, and clinical remission were compared for patients with and without antiadalimumab antibodies. Results After 3 years, 76 of 272 patients (28%) developed antiadalimumab antibodies-51 of these (67%) during the first 28 weeks of treatment. Patients without antiadalimumab antibodies had much higher adalimumab concentrations (median, 12 mg/L; IQR, 9-16 mg/L) compared with patients with antibody titers from 13 to 100 AU/mL (median, 5 mg/L; IQR, 3-9 mg/L; regression coefficient, -4.5; 95% CI, -6.0 to -2.9; P < .001) and also those greater than 100 AU/mL (median, 0 mg/L; IQR, 0-3 mg/L; regression coefficient, -7.1; 95% CI, -8.4 to -5.8; P < .001). Patients with antiadalimumab antibodies more often discontinued participation due to treatment failure (n=29 [38%]; hazard ratio [HR], 3.0; 95% CI, 1.6-5.5; P < .001) compared with antiadalimumab antibody-negative ones (n=28 [14%]). Ninety-five of 196 patients (48%) without antiadalimumab antibodies had minimal disease activity vs 10 of 76 patients (13%) with antiadalimumab antibodies; patients with antiadalimumab antibodies less often had sustained minimal disease activity score in 28 joints (DAS28) (<3.2; HR, 3.6; 95% CI, 1.8-7.2; P < .001) compared with antiadalimumab antibody-negative ones. Three of 76 patients (4%) with antiadalimumab antibodies achieved sustained remission compared with 67 of 196 (34%) antiadalimumab antibody-negative ones; patients with antiadalimumab antibodies less often achieved remission (DAS28 <2.6; HR, -7.1; 95% CI, 2.1-23.4; P < .001) compared with antiadalimumab antibody-negative ones. Conclusion Among outpatients with RA in whom adalimumab was started over 3 years, the development of antidrug antibodies was associated with lower adalimumab concentration and lower likelihood of minimal disease activity or clinical remission. JAMA. 2011;305(14):1460-1468 www.jama.com	[Bartelds, Geertje M.; Krieckaert, Charlotte L. M.; Nurmohamed, Michael T.; Wolbink, Gerrit Jan] Jan van Breemen Res Inst, Amsterdam, Netherlands; [Nurmohamed, Michael T.; Lems, Willem F.; Twisk, Jos W. R.; Dijkmans, A. C.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [van Schouwenburg, Pauline A.; Aarden, Lucien; Wolbink, Gerrit Jan] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Wolbink, GJ (corresponding author), Reade Ctr Rehabil & Rheumatol, Div Rheumatol, Dr Jan van Breemenstr 2, NL-1056 AB Amsterdam, Netherlands.	g.wolbink@reade.nl		van Schouwenburg, Pauline/0000-0003-2779-1415; Nurmohamed, Michael/0000-0002-6274-1934; Wolbink, Gerrit Jan/0000-0003-1924-7460	Abbott; Roche; Pfizer; MSD; UCB; BMS; Wyeth; Schering-Plough; Wyeth Pharmaceuticals; Abbott Laboratories; Dutch Arthritis Foundation	Abbott(Abbott Laboratories); Roche(Roche Holding); Pfizer(Pfizer); MSD; UCB(UCB Pharma SA); BMS(Bristol-Myers Squibb); Wyeth(Wyeth); Schering-Plough(Merck & CompanySchering Plough Corporation); Wyeth Pharmaceuticals(Wyeth); Abbott Laboratories(Abbott Laboratories); Dutch Arthritis Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Nurmohamed reports having received consultancy fees from Abbott, Roche, Pfizer, MSD, UCB, BMS, and Wyeth; payment for lectures from Abbott, Roche, and Pfizer; and research grants from Abbott, Roche, and Pfizer. Dr Lems reports having received honoraria for lectures from Abbott, Roche, and Schering-Plough. Dr Dijkmans reports having received research grants from Schering-Plough, Abbott, and Wyeth. Dr Wolbink reports having received a research grant from Wyeth Pharmaceuticals and honoraria for lectures from Amgen and Pfizer. No other disclosures were reported.; Funding was provided by Abbott Laboratories and Wyeth Pharmaceuticals.; We are grateful to the Clinical Research Bureau of Reade, formerly the Jan van Breemen Institute, which receives support from the Dutch Arthritis Foundation, for help in the practical aspects of the cohort study. We thank the following research nurses for performing clinical assessments: Marga Kammeijer-Rippen, Anne-Marie Abrahams, Astrid Twisk, and Martine Kos, Department of Rheumatology, Jan van Breemen Research Institute; and for preparation and performing the assays, we thank Henk de Vrieze, MSc, and Kim van Houten, MSc, Sanquin Research; and Margret de Koning, MSc, Department of the Clinical Laboratory, Jan van Breemen Research Institute. None of the individuals listed in this acknowledgment received compensation for their work in association with this study.	Allez M, 2010, J CROHNS COLITIS, V4, P355, DOI 10.1016/j.crohns.2010.04.004; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Bartelds GM, 2010, ANN RHEUM DIS, V69, P817, DOI 10.1136/ard.2009.112847; Bartelds GM, 2009, ARTHRITIS RHEUM, V60, P2541, DOI 10.1002/art.24709; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Bartelds GM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3208; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Blom M, 2010, ARTHRIT CARE RES, V62, P1335, DOI 10.1002/acr.20211; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Furst DE, 2007, ANN RHEUM DIS, V66, P2, DOI 10.1136/ard.2007.081430; Jamnitski A, 2011, ANN RHEUM DIS, V70, P284, DOI 10.1136/ard.2010.135111; Karmiris K, 2009, GASTROENTEROLOGY, V137, P1628, DOI 10.1053/j.gastro.2009.07.062; Krieckaert CLM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3147; Lecluse LLA, 2010, ARCH DERMATOL, V146, P127, DOI 10.1001/archdermatol.2009.347; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P624, DOI 10.1136/ard.2009.108787; van Schouwenburg PA, 2010, J IMMUNOL METHODS, V362, P82, DOI 10.1016/j.jim.2010.09.005; Vermeire S, 2007, GUT, V56, P1226, DOI 10.1136/gut.2006.099978; West RL, 2008, ALIMENT PHARM THER, V28, P1122, DOI 10.1111/j.1365-2036.2008.03828.x; Wolbink GJ, 2005, ANN RHEUM DIS, V64, P704, DOI 10.1136/ard.2004.030452; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671	23	567	607	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1460	1468		10.1001/jama.2011.406	http://dx.doi.org/10.1001/jama.2011.406			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486979	Bronze			2022-12-01	WOS:000289424100023
J	Sliwa, K; Stewart, S				Sliwa, Karen; Stewart, Simon			A low-cost solar-powered blood-pressure device	LANCET			English	Editorial Material							DISEASES CHRONIC DISEASES; HEART-DISEASE; SOWETO; HYPERTENSION; INSIGHTS		[Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7935 Cape Town, Western Cape, South Africa; [Stewart, Simon] Baker IDI, Melbourne, Vic, Australia	University of Cape Town; Baker Heart and Diabetes Institute	Sliwa, K (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7935 Cape Town, Western Cape, South Africa.	sliwa-hahnlek@mdh-africa.org	Stewart, Simon/M-3316-2016	Stewart, Simon/0000-0001-9032-8998; Sliwa, Karen/0000-0002-8272-0911				Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Lock K, 2010, LANCET, V376, P1699, DOI 10.1016/S0140-6736(10)61352-9; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mendis S, 2004, J HYPERTENS, V22, P59, DOI 10.1097/00004872-200401000-00013; Parati G, 2010, HYPERTENSION, V56, P1047, DOI 10.1161/HYPERTENSIONAHA.110.160408; Sliwa K, 2010, EUR HEART J, V31, P719, DOI 10.1093/eurheartj/ehp530; Stewart S, 2011, EUR HEART J, V32, P492, DOI 10.1093/eurheartj/ehq439; Stewart S, 2011, INT J CARDIOL, V146, P22, DOI 10.1016/j.ijcard.2009.05.061; Stewart S, 2009, NAT REV CARDIOL, V6, P489, DOI 10.1038/nrcardio.2009.79	9	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					647	648		10.1016/S0140-6736(11)60131-1	http://dx.doi.org/10.1016/S0140-6736(11)60131-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21513974				2022-12-01	WOS:000294509900008
J	Schlingmann, KP; Kaufmann, M; Weber, S; Irwin, A; Goos, C; John, U; Misselwitz, J; Klaus, G; Kuwertz-Broking, E; Fehrenbach, H; Wingen, AM; Guran, T; Hoenderop, JG; Bindels, RJ; Prosser, DE; Jones, G; Konrad, M				Schlingmann, Karl P.; Kaufmann, Martin; Weber, Stefanie; Irwin, Andrew; Goos, Caroline; John, Ulrike; Misselwitz, Joachim; Klaus, Guenter; Kuwertz-Broeking, Eberhard; Fehrenbach, Henry; Wingen, Anne M.; Gueran, Tuelay; Hoenderop, Joost G.; Bindels, Rene J.; Prosser, David E.; Jones, Glenville; Konrad, Martin			Mutations in CYP24A1 and Idiopathic Infantile Hypercalcemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SITE-DIRECTED MUTAGENESIS; VITAMIN-D; CALCITROIC ACID; METABOLISM; BONE; 1,25-DIHYDROXYVITAMIN-D3; PHARMACOKINETICS; INACTIVATION; MECHANISM; RESIDUES	BACKGROUND Vitamin D supplementation for the prevention of rickets is one of the oldest and most effective prophylactic measures in medicine, having virtually eradicated rickets in North America. Given the potentially toxic effects of vitamin D, the recommendations for the optimal dose are still debated, in part owing to the increased incidence of idiopathic infantile hypercalcemia in Britain in the 1950s during a period of high vitamin D supplementation in fortified milk products. We investigated the molecular basis of idiopathic infantile hypercalcemia, which is characterized by severe hypercalcemia, failure to thrive, vomiting, dehydration, and nephrocalcinosis. METHODS We used a candidate-gene approach in a cohort of familial cases of typical idiopathic infantile hypercalcemia with suspected autosomal recessive inheritance. Identified mutations in the vitamin D-metabolizing enzyme CYP24A1 were evaluated with the use of a mammalian expression system. RESULTS Sequence analysis of CYP24A1, which encodes 25-hydroxyvitamin D 24-hydroxylase, the key enzyme of 1,25-dihydroxyvitamin D-3 degradation, revealed recessive mutations in six affected children. In addition, CYP24A1 mutations were identified in a second cohort of infants in whom severe hypercalcemia had developed after bolus prophylaxis with vitamin D. Functional characterization revealed a complete loss of function in all CYP24A1 mutations. CONCLUSIONS The presence of CYP24A1 mutations explains the increased sensitivity to vitamin D in patients with idiopathic infantile hypercalcemia and is a genetic risk factor for the development of symptomatic hypercalcemia that may be triggered by vitamin D prophylaxis in otherwise apparently healthy infants.	[Konrad, Martin] Univ Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany; [Schlingmann, Karl P.; Goos, Caroline] Univ Childrens Hosp, Marburg, Germany; [Weber, Stefanie; Wingen, Anne M.] Univ Childrens Hosp, Essen, Germany; [John, Ulrike; Misselwitz, Joachim] Univ Childrens Hosp, Jena, Germany; [Klaus, Guenter] Kuratorium Heimdialyse Pediat Kidney Ctr, Marburg, Germany; [Fehrenbach, Henry] Childrens Hosp, Memmingen, Germany; [Kaufmann, Martin; Irwin, Andrew; Prosser, David E.; Jones, Glenville] Queens Univ, Kingston, ON, Canada; [Gueran, Tuelay] Univ Childrens Hosp, Istanbul, Turkey; [Hoenderop, Joost G.; Bindels, Rene J.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Queens University - Canada; Radboud University Nijmegen	Konrad, M (corresponding author), Univ Childrens Hosp, Dept Gen Pediat, Waldeyerstr 22, D-48149 Munster, Germany.	konradma@uni-muenster.de	Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544	Canadian Institutes of Health Research; Cytochroma	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cytochroma	Supported by grants from the Canadian Institutes of Health Research and Cytochroma (to Dr. Jones).	Annalora AJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P262, DOI 10.1016/j.abb.2006.11.018; [Anonymous], 1956, BRIT MED J, V2, P149; BEUREN AJ, 1962, CIRCULATION, V26, P1235, DOI 10.1161/01.CIR.26.6.1235; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V505, P226, DOI 10.1016/j.abb.2010.10.012; DELUCA HF, 1976, ANNU REV BIOCHEM, V45, P631, DOI 10.1146/annurev.bi.45.070176.003215; FANCONI G, 1951, SCHWEIZ MED WSCHR, V81, P908; FRASER DONALD, 1967, PEDIATRICS, V40, P1050; Hamamoto H, 2006, MOL PHARMACOL, V70, P120, DOI 10.1124/mol.106.023275; Hesse V, 1985, Kinderarztl Prax, V53, P383; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; LIGHTWOOD R, 1952, P ROY SOC MED, V45, P401; LIGHTWOOD R, 1953, LANCET, V265, P255; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; Masuda S, 2005, ENDOCRINOLOGY, V146, P825, DOI 10.1210/en.2004-1116; Masuda S, 2007, ARCH BIOCHEM BIOPHYS, V460, P177, DOI 10.1016/j.abb.2006.11.030; Misselwitz J, 1986, Kinderarztl Prax, V54, P431; Nguyen M, 2010, J PEDIATR-US, V157, P296, DOI 10.1016/j.jpeds.2010.02.025; Pronicka E, 1997, PEDIATR NEPHROL, V11, P2, DOI 10.1007/s004670050221; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Prosser DE, 2006, BIOPHYS J, V90, P3389, DOI 10.1529/biophysj.105.069369; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; REDDY GS, 1989, BIOCHEMISTRY-US, V28, P1763, DOI 10.1021/bi00430a051; RHANEY K, 1956, LANCET, V270, P1028; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SAMUEL H S, 1964, Br Med J, V1, P1659; SHEPARD RM, 1980, ARCH BIOCHEM BIOPHYS, V202, P43, DOI 10.1016/0003-9861(80)90404-X; SMITH DW, 1959, PEDIATRICS, V24, P258; St-Arnaud R, 1999, BONE, V25, P127, DOI 10.1016/S8756-3282(99)00118-0; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; STAPLETON T, 1957, AM J CLIN NUTR, V5, P533, DOI 10.1093/ajcn/5.5.533; WEISMAN Y, 1979, MED HYPOTHESES, V5, P379, DOI 10.1016/0306-9877(79)90019-7; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311	34	382	406	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					410	421		10.1056/NEJMoa1103864	http://dx.doi.org/10.1056/NEJMoa1103864			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21675912				2022-12-01	WOS:000293447800005
J	Brownell, KD; Koplan, JP				Brownell, Kelly D.; Koplan, Jeffrey P.			Front-of-Package Nutrition Labeling - An Abuse of Trust by the Food Industry?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brownell, Kelly D.] Yale Univ, New Haven, CT 06520 USA; [Koplan, Jeffrey P.] Emory Univ, Atlanta, GA 30322 USA	Yale University; Emory University	Brownell, KD (corresponding author), Yale Univ, New Haven, CT 06520 USA.							Koplan JP, 2010, JAMA-J AM MED ASSOC, V304, P1487, DOI 10.1001/jama.2010.1436; Pomeranz JL, 2011, AM J PREV MED, V40, P382, DOI 10.1016/j.amepre.2010.11.009; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P330, DOI 10.1017/S1368980007223870; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960	4	64	65	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2373	2375		10.1056/NEJMp1101033	http://dx.doi.org/10.1056/NEJMp1101033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781MG	21696305				2022-12-01	WOS:000291936100001
J	Solomon, DH; Massarotti, E; Garg, R; Liu, J; Canning, C; Schneeweiss, S				Solomon, Daniel H.; Massarotti, Elena; Garg, Rajesh; Liu, Jun; Canning, Claire; Schneeweiss, Sebastian			Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE; ANKYLOSING-SPONDYLITIS; MELLITUS; HYDROXYCHLOROQUINE; ATHEROSCLEROSIS; INFLAMMATION; DATABASES; ACCURACY; MARKERS; COHORT	Context Rheumatoid arthritis (RA) and psoriasis have been linked with insulin resistance and diabetes mellitus (DM). Prior investigations suggest that systemic immunosuppressive drugs may improve insulin resistance and reduce the risk of DM. Objective To compare the risk of newly recorded DM among participants diagnosed with RA or psoriasis based on use of a variety of disease-modifying antirheumatic drugs (DMARDs). Design, Setting, and Participants A retrospective cohort study among 121 280 patients with a diagnosis of either RA or psoriasis on at least 2 visits. The analyses were conducted in the context of 2 large health insurance programs, 1 in Canada and 1 in the United States, using administrative data. The mean follow-up was 5.8 months and began with the first prescription for a DMARD after study eligibility was met. Drug regimens were categorized into 4 mutually exclusive groups: (1) tumor necrosis factor (TNF) inhibitors with or without other DMARDs; (2) methotrexate without TNF inhibitors or hydroxychloroquine; (3) hydroxychloroquine without TNF inhibitors or methotrexate; or (4) other nonbiologic DMARDs without TNF inhibitors, methotrexate, or hydroxychloroquine (reference exposure). Main Outcome Measure Newly recorded DM as evidenced by a new diagnosis of DM with use of a DM-specific medication. Results The study cohort consisted of 13 905 participants with 22 493 treatment episodes starting 1 of the categories of DMARD regimens between January 1996 and June 2008. New diabetes cases and respective incidence rates per 1000 person-years were: other nonbiologic DMARDs (55 cases among 3993 treatment episodes; rate, 50.2; 95% confidence interval [CI], 47.3-53.2); TNF inhibitors (80 cases among 4623 treatment episodes; rate, 19.7; 95% CI, 19.1-20.3); methotrexate (82 cases among 8195 treatment episodes; rate, 23.8; 95% CI, 23.0-24.6); and hydroxychloroquine (50 cases among 5682 treatment episodes; rate, 22.2; 95% CI, 21.3-23.1). The multivariate adjusted hazard ratios for DM were 0.62 (95% CI, 0.42-0.91) for TNF inhibitors, 0.77 (95% CI, 0.53-1.13) for methotrexate, and 0.54 (95% CI, 0.36-0.80) for hydroxychloroquine compared with other nonbiologic DMARDS. Conclusion Among patients with RA or psoriasis, the adjusted risk of DM was lower for individuals starting a TNF inhibitor or hydroxychloroquine compared with initiation of other nonbiologic DMARDs. JAMA. 2011;305(24):2525-2531	[Solomon, Daniel H.; Massarotti, Elena] Brigham & Womens Hosp, Div Rheumatol, Dept Med, Boston, MA 02115 USA; [Solomon, Daniel H.; Liu, Jun; Canning, Claire; Schneeweiss, Sebastian] Brigham & Womens Hosp, Div Pharmacoepidemiol, Dept Med, Boston, MA 02115 USA; [Garg, Rajesh] Brigham & Womens Hosp, Div Endocrinol, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Solomon, DH (corresponding author), Brigham & Womens Hosp, Div Rheumatol, Dept Med, 75 Francis St,PBB B3, Boston, MA 02115 USA.	dsolomon@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	Abbott; Bristol-Myers Squibb; Pfizer; EMD-Serono; UCB; Human Genome Sciences; Ampimmune; Policy Analysis Inc.; sanofi-aventis; Novartis; Biogen Idec; Teva; Agency for Healthcare Research and Quality; FDA; Amgen; Brigham and Women's Hospital	Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); EMD-Serono; UCB(UCB Pharma SA); Human Genome Sciences(GlaxoSmithKline); Ampimmune; Policy Analysis Inc.; sanofi-aventis(Sanofi-Aventis); Novartis(Novartis); Biogen Idec(Biogen); Teva(Teva Pharmaceutical Industries); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FDA(United States Department of Health & Human Services); Amgen(Amgen); Brigham and Women's Hospital	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Solomon reports having received support through a research grant from Abbott, directing an educational course supported by Bristol-Myers Squibb, and serving in an unpaid role on 2 Pfizer-sponsored trials. Dr Massarotti reports being a clinical investigator for an RA therapeutics trial sponsored by Bristol-Myers Squibb, and for 2 sponsored systemic lupus erythematosus trials, 1 funded by EMD-Serono, and the second as part of the Autoimmune Centers of Excellence through the National Institutes of Health; and receiving consulting fees from UCB, Human Genome Sciences, Pfizer, Ampimmune, and Policy Analysis Inc. Dr Garg (or spouse) reports having received consultant fees from sanofi-aventis, Pfizer, Novartis, Biogen Idec, Teva, and EMD Serono. Dr Schneeweiss is principal investigator of the Brigham and Women's Hospital DEcIDE Center on Comparative Effectiveness Research and the DEcIDE Methods Center both funded by Agency for Healthcare Research and Quality and of the Harvard-Brigham Drug Safety and Risk Management Research Center funded by the FDA. Dr Schneeweiss reports being a paid member of the scientific advisory board of HealthCore; a consultant to HealthCore and WHISCON; and a recipient of investigator-initiated grants from Pfizer and Novartis.; Amgen paid for the research through a research contract with the Brigham and Women's Hospital. Amgen reviewed the study protocol and reviewed a draft manuscript but had no editorial control.	Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; Emami J, 1998, LIFE SCI, V64, P325, DOI 10.1016/S0024-3205(98)00568-2; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; GARCIAWEBB P, 1985, BIOCHEM BIOPH RES CO, V128, P487, DOI 10.1016/0006-291X(85)90073-7; Garg R, 2003, CURR DRUG TARGETS, V4, P487, DOI 10.2174/1389450033490920; Gelfand JM, 2003, ARCH DERMATOL, V139, P1425, DOI 10.1001/archderm.139.11.1425; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gerstein HC, 2002, DIABETES RES CLIN PR, V55, P209, DOI 10.1016/S0168-8227(01)00325-4; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Han CL, 2006, J RHEUMATOL, V33, P2167; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Meigs JB, 2006, DIABETES, V55, P530, DOI 10.2337/diabetes.55.02.06.db05-1041; O'Connor PJ, 1998, AM J MANAG CARE, V4, P335; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; QUATRARO A, 1990, ANN INTERN MED, V112, P678, DOI 10.7326/0003-4819-112-9-678; Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8; Wasko MCM, 2007, JAMA-J AM MED ASSOC, V298, P187, DOI 10.1001/jama.298.2.187; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	36	281	293	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2525	2531		10.1001/jama.2011.878	http://dx.doi.org/10.1001/jama.2011.878			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693740	Bronze			2022-12-01	WOS:000291860400019
J	Cole, M				Cole, Mike			Poison in party pills is too much to swallow	NATURE			English	Editorial Material									Anglia Ruskin Univ, Cambridge, England	Anglia Ruskin University	Cole, M (corresponding author), Anglia Ruskin Univ, Cambridge, England.	Michael.cole@anglia.ac.uk							0	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					253	253		10.1038/474253a	http://dx.doi.org/10.1038/474253a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777TD	21677705	Bronze			2022-12-01	WOS:000291647100004
J	Benowitz, NL; Samet, JM				Benowitz, Neal L.; Samet, Jonathan M.			The Threat of Menthol Cigarettes to U.S. Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Benowitz, Neal L.] San Francisco Gen Hosp, Med Ctr, Med Serv, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA 94110 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco, CA 94143 USA; [Samet, Jonathan M.] USC, Dept Prevent Med, Keck Sch Med, Los Angeles, CA USA; [Samet, Jonathan M.] Univ So Calif, USC Inst Global Hlth, Los Angeles, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; University of Southern California Keck Hospital; University of Southern California	Benowitz, NL (corresponding author), San Francisco Gen Hosp, Med Ctr, Med Serv, Div Clin Pharmacol & Expt Therapeut, San Francisco, CA 94110 USA.							TPSAC (Tobacco Products Scientific Advisory Committee), 2011, SACN IR HLTH REP SCI; US Dep Health Educ Welfare (DHEW), 1964, DHEW PUBL	2	26	27	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2179	2181		10.1056/NEJMp1103610	http://dx.doi.org/10.1056/NEJMp1103610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21542737				2022-12-01	WOS:000291392100002
J	Mishra, SK; Ammon, T; Popowicz, GM; Krajewski, M; Nagel, RJ; Ares, M; Holak, TA; Jentsch, S				Mishra, Shravan Kumar; Ammon, Tim; Popowicz, Grzegorz M.; Krajewski, Marcin; Nagel, Roland J.; Ares, Manuel, Jr.; Holak, Tad A.; Jentsch, Stefan			Role of the ubiquitin-like protein Hub1 in splice-site usage and alternative splicing	NATURE			English	Article							GENE-EXPRESSION; MESSENGER-RNAS; YEAST GENES; MODIFIER; INTRON; SENSITIVITY; DESIGN; SRC1; STEP; UBL5	Alternative splicing of pre-messenger RNAs diversifies gene products in eukaryotes and is guided by factors that enable spliceosomes to recognize particular splice sites. Here we report that alternative splicing of Saccharomyces cerevisiae SRC1 pre-mRNA is promoted by the conserved ubiquitin-like protein Hub1. Structural and biochemical data show that Hub1 binds non-covalently to a conserved element termed HIND, which is present in the spliceosomal protein Snu66 in yeast and mammals, and Prp38 in plants. Hub1 binding mildly alters spliceosomal protein interactions and barely affects general splicing in S. cerevisiae. However, spliceosomes that lack Hub1, or are defective in Hub1-HIND interaction, cannot use certain non-canonical 59 splice sites and are defective in alternative SRC1 splicing. Hub1 confers alternative splicing not only when bound to HIND, but also when experimentally fused to Snu66, Prp38, or even the core splicing factor Prp8. Our study indicates a novel mechanism for splice site utilization that is guided by non-covalent modification of the spliceosome by an unconventional ubiquitin-like modifier.	[Mishra, Shravan Kumar; Ammon, Tim; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Popowicz, Grzegorz M.; Krajewski, Marcin; Holak, Tad A.] Max Planck Inst Biochem, NMR Spect, D-82152 Martinsried, Germany; [Nagel, Roland J.; Ares, Manuel, Jr.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	Max Planck Society; Max Planck Society; University of California System; University of California Santa Cruz	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de	Popowicz, Grzegorz/G-4769-2017	Popowicz, Grzegorz/0000-0003-2818-7498; Ares, Manny/0000-0002-2552-9168; Mishra, Shravan Kumar/0000-0003-3899-0495	Max Planck Society; Deutsche Forschungsgemeinschaft; Fonds der chemischen Industrie; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; NIH [GM040478]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040478] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank U. Cramer and M. Kost for technical assistance, G. Dittmar, C. Guthrie, M. Konarska, K. Matuschewski, O. Nielsen, M. Rosbash and H. Yashiroda for materials, S. Uebel and C. Boulegue for mass spectrometric analysis and help, K. Hofmann for pointing out putative HIND elements in Prp38 proteins of plants, and M. Singh for initiating structural work. S.J. is supported by the Max Planck Society, Deutsche Forschungsgemeinschaft, Fonds der chemischen Industrie, Center for Integrated Protein Science Munich and RUBICON EU Network of Excellence; T.A.H. by the Max Planck Society; M.A. by NIH (GM040478).	ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Burckin T, 2005, NAT STRUCT MOL BIOL, V12, P175, DOI 10.1038/nsmb891; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dittmar GAG, 2002, SCIENCE, V295, P2442, DOI 10.1126/science.1069989; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Friedmann JS, 2001, GENOMICS, V71, P252, DOI 10.1006/geno.2000.6439; Grund SE, 2008, J CELL BIOL, V182, P897, DOI 10.1083/jcb.200803098; Hagan IM, 2000, PRACT APPROACH SER, V218, P179; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; JACQUIER A, 1985, CELL, V43, P423, DOI 10.1016/0092-8674(85)90172-2; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kress TL, 2008, MOL CELL, V32, P727, DOI 10.1016/j.molcel.2008.11.013; Kuhn AN, 2003, CURR GENET, V42, P241, DOI 10.1007/s00294-002-0355-2; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LESSER CF, 1993, GENETICS, V133, P851; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Luders J, 2003, EMBO REP, V4, P1169, DOI 10.1038/sj.embor.7400025; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; McNally T, 2003, PROTEIN SCI, V12, P1562, DOI 10.1110/ps.0382803; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Okazaki K, 2000, DNA RES, V7, P27, DOI 10.1093/dnares/7.1.27; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; RAMAGE R, 1994, BIOCHEM J, V299, P151, DOI 10.1042/bj2990151; Ramelot Theresa A., 2003, Journal of Structural and Functional Genomics, V4, P25, DOI 10.1023/A:1024674220425; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wilkinson CRM, 2004, CURR BIOL, V14, P2283, DOI 10.1016/j.cub.2004.11.058; Yashiroda H, 2004, GENES CELLS, V9, P1189, DOI 10.1111/j.1365-2443.2004.00807.x; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	44	60	62	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					173	U205		10.1038/nature10143	http://dx.doi.org/10.1038/nature10143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21614000	Green Accepted			2022-12-01	WOS:000291397800041
J	Davis, MM; Dayoub, EJ				Davis, Matthew M.; Dayoub, Elias J.			A Strategic Approach to Therapeutic Cancer Vaccines in the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Davis, Matthew M.] Univ Michigan, Div Gen Med, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Dayoub, Elias J.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Davis, MM (corresponding author), Univ Michigan, Div Gen Med, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA.	mattdav@med.umich.edu						Brower V, 2010, J NATL CANCER I, V102, P1108, DOI 10.1093/jnci/djq295; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P243; Davis MM, 2010, HUM VACCINES, V6, P689, DOI 10.4161/hv.6.9.13496; Howlader N, 2011, SEER CANC STAT UNPUB; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294	6	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2343	2344		10.1001/jama.2011.814	http://dx.doi.org/10.1001/jama.2011.814			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642687				2022-12-01	WOS:000291349100028
J	Chou, HH; Chiu, HC; Delaney, NF; Segre, D; Marx, CJ				Chou, Hsin-Hung; Chiu, Hsuan-Chao; Delaney, Nigel F.; Segre, Daniel; Marx, Christopher J.			Diminishing Returns Epistasis Among Beneficial Mutations Decelerates Adaptation	SCIENCE			English	Article							ESCHERICHIA-COLI; EVOLUTION; FITNESS; ARCHITECTURE; LANDSCAPE; DYNAMICS; PROTEIN	Epistasis has substantial impacts on evolution, in particular, the rate of adaptation. We generated combinations of beneficial mutations that arose in a lineage during rapid adaptation of a bacterium whose growth depended on a newly introduced metabolic pathway. The proportional selective benefit for three of the four loci consistently decreased when they were introduced onto more fit backgrounds. These three alleles all reduced morphological defects caused by expression of the foreign pathway. A simple theoretical model segregating the apparent contribution of individual alleles to benefits and costs effectively predicted the interactions between them. These results provide the first evidence that patterns of epistasis may differ for within- and between-gene interactions during adaptation and that diminishing returns epistasis contributes to the consistent observation of decelerating fitness gains during adaptation.	[Chou, Hsin-Hung; Delaney, Nigel F.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Chiu, Hsuan-Chao; Segre, Daniel] Boston Univ, Grad Program Bioinformat, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Marx, Christopher J.] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Boston University; Boston University; Boston University; Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu	Segrè, Daniel/A-1993-2009; Chiu, Hsuan-Chao/F-8963-2011	Segrè, Daniel/0000-0003-4859-1914; Chiu, Hsuan-Chao/0000-0001-9828-2955; CHOU, HSIN-HUNG/0000-0001-6003-5609	NIH [R01 GM078209]; NSF [DEB-0845893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kryazhminskiy, D. Weinreich, J. Weitz, C. Wilke, R. Whitaker, and members of the Marx and Segre labs for suggestions and discussions. Supported by NIH grant R01 GM078209, and NSF grant DEB-0845893. The resulting single-end 36-bp read data have been deposited in the NCBI Short Read Archive with accession no. SRA030695.1.	Applebee MK, 2008, J BACTERIOL, V190, P5087, DOI 10.1128/JB.01976-07; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Martin G, 2007, NAT GENET, V39, P555, DOI 10.1038/ng1998; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	19	315	318	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1190	1192		10.1126/science.1203799	http://dx.doi.org/10.1126/science.1203799			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636771	Green Accepted			2022-12-01	WOS:000291205200046
J	Wenzel, DM; Lissounov, A; Brzovic, PS; Klevit, RE				Wenzel, Dawn M.; Lissounov, Alexei; Brzovic, Peter S.; Klevit, Rachel E.			UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids	NATURE			English	Article							UBIQUITIN-CONJUGATING ENZYME; CRYSTAL-STRUCTURE; PROTEIN; LIGASE; RING; EXPRESSION; ACTIVATION; RESIDUES; INSIGHTS; COMPLEX	Although the functional interaction between ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s) is essential in ubiquitin (Ub) signalling, the criteria that define an active E2-E3 pair are not well established. The human E2 UBCH7 (also known as UBE2L3) shows broad specificity for HECT-type E3s(1), but often fails to function with RING E3s in vitro despite forming specific complexes(2-4). Structural comparisons of inactive UBCH7-RING complexes with active UBCH5-RING complexes reveal no defining differences(3,4), highlighting a gap in our understanding of Ub transfer. Here we show that, unlike many E2s that transfer Ub with RINGs, UBCH7 lacks intrinsic, E3-independent reactivity with lysine, explaining its preference for HECTs. Despite lacking lysine reactivity, UBCH7 exhibits activity with the RING-inbetween-RING (RBR) family of E3s that includes parkin (also known as PARK2) and human homologue of ariadne (HHARI; also known as ARIH1)(5,6). Found in all eukaryotes(7), RBRs regulate processes such as translation(8) and immune signalling(9). RBRs contain a canonical C3HC4-type RING, followed by two conserved Cys/His-rich Zn2+-binding domains, in-between-RING (IBR) and RING2 domains, which together define this E3 family(7). We show that RBRs function like RING/HECT hybrids: they bind E2s via a RING domain, but transfer Ub through an obligate thioester-linked Ub (denoted Ub), requiring a conserved cysteine residue in RING2. Our results define the functional cadre of E3s for UBCH7, an E2 involved in cell proliferation(10) and immune function(11), and indicate a novel mechanism for an entire class of E3s.	[Wenzel, Dawn M.; Lissounov, Alexei; Brzovic, Peter S.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	National Institute of General Medical Sciences [5R01 GM088055, T32 GM07270]; National Science Foundation [MCB0615632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088055, T32GM007270] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Stoll, M. Schwartz and N. Zheng for critical reading of the manuscript and discussions and V. Vittal, K. Stoll and P. Littlefield for technical help. We thank K. Borden, E. Fon, B. Schulman, L. Boyd, J. Chen and A. Merz for expression vectors for HHARI, parkin, E6-AP, Ubc18, human E1 and GST pull-down reagents, respectively. We acknowledge support from the National Institute of General Medical Sciences in the form of 5R01 GM088055 (R.E.K.) and T32 GM07270 (D.M.W.), and the National Science Foundation in the form of MCB0615632 (R.E.K.)	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones D, 2002, GENOME BIOL, V3; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Maruyama M, 2000, ANN NEUROL, V48, P245, DOI 10.1002/1531-8249(200008)48:2<245::AID-ANA15>3.0.CO;2-2; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tan NGS, 2003, FEBS LETT, V554, P501, DOI 10.1016/S0014-5793(03)01235-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Whitcomb EA, 2009, MOL BIOL CELL, V20, P1, DOI 10.1091/mbc.E08-01-0036; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	35	370	386	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					105	U136		10.1038/nature09966	http://dx.doi.org/10.1038/nature09966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21532592	Green Accepted			2022-12-01	WOS:000291156700047
J	Williams, K; Christensen, J; Pedersen, MT; Johansen, JV; Cloos, PAC; Rappsilber, J; Helin, K				Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Johansen, Jens V.; Cloos, Paul A. C.; Rappsilber, Juri; Helin, Kristian			TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity	NATURE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; WIDE; PLURIPOTENT; CONVERSION; COMPLEX; GENES; MAPS	Enzymes catalysing the methylation of the 5-position of cytosine (mC) have essential roles in regulating gene expression and maintaining cellular identity. Recently, TET1 was found to hydroxylate the methyl group of mC, converting it to 5-hydroxymethyl cytosine (hmC). Here we show that TET1 binds throughout the genome of embryonic stem cells, with the majority of binding sites located at transcription start sites (TSSs) of CpG-rich promoters and within genes. The hmC modification is found in gene bodies and in contrast to mC is also enriched at CpG-rich TSSs. We provide evidence further that TET1 has a role in transcriptional repression. TET1 binds a significant proportion of Polycomb group target genes. Furthermore, TET1 associates and colocalizes with the SIN3A co-repressor complex. We propose that TET1 fine-tunes transcription, opposes aberrant DNA methylation at CpG-rich sequences and thereby contributes to the regulation of DNA methylation fidelity.	[Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Johansen, Jens V.; Cloos, Paul A. C.; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Williams, Kristine; Christensen, Jesper; Pedersen, Marianne Terndrup; Cloos, Paul A. C.; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Johansen, Jens V.] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Edinburgh	Helin, K (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Rappsilber, Juri/B-7265-2015; Rappsilber, Juri/ABF-3328-2020; Helin, Kristian/HDM-8306-2022; Helin, Kristian/K-2526-2019; Williams, Kristine/AAA-5662-2022	Rappsilber, Juri/0000-0001-5999-1310; Williams, Kristine/0000-0002-1198-6552; Helin, Kristian/0000-0003-1975-6097; Cloos, Paul/0000-0001-5863-0054; Vilstrup Johansen, Jens/0000-0001-7094-6801; Pedersen, Marianne Terndrup/0000-0003-3808-0352	Danish Cancer Society; University of Copenhagen; Danish National Research Foundation; Lundbeck foundation; Novo Nordisk Foundation; Danish Medical Research Council	Danish Cancer Society(Danish Cancer Society); University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank U. Toftegaard for excellent technical help, M. Okano for the donation of TKO ES cells, and members of the Helin lab for discussions. M.T.P. was supported by a fellowship from the Danish Cancer Society. J.R. is a senior research fellow of the Wellcome Trust. The work in the Helin lab was supported by grants from the Excellence Program of the University of Copenhagen, the Danish National Research Foundation, the Danish Cancer Society, the Lundbeck foundation, the Novo Nordisk Foundation, and the Danish Medical Research Council.	Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; ERLANGER BF, 1964, P NATL ACAD SCI USA, V52, P68, DOI 10.1073/pnas.52.1.68; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohamedali AM, 2009, J CLIN ONCOL, V27, P4002, DOI 10.1200/JCO.2009.22.6985; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	29	759	797	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					343	U472		10.1038/nature10066	http://dx.doi.org/10.1038/nature10066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21490601	Green Accepted			2022-12-01	WOS:000290722400041
J	Badouel, C; McNeill, H				Badouel, Caroline; McNeill, Helen			SnapShot: The Hippo Signaling Pathway	CELL			English	Editorial Material							SIZE CONTROL		[Badouel, Caroline; McNeill, Helen] Univ Toronto, Samuel Lunenfeld Res Inst, Dept Mol Genet, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Badouel, C (corresponding author), Univ Toronto, Samuel Lunenfeld Res Inst, Dept Mol Genet, Mt Sinai Hosp, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154				Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	6	70	74	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 29	2011	145	3					484	U162	484.e1	10.1016/j.cell.2011.04.009	http://dx.doi.org/10.1016/j.cell.2011.04.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529719	Bronze			2022-12-01	WOS:000290022900017
J	Jain, R; Kralovic, SM; Evans, ME; Ambrose, M; Simbartl, LA; Obrosky, DS; Render, ML; Freyberg, RW; Jernigan, JA; Muder, RR; Miller, LJ; Roselle, GA				Jain, Rajiv; Kralovic, Stephen M.; Evans, Martin E.; Ambrose, Meredith; Simbartl, Loretta A.; Obrosky, D. Scott; Render, Marta L.; Freyberg, Ron W.; Jernigan, John A.; Muder, Robert R.; Miller, LaToya J.; Roselle, Gary A.			Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; NOSOCOMIAL TRANSMISSION; COLONIZATION PRESSURE; HOSPITAL ADMISSION; MRSA; SURVEILLANCE; RISK; PRECAUTIONS; PREVALENCE	BACKGROUND Health care-associated infections with methicillin-resistant Staphylococcus aureus (MRSA) have been an increasing concern in Veterans Affairs (VA) hospitals. METHODS A "MRSA bundle" was implemented in 2007 in acute care VA hospitals nationwide in an effort to decrease health care-associated infections with MRSA. The bundle consisted of universal nasal surveillance for MRSA, contact precautions for patients colonized or infected with MRSA, hand hygiene, and a change in the institutional culture whereby infection control would become the responsibility of everyone who had contact with patients. Each month, personnel at each facility entered into a central database aggregate data on adherence to surveillance practice, the prevalence of MRSA colonization or infection, and health care-associated transmissions of and infections with MRSA. We assessed the effect of the MRSA bundle on health care-associated MRSA infections. RESULTS From October 2007, when the bundle was fully implemented, through June 2010, there were 1,934,598 admissions to or transfers or discharges from intensive care units (ICUs) and non-ICUs (ICUs, 365,139; non-ICUs, 1,569,459) and 8,318,675 patient-days (ICUs, 1,312,840; and non-ICUs, 7,005,835). During this period, the percentage of patients who were screened at admission increased from 82% to 96%, and the percentage who were screened at transfer or discharge increased from 72% to 93%. The mean (+/- SD) prevalence of MRSA colonization or infection at the time of hospital admission was 13.6 +/- 3.7%. The rates of health care-associated MRSA infections in ICUs had not changed in the 2 years before October 2007 (P = 0.50 for trend) but declined with implementation of the bundle, from 1.64 infections per 1000 patient-days in October 2007 to 0.62 per 1000 patient-days in June 2010, a decrease of 62% (P<0.001 for trend). During this same period, the rates of health care-associated MRSA infections in non-ICUs fell from 0.47 per 1000 patient-days to 0.26 per 1000 patient-days, a decrease of 45% (P<0.001 for trend). CONCLUSIONS A program of universal surveillance, contact precautions, hand hygiene, and institutional culture change was associated with a decrease in health care-associated transmissions of and infections with MRSA in a large health care system.	[Jain, Rajiv; Evans, Martin E.; Ambrose, Meredith; Miller, LaToya J.] Vet Affairs Cent Off, Patient Care Serv, Vet Hlth Adm MRSA Program Off, Pittsburgh, PA USA; [Jain, Rajiv; Evans, Martin E.; Ambrose, Meredith; Miller, LaToya J.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Jain, Rajiv; Muder, Robert R.] VA Pittsburgh Healthcare Syst, Dept Internal Med, Pittsburgh, PA USA; [Jain, Rajiv; Muder, Robert R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Obrosky, D. Scott] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Kralovic, Stephen M.; Simbartl, Loretta A.; Roselle, Gary A.] VA Cent Off, Patient Care Serv, Natl Infect Dis Program Off, Cincinnati, OH USA; [Kralovic, Stephen M.; Simbartl, Loretta A.; Roselle, Gary A.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Kralovic, Stephen M.; Render, Marta L.; Roselle, Gary A.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA; [Render, Marta L.; Freyberg, Ron W.] VA Inpatient Evaluat Ctr, Cincinnati, OH USA; [Evans, Martin E.] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40506 USA; [Jernigan, John A.] Ctr Dis Control & Prevent, Prevent & Response Branch, Div Healthcare Qual Promot, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; University of Kentucky; Centers for Disease Control & Prevention - USA	Evans, ME (corresponding author), Lexington VAMC, VHA MDRO Program, 1101 Vet Dr,11I-CDD, Lexington, KY 40502 USA.	martin.evans@va.gov		Jernigan, John/0000-0001-8163-925X				[Anonymous], 2009, VHA HDB; Boyce JM, 2004, INFECT CONT HOSP EP, V25, P395, DOI 10.1086/502412; Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Centers for Disease Control and Prevention/National Healthcare Safety Network (NHSN), ID HEALTHC ASS INF H; Chang S, 2009, CLIN INFECT DIS, V48, P1423, DOI 10.1086/598505; Chowers MY, 2009, INFECT CONT HOSP EP, V30, P778, DOI 10.1086/599019; Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; Croft CA, 2009, AM SURGEON, V75, P458; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; Hidron AI, 2009, INFECT CONT HOSP EP, V30, DOI 10.1086/595954; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lee BY, 2010, INFECT CONT HOSP EP, V31, P598, DOI 10.1086/652524; Lucet JC, 2003, ARCH INTERN MED, V163, P181, DOI 10.1001/archinte.163.2.181; Lucet JC, 2005, INTENS CARE MED, V31, P1051, DOI 10.1007/s00134-005-2679-0; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721; Muder RR, 2008, INFECT CONT HOSP EP, V29, P702, DOI 10.1086/589981; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Nyman JA, 2011, AM J INFECT CONTROL, V39, P27, DOI 10.1016/j.ajic.2010.09.006; Pan A, 2005, INFECT CONT HOSP EP, V26, P127, DOI 10.1086/502515; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2009, INFECT CONT HOSP EP, V30, P623, DOI 10.1086/597550; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; The World Health Organisation, 2009, WHO GUID HAND HYG HL; Vos MC, 2009, INFECT CONT HOSP EP, V30, P977, DOI 10.1086/605921; Williams VR, 2009, AM J INFECT CONTROL, V37, P106, DOI 10.1016/j.ajic.2008.05.007; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08	34	376	399	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1419	1430		10.1056/NEJMoa1007474	http://dx.doi.org/10.1056/NEJMoa1007474			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21488764				2022-12-01	WOS:000289467200006
J	Cardinale, BJ				Cardinale, Bradley J.			Biodiversity improves water quality through niche partitioning	NATURE			English	Article							PLANT DIVERSITY; STREAM PERIPHYTON; PATCH DYNAMICS; NITROGEN; EUTROPHICATION; PRODUCTIVITY; DISTURBANCE; ECOLOGY; NITRATE; RESPONSES	Excessive nutrient loading of water bodies is a leading cause of water pollution worldwide(1,2), and controlling nutrient levels in watersheds is a primary objective of most environmental policy(3). Over the past two decades, much research has shown that ecosystems with more species are more efficient at removing nutrients from soil and water than are ecosystems with fewer species(4-7). This has led some to suggest that conservation of biodiversity might be a useful tool for managing nutrient uptake and storage(7-10), but this suggestion has been controversial, in part because the specific biological mechanisms by which species diversity influences nutrient uptake have not been identified(10-12). Here I use a model system of stream biofilms to show that niche partitioning among species of algae can increase the uptake and storage of nitrate, a nutrient pollutant of global concern. I manipulated the number of species of algae growing in the biofilms of 150 stream mesocosms that had been set up to mimic the variety of flow habitats and disturbance regimes that are typical of natural streams. Nitrogen uptake rates, as measured by using N-15-labelled nitrate, increased linearly with species richness and were driven by niche differences among species. As different forms of algae came to dominate each unique habitat in a stream, the more diverse communities achieved a higher biomass and greater N-15 uptake. When these niche opportunities were experimentally removed by making all of the habitats in a stream uniform, diversity did not influence nitrogen uptake, and biofilms collapsed to a single dominant species. These results provide direct evidence that communities with more species take greater advantage of the niche opportunities in an environment, and this allows diverse systems to capture a greater proportion of biologically available resources such as nitrogen. One implication is that biodiversity may help to buffer natural ecosystems against the ecological impacts of nutrient pollution.	Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cardinale, BJ (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	bradcard@umich.edu	Cardinale, Bradley J/I-7076-2013		US National Science Foundation [DEB 0614428, DEB 1046121]; Division Of Environmental Biology [1046121] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Byrnes, W. Dodds, J. Levine and A. Steinman for comments that improved the manuscript. D. Bennett, K. Matulich, L. Power and J. Weis helped to set up and run the experiment. M. Potapova provided images of the algae in Fig. 2. This work was funded by grants from the US National Science Foundation (DEB 0614428 and DEB 1046121).	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Andersen R. A., 2005, ALGAL CULTURING TECH; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Biggs BJF, 1998, ARCH HYDROBIOL, V143, P21; BIGGS BJF, 1995, J PHYCOL, V31, P233, DOI 10.1111/j.0022-3646.1995.00233.x; Biggs BJF, 1998, J PHYCOL, V34, P598, DOI 10.1046/j.1529-8817.1998.340598.x; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carroll I. T., ECOLOGY IN PRESS; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cooper SD, 1997, J N AM BENTHOL SOC, V16, P174, DOI 10.2307/1468250; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dodds WK, 2006, LIMNOL OCEANOGR, V51, P671, DOI 10.4319/lo.2006.51.1_part_2.0671; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; FRY B., 2006, STABLE ISOTOPE ECOLO; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Legendre L, 1997, J PLANKTON RES, V19, P263, DOI 10.1093/plankt/19.2.263; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Nusch E. A., 1980, ARCH HYDROBIOL, V14, P14; Passy SI, 2001, J PHYCOL, V37, P370, DOI 10.1046/j.1529-8817.2001.037003370.x; PETERSON CG, 1992, ECOLOGY, V73, P1445, DOI 10.2307/1940689; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; PRINGLE CM, 1988, J N AM BENTHOL SOC, V7, P503, DOI 10.2307/1467303; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; STEINMAN AD, 1986, J PHYCOL, V22, P352, DOI 10.1111/j.1529-8817.1986.tb00035.x; Steinman Alan D., 1996, P295; Stevenson R. Jan, 1996, P321; STEVENSON RJ, 1983, ECOLOGY, V64, P1514, DOI 10.2307/1937506; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Townsend CR, 1998, ECOL LETT, V1, P200; TOWNSEND CR, 1989, J N AM BENTHOL SOC, V8, P36, DOI 10.2307/1467400; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VOGEL S, 1978, BIOSCIENCE, V28, P638, DOI 10.2307/1307394	49	455	480	21	927	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					86	U113		10.1038/nature09904	http://dx.doi.org/10.1038/nature09904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475199				2022-12-01	WOS:000289199400042
J	Dominguez-Escobar, J; Chastanet, A; Crevenna, AH; Fromion, V; Wedlich-Soldner, R; Carballido-Lopez, R				Dominguez-Escobar, Julia; Chastanet, Arnaud; Crevenna, Alvaro H.; Fromion, Vincent; Wedlich-Soeldner, Roland; Carballido-Lopez, Rut			Processive Movement of MreB-Associated Cell Wall Biosynthetic Complexes in Bacteria	SCIENCE			English	Article							PENICILLIN-BINDING PROTEINS; ACTIN-LIKE PROTEINS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SYNTHETIC COMPLEXES; SHAPE DETERMINATION; MORPHOGENESIS; LOCALIZATION; CYTOSKELETON; ELONGATION	The peptidoglycan cell wall and the actin-like MreB cytoskeleton are major determinants of cell shape in rod-shaped bacteria. The prevailing model postulates that helical, membrane-associated MreB filaments organize elongation-specific peptidoglycan-synthesizing complexes along sidewalls. We used total internal reflection fluorescence microscopy to visualize the dynamic relation between MreB isoforms and cell wall synthesis in live Bacillus subtilis cells. During exponential growth, MreB proteins did not form helical structures. Instead, together with other morphogenetic factors, they assembled into discrete patches that moved processively along peripheral tracks perpendicular to the cell axis. Patch motility was largely powered by cell wall synthesis, and MreB polymers restricted diffusion of patch components in the membrane and oriented patch motion.	[Dominguez-Escobar, Julia; Crevenna, Alvaro H.; Wedlich-Soeldner, Roland] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Chastanet, Arnaud; Carballido-Lopez, Rut] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Chastanet, Arnaud; Carballido-Lopez, Rut] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Fromion, Vincent] INRA, Math Informat & Genomes UR1077, F-78352 Jouy En Josas, France	Max Planck Society; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Wedlich-Soldner, R (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	wedlich@biochem.mpg.de; rut.carballido-lopez@jouy.inra.fr	Crevenna, Alvaro/Q-4476-2019; LOPEZ, RUT CARBALLIDO/G-2283-2015; Crevenna, Alvaro/E-9125-2016	Crevenna, Alvaro/0000-0002-5580-3711; LOPEZ, RUT CARBALLIDO/0000-0001-9383-8811; Crevenna, Alvaro/0000-0002-5580-3711; CHASTANET, Arnaud/0000-0003-0320-4861	Human Frontier Science Program (HFSP) [HFSP-RGY0067/2009-C]; European Molecular Biology Organization; French National Research Agency (ANR) [ANR-08-JCJC-0024-01]; Max Planck society	Human Frontier Science Program (HFSP)(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); French National Research Agency (ANR)(French National Research Agency (ANR)); Max Planck society(Max Planck Society)	We thank R. Daniel and L. J. Wu for sharing unpublished strains and for helpful suggestions, D.-J. Scheffers for strains, N. Campo for the antibody against GFP, and P. Hardy for manuscript editing. This work was supported by a Human Frontier Science Program (HFSP) Young Investigator grant (R.C.-L. and R.W.-S., HFSP-RGY0067/2009-C); a European Molecular Biology Organization short-term fellowship (R.C.-L), The French National Research Agency (ANR) (R.C.-L., ANR-08-JCJC-0024-01), and the Max Planck society (R.W.-S.).	Barrett D, 2007, J BIOL CHEM, V282, P31964, DOI 10.1074/jbc.M705440200; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Fleming TC, 2010, GENE DEV, V24, P1160, DOI 10.1101/gad.1925210; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Murray T, 1997, J BACTERIOL, V179, P3021, DOI 10.1128/jb.179.9.3021-3029.1997; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Soufo HJD, 2006, MOL MICROBIOL, V62, P1340, DOI 10.1111/j.1365-2958.2006.05457.x; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Wei YP, 2003, J BACTERIOL, V185, P4717, DOI 10.1128/JB.185.16.4717-4726.2003; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038	25	362	368	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					225	228		10.1126/science.1203466	http://dx.doi.org/10.1126/science.1203466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636744	Green Published			2022-12-01	WOS:000292502700051
J	Schafer, RJ; Moore, T				Schafer, Robert J.; Moore, Tirin			Selective Attention from Voluntary Control of Neurons in Prefrontal Cortex	SCIENCE			English	Article							FRONTAL EYE FIELDS	Animals can learn to voluntarily control neuronal activity within various brain areas through operant conditioning, but the relevance of that control to cognitive functions is unknown. We found that rhesus monkeys can control the activity of neurons within the frontal eye field (FEF), an oculomotor area of the prefrontal cortex. However, operantly driven FEF activity was primarily associated with selective visual attention, and not oculomotor preparation. Attentional effects were untrained and were observed both behaviorally and neurophysiologically. Furthermore, selective attention correlated with voluntary, but not spontaneous, fluctuations in FEF activity. Our results reveal a specific association of voluntarily driven neuronal activity with "top-down" attention and suggest a basis for the use of neurofeedback training to treat disorders of attention.	[Schafer, Robert J.; Moore, Tirin] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Moore, Tirin] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Moore, T (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	tirin@stanford.edu		Schafer, Robert/0000-0002-0874-830X	NIH [EY14924]; National Defense Science and Engineering Graduate fellowship; National Research Service Award [F31MH078490]; NATIONAL EYE INSTITUTE [R56EY014924, R01EY014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH078490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate fellowship; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Aldrich for technical assistance, and E. I. Knudsen and K. V. Shenoy for comments on the manuscript. Supported by NIH grant EY14924, a National Defense Science and Engineering Graduate fellowship, and National Research Service Award F31MH078490 (R.J.S.).	BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Cerf M, 2010, NATURE, V467, P1104, DOI 10.1038/nature09510; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; FETZ EE, 1975, EXP BRAIN RES, V23, P217; Gevensleben H, 2009, J CHILD PSYCHOL PSYC, V50, P780, DOI 10.1111/j.1469-7610.2008.02033.x; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Kobayashi S, 2010, J NEUROPHYSIOL, V103, P1843, DOI 10.1152/jn.00173.2009; Loo SK, 2005, APPL NEUROPSYCHOL, V12, P64, DOI 10.1207/s15324826an1202_2; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005	17	105	109	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1568	1571		10.1126/science.1199892	http://dx.doi.org/10.1126/science.1199892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21617042	Green Submitted, Green Accepted			2022-12-01	WOS:000291990000048
J	Fernandez, A; Lynch, M				Fernandez, Ariel; Lynch, Michael			Non-adaptive origins of interactome complexity	NATURE			English	Article							PROTEIN; DYNAMICS; ALGORITHMS; EVOLUTION	The boundaries between prokaryotes, unicellular eukaryotes and multicellular eukaryotes are accompanied by orders-of-magnitude reductions in effective population size, with concurrent amplifications of the effects of random genetic drift and mutation(1). The resultant decline in the efficiency of selection seems to be sufficient to influence a wide range of attributes at the genomic level in a non-adaptive manner(2). A key remaining question concerns the extent to which variation in the power of random genetic drift is capable of influencing phylogenetic diversity at the subcellular and cellular levels(2-4). Should this be the case, population size would have to be considered as a potential determinant of the mechanistic pathways underlying long-term phenotypic evolution. Here we demonstrate a phylogenetically broad inverse relation between the power of drift and the structural integrity of protein subunits. This leads to the hypothesis that the accumulation of mildly deleterious mutations in populations of small size induces secondary selection for protein-protein interactions that stabilize key gene functions. By this means, the complex protein architectures and interactions essential to the genesis of phenotypic diversity may initially emerge by non-adaptive mechanisms.	[Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Fernandez, Ariel] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Fernandez, Ariel] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Indiana University System; Indiana University Bloomington; University of Chicago; Rice University	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ariel@uchicago.edu; milynch@indiana.edu	Fernandez, Ariel/I-7925-2016	Fernandez, Ariel/0000-0002-5102-4294	National Institutes of Health [R01GM072614, R01GM036827]; Institute of Biophysical Dynamics; Department of Computer Science at The University of Chicago; National Science Foundation [EF-0827411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072614, R01GM036827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Biophysical Dynamics; Department of Computer Science at The University of Chicago; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.F. was supported by National Institutes of Health grant R01GM072614, and by the Institute of Biophysical Dynamics and the Department of Computer Science at The University of Chicago. M.L. was supported by National Institutes of Health grant R01GM036827 and National Science Foundation grant EF-0827411.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; Fernandez A, 2002, J MOL BIOL, V321, P659, DOI 10.1016/S0022-2836(02)00679-4; Fernandez A, 2010, J PROTEOME RES, V9, P2643, DOI 10.1021/pr100089t; Gabaldon T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-403; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M., 2007, ORIGINS GENOME ARCHI; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pietrosemoli N, 2007, J PROTEOME RES, V6, P3519, DOI 10.1021/pr070208k; Rizzo RC, 1999, J AM CHEM SOC, V121, P4827, DOI 10.1021/ja984106u; Rowlinson J.S, 1984, MOL THEORY CAPILLARI; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Scott R, 2004, J PHYS A-MATH GEN, V37, P9791, DOI 10.1088/0305-4470/37/41/012; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zhou HY, 2010, PROTEINS, V78, P2041, DOI 10.1002/prot.22717	30	90	93	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					502	U130		10.1038/nature09992	http://dx.doi.org/10.1038/nature09992			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21593762	Green Accepted			2022-12-01	WOS:000291939700047
J	Lovett, KM; Liang, BA				Lovett, Kimberly M.; Liang, Bryan A.			Direct-to-Consumer Cardiac Screening and Suspect Risk Evaluation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lovett, Kimberly M.] Kaiser Permanente, San Diego, CA USA; [Liang, Bryan A.] UCSD Sch Med, San Diego Ctr Patient Safety, San Diego, CA USA; [Liang, Bryan A.] Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA USA	Kaiser Permanente; University of California System; University of California San Diego	Lovett, KM (corresponding author), Kaiser Permanente, 1630 E Main St, El Cajon, CA 92021 USA.	klovett@ucsd.edu						FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Greenland P, 2010, J AM COLL CARDIOL, V56, P2182, DOI 10.1016/j.jacc.2010.09.002; Health Fair, HLTH SCREEN TEST PAC; Healthy Life Screening, LV DYSF SUDD CARD DE; Lifeline Screening, ASS YOUR RISK CAR AR; U.S. Preventive Services Task Force (USPSTF), REC; US Department of Health and Human Services, 2011, MOL CLIN GEN PAN M M; *US FDA, DRAFT GUID IND CLIN; Vital Scanning Inc, ART STIFFN SCREEN; Wilson JMG, 1968, PUBLIC HLTH PAPERS	10	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2567	2568		10.1001/jama.2011.865	http://dx.doi.org/10.1001/jama.2011.865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693746				2022-12-01	WOS:000291860400025
J	Wang, D; Garcia-Bassets, I; Benner, C; Li, WB; Su, X; Zhou, YM; Qiu, JS; Liu, W; Kaikkonen, MU; Ohgi, KA; Glass, CK; Rosenfeld, MG; Fu, XD				Wang, Dong; Garcia-Bassets, Ivan; Benner, Chris; Li, Wenbo; Su, Xue; Zhou, Yiming; Qiu, Jinsong; Liu, Wen; Kaikkonen, Minna U.; Ohgi, Kenneth A.; Glass, Christopher K.; Rosenfeld, Michael G.; Fu, Xiang-Dong			Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA	NATURE			English	Article							FORKHEAD BOX A1; PROSTATE-CANCER; GENE-EXPRESSION; ANDROGEN RECEPTOR; HISTONE MODIFICATIONS; NUCLEAR RECEPTORS; HUMAN GENOME; IN-VIVO; CHROMATIN; SIGNATURES	Mammalian genomes are populated with thousands of transcriptional enhancers that orchestrate cell-type-specific gene expression programs(1-4), but how those enhancers are exploited to institute alternative, signal-dependent transcriptional responses remains poorly understood. Here we present evidence that cell-lineage-specific factors, such as FoxA1, can simultaneously facilitate and restrict key regulated transcription factors, exemplified by the androgen receptor (AR), to act on structurally and functionally distinct classes of enhancer. Consequently, FoxA1 downregulation, an unfavourable prognostic sign in certain advanced prostate tumours, triggers dramatic reprogramming of the hormonal response by causing a massive switch in AR binding to a distinct cohort of pre-established enhancers. These enhancers are functional, as evidenced by the production of enhancer-templated non-coding RNA (eRNA(5)) based on global nuclear run-on sequencing (GRO-seq) analysis(6), with a unique class apparently requiring no nucleosome remodelling to induce specific enhancer-promoter looping and gene activation. GRO-seq data also suggest that liganded AR induces both transcription initiation and elongation. Together, these findings reveal a large repository of active enhancers that can be dynamically tuned to elicit alternative gene expression programs, which may underlie many sequential gene expression events in development, cell differentiation and disease progression.	[Wang, Dong; Benner, Chris; Qiu, Jinsong; Kaikkonen, Minna U.; Glass, Christopher K.; Fu, Xiang-Dong] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Garcia-Bassets, Ivan; Li, Wenbo; Su, Xue; Liu, Wen; Ohgi, Kenneth A.; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Garcia-Bassets, Ivan] Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Su, Xue; Liu, Wen] Univ Calif San Diego, Sch Med, Grad Program Biol, La Jolla, CA 92093 USA; [Zhou, Yiming] Digomics LLC, Malden, MA 02148 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Fu, XD (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ibassets@ucsd.edu; mrosenfeld@ucsd.edu; xdfu@ucsd.edu	li, wenbo/GZM-8930-2022; Kaikkonen, Minna U/AAK-3612-2020; Wang, Dong/C-8775-2013; Glass, Christopher/AAI-3933-2021; Wang, Dong/AAH-5611-2020; Garcia-Bassets, Ivan/F-5075-2010; Qiu, Jinsong/K-2325-2013	Kaikkonen, Minna U/0000-0001-6294-0979; Glass, Christopher/0000-0003-4344-3592; Wang, Dong/0000-0001-7877-7440; Benner, Christopher/0000-0002-4618-0719; Wang, Dong/0000-0002-3656-329X; Garcia-Bassets, Ivan/0000-0002-6941-9585	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA097134-10, R01 CA097134] Funding Source: Medline; NHGRI NIH HHS [HG004659, R01 HG004659, R01 HG004659-03] Funding Source: Medline; NHLBI NIH HHS [R01 HL065445-12, R01 HL065445] Funding Source: Medline; NIDDK NIH HHS [DK01847, R37 DK039949-28, DK37949, DK074868, R01 DK039949-30, P01 DK074868-05, R01 DK039949, R01 DK018477, R01 DK091183, R01 DK018477-35, R37 DK039949, P01 DK074868] Funding Source: Medline; NIGMS NIH HHS [R01 GM049369-17, R01 GM049369, GM049369] Funding Source: Medline; NINDS NIH HHS [NS34934, R01 NS034934-23, R01 NS034934] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091183, R01DK018477, P01DK074868, R01DK039949, R37DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crowe AJ, 1999, J BIOL CHEM, V274, P25113, DOI 10.1074/jbc.274.35.25113; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Laitinen S, 2002, GENE CHROMOSOME CANC, V35, P66, DOI 10.1002/gcc.10097; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V367, P481, DOI 10.1016/j.bbrc.2007.12.162; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Legrier ME, 2009, INT J CANCER, V124, P1103, DOI 10.1002/ijc.24073; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mirosevich J, 2005, PROSTATE, V62, P339, DOI 10.1002/pros.20131; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shim EY, 1998, GENE DEV, V12, P5, DOI 10.1101/gad.12.1.5; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomsen MK, 2010, CANCER RES, V70, P979, DOI 10.1158/0008-5472.CAN-09-2370; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	40	619	633	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					390	+		10.1038/nature10006	http://dx.doi.org/10.1038/nature10006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21572438	Green Accepted			2022-12-01	WOS:000291647100048
J	Maciejewski, ML; Livingston, EH; Smith, VA; Kavee, AL; Kahwati, LC; Henderson, WG; Arterburn, DE				Maciejewski, Matthew L.; Livingston, Edward H.; Smith, Valerie A.; Kavee, Andrew L.; Kahwati, Leila C.; Henderson, William G.; Arterburn, David E.			Survival Among High-Risk Patients After Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM MORTALITY; QUALITY IMPROVEMENT PROGRAM; TREATMENT SELECTION BIAS; AFFAIRS MEDICAL-CENTERS; GASTRIC BYPASS-SURGERY; VETERANS-AFFAIRS; PROPENSITY-SCORE; OBESITY; PERFORMANCE; PREVALENCE	Context Existing evidence of the survival associated with bariatric surgery is based on cohort studies of predominantly younger women with a low inherent obesity-related mortality risk. The association of survival and bariatric surgery for older men is less clear. Objective To determine whether bariatric surgery is associated with reduced mortality in a multisite cohort of predominantly older male patients who have a high baseline mortality rate. Design, Setting, and Participants Retrospective cohort study of bariatric surgery programs in Veterans Affairs medical centers. Mortality was examined for 850 veterans who had bariatric surgery in January 2000 to December 2006 (mean age 49.5 years; SD 8.3; mean body mass index [BMI] 47.4; SD 7.8) and 41 244 nonsurgical controls (mean age 54.7 years, SD 10.2; mean BMI 42.0, SD 5.0) from the same 12 Veteran Integrated Service Networks; the mean follow-up was 6.7 years. Four Cox proportional hazards models were assessed: unadjusted and controlled for baseline covariates on unmatched and propensity-matched cohorts. Main Outcome Measure All-cause mortality through December 2008. Results Among patients who had bariatric surgery, the 1-, 2-, and 6-year crude mortality rates were, respectively, 1.5%, 2.2%, and 6.8% compared with 2.2%, 4.6%, and 15.2% for nonsurgical controls. In unadjusted Cox regression, bariatric surgery was associated with reduced mortality (hazard ratio [HR], 0.64; 95% confidence interval [CI], 0.51-0.80). After covariate adjustment, bariatric surgery remained associated with reduced mortality (HR, 0.80; 95% CI, 0.63-0.995). In analysis of 1694 propensity-matched patients, bariatric surgery was no longer significantly associated with reduced mortality in unadjusted (HR, 0.83; 95% CI, 0.61-1.14) and time-adjusted (HR, 0.94; 95% CI, 0.64-1.39) Cox regressions. Conclusion In propensity score-adjusted analyses of older severely obese patients with high baseline mortality in Veterans Affairs medical centers, the use of bariatric surgery compared with usual care was not associated with decreased mortality during a mean 6.7 years of follow-up. JAMA. 2011;305(23):2419-2426 www.jama.com	[Maciejewski, Matthew L.; Smith, Valerie A.; Kavee, Andrew L.] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Dept Med, Div Gen Internal Med, Durham, NC USA; [Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA; [Livingston, Edward H.] Vet Adm N Texas Hlth Care Syst, Dallas, TX USA; [Livingston, Edward H.] Univ Texas Arlington, Arlington, TX USA; [Kahwati, Leila C.] US Dept Vet Affairs, Natl Ctr Hlth Promot & Dis Prevent, Off Patient Care Serv, Durham, NC USA; [Henderson, William G.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Henderson, William G.] Univ Colorado, Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Henderson, William G.] Univ Colorado, Colorado Hlth Outcomes Program, Aurora, CO USA; [Arterburn, David E.] Grp Hlth Res Inst, Seattle, WA USA; [Arterburn, David E.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Arlington; US Department of Veterans Affairs; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Washington; University of Washington Seattle	Maciejewski, ML (corresponding author), Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care 152, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.	matthew.maciejewski@va.gov		Kahwati, Leila/0000-0001-6963-2848; Smith, Valerie/0000-0001-5170-9819	Takeda Pharmaceuticals; Novartis; Surgical Review Corporation; Research Data and Assistance Center at the University of Minnesota; Texas Instruments; Foundation for Informed Medical Decision Making [501[3]c]	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Surgical Review Corporation; Research Data and Assistance Center at the University of Minnesota; Texas Instruments; Foundation for Informed Medical Decision Making	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Maciejewski reports receiving consultation funds from Takeda Pharmaceuticals, Novartis, the Surgical Review Corporation, and the Research Data and Assistance Center at the University of Minnesota and owns stock in Amgen. Dr Livingston reports receiving consulting funds from Texas Instruments. Dr Arterburn reports receiving research funding and has received salary support as a medical editor for the not-for-profit (501[3]c) Foundation for Informed Medical Decision Making (http://www.fimdm.org), which develops content for patient education programs. The foundation has an arrangement with a for-profit company, Health Dialog, to coproduce and market these programs to health care organizations. Dr Arterburn was formerly with the Cincinnati Veterans Affairs and Dr Livingston was formerly with the Dallas Veterans Affairs. No other disclosures were reported.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Arterburn D, 2009, ARCH SURG-CHICAGO, V144, P914, DOI 10.1001/archsurg.2009.134; Austin PC, 2008, J CLIN EPIDEMIOL, V61, P537, DOI 10.1016/j.jclinepi.2007.07.011; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P136, DOI 10.1016/j.jclinepi.2009.05.009; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Beyersmann J, 2008, STAT MED, V27, P6439, DOI 10.1002/sim.3437; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Das SR, 2005, AM J PREV MED, V28, P291, DOI 10.1016/j.amepre.2004.12.007; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; Fan VS, 2006, HEALTH SERV OUTCOME, V6, P21, DOI 10.1007/s10742-006-0004-1; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flum David R, 2006, Surg Obes Relat Dis, V2, P78, DOI 10.1016/j.soard.2006.02.008; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Hutter MM, 2009, OBESITY, V17, P924, DOI 10.1038/oby.2008.568; Lautz DB, 2007, J AM COLL SURGEONS, V204, P1261, DOI 10.1016/j.jamcollsurg.2007.04.003; Livingston EH, 2006, J AM COLL SURGEONS, V203, P625, DOI 10.1016/j.jamcollsurg.2006.07.006; Livingston EH, 2010, AM J SURG, V200, P378, DOI 10.1016/j.amjsurg.2009.11.007; Livingston EH, 2005, SURGERY, V137, P16, DOI 10.1016/j.surg.2004.05.049; Livingston EH, 2002, ANN SURG, V236, P576, DOI 10.1097/00000658-200211000-00007; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Maciejewski ML, 2010, SURG OBES RELAT DIS, V6, P601, DOI 10.1016/j.soard.2010.07.005; Maciejewski ML, 2010, MED CARE, V48, P989, DOI 10.1097/MLR.0b013e3181ef9cf7; Maciejewski ML, 2009, DIABETES CARE, V32, P75, DOI 10.2337/dc08-1099; Maciejewski ML, 2005, HEALTH SERV RES, V40, P887, DOI 10.1111/j.1475-6773.2005.00390.x; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Parsons LS, REDUCING BIAS PROPEN; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; *VET ADM, MAN OB OV	39	112	114	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2419	2426		10.1001/jama.2011.817	http://dx.doi.org/10.1001/jama.2011.817			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21666276	Bronze			2022-12-01	WOS:000291597300021
J	George, TJ; Arnaoutakis, GJ; Merlo, CA; Kemp, CD; Baumgartner, WA; Conte, JV; Shah, AS				George, Timothy J.; Arnaoutakis, George J.; Merlo, Christian A.; Kemp, Clinton D.; Baumgartner, William A.; Conte, John V.; Shah, Ashish S.			Association of Operative Time of Day With Outcomes After Thoracic Organ Transplant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS; SURVIVAL; VOLUME; IMPACT	Context Recent emphasis on systems-based approaches to patient safety has led to several studies demonstrating worse outcomes associated with surgery at night. Objective To evaluate whether operative time of day was associated with thoracic organ transplant outcomes, hypothesizing that it would not be associated with increased morbidity or mortality. Design, Setting, and Participants We conducted a retrospective cohort study of adult heart and lung transplant recipients in the United Network for Organ Sharing database from January 2000 through June 2010. Primary stratification was by operative time of day (night, 7 PM-7 AM; day, 7 AM-7 PM). Main Outcome Measures Primary end points were short-term survival, assessed by the Kaplan-Meier method at 30, 90, and 365 days. Secondary end points encompassed common postoperative complications. Risk-adjusted multivariable Cox proportional hazards regression examined mortality. Results A total of 27 118 patients were included in the study population. Of the 16 573 who underwent a heart transplant, 8346 (50.36%) did so during the day and 8227 (49.64%) during the night. Of the 10 545 who underwent a lung transplant, 5179 (49.11%) did so during the day and 5366 (50.89%) during the night. During a median follow-up of 32.2 months (interquartile range, 11.2-61.1 months), 8061 patients (28.99%) died. Survival was similar for organ transplants performed during the day and night. Survival rates at 30 days for heart transplants during the day were 95.0% vs 95.2% during the night (hazard ratio [HR], 1.05; 95% confidence interval, 0.83-1.32; P=.67) and for lung transplants during the day were 96.0% vs 95.5% during the night (HR, 1.22; 95% CI, 0.97-1.55; P=.09). At 90 days, survival rates for heart transplants were 92.6% during the day vs 92.7% during the night (HR, 1.05; 95% CI, 0.88-1.26; P=.59) and for lung transplants during the day were 92.7% vs 91.7% during the night (HR, 1.23; 95% CI, 1.04-1.47; P=.02). At 1 year, survival rates for heart transplants during the day were 88.0% vs 87.7% during the night (HR, 1.05; 95% CI, 0.91-1.21; P=.47) and for lung transplants during the day were 83.8% vs 82.6% during the night (HR, 1.08; 95% CI, 0.96-1.22; P=.19). Among lung transplant recipients, there was a slightly higher rate of airway dehiscence associated with nighttime transplants (57 of 5022 [1.1%] vs 87 of 5224 [1.7%], P=.02). Conclusion Among patients who underwent thoracic organ transplants, there was no significant association between operative time of day and survival up to 1 year after organ transplant. JAMA. 2011;305(21):2193-2199 www.jama.com	[George, Timothy J.; Arnaoutakis, George J.; Kemp, Clinton D.; Baumgartner, William A.; Conte, John V.; Shah, Ashish S.] Johns Hopkins Med Inst, Div Cardiac Surg, Baltimore, MD 21205 USA; [Merlo, Christian A.] Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Shah, AS (corresponding author), Johns Hopkins Univ Hosp, Div Cardiac Surg, 600 N Wolfe St,Blalock 618, Baltimore, MD 21287 USA.	ashah29@jhmi.edu	Arnaoutakis, George/AAE-8796-2022	Shah, Ashish/0000-0002-1821-9110	Thoratec; Heartware; Medtronic; National Institutes of Health [T32 2T32DK007713-12]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007713] Funding Source: NIH RePORTER	Thoratec; Heartware; Medtronic(Medtronic); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Conte reported that he receives research support from Thoratec, Heartware, and Medtronic; otherwise no other conflicts of interest were reported.; This research was supported by grant T32 2T32DK007713-12 from the National Institutes of Health (Dr George). Dr George is the Hugh R. Sharp Cardiac Surgery Research Fellow. Dr Arnaoutakis is the Irene Piccinini Investigator in Cardiac Surgery.	Fechner G, 2008, TRANSPL P, V40, P1341, DOI 10.1016/j.transproceed.2008.02.072; Glaser R, 2008, JACC-CARDIOVASC INTE, V1, P681, DOI 10.1016/j.jcin.2008.08.020; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Iglehart JK, 2008, NEW ENGL J MED, V359, P2633, DOI 10.1056/NEJMp0808736; Kohn L., 1999, ERR IS HUMAN BUILDIN; Komen N, 2009, INT J COLORECTAL DIS, V24, P789, DOI 10.1007/s00384-009-0692-4; Lonze BE, 2010, AM J TRANSPLANT, V10, P1842, DOI 10.1111/j.1600-6143.2010.03177.x; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Ricci WM, 2009, J BONE JOINT SURG AM, V91A, P2067, DOI 10.2106/JBJS.H.00661; Seow YY, 2004, TRANSPLANTATION, V77, P1386, DOI 10.1097/01.TP.0000122230.46091.E2; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Weiss ES, 2008, ANN THORAC SURG, V86, P1250, DOI 10.1016/j.athoracsur.2008.06.071; Weiss ES, 2009, ANN THORAC SURG, V88, P1062, DOI 10.1016/j.athoracsur.2009.06.005	13	53	54	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2011	305	21					2193	2199		10.1001/jama.2011.726	http://dx.doi.org/10.1001/jama.2011.726			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770RN	21632483	Bronze			2022-12-01	WOS:000291106300022
J	van't Hof, AE; Edmonds, N; Dalikova, M; Marec, F; Saccheri, IJ				van't Hof, Arjen E.; Edmonds, Nicola; Dalikova, Martina; Marec, Frantisek; Saccheri, Ilik J.			Industrial Melanism in British Peppered Moths Has a Singular and Recent Mutational Origin	SCIENCE			English	Article							BLACK-AND-WHITE; LINKAGE DISEQUILIBRIUM; HELICONIUS BUTTERFLIES; SELECTION	The rapid spread of a novel black form (known as carbonaria) of the peppered moth Biston betularia in 19th-century Britain is a textbook example of how an altered environment may produce morphological adaptation through genetic change. However, the underlying genetic basis of the difference between the wild-type (light-colored) and carbonaria forms has remained unknown. We have genetically mapped the carbonaria morph to a 200-kilobase region orthologous to a segment of silkworm chromosome 17 and show that there is only one core sequence variant associated with the carbonaria morph, carrying a signature of recent strong selection. The carbonaria region coincides with major wing-patterning loci in other lepidopteran systems, suggesting the existence of basal color-patterning regulators in this region.	[van't Hof, Arjen E.; Edmonds, Nicola; Saccheri, Ilik J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Dalikova, Martina; Marec, Frantisek] Acad Sci Czech Republic, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; [Dalikova, Martina; Marec, Frantisek] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	University of Liverpool; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Saccheri, IJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	saccheri@liv.ac.uk	Dalikova, Martina/J-5722-2015; Van 't Hof, Arjen/AAE-8044-2022; Marec, Frantisek/G-7943-2014	Dalikova, Martina/0000-0002-0266-8894; Marec, Frantisek/0000-0002-6745-5603	Natural Environment Research Council [NE/C003101/1]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA600960925]; Entomology Institute [Z50070508]; Grant Agency of the Czech Republic [521/08/H042]; Natural Environment Research Council [NE/H024352/1] Funding Source: researchfish; NERC [NE/H024352/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Entomology Institute; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council grant NE/C003101/1 to I.J.S. Cytogenetic experiments were financed by Grant Agency of the Academy of Sciences of the Czech Republic grant IAA600960925, Entomology Institute project Z50070508, and Grant Agency of the Czech Republic 521/08/H042 grants to F.M. and M.D. Specimens for the UK-wide survey were made available by several museums and private collectors, listed in table S4. J. Delf produced fig. S3. GenBank accession numbers are listed in table S1.	Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Cook Laurence M., 2003, Entomologist's Gazette, V54, P211; Cook LM, 2005, J HERED, V96, P522, DOI 10.1093/jhered/esi082; Cook LM, 2003, Q REV BIOL, V78, P399, DOI 10.1086/378925; GOLDSMITH MR, 1995, MOL MODEL SYSTEMS LE; Hedrick P, 2001, EUR J HUM GENET, V9, P969, DOI 10.1038/sj.ejhg.5200735; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527; Lees D. R., 1981, GENETIC CONSEQUENCES, P129; Majerus M.E.N., 1998, MELANISM EVOLUTION A; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Pfaffelhuber P, 2008, GENETICS, V179, P527, DOI 10.1534/genetics.107.081497; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Stern D. L., 2010, EVOLUTION DEV PREDIC; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; van't Hof AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010889; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X	18	101	104	3	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					958	960		10.1126/science.1203043	http://dx.doi.org/10.1126/science.1203043			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21493823				2022-12-01	WOS:000290766600041
J	Flenady, V; Middleton, P; Smith, GC; Duke, W; Erwich, JJ; Khong, TY; Neilson, J; Ezzati, M; Koopmans, L; Ellwood, D; Fretts, R; Froen, JF				Flenady, Vicki; Middleton, Philippa; Smith, Gordon C.; Duke, Wes; Erwich, Jan Jaap; Khong, T. Yee; Neilson, Jim; Ezzati, Majid; Koopmans, Laura; Ellwood, David; Fretts, Ruth; Froen, J. Frederik		Lancet's Stillbirths Series Steeri	Stillbirths 5 Stillbirths: the way forward in high-income countries	LANCET			English	Article							PERINATAL-MORTALITY; GESTATIONAL-AGE; FETAL-DEATH; PERIODONTAL-DISEASE; AVOIDABLE MORTALITY; ALCOHOL-CONSUMPTION; NEONATAL DEATHS; AUTOPSY RATES; PRENATAL-CARE; BIRTH-WEIGHT	Stillbirth rates in high-income countries declined dramatically from about 1940, but this decline has slowed or stalled over recent times. The present variation in stillbirth rates across and within high-income countries indicates that further reduction in stillbirth is possible. Large disparities (linked to disadvantage such as poverty) in stillbirth rates need to be addressed by providing more educational opportunities and improving living conditions for women. Placental pathologies and infection associated with preterm birth are linked to a substantial proportion of stillbirths. The proportion of unexplained stillbirths associated with under investigation continues to impede efforts in stillbirth prevention. Overweight, obesity, and smoking are important modifiable risk factors for stillbirth, and advanced maternal age is also an increasingly prevalent risk factor. Intensified efforts are needed to ameliorate the effects of these factors on stillbirth rates. Culturally appropriate preconception care and quality antenatal care that is accessible to all women has the potential to reduce stillbirth rates in high-income countries. Implementation of national perinatal mortality audit programmes aimed at improving the quality of care could substantially reduce stillbirths. Better data on numbers and causes of stillbirth are needed, and international consensus on definition and classification related to stillbirth is a priority. All parents should be offered a thorough investigation including a high-quality autopsy and placental histopathology. Parent organisations are powerful change agents and could have an important role in raising awareness to prevent stillbirth. Future research must focus on screening and interventions to reduce antepartum stillbirth as a result of placental dysfunction. Identification of ways to reduce maternal overweight and obesity is a high priority for high-income countries.	[Flenady, Vicki] Mater Med Res Inst, Mater Hlth Serv, Brisbane, Qld 4101, Australia; [Flenady, Vicki] Univ Queensland, Brisbane, Qld, Australia; [Flenady, Vicki] Int Stillbirth Alliance, Baltimore, MD USA; [Middleton, Philippa] Univ Adelaide, Adelaide, SA, Australia; [Smith, Gordon C.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Duke, Wes] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Erwich, Jan Jaap] Univ Groningen, Dept Obstet, Utrecht, Netherlands; [Erwich, Jan Jaap] Fdn Perinatal Audit Netherlands, Utrecht, Netherlands; [Khong, T. Yee] Womens & Childrens Hosp, SA Pathol, Adelaide, SA, Australia; [Neilson, Jim] Univ Liverpool, Cochrane Pregnancy & Childbirth Grp, Liverpool L69 3BX, Merseyside, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Ellwood, David] Canberra Hosp, Canberra, ACT, Australia; [Ellwood, David] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Fretts, Ruth] Harvard Vanguard Med Associates, Wellesley, MA USA; [Froen, J. Frederik] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway	Mater Health Services; Mater Research; University of Queensland; University of Adelaide; University of Cambridge; Centers for Disease Control & Prevention - USA; University of Groningen; SA Pathology; Womens & Childrens Hospital Australia; University of Liverpool; Imperial College London; Australian National University; Canberra Hospital; Australian National University; Harvard Vanguard Medical Associates; Norwegian Institute of Public Health (NIPH)	Flenady, V (corresponding author), Mater Med Res Inst, Mater Hlth Serv, Brisbane, Qld 4101, Australia.	Vicki.Flenady@mmri.mater.org.au	Flenady, Vicki Jane/O-9609-2014; Lawn, Joy/ABE-6382-2020; Ellwood, David Alan/GNW-4485-2022; Frøen, J. Frederik/C-3271-2009; Smith, Gordon/A-8070-2008	Flenady, Vicki Jane/0000-0001-8114-7677; Lawn, Joy/0000-0002-4573-1443; Ellwood, David Alan/0000-0003-4512-6443; Smith, Gordon/0000-0003-2124-0997; Froen Froen, Jahn Frederik/0000-0001-9390-8509	Bill & Melinda Gates Foundation; International Stillbirth Alliance; Norwegian Institute of Public Health; Medical Research Council [G0801056B] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International Stillbirth Alliance; Norwegian Institute of Public Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Bill & Melinda Gates Foundation for a grant to support this work to the International Stillbirth Alliance administered by the Mater Medical Research Institute, Brisbane, QLD, Australia. Additionally, we thank the International Stillbirth Alliance and the Norwegian Institute of Public Health for seed funding to support meetings of the steering committee. We thank the following for technical support: Dominique Rossouw, Madeleine Elder, and, Elizabeth Flenady for literature searching and reference management, Kristen Gibbons for statistical advice, and Glenda Hawley, Teresa Walsh, Shelley Wilkinson, and Ann Kingsbury for providing feedback on the report. We thank Janet Scott of Sands UK, Sue Hale of Sands UK and ISA Parent Advisory Committee, and Liz Conway Sands Australia and the ISA Parent Advisory Committee for their comments and contributions to the report. We thank the following for their contributions to the research priority component: Justus Hofmeyr for his assistance with the development of the research priority questions, review of interventions, and comment of drafts of the report; Eckhart Buchmann for development of the initial drafts of all the research questions; Igor Rudan for guidance and support; and Ibinabo Ibiebele for data analysis. We thank all those who scored the stillbirth research priorities: Adrian Charles, Paul Colditz, Linda Dodds, Lelia Duley, Jason Gardosi, Sanne Gordijn, Grace Guyon, Justus Hofmeyr, Alex Heazell, Robyn Kennare, Russell Kirby, Wolfgang Kuenzel, Kassam Mahomed, Luigi Matturri, Elizabeth M McClure, Lesley McCowan, Giorgio Mello, Ayman el Mohandes, Halit Pinar, Ingela Radestad, Uma M Reddy, Birgit Reime, Bob Silver, and Bert Timmer, and members of the GAPPS Basic Biology Working Group: Craig Rubens, Michael Gravett, Gordon Smith, Leslie Myatt, Oslem Equils, Roger Smith, and Sarah England.	Acolet D, 2005, PEDIATRICS, V116, P1457, DOI 10.1542/peds.2004-2691; Alderliesten ME, 2008, EUR J OBSTET GYN R B, V137, P141, DOI 10.1016/j.ejogrb.2007.06.002; Alfirevic Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007529.pub2; Aliyu MH, 2008, ALCOHOL, V42, P369, DOI 10.1016/j.alcohol.2008.04.003; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2007, DIAB PREGN AR WE PRO; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bateman BT, 2006, AM J OBSTET GYNECOL, V194, P840, DOI 10.1016/j.ajog.2005.08.038; Bergsjo P, 2003, ACTA OBSTET GYN SCAN, V82, P780, DOI 10.1034/j.1600-0412.2003.00224.x; BHUTTA ZA, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)62050-8; Bolling K, 2007, INFANT FEEDING SURVE; Breeze ACG, 2008, ULTRASOUND OBST GYN, V31, P187, DOI 10.1002/uog.5199; Brookes JS, 2006, J MAGN RESON IMAGING, V24, P1221, DOI 10.1002/jmri.20770; Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864; Burnley H, 2005, J CLIN PATHOL, V58, P93, DOI 10.1136/jcp.2004.020636; *CCOPMM, 2007, ANN REP YEAR 2007 IN; *CESDI, 2001, 8 CESDI; Chan A, 2004, J PAEDIATR CHILD H, V40, P340, DOI 10.1111/j.1440-1754.2004.00398.x; *CMACE, 2010, CTR MAT CHILD ENQ PE; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; Cogswell ME, 1999, OBSTET GYNECOL, V94, P616, DOI 10.1016/S0029-7844(99)00375-0; Cohen MC, 2008, PEDIATR DEVEL PATHOL, V11, P1, DOI 10.2350/07-01-0213.1; Corabian P, 2007, J OBSTET GYNAECOL CA, V29, P560, DOI 10.1016/S1701-2163(16)32500-2; Crowther CA, 1999, AUST NZ J OBSTET GYN, V39, P12, DOI 10.1111/j.1479-828X.1999.tb03434.x; d'Espaignet ET, 2008, FORENSIC SCI MED PAT, V4, P83, DOI 10.1007/s12024-007-9011-y; Darmstadt GL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S6; De Lange TE, 2008, AUST NZ J OBSTET GYN, V48, P50, DOI 10.1111/j.1479-828X.2007.00801.x; De Reu PAOM, 2000, EUR J OBSTET GYN R B, V88, P65, DOI 10.1016/S0301-2115(99)00135-9; De Reu P, 2009, ACTA OBSTET GYN SCAN, V88, P1201, DOI 10.3109/00016340903280990; De Reu PAOM, 2010, J PERINAT MED, V38, P311, DOI [10.1515/JPM.2010.027, 10.1515/jpm.2010.027]; Dodd JM, 2010, BJOG-INT J OBSTET GY, V117, P1316, DOI 10.1111/j.1471-0528.2010.02540.x; Doumit G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000125.pub3; Doyle LW, 2000, LANCET, V355, P2093, DOI 10.1016/S0140-6736(00)02373-4; Dudley DJ, 2010, OBSTET GYNECOL, V116, P254, DOI 10.1097/AOG.0b013e3181e7d975; Duke W, 2010, WOMEN HEALTH ISS, V20, P366, DOI 10.1016/j.whi.2010.06.004; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Essen B, 2002, BJOG-INT J OBSTET GY, V109, P677, DOI 10.1016/S1470-0328(02)01077-7; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flenady V, 2010, AUST NZ J OBSTET GYN, V50, P138, DOI 10.1111/j.1479-828X.2009.01125.x; Flenady V, 2010, STILLBIRTH UNDERSTAN; FLENADY V, 2010, J PAEDIATR CHILD H, V46, P46; Flenady V., 2009, CLIN PRACTICE GUIDEL; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flenady V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-24; Floyd RL, 2007, AM J PREV MED, V32, P1, DOI 10.1016/j.amepre.2006.08.028; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-22; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Getahun D, 2005, OBSTET GYNECOL, V106, P81, DOI 10.1097/01.AOG.0000165274.06811.86; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; Goldenberg R L, 2004, J Matern Fetal Neonatal Med, V16, P79; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gordijn SJ, 2007, EUR J OBSTET GYN R B, V132, P3, DOI 10.1016/j.ejogrb.2006.10.031; Gordijn SJ, 2002, PEDIATR DEVEL PATHOL, V5, P480, DOI 10.1007/s10024-002-0008-y; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Haavaldsen C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.014; Hagmann CF, 2007, ARCH DIS CHILD-FETAL, V92, pF215, DOI 10.1136/fnn.2005.092387; HALL MH, 1980, LANCET, V2, P78; HARVEY SM, 1993, FAM PLANN PERSPECT, V25, P32, DOI 10.2307/2135990; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Hawthorne G, 1997, BRIT MED J, V315, P279, DOI 10.1136/bmj.315.7103.279; Henderson-Smart DJ, 2003, CLIN PERINATOL, V30, P333, DOI 10.1016/S0095-5108(03)00026-5; Herring Sharon J, 2008, BMC Pregnancy Childbirth, V8, P54, DOI 10.1186/1471-2393-8-54; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; Holt J, 2002, ACTA OBSTET GYN SCAN, V81, P899, DOI 10.1034/j.1600-0412.2002.811001.x; Huisman Thierry A G M, 2004, Semin Neonatol, V9, P347, DOI 10.1016/j.siny.2003.09.004; Hutcheon JA, 2011, PAEDIATR PERINAT EP, V25, P11, DOI 10.1111/j.1365-3016.2010.01155.x; Institute of Medicine and National Research Council, 2009, WEIGHT GAIN PREGN RE; *INT STILLB ALL, 2009, ISA POS STAT FET MOV; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Jorgensen T, 2008, SCAND J PUBLIC HEALT, V36, P635, DOI 10.1177/1403494808089653; Kenyon S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001058.pub2; Khong TY, 2006, J PAEDIATR CHILD H, V42, P366, DOI 10.1111/j.1440-1754.2006.00874.x; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Khong TY, 2003, PEDIATR DEVEL PATHOL, V6, P54, DOI 10.1007/s10024-001-0263-3; Khong TY, 1996, PAEDIATR PERINAT EP, V10, P97, DOI 10.1111/j.1365-3016.1996.tb00030.x; Khong TY., 2006, CURR DIAG PATHOL, V12, P61, DOI 10.1016/j.cdip.2006.03.001; KHONG TY, 2009, STILLBIRTH UNDERSTAN, P91; Korteweg FJ, 2008, PLACENTA, V29, P71, DOI 10.1016/j.placenta.2007.07.003; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; Korteweg FJ, 2010, OBSTET GYNECOL, V116, P355, DOI 10.1097/AOG.0b013e3181e66d58; Krebs L, 2002, J PERINAT MED, V30, P220, DOI 10.1515/JPM.2002.030; Laing Ian A, 2004, Semin Neonatol, V9, P247, DOI 10.1016/j.siny.2003.11.004; Lauenborg J, 2003, DIABETES CARE, V26, P1385, DOI 10.2337/diacare.26.5.1385; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Laws P, 2009, PERINATAL STAT SERIE; Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10; Lumley J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub3; Luo ZC, 2010, CAN MED ASSOC J, V182, P235, DOI 10.1503/cmaj.082042; Macdorman Marian F, 2009, NCHS Data Brief, P1; Macones GA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.892; MANGESI L, 2007, COCHRANE DB SYST REV, V1; McDonnell KA, 2004, MATERN CHILD HLTH J, V8, P231, DOI 10.1023/B:MACI.0000047421.93207.51; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Menezes EV, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S4; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; *NAT I HLTH CLIN E, 2010, NICE CLIN GUID, V107; *NAT I HLTH CLIN E, 2010, QUITT SMOK PREGN FOL, V26; National Collaborating Centre for Women's and Children's Health (UK), 2008, DIAB PREGN MAN DIAB; National Institute for Health and Clinical Excellence, 2010, WEIGHT MAN PREGN, V27; NEILSON JP, 2000, COCHRANE DB SYST REV, V2; Newnham JP, 2009, OBSTET GYNECOL, V114, P1239, DOI 10.1097/AOG.0b013e3181c15b40; Orentlicher D, 2010, HASTINGS CENT REP, V40, P12; Pattinson RC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002961.pub2; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Pinar H, 2010, CLIN OBSTET GYNECOL, V53, P656, DOI 10.1097/GRF.0b013e3181eb68fe; *PMMRC, 2010, 4 PMMRC MIN HLTH; PRESTON P, 2010, J PAEDIAT CHILD H S3, V46, P45; Ravelli ACJ, 2011, J EPIDEMIOL COMMUN H, V65, P696, DOI 10.1136/jech.2009.095406; Richardus J H, 2003, J Matern Fetal Neonatal Med, V14, P267, DOI 10.1080/713606659; Roberts CL, 2000, AUST NZ J PUBL HEAL, V24, P291, DOI 10.1111/j.1467-842X.2000.tb01571.x; Robson S, 2006, AUST NZ J OBSTET GYN, V46, P305, DOI 10.1111/j.1479-828X.2006.00597.x; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; *ROYAL COLL PAED C, 2002, FUT PAED PATH SERV F; Saastad E, 2007, ACTA OBSTET GYN SCAN, V86, P444, DOI 10.1080/00016340701207724; Salihu H, 2004, OBSTET GYNECOL, V104, P734, DOI 10.1097/01.AOG.0000139944.15133.e3; Salihu HM, 2003, OBSTET GYNECOL, V102, P1006, DOI 10.1016/S0029-7844(03)00739-7; Silver RM, 2007, OBSTET GYNECOL, V109, P153, DOI 10.1097/01.AOG.0000248537.89739.96; Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Smith GCS, 2010, JAMA-J AM MED ASSOC, V303, P561, DOI 10.1001/jama.2010.102; Stade BC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004228.pub2; Stock SJ, 2010, EUR J OBSTET GYN R B, V153, P148, DOI 10.1016/j.ejogrb.2010.07.022; Streuling I, 2010, AM J CLIN NUTR, V92, P678, DOI 10.3945/ajcn.2010.29363; Sun CCJ, 2002, ARCH PATHOL LAB MED, V126, P706; Tan K. H., 1999, SMJ, V40, P251; Thomas LH, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000349, DOI 10.1002/14651858.CD000349]; Thornton CM, 1998, BRIT J OBSTET GYNAEC, V105, P18, DOI 10.1111/j.1471-0528.1998.tb09344.x; Tieu J, 2010, COCHRANE DB SYST REV, V12; TUGWELL P, 1985, J CHRON DIS, V38, P339, DOI 10.1016/0021-9681(85)90080-3; Tveit JVH, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-32; Van Diem M, 2010, ACTA OBSTET GYN SCAN, V89, P1168, DOI 10.3109/00016349.2010.500468; VERKERK PH, 1993, EARLY HUM DEV, V32, P121, DOI 10.1016/0378-3782(93)90006-G; Vintzileos AM, 2002, OBSTET GYNECOL, V99, P483, DOI 10.1016/S0029-7844(01)01758-6; Vredevoogd C B, 2001, Ned Tijdschr Geneeskd, V145, P482; VUJANIC GM, 1995, J CLIN PATHOL, V48, P998, DOI 10.1136/jcp.48.11.998; *W MIDL PER I, 2009, W MIDL KEY HLTH DAT, pCH13; Whitworth M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007058.pub2; Whitworth M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007536.pub2; WIGGLESWORTH JS, 1987, ARCH DIS CHILD, V62, P1207, DOI 10.1136/adc.62.12.1207; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Wolleswinkel-van den Bosch JH, 2002, ACTA OBSTET GYN SCAN, V81, P17, DOI 10.1034/j.1600-0412.2002.810104.x; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; Wright C, 1998, BRIT J OBSTET GYNAEC, V105, P24, DOI 10.1111/j.1471-0528.1998.tb09345.x; Wylie BJ, 2010, OBSTET GYNECOL, V115, P1039, DOI 10.1097/AOG.0b013e3181da7929; Yakoob MY, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S3; YUDKIN PL, 1987, LANCET, V1, P1192; [No title captured]	155	297	305	3	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1703	1717		10.1016/S0140-6736(11)60064-0	http://dx.doi.org/10.1016/S0140-6736(11)60064-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	766JF	21496907				2022-12-01	WOS:000290777700035
J	Saijo, K; Collier, JG; Li, AC; Katzenellenbogen, JA; Glass, CK				Saijo, Kaoru; Collier, Jana G.; Li, Andrew C.; Katzenellenbogen, John A.; Glass, Christopher K.			An ADIOL-ER beta-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated Inflammation	CELL			English	Article							ESTROGEN-RECEPTOR-BETA; T-CELLS; FRACTALKINE RECEPTOR; SELECTIVE LIGANDS; GENE-EXPRESSION; ALPHA; BRAIN; BINDING; ENCEPHALOMYELITIS; TRANSCRIPTION	Microglia and astrocytes play essential roles in the maintenance of homeostasis within the central nervous system, but mechanisms that control the magnitude and duration of responses to infection and injury remain poorly understood. Here, we provide evidence that 5-androsten-3 beta, 17 beta-diol (ADIOL) functions as a selective modulator of estrogen receptor (ER)beta to suppress inflammatory responses of microglia and astrocytes. ADIOL and a subset of synthetic ER beta-specific ligands, but not 17 beta-estradiol, mediate recruitment of CtBP corepressor complexes to AP-1-dependent promoters, thereby repressing genes that amplify inflammatory responses and activate Th17 T cells. Reduction of ADIOL or ER beta expression results in exaggerated inflammatory responses to TLR4 agonists. Conversely, the administration of ADIOL or synthetic ER beta-specific ligands that promote CtBP recruitment prevents experimental autoimmune encephalomyelitis in an ER beta-dependent manner. These findings provide evidence for an ADIOL/ER beta/CtBP-transrepression pathway that regulates inflammatory responses in microglia and can be targeted by selective ER beta modulators.	[Saijo, Kaoru; Collier, Jana G.; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Li, Andrew C.; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign	Saijo, K (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ksaijo@ucsd.edu; ckg@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	NIH [CA52599, HL087391, DK015556]; NATIONAL CANCER INSTITUTE [R01CA052599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015556, R01DK091183, R37DK015556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Benita Katzenellenbogen, Joshua Stender, and Christian Schmedt for the critical reading of this manuscript. We are grateful to Norio Yasui for the preparation of Indazole-Cl; and Mel Simon for retrovirus carrying shRNA against PKA catalytic subunits; the CMMW vivarium for taking care of animals; and Lynn Bautista for help with preparing figures. This work was supported by grants from the NIH (CA52599 to C. K. G., HL087391 to A. C. L., and DK015556 to J.A.K.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bonetti A, 2009, J NEUROIMMUNOL, V208, P119, DOI 10.1016/j.jneuroim.2009.01.003; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; De Angelis M, 2005, J MED CHEM, V48, P1132, DOI 10.1021/jm049223g; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gold SM, 2009, J NEUROL SCI, V286, P99, DOI 10.1016/j.jns.2009.05.028; Gold SM, 2009, LAB INVEST, V89, P1076, DOI 10.1038/labinvest.2009.79; Gottfried-Blackmore A, 2008, J STEROID BIOCHEM, V109, P96, DOI 10.1016/j.jsbmb.2007.12.013; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jellinck PH, 2007, J STEROID BIOCHEM, V107, P156, DOI 10.1016/j.jsbmb.2007.04.004; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Laflamme N, 1998, J NEUROBIOL, V36, P357, DOI 10.1002/(SICI)1097-4695(19980905)36:3<357::AID-NEU5>3.0.CO;2-V; Lin SX, 2006, MOL CELL ENDOCRINOL, V248, P38, DOI 10.1016/j.mce.2005.11.035; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lukacik P, 2007, BIOCHEM J, V402, P419, DOI 10.1042/BJ20061319; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; MINUTOLO F, 2009, ESTROGEN RECEPTOR BE; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; PIECHACZYK M, 1994, CRIT REV ONCOL HEMAT, V17, P93, DOI 10.1016/1040-8428(94)90021-3; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vegeto E, 2000, EXP GERONTOL, V35, P1309, DOI 10.1016/S0531-5565(00)00161-3; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2	54	223	229	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					584	595		10.1016/j.cell.2011.03.050	http://dx.doi.org/10.1016/j.cell.2011.03.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565615	Bronze, Green Accepted			2022-12-01	WOS:000290560800011
J	Sang, LY; Miller, JJ; Corbit, KC; Giles, RH; Brauer, MJ; Otto, EA; Baye, LM; Wen, XH; Scales, SJ; Kwong, M; Huntzicker, EG; Sfakianos, MK; Sandoval, W; Bazan, JF; Kulkarni, P; Garcia-Gonzalo, FR; Seol, AD; O'Toole, JF; Held, S; Reutter, HM; Lane, WS; Rafiq, MA; Noor, A; Ansar, M; Devi, ARR; Sheffield, VC; Slusarski, DC; Vincent, JB; Doherty, DA; Hildebrandt, F; Reiter, JF; Jackson, PK				Sang, Liyun; Miller, Julie J.; Corbit, Kevin C.; Giles, Rachel H.; Brauer, Matthew J.; Otto, Edgar A.; Baye, Lisa M.; Wen, Xiaohui; Scales, Suzie J.; Kwong, Mandy; Huntzicker, Erik G.; Sfakianos, Mindan K.; Sandoval, Wendy; Bazan, J. Fernando; Kulkarni, Priya; Garcia-Gonzalo, Francesc R.; Seol, Allen D.; O'Toole, John F.; Held, Susanne; Reutter, Heiko M.; Lane, William S.; Rafiq, Muhammad Arshad; Noor, Abdul; Ansar, Muhammad; Devi, Akella Radha Rama; Sheffield, Val C.; Slusarski, Diane C.; Vincent, John B.; Doherty, Daniel A.; Hildebrandt, Friedhelm; Reiter, Jeremy F.; Jackson, Peter K.			Mapping the NPHP-JBTS-MKS Protein Network Reveals Ciliopathy Disease Genes and Pathways	CELL			English	Article							MECKEL-SYNDROME; PRIMARY CILIA; TRANSITION ZONE; INTRAFLAGELLAR TRANSPORT; RETINAL DEGENERATION; KIDNEY-DISEASE; NEPHRONOPHTHISIS; NEPHROCYSTIN; MOUSE; CILIOGENESIS	Nephronophthisis (NPHP), Joubert (JBTS), and Meckel-Gruber (MKS) syndromes are autosomal-recessive ciliopathies presenting with cystic kidneys, retinal degeneration, and cerebellar/neural tube malformation. Whether defects in kidney, retinal, or neural disease primarily involve ciliary, Hedgehog, or cell polarity pathways remains unclear. Using high-confidence proteomics, we identified 850 interactors copurifying with nine NPHP/JBTS/MKS proteins and discovered three connected modules: "NPHP1-4-8" functioning at the apical surface, "NPHP5-6" at centrosomes, and "MKS" linked to Hedgehog signaling. Assays for ciliogenesis and epithelial morphogenesis in 3D renal cultures link renal cystic disease to apical organization defects, whereas ciliary and Hedgehog pathway defects lead to retinal or neural deficits. Using 38 interactors as candidates, linkage and sequencing analysis of 250 patients identified ATXN10 and TCTN2 as new NPHP-JBTS genes, and our Tctn2 mouse knockout shows neural tube and Hedgehog signaling defects. Our study further illustrates the power of linking proteomic networks and human genetics to uncover critical disease pathways.	[Sang, Liyun; Brauer, Matthew J.; Wen, Xiaohui; Scales, Suzie J.; Kwong, Mandy; Huntzicker, Erik G.; Sfakianos, Mindan K.; Sandoval, Wendy; Bazan, J. Fernando; Kulkarni, Priya; Jackson, Peter K.] Genentech Inc, San Francisco, CA 94080 USA; [Miller, Julie J.] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Corbit, Kevin C.; Garcia-Gonzalo, Francesc R.; Seol, Allen D.; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Giles, Rachel H.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CX Utrecht, Netherlands; [Giles, Rachel H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands; [Otto, Edgar A.; O'Toole, John F.; Held, Susanne; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Otto, Edgar A.; O'Toole, John F.; Held, Susanne; Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Baye, Lisa M.; Slusarski, Diane C.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Reutter, Heiko M.] Univ Bonn, Childrens Hosp, Inst Human Genet, D-53111 Bonn, Germany; [Reutter, Heiko M.] Univ Bonn, Childrens Hosp, Dept Neonatol, D-53111 Bonn, Germany; [Lane, William S.] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Ctr Syst Biol, Cambridge, MA 02138 USA; [Rafiq, Muhammad Arshad; Noor, Abdul; Vincent, John B.] Ctr Addict & Mental Hlth, Mol Neuropsychiat & Dev Lab, Neurogenet Sect, Toronto, ON M5T 1R8, Canada; [Ansar, Muhammad] Quaid i Azam Univ, Dept Biochem, Islamabad 45320, Pakistan; [Devi, Akella Radha Rama] Rainbow Childrens Hosp, Hyderabad 500034, Andhra Pradesh, India; [Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Doherty, Daniel A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Sheffield, Val C.; Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Roche Holding; Genentech; Stanford University; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Iowa; University of Iowa; University of Bonn; University of Bonn; Harvard University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Quaid I Azam University; University of Toronto; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Jackson, PK (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	pjackson@gene.com	Scales, Suzie J./H-4507-2019; Ansar, Muhammad/F-4808-2015; Garcia-Gonzalo, Francesc/W-2639-2017; Ansar, Muhammad/H-5967-2011; Noor, Abdul/J-2345-2016	Scales, Suzie J./0000-0003-2544-0283; Garcia-Gonzalo, Francesc/0000-0002-9152-2191; Ansar, Muhammad/0000-0001-5891-7063; Sheffield, Val/0000-0002-6282-0835; Slusarski, Diane/0000-0003-3793-8636; Otto, Edgar/0000-0002-2387-9973; Giles, Rachel/0000-0001-9133-2008; Jackson, Peter/0000-0002-1742-2539	NIH [GM07365-33, DK071108, CA112369, R01-AR054396, R01-EY11298, R01-EY017168, DK1068306, DK1069274, DK090917]; Netherlands Organisation for Scientific Research VIDI [016.066.354]; EU [241955]; Cardiovascular Center Interdisciplinary Research Fellowship, University of Iowa; Canadian Institutes of Health Research [MOP-102758, KL2RR025015, R01NS064077]; March of Dimes; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; Roy J. Carver Charitable Trust; Carver Endowment for Molecular Ophthalmology, and Research to Prevent Blindness; NATIONAL CANCER INSTITUTE [R01CA112369] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011298, R01EY017168] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090917, K08DK071108, R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095941, T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research VIDI(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); Cardiovascular Center Interdisciplinary Research Fellowship, University of Iowa; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; Roy J. Carver Charitable Trust; Carver Endowment for Molecular Ophthalmology, and Research to Prevent Blindness; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge expert advice and contributions from Chris Westlake, Guowei Fang, Ben Chih, Andy Peterson, Cecile Chalouni, John S. Beck, Darryl Y. Nishimura, Charles C. Searby, Martin Griebel, John Neveu, Bogdan Budnik, Renee Robinson, Alex Loktev, Jorge Torres, Saikat Mukhopadhyay, Dirk Siepe, and Kevin Wright. We acknowledge the following support: J.J.M., NIH Medical Scientist Training Program Grant GM07365-33; R. H. G., the Netherlands Organisation for Scientific Research VIDI grant 016.066.354 and the EU FP7 "Syscilia" project 241955; L. M. B., the Cardiovascular Center Interdisciplinary Research Fellowship, University of Iowa; J.F.O., NIH grant DK071108; D. C. S., NIH Grant CA112369; J.B.V., Canadian Institutes of Health Research grant MOP-102758; D. A. D., KL2RR025015 and R01NS064077; J.F.R., NIH Grant R01-AR054396, the March of Dimes, the Burroughs Wellcome Fund, the Packard Foundation, and the Sandler Family Supporting Foundation; V. C. S., NIH Grants R01-EY11298, R01-EY017168, the Roy J. Carver Charitable Trust, Carver Endowment for Molecular Ophthalmology, and Research to Prevent Blindness. V. C. S. is an HHMI investigator. F. H. is an HHMI Investigator, a Doris Duke Distinguished Clinical Scientist, and a Frederick G. L. Huetwell Professor. F. H. acknowledges support from the NIH grants (DK1068306, DK1069274, and DK090917). L. S., M. J. B., X. W., S. J. S., M. K., E. G. H., M. K. S., W. S., J. F. B., P. K., and P. K. J. are employees of Genentech, Inc.	Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Mougou-Zerelli S, 2009, HUM MUTAT, V30, P1574, DOI 10.1002/humu.21116; Murga-Zamalloa CA, 2010, MOL VIS, V16, P1373; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Reiter JF, 2006, GENE DEV, V20, P22, DOI 10.1101/gad.1363606; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Salonen R, 1998, J MED GENET, V35, P497, DOI 10.1136/jmg.35.6.497; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Scholtens D, 2005, BIOINFORMATICS, V21, P3548, DOI 10.1093/bioinformatics/bti567; SCHOLTENS D, 2004, APCOMPLEX ESTIMATE P; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Waragai M, 2006, J NEUROSCI RES, V83, P1170, DOI 10.1002/jnr.20807; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Winkelbauer ME, 2005, J CELL SCI, V118, P5575, DOI 10.1242/jcs.02665; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	46	413	438	1	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					513	528		10.1016/j.cell.2011.04.019	http://dx.doi.org/10.1016/j.cell.2011.04.019			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565611	Green Accepted, Bronze			2022-12-01	WOS:000290560800006
J	Allen, AE; Dupont, CL; Obornik, M; Horak, A; Nunes-Nesi, A; McCrow, JP; Zheng, H; Johnson, DA; Hu, HH; Fernie, AR; Bowler, C				Allen, Andrew E.; Dupont, Christopher L.; Obornik, Miroslav; Horak, Ales; Nunes-Nesi, Adriano; McCrow, John P.; Zheng, Hong; Johnson, Daniel A.; Hu, Hanhua; Fernie, Alisdair R.; Bowler, Chris			Evolution and metabolic significance of the urea cycle in photosynthetic diatoms	NATURE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; TREE; INFERENCE; ACCURATE; INSIGHTS; HISTORY; MRBAYES; GENOME	Diatoms dominate the biomass of phytoplankton in nutrient-rich conditions and form the basis of some of the world's most productive marine food webs(1-4). The diatom nuclear genome contains genes with bacterial and plastid origins as well as genes of the secondary endosymbiotic host (the exosymbiont(5))(1,6-10), yet little is known about the relative contribution of each gene group to diatom metabolism. Here we show that the exosymbiont-derived ornithine-urea cycle, which is similar to that of metazoans but is absent in green algae and plants, facilitates rapid recovery from prolonged nitrogen limitation. RNA-interference-mediated knockdown of a mitochondrial carbamoyl phosphate synthase impairs the response of nitrogen-limited diatoms to nitrogen addition. Metabolomic analyses indicate that intermediates in the ornithine-urea cycle are particularly depleted and that both the tricarboxylic acid cycle and the glutamine synthetase/glutamate synthase cycles are linked directly with the ornithine-urea cycle. Several other depleted metabolites are generated from ornithine-urea cycle intermediates by the products of genes laterally acquired from bacteria. This metabolic coupling of bacterial-and exosymbiont-derived proteins seems to be fundamental to diatom physiology because the compounds affected include the major diatom osmolyte proline(12) and the precursors for long-chain polyamines required for silica precipitation during cell wall formation(11). So far, the ornithine-urea cycle is only known for its essential role in the removal of fixed nitrogen in metazoans. In diatoms, this cycle serves as a distribution and repackaging hub for inorganic carbon and nitrogen and contributes significantly to the metabolic response of diatoms to episodic nitrogen availability. The diatom ornithine-urea cycle therefore represents a key pathway for anaplerotic carbon fixation into nitrogenous compounds that are essential for diatom growth and for the contribution of diatoms to marine productivity.	[Allen, Andrew E.; Dupont, Christopher L.; McCrow, John P.; Zheng, Hong; Johnson, Daniel A.] J Craig Venter Inst, San Diego, CA 92121 USA; [Allen, Andrew E.; Hu, Hanhua; Bowler, Chris] Ecole Normale Super, Inst Biol, Environm & Evolutionary Genom Sect, CNRS,UMR8197,INSERM,U1024, F-75005 Paris, France; [Obornik, Miroslav; Horak, Ales] Biol Ctr ASCR, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav; Horak, Ales] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Nunes-Nesi, Adriano; Fernie, Alisdair R.] Max Planck Insitut Mol Pfanzenphysiol, D-14476 Potsdam, Germany	J. Craig Venter Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Max Planck Society	Allen, AE (corresponding author), J Craig Venter Inst, San Diego, CA 92121 USA.	aallen@jcvi.org	Obornik, Miroslav/G-9350-2014; Allen, Andrew E/C-4896-2012; Bowler, Chris/AAC-6256-2019; Horak, Ales/H-6723-2012; Nunes-Nesi, Adriano/D-6430-2013	Allen, Andrew E/0000-0001-5911-6081; Horak, Ales/0000-0002-3364-7383; Bowler, Chris/0000-0003-3835-6187; McCrow, John/0000-0002-7014-5040; Nunes-Nesi, Adriano/0000-0002-9581-9355	National Science Foundation [NSF-OCE-0722374, NSF-OCE-0727997, NSF-MCB-1024913]; JCVI; European Commission; Agence Nationale de la Recherche (France); Czech Science Foundation [206/08/1423]	National Science Foundation(National Science Foundation (NSF)); JCVI; European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Czech Science Foundation(Grant Agency of the Czech Republic)	We thank A. Meichenin and C. Lichtle for assistance with electron microscropy, J. C. Thomas for CPS purification and activity experiments, A. Falciatore for advice on RNAi constructs and A. Main for screening and evaluation of RNAi lines. This study was supported by the National Science Foundation (NSF-OCE-0722374, NSF-OCE-0727997, NSF-MCB-1024913) and JCVI internal funding to A.E.A., the European Commission Diatomics project and Agence Nationale de la Recherche (France) (C.B.) and the Czech Science Foundation (206/08/1423) (M.O.).	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; ANDERSON PM, 1980, SCIENCE, V208, P291, DOI 10.1126/science.6245445; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2020, R LANG ENV STAT COMP; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ast M, 2009, P NATL ACAD SCI USA, V106, P3621, DOI 10.1073/pnas.0808862106; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Esteban-Pretel G, 2010, J NUTR, V140, P792, DOI 10.3945/jn.109.119388; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUPPY M, 1986, TRENDS BIOCHEM SCI, V11, P274, DOI 10.1016/0968-0004(86)90022-8; Hamm Christian, 2007, P311, DOI 10.1016/B978-012370518-1/50015-1; Holden HM, 1999, CELL MOL LIFE SCI, V56, P507, DOI 10.1007/s000180050448; HONG J, 1994, J MOL BIOL, V243, P131, DOI 10.1006/jmbi.1994.1638; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krell A, 2007, J PHYCOL, V43, P753, DOI 10.1111/j.1529-8817.2007.00366.x; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lawson FS, 1996, MOL BIOL EVOL, V13, P970, DOI 10.1093/oxfordjournals.molbev.a025665; Lee B, 2000, P NATL ACAD SCI USA, V97, P8021, DOI 10.1073/pnas.140082197; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Maheswari U, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r85; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Quang LS, 2008, BIOINFORMATICS, V24, P2317, DOI 10.1093/bioinformatics/btn445; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Young EB, 2003, J PHYCOL, V39, P897, DOI 10.1046/j.1529-8817.2003.03042.x	49	306	317	17	331	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					203	+		10.1038/nature10074	http://dx.doi.org/10.1038/nature10074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562560	Green Published			2022-12-01	WOS:000290487200036
J	Stolarz-Skrzypek, K; Kuznetsova, T; Thijs, L; Tikhonoff, V; Seidlerova, J; Richart, T; Jin, Y; Olszanecka, A; Malyutina, S; Casiglia, E; Filipovsky, J; Kawecka-Jaszcz, K; Nikitin, Y; Staessen, JA				Stolarz-Skrzypek, Katarzyna; Kuznetsova, Tatiana; Thijs, Lutgarde; Tikhonoff, Valerie; Seidlerova, Jitka; Richart, Tom; Jin, Yu; Olszanecka, Agnieszka; Malyutina, Sofia; Casiglia, Edoardo; Filipovsky, Jan; Kawecka-Jaszcz, Kalina; Nikitin, Yuri; Staessen, Jan A.		European Project Genes Hypertensio	Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REDUCED DIETARY-SODIUM; CARDIOVASCULAR-DISEASE; SALT INTAKE; NATIONAL-HEALTH; POTASSIUM; MORTALITY; RISK; POPULATION; METAANALYSIS; CONSUMPTION	Context Extrapolations from observational studies and short-term intervention trials suggest that population-wide moderation of salt intake might reduce cardiovascular events. Objective To assess whether 24-hour urinary sodium excretion predicts blood pressure (BP) and health outcomes. Design, Setting, and Participants Prospective population study, involving 3681 participants without cardiovascular disease (CVD) who are members of families that were randomly enrolled in the Flemish Study on Genes, Environment, and Health Outcomes (1985-2004) or in the European Project on Genes in Hypertension (1999-2001). Of 3681 participants without CVD, 2096 were normotensive at baseline and 1499 had BP and sodium excretion measured at baseline and last follow-up (2005-2008). Main Outcome Measures Incidence of mortality and morbidity and association between changes in BP and sodium excretion. Multivariable-adjusted hazard ratios (HRs) express the risk in tertiles of sodium excretion relative to average risk in the whole study population. Results Among 3681 participants followed up for a median 7.9 years, CVD deaths decreased across increasing tertiles of 24-hour sodium excretion, from 50 deaths in the low (mean, 107 mmol), 24 in the medium (mean, 168 mmol), and 10 in the high excretion group (mean, 260 mmol; P<.001), resulting in respective death rates of 4.1% (95% confidence interval [CI], 3.5%-4.7%), 1.9% (95% CI, 1.5%-2.3%), and 0.8% (95% CI, 0.5%-1.1%). In multivariable-adjusted analyses, this inverse association retained significance (P=.02): the HR in the low tertile was 1.56 (95% CI, 1.02-2.36; P=.04). Baseline sodium excretion predicted neither total mortality (P=.10) nor fatal combined with nonfatal CVD events (P=.55). Among 2096 participants followed up for 6.5 years, the risk of hypertension did not increase across increasing tertiles (P=.93). Incident hypertension was 187 (27.0%; HR, 1.00; 95% CI, 0.87-1.16) in the low, 190 (26.6%; HR, 1.02; 95% CI, 0.89-1.16) in the medium, and 175 (25.4%; HR, 0.98; 95% CI, 0.86-1.12) in the high sodium excretion group. In 1499 participants followed up for 6.1 years, systolic blood pressure increased by 0.37 mm Hg per year (P<.001), whereas sodium excretion did not change (-0.45 mmol per year, P=.15). However, in multivariable-adjusted analyses, a 100-mmol increase in sodium excretion was associated with 1.71 mm Hg increase in systolic blood pressure (P.<001) but no change in diastolic BP. Conclusions In this population-based cohort, systolic blood pressure, but not diastolic pressure, changes over time aligned with change in sodium excretion, but this association did not translate into a higher risk of hypertension or CVD complications. Lower sodium excretion was associated with higher CVD mortality. JAMA. 2011;305(17):1777-1785 www.jama.com	[Staessen, Jan A.] Katholieke Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis,Lab Hypertens, BE-3000 Louvain, Belgium; [Stolarz-Skrzypek, Katarzyna; Olszanecka, Agnieszka; Kawecka-Jaszcz, Kalina] Jagiellonian Univ, Coll Med, Dept Cardiol & Hypertens 1, Krakow, Poland; [Tikhonoff, Valerie; Casiglia, Edoardo] Univ Padua, Dept Clin & Expt Med, Padua, Italy; [Seidlerova, Jitka; Filipovsky, Jan] Charles Univ Prague, Fac Med Pilsen, Plzen, Czech Republic; [Malyutina, Sofia; Nikitin, Yuri] Inst Internal Med, Novosibirsk, Russia; [Richart, Tom; Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	KU Leuven; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Padua; Charles University Prague; Maastricht University	Staessen, JA (corresponding author), Katholieke Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis,Lab Hypertens, Campus Sint Rafael,Kapucijnenvoer 35,Block D,POB, BE-3000 Louvain, Belgium.	jan.staessen@med.kuleuven.be	Seidlerova, Jitka/P-1188-2017; Staessen, Jan A/A-1065-2011; Kuznetsova, Tatiana/ABI-5662-2020; Stolarz-Skrzypek, Katarzyna/E-1589-2011; Tikhonoff, Valerie/AAC-3728-2019; Nikitin, Yuri/D-2774-2018; Malyutina, Sofia/J-1651-2018	Seidlerova, Jitka/0000-0002-2731-4961; Staessen, Jan A/0000-0002-3026-1637; Kuznetsova, Tatiana/0000-0003-4293-4576; Tikhonoff, Valerie/0000-0001-7846-0101; Nikitin, Yuri/0000-0002-3932-2299; Malyutina, Sofia/0000-0001-6539-0466; Casiglia, Edoardo/0000-0002-0003-3289; Thijs, Lutgarde/0000-0002-8108-2356; Olszanecka, Agnieszka/0000-0001-7020-9641	European Union [IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093]; Studies Coordinating Centre (Leuven, Belgium) [HEALTH-F4-2007-201550]; studies in Pilsen (Czech Republic); studies in Pilsen, Padova (Italy); studies in Pilsen, Krakow (Poland); Novosibirsk (Russian Federation); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0575.06, G.0734.09]; Katholieke Universiteit Leuven, Belgium [OT/00/25, OT/05/49]; Polish Ministry for Science and Higher Education; Czech Society of Hypertension	European Union(European Commission); Studies Coordinating Centre (Leuven, Belgium); studies in Pilsen (Czech Republic)(Czech Republic Government); studies in Pilsen, Padova (Italy); studies in Pilsen, Krakow (Poland); Novosibirsk (Russian Federation)(Russian Federation); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); Katholieke Universiteit Leuven, Belgium(KU Leuven); Polish Ministry for Science and Higher Education(Ministry of Science and Higher Education, Poland); Czech Society of Hypertension	The European Union grants IC15-CT98-0329-EPOGH, LSHM-CT-2006-037093. InGenious HyperCare, and HEALTH-F4-2007-201550 HyperGenes supported the Studies Coordinating Centre (Leuven, Belgium) and the studies in Pilsen (Czech Republic), Padova (Italy), Krakow (Poland), and Novosibirsk (Russian Federation). The Studies Coordinating Centre also received grants G.0575.06 and G.0734.09 from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium, and the grants OT/00/25 and OT/05/49 from the Katholieke Universiteit Leuven, Belgium. The Polish Ministry for Science and Higher Education supported the fellowship of Dr Stolarz-Skrzypek in Leuven. The Czech Society of Hypertension provided additional funding to Dr Seidlerova.	ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; Alderman MH, 1998, LANCET, V351, P781, DOI 10.1016/S0140-6736(97)09092-2; Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Bernstein AM, 2010, AM J CLIN NUTR, V92, P1172, DOI 10.3945/ajcn.2010.29367; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Campese VM, 1999, NUTR METAB CARDIOVAS, V9, P143; Chien KL, 2008, J HYPERTENS, V26, P1750, DOI 10.1097/HJH.0b013e328306a0a7; CLELAND JGF, 1987, BRIT HEART J, V58, P230; Cohen HW, 2008, J GEN INTERN MED, V23, P1297, DOI 10.1007/s11606-008-0645-6; Cohen HW, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.042; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Franklin SS, 1997, CIRCULATION, V96, P308; Gavin JR, 1999, DIABETES CARE, V22, pS5; GELEIJNSE JM, 1990, BMJ-BRIT MED J, V300, P899, DOI 10.1136/bmj.300.6729.899; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYP.0b013e3181dfc0ad, 10.1161/HYPERTENSIONAHA.109.140798]; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; KAGAN A, 1985, STROKE, V16, P390, DOI 10.1161/01.STR.16.3.390; Kuznetsova T, 2002, BLOOD PRESS MONIT, V7, P215, DOI 10.1097/00126097-200208000-00003; LEVER AF, 1981, BRIT MED J, V283, P463, DOI 10.1136/bmj.283.6289.463; Li Y, 2007, HYPERTENSION, V49, P1291, DOI 10.1161/HYPERTENSIONAHA.106.085498; LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805; McCarron DA, 2009, CLIN J AM SOC NEPHRO, V4, P1878, DOI 10.2215/CJN.04660709; Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590; Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schmidlin O, 1999, HYPERTENSION, V33, P633, DOI 10.1161/01.HYP.33.2.633; SMITH WCS, 1988, BRIT MED J, V297, P329, DOI 10.1136/bmj.297.6644.329; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; STAESSEN J, 1983, AM J EPIDEMIOL, V117, P676, DOI 10.1093/oxfordjournals.aje.a113601; STAESSEN J, 1988, J HYPERTENS, V6, P965, DOI 10.1097/00004872-198812000-00003; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Staessen JA, 1997, AM J CLIN NUTR, V65, P661; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Umesawa M, 2008, AM J CLIN NUTR, V88, P195, DOI 10.1093/ajcn/88.1.195; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038	45	417	429	0	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2011	305	17					1777	1785		10.1001/jama.2011.574	http://dx.doi.org/10.1001/jama.2011.574			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	758HZ	21540421	Green Published, Bronze			2022-12-01	WOS:000290156200018
J	Koenig, J; Linder, AN; Leutgeb, JK; Leutgeb, S				Koenig, Julie; Linder, Ashley N.; Leutgeb, Jill K.; Leutgeb, Stefan			The Spatial Periodicity of Grid Cells Is Not Sustained During Reduced Theta Oscillations	SCIENCE			English	Article							ENTORHINAL CORTEX; PLACE CELLS; UNIT-ACTIVITY; HIPPOCAMPUS; NEURONS; INTERFERENCE; NAVIGATION; FREQUENCY; SEPTUM; PHASE	Grid cells in parahippocampal cortices fire at vertices of a periodic triangular grid that spans the entire recording environment. Such precise neural computations in space have been proposed to emerge from equally precise temporal oscillations within cells or within the local neural circuitry. We found that grid-like firing patterns in the entorhinal cortex vanished when theta oscillations were reduced after intraseptal lidocaine infusions in rats. Other spatially modulated cells in the same cortical region and place cells in the hippocampus retained their spatial firing patterns to a larger extent during these periods without well-organized oscillatory neuronal activity. Precisely timed neural activity within single cells or local networks is thus required for periodic spatial firing but not for single place fields.	[Leutgeb, Stefan] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA; Univ Calif San Diego, Ctr Neural Circuits & Behav, Div Biol Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Leutgeb, S (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, San Diego, CA 92103 USA.	sleutgeb@ucsd.edu	koenig, julie/O-7865-2016	koenig, julie/0000-0003-0516-6627; Leutgeb, Jill/0000-0002-2014-842X	NSF/NIH/Bundesministerium fur Bildung und Forschung [1010463]; Ellison Medical Foundation [AG-NS-0724-10]; Alfred P. Sloan Foundation; Alzheimer's Association [NIRG-09-133414]	NSF/NIH/Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Alzheimer's Association(Alzheimer's Association)	The authors thank T. Solstad and E. Mankin for Matlab scripts and M. Hasselmo, L. Squire, and M. Scanziani for comments and discussions. Supported by the Walter F. Heiligenberg Professorship, NSF/NIH/Bundesministerium fur Bildung und Forschung grant 1010463, Ellison Medical Foundation grant AG-NS-0724-10, the Alfred P. Sloan Foundation, and Alzheimer's Association grant NIRG-09-133414.	Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brazhnik E, 2004, J NEUROSCI, V24, P9313, DOI 10.1523/JNEUROSCI.1618-04.2004; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1989, BRAIN RES, V500, P99, DOI 10.1016/0006-8993(89)90303-X; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	27	278	280	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					592	595		10.1126/science.1201685	http://dx.doi.org/10.1126/science.1201685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527713				2022-12-01	WOS:000289991100050
J	West-Eberhard, MJ; Smith, JAC; Winter, K				West-Eberhard, Mary Jane; Smith, J. Andrew C.; Winter, Klaus			Photosynthesis, Reorganized	SCIENCE			English	Editorial Material							CRASSULACEAN ACID METABOLISM; EVOLUTIONARY; EXPRESSION; ORIGINS		[West-Eberhard, Mary Jane] Univ Costa Rica, Smithsonian Trop Res Inst, Escuela Biol, San Pedro, Costa Rica; [Smith, J. Andrew C.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Winter, Klaus] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Costa Rica; University of Oxford; Smithsonian Institution; Smithsonian Tropical Research Institute	West-Eberhard, MJ (corresponding author), Univ Costa Rica, Smithsonian Trop Res Inst, Escuela Biol, San Pedro, Costa Rica.	mjwe@sent.com; andrew.smith@plants.ox.ac.uk; winterk@si.edu	Smith, J.A.C./M-3338-2014	Smith, J.A.C./0000-0001-9188-0258				Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Brown NJ, 2011, SCIENCE, V331, P1436, DOI 10.1126/science.1201248; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; Crayn DM, 2004, P NATL ACAD SCI USA, V101, P3703, DOI 10.1073/pnas.0400366101; Cushman JC, 1997, PLANT PHYSIOL, V113, P667, DOI 10.1104/pp.113.3.667; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Silvera K, 2009, PLANT PHYSIOL, V149, P1838, DOI 10.1104/pp.108.132555; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; West-Eberhard Mary Jane, 2003, pi; Winter K, 1996, CRASSULACEAN ACID ME; Winter K, 2007, PLANT PHYSIOL, V143, P98, DOI 10.1104/pp.106.088922	15	43	49	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					311	312		10.1126/science.1205336	http://dx.doi.org/10.1126/science.1205336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493847				2022-12-01	WOS:000289516600030
J	Mombouli, JV; Ostroff, SM				Mombouli, Jean-Vivien; Ostroff, Stephen M.			The remaining smallpox stocks: the healthiest outcome	LANCET			English	Editorial Material							MONKEYPOX; CONGO		[Ostroff, Stephen M.] Penn Dept Hlth Harrisburg, Bur Epidemiol, Harrisburg, PA 17120 USA; [Mombouli, Jean-Vivien] Natl Publ Hlth Lab, Brazzaville, Rep Congo		Ostroff, SM (corresponding author), Penn Dept Hlth Harrisburg, Bur Epidemiol, Harrisburg, PA 17120 USA.	sostroff@state.pa.us						Advisory Group of Independent Experts to review the smallpox research programme (AGIES), 2010, ADV GROUP IND EXP RE; [Anonymous], 1999, SMALLP ER DESTR VAR; Damon IK, 2006, NEW ENGL J MED, V355, P962, DOI 10.1056/NEJMc060792; Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340; [Institute of Medicine National Acadamies of Sciences USA], 2009, LIV VAR VIR CONS CON; Khan AS, 2010, SCI REV VARIOLA VIRU; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; WHO, 2007, SMALLP ER DESTR VAR	9	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					10	12		10.1016/S0140-6736(11)60694-6	http://dx.doi.org/10.1016/S0140-6736(11)60694-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873WC	21601271				2022-12-01	WOS:000298913000011
J	Valouev, A; Johnson, SM; Boyd, SD; Smith, CL; Fire, AZ; Sidow, A				Valouev, Anton; Johnson, Steven M.; Boyd, Scott D.; Smith, Cheryl L.; Fire, Andrew Z.; Sidow, Arend			Determinants of nucleosome organization in primary human cells	NATURE			English	Article							HIGH-RESOLUTION; HUMAN GENOME; SACCHAROMYCES-CEREVISIAE; C. ELEGANS; IN-VIVO; CHROMATIN; DNA; SEQUENCE; YEAST; METHYLATIONS	Nucleosomes are the basic packaging units of chromatin, modulating accessibility of regulatory proteins to DNA and thus influencing eukaryotic gene regulation. Elaborate chromatin remodelling mechanisms have evolved that govern nucleosome organization at promoters, regulatory elements, and other functional regions in the genome(1). Analyses of chromatin landscape have uncovered a variety of mechanisms, including DNA sequence preferences, that can influence nucleosome positions(2-4). To identify major determinants of nucleosome organization in the human genome, we used deep sequencing to map nucleosome positions in three primary human cell types and in vitro. A majority of the genome showed substantial flexibility of nucleosome positions, whereas a small fraction showed reproducibly positioned nucleosomes. Certain sites that position in vitro can anchor the formation of nucleosomal arrays that have cell type-specific spacing in vivo. Our results unveil an interplay of sequence-based nucleosome preferences and non-nucleosomal factors in determining nucleosome organization within mammalian cells.	[Valouev, Anton; Boyd, Scott D.; Smith, Cheryl L.; Fire, Andrew Z.; Sidow, Arend] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Johnson, Steven M.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Fire, Andrew Z.; Sidow, Arend] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Brigham Young University; Stanford University	Sidow, A (corresponding author), Stanford Univ, Dept Pathol, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	afire@stanford.edu; arend@stanford.edu	Johnson, Steven M/B-3940-2013	Fire, Andrew/0000-0001-6217-8312; Johnson, Steven/0000-0002-7399-8153; Smith, Cheryl/0000-0003-4323-6382	NIGMS [R01GM37706]; NHGRI [U01HG004695, T32HG00044]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004695, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Stanford Genetics/Pathology Sequencing Initiative. We thank G. Narlikar for help with in vitro experiments, Life Technologies, especially J. Briggs, for help with generating sequencing data, P. Lacroute for help with sequence alignment, S. Galli for valuable discussions, L. Gracey for critical reading of the manuscript, and members of the Sidow and Fire labs for valuable feedback and discussions. Work in the Fire lab was partially supported by NIGMS (R01GM37706). A.V. was partially supported by an ENCODE subcontract to A.S. (NHGRI U01HG004695). S.M.J. was partially supported by the Stanford Genome Training program (NHGRI T32HG00044).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Field Y, 2009, NAT GENET, V41, P438, DOI 10.1038/ng.324; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SCHLEGEL RA, 1980, BIOCHIM BIOPHYS ACTA, V606, P316, DOI 10.1016/0005-2787(80)90041-6; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sha K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-465; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	34	424	430	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					516	U148		10.1038/nature10002	http://dx.doi.org/10.1038/nature10002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21602827	Green Accepted			2022-12-01	WOS:000291939700050
J	Ely, EW				Ely, E. Wesley			Cyanosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ely, E. Wesley] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ely, E. Wesley] VA GRECC, Nashville, TN USA	Vanderbilt University; Geriatric Research Education & Clinical Center	Ely, EW (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	wes.ely@vanderbilt.edu	Adeyinka, Adebayo/K-7917-2019; Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2388	2389		10.1001/jama.2011.816	http://dx.doi.org/10.1001/jama.2011.816			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673285				2022-12-01	WOS:000291597300001
J	Mendes, R; Kruijt, M; de Bruijn, I; Dekkers, E; van der Voort, M; Schneider, JHM; Piceno, YM; DeSantis, TZ; Andersen, GL; Bakker, PAHM; Raaijmakers, JM				Mendes, Rodrigo; Kruijt, Marco; de Bruijn, Irene; Dekkers, Ester; van der Voort, Menno; Schneider, Johannes H. M.; Piceno, Yvette M.; DeSantis, Todd Z.; Andersen, Gary L.; Bakker, Peter A. H. M.; Raaijmakers, Jos M.			Deciphering the Rhizosphere Microbiome for Disease-Suppressive Bacteria	SCIENCE			English	Article							PATHOGENS	Disease-suppressive soils are exceptional ecosystems in which crop plants suffer less from specific soil-borne pathogens than expected owing to the activities of other soil microorganisms. For most disease-suppressive soils, the microbes and mechanisms involved in pathogen control are unknown. By coupling PhyloChip-based metagenomics of the rhizosphere microbiome with culture-dependent functional analyses, we identified key bacterial taxa and genes involved in suppression of a fungal root pathogen. More than 33,000 bacterial and archaeal species were detected, with Proteobacteria, Firmicutes, and Actinobacteria consistently associated with disease suppression. Members of the gamma-Proteobacteria were shown to have disease-suppressive activity governed by nonribosomal peptide synthetases. Our data indicate that upon attack by a fungal root pathogen, plants can exploit microbial consortia from soil for protection against infections.	[Mendes, Rodrigo; Kruijt, Marco; de Bruijn, Irene; Dekkers, Ester; van der Voort, Menno; Raaijmakers, Jos M.] Wageningen Univ, Phytopathol Lab, NL-6700 EE Wageningen, Netherlands; [Schneider, Johannes H. M.] Inst Sugar Beet Res, NL-4611 HL Bergen Op Zoom, Netherlands; [Piceno, Yvette M.; DeSantis, Todd Z.; Andersen, Gary L.] Lawrence Berkeley Natl Lab, Dept Ecol, Berkeley, CA 94720 USA; [DeSantis, Todd Z.] Second Genome Inc, San Francisco, CA 94158 USA; [Bakker, Peter A. H. M.] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands	Wageningen University & Research; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Utrecht University	Raaijmakers, JM (corresponding author), Wageningen Univ, Phytopathol Lab, Droevendaalsesteeg 1, NL-6700 EE Wageningen, Netherlands.	jos.raaijmakers@wur.nl	Mendes, Rodrigo/AAV-6490-2020; Piceno, Yvette/I-6738-2016; Bakker, Peter A.H.M./B-9355-2011; Raaijmakers, Jos M/D-1574-2014; rolshausen, philippe/F-7999-2011; Mendes, Rodrigo/F-1534-2010; de Bruijn, Irene/A-7437-2014; Andersen, Gary/G-2792-2015	Mendes, Rodrigo/0000-0002-9817-4118; Piceno, Yvette/0000-0002-7915-4699; Raaijmakers, Jos M/0000-0003-1608-6614; Mendes, Rodrigo/0000-0002-9817-4118; de Bruijn, Irene/0000-0002-4889-3253; Andersen, Gary/0000-0002-1618-9827	Netherlands Science Organisation (NWO) [838.06.101]; Netherlands Genomics Initiative-Ecogenomics, Netherlands; Lawrence Berkeley National Laboratory (LBNL) [DE-AC02-05CH11231]; U.S. Department of Energy	Netherlands Science Organisation (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative-Ecogenomics, Netherlands(Netherlands Government); Lawrence Berkeley National Laboratory (LBNL); U.S. Department of Energy(United States Department of Energy (DOE))	We thank T. Bisseling for critical reading and valuable suggestions. We acknowledge assistance by L. Sibbel-Wagemakers, N. Pangesti, M. de Milliano, N. Sharma, R. de Vries, P. M. S. van Oorschot, A. H. L. Schoone, and Y. Bakker. This work was financially supported by grants from Netherlands Science Organisation (NWO)-ERGO (#838.06.101) and Netherlands Genomics Initiative-Ecogenomics, Netherlands. Additional work was performed at Lawrence Berkeley National Laboratory (LBNL) (contract DE-AC02-05CH11231 with the U.S. Department of Energy). The 16S rDNA sequences are available on GenBank under accessions HQ848634 to HQ848643, and the thaABCD sequences under accession HQ888764. LBNL has a patent on the PhyloChip assay and Second Genome has licensed this assay from LBNL. Although the G3 PhyloChip is under patent (and under exclusive license to Second Genome), the data generated from the use of the chip are not patented or restricted. T.Z.dS. owns stock in Second Genome valued at under $10,000.	Bisseling T, 2009, SCIENCE, V324, P691, DOI 10.1126/science.1174404; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Garbeva P, 2011, ISME J; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Marschner H., 1995, MINERAL NUTR PLANTS; Postma J, 2010, SOIL BIOL BIOCHEM, V42, P804, DOI 10.1016/j.soilbio.2010.01.017; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010	14	1342	1460	77	1135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1097	1100		10.1126/science.1203980	http://dx.doi.org/10.1126/science.1203980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21551032				2022-12-01	WOS:000290996700048
J	Paeschke, K; Capra, JA; Zakian, VA				Paeschke, Katrin; Capra, John A.; Zakian, Virginia A.			DNA Replication through G-Quadruplex Motifs Is Promoted by the Saccharomyces cerevisiae Pif1 DNA Helicase	CELL			English	Article							FALSE DISCOVERY RATE; TELOMERE ELONGATION; FORK PROGRESSION; YEAST; RRM3P; INSTABILITY; SEQUENCES; PROTEIN; GENES; PAUSE	G-quadruplex (G4) DNA structures are extremely stable four-stranded secondary structures held together by noncanonical G-G base pairs. Genome-wide chromatin immunoprecipitation was used to determine the in vivo binding sites of the multifunctional Saccharomyces cerevisiae Pif1 DNA helicase, a potent unwinder of G4 structures in vitro. G4 motifs were a significant subset of the high-confidence Pif1-binding sites. Replication slowed in the vicinity of these motifs, and they were prone to breakage in Pif1-deficient cells, whereas non-G4 Pif1-binding sites did not show this behavior. Introducing many copies of G4 motifs caused slow growth in replication-stressed Pif1-deficient cells, which was relieved by spontaneous mutations that eliminated their ability to form G4 structures, bind Pif1, slow DNA replication, and stimulate DNA breakage. These data suggest that G4 structures form in vivo and that they are resolved by Pif1 to prevent replication fork stalling and DNA breakage.	[Paeschke, Katrin; Zakian, Virginia A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Capra, John A.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94158 USA	Princeton University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	vzakian@princeton.edu	Capra, Tony/C-7784-2013		NIH [GM26938]; Deutsche Forschungsgemeinschaft; NJCCR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026938, R37GM026938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NJCCR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. A. Lenzmeier for strains and advice on the recombination assay and C. Webb, N. Sabouri, M. Bochman, and J. Broach for comments on the manuscript. This work was supported by NIH grant GM26938 (V.A.Z.) and postdoctoral fellowships from Deutsche Forschungsgemeinschaft and NJCCR (K.P.).	Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/417405a, 10.1038/ng928]; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Mateyak MK, 2006, CELL CYCLE, V5, P2796, DOI 10.4161/cc.5.23.3524; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nakken S, 2009, NUCLEIC ACIDS RES, V37, P5749, DOI 10.1093/nar/gkp590; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; RUNGE KW, 1989, MOL CELL BIOL, V9, P1488, DOI 10.1128/MCB.9.4.1488; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Vega LR, 2007, PLOS GENET, V3, P1065, DOI 10.1371/journal.pgen.0030105; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	37	397	406	1	71	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					678	691		10.1016/j.cell.2011.04.015	http://dx.doi.org/10.1016/j.cell.2011.04.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620135	Bronze, Green Accepted			2022-12-01	WOS:000291018600009
J	Xu, CR; Cole, PA; Meyers, DJ; Kormish, J; Dent, S; Zaret, KS				Xu, Cheng-Ran; Cole, Philip A.; Meyers, David J.; Kormish, Jay; Dent, Sharon; Zaret, Kenneth S.			Chromatin "Prepattern" and Histone Modifiers in a Fate Choice for Liver and Pancreas	SCIENCE			English	Article							TRANSCRIPTION FACTORS; STEM-CELLS; IN-VITRO; GENE; EXPRESSION; ENDODERM; PROMOTER; DISTINCT; ACETYLTRANSFERASE; DIFFERENTIATION	Transcriptionally silent genes can be marked by histone modifications and regulatory proteins that indicate the genes' potential to be activated. Such marks have been identified in pluripotent cells, but it is unknown how such marks occur in descendant, multipotent embryonic cells that have restricted cell fate choices. We isolated mouse embryonic endoderm cells and assessed histone modifications at regulatory elements of silent genes that are activated upon liver or pancreas fate choices. We found that the liver and pancreas elements have distinct chromatin patterns. Furthermore, the histone acetyltransferase P300, recruited via bone morphogenetic protein signaling, and the histone methyltransferase Ezh2 have modulatory roles in the fate choice. These studies reveal a functional "prepattern" of chromatin states within multipotent progenitors and potential targets to modulate cell fate induction.	[Xu, Cheng-Ran; Kormish, Jay; Zaret, Kenneth S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Inst Regenerat Med,Epigenet Program, Philadelphia, PA 19104 USA; [Cole, Philip A.; Meyers, David J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Dent, Sharon] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Pennsylvania; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center	Zaret, KS (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Inst Regenerat Med,Epigenet Program, Philadelphia, PA 19104 USA.	zaret@upenn.edu	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269	FAMRI Foundation; NIH [U54MH084691, RO1 GM067718, R37GM36477, U01DK072503]; Acylin Therapeutics; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067718, R01GM062437, R37GM036477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	FAMRI Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Acylin Therapeutics; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Jiang, R. Hardy, J. Oesterling, and W. DeMuth for assistance; Z. Zhang, J. Xu, and S. Hua for advice; P. Streeter and K. Kaestner for reagents; J. Epstein, E. Wandzioch, D. Metzger, A. Wecker, A. Hines, and D. Freedman-Cass for comments; and E. Pytko for preparing the manuscript. Supported by the FAMRI Foundation and NIH grant U54MH084691 (P.A.C. and D.J.M.), NIH grant RO1 GM067718 (S.D.), and NIH grants R37GM36477 and U01DK072503 (K.S.Z.). There is a patent on P300i: "Methods and compositions for modulating p300/CBP activity" (pub. WO/2008/157680; international application PCT/US2008/067477 to D.J.M. and P.A.C.). P.A.C. is co-founder, owns equity, and receives consulting fees as science advisor to Acylin Therapeutics, which is attempting the development of clinically useful HAT inhibitors and licenses from Johns Hopkins some of our discoveries related to C646.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Boyer DF, 2006, DEV BIOL, V298, P616, DOI 10.1016/j.ydbio.2006.07.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; Deutsch G, 2001, DEVELOPMENT, V128, P871; FEUERMAN MH, 1989, MOL CELL BIOL, V9, P4204, DOI 10.1128/MCB.9.10.4204; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lin WC, 2008, DEV DYNAM, V237, P928, DOI 10.1002/dvdy.21479; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Seydel F, 2008, J AUTOIMMUN, V31, P377, DOI 10.1016/j.jaut.2008.08.010; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318	36	154	158	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					963	966		10.1126/science.1202845	http://dx.doi.org/10.1126/science.1202845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596989	Green Accepted			2022-12-01	WOS:000290766600043
J	Shekelle, PG; Pronovost, PJ; Wachter, RM; Taylor, SL; Dy, SM; Foy, R; Hempel, S; McDonald, KM; Ovretveit, J; Rubenstein, LV; Adams, AS; Angood, PB; Bates, DW; Bickman, L; Carayon, P; Donaldson, L; Duan, N; Farley, DO; Greenhalgh, T; Haughom, J; Lake, ET; Lilford, R; Lohr, KN; Meyer, GS; Miller, MR; Neuhauser, DV; Ryan, G; Saint, S; Shojania, KG; Shortell, SM; Stevens, DP; Walshe, K				Shekelle, Paul G.; Pronovost, Peter J.; Wachter, Robert M.; Taylor, Stephanie L.; Dy, Sydney M.; Foy, Robbie; Hempel, Susanne; McDonald, Kathryn M.; Ovretveit, John; Rubenstein, Lisa V.; Adams, Alyce S.; Angood, Peter B.; Bates, David W.; Bickman, Leonard; Carayon, Pascale; Donaldson, Liam; Duan, Naihua; Farley, Donna O.; Greenhalgh, Trisha; Haughom, John; Lake, Eileen T.; Lilford, Richard; Lohr, Kathleen N.; Meyer, Gregg S.; Miller, Marlene R.; Neuhauser, Duncan V.; Ryan, Gery; Saint, Sanjay; Shojania, Kaveh G.; Shortell, Stephen M.; Stevens, David P.; Walshe, Kieran			Advancing the Science of Patient Safety	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EVIDENCE-BASED MEDICINE; PHYSICIAN ORDER ENTRY; QUALITY IMPROVEMENT; MEDICATION ERRORS; CARE; ACCOUNTABILITY; INTERVENTION; PUBLICATION	Despite a decade's worth of effort, patient safety has improved slowly, in part because of the limited evidence base for the development and widespread dissemination of successful patient safety practices. The Agency for Healthcare Research and Quality sponsored an international group of experts in patient safety and evaluation methods to develop criteria to improve the design, evaluation, and reporting of practice research in patient safety. This article reports the findings and recommendations of this group, which include greater use of theory and logic models, more detailed descriptions of interventions and their implementation, enhanced explanation of desired and unintended outcomes, and better description and measurement of context and of how context influences interventions. Using these criteria and measuring and reporting contexts will improve the science of patient safety.	RAND Hlth, Santa Monica, CA USA; RAND Hlth, Pittsburgh, PA USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Leeds, Leeds, W Yorkshire, England; Stanford Univ, Stanford, CA 94305 USA; Karolinska Inst, Stockholm, Sweden; Kaiser Permanente, Oakland, CA USA; Natl Qual Forum, Washington, DC USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Phys Org, Boston, MA USA; Vanderbilt Univ, Nashville, TN USA; Univ Wisconsin, Madison, WI USA; Dept Hlth, London SE1 6TE, England; UCL, London, England; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; PeaceHealth, Bellevue, WA USA; Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; Univ Birmingham, Birmingham, W Midlands, England; RTI Int, Res Triangle Pk, NC USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Michigan, Ann Arbor, MI 48109 USA; [Shojania, Kaveh G.] Univ Toronto, Toronto, ON, Canada; Univ Calif Berkeley, Berkeley, CA 94720 USA; Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; Univ Manchester, Manchester, Lancs, England	RAND Corporation; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Johns Hopkins University; University of California System; University of California San Francisco; University of Leeds; Stanford University; Karolinska Institutet; Kaiser Permanente; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; New York State Psychiatry Institute; University of Pennsylvania; University of Birmingham; Research Triangle Institute; Case Western Reserve University; University of Michigan System; University of Michigan; University of Toronto; University of California System; University of California Berkeley; Dartmouth College; University of Manchester	Shekelle, PG (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	shekelle@rand.org	Chang, Shulan/H-2270-2011; TAYLOR, STEPHANIE/GYV-4768-2022; Bates, David/AAE-7283-2019; Greenhalgh, Trisha/B-1825-2015; Saint, Sanjay/AAF-5126-2019	Greenhalgh, Trisha/0000-0003-2369-8088; Taylor, Stephanie/0000-0002-3266-1132; ovretveit, john/0000-0002-5177-6613; Duan, Naihua/0000-0001-9411-2924; Lohr, Kathleen/0000-0002-3825-0713; Lilford, Richard/0000-0002-0634-984X; Hempel, Susanne/0000-0003-1597-5110; Foy, Robbie/0000-0003-0605-7713; Walshe, Kieran/0000-0002-0696-480X; Bickman, Leonard/0000-0002-0746-3791	AHRQ [HHSA-290-2009-10001C]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By the AHRQ (contract HHSA-290-2009-10001C).	Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Davidoff F, 2008, ANN INTERN MED, V149, P670, DOI 10.7326/0003-4819-149-9-200811040-00009; Glasziou P, 2010, BMJ-BRIT MED J, V341, pc3852; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; Office of the Inspector General, 2010, ADVERSE EVENTS HOSP; Pronovost P, 2006, QUAL SAF HEALTH CARE, V15, P152, DOI 10.1136/qshc.2006.018432; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; Pronovost PJ, 2009, JAMA-J AM MED ASSOC, V302, P890, DOI 10.1001/jama.2009.1177; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, pc309; Shekelle PG, 2010, AHRQ PUBLICATION; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Shojania KG, 2002, JAMA-J AM MED ASSOC, V288, P508, DOI 10.1001/jama.288.4.508; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785	23	134	134	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2011	154	10					693	696		10.7326/0003-4819-154-10-201105170-00011	http://dx.doi.org/10.7326/0003-4819-154-10-201105170-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764HK	21576538				2022-12-01	WOS:000290620300019
J	Brady, CA; Jiang, D; Mello, SS; Johnson, TM; Jarvis, LA; Kozak, MM; Broz, DK; Basak, S; Park, EJ; McLaughlin, ME; Karnezis, AN; Attardi, LD				Brady, Colleen A.; Jiang, Dadi; Mello, Stephano S.; Johnson, Thomas M.; Jarvis, Lesley A.; Kozak, Margaret M.; Broz, Daniela Kenzelmann; Basak, Shashwati; Park, Eunice J.; McLaughlin, Margaret E.; Karnezis, Anthony N.; Attardi, Laura D.			Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression	CELL			English	Article							RADIATION-INDUCED APOPTOSIS; P53-DEPENDENT APOPTOSIS; DEFICIENT MUTANT; ONCOGENIC RAS; ONLY PROTEIN; ACTIVATION; DOMAIN; SENESCENCE; BINDING; TARGET	The molecular basis for p53-mediated tumor suppression remains unclear. Here, to elucidate mechanisms of p53 tumor suppression, we use knockin mice expressing an allelic series of p53 transcriptional activation mutants. Microarray analysis reveals that one mutant, p53(25,26), is severely compromised for transactivation of most p53 target genes, and, moreover, p53(25,26) cannot induce G(1)-arrest or apoptosis in response to acute DNA damage. Surprisingly, p(5325,26) retains robust activity in senescence and tumor suppression, indicating that efficient transactivation of the majority of known p53 targets is dispensable for these pathways. In contrast, the transactivation-dead p53(25,26,53,54) mutant cannot induce senescence or inhibit tumorigenesis, like p53 nullizygosity. Thus, p53 transactivation is essential for tumor suppression but, intriguingly, in association with a small set of novel p53 target genes. Together, our studies distinguish the p53 transcriptional programs involved in acute DNA-damage responses and tumor suppression-a critical goal for designing therapeutics that block p53-dependent side effects of chemotherapy without compromising p53 tumor suppression.	[Brady, Colleen A.; Jiang, Dadi; Mello, Stephano S.; Johnson, Thomas M.; Jarvis, Lesley A.; Kozak, Margaret M.; Broz, Daniela Kenzelmann; Basak, Shashwati; Park, Eunice J.; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Sch Med, Stanford, CA 94305 USA; [Attardi, Laura D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kozak, Margaret M.] MIT, Ctr Canc Res, Cambridge, MA 02142 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Canc Res Inst, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Dept Pathol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Attardi, LD (corresponding author), Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Sch Med, Stanford, CA 94305 USA.	attardi@stanford.edu	Mello, Stephano Spano/ABF-9477-2020	Kozak, Margaret/0000-0001-9111-1942; Mello, Stephano Spano/0000-0002-2484-086X	Smith Stanford Graduate Fellowship; Lucille P. Markey Biomedical Research Stanford Graduate Fellowship; National Science Foundation; Gerald Lieberman Dissertation Fellowship; C.A.P.E.S; Swiss National Science Foundation; American Cancer Society; Leukemia and Lymphoma Society; National Institutes of Health [CA140875]; NATIONAL CANCER INSTITUTE [R01CA140875, R21CA141087] Funding Source: NIH RePORTER	Smith Stanford Graduate Fellowship; Lucille P. Markey Biomedical Research Stanford Graduate Fellowship; National Science Foundation(National Science Foundation (NSF)); Gerald Lieberman Dissertation Fellowship; C.A.P.E.S(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Microarray analyses were performed using BRB-ArrayTools developed by Dr. Richard Simon and the BRB-ArrayTools Development Team. We thank T. Jacks for providing the Rosa26CreER<SUP>T2</SUP> mice, S. Lowe for the pWZL-HrasV12 plasmid and Pml antibody, S. Artandi for the 3xHA expression plasmid, and W. Hahn and A. Schinzel and the Dana Farber RNAi facility for the lentiviral shRNA constructs; D. Burkhart, A. Krieg, J. Sage, and L. Sayles for technical assistance; and S. Artandi, A. Brunet, A. Giaccia, and J. Sage for critical reading of the manuscript. This work was supported by a Smith Stanford Graduate Fellowship to C. A. B., a Lucille P. Markey Biomedical Research Stanford Graduate Fellowship to T. M. J., National Science Foundation Graduate Research Fellowships to C. A. B. and T. M. J., a Gerald Lieberman Dissertation Fellowship to C. A. B., a C.A.P.E.S Fellowship to S. S. M., a Swiss National Science Foundation Fellowship to D. K. B., and funding from the American Cancer Society, the Leukemia and Lymphoma Society, and the National Institutes of Health (CA140875) to LD.A.	Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; Bugni JM, 2009, ONCOGENE, V28, P734, DOI 10.1038/onc.2008.426; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Efeyan A, 2007, ONCOGENE, V26, P1645, DOI 10.1038/sj.onc.1209972; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Ferbeyre G, 2000, GENE DEV, V14, P2015; Gaidarenko O, 2009, ONCOGENE, V28, P4397, DOI 10.1038/onc.2009.290; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Kapushesky M, 2010, NUCLEIC ACIDS RES, V38, pD690, DOI 10.1093/nar/gkp936; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kennedy AL, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-16; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu J, 2008, NEUROPHARMACOLOGY, V54, P1, DOI 10.1016/j.neuropharm.2007.05.020; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lozano G, 2005, J PATHOL, V205, P206, DOI 10.1002/path.1704; Lu WJ, 2006, CELL DEATH DIFFER, V13, P909, DOI 10.1038/sj.cdd.4401922; Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131; MERRITT AJ, 1994, CANCER RES, V54, P614; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Ham M, 2003, GENES CELLS, V8, P631, DOI 10.1046/j.1365-2443.2003.00660.x; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	57	372	379	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2011	145	4					571	583		10.1016/j.cell.2011.03.035	http://dx.doi.org/10.1016/j.cell.2011.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565614	Green Accepted, Bronze			2022-12-01	WOS:000290560800010
J	Cirimotich, CM; Dong, YM; Clayton, AM; Sandiford, SL; Souza-Neto, JA; Mulenga, M; Dimopoulos, G				Cirimotich, Chris M.; Dong, Yuemei; Clayton, April M.; Sandiford, Simone L.; Souza-Neto, Jayme A.; Mulenga, Musapa; Dimopoulos, George			Natural Microbe-Mediated Refractoriness to Plasmodium Infection in Anopheles gambiae	SCIENCE			English	Article							MALARIA PARASITE INFECTION; GRAM-NEGATIVE BACTERIA; SPOROGONIC DEVELOPMENT; POPULATION-DYNAMICS; NITRIC-OXIDE; MOSQUITO; STEPHENSI; FALCIPARUM; RESISTANCE; IMMUNITY	Malaria parasite transmission depends on the successful transition of Plasmodium through discrete developmental stages in the lumen of the mosquito midgut. Like the human intestinal tract, the mosquito midgut contains a diverse microbial flora, which may compromise the ability of Plasmodium to establish infection. We have identified an Enterobacter bacterium isolated from wild mosquito populations in Zambia that renders the mosquito resistant to infection with the human malaria parasite Plasmodium falciparum by interfering with parasite development before invasion of the midgut epithelium. Phenotypic analyses showed that the anti-Plasmodium mechanism requires small populations of replicating bacteria and is mediated through a mosquito-independent interaction with the malaria parasite. We show that this anti-Plasmodium effect is largely caused by bacterial generation of reactive oxygen species.	[Cirimotich, Chris M.; Dong, Yuemei; Clayton, April M.; Sandiford, Simone L.; Souza-Neto, Jayme A.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Mulenga, Musapa] Malaria Inst Macha, Choma, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA.	gdimopou@jhsph.edu	Souza-Neto, Jayme A/E-7841-2010	Souza-Neto, Jayme A/0000-0001-9281-894X; Cirimotich, Chris/0000-0002-7636-0542; Dimopoulos, George/0000-0001-6755-8111; Dong, Yuemei/0000-0002-7902-2899	National Institutes of Health/National Institute of Allergy and Infectious Disease [R01AI061576]; Johns Hopkins Malaria Research Institute (JHMRI); Bloomberg Family Foundation; Calvin A. and Helen H. Lang fellowship; NSF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007417, R01AI061576] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins Malaria Research Institute (JHMRI); Bloomberg Family Foundation; Calvin A. and Helen H. Lang fellowship; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease R01AI061576 and a Johns Hopkins Malaria Research Institute (JHMRI) Pilot Grant (to G. D.), the Bloomberg Family Foundation, the Calvin A. and Helen H. Lang fellowship (to C. M. C.), a JHMRI postdoctoral fellowship (to J.S.-N.), and a fellowship from the NSF (to A. M. C.). The authors thank the mosquito collection team at the Malaria Institute at Macha, Zambia; the JHMRI Parasitology and Insectary Core facilities; Sanaria Inc.; E. Nelson (Cornell University) for providing mutant bacteria strains; and D. McClellan for editorial services. We performed all experiments according to Johns Hopkins Institutional Animal Care and Use Committee guidelines. Human landing catches were performed according to the approved protocol UNZA REC 011-02-04 with consent of participants. GenBank accession numbers generated for bacterial 16S rDNA sequences are listed in table S1, SOM.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; van Dijk K, 2000, APPL ENVIRON MICROB, V66, P5340, DOI 10.1128/AEM.66.12.5340-5347.2000; VAUGHAN JA, 1992, J PARASITOL, V78, P716, DOI 10.2307/3283550; VAUGHAN JA, 1994, AM J TROP MED HYG, V51, P233, DOI 10.4269/ajtmh.1994.51.233	23	386	400	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					855	858		10.1126/science.1201618	http://dx.doi.org/10.1126/science.1201618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566196	Green Accepted			2022-12-01	WOS:000290529900050
J	Barnes, K				Barnes, Katherine			EUROPE'S TICKING TIME BOMB	NATURE			English	News Item							VESUVIUS											Baxter PJ, 2008, J VOLCANOL GEOTH RES, V178, P454, DOI 10.1016/j.jvolgeores.2008.08.015; Mastrolorenzo G, 2006, P NATL ACAD SCI USA, V103, P4366, DOI 10.1073/pnas.0508697103; Mastrolorenzo G, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006871; Pappalardo L, 2010, EARTH PLANET SC LETT, V296, P133, DOI 10.1016/j.epsl.2010.05.010; Rolandi G, 2010, J VOLCANOL GEOTH RES, V189, P347, DOI 10.1016/j.jvolgeores.2009.08.007; Scaillet B, 2008, NATURE, V455, P216, DOI 10.1038/nature07232	6	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					140	141		10.1038/473140a	http://dx.doi.org/10.1038/473140a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562537	Bronze			2022-12-01	WOS:000290487200012
J	Ko, H; Hofer, SB; Pichler, B; Buchanan, KA; Sjostrom, PJ; Mrsic-Flogel, TD				Ko, Ho; Hofer, Sonja B.; Pichler, Bruno; Buchanan, Katherine A.; Sjoestroem, P. Jesper; Mrsic-Flogel, Thomas D.			Functional specificity of local synaptic connections in neocortical networks	NATURE			English	Article							PRIMARY VISUAL-CORTEX; IN-VIVO; HORIZONTAL CONNECTIONS; INTRACORTICAL CIRCUITS; NEURONAL NETWORKS; CORTICAL NETWORKS; STRIATE CORTEX; SIMPLE CELLS; CAT; INHIBITION	Neuronal connectivity is fundamental to information processing in the brain. Therefore, understanding the mechanisms of sensory processing requires uncovering how connection patterns between neurons relate to their function. On a coarse scale, long-range projections can preferentially link cortical regions with similar responses to sensory stimuli(1-4). But on the local scale, where dendrites and axons overlap substantially, the functional specificity of connections remains unknown. Here we determine synaptic connectivity between nearby layer 2/3 pyramidal neurons in vitro, the response properties of which were first characterized in mouse visual cortex in vivo. We found that connection probability was related to the similarity of visually driven neuronal activity. Neurons with the same preference for oriented stimuli connected at twice the rate of neurons with orthogonal orientation preferences. Neurons responding similarly to naturalistic stimuli formed connections at much higher rates than those with uncorrelated responses. Bidirectional synaptic connections were found more frequently between neuronal pairs with strongly correlated visual responses. Our results reveal the degree of functional specificity of local synaptic connections in the visual cortex, and point to the existence of fine-scale subnetworks dedicated to processing related sensory information.	[Ko, Ho; Hofer, Sonja B.; Pichler, Bruno; Buchanan, Katherine A.; Sjoestroem, P. Jesper; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England	University of London; University College London	Mrsic-Flogel, TD (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, 21 Univ St, London WC1E 6DE, England.	t.mrsic-flogel@ucl.ac.uk	Sjöström, Per Jesper/B-9696-2019; Ko, Ho/AAH-2755-2020; Ko, Ho/I-7513-2016	Sjöström, Per Jesper/0000-0001-7085-2223; Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274; Mrsic-Flogel, Tom/0000-0002-8947-408X; Hofer, Sonja/0000-0003-4921-8521	Wellcome Trust; European Research Council; European Molecular Biology Organisation; Medical Research Council [243914]; Overseas Research Students Award; UCL; Medical Research Council [G0700188] Funding Source: researchfish; MRC [G0700188] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organisation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Overseas Research Students Award; UCL; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Margrie for discussions about the project and the manuscript, and J. Vogelstein for the spike inference algorithm. This work was supported by the Wellcome Trust (T.D.M.-F.), the European Research Council (T.D.M.-F.), the European Molecular Biology Organisation (S.B.H.), the Medical Research Council and FP7 grant #243914 (K.A.B., P.J.S.), the Overseas Research Students Award Scheme and UCL studentship (H.K.).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Agresti, 2011, CATEGORICAL DATA ANA; Alitto HJ, 2010, CURR OPIN NEUROBIOL, V20, P340, DOI 10.1016/j.conb.2010.02.012; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Roerig B, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0002.1999; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thomson AM, 2002, PHILOS T R SOC B, V357, P1781, DOI 10.1098/rstb.2002.1163; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VOGELSTEIN JT, 2010, J NEUROPHYSIOL; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	38	501	504	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					87	U100		10.1038/nature09880	http://dx.doi.org/10.1038/nature09880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21478872	Green Accepted			2022-12-01	WOS:000290218300036
J	Yamada, K; Frouws, TD; Angst, B; Fitzgerald, DJ; DeLuca, C; Schimmele, K; Sargent, DF; Richmond, TJ				Yamada, Kazuhiro; Frouws, Timothy D.; Angst, Brigitte; Fitzgerald, Daniel J.; DeLuca, Carl; Schimmele, Kyoko; Sargent, David F.; Richmond, Timothy J.			Structure and mechanism of the chromatin remodelling factor ISW1a	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; HIGH-RESOLUTION; CRYSTAL-STRUCTURE; DNA COMPLEX; ORGANIZATION; EXPRESSION; POSITION; PROTEIN; DOMAIN; VISUALIZATION	Site-specific recognition of DNA in eukaryotic organisms depends on the arrangement of nucleosomes in chromatin. In the yeast Saccharomyces cerevisiae, ISW1a and related chromatin remodelling factors are implicated in establishing the nucleosome repeat during replication and altering nucleosome position to affect gene activity. Here we have solved the crystal structures of S. cerevisiae ISW1a lacking its ATPase domain both alone and with DNA bound at resolutions of 3.25 angstrom and 3.60 angstrom, respectively, and we have visualized two different nucleosome-containing remodelling complexes using cryo-electron microscopy. The composite X-ray and electron microscopy structures combined with site-directed photocrosslinking analyses of these complexes suggest that ISW1a uses a dinucleosome substrate for chromatin remodelling. Results from a remodelling assay corroborate the dinucleosome model. We show how a chromatin remodelling factor could set the spacing between two adjacent nucleosomes acting as a 'protein ruler'.	[Yamada, Kazuhiro; Frouws, Timothy D.; Angst, Brigitte; Fitzgerald, Daniel J.; DeLuca, Carl; Schimmele, Kyoko; Sargent, David F.; Richmond, Timothy J.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Richmond, TJ (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	richmond@mol.biol.ethz.ch						Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; BIENIOSSEK C, 2008, CURR PROT PROTEIN SC; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Cuperus G, 2002, GENETICS, V162, P633; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horton JR, 2007, PROTEINS, V67, P1198, DOI 10.1002/prot.21352; Hu DL, 2000, J BIOL CHEM, V275, P2705, DOI 10.1074/jbc.275.4.2705; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinskaya M, 2009, MOL CELL BIOL, V29, P2419, DOI 10.1128/MCB.01050-08; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Unser M, 2005, J STRUCT BIOL, V149, P243, DOI 10.1016/j.jsb.2004.10.011; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175	55	126	128	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					448	U536		10.1038/nature09947	http://dx.doi.org/10.1038/nature09947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525927				2022-12-01	WOS:000289949600029
J	Zhang, JM; Wang, Y; Chi, ZK; Keuss, MJ; Pai, YME; Kang, HC; Shin, JH; Bugayenko, A; Wang, H; Xiong, YL; Pletnikov, MV; Mattson, MP; Dawson, TM; Dawson, VL				Zhang, Jianmin; Wang, Yue; Chi, Zhikai; Keuss, Matthew J.; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Wang, Hong; Xiong, Yulan; Pletnikov, Mikhail V.; Mattson, Mark P.; Dawson, Ted M.; Dawson, Valina L.			The AAA(+) ATPase Thorase Regulates AMPA Receptor-Dependent Synaptic Plasticity and Behavior	CELL			English	Article							TRANSGENIC MICE; GLUR2; SYNAPSES; MEMORY; NMDA; TRAFFICKING; SUBUNIT; COMPLEX; BINDING; PROTEIN	The synaptic insertion or removal of AMPA receptors (AMPAR) plays critical roles in the regulation of synaptic activity reflected in the expression of long-term potentiation (LTP) and long-term depression (LTD). The cellular events underlying this important process in learning and memory are still being revealed. Here we describe and characterize the AAA(+) ATPase Thorase, which regulates the expression of surface AMPAR. In an ATPase-dependent manner Thorase mediates the internalization of AMPAR by disassembling the AMPAR-GRIP1 complex. Following genetic deletion of Thorase, the internalization of AMPAR is substantially reduced, leading to increased amplitudes of miniature excitatory postsynaptic currents, enhancement of LTP, and elimination of LTD. These molecular events are expressed as deficits in learning and memory in Thorase null mice. This study identifies an AAA(+) ATPase that plays a critical role in regulating the surface expression of AMPAR and thereby regulates synaptic plasticity and learning and memory.	[Zhang, Jianmin; Keuss, Matthew J.; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA; [Zhang, Jianmin; Chi, Zhikai; Pai, Ying-Min Emily; Kang, Ho Chul; Shin, Joo-Ho; Bugayenko, Artem; Xiong, Yulan; Pletnikov, Mikhail V.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Chi, Zhikai; Wang, Hong; Mattson, Mark P.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Pletnikov, Mikhail V.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Keuss, Matthew J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21205 USA; [Wang, Yue; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Mattson, Mark P/F-6038-2012; Shin, Joo-Ho/P-1417-2018; Pletnikov, Mikhail V/G-8709-2012	Pletnikov, Mikhail V/0000-0002-8819-6559; Dawson, Valina/0000-0002-2915-3970	National Institute on Aging, USPHS [AG029368, DA00266]; Simon's Foundation Autism Research Initiative; McKnight Endowment for the Neuroscience; American Heart Association [0725470U]; NATIONAL INSTITUTE ON AGING [ZIAAG000317, ZIAAG000312, R01AG029368, ZIAAG000330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	National Institute on Aging, USPHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)United States Public Health Service); Simon's Foundation Autism Research Initiative; McKnight Endowment for the Neuroscience; American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We apologize that, due to space limitations, we were not able to cite all the primary papers on AMPAR trafficking, LTD, and LTP. We thank all of our colleagues who generously contributed reagents as noted in the Supplemental Information and Dr. Richard Huganir for the generous gift of monoclonal anti-GluR1 N-terminal antibody. Research was supported by the Intramural Research Program of the National Institute on Aging, USPHS grants AG029368 and DA00266, the Simon's Foundation Autism Research Initiative, McKnight Endowment for the Neuroscience, and an American Heart Association Postdoctoral Fellowship to J.Z. (0725470U). We thank the Comparative Medicine Section of NIA for technical support. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases.	Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Singer HS, 2009, J NEUROIMMUNOL, V211, P39, DOI 10.1016/j.jneuroim.2009.03.011; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x	32	68	75	3	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					284	299		10.1016/j.cell.2011.03.016	http://dx.doi.org/10.1016/j.cell.2011.03.016			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496646	Green Accepted, Bronze			2022-12-01	WOS:000289549900016
J	Eiraku, M; Takata, N; Ishibashi, H; Kawada, M; Sakakura, E; Okuda, S; Sekiguchi, K; Adachi, T; Sasai, Y				Eiraku, Mototsugu; Takata, Nozomu; Ishibashi, Hiroki; Kawada, Masako; Sakakura, Eriko; Okuda, Satoru; Sekiguchi, Kiyotoshi; Adachi, Taiji; Sasai, Yoshiki			Self-organizing optic-cup morphogenesis in three-dimensional culture	NATURE			English	Article							RETINAL-PIGMENT EPITHELIUM; EMBRYONIC STEM-CELLS; EYE DEVELOPMENT; APICAL CONSTRICTION; MOUSE EMBRYOS; NEURAL PLATE; SHAPE CHANGE; VESICLE; DIFFERENTIATION; RHO	Balanced organogenesis requires the orchestration of multiple cellular interactions to create the collective cell behaviours that progressively shape developing tissues. It is currently unclear how individual, localized parts are able to coordinate with each other to develop a whole organ shape. Here we report the dynamic, autonomous formation of the optic cup (retinal primordium) structure from a three-dimensional culture of mouse embryonic stem cell aggregates. Embryonic-stem-cell-derived retinal epithelium spontaneously formed hemispherical epithelial vesicles that became patterned along their proximal-distal axis. Whereas the proximal portion differentiated into mechanically rigid pigment epithelium, the flexible distal portion progressively folded inward to form a shape reminiscent of the embryonic optic cup, exhibited interkinetic nuclear migration and generated stratified neural retinal tissue, as seen in vivo. We demonstrate that optic-cup morphogenesis in this simple cell culture depends on an intrinsic self-organizing program involving stepwise and domain-specific regulation of local epithelial properties.	[Eiraku, Mototsugu; Takata, Nozomu; Kawada, Masako; Sakakura, Eriko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Eiraku, Mototsugu; Sakakura, Eriko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Dimens Tissue Anal Unit 4, Kobe, Hyogo 6500047, Japan; [Ishibashi, Hiroki; Okuda, Satoru; Adachi, Taiji] Kyoto Univ, Inst Frontier Med Sci, Dept Biomech, Kyoto 6068507, Japan; [Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Adachi, Taiji] RIKEN, VCAD Syst Res Program, Computat Cell Biomech Team, Wako, Saitama 3510198, Japan	RIKEN; RIKEN; Kyoto University; Osaka University; RIKEN	Eiraku, M (corresponding author), RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	eiraku@cdb.riken.jp; yoshikisasai@cdb.riken.jp	Takata, Nozomu/AAI-9801-2020; Adachi, Taiji/P-8981-2016	Adachi, Taiji/0000-0001-5280-4156; Takata, Nozomu/0000-0003-0171-6994; Eiraku, Mototsugu/0000-0002-9433-9085	MEXT; Knowledge Cluster Initiative at Kobe; S-Innovation Project; Leading Project for Realization of Regenerative Medicine	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative at Kobe; S-Innovation Project; Leading Project for Realization of Regenerative Medicine	We are grateful to S. Nakanishi, S. Yonemura, R. Ladher, K. Muguruma, H. Inomata and M. Ohgushi for comments and to members of the Sasai laboratory for discussion. We also thank Olympus, particularly Y. Saito, M. Suzuki and Y. Imai, for their help and discussion regarding the design, assembly and optimized utility of the incubator-combined multi-photon and confocal optic systems, and T. Sugitate and N. Saito at JPK Instruments for technical advice on the AFM assay. This work was supported by grants-in-aid from MEXT (Y.S., M.E., T.A.), the Knowledge Cluster Initiative at Kobe and the S-Innovation Project (Y.S., K.S.), and the Leading Project for Realization of Regenerative Medicine (Y.S).	Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Agius E, 2004, DEV BIOL, V270, P308, DOI 10.1016/j.ydbio.2004.02.015; Allegra Mascaro AL, 2010, FRONT NEUROENERGETIC, P2; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Au E, 2008, CELL STEM CELL, V3, P472, DOI 10.1016/j.stem.2008.10.013; Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Fujiwara H, 2007, J BIOL CHEM, V282, P29701, DOI 10.1074/jbc.M611452200; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; HILFER SR, 1980, ANAT REC, V197, P423; Honda H, 2004, J THEOR BIOL, V226, P439, DOI 10.1016/j.jtbi.2003.10.001; Hyer J, 2003, DEV BIOL, V259, P351, DOI 10.1016/S0012-1606(03)00205-7; Hyer J, 1998, DEVELOPMENT, V125, P869; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Inoue Y, 2011, BIOMECH MODEL MECHAN, V10, P495, DOI 10.1007/s10237-010-0250-6; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lagutin O, 2001, DEV DYNAM, V221, P342, DOI 10.1002/dvdy.1148; Lewis WH, 1904, AM J ANAT, V3, P505, DOI 10.1002/aja.1000030405; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lopashov GV, 1963, DEV MECH VERTEBRATE; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nagai T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061903; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Picker A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000214; Pinzon-Duarte G, 2000, VISION RES, V40, P3455, DOI 10.1016/S0042-6989(00)00185-1; Martinez-Morales JR, 2009, CURR OPIN GENET DEV, V19, P511, DOI 10.1016/j.gde.2009.08.003; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; Seiler MJ, 2010, EUR J NEUROSCI, V31, P508, DOI 10.1111/j.1460-9568.2010.07085.x; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Spemann H, 1901, VERH ANAT GESELLSCH, V15, P61; Stella SL, 2008, BRAIN RES, V1215, P20, DOI 10.1016/j.brainres.2008.03.038; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004	53	1237	1303	6	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					51	U73		10.1038/nature09941	http://dx.doi.org/10.1038/nature09941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475194				2022-12-01	WOS:000289199400035
J	Duke, T				Duke, Trevor			What the African fluid-bolus trial means	LANCET			English	Editorial Material							SEPTIC SHOCK; MENINGITIS; SECRETION; PNEUMONIA; CHILDREN; HORMONE		[Duke, Trevor] Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic 3079, Australia; [Duke, Trevor] Royal Childrens Hosp, Intens Care Unit, Melbourne, Vic 3079, Australia; [Duke, Trevor] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Papua New Guinea	Duke, T (corresponding author), Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic 3079, Australia.	trevor.duke@rch.org.au						CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; DHAWAN A, 1992, ANN TROP PAEDIATR, V12, P455, DOI 10.1080/02724936.1992.11747614; DIXON BS, 1988, AM REV RESPIR DIS, V138, P512, DOI 10.1164/ajrccm/138.3.512; Duke T, 2002, ANN TROP PAEDIATR, V22, P145, DOI 10.1179/027249302125000878; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; JALAC SLR, 2010, PHILIPPINE J MICROBI, V39, P14; KAPLAN SL, 1978, J PEDIATR-US, V92, P758, DOI 10.1016/S0022-3476(78)80144-9; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Tibballs J, 2009, RESUSCITATION, V80, P61, DOI 10.1016/j.resuscitation.2008.10.002; World Health Organization, 2005, HOSP CAR CHILDR GUID; [No title captured]	12	30	30	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 12	2011	378	9804					1685	1687		10.1016/S0140-6736(11)60881-7	http://dx.doi.org/10.1016/S0140-6736(11)60881-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846LB	21683436				2022-12-01	WOS:000296899800011
J	Connell, KA				Connell, Kathleen A.			Elastogenesis in the Vaginal Wall and Pelvic-Organ Prolapse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Urogynecol & Reconstruct Pelv Surg, New Haven, CT 06520 USA	Yale University	Connell, KA (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Urogynecol & Reconstruct Pelv Surg, New Haven, CT 06520 USA.							Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Subak LL, 2001, OBSTET GYNECOL, V98, P646, DOI 10.1016/S0029-7844(01)01472-7; Takacs P, 2009, INT UROGYNECOL J, V20, P207, DOI 10.1007/s00192-008-0757-x; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3	5	13	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2356	2358		10.1056/NEJMcibr1104976	http://dx.doi.org/10.1056/NEJMcibr1104976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675895				2022-12-01	WOS:000291643800016
J	Pierce, M; Kurinczuk, JJ; Spark, P; Brocklehurst, P; Knight, M				Pierce, Matthias; Kurinczuk, Jennifer J.; Spark, Patsy; Brocklehurst, Peter; Knight, Marian		UKOSS	Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							2009 H1N1 INFLUENZA; PREGNANT-WOMEN; HOSPITALIZATIONS; STILLBIRTH; INTERVAL; ILLNESS; RISK	Objectives To follow up a UK national cohort of women admitted to hospital with confirmed 2009/H1N1 influenza in pregnancy in order to obtain a complete picture of pregnancy outcomes and estimate the risks of adverse fetal and infant outcomes. Design National cohort study. Setting 221 hospitals with obstetrician led maternity units in the UK. Participants 256 women admitted to hospital with confirmed 2009/H1N1 in pregnancy during the second wave of pandemic infection between September 2009 and January 2010; 1220 pregnant women for comparison. Main outcome measures Rates of stillbirth, perinatal mortality, and neonatal mortality; odds ratios for infected versus comparison women. Results Perinatal mortality was higher in infants born to infected women (10 deaths among 256 infants; rate 39 (95% confidence interval 19 to 71) per 1000 total births) than in infants of uninfected women (9 deaths among 1233 infants; rate 7 (3 to 13) per 1000 total births) (P<0.001). This was principally explained by an increase in the rate of stillbirth (27 per 1000 total births v 6 per 1000 total births; P=0.001). Infants of infected women were also more likely to be born prematurely than were infants of comparison women (adjusted odds ratio 4.0, 95% confidence interval 2.7 to 5.9). Infected women who delivered preterm were more likely to be infected in their third trimester (P=0.046), to have been admitted to an intensive care unit (P<0.001), and to have a secondary pneumonia (P=0.001) than were those who delivered at term. Conclusions This study suggests an increase in the risk of poor outcomes of pregnancy in women infected with 2009/H1N1, which reinforces the message from studies of maternal risk alone. The health of pregnant women is an important public health priority in future waves of this and other influenza pandemics.	[Pierce, Matthias; Kurinczuk, Jennifer J.; Spark, Patsy; Brocklehurst, Peter; Knight, Marian; UKOSS] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford	Knight, M (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	marian.knight@npeu.ox.ac.uk	Pierce, Matthias/D-8561-2011; Knight, Marian/B-6225-2009	Pierce, Matthias/0000-0003-2182-0369; Knight, Marian/0000-0002-1984-4575	National Institute for Health Research [09/84/47]; NIHR National Coordinating Centre for Research Capacity Development	National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR National Coordinating Centre for Research Capacity Development	The research presented here was funded by a grant from the National Institute for Health Research Health Technology Assessment Programme, grant reference 09/84/47. MK was funded by a personal award from the NIHR National Coordinating Centre for Research Capacity Development. All researchers are independent of the funders.	Australian and New Zealand Intensive Care Influenza Investigators, 2010, BRIT MED J, V340, pc1279; Centre for Maternal and Child Enquiries, 2010, PER MORT 2008 UK; Centre for Maternal and Child Enquiries (CMACE), 2010, PER MORT 2008 UK; COFFEY VP, 1959, LANCET, V2, P935; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Department of Health, 2010, CLIN MAN GUID PREGN; DOLL R, 1960, Br J Prev Soc Med, V14, P167; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Edwards MJ, 2006, BIRTH DEFECTS RES A, V76, P507, DOI 10.1002/bdra.20277; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; GRIFFITH GW, 1972, BMJ-BRIT MED J, V3, P553, DOI 10.1136/bmj.3.5826.553; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Information Services Division Scotland, 2010, BIRTHS SCOTT HOSP; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; Knight M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b542; Laibl VR, 2005, CLIN PERINATOL, V32, P727, DOI 10.1016/j.clp.2005.04.009; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; NHS Information Centre, 2010, HOSP EP STAT MAT DAT; Nishiura H, 2009, EUR J OBSTET GYN R B, V147, P115, DOI 10.1016/j.ejogrb.2009.07.009; Office for National Statistics, 2008, STAT REV NOT CONG AN; Office for National Statistics, 2010, BIRTH STAT 2008 SER, V37; Rogers VL, 2010, OBSTET GYNECOL, V115, P924, DOI 10.1097/AOG.0b013e3181da0c5e; Royal College of Obstetricians and Gynaecologists, UPD INFL H1N1 2009 P; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Stanwell-Smith R, 1994, Commun Dis Rep CDR Rev, V4, pR28; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121	35	177	180	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3214	10.1136/bmj.d3214	http://dx.doi.org/10.1136/bmj.d3214			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781KY	21672992	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000291932100002
J	Johnston, RJ; Otake, Y; Sood, P; Vogt, N; Behnia, R; Vasiliauskas, D; McDonald, E; Xie, BT; Koenig, S; Wolf, R; Cook, T; Gebelein, B; Kussell, E; Nakagoshi, H; Desplan, C				Johnston, Robert J., Jr.; Otake, Yoshiaki; Sood, Pranidhi; Vogt, Nina; Behnia, Rudy; Vasiliauskas, Daniel; McDonald, Elizabeth; Xie, Baotong; Koenig, Sebastian; Wolf, Reinhard; Cook, Tiffany; Gebelein, Brian; Kussell, Edo; Nakagoshi, Hideki; Desplan, Claude			Interlocked Feedforward Loops Control Cell-Type-Specific Rhodopsin Expression in the Drosophila Eye	CELL			English	Article							DEFECTIVE-PROVENTRICULUS; PHOTORECEPTOR CELLS; FATE SPECIFICATION; MOLECULAR SWITCH; ORTHODENTICLE; MORPHOGENESIS; PREFERENCE; OMMATIDIA; BEHAVIOR; SUBTYPES	How complex networks of activators and repressors lead to exquisitely specific cell-type determination during development is poorly understood. In the Drosophila eye, expression patterns of Rhodopsins define at least eight functionally distinct though related subtypes of photoreceptors. Here, we describe a role for the transcription factor gene defective proventriculus (dve) as a critical node in the network regulating Rhodopsin expression. dve is a shared component of two opposing, interlocked feedforward loops (FFLs). Orthodenticle and Dve interact in an incoherent FFL to repress Rhodopsin expression throughout the eye. In R7 and R8 photoreceptors, a coherent FFL relieves repression by Dve while activating Rhodopsin expression. Therefore, this network uses repression to restrict and combinatorial activation to induce cell-type-specific expression. Furthermore, Dve levels are finely tuned to yield cell-type-and region-specific repression or activation outcomes. This interlocked FFL motif may be a general mechanism to control terminal cell-fate specification.	[Otake, Yoshiaki; Nakagoshi, Hideki] Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan; [Johnston, Robert J., Jr.; Sood, Pranidhi; Vogt, Nina; Behnia, Rudy; Vasiliauskas, Daniel; Kussell, Edo; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [McDonald, Elizabeth; Xie, Baotong; Cook, Tiffany; Gebelein, Brian] Cincinnati Childrens Hosp, Div Dev Biol, Cincinnati, OH 45229 USA; [Koenig, Sebastian; Wolf, Reinhard] Univ Wurzburg, Rudolf Virchow Zentrum, Deutsch Forschungsgemeinschaft Res Ctr Expt Biome, D-97080 Wurzburg, Germany	Okayama University; New York University; Cincinnati Children's Hospital Medical Center; University of Wurzburg	Nakagoshi, H (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	goshi@cc.okayama-u.ac.jp; cd38@nyu.edu	NAKAGOSHI, Hideki/B-2145-2011; Vasiliauskas, Daniel/AAV-1981-2020	NAKAGOSHI, Hideki/0000-0003-0850-1814; Vasiliauskas, Daniel/0000-0002-0570-2322; Desplan, Claude/0000-0002-6914-1413; Cook, Tiffany/0000-0002-3100-5248; Vogt, Nina/0000-0002-2658-9138	Deutsche Forschungsgemeinschaft; European Molecular Biology Organization; Human Frontier Science Program; NIH [5F32EY016309-03, T32 HD046387, GM079428]; University of Cincinnati Research Council; Research to Prevent Blindness; Ziegler Foundation for the Blind; Burroughs Wellcome Fund Career Award at the Scientific Interface; National Eye Institute/NIH [R01 13010]; NCRR, NIH; Grants-in-Aid for Scientific Research [23570006] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046387] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY016309, R01EY013010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079428] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Research Council; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ziegler Foundation for the Blind; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); National Eye Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to S. Britt, Y.N. Jan, C. Zuker, and the Bloomington Stock Center for reagents. We thank U. Alon, R. Carthew, O. Hobert, H. Johnston, P. O'Farrell, F. Payre, and E. Siggia for helpful comments on the manuscript. We thank all members of the Desplan laboratory for suggestions throughout the project. R.J.J. was supported by a Jane Coffin Childs Memorial Fund for Medical Research postdoctoral fellowship. N.V. was supported by Deutsche Forschungsgemeinschaft. R.B. was supported by the European Molecular Biology Organization and Human Frontier Science Program. D.V. was supported by NIH Grant 5F32EY016309-03. B.X. was supported by the University of Cincinnati Research Council. T.C. was supported by NIH Grant T32 HD046387 (ECM), Research to Prevent Blindness, and the Ziegler Foundation for the Blind. B.G. was supported by an NIH grant (GM079428). E.K. was supported by a Burroughs Wellcome Fund Career Award at the Scientific Interface. This work was funded by a grant from the National Eye Institute/NIH R01 13010 to C.D. and conducted in a facility constructed with the support of a Research Facilities Improvement Grant from the NCRR, NIH.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; Carr M, 2005, DEV GENES EVOL, V215, P402, DOI 10.1007/s00427-005-0488-7; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Hu XB, 2009, J COMP NEUROL, V516, P334, DOI 10.1002/cne.22114; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kim D, 2008, BIOESSAYS, V30, P1204, DOI 10.1002/bies.20839; Li-Kroeger D, 2008, DEV CELL, V15, P298, DOI 10.1016/j.devcel.2008.06.001; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Nakagoshi H, 2002, DEV BIOL, V249, P44, DOI 10.1006/dbio.2002.0746; Nakagoshi H, 1998, GENE DEV, V12, P2724, DOI 10.1101/gad.12.17.2724; ROSSEL S, 1982, P NATL ACAD SCI-BIOL, V79, P4451, DOI 10.1073/pnas.79.14.4451; Shirai T, 2007, DEV BIOL, V312, P147, DOI 10.1016/j.ydbio.2007.09.003; Stowers RS, 1999, GENETICS, V152, P1631; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Terriente J, 2008, DEV BIOL, V320, P102, DOI 10.1016/j.ydbio.2008.04.028; TREISMAN J, 1989, CELL, V59, P553; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wolff Tanya, 1993, P1277; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; Zelhof AC, 2003, DEVELOPMENT, V130, P4383, DOI 10.1242/dev.00651	38	51	51	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					956	968		10.1016/j.cell.2011.05.003	http://dx.doi.org/10.1016/j.cell.2011.05.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663797	Bronze, Green Accepted			2022-12-01	WOS:000291461600021
J	Cluver, L				Cluver, Lucie			Children of the AIDS pandemic	NATURE			English	Editorial Material							DISTRESS; ORPHANS; AFRICA		Univ Oxford, Dept Social Policy & Intervent, Oxford OX1 2ER, England	University of Oxford	Cluver, L (corresponding author), Univ Oxford, Dept Social Policy & Intervent, Oxford OX1 2ER, England.	lucie.cluver@spi.ox.ac.uk		Cluver, Lucie/0000-0002-0418-835X	Economic and Social Research Council [ES/H001743/1] Funding Source: researchfish; ESRC [ES/H001743/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Cluver L, 2007, AIDS CARE, V19, P318, DOI 10.1080/09540120600986578; CLUVER L, 2011, 5 S AFR AIDS C DURB; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Kumakech E, 2009, SOC SCI MED, V68, P1038, DOI 10.1016/j.socscimed.2008.10.033; Nyamukapa CA, 2008, AM J PUBLIC HEALTH, V98, P133, DOI 10.2105/AJPH.2007.116038; RICHTER L, 2006, HEART IS; Zivin JG, 2009, J PUBLIC ECON, V93, P1008, DOI 10.1016/j.jpubeco.2009.03.003	10	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					27	29		10.1038/474027a	http://dx.doi.org/10.1038/474027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637236	Bronze			2022-12-01	WOS:000291156700018
J	Finks, JF; Osborne, NH; Birkmeyer, JD				Finks, Jonathan F.; Osborne, Nicholas H.; Birkmeyer, John D.			Trends in Hospital Volume and Operative Mortality for High-Risk Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL TRENDS; CARDIAC-SURGERY; CANCER-SURGERY; LUNG-CANCER; HEALTH-CARE; REGIONALIZATION; CENTERS; CALIFORNIA; RESECTION; OUTCOMES	Background There were numerous efforts in the United States during the previous decade to concentrate selected surgical procedures in high-volume hospitals. It remains unknown whether referral patterns for high-risk surgery have changed as a result and how operative mortality has been affected. Methods We used national Medicare data to study patients undergoing one of eight different cancer and cardiovascular operations from 1999 through 2008. For each procedure, we examined trends in hospital volume and market concentration, defined as the proportion of Medicare patients undergoing surgery in the top decile of hospitals by volume per year. We used regression-based techniques to assess the effects of volume and market concentration on mortality over time, adjusting for case mix. Results Median hospital volumes of four cancer resections (lung, esophagus, pancreas, and bladder) and of repair of abdominal aortic aneurysm (AAA) rose substantially. Depending on the procedure, higher hospital volumes were attributable to an increasing number of cases nationwide, an increasing market concentration, or both. Hospital volumes rose slightly for aortic-valve replacement but fell for coronary-artery bypass grafting and carotid endarterectomy. Operative mortality declined for all eight procedures, ranging from a relative decline of 8% for carotid endarterectomy (1.3% mortality in 1999 and 1.2% in 2008) to 36% for AAA repair (4.4% in 1999 and 2.8% in 2008). Higher hospital volumes explained a large portion of the decline in mortality for pancreatectomy (67% of the decline), cystectomy (37%), and esophagectomy (32%), but not for the other procedures. Conclusions Operative mortality with high-risk surgery fell substantially during the previous decade. Although increased market concentration and hospital volume have contributed to declining mortality with some high-risk cancer operations, declines in mortality with other procedures are largely attributable to other factors. (Funded by the National Institute on Aging.)	Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Surg, Sect Gen Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Finks, JF (corresponding author), 2210F Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jfinks@umich.edu			National Institute on Aging [P01AG019783-07S1]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant (P01AG019783-07S1) from the National Institute on Aging.	Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Chappel AR, 2006, J AM COLL SURGEONS, V203, P599, DOI 10.1016/j.jamcollsurg.2006.07.009; Cheung MC, 2009, ANN SURG ONCOL, V16, P3, DOI 10.1245/s10434-008-0025-9; *COMM QUAL HLTH CA, 2000, INT VOL OUTC REL CON; DIMICK JB, 2004, HLTH AFF MILLWOOD S, pVAR45; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FAIRLIE RW, 2003, 873 YAL U EC GROWTH; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Finlayson E V, 2001, Eff Clin Pract, V4, P172; FINLAYSON EVA, 2001, EFF CLIN PRACT, V4, P235; Finlayson SRG, 1999, MED CARE, V37, P204, DOI 10.1097/00005650-199902000-00010; Gasper WJ, 2009, ANN SURG, V250, P472, DOI 10.1097/SLA.0b013e3181b47c79; Giles KA, 2009, J VASC SURG, V49, P543, DOI 10.1016/j.jvs.2008.09.067; Goodney PP, 2002, J AM COLL SURGEONS, V195, P219, DOI 10.1016/S1072-7515(02)01228-0; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Hill JS, 2008, J VASC SURG, V48, P29, DOI 10.1016/j.jvs.2008.02.048; Ho V, 2006, ANN SURG ONCOL, V13, P851, DOI 10.1245/ASO.2006.07.021; Hollenbeck BK, 2005, J UROLOGY, V174, P1385, DOI 10.1097/01.ju.0000173632.58991.a7; Holmes JS, 2007, HEALTH AFFAIR, V26, P169, DOI 10.1377/hlthaff.26.1.169; Kirby JB, 2006, MED CARE, V44, P64; Kohn KT, 1999, ERR IS HUMAN BUILDIN; *LEAPFR GROUP, EV BAS HOSP REF; Matsen SL, 2006, J VASC SURG, V44, P488, DOI 10.1016/j.jvs.2006.05.017; Milstein A, 2000, Eff Clin Pract, V3, P313; MILSTEIN A, 2001, EFF CLIN PRACT, V4, P94; Oaxaca R., 1973, INT EC REV PHILADELP, V14, P693, DOI DOI 10.2307/2525981; OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841; Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Rowe JW, 2007, ANN INTERN MED, V146, P151, DOI 10.7326/0003-4819-146-11-200706050-00022; Rowe JW, 2006, ANN INTERN MED, V145, P695, DOI 10.7326/0003-4819-145-9-200611070-00013; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Steinbrook R, 2006, NEW ENGL J MED, V355, P1847, DOI 10.1056/NEJMp068222; Ward MM, 2004, J RURAL HEALTH, V20, P344, DOI 10.1111/j.1748-0361.2004.tb00048.x	37	950	969	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2128	2137		10.1056/NEJMsa1010705	http://dx.doi.org/10.1056/NEJMsa1010705			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21631325	Green Accepted			2022-12-01	WOS:000291200700011
J	Zhao, YF; Terry, DS; Shi, L; Quick, M; Weinstein, H; Blanchard, SC; Javitch, JA				Zhao, Yongfang; Terry, Daniel S.; Shi, Lei; Quick, Matthias; Weinstein, Harel; Blanchard, Scott C.; Javitch, Jonathan A.			Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue	NATURE			English	Article							BACTERIAL HOMOLOG; DOPAMINE TRANSPORTER; MOLECULAR-MECHANISM; SODIUM SYMPORTER; BINDING-SITE; LEUT; ION; CONFORMATION; STATE; IDENTIFICATION	Neurotransmitter/Na+ symporters (NSSs) terminate neuronal signalling by recapturing neurotransmitter released into the synapse in a co-transport (symport) mechanism driven by the Na+ electrochemical gradient(1-6). NSSs for dopamine, noradrenaline and serotonin are targeted by the psychostimulants cocaine and amphetamine(1), as well as by antidepressants(7). The crystal structure of LeuT, a prokaryotic NSS homologue, revealed an occluded conformation in which a leucine (Leu) and two Na+ are bound deep within the protein(8). This structure has been the basis for extensive structural and computational exploration of the functional mechanisms of proteins with a LeuT-like fold(9-22). Subsequently, an 'outward-open' conformation was determined in the presence of the inhibitor tryptophan(23), and the Na+-dependent formation of a dynamic outward-facing intermediate was identified using electron paramagnetic resonance spectroscopy(24). In addition, single-molecule fluorescence resonance energy transfer imaging has been used to reveal reversible transitions to an inward-open LeuT conformation, which involve the movement of transmembrane helix TM1a away from the transmembrane helical bundle(22). We investigated how substrate binding is coupled to structural transitions in LeuT during Na+-coupled transport. Here we report a process whereby substrate binding from the extracellular side of LeuT facilitates intracellular gate opening and substrate release at the intracellular face of the protein. In the presence of alanine, a substrate that is transported 10-fold faster than leucine(15,25), we observed alanine-induced dynamics in the intracellular gate region of LeuT that directly correlate with transport efficiency. Collectively, our data reveal functionally relevant and previously hidden aspects of the NSS transport mechanism that emphasize the functional importance of a second substrate (S2) binding site within the extracellular vestibule(15,20). Substrate binding in this S2 site appears to act cooperatively with the primary substrate (S1) binding site to control intracellular gating more than 30 angstrom away, in a manner that allows the Na+ gradient to power the transport mechanism.	[Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Zhao, Yongfang; Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Terry, Daniel S.; Shi, Lei; Weinstein, Harel; Blanchard, Scott C.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University; Cornell University	Javitch, JA (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 630 W 168th St, New York, NY 10032 USA.	scb2005@med.cornell.edu; jaj2@columbia.edu	WEINSTEIN, HAREL/O-8245-2019; Zhao, Yongfang/B-5437-2010; Blanchard, Scott C./A-5804-2009; Shi, Lei/AAV-1321-2020	WEINSTEIN, HAREL/0000-0003-3473-9818; Blanchard, Scott C./0000-0003-2717-9365; Shi, Lei/0000-0002-4137-096X; Javitch, Jonathan/0000-0001-7395-2967; Terry, Daniel/0000-0001-9021-0084	National Institutes of Health [DA17293, DA022413, DA12408, DA023694]; Irma T. Hirschl/Monique Weill-Caulier trusts; Lieber Center for Schizophrenia Research and Treatment; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408, R01DA017293, R00DA023694, K05DA022413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl/Monique Weill-Caulier trusts; Lieber Center for Schizophrenia Research and Treatment; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Altman for assistance in preparing reagents for single-molecule experiments and F. Carvalho for the preparation of membranes. Molecular graphics were prepared with PyMOL. Computations were performed on Ranger at the Texas Advanced Computing Center (TG-MCB090022) and the David A. Cofrin computational infrastructure of the Institute for Computational Biomedicine at Weill Cornell Medical College. This work was supported in part by National Institutes of Health grants DA17293 and DA022413 (J.A.J.), DA12408 (H.W.), DA023694 (L.S.), the Irma T. Hirschl/Monique Weill-Caulier trusts (S.C.B.) and the Lieber Center for Schizophrenia Research and Treatment. D.S.T. is supported by the Tri-Institutional Training Program in Computational Biology and Medicine.	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GU H, 1994, J BIOL CHEM, V269, P7124; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rudnick G., 2002, MECH BIOGENIC AMINE; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	33	188	192	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					109	U11		10.1038/nature09971	http://dx.doi.org/10.1038/nature09971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21516104	Green Accepted			2022-12-01	WOS:000291156700048
J	Chen, CY; Samuel, TK; Sinclair, J; Dailey, HA; Hamza, I				Chen, Caiyong; Samuel, Tamika K.; Sinclair, Jason; Dailey, Harry A.; Hamza, Iqbal			An Intercellular Heme-Trafficking Protein Delivers Maternal Heme to the Embryo during Development in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; GENE FAMILY; HEMOPEXIN; EXPRESSION; FERROCHELATASE; PROTOPORPHYRIA; IDENTIFICATION; BIOSYNTHESIS; HOMEOSTASIS; INFECTIONS	Extracellular free heme can intercalate into membranes and promote damage to cellular macromolecules. Thus it is likely that specific intercellular pathways exist for the directed transport, trafficking, and delivery of heme to cellular destinations, although none have been found to date. Here we show that Caenorhabditis elegans HRG-3 is required for the delivery of maternal heme to developing embryos. HRG-3 binds heme and is exclusively secreted by maternal intestinal cells into the interstitial fluid for transport of heme to extraintestinal cells, including oocytes. HRG-3 deficiency results either in death during embryogenesis or in developmental arrest immediately post-hatching-phenotypes that are fully suppressed by maternal but not zygotic hrg-3 expression. Our results establish a role for HRG-3 as an intercellular heme-trafficking protein.	[Chen, Caiyong; Samuel, Tamika K.; Sinclair, Jason; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Chen, Caiyong; Samuel, Tamika K.; Sinclair, Jason; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Dailey, Harry A.] Univ Georgia, Biomed & Hlth Sci Inst, Dept Microbiol, Athens, GA 30602 USA; [Dailey, Harry A.] Univ Georgia, Biomed & Hlth Sci Inst, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hamza, I (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	hamza@umd.edu		Hamza, Iqbal/0000-0003-0045-0610	National Institutes of Health [R01DK74797]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074797, R01DK032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Golden and M. Krause for critical discussions and reading of the manuscript; B. Grant, D. Hall, and J. McGhee for insights into intestinal regulation in C. elegans; J. Lippincott-Schwartz for the FPP assay; B. Grant for RNAi clones and C. elegans strain RT1315; J. Hanover for use of the COPAS BioSort; T. Blumenthal for the SL2 ICS sequence; and National Bioresource Project and S. Mitani for the hrg-3 strain. This work was supported by funding from the National Institutes of Health R01DK74797 (I. H.). C. C., T. K. S., J. S., and I. H. designed studies and interpreted data. H. A. D. conducted the biochemical heme-binding studies. C. C. and I. H. wrote the manuscript. All authors discussed the results and commented on the manuscript.	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BALLA G, 1991, LAB INVEST, V64, P648; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; BLUMENTHAL T, 1984, J MOL BIOL, V174, P1, DOI 10.1016/0022-2836(84)90361-9; BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; CHAN MS, 1994, PARASITOLOGY, V109, P373, DOI 10.1017/S0031182000078410; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Chotard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015662; Dailey HA, 2002, BIOCHEM SOC T, V30, P590, DOI 10.1042/bst0300590; Dooley KA, 2008, EXP HEMATOL, V36, P1132, DOI 10.1016/j.exphem.2008.04.008; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Fay DS, 2000, DEVELOPMENT, V127, P4049; Fuller VL, 2008, NEW PHYTOL, V180, P27, DOI 10.1111/j.1469-8137.2008.02508.x; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Held MR, 2006, INFECT IMMUN, V74, P289, DOI 10.1128/IAI.74.1.289-295.2006; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jasmer DP, 2003, ANNU REV PHYTOPATHOL, V41, P245, DOI 10.1146/annurev.phyto.41.052102.104023; Johnston WL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-35; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Magness ST, 2002, BLOOD, V100, P1470, DOI 10.1182/blood-2001-12-0283; McGhee James D, 2007, WormBook, P1; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Sinclair J, 2010, J BIOL CHEM, V285, P39536, DOI 10.1074/jbc.M110.167619; SPIETH J, 1985, MOL CELL BIOL, V5, P2495, DOI 10.1128/MCB.5.10.2495; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Uc A, 2004, AM J PHYSIOL-GASTR L, V287, pG1150, DOI 10.1152/ajpgi.00157.2004; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131	49	42	44	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					720	731		10.1016/j.cell.2011.04.025	http://dx.doi.org/10.1016/j.cell.2011.04.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620137	Green Accepted, Bronze			2022-12-01	WOS:000291018600012
J	Leung, AKW; Nagai, K; Li, J				Leung, Adelaine K. W.; Nagai, Kiyoshi; Li, Jade			Structure of the spliceosomal U4 snRNP core domain and its implication for snRNP biogenesis	NATURE			English	Article							AUTOMATED STRUCTURE SOLUTION; CRYSTAL-STRUCTURE; SM PROTEINS; U1 SNRNP; ELECTRON-MICROSCOPY; RNA-BINDING; COMPLEX; U5; U2; U6	The spliceosome is a dynamic macromolecular machine that assembles on pre-messenger RNA substrates and catalyses the excision of non-coding intervening sequences (introns)(1-3). Four of the five major components of the spliceosome, U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), contain seven Sm proteins (SmB/B9, SmD1, SmD2, SmD3, SmE, SmF and SmG) in common(4,5). Following export of the U1, U2, U4 and U5 snRNAs to the cytoplasm(6,7), the seven Sm proteins, chaperoned by the survival of motor neurons (SMN) complex, assemble around a single-stranded, U-rich sequence called the Sm site in each small nuclear RNA (snRNA), to form the core domain of the respective snRNP particle(8,9). Core domain formation is a prerequisite for re-import into the nucleus(10), where these snRNPs mature via addition of their particle-specific proteins. Here we present a crystal structure of the U4 snRNP core domain at 3.6 angstrom resolution, detailing how the Sm site heptad (AUUUUUG) binds inside the central hole of the heptameric ring of Sm proteins, interacting one-to-one with SmE-SmG-SmD3-SmB-SmD1-SmD2-SmF. An irregular backbone conformation of the Sm site sequence combined with the asymmetric structure of the heteromeric protein ring allows each base to interact in a distinct manner with four key residues at equivalent positions in the L3 and L5 loops of the Sm fold. A comparison of this structure with the U1 snRNP at 5.5 angstrom resolution(11,12) reveals snRNA-dependent structural changes outside the Sm fold, which may facilitate the binding of particle-specific proteins that are crucial to biogenesis of spliceosomal snRNPs.	[Leung, Adelaine K. W.; Nagai, Kiyoshi; Li, Jade] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Nagai, K (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	kn@mrc-lmb.cam.ac.uk; jl@mrc-lmb.cam.ac.uk	Leung, Adelaine/F-4132-2011; Leung, Adelaine/AAV-3357-2021	Leung, Adelaine/0000-0002-2849-4474; 	Medical Research Council of the UK; HFSP; NSERC; Sidney Sussex College, Cambridge University; Medical Research Council [MC_U105184330] Funding Source: researchfish; MRC [MC_U105184330] Funding Source: UKRI	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sidney Sussex College, Cambridge University(University of Cambridge); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council of the UK and a HFSP grant. A.K.W.L. was supported by the Overseas Research Students Awards Scheme, Canada-Cambridge Commonwealth studentship, a postgraduate scholarship from NSERC and a Junior Research Fellowship from Sidney Sussex College, Cambridge University. We thank the European Synchrotron Radiation Facility and Daresbury beamline staff for their support. We thank M. Jinek, M. Kampmann and Y. Kondo for their help with crystallization. We also thank C. Kambach, J. Avis, R. Young, S. Walke and H. Teo for laying the foundation of this project, C. Oubridge and D. Pomeranz Krummel for sharing Sm proteins and providing help and advice throughout the project, and P. Zwart for advice on twinning.	Arnold E., 2001, INT TABLES CRYSTALLO, VF, P705; BRINGMANN P, 1986, EMBO J, V5, P3509, DOI 10.1002/j.1460-2075.1986.tb04676.x; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burge C.B., 1999, RNA WORLD, V37, P525; Collins BM, 2003, J BIOL CHEM, V278, P17291, DOI 10.1074/jbc.M211826200; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DIAMOND R, 1992, PROTEIN SCI, V1, P1279, DOI 10.1002/pro.5560011006; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Draper DE, 2008, BIOPHYS J, V95, P5489, DOI 10.1529/biophysj.108.131813; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FISCHER U, 1993, EMBO J, V12, P573, DOI 10.1002/j.1460-2075.1993.tb05689.x; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Guthrie C., 2003, RNA, V9, P193; Hartmuth K, 1999, J MOL BIOL, V285, P133, DOI 10.1006/jmbi.1998.2300; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; HINTERBERGER M, 1983, J BIOL CHEM, V258, P2604; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; KASTNER B, 1990, P NATL ACAD SCI USA, V87, P1710, DOI 10.1073/pnas.87.5.1710; KASTNER B, 1989, EMBO J, V8, P277, DOI 10.1002/j.1460-2075.1989.tb03374.x; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leung AKW, 2010, J MOL BIOL, V402, P154, DOI 10.1016/j.jmb.2010.07.017; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; McConnell TS, 2003, RNA, V9, P193, DOI 10.1261/rna.2136103; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NELISSEN RLH, 1994, EMBO J, V13, P4113, DOI 10.1002/j.1460-2075.1994.tb06729.x; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Oubridge C, 2009, STRUCTURE, V17, P930, DOI 10.1016/j.str.2009.05.009; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Sauter C, 1999, J CRYST GROWTH, V196, P365, DOI 10.1016/S0022-0248(98)00852-5; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Toro I, 2002, J MOL BIOL, V320, P129, DOI 10.1016/S0022-2836(02)00406-0; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will CL, 2006, COLD SPRING HARB MON, V43, P369; YU YT, 1999, RNA WORLD, V2, P487	56	94	103	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					536	U285		10.1038/nature09956	http://dx.doi.org/10.1038/nature09956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21516107	Green Accepted			2022-12-01	WOS:000290951300046
J	Djulbegovic, B; Paul, A				Djulbegovic, Benjamin; Paul, Ash			From Efficacy to Effectiveness in the Face of Uncertainty Indication Creep and Prevention Creep	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Djulbegovic, Benjamin] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Dept Med, Div Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL 33612 USA; [Paul, Ash] Natl Hlth Serv, Bedford, England	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; NHS Blood & Transplant (NHSBT)	Djulbegovic, B (corresponding author), Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, 12901 Bruce B Downs Blvd,MDC27,Room 3127-3126, Tampa, FL 33612 USA.	bdjulbeg@health.usf.edu	Djulbegovic, Benjamin/I-3661-2012	Djulbegovic, Benjamin/0000-0003-0671-1447				Abernethy AP, 2009, ANN INTERN MED, V150, P336, DOI 10.7326/0003-4819-150-5-200903030-00107; Brody H, 2011, AM J PUBLIC HEALTH, V101, P399, DOI 10.2105/AJPH.2010.199844; Djulbegovic B, 2007, PLOS MED, V4, P211, DOI 10.1371/journal.pmed.0040026; Djulbegovic B, 2011, HBK PHILOS SCI, V16, P299; Djulbegovic M, 2011, JAMA-J AM MED ASSOC, V305, P298, DOI 10.1001/jama.2010.2013; Hammond K. R, 1996, HUMAN JUDGMENT SOCIA; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hebert PC, 2007, CAN MED ASSOC J, V177, P697, DOI 10.1503/cmaj.071223; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107	9	74	74	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					2005	2006		10.1001/jama.2011.650	http://dx.doi.org/10.1001/jama.2011.650			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21586716				2022-12-01	WOS:000290665500025
J	Skinner, J; Kay, P				Skinner, John; Kay, Peter			Commentary: Metal on metal hips	BRITISH MEDICAL JOURNAL			English	Editorial Material							RESURFACINGS; ARTHROPLASTY; FAILURE; BEARING		[Skinner, John] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; [Skinner, John] British Orthopaed Assoc, Joint Expert Advisory Grp Met Bearing Hips, British Hip Soc, London, England; [Kay, Peter] Wrightington Hosp, Wigan, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Skinner, J (corresponding author), Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.	john.skinner@ucl.ac.uk		Skinner, John/0000-0002-1901-9057				Berton C, 2010, J BONE JOINT SURG BR, V92B, P202, DOI 10.1302/0301-620X.92B2.22653; Bolland BJRF, 2011, J BONE JOINT SURG BR, V93B, P608, DOI 10.1302/0301-620X.93B5.26309; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P1614, DOI 10.2106/JBJS.H.01220; Brodner W, 2003, J BONE JOINT SURG AM, V85A, P2168, DOI 10.2106/00004623-200311000-00017; Carrothers AD, 2010, J BONE JOINT SURG BR, V92B, P1344, DOI 10.1302/0301-620X.92B10.23504; CLOHISY JC, 2004, CLIN ORTHOP RELAT R, V429, P66; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; HADDAD FS, J BONE JOINT SURG BR, V93, P572; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P738, DOI 10.1302/0301-620X.91B6.21682; McMinn D, 2006, P I MECH ENG H, V220, P239, DOI 10.1243/095441105X68944; Medicines and Healthcare Products Regulatory Agency, 2010, MED DEV AL MDA 2010; Morlock MM, 2008, J BONE JOINT SURG AM, V90A, P89, DOI 10.2106/JBJS.H.00621; National Joint Registry for England and Wales, 2010, 7 NAT JOINT REG ENGL; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Sandiford NA, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-88; Shimmin AJ, 2005, J BONE JOINT SURG BR, V87B, P463, DOI 10.1302/0301-620X.87B4	16	19	19	1	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 14	2011	342								d3009	10.1136/bmj.d3009	http://dx.doi.org/10.1136/bmj.d3009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	765OV	21572137				2022-12-01	WOS:000290719100008
J	Dutko, JA; Mullins, MC				Dutko, James A.; Mullins, Mary C.			SnapShot: BMP Signaling in Development	CELL			English	Editorial Material									[Dutko, James A.; Mullins, Mary C.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Dutko, JA (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.				NICHD NIH HHS [5T32HD007516] Funding Source: Medline; NIGMS NIH HHS [R01-GM56326] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056326] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zakin L, 2010, DEV BIOL, V347, P204, DOI 10.1016/j.ydbio.2010.08.025	8	28	29	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					636	U157		10.1016/j.cell.2011.05.001	http://dx.doi.org/10.1016/j.cell.2011.05.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565618	Bronze			2022-12-01	WOS:000290560800016
J	Short, PM; Lipworth, SIW; Elder, DHJ; Schembri, S; Lipworth, BJ				Short, Philip M.; Lipworth, Samuel I. W.; Elder, Douglas H. J.; Schembri, Stuart; Lipworth, Brian J.			Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INHALED CORTICOSTEROIDS; MORTALITY; COPD; RISK; SELECTIVITY; REDUCTION; BLOCKADE; AIRWAYS; ASTHMA	Objective To examine the effect of beta blockers in the management of chronic obstructive pulmonary disease (COPD), assessing their effect on mortality, hospital admissions, and exacerbations of COPD when added to established treatment for COPD. Design Retrospective cohort study using a disease specific database of COPD patients (TARDIS) linked to the Scottish morbidity records of acute hospital admissions, the Tayside community pharmacy prescription records, and the General Register Office for Scotland death registry. Setting Tayside, Scotland (2001-2010) Population 5977 patients aged >50 years with a diagnosis of COPD. Main outcome measures Hazard ratios for all cause mortality, emergency oral corticosteroid use, and respiratory related hospital admissions calculated through Cox proportional hazard regression after correction for influential covariates. Results Mean follow-up was 4.35 years, mean age at diagnosis was 69.1 years, and 88% of beta blockers used were cardioselective. There was a 22% overall reduction in all cause mortality with beta blocker use. Furthermore, there were additive benefits of beta blockers on all cause mortality at all treatment steps for COPD. Compared with controls (given only inhaled therapy with either short acting beta agonists or short acting antimuscarinics), the adjusted hazard ratio for all cause mortality was 0.28 (95% CI 0.21 to 0.39) for treatment with inhaled corticosteroid, long acting beta agonist, and long acting antimuscarinic plus beta blocker versus 0.43 (0.38 to 0.48) without beta blocker. There were similar trends showing additive benefits of beta blockers in reducing oral corticosteroid use and hospital admissions due to respiratory disease. beta blockers had no deleterious impact on lung function at all treatment steps when given in conjunction with either a long acting beta agonist or antimuscarinic agent Conclusions beta blockers may reduce mortality and COPD exacerbations when added to established inhaled stepwise therapy for COPD, independently of overt cardiovascular disease and cardiac drugs, and without adverse effects on pulmonary function.	[Short, Philip M.; Lipworth, Brian J.] Univ Dundee, Ctr Cardiovasc & Lung Biol, Div Med Sci, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland; [Lipworth, Samuel I. W.] Univ St Andrews, Bute Med Sch, St Andrews KY16 9UY, Fife, Scotland; [Schembri, Stuart] Perth Royal Infirm, Dept Resp Med, Perth PH1 1NX, Scotland	University of Dundee; University of St Andrews	Lipworth, BJ (corresponding author), Univ Dundee, Ctr Cardiovasc & Lung Biol, Div Med Sci, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.	brianlipworth@gmail.com	Hug, Balthasar L./G-1568-2010	Lipworth, Sam/0000-0001-5872-9214	University of Dundee	University of Dundee	This study was funded by the University of Dundee. The university had no influence over the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; [Anonymous], 2009, GLOB STRAT DIAGN MAN; Chang CL, 2010, INTERN MED J, V40, P193, DOI 10.1111/j.1445-5994.2009.01943.x; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; GAULD DR, 1979, MED J AUSTRALIA, V2, P88; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; IND PW, 1989, AM REV RESPIR DIS, V139, P1390, DOI 10.1164/ajrccm/139.6.1390; LIPWORTH BJ, 1991, EUR J CLIN PHARMACOL, V40, P135; LIPWORTH BJ, 1989, BRIT J CLIN PHARMACO, V28, P95, DOI 10.1111/j.1365-2125.1989.tb03510.x; LIPWORTH BJ, 1991, EUR J CLIN PHARMACOL, V40, P467, DOI 10.1007/BF00315224; Lipworth BJ, 2009, LANCET, V373, P104, DOI 10.1016/S0140-6736(09)60018-0; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Olenchock BA, 2009, AM J CARDIOL, V103, P295, DOI 10.1016/j.amjcard.2008.09.081; RAINE JM, 1981, BRIT MED J, V282, P548, DOI 10.1136/bmj.282.6263.548; Rodrigo GJ, 2009, CHEST, V136, P1029, DOI 10.1378/chest.09-0821; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Salpeter SR, 2003, RESP MED, V97, P1094, DOI 10.1016/S0954-6111(03)00168-9; Schembri S, 2009, RESP MED, V103, P1461, DOI 10.1016/j.rmed.2009.04.021; Scottish Government, 2009, SCOTT IND MULT DEPR; Shah SM, 2008, BRIT J GEN PRACT, V58, P862, DOI 10.3399/bjgp08X376195; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; van der Woude HJ, 2005, CHEST, V127, P818, DOI 10.1378/chest.127.3.818; van Gestel YRBM, 2008, AM J RESP CRIT CARE, V178, P695, DOI 10.1164/rccm.200803-384OC; van Gestel Yvette R B M, 2009, Int J Chron Obstruct Pulmon Dis, V4, P177; WHEELDON NM, 1992, BRIT J CLIN PHARMACO, V34, P337, DOI 10.1111/j.1365-2125.1992.tb05640.x; WILLIAMS IP, 1980, THORAX, V35, P160, DOI 10.1136/thx.35.2.160; Zvezdin B, 2009, CHEST, V136, P376, DOI 10.1378/chest.08-2918	32	165	180	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2011	342								d2549	10.1136/bmj.d2549	http://dx.doi.org/10.1136/bmj.d2549			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765OM	21558357	Green Published, hybrid			2022-12-01	WOS:000290718100001
J	Pelet, S; Rudolf, F; Nadal-Ribelles, M; de Nadal, E; Posas, F; Peter, M				Pelet, Serge; Rudolf, Fabian; Nadal-Ribelles, Mariona; de Nadal, Eulalia; Posas, Francesc; Peter, Matthias			Transient Activation of the HOG MAPK Pathway Regulates Bimodal Gene Expression	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SINGLE-CELL; TRANSCRIPTION; ADAPTATION; KINASE; OSMOREGULATION; NOISE	Mitogen-activated protein kinase (MAPK) cascades are conserved signaling modules that control many cellular processes by integrating intra- and extracellular cues. The p38/Hog1 MAPK is transiently activated in response to osmotic stress, leading to rapid translocation into the nucleus and induction of a specific transcriptional program. When investigating the dynamic interplay between Hog1 activation and Hog1-driven gene expression, we found that Hog1 activation increases linearly with stimulus, whereas the transcriptional output is bimodal. Modeling predictions, corroborated by single-cell experiments, established that a slow stochastic transition from a repressed to an activated transcriptional state in conjunction with transient Hog1 activation generates this behavior. Together, these findings provide a molecular mechanism by which a cell can impose a transcriptional threshold in response to a linear signaling behavior.	[Pelet, Serge; Rudolf, Fabian; Peter, Matthias] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Nadal-Ribelles, Mariona; de Nadal, Eulalia; Posas, Francesc] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain	Swiss Federal Institutes of Technology Domain; ETH Zurich; Pompeu Fabra University	Pelet, S (corresponding author), ETH, Dept Biol, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	serge.pelet@bc.biol.ethz.ch; matthias.peter@bc.biol.ethz.ch	Nadal-Ribelles, Mariona/T-7540-2017; Nadal-Ribelles, Mariona/ABE-4295-2021; de Nadal, Eulàlia/J-8178-2014; Posas, Francesc/K-1364-2013	Nadal-Ribelles, Mariona/0000-0003-3314-6711; Nadal-Ribelles, Mariona/0000-0003-3314-6711; de Nadal, Eulàlia/0000-0003-0039-5607; Posas, Francesc/0000-0002-4164-7076; Peter, Matthias/0000-0002-2160-6824; Pelet, Serge/0000-0002-0245-049X	ICREA Academia (Generalitat de Catalunya); Fundacion Marcelino Botin (FMB); Ministerio de Ciencia y Innovacion [BFU2008-00530, BIO2009-07762]; Swiss National Science Foundation; ETHZ;  [155111]	ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); Fundacion Marcelino Botin (FMB); Ministerio de Ciencia y Innovacion(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETHZ(ETH Zurich); 	We thank R. Dechant, C. Schuller, G. Ammerer, A Colman-Lerner, and A. Smith for strains, plasmids, and helpful discussions, and S.-S. Lee and H. Koeppl fur help with flow chamber experiments and model design, respectively. We are grateful to C. Rupp and D. Conde for technical assistance. This work was supported by QUASI, UNICELLSYS, the SystemsX.ch organization, and the Competence Centre "Systems Physiology and Metabolic Disease" (CC-SPMD). M.N.-R. is supported by 155111, and F.P is recipient of an ICREA Academia (Generalitat de Catalunya) award. Work in the Posas and de Nadal laboratories is funded by the Fundacion Marcelino Botin (FMB) and the Ministerio de Ciencia y Innovacion (BFU2008-00530 to E.N. and BIO2009-07762 to F.P.). The Peter Laboratory is supported by the Swiss National Science Foundation and ETHZ. The authors declare that they have no competing financial interests.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07	25	104	105	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					732	735		10.1126/science.1198851	http://dx.doi.org/10.1126/science.1198851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551064	Green Accepted			2022-12-01	WOS:000290265800047
J	Carlson, BA; Hasan, SM; Hollmann, M; Miller, DB; Harmon, LJ; Arnegard, ME				Carlson, Bruce A.; Hasan, Saad M.; Hollmann, Michael; Miller, Derek B.; Harmon, Luke J.; Arnegard, Matthew E.			Brain Evolution Triggers Increased Diversification of Electric Fishes	SCIENCE			English	Article							DIVERGENCE; MORMYRIDAE; SPECIATION; TELEOSTEI; RATES; MORMYROIDEA; RADIATION; DIVERSITY; DISCHARGE; SIGNALS	Communication can contribute to the evolution of biodiversity by promoting speciation and reinforcing reproductive isolation between existing species. The evolution of species-specific signals depends on the ability of individuals to detect signal variation, which in turn relies on the capability of the brain to process signal information. Here, we show that evolutionary change in a region of the brain devoted to the analysis of communication signals in mormyrid electric fishes improved detection of subtle signal variation and resulted in enhanced rates of signal evolution and species diversification. These results show that neural innovations can drive the diversification of signals and promote speciation.	[Carlson, Bruce A.; Hasan, Saad M.; Hollmann, Michael; Miller, Derek B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Arnegard, Matthew E.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	Washington University (WUSTL); Idaho; University of Idaho; Fred Hutchinson Cancer Center	Carlson, BA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	carlson.bruce@wustl.edu	Harmon, Luke/A-8225-2012; Hollmann, Michael/AAW-5574-2021	Hollmann, Michael/0000-0002-2209-2773; Harmon, Luke/0000-0002-4985-5750	NSF [IOS-0818390, DEB-0919499]; Division Of Integrative Organismal Systems [0818390] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. D. Hopkins and J. R. Gallant for help with field work, J. P. Friel (Cornell University Museum of Vertebrates) for providing specimens, and S. Lavoue and J. P. Sullivan for providing cytb sequences (GenBank accession numbers provided in table S1). Supported by NSF IOS-0818390 (B.A.C.); L.J.H. was supported by NSF DEB-0919499.	Arnegard ME, 2006, J EXP BIOL, V209, P2182, DOI 10.1242/jeb.02239; Arnegard ME, 2010, AM NAT, V176, P335, DOI 10.1086/655221; Bass A.H., 1986, P13; BASS AH, 1982, J MORPHOL, V174, P313, DOI 10.1002/jmor.1051740306; Bell C.C., 1986, P375; Carlson Bruce, 2006, P805; Eschmeyer W.N., 2010, CATALOG FISHES ELECT; Feulner PGD, 2007, J EVOLUTION BIOL, V20, P403, DOI 10.1111/j.1420-9101.2006.01181.x; Feulner PGD, 2009, BIOL LETTERS, V5, P225, DOI 10.1098/rsbl.2008.0566; HARDER W, 1968, Z VERGL PHYSIOL, V59, P272; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; HOPKINS CD, 1981, AM ZOOL, V21, P211; Hoskin CJ, 2010, ECOL LETT, V13, P409, DOI 10.1111/j.1461-0248.2010.01448.x; Lavoue S, 2004, ZOOSYSTEMA, V26, P511; Lavoue S, 2003, BIOL J LINN SOC, V78, P273, DOI 10.1046/j.1095-8312.2003.00170.x; Lavoue S, 2010, ZOOTAXA, P1; Lavoue S, 2008, J PHYSIOL-PARIS, V102, P322, DOI 10.1016/j.jphysparis.2008.10.003; Machnik P, 2008, J EXP BIOL, V211, P1969, DOI 10.1242/jeb.016949; MOLLER P, 1989, ETHOLOGY, V82, P177; O'Meara BC, 2006, EVOLUTION, V60, P922; Post N, 1999, PHYSIOL BEHAV, V68, P115, DOI 10.1016/S0031-9384(99)00153-5; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; RYAN MJ, 1986, P NATL ACAD SCI USA, V83, P1379, DOI 10.1073/pnas.83.5.1379; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; Sullivan JP, 2000, J EXP BIOL, V203, P665; Sylvester JB, 2010, P NATL ACAD SCI USA, V107, P9718, DOI 10.1073/pnas.1000395107; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Xu-Friedman MA, 1999, J EXP BIOL, V202, P1311; Zakon H.H., 1986, P103	30	71	71	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					583	586		10.1126/science.1201524	http://dx.doi.org/10.1126/science.1201524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21527711				2022-12-01	WOS:000289991100047
J	Masui, O; Bonnet, I; Le Baccon, P; Brito, I; Pollex, T; Murphy, N; Hupe, P; Barillot, E; Belmont, AS; Heard, E				Masui, Osamu; Bonnet, Isabelle; Le Baccon, Patricia; Brito, Isabel; Pollex, Tim; Murphy, Niall; Hupe, Philippe; Barillot, Emmanuel; Belmont, Andrew S.; Heard, Edith			Live-Cell Chromosome Dynamics and Outcome of X Chromosome Pairing Events during ES Cell Differentiation	CELL			English	Article							WIDESPREAD MONOALLELIC EXPRESSION; XIST EXPRESSION; INACTIVATION CENTER; NONCODING RNA; HISTONE H3; STEM-CELLS; REGION; TSIX; CHOICE; TRANSCRIPTION	Random X inactivation represents a paradigm for monoallelic gene regulation during early ES cell differentiation. In mice, the choice of X chromosome to inactivate in XX cells is ensured by monoallelic regulation of Xist RNA via its antisense transcription unit Tsix/Xite. Homologous pairing events have been proposed to underlie asymmetric Tsix expression, but direct evidence has been lacking owing to their dynamic and transient nature. Here we investigate the live-cell dynamics and outcome of Tsix pairing in differentiating mouse ES cells. We find an overall increase in genome dynamics including the Xics during early differentiation. During pairing, however, Xic loci show markedly reduced movements. Upon separation, Tsix expression becomes transiently monoallelic, providing a window of opportunity for monoallelic Xist upregulation. Our findings reveal the spatiotemporal choreography of the X chromosomes during early differentiation and indicate a direct role for pairing in facilitating symmetry-breaking and monoallelic regulation of Xist during random X inactivation.	[Masui, Osamu; Bonnet, Isabelle; Le Baccon, Patricia; Brito, Isabel; Pollex, Tim; Murphy, Niall; Hupe, Philippe; Barillot, Emmanuel; Heard, Edith] Inst Curie, F-75248 Paris, France; [Masui, Osamu; Bonnet, Isabelle; Pollex, Tim; Murphy, Niall; Heard, Edith] CNRS, UMR3215, F-75248 Paris, France; [Masui, Osamu; Bonnet, Isabelle; Pollex, Tim; Murphy, Niall; Heard, Edith] INSERM, U934, F-75248 Paris, France; [Le Baccon, Patricia] CNRS, UMR218, F-75248 Paris, France; [Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] INSERM, U900, F-75248 Paris, France; [Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Hupe, Philippe] CNRS, UMR144, F-75248 Paris, France; [Belmont, Andrew S.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; University of Illinois System; University of Illinois Urbana-Champaign	Heard, E (corresponding author), Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	edith.heard@curie.fr	Masui, Osamu/AAH-4111-2019; Heard, Edith/D-7197-2017; Hupe, Philippe/T-8793-2017	Heard, Edith/0000-0001-8052-7117; Hupe, Philippe/0000-0001-8468-3424; Bonnet, Isabelle/0000-0003-2343-3784; Pollex, Tim/0000-0001-5669-3940; BARILLOT, Emmanuel/0000-0003-2724-2002	Human Frontier Science Program; EU; ANR; FRM [SPF20080512397]; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058460] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); EU(European Commission); ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Heard laboratory and John Sedat for helpful discussions; Michele Guggiari, Christel Picard, Matt Plutz, and Patricia Diabangouaya for technical assistance; Yohanns Bellaiche, Francois Graner, and Jennifer Chow for helpful advice and for critical reading of the manuscript. We thank Olivier Renaud and Olivier Leroy (PICT@BDD imaging facility), as well as Sebastian Huart for assistance with image analysis. This work was supported by the Human Frontier Science Program to E.H. and A.S.B.; the EU FP7 program HEROIC IP; ANR and FRM funding, and an ERC Advanced Investigator Award to E.H.; and the FRM to I. Bonnet (postdoc grant n degrees SPF20080512397).	Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Carmo-Fonseca M, 2002, TRENDS CELL BIOL, V12, P491, DOI 10.1016/S0962-8924(02)02387-5; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2010, BIOESSAYS, V32, P581, DOI 10.1002/bies.201000019; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ohlsson R, 2007, SCIENCE, V318, P1077, DOI 10.1126/science.1150705; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rajapakse I, 2009, P NATL ACAD SCI USA, V106, P6679, DOI 10.1073/pnas.0900986106; ROUGEULLE C, 1994, MAMM GENOME, V5, P416, DOI 10.1007/BF00357001; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Sado T, 2001, DEVELOPMENT, V128, P1275; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Scialdone A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000244; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5	44	101	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					447	458		10.1016/j.cell.2011.03.032	http://dx.doi.org/10.1016/j.cell.2011.03.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529716	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000290022900013
J	Schoggins, JW; Wilson, SJ; Panis, M; Murphy, MY; Jones, CT; Bieniasz, P; Rice, CM				Schoggins, John W.; Wilson, Sam J.; Panis, Maryline; Murphy, Mary Y.; Jones, Christopher T.; Bieniasz, Paul; Rice, Charles M.			A diverse range of gene products are effectors of the type I interferon antiviral response	NATURE			English	Article							HEPATITIS-C VIRUS; IDENTIFICATION; PROTEINS; REVEALS; RNA; CLASSIFICATION; REPLICATION; EXPRESSION; RESISTANCE; DISEASE	The type I interferon response protects cells against invading viral pathogens. The cellular factors that mediate this defence are the products of interferon-stimulated genes (ISGs). Although hundreds of ISGs have been identified since their discovery more than 25 years ago(1-3), only a few have been characterized with respect to antiviral activity. For most ISG products, little is known about their antiviral potential, their target specificity and their mechanisms of action. Using an overexpression screening approach, here we show that different viruses are targeted by unique sets of ISGs. We find that each viral species is susceptible to multiple antiviral genes, which together encompass a range of inhibitory activities. To conduct the screen, more than 380 human ISGs were tested for their ability to inhibit the replication of several important human and animal viruses, including hepatitis C virus, yellow fever virus, West Nile virus, chikungunya virus, Venezuelan equine encephalitis virus and human immunodeficiency virus type-1. Broadly acting effectors included IRF1, C6orf150 (also known as MB21D1), HPSE, RIG-I (also known as DDX58), MDA5 (also known as IFIH1) and IFITM3, whereas more targeted antiviral specificity was observed with DDX60, IFI44L, IFI6, IFITM2, MAP3K14, MOV10, NAMPT (also known as PBEF1), OASL, RTP4, TREX1 and UNC84B (also known as SUN2). Combined expression of pairs of ISGs showed additive antiviral effects similar to those of moderate type I interferon doses. Mechanistic studies uncovered a common theme of translational inhibition for numerous effectors. Several ISGs, including ADAR, FAM46C, LY6E and MCOLN2, enhanced the replication of certain viruses, highlighting another layer of complexity in the highly pleiotropic type I interferon system.	[Schoggins, John W.; Panis, Maryline; Murphy, Mary Y.; Jones, Christopher T.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA; [Wilson, Sam J.; Bieniasz, Paul] Rockefeller Univ, Howard Hughes Med Inst, Aaron Diamond AIDS Res Ctr, Lab Retrovirol, New York, NY 10016 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA.	ricec@mail.rockefeller.edu		Wilson, Sam/0000-0002-6065-0895	New York State Department of Health (NYSDOH) [C023046]; National Institutes of Health [AI057158, AI064003]; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M. D. Memorial Fund; National Institute of Diabetes and Digestive and Kidney Diseases [DK082155, DK081193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064003, U54AI057158, R37AI064003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK081193, F32DK082155] Funding Source: NIH RePORTER	New York State Department of Health (NYSDOH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M. D. Memorial Fund; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following investigators for contributing viral molecular clones: C. Stoyanov (YFV), S. Higgs (CHIKV), I. Frolov (WNV and VEEV), M. MacDonald and J. Law (SINV(ts6) and SINV-Fluc), M. Heise (SINV and SINV-GFP). We thank E. Jouanguy and J.-L. Casanova for STAT1<SUP>-/-</SUP> fibroblasts. We acknowledge the support of C. Zhao, X. Wang and W. Zhang at The Rockefeller University Genomics Resource Center. For technical advice, we thank S. Mazel and C. Bare at The Rockefeller University Flow Cytometry Resource Center, supported by the Empire State Stem Cell Fund through the New York State Department of Health (NYSDOH) contract no. C023046; the opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Fund, the NYSDOH or the State of New York. We thank M. Holz, E. Castillo and A. Webson for laboratory support; C. Murray for critical reading and editing of the manuscript; and A. Ploss, M. Scull, M. T. Catanese and S. You for discussions. This work was supported in part by National Institutes of Health grants AI057158 (Northeast Biodefense Center-Lipkin) to C. M. R. and AI064003 to P. B. Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation and the Ronald A. Shellow, M. D. Memorial Fund (C. M. R.). J. W. S. and C. T. J. were supported by National Research Service Awards DK082155 and DK081193, respectively, from the National Institute of Diabetes and Digestive and Kidney Diseases.	Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brodsky LI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000584; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Hilkens CMU, 2003, J IMMUNOL, V171, P5255, DOI 10.4049/jimmunol.171.10.5255; Hultcrantz M, 2007, VIROLOGY, V367, P92, DOI 10.1016/j.virol.2007.05.010; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; KNIGHT E, 1979, P NATL ACAD SCI USA, V76, P1824, DOI 10.1073/pnas.76.4.1824; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; LARNER AC, 1984, P NATL ACAD SCI-BIOL, V81, P6733, DOI 10.1073/pnas.81.21.6733; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; ROY S, 1990, SCIENCE, V247, P1216, DOI 10.1126/science.2180064; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Spindler KR, 2010, J IMMUNOL, V184, P3055, DOI 10.4049/jimmunol.0903363; Suthar MS, 2005, J VIROL, V79, P4219, DOI 10.1128/JVI.79.7.4219-4228.2005; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	42	1586	1633	4	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					481	U545		10.1038/nature09907	http://dx.doi.org/10.1038/nature09907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21478870	Green Accepted			2022-12-01	WOS:000289949600036
J	Elshaug, AG; Garber, AM				Elshaug, Adam G.; Garber, Alan M.			How CER Could Pay for Itself - Insights from Vertebral Fracture Treatments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED-TRIAL; VERTEBROPLASTY		[Elshaug, Adam G.] Commonwealth Fund, Int Program Hlth Policy & Practice, New York, NY 10021 USA; [Elshaug, Adam G.] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia; [Garber, Alan M.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garber, Alan M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Garber, Alan M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Commonwealth Fund; University of Adelaide; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Elshaug, AG (corresponding author), Commonwealth Fund, Int Program Hlth Policy & Practice, New York, NY 10021 USA.		Elshaug, Adam G/A-5714-2008	Elshaug, Adam/0000-0002-4939-5379				Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Food and Drug Administration, MAN US FAC DEV EXP D; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Weinstein JN, 2009, NEW ENGL J MED, V361, P619, DOI 10.1056/NEJMe0905889	4	19	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1390	1393		10.1056/NEJMp1101475	http://dx.doi.org/10.1056/NEJMp1101475			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749LD	21488762	Green Published			2022-12-01	WOS:000289467200003
J	Edery, P; Marcaillou, C; Sahbatou, M; Labalme, A; Chastang, J; Touraine, R; Tubacher, E; Senni, F; Bober, MB; Nampoothiri, S; Jouk, PS; Steichen, E; Berland, S; Toutain, A; Wise, CA; Sanlaville, D; Rousseau, F; Clerget-Darpoux, F; Leutenegger, AL				Edery, Patrick; Marcaillou, Charles; Sahbatou, Mourad; Labalme, Audrey; Chastang, Joelle; Touraine, Renaud; Tubacher, Emmanuel; Senni, Faiza; Bober, Michael B.; Nampoothiri, Sheela; Jouk, Pierre-Simon; Steichen, Elisabeth; Berland, Siren; Toutain, Annick; Wise, Carol A.; Sanlaville, Damien; Rousseau, Francis; Clerget-Darpoux, Francoise; Leutenegger, Anne-Louise			Association of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNA	SCIENCE			English	Article							NONSENSE-MEDIATED DECAY; INBREEDING COEFFICIENT; RNA SURVEILLANCE; U4 SNRNA; PROTEIN; INTRONS; U12-TYPE; SPLICEOSOME; DWARFISM	The spliceosome, a ribonucleoprotein complex that includes proteins and small nuclear RNAs (snRNAs), catalyzes RNA splicing through intron excision and exon ligation to produce mature messenger RNAs, which, in turn serve as templates for protein translation. We identified four point mutations in the U4atac snRNA component of the minor spliceosome in patients with brain and bone malformations and unexplained postnatal death [microcephalic osteodysplastic primordial dwarfism type 1 (MOPD 1) or Taybi-Linder syndrome (TALS); Mendelian Inheritance in Man ID no. 210710]. Expression of a subgroup of genes, possibly linked to the disease phenotype, and minor intron splicing were affected in cell lines derived from TALS patients. Our findings demonstrate a crucial role of the minor spliceosome component U4atac snRNA in early human development and postnatal survival.	[Edery, Patrick; Labalme, Audrey; Chastang, Joelle; Senni, Faiza; Sanlaville, Damien] Hosp Civils Lyon, Serv Cytogenet Constitut, F-69677 Bron, France; [Edery, Patrick; Sanlaville, Damien] INSERM, U1028, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] CNRS, UMR5292, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] Univ Lyon 1, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] Ctr Rech Neurosci Lyon, Translat & Integrat Grp Epilepsy Res, F-69000 Lyon, France; [Marcaillou, Charles; Rousseau, Francis] IntegraGen, F-91030 Evry, France; [Sahbatou, Mourad; Tubacher, Emmanuel] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Touraine, Renaud] Hop Nord St Etienne, CHU, Serv Genet, F-42055 St Etienne, France; [Bober, Michael B.] Alfred I DuPont Hosp Children, Dept Pediat, Div Med Genet, Wilmington, DE 19803 USA; [Nampoothiri, Sheela] Amrita Inst Med Sci & Res Ctr, Dept Pediat Genet, Cochin 682041, Kerala, India; [Jouk, Pierre-Simon] CHU Grenoble, Dept Genet & Procreat, F-38043 Grenoble 9, France; [Jouk, Pierre-Simon] Univ Grenoble 1, CNRS, UMR 5525, F-38041 Grenoble, France; [Steichen, Elisabeth] Univ Innsbruck Hosp, Dept Pediat, A-6020 Innsbruck, Austria; [Berland, Siren] St Olavs Hosp, Dept Pathol, Clin Genet Sect, N-7006 Trondheim, Norway; [Berland, Siren] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Toutain, Annick] Hop Bretonneau, CHRU, Serv Genet, F-37044 Tours, France; [Toutain, Annick] Univ Tours, INSERM, U930, Tours, France; [Wise, Carol A.] Texas Scottish Rite Hosp Children, Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Clerget-Darpoux, Francoise] INSERM, U669, F-94804 Villejuif, France; [Clerget-Darpoux, Francoise] Univ Paris 11, UMR S669, F-94804 Villejuif, France; [Leutenegger, Anne-Louise] INSERM, U946, F-75010 Paris, France; [Leutenegger, Anne-Louise] Univ Paris Diderot, Inst Univ Hematol, UMR S946, F-75010 Paris, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Foundation Jean Dausset-CEPH; CHU de St Etienne; Nemours Alfred I. duPont Hospital for Children; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Medical University of Innsbruck; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Texas Scottish Rite Hospital for Children; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Edery, P (corresponding author), Hosp Civils Lyon, Serv Cytogenet Constitut, F-69677 Bron, France.	patrick.edery@chu-lyon.fr	Nampoothiri, Sheela/AAQ-4854-2021; Touraine, Renaud/AAV-1605-2020; Edery, Patrick/B-6407-2012; Jouk, Pierre-Simon/AAB-5262-2022; Sanlaville, Damien/M-4716-2014; Bober, Michael/AAH-4553-2021; Jouk, Pierre-Simon/M-7367-2014; Leutenegger, Anne-Louise/B-5597-2009; Clerget-Darpoux, Francoise/I-4825-2017	Nampoothiri, Sheela/0000-0002-9575-0722; Jouk, Pierre-Simon/0000-0001-8301-320X; Sanlaville, Damien/0000-0001-9939-2849; Leutenegger, Anne-Louise/0000-0002-1302-4357; Wise, Carol/0000-0002-6790-2194; Bober, Michael/0000-0002-6178-1264; Berland, Siren/0000-0002-8048-6682; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Toutain, Annick/0000-0002-5999-5300	Fondation Yves Cotrel-Institut de France; Hospices Civils de Lyon; French Ministry of Health; Lyon 1 University; INSERM; Association GEN'HOM; Texas Scottish Rite Hospital for Children	Fondation Yves Cotrel-Institut de France; Hospices Civils de Lyon; French Ministry of Health; Lyon 1 University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association GEN'HOM; Texas Scottish Rite Hospital for Children	We express our heartfelt thanks to the patients and families who participated in this study. We thank M. Gallagher-Gambarelli for her editorial assistance and R. Hennekam for his assistance during the project; M. Letexier for her assistance in analyzing high-throughput sequencing data; T. Rio Frio for helpful discussions on splicing analyses; M. de Tayrac and C. Depienne for helpful discussions on expression data analysis; I. Rouvet and M.-T. Zabot for fibroblast banking; and R. Padgett for providing us with the hand-built U4atac/U6atac bimolecular structure reflecting mfold software predictions. This work was supported by the Fondation Yves Cotrel-Institut de France, the Hospices Civils de Lyon, the French Ministry of Health (Direction de l'Hospitalisation et de l'Organisation des Soins, Plan Maladies Rares 2004), Lyon 1 University, the INSERM, the Association GEN'HOM, and the Texas Scottish Rite Hospital for Children Research Fund.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Padgett RA, 2002, RNA, V8, P125, DOI 10.1017/S1355838202017156; Pessa HKJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013215; Schultz A, 2006, J BIOL CHEM, V281, P28278, DOI 10.1074/jbc.M603350200; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shukla GC, 2002, NUCLEIC ACIDS RES, V30, P4650, DOI 10.1093/nar/gkf609; Sigaudy S, 1998, AM J MED GENET, V80, P16, DOI 10.1002/(SICI)1096-8628(19981102)80:1<16::AID-AJMG4>3.3.CO;2-X; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; TAYBI H, 1967, RADIOLOGY, V89, P275, DOI 10.1148/89.2.275; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3	20	140	142	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					240	243		10.1126/science.1202205	http://dx.doi.org/10.1126/science.1202205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474761				2022-12-01	WOS:000289251100053
J	Batista, LFZ; Pech, M; Zhong, FL; Nguyen, HN; Xie, KT; Zaug, AJ; Crary, SM; Choi, J; Sebastiano, V; Cherry, A; Giri, N; Wernig, M; Alter, BP; Cech, TR; Savage, SA; Pera, RAR; Artandi, SE				Batista, Luis F. Z.; Pech, MatthewF.; Zhong, Franklin L.; Nguyen, Ha Nam; Xie, Kathleen T.; Zaug, Arthur J.; Crary, Sharon M.; Choi, Jinkuk; Sebastiano, Vittorio; Cherry, Athena; Giri, Neelam; Wernig, Marius; Alter, Blanche P.; Cech, Thomas R.; Savage, Sharon A.; Pera, Renee A. Reijo; Artandi, Steven E.			Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells	NATURE			English	Article							REVERSE-TRANSCRIPTASE; MOUSE; RNA; LOCALIZATION; ANTICIPATION; ELONGATION; GENERATION; MUTATIONS; LENGTH; LEADS	The differentiation of patient-derived induced pluripotent stem cells (iPSCs) to committed fates such as neurons, muscle and liver is a powerful approach for understanding key parameters of human development and disease(1-6). Whether undifferentiated iPSCs themselves can be used to probe disease mechanisms is uncertain. Dyskeratosis congenita is characterized by defective maintenance of blood, pulmonary tissue and epidermal tissues and is caused by mutations in genes controlling telomere homeostasis(7,8). Short telomeres, a hallmark of dyskeratosis congenita, impair tissue stem cell function in mouse models, indicating that a tissue stem cell defect may underlie the pathophysiology of dyskeratosis congenita(9,10). Here we show that even in the undifferentiated state, iPSCs from dyskeratosis congenita patients harbour the precise biochemical defects characteristic of each form of the disease and that the magnitude of the telomere maintenance defect in iPSCs correlates with clinical severity. In iPSCs from patients with heterozygous mutations in TERT, the telomerase reverse transcriptase, a 50% reduction in telomerase levels blunts the natural telomere elongation that accompanies reprogramming. In contrast, mutation of dyskerin (DKC1) in X-linked dyskeratosis congenita severely impairs telomerase activity by blocking telomerase assembly and disrupts telomere elongation during reprogramming. In iPSCs from a form of dyskeratosis congenita caused by mutations in TCAB1 (also known as WRAP53), telomerase catalytic activity is unperturbed, yet the ability of telomerase to lengthen telomeres is abrogated, because telomerase mislocalizes from Cajal bodies to nucleoli within the iPSCs. Extended culture of DKC1-mutant iPSCs leads to progressive telomere shortening and eventual loss of self-renewal, indicating that a similar process occurs in tissue stem cells in dyskeratosis congenita patients. These findings in iPSCs from dyskeratosis congenita patients reveal that undifferentiated iPSCs accurately recapitulate features of a human stem cell disease and may serve as a cell-culture-based system for the development of targeted therapeutics.	[Batista, Luis F. Z.; Pech, MatthewF.; Zhong, Franklin L.; Choi, Jinkuk; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Pech, MatthewF.; Zhong, Franklin L.; Choi, Jinkuk; Pera, Renee A. Reijo; Artandi, Steven E.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Nguyen, Ha Nam; Sebastiano, Vittorio; Wernig, Marius; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Xie, Kathleen T.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Zaug, Arthur J.; Crary, Sharon M.; Cech, Thomas R.] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; [Sebastiano, Vittorio; Cherry, Athena; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Giri, Neelam; Alter, Blanche P.; Savage, Sharon A.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Bethesda, MD 20852 USA; [Artandi, Steven E.] Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Savage, Sharon/AAB-5160-2019; Savage, Sharon A/B-9747-2015	Savage, Sharon/0000-0001-6006-0740; Savage, Sharon A/0000-0001-6006-0740; Reijo Pera, Renee/0000-0002-6487-1329; Choi, Jinkuk/0000-0002-2449-8291; Batista, Luis/0000-0002-7538-3240; Xie, Kathleen/0000-0002-3178-8959	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [T32 CA009302, R01 CA125453-05, R01 CA125453, R01 CA111691, R01 CA111691-05] Funding Source: Medline; NHLBI NIH HHS [RC1 HL100361-01, RC1 HL100361, U01 HL100397] Funding Source: Medline; NIA NIH HHS [R01 AG033747, R01 AG033747-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111691, T32CA009302, ZIACP010190, R01CA125453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, RC1HL100361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033747] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Alter BP, 2010, BRIT J HAEMATOL, V150, P179, DOI 10.1111/j.1365-2141.2010.08212.x; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019; Byrne J. A., 2009, PLOS ONE, V4, pe7118; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Liu G. H., 2011, NATURE          0223, DOI [10.1038/nature09879, DOI 10.1038/NATURE09879]; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Middleman EJ, 2006, MOL CELL BIOL, V26, P2146, DOI 10.1128/MCB.26.6.2146-2159.2006; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; SEABRIGH.M, 1971, LANCET, V2, P971; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Walne AJ, 2009, BRIT J HAEMATOL, V145, P164, DOI 10.1111/j.1365-2141.2009.07598.x; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	37	180	186	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					399	+		10.1038/nature10084	http://dx.doi.org/10.1038/nature10084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21602826	Green Accepted			2022-12-01	WOS:000291647100050
J	Lizak, C; Gerber, S; Numao, S; Aebi, M; Locher, KP				Lizak, Christian; Gerber, Sabina; Numao, Shin; Aebi, Markus; Locher, Kaspar P.			X-ray structure of a bacterial oligosaccharyltransferase	NATURE			English	Article							N-LINKED GLYCOSYLATION; HYDROXY AMINO-ACID; PROTEIN GLYCOSYLATION; COMPLEX; TRANSFERASE; GLYCOPROTEIN; PEPTIDE; SPECIFICITY; BIOLOGY; SYSTEM	Asparagine-linked glycosylation is a post-translational modification of proteins containing the conserved sequence motif Asn-X-Ser/Thr. The attachment of oligosaccharides is implicated in diverse processes such as protein folding and quality control, organism development or host-pathogen interactions. The reaction is catalysed by oligosaccharyltransferase (OST), a membrane protein complex located in the endoplasmic reticulum. The central, catalytic enzyme of OST is the STT3 subunit, which has homologues in bacteria and archaea. Here we report the X-ray structure of a bacterial OST, the PglB protein of Campylobacter lari, in complex with an acceptor peptide. The structure defines the fold of STT3 proteins and provides insight into glycosylation sequon recognition and amide nitrogen activation, both of which are prerequisites for the formation of the N-glycosidic linkage. We also identified and validated catalytically important, acidic amino acid residues. Our results provide the molecular basis for understanding the mechanism of N-linked glycosylation.	[Lizak, Christian; Gerber, Sabina; Locher, Kaspar P.] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Lizak, Christian; Numao, Shin; Aebi, Markus] ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Numao, Shin/0000-0002-6204-7117	NCCR Structural Biology Zurich; Swiss National Science Foundation [SNF 31003A-127098/1, SNF 31003A-131075/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the beamline staff at the Swiss Light Source for assistance with data collection, S. Fleurkens and M. Bucher for technical assistance, and D. Arigoni for discussions. E. coli SCM6 was provided by C. Marolda and M. Valvano. C. L. was affiliated with the Life Science Zurich Graduate School. This research was supported by the NCCR Structural Biology Zurich (grant to K. P. L.) and Swiss National Science Foundation grants to M. A. (SNF 31003A-127098/1) and K. P. L. (SNF 31003A-131075/1).	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BAUSE E, 1984, BIOCHEM SOC T, V12, P514, DOI 10.1042/bst0120514; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Chen WJ, 2000, TERR ATMOS OCEAN SCI, V11, P765, DOI 10.3319/TAO.2000.11.4.765(A); CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7942, DOI 10.1021/ja00046a068; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Li L, 2010, BIOCHEM BIOPH RES CO, V394, P1069, DOI 10.1016/j.bbrc.2010.03.126; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Valliere-Douglass JF, 2009, J BIOL CHEM, V284, P32493, DOI 10.1074/jbc.M109.014803; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; WIBERG KB, 1992, J AM CHEM SOC, V114, P831, DOI 10.1021/ja00029a005; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	53	265	275	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					350	U377		10.1038/nature10151	http://dx.doi.org/10.1038/nature10151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677752				2022-12-01	WOS:000291647100039
J	Clasquin, MF; Melamud, E; Singer, A; Gooding, JR; Xu, XH; Dong, AP; Cui, H; Campagna, SR; Savchenko, A; Yakunin, AF; Rabinowitz, JD; Caudy, AA				Clasquin, Michelle F.; Melamud, Eugene; Singer, Alexander; Gooding, Jessica R.; Xu, Xiaohui; Dong, Aiping; Cui, Hong; Campagna, Shawn R.; Savchenko, Alexei; Yakunin, Alexander F.; Rabinowitz, Joshua D.; Caudy, Amy A.			Riboneogenesis in Yeast	CELL			English	Article							PENTOSE-PHOSPHATE PATHWAY; SACCHAROMYCES-CEREVISIAE STRAINS; RED BLOOD CELL; HUMAN-ERYTHROCYTES; SEDOHEPTULOSE DIPHOSPHATE; METABOLOMIC ANALYSIS; OCTULOSE PHOSPHATES; F-TYPE; C-13; MUTANTS	Glucose is catabolized in yeast via two fundamental routes, glycolysis and the oxidative pentose phosphate pathway, which produces NADPH and the essential nucleotide component ribose-5-phosphate. Here, we describe riboneogenesis, a thermodynamically driven pathway that converts glycolytic intermediates into ribose-5-phosphate without production of NADPH. Riboneogenesis begins with synthesis, by the combined action of transketolase and aldolase, of the seven-carbon bisphosphorylated sugar sedoheptulose-1,7-bisphosphate. In the pathway's committed step, sedoheptulose bisphosphate is hydrolyzed to sedoheptulose-7-phosphate by the enzyme sedoheptulose-1,7-bisphosphatase (SHB17), whose activity we identified based on metabolomic analysis of the corresponding knockout strain. The crystal structure of Shb17 in complex with sedoheptulose-1,7-bisphosphate reveals that the substrate binds in the closed furan form in the active site. Sedoheptulose-7-phosphate is ultimately converted by known enzymes of the nonoxidative pentose phosphate pathway to ribose-5-phosphate. Flux through SHB17 increases when ribose demand is high relative to demand for NADPH, including during ribosome biogenesis in metabolically synchronized yeast cells.	[Clasquin, Michelle F.; Melamud, Eugene; Rabinowitz, Joshua D.; Caudy, Amy A.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Clasquin, Michelle F.; Melamud, Eugene; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Singer, Alexander; Xu, Xiaohui; Dong, Aiping; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Gooding, Jessica R.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	Princeton University; Princeton University; University of Toronto; University of Tennessee System; University of Tennessee Knoxville	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu; amy.caudy@utoronto.ca	Rabinowitz, Joshua/GPP-4019-2022; Yakunin, Alexander/J-1519-2014	Rabinowitz, Joshua/0000-0002-1247-4727; Yakunin, Alexander/0000-0003-0813-6490; Campagna, Shawn/0000-0001-6809-3862; Caudy, Amy/0000-0001-6307-8137	NSF [MCB-0643859]; NIH [GM071508, AI078063]; Merck and Company; Lewis-Sigler Fellows program; Beckman Foundation; American Heart Association [0635188N]; DOE; government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck and Company(Merck & Company); Lewis-Sigler Fellows program; Beckman Foundation; American Heart Association(American Heart Association); DOE(United States Department of Energy (DOE)); government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NSF Career Award MCB-0643859 to J.D.R. and NIH Grant GM071508 for the Center of Quantitative Biology at Princeton University. M.F.C. gratefully acknowledges financial support from Merck and Company through a Doctoral Research Fellowship and A.A.C. support through the Lewis-Sigler Fellows program. Additional support came from the Beckman Foundation, American Heart Association Grant 0635188N, NSF Career Award MCB-0643859, NIH Grant AI078063, the DOE Biohydrogen program (to J.D.R.), and the government of Canada through Genome Canada and the Ontario Genomics Institute (2009-OGI-ABC-1405) (to A.F.Y.). We thank Kate Kuznetsova for providing purified proteins, Wenyun Lu and Saw Kyin for assistance with mass spectrometry, and Dannie Durand and David Botstein for helpful discussions.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Amberg DC., 2005, METHODS YEAST GENETI; BARTLETT GR, 1968, BIOCHIM BIOPHYS ACTA, V156, P240, DOI 10.1016/0304-4165(68)90253-5; BARTLETT GR, 1960, BIOCHEM BIOPH RES CO, V3, P474, DOI 10.1016/0006-291X(60)90158-3; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; BERTHON HA, 1993, BIOCHEM J, V296, P379, DOI 10.1042/bj2960379; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; BUCOLO G, 1960, BIOCHEM BIOPH RES CO, V3, P620, DOI 10.1016/0006-291X(60)90073-5; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hegeman AD, 2007, ANAL CHEM, V79, P6912, DOI 10.1021/ac070346t; HORECKER BL, 1982, ANN NY ACAD SCI, V378, P215, DOI 10.1111/j.1749-6632.1982.tb31198.x; Jeppsson M, 2002, APPL ENVIRON MICROB, V68, P1604, DOI 10.1128/AEM.68.4.1604-1609.2002; Kleijn RJ, 2005, FEBS J, V272, P4970, DOI 10.1111/j.1742-4658.2005.04907.x; KOERNER TAW, 1973, BIOCHEM BIOPH RES CO, V51, P543, DOI 10.1016/0006-291X(73)91348-X; KUCHEL PW, 1990, BIOMED BIOCHIM ACTA, V49, pS105; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Kuznetsova E, 2010, J BIOL CHEM, V285, P21049, DOI 10.1074/jbc.M110.118315; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MCINTYRE LM, 1989, EUR J BIOCHEM, V180, P399, DOI 10.1111/j.1432-1033.1989.tb14662.x; Meijer A E, 1984, Acta Histochem Suppl, V29, P141; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; PAOLETTI F, 1979, ARCH BIOCHEM BIOPHYS, V198, P620, DOI 10.1016/0003-9861(79)90539-3; Ralser M., 2007, J BIOL-LONDON, V6, P10, DOI [10.1186/jbiol61, DOI 10.1186/jbiol61]; Rutthard H, 2001, J BIOL CHEM, V276, P18728, DOI 10.1074/jbc.M102122200; Saghatelian A, 2005, LIFE SCI, V77, P1759, DOI 10.1016/j.lfs.2005.05.019; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Saito N, 2006, J PROTEOME RES, V5, P1979, DOI 10.1021/pr0600576; SCHAAFFGERSTENS.GE, 1993, EUR J BIOCHEM, V217, P487; SGD Project, 2010, SACCH GEN DAT; SMYRNIOTIS PZ, 1956, J BIOL CHEM, V218, P745; Szyperski T, 1996, TRENDS BIOTECHNOL, V14, P453, DOI 10.1016/S0167-7799(96)10056-1; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; VALENTIN ML, 1993, TETRAHEDRON LETT, V34, P8103, DOI 10.1016/S0040-4039(00)61463-6; Walther T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.100; Wang LQ, 2006, METAB ENG, V8, P142, DOI 10.1016/j.ymben.2005.11.002; WEBB M, 1964, ENZYMES; WILLIAMS JF, 1987, INT J BIOCHEM, V19, P749, DOI 10.1016/0020-711X(87)90239-4; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004	51	81	82	4	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					969	980		10.1016/j.cell.2011.05.022	http://dx.doi.org/10.1016/j.cell.2011.05.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663798	Bronze, Green Accepted			2022-12-01	WOS:000291461600022
J	Bonadona, V; Bonaiti, B; Olschwang, S; Grandjouan, S; Huiart, L; Longy, M; Guimbaud, R; Buecher, B; Bignon, YJ; Caron, O; Colas, C; Nogues, C; Lejeune-Dumoulin, S; Olivier-Faivre, L; Polycarpe-Osaer, F; Nguyen, TD; Desseigne, F; Saurin, JC; Berthet, P; Leroux, D; Duffour, J; Manouvrier, S; Frebourg, T; Sobol, H; Lasset, C; Bonaiti-Pellie, C				Bonadona, Valerie; Bonaiti, Bernard; Olschwang, Sylviane; Grandjouan, Sophie; Huiart, Laetitia; Longy, Michel; Guimbaud, Rosine; Buecher, Bruno; Bignon, Yves-Jean; Caron, Olivier; Colas, Chrystelle; Nogues, Catherine; Lejeune-Dumoulin, Sophie; Olivier-Faivre, Laurence; Polycarpe-Osaer, Florence; Nguyen, Tan Dat; Desseigne, Francoise; Saurin, Jean-Christophe; Berthet, Pascaline; Leroux, Dominique; Duffour, Jacqueline; Manouvrier, Sylvie; Frebourg, Thierry; Sobol, Hagay; Lasset, Christine; Bonaiti-Pellie, Catherine		French Canc Genetics Network	Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; CUMULATIVE LIFETIME INCIDENCE; AGE-OF-ONSET; ESTIMATING PENETRANCE; ENDOMETRIAL CANCER; PROVEN MUTATIONS; 121 FAMILIES; GRL METHOD; CARRIERS; HNPCC	Context Providing accurate estimates of cancer risks is a major challenge in the clinical management of Lynch syndrome. Objective To estimate the age-specific cumulative risks of developing various tumors using a large series of families with mutations of the MLH1, MSH2, and MSH6 genes. Design, Setting, and Participants Families with Lynch syndrome enrolled between January 1, 2006, and December 31, 2009, from 40 French cancer genetics clinics participating in the ERISCAM (Estimation des Risques de Cancer chez les porteurs de mutation des genes MMR) study; 537 families with segregating mutated genes (248 with MLH1; 256 with MSH2; and 33 with MSH6) were analyzed. Main Outcome Measure Age-specific cumulative cancer risks estimated using the genotype restricted likelihood (GRL) method accounting for ascertainment bias. Results Significant differences in estimated cumulative cancer risk were found between the 3 mutated genes (P=.01). The estimated cumulative risks of colorectal cancer by age 70 years were 41% (95% confidence intervals [CI], 25%-70%) for MLH1 mutation carriers, 48% (95% CI, 30%-77%) for MSH2, and 12% (95% CI, 8%-22%) for MSH6. For endometrial cancer, corresponding risks were 54% (95% CI, 20%-80%), 21% (95% CI, 8%-77%), and 16% (95% CI, 8%-32%). For ovarian cancer, they were 20% (95% CI, 1%-65%), 24% (95% CI, 3%-52%), and 1% (95% CI, 0%-3%). The estimated cumulative risks by age 40 years did not exceed 2% (95% CI, 0%-7%) for endometrial cancer nor 1% (95% CI, 0%-3%) for ovarian cancer, irrespective of the gene. The estimated lifetime risks for other tumor types did not exceed 3% with any of the gene mutations. Conclusions MSH6 mutations are associated with markedly lower cancer risks than MLH1 or MSH2 mutations. Lifetime ovarian and endometrial cancer risks associated with MLH1 or MSH2 mutations were high but do not increase appreciably until after the age of 40 years. JAMA. 2011;305(22):2304-2310 www.jama.com	[Lasset, Christine] Ctr Leon Berard, Prevent & Genet Epidemiol Unit, F-69373 Lyon 08, France; [Bonadona, Valerie; Lasset, Christine] Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France; [Bonaiti, Bernard; Bonaiti-Pellie, Catherine] INSERM, U669, Villejuif, France; [Bonaiti, Bernard] INRA, GABI, Jouy En Josas, France; [Olschwang, Sylviane; Huiart, Laetitia; Sobol, Hagay] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Olschwang, Sylviane; Sobol, Hagay] INSERM, U891, F-13258 Marseille, France; [Grandjouan, Sophie] APHP, Paris, France; [Huiart, Laetitia] INSERM, UMR 912, F-13258 Marseille, France; [Longy, Michel] Inst Bergonie, Bordeaux, France; [Guimbaud, Rosine] Inst Claudius Regaud, Toulouse, France; [Guimbaud, Rosine] Ctr Hosp Univ, Toulouse, France; [Buecher, Bruno] CHU Nantes, F-44035 Nantes 01, France; [Bignon, Yves-Jean] Ctr Jean Perrin, Clermont Ferrand, France; [Caron, Olivier] Inst Gustave Roussy, Villejuif, France; [Colas, Chrystelle] Grp Hosp Pitie Salpetriere, APHP, INSERM, UMRS 938, F-75634 Paris, France; [Colas, Chrystelle] Univ Paris 06, Paris, France; [Nogues, Catherine] Hop Rene Huguenin, Inst Curie, St Cloud, France; [Lejeune-Dumoulin, Sophie; Manouvrier, Sylvie] CHRU, Lille, France; [Lejeune-Dumoulin, Sophie; Manouvrier, Sylvie] Univ Lille 2, Lille, France; [Olivier-Faivre, Laurence] Hop Enfants, Dijon, France; [Polycarpe-Osaer, Florence] Ctr Paul Strauss, Strasbourg, France; [Nguyen, Tan Dat] Inst Jean Godinot, Reims, France; [Saurin, Jean-Christophe] Hop Edouard Herriot, Lyon, France; [Berthet, Pascaline] Ctr Francois Baclesse, F-14021 Caen, France; [Leroux, Dominique] CHU Grenoble, F-38043 Grenoble, France; [Duffour, Jacqueline] Ctr Val Aurelle, Montpellier, France; [Frebourg, Thierry] INSERM, U614, Rouen, France; [Frebourg, Thierry] CHU, Rouen, France; [Sobol, Hagay] Univ Mediterranee, Marseille, France; [Bonaiti-Pellie, Catherine] Univ Paris Sud, Villejuif, France	UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UNICANCER; Institut Bergonie; UNICANCER; Institut Claudius Regaud; CHU de Toulouse; Nantes Universite; CHU de Nantes; UNICANCER; Centre Jean Perrin; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; CHU Dijon Bourgogne; UNICANCER; Centre Paul Strauss; UNICANCER; Institut Jean Godinot; CHU Lyon; UNICANCER; Centre Francois Baclesse; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay	Lasset, C (corresponding author), Ctr Leon Berard, Prevent & Genet Epidemiol Unit, 28 Rue Laennec, F-69373 Lyon 08, France.	lasset@lyon.fnclcc.fr	Colas, Chrystelle/ABA-3212-2020; Laurent-Puig, Pierre/K-3641-2019; GUIMBAUD, Rosine/M-7503-2014; Frebourg, Thierry/AAK-8390-2020; saurin, jean christophe/AAB-4077-2020; Huiart, Laetitia/GQB-4064-2022; , bignon/Y-3243-2019; Olschwang, Sylviane/G-2716-2013; laurent-puig, pierre/B-2226-2013; Leroux, Dominique/G-7309-2014	Laurent-Puig, Pierre/0000-0001-8475-5459; Olschwang, Sylviane/0000-0001-7078-3029; laurent-puig, pierre/0000-0001-8475-5459; Bonneau, Dominique/0000-0002-6886-0969; BAERT-DESURMONT, Stephanie/0000-0002-1172-4157; Faivre, Laurence/0000-0001-9770-444X; Frebourg, Thierry/0000-0003-0399-4007	Fondation de France	Fondation de France(Fondation de France)	This work was supported by the Fondation de France.	Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L; Alarcon F, 2007, EUR J HUM GENET, V15, P831, DOI 10.1038/sj.ejhg.5201843; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Barrow E, 2008, CLIN GENET, V74, P233, DOI 10.1111/j.1399-0004.2008.01035.x; Barrow E, 2009, CLIN GENET, V75, P141, DOI 10.1111/j.1399-0004.2008.01125.x; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Bonaiti B, 2011, EUR J HUM GENET, V19, P173, DOI 10.1038/ejhg.2010.158; Capelle LG, 2010, GASTROENTEROLOGY, V138, P487, DOI 10.1053/j.gastro.2009.10.051; Carayol J, 2004, GENET EPIDEMIOL, V27, P109, DOI 10.1002/gepi.20007; Carayol J, 2002, J MED GENET, V39, P335, DOI 10.1136/jmg.39.5.335; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Choi YH, 2009, HERED CANCER CLIN PR, V7, DOI 10.1186/1897-4287-7-14; DEVATHAIRE F, 1996, ESTIMATION INCIDENCE; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Green J, 2002, DIS COLON RECTUM, V45, P1223, DOI 10.1007/s10350-004-6397-4; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Kastrinos F, 2009, JAMA-J AM MED ASSOC, V302, P1790, DOI 10.1001/jama.2009.1529; Kauff ND, 2007, J CLIN ONCOL, V25, P2921, DOI 10.1200/JCO.2007.11.3449; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Offit K, 2006, NEW ENGL J MED, V354, P293, DOI 10.1056/NEJMe058284; Olschwang S, 2004, B CANCER, V91, P303; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Vasen HFA, 2010, FAM CANCER, V9, P109, DOI 10.1007/s10689-009-9291-3; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508	36	651	682	3	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2304	2310		10.1001/jama.2011.743	http://dx.doi.org/10.1001/jama.2011.743			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642682				2022-12-01	WOS:000291349100023
J	Hotez, PJ; Mistry, N; Rubinstein, J; Sachs, JD				Hotez, Peter J.; Mistry, Neeraj; Rubinstein, Joanna; Sachs, Jeffrey D.			Integrating Neglected Tropical Diseases into AIDS, Tuberculosis, and Malaria Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPACT		[Hotez, Peter J.; Mistry, Neeraj] Sabin Vaccine Inst, Washington, DC 20006 USA; [Hotez, Peter J.] Baylor Coll Med, Houston, TX 77030 USA; [Hotez, Peter J.] Texas Childrens Hosp, Houston, TX 77030 USA; [Rubinstein, Joanna; Sachs, Jeffrey D.] Columbia Univ, Earth Inst, New York, NY USA	Baylor College of Medicine; Baylor College of Medicine; Columbia University	Hotez, PJ (corresponding author), Sabin Vaccine Inst, Washington, DC 20006 USA.			Hotez, Peter/0000-0001-8770-1042				Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Kirwan P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-277; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Linehan M, 2011, AM J TROP MED HYG, V84, P5, DOI 10.4269/ajtmh.2011.10-0411; Walson JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub3	5	42	43	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2086	2089		10.1056/NEJMp1014637	http://dx.doi.org/10.1056/NEJMp1014637			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21631320				2022-12-01	WOS:000291200700004
J	Robock, A				Robock, Alan			Nuclear winter is a real and present danger	NATURE			English	Editorial Material							CONSEQUENCES		Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Robock, A (corresponding author), Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA.	robock@envsci.rutgers.edu	Robock, Alan/B-6385-2016	Robock, Alan/0000-0002-6319-5656				Badash L, 2009, TRANSFORMATIONS-STUD, P1; Robock A, 2007, ATMOS CHEM PHYS, V7, P2003, DOI 10.5194/acp-7-2003-2007; Robock A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008235; SAGAN C, 1984, FOREIGN AFF, V62, P257; THOMPSON SL, 1986, FOREIGN AFF, V64, P981, DOI 10.2307/20042777; TURCO RP, 1983, SCIENCE, V222, P1283, DOI 10.1126/science.222.4630.1283	6	4	5	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 19	2011	473	7347					275	276		10.1038/473275a	http://dx.doi.org/10.1038/473275a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765QA	21593838	Bronze			2022-12-01	WOS:000290722400013
J	Watanabe, T; Tomizawa, S; Mitsuya, K; Totoki, Y; Yamamoto, Y; Kuramochi-Miyagawa, S; Iida, N; Hoki, Y; Murphy, PJ; Toyoda, A; Gotoh, K; Hiura, H; Arima, T; Fujiyama, A; Sado, T; Shibata, T; Nakano, T; Lin, HF; Ichiyanagi, K; Soloway, PD; Sasaki, H				Watanabe, Toshiaki; Tomizawa, Shin-ichi; Mitsuya, Kohzoh; Totoki, Yasushi; Yamamoto, Yasuhiro; Kuramochi-Miyagawa, Satomi; Iida, Naoko; Hoki, Yuko; Murphy, Patrick J.; Toyoda, Atsushi; Gotoh, Kengo; Hiura, Hitoshi; Arima, Takahiro; Fujiyama, Asao; Sado, Takashi; Shibata, Tatsuhiro; Nakano, Toru; Lin, Haifan; Ichiyanagi, Kenji; Soloway, Paul D.; Sasaki, Hiroyuki			Role for piRNAs and Noncoding RNA in de Novo DNA Methylation of the Imprinted Mouse Rasgrf1 Locus	SCIENCE			English	Article							GERM-CELL DEVELOPMENT; MAMMALIAN DEVELOPMENT; DROSOPHILA; TRANSCRIPTION; FAMILY; GENES; PIWI; MILI	Genomic imprinting causes parental origin-specific monoallelic gene expression through differential DNA methylation established in the parental germ line. However, the mechanisms underlying how specific sequences are selectively methylated are not fully understood. We have found that the components of the PIWI-interacting RNA (piRNA) pathway are required for de novo methylation of the differentially methylated region (DMR) of the imprinted mouse Rasgrf1 locus, but not other paternally imprinted loci. A retrotransposon sequence within a noncoding RNA spanning the DMR was targeted by piRNAs generated from a different locus. A direct repeat in the DMR, which is required for the methylation and imprinting of Rasgrf1, served as a promoter for this RNA. We propose a model in which piRNAs and a target RNA direct the sequence-specific methylation of Rasgrf1.	[Watanabe, Toshiaki; Tomizawa, Shin-ichi; Yamamoto, Yasuhiro; Iida, Naoko; Hoki, Yuko; Sado, Takashi; Ichiyanagi, Kenji; Sasaki, Hiroyuki] Res Org Informat & Syst, Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 4118540, Japan; [Watanabe, Toshiaki; Tomizawa, Shin-ichi; Yamamoto, Yasuhiro; Iida, Naoko; Hoki, Yuko; Sado, Takashi; Ichiyanagi, Kenji; Sasaki, Hiroyuki] Res Org Informat & Syst, Natl Inst Genet, Dept Integrated Genet, Mishima, Shizuoka 4118540, Japan; [Watanabe, Toshiaki; Lin, Haifan] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Tomizawa, Shin-ichi] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Mitsuya, Kohzoh] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA; [Totoki, Yasushi; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 1040045, Japan; [Yamamoto, Yasuhiro; Hoki, Yuko; Sado, Takashi; Ichiyanagi, Kenji; Sasaki, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Div Epigenom, Higashi Ku, Fukuoka 8128582, Japan; [Kuramochi-Miyagawa, Satomi; Gotoh, Kengo; Nakano, Toru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Iida, Naoko] Res Org Informat & Syst, Natl Inst Genet, Dept Mol Genet, Div Mutagenesis, Mishima, Shizuoka 4118540, Japan; [Murphy, Patrick J.; Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA; [Toyoda, Atsushi; Fujiyama, Asao] Res Org Informat & Syst, Natl Inst Genet, Ctr Genet Resource Informat, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Hiura, Hitoshi; Arima, Takahiro] Tohoku Univ, Grad Sch Med, Environm & Genome Res Ctr, Dept Informat Genet,Aoba Ku, Sendai, Miyagi 9808575, Japan; [Fujiyama, Asao] Natl Inst Informat, Principle Informat Res Div, Chiyoda Ku, Tokyo 1018430, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Yale University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Texas System; University of Texas Health San Antonio; National Cancer Center - Japan; Kyushu University; Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Cornell University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tohoku University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Watanabe, T (corresponding author), Res Org Informat & Syst, Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 4118540, Japan.	toshwatatoshiakiwatanabe@gmail.com; hsasaki@bioreg.kyushu-u.ac.jp	Soloway, Paul/T-8243-2019; Tomizawa, Shinichi/AAT-7149-2020; Ichiyanagi, Kenji/J-2141-2015; Sado, Takashi/AAI-1689-2019; Mitsuya, Kohzoh/F-4437-2010; Shibata, Tatsuhiro/AAO-1278-2021; Shibata, Tatsuhiro/ABA-8234-2020	Tomizawa, Shinichi/0000-0002-8291-6623; Sado, Takashi/0000-0002-1232-0250; Ichiyanagi, Kenji/0000-0002-6831-6525; Soloway, Paul/0000-0003-1967-0437; Mitsuya, Kohzoh/0000-0002-0950-5406	Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23390385, 23013003, 23659768, 19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Kaneda, S. Chuma, V. Shteyn, and J. Peng for comments on the manuscript and H. Horiike, H. Furuumi, T. Ichiyanagi, Y. Amakawa, H. Chiba, and Y. Li for sample preparation. The accession number for the small RNA sequences is GSE20327. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to H. S. and K.M.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; de la Puente A, 2002, GENE, V291, P287, DOI 10.1016/S0378-1119(02)00601-7; Drake NM, 2009, MAMM GENOME, V20, P654, DOI 10.1007/s00335-009-9192-7; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795	29	280	293	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					848	852		10.1126/science.1203919	http://dx.doi.org/10.1126/science.1203919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566194	Green Accepted			2022-12-01	WOS:000290529900048
J	Klinakis, A; Lobry, C; Abdel-Wahab, O; Oh, P; Haeno, H; Buonamici, S; van De Walle, I; Cathelin, S; Trimarchi, T; Araldi, E; Liu, C; Ibrahim, S; Beran, M; Zavadil, J; Efstratiadis, A; Taghon, T; Michor, F; Levine, RL; Aifantis, I				Klinakis, Apostolos; Lobry, Camille; Abdel-Wahab, Omar; Oh, Philmo; Haeno, Hiroshi; Buonamici, Silvia; van De Walle, Inge; Cathelin, Severine; Trimarchi, Thomas; Araldi, Elisa; Liu, Cynthia; Ibrahim, Sherif; Beran, Miroslav; Zavadil, Jiri; Efstratiadis, Argiris; Taghon, Tom; Michor, Franziska; Levine, Ross L.; Aifantis, Iannis			A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia	NATURE			English	Article							T-CELL DEVELOPMENT; MICE; DIFFERENTIATION; SPECIFICATION; ACTIVATION; EXPRESSION; PROGENITOR; COMPLEX	Notch signalling is a central regulator of differentiation in a variety of organisms and tissue types(1). Its activity is controlled by the multisubunit gamma-secretase (gamma SE) complex(2). Although Notch signalling can play both oncogenic and tumour-suppressor roles in solid tumours, in the haematopoietic system it is exclusively oncogenic, notably in T-cell acute lymphoblastic leukaemia, a disease characterized by Notch1-activating mutations(3). Here we identify novel somatic-inactivating Notch pathway mutations in a fraction of patients with chronic myelomonocytic leukaemia (CMML). Inactivation of Notch signalling in mouse haematopoietic stem cells (HSCs) results in an aberrant accumulation of granulocyte/monocyte progenitors (GMPs), extramedullary haematopoieisis and the induction of CMML-like disease. Transcriptome analysis revealed that Notch signalling regulates an extensive myelomonocytic-specific gene signature, through the direct suppression of gene transcription by the Notch target Hes1. Our studies identify a novel role for Notch signalling during early haematopoietic stem cell differentiation and suggest that the Notch pathway can play both tumour-promoting and -suppressive roles within the same tissue.	[Lobry, Camille; Oh, Philmo; Buonamici, Silvia; Cathelin, Severine; Trimarchi, Thomas; Araldi, Elisa; Liu, Cynthia; Ibrahim, Sherif; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Lobry, Camille; Oh, Philmo; Buonamici, Silvia; Cathelin, Severine; Trimarchi, Thomas; Araldi, Elisa; Liu, Cynthia; Ibrahim, Sherif; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Klinakis, Apostolos; Efstratiadis, Argiris] Acad Athens, Biomed Res Fdn, Athens, Greece; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, New York, NY 10016 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10016 USA; [Haeno, Hiroshi; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Haeno, Hiroshi; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [van De Walle, Inge; Taghon, Tom] Univ Ghent, State Univ Ghent Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Beran, Miroslav] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Zavadil, Jiri] NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri] NYU Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Buonamici, Silvia] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; New York University; New York University; Academy of Athens; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Ghent University; Ghent University Hospital; University of Texas System; UTMD Anderson Cancer Center; New York University; NYU Langone Medical Center; Novartis	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	aklinakis@bioacademy.gr; iannis.aifantis@nyumc.org	Araldi, Elisa/AAZ-5946-2021; Zavadil, Jiri/ABG-1780-2020; Taghon, Tom/M-9111-2018; lobry, camille/A-6188-2015; levine, ross/AAE-7658-2019	Zavadil, Jiri/0000-0003-0640-5562; lobry, camille/0000-0003-0550-4921; Taghon, Tom/0000-0002-5781-0288; Abdel-Wahab, Omar/0000-0002-3907-6171; Van de Walle, Inge/0000-0002-7631-399X; Araldi, Elisa/0000-0002-6596-6784	National Institutes of Health [RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655, R01CA1328234, U54CA143798]; Leukemia & Lymphoma Society; American Cancer Society; Irma T. Hirschl Trust; Dana Foundation; Mallinckrodt Foundation; Alex's Lemonade Stand Foundation; Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek); National Cancer Institute [1P01CA97403]; EU; Institute for the Promotion of Innovation by Science and Technology in Flanders (Agentschap voor Innovatie door Wetenschap en Technologie); Hope Street Kids Foundations; New York University; Fonds Wetenschappelijk Onderzoek; Memorial Sloan Kettering Cancer Center; American Society of Hematology; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U54CA143798, R21CA141399, P01CA097403, R01CA133379, R01CA149655, R01CA105129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); Irma T. Hirschl Trust; Dana Foundation; Mallinckrodt Foundation; Alex's Lemonade Stand Foundation; Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek)(FWO); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EU(European Commission); Institute for the Promotion of Innovation by Science and Technology in Flanders (Agentschap voor Innovatie door Wetenschap en Technologie)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Hope Street Kids Foundations; New York University; Fonds Wetenschappelijk Onderzoek(FWO); Memorial Sloan Kettering Cancer Center; American Society of Hematology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Fishel, F. Radtke and R. Kopan for donating mouse strains; P. Lopez and the New York University Flow Facility for cell sorting; and A. Heguy and the Geoffrey Beene Translational Core laboratory for assistance with DNA resequencing. The New York University Cancer Institute Genomics Facility helped with micro-array processing. This work was supported by the National Institutes of Health (RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655 to I.A.; R01CA1328234 to R.L.L. and F.M.; U54CA143798 to F.M.), the Leukemia & Lymphoma Society (to I.A.), the American Cancer Society (to I.A.), the Irma T. Hirschl Trust, the Dana Foundation, The Mallinckrodt Foundation, the Alex's Lemonade Stand Foundation (to I.A.), and the Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek) and its Odysseus Research Program (to T.T.). A.E. was supported by the National Cancer Institute (1P01CA97403, Project 2) and a gift from the Berrie Foundation. A.K. was supported by an EU Marie Curie International Re-integration Grant. I.v.D.W. was supported by the Institute for the Promotion of Innovation by Science and Technology in Flanders (Agentschap voor Innovatie door Wetenschap en Technologie). S.C. was supported by the Hope Street Kids Foundations and P.O. by the New York University Medical Scientist Training Program. T.T. was supported by the Fonds Wetenschappelijk Onderzoek). O.A.W. was supported by the Clinical Scholars Program at Memorial Sloan Kettering Cancer Center and by the American Society of Hematology. R.L.L. is an Early Career Award recipient of the Howard Hughes Medical Institute and is the Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center. I.A. is a Howard Hughes Medical Institute Early Career Scientist.	Aifantis I, 1999, J EXP MED, V190, P141, DOI 10.1084/jem.190.1.141; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; De Strooper B, 2005, CELL, V122, P318, DOI 10.1016/j.cell.2005.07.021; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; GRABHER C, 2006, NAT REV CANCER, V6, P1; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Taghon T, 2009, BLOOD, V113, P3254, DOI 10.1182/blood-2008-07-168906; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	32	284	295	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					230	+		10.1038/nature09999	http://dx.doi.org/10.1038/nature09999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562564	Green Accepted			2022-12-01	WOS:000290487200042
J	Eddy, DM; Adler, J; Patterson, B; Lucas, D; Smith, KA; Morris, M				Eddy, David M.; Adler, Joshua; Patterson, Bradley; Lucas, Don; Smith, Kurt A.; Morris, Macdonald			Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; CARDIOVASCULAR-DISEASE; STATIN TREATMENT; PREVENTION; ARCHIMEDES; RISK; CARE; OUTCOMES; PROFILE; IMPACT	Background: Current guidelines focus on a particular risk factor and specify criteria for categorizing persons into a small number of treatment groups. Objective: To compare current guidelines with individualized guidelines (that use readily available characteristics from each person to calculate the risk reduction expected from treatment and to identify persons for treatment in ranked order of decreasing expected benefit), in the context of blood pressure management. Design: Analysis of person-specific, longitudinal data. Setting: The ARIC (Atherosclerosis Risk in Communities) Study. Participants: Persons aged 45 to 64 years without preexisting cardiovascular disease who currently do not receive antihypertensive treatment. Intervention: Treatment according to the criteria of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 guidelines); individualized guidelines, or treatment in decreasing order of expected benefit; and random care, or treatment of persons selected at random. Measurements: Number of myocardial infarctions (MIs) and strokes and medical costs. Results: Compared with treating people according to random care, individualized guidelines could prevent the same number of MIs and strokes as JNC 7 guidelines at savings that are 67% greater than using JNC 7 guidelines, or it could prevent 43% more MIs and strokes for the same cost as treatment according to JNC 7 guidelines. The superiority of individualized guidelines was not sensitive to a wide range of assumptions about costs, treatment effectiveness, level of risk for cardiovascular disease in the population, or effects on workflow. The degree of superiority was sensitive to the accuracy of the method used to rank patients and to its span (the proportion of the population for whom all of the outcomes of interest can be calculated). Limitations: Specific results apply to the effects of blood pressure management on MI and stroke in the ARIC Study population. The methods for calculating individual benefits require quantitative evidence about the relationships among risk factors, long-term outcomes, and treatment effects. Conclusion: Use of individualized guidelines can help to increase the quality and reduce the cost of care.	[Eddy, David M.; Adler, Joshua; Patterson, Bradley; Lucas, Don; Smith, Kurt A.; Morris, Macdonald] Archimedes, San Francisco, CA USA		Eddy, DM (corresponding author), 201 Mission St,29th Floor, San Francisco, CA 94105 USA.	author@archimedesmodel.com			National Heart, Lung, and Blood Institute; ARIC study investigators	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ARIC study investigators	The ARIC Study is conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with the ARIC study investigators. This article was prepared using a limited-access data set and does not necessarily reflect the opinions or views of the ARIC Study investigators or the National Heart, Lung, and Blood Institute.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Bundorf MK, 2004, HEALTH SERV RES, V39, P131; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eddy DM, 2003, DIABETES CARE, V26, P3093, DOI 10.2337/diacare.26.11.3093; EDDY DM, 1982, NEW ENGL J MED, V307, P343, DOI 10.1056/NEJM198208053070604; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P877; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; *FRAM HEART STUD, STORK; Framingham Heart Study, HARD COR HEART DIS 1; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Genest J, 2003, CAN MED ASSOC J, V169, P921; Halfhill TR, TOMS INFLATION CALCU; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; *HEART FDN, QUICK REF GUID HLTH; Honaker J, AMELIA 2 PROGRAM MIS; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; *NAT I HLTH CLIN E, STAT PREV CARD EV PA; National Heart Lung and Blood Institute, BIOL SPEC DAT REP IN; New Zealand Guidelines Group, ASS MAN CARD RISK; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Tonkin Andrew, 2005, Heart Lung Circ, V14, P275; U.S. Department of Health and Human Services (National Heart Lung and Blood Institute, 7 US DEP HLTH HUM SE; U.S. Department of Health and Human Services National Institutes of Health, 3 US DEP HLTH HUM SE; *WIK, PERS MED; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; ARIC ATHEROSCLEROSIS	39	90	90	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					627	634		10.7326/0003-4819-154-9-201105030-00008	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21536939				2022-12-01	WOS:000290112300006
J	West, AP; Brodsky, IE; Rahner, C; Woo, DK; Erdjument-Bromage, H; Tempst, P; Walsh, MC; Choi, Y; Shadel, GS; Ghosh, S				West, A. Phillip; Brodsky, Igor E.; Rahner, Christoph; Woo, Dong Kyun; Erdjument-Bromage, Hediye; Tempst, Paul; Walsh, Matthew C.; Choi, Yongwon; Shadel, Gerald S.; Ghosh, Sankar			TLR signalling augments macrophage bactericidal activity through mitochondrial ROS	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; REACTIVE OXYGEN; PHAGOSOME MATURATION; ECSIT; ASSOCIATION; HOMEOSTASIS; UBIQUITIN; MEMBRANE; COMPLEX; PROTEIN	Reactive oxygen species (ROS) are essential components of the innate immune response against intracellular bacteria and it is thought that professional phagocytes generate ROS primarily via the phagosomal NADPH oxidase machinery(1). However, recent studies have suggested that mitochondrial ROS (mROS) also contribute to mouse macrophage bactericidal activity, although the mechanisms linking innate immune signalling to mitochondria for mROS generation remain unclear(2-4). Here we demonstrate that engagement of a subset of Toll-like receptors (TLR1, TLR2 and TLR4) results in the recruitment of mitochondria to macrophage phagosomes and augments mROS production. This response involves translocation of a TLR signalling adaptor, tumour necrosis factor receptor-associated factor 6 (TRAF6), to mitochondria, where it engages the protein ECSIT (evolutionarily conserved signalling intermediate in Toll pathways), which is implicated in mitochondrial respiratory chain assembly(5). Interaction with TRAF6 leads to ECSIT ubiquitination and enrichment at the mitochondrial periphery, resulting in increased mitochondrial and cellular ROS generation. ECSIT-and TRAF6-depleted macrophages have decreased levels of TLR-induced ROS and are significantly impaired in their ability to kill intracellular bacteria. Additionally, reducing macrophage mROS levels by expressing catalase in mitochondria results in defective bacterial killing, confirming the role of mROS in bactericidal activity. These results reveal a novel pathway linking innate immune signalling to mitochondria, implicate mROS as an important component of antibacterial responses and further establish mitochondria as hubs for innate immune signalling.	[Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [West, A. Phillip; Brodsky, Igor E.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Rahner, Christoph] Yale Univ, Dept Cell Biol, Sch Med, New Haven, CT 06520 USA; [Woo, Dong Kyun; Shadel, Gerald S.] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Walsh, Matthew C.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Columbia University; Yale University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; University of Pennsylvania	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA.	sg2715@columbia.edu	West, A. Phillip/W-8171-2019; West, A. Phillip/A-7867-2009	West, A. Phillip/0000-0003-2884-6895; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NIH [R37-AI33443, NS-056206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033443, R37AI033443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank C. Schindler, B. Reizis and L. Ciaccia for comments on the manuscript. We also thank P. Rabinovitch for MCAT mice, J. Cotney for technical assistance, Z. Zhang for animal maintenance and M. Graham and K. Zichichi for assistance with immuno-electron microscopy. This work was supported by NIH grants to S. G. (R37-AI33443) and G. S. S. (NS-056206).	Adachi Y, 2006, J IMMUNOL, V176, P5033, DOI 10.4049/jimmunol.176.8.5033; Arnoult D, 2009, SEMIN IMMUNOL, V21, P223, DOI 10.1016/j.smim.2009.05.009; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brodsky IE, 2005, MOL MICROBIOL, V55, P954, DOI 10.1111/j.1365-2958.2004.04444.x; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chong A, 2009, INFECT IMMUN, V77, P4724, DOI 10.1128/IAI.00150-09; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; MATSUMOTO A, 1991, J ELECTRON MICROSC, V40, P356; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Remer KA, 2005, CLIN EXP IMMUNOL, V140, P73, DOI 10.1111/j.1365-2249.2005.02740.x; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Sinai AP, 1997, J CELL SCI, V110, P2117; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Vazquez-Torres A, 2001, MICROBES INFECT, V3, P1313, DOI 10.1016/S1286-4579(01)01492-7; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Werling D, 2004, IMMUNOLOGY, V111, P41, DOI 10.1111/j.1365-2567.2004.01781.x; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603	36	984	1017	10	259	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 28	2011	472	7344					476	U543		10.1038/nature09973	http://dx.doi.org/10.1038/nature09973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21525932	Green Accepted			2022-12-01	WOS:000289949600035
J	Modi, AC; Rausch, JR; Glauser, TA				Modi, Avani C.; Rausch, Joseph R.; Glauser, Tracy A.			Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; TREATMENT ADHERENCE; REPORTED ADHERENCE; PEDIATRIC-PATIENTS; CYSTIC-FIBROSIS; ASTHMA; TRAJECTORIES; MEDICATION; ADOLESCENTS; DEFINITION	Context Because of epilepsy's common occurrence, the narrow therapeutic and safety margins of antiepileptic medications, and the recognized complications of medication nonadherence in adults with epilepsy, identifying the rates, patterns, and predictors of nonadherence in children with epilepsy is imperative. The onset and evolution of antiepileptic drug nonadherence in children with newly diagnosed epilepsy remains unknown. Objectives To identify and characterize trajectories of adherence in children with newly diagnosed epilepsy over the first 6 months of therapy and to determine sociodemographic and epilepsy-specific predictors of adherence trajectories. Design, Setting, and Patients Prospective, longitudinal observational study of antiepileptic drug adherence in a consecutive cohort of 124 children (2-12 years old) with newly diagnosed epilepsy at Cincinnati Children's Hospital Medical Center. Patients were recruited from April 2006 through March 2009, and final data collection occurred in September 2009. Main Outcome Measure Objective adherence measured using electronic monitors. Results Fifty-eight percent of children with newly diagnosed epilepsy demonstrated persistent nonadherence during the first 6 months of therapy. Group-based trajectory models identified 5 differential adherence patterns (Bayesian information criterion=-23611.8): severe early nonadherence (13%; 95% confidence interval [CI], 8%-20%), severe delayed nonadherence (7%; 95% CI, 3%-12%), moderate nonadherence (13%; 95% CI, 8%-20%), mild nonadherence (26%; 95% CI, 19%-34%), and near-perfect adherence (42%; 95% CI, 33%-50%). The adherence pattern of most patients was established by the first month of therapy. Socioeconomic status was the sole predictor of adherence trajectory group status (chi(2)(4)=19.3 [n=115]; P<.001; partial r(2)=0.25), with lower socioeconomic status associated with higher nonadherence. Conclusion Five trajectory patterns were identified that captured the spectrum of nonadherence to antiepileptic drugs among children with newly diagnosed epilepsy; the patterns were significantly associated with socioeconomic status. JAMA. 2011;305(16):1669-1676 www.jama.com	[Modi, Avani C.; Rausch, Joseph R.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Glauser, Tracy A.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Modi, AC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave,MLC 7039 Adherence Ctr, Cincinnati, OH 45229 USA.	avani.modi@cchmc.org	Rausch, Joseph R/E-8107-2018	Modi, Avani/0000-0002-7580-3751	National Institutes of Health [K23HD057333]; ucb Pharma; Eisai; Upsher-Smith; Lundbeck; Sunovion; Supernus; Questcor; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ucb Pharma(UCB Pharma SA); Eisai(Eisai Co Ltd); Upsher-Smith; Lundbeck(Lundbeck Corporation); Sunovion; Supernus; Questcor; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Modi reports that she has been a consultant for Novartis Pharmaceuticals Inc, which has an interest in antiepileptic drugs. Dr Glauser reports that he is an advisor to, a speaker for, and has received research grants from companies with interests in antiepileptic drugs, including ucb Pharma, Eisai, Upsher-Smith, Lundbeck, Sunovion, Supernus, and Questcor. No other disclosures were reported.; This research was funded by grant K23HD057333 from the National Institutes of Health awarded to Dr Modi.	Adams CD, 2004, CURR ALLERGY ASTHM R, V4, P425, DOI 10.1007/s11882-004-0007-3; Al-Faris EA, 2002, SAUDI MED J, V23, P969; Asadi-Pooya AA, 2005, SEIZURE-EUR J EPILEP, V14, P393, DOI 10.1016/j.seizure.2005.05.003; Asato MR, 2009, J CHILD NEUROL, V24, P562, DOI 10.1177/0883073809332396; Bassili A, 2002, INT J QUAL HEALTH C, V14, P277, DOI 10.1093/intqhc/14.4.277; Berquist RK, 2006, PEDIATR TRANSPLANT, V10, P304, DOI 10.1111/j.1399-3046.2005.00451.x; Cohen J., 2003, APPL MULTIPLE REGRES; Conklin CA, 2005, NICOTINE TOB RES, V7, P533, DOI 10.1080/14622200500185371; Ettinger AB, 2009, EPILEPSY BEHAV, V14, P324, DOI 10.1016/j.yebeh.2008.10.021; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Fiese BH, 2005, J PEDIATR-US, V146, P171, DOI 10.1016/j.jpeds.2004.08.083; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Graves MM, 2007, CURR ALLERGY ASTHM R, V7, P427, DOI 10.1007/s11882-007-0065-4; HAYNES RB, 1976, LANCET, V1, P1265; Irvine L, 2002, EUR RESPIR J, V20, P1464, DOI 10.1183/09031936.02.00302102; Kahana S, 2008, J PEDIATR PSYCHOL, V33, P590, DOI 10.1093/jpepsy/jsm128; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Kyngas H, 2000, SEIZURE-EUR J EPILEP, V9, P598, DOI 10.1053/seiz.2000.0470; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; LUND L, 1974, ARCH NEUROL-CHICAGO, V31, P289, DOI 10.1001/archneur.1974.00490410037002; MATSUI D, 1994, J CLIN PHARMACOL, V34, P944, DOI 10.1002/j.1552-4604.1994.tb04009.x; Mitchell WG, 2000, EPILEPSIA, V41, P1616; Modi AC, 2011, SOC BEHAV EPILEPSY, P175; Modi AC, 2008, PEDIATRICS, V121, pE961, DOI 10.1542/peds.2007-1690; Modi AC, 2006, J PEDIATR PSYCHOL, V31, P846, DOI 10.1093/jpepsy/jsj096; Modi AC, 2011, J PEDIATR PSYCHOL, V36, P466, DOI 10.1093/jpepsy/jsq114; Modi AC, 2011, EPILEPSIA, V52, P370, DOI 10.1111/j.1528-1167.2010.02789.x; Modi AC, 2010, J PEDIATR PSYCHOL, V35, P1028, DOI 10.1093/jpepsy/jsq015; Modi AC, 2010, EPILEPSY BEHAV, V18, P94, DOI 10.1016/j.yebeh.2010.03.009; Modi AC, 2009, CHILD HEALTH CARE, V38, P107, DOI 10.1080/02739610902813245; MUELLER CW, 1981, CHILD DEV, V52, P13, DOI 10.2307/1129211; Mulvaney S, 2006, J AM ACAD CHILD PSY, V45, P737, DOI 10.1097/10.chi.0000214192.57993.06; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nagin D.S., 2005, GROUP BASED MODELING; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; NEUSPIEL DR, 1985, JAMA-J AM MED ASSOC, V254, P1321, DOI 10.1001/jama.254.10.1321; Pai ALH, 2010, PEDIATR TRANSPLANT, V14, P993, DOI 10.1111/j.1399-3046.2010.01391.x; Riekert KA, 2002, J CLIN PSYCHOL MED S, V9, P25, DOI 10.1023/A:1014131928789; Schurman JV, 2011, J PEDIATR PSYCHOL, V36, P116, DOI 10.1093/jpepsy/jsq046; Schwebel DC, 2007, J DEV BEHAV PEDIATR, V28, P245, DOI 10.1097/01.DBP.0000268561.80204.2a; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9	43	160	162	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1669	1676		10.1001/jama.2011.506	http://dx.doi.org/10.1001/jama.2011.506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	754XG	21521848	Green Accepted, Bronze			2022-12-01	WOS:000289890500020
J	Cousens, S; Blencowe, H; Stanton, C; Chou, D; Ahmed, S; Steinhardt, L; Creanga, AA; Tuncalp, O; Balsara, ZP; Gupta, S; Say, L; Lawn, JE				Cousens, Simon; Blencowe, Hannah; Stanton, Cynthia; Chou, Doris; Ahmed, Saifuddin; Steinhardt, Laura; Creanga, Andreea A.; Tuncalp, Oezge; Balsara, Zohra Patel; Gupta, Shivam; Say, Lale; Lawn, Joy E.			National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis	LANCET			English	Article							COUNTRIES; MORTALITY	Background Stillbirths do not count in routine worldwide data-collating systems or for the Millennium Development Goals. Two sets of national stillbirth estimates for 2000 produced similar worldwide totals of 3.2 million and 3.3 million, but rates differed substantially for some countries. We aimed to develop more reliable estimates and a time series from 1995 for 193 countries, by increasing input data, using recent data, and applying improved modelling approaches. Methods For international comparison, stillbirth is defined as fetal death in the third trimester (>= 1000 g birthweight or >= 28 completed weeks of gestation). Several sources of stillbirth data were identified and assessed against prespecified inclusion criteria: vital registration data; nationally representative surveys; and published studies identified through systematic literature searches, unpublished studies, and national data identified through a WHO country consultation process. For 2009, reported rates were used for 33 countries and model-based estimates for 160 countries. A regression model of log stillbirth rate was developed and used to predict national stillbirth rates from 1995 to 2009. Uncertainty ranges were obtained with a bootstrap approach. The final model included log(neonatal mortality rate) (cubic spline), log(low birthweight rate) (cubic spline), log(gross national income purchasing power parity) (cubic spline), region, type of data source, and definition of stillbirth. Findings Vital registration data from 79 countries, 69 nationally representative surveys from 39 countries, and 113 studies from 42 countries met inclusion criteria. The estimated number of global stillbirths was 2.64 million (uncertainty range 2.14 million to 3.82 million) in 2009 compared with 3.03 million (uncertainty range 2.37 million to 4.19 million) in 1995. Worldwide stillbirth rate has declined by 14.5%, from 22.1 stillbirths per 1000 births in 1995 to 18.9 stillbirths per 1000 births in 2009. In 2009,76.2% of stillbirths occurred in south Asia and sub-Saharan Africa. Interpretation This study draws attention to the dearth of reliable data in regions where most stillbirths occur. The estimated trend in stillbirth rate reduction is slower than that for maternal mortality and lags behind the increasing progress in reducing deaths in children younger than 5 years. Improved data and improved use of data are crucial to ensure that stillbirths count in global and national policy.	[Cousens, Simon; Blencowe, Hannah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Stanton, Cynthia; Ahmed, Saifuddin; Steinhardt, Laura; Creanga, Andreea A.; Tuncalp, Oezge; Balsara, Zohra Patel; Gupta, Shivam] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Chou, Doris; Say, Lale] WHO, CH-1211 Geneva, Switzerland; [Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Save the Children	Cousens, S (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	simon.cousens@lshtm.ac.uk	, lalesay/AAG-1912-2021; Tunçalp, Ӧzge/Y-2724-2018; Lawn, Joy/ABE-6382-2020; Blencowe, Hannah/K-7415-2012	Tunçalp, Ӧzge/0000-0002-5370-682X; Lawn, Joy/0000-0002-4573-1443; Blencowe, Hannah/0000-0003-1556-3159	Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children; International Stillbirth Alliance; Department of Reproductive Health and Research, WHO; WHO; World Bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children; International Stillbirth Alliance; Department of Reproductive Health and Research, WHO(World Health Organization); WHO(World Health Organization); World Bank(The World Bank India); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Bill & Melinda Gates Foundation through the Global Alliance to Prevent Prematurity and Stillbirth, Saving Newborn Lives/Save the Children, and the International Stillbirth Alliance. The Department of Reproductive Health and Research, WHO, through the UN Development Programme, UN Population Fund, WHO, and World Bank Special Programme of Research, Development and Research Training in Human Reproduction.	*AUSTR I HLTH WELF, NAT PER STAT UN; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *I NAT STAT ET EC, 1994, NES VIV ENF SANS VIE; *INF GES BUND, FED HLTH MON; Joint United Nations Programme on HIV/AIDS, UNAIDS REP GLOB AIDS; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; OESTERGAARD MZ, WORLD HLTH IN PRESS; *ORC MACR, DEM HLTH SURV; *ORC MACR, 2001, MOD A QUEST HIGH CON; *PLOS COLL, GLOB HLTH EST; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Scott J, 2011, LANCET, V377, P1386, DOI 10.1016/S0140-6736(11)60107-4; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; UNICEF, 2009, STAT WORLDS CHILDR; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; WHO, 1993, INT STAT CLASS DIS R, V2; WHO, COUNTD 2015 MAT NEWB; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471; World Bank, WORLD DEV IND 2008; World Health Organization, 2010, TRENDS MAT MORT 1990, P18; World Health Organization, 2006, NEON PER MORT YEAR 2	32	412	423	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1319	1330		10.1016/S0140-6736(10)62310-0	http://dx.doi.org/10.1016/S0140-6736(10)62310-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UE	21496917	Green Accepted			2022-12-01	WOS:000289962900033
J	Holm, TM; Habashi, JP; Doyle, JJ; Bedja, D; Chen, YC; van Erp, C; Lindsay, ME; Kim, D; Schoenhoff, F; Cohn, RD; Loeys, BL; Thomas, CJ; Patnaik, S; Marugan, JJ; Judge, DP; Dietz, HC				Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Bedja, Djahida; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Loeys, Bart L.; Thomas, Craig J.; Patnaik, Samarjit; Marugan, Juan J.; Judge, Daniel P.; Dietz, Harry C.			Noncanonical TGF beta Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice	SCIENCE			English	Article							N-TERMINAL KINASE; MOUSE MODEL; NOONANS-SYNDROME; ACTIVATION; RECEPTOR; CELLS; PATHOGENESIS; INHIBITOR; MUTATIONS; VALSALVA	Transforming growth factor-beta (TGF beta) signaling drives aneurysm progression in multiple disorders, including Marfan syndrome (MFS), and therapies that inhibit this signaling cascade are in clinical trials. TGF beta can stimulate multiple intracellular signaling pathways, but it is unclear which of these pathways drives aortic disease and, when inhibited, which result in disease amelioration. Here we show that extracellular signal-regulated kinase (ERK) 1 and 2 and Smad2 are activated in a mouse model of MFS, and both are inhibited by therapies directed against TGF beta. Whereas selective inhibition of ERK1/2 activation ameliorated aortic growth, Smad4 deficiency exacerbated aortic disease and caused premature death in MFS mice. Smad4-deficient MFS mice uniquely showed activation of Jun N-terminal kinase-1 (JNK1), and a JNK antagonist ameliorated aortic growth in MFS mice that lacked or retained full Smad4 expression. Thus, noncanonical (Smad-independent) TGF beta signaling is a prominent driver of aortic disease in MFS mice, and inhibition of the ERK1/2 or JNK1 pathways is a potential therapeutic strategy for the disease.	[Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Holm, Tammy M.; Habashi, Jennifer P.; Doyle, Jefferson J.; Chen, YiChun; van Erp, Christel; Lindsay, Mark E.; Kim, David; Schoenhoff, Florian; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Habashi, Jennifer P.; Lindsay, Mark E.; Cohn, Ronald D.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Bedja, Djahida] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Loeys, Bart L.] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Thomas, Craig J.; Patnaik, Samarjit; Marugan, Juan J.] NIH, Chem Genom Ctr, Rockville, MD 20850 USA; [Judge, Daniel P.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Ghent University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	Loeys, Bart/B-3236-2017; Doyle, Jefferson/C-3156-2013; Cohn, Ronald/AAC-5835-2021; Chen, Yi-Chun/H-4468-2013	Loeys, Bart/0000-0003-3703-9518; Judge, Daniel/0000-0002-3407-0248; Schoenhoff, Florian/0000-0002-3311-4595; Thomas, Craig/0000-0001-9386-9001	National Institutes of Health; Howard Hughes Medical Institute; National Marfan Foundation; Cellular and Molecular Medicine Training Program; National Human Genome Research Institute; Smilow Center for Marfan Syndrome Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135, P01AR049698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Marfan Foundation; Cellular and Molecular Medicine Training Program; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Smilow Center for Marfan Syndrome Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Institutes of Health (H. C. D. and D.P.J), Howard Hughes Medical Institute (H. C. D.), National Marfan Foundation (H. C. D., J.P.H., and J.J.D.), Cellular and Molecular Medicine Training Program (J.J.D.), National Human Genome Research Institute Intramural Research Program and the NIH Therapeutics for Rare and Neglected Diseases Program (C.J.T., S. P., and J.J.M.), and the Smilow Center for Marfan Syndrome Research (H. C. D.). We thank Dr. C. Deng for the Smad4-targeted mice. Johns Hopkins University and the authors (H. C. D., J.P.H., D.P.J., and R. C.) have filed a patent relating to the use of TGF beta antagonists, including angiotensin II type 1 receptor blockers, for the treatment of Marfan syndrome.	Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; MORGAN JM, 1989, EUR HEART J, V10, P190, DOI 10.1093/oxfordjournals.eurheartj.a059462; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Purnell R, 2005, EUR J CARDIO-THORAC, V28, P346, DOI 10.1016/j.ejcts.2005.05.004; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028; Xu XL, 2000, ONCOGENE, V19, P1868, DOI 10.1038/sj.onc.1203504; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	26	337	350	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					358	361		10.1126/science.1192149	http://dx.doi.org/10.1126/science.1192149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21493862	Green Accepted			2022-12-01	WOS:000289516600047
J	Stein, RA				Stein, Richard A.			Epigenetics-The Link Between Infectious Diseases and Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELLS		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Stein, RA (corresponding author), Princeton Univ, Dept Mol Biol, 1 Washington Rd,LTL 320, Princeton, NJ 08544 USA.	ras2@princeton.edu						DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; Fernandez AF, 2010, ONCOGENE, V29, P1405, DOI 10.1038/onc.2009.517; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Westra WH, 2009, HEAD NECK PATHOL, V3, P78, DOI 10.1007/s12105-009-0100-y; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	10	29	29	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1484	1485		10.1001/jama.2011.446	http://dx.doi.org/10.1001/jama.2011.446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486982				2022-12-01	WOS:000289424100028
J	Bhabha, G; Lee, J; Ekiert, DC; Gam, J; Wilson, IA; Dyson, HJ; Benkovic, SJ; Wright, PE				Bhabha, Gira; Lee, Jeeyeon; Ekiert, Damian C.; Gam, Jongsik; Wilson, Ian A.; Dyson, H. Jane; Benkovic, Stephen J.; Wright, Peter E.			A Dynamic Knockout Reveals That Conformational Fluctuations Influence the Chemical Step of Enzyme Catalysis	SCIENCE			English	Article							COLI DIHYDROFOLATE-REDUCTASE; ESCHERICHIA-COLI; LOOP; MOTIONS; COMPLEXES; MECHANISM	Conformational dynamics play a key role in enzyme catalysis. Although protein motions have clear implications for ligand flux, a role for dynamics in the chemical step of enzyme catalysis has not been clearly established. We generated a mutant of Escherichia coli dihydrofolate reductase that abrogates millisecond-time-scale fluctuations in the enzyme active site without perturbing its structural and electrostatic preorganization. This dynamic knockout severely impairs hydride transfer. Thus, we have found a link between conformational fluctuations on the millisecond time scale and the chemical step of an enzymatic reaction, with broad implications for our understanding of enzyme mechanisms and for design of novel protein catalysts.	[Bhabha, Gira; Ekiert, Damian C.; Wilson, Ian A.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Bhabha, Gira; Ekiert, Damian C.; Wilson, Ian A.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Lee, Jeeyeon; Gam, Jongsik; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Dyson, Jane/D-4160-2011	Dyson, Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223; Ekiert, Damian/0000-0002-2570-0404	National Institutes of Health (NIH) [GM75995, GM080209]; Skaggs Institute of Chemical Biology; NIH National Institute of General Medical Sciences (NIGMS) [U54 GM094586]; Achievement Rewards for College Scientists Foundation; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075995, T32GM080209, U54GM094586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute of Chemical Biology; NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); Achievement Rewards for College Scientists Foundation(General Electric); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge L. Tuttle for invaluable discussions, S. Bae for NMR data on the S148A mutant, H. Tien and D. Marciano of the Robotics Core at the Joint Center for Structural Genomics (JCSG) for automated crystal screening, and X. Dai for technical assistance with crystallographic data collection. This work was supported by the National Institutes of Health (NIH) grant GM75995 and the Skaggs Institute of Chemical Biology. The JCSG is supported by NIH National Institute of General Medical Sciences (NIGMS) (U54 GM094586). D. C. E. is supported by a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation and grant GM080209 from the NIH Molecular Evolution Training Program. The GM/CA CAT 23-ID-D has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or NIH. Coordinates and structure factors of N23PP/S148A ecDHFR and 1RX2-re-refined are deposited in PDB (code 3QL0 and 3QL3). G. B. and P. E. W. designed the research. G. B. performed NMR experiments. G. B. and D. C. E. performed crystallography experiments and structure refinement. I. A. W. supervised structure refinement. J.L. and J.G. performed kinetic experiments and analysis. G. B., P. E. W., and S.J.B. analyzed and interpreted the data. G. B., P. E. W., and J.L. wrote the manuscript. I. A. W., H.J.D., and S.J.B. edited the manuscript.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; DAVIES JF, 1990, BIOCHEMISTRY-US, V29, P9467, DOI 10.1021/bi00492a021; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Khavrutskii IV, 2007, PROTEIN SCI, V16, P1087, DOI 10.1110/ps.062724307; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miller GP, 2001, BIOCHEMISTRY-US, V40, P867, DOI 10.1021/bi001608n; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; Osborne MJ, 2003, PROTEIN SCI, V12, P2230, DOI 10.1110/ps.03219603; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821	26	345	345	4	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					234	238		10.1126/science.1198542	http://dx.doi.org/10.1126/science.1198542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474759	Green Accepted			2022-12-01	WOS:000289251100051
J	Deutsch, C; Brix, H; Ito, T; Frenzel, H; Thompson, L				Deutsch, Curtis; Brix, Holger; Ito, Taka; Frenzel, Hartmut; Thompson, LuAnne			Climate-Forced Variability of Ocean Hypoxia	SCIENCE			English	Article							NORTH PACIFIC; ARABIAN SEA; DENITRIFICATION; NITROGEN; RATIOS; WATERS	Oxygen (O-2) is a critical constraint on marine ecosystems. As oceanic O-2 falls to hypoxic concentrations, habitability for aerobic organisms decreases rapidly. We show that the spatial extent of hypoxia is highly sensitive to small changes in the ocean's O-2 content, with maximum responses at suboxic concentrations where anaerobic metabolisms predominate. In model-based reconstructions of historical oxygen changes, the world's largest suboxic zone, in the Pacific Ocean, varies in size by a factor of 2. This is attributable to climate-driven changes in the depth of the tropical and subtropical thermocline that have multiplicative effects on respiration rates in low-O-2 water. The same mechanism yields even larger fluctuations in the rate of nitrogen removal by denitrification, creating a link between decadal climate oscillations and the nutrient limitation of marine photosynthesis.	[Deutsch, Curtis; Brix, Holger; Frenzel, Hartmut] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Ito, Taka] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Thompson, LuAnne] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; Colorado State University; University of Washington; University of Washington Seattle	Deutsch, C (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	cdeutsch@atmos.ucla.edu	Thompson, LuAnne/AAA-1000-2020; Ito, Takamitsu/F-3856-2010	Thompson, LuAnne/0000-0001-8295-0533; Ito, Takamitsu/0000-0001-9873-099X; Brix, Holger/0000-0003-4229-6164	Gordon and Betty Moore Foundation; NSF [OCE-0851483, OCE-0851497]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF))	Supported by a grant from the Gordon and Betty Moore Foundation (C. D.) and NSF grants OCE-0851483 (C. D.) and OCE-0851497 (T.I.).	ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Castro CG, 2001, GLOBAL BIOGEOCHEM CY, V15, P819, DOI 10.1029/2000GB001324; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Emerson S, 2004, J OCEANOGR, V60, P139, DOI 10.1023/B:JOCE.0000038323.62130.a0; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Garcia H., 2006, NOAA ATLAS NESDROS I, V63; Hallberg R, 2006, J PHYS OCEANOGR, V36, P2232, DOI 10.1175/JPO2980.1; Ito T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041595; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Mecking S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003101; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007	27	234	239	3	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					336	339		10.1126/science.1202422	http://dx.doi.org/10.1126/science.1202422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21659566				2022-12-01	WOS:000292732000041
J	Smart, N; Bollini, S; Dube, KN; Vieira, JM; Zhou, B; Davidson, S; Yellon, D; Riegler, J; Price, AN; Lythgoe, MF; Pu, WT; Riley, PR				Smart, Nicola; Bollini, Sveva; Dube, Karina N.; Vieira, Joaquim M.; Zhou, Bin; Davidson, Sean; Yellon, Derek; Riegler, Johannes; Price, Anthony N.; Lythgoe, Mark F.; Pu, William T.; Riley, Paul R.			De novo cardiomyocytes from within the activated adult heart after injury	NATURE			English	Article							EPICARDIAL PROGENITORS; SMOOTH-MUSCLE; NEOVASCULARIZATION; LINEAGE; CELLS; TBX18	A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable source of stem/progenitor cells that could contribute new muscle after ischaemic heart disease and acute myocardial infarction(1). A therapeutic ideal-relative to cell transplantation-would be to stimulate a resident source, thus avoiding the caveats of limited graft survival, restricted homing to the site of injury and host immune rejection. Here we demonstrate in mice that the adult heart contains a resident stem or progenitor cell population, which has the potential to contribute bona fide terminally differentiated cardiomyocytes after myocardial infarction. We reveal a novel genetic label of the activated adult progenitors via re-expression of a key embryonic epicardial gene, Wilm's tumour 1 (Wt1), through priming by thymosin beta 4, a peptide previously shown to restore vascular potential to adult epicardium-derived progenitor cells(2) with injury. Cumulative evidence indicates an epicardial origin of the progenitor population, and embryonic reprogramming results in the mobilization of this population and concomitant differentiation to give rise to de novo cardiomyocytes. Cell transplantation confirmed a progenitor source and chromosome painting of labelled donor cells revealed transdifferentiation to a myocyte fate in the absence of cell fusion. Derived cardiomyocytes are shown here to structurally and functionally integrate with resident muscle; as such, stimulation of this adult progenitor pool represents a significant step towards resident-cell-based therapy in human ischaemic heart disease.	[Smart, Nicola; Bollini, Sveva; Dube, Karina N.; Vieira, Joaquim M.; Riley, Paul R.] UCL Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Zhou, Bin; Pu, William T.] Childrens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Zhou, Bin; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Zhou, Bin; Pu, William T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Beijing 20031, Peoples R China; [Davidson, Sean; Yellon, Derek] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [Riegler, Johannes; Lythgoe, Mark F.] UCL, Dept Med, Ctr Adv Biomed Imaging CABI, London WC1E 6DD, England; [Riegler, Johannes; Lythgoe, Mark F.] UCL, Inst Child Hlth, London WC1E 6DD, England; [Riegler, Johannes] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London WC1E 6BT, England; [Price, Anthony N.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Fac Med, London W12 0NN, England	University of London; University College London; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Riley, PR (corresponding author), UCL Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England.	p.riley@ich.ucl.ac.uk	Bollini, Sveva/J-6004-2016; Yellon, Derek M/ABD-5110-2021; Smart, Nicola/AAN-4011-2020; Pu, William/AAJ-8301-2020; Davidson, Sean M/F-5275-2010; Smart, Nicola/AAD-3874-2020	Bollini, Sveva/0000-0003-1076-0823; Pu, William/0000-0002-4551-8079; Davidson, Sean M/0000-0001-5182-4980; Smart, Nicola/0000-0002-3501-7254; Vieira, Joaquim/0000-0003-2023-6304; Yellon, Derek/0000-0001-7791-9320; Lythgoe, Mark/0000-0002-4945-0171; Zhou, Bin/0000-0001-5278-5522; Price, Anthony/0000-0002-6907-7554	British Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100401] Funding Source: NIH RePORTER; EPSRC [EP/I014667/1] Funding Source: UKRI; MRC [G0700933] Funding Source: UKRI; British Heart Foundation [RG/08/015/26411, PG/10/005/28175, RG/08/003/25264, FS/08/004/23625] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I014667/1] Funding Source: researchfish; Medical Research Council [G0700933] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the British Heart Foundation. We are grateful to F. Costantini and S. Srinivas for providing the R26R-EYFP mouse strain, to B. Vernay for assistance with confocal microscopy and A. Eddaoudi, P. Chana and A. Angheluta for assistance in flow cytometry. We thank A. Taylor and V. Muthurangu for functional interpretation of MRI data and RegeneRx Biopharmaceuticals for provision of clinical grade T beta 4.	Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen J, 1998, DEVELOPMENT, V125, P1943; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Heiberg E, 2005, COMPUT CARDIOL, V32, P599; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Price A., 2010, J CARDIOVASC MAGN S1, V12, pP98; Rubart M, 2003, AM J PHYSIOL-CELL PH, V284, pC1654, DOI 10.1152/ajpcell.00469.2002; Smart N., 2009, CURR PROTOC STEM CEL; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Willems E, 2009, PEDIATR CARDIOL, V30, P635, DOI 10.1007/s00246-009-9409-2; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	24	479	500	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					640	U117		10.1038/nature10188	http://dx.doi.org/10.1038/nature10188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21654746	Bronze, Green Accepted			2022-12-01	WOS:000292204300039
J	Taveira-DaSilva, AM; Hathaway, O; Stylianou, M; Moss, J				Taveira-DaSilva, Angelo M.; Hathaway, Olanda; Stylianou, Mario; Moss, Joel			Changes in Lung Function and Chylous Effusions in Patients With Lymphangioleiomyomatosis Treated With Sirolimus	ANNALS OF INTERNAL MEDICINE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; GENE-PRODUCTS; MOUSE MODELS; IFN-GAMMA; RAPAMYCIN; LAM; CHYLOTHORAX; DISEASE; WOMEN	Background: Lymphangioleiomyomatosis (LAM) is a disorder that affects women and is characterized by cystic lung destruction, chylous effusions, lymphangioleiomyomas, and angiomyolipomas. It is caused by proliferation of abnormal smooth muscle-like cells. Sirolimus is a mammalian target of rapamycin inhibitor that has been reported to decrease the size of neoplastic growths in animal models of tuberous sclerosis complex and to reduce the size of angiomyolipomas and stabilize lung function in humans. Objective: To assess whether sirolimus therapy is associated with improvement in lung function and a decrease in the size of chylous effusions and lymphangioleiomyomas in patients with LAM. Design: Observational study. Setting: The National Institutes of Health Clinical Center. Patients: 19 patients with rapidly progressing LAM or chylous effusions. Intervention: Treatment with sirolimus. Measurements: Lung function and the size of chylous effusions and lymphangioleiomyomas before and during sirolimus therapy. Results: Over a mean of 2.5 years before beginning sirolimus therapy, the mean (+/- SE) FEV1 decreased by 2.8% +/- 0.8% predicted and diffusing capacity of the lung for carbon monoxide (DLCO) decreased by 4.8% +/- 0.9% predicted per year. In contrast, over a mean of 2.6 years of sirolimus therapy, the mean (+/- SE) FEV1 increased by 1.8% +/- 0.5% predicted and DLCO increased by 0.8% +/- 0.5% predicted per year (P < 0.001). After beginning sirolimus therapy, 12 patients with chylous effusions and 11 patients with lymphangioleiomyomas experienced almost complete resolution of these conditions. In 2 of the 12 patients, sirolimus therapy enabled discontinuation of pleural fluid drainage. Limitations: This was an observational study. The resolution of effusions may have affected improvements in lung function. Conclusion: Sirolimus therapy is associated with improvement or stabilization of lung function and reduction in the size of chylous effusions and lymphangioleiomyomas in patients with LAM.	[Taveira-DaSilva, Angelo M.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Taveira-DaSilva, AM (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10,Room 6D05,MSC 1590, Bethesda, MD 20892 USA.	dasilvaa@nhlbi.nih.gov			NHLBI, NIH [95-H-0186]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541] Funding Source: NIH RePORTER	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the Intramural Research Program, NHLBI, NIH (protocol 95-H-0186).	Almoosa KF, 2006, CLIN CHEST MED, V27, P355, DOI 10.1016/j.ccm.2006.01.005; Avila NA, 2000, RADIOLOGY, V216, P147, DOI 10.1148/radiology.216.1.r00jl42147; Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cohen MM, 2005, THORAX, V60, P875, DOI 10.1136/thx.2004.035154; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Glasgow Connie G., 2009, Lymphatic Research and Biology, V7, P221, DOI 10.1089/lrb.2009.0017; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2008, J CELL BIOCHEM, V103, P369, DOI 10.1002/jcb.21419; Gupta Dipin, 2004, Ann Thorac Surg, V78, pe9, DOI 10.1016/j.athoracsur.2003.12.069; Hayashida M, 2007, RESPIROLOGY, V12, P523, DOI 10.1111/j.1440-1843.2007.01101.x; Jaiswal VR, 2003, ARCH PATHOL LAB MED, V127, P879; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Krymskaya VP, 2009, CELL CYCLE, V8, P403, DOI 10.4161/cc.8.3.7555; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Lazor R, 2004, RESP MED, V98, P536, DOI 10.1016/j.rmed.2003.11.013; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lu HC, 2003, CLIN IMAG, V27, P166, DOI 10.1016/S0899-7071(01)00349-7; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Makrilakis K, 2004, ANN INTERN MED, V141, P246, DOI 10.7326/0003-4819-141-3-200408030-00028; Matsui K, 2000, HUM PATHOL, V31, P1242, DOI 10.1053/hupa.2000.18500; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Mikroulis D, 2002, CHEST, V121, P2079, DOI 10.1378/chest.121.6.2079; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; NELLIST M, 1993, CELL, V75, P1305; Ohara T, 2008, ANN THORAC SURG, V86, pE7, DOI 10.1016/j.athoracsur.2008.07.062; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; Ryu JH, 2003, CHEST, V123, P623, DOI 10.1378/chest.123.2.623; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Sooriakumaran P, 2010, BJU INT, V105, P101, DOI 10.1111/j.1464-410X.2009.08649.x; Sugimoto R, 2008, J HEART LUNG TRANSPL, V27, P921, DOI 10.1016/j.healun.2008.05.012; Taille C, 2007, ANN INTERN MED, V146, P687, DOI 10.7326/0003-4819-146-9-200705010-00022; Taveira-DaSilva AM, 2004, CHEST, V126, P1867, DOI 10.1378/chest.126.6.1867; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wong YY, 2003, AM J ROENTGENOL, V181, P284, DOI 10.2214/ajr.181.1.1810284	45	138	142	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					797	805		10.7326/0003-4819-154-12-201106210-00007	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690594	Green Accepted			2022-12-01	WOS:000291800500015
J	Smith, DL; Cohen, JM; Moonen, B; Tatem, AJ; Sabot, OJ; Ali, A; Mugheiry, SM				Smith, David L.; Cohen, Justin M.; Moonen, Bruno; Tatem, Andrew J.; Sabot, Oliver J.; Ali, Abdullah; Mugheiry, Sultan M.			Solving the Sisyphean Problem of Malaria in Zanzibar	SCIENCE			English	Editorial Material							ELIMINATION		[Smith, David L.; Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Smith, David L.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Cohen, Justin M.; Moonen, Bruno; Sabot, Oliver J.] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Ali, Abdullah] Zanzibar Malaria Control Programme, Zanzibar, Tanzania; [Mugheiry, Sultan M.] Hlth & Social Welf, Zanzibar, Tanzania	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Smith, DL (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.	smitdave@gmail.com	Smith, David L/L-8850-2013	Smith, David L/0000-0003-4367-3849; Tatem, Andrew/0000-0002-7270-941X; Cohen, Justin/0000-0003-4481-6784				Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Feachem RG., 2009, SHRINKING MALARIA MA; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; MATOLA YG, 1984, CENT AFR J MED, V30, P95; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; OAKES A, 1900, BRIT FOREIGN STATE P; RBMP, 2008, GLOB MAL ACT PLAN MA; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zanzibar Malaria Control Programme (ZMCP), 2008, ROLL BACK MAL IND SU; *ZMCP, 2009, MAL EL ZANZ FEAS ASS; *ZMCP, 2011, ROLL BACK MAL IND SU	15	27	28	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1384	1385		10.1126/science.1201398	http://dx.doi.org/10.1126/science.1201398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778FT	21680828				2022-12-01	WOS:000291689000024
J	Issigonis, M; Matunis, E				Issigonis, Melanie; Matunis, Erika			SnapShot: Stem Cell Niches of the Drosophila Testis and Ovary	CELL			English	Editorial Material							DIVISION		[Issigonis, Melanie; Matunis, Erika] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Issigonis, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.				NCRR NIH HHS [S10 RR024550] Funding Source: Medline; NICHD NIH HHS [R01 HD040307] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Cheng J, 2011, DEVELOPMENT, V138, P831, DOI 10.1242/dev.057901; DECUEVAS M, 2011, DEV IN PRESS, V138, DOI DOI 10.1242/DEV.056242; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Ueishi S, 2009, CELL STRUCT FUNCT, V34, P61, DOI 10.1247/csf.08042; Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313	10	9	9	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					994	U197		10.1016/j.cell.2011.05.037	http://dx.doi.org/10.1016/j.cell.2011.05.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663800	Bronze			2022-12-01	WOS:000291461600025
J	Scott, CT; McCormick, JB; DeRouen, MC; Owen-Smith, J				Scott, Christopher Thomas; McCormick, Jennifer B.; DeRouen, Mindy C.; Owen-Smith, Jason			Democracy Derived? New Trajectories in Pluripotent Stem Cell Research	CELL			English	Editorial Material								How has the development of human induced pluripotent stem cells (hiPSCs) modified the trajectory of stem cell research? Here, coauthorship networks of stem cell research articles and analysis of cell lines used in stem cell research indicate that hiPSCs are not replacing human embryonic stem cells, but instead, the two cell types are complementary, interdependent research tools. Thus, we conclude that a ban on funding for embryonic stem cell research could have unexpected negative ramifications on the nascent field of hiPSCs.	[Scott, Christopher Thomas; DeRouen, Mindy C.] Stanford Univ, Stanford Univ Ctr Biomed Eth Program Stem Cells &, Stanford, CA 94305 USA; [McCormick, Jennifer B.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [McCormick, Jennifer B.] Mayo Clin, Div Hlth Care Policy Res, Rochester, MN 55905 USA; [Owen-Smith, Jason] Univ Michigan, Ann Arbor, MI 48109 USA	Stanford University; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan	Scott, CT (corresponding author), Stanford Univ, Stanford Univ Ctr Biomed Eth Program Stem Cells &, Stanford, CA 94305 USA.	cscott@stanford.edu; jdos@umich.edu	McBee, David J/F-3968-2012; Owen-Smith, Jason/B-3665-2012	DeRouen, Mindy/0000-0002-7198-7629; Owen-Smith, Jason/0000-0001-8007-1121	NCRR NIH HHS [UL1 RR024150, UL1 RR024150-4] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Karmali RN, 2010, NAT BIOTECHNOL, V28, P1246, DOI 10.1038/nbt1210-1246; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Moody J, 2004, AM SOCIOL REV, V69, P213, DOI 10.1177/000312240406900204; Mosher JT, 2010, NEW ENGL J MED, V362, P183, DOI 10.1056/NEJMc0910371; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Scott CT, 2010, NAT METHODS, V7, P866, DOI 10.1038/nmeth1110-866; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	14	33	34	5	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					820	826		10.1016/j.cell.2011.05.032	http://dx.doi.org/10.1016/j.cell.2011.05.032			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663787	Bronze, Green Accepted			2022-12-01	WOS:000291461600009
J	Banwart, S				Banwart, Steve			Save our soils	NATURE			English	Editorial Material									[Banwart, Steve] Univ Sheffield, Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England	University of Sheffield	Banwart, S (corresponding author), Univ Sheffield, Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England.	s.a.banwart@sheffield.ac.uk	Banwart, Steven/B-3915-2016; Robinson, David A/A-6287-2010	Banwart, Steven/0000-0001-7223-6678; Robinson, David A/0000-0001-7290-4867				Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; [Anonymous], 2006, 10 EEA; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; European Commission, 2006, COM2006231 EUR COMM; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Shein E.V., 2005, KURS FIZIKI POCHV UC	7	125	134	3	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					151	152		10.1038/474151a	http://dx.doi.org/10.1038/474151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21654781	Green Accepted			2022-12-01	WOS:000291397800025
J	Roeling, D; Morelli, LG; Ares, S; Julicher, F; Oates, AC				Roeling, Daniela; Morelli, Luis G.; Ares, Saul; Juelicher, Frank; Oates, Andrew C.			SnapShpt: The Segmentation Clock	CELL			English	Editorial Material							SOMITOGENESIS; NUMBER		[Roeling, Daniela; Morelli, Luis G.; Oates, Andrew C.] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Ares, Saul; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Max Planck Society; Max Planck Society	Roeling, D (corresponding author), Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany.		Morelli, Luis G/A-6345-2009; Ares, Saúl/B-4082-2008; Julicher, Frank/B-1828-2009	Morelli, Luis G/0000-0001-5614-073X; Ares, Saúl/0000-0001-6214-4083; Julicher, Frank/0000-0003-4731-9185				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; KROL AJ, 2011, IN PRESS; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Schroter C, 2010, CURR BIOL, V20, P1254, DOI 10.1016/j.cub.2010.05.071	12	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					800	+		10.1016/j.cell.2011.05.007	http://dx.doi.org/10.1016/j.cell.2011.05.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620141	Bronze			2022-12-01	WOS:000291018600018
J	Rappuoli, R; Aderem, A				Rappuoli, Rino; Aderem, Alan			A 2020 vision for vaccines against HIV, tuberculosis and malaria	NATURE			English	Article							CELL-MEDIATED-IMMUNITY; YELLOW-FEVER VACCINE; DOUBLE-BLIND; SYSTEMS BIOLOGY; EFFICACY; DESIGN; ANTIBODIES; TRIAL; IMMUNOGENICITY; IMMUNIZATION	Acquired immune deficiency syndrome (AIDS), malaria and tuberculosis collectively cause more than five million deaths per year, but have nonetheless eluded conventional vaccine development; for this reason they represent one of the major global public health challenges as we enter the second decade of the twenty-first century. Recent trials have provided evidence that it is possible to develop vaccines that can prevent infection by human immunodeficiency virus (HIV) and malaria. Furthermore, advances in vaccinology, including novel adjuvants, prime-boost regimes and strategies for intracellular antigen presentation, have led to progress in developing a vaccine against tuberculosis. Here we discuss these advances and suggest that new tools such as systems biology and structure-based antigen design will lead to a deeper understanding of mechanisms of protection which, in turn, will lead to rational vaccine development. We also argue that new and innovative approaches to clinical trials will accelerate the availability of these vaccines.	[Rappuoli, Rino] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Novartis; Center for Infectious Disease Research	Rappuoli, R (corresponding author), Novartis Vaccines & Diagnost, I-53100 Siena, Italy.	rino.rappuoli@novartis.com	Rivet, Catherine A/M-7978-2014					Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2010, MILL DEV GOALS REP; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Calmette A, 1927, VACCINATION PREVENTI; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Corey L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001863; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Freidlin B, 2005, CLIN CANCER RES, V11, P7872, DOI 10.1158/1078-0432.CCR-05-0605; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HORWITZ MA, 2010, NEW GENERATION VACCI; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Masignani V, 2003, VACCINE, V21, pS110, DOI 10.1016/S0264-410X(03)00209-3; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; O'Hallahan J, 2009, NEW ZEAL MED J, V122, P48; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Palermo RE, 2011, J VIROL, V85, P1099, DOI 10.1128/JVI.01522-10; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; SCARSELLI M, SCI TRANSL IN PRESS; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, 2010, MDG6 COMB HIV AIDS M; WHO, 2010, GLOB TUB CONTR 2010; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x	58	191	199	0	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					463	469		10.1038/nature10124	http://dx.doi.org/10.1038/nature10124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21614073	Bronze			2022-12-01	WOS:000290951300031
J	Narita, M; Young, ARJ; Arakawa, S; Samarajiwa, SA; Nakashima, T; Yoshida, S; Hong, SK; Berry, LS; Reichelt, S; Ferreira, M; Tavare, S; Inoki, K; Shimizu, S; Narita, M				Narita, Masako; Young, Andrew R. J.; Arakawa, Satoko; Samarajiwa, Shamith A.; Nakashima, Takayuki; Yoshida, Sei; Hong, Sungki; Berry, Lorraine S.; Reichelt, Stefanie; Ferreira, Manuela; Tavare, Simon; Inoki, Ken; Shimizu, Shigeomi; Narita, Masashi			Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes	SCIENCE			English	Article							RAG GTPASES; PROTEIN; COMPLEX	Protein synthesis and autophagic degradation are regulated in an opposite manner by mammalian target of rapamycin (mTOR), whereas under certain conditions it would be beneficial if they occurred in unison to handle rapid protein turnover. We observed a distinct cellular compartment at the trans side of the Golgi apparatus, the TOR-autophagy spatial coupling compartment (TASCC), where (auto)lysosomes and mTOR accumulated during Ras-induced senescence. mTOR recruitment to the TASCC was amino acid-and Rag guanosine triphosphatase-dependent, and disruption of mTOR localization to the TASCC suppressed interleukin-6/8 synthesis. TASCC formation was observed during macrophage differentiation and in glomerular podocytes; both displayed increased protein secretion. The spatial coupling of cells' catabolic and anabolic machinery could augment their respective functions and facilitate the mass synthesis of secretory proteins.	[Narita, Masako; Young, Andrew R. J.; Samarajiwa, Shamith A.; Nakashima, Takayuki; Berry, Lorraine S.; Reichelt, Stefanie; Ferreira, Manuela; Tavare, Simon; Narita, Masashi] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Arakawa, Satoko; Shimizu, Shigeomi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol & Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Samarajiwa, Shamith A.; Tavare, Simon] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Yoshida, Sei; Hong, Sungki; Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol & Internal Med, Inst Life Sci, Ann Arbor, MI 48109 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Tokyo Medical & Dental University (TMDU); University of Cambridge; University of Michigan System; University of Michigan	Narita, M (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	masashi.narita@cancer.org.uk; masashi.narita@cancer.org.uk	Samarajiwa, Shamith/B-1601-2013; Ferreira, Manuela/AAF-5299-2020; Ferreira, Manuela/I-7904-2018; Arakawa, Satoko/AAM-9638-2020	Samarajiwa, Shamith/0000-0003-1046-0601; Ferreira, Manuela/0000-0001-9498-8061; Ferreira, Manuela/0000-0001-9498-8061; Arakawa, Satoko/0000-0002-4375-1643; Reichelt, Stefanie/0000-0003-4151-0712; Young, Andrew/0000-0002-7522-5525; Narita, Masako/0000-0002-9774-4908; Ferreira, Manuela/0000-0002-0075-2400; Yoshida, Sei/0000-0002-4771-3900; Narita, Masashi/0000-0001-7764-577X	Univ. of Cambridge; Cancer Research UK; Hutchison Whampoa; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation; Juvenile Diabetes Research Foundation; NIH [DK083491]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491] Funding Source: NIH RePORTER; Cancer Research UK [19556] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22770054, 23657084] Funding Source: KAKEN	Univ. of Cambridge; Cancer Research UK(Cancer Research UK); Hutchison Whampoa; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Ryan, N. Mizushima, F. Watt, and R. Rios for reagents; R. Rios, D. Tuveson, T. Kanaseki, I. Mills, N. Dolman, and members of Narita lab for helpful discussion; L. Blackburn for editing; CRI's Genomics, Bioinformatics, Microscopy (J. Harris), and Histopathology facilities for technical support; and the Gurdon Institute's microscopy facility (A. Sossick) for optical microscopy experimental. This work was supported by the Univ. of Cambridge; Cancer Research UK; Hutchison Whampoa; Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan; the Program for Promotion of Fundamental Studies in the National Institute of Biomedical Innovation (S.A. and S.S.); and Juvenile Diabetes Research Foundation Award and NIH grant DK083491 (K.I.). Expression data are available at the National Center for Biotechnology Information Gene Expression Omnibus under accession number GSE28464.	Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	13	368	379	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					966	970		10.1126/science.1205407	http://dx.doi.org/10.1126/science.1205407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21512002	Green Accepted			2022-12-01	WOS:000290766600044
J	Astrow, AB; Popp, B				Astrow, Alan B.; Popp, Beth			The Palliative Care Information Act in Real Life	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Astrow, Alan B.; Popp, Beth] Maimonides Hosp, Brooklyn, NY 11219 USA	Maimonides Medical Center	Astrow, AB (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.								0	28	28	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2011	364	20					1885	1887		10.1056/NEJMp1102392	http://dx.doi.org/10.1056/NEJMp1102392			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	765PJ	21591941				2022-12-01	WOS:000290720700001
J	Schwanhausser, B; Busse, D; Li, N; Dittmar, G; Schuchhardt, J; Wolf, J; Chen, W; Selbach, M				Schwanhaeusser, Bjoern; Busse, Dorothea; Li, Na; Dittmar, Gunnar; Schuchhardt, Johannes; Wolf, Jana; Chen, Wei; Selbach, Matthias			Global quantification of mammalian gene expression control	NATURE			English	Article							QUANTITATIVE PROTEOMICS; NUCLEOTIDE RESOLUTION; REGULATORY NETWORKS; IN-VIVO; PROTEIN; DYNAMICS; TRANSLATION; TRANSCRIPTION; STABILITY; CELLS	Gene expression is a multistep process that involves the transcription, translation and turnover of messenger RNAs and proteins. Although it is one of the most fundamental processes of life, the entire cascade has never been quantified on a genome-wide scale. Here we simultaneously measured absolute mRNA and protein abundance and turnover by parallel metabolic pulse labelling for more than 5,000 genes in mammalian cells. Whereas mRNA and protein levels correlated better than previously thought, corresponding half-lives showed no correlation. Using a quantitative model we have obtained the first genome-scale prediction of synthesis rates of mRNAs and proteins. We find that the cellular abundance of proteins is predominantly controlled at the level of translation. Genes with similar combinations of mRNA and protein stability shared functional properties, indicating that half-lives evolved under energetic and dynamic constraints. Quantitative information about all stages of gene expression provides a rich resource and helps to provide a greater understanding of the underlying design principles.	[Schwanhaeusser, Bjoern; Busse, Dorothea; Li, Na; Dittmar, Gunnar; Wolf, Jana; Chen, Wei; Selbach, Matthias] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Schuchhardt, Johannes] MicroDiscovery GmbH, D-10405 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Wolf, J (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	jana.wolf@mdc-berlin.de; wei.chen@mdc-berlin.de; matthias.selbach@mdc-berlin.de	Chen, Wei/C-1273-2011; Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016; Selbach, Matthias/C-5988-2008	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Li, Na/0000-0001-6163-1648; Chen, Wei/0000-0003-3263-1627	Helmholtz Association; German Ministry of Education and Research (BMBF); Senate of Berlin by Berlin Institute of Medical Systems Biology (BIMSB) [315362A]; German Ministry of Education and Research [315289]; Helmholtz Alliance on Systems Biology/MSBN; China Scholarship Council CSC	Helmholtz Association(Helmholtz Association); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Senate of Berlin by Berlin Institute of Medical Systems Biology (BIMSB); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance on Systems Biology/MSBN; China Scholarship Council CSC(China Scholarship Council)	We thank N. Rajewsky and L. Dolken for fruitful discussions and C. Sommer for technical assistance. M.S. and W.C. are supported by the Helmholtz Association, the German Ministry of Education and Research (BMBF) and the Senate of Berlin by funds aimed at establishing the Berlin Institute of Medical Systems Biology (BIMSB) (grant number 315362A). J.W. is supported by the ForSys-programme of the German Ministry of Education and Research (grant number 315289); D.B. by the Helmholtz Alliance on Systems Biology/MSBN; and N.L. by the China Scholarship Council CSC.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Beynon RJ, 2005, MOL CELL PROTEOMICS, V4, P857, DOI 10.1074/mcp.R400010-MCP200; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; de-Leon SBT, 2009, DEV BIOL, V325, P317, DOI 10.1016/j.ydbio.2008.10.043; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gouw JW, 2010, MOL CELL PROTEOMICS, V9, P11, DOI 10.1074/mcp.R900001-MCP200; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	44	3874	3953	22	673	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					337	342		10.1038/nature10098	http://dx.doi.org/10.1038/nature10098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593866	Green Accepted			2022-12-01	WOS:000290722400040
J	Iheanacho, I				Iheanacho, Ike			DRUG TALES AND OTHER STORIES Take it like a man: pseudodrugs for man flu	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	1	1	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2011	342								d2863	10.1136/bmj.d2863	http://dx.doi.org/10.1136/bmj.d2863			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	765OP	21562005				2022-12-01	WOS:000290718400004
J	Green, RA; Kao, HL; Audhya, A; Arur, S; Mayers, JR; Fridolfsson, HN; Schulman, M; Schloissnig, S; Niessen, S; Laband, K; Wang, SH; Starr, DA; Hyman, AA; Schedl, T; Desai, A; Piano, F; Gunsalus, KC; Oegema, K				Green, Rebecca A.; Kao, Huey-Ling; Audhya, Anjon; Arur, Swathi; Mayers, Jonathan R.; Fridolfsson, Heidi N.; Schulman, Monty; Schloissnig, Siegfried; Niessen, Sherry; Laband, Kimberley; Wang, Shaohe; Starr, Daniel A.; Hyman, Anthony A.; Schedl, Tim; Desai, Arshad; Piano, Fabio; Gunsalus, Kristin C.; Oegema, Karen			A High-Resolution C. elegans Essential Gene Network Based on Phenotypic Profiling of a Complex Tissue	CELL			English	Article							FUNCTIONAL GENOMIC ANALYSIS; WIDE RNAI SCREENS; NUCLEAR-ENVELOPE; INTERACTOME NETWORK; CELL-DIVISION; CHROMOSOME-I; KINETOCHORE; MICROSCOPY; OVARY; MAP	High-content screening for gene profiling has generally been limited to single cells. Here, we explore an alternative approach-profiling gene function by analyzing effects of gene knockdowns on the architecture of a complex tissue in a multicellular organism. We profile 554 essential C. elegans genes by imaging gonad architecture and scoring 94 phenotypic features. To generate a reference for evaluating methods for network construction, genes were manually partitioned into 102 phenotypic classes, predicting functions for uncharacterized genes across diverse cellular processes. Using this classification as a benchmark, we developed a robust computational method for constructing gene networks from high-content profiles based on a network context-dependent measure that ranks the significance of links between genes. Our analysis reveals that multi-parametric profiling in a complex tissue yields functional maps with a resolution similar to genetic interaction-based profiling in unicellular eukaryotes-pinpointing subunits of macromolecular complexes and components functioning in common cellular processes.	[Kao, Huey-Ling; Schulman, Monty; Piano, Fabio; Gunsalus, Kristin C.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Green, Rebecca A.; Laband, Kimberley; Wang, Shaohe; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Green, Rebecca A.; Laband, Kimberley; Wang, Shaohe; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Audhya, Anjon; Mayers, Jonathan R.] Univ Wisconsin, Dept Biomol Chem, Madison Med Sch, Madison, WI 53706 USA; [Arur, Swathi] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Fridolfsson, Heidi N.; Starr, Daniel A.] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; [Schedl, Tim] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Schloissnig, Siegfried; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Niessen, Sherry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Niessen, Sherry] Scripps Res Inst, Dept Physiol Chem, Ctr Physiol Prote, La Jolla, CA 92037 USA; [Piano, Fabio; Gunsalus, Kristin C.] New York Univ Abu Dhabi, Abu Dhabi, U Arab Emirates	New York University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; Washington University (WUSTL); Max Planck Society; Scripps Research Institute; Scripps Research Institute	Gunsalus, KC (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, 12 Waverly Pl,8th Floor, New York, NY 10003 USA.	kcg1@nyu.edu; koegema@ucsd.edu	Wang, Shaohe/J-6456-2019; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Wang, Shaohe/0000-0001-9522-2359; Hyman, Anthony A/0000-0003-3664-154X; Laband, Kimberley/0000-0002-8535-2050; Green, Rebecca/0000-0002-4528-011X; Starr, Daniel/0000-0001-7339-6606; Schloissnig, Siegfried/0000-0003-4574-8330	American Cancer Society [PF-06-254-01-CCG]; Helen Hay Whitney Foundation; NIH [R01 GM074207, R01 HD046236, R01 GM085503, R01 GM085150, R01 GM088151, R01 GM073874]; Ludwig Institute for Cancer Research; NIH National Center for Research Resources, for strains; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088151, R01GM074207, R01GM085150, R01GM085503, R01GM073874] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NIH National Center for Research Resources, for strains(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the American Cancer Society (PF-06-254-01-CCG, to RG), the Helen Hay Whitney Foundation (to A. A.), and the NIH R01 GM074207 to K.O., R01 HD046236 to K.C.G. and FP; R01 GM085503 to K.C.G.; R01 GM085150 to TS; R01 GM088151 to A.A.; R01 GM073874 to D.A.S.) and by funding from the Ludwig Institute for Cancer Research to KO and AD. We thank Kahn Rhrissorrakrai for the MINE algorithm, Michael Volkmer for movie formatting, and the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains. Author Contributions: Conceived and designed the experiments: KO, AD, RG, AA. Performed the experiments: RG, AA, SN, SA, TS, SW, HF, DS, JM. Scored the data: AA, RG, KO. Manually partitioned the genes into classes: RG, KO. Reworked Phenobank to include the gonad morphology data: SS, RG, KO, AH. Developed N-Browse: HK, MS, FP, KG. Developed CSI: KO, RG, HK, MS, FP, KG. Conceptualized and performed network analysis: HK, FP, KG. Contributed reagents/materials/analysis tools: KO, RG, AA, SN, KL, SA, TS, AD, HK, MS, KG, FP, HF, DS.	[Anonymous], 2008, CURR PROTOC BIOINFOR; [Anonymous], WORMBOOK C ELEGANS R; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2009, NAT METHODS, V6, P721, DOI 10.1038/nmeth1009-721; Conrad C, 2010, J CELL BIOL, V188, P453, DOI 10.1083/jcb.200910105; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Essex A, 2009, MOL BIOL CELL, V20, P1252, DOI 10.1091/mbc.E08-10-1047; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Gunsalus Kristin C, 2008, J Biol, V7, P8, DOI 10.1186/jbiol70; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kimble Judith, 2005, WormBook, P1; Kops GJPL, 2010, J CELL SCI, V123, P1623, DOI 10.1242/jcs.061549; Lee MH, 2007, GENETICS, V177, P2039, DOI 10.1534/genetics.107.081356; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r26; MADURO M, 1995, GENETICS, V141, P977; Mathey-Prevot B, 2006, COLD SPRING HARB SYM, V71, P141, DOI 10.1101/sqb.2006.71.027; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Praitis V, 2001, GENETICS, V157, P1217; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Starr DA, 2001, DEVELOPMENT, V128, P5039; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Zhou K, 2009, J CELL BIOL, V186, P229, DOI 10.1083/jcb.200902101; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	49	142	144	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					470	482		10.1016/j.cell.2011.03.037	http://dx.doi.org/10.1016/j.cell.2011.03.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529718	Bronze, Green Accepted			2022-12-01	WOS:000290022900015
J	Merritt, DJ; Dixon, KW				Merritt, David J.; Dixon, Kingsley W.			Restoration Seed Banks-A Matter of Scale	SCIENCE			English	Editorial Material							ECOLOGICAL RESTORATION		[Merritt, David J.; Dixon, Kingsley W.] Kings Pk & Bot Gardens, Perth, WA 6005, Australia; [Merritt, David J.; Dixon, Kingsley W.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Crawley, WA 6009, Australia	University of Western Australia	Merritt, DJ (corresponding author), Kings Pk & Bot Gardens, Perth, WA 6005, Australia.	david.merritt@bgpa.wa.gov.au	Dixon, Kingsley W/A-8133-2016; Dixon, Kingsley W/B-1042-2011; Merritt, David J/G-9376-2011	Dixon, Kingsley W/0000-0001-5989-2929; Merritt, David J/0000-0002-3250-6861				*BHP BILL IR OR, 2006, JIMB WHEEL HILL MIN; BOWERS K, RHIZOME; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Crane PR, 2009, TRENDS PLANT SCI, V14, P575, DOI 10.1016/j.tplants.2009.09.007; CUNNINGHAM S, 2008, REWEALTHL; DELANGE JH, 1990, S AFR J BOT, V59, P145; Dixon KW, 2009, ACTA HORTIC, V813, P155; *GREAT BAS RES CTR, SEED WAR; Hardwick KA, 2011, CONSERV BIOL, V25, P265, DOI 10.1111/j.1523-1739.2010.01632.x; Higgs E, 2005, RESTOR ECOL, V13, P159, DOI 10.1111/j.1526-100X.2005.00020.x; *KEW, BREATH PLAN PROGR; Koch JM, 2007, RESTOR ECOL, V15, pS26, DOI 10.1111/j.1526-100X.2007.00290.x; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; MERRITT DJ, 2005, P 5 AUSTR WORKSH NAT, P69; Mortlock BW., 2000, ECOLOGICAL MANAGEMEN, V1, P93, DOI [10.1046/j.1442-8903.2000.00029.x, DOI 10.1046/J.1442-8903.2000.00029.X]; Nelleman C, 2010, DEAD PLANET LIVING P; OMAR SAS, 2009, HDB ENV CHEM, V3, P141; Rokich DP, 2007, AUST J BOT, V55, P375, DOI 10.1071/BT06108; *SECR CONV BIOL DI, 2010, CBD PUBL; Smith P, 2011, SEED SCI RES, V21, P1, DOI 10.1017/S0960258510000309; SMITH RD, 2003, SEED CONSERVATION TU, pCH56; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Wehi PM, 2009, ECOL APPL, V19, P267, DOI 10.1890/07-1693.1; Wijdeven SMJ, 2000, RESTOR ECOL, V8, P414, DOI 10.1046/j.1526-100x.2000.80056.x; Williams MI, 2002, RESTOR ECOL, V10, P385, DOI 10.1046/j.1526-100X.2002.01025.x	26	221	228	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					424	425		10.1126/science.1203083	http://dx.doi.org/10.1126/science.1203083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512021				2022-12-01	WOS:000289784900028
J	Cain, LE; Logan, R; Robins, JM; Sterne, JAC; Sabin, C; Bansi, L; Justice, A; Goulet, J; van Sighem, A; de Wolf, F; Bucher, HC; von Wyl, V; Esteve, A; Casabona, J; del Amo, J; Moreno, S; Seng, R; Meyer, L; Perez-Hoyos, S; Muga, R; Lodi, S; Lanoy, E; Costagliola, D; Hernan, MA				Cain, Lauren E.; Logan, Roger; Robins, James M.; Sterne, Jonathan A. C.; Sabin, Caroline; Bansi, Loveleen; Justice, Amy; Goulet, Joseph; van Sighem, Ard; de Wolf, Frank; Bucher, Heiner C.; von Wyl, Viktor; Esteve, Anna; Casabona, Jordi; del Amo, Julia; Moreno, Santiago; Seng, Remonie; Meyer, Laurence; Perez-Hoyos, Santiago; Muga, Roberto; Lodi, Sara; Lanoy, Emilie; Costagliola, Dominique; Hernan, Miguel A.		HIV-CAUSAL Collaboration	When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; CONTROLLED-TRIAL; BASE-LINE; DEATH; INDIVIDUALS; PROGNOSIS; SURVIVAL; DISEASE	Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0.350 x 10(9) cells/L initiate combined antiretroviral therapy (cART), but the optimal CD4 cell count at which cART should be initiated remains a matter of debate. Objective: To identify the optimal CD4 cell count at which cART should be initiated. Design: Prospective observational data from the HIV-CAUSAL Collaboration and dynamic marginal structural models were used to compare cART initiation strategies for CD4 thresholds between 0.200 and 0.500 x 10(9) cells/L. Setting: HIV clinics in Europe and the Veterans Health Administration system in the United States. Patients: 20 971 HIV-infected, therapy-naive persons with baseline CD4 cell counts at or above 0.500 x 10(9) cells/L and no previous AIDS-defining illnesses, of whom 8392 had a CD4 cell count that decreased into the range of 0.200 to 0.499 x 10(9) cells/L and were included in the analysis. Measurements: Hazard ratios and survival proportions for all-cause mortality and a combined end point of AIDS-defining illness or death. Results: Compared with initiating cART at the CD4 cell count threshold of 0.500 x 10(9) cells/L, the mortality hazard ratio was 1.01 (95% CI, 0.84 to 1.22) for the 0.350 threshold and 1.20 (CI, 0.97 to 1.48) for the 0.200 threshold. The corresponding hazard ratios were 1.38 (CI, 1.23 to 1.56) and 1.90 (CI, 1.67 to 2.15), respectively, for the combined end point of AIDS-defining illness or death. Limitations: CD4 cell count at cART initiation was not randomized. Residual confounding may exist. Conclusion: Initiation of cART at a threshold CD4 count of 0.500 x 10(9) cells/L increases AIDS-free survival. However, mortality did not vary substantially with the use of CD4 thresholds between 0.300 and 0.500 x 10(9) cells/L.	[Cain, Lauren E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Bristol, Bristol, Avon, England; UCL, Sch Med, London W1N 8AA, England; MRC, London, England; Yale Univ, Sch Med, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; Univ Amsterdam, Amsterdam, Netherlands; Univ Spital Basel, Basel, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Zurich, Zurich, Switzerland; Hosp Badalona Germans Trias & Pujol, Badalona, Spain; Inst Salud Carlos III, Madrid, Spain; Hosp Ramon & Cajal, Madrid, Spain; Hop Bicetre, Le Kremlin Bicetre, France; Barcelona Ctr Int Hlth Res, Barcelona, Spain; Hosp Clin Barcelona, Barcelona, Spain; Univ Paris 06, INSERM, U943, Paris, France; Hop La Pitie Salpetriere, Paris, France	Harvard University; Harvard T.H. Chan School of Public Health; University of Bristol; University of London; University College London; UCL Medical School; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Amsterdam; University of Basel; University of Zurich; University Zurich Hospital; University of Zurich; Hospital Germans Trias i Pujol; Instituto de Salud Carlos III; Hospital Universitario Ramon y Cajal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Cain, LE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	lcain@hsph.harvard.edu	Muga, Roberto/AAY-8655-2021; Pantaleo, Giuseppe/K-6163-2016; Sobrino-Vegas, Paz/E-1741-2015; Boucherit, Soraya/I-1704-2017; Costagliola, Dominique/H-5849-2011; Perez-Hoyos, Santiago/E-2370-2012; Pulido, Federico/B-8417-2009; Cepeda, Concepción/D-7728-2016; Mahamat, Aba/V-7888-2019; TISSOT-DUPONT, Hervé/P-5808-2016; , Felipe/F-4242-2014; Sabin, Caroline/C-2464-2008; van der Ven, A.J.A.M./H-8102-2014; Perez Hoyos, Santiago/O-1075-2019; Cuellar, Sandra/I-3069-2015; DEL AMO VALERO, JULIA/M-7020-2015; Oteo, Jose A./AAB-3134-2020; Lanoy, Emilie/A-8541-2011; Sterne, Jonathan/Z-3106-2019; Guevara, Marcela/B-4473-2015; Victor, Moreno-Cuerda/G-3851-2016; Guiguet, Marguerite/L-8480-2018; Soriano, Vicente/O-5730-2018; Bergmann, Jean-Francois/L-6044-2017; Matheron, Sophie/D-7420-2017; Lopez.Cortes, Luis Fernando/S-5625-2018	Muga, Roberto/0000-0001-6301-431X; Sobrino-Vegas, Paz/0000-0002-0775-1558; Boucherit, Soraya/0000-0002-8819-7594; Costagliola, Dominique/0000-0003-0765-0869; Perez-Hoyos, Santiago/0000-0001-9797-4917; Pulido, Federico/0000-0002-7414-8812; Cepeda, Concepción/0000-0002-9197-9589; Mahamat, Aba/0000-0001-8755-0424; , Felipe/0000-0001-7658-5832; Sabin, Caroline/0000-0001-5173-2760; van der Ven, A.J.A.M./0000-0003-1833-3391; Perez Hoyos, Santiago/0000-0001-9797-4917; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Oteo, Jose A./0000-0001-7080-6542; Lanoy, Emilie/0000-0002-4789-7770; Sterne, Jonathan/0000-0001-8496-6053; Guevara, Marcela/0000-0001-9242-6364; Victor, Moreno-Cuerda/0000-0003-0262-8216; Sanchez-Hellin, Victoria/0000-0002-4101-0120; /0000-0001-7808-5479; Rijnders, Bart/0000-0003-3343-9610; Casabona-Barbara, Jordi/0000-0003-4816-5536; Easterbrook, Philippa/0000-0002-2603-5418; delpech, valerie/0000-0002-9952-8109; Soriano, Vicente/0000-0002-4624-5199; Goulet, Joseph Lucien/0000-0002-0842-804X; Bergmann, Jean-Francois/0000-0001-6861-9748; Cabie, Andre/0000-0003-0117-3061; Gayet-Ageron, Angele/0000-0002-6164-9693; Hernan, Miguel/0000-0003-1619-8456; De Lazzari, Elisa/0000-0003-2614-6545; Matheron, Sophie/0000-0001-7879-6553; Hervas Gomez, Rafael/0000-0002-2840-8839; Fidler, Sarah/0000-0003-1676-7583; JARRIN, INMA/0000-0002-7485-2252; von Wyl, Viktor/0000-0002-8754-9797; Cabellos, Carmen/0000-0001-7392-7382; ABEL, Sylvie/0000-0002-3351-0547; Galinier, Anne/0000-0003-2454-5681; Gnatiuc Friedrichs, Louisa/0000-0002-0641-2220; Bernal, Enrique/0000-0002-4041-0579; Taffe, Patrick/0000-0002-2049-6651; Leen, Clifford/0000-0001-8439-7719; Vilades, Consuelo/0000-0002-2991-9593; Negredo, Eugenia/0000-0001-5298-1734; Kozal, Michael/0000-0002-3100-8254; Vargas Laguna, Montserrat/0000-0001-7650-0587; Montoliu, Alexandra/0000-0002-4251-7062; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Gerschenson, Mariana/0000-0002-8615-5964; Arvieux, Cedric/0000-0003-2332-2507	National Institutes of Health [R01-AI073127, U10-AA013566]; Medical Research Council [G0700820]; MRC [G0700820, G0900274, G0100221, MC_U122886351] Funding Source: UKRI; Medical Research Council [G0900274, G0100221, MC_U122886351] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032475, R01AI073127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020794, U10AA013566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant Support: By the National Institutes of Health (grants R01-AI073127 and U10-AA013566) and the Medical Research Council (grant G0700820).	ANGLARET X, EARLY ANTIRETROVIRAL; [Anonymous], [No title captured]; [Anonymous], 2009, RAP ADV ANT THER HIV; BERAL V, 1996, EPIDEMIOL INFECT, V117, P305; Cain LE, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1212; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; *CDCP, 1992, MMWR-MORBID MORTAL W, V41; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Desquilbet L, 2004, AIDS, V18, P2361; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; European AIDS Clinical Society, 2009, GUID CLIN MAN TREATM; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hernan MA, 2006, BASIC CLIN PHARMACOL, V98, P237, DOI 10.1111/j.1742-7843.2006.pto_329.x; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2009, NEW ENGL J MED, V361, P822; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Orellana L, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1200; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Perez-Hoyos S, 2003, AIDS, V17, P353, DOI 10.1097/00002030-200302140-00009; Phillips AN, 2007, AIDS, V21, P1717; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Robins J, 2008, STAT MED, V27, P4678, DOI 10.1002/sim.3301; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van der Laan Mark J, 2007, Int J Biostat, V3, P3, DOI 10.2202/1557-4679.1022; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; 2009, STRATEGIC TIMING ANT	44	171	176	0	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					509	515		10.7326/0003-4819-154-8-201104190-00001	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21502648				2022-12-01	WOS:000289622000013
J	Orans, J; McSweeney, EA; Iyer, RR; Hast, MA; Hellinga, HW; Modrich, P; Beese, LS				Orans, Jillian; McSweeney, Elizabeth A.; Iyer, Ravi R.; Hast, Michael A.; Hellinga, Homme W.; Modrich, Paul; Beese, Lorena S.			Structures of Human Exonuclease 1 DNA Complexes Suggest a Unified Mechanism for Nuclease Family	CELL			English	Article							HUMAN FLAP ENDONUCLEASE-1; HUMAN MISMATCH REPAIR; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; POLYMERASE-I; CANCER SUSCEPTIBILITY; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ACTIVE-SITE; RESECT DNA	Human exonuclease 1 (hExo1) plays important roles in DNA repair and recombination processes that maintain genomic integrity. It is a member of the 50 structure-specific nuclease family of exonucleases and endonucleases that includes FEN-1, XPG, and GEN1. We present structures of hExo1 in complex with a DNA substrate, followed by mutagenesis studies, and propose a common mechanism by which this nuclease family recognizes and processes diverse DNA structures. hExo1 induces a sharp bend in the DNA at nicks or gaps. Frayed 50 ends of nicked duplexes resemble flap junctions, unifying the mechanisms of endo- and exonucleolytic processing. Conformational control of a mobile region in the catalytic site suggests a mechanism for allosteric regulation by binding to protein partners. The relative arrangement of substrate binding sites in these enzymes provides an elegant solution to a complex geometrical puzzle of substrate recognition and processing.	[Orans, Jillian; McSweeney, Elizabeth A.; Iyer, Ravi R.; Hast, Michael A.; Hellinga, Homme W.; Modrich, Paul; Beese, Lorena S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Beese, LS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	lb12@duke.edu	Classen, Scott/AAY-8176-2020	Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [R01 GM091487, R01 GM45190, P01 CA092584]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; DOE with the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091487, R01GM045190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE with the U.S. Department of Energy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anita Changela, Shannon Kelly, and Miaw-Sheue Tsai for assistance with cloning and purification. This work was supported by National Institutes of Health grants R01 GM091487 to L.S.B., R01 GM45190 to P.M., and P01 CA092584 to L.S.B. and P.M. P.M. is an Investigator of the Howard Hughes Medical Institute. Use of the Advanced Photon Source was supported, in part, by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38. Use of the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, was supported, in part, by the DOE program Integrated Diffraction Analysis Technologies (IDAT) and the DOE program Molecular Assemblies Genes and Genomics Integrated Efficiently (MAGGIE) under contract number DE-AC02-05CH11231 with the U.S. Department of Energy.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; Brautigam CA, 1999, BIOCHEMISTRY-US, V38, P696, DOI 10.1021/bi981537g; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; Dore AS, 2006, NUCLEIC ACIDS RES, V34, P4515, DOI 10.1093/nar/gkl623; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FANG WH, 1993, J BIOL CHEM, V268, P11838; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Genschel J, 2009, J BIOL CHEM, V284, P21536, DOI 10.1074/jbc.M109.021287; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Liberti SE, 2011, DNA REPAIR, V10, P73, DOI 10.1016/j.dnarep.2010.09.023; Matsui E, 2002, J BIOL CHEM, V277, P37840, DOI 10.1074/jbc.M205235200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; OTWINOWSKI Z, 1998, DENZO SCALEPACK PROG; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schmutte C, 1998, CANCER RES, V58, P4537; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sharma S, 2003, J BIOL CHEM, V278, P23487, DOI 10.1074/jbc.M212798200; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Vallur AC, 2010, J BIOL CHEM, V285, P28514, DOI 10.1074/jbc.M110.132738; Vallur AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008908; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	63	120	122	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					212	223		10.1016/j.cell.2011.03.005	http://dx.doi.org/10.1016/j.cell.2011.03.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21496642	Bronze, Green Accepted			2022-12-01	WOS:000289549900011
J	Powers, KA; Ghani, AC; Miller, WC; Hoffman, IF; Pettifor, AE; Kamanga, G; Martinson, FEA; Cohen, MS				Powers, Kimberly A.; Ghani, Azra C.; Miller, William C.; Hoffman, Irving F.; Pettifor, Audrey E.; Kamanga, Gift; Martinson, Francis E. A.; Cohen, Myron S.			The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study	LANCET			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; PROSPECTIVE COHORT; UNITED-STATES; VIRAL LOAD; STAGE; RISK; PARTNERSHIPS	Background HIV transmission risk is higher during acute and early HIV infection than it is during chronic infection, but the contribution of early infection to the spread of HIV is controversial. We estimated the contribution of early infection to HIV incidence in Lilongwe, Malawi, and predict the future effect of hypothetical prevention interventions targeted at early infection only, chronic infection only, or both stages. Methods We developed a deterministic mathematical model describing heterosexual HIV transmission, informed by detailed behavioural and viral-load data collected in Lilongwe. We included sexual contact within and outside of steady pairs and divided the infectious period into intervals to allow for changes in transmissibility by infection stage. We used a Bayesian melding approach to fit the model to HIV prevalence data collected between 1987 and 2005 at Lilongwe antenatal clinics. We assessed interventions that reduced the per-contact transmission probability to 0.00003 in people receiving them, and varied the proportion of individuals receiving the intervention in each stage. Findings We estimated that 38.4% (95% credible interval 18-6-52.3) of HIV transmissions in Lilongwe are attributable to sexual contact with individuals with early infection. Interventions targeted at only early infection substantially reduced HIV prevalence, but did not lead to elimination, even with 100% coverage. Interventions targeted at only chronic infections also reduced HIV prevalence, but coverage levels of 95-99% were needed for the elimination of HIV. In scenarios with less than 95% coverage of interventions targeted at chronic infections, additional interventions reaching 25-75% of individuals with early infection reduced HIV prevalence substantially. Interpretation Our results suggest that early infection plays an important part in HIV transmission in this sub-Saharan African setting. Without near-complete coverage, interventions during chronic infection will probably have incomplete effectiveness unless complemented by strategies targeting individuals with early HIV infection.	[Powers, Kimberly A.; Miller, William C.; Hoffman, Irving F.; Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Powers, Kimberly A.; Miller, William C.; Pettifor, Audrey E.; Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London SW7 2AZ, England; [Kamanga, Gift; Martinson, Francis E. A.] UNC Project Malawi, Lilongwe, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London	Powers, KA (corresponding author), Ctr Infect Dis, CB 7030,Bioinformat 2nd Floor, Chapel Hill, NC 27599 USA.	powersk@email.unc.edu	Pettifor, Audrey/H-6793-2019; Miller, William C/H-4800-2014; Ghani, Azra/B-8560-2009	Pettifor, Audrey/0000-0002-3387-0817; Miller, William C/0000-0002-1934-7827; Ghani, Azra/0000-0002-0007-4910	National Institutes of Health (NIH) [R01 MH068686, R37 DK049381, R01 AI083059, 5T32AI070114, P30 AI50410]; University of North Carolina Center for AIDS Research; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); Medical Research Council [G0600719B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083059, T32AI070114, P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068686] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Center for AIDS Research; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health, University of North Carolina Center for AIDS Research.; We thank Christophe Fraser for suggestions on the mathematical modelling methods, and Ward Cates, Jim Shelton, and David Burns for providing helpful comments on an earlier draft of this paper. We also thank four anonymous reviewers, whose comments on our work substantially improved this Article. This research was supported by the National Institutes of Health (NIH; grant numbers R01 MH068686, R37 DK049381, R01 AI083059, and 5T32AI070114) and the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded programme (grant number P30 AI50410).	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; Assefa Y, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60647-4; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cates W, 1997, AM J PUBLIC HEALTH, V87, P1928, DOI 10.2105/AJPH.87.12.1928; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Epstein H, 2010, AIDS BEHAV, V14, P29, DOI 10.1007/s10461-009-9627-x; Epstein H, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60643-7; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fiscus SA, 2007, J INFECT DIS, V195, P416, DOI 10.1086/510755; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Glynn JR, 2008, SEX TRANSM INFECT, V84, P356, DOI 10.1136/sti.2008.030056; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Hallett TB, 2008, PLOS MED, V5, P403, DOI 10.1371/journal.pmed.0050053; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 2010, INT J CLIN PRACT, V64, P678, DOI 10.1111/j.1742-1241.2010.02381.x; HOSSEINIPOUR M, 2004, 11 C RETR OPP INF; Hsieh YH, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60645-0; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jaffe H, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60646-2; Jurgens R, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60644-9; Kim JH, 2010, EPIDEMIOLOGY, V21, P676, DOI 10.1097/EDE.0b013e3181e6639f; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lurie M, 2009, LANCET, V374, P1420, DOI 10.1016/S0140-6736(09)61860-2; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Miller WC, 2009, AIDS, V23, P835, DOI 10.1097/QAD.0b013e328326f55e; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; *NSO MAL, 2008, MAL POP HOUS CENS; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pinkerton SD, 1996, EVALUATION REV, V20, P516, DOI 10.1177/0193841X9602000502; PINKERTON SD, 2007, AIDS BEHAV, V7, P7; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Powers KA, 2011, SEX TRANSM DIS, V38, P657, DOI 10.1097/OLQ.0b013e31820cb223; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ruark A, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60642-5; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Taylor MM, 2007, CLIN INFECT DIS, V44, P301, DOI 10.1086/510487; *US BUR CENS, HIV AIDS SURV DAT; Vaidya NK, 2010, J VIROL, V84, P4302, DOI 10.1128/JVI.02284-09; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wakabi W, 2008, LANCET INFECT DIS, V8, P285, DOI 10.1016/S1473-3099(08)70090-2; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson DP, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60641-3; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; 2004, MALAWI DEMOGRAPHIC H	74	246	252	0	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					256	268		10.1016/S0140-6736(11)60842-8	http://dx.doi.org/10.1016/S0140-6736(11)60842-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21684591	Green Accepted			2022-12-01	WOS:000293201100033
J	Das, SK; Eder, S; Schauer, S; Diwoky, C; Temmel, H; Guertl, B; Gorkiewicz, G; Tamilarasan, KP; Kumari, P; Trauner, M; Zimmermann, R; Vesely, P; Haemmerle, G; Zechner, R; Hoefler, G				Das, Suman K.; Eder, Sandra; Schauer, Silvia; Diwoky, Clemens; Temmel, Hannes; Guertl, Barbara; Gorkiewicz, Gregor; Tamilarasan, Kuppusamy P.; Kumari, Pooja; Trauner, Michael; Zimmermann, Robert; Vesely, Paul; Haemmerle, Guenter; Zechner, Rudolf; Hoefler, Gerald			Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia	SCIENCE			English	Article							WHOLE-BODY LIPOLYSIS; ENERGY-METABOLISM; SKELETAL-MUSCLE; WEIGHT-LOSS; FATTY-ACID; MICE; TISSUE; INFLAMMATION; DEFINITION; MECHANISMS	Cachexia is a multifactorial wasting syndrome most common in patients with cancer that is characterized by the uncontrolled loss of adipose and muscle mass. We show that the inhibition of lipolysis through genetic ablation of adipose triglyceride lipase (Atgl) or hormone-sensitive lipase (Hsl) ameliorates certain features of cancer-associated cachexia (CAC). In wild-type C57BL/6 mice, the injection of Lewis lung carcinoma or B16 melanoma cells causes tumor growth, loss of white adipose tissue (WAT), and a marked reduction of gastrocnemius muscle. In contrast, Atgl-deficient mice with tumors resisted increased WAT lipolysis, myocyte apoptosis, and proteasomal muscle degradation and maintained normal adipose and gastrocnemius muscle mass. Hsl-deficient mice with tumors were also protected although to a lesser degree. Thus, functional lipolysis is essential in the pathogenesis of CAC. Pharmacological inhibition of metabolic lipases may help prevent cachexia.	[Eder, Sandra; Zimmermann, Robert; Haemmerle, Guenter; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Das, Suman K.; Schauer, Silvia; Temmel, Hannes; Guertl, Barbara; Gorkiewicz, Gregor; Tamilarasan, Kuppusamy P.; Kumari, Pooja; Vesely, Paul; Hoefler, Gerald] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; [Diwoky, Clemens] Graz Univ Technol, Inst Med Engn, A-8010 Graz, Austria; [Kumari, Pooja; Trauner, Michael] Med Univ Graz, Div Gastroenterol & Hepatol, Dept Internal Med, A-8036 Graz, Austria	University of Graz; Medical University of Graz; Graz University of Technology; Medical University of Graz	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at; gerald.hoefler@medunigraz.at	Vesely, Paul/AAO-1286-2020; Gorkiewicz, Gregor/ABF-1602-2021; Hoefler, Gerald/B-7006-2008; Das, Suman kumar/E-1270-2015; Hoefler, Gerald/H-1796-2016	Gorkiewicz, Gregor/0000-0003-1149-4782; Das, Suman kumar/0000-0002-0539-5174; Green, Tami/0000-0002-4070-6214; Haemmerle, Guenter/0000-0001-9900-5896; Hoefler, Gerald/0000-0002-9056-3063; Jha, Pooja/0000-0002-0293-9287; Zechner, Rudolf/0000-0001-5483-1182; Trauner, Michael/0000-0002-1275-6425; Vesely, Paul Willibald/0000-0003-3608-1060; Zimmermann, Robert/0000-0002-7354-870X; Green, Tami/0000-0003-0485-0363	Medical University of Graz; Forschungsforderungsgesellschaft; Bundesministerium fur Wissenschaft und Forschung; SFB LIPOTOX [F30]; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [Z136]; Austrian Science Fund (FWF) [F 3002, F 3008, Z 136] Funding Source: researchfish	Medical University of Graz; Forschungsforderungsgesellschaft; Bundesministerium fur Wissenschaft und Forschung; SFB LIPOTOX(German Research Foundation (DFG)); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank E. Zechner and C. Schober-Trummler for reviewing the manuscript. The research was supported by the doctoral program Molecular Medicine of the Medical University of Graz (S. D.); GOLD, Genomics of Lipid-Associated Disorders as part of the Austrian Genome Project GEN-AU funded by Forschungsforderungsgesellschaft and Bundesministerium fur Wissenschaft und Forschung (Ru.Ze.); SFB LIPOTOX grant no. F30 (Ru.Ze., G. H.), the Wittgenstein Award 2007 grant no. Z136 funded by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (Ru.Ze.). S. K. D., Ro.Zi., G. H., and Ru.Ze. hold a patent related to the modulation of ATGL for prevention and treatment of cachexia.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Belizario JE, 2001, BRIT J CANCER, V84, P1135, DOI 10.1054/bjoc.2001.1700; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Busquets S, 2007, CLIN NUTR, V26, P239, DOI 10.1016/j.clnu.2006.12.001; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FEARON KCH, 1992, P NUTR SOC, V51, P251, DOI 10.1079/PNS19920036; Fearon KCH, 2002, INT J CARDIOL, V85, P73, DOI 10.1016/S0167-5273(02)00235-8; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hyltander A, 2000, EUR J CANCER, V36, P330, DOI 10.1016/S0959-8049(99)00273-7; JEEVANANDAM M, 1986, METABOLISM, V35, P304, DOI 10.1016/0026-0495(86)90145-9; Kawamura I, 1999, ANTICANCER RES, V19, P341; Khal J, 2005, INT J BIOCHEM CELL B, V37, P2196, DOI 10.1016/j.biocel.2004.10.017; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Lainscak M, 2008, AM J CARDIOL, V101, p8E, DOI 10.1016/j.amjcard.2008.02.065; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; LEGASPI A, 1987, METABOLISM, V36, P958, DOI 10.1016/0026-0495(87)90132-6; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; RENNIE MJ, 1983, CLIN PHYSIOL, V3, P387, DOI 10.1111/j.1475-097X.1983.tb00847.x; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; SHAW JHF, 1987, ANN SURG, V205, P368, DOI 10.1097/00000658-198704000-00005; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; van Royen M, 2000, BIOCHEM BIOPH RES CO, V270, P533, DOI 10.1006/bbrc.2000.2462; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	30	362	378	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					233	238		10.1126/science.1198973	http://dx.doi.org/10.1126/science.1198973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21680814				2022-12-01	WOS:000292502700053
J	Tada, K; Susumu, H; Sakuno, T; Watanabe, Y				Tada, Kenji; Susumu, Hiroaki; Sakuno, Takeshi; Watanabe, Yoshinori			Condensin association with histone H2A shapes mitotic chromosomes	NATURE			English	Article							AURORA-B KINASE; FISSION YEAST; MEIOSIS-I; BUDDING YEAST; SCHIZOSACCHAROMYCES-POMBE; MONOPOLAR ATTACHMENT; GENE-TRANSCRIPTION; H3 PHOSPHORYLATION; MITOSIS; KINETOCHORES	Chromosome structure is dynamically regulated during cell division, and this regulation is dependent, in part, on condensin. The localization of condensin at chromosome arms is crucial for chromosome partitioning during anaphase. Condensin is also enriched at kinetochores but its precise role and loading machinery remain unclear. Here we show that fission yeast (Schizosaccharomyces pombe) kinetochore proteins Pcs1 and Mde4-homologues of budding yeast (Saccharomyces cerevisiae) monopolin subunits and known to prevent merotelic kinetochore orientation-act as a condensin 'recruiter' at kinetochores, and that condensin itself may act to clamp microtubule binding sites during metaphase. In addition to the regional recruitment factors, overall condensin association with chromatin is governed by the chromosomal passenger kinase Aurora B. Aurora-B-dependent phosphorylation of condensin promotes its association with histone H2A and H2A.Z, which we identify as conserved chromatin 'receptors' of condensin. Condensin phosphorylation and its deposition onto chromosome arms reach a peak during anaphase, when Aurora B kinase relocates from centromeres to the spindle midzone, where the separating chromosome arms are positioned. Our results elucidate the molecular basis for the spatiotemporal regulation of mitotic chromosome architecture, which is crucial for chromosome partitioning.	[Tada, Kenji; Susumu, Hiroaki; Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Tada, Kenji; Susumu, Hiroaki; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Sakuno, Takeshi/Y-9478-2019	Watanabe, Yoshinori/0000-0002-5488-4812	Global COE Program(Integrative Life Science Based on the Study of Biosignaling Mechanisms); Special Coordination Funds for Promoting Science and Technology; MEXT, Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Global COE Program(Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript and K.-i. Noma, T. Hirano and the Yeast Genetic Resource Center (YGRC) for yeast strains or reagents. We also thank S. Hauf and M. Yanagida for communicating unpublished results, and all the members of our laboratory for their support and discussion. This work was supported in part by Global COE Program(Integrative Life Science Based on the Study of Biosignaling Mechanisms) (to K.T. and H.S.), Special Coordination Funds for Promoting Science and Technology (to T.S.) and a Grant-in-Aid for Specially Promoted Research, MEXT, Japan (to Y.W.).	Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bazile F, 2010, CELL CYCLE, V9, P3243, DOI 10.4161/cc.9.16.12620; Brito IL, 2010, GENETICS, V185, P55, DOI 10.1534/genetics.110.115139; Buchanan L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000726; Corbett KD, 2010, CELL, V142, P556, DOI 10.1016/j.cell.2010.07.017; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gregan J, 2007, CURR BIOL, V17, P1190, DOI 10.1016/j.cub.2007.06.044; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2007, EMBO J, V26, P4475, DOI 10.1038/sj.emboj.7601880; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Iwasaki O, 2010, MOL BIOL CELL, V21, P254, DOI 10.1091/mbc.E09-09-0790; Johzuka K, 2009, MOL CELL, V34, P26, DOI 10.1016/j.molcel.2009.02.021; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Parra MA, 2007, MOL CELL BIOL, V27, P7641, DOI 10.1128/MCB.00742-07; Petersen J, 2003, CURR BIOL, V13, P590, DOI 10.1016/S0960-9822(03)00205-7; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Renshaw MJ, 2010, DEV CELL, V19, P232, DOI 10.1016/j.devcel.2010.07.013; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Samoshkin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006831; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Takemoto A, 2009, NAT STRUCT MOL BIOL, V16, P1302, DOI 10.1038/nsmb.1708; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	58	142	142	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					477	U105		10.1038/nature10179	http://dx.doi.org/10.1038/nature10179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21633354				2022-12-01	WOS:000291939700041
J	Duong, HA; Robles, MS; Knutti, D; Weitz, CJ				Duong, Hao A.; Robles, Maria S.; Knutti, Darko; Weitz, Charles J.			A Molecular Mechanism for Circadian Clock Negative Feedback	SCIENCE			English	Article							HISTONE ACETYLATION; TRANSCRIPTION; BINDING; PSF; COMPONENTS; REVEALS; FBXL3; MPER1; LOOP; LIMB	Circadian rhythms in mammals are generated by a feedback loop in which the three PERIOD (PER) proteins, acting in a large complex, inhibit the transcriptional activity of the CLOCK-BMAL1 dimer, which represses their own expression. Although fundamental, the mechanism of negative feedback in the mammalian clock, or any eukaryotic clock, is unknown. We analyzed protein constituents of PER complexes purified from mouse tissues and identified PSF (polypyrimidine tract-binding protein-associated splicing factor). Our analysis indicates that PSF within the PER complex recruits SIN3A, a scaffold for assembly of transcriptional inhibitory complexes and that the PER complex thereby rhythmically delivers histone deacetylases to the Per1 promoter, which repress Per1 transcription. These findings provide a function for the PER complex and a molecular mechanism for circadian clock negative feedback.	[Duong, Hao A.; Robles, Maria S.; Knutti, Darko; Weitz, Charles J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Robles, Maria/ABH-1497-2020; Robles, Maria S/D-6307-2015	Robles, Maria/0000-0001-9149-8761; Robles, Maria S/0000-0001-9149-8761	G. Harold and Leila Y. Mathers Charitable Foundation; NIH; Edward R. and Anne G. Lefler Center; Swiss National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward R. and Anne G. Lefler Center; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Liu for technical assistance, P. Nakatani (Dana Farber Cancer Institute) for the FH tag, D. Weaver and S. Reppert (University of Massachusetts) for Per1<SUP>-/-</SUP>;Per2<SUP>-/-</SUP> mice, N. Copeland (Institute of Molecular and Cell Biology, Singapore) for reagents, and Y. Kurihara (Yokohama National University) for PSF plasmid. This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation (C.J.W.), NIH Training Grant in Fundamental Neurobiology fellowship (H.A.D.), an Edward R. and Anne G. Lefler Center fellowship (M.S.R.), and a Swiss National Science Foundation fellowship (D.K.).	Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Padmanabhan K., UNPUB; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07	29	194	202	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1436	1439		10.1126/science.1196766	http://dx.doi.org/10.1126/science.1196766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680841	Green Accepted			2022-12-01	WOS:000291689000043
J	Patel, MM; Lopez-Collada, VR; Bulhoes, MM; De Oliveira, LH; Marquez, AB; Flannery, B; Esparza-Aguilar, M; Renoiner, EIM; Luna-Cruz, ME; Sato, HK; Hernandez-Hernandez, LD; Toledo-Cortina, G; Ceron-Rodriguez, M; Osnaya-Romero, N; Martinez-Alcazar, M; Aguinaga-Villasenor, RG; Plascencia-Hernandez, A; Fojaco-Gonzalez, F; Rezk, GHP; Gutierrez-Ramirez, SF; Dorame-Castillo, R; Tinajero-Pizano, R; Mercado-Villegas, B; Barbosa, MR; Maluf, EMC; Ferreira, LB; de Carvalho, FM; dos Santos, AR; Cesar, ED; de Oliveira, MEP; Silva, CLO; Cortes, MD; Matus, CR; Tate, J; Gargiullo, P; Parashar, UD				Patel, Manish M.; Richardson Lopez-Collada, Vesta; Bulhoes, Marilia Mattos; Helena De Oliveira, Lucia; Bautista Marquez, Aurora; Flannery, Brendan; Esparza-Aguilar, Marcelino; Montenegro Renoiner, Ernesto Isaac; Edilia Luna-Cruz, Maria; Sato, Helena Keico; del Carmen Hernandez-Hernandez, Luz; Toledo-Cortina, Gerardo; Ceron-Rodriguez, Magdalena; Osnaya-Romero, Neydi; Martinez-Alcazar, Mario; Gabriela Aguinaga-Villasenor, Rocio; Plascencia-Hernandez, Arturo; Fojaco-Gonzalez, Francisco; Hernandez-Peredo Rezk, Guillermo; Fortino Gutierrez-Ramirez, Sixto; Dorame-Castillo, Roberto; Tinajero-Pizano, Rogelio; Mercado-Villegas, Bernice; Barbosa, Marilia Reichelt; Cesario Maluf, Eliane Mara; Ferreira, Lucimar Bozza; de Carvalho, Francisca Maria; dos Santos, Ana Rosa; Cesar, Eduardo Dolabella; Paula de Oliveira, Maria Elisa; Osterno Silva, Carmem Lucia; de los Angeles Cortes, Maria; Ruiz Matus, Cuauhtemoc; Tate, Jacqueline; Gargiullo, Paul; Parashar, Umesh D.			Intussusception Risk and Health Benefits of Rotavirus Vaccination in Mexico and Brazil	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD DIARRHEA; CASE SERIES; SAFETY; INFANTS; EFFICACY; CHILDREN; GASTROENTERITIS; IMMUNIZATION; VACCINES	Background Because postlicensure surveillance determined that a previous rotavirus vaccine, RotaShield, caused intussusception in 1 of every 10,000 recipients, we assessed the association of the new monovalent rotavirus vaccine (RV1) with intussusception after routine immunization of infants in Mexico and Brazil. Methods We used case-series and case-control methods to assess the association between RV1 and intussusception. Infants with intussusception were identified through active surveillance at 69 hospitals (16 in Mexico and 53 in Brazil), and age-matched infants from the same neighborhood were enrolled as controls. Vaccination dates were verified by a review of vaccination cards or clinic records. Results We enrolled 615 case patients (285 in Mexico and 330 in Brazil) and 2050 controls. An increased risk of intussusception 1 to 7 days after the first dose of RV1 was identified among infants in Mexico with the use of both the case-series method (incidence ratio, 5.3; 95% confidence interval [CI], 3.0 to 9.3) and the case-control method (odds ratio, 5.8; 95% CI, 2.6 to 13.0). No significant risk was found after the first dose among infants in Brazil, but an increased risk, albeit smaller than that seen after the first dose in Mexico - an increase by a factor of 1.9 to 2.6 - was seen 1 to 7 days after the second dose. A combined annual excess of 96 cases of intussusception in Mexico (approximately 1 per 51,000 infants) and in Brazil (approximately 1 per 68,000 infants) and of 5 deaths due to intussusception was attributable to RV1. However, RV1 prevented approximately 80,000 hospitalizations and 1300 deaths from diarrhea each year in these two countries. Conclusions RV1 was associated with a short-term risk of intussusception in approximately 1 of every 51,000 to 68,000 vaccinated infants. The absolute number of deaths and hospitalizations averted because of vaccination far exceeded the number of intussusception cases that may have been associated with vaccination. (Funded in part by the GAVI Alliance and the U. S. Department of Health and Human Services.)	[Patel, Manish M.; Tate, Jacqueline; Gargiullo, Paul; Parashar, Umesh D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Richardson Lopez-Collada, Vesta; Bautista Marquez, Aurora; Esparza-Aguilar, Marcelino; Edilia Luna-Cruz, Maria; del Carmen Hernandez-Hernandez, Luz] Minist Hlth, Natl Ctr Child & Adolescent Hlth, Mexico City, DF, Mexico; [Toledo-Cortina, Gerardo] Hosp Pediat Moctezuma, Mexico City, DF, Mexico; [Ceron-Rodriguez, Magdalena] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [Osnaya-Romero, Neydi] Inst Nacl Pediat, Mexico City, DF, Mexico; [Bulhoes, Marilia Mattos; Montenegro Renoiner, Ernesto Isaac; dos Santos, Ana Rosa] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil; [Montenegro Renoiner, Ernesto Isaac] Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil; [Flannery, Brendan] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Sato, Helena Keico] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil; [Ferreira, Lucimar Bozza] Secretaria Municipal Saude Curitiba, Curitiba, Parana, Brazil; [de Carvalho, Francisca Maria] Secretaria Estado Saude Rio de Janeiro, Rio De Janeiro, Brazil; [Cesar, Eduardo Dolabella] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil; [Osterno Silva, Carmem Lucia] Secretaria Estado Saude Curitiba, Ceara, Brazil; [Helena De Oliveira, Lucia; de los Angeles Cortes, Maria; Ruiz Matus, Cuauhtemoc] Pan Amer Hlth Org, Washington, DC USA; [Osnaya-Romero, Neydi] Hosp Nino Morelense, Cuernavaca, Morelos, Mexico; [Martinez-Alcazar, Mario; Gabriela Aguinaga-Villasenor, Rocio] Hosp Infantil Morelia Eva Samano de Lopez Mateos, Morelia, Michoacan, Mexico; [Plascencia-Hernandez, Arturo] Hosp Civil Reg Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Plascencia-Hernandez, Arturo] Hosp Civil Nuevo Guadalajara Juan I Menchaca, Guadalajara, Jalisco, Mexico; [Fojaco-Gonzalez, Francisco] Hosp Alta Especialidad Nino Dr Rodolfo Nieto Padr, Villahermosa, Tabasco, Mexico; [Hernandez-Peredo Rezk, Guillermo] Ctr Especialidades Med Veracruz, Xalapa, Veracruz, Mexico; [Fortino Gutierrez-Ramirez, Sixto] Hosp Metropolitano Dr Bernardo Sepulveda, Monterrey, Nuevo Leon, Mexico; [Dorame-Castillo, Roberto] Hosp Infantil Estado Sonora, Hermosillo, Sonora, Mexico; [Tinajero-Pizano, Rogelio] Hosp Gen Reg Leon, Guanajuato, Mexico; [Mercado-Villegas, Bernice] Hosp Civil Tepic Dr Antonio Gonzalez Guevara, Tepic, Nayarit, Mexico	Centers for Disease Control & Prevention - USA; Hospital Infantil de Mexico Federico Gomez; Universidade de Brasilia; Pan American Health Organization; Pan American Health Organization	Patel, MM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS A-47, Atlanta, GA 30333 USA.	mpatel@cdc.gov	Osnaya-Romero, Neydi/AAI-2458-2020; Hernandez, Arturo Plascencia/K-9659-2017	Hernandez, Arturo Plascencia/0000-0002-7950-3019; /0000-0003-1486-3651	GAVI Alliance; U.S. Department of Health and Human Services	GAVI Alliance; U.S. Department of Health and Human Services	Funded in part by the GAVI Alliance under a collaborative agreement with the Program for Appropriate Technology in Health (PATH) and in part by the U.S. Department of Health and Human Services.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P38; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P325; [Anonymous], 45 INT C ANT AG CHEM; Araujo EC, 2007, J PEDIAT-BRAZIL, V83, P217, DOI [10.2223/JPED.1600, 10.1590/S0021-75572007000400006]; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Cortese M, ESTIMATES BENEFITS P; Cortese Margaret M., 2010, Morbidity and Mortality Weekly Report, V59, P1074; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Moser CA, 2001, J INFECT DIS, V183, P1108, DOI 10.1086/319294; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Musonda P, 2006, STAT MED, V25, P2618, DOI 10.1002/sim.2477; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Patel MM, 2009, VACCINE, V27, P2916, DOI 10.1016/j.vaccine.2009.03.016; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1; Simonsen L, 2001, LANCET, V358, P1224, DOI 10.1016/S0140-6736(01)06346-2; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285	30	272	287	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2283	2292		10.1056/NEJMoa1012952	http://dx.doi.org/10.1056/NEJMoa1012952			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675888	Bronze			2022-12-01	WOS:000291643800006
J	Sander, LE; Davis, MJ; Boekschoten, MV; Amsen, D; Dascher, CC; Ryffel, B; Swanson, JA; Muller, M; Blander, JM				Sander, Leif E.; Davis, Michael J.; Boekschoten, Mark V.; Amsen, Derk; Dascher, Christopher C.; Ryffel, Bernard; Swanson, Joel A.; Mueller, Michael; Blander, J. Magarian			Detection of prokaryotic mRNA signifies microbial viability and promotes immunity	NATURE			English	Article							TOLL-LIKE RECEPTORS; T-CELL RESPONSES; TRANSCRIPTION FACTORS; PROTECTIVE IMMUNITY; INNATE; INFLAMMASOME; RECOGNITION; ACTIVATION; REGULATORS; PHAGOSOME	Live vaccines have long been known to trigger far more vigorous immune responses than their killed counterparts(1-6). This has been attributed to the ability of live microorganisms to replicate and express specialized virulence factors that facilitate invasion and infection of their hosts(7). However, protective immunization can often be achieved with a single injection of live, but not dead, attenuated microorganisms stripped of their virulence factors. Pathogen-associated molecular patterns (PAMPs), which are detected by the immune system(8,9), are present in both live and killed vaccines, indicating that certain poorly characterized aspects of live microorganisms, not incorporated in dead vaccines, are particularly effective at inducing protective immunity. Here we show that the mammalian innate immune system can directly sense microbial viability through detection of a special class of viability-associated PAMPs (vita-PAMPs). We identify prokaryotic messenger RNA as a vita-PAMP present only in viable bacteria, the recognition of which elicits a unique innate response and a robust adaptive antibody response. Notably, the innate response evoked by viability and prokaryotic mRNA was thus far considered to be reserved for pathogenic bacteria, but we show that even non-pathogenic bacteria in sterile tissues can trigger similar responses, provided that they are alive. Thus, the immune system actively gauges the infectious risk by searching PAMPs for signatures of microbial life and thus infectivity. Detection of vita-PAMPs triggers a state of alert not warranted for dead bacteria. Vaccine formulations that incorporate vita-PAMPs could thus combine the superior protection of live vaccines with the safety of dead vaccines.	[Sander, Leif E.; Dascher, Christopher C.; Blander, J. Magarian] Mt Sinai Sch Med, Inst Immunol, Dept Med, New York, NY 10029 USA; [Davis, Michael J.; Swanson, Joel A.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Boekschoten, Mark V.; Mueller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6703 HD Wageningen, Netherlands; [Amsen, Derk] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Ryffel, Bernard] Univ Orleans, Lab Mol Immunol & Embryol, F-45071 Orleans, France; [Ryffel, Bernard] CNRS, F-45071 Orleans, France	Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS)	Blander, JM (corresponding author), Mt Sinai Sch Med, Inst Immunol, Dept Med, 1425 Madison Ave, New York, NY 10029 USA.	julie.blander@mssm.edu	Boekschoten, Mark/AAS-4597-2021; Swanson, Joel A/P-4362-2014; Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Boekschoten, Mark V/A-2458-2011; Sander, Leif Erik/AAI-8619-2020	Boekschoten, Mark/0000-0002-2139-0795; Swanson, Joel A/0000-0003-0900-8212; Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark V/0000-0002-2139-0795; Sander, Leif Erik/0000-0002-0476-9947; Davis, Michael/0000-0002-3970-2208; Blander, Julie Magarian/0000-0001-9207-1700	NIAID NIH HHS [R21 AI080959, R01 AI064668, AI080959A, R01 AI095245, R21 AI080959-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080959, R01AI095245, R01AI064668] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; BUCHMEIER NA, 1990, SCIENCE, V248, P730, DOI 10.1126/science.1970672; Cheers C, 1996, TRENDS MICROBIOL, V4, P453, DOI 10.1016/0966-842X(96)10067-6; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis MJ, 2010, J LEUKOCYTE BIOL, V88, P813, DOI 10.1189/jlb.0310159; Detmer A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-23; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; KAWAMURA I, 1994, INFECT IMMUN, V62, P4396, DOI 10.1128/IAI.62.10.4396-4403.1994; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lim So-Yon, 2006, J Immune Based Ther Vaccines, V4, P5, DOI 10.1186/1476-8518-4-5; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; MAURELLI AT, 1985, INFECT IMMUN, V49, P164, DOI 10.1128/IAI.49.1.164-171.1985; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; VONKOENIG CHW, 1982, NATURE, V297, P233, DOI 10.1038/297233a0; Wing HJ, 2004, J BACTERIOL, V186, P699, DOI 10.1128/JB.186.3.699-705.2004; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	51	296	300	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					385	+		10.1038/nature10072	http://dx.doi.org/10.1038/nature10072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21602824	Green Accepted			2022-12-01	WOS:000291647100047
J	Yu, YH; Yoon, SO; Poulogiannis, G; Yang, Q; Ma, XJM; Villen, J; Kubica, N; Hoffman, GR; Cantley, LC; Gygi, SP; Blenis, J				Yu, Yonghao; Yoon, Sang-Oh; Poulogiannis, George; Yang, Qian; Ma, Xiaoju Max; Villen, Judit; Kubica, Neil; Hoffman, Gregory R.; Cantley, Lewis C.; Gygi, Steven P.; Blenis, John			Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling	SCIENCE			English	Article							INHIBITION; DISRUPTION; RESISTANCE; ACTIVATION; KINASE; LEADS	The evolutionarily conserved serine-threonine kinase mammalian target of rapamycin (mTOR) plays a critical role in regulating many pathophysiological processes. Functional characterization of the mTOR signaling pathways, however, has been hampered by the paucity of known substrates. We used large-scale quantitative phosphoproteomics experiments to define the signaling networks downstream of mTORC1 and mTORC2. Characterization of one mTORC1 substrate, the growth factor receptor-bound protein 10 (Grb10), showed that mTORC1-mediated phosphorylation stabilized Grb10, leading to feedback inhibition of the phosphatidylinositol 3-kinase (PI3K) and extracellular signal-regulated, mitogen-activated protein kinase (ERK-MAPK) pathways. Grb10 expression is frequently down-regulated in various cancers, and loss of Grb10 and loss of the well-established tumor suppressor phosphatase PTEN appear to be mutually exclusive events, suggesting that Grb10 might be a tumor suppressor regulated by mTORC1.	[Yu, Yonghao; Yoon, Sang-Oh; Yang, Qian; Ma, Xiaoju Max; Villen, Judit; Kubica, Neil; Hoffman, Gregory R.; Gygi, Steven P.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Poulogiannis, George; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Yang, Qian] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard School of Dental Medicine	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Steven_gygi@hms.harvard.edu; john_blenis@hms.harvard.edu	Poulogiannis, George/AAY-2210-2021; Cantley, Lewis C/D-1800-2014; Poulogiannis, George/AAE-1966-2019	Cantley, Lewis C/0000-0002-1298-7653; Poulogiannis, George/0000-0002-0529-8614; Villen, Judit/0000-0002-1005-1739	Tuberous Sclerosis Alliance [ID-146]; NIH [GM051405, CA46595, HG3456, R00CA140789]; NATIONAL CANCER INSTITUTE [R37CA046595, R00CA140789, R01CA046595] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, R01GM041890, R01GM051405] Funding Source: NIH RePORTER	Tuberous Sclerosis Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Blenis and Gygi laboratories for critical discussion. This work was supported by a postdoctoral fellowship from the Tuberous Sclerosis Alliance (grant ID-146 to Y.Y.), and NIH grants GM051405 and CA46595 (J.B.), HG3456 (S. P. G.), and R00CA140789 (J.V.). J.B. is an Established Investigator of the LAM Foundation. A provisional patent on the phosphorylation sites identified and the participation of Grb10 in the feedback loop was filed on 9/23/2010 (no. 61/403, 932 to J.B., S. P. G. and Y.Y.).	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Langlais P, 2005, BIOCHEMISTRY-US, V44, P8890, DOI 10.1021/bi050413i; Lim MA, 2004, FRONT BIOSCI-LANDMRK, V9, P387, DOI 10.2741/1226; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07	16	628	645	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1322	1326		10.1126/science.1199484	http://dx.doi.org/10.1126/science.1199484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659605	Green Accepted			2022-12-01	WOS:000291441700045
J	Sylvestre, D				Sylvestre, Diana			Recognizing resistance	NATURE			English	Editorial Material							ADHERENCE; MUTATIONS		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sylvestre, D (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	diana.sylvestre@ucsf.edu						Ferrando SJ, 1996, AM J DRUG ALCOHOL AB, V22, P475, DOI 10.3109/00952999609001674; Foretier N, 2008, HEPATOLOGY, V48, p760A; Singh N, 1999, CLIN INFECT DIS, V29, P824, DOI 10.1086/520443; Tong X, 2008, ANTIVIR RES, V77, P177, DOI 10.1016/j.antiviral.2007.11.010; Tulsky JP, 2000, ARCH INTERN MED, V160, P697, DOI 10.1001/archinte.160.5.697; Yi MK, 2006, J BIOL CHEM, V281, P8205, DOI 10.1074/jbc.M510246200	6	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S11	S11		10.1038/474S11a	http://dx.doi.org/10.1038/474S11a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666727	Bronze			2022-12-01	WOS:000291397800007
J	Keating, NL; Landrum, MB; Lamont, EB; Bozeman, SR; Krasnow, SH; Shulman, LN; Brown, JR; Earle, CC; Oh, WK; Rabin, M; McNeil, BJ				Keating, Nancy L.; Landrum, Mary Beth; Lamont, Elizabeth B.; Bozeman, Samuel R.; Krasnow, Steven H.; Shulman, Lawrence N.; Brown, Jennifer R.; Earle, Craig C.; Oh, William K.; Rabin, Michael; McNeil, Barbara J.			Quality of Care for Older Patients With Cancer in the Veterans Health Administration Versus the Private Sector A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CELL LUNG-CANCER; III COLON-CANCER; PROSTATE-CANCER; ADJUVANT CHEMOTHERAPY; MYOCARDIAL-INFARCTION; PROPENSITY SCORE; ADVERSE EVENTS; SENSITIVITY; MEDICARE; SYSTEM	Background: The Veterans Health Administration (VHA) is the largest integrated health care system in the United States. Studies suggest that the VHA provides better preventive care and care for some chronic illnesses than does the private sector. Objective: To assess the quality of cancer care for older patients provided by the VHA versus fee-for-service Medicare. Design: Observational study of patients with cancer that was diagnosed between 2001 and 2004 who were followed through 2005. Setting: VHA and non-VHA hospitals and office-based practices. Patients: Men older than 65 years with incident colorectal, lung, or prostate cancer; lymphoma; or multiple myeloma. Measurements: Rates of processes of care for colorectal, lung, or prostate cancer; lymphoma; or multiple myeloma. Rates were adjusted by using propensity score weighting. Results: Compared with the fee-for-service Medicare population, the VHA population received diagnoses of colon (P < 0.001) and rectal (P = 0.007) cancer at earlier stages and had higher adjusted rates of curative surgery for colon cancer (92.7% vs. 90.5%; P < 0.010), standard chemotherapy for diffuse large B-cell non-Hodgkin lymphoma (71.1% vs. 59.3%; P < 0.001), and bisphosphonate therapy for multiple myeloma (62.1% vs. 50.4%; P < 0.001). The VHA population had lower adjusted rates of 3-dimensional conformal or intensity-modulated radiation therapy for prostate cancer treated with external-beam radiation therapy (61.6% vs. 86.0%; P < 0.001). Adjusted rates were similar for 9 other measures. Sensitivity analyses suggest that if patients with cancer in the VHA system have more severe comorbid illness than other patients, rates for most indicators would be higher in the VHA population than in the fee-for-service Medicare population. Limitation: This study included only older men and did not include information about performance status, severity of comorbid illness, or patient preferences. Conclusion: Care for older men with cancer in the VHA system was generally similar to or better than care for fee-for-service Medicare beneficiaries, although adoption of some expensive new technologies may be delayed in the VHA system.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Massachusetts Gen Hosp,Ctr Canc, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Abt Associates Inc, Cambridge, MA USA; Vet Affairs Med Ctr, Washington, DC 20422 USA; Inst Clin Evaluat Sci, Toronto, ON, Canada; Mt Sinai Med Ctr, New York, NY 10029 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; ABT Associates; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Toronto; Icahn School of Medicine at Mount Sinai	Keating, NL (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	keating@hcp.med.harvard.edu	Keating, Nancy L/I-9968-2019; Oh, William K/B-9163-2012	Keating, Nancy L/0000-0002-8274-4681; Oh, William K/0000-0001-5113-8147; Lamont, Elizabeth/0000-0001-6604-678X	Department of Veterans Affairs; Department of Veterans Affairs through the Office of Policy and Planning [101-35-04]	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs through the Office of Policy and Planning(US Department of Veterans Affairs)	Department of Veterans Affairs.r By contract 101-35-04 from the Department of Veterans Affairs through the Office of Policy and Planning.	Adib RS, 1997, BRIT J UROL, V79, P235; [Anonymous], SURV EP END RES OV S; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Baker LH, 2000, ONCOLOGY-NY, V14, P111; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chrischilles EA, 2010, J CLIN ONCOL, V28, P620, DOI 10.1200/JCO.2009.23.8485; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Huggins C, 1941, CANCER RES, V1, P293; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kahn KL, 2010, JAMA-J AM MED ASSOC, V303, P1037, DOI 10.1001/jama.2010.272; Keating NL, 2008, J CLIN ONCOL, V26, P2532, DOI 10.1200/JCO.2007.15.9434; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Kizer KW, 2000, MED CARE, V38, pS7; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Ladapo Pearson SJ., 2007, INTENSITY MODULATED; Lamont E, 2011, J GERIATRI IN PRESS; Lamont EB, 2003, JNCI-J NATL CANCER I, V95, P1370, DOI 10.1093/jnci/djg035; Lamont EB, 2010, J CLIN ONCOL, V28, P215, DOI 10.1200/JCO.2008.21.3652; Landrum MB, 2004, HEALTH SERV RES, V39, P1773, DOI 10.1111/j.1475-6773.2004.00317.x; Laurie SA, 2004, LUNG CANCER, V43, P223, DOI 10.1016/j.lungcan.2003.09.002; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; National Comprehensive Cancer Network, 2001, CLIN PRACT GUID ONC; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Petersen LA, 2000, NEW ENGL J MED, V343, P1934, DOI 10.1056/NEJM200012283432606; Pisansky TM, 2006, NEW ENGL J MED, V355, P1583, DOI 10.1056/NEJMct055263; POTOSKY AL, 1993, MED CARE, V31, P732; Rogers SO, 2010, ANN SURG ONCOL, V17, P1581, DOI 10.1245/s10434-010-0946-y; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P42, DOI 10.1097/EDE.0b013e3181f74493; Wilson NJ, 1998, CANCER, V82, P2003, DOI 10.1002/(SICI)1097-0142(19980515)82:10+<2003::AID-CNCR5>3.3.CO;2-U; Wilt T, 2008, COMP EFFECTIVENESS R	40	72	72	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00004	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00004			90	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646556				2022-12-01	WOS:000291312300003
J	Debiec, H; Lefeu, F; Kemper, MJ; Niaudet, P; Deschenes, G; Remuzzi, G; Ulinski, T; Ronco, P				Debiec, Hanna; Lefeu, Florence; Kemper, Markus J.; Niaudet, Patrick; Deschenes, Georges; Remuzzi, Giuseppe; Ulinski, Tim; Ronco, Pierre			Early-Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNE-RESPONSES; DIETARY ANTIGENS; IGG4 ANTIBODIES; PREVALENCE; COMPLEXES; PROTEINS; INFANTS; DISEASE; TARGET; CELLS	Background The M-type phospholipase A(2) receptor (PLA(2)R) was recently identified as a candidate antigen in 70% of cases of idiopathic membranous nephropathy, a common form of the nephrotic syndrome. The nature of antigens involved in other idiopathic and secondary membranous nephropathies remains unclear. Methods We searched for antibodies against bovine serum albumin and circulating bovine serum albumin by means of enzyme-linked immunosorbent assay and Western blotting in serum specimens obtained from 50 patients with membranous nephropathy and 172 controls. The properties of immunopurified circulating bovine serum albumin obtained from serum specimens were analyzed with the use of two-dimensional sodium dodecyl sulfate-polyacrylamide-gel electrophoresis. We detected bovine serum albumin in glomerular deposits and analyzed the reactivity of eluted IgG. Results Eleven patients, including four children, had high levels of circulating anti-bovine serum albumin antibodies, of both the IgG1 and IgG4 subclasses. These patients also had elevated levels of circulating bovine serum albumin, without an increase in circulating immune complex levels. Bovine serum albumin immunopurified from the serum specimens of these four children migrated in the basic range of pH, whereas the bovine serum albumin from adult patients migrated in neutral regions as native bovine serum albumin. Bovine serum albumin was detected in subepithelial immune deposits only in the children with both high levels of cationic circulating bovine serum albumin and bovine serum albumin-specific antibodies, and it colocalized with IgG in the absence of PLA(2)R. IgG eluted from such deposits was specific for bovine serum albumin. Conclusions Some patients with childhood membranous nephropathy have both circulating cationic bovine serum albumin and anti-bovine serum albumin antibodies. Bovine serum albumin is present in immune deposits, suggesting that cationic bovine serum albumin is pathogenic through binding to the anionic glomerular capillary wall and in situ formation of immune complexes, as shown in experimental models.	[Debiec, Hanna] Univ Paris 06, Tenon Hosp, AP HP, INSERM,Unite Mixte Rech Sci 702, F-75020 Paris, France; [Niaudet, Patrick] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Pediat Nephrol, Paris, France; [Deschenes, Georges] Univ Paris 07, Hop Robert Debre, AP HP, Dept Pediat Nephrol, Paris, France; [Ulinski, Tim] Armand Trousseau Childrens Hosp, AP HP, Pediat Nephrol Unit, Paris, France; [Kemper, Markus J.] Univ Med Ctr, Dept Pediat Nephrol, Hamburg, Germany; [Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Nephrol Unit, I-24100 Bergamo, Italy; [Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Unit Dialysis, I-24100 Bergamo, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Debiec, H (corresponding author), Univ Paris 06, Tenon Hosp, AP HP, INSERM,Unite Mixte Rech Sci 702, 4 Rue Chine, F-75020 Paris, France.	hanna.debiec@upmc.fr	Ronco, Pierre/AAC-8390-2022; Debiec, Hanna/AAL-8144-2021; Remuzzi, Giuseppe/V-9766-2017	Debiec, Hanna/0000-0002-8946-8245; Remuzzi, Giuseppe/0000-0002-6194-3446; deschenes, georges/0000-0002-5158-2915	Agence Nationale pour la Recherche [ANR-07-Physio-016-01]; European Community [HEALTH-F2-2007-201590]; Association pour l'Utilisation du Rein Artificiel; Amgen France; Fondation pour la Recherche Medicale; Assistance Publique-Hopitaux de Paris	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Community(European Commission); Association pour l'Utilisation du Rein Artificiel; Amgen France(Amgen); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Assistance Publique-Hopitaux de Paris	Supported by grants from Agence Nationale pour la Recherche (ANR-07-Physio-016-01), Coordination Theme 1 (Health) of the European Community's 7th Framework Program (HEALTH-F2-2007-201590), Association pour l'Utilisation du Rein Artificiel, Amgen France, and Fondation pour la Recherche Medicale, and by a Translational Research Contract from Assistance Publique-Hopitaux de Paris (to Dr. Debiec).	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Alting AC, 1997, DIABETES CARE, V20, P875, DOI 10.2337/diacare.20.5.875; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; BORDER WA, 1982, J CLIN INVEST, V69, P451, DOI 10.1172/JCI110469; Briani C, 2008, AUTOIMMUN REV, V7, P644, DOI 10.1016/j.autrev.2008.05.006; Chen Ashton, 2007, BMC Nephrol, V8, P11, DOI 10.1186/1471-2369-8-11; Chen JS, 2004, NEPHROL DIAL TRANSPL, V19, P2721, DOI 10.1093/ndt/gfh419; Davis PJ, 1998, ALLERGY, V53, P102, DOI 10.1111/j.1398-9995.1998.tb04975.x; Debiec H, 2004, LANCET, V364, P1252, DOI 10.1016/S0140-6736(04)17142-0; FIOCCHI A, 1995, J AM COLL NUTR, V14, P239; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Husby S, 2000, J PEDIATR GASTR NUTR, V30, pS13, DOI 10.1097/00005176-200001001-00003; KLETTER B, 1971, INT ARCH ALLER A IMM, V40, P656, DOI 10.1159/000230447; KOYAMA A, 1986, IMMUNOLOGY, V58, P535; Kuroki A, 2005, KIDNEY INT, V68, P302, DOI 10.1111/j.1523-1755.2005.00415.x; Kuroki A, 2002, INTERNAL MED, V41, P936, DOI 10.2169/internalmedicine.41.936; Lempainen J, 2009, J AUTOIMMUN, V33, P155, DOI 10.1016/j.jaut.2009.04.003; MALOSSE D, 1992, NEUROEPIDEMIOLOGY, V11, P304, DOI 10.1159/000110946; Menon S, 2010, PEDIATR NEPHROL, V25, P1419, DOI 10.1007/s00467-009-1324-5; Mogues T, 2005, J IMMUNOL METHODS, V300, P1, DOI 10.1016/j.jim.2005.01.022; Oliveira DBG, 1998, LANCET, V351, P670, DOI 10.1016/S0140-6736(97)04122-6; PEREZMACEDA B, 1991, CLIN CHIM ACTA, V203, P153, DOI 10.1016/0009-8981(91)90287-M; Ponticelli C, 2007, J NEPHROL, V20, P268; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Sanchez C, 2003, REV FR ALLERGOL, V43, P13, DOI 10.1016/S0335-7457(02)00003-5; Sathe SK, 2005, BIOTECHNOL ADV, V23, P423, DOI 10.1016/j.biotechadv.2005.05.008; SCHMIDT DG, 1995, CLIN EXP ALLERGY, V25, P1007, DOI 10.1111/j.1365-2222.1995.tb00404.x; Sreedharan R, 2004, PEDIATRICS, V113, P1044; Strobel S, 1998, IMMUNOL TODAY, V19, P173, DOI 10.1016/S0167-5699(97)01239-5; Tipping PG, 2005, CLIN EXP IMMUNOL, V142, P207, DOI 10.1111/j.1365-2249.2005.02842.x; Torente F, 2004, PEDIAT GASTROINTESTI, P944; van Elburg RM, 2003, ARCH DIS CHILD-FETAL, V88, P52; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; Winer S, 2001, J IMMUNOL, V166, P4751, DOI 10.4049/jimmunol.166.7.4751	35	139	156	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2101	2110		10.1056/NEJMoa1013792	http://dx.doi.org/10.1056/NEJMoa1013792			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772AB	21631322	Bronze			2022-12-01	WOS:000291200700008
J	Cohen, NM; Kenigsberg, E; Tanay, A				Cohen, Netta Mendelson; Kenigsberg, Ephraim; Tanay, Amos			Primate CpG Islands Are Maintained by Heterogeneous Evolutionary Regimes Involving Minimal Selection	CELL			English	Article							BIASED GENE CONVERSION; DIFFERENTIALLY METHYLATED REGIONS; PLURIPOTENT STEM-CELLS; DNA METHYLATION; HUMAN GENOME; BINDING SITES; HYPERMETHYLATION; PATTERNS; FREQUENCIES; SEQUENCES	Mammalian CpG islands are key epigenomic elements that were first characterized experimentally as genomic fractions with low levels of DNA methylation. Currently, CpG islands are defined based on their genomic sequences alone. Here, we develop evolutionary models to show that several distinct evolutionary processes generate and maintain CpG islands. One central evolutionary regime resulting in enriched CpG content is driven by low levels of DNA methylation and consequentially low rates of CpG deamination. Another major force forming CpG islands is biased gene conversion that stabilizes constitutively methylated CpG islands by balancing rapid deamination with CpG fixation. Importantly, evolutionary analysis and population genetics data suggest that selection for high CpG content is not a significant factor contributing to conservation of CpGs in differentially methylated regions. The heterogeneous, but not selective, origins of CpG islands have direct implications for the understanding of DNA methylation patterns in healthy and diseased cells.	[Cohen, Netta Mendelson; Kenigsberg, Ephraim; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il	Kenigsberg, Ephraim/AAM-5690-2020		Israeli Science foundation [1372/08]; EU EPIGENESYS NoE	Israeli Science foundation(Israel Science Foundation); EU EPIGENESYS NoE	We'd like to thank members of the Tanay group for discussions and critical reading of the manuscript. A. T. wishes to thank Tim Bestor, Peter Jones, and Einav Nili Gal-Yam for discussions. Research in A.T.'s lab was supported by the Israeli Science foundation (1372/08) and the EU EPIGENESYS NoE program.	Arndt PF, 2007, GENE, V390, P75, DOI 10.1016/j.gene.2006.11.022; Baele G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-244; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; Cohen NM, 2009, GENOME RES, V19, P2193, DOI 10.1101/gr.096685.109; Cohn I, 2010, J MACH LEARN RES, V11, P2745; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Galtier N, 2001, GENETICS, V159, P907; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jorgensen HF, 2002, MENT RETARD DEV D R, V8, P87, DOI 10.1002/mrdd.10021; Kenigsberg E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001039; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KSCHISCHANG FR, 2001, IEEE T INFORM THEORY, V47, P21; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	39	104	104	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					773	786		10.1016/j.cell.2011.04.024	http://dx.doi.org/10.1016/j.cell.2011.04.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620139	Bronze			2022-12-01	WOS:000291018600016
J	Rios, AC; Serralbo, O; Salgado, D; Marcelle, C				Rios, Anne C.; Serralbo, Olivier; Salgado, David; Marcelle, Christophe			Neural crest regulates myogenesis through the transient activation of NOTCH	NATURE			English	Article							DERMOMYOTOME DORSOMEDIAL LIP; PROGENITOR CELLS; GENE-EXPRESSION; MUSCLE; DIFFERENTIATION; MAINTENANCE; POPULATION; INHIBITION; MOVEMENTS; MECHANISM	How dynamic signalling and extensive tissue rearrangements interact to generate complex patterns and shapes during embryogenesis is poorly understood(1-3). Here we characterize the signalling events taking place during early morphogenesis of chick skeletal muscles. We show that muscle progenitors present in somites require the transient activation of NOTCH signalling to undergo terminal differentiation. The NOTCH ligand Delta1 is expressed in a mosaic pattern in neural crest cells that migrate past the somites. Gain and loss of Delta1 function in neural crest modifies NOTCH signalling in somites, which results in delayed or premature myogenesis. Our results indicate that the neural crest regulates early muscle formation by a unique mechanism that relies on the migration of Delta1-expressing neural crest cells to trigger the transient activation of NOTCH signalling in selected muscle progenitors. This dynamic signalling guarantees a balanced and progressive differentiation of the muscle progenitor pool.	[Rios, Anne C.; Serralbo, Olivier; Salgado, David; Marcelle, Christophe] Monash Univ, EMBL Australia, Clayton, Vic 3800, Australia; [Rios, Anne C.; Serralbo, Olivier; Salgado, David; Marcelle, Christophe] Monash Univ, ARMI, Clayton, Vic 3800, Australia	European Molecular Biology Laboratory (EMBL); Monash University; Australian Regenerative Medicine Institute; Monash University	Marcelle, C (corresponding author), Monash Univ, EMBL Australia, Bldg 75, Clayton, Vic 3800, Australia.	christophe.marcelle@monash.edu	SALGADO, David/A-1417-2014	Salgado, David/0000-0002-5905-3591; Rios, Anne/0000-0002-9082-8068; Serralbo, Olivier/0000-0003-0808-3464	Agence Nationale pour le Recherche (ANR); EU	Agence Nationale pour le Recherche (ANR)(French National Research Agency (ANR)); EU(European Commission)	We thank N. Rosenthal and P. Currie for critical reading of the manuscript. This study was funded by grants from the Agence Nationale pour le Recherche (ANR), and by the EU 6th Framework Programme Network of Excellence MYORES. The help of P. Weber, S. Firth, C. Johnson and I. Harper from Imaging Facilities (IBDML, Marseille and MMI, Monash University) is acknowledged.	Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Cinnamon Y, 1999, DEVELOPMENT, V126, P4305; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Denetclaw WF, 2001, DEVELOPMENT, V128, P1745; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Henrique D, 1997, GENE DEV, V11, P603, DOI 10.1101/gad.11.5.603; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kahane N, 2002, DEVELOPMENT, V129, P2675; Kahane N, 1998, DEVELOPMENT, V125, P4259; Kahane N, 2001, DEVELOPMENT, V128, P2187; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Marcelle C, 1997, DEVELOPMENT, V124, P3955; MAXWELL IH, 1986, CANCER RES, V46, P4660; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rios AC, 2010, DEV DYNAM, V239, P346, DOI 10.1002/dvdy.22174; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Tobiume M, 2002, J VIROL, V76, P5959, DOI 10.1128/JVI.76.12.5959-5965.2002; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Venters SJ, 2002, DEVELOPMENT, V129, P3873; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727	41	111	112	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					532	U279		10.1038/nature09970	http://dx.doi.org/10.1038/nature09970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21572437				2022-12-01	WOS:000290951300045
J	Treasure, T; Hasan, A; Yacoub, M				Treasure, Tom; Hasan, Asif; Yacoub, Magdi			Is there a risk in avoiding risk for younger patients with aortic valve disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ROOT REPLACEMENT; ROSS PROCEDURE; HEART-VALVES; OUTCOMES; DURABILITY; AUTOGRAFT; SURVIVAL; MODELS; AGE		[Treasure, Tom] UCL, Dept Math, Clin Operat Res Unit, London WC1H 0BT, England; [Hasan, Asif] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Yacoub, Magdi] Harefield Hosp, Heart Sci Ctr, Harefield UB9 6JH, Middx, England	University of London; University College London; Newcastle Freeman Hospital; Newcastle University - UK; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Treasure, T (corresponding author), UCL, Dept Math, Clin Operat Res Unit, London WC1H 0BT, England.	tom.treasure@gmail.com						Banbury MK, 2001, ANN THORAC SURG, V72, P753, DOI 10.1016/S0003-4975(01)02992-7; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Bridgewater B, 2009, 6 NATL ADULT CARDIAC; El-Hamamsy I, 2010, LANCET, V376, P524, DOI 10.1016/S0140-6736(10)60828-8; El-Hamamsy I, 2010, J AM COLL CARDIOL, V55, P368, DOI 10.1016/j.jacc.2009.09.030; Hasan A, 2000, BRIT MED J, V320, P171, DOI 10.1136/bmj.320.7228.171; Hirsh J, 2009, LANCET, V374, P273, DOI 10.1016/S0140-6736(09)60787-X; Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7; Mokhles MM, 2011, CIRCULATION, V123, P31, DOI 10.1161/CIRCULATIONAHA.110.947341; Murday AJ, 2003, ANN THORAC SURG, V76, P66, DOI 10.1016/S0003-4975(03)00118-8; ROSS DN, 1967, LANCET, V2, P956; Royston G, 1999, BMJ-BRIT MED J, V318, P360; Society for Cardiothoracic Surgery in Great Britain and Ireland, 2011, CARD SURG DAT; Stoica S, 2010, HEART, V96, P1730, DOI 10.1136/hrt.2010.201939; Takkenberg JJM, 2004, J AM COLL CARDIOL, V44, P1142, DOI 10.1016/j.jacc.2004.06.010; Takkenberg JJM, 2003, ANN THORAC SURG, V75, P1372, DOI 10.1016/S0003-4975(02)04996-2; Takkenberg JJM, 2010, HEART, V96, P1691, DOI 10.1136/hrt.2010.207050; Takkenberg JJM, 2009, CIRCULATION, V119, P222, DOI 10.1161/CIRCULATIONAHA.107.726349; TREASURE T, 1990, LANCET, V336, P1115, DOI 10.1016/0140-6736(90)92583-4; TREASURE T, 1994, LANCET, V343, P1308, DOI 10.1016/S0140-6736(94)92463-5; Vink R, 2003, J AM COLL CARDIOL, V42, P2042, DOI 10.1016/j.jacc.2003.07.029	21	24	24	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2011	342								d2466	10.1136/bmj.d2466	http://dx.doi.org/10.1136/bmj.d2466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KG	21622509				2022-12-01	WOS:000291155000001
J	Innocenti, P; Morrow, EH; Dowling, DK				Innocenti, Paolo; Morrow, Edward H.; Dowling, Damian K.			Experimental Evidence Supports a Sex-Specific Selective Sieve in Mitochondrial Genome Evolution	SCIENCE			English	Article							POPULATION VIABILITY; MALE-STERILITY; MOTHERS CURSE; NUCLEAR; GENES; CONSEQUENCES; INHERITANCE; MUTATIONS; WOLBACHIA; CONFLICT	Mitochondria are maternally transmitted; hence, their genome can only make a direct and adaptive response to selection through females, whereas males represent an evolutionary dead end. In theory, this creates a sex-specific selective sieve, enabling deleterious mutations to accumulate in mitochondrial genomes if they exert male-specific effects. We tested this hypothesis, expressing five mitochondrial variants alongside a standard nuclear genome in Drosophila melanogaster, and found striking sexual asymmetry in patterns of nuclear gene expression. Mitochondrial polymorphism had few effects on nuclear gene expression in females but major effects in males, modifying nearly 10% of transcripts. These were mostly male-biased in expression, with enrichment hotspots in the testes and accessory glands. Our results suggest an evolutionary mechanism that results in mitochondrial genomes harboring male-specific mutation loads.	[Dowling, Damian K.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Innocenti, Paolo; Morrow, Edward H.] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, S-75236 Uppsala, Sweden	Monash University; Uppsala University	Dowling, DK (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.	damian.dowling@monash.edu	Morrow, Edward/C-2358-2011; Morrow, Edward H/Q-6730-2019; Dowling, Damian/C-9016-2009	Morrow, Edward/0000-0002-1853-7469; Morrow, Edward H/0000-0002-1853-7469; Dowling, Damian/0000-0003-2209-3458; Innocenti, Paolo/0000-0003-2082-0586	Australian Research Council [DP1092897]; Monash University; Swedish Research Council [2008-5533]	Australian Research Council(Australian Research Council); Monash University(Monash University); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by grants from the Australian Research Council (Discovery Project and Australian Research Fellowship, number DP1092897) and Monash University to D. K. D.; P. I. and E. H. M. were supported by the Swedish Research Council (grant 2008-5533 to E. H. M.). We thank D. Clancy for fly strains; U. Friberg for discussion; M. Norgate for sequencing; G. Arnqvist, U. Friberg, and J. Abbott for comments on the manuscript; and the Uppsala Array Platform. Microarray data have been deposited on the Gene Expression Omnibus database, accession no. GSE24729.	ADAMS MD, 2000, Insect Mol Biol, V287, P263; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x; Dowling DK, 2007, J EVOLUTION BIOL, V20, P358, DOI 10.1111/j.1420-9101.2006.01189.x; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Dowling DK, 2010, AM NAT, V176, P131, DOI 10.1086/653671; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Gemmell NJ, 2001, TRENDS ECOL EVOL, V16, P115, DOI 10.1016/S0169-5347(00)02087-5; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834; Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Rhoades MM, 1931, SCIENCE, V73, P340, DOI 10.1126/science.73.1891.340; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Smith S, 2010, MOL ECOL, V19, P36, DOI 10.1111/j.1365-294X.2009.04444.x; de Moraes VCS, 2009, BIOCHEM BIOPH RES CO, V381, P210, DOI 10.1016/j.bbrc.2009.02.014; Wade MJ, 2009, EVOLUTION, V63, P1084, DOI 10.1111/j.1558-5646.2009.00614.x; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Zeh JA, 2005, TRENDS GENET, V21, P281, DOI 10.1016/j.tig.2005.03.006	27	196	199	5	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					845	848		10.1126/science.1201157	http://dx.doi.org/10.1126/science.1201157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566193				2022-12-01	WOS:000290529900047
J	Wagner, DE; Wang, IE; Reddien, PW				Wagner, Daniel E.; Wang, Irving E.; Reddien, Peter W.			Clonogenic Neoblasts Are Pluripotent Adult Stem Cells That Underlie Planarian Regeneration	SCIENCE			English	Article							SCHMIDTEA-MEDITERRANEA; SELF-RENEWAL; MARROW-CELLS; GENE; PLASTICITY; PROTEIN; DIFFERENTIATION; IDENTIFICATION; REPOPULATION; CULTURE	Pluripotent cells in the embryo can generate all cell types, but lineage-restricted cells are generally thought to replenish adult tissues. Planarians are flatworms and regenerate from tiny body fragments, a process requiring a population of proliferating cells (neoblasts). Whether regeneration is accomplished by pluripotent cells or by the collective activity of multiple lineage-restricted cell types is unknown. We used ionizing radiation and single-cell transplantation to identify neoblasts that can form large descendant-cell colonies in vivo. These clonogenic neoblasts (cNeoblasts) produce cells that differentiate into neuronal, intestinal, and other known postmitotic cell types and are distributed throughout the body. Single transplanted cNeoblasts restored regeneration in lethally irradiated hosts. We conclude that broadly distributed, adult pluripotent stem cells underlie the remarkable regenerative abilities of planarians.	[Wagner, Daniel E.; Wang, Irving E.; Reddien, Peter W.] MIT, Dept Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Wagner, DE (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu		/0000-0002-5569-333X; Wagner, Daniel/0000-0002-2983-635X	NIH [R01GM080639]; Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kim for manuscript comments; S. Lapan for neuronal and intestinal markers; M. Srivastava for phylogenetics advice; D. Wenemoser for SMEDWI-1 antibody purification; J. Owen for Illumina data; M. Griffin for flow cytometry assistance; and P. Hsu, G. Bell, R. Young, and all members of the Reddien Lab for extensive comments and discussion. P. W. R. is an early career scientist of the Howard Hughes Medical Institute and an associate member of the Broad Institute of Harvard and MIT. We acknowledge support from the NIH (grant R01GM080639) and the Keck Foundation.	BAGUNA J, 1976, J EXP ZOOL, V195, P53, DOI 10.1002/jez.1401950106; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Bardeen CR, 1904, J EXP ZOOL, V1, P191, DOI 10.1002/jez.1400010107; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Dubois F, 1949, B BIOL FR BELG, V83, P213; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EVANS MJ, 1972, J EMBRYOL EXP MORPH, V28, P163; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hewitson Tim D, 2006, Methods Mol Biol, V326, P219; Keller J, 1894, JEN Z NATURW, V28, P370; LANGE CS, 1968, INT J RADIAT BIOL RE, V14, P373, DOI 10.1080/09553006814551221; LENDER T, 1965, CR HEBD ACAD SCI, V260, P4095; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Nishimura K, 2010, NEUROSCIENCE, V168, P18, DOI 10.1016/j.neuroscience.2010.03.038; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Salvetti A, 2009, DEV BIOL, V328, P305, DOI 10.1016/j.ydbio.2009.01.029; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; WOLFF ETIENNE, 1948, REV SUISSE ZOOL, V55, P218	37	407	423	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					811	816		10.1126/science.1203983	http://dx.doi.org/10.1126/science.1203983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566185	Green Published, Green Accepted			2022-12-01	WOS:000290529900038
J	Kondrashov, N; Pusic, A; Stumpf, CR; Shimizu, K; Hsieh, AC; Xue, SF; Ishijima, J; Shiroishi, T; Barna, M				Kondrashov, Nadya; Pusic, Aya; Stumpf, Craig R.; Shimizu, Kunihiko; Hsieh, Andrew C.; Xue, Shifeng; Ishijima, Junko; Shiroishi, Toshihiko; Barna, Maria			Ribosome-Mediated Specificity in Hox mRNA Translation and Vertebrate Tissue Patterning	CELL			English	Article							AXIAL SKELETON; HOMEOBOX GENES; RETINOIC ACID; MOUSE; INITIATION; ACTIVATION; MUTATION; PROTEINS; IDENTITY; SUBUNIT	Historically, the ribosome has been viewed as a complex ribozyme with constitutive rather than regulatory capacity in mRNA translation. Here we identify mutations of the Ribosomal Protein L38 (Rpl38) gene in mice exhibiting surprising tissue-specific patterning defects, including pronounced homeotic transformations of the axial skeleton. In Rpl38 mutant embryos, global protein synthesis is unchanged; however the translation of a select subset of Homeobox mRNAs is perturbed. Our data reveal that RPL38 facilitates 80S complex formation on these mRNAs as a regulatory component of the ribosome to confer transcript-specific translational control. We further show that Rpl38 expression is markedly enriched in regions of the embryo where loss-of-function phenotypes occur. Unexpectedly, a ribosomal protein (RP) expression screen reveals dynamic regulation of individual RPs within the vertebrate embryo. Collectively, these findings suggest that RP activity may be highly regulated to impart a new layer of specificity in the control of gene expression and mammalian development.	[Kondrashov, Nadya; Pusic, Aya; Stumpf, Craig R.; Hsieh, Andrew C.; Xue, Shifeng; Barna, Maria] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Hsieh, Andrew C.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94158 USA; [Shimizu, Kunihiko] Nihon Univ, Dept Pediat Dent, Sch Dent Matsudo, Chiba 2718587, Japan; [Shimizu, Kunihiko; Ishijima, Junko; Shiroishi, Toshihiko] Natl Inst Genet, Mammalian Genet Lab, Mishima, Shizuoka 4118540, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nihon University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Barna, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	maria.barna@ucsf.edu	Stumpf, Craig/B-8703-2014	Stumpf, Craig/0000-0002-9946-8986; Xue, Shifeng/0000-0002-4668-5952	NICHD; UCSF; March of Dimes Basil O'Connor Scholar Research Award; MEXT, Japan; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008509] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UCSF; March of Dimes Basil O'Connor Scholar Research Award(March of Dimes); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are very grateful to Dr. Davide Ruggero for helpful discussions and CMV-HCV-IRES transgenic mice. We thank Katrina Cabaltera for technical assistance; Dr. Gail Martin and members of her lab, Drs. Davide Ruggero, Tom Kornberg, and Ross Metzger for critical reading of the manuscript; Drs. Rudi Balling and Toshio Uchiumi for discussion and comments; Dr. Lee Niswander for helpful discussions on neural tube patterning; Drs. Jens Schuster and Cristina Al-Khalili Szigyarto for the RPL38 antibody; and Dr. Lucie Jeannotte for the Hoxa5 antibody. We are grateful to Dr. Jean-Louis Guenet for providing Rbt and Dr. Tsutomu Hirasawa for providing Tss; Dr. Catherine Kirn-Safran for Rpl29<SUP>+/-</SUP> mice; Dr. Greg Barsh for Rps19<SUP>DSK3/+</SUP> and Rps20<SUP>DSK4/+</SUP> mice. The monoclonal antibodies against Shh, Nkx2.2, Isl1, Pax6, and Pax7 were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA, USA. This work was supported by the Program for Breakthrough Biomedical Research, UCSF (M.B.), the March of Dimes Basil O'Connor Scholar Research Award (M.B.), and Special coordination funds for promoting Science and Technology from the MEXT, Japan (T.S.).	Agmon I, 2009, INT J MOL SCI, V10, P2921, DOI 10.3390/ijms10072921; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; BURKE AC, 1995, DEVELOPMENT, V121, P333; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; DEOL MS, 1961, PROC R SOC SER B-BIO, V155, P78, DOI 10.1098/rspb.1961.0058; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; HORAN GSB, 1994, P NATL ACAD SCI USA, V91, P12644, DOI 10.1073/pnas.91.26.12644; Hustert E, 1996, MAMM GENOME, V7, P881, DOI 10.1007/s003359900261; Iimura T, 2009, CURR TOP DEV BIOL, V88, P201, DOI 10.1016/S0070-2153(09)88007-1; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Juan AH, 2003, DEVELOPMENT, V130, P4823, DOI 10.1242/dev.00672; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; LABORATORY CSH, 2002, RIBOSOME, V66; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; Lipton JM, 2010, CURR OPIN PEDIATR, V22, P12, DOI 10.1097/MOP.0b013e328334573b; Mauro VP, 2007, CELL CYCLE, V6, P2246, DOI 10.4161/cc.6.18.4739; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; MORGAN WC, 1950, J HERED, V41, P208, DOI 10.1093/oxfordjournals.jhered.a106131; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; OH SK, 1992, GENE DEV, V6, P1643, DOI 10.1101/gad.6.9.1643; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Oristian DS, 2009, J ORTHOP RES, V27, P28, DOI 10.1002/jor.20706; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; RAMAGOPAL S, 1992, BIOCHEM CELL BIOL, V70, P738, DOI 10.1139/o92-113; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Sagliocco F A, 1996, Methods Mol Biol, V53, P297; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; Tsukahara K, 2000, EXP ANIM TOKYO, V49, P131, DOI 10.1538/expanim.49.131; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Ye X, 1997, MOL CELL BIOL, V17, P1714, DOI 10.1128/MCB.17.3.1714; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; ZAPPAVIGNA V, 1991, EMBO J, V10, P4177, DOI 10.1002/j.1460-2075.1991.tb04996.x; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200	65	371	377	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2011	145	3					383	397		10.1016/j.cell.2011.03.028	http://dx.doi.org/10.1016/j.cell.2011.03.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	756OO	21529712	Green Accepted, Bronze			2022-12-01	WOS:000290022900008
J	Clementz, MT; Sewall, JO				Clementz, Mark T.; Sewall, Jacob O.			Latitudinal Gradients in Greenhouse Seawater delta O-18: Evidence from Eocene Sirenian Tooth Enamel	SCIENCE			English	Article							PALAEOCENE/EOCENE THERMAL MAXIMUM; STABLE-ISOTOPE ANALYSIS; MIDDLE EOCENE; TEMPERATURES; REGION; WATER	The Eocene greenhouse climate state has been linked to a more vigorous hydrologic cycle at mid-and high latitudes; similar information on precipitation levels at low latitudes is, however, limited. Oxygen isotopic fluxes track moisture fluxes and, thus, the delta O-18 values of ocean surface waters can provide insight into hydrologic cycle changes. The offset between tropical d18O values from sampled Eocene sirenian tooth enamel and modern surface waters is greater than the expected 1.0 per mil increase due to increased continental ice volume. This increased offset could result from suppression of surface-water delta O-18 values by a tropical, annual moisture balance substantially wetter than that of today. Results from an atmospheric general circulation model support this interpretation and suggest that Eocene low latitudes were extremely wet.	[Clementz, Mark T.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [Clementz, Mark T.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Sewall, Jacob O.] Kutztown State Univ, Dept Phys Sci, Kutztown, PA 19530 USA	University of Wyoming; University of Wyoming; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania	Clementz, MT (corresponding author), Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA.	mclemen1@uwyo.edu; sewall@kutztown.edu			American Chemical Society; NSF; Directorate For Geosciences [0847413] Funding Source: National Science Foundation	American Chemical Society(American Chemical Society); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank S. Bajpai, D. P. Domning, S. Sorbi, and the museums and institutions that made fossil specimens available for this study (a list of all institutions is provided in the SOM); P. Haselhorst and S. L. Peek for assistance with sample preparation; the University of Wyoming Stable Isotope Facility for stable isotope analyses; and E. Speelman. Funding for travel and analyses was provided by the American Chemical Society Petroleum Research Fund (M. T. C.) and the NSF (M. T. C.). Computation was supported by Virginia Tech Advanced Research Computing and the Department of Geosciences. We also thank two anonymous reviewers for critical and thoughtful comments that improved this manuscript.	[Anonymous], 1965, U RHODE ISLAND OCC P; Bice KL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000678; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Clementz MT, 2009, GEOLOGY, V37, P307, DOI 10.1130/G25533A.1; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Manabe S, 1997, AMBIO, V26, P47; McConnell MC, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002035; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Schmidt G. A., 1999, GLOBAL SEAWATER OXYG; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Speelman EN, 2010, EARTH PLANET SC LETT, V298, P57, DOI 10.1016/j.epsl.2010.07.026; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; YOSHIDA N, 1991, J GEOPHYS RES-OCEANS, V96, P815, DOI 10.1029/90JC01580; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	23	29	30	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					455	458		10.1126/science.1201182	http://dx.doi.org/10.1126/science.1201182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21512030				2022-12-01	WOS:000289784900040
J	Tronstein, E; Johnston, C; Huang, ML; Selke, S; Magaret, A; Warren, T; Corey, L; Wald, A				Tronstein, Elizabeth; Johnston, Christine; Huang, Meei-Li; Selke, Stacy; Magaret, Amalia; Warren, Terri; Corey, Lawrence; Wald, Anna			Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2 INFECTION; UNITED-STATES; TRANSMISSION; REACTIVATION; DNA; ACYCLOVIR; WOMEN; PREVALENCE; PREVENTION; DIAGNOSIS	Context Since herpes simplex virus type 2 (HSV-2) antibody tests have become commercially available, an increasing number of persons have learned that they have genital herpes through serologic testing. The course of natural history of HSV-2 in asymptomatic, seropositive persons is uncertain. Objective To evaluate the virologic and clinical course of HSV genital shedding among individuals with symptomatic and asymptomatic HSV-2 infection. Design, Setting, and Participants Cohort of 498 immunocompetent HSV-2-seropositive persons enrolled in prospective studies of genital HSV shedding at the University of Washington Virology Research Clinic, Seattle, and Westover Heights Clinic, Portland, Oregon, between March 1992 and April 2008. Each participant obtained daily self-collected swabs of genital secretions for at least 30 days. Main Outcome Measure The rate of viral shedding measured by quantitative realtime fluorescence polymerase chain reaction for HSV DNA from genital swabs. Results Herpes simplex virus type 2 was detected on 4753 of 23 683 days (20.1%; 95% confidence interval [CI], 18.3%-22.0%) in 410 persons with symptomatic genital HSV-2 infection compared with 519 of 5070 days (10.2%; 95% CI, 7.7%-13.6%) in 88 persons with asymptomatic infection (P < .001). Subclinical shedding rates were higher in persons with symptomatic infection compared with asymptomatic infection (2708 of 20 735 days [13.1%; 95% CI, 11.5%-14.6%) vs 434 of 4929 days [8.8%; 95% CI, 6.3%-11.5%]) (P < .001). However, the amount of HSV detected during subclinical shedding episodes was similar (median, 4.3 [interquartile range, 3.1-5.6] log(10) copies in the symptomatic infection group vs 4.2 [interquartile range, 2.9-5.5] in the asymptomatic infection group, P=.27). Days with lesions accounted for 2045 of 4753 days (43.0%; 95% CI, 39.8%-46.5%) with genital viral shedding among persons with symptomatic genital HSV-2 infection compared with 85 of 519 days (16.4%; 95% CI, 11.2%-23.9%) among persons with asymptomatic infection (P < .001). Conclusion Persons with asymptomatic HSV-2 infection shed virus in the genital tract less frequently than persons with symptomatic infection, but much of the difference is attributable to less frequent genital lesions because lesions are accompanied by frequent viral shedding. JAMA. 2011;305(14):1441-1449 www.jama.com	[Wald, Anna] Univ Washington, Virol Res Clin, Dept Med, Seattle, WA 98104 USA; [Huang, Meei-Li; Selke, Stacy; Magaret, Amalia; Corey, Lawrence; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Johnston, Christine; Huang, Meei-Li; Magaret, Amalia; Corey, Lawrence; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Magaret, Amalia] Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA 98104 USA; [Warren, Terri] Westover Hts Clin, Portland, OR USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Wald, A (corresponding author), Univ Washington, Virol Res Clin, Dept Med, Box 359928,325 9th Ave, Seattle, WA 98104 USA.	annawald@u.washington.edu	Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012; Warren, Terri/AAJ-1650-2021	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Johnston, Christine/0000-0002-3073-0843	National Institutes of Health (NIH) [P01AI030731, K23AI079394, K24AI071113, R37AI042528, PO1A1030731]; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042528, K23AI079394, K24AI071113, P01AI030731] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Tronstein, Ms Selke, and Dr Huang all reported receiving research support from National Institutes of Health (NIH) P01AI030731. Dr Johnston reported receiving research support from NIH K23AI079394 and having received funding from GlaxoSmithKline and AiCuris. Dr Magaret reported receiving funding from NIH (P01AI030731 and K24AI071113) and consulting for Immune Design. Ms Warren reported having received research support from AiCuris and having served on the GlaxoSmithKline speakers' bureau. Dr Corey reported receiving research support from NIH (P01AI030731, R37AI042528) and consulting for AiCuris; he reports being listed as a coinventor on several patents describing antigens and epitopes to which T-cell responses to HSV-2 are directed (these proteins have the potential to be used in candidate vaccines against HSV), and he has received fees for serving as the head of the scientific advisory board of Immune Design, including equity shares that are less than 1% ownership. Dr Wald reported receiving research support from NIH (K24AI071113, P01AI030731) and GlaxoSmithKline and consulting for AiCuris.; This work was supported by NIH grants PO1A1030731 and K24 AI 071113.	ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Bochud PY, 2007, J INFECT DIS, V196, P505, DOI 10.1086/519693; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; CONE RW, 1994, JAMA-J AM MED ASSOC, V272, P792, DOI 10.1001/jama.272.10.792; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; COREY L, 1983, ANN INTERN MED, V98, P973, DOI 10.7326/0003-4819-98-6-973; COWAN FM, 1994, BRIT MED J, V309, P1325, DOI 10.1136/bmj.309.6965.1325; Diggle P. J., 2002, J R STAT SOC, V2nd, DOI DOI 10.2307/2983303; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Guerry SL, 2005, CLIN INFECT DIS, V40, P38, DOI 10.1086/426438; Leone P, 2010, CURR MED RES OPIN, V26, P653, DOI 10.1185/03007990903554471; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Magaret AS, 2009, SEX TRANSM INFECT, V85, P270, DOI 10.1136/sti.2008.034751; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Melville J, 2003, SEX TRANSM INFECT, V79, P280, DOI 10.1136/sti.79.4.280; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Mertz GJ, 2008, J INFECT DIS, V198, P1098, DOI 10.1086/591914; Mertz KJ, 1998, J INFECT DIS, V178, P1795, DOI 10.1086/314502; Phipps W, 2011, J INFECT DIS, V203, P180, DOI 10.1093/infdis/jiq035; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Sucato G, 1998, J INFECT DIS, V177, P1069, DOI 10.1086/515261; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	34	181	189	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1441	1449		10.1001/jama.2011.420	http://dx.doi.org/10.1001/jama.2011.420			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21486977	Green Accepted, Bronze			2022-12-01	WOS:000289424100021
